Recursive Self-Improvement in Healthcare AI Agents. Unified search of 4 November 2026, covering January2023 through that date. Screening and extraction used large-language-model assistance against written criteria; borderline-category rules were set by the authors. Author spotchecks remain pending. The original70-record sample covers only the initial three-source cohort.
S1: (abs:%22LLM%20agent%22+OR+abs:%22LLM%20agents%22+OR+abs:%22language%20model%20agent%22+OR+abs:%22language%20model%20agents%22+OR+abs:agentic+OR+abs:multi-agent+OR+abs:agent)+AND+(abs:self-evolving+OR+abs:self-improving+OR+abs:self-improvement+OR+abs:self-evolution+OR+abs:evolvable+OR+abs:%22evolving%20agent%22+OR+abs:%22persistent%20memory%22+OR+abs:%22long-term%20memory%22+OR+abs:%22experience%20memory%22+OR+abs:%22experience%20library%22+OR+abs:%22skill%20library%22+OR+abs:%22skill%20evolution%22+OR+abs:%22continual%20learning%22+OR+abs:%22lifelong%20learning%22+OR+abs:notebook+OR+abs:reflection+OR+abs:%22online%20adaptation%22)+AND+(abs:medical+OR+abs:clinical+OR+abs:healthcare+OR+abs:radiology+OR+abs:patient+OR+abs:diagnosis+OR+abs:diagnostic)+AND+submittedDate:[202301010000+TO+202611042359]
S2: (abs:%22recursive%20self-improvement%22+OR+abs:%22recursive%20self-improving%22+OR+abs:%22recursively%20self-improving%22)+AND+(abs:medical+OR+abs:clinical+OR+abs:healthcare+OR+abs:radiology+OR+abs:patient+OR+abs:diagnosis+OR+abs:diagnostic)+AND+submittedDate:[202301010000+TO+202611042359]
Run 2026-11-04 02:30 JST; cutoff 2026-11-04; 715 records.
main: ("LLM agent"[tiab] OR "LLM agents"[tiab] OR "language model agent"[tiab] OR "language model agents"[tiab] OR agentic[tiab] OR "multi-agent"[tiab] OR agent[tiab]) AND ("self-evolving"[tiab] OR "self-improving"[tiab] OR "self-improvement"[tiab] OR "self-evolution"[tiab] OR evolvable[tiab] OR "evolving agent"[tiab] OR "persistent memory"[tiab] OR "long-term memory"[tiab] OR "experience memory"[tiab] OR "experience library"[tiab] OR "skill library"[tiab] OR "skill evolution"[tiab] OR "continual learning"[tiab] OR "lifelong learning"[tiab] OR notebook[tiab] OR reflection[tiab] OR "online adaptation"[tiab]) AND (medical[tiab] OR clinical[tiab] OR healthcare[tiab] OR radiology[tiab] OR patient[tiab] OR diagnosis[tiab] OR diagnostic[tiab]) AND 2023/01/01:2026/11/04[dp]
rsi: ("recursive self-improvement"[tiab] OR "recursive self-improving"[tiab] OR "recursively self-improving"[tiab]) AND (medical[tiab] OR clinical[tiab] OR healthcare[tiab] OR radiology[tiab] OR patient[tiab] OR diagnosis[tiab] OR diagnostic[tiab]) AND 2023/01/01:2026/11/04[dp]
Run 2026-11-04 02:30 JST; cutoff 2026-11-04; 76 records.
S1: (TITLE:"large language model" OR TITLE:"large language models" OR TITLE:"LLM agent" OR TITLE:"LLM agents" OR TITLE:"language model agent" OR TITLE:agentic OR TITLE:"multi-agent" OR ABSTRACT:"large language model" OR ABSTRACT:"large language models" OR ABSTRACT:"LLM agent" OR ABSTRACT:"LLM agents" OR ABSTRACT:"language model agent" OR ABSTRACT:agentic OR ABSTRACT:"multi-agent") AND (TITLE:"self-evolving" OR TITLE:"self-improving" OR TITLE:"self-improvement" OR TITLE:"self-evolution" OR TITLE:evolvable OR TITLE:"evolving agent" OR TITLE:"persistent memory" OR TITLE:"long-term memory" OR TITLE:"experience memory" OR TITLE:"experience library" OR TITLE:"skill library" OR TITLE:"skill evolution" OR TITLE:"continual learning" OR TITLE:"lifelong learning" OR TITLE:notebook OR TITLE:reflection OR TITLE:"online adaptation" OR ABSTRACT:"self-evolving" OR ABSTRACT:"self-improving" OR ABSTRACT:"self-improvement" OR ABSTRACT:"self-evolution" OR ABSTRACT:evolvable OR ABSTRACT:"evolving agent" OR ABSTRACT:"persistent memory" OR ABSTRACT:"long-term memory" OR ABSTRACT:"experience memory" OR ABSTRACT:"experience library" OR ABSTRACT:"skill library" OR ABSTRACT:"skill evolution" OR ABSTRACT:"continual learning" OR ABSTRACT:"lifelong learning" OR ABSTRACT:notebook OR ABSTRACT:reflection OR ABSTRACT:"online adaptation") AND (TITLE:medical OR TITLE:clinical OR TITLE:healthcare OR TITLE:radiology OR TITLE:patient OR TITLE:diagnosis OR TITLE:diagnostic OR ABSTRACT:medical OR ABSTRACT:clinical OR ABSTRACT:healthcare OR ABSTRACT:radiology OR ABSTRACT:patient OR ABSTRACT:diagnosis OR ABSTRACT:diagnostic) AND FIRST_PDATE:[2023-01-01 TO 2026-11-04]
S2: (TITLE:"recursive self-improvement" OR TITLE:"recursive self-improving" OR TITLE:"recursively self-improving" OR ABSTRACT:"recursive self-improvement" OR ABSTRACT:"recursive self-improving" OR ABSTRACT:"recursively self-improving") AND (TITLE:medical OR TITLE:clinical OR TITLE:healthcare OR TITLE:radiology OR TITLE:patient OR TITLE:diagnosis OR TITLE:diagnostic OR ABSTRACT:medical OR ABSTRACT:clinical OR ABSTRACT:healthcare OR ABSTRACT:radiology OR ABSTRACT:patient OR ABSTRACT:diagnosis OR ABSTRACT:diagnostic) AND FIRST_PDATE:[2023-01-01 TO 2026-11-04]
Run 2026-11-04 02:44 JST; cutoff 2026-11-04; 148 records.
Scope title_and_abstract.search; publication_date 2023-01-01 through 2026-11-04. S1 returned10,627 and S2 returned56, with31 in common, giving10,652 distinct IDs. The59 IDs missed by relevance cursor pagination were recovered by disjoint calendar-year enumeration and exact-ID reconciliation. Date scope, vocabulary and eligibility rules were unchanged.
S1 ("LLM agent" OR "LLM agents" OR "language model agent" OR "language model agents" OR "agentic" OR "multi-agent" OR "agent") AND ("self-evolving" OR "self-improving" OR "self-improvement" OR "self-evolution" OR "evolvable" OR "evolving agent" OR "persistent memory" OR "long-term memory" OR "experience memory" OR "experience library" OR "skill library" OR "skill evolution" OR "continual learning" OR "lifelong learning" OR "notebook" OR "reflection" OR "online adaptation") AND ("medical" OR "clinical" OR "healthcare" OR "radiology" OR "patient" OR "diagnosis" OR "diagnostic")
S2 ("recursive self-improvement" OR "recursive self-improving" OR "recursively self-improving") AND ("medical" OR "clinical" OR "healthcare" OR "radiology" OR "patient" OR "diagnosis" OR "diagnostic")
11,622 raw query hits;10,720 unique records;902 duplicates.33 records matched31 previously charted studies.10,687 records were screened and210 entered the full-text stage.52 studies were included and158 excluded, including13 primary reports not obtained and2 author-approved reporting-quality exclusions during revision. The85-study map combines31 re-confirmed studies,52 new inclusions (34 initial;18 OpenAlex), and2 purposive comparators. Previous decisions and revision reasons are retained in the records.
F1 non-primary research; F2 healthcare not the primary focus; F3 not an LLM acting agent; F4 no retained cross-case experience under the written rules; F5 primary report not obtained; F6 duplicate of an already included study. Actual primary-report access outcomes are retained individually. F7 denotes an author-approved reporting-quality exclusion made during manuscript revision; previous decisions are preserved. No aggregate reporting-quality score is used.
| id | title | date | sources | arxiv | doi | stage | outcome | reason | openalex_ids | source_used | source_completeness |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Artifacts and Technical Considerations at Contrast-enhanced US. | 2023 | PubMed | 10.1148/rg.220093 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 2 | From eye-blinks to state construction: Diagnostic benchmarks for online representation learning. | 2023 | PubMed | 10.1177/10597123221085039 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; non-clinical ML or agent work. | ||||
| 3 | Towards trust-based governance of health data research. | 2023 | EuropePMC; PubMed | 10.1007/s11019-022-10134-8 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 4 | Application of anti-Xa assay in monitoring unfractionated heparin therapy in contemporary antithrombotic management. | 2023 | PubMed | 10.1080/17474086.2023.2169126 | Title/abstract | Excluded | Not primary research: Clinical pharmacology review of anti-Xa monitoring; not an agent study. | ||||
| 5 | Integration of Silica Nanorattles with Manganese-Doped In 2 S 3 /InOOH to Enable Ultrasound-Mediated Tumor Theranostics. | 2023 | PubMed | 10.1021/acsami.2c18095 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 6 | [End of life and cancer: Understanding the ethical issues of voluntary assisted dying]. | 2023 | PubMed | 10.1016/j.bulcan.2023.01.005 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 7 | A label-free electrochemical immunosensor based on 11-mercaptoundecanoic acid grafted chitosan and poly(N-methylaniline) for the detection of carcinoembryonic antigen. | 2023 | PubMed | 10.1016/j.bioelechem.2023.108446 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 8 | [Artificial Intelligence in Medicine. Ethical reflections from the thought of Edmund Pellegrino]. | 2023 | PubMed | 10.30444/cb.140 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 9 | Root coverage with apical tunnel approach using propolis as a root conditioning agent: A case report with 2-year follow-up and review of the literature. | 2023 | PubMed | 10.1002/cre2.751 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 10 | [Understanding the mode of transmission of malaria agents: an astonishing series of hypotheses, observations, research and controversy]. | 2023 | PubMed | 10.48327/mtsi.v3i1.2023.312 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 11 | Aesthetic Attitude Based on Kant's Aesthetics of Caring Relationships in Nursing. | 2023 | PubMed | 10.3390/healthcare11162324 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 12 | Impact of Targeting Moiety Type and Protein Corona Formation on the Uptake of Fn14-Targeted Nanoparticles by Cancer Cells. | 2023 | PubMed | 10.1021/acsnano.3c02575 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 13 | Bactericidal Activity of Silver-Doped Chitosan Coatings via Electrophoretic Deposition on Ti 6 Al 4 V Additively Manufactured Substrates. | 2023 | PubMed | 10.3390/polym15204130 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 14 | Same Pathogen, Different Manifestations: A Case of Extrapulmonary Tuberculosis. | 2023 | PubMed | 10.7759/cureus.50436 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 15 | Reinforced Labels: Multi-Agent Deep Reinforcement Learning for Point-Feature Label Placement | 2023-03-02 | arXiv | 2303.01388 | 10.1109/tvcg.2023.3313729 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; non-clinical ML or agent work. | |||
| 16 | Towards Explainable and Safe Conversational Agents for Mental Health: A Survey | 2023-04-25 | arXiv | 2304.13191 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 17 | A Domain-Independent Agent Architecture for Adaptive Operation in Evolving Open Worlds | 2023-06-09 | arXiv | 2306.06272 | 10.1016/j.artint.2024.104161 | Title/abstract | Excluded | Not healthcare or clinical: Non-LLM, non-healthcare agent or RL system. | |||
| 18 | SMARLA: A Safety Monitoring Approach for Deep Reinforcement Learning Agents | 2023-08-03 | arXiv | 2308.02594 | 10.1109/tse.2024.3491496 | Title/abstract | Excluded | Not healthcare or clinical: Non-LLM, non-healthcare agent or RL system. | |||
| 19 | Who is ChatGPT? Benchmarking LLMs' Psychological Portrayal Using PsychoBench | 2023-10-02 | arXiv | 2310.01386 | Title/abstract | Excluded | Not primary research: Psychological benchmark of LLMs; systems do not adapt. | ||||
| 20 | Reinforcement learning in large, structured action spaces: A simulation study of decision support for spinal cord injury rehabilitation | 2023-10-23 | arXiv | 2310.14976 | Title/abstract | Excluded | Not an LLM agent: Non-LLM method (RL, federated or imaging model). | ||||
| 21 | Visually Grounded Continual Language Learning with Selective Specialization | 2023-10-24 | arXiv | 2310.15571 | 10.18653/v1/2023.findings-emnlp.469 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; non-clinical ML or agent work. | |||
| 22 | A Multilingual Virtual Guide for Self-Attachment Technique | 2023-10-25 | arXiv | 2310.18366 | 10.1109/cogmi56440.2022.00025 | Title/abstract | Excluded | Not an LLM agent: Conversational agent not LLM-agent; no persistent improvement from experience. | |||
| 23 | Towards AI-assisted cardiology: a reflection on the performance and limitations of using large language models in clinical decision-making. | 2023-12-04 | EuropePMC | 10.4244/eij-d-23-00461 | Title/abstract | Excluded | Not primary research: No abstract; commentary on LLM limitations in cardiology. | ||||
| 24 | AVA: Towards Autonomous Visualization Agents through Visual Perception-Driven Decision-Making | 2023-12-07 | arXiv | 2312.04494 | Title/abstract | Excluded | Not healthcare or clinical: Non-healthcare LLM agent (visualization or charts). | ||||
| 25 | [Significance of natural language processing and chat-based generative language models]. | 2023-12-18 | EuropePMC | 10.1007/s00063-023-01098-5 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 26 | Credentialing Character: A Virtue Ethics Approach to Professionalizing Healthcare Ethics Consultation Services. | 2024 | PubMed | 10.1007/s10730-023-09505-2 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 27 | A coupling, stabilizing, and shaping strategy for breast ultrasound computed tomography (USCT) with a ring array transducer. | 2024 | PubMed | 10.1016/j.ultras.2023.107212 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 28 | Pharmacotherapy for leptomeningeal disease in breast cancer. | 2024 | PubMed | 10.1016/j.ctrv.2023.102653 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 29 | Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer's disease. | 2024 | PubMed | 10.1186/s40035-023-00388-4 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 30 | Construction of a Tumor-Targeting Nanobubble with Multiple Scattering Interfaces and its Enhancement of Ultrasound Imaging. | 2024 | PubMed | 10.2147/ijn.s462917 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 31 | Subjective Experience and Perceived Benefits in Clients with Schizophrenia Following Participation in Metacognition Reflection and Insight Therapy (MERIT). | 2024 | PubMed | 10.3390/bs14060450 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 32 | Decoding the Reference Letter: Strategies to Reduce Unintentional Gender Bias in Letters of Recommendation. | 2024 | EuropePMC; PubMed | 10.15766/mep_2374-8265.11419 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 33 | Artificial Intelligent Agent Architecture and Clinical Decision-Making in the Healthcare Sector. | 2024 | PubMed | 10.7759/cureus.64115 | Title/abstract | Excluded | Not primary research: Theoretical overview of agent architectures; not a primary study. | ||||
| 34 | Intrathecal ziconotide for the treatment of chronic pain: a collection of clinical experiences and literature review. | 2024 | PubMed | 10.26355/eurrev_202408_36640 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 35 | Lawsonia intracellularis regulates nuclear factor-κB signalling pathway during infection. | 2024 | PubMed | 10.1371/journal.pone.0310804 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 36 | EHRAgent: Code Empowers Large Language Models for Few-shot Complex Tabular Reasoning on Electronic Health Records | 2024-01-13 | arXiv | 2401.07128 | Full text | Included | shi2024ehragent | ||||
| 37 | Peer review of GPT-4 technical report and systems card. | 2024-01-18 | EuropePMC | 10.1371/journal.pdig.0000417 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 38 | ArgMed-Agents: Explainable Clinical Decision Reasoning with LLM Disscusion via Argumentation Schemes | 2024-03-10 | arXiv | 2403.06294 | Title/abstract | Excluded | No persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning. | ||||
| 39 | Recurrent Events Modeling Based on a Reflected Brownian Motion with Application to Hypoglycemia | 2024-03-14 | arXiv | 2403.09042 | Title/abstract | Excluded | Not an LLM agent: Non-LLM model (segmentation or statistical model). | ||||
| 40 | Generative Artificial Intelligence as a Tool for Teaching Communication in Nutrition and Dietetics Education-A Novel Education Innovation. | 2024-03-22 | EuropePMC | 10.3390/nu16070914 | Title/abstract | Excluded | No persistent cross-case improvement: LLM simulated patient platform for dietetics teaching; no persistent agent improvement. | ||||
| 41 | Exploring LLM Multi-Agents for ICD Coding | 2024-04-01 | arXiv | 2406.15363 | Title/abstract | Excluded | No persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning. | ||||
| 42 | IryoNLP at MEDIQA-CORR 2024: Tackling the Medical Error Detection & Correction Task On the Shoulders of Medical Agents | 2024-04-23 | arXiv | 2404.15488 | Title/abstract | Excluded | No persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning. | ||||
| 43 | Exploring the Promise and Challenges of Artificial Intelligence in Biomedical Research and Clinical Practice. | 2024-05-01 | EuropePMC | 10.1097/fjc.0000000000001546 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 44 | Agent Hospital: A Simulacrum of Hospital with Evolvable Medical Agents | 2024-05-05 | arXiv | 2405.02957 | Already charted | Included (re-confirmed) | medhospital2024 | ||||
| 45 | Orbital learning: a novel, actively orchestrated decentralised learning for healthcare. | 2024-05-07 | EuropePMC | 10.1038/s41598-024-60915-9 | Title/abstract | Excluded | Not an LLM agent: Non-LLM method (RL, federated or imaging model). | ||||
| 46 | AgentClinic: a multimodal agent benchmark to evaluate AI in simulated clinical environments | 2024-05-13 | arXiv | 2405.07960 | Already charted | Included (re-confirmed) | schmidgall2026agentclinic | ||||
| 47 | 3D Vessel Reconstruction from Sparse-View Dynamic DSA Images via Vessel Probability Guided Attenuation Learning | 2024-05-17 | arXiv | 2405.10705 | 10.1016/j.media.2026.104088 | Title/abstract | Excluded | Not an LLM agent: Non-LLM method (RL, federated or imaging model). | |||
| 48 | Coaching Copilot: Blended Form of an LLM-Powered Chatbot and a Human Coach to Effectively Support Self-Reflection for Leadership Growth | 2024-05-24 | arXiv | 2405.15250 | 10.1145/3640794.3665549 | Title/abstract | Excluded | No persistent cross-case improvement: Single-pass LLM evaluation or tool; no persistent improvement. | |||
| 49 | Improving medical reasoning through retrieval and self-reflection with retrieval-augmented large language models. | 2024-06-01 | EuropePMC | 10.1093/bioinformatics/btae238 | Title/abstract | Excluded | No persistent cross-case improvement: Retrieval plus self-reflection tokens with one-off fine-tuning; static retrieval. | ||||
| 50 | The Role of Humanization and Robustness of Large Language Models in Conversational Artificial Intelligence for Individuals With Depression: A Critical Analysis. | 2024-07-02 | EuropePMC | 10.2196/56569 | Title/abstract | Excluded | No persistent cross-case improvement: Single-pass LLM evaluation or tool; no persistent improvement. | ||||
| 51 | AgentPoison: Red-teaming LLM Agents via Poisoning Memory or Knowledge Bases | 2024-07-17 | arXiv | 2407.12784 | Title/abstract | Excluded | No persistent cross-case improvement: Red-teaming attack on agent memory; not an improvement method. | ||||
| 52 | Agentic LLM Workflows for Generating Patient-Friendly Medical Reports | 2024-08-02 | arXiv | 2408.01112 | Title/abstract | Excluded | No persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning. | ||||
| 53 | Large language models in medical ethics: useful but not expert. | 2024-08-21 | EuropePMC | 10.1136/jme-2023-109770 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 54 | The digital Balint: using AI in reflective practice. | 2024-08-23 | EuropePMC | 10.1080/14739879.2024.2372606 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 55 | Chatting Up Attachment: Using LLMs to Predict Adult Bonds | 2024-08-31 | arXiv | 2409.00347 | Title/abstract | Excluded | No persistent cross-case improvement: LLM persona or simulation evaluation; no persistent cross-case improvement. | ||||
| 56 | MAGDA: Multi-agent guideline-driven diagnostic assistance | 2024-09-10 | arXiv | 2409.06351 | Title/abstract | Excluded | No persistent cross-case improvement: MAGDA zero-shot guideline agents; self-refine within case. | ||||
| 57 | Surveying the MLLM Landscape: A Meta-Review of Current Surveys | 2024-09-17 | arXiv | 2409.18991 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 58 | Agent Aggregator with Mask Denoise Mechanism for Histopathology Whole Slide Image Analysis | 2024-09-18 | arXiv | 2409.11664 | 10.1145/3664647.3681425 | Title/abstract | Excluded | Not an LLM agent: Non-LLM method (RL, federated or imaging model). | |||
| 59 | Depression Diagnosis Dialogue Simulation: Self-improving Psychiatrist with Tertiary Memory | 2024-09-20 | arXiv | 2409.15084 | Already charted | Included (re-confirmed) | lan2024amc | ||||
| 60 | OMG-RL:Offline Model-based Guided Reward Learning for Heparin Treatment | 2024-09-20 | arXiv | 2409.13299 | 10.1016/j.bea.2025.100198 | Title/abstract | Excluded | Not an LLM agent: Non-LLM method (RL, federated or imaging model). | |||
| 61 | Demonstrating the Continual Learning Capabilities and Practical Application of Discrete-Time Active Inference | 2024-09-30 | arXiv | 2410.00240 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; non-clinical ML or agent work. | ||||
| 62 | Muli-Agent AI Systems in Healthcare: Technical and Clinical Analysis | 2024-10-02 | EuropePMC | 10.20944/preprints202410.0182.v1 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 63 | Prompt Engineering a Schizophrenia Chatbot: Utilizing a Multi-Agent Approach for Enhanced Compliance with Prompt Instructions | 2024-10-10 | arXiv | 2410.12848 | Title/abstract | Excluded | No persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning. | ||||
| 64 | AGENTiGraph: An Interactive Knowledge Graph Platform for LLM-based Chatbots Utilizing Private Data | 2024-10-15 | arXiv | 2410.11531 | Title/abstract | Excluded | No persistent cross-case improvement: Knowledge-graph chatbot platform; static KG retrieval. | ||||
| 65 | Large Language Models can Help with Biostatistics and Coding Needed in Radiology Research. | 2024-10-15 | EuropePMC | 10.1016/j.acra.2024.09.042 | Title/abstract | Excluded | No persistent cross-case improvement: Single-pass LLM evaluation or tool; no persistent improvement. | ||||
| 66 | Active inference and deep generative modeling for cognitive ultrasound | 2024-10-17 | arXiv | 2410.13310 | 10.1109/tuffc.2024.3466290 | Title/abstract | Excluded | Not an LLM agent: Active inference ultrasound (cognitive ultrasound perspective); not LLM agent. | |||
| 67 | AutoFLUKA: A Large Language Model Based Framework for Automating Monte Carlo Simulations in FLUKA | 2024-10-19 | arXiv | 2410.15222 | Title/abstract | Excluded | Not healthcare or clinical: Non-clinical tool (pharmacovigilance documentation or Monte Carlo physics automation). | ||||
| 68 | Jailbreaking and Mitigation of Vulnerabilities in Large Language Models | 2024-10-20 | arXiv | 2410.15236 | 10.63336/eureka.47 | Title/abstract | Excluded | Not primary research: Jailbreak/vulnerability assessment; not an improving agent. | |||
| 69 | Retrieval-Augmented Medical Large Language Models | 2024-10-22 | EuropePMC | 10.20944/preprints202410.1658.v1 | Title/abstract | Excluded | No persistent cross-case improvement: Static retrieval-augmented model; no agent loop. | ||||
| 70 | ReflecTool: Towards Reflection-Aware Tool-Augmented Clinical Agents | 2024-10-23 | arXiv | 2410.17657 | Full text | Included | liao2025reflectool | ||||
| 71 | Towards Next-Generation Medical Agent: How o1 is Reshaping Decision-Making in Medical Scenarios | 2024-11-16 | arXiv | 2411.14461 | Title/abstract | Excluded | No persistent cross-case improvement: Compares backbone LLMs in medical agents; no improvement loop. | ||||
| 72 | Developer Challenges on Large Language Models: A Study of Stack Overflow and OpenAI Developer Forum Posts | 2024-11-16 | arXiv | 2411.10873 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general LLM developer or inference-scaling study. | ||||
| 73 | Regulator-Manufacturer AI Agents Modeling: Mathematical Feedback-Driven Multi-Agent LLM Framework | 2024-11-22 | arXiv | 2411.15356 | Title/abstract | Excluded | Not healthcare or clinical: Regulatory-affairs LLM agent simulation; not clinical; adaptation within simulation unclear. | ||||
| 74 | How Well Can Modern LLMs Act as Agent Cores in Radiology Environments? | 2024-12-12 | arXiv | 2412.09529 | Title/abstract | Excluded | Not primary research: Benchmark or evaluation framework; evaluated systems do not adapt. | ||||
| 75 | LLMs Can Simulate Standardized Patients via Agent Coevolution | 2024-12-16 | arXiv | 2412.11716 | Already charted | Included (re-confirmed) | du2025evopatient | ||||
| 76 | Multi-OphthaLingua: A Multilingual Benchmark for Assessing and Debiasing LLM Ophthalmological QA in LMICs | 2024-12-18 | arXiv | 2412.14304 | Title/abstract | Excluded | No persistent cross-case improvement: Fixed LLM evaluation or debiasing benchmark. | ||||
| 77 | Metaphorical markers of pain catastrophizing, depression, anxiety, and pain interference in people with chronic pain. | 2025 | PubMed | 10.1016/j.jpain.2024.104733 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 78 | Developmental Coaching for Clinician Educators: Just What the Doctor Ordered. | 2025 | EuropePMC; PubMed | 10.1097/ceh.0000000000000586 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 79 | A feasibility study of automating radiotherapy planning with large language model agents. | 2025 | EuropePMC; PubMed | 10.1088/1361-6560/adbff1 | Title/abstract | Excluded | No persistent cross-case improvement: GPT-Plan retrieves historical plans from fixed store; iterates within case. Possible static RAG only. | ||||
| 80 | AI-Enhanced Virtual Reality Self-Talk for Psychological Counseling: Formative Qualitative Study. | 2025 | EuropePMC; PubMed | 10.2196/67782 | Title/abstract | Excluded | No persistent cross-case improvement: VR counseling agent formative study; no persistent improvement. | ||||
| 81 | Hybrid structure combining essential oil derivatives and polydopamine for anti-bacterial coatings. | 2025 | PubMed | 10.1016/j.colsurfb.2025.114679 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 82 | Experience with isavuconazole in the treatment of mucormycosis and breakthrough fungal infections. | 2025 | PubMed | 10.1016/j.riam.2025.01.005 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 83 | Performance of single-agent and multi-agent language models in Spanish language medical competency exams. | 2025 | EuropePMC; PubMed | 10.1186/s12909-025-07250-3 | Title/abstract | Excluded | No persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning. | ||||
| 84 | Uncertainty management strategies in clinical reasoning: perceptions of nurses in post-anesthesia care units. | 2025 | PubMed | 10.1186/s12912-025-03193-8 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 85 | Artificial intelligence in nursing care: A reflection from the ethics of care. | 2025 | PubMed | 10.1177/09697330251366619 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 86 | Multiagent AI Systems in Health Care: Envisioning Next-Generation Intelligence. | 2025 | EuropePMC; PubMed | 10.12788/fp.0589 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 87 | Immunoglobulin GM (γ marker) and FcγR genotypes interact to contribute to the magnitude of ADCC against SARS CoV-2 S-transfected cells. | 2025 | PubMed | 10.1007/s00251-025-01385-9 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 88 | A foundational architecture for AI agents in healthcare. | 2025 | EuropePMC; PubMed | 10.1016/j.xcrm.2025.102374 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 89 | A Neuroaffirmative, Self-Determination Theory-Based Psychosocial Intervention for Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Feasibility Study. | 2025 | EuropePMC; PubMed | 10.2196/69943 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 90 | β-glucan-loaded nano-niosomes ameliorate spatial and associative memory impairment in a D-galactose-induced aging rat model via modulation of microglial pyroptosis and autophagy. | 2025 | PubMed | 10.1016/j.biopha.2025.118834 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 91 | A dynamically tunable terahertz human serum albumin biosensor based on Dirac semimetal nanozyme. | 2025 | PubMed | 10.3389/fbioe.2025.1736291 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 92 | A retrieval-augmented knowledge mining method with deep thinking LLMs for biomedical research and clinical support. | 2025-01-01 | EuropePMC | 10.1093/gigascience/giaf109 | Title/abstract | Excluded | No persistent cross-case improvement: Retrieval-augmented knowledge mining; static, not persistent agent learning. | ||||
| 93 | ENTAgents: AI Agents for Complex Knowledge Otolaryngology | 2025-01-07 | EuropePMC | 10.1101/2025.01.01.25319863 | Title/abstract | Excluded | No persistent cross-case improvement: ENTAgents uses Reflexion within a question; RAG static. | ||||
| 94 | Agentic Retrieval-Augmented Generation: A Survey on Agentic RAG | 2025-01-15 | arXiv | 2501.09136 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 95 | IntellAgent: A Multi-Agent Framework for Evaluating Conversational AI Systems | 2025-01-19 | arXiv | 2501.11067 | Title/abstract | Excluded | Not primary research: Benchmark framework for conversational AI; not clinical. | ||||
| 96 | Developing an Agent-Based Mathematical Model for Simulating Post-Irradiation Cellular Response: A Crucial Component of a Digital Twin Framework for Personalized Radiation Treatment | 2025-01-21 | arXiv | 2501.11875 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | ||||
| 97 | Towards Safe AI Clinicians: A Comprehensive Study on Large Language Model Jailbreaking in Healthcare | 2025-01-27 | arXiv | 2501.18632 | Title/abstract | Excluded | Not primary research: Jailbreak/vulnerability assessment; not an improving agent. | ||||
| 98 | Al-Khwarizmi: Discovering Physical Laws with Foundation Models | 2025-02-03 | arXiv | 2502.01702 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; non-clinical ML or agent work. | ||||
| 99 | Agentic AI for Scaling Diagnosis and Care in Neurodegenerative Disease | 2025-02-06 | arXiv | 2502.06842 | Title/abstract | Excluded | Not primary research: Roadmap/perspective on agentic AI in ADRD care; not primary. | ||||
| 100 | CASC-AI: Consensus-aware Self-corrective Learning for Noise Cell Segmentation | 2025-02-11 | arXiv | 2502.07302 | Title/abstract | Excluded | Not an LLM agent: Non-LLM model (segmentation or statistical model). | ||||
| 101 | Foundations of AI for future physicians: A practical, accessible curriculum. | 2025-02-12 | EuropePMC | 10.1080/0142159x.2025.2463492 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 102 | Nuclear Deployed: Analyzing Catastrophic Risks in Decision-making of Autonomous LLM Agents | 2025-02-17 | arXiv | 2502.11355 | Title/abstract | Excluded | Not healthcare or clinical: Catastrophic-risk CBRN agent decision analysis; not clinical. | ||||
| 103 | Benchmarking Automatic Speech Recognition coupled LLM Modules for Medical Diagnostics | 2025-02-18 | arXiv | 2502.13982 | Title/abstract | Excluded | No persistent cross-case improvement: Benchmark of ASR plus LLM modules; no agent improvement. | ||||
| 104 | Building virtual patients for training mental health professionals | 2025-02-20 | EuropePMC | 10.31234/osf.io/epqtc_v2 | Title/abstract | Excluded | No persistent cross-case improvement: Virtual patient engine with within-dialogue memory; no cross-case improvement. | ||||
| 105 | A Comprehensive Survey on the Trustworthiness of Large Language Models in Healthcare | 2025-02-21 | arXiv | 2502.15871 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 106 | METAL: A Multi-Agent Framework for Chart Generation with Test-Time Scaling | 2025-02-24 | arXiv | 2502.17651 | Title/abstract | Excluded | Not healthcare or clinical: Non-clinical tool (pharmacovigilance documentation or Monte Carlo physics automation). | ||||
| 107 | Can Multimodal LLMs Perform Time Series Anomaly Detection? | 2025-02-25 | arXiv | 2502.17812 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; non-clinical ML or agent work. | ||||
| 108 | MEDDxAgent: A Unified Modular Agent Framework for Explainable Automatic Differential Diagnosis | 2025-02-26 | arXiv | 2502.19175 | Title/abstract | Excluded | No persistent cross-case improvement: MEDDxAgent iterative diagnosis within a case only. | ||||
| 109 | GEMA-Score: Granular Explainable Multi-Agent Scoring Framework for Radiology Report Evaluation | 2025-03-07 | arXiv | 2503.05347 | Title/abstract | Excluded | No persistent cross-case improvement: Multi-agent report scoring metric; agents do not adapt across cases. | ||||
| 110 | Towards Conversational AI for Disease Management | 2025-03-08 | arXiv | 2503.06074 | Title/abstract | Excluded | No persistent cross-case improvement: AMIE management agent with in-context guideline retrieval; no cross-case learning. | ||||
| 111 | Assessment of the Efficiency of a ChatGPT-Based Tool, MyGenAssist, in an Industry Pharmacovigilance Department for Case Documentation: Cross-Over Study. | 2025-03-10 | EuropePMC | 10.2196/65651 | Title/abstract | Excluded | No persistent cross-case improvement: Cross-over efficiency study of a fixed LLM tool; no agent improvement. | ||||
| 112 | Diagnostic performance of multimodal large language models in radiological quiz cases: the effects of prompt engineering and input conditions. | 2025-03-11 | EuropePMC | 10.14366/usg.25012 | Title/abstract | Excluded | No persistent cross-case improvement: Prompt or fixed-model diagnostic evaluation; no agent improvement. | ||||
| 113 | COVID-19 Pneumonia Diagnosis Using Medical Images: Deep Learning-Based Transfer Learning Approach | 2025-03-16 | arXiv | 2503.12642 | 10.2196/75015 | Title/abstract | Excluded | Not an LLM agent: Non-LLM clinical or lab work; no LLM agent. | |||
| 114 | MDTeamGPT: A Self-Evolving LLM-based Multi-Agent Framework for Multi-Disciplinary Team Medical Consultation | 2025-03-18 | arXiv | 2503.13856 | Full text | Included | chen2026mdteamgpt | ||||
| 115 | [The use of large language models in medicine and in radiology in particular]. | 2025-03-19 | EuropePMC | 10.1007/s00117-025-01433-1 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 116 | AI-Driven Mental Healthcare 5.0: A Survey of Opportunities and Challenges in Leveraging Large Language Models and Generative AI | 2025-03-25 | EuropePMC | 10.22541/au.174291179.92552739/v1 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 117 | DEMENTIA-PLAN: An Agent-Based Framework for Multi-Knowledge Graph Retrieval-Augmented Generation in Dementia Care | 2025-03-26 | arXiv | 2503.20950 | Title/abstract | Excluded | No persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning. | ||||
| 118 | Specialized Large Language Model Outperforms Neurologists at Complex Diagnosis in Blinded Case-Based Evaluation. | 2025-03-27 | EuropePMC | 10.3390/brainsci15040347 | Title/abstract | Excluded | No persistent cross-case improvement: Prompt or fixed-model diagnostic evaluation; no agent improvement. | ||||
| 119 | Self-Evolving Multi-Agent Simulations for Realistic Clinical Interactions | 2025-03-28 | arXiv | 2503.22678 | Already charted | Included (re-confirmed) | almansoori2025medagentsim | ||||
| 120 | Agentic Large Language Models, a survey | 2025-03-29 | arXiv | 2503.23037 | 10.1613/jair.1.18675 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | |||
| 121 | Survey and Experiments on Mental Disorder Detection via Social Media: From Large Language Models and RAG to Agents | 2025-04-03 | arXiv | 2504.02800 | 10.1109/icdew67478.2025.00027 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | |||
| 122 | NAACL2025 Tutorial: Adaptation of Large Language Models | 2025-04-04 | arXiv | 2504.03931 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 123 | Beyond Single-Turn: A Survey on Multi-Turn Interactions with Large Language Models | 2025-04-07 | arXiv | 2504.04717 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 124 | Prism: Dynamic and Flexible Benchmarking of LLMs Code Generation with Monte Carlo Tree Search | 2025-04-07 | arXiv | 2504.05500 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; non-clinical ML or agent work. | ||||
| 125 | Evaluating the Bias in LLMs for Surveying Opinion and Decision Making in Healthcare | 2025-04-11 | arXiv | 2504.08260 | Title/abstract | Excluded | No persistent cross-case improvement: LLM persona or simulation evaluation; no persistent cross-case improvement. | ||||
| 126 | Learning to Be A Doctor: Searching for Effective Medical Agent Architectures | 2025-04-15 | arXiv | 2504.11301 | Full text | Included | zhuang2025doctor | ||||
| 127 | Rethinking Inference-Time Scaling: Efficiency Limits and Linguistic Signals | 2025-04-18 | arXiv | 2504.14047 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general LLM developer or inference-scaling study. | ||||
| 128 | Do Large Language Models know who did what to whom? | 2025-04-23 | arXiv | 2504.16884 | 10.1162/opmi.a.365 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; non-clinical ML or agent work. | |||
| 129 | LLM Agent Swarm for Hypothesis-Driven Drug Discovery | 2025-04-24 | arXiv | 2504.17967 | Title/abstract | Excluded | Not healthcare or clinical: Drug discovery agent swarm; no clinical task. | ||||
| 130 | Knowledge-Driven Agentic Scientific Corpus Distillation Framework for Biomedical Large Language Models Training | 2025-04-28 | arXiv | 2504.19565 | Title/abstract | Excluded | No persistent cross-case improvement: Corpus distillation for LLM training; not an improving clinical agent. | ||||
| 131 | From LLM Reasoning to Autonomous AI Agents: A Comprehensive Review | 2025-04-28 | arXiv | 2504.19678 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 132 | AKIBoards: A Structure-Following Multiagent System for Predicting Acute Kidney Injury | 2025-04-29 | arXiv | 2504.20368 | Title/abstract | Excluded | No persistent cross-case improvement: Learned global structure and fine-tuned agents; no evident experience-driven loop; unclear. | ||||
| 133 | SSRLBot: Designing and Developing a Large Language Model-based Agent using Socially Shared Regulated Learning | 2025-05-02 | arXiv | 2505.00945 | Title/abstract | Excluded | No persistent cross-case improvement: LLM agents with within-case reasoning, reflection or static retrieval; no persistent learning. | ||||
| 134 | Human-AI Governance (HAIG): A Trust-Utility Approach | 2025-05-03 | arXiv | 2505.01651 | 10.1016/j.jrt.2026.100167 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | |||
| 135 | A Survey of Slow Thinking-based Reasoning LLMs using Reinforced Learning and Inference-time Scaling Law | 2025-05-05 | arXiv | 2505.02665 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 136 | Vision-Language-Action (VLA) Models: Concepts, Progress, Applications and Challenges | 2025-05-07 | arXiv | 2505.04769 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 137 | Multi-agent Embodied AI: Advances and Future Directions | 2025-05-08 | arXiv | 2505.05108 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 138 | MARK: Memory Augmented Refinement of Knowledge | 2025-05-08 | arXiv | 2505.05177 | Full text | Excluded | Healthcare not the primary focus: Borderline: framed as domain-general enterprise chatbot memory (healthcare, law, manufacturing; Abstract, §1.1); MedMCQA is the only test domain (§2.2). Cross-session memory reuse itself qualifies. | ||||
| 139 | AI Agents vs. Agentic AI: A Conceptual Taxonomy, Applications and Challenges | 2025-05-15 | arXiv | 2505.10468 | 10.1016/j.inffus.2025.103599 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | |||
| 140 | MedAgentBoard: Benchmarking Multi-Agent Collaboration with Conventional Methods for Diverse Medical Tasks | 2025-05-18 | arXiv | 2505.12371 | Title/abstract | Excluded | Not primary research: Benchmark or evaluation framework; evaluated systems do not adapt. | ||||
| 141 | A Survey of Attacks on Large Language Models | 2025-05-18 | arXiv | 2505.12567 | Title/abstract | Excluded | Not primary research: Survey, review, tutorial or perspective; not a primary study. | ||||
| 142 | Silent teachers: Narratives from the simulation lab. | 2025-05-20 | EuropePMC | 10.1111/medu.15711 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 143 | USTBench: Benchmarking and Dissecting Spatiotemporal Reasoning of LLMs as Urban Agents | 2025-05-23 | arXiv | 2505.17572 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; non-clinical ML or agent work. | ||||
| 144 | CPathAgent: An Agent-based Foundation Model for Interpretable High-Resolution Pathology Image Analysis Mimicking Pathologists' Diagnostic Logic | 2025-05-26 | arXiv | 2505.20510 | Title/abstract | Excluded | No persistent cross-case improvement: Trained pathology agent via multi-stage SFT; no improvement loop. | ||||
| 145 | FUAS-Agents: Autonomous Multi-Modal LLM Agents for Treatment Planning in Focused Ultrasound Ablation Surgery | 2025-05-27 | arXiv | 2505.21418 | Title/abstract | Excluded | No persistent cross-case improvement: FUAS-Agents reflect within a case; no persistent learning evident. | ||||
| 146 | Patient-Centered Research Through Artificial Intelligence to Identify Priorities in Cancer Care. | 2025-06-01 | EuropePMC | 10.1001/jamaoncol.2025.0694 | Title/abstract | Excluded | Not primary research: Not primary study of an LLM agent: ethics, case report, commentary, clinical or lab study. | ||||
| 147 | MAPLE: Multi-Agent Adaptive Planning with Long-Term Memory for Table Reasoning | 2025-06-06 | arXiv | 2506.05813 | Title/abstract | Excluded | Not healthcare or clinical: Long-term-memory table reasoning agent, but evaluated on WikiTQ and TabFact, not healthcare. | ||||
| 148 | OriGene: A Self-Evolving Virtual Disease Biologist Automating Therapeutic Target Discovery | 2025-06-06 | EuropePMC | 10.1101/2025.06.03.657658 | Full text | Excluded | Healthcare not the primary focus: Therapeutic target discovery with organoid and tumor-fragment validation, not clinical care or diagnosis (Abstract, Results); template-library evolution described (§4.3) but not separately quantified. | ||||
| 149 | Patient-Specific Deep Reinforcement Learning for Automatic Replanning in Head-and-Neck Cancer Proton Therapy | 2025-06-11 | arXiv | 2506.10073 | Title/abstract | Excluded | Not an LLM agent: Non-LLM method (RL, federated or imaging model). | ||||
| 150 | Sectoral Coupling in Linguistic State Space | 2025-06-15 | arXiv | 2506.12927 | Title/abstract | Excluded | Not healthcare or clinical: Abstract formal framework for belief sectors; no healthcare application. | ||||
| 151 | From RAG to Agentic: Validating Islamic-Medicine Responses with LLM Agents | 2025-06-18 | arXiv | 2506.15911 | Title/abstract | Excluded | No persistent cross-case improvement: Evaluation pipeline comparing direct, RAG and agentic configs; no cross-case learning. | ||||
| 152 | Leveraging the Long-Term Health Monitoring Dataset for Personalized Healthcare: A Large Language Model Approach. | 2025-07-01 | EuropePMC | 10.1109/embc58623.2025.11254888 | Title/abstract | Excluded | Rule P1 per-patient memory only | ||||
| 153 | Are You Listening to Me? Fine-Tuning Chatbots for Empathetic Dialogue | 2025-07-03 | arXiv | 2507.02537 | Title/abstract | Excluded | No persistent cross-case improvement: Supervised fine-tuning of empathetic chatbots on a fixed dataset. | ||||
| 154 | Multi-Agent Reasoning for Cardiovascular Imaging Phenotype Analysis | 2025-07-04 | arXiv | 2507.03460 | Title/abstract | Excluded | No persistent cross-case improvement: Multi-agent consensus within one analysis; no retained experience. | ||||
| 155 | The Agency Gap in AI-Supported Writing: How Reactive and Proactive Agent Designs Shape Multimodal Reasoning | 2025-07-06 | arXiv | 2507.04398 | Title/abstract | Excluded | No persistent cross-case improvement: Reactive vs proactive writing agent in students; no persistent improvement. | ||||
| 156 | Quantitative Single-particle Profiling of Extracellular Vesicles via Fluorescent Nanoparticle Tracking Analysis | 2025-07-07 | arXiv | 2507.04655 | Title/abstract | Excluded | Not an LLM agent: Nanoparticle tracking protocol; no LLM. | ||||
| 157 | An autonomous agent for auditing and improving the reliability of clinical AI models | 2025-07-08 | arXiv | 2507.05755 | Full text | Excluded | No persistent cross-case improvement: Each audit is a fresh dialogue; re-audit used "a fresh instance ... without any knowledge of the ... previous audit" (§2.2). Gains go to the audited CNN, not the agent. | ||||
| 158 | Mixed Methods Feasibility Study of Socrates 2.0, an AI-Based Cognitive Reappraisal Tool for Reducing Mental Health Symptoms | 2025-07-08 | EuropePMC | 10.31234/osf.io/6qhw5_v1 | Title/abstract | Excluded | No persistent cross-case improvement: Feasibility study of multi-agent reappraisal tool; no cross-case learning described. | ||||
| 159 | 4KAgent: Agentic Any Image to 4K Super-Resolution | 2025-07-09 | arXiv | 2507.07105 | Title/abstract | Excluded | Not healthcare or clinical: General image super-resolution agent; not clinical. | ||||
| 160 | Prompt Engineering in Segment Anything Model: Methodologies, Applications, and Emerging Challenges | 2025-07-13 | arXiv | 2507.09562 | Title/abstract | Excluded | Not primary research: Survey of SAM prompt engineering. | ||||
| 161 | InsightX Agent: An LMM-based Agentic Framework with Integrated Tools for Reliable X-ray NDT Analysis | 2025-07-20 | arXiv | 2507.14899 | 10.1109/tr.2026.3668946 | Title/abstract | Excluded | Not healthcare or clinical: Industrial X-ray NDT, not healthcare. | |||
| 162 | Leveraging Knowledge Graphs and LLM Reasoning to Identify Operational Bottlenecks for Warehouse Planning Assistance | 2025-07-23 | arXiv | 2507.17273 | Title/abstract | Excluded | Not healthcare or clinical: Warehouse simulation analysis. | ||||
| 163 | An Empirical Study on Embodied Artificial Intelligence Robot (EAIR) Software Bugs | 2025-07-24 | arXiv | 2507.18267 | Title/abstract | Excluded | Not healthcare or clinical: Empirical study of robot software bugs. | ||||
| 164 | A Survey of Self-Evolving Agents: What, When, How, and Where to Evolve on the Path to Artificial Super Intelligence | 2025-07-28 | arXiv | 2507.21046 | Title/abstract | Excluded | Not primary research: Survey of self-evolving agents. | ||||
| 165 | Privacy Protection for Chinese Electronic Medical Records Using Large Language Models: Effectiveness Evaluation and Application of LLM Models in Medical Data Tasks | 2025-07-28 | EuropePMC | 10.1101/2025.07.27.25332177 | Title/abstract | Excluded | No persistent cross-case improvement: LLM evaluation for EMR de-identification; no persistent adaptation. | ||||
| 166 | Addressing Benchmarking Gaps in Large Language Models for Health and Medicine with Dynamic Red-Teaming | 2025-07-30 | arXiv | 2508.00923 | Full text | Excluded | No persistent cross-case improvement: Attacker orchestrator adapts only within each item over up to five rounds from a predefined tool set (Results, Methods); nothing retained across items; audited LLMs do not adapt. | ||||
| 167 | Enhanced guidance on artificial intelligence for medical publication and communication professionals. | 2025-08-01 | EuropePMC | 10.1080/03007995.2025.2556012 | Title/abstract | Excluded | Not primary research: Commentary on AI guidance for publication professionals. | ||||
| 168 | HealthFlow: A Self-Evolving AI Agent with Meta Planning for Autonomous Healthcare Research | 2025-08-04 | arXiv | 2508.02621 | Already charted | Included (re-confirmed) | zhu2026healthflow | ||||
| 169 | Stretchable and self-adhesive triboelectric sensor for real-time musculoskeletal monitoring and personalized recovery | 2025-08-05 | arXiv | 2508.11655 | Title/abstract | Excluded | Not an LLM agent: Wearable triboelectric sensor; no LLM. | ||||
| 170 | ConfAgents: A Conformal-Guided Multi-Agent Framework for Cost-Efficient Medical Diagnosis | 2025-08-06 | arXiv | 2508.04915 | Full text | Excluded | No persistent cross-case improvement: Conformal calibration over a fixed labeled knowledge base and static RAG on the MSD Manual (§3.2, §4.2); nothing learned is retained. Screening note described HealthFlow (ids 168/292). | ||||
| 171 | Continual Learning for VLMs: A Survey and Taxonomy Beyond Forgetting | 2025-08-06 | arXiv | 2508.04227 | Title/abstract | Excluded | Not primary research: Survey of continual learning for VLMs. | ||||
| 172 | GroundAct: Can LLM Agents Ground Actions in Environmental States? | 2025-08-07 | arXiv | 2508.05614 | Title/abstract | Excluded | Not healthcare or clinical: Benchmark of action grounding, non-clinical. | ||||
| 173 | Towards Embodied Agentic AI: Review and Classification of LLM- and VLM-Driven Robot Autonomy and Interaction | 2025-08-07 | arXiv | 2508.05294 | Title/abstract | Excluded | Not primary research: Survey of embodied agentic AI. | ||||
| 174 | Mediator-Guided Multi-Agent Collaboration among Open-Source Models for Medical Decision-Making | 2025-08-08 | arXiv | 2508.05996 | Title/abstract | Excluded | No persistent cross-case improvement: Mediator-guided multi-agent collaboration without training; single-case reflection. | ||||
| 175 | EndoCogniAgent: Closed-Loop Agentic Reasoning with Self-Consistency Validation for Endoscopic Diagnosis | 2025-08-10 | arXiv | 2508.07292 | Title/abstract | Excluded | No persistent cross-case improvement: Closed-loop reasoning with self-consistency within a single case. | ||||
| 176 | Ethics2vec: aligning automatic agents and human preferences | 2025-08-11 | arXiv | 2508.07673 | Title/abstract | Excluded | Not healthcare or clinical: Ethics alignment of agents, not clinical. | ||||
| 177 | FEAT: A Multi-Agent Forensic AI System with Domain-Adapted Large Language Model for Automated Cause-of-Death Analysis | 2025-08-11 | arXiv | 2508.07950 | Full text | Excluded | No persistent cross-case improvement: Memory & Reflection is a per-case dynamic case file (Methods, Reflection & Memory Module); the forensic LLM is fine-tuned once; no cross-case retention is described or tested. | ||||
| 178 | PASS: Probabilistic Agentic Supernet Sampling for Interpretable and Adaptive Chest X-Ray Reasoning | 2025-08-14 | arXiv | 2508.10501 | Full text | Excluded | Not an LLM agent (no tools or environment interaction, or non-LLM controller) | ||||
| 179 | A Self-Correcting Multi-Agent LLM Framework for Language-Based Physics Simulation and Explanation | 2025-08-14 | EuropePMC | 10.21203/rs.3.rs-7313618/v1 | Title/abstract | Excluded | Not healthcare or clinical: Physics simulation framework. | ||||
| 180 | CORE: Measuring Multi-Agent LLM Interaction Quality under Game-Theoretic Pressures | 2025-08-16 | arXiv | 2508.11915 | Title/abstract | Excluded | Not healthcare or clinical: Game-theoretic dialogue metric, non-clinical. | ||||
| 181 | MedKGent: A Large Language Model Agent Framework for Constructing Temporally Evolving Medical Knowledge Graph | 2025-08-17 | arXiv | 2508.12393 | Full text | Excluded | No persistent cross-case improvement: KG is built from PubMed abstracts, not task experience; QA uses frozen LLMs with static KG RAG, no feedback from cases (Results, QA evaluation; Methods, RAG). | ||||
| 182 | You Don't Know Until You Click:Automated GUI Testing for Production-Ready Software Evaluation | 2025-08-17 | arXiv | 2508.14104 | Title/abstract | Excluded | Not healthcare or clinical: Software GUI testing benchmark. | ||||
| 183 | Exploring Autonomous Agents: A Closer Look at Why They Fail When Completing Tasks | 2025-08-18 | arXiv | 2508.13143 | Title/abstract | Excluded | Not healthcare or clinical: Agent failure analysis, non-clinical. | ||||
| 184 | CardAIc-Agents: A Multimodal Framework with Hierarchical Adaptation for Cardiac Care Support | 2025-08-18 | arXiv | 2508.13256 | Full text | Excluded | No persistent cross-case improvement: Curated static cardiac knowledge base; 'stepwise update' revises the plan within one case; cross-turn memory is within-case (Sections 2.1, 2.2). | ||||
| 185 | Expertise-aware Multi-LLM Recruitment and Collaboration for Medical Decision-Making | 2025-08-19 | arXiv | 2508.13754 | Title/abstract | Excluded | No persistent cross-case improvement: Static expertise table from public corpus; per-query recruitment and debate. | ||||
| 186 | End-to-End Agentic RAG System Training for Traceable Diagnostic Reasoning | 2025-08-21 | arXiv | 2508.15746 | Full text | Excluded | No persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment | ||||
| 187 | Beyond Prediction: Reinforcement Learning as the Defining Leap in Healthcare AI | 2025-08-28 | arXiv | 2508.21101 | Title/abstract | Excluded | Not primary research: Survey of RL in healthcare. | ||||
| 188 | HiVA: Self-organized Hierarchical Variable Agent via Goal-driven Semantic-Topological Evolution | 2025-08-29 | arXiv | 2509.00189 | Title/abstract | Excluded | Not healthcare or clinical: General agent workflow evolution; no healthcare tasks. | ||||
| 189 | Instruction-Level Weight Shaping: A Framework for Self-Improving AI Agents | 2025-08-29 | arXiv | 2509.00251 | Title/abstract | Excluded | Not healthcare or clinical: Self-improving instructions evaluated in enterprise support, not healthcare. | ||||
| 190 | Lagrangian Relaxation for Multi-Action Partially Observable Restless Bandits: Heuristic Policies and Indexability | 2025-08-30 | arXiv | 2509.00415 | Title/abstract | Excluded | Not an LLM agent: Restless bandit theory; no LLM. | ||||
| 191 | ChatCLIDS: Simulating Persuasive AI Dialogues to Promote Closed-Loop Insulin Adoption in Type 1 Diabetes Care | 2025-08-31 | arXiv | 2509.00891 | 10.1609/aaai.v40i46.41305 | Title/abstract | Excluded | Not primary research: Benchmark of persuasive dialogue for diabetes; evaluated LLMs not adapting across cases. | |||
| 192 | Q-Learning-Driven Adaptive Rewiring for Cooperative Control in Heterogeneous Networks | 2025-09-01 | arXiv | 2509.01057 | Title/abstract | Excluded | Not healthcare or clinical: Q-learning network cooperation, non-clinical. | ||||
| 193 | Towards Personalized Explanations for Health Simulations: A Mixed-Methods Framework for Stakeholder-Centric Summarization | 2025-09-04 | arXiv | 2509.04646 | Title/abstract | Excluded | No persistent cross-case improvement: LLM summarization of health simulations; no persistent learning. | ||||
| 194 | Hybrid Memory-Retrieval Model: Enhancing Trust in Medical Chatbots | 2025-09-08 | EuropePMC | 10.32388/r6ojq5 | Full text | Excluded | No persistent cross-case improvement: Memory stores each user's own query-response pairs for that user (P1-type); document RAG corpus is static; Phi-2 chatbot, agent status weak (Sections V.A, V.C, V.E). | ||||
| 195 | From Coordination to Personalization: A Trust-Aware Simulation Framework for Emergency Department Decision Support | 2025-09-09 | arXiv | 2510.15896 | Title/abstract | Excluded | Not an LLM agent: Trust-based ED simulation agents; not LLM-based. | ||||
| 196 | Detecting Model Drifts in Non-Stationary Environment Using Edit Operation Measures | 2025-09-14 | arXiv | 2509.11367 | Title/abstract | Excluded | Not an LLM agent: RL drift detection; no LLM agent. | ||||
| 197 | Leveraging Large Language Models to Advance Certification, Physician Learning, and Diagnostic Excellence. | 2025-09-15 | EuropePMC | 10.3122/jabfm.2024.240385r1 | Title/abstract | Excluded | Not primary research: Commentary on LLMs for physician certification. | ||||
| 198 | A Knowledge-driven Adaptive Collaboration of LLMs for Enhancing Medical Decision-making | 2025-09-18 | arXiv | 2509.14998 | Title/abstract | Excluded | No persistent cross-case improvement: Dynamic expert recruitment within a case; no retained experience. | ||||
| 199 | Failure Makes the Agent Stronger: Enhancing Accuracy through Structured Reflection for Reliable Tool Interactions | 2025-09-23 | arXiv | 2509.18847 | Title/abstract | Excluded | Not healthcare or clinical: Tool-use reflection training on general benchmarks, not healthcare. | ||||
| 200 | MACD: Multi-Agent Clinical Diagnosis with Self-Learned Knowledge for LLM | 2025-09-24 | arXiv | 2509.20067 | Full text | Included | li2025macd | ||||
| 201 | A co-evolving agentic AI system for medical imaging analysis | 2025-09-24 | arXiv | 2509.20279 | Already charted | Included (re-confirmed) | coevolving2025 | ||||
| 202 | RadAgents: Multimodal Agentic Reasoning for Chest X-ray Interpretation with Radiologist-like Workflows | 2025-09-24 | arXiv | 2509.20490 | Title/abstract | Excluded | No persistent cross-case improvement: Radiologist-like multi-agent workflow within a case; no persistent learning. | ||||
| 203 | Rethinking Explainable Disease Prediction: Synergizing Accuracy and Reliability via Reflective Cognitive Architecture | 2025-09-25 | arXiv | 2509.21266 | Full text | Excluded | Not an LLM agent (no tools or environment interaction, or non-LLM controller) | ||||
| 204 | Leveraging LLM Agents for Automated Video Game Testing | 2025-09-26 | arXiv | 2509.22170 | Title/abstract | Excluded | Not healthcare or clinical: Game testing agent. | ||||
| 205 | Transparent Visual Reasoning via Object-Centric Agent Collaboration | 2025-09-28 | arXiv | 2509.23757 | Title/abstract | Excluded | Not an LLM agent: End-to-end trained interpretable visual classifier, not LLM agent. | ||||
| 206 | PSG-Agent: Personality-Aware Safety Guardrail for LLM-based Agents | 2025-09-28 | arXiv | 2509.23614 | Title/abstract | Excluded | Rule P2 healthcare not the study focus | ||||
| 207 | PAME-AI: Patient Messaging Creation and Optimization using Agentic AI | 2025-09-29 | arXiv | 2509.24263 | Full text | Excluded | No persistent cross-case improvement: Borderline: one analysis-to-generation pass from a prior RCT to 20 new messages; second RCT tests messages, not a retained, reused artifact (Sections 4.1, 4.4, 5); F2 also arguable. | ||||
| 208 | SoK: Measuring What Matters for Closed-Loop Security Agents | 2025-10-02 | arXiv | 2510.01654 | Title/abstract | Excluded | Not healthcare or clinical: Cybersecurity closed-loop agents SoK. | ||||
| 209 | Say One Thing, Do Another? Diagnosing Reasoning-Execution Gaps in VLM-Powered Mobile-Use Agents | 2025-10-02 | arXiv | 2510.02204 | Title/abstract | Excluded | Not healthcare or clinical: Mobile-use agent evaluation, non-clinical. | ||||
| 210 | Adaptive and Explainable AI Agents for Anomaly Detection in Critical IoT Infrastructure using LLM-Enhanced Contextual Reasoning | 2025-10-04 | arXiv | 2510.03859 | Title/abstract | Excluded | Not healthcare or clinical: IoT anomaly detection proposal; healthcare only mentioned. | ||||
| 211 | RareAgent: Self-Evolving Reasoning for Drug Repurposing in Rare Diseases | 2025-10-07 | arXiv | 2510.05764 | Full text | Excluded | Healthcare not the primary focus: Borderline: drug-repurposing discovery, not clinical care; persistent heuristic library and prompt updates do exist across tasks (Sections 3.5, 4.1-4.2, Fig. 2). | ||||
| 212 | Inclusivity and Innovation: A Pilot Study on Free AI Models for Clinical Supervision in Gestalt Therapy (GT) | 2025-10-09 | EuropePMC | 10.20944/preprints202510.0727.v1 | Title/abstract | Excluded | No persistent cross-case improvement: Prompt framework comparison for supervision; no persistent adaptation. | ||||
| 213 | Agentic Systems in Radiology: Design, Applications, Evaluation, and Challenges | 2025-10-10 | arXiv | 2510.09404 | Title/abstract | Excluded | Not primary research: Review of agentic systems in radiology. | ||||
| 214 | Traj-CoA: Patient Trajectory Modeling via Chain-of-Agents for Lung Cancer Risk Prediction | 2025-10-12 | arXiv | 2510.10454 | Title/abstract | Excluded | No persistent cross-case improvement: Shared memory built within one patient timeline; not reused across patients. | ||||
| 215 | TraceAegis: Securing LLM-Based Agents via Hierarchical and Behavioral Anomaly Detection | 2025-10-13 | arXiv | 2510.11203 | Title/abstract | Excluded | Not healthcare or clinical: Agent security anomaly detection, non-clinical. | ||||
| 216 | MedKGEval: A Knowledge Graph-Based Multi-Turn Evaluation Framework for Open-Ended Patient Interactions with Clinical LLMs | 2025-10-14 | arXiv | 2510.12224 | Title/abstract | Excluded | Not primary research: Evaluation framework/benchmark for clinical LLMs; systems do not adapt. | ||||
| 217 | Large Language Model Agents for Biomedicine: A Comprehensive Review of Methods, Evaluations, Challenges, and Future Directions | 2025-10-14 | EuropePMC | 10.22541/au.175795684.47167615/v2 | Title/abstract | Excluded | Not primary research: Review of biomedical LLM agents. | ||||
| 218 | The Digital Standardized Patient: An Artificial Intelligence Coach for Cultural Dexterity in Surgical Care. | 2025-10-15 | EuropePMC | 10.1097/xcs.0000000000001505 | Title/abstract | Excluded | No persistent cross-case improvement: Feasibility study of LLM standardized patient; no cross-case learning. | ||||
| 219 | Towards Error Centric Intelligence I, Beyond Observational Learning | 2025-10-16 | arXiv | 2510.15128 | Title/abstract | Excluded | Not primary research: Position/theory paper on error-centric intelligence. | ||||
| 220 | A Survey of LLM-based Multi-agent Systems in Medicine | 2025-10-20 | EuropePMC | 10.20944/preprints202510.1448.v1 | Title/abstract | Excluded | Not primary research: Survey of medical multi-agent systems. | ||||
| 221 | Med-VRAgent: A Framework for Medical Visual Reasoning-Enhanced Agents | 2025-10-21 | arXiv | 2510.18424 | Full text | Excluded | No persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment | ||||
| 222 | InspectCoder: Dynamic Analysis-Enabled Self Repair through interactive LLM-Debugger Collaboration | 2025-10-21 | arXiv | 2510.18327 | Title/abstract | Excluded | Not healthcare or clinical: Code repair agent. | ||||
| 223 | Photoresponsive HOF-Based Platforms for Large Language Model-Assisted Multimodal Diagnosis of Metabolic Diseases. | 2025-10-23 | EuropePMC | 10.1021/acs.analchem.5c04807 | Title/abstract | Excluded | Not an LLM agent: Chemical sensor with GPT-4o interpretation; not an agent. | ||||
| 224 | Human-AI Collaborative Uncertainty Quantification | 2025-10-27 | arXiv | 2510.23476 | Title/abstract | Excluded | Not healthcare or clinical: Human-AI uncertainty quantification, non-clinical. | ||||
| 225 | OpsAgent: An Evolving Multi-agent System for Incident Management in Microservices | 2025-10-28 | arXiv | 2510.24145 | Title/abstract | Excluded | Not healthcare or clinical: Microservice incident management. | ||||
| 226 | Evolving Interactive Diagnostic Agents in a Virtual Clinical Environment | 2025-10-28 | arXiv | 2510.24654 | Already charted | Included (re-confirmed) | qiu2025diaggym | ||||
| 227 | FT-ARM: Fine-Tuned Agentic Reflection Multimodal Language Model for Pressure Ulcer Severity Classification with Reasoning | 2025-10-28 | arXiv | 2510.24980 | Title/abstract | Excluded | No persistent cross-case improvement: Single-case self-reflection plus one-off fine-tuning for pressure ulcer staging. | ||||
| 228 | Towards actionable hypotension prediction -- predicting catecholamine therapy initiation in the intensive care unit | 2025-10-28 | arXiv | 2510.24287 | Title/abstract | Excluded | Not an LLM agent: Conventional ML prediction in ICU; no LLM. | ||||
| 229 | TheraMind: A Strategic and Adaptive Agent for Longitudinal Psychological Counseling | 2025-10-29 | arXiv | 2510.25758 | Full text | Excluded | No persistent cross-case improvement: P1: cross-session memory and therapy reselection use only the same simulated patient's history; nothing is retained across patients (Sections 3.1.2, 3.2). | ||||
| 230 | CGM-Led Multimodal Tracking with Chatbot Support: An Autoethnography in Sub-Health | 2025-10-29 | arXiv | 2510.25381 | Title/abstract | Excluded | No persistent cross-case improvement: Autoethnography of CGM and chatbot; no agent learning. | ||||
| 231 | Cloning Deterministic Worlds: The Critical Role of Latent Geometry in Long-Horizon World Models | 2025-10-30 | arXiv | 2510.26782 | Title/abstract | Excluded | Not healthcare or clinical: World model for mazes. | ||||
| 232 | Learning from experts: A self-improving LLM framework for study population generation in clinical research. | 2025-10-30 | EuropePMC | 10.1016/j.ijmedinf.2025.106171 | Full text | Excluded | Not an LLM agent: Borderline: single-call in-context LLM generation with retrieved expert-correction records, no agentic behaviour; correction store from training set is reused on test (Sections 2.2, 2.3, Fig. 6). | ||||
| 233 | Prompt-dependent performance of multimodal AI model in oral diagnosis: a comprehensive analysis of accuracy, narrative quality, calibration, and latency versus human experts. | 2025-10-30 | EuropePMC | 10.1038/s41598-025-22979-z | Title/abstract | Excluded | No persistent cross-case improvement: Prompt strategy comparison for oral diagnosis. | ||||
| 234 | Navigating the intersection of clinical and artificial intelligence in nurse practitioner practice. | 2025-11-01 | EuropePMC | 10.1097/jxx.0000000000001193 | Title/abstract | Excluded | Not primary research: Reflective commentary on AI in nursing. | ||||
| 235 | LMT++: Adaptively Collaborating LLMs With Multi-Specialized Teachers for Continual VQA in Robotic Surgical Videos. | 2025-11-01 | EuropePMC | 10.1109/tmi.2025.3581108 | Title/abstract | Excluded | Not an LLM agent: Continual learning of VQA models with LLM teacher; not an LLM agent. | ||||
| 236 | MicroRemed: Benchmarking LLMs in Microservices Remediation | 2025-11-03 | arXiv | 2511.01166 | Title/abstract | Excluded | Not healthcare or clinical: Microservice remediation benchmark. | ||||
| 237 | ASAP: an Agentic Solution to Auto-optimize Performance of Large-Scale LLM Training | 2025-11-05 | arXiv | 2511.03844 | Title/abstract | Excluded | Not healthcare or clinical: LLM training performance optimization agents. | ||||
| 238 | Towards Human-AI-Robot Collaboration and AI-Agent based Digital Twins for Parkinson's Disease Management: Review and Outlook | 2025-11-08 | arXiv | 2511.06036 | Title/abstract | Excluded | Not primary research: Review and outlook on Parkinson digital twins. | ||||
| 239 | A Mathematical Framework for AI Singularity: Conditions, Bounds, and Control of Recursive Improvement | 2025-11-08 | arXiv | 2511.10668 | Title/abstract | Excluded | Not healthcare or clinical: Mathematical framework for AI self-improvement; no healthcare. | ||||
| 240 | TwinOR: Photorealistic Digital Twins of Dynamic Operating Rooms for Embodied AI Research | 2025-11-10 | arXiv | 2511.07412 | 10.1007/s11548-026-03644-w | Title/abstract | Excluded | Not an LLM agent: OR digital twin infrastructure; no LLM agent. | |||
| 241 | Refine and Align: Confidence Calibration through Multi-Agent Interaction in VQA | 2025-11-14 | arXiv | 2511.11169 | Title/abstract | Excluded | No persistent cross-case improvement: Debate-based calibration within a question. | ||||
| 242 | Multi-agent Self-triage System with Medical Flowcharts | 2025-11-16 | arXiv | 2511.12439 | 10.1038/s44360-026-00112-2 | Title/abstract | Excluded | No persistent cross-case improvement: Multi-agent triage over fixed flowcharts; no learning. | |||
| 243 | MedDCR: Learning to Design Agentic Workflows for Medical Coding | 2025-11-17 | arXiv | 2511.13361 | Full text | Included | zheng2026meddcr | ||||
| 244 | Fault2Flow: An AlphaEvolve-Optimized Human-in-the-Loop Multi-Agent System for Fault-to-Workflow Automation | 2025-11-17 | arXiv | 2511.12916 | Title/abstract | Excluded | Not healthcare or clinical: Power grid fault workflow. | ||||
| 245 | MedBench v4: A Robust and Scalable Benchmark for Evaluating Chinese Medical Language Models, Multimodal Models, and Intelligent Agents | 2025-11-18 | arXiv | 2511.14439 | Title/abstract | Excluded | Not primary research: Benchmark of Chinese medical models and agents. | ||||
| 246 | OEMA: Ontology-Enhanced Multi-Agent Collaboration Framework for Zero-Shot Clinical Named Entity Recognition | 2025-11-19 | EuropePMC; PubMed; arXiv | 2511.15211 | 10.1093/jamiaopen/ooag049 | Full text | Excluded | No persistent cross-case improvement: Self-annotated corpus is built once by zero-shot annotation of unlabeled training text, then retrieved statically; no outcome feedback or cross-case updating (§3.2.1–3.2.2, §4.1). | |||
| 247 | MRG-R3: Retrieval-Reflection-Reward via Multimodal LLMs Advances Clinical Automated Medical Report Generation | 2025-11-20 | EuropePMC | 10.21203/rs.3.rs-7914595/v1 | Title/abstract | Excluded | No persistent cross-case improvement: Retrieval from fixed store, reflection and RL on report generation; not an agent improvement loop. | ||||
| 248 | PathAgent: Toward Interpretable Analysis of Whole-slide Pathology Images via Large Language Model-based Agentic Reasoning | 2025-11-21 | arXiv | 2511.17052 | Title/abstract | Excluded | No persistent cross-case improvement: Training-free agent reasoning within one slide. | ||||
| 249 | DR Tulu: Reinforcement Learning with Evolving Rubrics for Deep Research | 2025-11-24 | arXiv | 2511.19399 | Title/abstract | Excluded | Not healthcare or clinical: Deep research agent RL, not healthcare. | ||||
| 250 | MTBBench: A Multimodal Sequential Clinical Decision-Making Benchmark in Oncology | 2025-11-25 | arXiv | 2511.20490 | Title/abstract | Excluded | Not primary research: Benchmark of oncology tumor-board decisions. | ||||
| 251 | PathReasoning: A multimodal reasoning agent for query-based ROI navigation on whole-slide images | 2025-11-26 | arXiv | 2511.21902 | Title/abstract | Excluded | No persistent cross-case improvement: Iterative ROI navigation within one slide. | ||||
| 252 | Auditable Context-Aware HFMD Forecasting with Structured LLM Agents | 2025-11-28 | arXiv | 2511.23276 | Title/abstract | Excluded | No persistent cross-case improvement: Two-agent forecasting without persistent learning. | ||||
| 253 | Can Large Language Models Foster Reflective Practice? A Dialogically-Informed Exploration by a Trainee-Educator Dyad. | 2025-11-28 | EuropePMC | 10.1007/s40670-025-02570-x | Title/abstract | Excluded | Not primary research: Commentary on LLMs and reflective practice. | ||||
| 254 | Reinventing Clinical Dialogue: Agentic Paradigms for LLM Enabled Healthcare Communication | 2025-12-01 | arXiv | 2512.01453 | Title/abstract | Excluded | Not primary research: Survey of agentic clinical dialogue. | ||||
| 255 | Shared Decision-Making with Palliative Care Specialist. | 2025-12-01 | EuropePMC | 10.14475/jhpc.2025.28.4.131 | Title/abstract | Excluded | Not primary research: Review of shared decision-making in palliative care. | ||||
| 256 | Process-Centric Analysis of Agentic Software Systems | 2025-12-02 | arXiv | 2512.02393 | 10.1145/3798271 | Title/abstract | Excluded | Not healthcare or clinical: Trajectory analysis of software agents. | |||
| 257 | Colon-X: Advancing Intelligent Colonoscopy toward Clinical Reasoning | 2025-12-03 | arXiv | 2512.03667 | Title/abstract | Excluded | No persistent cross-case improvement: Dataset and reasoning study of MLLMs for colonoscopy; no agent loop. | ||||
| 258 | Advancing Chinese Conversation-based Patient Guidance with a Benchmark and Knowledge-Evolvable Assistant. | 2025-12-03 | EuropePMC | 10.1109/jbhi.2025.3639805 | Full text | Included | lu2025kea | ||||
| 259 | AI-Facilitated Cognitive Reappraisal via Socrates 2.0: Mixed Methods Feasibility Study. | 2025-12-05 | EuropePMC | 10.2196/80461 | Title/abstract | Excluded | No persistent cross-case improvement: Feasibility study of Socrates 2.0 (duplicate of record 158); no cross-case learning. | ||||
| 260 | SGEMAS: A Self-Growing Ephemeral Multi-Agent System for Unsupervised Online Anomaly Detection via Entropic Homeostasis | 2025-12-08 | arXiv | 2512.14708 | Title/abstract | Excluded | Not an LLM agent: Non-LLM bio-inspired agents for ECG. | ||||
| 261 | VIGIL: A Reflective Runtime for Self-Healing Agents | 2025-12-08 | arXiv | 2512.07094 | Title/abstract | Excluded | Not healthcare or clinical: General self-healing agent runtime, not healthcare. | ||||
| 262 | Ophiuchus: Incentivizing Tool-augmented "Think with Images" for Joint Medical Segmentation, Understanding and Reasoning | 2025-12-16 | arXiv | 2512.14157 | Full text | Excluded | No persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment | ||||
| 263 | Physician Associate Student Use of Large Language Models to Support Learning: A Phenomenological Study. | 2025-12-24 | EuropePMC | 10.1097/jpa.0000000000000733 | Title/abstract | Excluded | Not an LLM agent: Qualitative interview study of student LLM use. | ||||
| 264 | Multi-Agent AI Systems for Biological and Clinical Data Analysis | 2025-12-30 | EuropePMC | 10.20944/preprints202512.2602.v1 | Title/abstract | Excluded | Not primary research: Review of multi-agent biomedical systems. | ||||
| 265 | Artificial intelligence guidance in ethically challenging clinical scenarios in child and adolescent psychiatry: a qualitative study in the context of Turkiye. | 2025-12-30 | EuropePMC | 10.1186/s12910-025-01323-0 | Title/abstract | Excluded | No persistent cross-case improvement: Qualitative comparison of LLM ethics guidance. | ||||
| 266 | MAMA-Memeia! Multi-Aspect Multi-Agent Collaboration for Depressive Symptoms Identification in Memes | 2025-12-31 | arXiv | 2512.25015 | Title/abstract | Excluded | No persistent cross-case improvement: Multi-agent discussion for meme classification; within-case. | ||||
| 267 | Hierarchical agent reflection for aligning LLM reasoning with clinical diagnostic processes. | 2026 | EuropePMC; PubMed | 10.1007/s13755-025-00410-1 | Title/abstract | Excluded | No persistent cross-case improvement: Agent reflection generates notes for one-off supervised fine-tuning. | ||||
| 268 | Phronesis and Ethical Nursing Practice: Insights From Nursing Ontology. | 2026 | PubMed | 10.1111/nin.70074 | Title/abstract | Excluded | Not primary research: Philosophical essay on nursing ethics. | ||||
| 269 | EvoMDT: a self-evolving multi-agent system for structured clinical decision-making in multi-cancer. | 2026 | EuropePMC; PubMed | 10.1038/s41746-025-02304-8 | Already charted | Included (re-confirmed) | liu2026evomdt | ||||
| 270 | How interprofessional simulation supports medical students' transition to clinical practice. | 2026 | EuropePMC; PubMed | 10.1186/s41077-025-00392-w | Title/abstract | Excluded | Not an LLM agent: Qualitative simulation education study. | ||||
| 271 | Agentic AI in Radiology: Evolution from Large Language Models to Future Clinical Integration. | 2026 | EuropePMC; PubMed | 10.1148/ryai.250651 | Title/abstract | Excluded | Not primary research: Review of agentic AI in radiology. | ||||
| 272 | Early diagnosis of axial spondyloarthritis in primary care using multi-agent systems. | 2026 | EuropePMC; PubMed | 10.1038/s41746-026-02372-4 | Full text | Included | ji2026spagents | ||||
| 273 | Artificial intelligence and medicine: an epistemological inquiry. | 2026 | PubMed | 10.1136/medhum-2025-013509 | Title/abstract | Excluded | Not primary research: Epistemological essay on AI in medicine. | ||||
| 274 | FHIR-AgentEval: A Modular Sandbox for Benchmarking Clinical LLM Agents with an Evaluation of Memory-Augmented Configurations. | 2026 | EuropePMC; PubMed | 10.21203/rs.3.rs-8746188/v1 | Full text | Included | mokssit2026fhiragenteval | ||||
| 275 | Transgender people and nursing: Ethical reflections between care and invisibility. | 2026 | PubMed | 10.1177/09697330261418162 | Title/abstract | Excluded | Not primary research: Theoretical essay on nursing ethics. | ||||
| 276 | Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenarios. | 2026 | PubMed | 10.1128/cmr.00228-25 | Title/abstract | Excluded | Not primary research: Clinical opinion on antifungal drug. | ||||
| 277 | DILIConsult: A Multi-Agent Large Language Model Framework for Evaluating Drug-Induced Liver Injury in ICU Settings. | 2026 | EuropePMC; PubMed | 10.1002/phar.70131 | Title/abstract | Excluded | No persistent cross-case improvement: Agentic pipeline for DILI; no persistent learning. | ||||
| 278 | Tabular LLMs for Interpretable Few-Shot Alzheimer's Disease Prexdiction with Multimodal Biomedical Data. | 2026 | PubMed | 10.1145/3765612.3767229 | Title/abstract | Excluded | Not an LLM agent: Fine-tuned tabular LLM classifier; not an agent. | ||||
| 279 | AgentClinic: a multimodal benchmark for tool-using clinical AI agents. | 2026 | EuropePMC; PubMed | 10.1038/s41746-026-02674-7 | Already charted | Included (re-confirmed) | schmidgall2026agentclinic | ||||
| 280 | Large Language Model and Pediatric Neurosurgery - A Neurosurgeon's Perspective on the Artificial Nervous System. | 2026 | EuropePMC; PubMed | 10.3340/jkns.2026.0029 | Title/abstract | Excluded | Not primary research: Narrative review of LLMs in neurosurgery. | ||||
| 281 | Reconfiguring work: artificial intelligence, agentic AI, and the future of the radiology profession. | 2026 | EuropePMC; PubMed | 10.1093/bjrai/ubag006 | Title/abstract | Excluded | Not primary research: Perspective on agentic AI and radiology profession. | ||||
| 282 | The next paradigm in bioinformatics: a review of multi-agent systems and foundational models for end-to-end scientific discovery. | 2026 | EuropePMC; PubMed | 10.1093/bib/bbag245 | Title/abstract | Excluded | Not primary research: Review of multi-agent bioinformatics. | ||||
| 283 | ReclAIm: A Multiagent Framework for Monitoring and Correcting Performance Decline in Medical Imaging AI. | 2026 | EuropePMC; PubMed | 10.1148/ryai.250923 | Already charted | Included (re-confirmed) | tzanis2026reclaim | ||||
| 284 | Acquired enamel pellicle engineering and the use of vitamin e as a preventive strategy for dental erosion. | 2026 | PubMed | 10.1016/j.jdent.2026.106808 | Title/abstract | Excluded | Not primary research: Narrative review of dental erosion. | ||||
| 285 | Designing Artificial Intelligence Tools to Strengthen Human Connection in Healthcare: The CoCo Experience. | 2026 | PubMed | 10.1177/23743735261461903 | Title/abstract | Excluded | No persistent cross-case improvement: Description of Mayo communication agent; no learning loop. | ||||
| 286 | Building CAR-E: A Novel Artificial Intelligence Agent for Coaching Conversations. | 2026 | EuropePMC; PubMed | 10.5334/pme.2563 | Full text | Excluded | Healthcare not the primary focus: Coaching conversations in medical education without clinical cases; also long-term memory is per-user history and refinement was human-led redesign (Steps taken; Table 1). | ||||
| 287 | The Next Paradigm in Medical AI: A Survey of Agentic AI in Biomedicine. | 2026 | EuropePMC; PubMed | 10.1109/rbme.2026.3704162 | Title/abstract | Excluded | Not primary research: Survey of agentic AI in biomedicine. | ||||
| 288 | Agent4CD: Generative Agent for Cognitive Diagnosis in Intelligent Education. | 2026 | EuropePMC; PubMed | 10.1109/tnnls.2026.3706957 | Title/abstract | Excluded | Not healthcare or clinical: Cognitive diagnosis in general education. | ||||
| 289 | From glycemic control to neuroprotection: alogliptin as a repurposed candidate for Huntington's disease. | 2026 | PubMed | 10.1007/s11011-026-01942-5 | Title/abstract | Excluded | Not an LLM agent: Pharmacology study of alogliptin. | ||||
| 290 | Medical AI Agents for Clinical Decision Support: Viewpoint Using the Planning, Action, Reflection, and Memory (PARM) Analytical Lens. | 2026 | EuropePMC; PubMed | 10.2196/92584 | Title/abstract | Excluded | Not primary research: Viewpoint on medical AI agents. | ||||
| 291 | Closed-loop agentic AI in drug discovery. | 2026 | EuropePMC; PubMed | 10.1039/d6md00319b | Title/abstract | Excluded | Not primary research: Review of agentic drug discovery. | ||||
| 292 | HealthFlow: automating electronic health record analysis via a strategically self-evolving multi-agent framework. | 2026 | EuropePMC; PubMed | 10.1038/s41746-026-03097-0 | Already charted | Included (re-confirmed) | zhu2026healthflow | ||||
| 293 | Cross-interface persistent memory for large language model-assisted radiology research workflows: a Claude-based proof-of-concept technical development. | 2026 | EuropePMC; PubMed | 10.3389/fradi.2026.1890122 | Full text | Excluded | Healthcare not the primary focus: Memory carries software-development project context; authors state it is not a clinical tool and processes no patient data (Abstract; Methods scope paragraph). | ||||
| 294 | Questioning the Foundations of Research Methodologies in Nursing: A Reflection Based on Problematology. | 2026 | PubMed | 10.1111/nup.70116 | Title/abstract | Excluded | Not primary research: Reflective essay on nursing research methods. | ||||
| 295 | Developing agency through experiences of misalignment: A path to becoming a physician. | 2026 | EuropePMC; PubMed | 10.1111/medu.70334 | Title/abstract | Excluded | Not an LLM agent: Qualitative study of medical student agency. | ||||
| 296 | Opening doors together: Agentic engagement as a relational practice in medical education. | 2026 | EuropePMC; PubMed | 10.1080/0142159x.2026.2738746 | Title/abstract | Excluded | Not an LLM agent: Qualitative interview study. | ||||
| 297 | Skill-guided agentic reasoning enables longitudinal synthesis of myeloma records at expert-level concordance. | 2026 | EuropePMC; PubMed | 10.1038/s41698-026-01733-2 | Full text | Excluded | No persistent cross-case improvement: The 42-module clinical skill library is predefined and selected at runtime; no experience-driven creation or updating of skills is reported (Methods, Clinical skill library). | ||||
| 298 | PARDA: A Perceive-Act-Reflect-Distill Agent for Source-Free Unsupervised Domain Adaptation. | 2026 | PubMed | 10.1109/tmi.2026.3744091 | Title/abstract | Excluded | No persistent cross-case improvement: Closed-loop domain adaptation distilled to a student model; unclear LLM-agent and cross-case retention. | ||||
| 299 | Agentic artificial intelligence for code status extraction from clinical notes: a cross-model comparison of single agent, reflective agent, and multiagent extractor-reviewer system. | 2026 | EuropePMC; PubMed | 10.1093/jamia/ocag179 | Title/abstract | Excluded | No persistent cross-case improvement: Single, reflective and multi-agent extraction compared; no persistent learning. | ||||
| 300 | Auditable Automation of Activated Sludge Modeling for Wastewater Treatment Diagnosis Using LLM-Agents. | 2026 | EuropePMC; PubMed | 10.1021/acs.est.6c09278 | Title/abstract | Excluded | Not healthcare or clinical: Wastewater modeling agent. | ||||
| 301 | Can emotions be professional? A decolonial reframing of professional identity formation. | 2026 | PubMed | 10.3389/fmed.2026.1952561 | Title/abstract | Excluded | Not primary research: Conceptual argument on professional identity formation; not a system | ||||
| 302 | ClinicalReTrial: Clinical Trial Redesign with Self-Evolving Agents | 2026-01-01 | arXiv | 2601.00290 | Full text | Included | xing2026clinicalretrial | ||||
| 303 | An Agentic Software Framework for Data Governance under DPDP | 2026-01-03 | arXiv | 2601.01101 | Title/abstract | Excluded | Not healthcare or clinical: Data governance under DPDP; not clinical | ||||
| 304 | Digital Twin AI: Opportunities and Challenges from Large Language Models to World Models | 2026-01-04 | arXiv | 2601.01321 | Title/abstract | Excluded | Not primary research: Digital twin AI overview framework; not primary clinical system | ||||
| 305 | Clinical Knowledge Graph Construction and Evaluation with Multi-LLMs via Retrieval-Augmented Generation | 2026-01-05 | arXiv | 2601.01844 | Title/abstract | Excluded | No persistent cross-case improvement: Multi-agent KG construction with RAG; no cross-case learning | ||||
| 306 | Model confrontation and collaboration: A debate intelligence framework for enhancing medical reasoning in large language models. | 2026-01-05 | EuropePMC | 10.1016/j.xcrm.2025.102547 | Title/abstract | Excluded | No persistent cross-case improvement: Multi-LLM debate within a single question; no persistence | ||||
| 307 | Replacing Tunable Parameters in Weather and Climate Models with State-Dependent Functions using Reinforcement Learning | 2026-01-07 | arXiv | 2601.04268 | 10.1029/2026ms005745 | Title/abstract | Excluded | Not healthcare or clinical: Weather/climate model RL; not healthcare | |||
| 308 | From Laboratory to Real-World Applications: Benchmarking Agentic Code Reasoning at the Repository Level | 2026-01-07 | arXiv | 2601.03731 | Title/abstract | Excluded | Not healthcare or clinical: Code reasoning benchmark; not healthcare | ||||
| 309 | AgentDevel: Reframing Self-Evolving LLM Agents as Release Engineering | 2026-01-08 | arXiv | 2601.04620 | Title/abstract | Excluded | Not healthcare or clinical: General agent release-engineering; no clinical task | ||||
| 310 | Memory Poisoning Attack and Defense on Memory Based LLM-Agents | 2026-01-09 | arXiv | 2601.05504 | Title/abstract | Excluded | Not healthcare or clinical: Memory poisoning on generic agents; not clinical | ||||
| 311 | MedEinst: Benchmarking the Einstellung Effect in Medical LLMs through Counterfactual Differential Diagnosis | 2026-01-10 | arXiv | 2601.06636 | Title/abstract | Excluded | Not primary research: Benchmark of static LLMs; no adaptation | ||||
| 312 | Hallucinations Live in Variance | 2026-01-11 | arXiv | 2601.07058 | Title/abstract | Excluded | Not healthcare or clinical: Generic reliability/variance paper; not clinical | ||||
| 313 | Route, Retrieve, Reflect, Repair: Self-Improving Agentic Framework for Visual Detection and Linguistic Reasoning in Medical Imaging | 2026-01-13 | arXiv | 2601.08192 | Full text | Included | sayeedi2026r4 | ||||
| 314 | AI Agents Need Memory Control Over More Context | 2026-01-15 | arXiv | 2601.11653 | Title/abstract | Excluded | Not healthcare or clinical: Generic agent memory control; not clinical | ||||
| 315 | A Survey of Agentic Reasoning for Large Language Models: Towards Recursively Self-Improving and Collective Agents | 2026-01-18 | arXiv | 2601.12538 | Title/abstract | Excluded | Not primary research: Survey of agentic reasoning | ||||
| 316 | HyperWalker: Dynamic Hypergraph-Based Deep Diagnosis for Multi-Hop Clinical Modeling across EHR and X-Ray in Medical VLMs | 2026-01-20 | arXiv | 2601.13919 | Full text | Excluded | No persistent cross-case improvement: Appendix A: hypergraph pre-built from training data, Walker trained offline, adapters tuned by TTT for each single test sample; nothing retained across test cases. Walker is a scoring network. | ||||
| 317 | AgentEHR: Advancing Autonomous Clinical Decision-Making via Retrospective Summarization | 2026-01-20 | arXiv | 2601.13918 | Full text | Included | liao2026agentehr | ||||
| 318 | TruthTensor: Evaluating LLMs through Human Imitation on Prediction Market under Drift and Holistic Reasoning | 2026-01-20 | arXiv | 2601.13545 | Title/abstract | Excluded | Not healthcare or clinical: Prediction market evaluation; not clinical | ||||
| 319 | Epistemic and ethical limits of large language models in evidence-based medicine: from knowledge to judgment. | 2026-01-20 | EuropePMC | 10.3389/fdgth.2025.1706383 | Title/abstract | Excluded | No persistent cross-case improvement: Empirical evaluation of static LLMs on EBM tasks | ||||
| 320 | XInsight: Integrative Stage-Consistent Psychological Counseling Support Agents for Digital Well-Being | 2026-01-21 | arXiv | 2603.06583 | Title/abstract | Excluded | No persistent cross-case improvement: Multi-agent counseling workflow; adaptation within client session only | ||||
| 321 | From Passive Metric to Active Signal: The Evolving Role of Uncertainty Quantification in Large Language Models | 2026-01-22 | arXiv | 2601.15690 | Title/abstract | Excluded | Not primary research: Survey on uncertainty quantification | ||||
| 322 | D-Optimality-Guided Reinforcement Learning for Efficient Open-Loop Calibration of a 3-DOF Ankle Rehabilitation Robot | 2026-01-22 | arXiv | 2601.15707 | Title/abstract | Excluded | Not an LLM agent: RL calibration of rehab robot; not an LLM agent | ||||
| 323 | Robust Tool Use via Fission-GRPO: Learning to Recover from Execution Errors | 2026-01-22 | arXiv | 2601.15625 | Title/abstract | Excluded | Not healthcare or clinical: General tool-use RL training; not healthcare | ||||
| 324 | Comparison of online radiologists and large language model chatbots in responding to common radiology-related questions in Chinese: a cross-sectional comparative analysis. | 2026-01-22 | EuropePMC | 10.21037/qims-2025-1716 | Title/abstract | Excluded | Not an LLM agent: Cross-sectional comparison of chatbots vs radiologists; no agent adaptation | ||||
| 325 | EvoConfig: Self-Evolving Multi-Agent Systems for Efficient Autonomous Environment Configuration | 2026-01-23 | arXiv | 2601.16489 | Title/abstract | Excluded | Not healthcare or clinical: Software environment configuration; not healthcare | ||||
| 326 | CreditAudit: 2$^\text{nd}$ Dimension for LLM Evaluation and Selection | 2026-01-23 | arXiv | 2602.02515 | Title/abstract | Excluded | Not healthcare or clinical: LLM evaluation method; not healthcare | ||||
| 327 | Sentipolis: Emotion-Aware Agents for Social Simulations | 2026-01-25 | arXiv | 2601.18027 | Title/abstract | Excluded | Not healthcare or clinical: Social simulation emotion agents; not clinical | ||||
| 328 | Planner-Auditor Twin: Agentic Discharge Planning with FHIR-Based LLM Planning, Guideline Recall, Optional Caching and Self-Improvement | 2026-01-28 | arXiv | 2601.21113 | Full text | Excluded | No persistent cross-case improvement: Sec. 2.3: self-improvement regenerates within the request; buffer replay re-runs the same flagged cases (N=7). Borderline: 'context caching' is never defined, so cross-patient reuse is unverifiable. | ||||
| 329 | Conversation for Non-verifiable Learning: Self-Evolving LLMs through Meta-Evaluation | 2026-01-29 | arXiv | 2601.21464 | Title/abstract | Excluded | Not healthcare or clinical: Self-evolving LLM for non-verifiable tasks; not clinical | ||||
| 330 | Payoff-Free Coordination Reveals Hidden Quantum Correlation Structure | 2026-01-29 | arXiv | 2601.21139 | Title/abstract | Excluded | Not healthcare or clinical: Quantum coordination model; not healthcare | ||||
| 331 | EvoClinician: A Self-Evolving Agent for Multi-Turn Medical Diagnosis via Test-Time Evolutionary Learning | 2026-01-30 | arXiv | 2601.22964 | Already charted | Included (re-confirmed) | he2026evoclinician | ||||
| 332 | RE-MCDF: Closed-Loop Multi-Expert LLM Reasoning for Knowledge-Grounded Clinical Diagnosis | 2026-02-01 | arXiv | 2602.01297 | Title/abstract | Excluded | No persistent cross-case improvement: Closed-loop multi-expert diagnosis within one case; no persistence | ||||
| 333 | Think Like a Doctor: Conversational Diagnosis through the Exploration of Diagnostic Knowledge Graphs | 2026-02-02 | arXiv | 2602.01995 | Title/abstract | Excluded | No persistent cross-case improvement: KG-guided conversational diagnosis; per-case only | ||||
| 334 | MedSAM-Agent: Empowering Interactive Medical Image Segmentation with Multi-turn Agentic Reinforcement Learning | 2026-02-03 | arXiv | 2602.03320 | Full text | Excluded | No persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment | ||||
| 335 | MeetBench-XL: Calibrated Multi-Dimensional Evaluation and Learned Dual-Policy Agents for Real-Time Meetings | 2026-02-03 | arXiv | 2602.03285 | Title/abstract | Excluded | Not healthcare or clinical: Enterprise meeting agents; not healthcare | ||||
| 336 | SE-Bench: Benchmarking Self-Evolution with Knowledge Internalization | 2026-02-04 | arXiv | 2602.04811 | Title/abstract | Excluded | Not healthcare or clinical: Self-evolution benchmark for knowledge internalization; not clinical | ||||
| 337 | AI Chatbot Suicide Risk Detection and Response: Human Validation Study of the Open-Source VERA-MH Safety Evaluation | 2026-02-04 | arXiv | 2602.05088 | 10.2196/92817 | Title/abstract | Excluded | Not an LLM agent: Human validation of chatbot safety evaluation; not an adapting agent | |||
| 338 | "A Safe First Step": Design and Evaluation of an Emotionally Expressive AI Virtual Patient for Clinical Simulation in Speech-Language Pathology Training | 2026-02-04 | EuropePMC | 10.21203/rs.3.rs-8588902/v1 | Title/abstract | Excluded | No persistent cross-case improvement: AI virtual patient for SLP training; no cross-case learning | ||||
| 339 | TemporalBench: A Benchmark for Evaluating LLM-Based Agents on Contextual and Event-Informed Time Series Tasks | 2026-02-05 | arXiv | 2602.13272 | Title/abstract | Excluded | Not healthcare or clinical: Time series benchmark; not healthcare | ||||
| 340 | From Conflict to Consensus: Boosting Medical Reasoning via Multi-Round Agentic RAG | 2026-02-06 | arXiv | 2603.03292 | Title/abstract | Excluded | No persistent cross-case improvement: Multi-round agentic RAG within a single question | ||||
| 341 | The Value of Variance: Mitigating Debate Collapse in Multi-Agent Systems via Uncertainty-Driven Policy Optimization | 2026-02-06 | arXiv | 2602.07186 | Title/abstract | Excluded | Not healthcare or clinical: Multi-agent debate policy optimization; generic reasoning | ||||
| 342 | Agentic Unlearning: When LLM Agent Meets Machine Unlearning | 2026-02-06 | arXiv | 2602.17692 | Title/abstract | Excluded | Not healthcare or clinical: Agentic unlearning; generic | ||||
| 343 | VenusBench-Mobile: A Challenging and User-Centric Benchmark for Mobile GUI Agents with Capability Diagnostics | 2026-02-06 | arXiv | 2604.06182 | Title/abstract | Excluded | Not healthcare or clinical: Mobile GUI benchmark; not healthcare | ||||
| 344 | MedCoG: Maximizing LLM Inference Density in Medical Reasoning via Meta-Cognitive Regulation | 2026-02-08 | arXiv | 2602.07905 | Title/abstract | Excluded | No persistent cross-case improvement: Meta-cognitive regulation of knowledge use per query; no accumulation | ||||
| 345 | EvoCorps: An Evolutionary Multi-Agent Framework for Depolarizing Online Discourse | 2026-02-09 | arXiv | 2602.08529 | Title/abstract | Excluded | Not healthcare or clinical: Online discourse depolarization; not healthcare | ||||
| 346 | Situation Graph Prediction for User Perspective Modeling | 2026-02-10 | arXiv | 2602.13319 | Title/abstract | Excluded | Not healthcare or clinical: User perspective modeling; not clinical | ||||
| 347 | Virtual Immersion in Biomedical Engineering (VIBE): Exposing undergraduates to culturally sensitive engineering design and professional experiences at scale | 2026-02-10 | EuropePMC | 10.64898/2026.02.08.704621 | Title/abstract | Excluded | Not healthcare or clinical: Biomedical engineering education programme; not clinical agent | ||||
| 348 | ASQ-PHI: An adversarial synthetic data benchmark for clinical de-identification and search utility. | 2026-02-11 | EuropePMC | 10.1016/j.dib.2026.112586 | Title/abstract | Excluded | Not primary research: De-identification benchmark; no adapting system | ||||
| 349 | Historical Perspectives in Medicine using a Large Language Model: Emulating an 18th Century Physician | 2026-02-12 | EuropePMC | 10.64898/2026.02.10.26345990 | Title/abstract | Excluded | No persistent cross-case improvement: LLM emulating historical physician for education; no learning loop | ||||
| 350 | Vital Trace: Protocol-Constrained Patient-State Reasoning for Longitudinal Clinical Trajectories | 2026-02-13 | arXiv | 2602.12833 | Title/abstract | Excluded | No persistent cross-case improvement: Persistent patient-state memory within one ICU trajectory; no cross-patient learning | ||||
| 351 | NeuroWeaver: An Autonomous Evolutionary Agent for Exploring the Programmatic Space of EEG Analysis Pipelines | 2026-02-13 | arXiv | 2602.13473 | Full text | Excluded | Healthcare not the primary focus: Sec. 1 and 3.1: general EEG/BCI pipeline AutoML including emotion and workload tasks, not healthcare-primary; also per-dataset search, nothing carried across tasks (Sec. 2.4). Borderline on scope. | ||||
| 352 | Learning to Remember: End-to-End Training of Memory Agents for Long-Context Reasoning | 2026-02-13 | arXiv | 2602.18493 | Title/abstract | Excluded | Not healthcare or clinical: Generic memory agent training; not healthcare | ||||
| 353 | AnomaMind: Agentic Time Series Anomaly Detection with Tool-Augmented Reasoning | 2026-02-14 | arXiv | 2602.13807 | Title/abstract | Excluded | Not healthcare or clinical: Time series anomaly detection agent; not healthcare | ||||
| 354 | Does Socialization Emerge in AI Agent Society? A Case Study of Moltbook | 2026-02-15 | arXiv | 2602.14299 | Title/abstract | Excluded | Not healthcare or clinical: Agent society analysis; not healthcare | ||||
| 355 | AgentFixer: From Failure Detection to Fix Recommendations in LLM Agentic Systems | 2026-02-18 | arXiv | 2603.29848 | Title/abstract | Excluded | Not healthcare or clinical: Generic agent failure diagnosis; not healthcare | ||||
| 356 | MedClarify: An information-seeking AI agent for medical diagnosis with case-specific follow-up questions | 2026-02-19 | arXiv | 2602.17308 | Title/abstract | Excluded | No persistent cross-case improvement: Information-seeking follow-up questions per case; no persistence | ||||
| 357 | Adaptive Weighting for Time-to-Event Continual Reassessment Method: Improving Safety in Phase I Dose-Finding Through Data-Driven Delay Distribution Estimation | 2026-02-22 | arXiv | 2602.19012 | Title/abstract | Excluded | Not an LLM agent: Statistical dose-finding method; not LLM | ||||
| 358 | Data mining in pediatric radiology in the era of artificial intelligence. | 2026-02-25 | EuropePMC | 10.1007/s00247-026-06551-z | Title/abstract | Excluded | Not primary research: Review of data mining in pediatric radiology | ||||
| 359 | ESAA: Event Sourcing for Autonomous Agents in LLM-Based Software Engineering | 2026-02-26 | arXiv | 2602.23193 | Title/abstract | Excluded | Not healthcare or clinical: Software engineering agents; not healthcare | ||||
| 360 | Tell Me What To Learn: Generalizing Neural Memory to be Controllable in Natural Language | 2026-02-26 | arXiv | 2602.23201 | Title/abstract | Excluded | Not healthcare or clinical: Neural memory method; not healthcare | ||||
| 361 | Structure Matters: Evaluating Multi-Agents Orchestration in Generative Therapeutic Chatbots | 2026-02-28 | arXiv | 2603.00774 | Title/abstract | Excluded | No persistent cross-case improvement: Evaluates therapeutic chatbot orchestration designs; no learning loop | ||||
| 362 | TARSE: Test-Time Adaptation via Retrieval of Skills and Experience for Reasoning Agents | 2026-03-01 | arXiv | 2603.01241 | Full text | Excluded | No persistent cross-case improvement: Sec. 4-5: skills and experience libraries curated offline from guidelines and QA rationales, fixed at test; per-query TTT restarts from base parameters; no cross-case retention. | ||||
| 363 | ASTRA-bench: Evaluating Tool-Use Agent Reasoning and Action Planning with Personal User Context | 2026-03-02 | arXiv | 2603.01357 | Title/abstract | Excluded | Not healthcare or clinical: Personal assistant benchmark; not healthcare | ||||
| 364 | AMemGym: Interactive Memory Benchmarking for Assistants in Long-Horizon Conversations | 2026-03-02 | arXiv | 2603.01966 | Title/abstract | Excluded | Not healthcare or clinical: Memory benchmark for assistants; not healthcare | ||||
| 365 | AOI: Turning Failed Trajectories into Training Signals for Autonomous Cloud Diagnosis | 2026-03-03 | arXiv | 2603.03378 | Title/abstract | Excluded | Not healthcare or clinical: Cloud SRE agents; not healthcare | ||||
| 366 | Conversational Learning Diagnosis via Reasoning Multi-Turn Interactive Learning | 2026-03-03 | arXiv | 2603.03236 | Title/abstract | Excluded | Not healthcare or clinical: Education learning diagnosis; not clinical | ||||
| 367 | Specification-Driven Generation and Evaluation of Discrete-Event World Models via the DEVS Formalism | 2026-03-04 | arXiv | 2603.03784 | Title/abstract | Excluded | Not healthcare or clinical: World models for business processes; not healthcare | ||||
| 368 | EvoTool: Self-Evolving Tool-Use Policy Optimization in LLM Agents via Blame-Aware Mutation and Diversity-Aware Selection | 2026-03-05 | arXiv | 2603.04900 | Title/abstract | Excluded | Not healthcare or clinical: Generic tool-use policy evolution; not healthcare | ||||
| 369 | Tool-Genesis: A Task-Driven Tool Creation Benchmark for Self-Evolving Language Agent | 2026-03-05 | arXiv | 2603.05578 | Title/abstract | Excluded | Not healthcare or clinical: Tool creation benchmark; not healthcare | ||||
| 370 | Evolving Medical Imaging Agents via Experience-driven Self-skill Discovery | 2026-03-06 | arXiv | 2603.05860 | Already charted | Included (re-confirmed) | fan2026macro | ||||
| 371 | The World Won't Stay Still: Programmable Evolution for Agent Benchmarks | 2026-03-06 | arXiv | 2603.05910 | Title/abstract | Excluded | Not healthcare or clinical: Agent benchmark with evolving environments; not healthcare | ||||
| 372 | Dual-Agent Multiple-Model Reinforcement Learning for Event-Triggered Human-Robot Co-Adaptation in Decoupled Task Spaces | 2026-03-06 | arXiv | 2603.06163 | Title/abstract | Excluded | Not an LLM agent: RL rehab robot control; not an LLM agent | ||||
| 373 | Sensitivity-Aware Retrieval-Augmented Intent Clarification | 2026-03-06 | arXiv | 2603.06025 | Title/abstract | Excluded | Not healthcare or clinical: Conversational search clarification; not healthcare | ||||
| 374 | \$OneMillion-Bench: How Far are Language Agents from Human Experts? | 2026-03-09 | arXiv | 2603.07980 | Title/abstract | Excluded | Not primary research: Multi-domain agent benchmark | ||||
| 375 | GPT-Powered Chatbot-Based Positive Psychology Intervention for Well-Being Among Parents of Children With Autism Spectrum Disorder: Single-Arm Mixed Methods Study. | 2026-03-09 | EuropePMC | 10.2196/85060 | Title/abstract | Excluded | No persistent cross-case improvement: Single-arm study of GPT chatbot intervention; no agent learning loop | ||||
| 376 | Real-Time Trust Verification for Safe Agentic Actions using TrustBench | 2026-03-10 | arXiv | 2603.09157 | Title/abstract | Excluded | Not healthcare or clinical: Generic agent action trust verification; not healthcare | ||||
| 377 | Emulating Clinician Cognition via Self-Evolving Deep Clinical Research | 2026-03-11 | arXiv | 2603.10677 | Already charted | Included (re-confirmed) | ren2026dxevolve | ||||
| 378 | UltrasoundAgents: Hierarchical Multi-Agent Evidence-Chain Reasoning for Breast Ultrasound Diagnosis | 2026-03-11 | arXiv | 2603.10852 | Full text | Included | zhu2026ultrasoundagents | ||||
| 379 | When OpenClaw Meets Hospital: Toward an Agentic Operating System for Dynamic Clinical Workflows | 2026-03-12 | arXiv | 2603.11721 | Title/abstract | Excluded | No persistent cross-case improvement: Agentic hospital OS; memory is patient-record retrieval and curated skills, not learned | ||||
| 380 | Improving TCM question answering through tree-organized self-reflective retrieval with LLMs. | 2026-03-12 | EuropePMC | 10.3389/fmed.2026.1752778 | Title/abstract | Excluded | No persistent cross-case improvement: TCM QA with tree retrieval and per-query reflection; static store | ||||
| 381 | TheraAgent: Multi-Agent Framework with Self-Evolving Memory and Evidence-Calibrated Reasoning for PET Theranostics | 2026-03-14 | arXiv | 2603.13676 | Full text | Included | chen2026theraagent | ||||
| 382 | OpenHospital: A Thing-in-itself Arena for Evolving and Benchmarking LLM-based Collective Intelligence | 2026-03-16 | arXiv | 2603.14771 | Full text | Included | liu2026openhospital | ||||
| 383 | Elder-Sim: A Psychometrically Validated Platform for Personality-Stable Elderly Digital Twins | 2026-03-16 | EuropePMC; arXiv | 2604.16343 | 10.64898/2026.03.25.26349036 | Title/abstract | Excluded | No persistent cross-case improvement: Per-twin persistent memory and LoRA for personality consistency; no cross-case improvement | |||
| 384 | AgentTrace: Causal Graph Tracing for Root Cause Analysis in Deployed Multi-Agent Systems | 2026-03-16 | arXiv | 2603.14688 | Title/abstract | Excluded | Not healthcare or clinical: Multi-agent failure root cause analysis; not healthcare | ||||
| 385 | GUI-CEval: A Hierarchical and Comprehensive Chinese Benchmark for Mobile GUI Agents | 2026-03-16 | arXiv | 2603.15039 | Title/abstract | Excluded | Not healthcare or clinical: Mobile GUI benchmark; not healthcare | ||||
| 386 | The Internet of Physical AI Agents: Interoperability, Longevity, and the Cost of Getting It Wrong | 2026-03-16 | arXiv | 2603.15900 | Title/abstract | Excluded | Not healthcare or clinical: Physical AI agents internet vision; not healthcare | ||||
| 387 | GNNVerifier: Graph-based Verifier for LLM Task Planning | 2026-03-16 | arXiv | 2603.14730 | Title/abstract | Excluded | Not healthcare or clinical: Task planning verifier; not healthcare | ||||
| 388 | Probe-then-Plan: Environment-Aware Planning for Industrial E-commerce Search | 2026-03-16 | arXiv | 2603.15262 | 10.1145/3805712.3808459 | Title/abstract | Excluded | Not healthcare or clinical: E-commerce search; not healthcare | |||
| 389 | A Two-Dimensional Framework for AI Agent Design Patterns: Cognitive Function and Execution Topology | 2026-03-16 | arXiv | 2605.13850 | Title/abstract | Excluded | Not primary research: Taxonomy of agent design patterns | ||||
| 390 | Using large language models to assist qualitative thematic analysis of student reflections on advance care planning education. | 2026-03-16 | EuropePMC | 10.1186/s12909-026-08851-2 | Title/abstract | Excluded | No persistent cross-case improvement: LLM-assisted thematic analysis of student reflections; no agent loop | ||||
| 391 | Empowering Women in Academic Emergency Medicine: A Time-Efficient Workshop Incorporating Large Language Models to Enhance Leadership Skills. | 2026-03-16 | EuropePMC | 10.1002/aet2.70128 | Title/abstract | Excluded | No persistent cross-case improvement: Workshop using LLMs for leadership training; no agent loop | ||||
| 392 | VIGIL: Towards Edge-Extended Agentic AI for Enterprise IT Support | 2026-03-17 | arXiv | 2603.16110 | Title/abstract | Excluded | Not healthcare or clinical: Enterprise IT support agents; not healthcare | ||||
| 393 | Tabular LLMs for Interpretable Few-Shot Alzheimer's Disease Prediction with Multimodal Biomedical Data | 2026-03-17 | arXiv | 2603.17191 | Title/abstract | Excluded | No persistent cross-case improvement: Few-shot tabular LLM for Alzheimer prediction; no agent loop | ||||
| 394 | Kestrel: Grounding Self-Refinement for LVLM Hallucination Mitigation | 2026-03-17 | arXiv | 2603.16664 | Title/abstract | Excluded | Not healthcare or clinical: LVLM hallucination mitigation; generic | ||||
| 395 | Learning to Predict, Discover, and Reason in High-Cardinality Event Sequences | 2026-03-17 | arXiv | 2603.16313 | Title/abstract | Excluded | Not healthcare or clinical: Automotive event sequences; not healthcare | ||||
| 396 | A modular clinical thinking navigation system: an exploration in the '101 Project' diagnostics textbook reform. | 2026-03-18 | EuropePMC | 10.1186/s12909-026-09023-y | Title/abstract | Excluded | Not an LLM agent: Textbook-based clinical thinking navigation system; not LLM agent | ||||
| 397 | Blocking the Reflection: Milestones and Hurdles for Digital Twins in Mental Health. | 2026-03-19 | EuropePMC | 10.1055/a-2816-2869 | Title/abstract | Excluded | Not primary research: Perspective on mental health digital twins | ||||
| 398 | Deep reflective reasoning in interdependence constrained structured data extraction from clinical notes for digital health | 2026-03-20 | arXiv | 2603.20435 | Title/abstract | Excluded | No persistent cross-case improvement: Iterative self-critique within one note; no persistence | ||||
| 399 | Wearable Foundation Models Should Go Beyond Static Encoders | 2026-03-20 | arXiv | 2603.19564 | Title/abstract | Excluded | Not primary research: Position paper on wearable foundation models | ||||
| 400 | Integration of Artificial Intelligence Into Extended Reality Debriefing in Healthcare Simulation: A Narrative Review. | 2026-03-20 | EuropePMC | 10.2147/amep.s578857 | Title/abstract | Excluded | Not primary research: Narrative review | ||||
| 401 | WirelessBench: A Tolerance-Aware LLM Agent Benchmark for Wireless Network Intelligence | 2026-03-22 | arXiv | 2603.21251 | Title/abstract | Excluded | Not healthcare or clinical: Wireless networking benchmark; not healthcare | ||||
| 402 | Anatomical Prior-Driven Framework for Autonomous Robotic Cardiac Ultrasound Standard View Acquisition | 2026-03-22 | arXiv | 2603.21134 | Title/abstract | Excluded | Not an LLM agent: Robotic cardiac ultrasound acquisition; not LLM agent | ||||
| 403 | ARYA: A Physics-Constrained Composable & Deterministic World Model Architecture | 2026-03-22 | arXiv | 2603.21340 | Title/abstract | Excluded | Not healthcare or clinical: World model architecture; not healthcare | ||||
| 404 | SOLAR: A Self-Optimizing Open-Ended Autonomous Agent for Lifelong Learning and Continual Adaptation | 2026-03-23 | arXiv | 2605.20189 | Title/abstract | Excluded | Not healthcare or clinical: General lifelong learning agent; medical only one eval task | ||||
| 405 | Cerebra: A Multidisciplinary AI Board for Multimodal Dementia Characterization and Risk Assessment | 2026-03-23 | arXiv | 2603.21597 | Title/abstract | Excluded | No persistent cross-case improvement: Multi-agent dementia assessment; no persistent learning | ||||
| 406 | GSEM: Graph-based Self-Evolving Memory for Experience Augmented Clinical Reasoning | 2026-03-23 | arXiv | 2603.22096 | Already charted | Included (re-confirmed) | han2026gsem | ||||
| 407 | Privacy-PreservingLLM Middleware in LIS: Edge-Computing for Coagulation InterpretationUnder High-Dimensional Noise | 2026-03-23 | EuropePMC | 10.21203/rs.3.rs-9171815/v1 | Title/abstract | Excluded | No persistent cross-case improvement: Edge LLM RAG middleware with per-query retries; no persistence | ||||
| 408 | Large language model scoring of medical student reflection essays: Accuracy and reproducibility of prompt-model variations | 2026-03-24 | EuropePMC | 10.64898/2026.03.20.26348918 | Title/abstract | Excluded | No persistent cross-case improvement: Prompt-model comparison for essay scoring; no agent loop | ||||
| 409 | A Scalable Four-Level Functional Hierarchy for Evaluating Large Language Models: Hallucination, Self-Monitoring, and the Hypothesized Structural Advantages of Arabic and Chinese | 2026-03-24 | EuropePMC | 10.20944/preprints202603.1858.v1 | Title/abstract | Excluded | Not primary research: Conceptual evaluation hierarchy for LLMs; not clinical system | ||||
| 410 | Multi-Agent Reasoning with Consistency Verification Improves Uncertainty Calibration in Medical MCQA | 2026-03-25 | arXiv | 2603.24481 | Title/abstract | Excluded | No persistent cross-case improvement: Multi-agent verification for calibration within a question | ||||
| 411 | AnalogAgent: Self-Improving Analog Circuit Design Automation with LLM Agents | 2026-03-25 | arXiv | 2603.23910 | Title/abstract | Excluded | Not healthcare or clinical: Analog circuit design agent; not healthcare | ||||
| 412 | DUPLEX: Agentic Dual-System Planning via LLM-Driven Information Extraction | 2026-03-25 | arXiv | 2603.23909 | 10.1109/icras70064.2026.11717896 | Title/abstract | Excluded | Not healthcare or clinical: Robot task planning; not healthcare | |||
| 413 | SkinGPT-X: A Self-Evolving Collaborative Multi-Agent System for Transparent and Trustworthy Dermatological Diagnosis | 2026-03-27 | arXiv | 2603.26122 | Full text | Included | chen2026skingptx | ||||
| 414 | ClinicalAgents: Multi-Agent Orchestration for Clinical Decision Making with Dual-Memory | 2026-03-27 | arXiv | 2603.26182 | 10.1145/3770855.3818931 | Already charted | Included (re-confirmed) | clinicalagents2026 | |||
| 415 | StressWeb: A Diagnostic Benchmark for Web Agent Robustness under Realistic Interaction Variability | 2026-03-27 | arXiv | 2604.16385 | Title/abstract | Excluded | Not healthcare or clinical: Web agent robustness benchmark; not healthcare | ||||
| 416 | Autonomous Agent-Orchestrated Digital Twins (AADT): Leveraging the OpenClaw Framework for State Synchronization in Rare Genetic Disorders | 2026-03-28 | arXiv | 2603.27104 | Title/abstract | Excluded | No persistent cross-case improvement: OpenClaw digital twin synchronization with agent skills; state updates, no learned reuse evident | ||||
| 417 | PubMed Reasoner: Dynamic Reasoning-based Retrieval for Evidence-Grounded Biomedical Question Answering | 2026-03-28 | arXiv | 2603.27335 | Title/abstract | Excluded | No persistent cross-case improvement: Per-query retrieval refinement for biomedical QA; no persistence | ||||
| 418 | Harnessing Artificial Intelligence to Deliver Growth Mindset Education in a Pre-matriculation Curriculum for Incoming Medical Students. | 2026-03-28 | EuropePMC | 10.7759/cureus.106023 | Title/abstract | Excluded | No persistent cross-case improvement: AI-supported growth mindset education; no agent learning loop | ||||
| 419 | EffiSkill: Agent Skill Based Automated Code Efficiency Optimization | 2026-03-29 | arXiv | 2603.27850 | Title/abstract | Excluded | Not healthcare or clinical: Code efficiency skills; not healthcare | ||||
| 420 | Let the Agent Steer: Closed-Loop Ranking Optimization via Influence Exchange | 2026-03-29 | arXiv | 2603.27765 | Title/abstract | Excluded | Not healthcare or clinical: Recommendation ranking optimization; not healthcare | ||||
| 421 | FeDMRA: Federated Incremental Learning with Dynamic Memory Replay Allocation | 2026-03-30 | arXiv | 2603.28455 | Title/abstract | Excluded | Not an LLM agent: Federated incremental learning with replay; not LLM agent | ||||
| 422 | MiroEval: Benchmarking Multimodal Deep Research Agents in Process and Outcome | 2026-03-30 | arXiv | 2603.28407 | Title/abstract | Excluded | Not healthcare or clinical: Deep research agent benchmark; not healthcare | ||||
| 423 | An Artifact-based Agent Framework for Adaptive and Reproducible Medical Image Processing | 2026-03-31 | arXiv | 2604.21936 | Title/abstract | Excluded | No persistent cross-case improvement: Imaging workflow agent with static rule library and provenance; no learning | ||||
| 424 | CausalPulse: An Industrial-Grade Neurosymbolic Multi-Agent Copilot for Causal Diagnostics in Smart Manufacturing | 2026-03-31 | arXiv | 2603.29755 | Title/abstract | Excluded | Not healthcare or clinical: Manufacturing causal diagnostics; not healthcare | ||||
| 425 | Bias Patterns in the Application of LLMs for Clinical Decision Support: A Comprehensive Study. | 2026-03-31 | EuropePMC | 10.32481/djph.2026.03.10 | Title/abstract | Excluded | No persistent cross-case improvement: Bias evaluation of static LLMs in clinical decision support | ||||
| 426 | Toward Vibe Medicine: A Self-Evolving Multi-Agent Framework for Clinical Decision Support | 2026-04-01 | arXiv | 2606.15504 | 10.1016/j.metrad.2026.100223 | Already charted | Included (re-confirmed) | zhang2026vibemed | |||
| 427 | PsychAgent: An Experience-Driven Lifelong Learning Agent for Self-Evolving Psychological Counselor | 2026-04-01 | arXiv | 2604.00931 | Already charted | Included (re-confirmed) | yang2026psychagent | ||||
| 428 | Breakdowns in Conversational AI: Interactional Failures in Emotionally and Ethically Sensitive Contexts | 2026-04-03 | arXiv | 2604.02713 | Title/abstract | Excluded | No persistent cross-case improvement: Qualitative analysis of conversational AI breakdowns; no adapting system | ||||
| 429 | Eligibility-Aware Evidence Synthesis: An Agentic Framework for Clinical Trial Meta-Analysis | 2026-04-03 | arXiv | 2604.02678 | Title/abstract | Excluded | No persistent cross-case improvement: Agentic trial meta-analysis pipeline; no cross-task learning | ||||
| 430 | Towards Next-Generation Healthcare: A Survey of Medical Embodied AI for Perception, Decision-Making, and Action | 2026-04-05 | arXiv | 2606.15647 | Title/abstract | Excluded | Not primary research: Survey of medical embodied AI | ||||
| 431 | RoboPhD: Evolving Diverse Complex Agents Under Tight Evaluation Budgets | 2026-04-06 | arXiv | 2604.04347 | Title/abstract | Excluded | Not healthcare or clinical: Generic agent evolution algorithms; not healthcare | ||||
| 432 | Springdrift: An Auditable Persistent Runtime for LLM Agents with Case-Based Memory, Normative Safety, and Ambient Self-Perception | 2026-04-06 | arXiv | 2604.04660 | Title/abstract | Excluded | Not healthcare or clinical: Generic persistent agent runtime; not healthcare | ||||
| 433 | PSY-STEP: Structuring Therapeutic Targets and Action Sequences for Proactive Counseling Dialogue Systems | 2026-04-06 | arXiv | 2604.04448 | Title/abstract | Excluded | No persistent cross-case improvement: CBT counseling dataset and dialogue system; no persistent learning loop | ||||
| 434 | Enhancing LLM-based medical decision-making by test-time knowledge acquisition. | 2026-04-06 | EuropePMC | 10.1007/s13755-026-00449-8 | Full text | Excluded | Not an LLM agent (no tools or environment interaction, or non-LLM controller) | ||||
| 435 | EMSDialog: Synthetic Multi-person Emergency Medical Service Dialogue Generation from Electronic Patient Care Reports via Multi-LLM Agents | 2026-04-08 | arXiv | 2604.07549 | Title/abstract | Excluded | No persistent cross-case improvement: Synthetic EMS dialogue generation with per-dialogue self-refinement | ||||
| 436 | Joint Optimization of Reasoning and Dual-Memory for Self-Learning Diagnostic Agent | 2026-04-08 | arXiv | 2604.07269 | Full text | Included | li2026sea | ||||
| 437 | Generate, Filter, Control, Replay: A Comprehensive Survey of Rollout Strategies for LLM Reinforcement Learning | 2026-04-08 | arXiv | 2605.02913 | Title/abstract | Excluded | Not primary research: Survey of rollout strategies for LLM RL | ||||
| 438 | Self-Preference Bias in Rubric-Based Evaluation of Large Language Models | 2026-04-08 | arXiv | 2604.06996 | Title/abstract | Excluded | Not healthcare or clinical: Judge self-preference bias; not healthcare | ||||
| 439 | Aligning Agents via Planning: A Benchmark for Trajectory-Level Reward Modeling | 2026-04-09 | arXiv | 2604.08178 | Title/abstract | Excluded | Not healthcare or clinical: Agent reward model benchmark; not healthcare | ||||
| 440 | Constraint-Aware Corrective Memory for Language-Based Drug Discovery Agents | 2026-04-10 | arXiv | 2604.09308 | Title/abstract | Excluded | Not healthcare or clinical: Drug discovery agent corrective memory; no clinical task | ||||
| 441 | NetForge RL: A Multi-Agent Simulation Environment for Cyber Defense with Durative Actions | 2026-04-10 | arXiv | 2604.09523 | Title/abstract | Excluded | Not healthcare or clinical: Cyber defense RL environment; not healthcare | ||||
| 442 | The Enduring Promise of Personalising Patient Preference Prediction. | 2026-04-10 | EuropePMC | 10.1007/s12152-026-09635-7 | Title/abstract | Excluded | Not primary research: Ethics commentary on patient preference prediction | ||||
| 443 | On simulation, artificial intelligence, and the spirit of the Shokunin. | 2026-04-10 | EuropePMC | 10.1186/s41077-026-00435-w | Title/abstract | Excluded | Not primary research: Commentary on simulation and AI | ||||
| 444 | TrajOnco: a multi-agent framework for temporal reasoning over longitudinal EHR for multi-cancer early detection | 2026-04-12 | arXiv | 2604.10386 | Title/abstract | Excluded | No persistent cross-case improvement: Zero-shot multi-agent EHR reasoning; long-term memory within patient only | ||||
| 445 | VCC-DSA: A Novel Vascular Consistency Constrained DSA Imaging Model for Motion Artifact Suppression | 2026-04-12 | PubMed; arXiv | 2604.10700 | 10.1016/j.media.2026.104070 | Title/abstract | Excluded | Not an LLM agent: DSA imaging model; not LLM agent | |||
| 446 | Camyla: Scaling Autonomous Research in Medical Image Segmentation | 2026-04-12 | arXiv | 2604.10696 | Full text | Excluded | No persistent cross-case improvement: Global memory re-initialized per dataset (Algorithm 1 line 8, Sec 3.4); 62 runs are 31 datasets x 2 independent runs (App 17). Also borderline F2 (research automation). | ||||
| 447 | Governed Reasoning for Institutional AI | 2026-04-12 | arXiv | 2604.10658 | Title/abstract | Excluded | No persistent cross-case improvement: Governed decision framework, prior authorization examples; no learning from experience | ||||
| 448 | VERITAS: A Multi-Agent Co-Scientist for Verifiable Image-Derived Hypothesis Testing | 2026-04-13 | arXiv | 2604.12144 | Title/abstract | Excluded | No persistent cross-case improvement: Multi-agent imaging hypothesis testing; no persistent learning evident | ||||
| 449 | CodeTracer: Towards Traceable Agent States | 2026-04-13 | arXiv | 2604.11641 | Title/abstract | Excluded | Not healthcare or clinical: Code agent tracing; not healthcare | ||||
| 450 | A Framework for Longitudinal Health AI Agents | 2026-04-13 | arXiv | 2604.12019 | Title/abstract | Excluded | Not primary research: Conceptual framework with use cases for longitudinal health agents; not empirical system | ||||
| 451 | QuarkMedSearch: A Long-Horizon Deep Search Agent for Exploring Medical Intelligence | 2026-04-14 | arXiv | 2604.12867 | Full text | Excluded | No persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment | ||||
| 452 | Cross-Domain Query Translation for Network Troubleshooting: A Multi-Agent LLM Framework with Privacy Preservation and Self-Reflection | 2026-04-14 | arXiv | 2604.13353 | 10.1109/eucnc/6gsummit68295.2026.11577467 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | |||
| 453 | Evo-MedAgent: Beyond One-Shot Diagnosis with Agents That Remember, Reflect, and Improve | 2026-04-15 | arXiv | 2604.14475 | Already charted | Included (re-confirmed) | shen2026evomedagent | ||||
| 454 | Can LLMs Accurately Score Medical Diagnoses and Clinical Reasoning? | 2026-04-16 | arXiv | 2604.14892 | 10.1007/978-3-032-30710-1_44 | Title/abstract | Excluded | Not primary research: LLM jury scoring of diagnoses; evaluation study, not adapting agent. | |||
| 455 | Benchmarks for Trajectory Safety Evaluation and Diagnosis in OpenClaw and Codex: ATBench-Claw and ATBench-Codex | 2026-04-16 | arXiv | 2604.14858 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 456 | Harnessing Pre-Resolution Signals for Future Prediction Agents | 2026-04-17 | arXiv | 2604.15719 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 457 | If Only My CGM Could Speak: A Privacy-Preserving Agent for Question Answering over Continuous Glucose Data | 2026-04-18 | arXiv | 2604.17133 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 458 | PRISM: Probing Reasoning, Instruction, and Source Memory in LLM Hallucinations | 2026-04-18 | arXiv | 2604.16909 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 459 | Towards Self-Improving Error Diagnosis in Multi-Agent Systems | 2026-04-19 | arXiv | 2604.17658 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 460 | AIT Academy: Cultivating the Complete Agent with a Confucian Three-Domain Curriculum | 2026-04-20 | arXiv | 2604.17989 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 461 | TEAM-SimHRA: A Team-Based Simulation Framework for Human Reliability Analysis Using Multi-Agent Large Language Models | 2026-04-21 | arXiv | 2605.23927 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 462 | RL-ABC: Reinforcement Learning for Accelerator Beamline Control | 2026-04-21 | arXiv | 2604.19146 | 10.1016/j.cpc.2026.110407 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | |||
| 463 | MedSkillAudit: A Domain-Specific Audit Framework for Medical Research Agent Skills | 2026-04-22 | arXiv | 2604.20441 | Title/abstract | Excluded | No persistent cross-case improvement: Audit framework scoring existing agent skills; no adaptation loop. | ||||
| 464 | When Agents Look the Same: Quantifying Distillation-Induced Similarity in Tool-Use Behaviors | 2026-04-23 | arXiv | 2604.21255 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 465 | Transient Turn Injection: Exposing Stateless Multi-Turn Vulnerabilities in Large Language Models | 2026-04-23 | arXiv | 2604.21860 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 466 | Seeing the Whole Elephant: A Benchmark for Failure Attribution in LLM-based Multi-Agent Systems | 2026-04-24 | arXiv | 2604.22708 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 467 | Self-Correction as Feedback Control: Error Dynamics, Stability Thresholds, and Prompt Interventions in LLMs | 2026-04-24 | arXiv | 2604.22273 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 468 | GSAR: Typed Grounding for Hallucination Detection and Recovery in Multi-Agent LLMs | 2026-04-25 | arXiv | 2604.23366 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 469 | Green Shielding: A User-Centric Approach Towards Trustworthy AI | 2026-04-27 | arXiv | 2604.24700 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 470 | TSAssistant: A Human-in-the-Loop Agentic Framework for Automated Target Safety Assessment | 2026-04-27 | arXiv | 2604.23938 | Title/abstract | Excluded | No persistent cross-case improvement: Drug target safety report agents; persistent memory stores enforce constraints, not learned from experience. | ||||
| 471 | Frontier Coding Agents Can Now Implement an AlphaZero Self-Play Machine Learning Pipeline For Connect Four That Performs Comparably to an External Solver | 2026-04-27 | arXiv | 2604.25067 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 472 | Plausible but Wrong: A case study on Agentic Failures in Astrophysical Workflows | 2026-04-28 | arXiv | 2604.25345 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 473 | Agentic Architect: An Agentic AI Framework for Architecture Design Exploration and Optimization | 2026-04-28 | arXiv | 2604.25083 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 474 | Detecting Clinical Discrepancies in Health Coaching Agents: A Dual-Stream Memory and Reconciliation Architecture | 2026-04-29 | arXiv | 2604.27045 | Title/abstract | Excluded | Rule P1 per-patient memory only | ||||
| 475 | Performance of large language models and prompt engineering strategies for data extraction in systematic reviews. | 2026-04-29 | EuropePMC | 10.3389/fdgth.2026.1799623 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 476 | SAAG: Structured Agent Assessment and Grounding | 2026-04-30 | arXiv | 2607.18245 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 477 | Healthcare AI GYM for Medical Agents | 2026-05-01 | arXiv | 2605.02943 | Full text | Included | jeong2026healthcaregym | ||||
| 478 | Virtual Speech Therapist: A Clinician-in-the-Loop AI Agent for Speech Therapy Planning | 2026-05-01 | arXiv | 2605.01101 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 479 | Evaluating a Consumer LLM for Suicide Risk Response Calibration: A Pilot Study. | 2026-05-01 | EuropePMC | 10.3233/shti260331 | Title/abstract | Excluded | Not an LLM agent: Not an LLM-based agent system. | ||||
| 480 | MAP-Law: Coverage-Driven Retrieval Control for Multi-Turn Legal Consultation | 2026-05-02 | arXiv | 2605.01486 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 481 | Catching the Infection Before It Spreads: Foresight-Guided Defense in Multi-Agent Systems | 2026-05-03 | arXiv | 2605.01758 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 482 | From Where Things Are to What They Are For: Benchmarking Spatial-Functional Intelligence in Multimodal LLMs | 2026-05-04 | arXiv | 2605.02130 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 483 | CASCADE: Case-Based Continual Adaptation for Large Language Models During Deployment | 2026-05-05 | arXiv | 2605.06702 | Title/abstract | Excluded | Rule P2 healthcare not the study focus | ||||
| 484 | LATS-RCA: Language Agent Tree Search for Root Cause Analysis in Microservices | 2026-05-05 | arXiv | 2605.03505 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 485 | Device-Induced Thrombus Formation in Cerebral Aneurysms: Linking Patient-Specific Clot Modeling and Functional Occlusion to Virtual Angiographic Assessment | 2026-05-05 | arXiv | 2605.03536 | Title/abstract | Excluded | Not an LLM agent: Not an LLM-based agent system. | ||||
| 486 | MemReranker: Reasoning-Aware Reranking for Agent Memory Retrieval | 2026-05-07 | arXiv | 2605.06132 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 487 | AI-Care: A Conversational Agentic System for Task Coordination in Alzheimer's Disease Care | 2026-05-08 | arXiv | 2605.08480 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 488 | Mirror, Mirror on the Wall: Can VLM Agents Tell Who They Are at All? | 2026-05-09 | arXiv | 2605.08816 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 489 | CodeClinic: Evaluating Automation of Coding Skills for Clinical Reasoning Agents | 2026-05-10 | arXiv | 2605.09675 | Full text | Included | ossowski2026codeclinic | ||||
| 490 | MAGE: Multi-Agent Self-Evolution with Co-Evolutionary Knowledge Graphs | 2026-05-11 | arXiv | 2605.10064 | Full text | Excluded | Healthcare not the primary focus: General self-evolution framework on nine benchmarks; MedQA-USMLE is one domain extension and authors state it is not a clinical system (Sec 4.1, Table 2). Rule P2. | ||||
| 491 | DeepRefine: Agentic Knowledge Refinement via Reinforcement Learning | 2026-05-11 | arXiv | 2605.10488 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 492 | AnomalyClaw: A Universal Visual Anomaly Detection Agent via Tool-Grounded Refutation | 2026-05-11 | arXiv | 2605.10397 | Full text | Excluded | Healthcare not the primary focus: Universal anomaly detection on 12 domains (CrossDomainVAD-12, Sec 4.1); medical sources are 4 of 12 (DermaMNIST, BraTS, BMAD-Liver, HyperKvasir). Rule P2. | ||||
| 493 | Generating synthetic electronic health record data using agent-based models to evaluate machine learning robustness under mass casualty incidents | 2026-05-11 | arXiv | 2605.09951 | Title/abstract | Excluded | Not an LLM agent: Not an LLM-based agent system. | ||||
| 494 | PrimeKG-CL: A Continual Graph Learning Benchmark on Evolving Biomedical Knowledge Graphs | 2026-05-11 | arXiv | 2605.10529 | Title/abstract | Excluded | Not an LLM agent: Not an LLM-based agent system. | ||||
| 495 | SAGE: A Self-Evolving Agentic Graph-Memory Engine for Structure-Aware Associative Memory | 2026-05-12 | arXiv | 2605.12061 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 496 | On-Policy Self-Evolution via Failure Trajectories for Agentic Safety Alignment | 2026-05-12 | arXiv | 2605.11882 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 497 | EvolveMem:Self-Evolving Memory Architecture via AutoResearch for LLM Agents | 2026-05-13 | arXiv | 2605.13941 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 498 | SkillFlow: Flow-Driven Recursive Skill Evolution for Agentic Orchestration | 2026-05-13 | arXiv | 2605.14089 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 499 | An Agentic LLM-Based Framework for Population-Scale Mental Health Screening | 2026-05-13 | arXiv | 2605.13046 | Full text | Excluded | No persistent cross-case improvement: Pipeline configuration swept once on DAIC-WOZ validation and locked (Sec IV-D, Table III); no reuse on later held-out cases reported. Borderline: tuned-workflow reading; also F3 (stage agents apply fixed rules). | ||||
| 500 | Is Agentic AI Ready for Real-World Hardware Engineering? A Deep Dive with Phoenix-bench | 2026-05-13 | arXiv | 2605.15226 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 501 | RealICU: Do LLM Agents Understand Long-Context ICU Data? A Benchmark Beyond Behavior Imitation | 2026-05-13 | arXiv | 2605.13542 | Full text | Excluded | No persistent cross-case improvement: ICU-Evo memory is initialized per ICU stay and updated only within that stay (Sec 4.1, App C.3 Algorithm 2); rule P1. Baselines are within-stay context or RAG (App A.1). | ||||
| 502 | Large Language Models Lack Temporal Awareness of Medical Knowledge | 2026-05-13 | arXiv | 2605.13045 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 503 | Agentifying Patient Dynamics within LLMs through Interacting with Clinical World Model | 2026-05-14 | arXiv | 2605.14723 | Full text | Included | wu2026sepsisagent | ||||
| 504 | DermAgent: A Self-Reflective Agentic System for Dermatological Image Analysis with Multi-Tool Reasoning and Traceable Decision-Making | 2026-05-14 | arXiv | 2605.14403 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 505 | Towards In-Depth Root Cause Localization for Microservices with Multi-Agent Recursion-of-Thought | 2026-05-14 | arXiv | 2605.14866 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 506 | FuzzAgent: Multi-Agent System for End-to-End Evolutionary Library Fuzzing | 2026-05-14 | arXiv | 2605.14431 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 507 | After the Interface: Relocating Human Agency in the Age of Conversational AI | 2026-05-14 | arXiv | 2605.15064 | 10.1145/3816046.3816301 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | |||
| 508 | From Text to Voice: A Reproducible and Verifiable Framework for Evaluating Tool Calling LLM Agents | 2026-05-14 | arXiv | 2605.15104 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 509 | Accurate and Efficient Long-Term Memory for LLM Agents | 2026-05-15 | arXiv | 2607.16211 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 510 | STAR: A Stage-attributed Triage and Repair framework for RCA Agents in Microservices | 2026-05-15 | arXiv | 2605.15581 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 511 | SEMA-RAG: A Self-Evolving Multi-Agent Retrieval-Augmented Generation Framework for Medical Reasoning | 2026-05-16 | arXiv | 2605.17101 | Title/abstract | Excluded | No persistent cross-case improvement: Self-evolving retrieval within a question across rounds; no persistence across cases evident. | ||||
| 512 | Representation Signatures and Risk-Feedback Alignment in LLM Trading Agents | 2026-05-16 | arXiv | 2605.28850 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 513 | Designing for Being-With: Presence Without Personhood in Conversational Human-AI Interaction | 2026-05-16 | arXiv | 2605.17194 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 514 | GraphMind: From Operational Traces to Self-Evolving Workflow Automation | 2026-05-17 | arXiv | 2605.17617 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 515 | SkillGenBench: Benchmarking Skill Generation Pipelines for LLM Agents | 2026-05-18 | arXiv | 2605.18693 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 516 | KISS - Knowledge Infrastructure for Scientific Simulation: A Scaffolding for Agentic Earth Science | 2026-05-18 | arXiv | 2605.17856 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 517 | AI-powered digital innovations in pharmaceuticals research & development: Current landscape and case examples. | 2026-05-18 | EuropePMC | 10.1080/10543406.2026.2670522 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 518 | Library Drift: Diagnosing and Fixing a Silent Failure Mode in Self-Evolving LLM Skill Libraries | 2026-05-19 | arXiv | 2605.19576 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 519 | KernelBrain: Coarse-to-Fine, Budget-Aware Search for Agentic GPU Kernel Optimization | 2026-05-19 | arXiv | 2608.02611 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 520 | What Do Evolutionary Coding Agents Evolve? | 2026-05-19 | arXiv | 2605.20086 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 521 | MedExpMem: Adapting Experience Memory for Differential Diagnosis | 2026-05-20 | arXiv | 2605.22872 | Already charted | Included (re-confirmed) | feng2026medexpmem | ||||
| 522 | Trace2Skill: Verifier-Guided Skill Evolution for Long-Context EDA Agents | 2026-05-20 | arXiv | 2605.21810 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 523 | MemConflict: Evaluating Long-Term Memory Systems Under Memory Conflicts | 2026-05-20 | arXiv | 2605.20926 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 524 | Benchmarking Large Language Models and Prompt Engineering Strategies in Microsatellite Instability Cancers: Evaluation Study. | 2026-05-21 | EuropePMC | 10.2196/88614 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 525 | SkillEvolBench: Benchmarking the Evolution from Episodic Experience to Procedural Skills | 2026-05-22 | arXiv | 2605.24117 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 526 | Human-in-the-Loop Multi-Agent Ventilator Decision Support with Contextual Bandit Preference Learning | 2026-05-22 | arXiv | 2605.23320 | Full text | Included | li2026vdss | ||||
| 527 | Self-Evolving Agent Engineering for Healthcare: Methodologies and Applications | 2026-05-22 | EuropePMC | 10.20944/preprints202605.1547.v1 | Title/abstract | Excluded | Not primary research: Review of self-evolving agent engineering in healthcare; not primary research. | ||||
| 528 | SEAL: Synergistic Co-Evolution of Agents and Learning Environments | 2026-05-23 | arXiv | 2605.24426 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 529 | DemoEvolve: Demonstration-Guided Harness Evolution under Sparse Feedback | 2026-05-23 | arXiv | 2605.24539 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 530 | IterInject: Indirect Prompt Injection Against LLM Agents via Feedback-Guided Iterative Optimization | 2026-05-23 | arXiv | 2605.24659 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 531 | Eureka: Intelligent Feature Engineering for Enterprise AI Cloud Resource Demand Prediction | 2026-05-24 | arXiv | 2605.25297 | 10.1007/978-981-92-0378-9_33 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | |||
| 532 | CyberEvolver: Structured Self-Evolution for Cybersecurity Agents On the Fly | 2026-05-25 | arXiv | 2605.26195 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 533 | RepoMirage: Probing Repository Context Reasoning in Code Agents with Perturbations | 2026-05-25 | arXiv | 2605.26177 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 534 | Language-Specific Differences in Large Language Model Diagnostic Reasoning: A Translation-Controlled Clinical Vignette Study. | 2026-05-25 | EuropePMC | 10.3390/jcm15114082 | Title/abstract | Excluded | Not an LLM agent: Not an LLM-based agent system. | ||||
| 535 | SkillGrad: Optimizing Agent Skills Like Gradient Descent | 2026-05-26 | arXiv | 2605.27760 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 536 | TCP-MCP: Landscape-Guided Co-Evolution of Prompts and Communication Topologies for Multi-Agent Systems | 2026-05-27 | arXiv | 2605.27850 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 537 | MaskClaw: Edge-Side Personalized Privacy Arbitration for GUI Agents with Behavior-Driven Skill Evolution | 2026-05-27 | arXiv | 2605.28646 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 538 | Digital Registrar: A Schema-First Framework for Multi-Cancer Privacy-Preserving Pathology Abstraction via Local LLMs. | 2026-05-27 | EuropePMC | 10.3390/diagnostics16111644 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 539 | BenchTrace: A Benchmark for Testing Reflection Ability and Controlled Evolution in LLM Agents | 2026-05-28 | arXiv | 2605.29225 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 540 | GRASP: Gated Regression-Aware Skill Proposer for Self-Improving LLM Agents | 2026-05-28 | arXiv | 2605.29668 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 541 | Specialize Roles, Mix Deployments: Pushing the Cost-Accuracy Frontier of LLM Agent Teams | 2026-05-28 | arXiv | 2606.20629 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 542 | WorldMemArena: Evaluating Multimodal Agent Memory Through Action-World Interaction | 2026-05-28 | arXiv | 2605.29341 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 543 | LLM-ALSO: LLM-Driven Adaptive Learning-Signal Optimization for Multi-Agent Reinforcement Learning | 2026-05-28 | arXiv | 2605.29293 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 544 | Honest Lying: Understanding Memory Confabulation in Reflexive Agents | 2026-05-28 | arXiv | 2605.29463 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 545 | AgentOdyssey: Open-Ended Long-Horizon Text Game Generation for Test-Time Continual Learning Agents | 2026-05-29 | arXiv | 2606.24893 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 546 | What Drives LLM Self-Reflection? A Controlled Ablation of Uncertainty Routing in Armed Conflict Forecasting | 2026-05-29 | arXiv | 2608.12322 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 547 | VIABLE: A Visually Impaired Assistance Benchmark for VLM-as-a-Judge Evaluation | 2026-05-29 | arXiv | 2605.31351 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 548 | Verifier-First Evaluation of Agentic LLMs for Infrastructure-as-Code Generation | 2026-05-29 | arXiv | 2607.20478 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 549 | EGOSTREAM: A Diagnostic Benchmark for Streaming Episodic Memory in Egocentric Vision | 2026-05-29 | arXiv | 2605.31557 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 550 | Teaching Personalized Doctor-Patient Communication with AI: PerTRAIN - a Prototype for Interpersonally Responsive Virtual Patients in Medical Education. | 2026-05-29 | EuropePMC | 10.5334/pme.2379 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 551 | ANDES: Agent Native Data Evolving Synthesis Tool for Autonomous Instruction Alignment | 2026-05-31 | arXiv | 2606.01279 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 552 | DrugClaw and DrugAudit: A Primary-Source-Grounded Agent and Authority-Aware Benchmark for Drug-Information Question Answering | 2026-05-31 | arXiv | 2606.01434 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 553 | Traj-Evolve: A Self-Evolving Multi-Agent System for Patient Trajectory Modeling in Lung Cancer Early Detection | 2026-06-01 | arXiv | 2606.02812 | Full text | Included | zeng2026trajevolve | ||||
| 554 | ClinicalMC: A Benchmark for Multi-Course Clinical Decision-Making with Large Language Models | 2026-06-02 | arXiv | 2606.03157 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 555 | EvoTrainer: Co-Evolving LLM Policies and Training Harnesses for Autonomous Agentic Reinforcement Learning | 2026-06-02 | arXiv | 2606.03108 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 556 | The Saturation Trap and the Subjectivity of Intervention Timing: Why Affect-Based Triggers and LLM Judges Fail to Time Interventions on Autonomous Agents | 2026-06-02 | arXiv | 2606.04296 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 557 | Deliberate Evolution: Agentic Reasoning for Sample-Efficient Symbolic Regression with LLMs | 2026-06-03 | arXiv | 2606.04360 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 558 | Policy-Conditioned Counterfactual Credit for Verifiable Reinforcement Learning of Long-Horizon Language Agents | 2026-06-03 | arXiv | 2606.05263 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 559 | From Failed Trajectories to Reliable LLM Agents: Diagnosing and Repairing Harness Flaws | 2026-06-04 | arXiv | 2606.06324 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 560 | Elmes*: Automated Construction of Fine-Grained Evaluation Rubrics for Large Language Models in Long-Tail Educational Scenarios | 2026-06-04 | arXiv | 2606.06546 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 561 | SubtleMemory: A Benchmark for Fine-Grained Relational Memory Discrimination in Long-Horizon AI Agents | 2026-06-04 | arXiv | 2606.05761 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 562 | MADE: Beyond Scoring via a Multilingual Agentic Diagnosing Engine for Fine-Grained Evaluation Insights | 2026-06-05 | arXiv | 2606.07020 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 563 | SSR: Can Simulated Patients Learn to Stigmatize Themselves? Modeling Self-Stigma through Internal Monologue | 2026-06-06 | arXiv | 2606.08254 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 564 | Mitigating hallucinations in healthcare AI: a systematic review of evidence-based strategies. | 2026-06-06 | EuropePMC | 10.1186/s12913-026-14851-1 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 565 | Experience Makes Skillful: Enabling Generalizable Medical Agent Reasoning via Self-Evolving Skill Memory | 2026-06-08 | arXiv | 2606.09365 | Already charted | Included (re-confirmed) | sun2026skemex | ||||
| 566 | Multi-Turn Evaluation of Deep Research Agents Under Process-Level Feedback | 2026-06-08 | arXiv | 2606.09748 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 567 | LargeMonitor: Monitoring Online Task-Free Continual Learning via Large Pretrained Models | 2026-06-08 | arXiv | 2606.09430 | Title/abstract | Excluded | Not an LLM agent: Not an LLM-based agent system. | ||||
| 568 | Complexity synchronization as a diagnostic and control principle for adaptive systems | 2026-06-09 | arXiv | 2606.10948 | Title/abstract | Excluded | Not an LLM agent: Not an LLM-based agent system. | ||||
| 569 | HERO: Hindsight-Enhanced Reflection from Environment Observations for Agentic Self-Distillation | 2026-06-10 | arXiv | 2606.11559 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 570 | Arbor: Tree Search as a Cognition Layer for Autonomous Agents | 2026-06-10 | arXiv | 2606.12563 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 571 | Embodied-BenchClaw: An Autonomous Multi-Agent System for Embodied Spatial Intelligence Benchmark Construction | 2026-06-10 | arXiv | 2606.11909 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 572 | LatentDx: Latent Multi-Agent Communication for Cross-Hospital Rare-Disease Diagnosis | 2026-06-11 | arXiv | 2606.13945 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 573 | The Containment Gap: How Deployed Agentic AI Frameworks Fail Public-Facing Safety Requirements | 2026-06-11 | arXiv | 2606.12797 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 574 | Reasoning for Mobile User Experience with Multimodal LLMs: Task, Benchmark, and Approach | 2026-06-11 | arXiv | 2606.13192 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 575 | Augmenting large language models with clinical knowledge graph for personalized perioperative fluid therapy question answering. | 2026-06-11 | EuropePMC | 10.1371/journal.pdig.0001474 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 576 | Experience-Sensitive Game Learning: A Behavioral Study of Humans and Language Agents | 2026-06-15 | arXiv | 2608.07490 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 577 | MemSlides: A Hierarchical Memory Driven Agent Framework for Personalized Slide Generation with Multi-turn Local Revision | 2026-06-15 | arXiv | 2606.17162 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 578 | SEAGym: An Evaluation Environment for Self-Evolving LLM Agents | 2026-06-16 | arXiv | 2606.17546 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 579 | RubricsTree: Scalable and Evolving Open-Ended Evaluation of Personal Health Agents across Health Memory and Medical Skills | 2026-06-16 | arXiv | 2606.18203 | Title/abstract | Excluded | Not primary research: Evaluation rubric framework for health agents; evaluator evolves, not the agents; used as reward. | ||||
| 580 | Talking to Your Data: Exploring Embodied Conversation as an Interface for Personal Health Reflection | 2026-06-16 | arXiv | 2606.17767 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 581 | RTSGameBench: An RTS Benchmark for Strategic Reasoning by Vision-Language Models | 2026-06-17 | arXiv | 2606.18950 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 582 | EmoPatient: An Emotion-Directed Patient Simulator for Realistic Palliative Care Communication Training | 2026-06-17 | arXiv | 2608.07495 | Title/abstract | Excluded | No persistent cross-case improvement: Healthcare agent but adaptation only within case/session or static retrieval/fixed tuning. | ||||
| 583 | AgenticDB: Self-Evolving Reconfiguration Framework for Database Workloads | 2026-06-18 | arXiv | 2606.20318 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 584 | Empowering Polymeric Materials Discovery by Artificial Intelligence | 2026-06-18 | arXiv | 2606.20753 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 585 | Automating SKILL.md Generation for Computer-Using Agents via Interaction Trajectory Mining | 2026-06-18 | arXiv | 2606.20363 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 586 | ARTEMIS: Agent-guided Reliability-aware Temporal Mask Evolution for Imperfectly Supervised Video Polyp Segmentation | 2026-06-18 | arXiv | 2606.20161 | Title/abstract | Excluded | No persistent cross-case improvement: Debate VLM agent selects anchors within video; no cross-case retention evident. | ||||
| 587 | Measuring What Persists: Conditioning Mechanisms and a Geometric Framework for AI Agent Identity | 2026-06-20 | arXiv | 2606.21843 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 588 | Hypothesis-Driven Skill Optimization for LLM Agents | 2026-06-21 | arXiv | 2606.22330 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 589 | Evo-RAD: Navigating Rare Retinal Disease Diagnosis via Self-Evolving Agentic Retrieval | 2026-06-22 | arXiv | 2606.22955 | Full text | Excluded | Not an LLM agent: Sec 2.1-2.3: the retrieval agent is a 2-layer GCN policy trained by GRPO and diagnosis is majority vote; an LLM only expands label tags. Published MICCAI 2026 (LNCS). | ||||
| 590 | EHR-Complex: Benchmarking Medical Agents for Complex Clinical Reasoning | 2026-06-22 | arXiv | 2606.23301 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 591 | Self-Evolution for Multi-Turn Tool-Calling Agents via Divergence-Point Preference Learning | 2026-06-22 | arXiv | 2606.23112 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 592 | Density-dependent growth emerges from Bayesian adaptation of phenotype | 2026-06-24 | arXiv | 2606.25918 | Title/abstract | Excluded | Not an LLM agent: Not an LLM-based agent system. | ||||
| 593 | Evidence-Driven LLM Agent for C-to-Synthesizable-C Conversion and Verification | 2026-06-25 | arXiv | 2606.28409 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 594 | GenWorld: Empirically Grounded Urban Simulation Infrastructure for Scalable LLM-Agent Studies | 2026-06-26 | arXiv | 2606.27650 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 595 | An Agentic AI Pipeline for Appliance-Level Energy Anomaly Detection and LLM-Driven Recommendations | 2026-06-26 | arXiv | 2606.28467 | Title/abstract | Excluded | Not healthcare or clinical: Not a healthcare or clinical application. | ||||
| 596 | Artificial Intelligence, Cognitive Abundance, and the Multi-Layered Competence of Health Professionals. | 2026-06-26 | EuropePMC | 10.1097/ceh.0000000000000656 | Title/abstract | Excluded | Not primary research: Review, benchmark, evaluation, or position paper; evaluated systems do not adapt. | ||||
| 597 | An AI agent for treatment reasoning over a biomedical tool universe | 2026-06-27 | arXiv | 2606.28692 | Full text | Excluded | No persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment | ||||
| 598 | MedEvoEval: Evaluating Continual Evolution of Doctor Agents through Simulated Clinical Episodes | 2026-06-27 | arXiv | 2606.28900 | Full text | Included | zhang2026medevoeval | ||||
| 599 | How much of an LLM-generated clinical corpus is actually new? A production-scale measurement of content redundancy for provenance classification | 2026-06-28 | arXiv | 2606.29605 | Title/abstract | Excluded | No persistent cross-case improvement: Measures redundancy of LLM-generated clinical corpus; no agent improvement loop. | ||||
| 600 | CLQT: A Closed-Loop, Cost-Aware, Strategy-Consistent Benchmark for Diagnostic Evaluation of LLM Portfolio-Management Agents | 2026-06-29 | arXiv | 2606.29771 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 601 | SEVA: Self-Evolving Verification Agent with Process Reward for Fact Attribution | 2026-06-29 | arXiv | 2606.29713 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 602 | TopoAgent: An Agentic Framework for Automated Topology Learning in Medical Imaging | 2026-06-29 | arXiv | 2606.29763 | Full text | Included | meng2026topoagent | ||||
| 603 | One Reflection Is Not Enough: Self-Correcting Autonomous Research via Multi-Hypothesis Failure Attribution | 2026-06-30 | arXiv | 2606.31478 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 604 | Counterexamples as Feedback for Agent Self-Correction | 2026-07-01 | arXiv | 2609.02892 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 605 | Evaluating Agentic Harness Systems for Autonomous Computational Pathology | 2026-07-01 | arXiv | 2607.02598 | Title/abstract | Excluded | Not primary research: Benchmark of existing pathology harnesses; systems do not adapt. | ||||
| 606 | Adversarial Pragmatics for AI Safety Evaluation: A Diagnostic Framework and Seed Benchmark for Language-Mediated Control | 2026-07-01 | arXiv | 2607.01153 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 607 | Behavior-Adaptive Conversational Agents: Toward a Fluid Personality Framework | 2026-07-01 | arXiv | 2607.01034 | Title/abstract | Excluded | Not primary research: Conceptual framework sketch for adaptive persona; no evaluated system. | ||||
| 608 | KRCA: An Efficient Root Cause Analysis System in Hyper-scale Microservice Systems via Agentic AI | 2026-07-02 | arXiv | 2607.01788 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 609 | Benchmarking Motivational Interviewing Competence of Large Language Models. | 2026-07-04 | EuropePMC | 10.1159/000553455 | Title/abstract | Excluded | Not primary research: Benchmark of LLM motivational interviewing competence; no agent. | ||||
| 610 | Measuring Harness-Induced Belief Divergence in Multi-Step LLM Agents | 2026-07-05 | arXiv | 2607.04528 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 611 | EvoAgentBench: Benchmarking Agent Self-Evolution via Ability Transfer | 2026-07-06 | arXiv | 2607.05202 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 612 | Structured Large Language Model Workflows for Motivational Interviewing in Health Behavior Change: Proof-of-Concept Study. | 2026-07-06 | EuropePMC | 10.2196/94036 | Title/abstract | Excluded | No persistent cross-case improvement: Structured-workflow MI coaching agent; no persistent learning across users. | ||||
| 613 | AgentTether: Graph-Guided Diagnosis and Runtime Intervention for Reliable LLM Agent Operation | 2026-07-07 | arXiv | 2607.06273 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 614 | LLM Agents for Deliberative Collaboration: A Study on Joint Decision Making Under Partial Observability | 2026-07-07 | arXiv | 2607.06157 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 615 | Diagnosing Semantic Handoff Failures in Agent-Orchestrated Vision-Language-Action Skill Composition | 2026-07-07 | arXiv | 2607.06256 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 616 | Cost-Effective Agent Harnesses for Abstract Reasoning and Generalization on ARC-AGI-1 | 2026-07-07 | arXiv | 2607.06764 | Title/abstract | Excluded | Not healthcare or clinical: Persona dialogue emotion modelling; healthcare only a listed use. | ||||
| 617 | From Triggers to Emotions: A CPM-Grounded Appraisal Multi-Agent for Dynamic Emotional Evolution in Persona-Based Dialogue | 2026-07-08 | arXiv | 2607.07824 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 618 | Self-Adaptive Anomaly Detection with Reinforcement Learning and Human Feedback in Connected Vehicles | 2026-07-09 | arXiv | 2607.08373 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 619 | Cerebro Tune: A novel Bio-Inspired Hybrid Metaheuristic for Hyperparameter Optimizations in Deep Learning Using Cellular Automata and Reinforcement Learning | 2026-07-09 | EuropePMC | 10.21203/rs.3.rs-10103501/v1 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 620 | LongMedBench: Benchmarking Medical Agents for Long-Horizon Clinical Decision-Making | 2026-07-10 | arXiv | 2607.09322 | Full text | Excluded | Not primary research: Benchmark paper; evaluated long-context, RAG and Mem0 systems only hold each patient's own visit history and do not adapt across patients (Sec 2.1, 3.1); P1 also applies. | ||||
| 621 | SAGEAgent: A Self-Evolving Agent for Cost-Aware Modality Acquisition in Multimodal Survival Prediction | 2026-07-10 | arXiv | 2607.09521 | Full text | Included | qu2026sageagent | ||||
| 622 | All Explanations are Wrong, But Many Are Useful: Exploring the Rashomon Explanation Set with Large Language Models | 2026-07-10 | arXiv | 2607.09502 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 623 | Q-Learning Lab: Teaching Reinforcement Learning Through Learner-Generated Trace Analysis | 2026-07-12 | arXiv | 2607.10802 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 624 | The Path to Self-Evolving Clinical Systems: Scaling Medical Agents from Assistance to Autonomy | 2026-07-13 | arXiv | 2607.11175 | Title/abstract | Excluded | Not primary research: Survey of medical agents. | ||||
| 625 | OpsMem: Dual-Memory Reasoning with Cross-Memory Resonance for Failure Diagnosis | 2026-07-13 | arXiv | 2607.11357 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 626 | NextFund: A Unified Performance Tracking Platform for Agentic Portfolio Management | 2026-07-13 | arXiv | 2607.11141 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 627 | Human AI Construction of Bayesian Networks for Operational Decision Support -- A Virtual Survey Approach | 2026-07-13 | arXiv | 2607.14141 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 628 | AutoMem: A Text-Gradient Recursive Self-Improvement Framework for Automated Memory Architectures Search | 2026-07-14 | arXiv | 2608.14621 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 629 | MemOps: Benchmarking Lifecycle Memory Operations in Long-Horizon Conversations | 2026-07-14 | arXiv | 2607.12893 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 630 | HarnessBank: Semantic Gene-Bank Search with Gated Verification for Agent-Harness Self-Evolution | 2026-07-15 | arXiv | 2607.13683 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 631 | Cura 1T: Healthcare Foundation Model via Recursive Self-Improvement | 2026-07-15 | arXiv | 2607.15314 | Full text | Included | chen2026cura | ||||
| 632 | A Self-Evolving Agent for Longitudinal Personal Health Management | 2026-07-15 | arXiv | 2607.13940 | Already charted | Included (re-confirmed) | li2026healthclaw | ||||
| 633 | One-for-All Adaptive Radiotherapy Planning Agent: A Foundation Framework for Daily CBCT-guided Radiotherapy | 2026-07-16 | arXiv | 2607.14870 | Title/abstract | Excluded | No persistent cross-case improvement: Radiotherapy planning foundation-model agent; no cross-case learning described. | ||||
| 634 | OmniaBench: Benchmarking General AI Agents Across Diverse Scenarios | 2026-07-16 | arXiv | 2607.14989 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 635 | SCITUS: A Multi-Jurisdictional Framework for Adapting NIST AI RMF to the Canadian Regulatory Context | 2026-07-16 | arXiv | 2607.15051 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 636 | 3D Geometric Tooth Alignment Planning via Deep Reinforcement Learning | 2026-07-16 | arXiv | 2607.14544 | Title/abstract | Excluded | Not an LLM agent: DRL tooth alignment, no LLM. | ||||
| 637 | Fantastic Adaptive Taxonomies and How to Use Them | 2026-07-17 | arXiv | 2607.16387 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 638 | Review: Techniques in Egocentric Multi-View Image Analysis: Advances, Challenges, and Future Directions. | 2026-07-17 | EuropePMC | 10.3390/jimaging12070324 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 639 | PERA: A Perceive-Reason-Act Interface Bridging Sensing, Cognitive Reasoning, and Trustworthy Agentic Response for 6G | 2026-07-18 | arXiv | 2607.16896 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 640 | Enhancing Personalized Bladder Cancer Treatment Through Reinforcement Learning: A Recurrent Patient State Transition Decision Support Framework | 2026-07-18 | arXiv | 2607.16916 | Title/abstract | Excluded | Not an LLM agent: DQN bladder cancer treatment simulation, no LLM. | ||||
| 641 | Evolving Self-Organising Agents Without Fitness: Three Falsifiable Experiments from Constraint-Driven Selection to Developmental Encoding | 2026-07-18 | arXiv | 2607.21630 | 10.1145/3795101.3814687 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | |||
| 642 | Can Motivational Interviewing be delivered using Artificial Intelligence chatbots? Evaluating the capability of GPT-4o. | 2026-07-18 | EuropePMC | 10.1016/j.pec.2026.109782 | Title/abstract | Excluded | Not an LLM agent: GPT-4o chatbot evaluation for MI; not an agent, no learning. | ||||
| 643 | SR-Agent: An Experience-Driven Agentic Framework for Post-Ranking Strategy Refinement in E-Commerce Recommendation | 2026-07-20 | arXiv | 2607.17719 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 644 | LLMs and Agentic AI Systems for Smart Grids: A Tutorial on Architectures and Applications | 2026-07-20 | arXiv | 2607.18147 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 645 | Oracle Gap and Signal Fidelity: A Fixed-Pool Diagnostic for Test-Time Collaboration | 2026-07-20 | arXiv | 2607.17531 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 646 | jina-reranker-v3.5: An Efficient Listwise Reranker with Hybrid Attention and Self-Distillation | 2026-07-20 | arXiv | 2607.18152 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 647 | Verifiable Self-Evolution for Open-Ended Dialogue Skills via Future-Feedback Prediction | 2026-07-21 | arXiv | 2607.18973 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 648 | AgentDebugX: An Open-Source Toolkit for Failure Observability, Attribution, and Recovery in LLM Agents | 2026-07-21 | arXiv | 2607.18754 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 649 | TOUR: A Trajectory-Level Unlearning Benchmark for Offline Reinforcement Learning | 2026-07-23 | arXiv | 2607.21111 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 650 | AgentOmnia: Scaling Agentic Models for Full-Scenario Applications | 2026-07-25 | arXiv | 2607.23124 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 651 | MulRobBench: A Decision-Level Benchmark for Safe and Security-Policy-Compliant Multimodal UAV Agents | 2026-07-26 | arXiv | 2607.23870 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 652 | Falsifiable Commitment Planning for Self-Correcting Web Agents | 2026-07-27 | arXiv | 2607.24167 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 653 | Keep It InMind: Benchmarking the Implicit-Association Blind Spot in Agent Memory | 2026-07-27 | arXiv | 2607.24368 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 654 | PatientAgentBench: A Benchmark Framework for Evaluating Patient-Facing Health AI Agents | 2026-07-28 | arXiv | 2607.25485 | Title/abstract | Excluded | Not primary research: Benchmark of patient-facing agents; systems do not adapt. | ||||
| 655 | SkillMentor: LLM Agent Self-Evolution via Learning Blind-Spot Diagnosis | 2026-07-29 | arXiv | 2607.27360 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 656 | Leveraging Trajectory Graphs for Pre-Execution Error Diagnosis in Agentic LLM Systems | 2026-07-29 | arXiv | 2607.27443 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 657 | Rethinking AI in Medical Imaging: Assumptions, Reality, and Reframing; Towards Physician-Centered Agentic Reasoning | 2026-07-29 | arXiv | 2607.27428 | Title/abstract | Excluded | Not primary research: Position paper on medical imaging AI. | ||||
| 658 | VeriSkill: A Self-Evolution Framework for Program Verification Skills | 2026-07-30 | arXiv | 2607.27733 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 659 | Reflection or Re-Generation? Why LLM Revision Fails Where Human Revision Succeeds | 2026-07-31 | arXiv | 2607.28908 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 660 | AgentHPOBench: A Benchmark For Evaluating LLM Agents as Sequential Hyperparameter Optimizers | 2026-07-31 | arXiv | 2607.29626 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 661 | Alignment Is Local: A Paired Diagnostic for GUI Agents under User-Side Persuasion | 2026-07-31 | arXiv | 2607.29199 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 662 | The Multi-Lab Enterprise: Governance, FinOps, and Telemetry Challenges of Multi-Model AI Adoption | 2026-07-31 | arXiv | 2609.31622 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 663 | TrajWiki: Source-Grounded Memory Trajectories for Long-Horizon Dialogue Agents | 2026-08-02 | arXiv | 2608.00967 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 664 | EntailLLM: Verifying Agent-Generated Vulnerability Discovery Paths with Domain Knowledge via Logic Programming | 2026-08-03 | arXiv | 2608.01763 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 665 | GDPevo: Evaluating Agent Self-Evolution on Real Business Tasks | 2026-08-04 | arXiv | 2608.03764 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 666 | DiagChain: A Diagnostic Benchmark for Evaluating LLM Agents on Evidence-Grounded Attack Chain Reconstruction | 2026-08-04 | arXiv | 2608.03591 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 667 | TumorBoard: Evidence-Grounded Multi-Agent Decision Support for Longitudinal Neuro-Oncology | 2026-08-04 | arXiv | 2608.03190 | Title/abstract | Excluded | No persistent cross-case improvement: Multi-agent neuro-oncology decision support; per-case state only. | ||||
| 668 | DP-MemView: A Memory Interface for Attribute-Level Transcript Privacy in Long-Term LLM Agents | 2026-08-04 | arXiv | 2608.03130 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 669 | PAST-Bench: Benchmarking the Foundations of Recursive Self-Improvement in Personal Agents | 2026-08-04 | arXiv | 2608.04003 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 670 | A-SR: Self-Evolving Agentic LLMs for Symbolic Regression via Hierarchical Coordination | 2026-08-05 | arXiv | 2608.04872 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 671 | Agentic Reinforcement Learning with Observation-Calibrated Self-Distillation | 2026-08-05 | arXiv | 2608.04788 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 672 | SkillHEX: Improving Agent Skills via Hypothesis-Driven Autonomous Exploration and Exploitation | 2026-08-06 | arXiv | 2608.05628 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 673 | SkillTFM: Gated Skill Evolution for Training-Free Adaptation of Tabular Foundation Models | 2026-08-06 | arXiv | 2608.06137 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 674 | Controlled Memory Interference in Continual LLM Agents | 2026-08-07 | arXiv | 2608.07622 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 675 | An Agentic AI Framework Overcomes Fundamental Limitations of Large Language Models for Glaucoma Detection from Fundus Photography | 2026-08-07 | arXiv | 2608.07651 | Title/abstract | Excluded | No persistent cross-case improvement: Glaucoma agentic workflow with single-case reflection; no persistence. | ||||
| 676 | Gated-BEPO: Confidence-Gated Bellman Credit Assignment for Large Language Model Agents | 2026-08-07 | arXiv | 2608.06861 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 677 | EMAS: Stabilizing Multi-Agent System Evolution through Evidence-Guided Revision | 2026-08-07 | arXiv | 2608.07196 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 678 | Lingjing: A Simulation Testbed for Multi-Agent Embodied Tasks in Open-Ended Cities | 2026-08-08 | arXiv | 2608.08045 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 679 | SkillSmith: Enhancing Locally Deployed Agents via Automatic Skill Construction and Evolution | 2026-08-08 | arXiv | 2608.08037 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 680 | Branch2Skill: Efficient Skill Evolution Through Reasoning Trees | 2026-08-09 | arXiv | 2608.08677 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 681 | An Agentic Generative Large Language Model for Treatment Planning of Colorectal Cancer | 2026-08-10 | arXiv | 2608.09142 | Full text | Excluded | No persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment | ||||
| 682 | SiriusDeliver: Automating Data Warehouse Delivery at Tencent | 2026-08-10 | arXiv | 2608.09185 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 683 | SpecPath: Testing Coding Agents Across Contract-Equivalent Specification Histories | 2026-08-10 | arXiv | 2608.09799 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 684 | STAIR: Effective Incident Response Using an End-to-End Agentic Planning Framework | 2026-08-10 | arXiv | 2608.09524 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 685 | MIRA: Medical Image Reflection for Agentic Diagnosis | 2026-08-11 | arXiv | 2608.10827 | Full text | Included | wang2026mira | ||||
| 686 | ComBodied Agents: a New Paradigm of Human-Centric Agentic AI | 2026-08-11 | arXiv | 2608.10915 | Title/abstract | Excluded | Not primary research: Position/paradigm paper on human-centric agents. | ||||
| 687 | BioKG Explorer: Interactive Visual Analytics for Biomedical Knowledge Graph Exploration over PrimeKG | 2026-08-11 | EuropePMC | 10.21203/rs.3.rs-10004105/v2 | Title/abstract | Excluded | Not an LLM agent: Visual analytics tool for biomedical knowledge graph; no agent loop. | ||||
| 688 | Diagnosis Before Recovery: Turning Agent Failures into Selective Self-Correction | 2026-08-12 | arXiv | 2608.11772 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 689 | CAKE: Compiler-Agent Co-Design for Frontier Kernel Evolution | 2026-08-12 | arXiv | 2608.12629 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 690 | Large Language Models for Mental Health Prediction: Scoping Review of Bias and Clinical Utility Documentation in 2019-2024. | 2026-08-13 | EuropePMC | 10.2196/88082 | Title/abstract | Excluded | Not primary research: Scoping review. | ||||
| 691 | PACE-Bench: Benchmarking Physics Adaptation via Code Evolution in Dynamic Environments | 2026-08-14 | arXiv | 2608.14441 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 692 | BaT: Towards Self-Evolving Medical Research Agent with Stage Rubrics | 2026-08-17 | arXiv | 2608.16211 | Full text | Included | liu2026bat | ||||
| 693 | HarnessEval-W: Agentifying the Evaluation of Visual Worlds | 2026-08-17 | arXiv | 2608.16859 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 694 | Bounded Recursive Self-Improvement Under Human Governance: Evidence from a Seven-Cycle Reinforcement Learning Contour Experiment | 2026-08-17 | EuropePMC | 10.20944/preprints202608.0975.v2 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 695 | D$^2$ACCI: A Dual-Loop Diagnostic Protocol for Evidence-Preserving Agent Memory | 2026-08-18 | arXiv | 2608.17756 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 696 | Adaptive Memory and Reflection Multi-Agent System for Medical Question Answering | 2026-08-19 | arXiv | 2608.19029 | Full text | Included | murugesan2026amr | ||||
| 697 | EVADE: Evidence-Verified Agentic Diagnosis with Escape | 2026-08-19 | arXiv | 2608.18833 | Title/abstract | Excluded | No persistent cross-case improvement: Training-free single-case zoom and verification for VLM diagnosis. | ||||
| 698 | Competence, Not Accuracy: A Diagnostic for Reference-Free Judge Gates in Skill Optimization | 2026-08-19 | arXiv | 2608.18719 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 699 | MileGPO: Milestone Inference with Local Evidence for Graph-Based Policy Optimization of Long-Horizon LLM Agents | 2026-08-20 | arXiv | 2608.19803 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 700 | Sparse Multi-Stage Expert-Agent Routing for Complex Clinical Reasoning | 2026-08-22 | arXiv | 2608.21948 | Title/abstract | Excluded | No persistent cross-case improvement: Clinical multi-agent routing; memory only across stages within a case. | ||||
| 701 | MSM-Mem: A Universal Medical Structured Multimodal Memory Framework for Medical AI Agents | 2026-08-22 | arXiv | 2608.21810 | 10.48550/arxiv.1905.02269 | Full text | Excluded | No persistent cross-case improvement: P1: episodic and visual retrieval is filtered by patient_id and semantic memory is per-patient, so memory is reused only for the same patient (App A.1.1(e)-(f)). | |||
| 702 | GUI-Primitives: Diagnosing Spatial Reasoning Failures in Vision-Language GUI Grounding | 2026-08-22 | arXiv | 2608.21832 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 703 | MediSkill-Evo: Process-Constrained Self-Evolution for Evidence-Grounded Clinical Interaction | 2026-08-24 | arXiv | 2608.23397 | Full text | Included | wu2026mediskillevo | ||||
| 704 | A Source-Grounded Framework for Constructing and Evaluating Progressive Multimodal Diagnostic Dialogues from Clinical Case Reports | 2026-08-24 | arXiv | 2608.22713 | Title/abstract | Excluded | Not primary research: Benchmark construction from case reports; no adaptive system. | ||||
| 705 | CDEG: Learning Decision-Critical Evidence for Long-Horizon Diagnostic Agents | 2026-08-24 | arXiv | 2608.22899 | Full text | Included | dai2026cdeg | ||||
| 706 | AutoSaddler: Automatic Harness Optimization with Durable Updates from Agent Execution Traces | 2026-08-24 | arXiv | 2608.23041 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 707 | Resilience Matters for Embodied Agents System: New Metrics, Systematic Evaluation, and Optimization | 2026-08-24 | arXiv | 2608.23839 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 708 | EviDx: Evidence-Aware Active Diagnosis with Scaffolded LLM Agents | 2026-08-25 | arXiv | 2608.24570 | Title/abstract | Excluded | No persistent cross-case improvement: Active diagnosis scaffold; per-case evidence states only. | ||||
| 709 | RecurSE: Bounded Recursive Self-Evaluation for LLM Rubric Judges | 2026-08-25 | arXiv | 2608.24231 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 710 | Reflection- and Curriculum-Based Instruction Tuning for Diabetes-Specialized Large Language Models: Model Development and Evaluation Study. | 2026-08-25 | EuropePMC | 10.2196/92843 | Title/abstract | Excluded | Not an LLM agent: Instruction-tuned diabetes LLM; one-off fine-tuning, not an agent. | ||||
| 711 | From General Agents to RCA Experts: A Self-Evolving Harness for Root Cause Analysis | 2026-08-26 | arXiv | 2608.25661 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 712 | VISA: Agentic Self-Evolving Data Synthesis for Multimodal Instruction Following | 2026-08-26 | arXiv | 2608.26013 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 713 | A Practical Guide to Becoming a Clinical Problem Solving Discussant. | 2026-08-26 | EuropePMC | 10.1007/s11606-026-10699-7 | Title/abstract | Excluded | Not primary research: Practical guide for clinicians; not research system. | ||||
| 714 | ORDDAR: Observation-Driven Reasoning for Distortion-Resilient Decision, Action, and Cognitive Recovery | 2026-08-27 | arXiv | 2608.28704 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 715 | From Atomic to Agentic: Towards Interpretable Evaluation of LLMs' Agentic Mathematical Capabilities | 2026-08-27 | arXiv | 2608.26950 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 716 | EvoUndo: Recoverability-Constrained Self-Evolution for LLM Agent Harnesses | 2026-08-28 | arXiv | 2608.28363 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 717 | openJiuwen: Beyond Static Harnesses for Long-Horizon Coding Agents | 2026-08-28 | arXiv | 2608.27969 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 718 | Pandora’s Toolbox: A Survey of Generalist Agent Security from the Lifecycle Perspective | 2026-08-28 | EuropePMC | 10.20944/preprints202608.2066.v1 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 719 | MedCache: Efficient and Temporally Valid Memory for Longitudinal Clinical Agents | 2026-08-30 | arXiv | 2608.29528 | Title/abstract | Excluded | Rule P1 per-patient memory only | ||||
| 720 | DataFoundry: Evolving Data Preparators via Recursive Self-Improvement | 2026-08-30 | arXiv | 2608.29966 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 721 | Understanding Stage-Wise Utility-Risk Trade-offs in LLM Agent Memory | 2026-08-31 | arXiv | 2608.30177 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 722 | ATLAS: Dual-Horizon Diagnostic Evaluation for Tool-Use Agents in Meituan Xiaotua | 2026-08-31 | arXiv | 2608.30685 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 723 | S3C-LLM: Skill-Code Guided Agentic Language Models for Spectrum-to-Structure Elucidation | 2026-08-31 | arXiv | 2608.30910 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 724 | UTILMEM: Benchmarking Evidence Utilization in Long-Term Conversational Memory | 2026-08-31 | arXiv | 2608.30508 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 725 | RingMoClaw: An Experience-Inspired Multi-Agent Framework for Self-Evolving Research in Remote Sensing | 2026-09-01 | arXiv | 2609.00814 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 726 | Jailbreaking Text-to-Image Models Through Cracks: Navigating Heterogeneous Safety Filters via Multi-Agent Debate | 2026-09-01 | arXiv | 2609.01168 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 727 | Reveree: Diagnosing LLM Reverse-Engineering Agents | 2026-09-01 | arXiv | 2609.01185 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 728 | Embodied artificial intelligence in robotic orthopaedic surgery: from intelligent assistance to adaptive surgical autonomy. | 2026-09-01 | EuropePMC | 10.1007/s11701-026-03913-5 | Title/abstract | Excluded | Not primary research: Narrative review of embodied AI in orthopaedic surgery. | ||||
| 729 | Accountable AI with Grounded, Faithful, Consistent, Actionable Rationales: A Case Study in Clinical Trial Matching with VERDICT | 2026-09-03 | arXiv | 2609.03366 | Title/abstract | Excluded | No persistent cross-case improvement: Clinical trial matching accountability case study; no cross-case learning. | ||||
| 730 | AI models as consciousness attributors: how LLMs ascribe consciousness to other agents. | 2026-09-03 | EuropePMC | 10.3389/fpsyg.2026.1926286 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 731 | A Structured Debate-Mixture-of-Agents Framework for Complex Clinical Diagnostic Decision Support | 2026-09-04 | arXiv | 2609.05069 | Title/abstract | Excluded | No persistent cross-case improvement: Debate multi-agent diagnosis; adaptation within single case only. | ||||
| 732 | Interchangeable in Role, Not in History: Replacing Members of Formed LLM Teams | 2026-09-04 | arXiv | 2609.05279 | Title/abstract | Excluded | Rule P2 healthcare not the study focus | ||||
| 733 | ViT3Flow: A Test-Time Training Transformer MeanFlow for Postoperative Radiograph Synthesis in Scoliosis | 2026-09-04 | arXiv | 2609.05579 | Title/abstract | Excluded | Not an LLM agent: Radiograph synthesis model, not LLM agent. | ||||
| 734 | Closing the Consistency Gap: Self-Evolving Agents That Learn to Stay on Course | 2026-09-08 | arXiv | 2609.08832 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 735 | Evaluating the Teaching Effectiveness of Interactive Virtual Platform Based on Artificial Intelligence for Obstetrics and Gynecology Residency Training. | 2026-09-09 | EuropePMC | 10.2147/amep.s634648 | Title/abstract | Excluded | No persistent cross-case improvement: AI virtual teaching platform for OB/GYN residents; no agent improvement loop. | ||||
| 736 | AlamX: A Privacy-Preserving Local AI Framework for Symptom-Based Disease Prediction and Conversational Clinical Triage | 2026-09-09 | EuropePMC | 10.21203/rs.3.rs-10960720/v1 | Title/abstract | Excluded | Not an LLM agent: Local ML symptom triage; not LLM agent learning. | ||||
| 737 | A comparative evaluation of LLM-generated and clinician-written psychotherapy session summaries. | 2026-09-09 | EuropePMC | 10.1080/10503307.2026.2729093 | Title/abstract | Excluded | Not an LLM agent: Evaluation of LLM psychotherapy summaries; no agent or learning. | ||||
| 738 | Asclepius: An Adaptive Harness for Long-Horizon Clinical Agents | 2026-09-11 | arXiv | 2609.13543 | Already charted | Included (re-confirmed) | yuan2026asclepius | ||||
| 739 | MedRoundsQA: A Persona and Difficulty Aware Evaluation for Multi-Turn Medical Consultations | 2026-09-11 | arXiv | 2609.12851 | Title/abstract | Excluded | Not primary research: Multi-turn medical consultation benchmark; systems do not adapt. | ||||
| 740 | ParaRecover: A Process-Level Benchmark for Error Localization and Recovery in Parallel Tool-Use Agents | 2026-09-11 | arXiv | 2609.12345 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 741 | PiMiX 2.02: Toward AI-Driven Data Fusion in Radiographic Imaging and Tomography | 2026-09-11 | arXiv | 2609.13347 | Title/abstract | Excluded | Not an LLM agent: Imaging data fusion instrument, not LLM agent. | ||||
| 742 | HarnessBandit: Joint Learnability-Transferability Scheduling for Multi-Harness Agentic Reinforcement Learning | 2026-09-12 | arXiv | 2609.13739 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 743 | EMR: Self-Evolving Medical Multi-Agent System via Experience Mining and Reuse | 2026-09-14 | arXiv | 2609.15161 | Already charted | Included (re-confirmed) | shi2026emr | ||||
| 744 | Mapping U.S. Federal AI Governance Against Sector Vulnerability | 2026-09-14 | arXiv | 2609.16260 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare or clinical application. | ||||
| 745 | CLEAR: Cross-Source Evidence Adjudication for Large Language Models in Medicine | 2026-09-14 | arXiv | 2609.16301 | Title/abstract | Excluded | No persistent cross-case improvement: Cross-source evidence adjudication per query; static retrieval. | ||||
| 746 | AnchorGUI: Asymmetric Memory for Dual-Scale Learning in GUI Navigation | 2026-09-14 | arXiv | 2609.15457 | 10.1007/978-3-032-37447-9_6 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | |||
| 747 | AURA: Agentic Diagnosis and Refinement for Production Recommender Systems at Scale | 2026-09-15 | arXiv | 2609.16625 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 748 | DriveMCP: An Agentic AI framework for Advanced Driver Assistance System | 2026-09-15 | arXiv | 2609.17247 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 749 | Agentic Image Restoration Links Closed-Loop Controllers with Protocol-Aware Evaluation | 2026-09-15 | EuropePMC | 10.20944/preprints202609.1256.v1 | Title/abstract | Excluded | Not primary research: Review/perspective of agentic image restoration. | ||||
| 750 | Recursive Reasoning or Statistical Extrapolation? In-Context Learning in Multi-Agent Interdependent Decision-Making | 2026-09-16 | arXiv | 2609.18591 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 751 | Where Should Agents Live? Energy-Memory Characterization of Agentic AI for the Edge-Cloud Continuum | 2026-09-16 | arXiv | 2609.18283 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 752 | MAGMA-GEN: Validated Recovery Supervision from Ambiguous Failures via Counterfactual Re-Execution | 2026-09-17 | arXiv | 2609.20056 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 753 | LearnActCoder: Role-Aware Error Memory for Adaptive Clinical Coding Agents | 2026-09-17 | arXiv | 2609.19721 | Full text | Included | ghaffari2026learnactcoder | ||||
| 754 | The economics of accuracy for medical reasoning with large language models. | 2026-09-18 | EuropePMC | 10.1371/journal.pdig.0001182 | Title/abstract | Excluded | Not an LLM agent: Test-time scaling and fine-tuning comparison on medical QA; no agent. | ||||
| 755 | RPMem: Learning Long-Term Recurrent Parametric Memory Across Sessions for LLM Agents | 2026-09-20 | arXiv | 2609.23466 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 756 | MedRSI: Recursive Self-Improvement for Medical Agents via Clinically Aligned Self-Evolution | 2026-09-21 | arXiv | 2609.24838 | Already charted | Included (re-confirmed) | wu2026medrsi | ||||
| 757 | From Pattern Recognizers to Personalized Companions: A Survey of Large Language Models in Mental Health | 2026-09-21 | arXiv | 2609.25186 | Title/abstract | Excluded | Not primary research: Survey of LLMs in mental health. | ||||
| 758 | Reinforcement Learning with Decomposed Subtasks | 2026-09-22 | arXiv | 2609.27035 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 759 | Propose, Don't Judge: An Anytime-Valid Referee for LLM Agents That Mine Investment Factors | 2026-09-22 | arXiv | 2609.27051 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 760 | Process-Oriented, Behaviorally Anchored Assessment of Clinical Reasoning in Large Language Models and the Effect of Extended Thinking: Protocol for a Prospective, Multigroup, Comparative Study. | 2026-09-22 | EuropePMC | 10.2196/103220 | Title/abstract | Excluded | Not primary research: Protocol-only study on clinical reasoning assessment. | ||||
| 761 | Verifiable Hidden Dynamics Play: Generating Agentic RL Environments from Solved Mechanisms | 2026-09-23 | arXiv | 2609.27321 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 762 | EVAGE: Autonomous MEV Generation and Adaptation via Multi-Agent Harness | 2026-09-23 | arXiv | 2609.27424 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 763 | PASTABench: Proactive Assessment of Sequential Trajectories for Agent Safety | 2026-09-23 | arXiv | 2609.28197 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 764 | Probing Stability-Plasticity Tradeoffs in Agent Memory through Cognitive Experimental Paradigms | 2026-09-24 | arXiv | 2609.30558 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 765 | Research with AI Agents: How Agentic Systems Are Changing Scientific Work | 2026-09-25 | arXiv | 2609.31219 | Title/abstract | Excluded | Not primary research: Review of agentic systems in scientific work. | ||||
| 766 | SenseAgent: An LLM Agent for Adaptive Cross-Domain IMU Sensing | 2026-09-25 | arXiv | 2609.32000 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 767 | ReVision3D: Attribution-Guided Recursive Self-Improvement for 3D Medical Perception | 2026-09-26 | arXiv | 2609.32984 | Already charted | Included (re-confirmed) | lee2026revision3d | ||||
| 768 | Sivia: Learning to Draw, Learning to Learn | 2026-09-27 | arXiv | 2609.33386 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 769 | V-Gym: Enhancing Agentic Visual Reasoning via Skill-Data Co-Evolution | 2026-09-28 | arXiv | 2609.34682 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 770 | GenMem: Generative Symbolic Memory for Self-Evolving Harness | 2026-09-28 | arXiv | 2609.34633 | Title/abstract | Excluded | Not healthcare or clinical: Generalist memory method; medical reasoning only one of several benchmarks. | ||||
| 771 | ResonAct: Streaming Metrics for Runtime Diagnosis and Self-Healing in Multi-Agent Systems | 2026-09-28 | arXiv | 2609.34701 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 772 | UniOPSD: Unifying Outcome and Hindsight Feedback for Agentic Reinforcement Learning | 2026-09-28 | arXiv | 2609.34810 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 773 | Same Winners, Different Success Rates: Evaluating How LLM Agents Recover from Failures | 2026-09-28 | arXiv | 2609.34215 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 774 | Evo2Team: When Do Evolved Skills Transfer? From Selection to Deployment | 2026-09-28 | arXiv | 2609.34135 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 775 | SIPO: Selective-Inference Policy Optimization for Tree-Structured Agentic RL | 2026-09-28 | arXiv | 2609.34805 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 776 | Reliability Engineering for AI Systems: Challenges, Methods, and Directions | 2026-09-28 | arXiv | 2609.35316 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 777 | JET: Judge-Guided Evolution at Test Time for Agent Programs | 2026-09-28 | arXiv | 2609.34126 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 778 | NeuronSifter: An Agent-in-Twin for Prioritizing Central Nervous System Interventions with World Action Models | 2026-09-28 | arXiv | 2609.35445 | Full text | Excluded | Not an LLM agent: Numerical belief-state planner; an LLM is only an optional proposal backend (Sec 4.4; App A.1.7). Also non-clinical intervention prioritization; current v4 withdrawn, v3 assessed. | ||||
| 779 | PrivMeSA: Privacy-Aware Self-Evolving Multi-Agent System for Medicine via Local-Remote LLM Collaboration | 2026-09-29 | arXiv | 2609.38458 | Already charted | Included (re-confirmed) | wang2026privmesa | ||||
| 780 | On-Policy Visual Evidence Distillation | 2026-09-29 | arXiv | 2609.36838 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 781 | MedForge-RSI: Medical Deepfake Detection via Recursive Self-Improvement | 2026-09-29 | arXiv | 2609.36549 | Already charted | Included (re-confirmed) | chen2026medforge | ||||
| 782 | OceanMind: A multi-agent AI system for ocean diagnosis | 2026-09-30 | arXiv | 2610.03780 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 783 | From Given to Gathered Evidence: Agentic Learning for Longitudinal Medical Reasoning | 2026-09-30 | arXiv | 2609.39566 | Full text | Included | shao2026case | ||||
| 784 | ReLiveGym: Evaluating Long-Lived Agents over Weeks of Replayed Reality | 2026-09-30 | arXiv | 2610.00710 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 785 | Can Terminal Agents Trust Their Own Verification? Diagnosing and Improving Self-Verification | 2026-09-30 | arXiv | 2609.38812 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 786 | EmbodiRSI: Recursive Self-Improvement for Data-Efficient Robot Adaptation | 2026-09-30 | arXiv | 2609.38905 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 787 | NarrativeSteward: Coordinating Delegation, Guidance, and Verification in Agent-Assisted Interactive Narrative Authoring | 2026-09-30 | arXiv | 2609.39333 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 788 | RoboAssist: Interactive Human-Humanoid Planning for Long-Horizon Surgical Assistance | 2026-09-30 | arXiv | 2609.39384 | Title/abstract | Excluded | No persistent cross-case improvement: Surgical assistance planning; within-task replanning, no cross-case learning. | ||||
| 789 | EgoTools: Towards Tool-Centric Reasoning in Real-World Egocentric Videos | 2026-09-30 | arXiv | 2609.39378 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 790 | My FAULT: Self-Diagnosis as Credit Assignment in Self-Evolving Agentic Reinforcement Learning | 2026-10-01 | arXiv | 2610.01161 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 791 | DeFA: Dependency-Guided Failure Attribution for LLM Agents | 2026-10-01 | arXiv | 2610.01256 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 792 | GUI-HARVEST: Self-Improving GUI Agents through Evidence-Driven Harness Evolution | 2026-10-01 | arXiv | 2610.00948 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 793 | YouRA: A Persistent-State Architecture for Evidence-Traceable Autonomous Research Agents | 2026-10-01 | arXiv | 2610.01097 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 794 | Permutation Robustness Is Not Enough: Action Collapse in Multi-Agent Transformer Policies | 2026-10-02 | arXiv | 2610.02848 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 795 | Training Numerical Intelligence via Auto-Diagnosis and Skill Discovery | 2026-10-02 | arXiv | 2610.03872 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 796 | ARISE: Adaptive Agentic Reasoning with Image-grounded Self-Evaluation for Interpretable IBD Assessment | 2026-10-03 | arXiv | 2610.04777 | Title/abstract | Excluded | No persistent cross-case improvement: Single-case 5-stage agentic workflow for IBD imaging; no retained learning. | ||||
| 797 | templar: agentic induction and evolution of standardized radiology reporting templates from large-scale clinical corpora | 2026-10-04 | arXiv | 2610.05247 | Already charted | Included (re-confirmed) | hu2026templar | ||||
| 798 | AutoSciBench: Autonomous Benchmark Generation for Evaluating Scientific Agents | 2026-10-04 | arXiv | 2610.05140 | Title/abstract | Excluded | Not healthcare or clinical: Benchmark-generation agent across sciences; clinical imaging one domain, not clinical task. | ||||
| 799 | AI Agents as a Research Team: A Human-Supervised Case Study in Stellar Spectroscopy | 2026-10-04 | arXiv | 2610.05424 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 800 | AIProver: Agentic Auto-Formalization of Mathematical Research via Certificate-Driven Evolving Harness | 2026-10-04 | arXiv | 2610.05367 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 801 | RF-Agent: Hierarchical Language-Agent Control for Instruction-Conditioned Active Spectrum Sensing | 2026-10-04 | arXiv | 2610.05485 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 802 | PsyCIDRA: A Dual-Agent Framework for Psychiatric Interviewing and Diagnostic Reasoning | 2026-10-05 | arXiv | 2610.07473 | Title/abstract | Excluded | No persistent cross-case improvement: Psychiatric interview agent uses fixed expert-written skills; no experience-driven update. | ||||
| 803 | PACMI: Provenance-Aware Cascading Memory Invalidation for Long-Term LLM Agents | 2026-10-05 | arXiv | 2610.05732 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 804 | VERA: Scaling Verifiable Environments for Agentic co-Evolution | 2026-10-05 | arXiv | 2610.05923 | Full text | Excluded | Healthcare not the primary focus: P2: general model-harness co-evolution method evaluated on two domains, AutoCoWorkBench and AutoMedBench (Sec 3-4, App A). Borderline: medical research is the motivating example and half the evaluation. | ||||
| 805 | Second-Order Problem Solving for Recursive Self-Improvement in Formal Verification | 2026-10-05 | arXiv | 2610.05701 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 806 | The Right Memory in the Wrong Context: Verifying Retrieval Admissibility in Long-Term Agent Memory | 2026-10-05 | arXiv | 2610.07309 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 807 | MedZERO: Self-Evolving Agents for Open-Ended Medical Reasoning Through Controlled Knowledge Accumulation | 2026-10-06 | arXiv | 2610.08327 | Already charted | Included (re-confirmed) | dang2026medzero | ||||
| 808 | PhysEvo: Astra Can Act, Let It | 2026-10-06 | arXiv | 2610.08995 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 809 | LiveMACE: Process-Aware Evaluation of LLM Agent Capabilities in Evolving Markets | 2026-10-07 | arXiv | 2610.09872 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 810 | Know the Shape, Find the Fault: Topology-Conditioned Diagnosis of Multi-Agent LLM Failures | 2026-10-07 | arXiv | 2610.10126 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 811 | Conversational Task Disambiguation over Tabular Data: Leakage-Aware Formulation, Benchmark Suite, and Training | 2026-10-07 | arXiv | 2610.10740 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 812 | OOM-RL II: Reality Is an Oracle, Not a Debugger Provenance-Constrained Diagnosis in Continually Evolving Agent-Engineered Systems | 2026-10-07 | arXiv | 2610.10256 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 813 | TRACE: Diagnosing Verifier Brittleness in Agentic Evaluation | 2026-10-08 | arXiv | 2610.11678 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 814 | RoboRSI: Stable, efficient, and reusable robot self-evolution in complex real-world environments | 2026-10-08 | arXiv | 2610.12424 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 815 | What Output-Only Review Cannot Verify: Study Contracts for Research Agents | 2026-10-08 | arXiv | 2610.11754 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 816 | Learning from Expert-Corrected Misdiagnoses: A Self-Evolving Consultation Agent for Traditional Chinese Medicine after Failed Treatment | 2026-10-09 | arXiv | 2610.40663 | Already charted | Included (re-confirmed) | wang2026tcmsea | ||||
| 817 | ClawLoop: Self-Improving Agents via Harness-Native Training Loop | 2026-10-09 | arXiv | 2610.14118 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 818 | MemForm: Benchmarking Memory Formation Poisoning in LLM Agents | 2026-10-10 | arXiv | 2610.14431 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 819 | VitaBench: Memory Lifecycles Beyond Retrieval | 2026-10-10 | arXiv | 2610.14731 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 820 | A Self-Defining Operator for Distributed Applications | 2026-10-10 | arXiv | 2610.14547 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 821 | Sensitivity or Criterion? Measuring and Moving When Language Models Act | 2026-10-11 | arXiv | 2610.15415 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 822 | EvoQuantLab: Training-Free Dual-Loop Evolution for Auditable Quantitative Research | 2026-10-12 | arXiv | 2610.17130 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 823 | Beyond Successful Play: Diagnosing Opponent Modeling in Large Language Models | 2026-10-12 | arXiv | 2610.17310 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 824 | Uncovering Robustness Weaknesses in LLM Agents via Persona Evolution with Task-Integrity Constraints | 2026-10-12 | arXiv | 2610.16155 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 825 | Verifier-Harness Co-Evolution for Training-Free Self-Improvement on Open-Ended Tasks | 2026-10-13 | arXiv | 2610.17609 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 826 | EmbodiedEvo: Self-Evolving Coding Agent For Physical Intelligence | 2026-10-13 | arXiv | 2610.18867 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 827 | StateHarness: Maintaining Evolving Project State for Long-Horizon Coding Agents | 2026-10-13 | arXiv | 2610.17616 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 828 | Failure Recovery via Belief Updates and World Modeling for Long-Horizon Agents | 2026-10-13 | arXiv | 2610.18082 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 829 | What Human-AI Interaction Leaves Behind: Residual Human States -- A Trajectory-Based Framework and Multi-Study Analysis | 2026-10-13 | arXiv | 2610.18765 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 830 | ECG-RSI: Recursive Self-Improvement through Targeted Electrocardiogram Waveform Evolution | 2026-10-13 | arXiv | 2610.17718 | Already charted | Included (re-confirmed) | wang2026ecgrsi | ||||
| 831 | Reclaiming human clinical reasoning in generative AI-enabled healthcare: a perspective on cognitive agency, skill evolution, and accountability. | 2026-10-13 | EuropePMC | 10.3389/fpubh.2026.1979099 | Title/abstract | Excluded | Not primary research: Perspective on clinical reasoning with GenAI. | ||||
| 832 | PRISMATIC : Prescription Risk Inspection System for Multi-Agent Treatment Interaction in Clinical Decision-Making | 2026-10-14 | arXiv | 2610.19762 | Full text | Excluded | F7: Sample size and learning/test separation are not reported. The claimed more-than-twofold EM advantage is unsupported by Table2:13.58% versus9.86%, approximately1.38-fold. Previously included; author-approved revision5November2026. | ||||
| 833 | When Non-Adversarial Noise Hurts Learning: Benchmarking Skill Self-Evolution in Agents | 2026-10-14 | arXiv | 2610.19910 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 834 | HEM-Med: A Hierarchical Agentic Memory Framework for Safe Multi-Center Medication Recommendation | 2026-10-14 | arXiv | 2610.20191 | Full text | Excluded | Not an LLM agent: LLM (DeepSeek-v4-flash) only annotates training records offline; recommendation uses count-based memories, a supervised reranker and DDI decoding, not an LLM agent (Sec IV-A to IV-E). | ||||
| 835 | StepSafe: Learning Timely Intervention with Context-Aware Safety Reasoning | 2026-10-14 | arXiv | 2610.20960 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 836 | PhySGA: A Physics-Space Grounded Agentic Framework for Generalizable and Interactive 3D Composition | 2026-10-14 | arXiv | 2610.20560 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 837 | AdCoEvo: A Co-Evolving Multi-Agent Advertising Delivery System | 2026-10-14 | arXiv | 2610.19454 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 838 | A Self-Improving Agent that Grows its Own DSL: Oracle-Free Operator Induction for Exact Question Answering | 2026-10-14 | arXiv | 2610.20809 | Title/abstract | Excluded | Not healthcare or clinical: Self-growing DSL agent; clinical-encounter QA only an extension domain. | ||||
| 839 | MedPAO-VL: Interpretable and Protocol-Compliant Agent for Structured Radiology Report Generation | 2026-10-15 | arXiv | 2610.21794 | Title/abstract | Excluded | No persistent cross-case improvement: Radiology report agent with per-case iterative self-correction only. | ||||
| 840 | TRACER: A Multimodal Harness for Patient Care in Hospitals | 2026-10-15 | arXiv | 2610.21266 | Title/abstract | Excluded | No persistent cross-case improvement: Training-free ICU video/record harness; no learning across cases. | ||||
| 841 | OPRD: On-Policy Reminder Distillation for Long-Horizon Coding Agents | 2026-10-15 | arXiv | 2610.21496 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 842 | Beyond Downstream QA: Rethinking How We Evaluate Agent Memory | 2026-10-15 | arXiv | 2610.22209 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 843 | Recursive Reward Improvement via Adversarial Meta-Prompt Evolution | 2026-10-15 | arXiv | 2610.21040 | Full text | Excluded | Healthcare not the primary focus: P2: general open-ended expert-task method; loops also target PRBench and ProfBench (Sec 4.4, App H). Borderline: HealthBench Professional is the main target; solver's agent status also marginal. | ||||
| 844 | Unified Multiparadigm Fusion Intelligence for Rare Disease Diagnosis | 2026-10-16 | arXiv | 2610.24024 | Title/abstract | Excluded | No persistent cross-case improvement: Fusion with static case retrieval and per-case agentic reflection; no retained learning evident. | ||||
| 845 | MobileInject: Evaluating Reasoning-to-Action Security of MLLM-Based Mobile Agents under Cross-Modal Consistency Injection | 2026-10-16 | arXiv | 2610.23307 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 846 | Pronouncing Hard Words: Phoneme Adaptation of a Pretrained Conversational Text to Speech Model | 2026-10-16 | arXiv | 2610.24164 | Title/abstract | Excluded | Not an LLM agent: TTS phoneme adaptation for drug names; not an agent. | ||||
| 847 | Organon : From Evolutionary Search to Recursive Self-Improving Agents for Scientific Discovery | 2026-10-17 | arXiv | 2610.33046 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 848 | Mining the Self-Rewriting System: A Vision for Data Mining on AI-Native Infrastructure | 2026-10-18 | arXiv | 2610.25374 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 849 | MemDerive: A Diagnostic Benchmark for Agent Memory over Evolving Data | 2026-10-18 | arXiv | 2610.25373 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 850 | Which Agent's Skill Should Change? Group-Relative Credit Assignment for Evolving Multi-Agent Teams | 2026-10-19 | arXiv | 2610.27227 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 851 | Does Multi-Agent Collaboration Reduce Hallucination in Clinical Tasks? | 2026-10-19 | arXiv | 2610.27027 | Title/abstract | Excluded | No persistent cross-case improvement: Evaluation of multi-agent hallucination in clinical tasks; no persistent adaptation. | ||||
| 852 | BetaMem: Learning to Remember a Changing World for Embodied Agents | 2026-10-19 | arXiv | 2610.26554 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 853 | MARC: Mechanism-Aware Reflective Correction for Articulated Object Code Generation | 2026-10-19 | arXiv | 2610.33060 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 854 | Elicitation or Expansion? Demystifying Gains from Agent Harness Optimization | 2026-10-20 | arXiv | 2610.27889 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 855 | When Does Experience Memory Help Closed-Loop LLM Driving Agents? A Controlled Evaluation with Resampled Warmup Pools, Token-Matched Fillers, and Audited Baselines | 2026-10-20 | arXiv | 2610.27714 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 856 | KPHarness: Co-Evolving Knowledge and Probing for Long-Horizon Gaming Harnesses | 2026-10-20 | arXiv | 2610.27417 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 857 | HGM-Dual: Lineage-Aware Guided Agent Harness Optimization for Long-Horizon Planning | 2026-10-21 | arXiv | 2610.30042 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 858 | CORD: Conflict-Aware Optimization for Joint RL and Distillation in Agents | 2026-10-21 | arXiv | 2610.29965 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 859 | VeruSteer: Learning What to Repair Next in Verus | 2026-10-21 | arXiv | 2610.29755 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 860 | RIPPLE: Recovery Internalization through Process-Level Policy Learning and Effect-Aware Credit for Long-Horizon Agentic Coding | 2026-10-22 | arXiv | 2610.31276 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 861 | The Value of Memory in Language Agents | 2026-10-22 | arXiv | 2610.31303 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 862 | An LLM-based decision aid for collaborative decision-making in juvenile idiopathic arthritis: A multimethod evaluation. | 2026-10-22 | EuropePMC | 10.1371/journal.pdig.0001655 | Title/abstract | Excluded | No persistent cross-case improvement: LLM decision aid for juvenile arthritis; no learning across cases. | ||||
| 863 | TGR-EvoDAG: A DAG-based Multi-Agent Code Evolution Framework for Generative Recommendation on Tencent | 2026-10-23 | arXiv | 2610.32326 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 864 | DMAIC-Bench: From Self-Reflection to Self-Restraint for Agents in Multi-Stage Analytical Tasks | 2026-10-23 | arXiv | 2610.32305 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 865 | Understanding Communication Failures in Multi-Agent LLM Systems | 2026-10-23 | arXiv | 2610.32060 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 866 | SkillShift-Bench: Benchmarking Skill Learning under Environment Evolution for Web Agents | 2026-10-24 | arXiv | 2610.33528 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 867 | Auditing evaluation artifacts and data leakage in large language model systems for rare disease diagnosis | 2026-10-24 | arXiv | 2610.33592 | Title/abstract | Excluded | No persistent cross-case improvement: Evaluation audit of rare-disease LLM systems; no adaptive agent. | ||||
| 868 | Continual Learning Exam: Benchmarking Long-Horizon RSI and Experiential Learning in LLM Agents | 2026-10-25 | arXiv | 2610.33956 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 869 | ClinVerse: A Realistic Multi-Agent Diagnostic Environment for Training and Evaluating Medical Agents | 2026-10-26 | arXiv | 2610.34878 | Full text | Included | chen2026clinverse | ||||
| 870 | Beyond Federated Learning: Decentralized Agentic Systems for Self-Evolving Clinical Intelligence | 2026-10-26 | arXiv | 2610.35453 | Title/abstract | Excluded | Not primary research: Perspective proposing decentralized agentic systems for clinical intelligence. | ||||
| 871 | CohortFlow: A Steerable Clinical Cohort Curation Agent with Localized Semantic Correction | 2026-10-26 | arXiv | 2610.36100 | Title/abstract | Excluded | No persistent cross-case improvement: Cohort curation agent with within-task persistent execution graph; no cross-task learning. | ||||
| 872 | Same Story, Different Lens: A Multi-Agent System for Cross-Outlet News Framing Analysis | 2026-10-26 | arXiv | 2610.35208 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 873 | Trustworthy Recursive Self-Improvement in the Era of Large Models: Foundation, Risks, Evaluation and Open Challenges | 2026-10-26 | arXiv | 2610.35193 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 874 | Systematic Scoring Differences in Large Language Model-Based Clinical Benchmarking Reveal Evaluator-Dependent Divergence: Controlled Evaluation Study. | 2026-10-26 | EuropePMC | 10.2196/103962 | Title/abstract | Excluded | Not an LLM agent: LLM-as-evaluator scoring differences in clinical benchmarking; not an agent. | ||||
| 875 | The View from Nowhere: Population-Centered Agent Evolution | 2026-10-27 | arXiv | 2610.36660 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 876 | GARDEN: Generalist Autonomous Reward Design Through Evidence Navigation for Cooperative Multi-Agent Reinforcement Learning | 2026-10-27 | arXiv | 2610.37926 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 877 | Self-Evolving Recommender Systems: A Survey and an Evaluation Audit | 2026-10-28 | EuropePMC | 10.20944/preprints202610.2336.v2 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| 878 | Try Before You Evolve: Ranking-Scored Trials for Recursive Self-Improvement of Recommender Systems | 2026-10-29 | arXiv | 2610.39352 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 879 | Can Personal Requirements Become Supervision for Planning? | 2026-10-29 | arXiv | 2610.40992 | Full text | Excluded | No persistent cross-case improvement: one-off post-training on fixed data without a changing generator or simulated clinical environment | ||||
| 880 | Advancing Clinical Genomic Analysis with a Skill-Centred Agent | 2026-10-29 | arXiv | 2610.40556 | Title/abstract | Excluded | No persistent cross-case improvement: Clinical genomics agent with curated static skill library; no learning from experience. | ||||
| 881 | Before the Next Rollout: Diagnosing Skill Utility Shifts from Policy Updates | 2026-10-29 | arXiv | 2610.39358 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 882 | KARMA: Training-Free Knowledge-Atomic Harness Evolution for Industrial Advertising Agents | 2026-10-29 | arXiv | 2610.39884 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 883 | A prospective randomized study of patient-centered AI for clinical visit preparation | 2026-10-30 | arXiv | 2610.41437 | Title/abstract | Excluded | No persistent cross-case improvement: Randomized study of visit-preparation chatbot; no cross-case adaptation. | ||||
| 884 | From Evaluation to Evolution: Benchmarking Image Editing and Evolving Image Models | 2026-10-30 | arXiv | 2610.41210 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 885 | Exo: An Architecture for Self-Improving Systems at Runtime | 2026-10-30 | arXiv | 2611.00463 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 886 | MATS: A Multi-Agent Framework for Controllable and Reflective Tumor Synthesis | 2026-10-30 | arXiv | 2610.41159 | Title/abstract | Excluded | No persistent cross-case improvement: Tumor synthesis multi-agent; closed-loop reflection within each generation only. | ||||
| 887 | Think in 360°: Benchmarking and Bootstrapping Panoramic Video Reasoning | 2026-10-30 | arXiv | 2610.42082 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 888 | Do Transaction Prices Reflect Visual Preference? A Diagnostic Study with Multimodal Language Models | 2026-10-30 | arXiv | 2610.41358 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 889 | Verify--Backtrack Loop: Structured Precondition Recovery for Long-Horizon Language Agents | 2026-10-30 | arXiv | 2610.41564 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 890 | From Single-Agent Self-Discovery to Multi-Agent Adaptation: Scaling Laws of Partner Feedback and Convention Rigidity in Meta Reinforcement Learning Algorithms | 2026-11-01 | arXiv | 2611.01742 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 891 | Accounting for Irregular State Transitions through Belief Estimation in Online Medical Consultation | 2026-11-01 | arXiv | 2611.01474 | Full text | Excluded | No persistent cross-case improvement: PRISM is trained once by SFT and GRPO against fixed LLM-annotated reference labels (App B.2.2); belief is within-dialogue; nothing is retained across cases. | ||||
| 892 | State-Aware Virtual Patient Simulation for Training Psychiatrists in Challenging Clinical Scenarios | 2026-11-01 | arXiv | 2611.02067 | Full text | Excluded | Not primary research: v1 is labelled work in progress and describes the pipeline and LinUCB selector (Sec III) without any experiments or results. Borderline: cross-session bandit learning only proposed, F4 also arguable. | ||||
| 893 | CARE: Grounded Recursive Self-Improvement for Production Customer-Service Agents | 2026-11-02 | arXiv | 2611.02839 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 894 | Multi-Modal Multi-Agent System for Bridge Operation and Maintenance based on Large Language Model | 2026-11-02 | arXiv | 2611.02738 | Title/abstract | Excluded | Not healthcare or clinical: Not healthcare; general-domain LLM agent or other domain. | ||||
| 895 | When Prediction Shapes the Future: A BlueSky Agenda for Reflexive Time Series Analysis | 2026-11-02 | arXiv | 2611.02511 | Title/abstract | Excluded | Not primary research: Non-health; survey, benchmark, evaluation or position work. | ||||
| W4387122547 | 2022 Association for Vascular Access Scientific Meeting: Poster Abstracts | 2023-01-01 | OpenAlex | 10.2309/jvad-28-03-49 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387122547 | |||
| W4386046933 | A Molecular Update and Review of Current Trials in Paediatric Low-Grade Gliomas | 2023-01-01 | OpenAlex | 10.1159/000533703 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386046933 | |||
| W4383873176 | A Scoping Review of Highly Cited Published Articles in the Iranian Endodontic Journal: A Reflection of Trends in Endodontic Research. | 2023-01-01 | OpenAlex | 10.22037/iej.v18i2.42524 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383873176 | |||
| W4388763471 | Abstracts Presented at the 2023 Advancing Healthcare Innovation Summit: Nov 11, 2023 (Virtual) | 2023-01-01 | OpenAlex | 10.36401/iddb-23-x1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388763471 | |||
| W4317931807 | Advanced approaches for the diagnosis and chemoprevention of canine vector-borne pathogens and parasites—Implications for the Asia-Pacific region and beyond | 2023-01-01 | OpenAlex | 10.1016/bs.apar.2022.12.001 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4317931807 | |||
| W4313573002 | Advances and Challenges of the Decade: The Ever-Changing Clinical and Genetic Landscape of Immunodeficiency | 2023-01-01 | OpenAlex | 10.1016/j.jaip.2022.11.007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4313573002 | |||
| W4410996421 | Advances in AI-Augmented Network Fault Detection and Self-Optimization in Multi-Layer Mobile Systems | 2023-01-01 | OpenAlex | 10.54660/.jfmr.2023.4.2.110-129 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410996421 | |||
| W4385385648 | Advancing XNAzymes as Nucleic Acid Therapeutics | 2023-01-01 | OpenAlex | 10.1007/978-981-19-9776-1_75 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385385648 | |||
| W7112730859 | Advancing the capabilities of base editing and protein delivery | 2023-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7112730859 | ||||
| W4396526058 | An Integrative Review on the Oncology Nurse Navigator Role in the Canadian Context | 2023-01-01 | OpenAlex | 10.5737/23688076334385 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396526058 | |||
| W4323821306 | Antiarrhythmic Drug Therapy for Ventricular Arrhythmias: The Changing Role in the Modern Era | 2023-01-01 | OpenAlex | 10.1159/000529968 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323821306 | |||
| W4383619189 | Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment | 2023-01-01 | OpenAlex | 10.1177/17588359231183679 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383619189 | |||
| W4327771094 | Antileprotic drugs | 2023-01-01 | OpenAlex | 10.1016/b978-0-323-90575-6.00016-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4327771094 | |||
| W4323026409 | Antimicrobial Resistance of Escherichia Coli Isolated from Cecum and Carcasses Samples of Broiler Chickens | 2023-01-01 | OpenAlex | 10.2991/978-94-6463-112-8_4 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4323026409 | |||
| W4316340211 | Análisis de la Guía de excelencia para la realización de ensayos clínicos en farmacia hospitalaria | 2023-01-01 | OpenAlex | 10.1016/j.farma.2022.10.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4316340211 | |||
| W4380901188 | Application of Mulberry and Mulberry Silkworm By-Products for Medical Uses | 2023-01-01 | OpenAlex | 10.1007/978-3-031-28478-6_11 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4380901188 | |||
| W4409809834 | Application of the EDAS Method in Artificial Intelligence A Comprehensive Analysis | 2023-01-01 | OpenAlex | 10.55124/jaim.v1i2.254 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4409809834 | |||
| W4382237099 | Authors’ reply to George and Gupta et al. | 2023-01-01 | OpenAlex | 10.4103/crst.crst_89_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382237099 | |||
| W7112040949 | Basket trials in upper gastrointestinal and hepato-pancreatico-biliary cancers:an emerging entity | 2023-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7112040949 | ||||
| W4387896838 | Biological Methods for Drug Delivery | 2023-01-01 | OpenAlex | 10.1007/978-981-99-6564-9_1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387896838 | |||
| W4385235582 | Biology in AI: New Frontiers in Hardware, Software, and Wetware Modeling of Cognition | 2023-01-01 | OpenAlex | 10.1162/artl_e_00412 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385235582 | |||
| W7216880609 | Biomimetic platforms for modeling in vitro the functional unit of the exocrine pancreas | 2023-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7216880609 | ||||
| W4380789988 | Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer | 2023-01-01 | OpenAlex | 10.1177/17562872231182219 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380789988 | |||
| W4367461339 | Bronchoscopy Education: New Insights | 2023-01-01 | OpenAlex | 10.1007/978-3-031-22610-6_6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4367461339 | |||
| W4313437612 | Bulk Fill Composites: Adhesion and Interfacial Adaptation | 2023-01-01 | OpenAlex | 10.1007/978-3-031-16388-3_3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4313437612 | |||
| W4327655900 | COVID-19 Pandemic and Vaccination | 2023-01-01 | OpenAlex | 10.1007/978-3-031-24903-7_2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4327655900 | |||
| W4367032859 | COVID-19 associated mucormycosis a recent challenge | 2023-01-01 | OpenAlex | 10.4322/acr.2023.427 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367032859 | |||
| W4386527884 | COVID-19: An Overview of Virology, Mutations, Pathology, Epidemiology, Diagnosis, Preventions, and Treatments | 2023-01-01 | OpenAlex | 10.1007/978-981-99-3664-9_1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386527884 | |||
| W7111865399 | Characterizing Functional Genetic Diversity in Mycobacterium tuberculosis | 2023-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7111865399 | ||||
| W4383959934 | Chat Generative Pretrained Transformer: A Disruptive or Constructive Technology? | 2023-01-01 | OpenAlex | 10.4103/jicdro.jicdro_37_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383959934 | |||
| W4365512576 | ChatGPT: A comprehensive review on background, applications, key challenges, bias, ethics, limitations and future scope | 2023-01-01 | OpenAlex | 10.1016/j.iotcps.2023.04.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4365512576 | |||
| W4362015242 | Chemoprevention of neuroblastoma: progress and promise beyond uncertainties | 2023-01-01 | OpenAlex | 10.20517/2394-4722.2022.40 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362015242 | |||
| W4389064782 | Chemotherapy-Related Toxicities and Management | 2023-01-01 | OpenAlex | 10.1007/978-3-031-41413-8_13 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389064782 | |||
| W4391801353 | Chromatography and Anti-Biofilm Activity of Chiral Carbon Nanoparticles | 2023-01-01 | OpenAlex | 10.7302/22326 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391801353 | |||
| W4324381470 | Clinical Benefit and Safety of Microneedle Patches Composed of Magnesium: A Pilot Study in Acne Patients | 2023-01-01 | OpenAlex | 10.1155/2023/7667296 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4324381470 | |||
| W4390884169 | Commentary | 2023-01-01 | OpenAlex | 10.2344/155994 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390884169 | |||
| W4367330987 | Comparison of the Qualities of Sevoflurane and Halothane in Paediatric Anaesthesia | 2023-01-01 | OpenAlex | 10.4103/njm.njm_126_22 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4367330987 | |||
| W4362636229 | Conceptual Change and Developmental Teaching: Comment on Gennen | 2023-01-01 | OpenAlex | 10.1159/000530505 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362636229 | |||
| W4365397536 | Current status of Cancer Nanotheranostics: Emerging strategies for cancer management | 2023-01-01 | OpenAlex | 10.7150/ntno.82263 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4365397536 | |||
| W4382284123 | Diarrhea Could Be a Triggering Factor in Atypical Hemolytic Uremic Syndrome in Children | 2023-01-01 | OpenAlex | 10.4103/pnjb.pnjb_4_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382284123 | |||
| W4391030016 | Dissociative Identity Disorder and the Human Brain; Neuroanatomy | 2023-01-01 | OpenAlex | 10.1007/978-3-031-39854-4_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391030016 | |||
| W4381300788 | Efficacy of Butorphanol and Tramadol as an Adjuvant to Levobupivacaine for Postoperative Analgesia in Brachial Plexus Block – A Randomized Double-Blind Study | 2023-01-01 | OpenAlex | 10.13107/ijra.2023.v04i01.068 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4381300788 | |||
| W4386386144 | Efficacy of Celecoxib and Diclofenac Sodium in the Management of Postoperative Pain, Swelling and Mouth Opening after Surgical Removal of Impacted Third Molars: A Split-mouth Randomised Clinical Study | 2023-01-01 | OpenAlex | 10.7860/jcdr/2023/63808.18307 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386386144 | |||
| W4362577180 | Environment poisoning in reinforcement learning: attacks and resilience | 2023-01-01 | OpenAlex | 10.32657/10356/164969 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362577180 | |||
| W4389610283 | Ethics Challenges in Pediatric Research | 2023-01-01 | OpenAlex | 10.5863/1551-6776-28.8.680 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389610283 | |||
| W4383000032 | Exploring Chatgpt: An Extensive Examination of its Background, Applications, Key Challenges, Bias, Ethics, Limitations, and Future Prospects | 2023-01-01 | OpenAlex | 10.2139/ssrn.4499278 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383000032 | |||
| W4385589100 | Exploring the antimicrobial potential of biologically synthesized zero valent iron nanoparticles | 2023-01-01 | OpenAlex | 10.1515/chem-2022-0355 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4385589100 | |||
| W4386038155 | Exploring the therapeutic potential of stem cells in glaucoma: A promising frontier for vision restoration | 2023-01-01 | OpenAlex | 10.4103/kjo.kjo_93_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386038155 | |||
| W4366319347 | From flint tools to robotics: The Journey of OMFS through time! | 2023-01-01 | OpenAlex | 10.4103/njms.njms_43_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366319347 | |||
| W4386107118 | Functionalized Nanoemulsions: Could Be a Promising Approach for Theranostic Applications | 2023-01-01 | OpenAlex | 10.1007/978-981-99-0538-6_7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386107118 | |||
| W4393041048 | Fundamentals of Medicinal Chemistry- For the Students of Medicinal Chemistry, Pharmaceutical Sciences, Pharmacology, and Biochemistry | 2023-01-01 | OpenAlex | 10.18231/978-81-962763-2-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393041048 | |||
| W4391226056 | Fungal Zoonosis and One Health | 2023-01-01 | OpenAlex | 10.47278/book.zoon/2023.165 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391226056 | |||
| W4385355164 | Fungal-mediated synthesis of gold and titanium nanoparticles and their application in agriculture | 2023-01-01 | OpenAlex | 10.1016/b978-0-443-15262-7.00010-3 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4385355164 | |||
| W4411195375 | Green intensive care unit in burn care: A sustainable approach to health care | 2023-01-01 | OpenAlex | 10.4103/ijb.ijb_9_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411195375 | |||
| W4319590105 | Green synthesized nanoparticles in hepatic disorder | 2023-01-01 | OpenAlex | 10.1016/b978-0-323-91195-5.00014-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4319590105 | |||
| W4382567563 | Human Herpesviruses: Human Herpesvirus 6 | 2023-01-01 | OpenAlex | 10.1007/978-1-4939-9544-8_37-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4382567563 | |||
| W4319294780 | IGF-1 and GLP-1 signaling: potential therapeutic target for neurological disorders – correspondence | 2023-01-01 | OpenAlex | 10.1097/ms9.0000000000000164 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4319294780 | |||
| W4362569645 | Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment | 2023-01-01 | OpenAlex | 10.20517/2394-4722.2022.92 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362569645 | |||
| W4313595882 | Immunosuppression | 2023-01-01 | OpenAlex | 10.1007/978-981-19-6045-1_41 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4313595882 | |||
| W4372053931 | Immunotherapy and Cancer: The Pharmacists’ Perspective | 2023-01-01 | OpenAlex | 10.1007/978-3-030-80962-1_215-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4372053931; https://openalex.org/W4414891897 | |||
| W4414737920 | Improving the Design of Antibody Drug Conjugates and Bispecific Agents for Cancer Therapy | 2023-01-01 | OpenAlex | 10.7302/8439 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414737920 | |||
| W4313530627 | In the Limelight: January 2023 | 2023-01-01 | OpenAlex | 10.1016/j.mayocp.2022.11.013 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4313530627 | |||
| W4377835499 | Indian vaccine on COVID-19, competitive analysis | 2023-01-01 | OpenAlex | 10.1063/5.0138203 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377835499 | |||
| W4390503001 | Intrathecal Analgesics: Choices and Optimization of Delivery | 2023-01-01 | OpenAlex | 10.1007/978-3-031-39558-1_29 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390503001 | |||
| W4362684655 | Is there an optimal sequence of biologic therapies for inflammatory bowel disease? | 2023-01-01 | OpenAlex | 10.1177/17562848231159452 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362684655 | |||
| W4386874652 | JIM Reading List | 2023-01-01 | OpenAlex | 10.17849/insm-50-1-74-79.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386874652 | |||
| W4391186626 | Juvenile Xanthogranuloma: the benignity behind an atypical lesion | 2023-01-01 | OpenAlex | 10.25060/residpediatr-2023.v13n4-720 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391186626; https://openalex.org/W4387397602 | |||
| W4364861988 | Langerhans Cell Granulomatosis and Smoking-Related Interstitial Lung Diseases | 2023-01-01 | OpenAlex | 10.1007/978-3-031-12950-6_18 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4364861988 | |||
| W4399121590 | Life Writing in the Posthuman Anthropocene ed. by Ina Batzke, Lea Espinoza Garrido, and Linda M. Hess (review) | 2023-01-01 | OpenAlex | 10.1353/bio.2023.a928386 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399121590 | |||
| W4390800269 | Longevity and Clinical Performance of Direct Posterior Restorations | 2023-01-01 | OpenAlex | 10.52533/johs.2023.30907 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390800269 | |||
| W4383959980 | Longitudinal extensive myelopathy (LEM): a case with investigation pitfalls | 2023-01-01 | OpenAlex | 10.5327/1516-3180.141s1.657 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4383959980 | |||
| W4387351461 | Mastocytosis | 2023-01-01 | OpenAlex | 10.1007/978-3-031-15130-9_59 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387351461 | |||
| W4400794823 | Medicalised Ketogenic Therapy Practice | 2023-01-01 | OpenAlex | 10.34074/thes.6419 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400794823 | |||
| W4384788607 | Microbial Nanotechnology: Current Development and Potential Applications in the Field of Biotechnology | 2023-01-01 | OpenAlex | 10.1007/978-3-031-31104-8_2 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4384788607 | |||
| W4388503537 | Model Checking-Based Decision Support System for Fault Diagnosis: A Comprehensive Framework and Application in Electric Power Systems | 2023-01-01 | OpenAlex | 10.2139/ssrn.4626676 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4388503537 | |||
| W4392053027 | Modelling, design, fabrication and characterization of engineered human myocardium made with melt electrowriting and cardiac cells derived from hiPSCs | 2023-01-01 | OpenAlex | 10.15581/10171/69152 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392053027 | |||
| W4391139481 | Molecular Techniques Used for Diagnosis of Zoonotic Diseases | 2023-01-01 | OpenAlex | 10.47278/book.zoon/2023.029 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391139481 | |||
| W4391332310 | Multidisciplinary treatment after doxorubicin extravasation: Improvement of range of motion in the elbow joint | 2023-01-01 | OpenAlex | 10.29289/259453942023v33s1060 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391332310 | |||
| W4388238998 | Nab-Paclitaxel-Loaded Poly (Lactic-Co-Glycolic Acid) Nanoparticles as Microtubule B-Tubulin Stabilizer in the Management of Pancreatic Cancer | 2023-01-01 | OpenAlex | 10.37047/jos.2022-94097 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388238998 | |||
| W4327518338 | Nasopharyngeal rapid diagnostic testing to reduce unnecessary antibiotic use and individualize management of acute otitis media | 2023-01-01 | OpenAlex | 10.1017/ash.2023.127 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4327518338 | |||
| W4361014800 | New Systemic Therapies in Salivary Gland Cancer | 2023-01-01 | OpenAlex | 10.1007/978-3-031-23175-9_20 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361014800 | |||
| W4313427904 | New developments and concepts in the diagnosis and management of diabetes insipidus (AVP‐deficiency and resistance) | 2023-01-01 | OpenAlex | 10.1111/jne.13233 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4313427904 | |||
| W4386775038 | Nursing advanced training: Person-centeredness and technology for innovative pedagogy | 2023-01-01 | OpenAlex | 10.1016/b978-0-443-15248-1.00010-2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386775038 | |||
| W4379352933 | Oncolytic virotherapy in lung cancer | 2023-01-01 | OpenAlex | 10.1016/bs.ircmb.2023.05.004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379352933 | |||
| W4365804305 | PH Roundtable: Pros and Cons of the 2022 ERS/ESC Guidelines: Practicality vs Real World View | 2023-01-01 | OpenAlex | 10.21693/1933-088x-22.1.71 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4365804305 | |||
| W4365804235 | PHA 2022 International Pulmonary Hypertension Conference Abstracts | 2023-01-01 | OpenAlex | 10.21693/1933-088x-22.1.4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4365804235 | |||
| W4313537568 | PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales | 2023-01-01 | OpenAlex | 10.1016/j.jtauto.2023.100188 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4313537568 | |||
| W4392235025 | Pathophysiology and Management Approaches for Traumatic Brain Injury | 2023-01-01 | OpenAlex | 10.1007/978-981-99-6807-7_7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392235025 | |||
| W4323343900 | Pediatric Heart Transplant Immunosuppression | 2023-01-01 | OpenAlex | 10.1007/978-981-19-6909-6_28 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4323343900 | |||
| W4381199224 | Phage design and directed evolution to evolve phage for therapy | 2023-01-01 | OpenAlex | 10.1016/bs.pmbts.2023.03.019 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4381199224 | |||
| W4321504792 | Pharmacology, Psychopharmacology, and Adverse Drug Reactions | 2023-01-01 | OpenAlex | 10.1007/978-3-031-20792-1_44 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4321504792 | |||
| W4384917338 | Philosophy for Healthcare Professions Education: A Tool for Thinking and Practice | 2023-01-01 | OpenAlex | 10.1007/978-981-15-3344-0_21 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384917338 | |||
| W4385670952 | Photoresponsive Inorganic Nanomaterials in Oncology | 2023-01-01 | OpenAlex | 10.1177/15330338231192850 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385670952 | |||
| W4386336912 | Polymer-based nanocarriers for biomedical and environmental applications | 2023-01-01 | OpenAlex | 10.1515/epoly-2023-0049 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386336912 | |||
| W4386763956 | Prelude to Tackling Contemporary Crises: William James and a Psychological Springboard to Political Change | 2023-01-01 | OpenAlex | 10.5406/21564795.44.1.02 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4386763956 | |||
| W4387467827 | Pulmonary Complications of Lung Cancer Treatment | 2023-01-01 | OpenAlex | 10.1007/978-3-031-38412-7_11 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387467827 | |||
| W4376478093 | Pulsing and Detection Strategies for Contrast-Enhanced Ultrasound: A Narrative Review | 2023-01-01 | OpenAlex | 10.1109/ojuffc.2023.3275936 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376478093 | |||
| W4323905491 | Raynaud's phenomenon: A brush up! | 2023-01-01 | OpenAlex | 10.4103/idoj.idoj_311_22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323905491 | |||
| W4317433933 | Recent advancements in critical care: Part I | 2023-01-01 | OpenAlex | 10.4103/ija.ija_1005_22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317433933 | |||
| W4387757202 | Recent advances in DNA nanomaterials for cancer diagnosis and treatment | 2023-01-01 | OpenAlex | 10.1515/ntrev-2023-0135 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387757202 | |||
| W4386847264 | Recovery, Transplantation, Destination, or Anything Following MCS? | 2023-01-01 | OpenAlex | 10.1007/978-3-030-86172-8_56-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386847264 | |||
| W4375935214 | Remembrances of Virology Past | 2023-01-01 | OpenAlex | 10.1007/978-3-031-21999-3_12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4375935214 | |||
| W4362648147 | Replies to Cruft, Radzik, and Misak | 2023-01-01 | OpenAlex | 10.1111/phpr.12962 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362648147 | |||
| W4318168031 | Reporting From the First EHA Research Conference: Exciting Science With Panoramic Views | 2023-01-01 | OpenAlex | 10.1097/hs9.0000000000000816 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318168031 | |||
| W4387197444 | Review: Machine learning in precision pharmacotherapy of type 2 diabetes—A promising future or a glimpse of hope? | 2023-01-01 | OpenAlex | 10.1177/20552076231203879 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387197444 | |||
| W4390594548 | Role of Radiotherapy and Hormone Therapy in Patients with Node-Positive Locally Advanced Prostate Cancer | 2023-01-01 | OpenAlex | 10.56434/j.arch.esp.urol.20237610.88 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390594548 | |||
| W4321098233 | SYMPOSIUM | 2023-01-01 | OpenAlex | 10.4103/0019-5545.368867 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321098233 | |||
| W4386711912 | Selective Laser Sintering (SLS) in Pharmaceuticals | 2023-01-01 | OpenAlex | 10.1007/978-981-99-2404-2_4 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4386711912 | |||
| W4367050138 | Serum from Men with the Severe Form of COVID‐19 Impairs the Nitric Oxide Signaling Pathway in Isolated Corpus Cavernosum from Mice: An In Vitro Study | 2023-01-01 | OpenAlex | 10.1155/2023/9059973 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4367050138 | |||
| W4389104124 | Severe Fungal and Parasitic Infections in the Intensive Care Unit | 2023-01-01 | OpenAlex | 10.1007/978-3-031-36398-6_13 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389104124 | |||
| W4388796630 | Small Molecules as Vectors for Radiopharmaceutical Therapy | 2023-01-01 | OpenAlex | 10.1007/978-3-031-39005-0_17 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388796630 | |||
| W4386393971 | Small molecules and conjugates as theranostic agents | 2023-01-01 | OpenAlex | 10.1039/d3cb00073g | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4386393971 | |||
| W4414101819 | Social media and disability: the impact of influencers on building digital citizenship | 2023-01-01 | OpenAlex | 10.56294/neuro202368 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414101819 | |||
| W4323063321 | Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials | 2023-01-01 | OpenAlex | 10.1177/17588359231157632 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323063321 | |||
| W4385195126 | Stem Cell Transplant for Hodgkin Lymphoma | 2023-01-01 | OpenAlex | 10.1007/978-981-19-5802-1_22 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385195126 | |||
| W4399013095 | Survival trends for patients with primary brain tumors worldwide: What have we learnt? | 2023-01-01 | OpenAlex | 10.4103/glioma.glioma_1_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399013095 | |||
| W4387374107 | Taking stock of the mutations in human SARS-CoV-2 spike proteins: From early days to nearly the end of COVID-19 pandemic | 2023-01-01 | OpenAlex | 10.1016/j.crstbi.2023.100107 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387374107 | |||
| W4385354170 | Targeted breast cancer treatment: progress and challenges | 2023-01-01 | OpenAlex | 10.1016/b978-0-323-91763-6.00014-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385354170 | |||
| W7172583968 | Technology as a Change Agent for Social Work Supervision | 2023-01-01 | OpenAlex | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7172583968 | ||||
| W4368282482 | The Evolving Therapeutic Landscape and Role of Enfortumab Vedotin in Advanced Urothelial Carcinoma: A Systematic Review | 2023-01-01 | OpenAlex | 10.17925/ohr.2023.19.1.27 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4368282482 | |||
| W4319936169 | The Immune Landscape and Therapy of Upper Tract Urothelial Carcinoma | 2023-01-01 | OpenAlex | 10.1007/16833_2023_127 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4319936169 | |||
| W4380442399 | The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer | 2023-01-01 | OpenAlex | 10.20517/cdr.2022.146 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380442399 | |||
| W4411910882 | Therapeutic Targets in Hepatic Fibrosis: Overcoming Current Limitations | 2023-01-01 | OpenAlex | 10.54660/.ijmrge.2023.4.2.865-869 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411910882 | |||
| W4388578865 | Time to act sustainably: Why can’t we wait any longer? | 2023-01-01 | OpenAlex | 10.1590/0034-7167-2022-0813 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388578865 | |||
| W7126292376 | Time-resolved recovery of intracellular magnetic nanoparticles | 2023-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7126292376 | ||||
| W4368250577 | Touched and Changed: Self-Reflexivity and Reciprocity in Fieldwork | 2023-01-01 | OpenAlex | 10.1162/afar_a_00705 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4368250577 | |||
| W4386183270 | Towards a Science/Education of Late Neoliberal Bodies | 2023-01-01 | OpenAlex | 10.1007/978-3-031-39330-3_6 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4386183270 | |||
| W4396689266 | Transverse Sinus Isolated-Type Dural Arteriovenous Fistula Mimicking Ischemic Stroke: A Cautionary Note for Emergency Neurologists; Transvenous Embolization, Fistula Disconnection, and Complete Clinical Recovery | 2023-01-01 | OpenAlex | 10.1007/978-3-030-85411-9_61-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396689266; https://openalex.org/W4404698064 | |||
| W4391150102 | UNDERSTANDING THE EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS AND DIAGNOSTIC APPROACHES OF FUNGAL INFECTIONS | 2023-01-01 | OpenAlex | 10.52458/9789388996846.nsp2023.eb.ch-19 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4391150102 | |||
| W4391457447 | Unraveling the Enigma: Navigating Challenges in the Diagnosis and Treatment of Neurocysticercosis – A Thorough Exploration Review | 2023-01-01 | OpenAlex | 10.18103/mra.v12i1.4902 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391457447 | |||
| W4392416362 | Uso de rellenadores dérmicos de ácido hialurónico para el tratamiento de patología periocular asociada a parálisis facial y a otras causas de malposición palpebral | 2023-01-01 | OpenAlex | 10.4321/repisalud.18867 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392416362 | |||
| W4378801504 | Vaccine Design: An Introduction | 2023-01-01 | OpenAlex | 10.1007/978-1-0716-3239-0_1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4378801504 | |||
| W7131828295 | Viral vector platforms within the gene therapy landscape | 2023-01-01 | OpenAlex | 10.29228/jrp.502 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7131828295 | |||
| W4388376699 | Volumetric and Regenerative Components of Fat Graft: Positioning in the Fat-Nanofat Spectrum | 2023-01-01 | OpenAlex | 10.1007/978-3-031-10881-5_8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388376699 | |||
| W4318391617 | [Translated article] Analysis of the guide to excellence in the conduct of clinical trials in hospital pharmacy | 2023-01-01 | OpenAlex | 10.1016/j.farma.2022.12.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318391617 | |||
| W4313647650 | A Reciprocal Link between Oral, Gut Microbiota during Periodontitis: The Potential Role of Probiotics in Reducing Dysbiosis-Induced Inflammation | 2023-01-06 | OpenAlex | 10.3390/ijms24021084 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4313647650 | |||
| W4313595711 | Acute myeloid leukemia: challenges for diagnosis and treatment in Latin America | 2023-01-06 | OpenAlex | 10.1080/16078454.2022.2158015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4313595711 | |||
| W4313641086 | Targeting the DNA damage response for cancer therapy | 2023-01-06 | OpenAlex | 10.1042/bst20220681 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4313641086 | |||
| W4313649292 | To Study the Role of PTEN, EGFR and HER2 in Early Glottic Squamous Cell Carcinoma | 2023-01-06 | OpenAlex | 10.1007/s12070-022-03455-w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4313649292 | |||
| W4313894787 | Local Antibiotics in the Treatment of Diabetic Foot Infections: A Narrative Review | 2023-01-09 | OpenAlex | 10.3390/antibiotics12010124 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4313894787 | |||
| W4313898011 | Choosing the right treatment for the right lesion, Part II: a narrative review of drug-coated balloon angioplasty and its evolving role in dialysis access maintenance | 2023-01-10 | OpenAlex | 10.21037/cdt-22-497 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4313898011 | |||
| W4389316415 | Decision letter: Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance | 2023-01-11 | OpenAlex | 10.7554/elife.85023.sa1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389316415 | |||
| W4389316426 | Editor's evaluation: Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance | 2023-01-11 | OpenAlex | 10.7554/elife.85023.sa0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389316426 | |||
| W4315574349 | Integrated Data Analysis Uncovers New COVID-19 Related Genes and Potential Drug Re-Purposing Candidates | 2023-01-11 | OpenAlex | 10.3390/ijms24021431 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4315574349 | |||
| W7112636188 | Biochemical and mechanical changes of the extracellular matrix during lung metastasis | 2023-01-12 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7112636188 | ||||
| W4315797958 | Applicability of a colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for SARS-CoV-2 detection in high exposure risk setting | 2023-01-13 | OpenAlex | 10.1016/j.ijid.2023.01.010 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4315797958 | |||
| W4315797128 | International consensus recommendations on the management of people with haemophilia B | 2023-01-13 | OpenAlex | 10.17615/akp4-ah24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4315797128 | |||
| W4316012746 | Pathogenesis of Breakthrough Infections with SARS-CoV-2 Variants in Syrian Hamsters | 2023-01-13 | OpenAlex | 10.1101/2023.01.12.523876 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4316012746 | |||
| W4316143370 | Key considerations for clinical trials in psychopharmacology | 2023-01-14 | OpenAlex | 10.1002/wps.21061 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4316143370 | |||
| W4316362821 | Editorial: Community series in antimicrobial peptides: Molecular design, structure function relationship and biosynthesis optimization | 2023-01-16 | OpenAlex | 10.3389/fmicb.2023.1125426 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4316362821 | |||
| W4322745931 | Estimation of the fluorescence emission spectrum of dental composite resin samples of varying thickness | 2023-01-16 | OpenAlex | 10.2352/ei.2023.35.15.color-190 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4322745931 | |||
| W4316591192 | Evolution of Antiphospholipid Syndrome | 2023-01-16 | OpenAlex | 10.1055/s-0042-1760333 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4316591192 | |||
| W7201845015 | Metastatik Lezyon Tedavi Algoritması | 2023-01-16 | OpenAlex | 10.37609/akya.2214.c17124 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7201845015 | |||
| W4317040262 | Association between COVID-19 and chronic liver disease: Mechanism, diagnosis, damage, and treatment | 2023-01-17 | OpenAlex | 10.5501/wjv.v12.i1.22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317040262 | |||
| W4317042806 | Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer | 2023-01-17 | OpenAlex | 10.3390/cancers15030566 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317042806 | |||
| W4317863204 | HER2-low expression in breast oncology: treatment implications in the smart chemotherapy era | 2023-01-17 | OpenAlex | 10.1097/cej.0000000000000781 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317863204 | |||
| W4317211921 | Myconanotechnology for Cancer Current Status and Future Prospects | 2023-01-18 | OpenAlex | 10.1201/9781003327356-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317211921 | |||
| W4317510582 | Study on the Collaboration between University and Educational Centers Mentors in the Development of the In-School Education Placements in Official University Degrees Qualifying for the Teaching Profession: The Case of the University of Santiago de Compostela | 2023-01-18 | OpenAlex | 10.3390/educsci13020104 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4317510582 | |||
| W4317209583 | The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases | 2023-01-18 | OpenAlex | 10.1111/jcmm.17669 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4317209583 | |||
| W4317434686 | Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma | 2023-01-18 | OpenAlex | 10.3390/cancers15030589 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317434686 | |||
| W4317508225 | Three Innovations of Next-Generation Antibiotics: Evolvability, Specificity, and Non-Immunogenicity | 2023-01-18 | OpenAlex | 2210.14017 | 10.3390/antibiotics12020204 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317508225 | ||
| W4317469188 | Dysphagia and Lung Disease in Children With Spinal Muscular Atrophy Treated With Disease-Modifying Agents | 2023-01-19 | OpenAlex | 10.1212/wnl.0000000000206826 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4317469188 | |||
| W4317470220 | Optimizing benefit/risk in oncology: Review of post-marketing dose optimization and reflections on the road ahead | 2023-01-19 | OpenAlex | 10.1016/j.critrevonc.2023.103913 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317470220 | |||
| W4317435358 | Pleuroparenchymal Fibroelastosis (PPFE) | 2023-01-19 | OpenAlex | 10.1201/9781003089384-11 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4317435358 | |||
| W4362710844 | Progresses on metal-organic framework materials for bacterial infection treatment | 2023-01-19 | OpenAlex | 10.1360/tb-2022-0974 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362710844 | |||
| W4317616069 | Ankylosing Spondylitis Pathogenesis and Pathophysiology | 2023-01-20 | OpenAlex | 10.5772/intechopen.109164 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4317616069 | |||
| W4317520087 | Encephalitis and cytokine storm secondary to respiratory viruses in children: Two case reports | 2023-01-20 | OpenAlex | 10.3389/fped.2022.1049724 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4317520087 | |||
| W4317745838 | Indonesian Vegetables: Searching for Antioxidant and Antidiabetic Therapeutic Agents | 2023-01-20 | OpenAlex | 10.3390/ddc2010002 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4317745838 | |||
| W4318993711 | Moving the Needle: Accelerating Drug Discovery in Nephrology | 2023-01-20 | OpenAlex | 10.1681/asn.0000000000000052 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318993711 | |||
| W4317651620 | Ischaemic heart disease: antithrombotic treatment and new therapeutic targets | 2023-01-21 | OpenAlex | 10.1093/eurheartj/ehac816 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317651620 | |||
| W4317734946 | Molecular and Biological Investigation of Isolated Marine Fungal Metabolites as Anticancer Agents: A Multi-Target Approach | 2023-01-21 | OpenAlex | 10.3390/metabo13020162 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4317734946 | |||
| W4317702939 | Network models in bioinformatics: modeling and analysis for complex diseases | 2023-01-21 | OpenAlex | 10.1093/bib/bbad016 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317702939 | |||
| W4317761498 | Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up | 2023-01-23 | OpenAlex | 10.1016/j.annonc.2022.12.009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317761498 | |||
| W4317863041 | Real-world registry of patients with unresectable hepatocellular carcinoma: The OREIOS study. | 2023-01-24 | OpenAlex | 10.1200/jco.2023.41.4_suppl.tps618 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317863041 | |||
| W4317890310 | The SHARON trial: A study of melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cell rescue for metastatic pancreatic cancer with an inherited BRCA mutation. | 2023-01-24 | OpenAlex | 10.1200/jco.2023.41.4_suppl.tps774 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4317890310 | |||
| W4317829865 | Trace Element Equilibrium in Acute Heart Failure and the Effect of Empagliflozin | 2023-01-24 | OpenAlex | 10.1002/ejhf.2779 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4317829865 | |||
| W4318039958 | Immune-Epithelial Cross Talk in Regeneration and Repair | 2023-01-25 | OpenAlex | 10.1146/annurev-immunol-101721-062818 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318039958 | |||
| W4318185011 | Clinical pharmacology of SGLT-2 inhibitors in heart failure | 2023-01-26 | OpenAlex | 10.1080/17512433.2023.2173574 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318185011 | |||
| W4318184345 | PRIMARY SCLEROSING CHOLANGITIS AND AUTOIMMUNE HEPATITIS: OVERLAPPING CHALLENGES IN DIAGNOSIS AND TREATMENT | 2023-01-26 | OpenAlex | 10.1093/ibd/izac247.055 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4318184345 | |||
| W4318203454 | Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges | 2023-01-26 | OpenAlex | 10.3390/jcm12030953 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318203454 | |||
| W4318046542 | The role of transplantation in Hodgkin lymphoma | 2023-01-26 | OpenAlex | 10.3389/fonc.2022.1054314 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318046542 | |||
| W4318263160 | Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis | 2023-01-27 | OpenAlex | 10.1080/17512433.2023.2173172 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318263160 | |||
| W4318455405 | Clinical Practice Guidelines for Assessment and Management of Patients Presenting with Psychosocial Crisis | 2023-01-29 | OpenAlex | 10.4103/indianjpsychiatry.indianjpsychiatry_485_22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318455405 | |||
| W4318455333 | Clinical Practice Guidelines for the Use of Transcranial Direct Current Stimulation in Psychiatry | 2023-01-29 | OpenAlex | 10.4103/indianjpsychiatry.indianjpsychiatry_496_22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318455333 | |||
| W4318588149 | Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective | 2023-01-30 | OpenAlex | 10.3389/fcell.2022.1081644 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318588149 | |||
| W4318539912 | DOP55 The increasing burden of direct and indirect costs of IBD | 2023-01-30 | OpenAlex | 10.1093/ecco-jcc/jjac190.0095 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318539912 | |||
| W4318473239 | Immunomodulatory nanosystems: An emerging strategy to combat viral infections | 2023-01-30 | OpenAlex | 10.1016/j.bbiosy.2023.100073 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318473239 | |||
| W4318482093 | Kidney Transplant Practice in Pandemic Times | 2023-01-30 | OpenAlex | 10.2215/cjn.0000000000000092 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318482093 | |||
| W4318591331 | An overview of novel therapies in advanced clinical testing for acute myeloid leukemia | 2023-01-31 | OpenAlex | 10.1080/17474086.2023.2174521 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4318591331 | |||
| W4319068852 | Evidence for Utilization of Injectable Biologic Augmentation in Primary Rotator Cuff Repair: A Systematic Review of Data From 2010 to 2022 | 2023-02-01 | OpenAlex | 10.1177/23259671221150037 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4319068852 | |||
| W7218677298 | IMMUNOTHERAPY AGENTS USE FOR TREATMENT OF WARTS | 2023-02-01 | OpenAlex | 10.47750/pnr.2023.14.03.50 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7218677298 | |||
| W4377094376 | Innovations triggered by India’s bold vision to end tuberculosis | 2023-02-01 | OpenAlex | 10.4103/ijmr.ijmr_373_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377094376 | |||
| W4320894692 | Introduction to the CLER National Report of Findings 2022: The COVID-19 Pandemic and Its Impact on the Clinical Learning Environment | 2023-02-01 | OpenAlex | 10.4300/jgme-d-22-00938.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4320894692 | |||
| W4319333210 | Methods to madness: The utility of complex systems science in a mad, mad world | 2023-02-01 | OpenAlex | 10.1111/cdoe.12824 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4319333210 | |||
| W4319320977 | MicroRNA biosensors for detection of gastrointestinal cancer | 2023-02-01 | OpenAlex | 10.1016/j.cca.2023.117245 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4319320977 | |||
| W4323049577 | Nipple Day | 2023-02-01 | OpenAlex | 10.14321/fourthgenre.25.1.0034 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4323049577 | |||
| W7120318727 | Organizational support perceived by social service public employees: study in the state of Rio Grande do Sul | 2023-02-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7120318727 | ||||
| W4318997133 | Research on Liver Damage Caused by the Treatment of Rheumatoid Arthritis with Novel Biological Agents or Targeted Agents | 2023-02-01 | OpenAlex | 10.2147/jir.s395137 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4318997133 | |||
| W4321167944 | SARS-CoV-2/Omicron subvariants: global outbreak upsurge and expected upcoming threats | 2023-02-01 | OpenAlex | 10.1097/js9.0000000000000240 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321167944 | |||
| W4364862149 | The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus Statement | 2023-02-01 | OpenAlex | 10.5005/japi-11001-0209 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4364862149 | |||
| W4318818698 | Tubulointerstitial nephritis and uveitis syndrome post‐COVID‐19 | 2023-02-01 | OpenAlex | 10.1002/ped4.12362 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4318818698 | |||
| W4362078397 | Anna Lvovsky. Vice Patrol: Cops, Courts, and the Struggle over Urban Gay Life before Stonewall. | 2023-02-02 | OpenAlex | 10.1093/ahr/rhad118 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362078397 | |||
| W4319063485 | Acridine/Acridone–Carborane Conjugates as Strong DNA‐Binding Agents with Anticancer Potential | 2023-02-03 | OpenAlex | 10.1002/cmdc.202200666 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4319063485 | |||
| W4319162246 | Identification of a basement membrane-based risk scoring system for prognosis prediction and individualized therapy in clear cell renal cell carcinoma | 2023-02-03 | OpenAlex | 10.3389/fgene.2023.1038924 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4319162246 | |||
| W4319156410 | The Effectiveness of an App (Insulia) in Recommending Basal Insulin Doses for French Patients With Type 2 Diabetes Mellitus: Longitudinal Observational Study | 2023-02-03 | OpenAlex | 10.2196/44277 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4319156410 | |||
| W4319067804 | Ultrasonography | 2023-02-03 | OpenAlex | 10.1002/9781119533221.ch4 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4319067804 | |||
| W4319071746 | Hepatitis delta: Epidemiology to recent advances in therapeutic agents | 2023-02-04 | OpenAlex | 10.1097/hep.0000000000000331 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4319071746 | |||
| W4319321093 | Editorial: Pulmonary hypertension in the modern era: Science and clinical practice, Volume II | 2023-02-06 | OpenAlex | 10.3389/fmed.2023.1136157 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4319321093 | |||
| W4319303916 | Hyperthermie maligne de l’anesthésie | 2023-02-06 | OpenAlex | 10.1016/j.anrea.2023.01.009 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4319303916 | |||
| W4319304575 | Nouvelle AMM : crizotinib dans le lymphome anaplasique à grandes cellules systémique ALK positif en pédiatrie | 2023-02-06 | OpenAlex | 10.1016/j.bulcan.2022.12.011 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4319304575 | |||
| W4319332953 | Preparing cardiovascular patients for the operative theatre | 2023-02-06 | OpenAlex | 10.1093/ehjacc/zuad005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4319332953 | |||
| W7218932286 | “Antimicrobial Susceptibility Pattern and Biofilm Producing Capacity of Wound Infection Isolates – A Clinico-microbiological Study from Tertiary Care Center of Central Gujarat.” | 2023-02-06 | OpenAlex | 10.47750/pnr.2023.14.03.077 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7218932286 | |||
| W4319599511 | Engineered Biosensors for Diagnosing Multidrug Resistance in Microbial and Malignant Cells | 2023-02-07 | OpenAlex | 10.3390/bios13020235 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4319599511 | |||
| W4319444960 | Treatment of extranodal NK/T-cell lymphoma: From past to future | 2023-02-07 | OpenAlex | 10.3389/fimmu.2023.1088685 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4319444960 | |||
| W4319461517 | Structural and Functional Analysis of a Highly Active Designed Phosphotriesterase for the Detoxification of Organophosphate Nerve Agents Reveals an Unpredicted Conformation of the Active Site Loop | 2023-02-08 | OpenAlex | 10.1021/acs.biochem.2c00666 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4319461517 | |||
| W4321004789 | Viral Respiratory Tract Infections in the Immunocompromised Child | 2023-02-08 | OpenAlex | 10.1097/inf.0000000000003855 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321004789 | |||
| W4319662820 | iPRESTO: Automated discovery of biosynthetic sub-clusters linked to specific natural product substructures | 2023-02-09 | OpenAlex | 10.1371/journal.pcbi.1010462 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4319662820 | |||
| W4319827715 | Initial experience with Scepter Mini dual lumen balloon for embolization of cerebrovascular diseases | 2023-02-10 | OpenAlex | 10.7461/jcen.2023.e2022.10.004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4319827715 | |||
| W4319878116 | Knowledge sharing in a dynamic, multi-level organization: an agent-based modeling approach | 2023-02-10 | OpenAlex | 10.1007/s10588-023-09373-8 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4319878116 | |||
| W4320039092 | Emerging Technologies in Water Treatment: Recent Advances | 2023-02-11 | OpenAlex | 10.5772/intechopen.109063 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4320039092 | |||
| W4320168159 | Endoscopic fluorescent lymphography for gastric cancer | 2023-02-12 | OpenAlex | 10.4253/wjge.v15.i2.32 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4320168159 | |||
| W4320492679 | Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer | 2023-02-13 | OpenAlex | 10.3390/ijms24043719 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4320492679 | |||
| W4320496094 | Editorial: An update on pediatric skeletal system infections | 2023-02-13 | OpenAlex | 10.3389/fped.2023.1128126 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4320496094 | |||
| W4320719837 | Getting to the Heart of the Issue: Demographics of Hypertrophic Cardiomyopathy | 2023-02-14 | OpenAlex | 10.1016/j.amjmed.2022.07.024 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4320719837 | |||
| W4320727862 | Self-Poisoning With Household Bleach in an Elderly Man | 2023-02-14 | OpenAlex | 10.7759/cureus.34957 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4320727862 | |||
| W4320857324 | Transitions of care for advanced cancer in post‐acute and long‐term care | 2023-02-15 | OpenAlex | 10.1111/jgs.18291 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4320857324 | |||
| W4321133142 | Oral submucous fibrosis: A review on current treatment approaches | 2023-02-16 | OpenAlex | 10.30574/wjbphs.2023.13.2.0088 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321133142 | |||
| W4321097482 | Selected Articles from This Issue | 2023-02-16 | OpenAlex | 10.1158/1078-0432.ccr-29-4-hi | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321097482 | |||
| W4321113920 | Trends and perspectives on the commercialization of bioactive glasses | 2023-02-16 | OpenAlex | 10.1016/j.actbio.2023.02.020 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4321113920 | |||
| W4321375676 | Evolving Treatment Landscape of HER2-mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond | 2023-02-17 | OpenAlex | 10.3390/cancers15041286 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321375676 | |||
| W4386058266 | Role of Cardiac Biomarkers in Monitoring Cardiotoxicity in Chemotherapy Patients | 2023-02-17 | OpenAlex | 10.1097/hpc.0000000000000314 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386058266 | |||
| W4321373043 | Drug Delivery Systems in Regenerative Medicine: An Updated Review | 2023-02-18 | OpenAlex | 10.3390/pharmaceutics15020695 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321373043 | |||
| W4321351407 | A theology of chaplaincy from below: changing the locus of theological agency | 2023-02-19 | OpenAlex | 10.1080/1756073x.2023.2168230 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4321351407 | |||
| W4321459206 | How I manage mantle cell lymphoma: indolent versus aggressive disease | 2023-02-20 | OpenAlex | 10.1111/bjh.18697 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321459206 | |||
| W4324136534 | Multi-centre review of systemic anti-cancer prescribing patterns and treatment drop off rates in the United Kingdom 2018-2021. | 2023-02-20 | OpenAlex | 10.1200/jco.2023.41.6_suppl.689 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4324136534 | |||
| W4324136820 | Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer. | 2023-02-20 | OpenAlex | 10.1200/jco.2023.41.6_suppl.76 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4324136820 | |||
| W4324136453 | Real-world treatment patterns and sequencing in patients with locally advanced or metastatic urothelial cancer (la/mUC) in the US. | 2023-02-20 | OpenAlex | 10.1200/jco.2023.41.6_suppl.572 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4324136453 | |||
| W4324137093 | Survival outcomes of metastatic castration-resistant prostate cancer in Brazil (LACOG 1818). | 2023-02-20 | OpenAlex | 10.1200/jco.2023.41.6_suppl.tps272 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4324137093 | |||
| W4321434834 | Anthony Monaco, MD, FACS (1932–2022) | 2023-02-21 | OpenAlex | 10.1097/tp.0000000000004506 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321434834 | |||
| W4321435607 | Antimicrobial Nanomaterials as Advanced Coatings for Self-Sanitizing of Textile Clothing and Personal Protective Equipment | 2023-02-21 | OpenAlex | 10.1021/acsomega.2c06343 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321435607 | |||
| W4321499941 | COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels | 2023-02-21 | OpenAlex | 10.3390/cells12050684 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321499941 | |||
| W4321464108 | Clinical and pathophysiological understanding of the hepatorenal syndrome: Still wrong or still not exactly right? | 2023-02-21 | OpenAlex | 10.12998/wjcc.v11.i6.1261 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321464108 | |||
| W4321463970 | Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report | 2023-02-21 | OpenAlex | 10.12998/wjcc.v11.i6.1372 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4321463970 | |||
| W4321434650 | Infected Pseudoaneurysm of the Radial Artery | 2023-02-21 | OpenAlex | 10.1055/a-2039-3563 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4321434650 | |||
| W4321749234 | 2022 International Conference on Life, Health and Modern Medicine | 2023-02-22 | OpenAlex | 10.1097/md.0000000000032897 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321749234 | |||
| W4321601037 | A Fatal Case of Staphylococcus capitis Endocarditis in a Patient With Transcatheter Aortic Valve Replacement | 2023-02-22 | OpenAlex | 10.7759/cureus.35333 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4321601037 | |||
| W4321509620 | Anabolic steroids | 2023-02-22 | OpenAlex | 10.1016/b978-0-12-824315-2.00306-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4321509620 | |||
| W4321479775 | Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology | 2023-02-22 | OpenAlex | 10.1002/cnr2.1796 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321479775 | |||
| W4321496757 | Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant – how far we have come and how much further we must go | 2023-02-22 | OpenAlex | 10.3389/fonc.2023.1148321 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321496757 | |||
| W4321600787 | Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first‐line JAK‐inhibitor | 2023-02-23 | OpenAlex | 10.1002/ajh.26890 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4321600787 | |||
| W4321614711 | Paediatric sepsis-associated encephalopathy (SAE): a comprehensive review | 2023-02-23 | OpenAlex | 10.1186/s10020-023-00621-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321614711 | |||
| W4321764355 | Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario | 2023-02-24 | OpenAlex | 10.1016/j.ctrv.2023.102528 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4321764355 | |||
| W4321785455 | Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia | 2023-02-24 | OpenAlex | 10.1002/jha2.663 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4321785455 | |||
| W4322013288 | Post-Residency Life: How to Build a Successful Career | 2023-02-25 | OpenAlex | 10.1176/appi.pn.2023.03.3.23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4322013288 | |||
| W4322718549 | Dynamics of Human Immunodeficiency Virus Type 1 A6 Variant Transmissions Between Poland and Ukraine | 2023-02-28 | OpenAlex | 10.1093/cid/ciad062 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4322718549 | |||
| W4323319963 | Editorial: Widely used and novel approaches of the measurement of arterial stiffness and central hemodynamic parameters: Is there a consensus on the horizon? | 2023-02-28 | OpenAlex | 10.3389/fphys.2023.1167257 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323319963 | |||
| W4322744177 | Harms, Wrongs, and Medical Moral Injury | 2023-02-28 | OpenAlex | 10.1177/09539468231160015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4322744177 | |||
| W4322617573 | LI-RADS: Looking Back, Looking Forward | 2023-02-28 | OpenAlex | 10.1148/radiol.222801 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4322617573 | |||
| W7215704627 | Therapeutic pathway of Malian patients suffering from chronic skin diseases at the Dermatology Hospital of Bamako | 2023-02-28 | OpenAlex | 10.5281/hsd.v24i3.4318 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7215704627 | |||
| W4415068082 | VIRAL DELIVERY SYSTEMS WITHIN THE GENE THERAPY LANDSCAPE | 2023-02-28 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415068082 | ||||
| W4323351096 | A235 “WHAT’S SPRUE WITH YOU?”: OLMESARTAN-INDUCED ENTEROPATHY AS AN UNCOMMON MIMICKER OF CELIAC DISEASE | 2023-03-01 | OpenAlex | 10.1093/jcag/gwac036.235 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4323351096 | |||
| W4385670201 | AIDS dementia complex and neuropsychiatric symptoms : a case report | 2023-03-01 | OpenAlex | 10.1192/j.eurpsy.2023.2039 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385670201 | |||
| W4367018740 | Abstract Number ‐ 211: Flow Diversion in Direct Carotid‐Cavernous Fistulas: Case Report and Literature Review | 2023-03-01 | OpenAlex | 10.1161/svin.03.suppl_1.211 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4367018740 | |||
| W4322772196 | Abstract OT1-20-02: Intralesional injection of anti-PD-1 (pembrolizumab) and OX40L/IL-23/IL-36 mRNAs (mRNA-2752) results in regression of DCIS characterized by lymphocytic infiltrates | 2023-03-01 | OpenAlex | 10.1158/1538-7445.sabcs22-ot1-20-02 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4322772196 | |||
| W4322773958 | Abstract P1-08-07: Educational Opportunities to Improve HER2 Testing and Use of Newer Therapies for HER2-Positive MBC Among Community Healthcare Professionals | 2023-03-01 | OpenAlex | 10.1158/1538-7445.sabcs22-p1-08-07 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4322773958 | |||
| W4322771157 | Abstract P2-21-10: Tumour associated macrophages in Breast Cancer - Are they critical players in response to Neo Adjuvant Chemotherapy? | 2023-03-01 | OpenAlex | 10.1158/1538-7445.sabcs22-p2-21-10 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4322771157 | |||
| W4360843144 | Advances in Diagnosis and Therapy of Retinal Diseases | 2023-03-01 | OpenAlex | 10.1097/apo.0000000000000604 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4360843144 | |||
| W4385669381 | An update on the Pharmacological and Psychotherapeutic Management of Treatment Resistant OCD | 2023-03-01 | OpenAlex | 10.1192/j.eurpsy.2023.104 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385669381 | |||
| W4365152314 | CLINICO-MYCOLOGICAL STUDY OF TINEA CAPITIS | 2023-03-01 | OpenAlex | 10.36106/ijar/4201629 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4365152314 | |||
| W4322620372 | Combinatorial targeting of immune checkpoints and epigenetic regulators for hepatocellular carcinoma therapy | 2023-03-01 | OpenAlex | 10.1038/s41388-023-02646-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4322620372 | |||
| W4362521695 | Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment. | 2023-03-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362521695 | ||||
| W4323971864 | Conspectus on nanodiagnostics as an incipient platform for detection of oral potentially malignant disorders and oral squamous cell carcinoma | 2023-03-01 | OpenAlex | 10.1097/js9.0000000000000021 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323971864 | |||
| W4362576970 | Embedding guidelines into clinical practice | 2023-03-01 | OpenAlex | 10.1002/pdi.2447 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362576970 | |||
| W4322754341 | Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents | 2023-03-01 | OpenAlex | 10.1182/blood.2022018827 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4322754341 | |||
| W4323923462 | Introduction to the Carceral Edgelands: Special Issue | 2023-03-01 | OpenAlex | 10.1111/johs.12416 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323923462 | |||
| W4361251175 | Networking Print in Shakespeare’s England: Influence, Agency, and Revolutionary Change | 2023-03-01 | OpenAlex | 10.1215/00267929-10189216 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361251175 | |||
| W4323971787 | Outbreak of tomato flu in India raising concerns: is it a false alarm or are we welcoming a new pandemic? | 2023-03-01 | OpenAlex | 10.1097/js9.0000000000000229 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323971787 | |||
| W4362674090 | PART 1: RAAS Blockers – Are They All The Same? | 2023-03-01 | OpenAlex | 10.31762/ahj2332.0101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362674090 | |||
| W4361196045 | Prime Time to Focus on Gastrointestinal Endoscopy Quality Improvement | 2023-03-01 | OpenAlex | 10.1055/s-0043-1762918 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361196045 | |||
| W4323533348 | Systematic review of the management of brain metastases from hormone receptor positive breast cancer | 2023-03-01 | OpenAlex | 10.1007/s11060-023-04276-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323533348 | |||
| W4362726050 | The Public Health Perspective of Gonococcal Infection in Neonates | 2023-03-01 | OpenAlex | 10.4103/ijcm.ijcm_1478_21 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362726050 | |||
| W4322631727 | Thrombotic thrombocytopenic purpura in caplacizumab era – An individualized approach | 2023-03-01 | OpenAlex | 10.1016/j.transci.2023.103682 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4322631727 | |||
| W4322758997 | Toward an adequate understanding of phenomenological and hermeneutic‐phenomenological nursing research | 2023-03-01 | OpenAlex | 10.1111/nhs.13015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4322758997 | |||
| W4377093081 | [Autoimmune/inflammatory syndrome induced by adjuvants. Case report]. | 2023-03-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4377093081 | ||||
| W4327680973 | [Pharmacologic Therapy for Bone Metastases-Current Strategies and Future Directions]. | 2023-03-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4327680973 | ||||
| W4322769284 | Evolving Treatment Patterns in Diabetic Macular Edema Between 2015 and 2020 | 2023-03-02 | OpenAlex | 10.1177/24741264231156096 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4322769284 | |||
| W4322768234 | Using the planetary health framework to assess phytotherapeutic agents in the treatment of benign prostatic hyperplasia | 2023-03-02 | OpenAlex | 10.1016/j.purol.2023.02.004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4322768234 | |||
| W4361228304 | AI-informed mental health care: A Bibliometric Analysis and Systematic Review (Preprint) | 2023-03-04 | OpenAlex | 10.2196/preprints.46987 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361228304 | |||
| W4323067070 | ATR‐FTIR spectrum analysis of plasma samples for rapid identification of recovered COVID ‐19 individuals | 2023-03-04 | OpenAlex | 10.1002/jbio.202200166 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4323067070 | |||
| W4353015451 | Myocarditis: causes, mechanisms, and evolving therapies | 2023-03-04 | OpenAlex | 10.1080/14728222.2023.2193330 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4353015451 | |||
| W4323267579 | Safety of Andexanet Alfa Use in Cardiac Surgery | 2023-03-05 | OpenAlex | 10.1053/j.jvca.2023.02.039 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4323267579 | |||
| W4397037624 | Study to Evaluate the Effectiveness of Structured Teaching Programme on Knowledge of Primary School Teachers Regarding Identification of Behavioral Related Emotional Problems among Children between Six to Ten Years in Selected Primary Schools at Bangalore | 2023-03-05 | OpenAlex | 10.21275/sr23301203634 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4397037624 | |||
| W4323311630 | Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care | 2023-03-06 | OpenAlex | 10.3390/biomedicines11030790 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323311630 | |||
| W4323315678 | Editorial: Leishmania genome variability: Impacts on parasite evolution, parasitism and leishmaniases control | 2023-03-06 | OpenAlex | 10.3389/fcimb.2023.1171962 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323315678 | |||
| W4323348833 | Definition der Hüftdysplasie im Jahr 2023 | 2023-03-07 | OpenAlex | 10.1007/s00132-023-04353-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323348833 | |||
| W4323662042 | Emergence of Multidrug Resistance Microbes: Bacteria, Fungi, and Viruses | 2023-03-07 | OpenAlex | 10.2174/9789815080056123020005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323662042 | |||
| W4323356434 | Escherichia coli | 2023-03-07 | OpenAlex | 10.1201/9781003155447-11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323356434 | |||
| W4323351497 | Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness? | 2023-03-07 | OpenAlex | 10.1093/clinchem/hvad016 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323351497 | |||
| W4323362942 | The biology and treatment of leiomyosarcomas | 2023-03-07 | OpenAlex | 10.1016/j.critrevonc.2023.103955 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323362942 | |||
| W4323652154 | Patient‐centricity: Research's new shibboleth? | 2023-03-08 | OpenAlex | 10.1111/jep.13830 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323652154 | |||
| W4323545761 | Strategies to target the cancer driver MYC in tumor cells | 2023-03-08 | OpenAlex | 10.3389/fonc.2023.1142111 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323545761 | |||
| W4323531728 | Supporting critically conscious integrated care: A toolbox for the health professions | 2023-03-08 | OpenAlex | 10.1111/tct.13569 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323531728 | |||
| W4323653382 | Assessing the effects of therapeutic combinations on SARS-CoV-2 infected patient outcomes: A big data approach | 2023-03-09 | OpenAlex | 10.1371/journal.pone.0282587 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4323653382 | |||
| W4323666640 | Situating personality disorder within its maladaptive narrative identity ecology | 2023-03-09 | OpenAlex | 10.3389/fpsyt.2023.1117525 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4323666640 | |||
| W4323665760 | The Ethics of Monadic Identity in Leibniz's Thought | 2023-03-09 | OpenAlex | 10.18662/brain/14.1/434 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4323665760 | |||
| W4323860102 | Editorial: Application of the biogenic silver nanoparticles as antimicrobial and anticancer agents | 2023-03-10 | OpenAlex | 10.3389/fchem.2023.1180027 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4323860102 | |||
| W4323921292 | Spectral imaging enables contrast agent–free real-time ischemia monitoring in laparoscopic surgery | 2023-03-10 | OpenAlex | 10.1126/sciadv.add6778 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4323921292 | |||
| W4323928385 | Acute profound thrombocytopenia induced by tirofiban in stent assisted embolization of intracranial ruptured aneurysm-a rare case report | 2023-03-11 | OpenAlex | 10.1016/j.heliyon.2023.e14504 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4323928385 | |||
| W4324296881 | Asynchronous Decentralized Federated Lifelong Learning for Landmark Localization in Medical Imaging | 2023-03-12 | OpenAlex | 2303.06783 | 10.48550/arxiv.2303.06783 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4324296881 | ||
| W4327597315 | Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience | 2023-03-13 | OpenAlex | 10.17650/1818-8346-2023-18-1-12-19 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4327597315 | |||
| W4324088165 | Editorial: Recent Advances on Myocardium Physiology, Volume II | 2023-03-13 | OpenAlex | 10.3389/fphys.2023.1170396 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4324088165 | |||
| W4324117788 | Targeted therapies in advanced biliary tract cancers—a narrative review | 2023-03-14 | OpenAlex | 10.21037/cco-22-93 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4324117788 | |||
| W4324128561 | Thrombolytic treatment of life-threatening pulmonary embolism in times of alteplase shortage | 2023-03-14 | OpenAlex | 10.1093/eurheartj/ehad120 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4324128561 | |||
| W4361005422 | A review on spinal muscular atrophy: An inherited neuromuscular disease | 2023-03-15 | OpenAlex | 10.18231/j.ijcaap.2023.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361005422 | |||
| W4375865426 | Clinical Experience with Epigenetic Drugs in Lymphoid Malignancies | 2023-03-15 | OpenAlex | 10.1002/9781119819950.ch16 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4375865426 | |||
| W4324378503 | Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option | 2023-03-15 | OpenAlex | 10.3389/fimmu.2023.1118246 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4324378503 | |||
| W4324359014 | Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility | 2023-03-15 | OpenAlex | 10.1186/s12967-023-04041-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4324359014 | |||
| W4327619162 | Brain science in American courts: the culpable neurotransmitters | 2023-03-16 | OpenAlex | 10.1108/jfp-05-2022-0028 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4327619162 | |||
| W7212465267 | Checkpoint and inflammatory markers in chronic colitis and colorectal cancer | 2023-03-16 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7212465267 | ||||
| W4327692917 | Identifying the Needs of Health Care Providers in Advanced First-Line Renal Cell Carcinoma: A Mixed-Methods Research | 2023-03-17 | OpenAlex | 10.1016/j.clgc.2023.03.005 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4327692917 | |||
| W4327747194 | Postural evaluation in horses submitted to perineural anesthetic blocks in the thoracic limbs | 2023-03-17 | OpenAlex | 10.56238/devopinterscie-030 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4327747194 | |||
| W4327694592 | The Clinical Journey of a Patient with Familial Mediterranean Fever: One Gene, Three Diseases | 2023-03-17 | OpenAlex | 10.1055/a-2000-5516 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4327694592 | |||
| W4327906119 | A Significant Role of Nontypeable Haemophilus influenzae in Acute Otitis Media in Bulgarian Children | 2023-03-20 | OpenAlex | 10.1055/s-0043-1764213 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4327906119 | |||
| W7139491100 | Developing an ethical framework of AI in healthcare : reflections for the construction of an operational ethical framework through the example of medical oncology | 2023-03-20 | OpenAlex | Title/abstract | Excluded | E5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established. | https://openalex.org/W7139491100 | ||||
| W4360613302 | Bonding Technologies in Young Permanent Molars: A Case Series | 2023-03-21 | OpenAlex | 10.5005/jp-journals-10005-2503 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4360613302 | |||
| W4328052280 | Emerging, re‐emerging and/or atypically behaving infectious diseases | 2023-03-21 | OpenAlex | 10.1111/apa.16744 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4328052280 | |||
| W4328094108 | Telemedicine, E-Health, and Multi-Agent Systems for Chronic Pain Management | 2023-03-21 | OpenAlex | 10.3390/clinpract13020042 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4328094108 | |||
| W4353041088 | The management of polypharmacy in people living with HIV | 2023-03-22 | OpenAlex | 10.24875/aidsrev.m23000059 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4353041088 | |||
| W4360615126 | 30 Years of Improved Survival in Non-Transplant-Eligible Newly Diagnosed Multiple Myeloma | 2023-03-23 | OpenAlex | 10.3390/cancers15071929 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4360615126 | |||
| W4360611871 | Fluorescent Magnetic Quantum Dots in Bioimaging | 2023-03-23 | OpenAlex | 10.1201/9781003319870-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4360611871 | |||
| W4360620253 | Modeling identifies variability in SARS-CoV-2 uptake and eclipse phase by infected cells as principal drivers of extreme variability in nasal viral load in the 48 h post infection | 2023-03-23 | OpenAlex | 10.1016/j.jtbi.2023.111470 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4360620253 | |||
| W4360874527 | An Evolving Understanding of the Basis and Management of Vascular Complications of COVID-19: Where Do We Go From Here? | 2023-03-24 | OpenAlex | 10.1016/j.cjca.2023.03.019 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4360874527 | |||
| W4360949464 | Recent advances in targeted therapies in acute myeloid leukemia | 2023-03-25 | OpenAlex | 10.1186/s13045-023-01424-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4360949464 | |||
| W4360976444 | Tumor-targeted superantigens produce curative tumor immunity with induction of memory and demonstrated antigen spreading | 2023-03-26 | OpenAlex | 10.1186/s12967-023-04064-z | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4360976444 | |||
| W4361007827 | 2023 update on the clinical management of gastroparesis | 2023-03-27 | OpenAlex | 10.1080/17474124.2023.2196404 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361007827 | |||
| W4380628180 | Author response: Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3 | 2023-03-27 | OpenAlex | 10.7554/elife.78601.sa2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380628180 | |||
| W4361011332 | Editorial: Insights in integrative physiology: 2021 | 2023-03-27 | OpenAlex | 10.3389/fphys.2023.1186581 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361011332 | |||
| W4366005792 | All-Fabric Triboelectric Nanogenerator (AF-TENG) Smart Face Mask: Remote Long-Rate Breathing Monitoring and Apnea Alarm | 2023-03-28 | OpenAlex | 10.5281/zenodo.7835255 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4366005792 | |||
| W4362601118 | Cardiac medications in obstetric patients | 2023-03-28 | OpenAlex | 10.1097/hco.0000000000001039 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362601118 | |||
| W4361204288 | Crystallized Intelligence Wisdom Repository Management System with a Conversational Agent | 2023-03-28 | OpenAlex | 10.5539/ies.v16n2p150 | Full text | Excluded | F3: The medical-student repository chatbot uses pattern matching, intent classification, retrieval and conventional RNN-style generation. Its implemented system does not establish an LLM-based acting agent. | https://openalex.org/W4361204288 | https://doi.org/10.5539/ies.v16n2p150 | ||
| W4361190156 | Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment | 2023-03-28 | OpenAlex | 10.1007/s13105-023-00954-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361190156 | |||
| W4361216707 | Recent advances in 3D printed microneedles and their skin delivery application in the treatment of various diseases | 2023-03-28 | OpenAlex | 10.1016/j.jddst.2023.104395 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361216707 | |||
| W4361190668 | Time for the Next Step in Clinical Trial Evolution? | 2023-03-28 | OpenAlex | 10.1002/ana.26655 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361190668 | |||
| W4361284754 | Can Molecular Imaging Find a Path to Navigate Evolving Breast Cancer Treatments? | 2023-03-29 | OpenAlex | 10.1158/1078-0432.ccr-23-0393 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361284754 | |||
| W4361270396 | Mania Associated with Cabergoline: a Brazilian Case Report | 2023-03-29 | OpenAlex | 10.22533/at.ed.15932023270310 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4361270396 | |||
| W4361195771 | Pentosan polysulfate maculopathy: a brief primer for general practitioners, ophthalmologists, optometrists and urologists | 2023-03-29 | OpenAlex | 10.5694/mja2.51913 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4361195771 | |||
| W4361198241 | Polymeric Stimuli Responsive Theranostic Agents | 2023-03-29 | OpenAlex | 10.1201/9781003411468-4 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4361198241 | |||
| W4361197110 | Sedation strategies in patients undergoing extracorporeal cardiopulmonary resuscitation | 2023-03-29 | OpenAlex | 10.1093/ehjacc/zuad028 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361197110 | |||
| W4361305979 | Stress induced immunomodulation and the risk of infections during major sporting events: Implications for the FIFA World Cup 2022 | 2023-03-29 | OpenAlex | 10.1016/j.jiph.2023.03.024 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361305979 | |||
| W4361195507 | Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past | 2023-03-29 | OpenAlex | 10.1016/s2352-3026(23)00064-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4361195507 | |||
| W4361259762 | Chaotic fractals: Why chaos is the dynamic of carcinogenesis | 2023-03-30 | OpenAlex | 10.1002/cai2.63 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361259762 | |||
| W4392724684 | Data from A Chemosensitization Screen Identifies TP53RK, a Kinase that Restrains Apoptosis after Mitotic Stress | 2023-03-30 | OpenAlex | 10.1158/0008-5472.c.6500558.v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392724684; https://openalex.org/W4361822730 | |||
| W4361256348 | Data from Cellular Targets of Gefitinib | 2023-03-30 | OpenAlex | 10.1158/0008-5472.c.6493059.v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4361256348; https://openalex.org/W4361268539 | |||
| W4407264566 | FREQUENCY OF INTRANASAL ADHESIONS IN SEPTOPLASTY WITHOUT NASAL SPLINTS IN CASES OF NASAL SEPTAL DEVIATION | 2023-03-30 | OpenAlex | 10.53555/sbcmpj45 | Full text | Excluded | F3: The original surgical methods and results describe 198 human septoplasty cases, without a computational LLM agent. The DoctorAssist abstract was mis-indexed and is not the surgical method. | https://openalex.org/W4407264566 | https://www.researchgate.net/publication/388818830_FREQUENCY_OF_INTRANASAL_ADHESIONS_IN_SEPTOPLASTY_WITHOUT_NASAL_SPLINTS_IN_CASES_OF_NASAL_SEPTAL_DEVIATION | original methods and results, public full-text copy; publisher PDF fetch403 | |
| W4367315570 | Prevalence of Hypertension among HIV/AIDS Patients Attending a Tertiary Hospital in North-East Nigeria | 2023-03-30 | OpenAlex | 10.21522/tijph.2013.11.01.art031 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4367315570 | |||
| W4361953531 | Data from Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting | 2023-03-31 | OpenAlex | 10.1158/1078-0432.c.6529751.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4361953531; https://openalex.org/W4361959648 | |||
| W7119370029 | EXPRESSÃO DA PROTEÍNA P16 COMO ELEMENTO PREDITIVO DA EVOLUÇÃO DAS LESÕES INTRAEPITELIAIS DE BAIXO GRAU: UMA REVISÃO SISTEMÁTICA | 2023-03-31 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119370029 | ||||
| W4362460255 | Inflammatory bowel disease in pregnancy and breastfeeding | 2023-03-31 | OpenAlex | 10.1038/s41575-023-00758-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4362460255 | |||
| W4385966177 | Muscle activity and emotional behavior changes in rats with chronic brain ischemia via comprehensive pathogenetic correction | 2023-03-31 | OpenAlex | 10.12775/jehs.2023.13.03.054 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4385966177 | |||
| W4362474810 | Precision Oncology Targets in Biliary Tract Cancer | 2023-03-31 | OpenAlex | 10.3390/cancers15072105 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362474810 | |||
| W4362519871 | The multiple roles of nsp6 in the molecular pathogenesis of SARS-CoV-2 | 2023-03-31 | OpenAlex | 10.1016/j.antiviral.2023.105590 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362519871 | |||
| W4365151472 | Treatment failure shortcomings, possible causes and upcoming phyto-optimism in oral cancer | 2023-03-31 | OpenAlex | 10.52679/tabcj.2023.0002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4365151472 | |||
| W4362736332 | 2023-04-01 | OpenAlex | 10.13040/ijpsr.0975-8232.14(4).1649-59 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362736332 | ||||
| W4362586435 | (655) Outcomes of Immunosuppression Reduction During Covid-19 Infection in Heart Transplant Patients | 2023-04-01 | OpenAlex | 10.1016/j.healun.2023.02.669 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4362586435 | |||
| W4367675661 | A Review of Antithrombotic Agents in Dermatologic Surgery and Context for a Practical Approach, With Cardiology and Pharmacologic Input | 2023-04-01 | OpenAlex | 10.36849/jdd.7456 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367675661 | |||
| W4366438848 | A review of Zenalb 20 with the focus on its application in the clinical setting for patients requiring low sodium or chloride albumin | 2023-04-01 | OpenAlex | 10.1093/rpsppr/rqad015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366438848 | |||
| W4362693009 | A review on drug-induced dry eye disease | 2023-04-01 | OpenAlex | 10.4103/ijo.ijo_2782_22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362693009 | |||
| W4367186666 | Afterword | 2023-04-01 | OpenAlex | 10.1215/00138282-10293195 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367186666 | |||
| W4380050464 | Air pollution and cardiovascular heath in a changing climate | 2023-04-01 | OpenAlex | 10.1097/cp9.0000000000000051 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380050464 | |||
| W4387506418 | Aldosterone Pathway Blockade Therapies for Resistant Hypertension: An Update | 2023-04-01 | OpenAlex | 10.4103/rcm.rcm_30_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387506418 | |||
| W4364382146 | Autonomous optimization of neuroprosthetic stimulation parameters that drive the motor cortex and spinal cord outputs in rats and monkeys | 2023-04-01 | OpenAlex | 10.1016/j.xcrm.2023.101008 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4364382146 | |||
| W4366424702 | CodeBreak 200: Sotorasib Has Not Broken the KRASG12C Enigma Code | 2023-04-01 | OpenAlex | 10.2147/lctt.s403461 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366424702 | |||
| W7112302890 | Cyberbiosecurity. A short review | 2023-04-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7112302890 | ||||
| W4367056539 | David L. Mathewson. Voice and Mood: A Linguistic Approach | 2023-04-01 | OpenAlex | 10.5325/bullbiblrese.33.1.0098 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367056539 | |||
| W4362575878 | Emergence and History | 2023-04-01 | OpenAlex | 10.1215/21599785-10253259 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362575878 | |||
| W4385494283 | Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy | 2023-04-01 | OpenAlex | 10.4103/crst.crst_176_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385494283 | |||
| W4366000193 | Is meat eating morally defensible? Contemporary ethical considerations | 2023-04-01 | OpenAlex | 10.1093/af/vfac097 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366000193 | |||
| W4376620946 | Lived Experience in Social Work: An Underutilised Expertise | 2023-04-01 | OpenAlex | 10.1093/bjsw/bcad028 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376620946 | |||
| W4362692839 | Newer paradigms in dry eye disease research | 2023-04-01 | OpenAlex | 10.4103/ijo.ijo_599_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362692839 | |||
| W4366831664 | P146 Pragmatic Biologic Tapering Combining Clinical and Ultrasound Assessment in Patients with Rheumatoid Arthritis in Routine Clinical Practice - Predictors of Failure from a Regional Centre in UK | 2023-04-01 | OpenAlex | 10.1093/rheumatology/kead104.187 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4366831664 | |||
| W4382045356 | Practicing pediatric regional anesthesia: Children are not small adults | 2023-04-01 | OpenAlex | 10.4103/joacp.joacp_248_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382045356 | |||
| W4362577626 | Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go? | 2023-04-01 | OpenAlex | 10.3390/cancers15072113 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362577626 | |||
| W4385494354 | Rare kidney tumor | 2023-04-01 | OpenAlex | 10.4103/crst.crst_275_22 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385494354 | |||
| W4376621004 | The Advanced Practitioner’s Role in the Rapidly Evolving Landscape of Precision Medicine | 2023-04-01 | OpenAlex | 10.6004/jadpro.2023.14.3.18 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4376621004 | |||
| W4362502160 | The Old Meets the New: Efficacy and Mechanisms of Biophotonic Therapies in Viral and Microbial Illness | 2023-04-01 | OpenAlex | 10.9734/bpi/ramb/v4/5464e | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4362502160 | |||
| W7163874347 | There Is No Consensus on the Myocardial Ischemia/Reperfusion Injury Induction Methods in Animal Studies | 2023-04-01 | OpenAlex | 10.22037/jpem.v10i1.41497 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163874347 | |||
| W4377094254 | Trends in the Epidemiology and Treatment of Pediatric-Onset Multiple Sclerosis in Alberta, Canada | 2023-04-01 | OpenAlex | 10.1177/08830738231176588 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4377094254 | |||
| W4367174488 | Understanding Nephrotic Syndrome Using Kidney Transcriptome Profiling and Computational Studies | 2023-04-01 | OpenAlex | 10.34067/kid.0000000000000117 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367174488 | |||
| W4386135055 | Author response: Novel pathogen introduction triggers rapid evolution in animal social movement strategies | 2023-04-02 | OpenAlex | 10.7554/elife.81805.sa2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386135055 | |||
| W4387983788 | The Rising Horizon of Silver Diamine Fluoride as an Anti-Caries Agent in Pediatric Dentistry: A Narrative Literature Review | 2023-04-02 | OpenAlex | 10.5866/2023.13.10013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387983788 | |||
| W4392699170 | Data from GPER-Targeted, 99mTc-Labeled, Nonsteroidal Ligands Demonstrate Selective Tumor Imaging and In Vivo Estrogen Binding | 2023-04-03 | OpenAlex | 10.1158/1541-7786.c.6539791.v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392699170; https://openalex.org/W4392688829 | |||
| W4392699980 | Data from Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers | 2023-04-03 | OpenAlex | 10.1158/1541-7786.c.6541339.v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392699980; https://openalex.org/W4362541716 | |||
| W4392697529 | Data from Identification of Novel Radiosensitizers in a High-Throughput, Cell-Based Screen for DSB Repair Inhibitors | 2023-04-03 | OpenAlex | 10.1158/1535-7163.c.6537469.v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392697529; https://openalex.org/W4392681501 | |||
| W4392689822 | Data from Targeting Mammalian Target of Rapamycin by Rapamycin Prevents Tumor Progression in an Oral-Specific Chemical Carcinogenesis Model | 2023-04-03 | OpenAlex | 10.1158/1940-6207.c.6543790 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392689822; https://openalex.org/W4392701179 | |||
| W4362542062 | Data from UNC-45A Is a Novel Microtubule-Associated Protein and Regulator of Paclitaxel Sensitivity in Ovarian Cancer Cells | 2023-04-03 | OpenAlex | 10.1158/1541-7786.c.6541335 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362542062; https://openalex.org/W4392700163 | |||
| W4362579266 | ERCP: a very personal history | 2023-04-03 | OpenAlex | 10.1097/cld.0000000000000028 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362579266 | |||
| W4362559529 | Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones | 2023-04-03 | OpenAlex | 10.3390/jcm12072675 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4362559529 | |||
| W4362544012 | Abstract 1568: Mechanistic studies of KL-50, a novel imidazotetrazine for the treatment of MGMT-/MMR- gliomas and glioblastoma | 2023-04-04 | OpenAlex | 10.1158/1538-7445.am2023-1568 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362544012 | |||
| W4362593475 | Abstract 2694: Blockade of the cyclooxygenase-2 prevents chemotherapy-induced cognitive impairments | 2023-04-04 | OpenAlex | 10.1158/1538-7445.am2023-2694 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362593475 | |||
| W4362593197 | Abstract 3172: Mapping the molecular landscape of acute myeloid leukemia enables prediction of drug response from proteogenomic data | 2023-04-04 | OpenAlex | 10.1158/1538-7445.am2023-3172 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362593197 | |||
| W4362596037 | Abstract 3578: Using a novel [68Ga]-radiolabeled peptide to detect cell surface expression of calreticulin in pancreatic adenocarcinoma | 2023-04-04 | OpenAlex | 10.1158/1538-7445.am2023-3578 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362596037 | |||
| W4362534914 | Abstract 3922: Assessing clonal evolution of myeloid neoplasms by flow cytometry guided, cell-enriched next generation sequencing | 2023-04-04 | OpenAlex | 10.1158/1538-7445.am2023-3922 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362534914 | |||
| W4362595634 | Abstract 4675: Chemoresistant patient-derived xenografts to identify treatment options in breast cancer patients not responding to standard chemotherapy | 2023-04-04 | OpenAlex | 10.1158/1538-7445.am2023-4675 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362595634 | |||
| W4380029736 | Abstract 6253: SP-3164, a novel molecular glue degrader with activity in preclinical models of multiple myeloma | 2023-04-04 | OpenAlex | 10.1158/1538-7445.am2023-6253 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4380029736 | |||
| W4362594095 | Abstract 6390: N17350 is an emerging therapeutic modality that selectively kills cancer cells and stimulates anti-tumor immunity | 2023-04-04 | OpenAlex | 10.1158/1538-7445.am2023-6390 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362594095 | |||
| W4379984252 | Abstract 6625: Mathematical modeling of single-cell data reveals the key role of stochasticity - not fitness - in determining the clonal origins of relapse in childhood leukemia | 2023-04-04 | OpenAlex | 10.1158/1538-7445.am2023-6625 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4379984252 | |||
| W4362592333 | Abstract 973: Uncovering gene signatures of Ewings sarcoma drug sensitivity during the evolution of resistance | 2023-04-04 | OpenAlex | 10.1158/1538-7445.am2023-973 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362592333 | |||
| W4362595630 | Abstract PL02-04: Malignancies in People with HIV: Successes and Challenges at the Intersection of Virology, Immunology, and Oncology | 2023-04-04 | OpenAlex | 10.1158/1538-7445.am2023-pl02-04 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362595630 | |||
| W4362521758 | Back-to-Africa introductions of Mycobacterium tuberculosis as the main cause of tuberculosis in Dar es Salaam, Tanzania | 2023-04-04 | OpenAlex | 10.1371/journal.ppat.1010893 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362521758 | |||
| W4362548499 | Data from Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes | 2023-04-04 | OpenAlex | 10.1158/2643-3230.c.6551018 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362548499; https://openalex.org/W4362547593 | |||
| W4362547037 | Data from Resolving the Heterogeneous Tumor-Centric Cellular Neighborhood through Multiplexed, Spatial Paracrine Interactions in the Setting of Immune Checkpoint Blockade | 2023-04-04 | OpenAlex | 10.1158/2767-9764.c.6550542.v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4362547037; https://openalex.org/W4362525199 | |||
| W4362561271 | Editorial: Emerging concepts in Mycobacterium tuberculosis pathogenesis: Host-pathogen interaction and stress adaption mechanisms | 2023-04-04 | OpenAlex | 10.3389/fcimb.2023.1148756 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362561271 | |||
| W4362612931 | Determination of the Antioxidant and Antiproliferative Properties of Pomegranate Peel Extract Obtained by Ultrasound on HCT-116 Colorectal Cancer Cell Line | 2023-04-05 | OpenAlex | 10.3390/pr11041111 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362612931 | |||
| W4362695654 | Epidemiological profile of pesticide poisoning cases in the State of Sergipe, Brazil: a retrospective analysis from 2007 to 2021 | 2023-04-05 | OpenAlex | 10.33448/rsd-v12i4.41127 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4362695654 | |||
| W4362609757 | Evolving Diagnostic and Management Advances in Coronary Heart Disease | 2023-04-05 | OpenAlex | 10.3390/life13040951 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4362609757 | |||
| W4362640955 | Financial toxicity of oral therapies in advanced prostate cancer | 2023-04-05 | OpenAlex | 10.1016/j.urolonc.2023.03.002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4362640955 | |||
| W4362634632 | The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer | 2023-04-05 | OpenAlex | 10.1016/j.hoc.2023.02.003 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4362634632 | |||
| W4362666608 | Car-T Hücre Tedavi Sistemi | 2023-04-06 | OpenAlex | 10.53478/tuba.978-625-8352-48-1.ch19 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362666608 | |||
| W4362660027 | Focal liver lesions in the setting of chronic liver disease | 2023-04-06 | OpenAlex | 10.1016/b978-0-323-87479-3.00022-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4362660027 | |||
| W4362689982 | Analysis of real-world data to investigate evolving treatment sequencing patterns in advanced non-small cell lung cancers and their impact on survival | 2023-04-07 | OpenAlex | 10.21037/jtd-22-1481 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4362689982 | |||
| W4362692726 | Comparison of human monkeypox, chickenpox and smallpox: a comprehensive review of pathology and dermatological manifestations | 2023-04-07 | OpenAlex | 10.1080/03007995.2023.2200122 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4362692726 | |||
| W4362697953 | Health-related Quality of Life and Cost Effectiveness of Treatment: Components to Be Included in Clinical Decision-making | 2023-04-07 | OpenAlex | 10.1016/j.euo.2023.03.011 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4362697953 | |||
| W4362722515 | Is There a Role of Artificial Intelligence in Preclinical Imaging? | 2023-04-08 | OpenAlex | 10.1053/j.semnuclmed.2023.03.003 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4362722515 | |||
| W4362723845 | Effect of probiotics as an immune modulator for the management of COVID-19 | 2023-04-09 | OpenAlex | 10.1007/s00203-023-03504-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4362723845 | |||
| W4363624516 | Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking | 2023-04-10 | OpenAlex | 10.1101/2023.04.08.536123 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4363624516 | |||
| W4367299816 | Changing the strategic paradigm for the treatment of adult acute myeloid leukemia | 2023-04-10 | OpenAlex | 10.5124/jkma.2023.66.4.234 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367299816 | |||
| W4377103548 | Cyclic adenosine monophosphate-elevating agents inhibit amyloid-beta internalization and neurotoxicity: their action in Alzheimer’s disease prevention | 2023-04-10 | OpenAlex | 10.4103/1673-5374.373664 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4377103548 | |||
| W4377103910 | TREM2 as an evolving therapeutic target in Alzheimer’s disease | 2023-04-10 | OpenAlex | 10.4103/1673-5374.371360 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4377103910 | |||
| W4363677308 | The More Things Change… | 2023-04-10 | OpenAlex | 10.1016/j.thorsurg.2023.02.002 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4363677308 | |||
| W4365483731 | Back to the Future II—A Comprehensive Update on the Rapidly Evolving Field of Lymphatic Imaging and Interventions | 2023-04-11 | OpenAlex | 10.1097/rli.0000000000000966 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4365483731 | |||
| W4365142399 | Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy | 2023-04-11 | OpenAlex | 10.3390/cancers15082240 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4365142399 | |||
| W4364361731 | This Month in Anesthesiology | 2023-04-11 | OpenAlex | 10.1097/aln.0000000000004561 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4364361731 | |||
| W4365143025 | Dynamics and specificities of T cells in cancer immunotherapy | 2023-04-12 | OpenAlex | 10.1038/s41568-023-00560-y | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4365143025 | |||
| W4365148457 | Orthobiologics in the knee | 2023-04-12 | OpenAlex | 10.1016/j.mporth.2023.03.002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4365148457 | |||
| W4367173556 | The Management of Relapsed and Refractory Multiple Myeloma | 2023-04-12 | OpenAlex | 10.46883/2023.25920991 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367173556 | |||
| W4365795802 | Historic recurrences in medicinal chemistry: nature-inspired structures as a new opportunity for novel multi-target anti-Alzheimer’s drugs | 2023-04-13 | OpenAlex | 10.4103/1673-5374.373685 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4365795802 | |||
| W4365443195 | Imaging Patients with Kidney Failure | 2023-04-13 | OpenAlex | 10.1148/rg.220116 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4365443195 | |||
| W4365795766 | Newfound physiological function of FAIM protein offers hope of novel disease-modifying therapy for Alzheimer’s disease | 2023-04-13 | OpenAlex | 10.4103/1673-5374.374003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4365795766 | |||
| W4365443688 | Protracted viral infections in patients with multiple myeloma receiving bispecific T-cell engager therapy targeting B-cell maturation antigen | 2023-04-13 | OpenAlex | 10.3324/haematol.2023.283003 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4365443688 | |||
| W4365795794 | Repurposing niclosamide for the treatment of neurological disorders | 2023-04-13 | OpenAlex | 10.4103/1673-5374.373705 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4365795794 | |||
| W4365450922 | Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer | 2023-04-13 | OpenAlex | 10.1016/j.ccell.2023.04.005 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4365450922 | |||
| W4365511661 | Abstract LB130: Single-cell multiomics analysis of myelodysplastic syndrome predicts clinical response to DNA methylation inhibitor therapy | 2023-04-14 | OpenAlex | 10.1158/1538-7445.am2023-lb130 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4365511661 | |||
| W4365483035 | New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE) | 2023-04-14 | OpenAlex | 10.1007/s11864-023-01076-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4365483035 | |||
| W4366217148 | Emerging evidence and treatment paradigm of non-small cell lung cancer | 2023-04-17 | OpenAlex | 10.1186/s13045-023-01436-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366217148 | |||
| W4366089987 | Mediality as a Mode of Existence: Technologies, Bodies, Matters | 2023-04-17 | OpenAlex | 10.14220/trns.2023.2.1.147 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4366089987 | |||
| W4379519343 | Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update | 2023-04-17 | OpenAlex | 10.3233/jpd-239901 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379519343 | |||
| W4366083030 | Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections | 2023-04-17 | OpenAlex | 10.1128/cmr.00059-22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366083030 | |||
| W4366263118 | Hybrid morphologies of paramagnetic manganese-based nanoparticles as theranostics | 2023-04-18 | OpenAlex | 10.1016/j.cej.2023.142970 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4366263118 | |||
| W4366308855 | Temperature-Induced Contrast Enhancement for Radar-Based Breast Tumor Detection at K-Band Using Tissue Mimicking Phantoms | 2023-04-18 | OpenAlex | 10.1109/jerm.2023.3265510 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4366308855 | |||
| W4366350970 | Antiplatelet therapy for coronary artery disease in 2023: current status and future prospects | 2023-04-19 | OpenAlex | 10.1080/14779072.2023.2201437 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366350970 | |||
| W4366438945 | CAR T-Cell Therapy Shows Superior PFS in R/R Multiple Myeloma | 2023-04-19 | OpenAlex | 10.1097/01.cot.0000932004.13185.49 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366438945 | |||
| W4366439897 | Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature | 2023-04-19 | OpenAlex | 10.1038/s41698-023-00375-y | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4366439897 | |||
| W4366578520 | Genomic features, antimicrobial susceptibility, and epidemiological insights into Burkholderia cenocepacia clonal complex 31 isolates from bloodstream infections in India | 2023-04-19 | OpenAlex | 10.3389/fcimb.2023.1151594 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4366578520 | |||
| W4366491558 | Hepatocellular carcinoma (HCC) immunotherapy by anti-PD-1 monoclonal antibodies: A rapidly evolving strategy | 2023-04-20 | OpenAlex | 10.1016/j.prp.2023.154473 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4366491558 | |||
| W4366464218 | What Is the Best Surgical Intervention for Patients With Idiopathic Intracranial Hypertension? | 2023-04-20 | OpenAlex | 10.1097/wno.0000000000001856 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366464218 | |||
| W4366699714 | Antimicrobial agents | 2023-04-21 | OpenAlex | 10.1016/b978-0-12-824315-2.00946-5 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4366699714 | |||
| W4366774890 | Efficacy, safety, and tolerability of antimicrobial agents for complicated intra-abdominal infection: a systematic review and network meta-analysis | 2023-04-21 | OpenAlex | 10.1186/s12879-023-08209-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366774890 | |||
| W4366603023 | Provider-directed analgesia for dental pain | 2023-04-21 | OpenAlex | 10.1080/17512433.2023.2206118 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366603023 | |||
| W4366779516 | Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon | 2023-04-23 | OpenAlex | 10.1016/j.gore.2023.101186 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366779516 | |||
| W4366779319 | The role of ETV4 in HCC: How transcription factors can inform immunotherapy combination treatments | 2023-04-23 | OpenAlex | 10.1016/j.jhep.2023.04.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366779319 | |||
| W3090350409 | A comparative study of bacterial contamination between open heart surgery wards and neurosurgery wards | 2023-04-24 | OpenAlex | 10.25130/tjphs.2013.11.1.1.1.14 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W3090350409 | |||
| W4366817338 | Aircraft noise and cardiovascular risk: are we witnessing an evolving risk factor of the future? | 2023-04-24 | OpenAlex | 10.1093/eurjpc/zwad129 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366817338 | |||
| W4366819512 | Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors | 2023-04-24 | OpenAlex | 10.1080/07853890.2023.2203946 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4366819512 | |||
| W4366821757 | Evolving from Didactic to Dialogic: How to Improve Faculty Development and Support Faculty Developers by Using Action Research | 2023-04-24 | OpenAlex | 10.1080/10401334.2023.2204091 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4366821757 | |||
| W4366815263 | The Continuous Adaptive Challenge Played by Arboviruses: An In Silico Approach to Define Relevant Molecular Interactions with the Host | 2023-04-24 | OpenAlex | 10.20944/preprints202304.0823.v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4366815263 | |||
| W4366988345 | Withania somnifera seed oil exhibits antibiofilm properties against drug-resistant Candida auris clinical isolate through modulation in cell permeability | 2023-04-24 | OpenAlex | 10.1093/jambio/lxad087 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4366988345 | |||
| W4386310383 | A Dual Beta Blocker and Calcium Channel Blocker Overdose in a Patient with Substance Abuse | 2023-04-25 | OpenAlex | 10.59657/2837-4681.brs.23.025 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386310383 | |||
| W4378716441 | Depression as a Prodromal Symptom of Neurodegenerative Diseases | 2023-04-25 | OpenAlex | 10.1272/jnms.jnms.2023_90-216 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4378716441 | |||
| W4366992539 | Hormones and COVID-19 | 2023-04-25 | OpenAlex | 10.1016/j.mayocp.2023.04.010 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4366992539 | |||
| W4366989494 | Ten characteristics of high-quality planetary health education—Results from a qualitative study with educators, students as educators and study deans at medical schools in Germany | 2023-04-25 | OpenAlex | 10.3389/fpubh.2023.1143751 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4366989494 | |||
| W4367047646 | Bringing the Promise of Artificial Intelligence to Critical Care: What the Experience With Sepsis Analytics Can Teach Us | 2023-04-26 | OpenAlex | 10.1097/ccm.0000000000005894 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367047646 | |||
| W4367056836 | The NOMS approach to metastatic tumors: Integrating new technologies to improve outcomes | 2023-04-26 | OpenAlex | 10.1016/j.recot.2023.04.008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367056836 | |||
| W4367185912 | Complement Inhibitors in the Management of Complement-Mediated Hemolytic Uremic Syndrome and Paroxysmal Nocturnal Hemoglobinuria | 2023-04-27 | OpenAlex | 10.1097/mjt.0000000000001609 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4367185912 | |||
| W4367311096 | A global perspective on gun violence injuries | 2023-04-28 | OpenAlex | 10.1016/j.injury.2023.04.050 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367311096 | |||
| W4367302247 | Clade-Specific MPXV PCR Assays | 2023-04-28 | OpenAlex | 10.1101/2023.04.24.538151 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4367302247 | |||
| W4367301771 | Clinically significant radiation necrosis following trastuzumab-deruxtecan and brain stereotactic radiosurgery: A case series in breast cancer patients | 2023-04-28 | OpenAlex | 10.1016/j.cpccr.2023.100242 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4367301771 | |||
| W4367307485 | Radiotherapeutic palliation of bone marrow diseases—leukemia and multiple myeloma | 2023-04-28 | OpenAlex | 10.1016/b978-0-323-87688-9.00028-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4367307485 | |||
| W4367298189 | The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer | 2023-04-28 | OpenAlex | 10.1007/s12149-023-01839-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4367298189 | |||
| W4367316583 | USE OF SODIUM-GLUCOSE TRANSPORT PROTEIN 2 (SGLT2) INHIBITORS IN DIABETIC KIDNEY DISEASE (DKD) | 2023-04-28 | OpenAlex | 10.53555/nnmhs.v9i4.1653 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367316583 | |||
| W4367301444 | Infodemic- A new rapidly evolving virtual communicable pandemic with global threat! Hypothetical or real? | 2023-04-29 | OpenAlex | 10.53346/wjapmr.2023.4.2.0023 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367301444 | |||
| W4367553231 | A kórházi túlélést meghatározó tényezők a COVID–19-járvány 3. és 4. hulláma idején súlyos koronavírus-fertőzéssel intenzív osztályra felvett betegekben | 2023-04-30 | OpenAlex | 10.1556/650.2023.32762 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4367553231 | |||
| W4382398399 | El microbio: Camino biológico a través de la especie humana | 2023-04-30 | OpenAlex | 10.52808/bmsa.8e7.632.00 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382398399 | |||
| W4375951405 | Emicizumab Prophylaxis in Patients with Hemophilia A Undergoing Immune Tolerance Induction Therapy: A Systematic Review | 2023-04-30 | OpenAlex | 10.17480/psk.2023.67.2.75 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4375951405 | |||
| W4377246392 | (417) Erectile Function after Treatment for Non-ischemic Priapism | 2023-05-01 | OpenAlex | 10.1093/jsxmed/qdad060.391 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4377246392 | |||
| W4378611305 | 1015 Chasing after Sleep in ROHHAD syndrome | 2023-05-01 | OpenAlex | 10.1093/sleep/zsad077.1015 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4378611305 | |||
| W4367595323 | A Rare Presentation of Hydralazine-Induced Lupus in the Setting of Pericarditis With Concomitant Angioedema | 2023-05-01 | OpenAlex | 10.7759/cureus.38376 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4367595323 | |||
| W4367599184 | Acetyl-CoA biosynthesis drives resistance to histone acetyltransferase inhibition | 2023-05-01 | OpenAlex | 10.1038/s41589-023-01320-7 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4367599184 | |||
| W4380051196 | Beliefs as dispositions to make judgments | 2023-05-01 | OpenAlex | 10.1111/phpr.12993 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380051196 | |||
| W4372333625 | Blastic plasmacytoid dendritic cell neoplasm: emerging developments and special considerations for 2023. | 2023-05-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4372333625 | ||||
| W4377041222 | Commentary: Current concepts, recent updates, and future treatment options for Pythium insidiosum keratitis | 2023-05-01 | OpenAlex | 10.4103/ijo.ijo_80_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377041222 | |||
| W4379507096 | Different diabetes | 2023-05-01 | OpenAlex | 10.1002/pdi.2451 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379507096 | |||
| W4366820609 | Efficacy of a chairside extraoral suction system in the reduction of aerosol contamination. | 2023-05-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4366820609 | ||||
| W4391897684 | From Doctor–Patient to Doctor–Community: Embedding a Public Health Approach in Psychiatry | 2023-05-01 | OpenAlex | 10.4103/wsp.wsp_34_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391897684 | |||
| W4378234224 | Insights into the Role of Inflammation in the Management of Atherosclerosis | 2023-05-01 | OpenAlex | 10.2147/jir.s276982 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4378234224 | |||
| W4381309666 | Leveraging Innovation to Mitigate Risk During Heart Surgery | 2023-05-01 | OpenAlex | 10.14503/thij-23-8214 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4381309666 | |||
| W4367692965 | Multiplying Preclinical Models for Multiple Myeloma | 2023-05-01 | OpenAlex | 10.1097/hs9.0000000000000898 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367692965 | |||
| W4377044073 | My tryst with academia – Reflections from an era gone by | 2023-05-01 | OpenAlex | 10.4103/ijo.ijo_865_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377044073 | |||
| W4367601934 | Navigating Available Treatment Options for Carbapenem-ResistantAcinetobacter baumannii-calcoaceticusComplex Infections | 2023-05-01 | OpenAlex | 10.1093/cid/ciad094 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4367601934 | |||
| W4376868640 | New Books across the Disciplines | 2023-05-01 | OpenAlex | 10.1215/10829636-10416684 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376868640 | |||
| W4387756545 | Optimal Health in Rheumatology: The Unmet Need of the Hour? | 2023-05-01 | OpenAlex | 10.4103/injr.injr_114_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387756545 | |||
| W4382619420 | P40 REAL-WORLD TREATMENT PATTERNS OF PATIENTS INITIATING THIRD-LINE THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA IN EUROPE | 2023-05-01 | OpenAlex | 10.1097/01.hs9.0000936288.27701.b7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4382619420 | |||
| W4376134798 | P60 EVOLVING OUTCOMES OF EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA: 20-YEARS SINGLE CENTER EXPERIENCE | 2023-05-01 | OpenAlex | 10.1097/01.hs9.0000936368.13093.f4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4376134798 | |||
| W4367673975 | Patient characteristics, management, and outcomes of acute myocardial infarction due to unprotected left main stem occlusion: insights from a real-world multicentre registry over a 12-year period | 2023-05-01 | OpenAlex | 10.1093/ehjacc/zuad036.053 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4367673975 | |||
| W4379157893 | Prostate Cancer Survivorship Today: Support that Spans the Journey | 2023-05-01 | OpenAlex | 10.1016/j.euf.2023.05.003 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379157893 | |||
| W4380075693 | Quality incident management | 2023-05-01 | OpenAlex | 10.1111/1744-1633.12634 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380075693 | |||
| W4377291466 | Standardizing Anaphylaxis Treatment in Pediatric Care Settings | 2023-05-01 | OpenAlex | 10.1097/pq9.0000000000000652 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4377291466 | |||
| W4367553815 | Synthesis and Determination of Antimicrobial Efficacies of Secondary Metabolite of Streptomyces longisporoflavus and its 3D-Protein Structural Prediction | 2023-05-01 | OpenAlex | 10.9734/jamps/2023/v25i3605 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4367553815 | |||
| W4385318580 | TRANSCON 2022 B: Poster Papers | 2023-05-01 | OpenAlex | 10.4103/0973-6247.377173 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385318580 | |||
| W4382316222 | TRANSMEDCON 2022: E-Poster Abstracts | 2023-05-01 | OpenAlex | 10.4103/0973-6247.377170 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382316222 | |||
| W4376106538 | Targeted Therapies and the Evolving Standard of Care for Triple-Negative and Germline BRCA1/2-Mutated Breast Cancers in the High-Risk, Early-Stage Setting | 2023-05-01 | OpenAlex | 10.1200/po.22.00446 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376106538 | |||
| W4381469772 | The Evolving Story of JAK Inhibitors for Treating Alopecia Areata: A Review of Current Progress and Future Directions. | 2023-05-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4381469772 | ||||
| W4389631329 | William James, W. E. B. Du Bois, and the Art of New Religious Ideals | 2023-05-01 | OpenAlex | 10.5406/21564795.44.2.03 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389631329 | |||
| W4367671353 | Tools and/or Agents? Reflections on Sedlakova and Trachsel’s Discussion of Conversational Artificial Intelligence | 2023-05-02 | OpenAlex | 10.1080/15265161.2023.2191053 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4367671353 | |||
| W4368372535 | Aspergillosis: an Update on Clinical Spectrum, Diagnostic Schemes, and Management | 2023-05-04 | OpenAlex | 10.1007/s12281-023-00461-5 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4368372535 | |||
| W4368366360 | Dravet Syndrome | 2023-05-04 | OpenAlex | 10.1201/9781003296478-23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4368366360 | |||
| W4368366246 | Engineered Monoamine Oxidase-Catalyzed Deracemization of Sterically Hindered Acylaminomethyl-tetrahydroisoquinoline: Asymmetric Synthesis of (R)-(−)-Praziquantel and Its Analogues | 2023-05-04 | OpenAlex | 10.1021/acssuschemeng.3c00985 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4368366246 | |||
| W4368340750 | Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs | 2023-05-04 | OpenAlex | 10.1016/j.jhepr.2023.100784 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4368340750 | |||
| W4368357532 | Maintenance therapy in acute myeloid leukemia: advances and controversies | 2023-05-04 | OpenAlex | 10.3324/haematol.2022.281810 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4368357532 | |||
| W4376630468 | Molecular Target and Action Mechanism of Anti-Cancer Agents | 2023-05-04 | OpenAlex | 10.3390/ijms24098259 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4376630468 | |||
| W4368360221 | Professional Identity Formation in Medical Education: Some Virtue-Based Insights | 2023-05-04 | OpenAlex | 10.1080/10401334.2023.2209067 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4368360221 | |||
| W4368365635 | Prospects for gene therapy | 2023-05-04 | OpenAlex | 10.1201/9781003423805-11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4368365635 | |||
| W4372348786 | Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum | 2023-05-05 | OpenAlex | 10.1016/j.nefroe.2023.04.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4372348786 | |||
| W4372295529 | Machine and deep learning in inflammatory bowel disease | 2023-05-05 | OpenAlex | 10.1097/mog.0000000000000945 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4372295529 | |||
| W4377564595 | Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development | 2023-05-05 | OpenAlex | 10.3389/fmed.2023.1155751 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377564595 | |||
| W4375932677 | Offline reinforcement learning methods for real-world problems | 2023-05-08 | OpenAlex | 10.1016/bs.adcom.2023.03.001 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4375932677 | |||
| W4375956021 | Pathogenicity and virulence of Clostridium botulinum | 2023-05-08 | OpenAlex | 10.1080/21505594.2023.2205251 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4375956021 | |||
| W4381597844 | HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept | 2023-05-09 | OpenAlex | 10.3390/cancers15102664 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4381597844 | |||
| W4376121851 | Influence of corticosteroid treatment on CXCR4 expression in DLBCL | 2023-05-10 | OpenAlex | 10.1186/s13550-023-00993-4 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4376121851 | |||
| W4376876243 | Pure and Other Phenomenologically Oriented Psychology | 2023-05-10 | OpenAlex | 10.1163/15691624-20231417 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4376876243 | |||
| W4376105661 | Treatment of Nondiabetic Kidney Diseases with Sodium-Glucose Cotransporter-2 Inhibitors | 2023-05-10 | OpenAlex | 10.2215/cjn.0000000000000194 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376105661 | |||
| W4376127662 | Assessment‐based management of placenta‐mediated pregnancy complications: Pragmatism until a precision medicine approach evolves | 2023-05-11 | OpenAlex | 10.1111/bjh.18856 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376127662 | |||
| W4376131143 | Effects of albuminuria‐lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials | 2023-05-11 | OpenAlex | 10.1111/dom.15109 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4376131143 | |||
| W4376110134 | Moving beyond ruxolitinib failure in myelofibrosis: evolving strategies for second line therapy | 2023-05-11 | OpenAlex | 10.1080/14656566.2023.2213435 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376110134 | |||
| W4376155506 | Russell’s viper venom: from diagnostic to bypassing agent for hemophilia? | 2023-05-11 | OpenAlex | 10.1016/j.jtha.2023.02.026 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4376155506 | |||
| W4376223654 | Update on Overactive Bladder Therapeutic Options | 2023-05-11 | OpenAlex | 10.1097/mjt.0000000000001637 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376223654 | |||
| W4379095029 | Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review | 2023-05-12 | OpenAlex | 10.1007/s40429-023-00478-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379095029 | |||
| W4376276000 | Novel agents and evolving strategies in myelofibrotive neoplasm: an update from 2022 ASH annual conference | 2023-05-12 | OpenAlex | 10.1186/s13045-023-01446-0 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4376276000 | |||
| W4376598195 | Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy | 2023-05-13 | OpenAlex | 10.1007/s10238-023-01087-0 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4376598195 | |||
| W4376603710 | Anorectal Manifestations of Treatment-Refractory Monkeypox Requiring Surgical Intervention | 2023-05-15 | OpenAlex | 10.1177/00031348231177931 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4376603710 | |||
| W4376605714 | Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update | 2023-05-15 | OpenAlex | 10.1136/jnis-2022-019844 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376605714 | |||
| W4376616656 | JFTR's venues and voices for family theorizing and critical review | 2023-05-15 | OpenAlex | 10.1111/jftr.12513 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376616656 | |||
| W4376613277 | Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer | 2023-05-15 | OpenAlex | 10.1016/j.clbc.2023.05.003 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4376613277 | |||
| W4376643389 | Protein kinases: drug targets for immunological disorders | 2023-05-15 | OpenAlex | 10.1038/s41577-023-00877-7 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4376643389 | |||
| W4376645773 | Editorial: Purinergic pharmacology, Volume II | 2023-05-16 | OpenAlex | 10.3389/fphar.2023.1200187 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376645773 | |||
| W4376637817 | Management of scalp arteriovenous malformations: a rising trend towards percutaneous direct puncture embolization technique—our experience | 2023-05-16 | OpenAlex | 10.1177/02841851231174458 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4376637817 | |||
| W4376646299 | The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease | 2023-05-16 | OpenAlex | 10.1080/1744666x.2023.2214728 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376646299 | |||
| W4377042074 | Editorial: The clinical application and progress of precise diagnosis and treatment of thyroid tumors | 2023-05-17 | OpenAlex | 10.3389/fendo.2023.1214596 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377042074 | |||
| W4377043274 | Essential Role of CgErg6p in Maintaining Oxidative Stress Tolerance and Iron Homeostasis in Candida glabrata | 2023-05-17 | OpenAlex | 10.3390/jof9050579 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4377043274 | |||
| W4376872922 | Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice | 2023-05-17 | OpenAlex | 10.1007/s11864-023-01103-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4376872922 | |||
| W4376872265 | Photodynamic therapy in the root canal treatment of primary teeth: A systematic review of clinical trials | 2023-05-17 | OpenAlex | 10.1111/ipd.13088 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4376872265 | |||
| W4377010905 | Design Development of the SMARTCLIC®/CLICWISE® Injection Device for Self-Administered Subcutaneous Therapies: Findings from Usability and Human Factor Studies | 2023-05-18 | OpenAlex | 10.1007/s12325-023-02512-2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4377010905 | |||
| W4387585237 | In vitro antibacterial effect of the extracts of Maranta arundinacea rhizomes against selected pathogens | 2023-05-18 | OpenAlex | 10.12692/ijb/22.5.160-167 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387585237 | |||
| W4377139906 | Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer | 2023-05-19 | OpenAlex | 10.1038/s41392-023-01468-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377139906 | |||
| W4377101625 | Liver Pathology: Diagnostic Challenges, Practical Considerations and Emerging Concepts | 2023-05-19 | OpenAlex | 10.1016/j.path.2023.04.004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4377101625 | |||
| W4377138221 | Mass Spectrometry–Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective | 2023-05-19 | OpenAlex | 10.1016/j.mcpro.2023.100578 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377138221 | |||
| W4377143134 | Adenovirotherapy delivering cross-hybrid IgGA Fc engineering PD-L1 inhibitors for enhanced cancer immunotherapy | 2023-05-20 | OpenAlex | 10.1016/j.omto.2023.05.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377143134 | |||
| W4377140517 | Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review | 2023-05-20 | OpenAlex | 10.1007/s40257-023-00786-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377140517 | |||
| W4377220356 | All Hands Needed for Intentional Professionalism | 2023-05-22 | OpenAlex | 10.1097/01.asw.0000933960.02727.4b | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377220356 | |||
| W4378083698 | Anaerobic Gram-Negative Bacteria: Role as a Reservoir of Antibiotic Resistance | 2023-05-22 | OpenAlex | 10.3390/antibiotics12050942 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4378083698 | |||
| W4377220820 | Culture-Independent Workflow for Nanopore MinION-Based Sequencing of Influenza A Virus | 2023-05-22 | OpenAlex | 10.1128/spectrum.04946-22 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4377220820 | |||
| W4377287503 | Nuclear Medicine Training: Skills and Competencies Required for Practice in the 21st Century | 2023-05-22 | OpenAlex | 10.1055/s-0043-1769588 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377287503 | |||
| W4409643886 | The role of recruitment and selection on organizational performance | 2023-05-22 | OpenAlex | 10.63544/ijss.v2i2.37 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4409643886 | |||
| W4378086119 | “ThermoTRP” Channel Expression in Cancers: Implications for Diagnosis and Prognosis (Practical Approach by a Pathologist) | 2023-05-22 | OpenAlex | 10.3390/ijms24109098 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4378086119 | |||
| W4378087326 | ASSESSING THE CURRENT THREAT OF MONKEYPOX EPIDEMIC EMERGENCE | 2023-05-23 | OpenAlex | 10.31718/2077-1096.23.2.1.73 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4378087326 | |||
| W4377862148 | Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis | 2023-05-23 | OpenAlex | 10.1038/s41375-023-01915-y | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4377862148 | |||
| W4377565273 | Kidney Preservation Strategies to Improve Transplant Outcomes | 2023-05-23 | OpenAlex | 10.2215/cjn.0000000000000212 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377565273 | |||
| W4377966648 | Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies | 2023-05-24 | OpenAlex | 10.1200/jco.23.00013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4377966648 | |||
| W4386192865 | Approach to multidrug resistant bacterial infections | 2023-05-24 | OpenAlex | 10.3329/bjm.v34i20.66143 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386192865 | |||
| W4377988719 | Exploring the usability of a chatbot-based conversational dietary assessment tool among cardiovascular patients | 2023-05-24 | OpenAlex | 10.1093/eurjpc/zwad125.281 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4377988719 | |||
| W4377989391 | Melancholia as a clinical and metapsychological agent | 2023-05-24 | OpenAlex | 10.4324/9781003336754-11 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4377989391 | |||
| W4378173467 | Pathophysiology and treatment of adults with arrhythmias in the emergency department, part 1: Atrial arrhythmias | 2023-05-25 | OpenAlex | 10.1093/ajhp/zxad108 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4378173467 | |||
| W4378191996 | The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update | 2023-05-25 | OpenAlex | 10.1016/j.healun.2022.12.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4378191996 | |||
| W4378218494 | Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology | 2023-05-25 | OpenAlex | 10.1016/j.neo.2023.100909 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4378218494 | |||
| W4381284050 | Pharmacologic and Other Noninvasive Treatments of the Aging Face: A Review of the Current Evidence | 2023-05-26 | OpenAlex | 10.1097/prs.0000000000010767 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4381284050 | |||
| W4378530541 | The role of therapy in the outcome of patients with myelofibrosis | 2023-05-27 | OpenAlex | 10.1002/cncr.34851 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4378530541 | |||
| W4378619346 | Risk of Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies | 2023-05-28 | OpenAlex | 10.3390/life13061272 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4378619346 | |||
| W4378648779 | Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis | 2023-05-29 | OpenAlex | 10.1016/j.leukres.2023.107331 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4378648779 | |||
| W4379801139 | AB1062 RENAL INVOLVEMENT IN SPONDYLOARTHRITIS | 2023-05-30 | OpenAlex | 10.1136/annrheumdis-2023-eular.1542 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379801139 | |||
| W4378801833 | Antifungal Stewardship Programs in Children: Challenges and Opportunities | 2023-05-30 | OpenAlex | 10.1097/inf.0000000000003967 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4378801833 | |||
| W4378783539 | Cell membrane‐coated nanoparticles for the treatment of cancer | 2023-05-30 | OpenAlex | 10.1002/ctm2.1285 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4378783539 | |||
| W4378807316 | Editorial: Kawasaki disease: an ongoing enigma tangled with the appearance of MIS-C | 2023-05-30 | OpenAlex | 10.3389/fped.2023.1209723 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4378807316 | |||
| W4379052900 | Innovative biomaterials for the treatment of periodontal disease | 2023-05-30 | OpenAlex | 10.3389/fdmed.2023.1163562 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379052900 | |||
| W4380626179 | #2663 KIDNEY INVOLVEMENT IN MYELODYSPLASTIC SYNDROMES | 2023-06-01 | OpenAlex | 10.1093/ndt/gfad063c_2663 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4380626179 | |||
| W4380626214 | #2664 CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS WITH LYSOZYME NEPHROPATHY AND CMML RENAL INFILTRATION DISPLAY MARKERS OF SEVERE DISEASE | 2023-06-01 | OpenAlex | 10.1093/ndt/gfad063c_2664 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4380626214 | |||
| W4379282447 | A real-world evaluation of treatment (Tx) patterns and outcomes of acute myeloid leukemia (AML) induction therapies in the community setting. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.e19006 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379282447 | |||
| W4379337376 | AFT-50 EndoMAP: A phase IB/II multi-cohort study of targeted agents for patients with recurrent or persistent endometrial cancer. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.tps5634 | Full text | Excluded | F1: This is a trial-in-progress treatment protocol; agents are pharmacological treatments, not an evaluated adaptive LLM system. | https://openalex.org/W4379337376; https://openalex.org/W4403250793 | https://scholars.duke.edu/publication/1686924 | complete conference trial-in-progress abstract including Methods | |
| W4379281510 | Advanced cervical cancer therapy: Comparison of contemporary expert and healthcare professional recommendations from an online treatment decision tool. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.5528 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379281510 | |||
| W4380681639 | An Appraisal of Infection Control in the Built Environment: The Architect's Perspective | 2023-06-01 | OpenAlex | 10.13189/ujph.2023.110305 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4380681639 | |||
| W4379281699 | Associations between androgen-directed treatments and AR mutational landscapes in the circulating tumor DNA of a real-world metastatic prostate cancer cohort. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.5061 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379281699 | |||
| W4379337740 | Awareness, preferences, and experiences of thrombosis and thromboprophylaxis in adults commencing systemic anticancer therapies: TARGET-TP trial. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.e24129 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379337740 | |||
| W4382025360 | BI20 Generalized pustular psoriasis in a patient receiving pembrolizumab for metastatic lung adenocarcinoma | 2023-06-01 | OpenAlex | 10.1093/bjd/ljad113.188 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4382025360 | |||
| W4387493190 | Caracterização molecular de isolados do vírus Varicela Zoster em amostras de líquido cefalorraquidiano de pacientes com quadro de meningite, encefalite ou meningoencefalite aguda | 2023-06-01 | OpenAlex | 10.11606/d.5.2023.tde-20092023-123627 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387493190 | |||
| W4381715712 | ChatGPT: revolutionizing cardiothoracic surgery research through artificial intelligence | 2023-06-01 | OpenAlex | 10.1093/icvts/ivad090 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4381715712 | |||
| W4380301317 | Clinical Pathologic Conference Case 5: Asymptomatic Patient Referred for Evaluation of Her Mouth | 2023-06-01 | OpenAlex | 10.1016/j.oooo.2022.11.021 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4380301317 | |||
| W4379285819 | Comparison of real-world outcomes over time in a large population-based cohort of patients with metastatic breast cancer. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.e13112 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379285819 | |||
| W4386596146 | Composition of Populations and Durations of Persistence of Bordetella pertussis Bacteria in Patients with Whooping Cough and Contact Persons | 2023-06-01 | OpenAlex | 10.3103/s0891416823020064 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386596146 | |||
| W4379281968 | Correlating expression of NaPi2b and FRa in high grade serous ovarian cancer (HGSOC). | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.5545 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379281968 | |||
| W4382025247 | DP12 Painful oral keratosis and skin lesions: a paraneoplastic diagnostic conundrum | 2023-06-01 | OpenAlex | 10.1093/bjd/ljad113.225 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4382025247 | |||
| W4380871835 | Dairying and the evolution and consequences of lactase persistence in humans | 2023-06-01 | OpenAlex | 10.1093/af/vfad022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380871835 | |||
| W4379799462 | Evaluation and management of abnormal liver enzymes in the liver transplant recipient: When, why, and what now? | 2023-06-01 | OpenAlex | 10.1097/cld.0000000000000057 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379799462 | |||
| W4378952150 | Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum | 2023-06-01 | OpenAlex | 10.1161/jaha.122.028892 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4378952150 | |||
| W4385476378 | Evolving landscape of targeted treatment options for HER2-positive gastric/gastroesophageal adenocarcinomas. | 2023-06-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385476378 | ||||
| W4379338743 | Expression of CD47 and CALR in myeloproliferative neoplasms: Potential new therapeutical targets. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.e19079 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4379338743 | |||
| W4379113734 | Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling | 2023-06-01 | OpenAlex | 10.1200/edbk_390428 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379113734 | |||
| W4383868484 | Improving the Scientific Impact of Medical Physics: Challenges and Opportunities: Editor‐in‐Chief 2014–2020 | 2023-06-01 | OpenAlex | 10.1002/mp.16022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383868484 | |||
| W4379285637 | Integrating radiation therapy with CDK4/6 inhibitors for breast cancer: A systematic review and meta-analysis of toxicity. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.e13075 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379285637 | |||
| W4380361168 | LGG-10. TREATMENT-RELATED MYELODYSPLASTIC SYNDROME FOLLOWING CHEMOTHERAPY FOR PEDIATRIC LOW-GRADE GLIOMA | 2023-06-01 | OpenAlex | 10.1093/neuonc/noad073.220 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4380361168 | |||
| W4380078557 | MY HODGKIN, MY HEALTH: FEASIBILITY OF A MOBILE APPLICATION TO COLLECT LONG TERM FOLLOW UP DATA ABOUT HODGKIN PATIENTS | 2023-06-01 | OpenAlex | 10.1002/hon.3165_531 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380078557 | |||
| W4379795864 | Nonfactor Therapies for Hemophilia | 2023-06-01 | OpenAlex | 10.1097/hs9.0000000000000911 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379795864 | |||
| W4378978412 | Optimizing the management of acute, prolonged decelerations and fetal bradycardia based on the understanding of fetal pathophysiology | 2023-06-01 | OpenAlex | 10.1016/j.ajog.2022.05.014 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4378978412 | |||
| W4382799175 | P-253 Single agent immunotherapy in advanced oesophago-gastric (OG) cancer: An option for frail patients | 2023-06-01 | OpenAlex | 10.1016/j.annonc.2023.04.309 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4382799175 | |||
| W4379792967 | POS1413 PRECLINICAL EVIDENCE FOR THE GLUCOCORTICOID-SPARING POTENTIAL OF A DUAL TLR7/8 INHIBITOR IN AUTOIMMUNE DISEASES | 2023-06-01 | OpenAlex | 10.1136/annrheumdis-2023-eular.2555 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4379792967 | |||
| W4382025348 | PS11 Dupilumab for moderate-to-severe atopic dermatitis: transformative changes in quality of life and low burden of treatment — a mixed-methods study | 2023-06-01 | OpenAlex | 10.1093/bjd/ljad113.363 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4382025348 | |||
| W4387269955 | Pathogenesis, Diseases, Immune Response, and Chemotherapy of Genus Simplexvirus | 2023-06-01 | OpenAlex | 10.59393/amb23390202 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387269955 | |||
| W4379283636 | Phase I solid tumor trials (PHIstt) in the era of precision oncology (PO): A systematic survey. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.e13603 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379283636 | |||
| W4392116189 | Precision in Anesthesia for Awake Craniotomies: Confronting Surgical Challenges | 2023-06-01 | OpenAlex | 10.1055/s-0044-1779597 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392116189 | |||
| W4384023470 | Recent advances in the treatment of IBD: Targets, mechanisms and related therapies | 2023-06-01 | OpenAlex | 10.1016/j.cytogfr.2023.07.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384023470 | |||
| W4379282834 | Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trials. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.3149 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379282834; https://openalex.org/W4388658908 | |||
| W4379329732 | State-of-the-art management of HER2-negative early breast cancer: Treatment patterns among healthcare professionals and concordance with expert recommendations. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.553 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379329732 | |||
| W4379282576 | Systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.7530 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379282576 | |||
| W4379284018 | Temporal trends of atypical drug access at an academic oncology unit: The Verona University Hospital experience. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.e13651 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379284018 | |||
| W4382364605 | The Trial of Superdebthunterbot | 2023-06-01 | OpenAlex | 10.1525/aft.2023.50.2.51 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4382364605 | |||
| W4379336130 | The emerging use of immunotherapy as a treatment option in metastatic renal cell carcinoma: Real-world evidence from a single UK tertiary cancer centre. | 2023-06-01 | OpenAlex | 10.1200/jco.2023.41.16_suppl.e16509 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379336130 | |||
| W4379979750 | The evolving therapy of DLBCL: Bispecific antibodies | 2023-06-01 | OpenAlex | 10.1002/hon.3154 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379979750 | |||
| W4383872234 | Through the executive director's lens: AAPM moves, grows and thrives | 2023-06-01 | OpenAlex | 10.1002/mp.16153 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383872234 | |||
| W4379185340 | Messenger RNA Expression and Quantification of L-plastin in Subgingival Tissue Samples of Generalized Severe Chronic Periodontitis Patients with and without Type 2 Diabetes Mellitus | 2023-06-02 | OpenAlex | 10.5005/jp-journals-10015-2202 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379185340 | |||
| W4380489086 | Mineralizing agents to manage early carious lesions. Part I: mode of action | 2023-06-02 | OpenAlex | 10.12968/denu.2023.50.6.490 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4380489086 | |||
| W4379232324 | PRISMA Systematic Literature Review, including with Meta-Analysis vs. Chatbot/GPT (AI) regarding Current Scientific Data on the Main Effects of the Calf Blood Deproteinized Hemoderivative Medicine (Actovegin) in Ischemic Stroke | 2023-06-02 | OpenAlex | 10.3390/biomedicines11061623 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379232324 | |||
| W4379197128 | Phenotyping heart failure by cardiac magnetic resonance imaging of cardiac macro- and microscopic structure: state of the art review | 2023-06-02 | OpenAlex | 10.1093/ehjci/jead124 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379197128 | |||
| W4379328615 | The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia | 2023-06-04 | OpenAlex | 10.1016/j.beha.2023.101485 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379328615 | |||
| W4379471304 | Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection | 2023-06-05 | OpenAlex | 10.3389/fmicb.2023.1201505 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4379471304 | |||
| W4379435254 | Editorial: Editors' introduction | 2023-06-05 | OpenAlex | 10.1108/pdsp-05-2023-009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379435254 | |||
| W4379386535 | Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases | 2023-06-05 | OpenAlex | 10.3389/fimmu.2023.1197364 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379386535 | |||
| W4379800542 | Structural transformation and reparative obligation: Reinterpreting the beneficiary pays principle | 2023-06-05 | OpenAlex | 10.1111/josp.12524 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4379800542 | |||
| W4379799725 | Ammi majus | 2023-06-07 | OpenAlex | 10.1201/9781003413004-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379799725 | |||
| W7120632025 | Autism spectrum disorders in the scope of public health policies | 2023-06-07 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7120632025 | ||||
| W4379739848 | Awakening the Future: Exploring Awake or Minimalistic Transcatheter Aortic Valve Replacement and the Evolving Role of Sedation Strategies | 2023-06-07 | OpenAlex | 10.1053/j.jvca.2023.05.049 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379739848 | |||
| W4384134344 | Cellular therapy in CLL/iNHL: Therapeutic agents in the pipeline | 2023-06-07 | OpenAlex | 10.58931/cht.2023.2232 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4384134344 | |||
| W4379649100 | Editorial: Clinical teaching and practice in intensive care medicine and anesthesiology | 2023-06-07 | OpenAlex | 10.3389/fmed.2023.1207363 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379649100 | |||
| W4379740272 | Evolving role of cytoreduction and HIPEC for colorectal cancer | 2023-06-07 | OpenAlex | 10.1016/j.scrs.2023.100970 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379740272 | |||
| W4384134175 | Evolving role of novel therapies in myeloma: T-cell engagers and antibody-drug conjugates | 2023-06-07 | OpenAlex | 10.58931/cht.2023.2233 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4384134175 | |||
| W4383888433 | "The History of the Study of the Etiology, Pathogenesis, Diagnosis, Treatment, and Prevention of Syphilis, in the Reflection of Philately, Numismatics and Bonistics" | 2023-06-08 | OpenAlex | 10.26717/bjstr.2023.50.008030 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4383888433 | |||
| W4380052484 | Crosstalk between interferon and interleukin-1 antiviral signaling in cancer cells: implications for immune evasion and therapeutic resistance | 2023-06-08 | OpenAlex | 10.3389/fimmu.2023.1219870 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380052484 | |||
| W4379768632 | SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022) | 2023-06-08 | OpenAlex | 10.1007/s12094-023-03206-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4379768632 | |||
| W4379927849 | “It’s my life, not theirs!” Therapeutic itineraries and refugee reflections on referral health care in western Tanzania | 2023-06-08 | OpenAlex | 10.1371/journal.pgph.0001655 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4379927849 | |||
| W4380084234 | ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis | 2023-06-09 | OpenAlex | 10.3390/biom13060968 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380084234 | |||
| W4405720004 | Meningoencephalitis of Unknown Origin in Dogs | 2023-06-09 | OpenAlex | 10.22456/1679-9216.126781 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405720004 | |||
| W4380203878 | Structure of a 10-23 deoxyribozyme exhibiting a homodimer conformation | 2023-06-10 | OpenAlex | 10.1038/s42004-023-00924-3 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4380203878 | |||
| W4380264946 | Parathyroid Crisis: A Case of Elective Parathyroidectomy | 2023-06-11 | OpenAlex | 10.7759/cureus.40251 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4380264946 | |||
| W4380355469 | Mink is an important possible route of introducing viral respiratory infections into the human population | 2023-06-12 | OpenAlex | 10.1002/vms3.1177 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380355469 | |||
| W4380322140 | OCT in Cariology | 2023-06-12 | OpenAlex | 10.1201/9781351104562-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380322140 | |||
| W4380486529 | RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways | 2023-06-12 | OpenAlex | 10.1101/2023.06.09.544432 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4380486529 | |||
| W4380682625 | An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity | 2023-06-14 | OpenAlex | 10.1172/jci158978 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4380682625 | |||
| W4380577154 | Surface Engineering of Nanoparticles toward Cancer Theranostics | 2023-06-14 | OpenAlex | 10.1021/acs.accounts.3c00122 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380577154 | |||
| W4380634180 | A Saudi multicenter experience on therapeutic plasma exchange for patients with thrombotic thrombocytopenic purpura: A call for national registry | 2023-06-15 | OpenAlex | 10.1002/jca.22067 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4380634180 | |||
| W7217926719 | Asepsia y antisepsia en procedimientos quirúrgicos dentales | 2023-06-15 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217926719 | ||||
| W4380768790 | Counteracting antibiotic resistance enzymes and efflux pumps | 2023-06-15 | OpenAlex | 10.1016/j.mib.2023.102334 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4380768790 | |||
| W4380767841 | EASL Recognition Award Recipient 2023: Prof. Julia A. Wendon | 2023-06-15 | OpenAlex | 10.1016/j.jhep.2023.03.036 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380767841 | |||
| W4380740792 | The North American perspective on short-term mechanical circulatory support for cardiogenic shock: could differences in policy be driving differences in temporary mechanical circulatory support use? | 2023-06-15 | OpenAlex | 10.1093/ehjacc/zuad065 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380740792 | |||
| W4380880178 | A Pharmacologic Update | 2023-06-16 | OpenAlex | 10.1016/j.cnur.2023.05.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4380880178 | |||
| W4381106273 | The Update in the Treatments of Surgical Wound Healing: An Overview | 2023-06-16 | OpenAlex | 10.5281/zenodo.8049223 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4381106273 | |||
| W4384566608 | 915 Safety and simulation: delivering early phase clinical trials for children and young people | 2023-06-19 | OpenAlex | 10.1136/archdischild-2023-rcpch.685 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4384566608 | |||
| W4381336333 | A Case Report on Pityriasis Rubra Pilaris (PRP) and Multisystem Inflammatory Syndrome in Children (MIS-C) | 2023-06-19 | OpenAlex | 10.52403/ijrr.20230638 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4381336333 | |||
| W4381486222 | Haemodynamic support for paediatric septic shock: a global perspective | 2023-06-21 | OpenAlex | 10.1016/s2352-4642(23)00103-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4381486222 | |||
| W4381480388 | The prothrombotic tendency of metabolic-associated fatty liver disease | 2023-06-21 | OpenAlex | 10.1016/j.jtha.2023.06.017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4381480388 | |||
| W4382723254 | Ex vivo study of the kinetics of ovarian tissue optical properties under the influence of 40%-glucose | 2023-06-22 | OpenAlex | 10.18500/1817-3020-2023-23-2-120-127 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4382723254 | |||
| W4381805609 | Hepatitis C Elimination: Opportunities and Challenges in 2023 | 2023-06-22 | OpenAlex | 10.3390/v15071413 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4381805609 | |||
| W4403085197 | Adenosine Deaminase Activity in Serum of Diabetics: A Reflection of Glycemic Profile? | 2023-06-23 | OpenAlex | 10.20956/ijab.v7i1.24466 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403085197 | |||
| W4381711275 | Platelet concentrates – A panacea for periodontal regeneration. | 2023-06-23 | OpenAlex | 10.7126/cumudj.1128860 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4381711275 | |||
| W4381943608 | Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer | 2023-06-24 | OpenAlex | 10.1186/s13045-023-01464-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4381943608 | |||
| W4381597466 | Switching to long-acting injectable antipsychotics: pharmacological considerations and practical approaches | 2023-06-24 | OpenAlex | 10.1080/14656566.2023.2228686 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4381597466 | |||
| W4381948594 | Bladder Cancer Prevention: Potential Molecular Targets and Their Clinically Relevant Agents | 2023-06-26 | OpenAlex | 10.1007/s40495-023-00326-y | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4381948594 | |||
| W4382456736 | MET Inhibitors for Papillary Renal Cell Carcinoma | 2023-06-26 | OpenAlex | 10.3233/kca-230005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382456736 | |||
| W4382197469 | An Overview of the Therapeutic Development of Cholangiocarcinoma with Special Emphasis on Targeted and Biologic Therapies | 2023-06-28 | OpenAlex | 10.1007/s11901-023-00607-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382197469 | |||
| W4382401694 | Dental Applications of Essential Oils | 2023-06-28 | OpenAlex | 10.1002/9781119829614.ch38 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382401694 | |||
| W4382369490 | Localized Drug Delivery Systems: An Update on Treatment Options for Head and Neck Squamous Cell Carcinomas | 2023-06-28 | OpenAlex | 10.3390/pharmaceutics15071844 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382369490 | |||
| W4382561852 | Clinical applications of circulating tumor DNA in indolent B-cell lymphomas | 2023-06-29 | OpenAlex | 10.1053/j.seminhematol.2023.06.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382561852 | |||
| W4382599985 | Design Strategy | 2023-06-29 | OpenAlex | 10.7551/mitpress/14842.001.0001 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4382599985 | |||
| W4382775608 | Editorial: Global excellence in rheumatology: Europe | 2023-06-29 | OpenAlex | 10.3389/fmed.2023.1242449 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382775608 | |||
| W4382539255 | History and Trends in Industrial Toxicology | 2023-06-29 | OpenAlex | 10.1002/0471125474.tox001.pub3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382539255 | |||
| W4382774910 | Infection, Dysbiosis and Inflammation Interplay in the COVID Era in Children | 2023-06-29 | OpenAlex | 10.3390/ijms241310874 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4382774910 | |||
| W4382700793 | General anaesthesia for dentistry | 2023-06-30 | OpenAlex | 10.1016/j.mpaic.2023.05.002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4382700793 | |||
| W4404830039 | Inflammation and its relationship to oral cavity | 2023-06-30 | OpenAlex | 10.70921/medev.v29i2.1012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404830039 | |||
| W7216607525 | Old problems in the face of new challenges | 2023-06-30 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216607525 | ||||
| W4382753300 | The Impact of Patient Infection Rate on Emergency Department Patient Flow: Hybrid Simulation Study in a Norwegian Case | 2023-06-30 | OpenAlex | 10.3390/healthcare11131904 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4382753300 | |||
| W4396564591 | The Promise of Exosomes as Drug Delivery Systems | 2023-06-30 | OpenAlex | 10.55627/pharma.002.01.0332 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396564591 | |||
| W4405466422 | 5-Fluorouracil-induced bilateral serpentine supravenous hyperpigmentation | 2023-07-01 | OpenAlex | 10.4103/ijdd.ijdd_3_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405466422 | |||
| W7160013357 | A One Health perspective reconciling medical mycology and fungal phytopathology | 2023-07-01 | OpenAlex | 10.63049/ohm.26.31.4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160013357 | |||
| W4390148626 | Abstracts of the Asian Congress of Pediatric Nephrology 2023 | 2023-07-01 | OpenAlex | 10.4103/ajpn.ajpn_14_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390148626 | |||
| W4386425130 | Acute Nonvariceal Gastrointestinal Bleeding: A Comprehensive Review and Approach for an Interventional Radiologist | 2023-07-01 | OpenAlex | 10.1055/s-0043-1770915 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386425130 | |||
| W4385306263 | Advancements of ALK inhibition of non-small cell lung cancer: a literature review | 2023-07-01 | OpenAlex | 10.21037/tlcr-22-619 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385306263 | |||
| W4387799192 | An E-mail interview with Prof. Mohammed Hafeez | 2023-07-01 | OpenAlex | 10.4103/tp.tp_51_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387799192 | |||
| W4384912502 | Are we missing the silver lining of COVID-19 pandemic: An analytical study to determine effects of three COVID-19 peaks on antimicrobial susceptibility of Staphylococcus aureus isolates | 2023-07-01 | OpenAlex | 10.4103/jfmpc.jfmpc_2420_22 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4384912502 | |||
| W4385152678 | Detection of Opportunistic Fungi from the Bronchoalveolar Lavage Specimens of Patients with Pulmonary Diseases | 2023-07-01 | OpenAlex | 10.4103/abr.abr_297_22 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385152678 | |||
| W4385398387 | E-102 Super-selective intra-arterial treatment of glioblastoma: current state and future directions | 2023-07-01 | OpenAlex | 10.1136/jnis-2023-snis.202 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385398387 | |||
| W4392413732 | Environmentalism, Radicalism, Activism | 2023-07-01 | OpenAlex | 10.14321/jstudradi.17.2.0001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392413732 | |||
| W4401494460 | Evolving paradigms in ocular surface squamous neoplasia management: A shift toward topical pharmacotherapy | 2023-07-01 | OpenAlex | 10.4103/odjo.odjo_13_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401494460 | |||
| W4390713867 | G20 and medical education: Embracing a holistic vision for health care | 2023-07-01 | OpenAlex | 10.4103/ijcfm.ijcfm_106_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390713867 | |||
| W4387028252 | Hepatocellular carcinoma in India: Time for a new focus | 2023-07-01 | OpenAlex | 10.4103/crst.crst_277_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387028252 | |||
| W4384120513 | Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders | 2023-07-01 | OpenAlex | 10.1002/jia2.26120 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384120513 | |||
| W4388563620 | Mind and World in Aristotle’s De Anima | 2023-07-01 | OpenAlex | 10.1215/00318108-10469525 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388563620 | |||
| W4383303157 | Person‐centred care: shifting the power dynamic in the delivery of adolescent and youth‐friendly health services | 2023-07-01 | OpenAlex | 10.1002/jia2.26116 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383303157 | |||
| W4384699497 | Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights | 2023-07-01 | OpenAlex | 10.2147/jhc.s341195 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384699497 | |||
| W4390995313 | Revolutions Aesthetic: A Cultural History of Ba‘thist Syria | 2023-07-01 | OpenAlex | 10.5325/bustan.14.1.0090 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390995313 | |||
| W4384156956 | The value of IMmotion010 for rare kidney cancer histologies – Authors' reply | 2023-07-01 | OpenAlex | 10.1016/s0140-6736(23)01066-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384156956 | |||
| W4383302277 | Therapeutic Angiogenesis Using Growth Factors After Myocardial Infarction: From Recombinant Proteins to Gene Therapies and Beyond | 2023-07-01 | OpenAlex | 10.1016/j.hlc.2023.05.018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383302277 | |||
| W4387167124 | Unraveling the Complex Web | 2023-07-01 | OpenAlex | 10.4103/hm.hm-d-23-00036 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387167124 | |||
| W4382931413 | “White Girls, They Get You Every Time”: Get Out 's Horror of Miscegenation and Its Conception of the Black Bro'mance | 2023-07-01 | OpenAlex | 10.5406/19346018.75.2.02 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4382931413 | |||
| W4383058815 | Clonal architecture and single‐cell transcriptome landscape in Richter's syndrome | 2023-07-03 | OpenAlex | 10.1111/bjh.18952 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4383058815 | |||
| W4382918428 | Contemporary trends in the utilization of second‐line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom | 2023-07-03 | OpenAlex | 10.1111/dom.15196 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4382918428 | |||
| W4386900147 | GOVERNING THE WARS; THEORY, LEGISLATION, HUMAN RIGHTS, HUMAN SECURITY, AND ETHICS | 2023-07-03 | OpenAlex | 10.48064/equinox.1119677 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4386900147 | |||
| W4383104021 | Harnessing the Immune System: Current and Emerging Immunotherapy Strategies for Pediatric Acute Lymphoblastic Leukemia | 2023-07-03 | OpenAlex | 10.3390/biomedicines11071886 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383104021 | |||
| W4382918716 | Stereotactic Body Radiation Therapy Salvage for Lymph Node Recurrent Prostate Cancer in the Era of PSMA PET Imaging | 2023-07-03 | OpenAlex | 10.1007/s11934-023-01174-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4382918716 | |||
| W4385262311 | Targets for obstructive sleep apnea pharmacotherapy: principles, approaches, and emerging strategies | 2023-07-03 | OpenAlex | 10.1080/14728222.2023.2240018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385262311 | |||
| W4383068574 | The Evolving Landscape of Immunotherapy in Uterine Cancer: A Comprehensive Review | 2023-07-03 | OpenAlex | 10.3390/life13071502 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383068574 | |||
| W4383227428 | Androgen deprivation therapy in metastatic salivary duct carcinoma of submandibular gland – A case report | 2023-07-04 | OpenAlex | 10.25259/ijms_343_2021 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4383227428 | |||
| W4385357905 | School principals as translators – examining Swedish school principals’ translations of the standards-based curriculum | 2023-07-04 | OpenAlex | 10.1080/00220272.2023.2234006 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4385357905 | |||
| W4383069328 | The Continuous Adaptive Challenge Played by Arboviruses: An In Silico Approach to Identify a Possible Interplay between Conserved Viral RNA Sequences and Host RNA Binding Proteins (RBPs) | 2023-07-04 | OpenAlex | 10.3390/ijms241311051 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4383069328 | |||
| W4386407716 | AI Chatbots in Clinical Laboratory Medicine: Foundations and Trends | 2023-07-05 | OpenAlex | 10.1093/clinchem/hvad106 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386407716 | |||
| W4383187111 | Acute Pancreatitis Review | 2023-07-05 | OpenAlex | 10.5152/tjg.2023.23175 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383187111 | |||
| W4383262633 | Axial Spondyloarthritis: Evolving concepts regarding the disease's diagnosis and treatment | 2023-07-05 | OpenAlex | 10.1016/j.ejim.2023.06.026 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4383262633 | |||
| W4383186457 | Insulin analogs as an add-on to metformin after failure to oral treatment in type 2 diabetic patients increase diastole duration. The INSUlin Regimens and VASCular Functions (INSUVASC) study | 2023-07-05 | OpenAlex | 10.23736/s2724-5683.23.06139-2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4383186457 | |||
| W4383313548 | Antibiotic usage and susceptibility patterns in Uncomplicated UTI in a Tertiary Hospital in South India | 2023-07-06 | OpenAlex | 10.1101/2023.07.02.23292129 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4383313548 | |||
| W4383314197 | Highly Parallelized Screening of Functionally Enhanced XNA Aptamers in Uniform Hydrogel Particles | 2023-07-06 | OpenAlex | 10.1021/acssynbio.3c00189 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4383314197 | |||
| W4383343296 | Managing Adverse Effects of Novel Therapeutic Agents in Gynecologic Malignancies | 2023-07-06 | OpenAlex | 10.1007/s42399-023-01518-9 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4383343296 | |||
| W4383483914 | Posttransplant Diabetes Mellitus: Recent Developments in Pharmacological Management of Hyperglycemia | 2023-07-06 | OpenAlex | 10.1210/clinem/dgad395 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383483914 | |||
| W4383302336 | Surfing the web as a patient with IBD: New horizons | 2023-07-06 | OpenAlex | 10.1002/ueg2.12437 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383302336 | |||
| W4383533122 | Arborealities, or Making Trees Matter in Elif Shafak’s The Island of Missing Trees | 2023-07-07 | OpenAlex | 10.1093/isle/isad040 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4383533122 | |||
| W4383482539 | Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease | 2023-07-07 | OpenAlex | 10.1097/cm9.0000000000002792 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383482539 | |||
| W4383536350 | Local immunotherapy of glioblastoma: A comprehensive review of the concept | 2023-07-07 | OpenAlex | 10.1016/j.jneuroim.2023.578146 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383536350 | |||
| W4383645757 | Biology and Clinical Use of Glucagon-Like Peptide-1 Receptor Agonists in Vascular Protection | 2023-07-08 | OpenAlex | 10.1016/j.cjca.2023.07.007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383645757 | |||
| W4383710785 | An Explicative Review on the Current Advancement in Schiff Base-Metal Complexes as Anticancer Agents Evolved in the Past Decade: Medicinal Chemistry Aspects | 2023-07-10 | OpenAlex | 10.2174/1573406419666230707105221 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4383710785 | |||
| W4383873255 | Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics | 2023-07-10 | OpenAlex | 10.1002/pbc.30563 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383873255 | |||
| W4383895589 | Multidrug-resistant infections in war victims in Ukraine | 2023-07-11 | OpenAlex | 10.1016/s1473-3099(23)00391-2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4383895589 | |||
| W4383998899 | Biochemical and cellular basis of oxidative stress: Implications for disease onset | 2023-07-12 | OpenAlex | 10.1002/jcp.31071 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383998899 | |||
| W4383998538 | Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer | 2023-07-12 | OpenAlex | 10.1158/1078-0432.ccr-23-0079 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4383998538 | |||
| W4384039032 | Clinical Strategies and Therapeutics for Human Monkeypox Virus: A Revised Perspective on Recent Outbreaks | 2023-07-12 | OpenAlex | 10.3390/v15071533 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384039032; https://openalex.org/W4375949504 | |||
| W4384155254 | Adenitis as Initial Mycobacterium marinum Presentation | 2023-07-13 | OpenAlex | 10.7759/cureus.41833 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4384155254 | |||
| W4384340510 | Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies | 2023-07-14 | OpenAlex | 10.1038/s41375-023-01968-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384340510 | |||
| W4384338524 | Exposure to organophosphorus compounds: best practice in managing timely, effective emergency responses | 2023-07-14 | OpenAlex | 10.1097/mej.0000000000001060 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384338524 | |||
| W4384401069 | Immunotherapy in biliary tract cancer: The race has begun! | 2023-07-14 | OpenAlex | 10.1111/liv.15651 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384401069 | |||
| W4384300259 | Targeted Therapies in Pediatric Acute Myeloid Leukemia - Evolving Therapeutic Landscape | 2023-07-14 | OpenAlex | 10.1007/s12098-023-04741-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4384300259 | |||
| W4384523601 | Biventricular mechanical circulatory support. History and current state of the problem | 2023-07-15 | OpenAlex | 10.15825/1995-1191-2023-2-49-56 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384523601 | |||
| W4384405610 | Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center | 2023-07-15 | OpenAlex | 10.1080/10428194.2023.2232489 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4384405610 | |||
| W4384636524 | Tocilizumab; A potential remedy against the ever-evolving threat of Coronavirus-2 (SARS-CoV-2) | 2023-07-15 | OpenAlex | 10.47391/jpma.8551 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384636524 | |||
| W4384523650 | Blood Oxidant Ties: The Evolving Concepts in Myocardial Injury and Cardiovascular Disease | 2023-07-16 | OpenAlex | 10.2174/97898151650121230101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384523650 | |||
| W4384525304 | Clinical and microbiological characteristics of nocardiosis: A 5-year single-center study in Crete, Greece | 2023-07-17 | OpenAlex | 10.1556/030.2023.02071 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4384525304 | |||
| W4384521344 | Evolving biofilm inhibition and eradication in clinical settings through plant-based antibiofilm agents | 2023-07-17 | OpenAlex | 10.1016/j.phymed.2023.154973 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4384521344 | |||
| W4384819777 | Evolving role of novel radiosensitizers and immune checkpoint inhibitors in (chemo)radiotherapy of locally advanced head and neck squamous cell carcinoma | 2023-07-17 | OpenAlex | 10.1016/j.oraloncology.2023.106520 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4384819777 | |||
| W4384559034 | Molecular mechanisms governing antifungal drug resistance | 2023-07-17 | OpenAlex | 10.1038/s44259-023-00007-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384559034 | |||
| W4384820325 | 2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes | 2023-07-19 | OpenAlex | 10.1186/s13098-023-01121-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384820325 | |||
| W4384663153 | Antithrombotic therapy with Transcatheter aortic valve replacement | 2023-07-19 | OpenAlex | 10.1002/phar.2847 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384663153 | |||
| W4384936511 | Comparative assessment of mechanical and chemical fluid diversion techniques during hydraulic fracturing in horizontal wells | 2023-07-19 | OpenAlex | 10.1016/j.petsci.2023.07.013 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4384936511 | |||
| W4384664443 | Nanotheranostics: The Fabrication of Theranostics with Nanoparticles and their Application to Treat the Neurological Disorders | 2023-07-19 | OpenAlex | 10.2174/1872210517666230718115651 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384664443 | |||
| W4384819845 | The complementarity of DDR, nucleic acids and anti-tumour immunity | 2023-07-19 | OpenAlex | 10.1038/s41586-023-06069-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4384819845 | |||
| W4384818758 | Disease Assessments in Patients with Glioblastoma | 2023-07-20 | OpenAlex | 10.1007/s11912-023-01440-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384818758 | |||
| W4385065897 | Editorial: Methods and applications in psychopathology: new methods and trends for the understanding of neuropsychiatric disorders | 2023-07-20 | OpenAlex | 10.3389/fpsyg.2023.1242921 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385065897 | |||
| W4384920179 | Preparation for the next pandemic: challenges in strengthening surveillance | 2023-07-20 | OpenAlex | 10.1080/22221751.2023.2240441 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4384920179 | |||
| W4385065440 | A reinforcement learning-based approach for online optimal control of self-adaptive real-time systems | 2023-07-21 | OpenAlex | 10.1007/s00521-023-08778-5 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4385065440 | |||
| W4385387767 | Newer strategies from the use of blood and blood products: Lessons learned from recent wars | 2023-07-21 | OpenAlex | 10.1016/b978-0-323-69787-3.00077-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385387767 | |||
| W4385071630 | Biofunctionalized Gold Nanoparticles Obtained from Two Different Plant Extracts and its Chemical and Structural Comparison | 2023-07-22 | OpenAlex | 10.1093/micmic/ozad067.640 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4385071630 | |||
| W4385240955 | Epidemiology of Antimicrobial Resistance Genes in Staphyloccocus aureus Isolates from a Public Database in a One Health Perspective—Sample Characteristics and Isolates’ Sources | 2023-07-24 | OpenAlex | 10.3390/antibiotics12071225 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4385240955 | |||
| W4385211224 | Neural stem cells for Parkinson’s disease management: Challenges, nanobased support, and prospects | 2023-07-24 | OpenAlex | 10.4252/wjsc.v15.i7.687 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385211224 | |||
| W4385241738 | Recent Progress in the Characterization, Synthesis, Delivery Procedures, Treatment Strategies, and Precision of Antimicrobial Peptides | 2023-07-24 | OpenAlex | 10.3390/ijms241411864 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385241738 | |||
| W7207175745 | Improved Middle Ear Imaging with Optical Coherence Tomography for Clinical Otology | 2023-07-25 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7207175745 | ||||
| W4385237517 | Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy | 2023-07-25 | OpenAlex | 10.1186/s12967-023-04360-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385237517 | |||
| W4385439671 | Editorial: Modulation of human immune parameters by anticancer therapies, volume II | 2023-07-26 | OpenAlex | 10.3389/fimmu.2023.1249099 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385439671 | |||
| W4385307049 | Half-Dose versus Single-Dose Gadobutrol for Extracellular Volume Measurements in Cardiac Magnetic Resonance | 2023-07-26 | OpenAlex | 10.3390/jcdd10080316 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385307049 | |||
| W4385341905 | Immersive Innovation: Exploring Interactive Virtual Reality through Distributed Simulations | 2023-07-26 | OpenAlex | 10.5772/intechopen.1002004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385341905 | |||
| W4385264865 | Microsatellite Instability in Colorectal Cancer: The Evolving Role of Immunotherapy | 2023-07-26 | OpenAlex | 10.1097/dcr.0000000000003017 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385264865 | |||
| W4385368349 | The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus | 2023-07-26 | OpenAlex | 10.3390/life13081626 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385368349 | |||
| W4385296762 | Access to physiotherapy services in South African settings: stretching a hand to under-resourced communities with students as agents of change | 2023-07-27 | OpenAlex | 10.3389/fresc.2023.1164525 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385296762 | |||
| W4385327348 | Editorial: Recent advances in pediatric inflammatory diseases | 2023-07-27 | OpenAlex | 10.3389/fped.2023.1237625 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385327348 | |||
| W4385347882 | Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review | 2023-07-27 | OpenAlex | 10.3390/ijms241512030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385347882 | |||
| W4385326122 | Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations | 2023-07-27 | OpenAlex | 10.1016/j.eclinm.2023.102113 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385326122 | |||
| W4385372357 | Administering Freedom: The State of Emancipation after the Freedmen's Bureau by Dale Kretz (review) | 2023-07-28 | OpenAlex | 10.1353/soh.2023.a903219 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385372357 | |||
| W4385331055 | Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Adult patients | 2023-07-28 | OpenAlex | 10.1111/ajd.14138 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385331055 | |||
| W4385410353 | Picking Up Where the Authors Left Off: Reading Research in Medical Education | 2023-07-28 | OpenAlex | 10.1097/acm.0000000000005373 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385410353 | |||
| W4385355308 | Post-COVID-19 | 2023-07-28 | OpenAlex | 10.4103/jalh.jalh_10_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385355308 | |||
| W4385331443 | Rectal cancer treatment: an embarrassment of riches? | 2023-07-28 | OpenAlex | 10.1111/ans.18634 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385331443 | |||
| W4385423642 | Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies | 2023-07-30 | OpenAlex | 10.3390/biology12081069 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385423642 | |||
| W4385395674 | The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials | 2023-07-31 | OpenAlex | 10.22465/juo.234600300015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385395674 | |||
| W4387493518 | Between Science and Society: Charting the Space of Science Fiction | 2023-08-01 | OpenAlex | 10.5325/style.57.3.0408 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387493518 | |||
| W4385463186 | How I Manage Chronic Lymphocytic Leukemia | 2023-08-01 | OpenAlex | 10.3390/hematolrep15030047 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385463186 | |||
| W4385484379 | O03 The effect of antibiotic selection on collateral susceptibility and evolvability of uropathogenic Escherichia coli | 2023-08-01 | OpenAlex | 10.1093/jacamr/dlad077.003 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385484379 | |||
| W4385702177 | P504: UPDATED DATA FOR ZIFTOMENIB IN PATIENTS WITH NPM1-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA | 2023-08-01 | OpenAlex | 10.1097/01.hs9.0000968924.19161.da | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385702177 | |||
| W4385705968 | P515: A REAL-WORLD EVALUATION OF TREATMENT PATTERNS AND OUTCOMES OF ACUTE MYELOID LEUKEMIA INDUCTION THERAPIES IN THE COMMUNITY SETTING | 2023-08-01 | OpenAlex | 10.1097/01.hs9.0000968968.68222.8c | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385705968 | |||
| W4385667173 | P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”. | 2023-08-01 | OpenAlex | 10.1097/01.hs9.0000969104.08302.5e | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385667173 | |||
| W4385955746 | P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY | 2023-08-01 | OpenAlex | 10.1097/01.hs9.0000969496.68553.26 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385955746 | |||
| W4385697853 | PB1826: CELLULAR AND MOLECULAR CHARACTERIZATION OF THE ANTINEOPLASTIC EFFECTS OF CEPHALOCHROMIN IN MODELS OF ACUTE MYELOID LEUKEMIA | 2023-08-01 | OpenAlex | 10.1097/01.hs9.0000974148.35451.e1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4385697853 | |||
| W4385655405 | PB1943: THE EFFECTS OF AN ONLINE CURRICULUM BASED APPROACH TO CME ON HEMATOLOGIST/ONCOLOGISTS’ ABILITY TO TREAT PATIENTS WITH BTK INHIBITORS FOR B-CELL MALIGNANCIES | 2023-08-01 | OpenAlex | 10.1097/01.hs9.0000974588.94917.4e | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385655405 | |||
| W4386102497 | PB1965: INSIGHTS INTO RELAPSED AND REFRACTORY CHRONIC MYELOID LEUKEMIA: MOLECULAR-GENETIC, BIOCHEMICAL AND PROGNOSIS PATTERNS | 2023-08-01 | OpenAlex | 10.1097/01.hs9.0000974676.34187.44 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386102497 | |||
| W4385705889 | PB2242: ACUTE LYMPHOBLASTIC LEUKEMIA SECONDARY TO ESSENTIAL THROMBOCYTHEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE REPORTS | 2023-08-01 | OpenAlex | 10.1097/01.hs9.0000975704.04209.78 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385705889 | |||
| W4385654999 | PB2437: ASSOCIATION OF WILMS TUMOR GENE 1 EXPRESSION WITH OVERALL SURVIVAL AFTER AZACYTIDINE AND DONOR LYMPHOCYTE INFUSIONS: A RETROSPECTIVE SINGLE CENTER ANALYSIS | 2023-08-01 | OpenAlex | 10.1097/01.hs9.0000976456.87899.bd | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385654999 | |||
| W4387383121 | REPRESENTATION OF THE SCENARIO «CONFLICT IN THE BRITISH ROYAL FAMILY» IN THE BRITISH MASS-MEDIA DISCOURSE | 2023-08-01 | OpenAlex | 10.24195/2616-5317-2023-36-7 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387383121 | |||
| W4385770707 | Sequencing systemic therapy in hormone-receptor positive metastatic breast cancer: a modern paradigm | 2023-08-01 | OpenAlex | 10.21037/cco-23-22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385770707 | |||
| W4385550410 | Superbugs or multidrug resistant microbes: A new threat to the society | 2023-08-01 | OpenAlex | 10.1002/hsr2.1480 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385550410 | |||
| W4385753183 | The WHO CNS 5th Edition: A Quandary for the Surgical Neurooncologist and Adult Diffuse Glioma Patients in LMICs | 2023-08-01 | OpenAlex | 10.1055/s-0043-1771473 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385753183 | |||
| W4385478772 | Evolving microbial patterns of acute mastoiditis in pediatric patients undergoing mastoidectomy | 2023-08-02 | OpenAlex | 10.1016/j.ijporl.2023.111690 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385478772 | |||
| W4385476298 | Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity | 2023-08-02 | OpenAlex | 10.1021/acsinfecdis.3c00063 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4385476298 | |||
| W4385491920 | Tumor Cells Transmit Drug Resistance via Cisplatin-Induced Extracellular Vesicles | 2023-08-02 | OpenAlex | 10.3390/ijms241512347 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385491920 | |||
| W4385484261 | Youth Capacity Building and Leadership Through CBPR and Conflict Transformation with the Montagnard Refugee‐Origin Community | 2023-08-02 | OpenAlex | 10.1002/jls.21857 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385484261 | |||
| W4385514156 | Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma | 2023-08-03 | OpenAlex | 10.1001/jamaoncol.2023.2677 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385514156 | |||
| W4385520482 | Editorial: Innovative technologies and materials for treatments of hepatobiliary and pancreatic diseases | 2023-08-03 | OpenAlex | 10.3389/fbioe.2023.1260144 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385520482 | |||
| W4386945206 | Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update | 2023-08-03 | OpenAlex | 10.1080/13543776.2023.2262136 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386945206 | |||
| W4385577486 | Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer | 2023-08-04 | OpenAlex | 10.3390/cancers15153969 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385577486 | |||
| W4385579436 | Molecular Studies of Phages- Klebsiella pneumoniae in a Mucoid Environment: Innovative use of mucolytic agents prior to the administration of lytic phages | 2023-08-04 | OpenAlex | 10.1101/2023.08.02.551690 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385579436 | |||
| W4385605341 | ChatGPT: The transformative influence of generative AI on science and healthcare | 2023-08-06 | OpenAlex | 10.1016/j.jhep.2023.07.028 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385605341 | |||
| W4385616628 | The Role of Estrogen Therapy as a Protective Factor for Alzheimer’s Disease and Dementia in Postmenopausal Women: A Comprehensive Review of the Literature | 2023-08-06 | OpenAlex | 10.7759/cureus.43053 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385616628 | |||
| W4385628231 | Promising Marker for Treatment Response in Prostate Cancer | 2023-08-07 | OpenAlex | 10.1097/01.cot.0000967172.88593.de | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385628231 | |||
| W7120725545 | (Multi)letramentos, leitura e interpretação do gênero charge: contribuição para formação do leitor proficiente | 2023-08-08 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7120725545 | ||||
| W4385752273 | El enfoque de NOMS para los tumores metastásicos: integración de nuevas tecnologías para mejorar los resultados | 2023-08-08 | OpenAlex | 10.1016/j.recot.2023.08.013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385752273 | |||
| W4385648796 | Next-generation antibody-drug conjugates for breast cancer: Moving beyond HER2 and TROP2 | 2023-08-08 | OpenAlex | 10.1016/j.critrevonc.2023.104090 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385648796 | |||
| W4385689343 | Reflections before the storm: the AI reproduction of biased imagery in global health visuals | 2023-08-09 | OpenAlex | 10.1016/s2214-109x(23)00329-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385689343 | |||
| W4385748343 | A translational blueprint for developing intraoperative imaging agents via radiopharmaceutical-guided drug design | 2023-08-10 | OpenAlex | 10.1016/j.cbpa.2023.102376 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385748343 | |||
| W4385719479 | Treponema pallidum resistance to azithromycin in France: A nationwide retrospective study from 2010 to 2022 | 2023-08-10 | OpenAlex | 10.1111/jdv.19399 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385719479 | |||
| W4405176579 | Chlamydia | 2023-08-11 | OpenAlex | 10.1002/9781683674849.mcm0066 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405176579; https://openalex.org/W4406364861 | |||
| W4386152360 | Current Treatments in Mantle Cell Lymphoma | 2023-08-11 | OpenAlex | 10.46883/2023.25921002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386152360; https://openalex.org/W4386122362 | |||
| W4385753955 | Data Modeling and Processing in Location Based Services: A Collaborative Research Agenda | 2023-08-11 | OpenAlex | 10.5194/ica-abs-6-95-2023 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385753955 | |||
| W4385753901 | Editorial: Use of DCE-MRI in female affecting cancers | 2023-08-11 | OpenAlex | 10.3389/fonc.2023.1260469 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385753901 | |||
| W4385812296 | Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma | 2023-08-12 | OpenAlex | 10.3390/jcm12165261 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385812296 | |||
| W4385779786 | GENOMIC INVESTIGATION ON THE ANTIMICROBIAL ACTIVITIES AND TOXICOLOGICAL STUDIES OF ANDROGRAPHIS PANICULATA (VINEGAR) LEAF AND STEM ON ED HUMAN PATHOGENS | 2023-08-12 | OpenAlex | 10.56726/irjmets43735 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4385779786 | |||
| W4385780874 | Novel targets for immune-checkpoint inhibition in cancer | 2023-08-12 | OpenAlex | 10.1016/j.ctrv.2023.102614 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385780874 | |||
| W4385783349 | Spike protein mutations and structural insights of pangolin lineage B.1.1.25 with implications for viral pathogenicity and ACE2 binding affinity | 2023-08-12 | OpenAlex | 10.1038/s41598-023-40005-y | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4385783349 | |||
| W4385898627 | At what point are we on the way to optimally treat multiple myeloma patients over 75 years of age in 2023? | 2023-08-14 | OpenAlex | 10.17219/acem/168685 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385898627 | |||
| W4385799549 | The Impact of Artificial Intelligence on Chatbot Technology: A Study on the Current Advancements and Leading Innovations | 2023-08-14 | OpenAlex | 10.47672/ejt.1561 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385799549 | |||
| W4385827571 | Evolving etiologies, comorbidities, survival, and costs of care in adult encephalitis | 2023-08-15 | OpenAlex | 10.1007/s13365-023-01165-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385827571 | |||
| W4385827915 | Improving the pharmacotherapeutic treatment of agitation associated with bipolar disorder | 2023-08-15 | OpenAlex | 10.1080/14656566.2023.2248893 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385827915 | |||
| W4386970218 | Perception and Acceptance of Medical Chatbot Among Undergraduates in Ekiti State University, Nigeria | 2023-08-15 | OpenAlex | 10.37745/bje.2013/vol11n11114 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386970218 | |||
| W4385878518 | Novel Cellular and Immunotherapy: Toxicities and Perioperative Implications | 2023-08-16 | OpenAlex | 10.3390/curroncol30080554 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385878518 | |||
| W4385985410 | Editorial: Implementation of novel drugs and modern radiotherapy in the treatment of lymphoma patients | 2023-08-17 | OpenAlex | 10.3389/fonc.2023.1273598 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385985410 | |||
| W4385951031 | Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer | 2023-08-17 | OpenAlex | 10.1038/s41571-023-00808-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4385951031 | |||
| W4386023440 | Malnutrición y hábitos alimenticios: una visión en el personal de salud | 2023-08-17 | OpenAlex | 10.58995/lb.redlic.16 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386023440 | |||
| W4385994562 | Type I Interferon Pathway-Related Hub Genes as a Potential Therapeutic Target for SARS-CoV-2 Omicron Variant-Induced Symptoms | 2023-08-17 | OpenAlex | 10.3390/microorganisms11082101 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4385994562 | |||
| W4385969682 | The Evolving Role of Nurse Educators and Leaders in Dismantling Racism in Nursing and Advocating for Health Equity and Justice | 2023-08-18 | OpenAlex | 10.1097/01.nep.0000000000001186 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385969682 | |||
| W4385989001 | Translating bacteriophage-derived depolymerases into antibacterial therapeutics: Challenges and prospects | 2023-08-18 | OpenAlex | 10.1016/j.apsb.2023.08.017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4385989001 | |||
| W4386072652 | Antithrombotic treatment: personalized antiplatelet therapies and lessons from the gut microbiota | 2023-08-21 | OpenAlex | 10.1093/eurheartj/ehad521 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386072652 | |||
| W4386033865 | Cantharidin analogue alleviates dextran sulfate sodium-induced colitis in mice by inhibiting the activation of NF-κB signaling | 2023-08-21 | OpenAlex | 10.1016/j.ejmech.2023.115731 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4386033865 | |||
| W4386033214 | O12/125 CHOICE, prospective multicenter study of endovascular treatment for cerebral AVMs treated with SQUID: clinical and angiographic results at 1 year | 2023-08-21 | OpenAlex | 10.1136/jnis-2023-esmint.12 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386033214 | |||
| W4386084162 | Perioperative Hemotherapy Management in Left Ventricular Assist Device Surgery | 2023-08-21 | OpenAlex | 10.14503/thij-23-8216 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386084162 | |||
| W4386027444 | Prostate-Specific Membrane Antigen-Ligand Therapy | 2023-08-21 | OpenAlex | 10.1016/j.rcl.2023.07.003 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386027444 | |||
| W4386073978 | A simplified mesoscale 3D model for characterizing fibrinolysis under flow conditions | 2023-08-22 | OpenAlex | 10.1038/s41598-023-40973-1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4386073978 | |||
| W4386054850 | Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non–Small-Cell Lung Cancer? | 2023-08-22 | OpenAlex | 10.1200/op.23.00416 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386054850 | |||
| W4386083694 | Integrating the Age-Friendly Health Systems Movement in Veterans Health Administration: National Advance Care Planning via Group Visits and the 4Ms Framework | 2023-08-22 | OpenAlex | 10.1093/hsw/hlad022 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386083694 | |||
| W4386055614 | Living donor uterus transplant in the UK: A case report | 2023-08-22 | OpenAlex | 10.1111/1471-0528.17639 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386055614 | |||
| W4386084863 | Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia | 2023-08-22 | OpenAlex | 10.1111/bjh.19060 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386084863 | |||
| W4386499305 | Understanding The Acute Interventions for Complicated Pleural Effusions | 2023-08-22 | OpenAlex | 10.19080/ijoprs.2023.06.555696 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386499305 | |||
| W4386098256 | Emergence of Monkeypox (MPX): A Close Relative of Small Pox During COVID-19 Era | 2023-08-23 | OpenAlex | 10.2174/1871526523666230823105945 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386098256 | |||
| W4386102279 | Prevalence of pharmaceuticals and personal care products, microplastics and co-infecting microbes in the post-COVID-19 era and its implications on antimicrobial resistance and potential endocrine disruptive effects | 2023-08-23 | OpenAlex | 10.1016/j.scitotenv.2023.166419 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4386102279 | |||
| W4386089067 | Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies | 2023-08-23 | OpenAlex | 10.1016/j.esmoop.2023.101618 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386089067 | |||
| W4386116273 | A Review of Available Medical Therapies to Treat Moderate-to-Severe Inflammatory Bowel Disease | 2023-08-24 | OpenAlex | 10.14309/ajg.0000000000002485 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386116273 | |||
| W4386156942 | Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression | 2023-08-25 | OpenAlex | 10.2337/dci23-0030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386156942 | |||
| W4386221403 | Metabolomics in Pulmonary Hypertension—A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology | 2023-08-25 | OpenAlex | 10.3390/ijms241713227 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386221403 | |||
| W4386161086 | Re-Engineering the Hospital Discharge to Improve the Transition From Hospital to Home | 2023-08-25 | OpenAlex | 10.4018/jhms.328775 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386161086 | |||
| W4386194645 | Advantages of using general anesthesia | 2023-08-26 | OpenAlex | 10.56238/seveniiimulti2023-202 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386194645 | |||
| W4386195456 | Perception of medical students in the internship developed in the discipline of integration teaching service and community I (IESC I) | 2023-08-26 | OpenAlex | 10.56238/seveniiimulti2023-196 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386195456 | |||
| W4386242064 | In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer | 2023-08-27 | OpenAlex | 10.1093/jncics/pkad062 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386242064 | |||
| W4386213563 | Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III | 2023-08-28 | OpenAlex | 10.1055/s-0043-1772841 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386213563 | |||
| W4386252768 | Novel high‐strength polyester composite scaffolds for bone regeneration | 2023-08-28 | OpenAlex | 10.1002/pat.6178 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4386252768 | |||
| W4386256836 | Approaches to Maximize Safety for Patients with Kidney Diseases after the End of COVID-19 Public Health Emergency | 2023-08-29 | OpenAlex | 10.2215/cjn.0000000000000303 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386256836 | |||
| W4386273684 | 04 Biologic disease modifying drugs in SLE | 2023-08-30 | OpenAlex | 10.1136/lupus-2023-la.4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386273684 | |||
| W4386271128 | ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy | 2023-08-30 | OpenAlex | 10.1016/s2152-2650(23)01338-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386271128 | |||
| W4386274920 | Finding Meaning in Life | 2023-08-30 | OpenAlex | 10.1097/prs.0000000000010534 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386274920 | |||
| W4386271540 | Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation | 2023-08-30 | OpenAlex | 10.3324/haematol.2023.282898 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386271540 | |||
| W4386647370 | Management of Oral Candidiasis in People Living With HIV | 2023-08-30 | OpenAlex | 10.30649/denta.v17i2.5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386647370 | |||
| W4387136039 | #195 Understanding current practices for the management of advanced epithelial high-grade ovarian cancer in the UK: interim analysis from the OC-NOW survey (2023) | 2023-09-01 | OpenAlex | 10.1136/ijgc-2023-esgo.532 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387136039 | |||
| W4387142209 | #242 Designing a clinical trial with chat generative pre-trained transformer (ChatGPT) on the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer | 2023-09-01 | OpenAlex | 10.1136/ijgc-2023-esgo.541 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387142209 | |||
| W4387497081 | #36915 D37 – the green footprint of regional anesthesia | 2023-09-01 | OpenAlex | 10.1136/rapm-2023-esra.675 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387497081 | |||
| W4387505290 | #36942 Neurological complications and infections after neuraxial analgesia during labor | 2023-09-01 | OpenAlex | 10.1136/rapm-2023-esra.667 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387505290 | |||
| W4386822621 | Central nervous system histoplasmosis in an immunocompetent 5-year-old patient: a case report | 2023-09-01 | OpenAlex | 10.1055/s-0043-1774626 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386822621 | |||
| W4386822554 | Childhood encephalitis: a challenging diagnosis | 2023-09-01 | OpenAlex | 10.1055/s-0043-1774627 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386822554 | |||
| W4387516225 | Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment. | 2023-09-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387516225 | ||||
| W4386822868 | Encephalomyelitis by adenovirus | 2023-09-01 | OpenAlex | 10.1055/s-0043-1774629 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386822868 | |||
| W4386887616 | Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer | 2023-09-01 | OpenAlex | 10.2147/btt.s426392 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386887616 | |||
| W4387003787 | P-192 Increased serum CRBN levels are associated with improved survival in MM patients | 2023-09-01 | OpenAlex | 10.1016/s2152-2650(23)01810-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387003787 | |||
| W4386380344 | Passive Sentences and Abstract Agents in German School Books | 2023-09-01 | OpenAlex | 10.1515/eujal-2022-0036 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4386380344 | |||
| W4386822639 | Post-covid Guillain-Barre syndrome with atypical clinical presentation | 2023-09-01 | OpenAlex | 10.1055/s-0043-1774631 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386822639 | |||
| W4386936293 | Sculpting Molecules in Silico: A Comprehensive Review of the Latest Innovations in Computer-Aided Drug Design to Revolutionize the Way Drugs are Engineered and Optimized | 2023-09-01 | OpenAlex | 10.55041/ijsrem25763 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386936293 | |||
| W4386822488 | Septic thrombosis of the cavernous sinus secondary to meningitis: case report from a referral hospital in Espirito Santo | 2023-09-01 | OpenAlex | 10.1055/s-0043-1774634 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386822488 | |||
| W4387157463 | Targeting Cytokines in Inflammatory Bowel Disease. | 2023-09-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387157463 | ||||
| W4386419777 | The Classification and Selection of Adhesive Agents; an Overview for the General Dentist | 2023-09-01 | OpenAlex | 10.2147/ccide.s425024 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4386419777 | |||
| W4388899098 | Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System | 2023-09-01 | OpenAlex | 10.1200/go.23.00271 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388899098 | |||
| W4386878148 | Experimental drugs for supraventricular tachycardia: an analysis of early phase clinical trials | 2023-09-02 | OpenAlex | 10.1080/13543784.2023.2259309 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386878148 | |||
| W4386391330 | Rational utilization of 1,2,3-triazole scaffold in anti-MRSA drug development: Design strategies, structural insights and pharmacological outcomes | 2023-09-02 | OpenAlex | 10.1016/j.molstruc.2023.136557 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4386391330 | |||
| W4386402473 | Contrast-Induced Nephropathy: An Overview | 2023-09-03 | OpenAlex | 10.1007/s44229-023-00040-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386402473 | |||
| W4386423219 | Exploring SGLT-2 Inhibitors: Benefits beyond the Glucose-Lowering Effect—What Is New in 2023? | 2023-09-04 | OpenAlex | 10.3390/endocrines4030045 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386423219 | |||
| W4386466167 | Improving patient communication on sunscreen choice: Updating mechanistic misconceptions | 2023-09-04 | OpenAlex | 10.1002/jvc2.251 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386466167 | |||
| W4387297304 | In vitro activity of cefiderocol against Pseudomonas aeruginosa demonstrating evolved resistance to novel β-lactam/β-lactamase inhibitors | 2023-09-04 | OpenAlex | 10.1093/jacamr/dlad107 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387297304 | |||
| W4386416293 | Malaysian and Chinese King Cobra Venom Cytotoxicity in Melanoma and Neonatal Foreskin Fibroblasts Is Mediated by Age and Geography | 2023-09-04 | OpenAlex | 10.3390/toxins15090549 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4386416293 | |||
| W4386860182 | Comprehensive Analysis of Scalded Skin Syndrome: Clinical Exploration, Underlying Pathophysiology and Advanced Therapeutic Approaches | 2023-09-06 | OpenAlex | 10.47191/ijmscrs/v3-i9-23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386860182 | |||
| W4386498934 | Antileukemic effect of venetoclax and hypomethylating agents via caspase-3/GSDME-mediated pyroptosis | 2023-09-07 | OpenAlex | 10.1186/s12967-023-04481-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386498934 | |||
| W4386503826 | Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease | 2023-09-07 | OpenAlex | 10.1016/j.ekir.2023.09.005 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386503826 | |||
| W4386530327 | The Current Place of DPP4 Inhibitors in the Evolving Landscape of Type 2 Diabetes Management: Is It Time to Bid Adieu? | 2023-09-08 | OpenAlex | 10.1007/s40256-023-00610-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386530327 | |||
| W4387970629 | A Randomized, Embedded, Multifactorial Adaptive Platform trial for ILD (REMAP-ILD): The conceptual design | 2023-09-09 | OpenAlex | 10.1183/13993003.congress-2023.oa2588 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387970629 | |||
| W4386580924 | The role and participation of immune cells in the endometrial tumor microenvironment | 2023-09-09 | OpenAlex | 10.1016/j.pharmthera.2023.108526 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386580924 | |||
| W4386593039 | ASO Author Reflections: Preventing Nephrotoxicities in Ovarian Cancer Patients Undergoing HIPEC | 2023-09-11 | OpenAlex | 10.1245/s10434-023-14268-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386593039 | |||
| W4386599425 | Advancing the Systems Science Paradigm in Public Health Through Intervention and Evaluation | 2023-09-11 | OpenAlex | 10.1097/fch.0000000000000382 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386599425 | |||
| W4386593328 | Nucleic Acid Based Testing (NABing): A Game Changer Technology for Public Health | 2023-09-11 | OpenAlex | 10.1007/s12033-023-00870-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386593328 | |||
| W4386601373 | Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy | 2023-09-11 | OpenAlex | 10.3390/cancers15184509 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386601373 | |||
| W4386592056 | The rapidly evolving landscape of HCC: Selecting the optimal systemic therapy | 2023-09-11 | OpenAlex | 10.1097/hep.0000000000000572 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386592056 | |||
| W4386629386 | A Descriptive Review of Medication Overuse HEADACHE-from Pathophysiology to the Clinic | 2023-09-12 | OpenAlex | 10.20944/preprints202309.0760.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386629386 | |||
| W4386624408 | Immunomodulatory cytokines and clonal dynamics in low‐risk myelodysplastic syndromes patients treated with luspatercept | 2023-09-12 | OpenAlex | 10.1002/ajh.27072 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386624408 | |||
| W4386624533 | Modern therapies of nonsmall cell lung cancer | 2023-09-12 | OpenAlex | 10.1007/s13353-023-00786-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386624533 | |||
| W4386646814 | Sequential management of postmenopausal health and osteoporosis: An update | 2023-09-12 | OpenAlex | 10.1016/j.maturitas.2023.107846 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386646814 | |||
| W4389314959 | Author response: Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistance | 2023-09-13 | OpenAlex | 10.7554/elife.85023.sa2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389314959 | |||
| W4386705320 | Cancer Immunology and Immunotherapy Showcased in the AACR Cancer Progress Report 2023 | 2023-09-13 | OpenAlex | 10.1158/2326-6066.cir-23-0672 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386705320 | |||
| W4386701529 | Definitions and implications of the pharmacokinetic-pharmacodynamic parameters of antibiotics in pediatric clinical practice | 2023-09-13 | OpenAlex | 10.1016/j.idnow.2023.104781 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386701529 | |||
| W4386704685 | Management of type 2 diabetes in the new era | 2023-09-13 | OpenAlex | 10.1007/s42000-023-00488-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386704685 | |||
| W4386741374 | Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy | 2023-09-14 | OpenAlex | 10.3390/biom13091388 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386741374 | |||
| W4386726541 | Commentary on: Wound Healing Complications With Tranexamic Acid: Not the Silver Bullet After All | 2023-09-14 | OpenAlex | 10.1093/asj/sjad294 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386726541 | |||
| W4386784975 | Abstract IA12: Fluorescence guided surgery: Rapidly evolving applications | 2023-09-15 | OpenAlex | 10.1158/1557-3265.aacrahns23-ia12 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386784975 | |||
| W4386835698 | Editorial: Advanced polymeric biomaterial technologies for biomedical applications | 2023-09-15 | OpenAlex | 10.3389/fmats.2023.1278259 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386835698 | |||
| W4386836616 | Editorial: Role of extracellular vesicles (EVs) in pathogenesis, diagnosis, therapeutic delivery, treatment and theranostic applications in cancer | 2023-09-15 | OpenAlex | 10.3389/fbioe.2023.1288806 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386836616 | |||
| W4386781405 | Migraine in older adults | 2023-09-15 | OpenAlex | 10.1016/s1474-4422(23)00206-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386781405 | |||
| W4386775955 | The principles of curative antibiotic treatments | 2023-09-15 | OpenAlex | 10.1016/j.idnow.2023.104780 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386775955 | |||
| W4386797192 | Dietary management of eosinophilic oesophagitis | 2023-09-16 | OpenAlex | 10.5694/mja2.52101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386797192 | |||
| W4386808342 | Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape | 2023-09-16 | OpenAlex | 10.1093/bjd/ljad345 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386808342 | |||
| W4386849674 | Editorial: Cancer metabolism: molecular insights, metabolic crosstalk in the tumor microenvironment, and implications for therapy | 2023-09-18 | OpenAlex | 10.3389/fonc.2023.1289397 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386849674 | |||
| W4386865727 | Efficacy and Safety of Immune Checkpoint Inhibitors in Hematologic Malignancies | 2023-09-19 | OpenAlex | 10.1016/j.clml.2023.09.002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386865727 | |||
| W4386862621 | The biofilm proteome of Staphylococcus aureus and its implications for therapeutic interventions to biofilm-associated infections | 2023-09-19 | OpenAlex | 10.1016/bs.apcsb.2023.08.002 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4386862621 | |||
| W4386863650 | The role of bacteriophages in shaping bacterial composition and diversity in the human gut | 2023-09-19 | OpenAlex | 10.3389/fmicb.2023.1232413 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386863650 | |||
| W4386878049 | Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification | 2023-09-20 | OpenAlex | 10.1007/s40265-023-01938-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386878049 | |||
| W4387241356 | Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences | 2023-09-20 | OpenAlex | 10.1097/yic.0000000000000510 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387241356 | |||
| W4386930725 | Editorial: Microbial production of medicinally important agents | 2023-09-20 | OpenAlex | 10.3389/fmicb.2023.1274087 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4386930725 | |||
| W4386895086 | Exploring the Use of Diabetic Medications for Non-Diabetic Conditions: A Comprehensive Literature Review | 2023-09-20 | OpenAlex | 10.47672/ajhmn.1586 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386895086 | |||
| W4387345885 | Infection Control in Dentistry: An Evaluation | 2023-09-21 | OpenAlex | 10.36348/sjodr.2023.v08i09.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387345885 | |||
| W4386917538 | Path Less Traveled: Targeting Rare Driver Oncogenes in Non–Small-Cell Lung Cancer | 2023-09-21 | OpenAlex | 10.1200/op.23.00273 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386917538 | |||
| W4386921854 | Special Report: Advancing Mood Disorder Care—From Parsimony to Precision | 2023-09-21 | OpenAlex | 10.1176/appi.pn.2023.10.10.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386921854 | |||
| W4386950971 | Thinking Small, Stinking Big: The World of Microbial Odors | 2023-09-21 | OpenAlex | 10.1093/infdis/jiad405 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386950971 | |||
| W4386947382 | Update on Outbreak of Fungal Meningitis Among US Residents Who Received Epidural Anesthesia at Two Clinics in Matamoros, Mexico | 2023-09-22 | OpenAlex | 10.1093/cid/ciad570 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4386947382 | |||
| W4386997696 | Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers | 2023-09-24 | OpenAlex | 10.1053/j.semnuclmed.2023.08.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386997696 | |||
| W4386995596 | Benzoindolizidine Alkaloids Tylophorine and Lycorine and Their Analogues with Antiviral, Anti-Inflammatory, and Anticancer Properties: Promises and Challenges | 2023-09-24 | OpenAlex | 10.3390/biomedicines11102619 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4386995596 | |||
| W4387007883 | Does perioperative immunotherapy reduce the risk of second primary cancers? | 2023-09-25 | OpenAlex | 10.1016/j.ejca.2023.113355 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387007883 | |||
| W4387008467 | From FDG and beyond: the evolving potential of nuclear medicine | 2023-09-25 | OpenAlex | 10.1007/s12149-023-01865-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387008467 | |||
| W4387023753 | Hepatocytic Ballooning in Non-alcoholic Steatohepatitis: Bridging the Knowledge Gap and Charting Future Avenues | 2023-09-25 | OpenAlex | 10.7759/cureus.45884 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387023753 | |||
| W4387002147 | Nurse leaders thriving | 2023-09-25 | OpenAlex | 10.1097/nmg.0000000000000054 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387002147 | |||
| W4391310423 | Oncogenic Viruses: A Comparative Evolutionary Study | 2023-09-25 | OpenAlex | 10.21786/bbrc/16.3.4 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391310423 | |||
| W4387025551 | Pharmacometric approaches to improve theranostics | 2023-09-25 | OpenAlex | 10.33540/1920 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387025551 | |||
| W4388424002 | MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa? | 2023-09-26 | OpenAlex | 10.1097/qco.0000000000000966 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388424002 | |||
| W4387078214 | A narrative review of potential drug treatments for nephritis in children with IgA vasculitis (HSP) | 2023-09-27 | OpenAlex | 10.1007/s10067-023-06781-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387078214 | |||
| W4387094769 | Chalcones as Anti-Infective Agents for Effective Management of Tuberculosis | 2023-09-27 | OpenAlex | 10.1080/10406638.2023.2261593 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4387094769 | |||
| W4387098332 | Clinical Profile and Outcomes of Patients With Hypercalcemia in an Indian Tertiary Care Center | 2023-09-27 | OpenAlex | 10.7759/cureus.46062 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387098332 | |||
| W4387077835 | Direct Oral Anticoagulants: An Overview of Indications, Pharmacokinetics, Comorbidities, and Perioperative Management | 2023-09-27 | OpenAlex | 10.1097/crd.0000000000000618 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387077835 | |||
| W4387081420 | OA02 Hip pain in the young and active patient? Don’t forget FAI | 2023-09-27 | OpenAlex | 10.1093/rap/rkad070.002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387081420 | |||
| W4387080987 | P07 Pityriasis amiantacea: a unique presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy | 2023-09-27 | OpenAlex | 10.1093/rap/rkad070.028 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387080987 | |||
| W4387080918 | P10 Collapse, confusion and acute kidney injury presenting in the context of bullous skin disease in a young male patient | 2023-09-27 | OpenAlex | 10.1093/rap/rkad070.031 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387080918 | |||
| W4387168392 | Right Ventricular Dysfunction During Left Ventricular Assist Device Implantation: Roles of Anesthesiologists | 2023-09-27 | OpenAlex | 10.1097/mat.0000000000002049 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387168392 | |||
| W4387115660 | Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects | 2023-09-28 | OpenAlex | 10.1093/neuonc/noad191 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387115660 | |||
| W4387127060 | Management of nonfermenting gram-negative infections: a critique of the guidelines | 2023-09-28 | OpenAlex | 10.1097/qco.0000000000000982 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387127060 | |||
| W4387128891 | Treatment of evolving cancers will require dynamic decision support | 2023-09-28 | OpenAlex | 10.1016/j.annonc.2023.08.008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387128891 | |||
| W4387208766 | Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking | 2023-09-29 | OpenAlex | 10.1016/j.immuni.2023.09.003 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387208766 | |||
| W4400307840 | Artificial intelligence and psychiatry: applications and challenges | 2023-09-29 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400307840 | ||||
| W4387220437 | Current directions in the treatment of classical Hodgkin lymphoma | 2023-09-29 | OpenAlex | 10.1002/jha2.784 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387220437 | |||
| W4387215306 | DEEPENING THEORETICAL KNOWLEDGE AND EXPLORING THE PROPERTIES OF LOCAL ANESTHETICS | 2023-09-29 | OpenAlex | 10.51891/rease.v9i9.11142 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387215306 | |||
| W4387157772 | Developing precision‐based multidisciplinary pharmacotherapy management plans in the critically ill | 2023-09-29 | OpenAlex | 10.1002/phar.2871 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387157772 | |||
| W4387206556 | Impact of Concurrent Targeted Therapy and Immunotherapy on the Incidence of Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases | 2023-09-29 | OpenAlex | 10.1016/j.ijrobp.2023.06.839 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387206556 | |||
| W4387206501 | Stereotactic Radiosurgery (SRS) for Brain Metastasis in the Era of Evolving Systemic Treatment (Immunotherapy or Targeted Therapy) in Patients with Non-Small Cell Lung Cancer (NSCLC) | 2023-09-29 | OpenAlex | 10.1016/j.ijrobp.2023.06.885 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387206501 | |||
| W4387233555 | ANTIBIOGRAM OF STAPHYLOCOCCUS AUREUS AMONG CLINICAL ISOLATES AT A TERTIARY CARE HOSPITAL IN LAHORE | 2023-09-30 | OpenAlex | 10.51642/ppmj.v34i03.607 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387233555 | |||
| W4387752510 | Advancements in Dermatological Therapies | 2023-09-30 | OpenAlex | 10.54393/tt.v4i03.137 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387752510 | |||
| W4387221797 | After Dobbs: Reflections on political and legal anthropology | 2023-09-30 | OpenAlex | 10.1111/plar.12535 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387221797 | |||
| W4387259012 | An Evaluation of Experimental Calcium Ion-Leachable Nanocomposite Glass Ionomer Cements | 2023-09-30 | OpenAlex | 10.3390/nano13192690 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387259012 | |||
| W4387160414 | IDRM: Brain tumor image segmentation with boosted RIME optimization | 2023-09-30 | OpenAlex | 10.1016/j.compbiomed.2023.107551 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387160414 | |||
| W4387493593 | 55.3 Evolving Nonstandard Tic Treatment Approaches | 2023-10-01 | OpenAlex | 10.1016/j.jaac.2023.07.399 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387493593 | |||
| W4387234618 | A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities | 2023-10-01 | OpenAlex | 10.3390/brainsci13101408 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387234618 | |||
| W4388972493 | A diagnostic conundrum in Bardet–Biedl syndrome: when genetic diagnosis precedes clinical diagnosis | 2023-10-01 | OpenAlex | 10.1530/edm-23-0055 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4388972493 | |||
| W4387380835 | Advancements in the Management of Moderate-to-Severe Ulcerative Colitis: A Revised 2023 Korean Treatment Guidelines | 2023-10-01 | OpenAlex | 10.3904/kjm.2023.98.5.223 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387380835 | |||
| W4389632445 | Antimicrobial Resistance – We Need to Put in Serious Steps to Thwart It! | 2023-10-01 | OpenAlex | 10.4103/injms.injms_171_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389632445 | |||
| W4389811826 | Authors’ Reply to Unraveling the Place of Small Molecules in the Treatment of Fistulizing Crohn’s Disease—A Systematic Review and Network Meta-analysis | 2023-10-01 | OpenAlex | 10.1093/crocol/otad075 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389811826 | |||
| W4387247820 | CAVITARY PULMONARY NODULES: A RARE MANIFESTATION OF RHEUMATOID ARTHRITIS | 2023-10-01 | OpenAlex | 10.1016/j.chest.2023.07.3572 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387247820 | |||
| W4387711162 | Cancer Pharmacology | 2023-10-01 | OpenAlex | 10.1891/9780826149336 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387711162 | |||
| W4399147498 | Comparative Efficacy of Polidocanol and Sodium Tetradecyl Sulfate in the Management of Oral Mucoceles – A Comparative Study | 2023-10-01 | OpenAlex | 10.4103/jiaomr.jiaomr_84_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399147498 | |||
| W4387303635 | Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol | 2023-10-01 | OpenAlex | 10.1136/bmjopen-2023-073071 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387303635 | |||
| W4387267583 | Current updates in HCC screening and treatment | 2023-10-01 | OpenAlex | 10.1097/cld.0000000000000083 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387267583 | |||
| W4388200887 | Drug development, clinical trials, and regulatory requirements | 2023-10-01 | OpenAlex | 10.1093/med/9780192869227.003.0030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388200887 | |||
| W4388248510 | Health Care Chatbot | 2023-10-01 | OpenAlex | 10.55041/ijsrem26399 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388248510 | |||
| W4387587017 | Lupus Miliaris Disseminatus Faciei – Lest we Forget: A Report of Two Cases | 2023-10-01 | OpenAlex | 10.4103/cdr.cdr_52_22 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387587017 | |||
| W4387255308 | MULTISYSTEM INVOLVEMENT OF IDIOPATHIC HYPEREOSINOPHILIC SYNDROME | 2023-10-01 | OpenAlex | 10.1016/j.chest.2023.07.474 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387255308 | |||
| W4387439933 | Navigating the maze of treatment strategies for RA‐ILD : Insights and innovations for better patient outcomes | 2023-10-01 | OpenAlex | 10.1111/1756-185x.14830 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387439933 | |||
| W4388597967 | PB0324 Burden of Symptoms and Healthcare Resource Utilization (HCRU) and Costs in U.S. Patients with Thrombotic Thrombocytopenic Purpura (TTP) | 2023-10-01 | OpenAlex | 10.1016/j.rpth.2023.101459 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388597967 | |||
| W4387253834 | PHENOBARBITAL-INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS: A CASE REPORT | 2023-10-01 | OpenAlex | 10.1016/j.chest.2023.07.1733 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387253834 | |||
| W4387256853 | POLYURIA IN THE ICU SETTING: IS DEXMEDETOMIDINE TO BLAME? | 2023-10-01 | OpenAlex | 10.1016/j.chest.2023.07.1595 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387256853 | |||
| W4398235252 | POSTER ABSTRACT | 2023-10-01 | OpenAlex | 10.4103/0970-9371.388619 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398235252 | |||
| W4387666280 | Palliative care integration for patients on phase I cancer clinical trials | 2023-10-01 | OpenAlex | 10.1016/j.currproblcancer.2023.101022 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387666280 | |||
| W4387733033 | S3276 Ustekinumab and Tofacitinib Combination Therapy: Success in a Difficult Case of Crohn’s Disease With Enteropathic Arthritis | 2023-10-01 | OpenAlex | 10.14309/01.ajg.0000962744.99545.ee | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387733033 | |||
| W4387248829 | SUCCESSFUL ENDOVASCULAR INTERVENTION FOR ACUTE BASILAR ARTERY OCCLUSION: A CASE REPORT AND REVIEW OF MANAGEMENT STRATEGIES | 2023-10-01 | OpenAlex | 10.1016/j.chest.2023.07.1337 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387248829 | |||
| W4387253212 | TUMOR LYSIS SYNDROME DUE TO CONCURRENT ADMINISTRATION OF PAXLOVID AND RUXOLITINIB | 2023-10-01 | OpenAlex | 10.1016/j.chest.2023.07.1829 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387253212 | |||
| W4387970000 | The evolution of pharmacovigilance: the contributions of Michael D Rawlins | 2023-10-01 | OpenAlex | 10.1097/fad.0000000000000070 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387970000 | |||
| W4387232261 | The implications of antithrombotic agents on subdural hematoma evacuation: what does "reversal" truly entail? | 2023-10-01 | OpenAlex | 10.3171/2023.7.focus23354 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387232261 | |||
| W4387253247 | UNIQUE PRESENTATION OF A RARE LYMPHOMA: ANAPLASTIC LARGE CELL LYMPHOMA WITH CARDIAC INVOLVEMENT | 2023-10-01 | OpenAlex | 10.1016/j.chest.2023.07.2291 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387253247 | |||
| W4387451452 | “This carpenter wende he were in despeir”: Misinterpretation and the Nightmare in Chaucer's Miller's Tale | 2023-10-01 | OpenAlex | 10.5406/1945662x.122.4.03 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387451452 | |||
| W4400183948 | A Fresh Beginning to an Old Conversation: Thoughts on Leon Hoffman’s “We Don’t Trust YOU: Reflections on Anti-Racism in Psychoanalysis” | 2023-10-02 | OpenAlex | 10.1080/00107530.2024.2323918 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400183948 | |||
| W4387253190 | Personalized treatment in localized pancreatic cancer | 2023-10-02 | OpenAlex | 10.1007/s10353-023-00814-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387253190 | |||
| W4387296889 | Re‐re‐biopsy? How much tumor is enough in the era of precision oncology? | 2023-10-02 | OpenAlex | 10.1111/ajco.14030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387296889 | |||
| W4387309617 | Editorial: Green nanomaterials: prospective biotechnological applications | 2023-10-03 | OpenAlex | 10.3389/fmicb.2023.1280398 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387309617 | |||
| W4387357252 | Managing pediatric Crohn’s disease: recent insights | 2023-10-03 | OpenAlex | 10.1080/17474124.2023.2267431 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387357252 | |||
| W4387954387 | Reflection on Collaborative Action: Fostering Collaborative Diagnostic Reasoning in an Agent-Based Medical Simulation | 2023-10-03 | OpenAlex | 10.22318/cscl2023.596913 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4387954387 | |||
| W4387325873 | For better or for worse: when chatbots influence human emotions and behaviours | 2023-10-04 | OpenAlex | 10.1093/eurjcn/zvad098 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387325873 | |||
| W4387326506 | Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma | 2023-10-04 | OpenAlex | 10.1007/s00277-023-05478-x | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387326506 | |||
| W4387352895 | Other molecular cohorts including ROS1, BRAF, HER2, MET, NTRK, RET, KRAS | 2023-10-04 | OpenAlex | 10.1016/b978-0-323-69573-2.00021-8 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387352895 | |||
| W4387357811 | The evolving landscape of oropharyngeal cancer: a window of opportunity for primary prevention | 2023-10-04 | OpenAlex | 10.1093/jnci/djad171 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387357811 | |||
| W4387344892 | The expanding universe of gene and cell therapy | 2023-10-04 | OpenAlex | 10.1093/ajhp/zxad251 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387344892 | |||
| W4387357614 | Is immunology doing well? A look at 100 immune‐mediated inflammatory diseases for 100 years of the Journal | 2023-10-05 | OpenAlex | 10.1111/imcb.12695 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387357614 | |||
| W4387523781 | The Challenge of Extensively Drug-resistant Gram-negative Pathogens in Children: Newer Antibiotics and When to Use Them for Empiric and Definitive Therapy | 2023-10-05 | OpenAlex | 10.1097/inf.0000000000004124 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387523781 | |||
| W4387396864 | Indications, Options, and Updates on Embolic Agents | 2023-10-06 | OpenAlex | 10.1016/j.coms.2023.09.006 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4387396864 | |||
| W4387392472 | Novel treatment for mantle cell lymphoma – impact of BTK inhibitors and beyond | 2023-10-06 | OpenAlex | 10.1080/10428194.2023.2264430 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387392472 | |||
| W4387422269 | Antibiotic Resistance Microbes’ (ARM) Mechanisms and Management: A Phytomedicinal Approach | 2023-10-07 | OpenAlex | 10.1007/s40011-023-01525-9 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387422269 | |||
| W4387432564 | The Evolving Role of Intra-arterial Chemotherapy in Adult and Pediatric Cancers: A Comprehensive Review | 2023-10-07 | OpenAlex | 10.7759/cureus.46631 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387432564 | |||
| W4387601946 | Bacteria biofilms: Navigating the way forward | 2023-10-08 | OpenAlex | 10.21608/mid.2023.236659.1621 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387601946 | |||
| W4387473302 | Cellular Therapy in Chronic Lymphocytic Leukemia: Have We Advanced in the Last Decade? | 2023-10-09 | OpenAlex | 10.1159/000534341 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387473302 | |||
| W4387453799 | Editorial: Lessons and policy consequences of mathematical modeling in relation to ongoing pandemics | 2023-10-09 | OpenAlex | 10.3389/fpubh.2023.1281493 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387453799 | |||
| W4387478957 | The Role of Patient Blood Management in Judicious Use of Blood | 2023-10-09 | OpenAlex | 10.4103/aihb.aihb_106_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387478957 | |||
| W4387486630 | A Global Review of Invasive Haemophilus influenzae Disease from 2000-2023: Current Status, Challenges and Future Perspectives | 2023-10-10 | OpenAlex | 10.21203/rs.3.rs-3412671/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387486630; https://openalex.org/W4380421161; https://openalex.org/W4391142718 | |||
| W4387475716 | Defining biology and recurrence risk in prostate cancers treated by neoadjuvant chemohormonal therapy | 2023-10-10 | OpenAlex | 10.1093/jnci/djad192 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387475716 | |||
| W4388707159 | Fellows’ Corner | 2023-10-10 | OpenAlex | 10.1097/hep.0000000000000620 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388707159 | |||
| W4387504242 | Molecular diagnostic approaches for SARS-CoV-2 detection and pathophysiological consequences | 2023-10-10 | OpenAlex | 10.1007/s11033-023-08844-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387504242 | |||
| W4387472387 | The FLT3N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib | 2023-10-10 | OpenAlex | 10.1002/ajh.27096 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387472387 | |||
| W4387493675 | Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping review | 2023-10-10 | OpenAlex | 10.1007/s00423-023-03133-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387493675 | |||
| W4387893340 | A review of the state of cervical cancer: updates from prevention to recurrent disease | 2023-10-11 | OpenAlex | 10.1097/gco.0000000000000918 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387893340 | |||
| W4387521826 | COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned? | 2023-10-11 | OpenAlex | 10.1159/000534540 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387521826 | |||
| W4409540016 | Managing Type 2 Diabetes Mellitus: A Personalized Approach | 2023-10-11 | OpenAlex | 10.31579/2768-0487/113 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409540016 | |||
| W4387534763 | Molecular studies of phages-Klebsiella pneumoniae in mucoid environment: innovative use of mucolytic agents prior to the administration of lytic phages | 2023-10-11 | OpenAlex | 10.3389/fmicb.2023.1286046 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387534763 | |||
| W4387578765 | A review of the explainability and safety of conversational agents for mental health to identify avenues for improvement | 2023-10-12 | OpenAlex | 10.3389/frai.2023.1229805 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4387578765 | |||
| W4387563115 | Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium | 2023-10-12 | OpenAlex | 10.1158/2159-8290.cd-23-0559 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387563115 | |||
| W4387569294 | Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers | 2023-10-12 | OpenAlex | 10.3390/cancers15204957 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387569294 | |||
| W4387589973 | Index | 2023-10-12 | OpenAlex | 10.1108/978-1-83753-618-420231018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387589973; https://openalex.org/W4317733600; https://openalex.org/W4377995751 | |||
| W4387562639 | PHYTOCHEMICAL SCREENING AND PHARMACOLOGICAL EVALUATION OF ANTICANCER ACTIVITY OF METHANOLIC EXTRACT OF MAYTENUS EMARGINATA (WILLD) IN RATS | 2023-10-12 | OpenAlex | 10.5281/zenodo.8434596 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387562639 | |||
| W4387608438 | THE FRENCH AMBULATORY CESARIAN SECTION (FAUCS) – MATERNAL AND NEONATAL OUTCOMES: 5 YEARS CLINICAL EXPERIENCE | 2023-10-12 | OpenAlex | 10.52340/jecm.2023.05.20 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387608438 | |||
| W4387589919 | Transformative Active Learning in the Saudi National Institute of Health: Promoting Education and Research Skills Capability | 2023-10-12 | OpenAlex | 10.1108/978-1-83753-618-420231003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387589919 | |||
| W4387609901 | Editorial: Education and society: new approaches for new challenges | 2023-10-13 | OpenAlex | 10.3389/feduc.2023.1290101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387609901 | |||
| W4387599986 | Management of Pediatric Psoriasis: A U.S. Survey Based on Visits from the National Ambulatory Medical Care Survey (NAMCS) | 2023-10-13 | OpenAlex | 10.1007/s13555-023-01051-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387599986 | |||
| W4387669860 | Experimental spectroscopic and molecular docking investigations of the anticancer drugs aprepitant and capecitabine | 2023-10-14 | OpenAlex | 10.1007/s00214-023-03055-z | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387669860 | |||
| W4387642987 | PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics | 2023-10-14 | OpenAlex | 10.1053/j.seminoncol.2023.09.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387642987 | |||
| W4387638744 | Xanthogranulomatous Pyelonephritis as a Complication of Obstructive Uropathy: Clinical Case | 2023-10-14 | OpenAlex | 10.14738/bjhmr.105.15652 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387638744 | |||
| W4387653749 | Combining scar-modulating agents for the treatment of hypertrophic scars and keloids: A systematic review | 2023-10-15 | OpenAlex | 10.1016/j.bjps.2023.10.065 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387653749 | |||
| W4387661213 | Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy | 2023-10-16 | OpenAlex | 10.1080/14737140.2023.2270161 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387661213 | |||
| W4387704187 | Case Report: Successful immune checkpoint inhibitor-based rechallenge in a patient with advanced renal clear cell cancer | 2023-10-17 | OpenAlex | 10.3389/fimmu.2023.1270828 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387704187 | |||
| W4387695148 | From climate change to AMR: understanding environmental-human health issues in a One Health framework | 2023-10-17 | OpenAlex | 10.3897/aca.6.e108165 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387695148 | |||
| W4387703853 | Overcoming the challenges of drug development in platinum-resistant ovarian cancer | 2023-10-17 | OpenAlex | 10.3389/fonc.2023.1258228 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387703853 | |||
| W4391149256 | Some reflections on immunosuppressants and their delivery to the lungs by aerosol in the treatment of COVID-19 | 2023-10-17 | OpenAlex | 10.15789/1563-0625-sro-2613 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391149256 | |||
| W4387709589 | Treatment of gastric adenocarcinoma: A rapidly evolving landscape | 2023-10-17 | OpenAlex | 10.1016/j.ejca.2023.113370 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387709589 | |||
| W4387744448 | A Great Conversation With Deborah Friedman | 2023-10-18 | OpenAlex | 10.1097/wno.0000000000001999 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387744448 | |||
| W4387733312 | Australian recommendations for the management of drug-resistant tuberculosis, 2023 | 2023-10-18 | OpenAlex | 10.33321/cdi.2023.47.48 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387733312 | |||
| W4387729994 | Evolving paradigms in locally advanced rectal cancer: the means justify the ends | 2023-10-18 | OpenAlex | 10.1093/jnci/djad196 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387729994 | |||
| W4387865887 | Inflammatory Pathways and Their Implications in Heart Failure With Preserved Ejection Fraction | 2023-10-18 | OpenAlex | 10.14503/thij-23-8223 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387865887 | |||
| W4387771520 | Clinical trials aimed at HIV cure or remission: new pathways and lessons learned | 2023-10-19 | OpenAlex | 10.1080/14787210.2023.2273919 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387771520 | |||
| W4387776385 | Nanotherapeutics for leptin resistance and obesity using metal nanocomposites | 2023-10-19 | OpenAlex | 10.1201/9781032621135-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387776385 | |||
| W4387765003 | Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts | 2023-10-19 | OpenAlex | 10.1007/s11912-023-01461-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387765003 | |||
| W4387826703 | Leveraging immunoliposomes as nanocarriers against SARS-CoV-2 and its emerging variants | 2023-10-20 | OpenAlex | 10.1016/j.ajps.2023.100855 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387826703 | |||
| W4387833724 | Plant crude drugs | 2023-10-20 | OpenAlex | 10.1016/b978-0-443-18657-8.00002-5 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387833724 | |||
| W4387810660 | RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort | 2023-10-20 | OpenAlex | 10.1038/s41375-023-02027-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387810660 | |||
| W4387799403 | Reimagining Nursing Education: The Power of a Shared Vision! | 2023-10-20 | OpenAlex | 10.1097/01.nep.0000000000001201 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387799403 | |||
| W4387799324 | Sixth Annual Mediclinic Middle East Research Conference | 2023-10-20 | OpenAlex | 10.1097/md.0000000000033794 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387799324 | |||
| W4387849722 | Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future | 2023-10-21 | OpenAlex | 10.1016/j.ijantimicag.2023.107014 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387849722 | |||
| W4387849423 | Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach | 2023-10-21 | OpenAlex | 10.1016/j.jbc.2023.105381 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387849423 | |||
| W4404195486 | Advancements in Therapeutic and Diagnostic Strategies for COVID-19: A Review of Recent Developments | 2023-10-23 | OpenAlex | 10.51470/apr.2023.2.2.20 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404195486 | |||
| W4387895008 | Applications of nanomaterials as treatments and diagnostic biosensors in microbial infections | 2023-10-23 | OpenAlex | 10.1002/mba2.62 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387895008 | |||
| W4387948673 | Surveillance and Management of Pouch Neoplasia in Familial Adenomatous Polyposis: A Systematic Review | 2023-10-23 | OpenAlex | 10.1097/dcr.0000000000003122 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387948673 | |||
| W4387905048 | Editorial Comment on “Atopic outcomes at 2 years in the CORAL cohort, born in COVID-19 lockdown” | 2023-10-24 | OpenAlex | 10.22541/au.169813277.70696178/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387905048 | |||
| W4387909389 | Evolving Clinical–Translational Investigations of Cerebroprotection in Ischemic Stroke | 2023-10-24 | OpenAlex | 10.3390/jcm12216715 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4387909389 | |||
| W4387893581 | Ivosidenib in acute myeloid leukemia | 2023-10-24 | OpenAlex | 10.1080/14656566.2023.2272659 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387893581 | |||
| W4387906139 | Study of Anesthesia Agents Used for Ophthalmic Surgery | 2023-10-24 | OpenAlex | 10.21203/rs.3.rs-3478626/v1 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4387906139 | |||
| W4387949152 | ASHP/SIDP Joint Statement on the Pharmacist’s Role in Antimicrobial Stewardship | 2023-10-25 | OpenAlex | 10.1093/ajhp/zxad164 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387949152 | |||
| W4387950323 | Aficamten—A Second in Class Cardiac Myosin Inhibitor for Hypertrophic Cardiomyopathy | 2023-10-25 | OpenAlex | 10.1097/crd.0000000000000620 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387950323 | |||
| W4391698718 | An overview of the Pathogenesis and Virulence of Mycoplasma gallisepticum infection – a review | 2023-10-25 | OpenAlex | 10.24099/vet.arhiv.1841 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391698718 | |||
| W4387950532 | Conversation with Dr. Daniela Novick | 2023-10-25 | OpenAlex | 10.1089/jir.2023.29057.int | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387950532 | |||
| W4387940918 | On the horns of a dilemma: choosing total intravenous anaesthesia or volatile anaesthesia for cancer surgery, an enduring controversy | 2023-10-25 | OpenAlex | 10.1016/j.bja.2023.10.001 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4387940918 | |||
| W4388265480 | Personalized management of differentiated thyroid cancer | 2023-10-25 | OpenAlex | 10.33540/1947 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388265480 | |||
| W4387948572 | Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis | 2023-10-26 | OpenAlex | 10.1007/s40265-023-01950-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387948572 | |||
| W4393208223 | Side Effects of Treatment in Multiple Myeloma | 2023-10-26 | OpenAlex | 10.1007/978-3-030-93702-7_10-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4393208223 | |||
| W4388308573 | The Age of Immune-therapy in Multiple Myeloma with a Collective Goal for a Cure | 2023-10-26 | OpenAlex | 10.18103/mra.v11i10.4607 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388308573 | |||
| W4388192635 | Does Haematological Toxicity Increase with the Use of Lipophilic Chemotherapeutic Agents in Obese Breast Cancer Patients? | 2023-10-27 | OpenAlex | 10.14744/ejmi.2023.59404 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4388192635 | |||
| W4387992163 | Selected Publications by David R. Maines | 2023-10-27 | OpenAlex | 10.1108/s0163-239620230000057022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387992163 | |||
| W4387971612 | The Evolving Landscape: Exploring the Future of Myelodysplastic Syndrome Treatment with Dr. Rami Komrokji | 2023-10-27 | OpenAlex | 10.3390/cancers15215170 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4387971612 | |||
| W4388001451 | Antibiotic Prophylaxis in Surgery: Current Insights and Future Directions for Surgical Site Infection Prevention | 2023-10-28 | OpenAlex | 10.7759/cureus.47858 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388001451 | |||
| W4387998345 | Investigating Flavonoid Extracts from Medicinal Plants: Evaluating their Anti-Cancer Potential, Mechanisms, and Synergistic Impact on Colon Cancer | 2023-10-28 | OpenAlex | 10.17762/jaz.v44is-3.1297 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4387998345 | |||
| W4388011358 | Nanoparticle-Based Theranostics: Simultaneous Diagnosis and Treatment | 2023-10-28 | OpenAlex | 10.31219/osf.io/hbcmy | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388011358 | |||
| W4388133043 | Solving Epidemics of Lyme and Other Vector-Borne Infections through the Immune System | 2023-10-28 | OpenAlex | 10.31038/idt.2023415 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388133043 | |||
| W4388038403 | Prevalence of Pseudomonas aeruginosa isolates and their antibiotic susceptibility among patients and healthcare workers in three Hospitals of Duhok city/ Iraq | 2023-10-29 | OpenAlex | 10.22317/jcms.v9i5.1428 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388038403 | |||
| W4388136912 | AI Chatbots and Psychotherapy: A Match Made in Heaven? | 2023-10-30 | OpenAlex | 10.47391/jpma.9608 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388136912 | |||
| W4388103679 | Implementation Evaluation of Community-Based Mental Health and Psychosocial Support Intervention for Refugee Newcomers in the United States | 2023-10-30 | OpenAlex | 10.1155/2023/6696415 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388103679 | |||
| W4388109283 | Portuguese Pancreatic Club Perspectives on Endoscopic Ultrasound-Guided and Surgical Treatment of Pancreatic Neuroendocrine Tumors | 2023-10-30 | OpenAlex | 10.1159/000534032 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388109283 | |||
| W4388104264 | Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma | 2023-10-30 | OpenAlex | 10.3390/cancers15215217 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388104264 | |||
| W4388042660 | Social Entrepreneurship In The New Economy Among The Younger Generation | 2023-10-30 | OpenAlex | 10.61160/jomss.v1i3.22 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4388042660; https://openalex.org/W4388263509; https://openalex.org/W4391168607 | |||
| W4388069529 | 1386 EVOLVE-106, a T cell engager with integrated CD2 costimulation targeting B7-H4, is a precision therapy for estrogen and Her2 receptor low breast cancers | 2023-10-31 | OpenAlex | 10.1136/jitc-2023-sitc2023.1386 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388069529 | |||
| W4388042634 | 463 Targeting a novel myeloid checkpoint Siglec-15 in GBM generates an extremely durable response with Zika virus oncolytic therapy | 2023-10-31 | OpenAlex | 10.1136/jitc-2023-sitc2023.0463 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4388042634 | |||
| W7204989898 | GLP-1 RECEPTOR AGONISTS: EXPANDING INDICATIONS FROM DIABETES AND OBESITY TO CARDIOVASCULAR AND NEURODEGENERATIVE DISEASES | 2023-10-31 | OpenAlex | 10.58175/gjrbp.2023.2.4.0225 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204989898 | |||
| W4388033339 | Reducing Gadolinium Contrast With Artificial Intelligence | 2023-10-31 | OpenAlex | 10.1002/jmri.29095 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388033339 | |||
| W4388072194 | Supporting Solidarity | 2023-10-31 | OpenAlex | 10.52214/vib.v9i.11758 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388072194 | |||
| W4388048888 | Unveiling Mesenchymal Stem Cells’ Regenerative Potential in Clinical Applications: Insights in miRNA and lncRNA Implications | 2023-10-31 | OpenAlex | 10.3390/cells12212559 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388048888 | |||
| W4388822265 | 2023 Index to Volume 85 of The American Biology Teacher | 2023-11-01 | OpenAlex | 10.1525/abt.2023.85.9.540 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388822265 | |||
| W4388527812 | A CASE OF DELAYED TYPE HYPERSENSITIVITY REACTION TO INSULIN | 2023-11-01 | OpenAlex | 10.1016/j.anai.2023.08.329 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388527812 | |||
| W4397041064 | A Rare Case of Renal-Limited Hydralazine-Induced Pauci-Immune Glomerulonephritis | 2023-11-01 | OpenAlex | 10.1681/asn.20233411s11120e | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4397041064 | |||
| W4388527767 | ANAPHYLAXIS WITH A GELATIN-CONTAINING SUPPOSITORY IN A TWO-YEAR-OLD GIRL | 2023-11-01 | OpenAlex | 10.1016/j.anai.2023.08.331 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388527767 | |||
| W4392462082 | Abstract 160: Recurrent Multi‐territorial Ischemic Stroke as an Initial Presentation of Thrombotic Thrombocytopenic Purpura | 2023-11-01 | OpenAlex | 10.1161/svin.03.suppl_2.160 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392462082 | |||
| W4389511785 | Advanced Practitioners as Agents of Change: Leveraging Quality Improvement to Improve Practice | 2023-11-01 | OpenAlex | 10.6004/jadpro.2023.14.7.13 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4389511785 | |||
| W4388129544 | An Overview of Contrast-induced Acute Kidney Injury | 2023-11-01 | OpenAlex | 10.1177/26324636231203498 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388129544 | |||
| W4397043013 | Anemia Treatment Among Prevalent Hemodialysis and Peritoneal Dialysis Patients in the United States | 2023-11-01 | OpenAlex | 10.1681/asn.20233411s1366b | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4397043013 | |||
| W4397040730 | Anti-Tumor Necrosis Factor Antibody-Induced Lupus-Like Glomerulonephritis | 2023-11-01 | OpenAlex | 10.1681/asn.20233411s1602c | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4397040730 | |||
| W4388527800 | DELAYED-TYPE HYPERSENSITIVITY REACTION FOLLOWING PEGFILGRASTIM EXPOSURE | 2023-11-01 | OpenAlex | 10.1016/j.anai.2023.08.328 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388527800 | |||
| W7132936886 | Deployment and Evaluation of a Motivational-Interviewing Chatbot for Moving Smokers Towards the Decision to Quit and Distillation of Large Foundational Language Models for Generating MI Reflections | 2023-11-01 | OpenAlex | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7132936886 | ||||
| W4388495018 | EP242/#366 Title understanding current practices for the management of advanced epithelial high-grade ovarian cancer in the UK: interim data from the OC-NOW survey (2023) | 2023-11-01 | OpenAlex | 10.1136/ijgc-2023-igcs.316 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388495018 | |||
| W4397042472 | From Famine to Feast in IgA Nephropathy: New Treatments Present New Opportunities for Patients | 2023-11-01 | OpenAlex | 10.1681/asn.20233411s1980a | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4397042472 | |||
| W4388706183 | Getting Ready for Certification | 2023-11-01 | OpenAlex | 10.1097/won.0000000000001037 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388706183 | |||
| W4388590658 | IMMU-39. EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN GLIOBLASTOMA FROM REAL-WORLD DATA ANALYSIS | 2023-11-01 | OpenAlex | 10.1093/neuonc/noad179.0571 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388590658 | |||
| W7218102966 | Idiosyncratic Drug-induced Liver Injury: A Diagnosis Beyond Simplicity | 2023-11-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7218102966 | ||||
| W4388303891 | Management and Outcomes of Anti-CD38 Refractory Patients: The Impact of Retreatment and of Subsequent Therapies | 2023-11-01 | OpenAlex | 10.1097/hs9.0000000000000975 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388303891 | |||
| W4389456261 | New Therapies in Melanoma: Current Trends, Evolving Paradigms, and Future Perspectives | 2023-11-01 | OpenAlex | 10.12788/cutis.0911 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389456261 | |||
| W4388478917 | Overcoming challenges with getting current evidence into practice | 2023-11-01 | OpenAlex | 10.11124/jbies-23-00473 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388478917 | |||
| W4388424653 | P85 Contemporary underlying causes of immunocompromise in severe PCP: a 10 year tertiary-centre experience | 2023-11-01 | OpenAlex | 10.1136/thorax-2023-btsabstracts.237 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388424653 | |||
| W4388527749 | SCITING TO A HALT: A CASE OF MAST CELL ACTIVATION SYNDROME AND RECURRENT ANAPHYLAXIS | 2023-11-01 | OpenAlex | 10.1016/j.anai.2023.08.330 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388527749 | |||
| W4389764398 | Second-line treatment of diffuse large B‐cell lymphoma: Evolution of options | 2023-11-01 | OpenAlex | 10.1053/j.seminhematol.2023.12.001 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389764398 | |||
| W3103198646 | Sexpertise: Sexual Knowledge and the Public in the Nineteenth and Twentieth Centuries | 2023-11-01 | OpenAlex | 10.1093/shm/hkae014 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W3103198646 | |||
| W4389514622 | Sigrid Boysen, Review of Marie-Catherine Petersmann. When Environmental Protection and Human Rights Collide: The Politics of Conflict Management by Regional Courts | 2023-11-01 | OpenAlex | 10.1093/ejil/chad064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389514622 | |||
| W4388588933 | TMIC-50. SIGLEC-15 IS A NEW MYELOID CHECKPOINT IN GBM, WHOSE SUPPRESSION LEADS TO EXTREMELY DURABLE RESPONSES WITH ONCOLYTIC THERAPY | 2023-11-01 | OpenAlex | 10.1093/neuonc/noad179.1116 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4388588933 | |||
| W4397045217 | Unveiling the Masquerade: Misdiagnosis of CKD in the Shadow of HIV Treatment | 2023-11-01 | OpenAlex | 10.1681/asn.20233411s1692a | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4397045217 | |||
| W4389235152 | A National Cancer Database Study of Survival Trends in Patients with Mantle Cell Lymphoma Stratified By Age Group | 2023-11-02 | OpenAlex | 10.1182/blood-2023-179611 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389235152 | |||
| W4389248281 | A Phase Ib Study of Linperlisib Monotherapy in Patients with Relapsed or Refractory B-Cell Malignancies | 2023-11-02 | OpenAlex | 10.1182/blood-2023-177550 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389248281 | |||
| W4389229518 | A Potential Paradigm for the Robust and Systematic Prioritisation of Assets in Academic-Led, Multi-Industry Collaborative Trials in Rare Populations (Glo-BNHL) | 2023-11-02 | OpenAlex | 10.1182/blood-2023-178724 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389229518 | |||
| W4389247955 | A Prospective Multicenter Phase II Study of Orelabrutinib-Lenalidomide-Rituximab (OLR) in Patients with Untreated Mantle Cell Lymphoma (MCL) in China (POLARIS Study): Preliminary Analysis on Efficacy, Safety, Mutation Spectrum and Impact of Mutation Profiling on Treatment Responses | 2023-11-02 | OpenAlex | 10.1182/blood-2023-178509 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389247955 | |||
| W4389220356 | A Systematic Literature Review (SLR) and Meta-Analysis of Clinical Evidence of Second Line or Later (2L+) Treatments for Follicular Lymphoma (FL) in Adult Patients | 2023-11-02 | OpenAlex | 10.1182/blood-2023-178738 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389220356 | |||
| W4389232332 | Acquisition of 1pLOH-1qGain Is a Frequent Trajectory in Expanding Relapsed/Refractory Myeloma Subclones | 2023-11-02 | OpenAlex | 10.1182/blood-2023-190584 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389232332 | |||
| W4389229646 | Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Therapy of Acute Myeloid Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine | 2023-11-02 | OpenAlex | 10.1182/blood-2023-186085 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4389229646 | |||
| W4389259708 | BCMA-Directed CAR-T Cell Therapy Is Associated with a Higher Risk of Infections: A Systematic Review and Meta-Analysis | 2023-11-02 | OpenAlex | 10.1182/blood-2023-189225 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389259708 | |||
| W4389229421 | Cladribine and Low-Dose Cytarabine-Based Salvage Therapy for Relapsed/Refractory AML in a Predominantly Venetoclax-Exposed Cohort | 2023-11-02 | OpenAlex | 10.1182/blood-2023-185524 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389229421 | |||
| W4389243249 | Cladribine-Based Chemotherapy for Patients with Secondary Acute Myeloid Leukemia (AML) Arising after Myeloproliferative Neoplasms (MPNs) | 2023-11-02 | OpenAlex | 10.1182/blood-2023-187968 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389243249 | |||
| W4389248190 | Clinical Manifestations Are Evolving and Progressive in Patients with Vexas Syndrome | 2023-11-02 | OpenAlex | 10.1182/blood-2023-187454 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4389248190 | |||
| W4389247258 | Clinical Outcomes in Real-World Patients (RW) with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM): A Retrospective Study Using Electronic Health Records from Flatiron Health and COTA Vantage Databases | 2023-11-02 | OpenAlex | 10.1182/blood-2023-173661 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389247258 | |||
| W4389243601 | Contemporary Multiple Myeloma Treatment Patterns Among HCPs and Concordance with Expert Recommendations: Analysis of an Interactive Online Decision Support Tool | 2023-11-02 | OpenAlex | 10.1182/blood-2023-180957 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389243601 | |||
| W4389243925 | Cytokine and Mutation Profiling Reveal Patterns of Complete Remission Rates with Lenzilumab Combination Therapy in Chronic Myelomonocytic Leukemia | 2023-11-02 | OpenAlex | 10.1182/blood-2023-179706 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389243925 | |||
| W4389228845 | DNA Vaccines Against GPRC5D in Myeloma | 2023-11-02 | OpenAlex | 10.1182/blood-2023-178251 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389228845 | |||
| W4389220467 | Down Syndrome with Acute Myeloid Leukemia in an Adolescent Male Successfully Treated with Low Dose Ara-C in Combination with Hypomethylating Agent | 2023-11-02 | OpenAlex | 10.1182/blood-2023-190834 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389220467 | |||
| W4389243930 | Emerging Trends in Frontline Treatment for Acute Myeloid Leukemia (AML): A Survey of NCI-Designated Cancer Centers | 2023-11-02 | OpenAlex | 10.1182/blood-2023-190839 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389243930 | |||
| W4389221864 | Epidemiology and Clinical Outcomes of Hematologic Patients with Proven and Probable Invasive Fungal Infections: A Latin American Tertiary Care Centre Experience | 2023-11-02 | OpenAlex | 10.1182/blood-2023-188730 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389221864 | |||
| W4389221656 | Ex Vivo Mathematical Myeloma Advisor (EMMA) - a Clinical, Molecular, and Phenotypic Platform to Tailor Personalized Therapeutic Strategies for Multiple Myeloma | 2023-11-02 | OpenAlex | 10.1182/blood-2023-190479 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389221656 | |||
| W4389230971 | Genome Sequencing to Discover Drivers of Clonal Expansion in Smoldering Multiple Myeloma | 2023-11-02 | OpenAlex | 10.1182/blood-2023-184900 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389230971 | |||
| W4389246672 | Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant | 2023-11-02 | OpenAlex | 10.1182/blood-2023-185151 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389246672 | |||
| W4389234924 | Impact of Recent Advancements in Relapsed/Refractory Acute Myeloid Leukemia on Overall Survival in Clinical Practice | 2023-11-02 | OpenAlex | 10.1182/blood-2023-185132 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389234924 | |||
| W4389233760 | Longitudinal Analysis of Patient Reported Quality of Life in Newly Diagnosed Chronic Lymphocytic Leukemia Stratified By Initial Management Strategy: A Multi-Institutional Prospective Cohort Study | 2023-11-02 | OpenAlex | 10.1182/blood-2023-187268 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389233760 | |||
| W4389233438 | Matching-Adjusted Indirect Comparison (MAIC) of Efficacy and Safety of Lisocabtagene Maraleucel (liso-cel) and Mosunetuzumab for the Treatment (Tx) of Third Line or Later (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) | 2023-11-02 | OpenAlex | 10.1182/blood-2023-178786 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389233438 | |||
| W4388451259 | Membranous nephropathy treatment standard | 2023-11-02 | OpenAlex | 10.1093/ndt/gfad225 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388451259 | |||
| W4389244147 | Monoclonal Immunoglobulin Deposition Disease - a Review of Current and Emerging Data | 2023-11-02 | OpenAlex | 10.1182/blood-2023-189950 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389244147 | |||
| W4389235102 | Multicenter Study to Assess the Outcomes and Prognosis of Richter's Transformation in the Era of Novel Agents and Cell Therapy | 2023-11-02 | OpenAlex | 10.1182/blood-2023-186703 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389235102 | |||
| W4389230863 | Novel Agents with Efficacy Against Cellular Models of Familial Platelet Disorder with Myeloid Malignancy (FPD-MM) Associated with Germline Mutant RUNX1 | 2023-11-02 | OpenAlex | 10.1182/blood-2023-190655 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389230863 | |||
| W4389234829 | Outcomes of Salvage VDT-PACE-like Regimens in Relapsed-Refractory Multiple Myeloma: 10-Year Experience of a Large Academic Institution | 2023-11-02 | OpenAlex | 10.1182/blood-2023-182972 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389234829 | |||
| W4389234489 | Patient Awareness of CAR-T and Bispecific Antibody Treatments for Multiple Myeloma: Real-World Learnings and Disparities | 2023-11-02 | OpenAlex | 10.1182/blood-2023-189642 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389234489 | |||
| W4389247051 | RAMP up: Risk Adapted Post-Autologous Transplant Maintenance Therapy in MRD Positive Myeloma Patients | 2023-11-02 | OpenAlex | 10.1182/blood-2023-191148 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389247051 | |||
| W4389247326 | RRMM and Post-BCMA Treated Subjects from the CC-220-MM-001 Study Show Increased Genomic Aberrations Associated with High-Risk and Significant Dysfunction in CD4+ T-Cell Compartment Compared to NDMM Subjects | 2023-11-02 | OpenAlex | 10.1182/blood-2023-178912 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389247326 | |||
| W4389248212 | Real-World Evaluation of Outcomes in Relapsed/Refractory Multiple Myeloma Patients That Are Triple-Class Exposed after Receiving 2 or More Prior Lines of Therapy | 2023-11-02 | OpenAlex | 10.1182/blood-2023-178824 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389248212 | |||
| W4389258228 | Real-World Outcomes Among 2L+ Patients with Chronic Lymphocytic Leukemia (CLL) By Line of Therapy (LOT) | 2023-11-02 | OpenAlex | 10.1182/blood-2023-178727 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389258228 | |||
| W4389259171 | Real-World Treatment Patterns, Outcomes, Health Care Resource Utilization and Cost Burden of Multiple Myeloma in South Korea Using the National Claims Data | 2023-11-02 | OpenAlex | 10.1182/blood-2023-174019 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389259171 | |||
| W4389221835 | Recent Advancements in Acute Myeloid Leukemia Have Led to Incremental Improvement in Overall Survival | 2023-11-02 | OpenAlex | 10.1182/blood-2023-183022 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389221835 | |||
| W4388672310 | Role of radiation in oligometastases and oligoprogression in metastatic non-small cell lung cancer: consensus and controversy | 2023-11-02 | OpenAlex | 10.1080/17476348.2023.2284362 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388672310 | |||
| W4389235299 | Second Line Treatment and Outcomes of Patients with Multiple Myeloma: A Real World Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database | 2023-11-02 | OpenAlex | 10.1182/blood-2023-181138 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389235299 | |||
| W4392391416 | Shared infections at the wildlife–livestock interface and their impact on public health, economy, and biodiversity | 2023-11-02 | OpenAlex | 10.1093/af/vfad067 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392391416 | |||
| W4389248293 | Taking Shared Decision Making from Concept to Clinical Practice: What Do Sickle Cell Healthcare Providers Need? | 2023-11-02 | OpenAlex | 10.1182/blood-2023-186739 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389248293 | |||
| W4389220539 | Targeting CD24 “Don't Eat Me” Signal Restores Phagocytic Activity of Nurse-like Cells from Patients with Chronic Lymphocytic Leukemia | 2023-11-02 | OpenAlex | 10.1182/blood-2023-190359 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389220539 | |||
| W4389233476 | The Cytogenetic and Molecular Testing Landscape in Patients with Newly Diagnosed Acute Myeloid Leukemia in Routine Clinical Practices in the United States | 2023-11-02 | OpenAlex | 10.1182/blood-2023-179370 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389233476 | |||
| W4389229743 | Treatment of Elderly Patients with Higher Risk Myelodysplastic Syndromes with Oral Azacitidine | 2023-11-02 | OpenAlex | 10.1182/blood-2023-190016 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389229743 | |||
| W4389232174 | Trends in Survival Outcomes for Mantle Cell Lymphoma in the Era of Novel Therapies | 2023-11-02 | OpenAlex | 10.1182/blood-2023-190383 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389232174 | |||
| W4389246451 | Venetoclax Resistance Results in Broad Resistance to Majority of Anti-MM Agents Due to the Suppression of Apoptosis but Can be Overcome By BCMA-Targeted Immunotherapy | 2023-11-02 | OpenAlex | 10.1182/blood-2023-187374 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389246451 | |||
| W4388304988 | Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story | 2023-11-03 | OpenAlex | 10.1136/ard-2023-223850 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388304988 | |||
| W4388282519 | Treatment of systemic juvenile idiopathic arthritis | 2023-11-03 | OpenAlex | 10.1038/s41584-023-01042-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388282519 | |||
| W4388342100 | Recent advances in genomics and therapeutics in mantle cell lymphoma | 2023-11-04 | OpenAlex | 10.1016/j.ctrv.2023.102651 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388342100 | |||
| W4403450217 | THE NOOTROPIC EFFECT OF A DIPEPTIDE MIMETIC OF NGF IN AN EXPERIMENTAL MODEL OF ALZHEIMER'S DISEASE | 2023-11-04 | OpenAlex | 10.29296/25877313-2023-11-10 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403450217 | |||
| W4388424559 | A Look at ctDNA Monitoring in Small Cell Lung Cancer | 2023-11-05 | OpenAlex | 10.1097/01.cot.0000995204.87551.8a | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388424559 | |||
| W4389790602 | Anticoagulation in Internal Medicine: Finding Equilibrium in the Face of Risks and Rewards | 2023-11-05 | OpenAlex | 10.21275/sr231121092535 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389790602 | |||
| W4388398313 | Encouraging but slow progress toward incorporating obesity care into diabetes care | 2023-11-05 | OpenAlex | 10.1002/oby.23925 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388398313 | |||
| W4390678581 | Introduction of Reinforcement Learning and Its Application Across Different Domain | 2023-11-05 | OpenAlex | 10.32628/cseit239066 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390678581 | |||
| W4388460862 | Entering a New Era of Antihypertensive Therapy | 2023-11-06 | OpenAlex | 10.1053/j.ajkd.2023.09.009 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388460862 | |||
| W4388423484 | Extracellular Vesicles: An Emerging Clinical Opportunity in Musculoskeletal Disease | 2023-11-06 | OpenAlex | 10.1089/ten.teb.2023.0208 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388423484 | |||
| W4388570815 | PRIMED for the Future: Purposing Raw Intake for Machine Learning-Enabled Detection (Final Report) | 2023-11-06 | OpenAlex | 10.2172/2204943 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4388570815 | |||
| W4388480894 | A review of chemical signaling pathways in the quorum sensing circuit of Pseudomonas aeruginosa | 2023-11-07 | OpenAlex | 10.1016/j.ijbiomac.2023.127861 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388480894 | |||
| W4388450345 | Harnessing liquid biopsies: Exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine | 2023-11-07 | OpenAlex | 10.1016/j.jlb.2023.100126 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388450345 | |||
| W4388462532 | Recent Modalities in Pain Control and Local Anesthesia in Dentistry: A Narrative Review | 2023-11-07 | OpenAlex | 10.7759/cureus.48428 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388462532 | |||
| W4388522807 | Editorial: New diagnostic perspectives in urogenital radiology | 2023-11-08 | OpenAlex | 10.3389/fmed.2023.1280300 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4388522807 | |||
| W4388532472 | Targeting FMN, TPP, SAM-I, and glmS Riboswitches with Chimeric Antisense Oligonucleotides for Completely Rational Antibacterial Drug Development | 2023-11-08 | OpenAlex | 10.3390/antibiotics12111607 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388532472 | |||
| W4388493484 | Treatment rates and factors associated with direct‐acting antiviral therapy for insured patients with hepatitis C‐related hepatocellular carcinoma – A real‐world nationwide study | 2023-11-08 | OpenAlex | 10.1111/apt.17794 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388493484 | |||
| W4394765159 | Cancer stem cells in head and neck squamous cell carcinoma and its associated markers: A review | 2023-11-09 | OpenAlex | 10.4103/ijpm.ijpm_467_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394765159 | |||
| W4388525218 | The West Becoming “Westless” and the Polish Experience of Totalitarianism and Modernity | 2023-11-09 | OpenAlex | 10.5406/23300841.68.4.06 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388525218 | |||
| W4388913762 | Acinetobacter baumannii: Epidemiology, Clinical Manifestations and Associated Infections | 2023-11-10 | OpenAlex | 10.5772/intechopen.1003618 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388913762 | |||
| W4388574400 | Genetic Diversity Resulting in the Development of AMR | 2023-11-10 | OpenAlex | 10.1201/9781003281238-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388574400 | |||
| W4388566341 | Nanotechnology Potent Photothermal and Photodynamic Immunotherapies of Cancer | 2023-11-10 | OpenAlex | 10.1007/s40846-023-00836-6 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4388566341 | |||
| W4403197628 | Tapping the Potential of Probiotics: An Insight on Probiotic Delivery Systems, Their Quantification, and Assessment | 2023-11-10 | OpenAlex | 10.15415/jprtm.2023.112007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403197628 | |||
| W4388634579 | Celebrating Versatility: Febuxostat’s Multifaceted Therapeutic Application | 2023-11-11 | OpenAlex | 10.3390/life13112199 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388634579 | |||
| W4388593151 | Emergence of Rapid-Onset Ototoxicity Following Three Doses of Vancomycin: A Unique Case Report in the Context of Normal Renal Function and Therapeutic Dosing | 2023-11-11 | OpenAlex | 10.7759/cureus.48647 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388593151 | |||
| W4388588221 | Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy | 2023-11-11 | OpenAlex | 10.1016/j.neo.2023.100949 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4388588221 | |||
| W4388637998 | New Insights in Hydrogels for Periodontal Regeneration | 2023-11-11 | OpenAlex | 10.3390/jfb14110545 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388637998 | |||
| W4388623815 | A Comprehensive Review of Postoperative Analgesics Used in Orthopedic Practice | 2023-11-13 | OpenAlex | 10.7759/cureus.48750 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388623815 | |||
| W4388660822 | Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice | 2023-11-13 | OpenAlex | 10.3390/cancers15225397 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388660822 | |||
| W4388670636 | Communities of practice: A theoretical framework for undergraduate longitudinal placements | 2023-11-13 | OpenAlex | 10.1111/tct.13692 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388670636 | |||
| W4388625962 | Rewind & Play | 2023-11-13 | OpenAlex | 10.5406/25784773.6.2.07 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388625962 | |||
| W4388671932 | Placemaking -the importance of kinship for migrants’ habitus and territorial integration | 2023-11-14 | OpenAlex | 10.33182/md.v2i3.3032 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4388671932 | |||
| W4389936002 | Triste tigre | 2023-11-14 | OpenAlex | 10.3917/gest.060.0140 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389936002 | |||
| W4388681952 | Contrast echocardiography: a practical guideline from the British Society of Echocardiography | 2023-11-15 | OpenAlex | 10.1186/s44156-023-00034-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388681952 | |||
| W4388735057 | Cellular and population strategies underpinning neurotoxin production and sporulation in Clostridium botulinum type E cultures | 2023-11-16 | OpenAlex | 10.1128/mbio.01866-23 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4388735057 | |||
| W4388761621 | Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review | 2023-11-17 | OpenAlex | 10.3390/jcm12227144 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388761621 | |||
| W4388783834 | Endoscopic treatment of gastric variceal bleeding: Where have we come from, and where are we going? | 2023-11-18 | OpenAlex | 10.1016/j.gie.2023.08.011 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388783834 | |||
| W4388831066 | A Case of Tinea Corporis Caused by Trichophyton benhamiae var. luteum from a Degu and Evolution of the Pathogen’s Taxonomy | 2023-11-19 | OpenAlex | 10.3390/jof9111122 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388831066 | |||
| W4388826332 | Changing Roles of Medical Teachers in the Era of Competency-based Medical Education | 2023-11-20 | OpenAlex | 10.4103/ajim.ajim_100_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388826332 | |||
| W7217441202 | Gastric Floating Beads: Revolution in Novel Drug Delivery | 2023-11-20 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217441202 | ||||
| W4388827846 | Pediatric acute myeloid leukemia – novel approaches | 2023-11-20 | OpenAlex | 10.1097/moh.0000000000000795 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388827846 | |||
| W7165916749 | Analysis of the Guide to Excellence in the Conduct of Clinical Trials in Hospital Pharmacy | 2023-11-21 | OpenAlex | 10.32629/ameir.v1i4.1641 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165916749 | |||
| W4388871729 | Detail analysis of puncture site complications in neuro-endovascular therapy: A single-center analysis | 2023-11-21 | OpenAlex | 10.1016/j.inat.2023.101912 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4388871729 | |||
| W4388861667 | Medical Tourism and Communication | 2023-11-21 | OpenAlex | 10.1093/acrefore/9780190228613.013.1461 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388861667 | |||
| W4388940326 | Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay | 2023-11-21 | OpenAlex | 10.3389/fped.2023.1251914 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388940326 | |||
| W4388867268 | Recent Advances in the Management of Anal Cancer | 2023-11-21 | OpenAlex | 10.3390/healthcare11233010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388867268 | |||
| W4388901137 | Examining the Safety Profile of Janus Kinase (JAK) Inhibitors in the Management of Immune-Mediated Diseases: A Comprehensive Review | 2023-11-22 | OpenAlex | 10.3390/life13122244 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388901137 | |||
| W4388921327 | The fibrinolysis renaissance | 2023-11-22 | OpenAlex | 10.1016/j.jtha.2023.09.012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388921327 | |||
| W4388934042 | Central Nervous System Lymphoma | 2023-11-23 | OpenAlex | 10.1055/s-0043-1776783 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388934042 | |||
| W4388979277 | Long non-coding RNA and Evolving drug resistance in lung cancer | 2023-11-24 | OpenAlex | 10.1016/j.heliyon.2023.e22591 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4388979277 | |||
| W4388978319 | Primate origins of human event cognition | 2023-11-24 | OpenAlex | 10.1101/2023.11.23.568086 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4388978319 | |||
| W4389099760 | Acute Myeloid Leukemia: Selecting Induction Therapy Based on Biological Disease Factors | 2023-11-25 | OpenAlex | 10.6004/jnccn.2023.5035 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389099760 | |||
| W4389031013 | 1288. Rapidly evolving Lyme epidemiology in central Ohio creates challenges in prompt diagnosis and management of Lyme arthritis | 2023-11-27 | OpenAlex | 10.1093/ofid/ofad500.1127 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389031013 | |||
| W4389029073 | 1948. Rise of Candida auris Infections Worldwide and Trends on the Activity of Fosmanogepix and Comparator Agents against C. auris Causing Invasive Infections | 2023-11-27 | OpenAlex | 10.1093/ofid/ofad500.102 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389029073 | |||
| W4389029556 | 2186. Treatment-emergent resistance to ceftazidime-avibactam (CZA) is more common than ceftolozane-tazobactam (CT) among patients infected with multidrug-resistant (MDR) Pseudomonas aeruginosa | 2023-11-27 | OpenAlex | 10.1093/ofid/ofad500.1808 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389029556 | |||
| W4389030762 | 2585. Identification of Risk Factors for Pseudomonas aeruginosa in Patients with Community-Acquired Pneumonia | 2023-11-27 | OpenAlex | 10.1093/ofid/ofad500.2200 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389030762 | |||
| W4389030977 | 2694. Infectious Complications in CAR-T Cell Therapy Recipients: A Systematic Review and Meta-Analysis | 2023-11-27 | OpenAlex | 10.1093/ofid/ofad500.2305 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389030977 | |||
| W4389030725 | 2742. The Prevalence and Clinical Impact of Antibiotic Allergy Labels in Solid Organ Transplant Recipients | 2023-11-27 | OpenAlex | 10.1093/ofid/ofad500.2353 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389030725 | |||
| W4389151444 | AI enhances drug discovery and development | 2023-11-27 | OpenAlex | 10.1093/nsr/nwad303 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389151444 | |||
| W4389097051 | Critically Ill Patients With Cardiac Dysfunction and the Rashomon Effect | 2023-11-27 | OpenAlex | 10.1016/j.chstcc.2023.100031 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389097051 | |||
| W4389084751 | Acquired Triazole Resistance Alters Pathogenicity-Associated Features in Candida auris in an Isolate-Dependent Manner | 2023-11-28 | OpenAlex | 10.3390/jof9121148 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389084751 | |||
| W4389110498 | Use and Engagement With Low-Intensity Cognitive Behavioral Therapy Techniques Used Within an App to Support Worry Management: Content Analysis of Log Data | 2023-11-28 | OpenAlex | 10.2196/47321 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389110498 | |||
| W4389206074 | Advancing Oro-Dental and Cranio-Maxillo-Facial Interventions for QoL: Injectable Hydrogel and BioCeramic NanoDelivery Platforms | 2023-11-29 | OpenAlex | 10.58624/svoade.2023.04.0159 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389206074 | |||
| W4389147438 | Biologics: Teriparatide and Newer Anabolics | 2023-11-29 | OpenAlex | 10.1007/s43465-023-01063-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389147438 | |||
| W4389144699 | C7‐Halomethylene/methyl‐C3‐thiophenyl‐spirocyclic‐β‐lactams: Synthesis, X‐ray Analysis, Antimicrobial Evaluation, Cytotoxicity Profile and Molecular Docking Interactions | 2023-11-29 | OpenAlex | 10.1002/cmdc.202300505 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389144699 | |||
| W4389122316 | Chatbots Overcome the Limit of Nursing Education (Preprint) | 2023-11-29 | OpenAlex | 10.2196/preprints.54987 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389122316 | |||
| W4389149426 | Frame Shift: Focusing on Harm Reduction and Shared Decision Making for People Who Use Drugs Hospitalized With Infections | 2023-11-29 | OpenAlex | 10.1093/cid/ciad664 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389149426 | |||
| W4389204818 | Crisis averted: a world united against the menace of multiple drug-resistant superbugs -pioneering anti-AMR vaccines, RNA interference, nanomedicine, CRISPR-based antimicrobials, bacteriophage therapies, and clinical artificial intelligence strategies to safeguard global antimicrobial arsenal | 2023-11-30 | OpenAlex | 10.3389/fmicb.2023.1270018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389204818 | |||
| W4389165584 | Preoperative Patient Evaluation: Obtaining the Information We Need to Inform the Care We Provide | 2023-11-30 | OpenAlex | 10.1016/j.anclin.2023.11.002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389165584 | |||
| W7217019992 | Prosopis Cineraria as Hepatoprotective: A Review | 2023-11-30 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217019992 | ||||
| W4389488067 | 70P LIST (Lung Initiative on Sequence Therapy): A real-world study of nivolumab for advanced NSCLC in France - First effectiveness, safety, and IO-rechallenge results | 2023-12-01 | OpenAlex | 10.1016/j.iotech.2023.100542 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389488067 | |||
| W4406643166 | A Comprehensive Overview of Restrictive Lung Disease: Diagnosis, Management, and Implications in Pulmonary Medicine | 2023-12-01 | OpenAlex | 10.25163/angiotherapy.72110109 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406643166 | |||
| W4390757947 | A Reflection of Fifty Years | 2023-12-01 | OpenAlex | 10.1525/aft.2023.50.4.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390757947 | |||
| W4399705622 | ANTIMICROBIAL RESISTANCE AND UPCOMING DNA VACCINE - A NEW CONCERN | 2023-12-01 | OpenAlex | 10.58532/v3bkbt24p1ch11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399705622 | |||
| W4390642100 | Aberrant Crypt Foci - Endpoint in Colorectal Cancer | 2023-12-01 | OpenAlex | 10.2478/inmed-2023-0266 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390642100 | |||
| W4389567682 | Advances in understanding and management of high-grade pancreatic neuroendocrine neoplasm: a comprehensive review | 2023-12-01 | OpenAlex | 10.21037/cco-23-79 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389567682 | |||
| W4389608862 | Brain Metastases and Leptomeningeal Disease | 2023-12-01 | OpenAlex | 10.1212/con.0000000000001354 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389608862 | |||
| W4399580815 | CARDIAC BIOENGINEERING | 2023-12-01 | OpenAlex | 10.58532/v3bjbt6p5ch2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399580815 | |||
| W4390952346 | CORTICOSTEROID OVERUSE AND UNINTENDED CONSEQUENCES IN CLINICAL PRACTICE | 2023-12-01 | OpenAlex | 10.24041/ejmr2023.37 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390952346 | |||
| W4390195664 | Cerebral microbleeds in Down syndrome: association with demographic, genetic, fluid and imaging biomarkers of Alzheimer’s disease | 2023-12-01 | OpenAlex | 10.1002/alz.079405 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390195664 | |||
| W4389208984 | Clinical Inquiry | 2023-12-01 | OpenAlex | 10.4037/ccn2023264 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389208984 | |||
| W4399592542 | DEVELOPING INNOVATION: STARTUP AND ENTREPRENEURSHIP DYNAMICS | 2023-12-01 | OpenAlex | 10.58532/v3bkso13p4ch8 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4399592542 | |||
| W4391137145 | Exosome and Other Extracellular Vesicles in Gene Therapy and Personalized Care | 2023-12-01 | OpenAlex | 10.2174/0118756921285480240118051820 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391137145 | |||
| W4389207650 | Fetal Tachyarrhythmia: A Tale of Two Presentations | 2023-12-01 | OpenAlex | 10.1542/neo.24-12-e819 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389207650 | |||
| W4405536489 | Happy Endings? Resisting Women and the Economy of Love in Day Five of Boccaccio's Decameron | 2023-12-01 | OpenAlex | 10.5406/23256672.100.5.12 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405536489 | |||
| W4390201357 | Lithium carbonate treatment decrease neuroinflammation and ameliorates long‐term memory in a Down syndrome animal model | 2023-12-01 | OpenAlex | 10.1002/alz.083124 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4390201357 | |||
| W4393092477 | Midwives’ oaths: everyday life and the law in seventeenth-century England | 2023-12-01 | OpenAlex | 10.1017/s0268416023000309 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393092477 | |||
| W4399614737 | NANOTECHNOLOGY IN ANAESTHESIA: PAST, PRESENT AND THE FUTURE | 2023-12-01 | OpenAlex | 10.58532/v3bfms1p3ch9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399614737 | |||
| W4399818959 | NAVIGATING HEART HEALTH A COMPREHENSIVE EXPLORATION OF NANOROBOT APPLICATIONS IN MANAGING CORONARY BLOCKAGES | 2023-12-01 | OpenAlex | 10.58532/v3bapn5ch15 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399818959 | |||
| W4392255095 | Neoliberalism and Disclosure 's New Trans Activism: The Politics of Discrimination in Hollywood and How to Fight It | 2023-12-01 | OpenAlex | 10.5406/19346018.75.4.02 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392255095 | |||
| W4389878138 | Non-Compressive Acute Myelitis: Epidemiologic, Clinical, Paraclinical and Evolution Aspects: Study of 48 Cases | 2023-12-01 | OpenAlex | 10.1016/j.msard.2023.105205 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389878138 | |||
| W4392842347 | Plague’s Preconditions and Literary Consequences | 2023-12-01 | OpenAlex | 10.1215/0041462x-10986848 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392842347 | |||
| W4389399417 | Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects | 2023-12-01 | OpenAlex | 10.1053/j.seminoncol.2023.11.003 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4389399417 | |||
| W4393326297 | Pulmonary Veno-Occlusive Disease | 2023-12-01 | OpenAlex | 10.21693/1933-088x-22.4.164 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393326297 | |||
| W4390513644 | Quality of Life and Side Effects Management in Cancer Treatment | 2023-12-01 | OpenAlex | 10.3390/books978-3-0365-9529-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390513644 | |||
| W4390124561 | RWD55 Retrospective Observational Study of Real-World Treatment Patterns and Financial Burden in Patients With Premenopausal Metastatic HR+/HER2- Breast Cancer | 2023-12-01 | OpenAlex | 10.1016/j.jval.2023.09.2772 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390124561 | |||
| W4389219365 | SOHO State of the Art Updates and Next Questions: Oral Therapy in Acute Myeloid Leukemia | 2023-12-01 | OpenAlex | 10.1016/j.clml.2023.11.009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389219365 | |||
| W4399590392 | SYNTHESIS OF COPPER OXIDE NANOPARTICLES USING CHEMICAL METHOD AND ITS CHARACTERIZATION AND CYTOTOXICITY STUDIES AND ANTI-MICROBIAL STUDIES | 2023-12-01 | OpenAlex | 10.58532/v3becm2ch6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399590392 | |||
| W4389208052 | Sterols in Inflammatory Diseases: Implications and Clinical Utility | 2023-12-01 | OpenAlex | 10.1007/978-3-031-43883-7_13 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389208052 | |||
| W4389244467 | The Tapestry of Thiamine | 2023-12-01 | OpenAlex | 10.1097/01.eem.0000997352.09967.11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389244467 | |||
| W4399819040 | UNLEASHING THE IMMUNE SYSTEM'S POTENTIAL AGAINST CUTANEOUS MALIGNANCIES: ADVANCES AND INNOVATIONS IN SKIN CANCER IMMUNOTHERAPY | 2023-12-01 | OpenAlex | 10.58532/v3bapn5ch14 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399819040 | |||
| W4389639049 | Unlocking the Intrathecal Route: A Comprehensive Review | 2023-12-01 | OpenAlex | 10.55041/ijsrem27467 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389639049 | |||
| W4389223216 | Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility | 2023-12-01 | OpenAlex | 10.1128/cmr.00100-22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389223216 | |||
| W4393172398 | Women and the Islamic Republic: How Gendered Citizenship Conditions the Iranian State | 2023-12-01 | OpenAlex | 10.5325/bustan.14.2.0184 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393172398 | |||
| W4389264905 | A novel holin from an Enterococcus faecalis phage and application in vitro and in vivo | 2023-12-02 | OpenAlex | 10.1016/j.micpath.2023.106471 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389264905 | |||
| W4389282941 | Diagnosis and Treatment of Immune Heamolytic Aneamia | 2023-12-02 | OpenAlex | 10.59298/nijbas/2023/1.2.11111 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389282941 | |||
| W4389277030 | SiCARIO: A Phase I/II Study of Split-Course Adaptive Radioimmunotherapy for the Treatment of Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Using Adaptive Radiotherapy | 2023-12-02 | OpenAlex | 10.1016/j.ijrobp.2023.10.075 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389277030 | |||
| W4391306714 | Virtual Agents in Internet-Based Cognitive Behavioral Therapy: Enhancing Engagement and Alleviating Depression | 2023-12-04 | OpenAlex | 10.1109/ica58824.2023.00019 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4391306714 | |||
| W4389339791 | Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment With Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors | 2023-12-05 | OpenAlex | 10.33590/emjoncol/10305999 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389339791 | |||
| W4389337675 | Emerging treatment strategies in chronic B-cell malignancies—News from ICML 2023 | 2023-12-05 | OpenAlex | 10.1007/s12254-023-00937-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389337675 | |||
| W4389338998 | Enterococcus species: insights into antimicrobial resistance and whole-genome features of isolates recovered from livestock and raw meat in Ghana | 2023-12-05 | OpenAlex | 10.3389/fmicb.2023.1254896 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389338998 | |||
| W4389330773 | PAs in the cancer care continuum | 2023-12-05 | OpenAlex | 10.1097/01.jaa.0000995668.27398.e2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389330773 | |||
| W4389326876 | Shop Talk | 2023-12-05 | OpenAlex | 10.1097/01.cot.0000997512.19409.7a | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389326876 | |||
| W4389329698 | What's New in Ototoxicity Management? | 2023-12-05 | OpenAlex | 10.1044/2023_persp-23-00153 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389329698 | |||
| W7119566406 | Évaluation rétrospective du développement préclinique effectué sur les anticorps monoclonaux | 2023-12-05 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7119566406 | ||||
| W4389741575 | erbal Alternatives for Managing Depression: Mechanisms and Efficacy | 2023-12-06 | OpenAlex | 10.46610/jqaqc.2023.v05i02.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389741575 | |||
| W7220449342 | A Review of Next-Generation Drug Delivery Systems And Technologies | 2023-12-07 | OpenAlex | 10.61096/ijrpp.v12.iss4.2023.289-300 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220449342 | |||
| W4389450548 | Changing Infection Dynamics with the Pandemic: Distribution of Viral Agents of Respiratory Tract Infections in the Last 5 Years | 2023-12-07 | OpenAlex | 10.4274/mjima.galenos.2023.23046 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389450548 | |||
| W4389453740 | Effect of CYP2C19 Pharmacogenetic Testing on Predicting Citalopram and Escitalopram Tolerability and Efficacy: A Retrospective, Longitudinal Cohort Study | 2023-12-07 | OpenAlex | 10.3390/biomedicines11123245 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389453740 | |||
| W4389426651 | Establishing mRNA and microRNA interactions driving disease heterogeneity in amyotrophic lateral sclerosis patient survival | 2023-12-07 | OpenAlex | 10.1093/braincomms/fcad331 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389426651 | |||
| W4389435329 | Genetic features of antimicrobial drug-susceptible extraintestinal pathogenic Escherichia coli pandemic sequence type 95 | 2023-12-07 | OpenAlex | 10.1128/spectrum.04189-22 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389435329 | |||
| W4389438134 | Targeted therapies for lupus nephritis: Current perspectives and future directions | 2023-12-07 | OpenAlex | 10.1097/cm9.0000000000002959 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389438134 | |||
| W4389477851 | Bispecific antibody therapies | 2023-12-08 | OpenAlex | 10.1182/hematology.2023000508 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389477851 | |||
| W4389489504 | Dual-targeted regimens for the frontline treatment of CLL | 2023-12-08 | OpenAlex | 10.1182/hematology.2023000506 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389489504 | |||
| W7218263482 | IMPORTÂNCIA DO EIXO CÉREBRO-INTESTINOMICROBIOTA NA MODULAÇÃO DO SISTEMA NERVOSO CENTRAL E SUA RELAÇÃO COM A DOENÇA DE ALZHEIMER: UMA REVISÃO INTEGRATIVA DA LITERATURA | 2023-12-08 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7218263482 | ||||
| W4389478671 | MRD-directed therapy in CLL: ready for prime time? | 2023-12-08 | OpenAlex | 10.1182/hematology.2023000441 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389478671 | |||
| W4389478205 | Next-generation therapy for lower-risk MDS | 2023-12-08 | OpenAlex | 10.1182/hematology.2023000520 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389478205 | |||
| W4389497377 | Nutritional Modulation of Periodontal Diseases: A Narrative Review of Recent Evidence | 2023-12-08 | OpenAlex | 10.7759/cureus.50200 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389497377 | |||
| W4389508801 | Pathogenesis and management of immune dysfunction secondary to B cell haematological malignancies | 2023-12-08 | OpenAlex | 10.1111/imj.16279 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389508801 | |||
| W4389506478 | Decision support for personalized therapy in implantable medical devices: A digital twin approach | 2023-12-09 | OpenAlex | 10.1016/j.eswa.2023.122883 | Full text | Excluded | F3: The described digital twin uses physiological calibration and a conventional reinforcement-learning therapy optimizer, with no LLM acting agent. | https://openalex.org/W4389506478 | https://www.sciencedirect.com/science/article/pii/S0957417423033857 | publisher abstract and introduction preview, author institutional abstract; not full methods | |
| W4389521406 | Articles from 2022 to 2023 to Inform Your Cancer Practice: Melanoma | 2023-12-10 | OpenAlex | 10.1245/s10434-023-14702-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389521406 | |||
| W4389558828 | High-level nitrofurantoin resistance in a clinical isolate of Klebsiella pneumoniae: a comparative genomics and metabolomics analysis | 2023-12-11 | OpenAlex | 10.1128/msystems.00972-23 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389558828 | |||
| W4390513217 | Intimate Partner Violence: Risk and Vulnerability Factors, Health Promotion and Prevention in Educational and Healthcare Contexts | 2023-12-11 | OpenAlex | 10.3390/books978-3-0365-9523-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390513217 | |||
| W4389620759 | Emerging therapies in the medical management of thyroid eye disease | 2023-12-12 | OpenAlex | 10.3389/fopht.2023.1295902 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389620759 | |||
| W4389612742 | Preventing ischaemic stroke in patients with isolated sinus node disease: the value of evaluating atrial cardiomyopathy | 2023-12-12 | OpenAlex | 10.1093/eurjpc/zwad386 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389612742 | |||
| W4389623600 | Single and Multitarget Systems for Drug Delivery and Detection: Up-to-Date Strategies for Brain Disorders | 2023-12-12 | OpenAlex | 10.3390/ph16121721 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389623600 | |||
| W4389683504 | miR ‐101‐5p modulation of CD47 in diffuse large B‐cell lymphoma: Implications for anti‐CD47 immunotherapy and prognostication | 2023-12-12 | OpenAlex | 10.1111/bjh.19264 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389683504 | |||
| W4389792037 | Letermovir Prophylaxis After Kidney Transplantation: Another Tool but Not a Revolution Yet | 2023-12-13 | OpenAlex | 10.1097/tp.0000000000004809 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389792037 | |||
| W4389670006 | The Role of t(11;14) in Tailoring Treatment Decisions in Multiple Myeloma | 2023-12-13 | OpenAlex | 10.3390/cancers15245829 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389670006 | |||
| W4389728235 | 764: NITROPRUSSIDE-INDUCED CYANIDE TOXICITY IN AN INFANT WITH COMPLEX CONGENITAL CARDIAC DISEASE | 2023-12-14 | OpenAlex | 10.1097/01.ccm.0001001224.86617.0a | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389728235 | |||
| W4389742335 | Alcohol Use Disorder and the Gut Microbiome | 2023-12-14 | OpenAlex | 10.1007/s40429-023-00527-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389742335 | |||
| W7220274058 | Autonomous Robotic Systems using Reinforcement Learning for Next-Gen Computing Applications | 2023-12-14 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220274058 | ||||
| W4390348940 | Clinical reflections – combined therapy of arterial hypertension with beta-blockers and dihydropyridine calcium antagonists | 2023-12-14 | OpenAlex | 10.37987/1997-9894.2023.9-10(275-276).294605 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390348940 | |||
| W4389765232 | Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy | 2023-12-14 | OpenAlex | 10.1159/000535647 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389765232 | |||
| W4389815445 | Medicine in Chinese History | 2023-12-14 | OpenAlex | 10.4324/9780367565152-rechs78-1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389815445 | |||
| W4389734782 | Metal–Organic Framework-Based Nano-Activators Facilitating Microwave Combined Therapy via a Divide-and-Conquer Tactic for Triple-Negative Breast Cancer | 2023-12-14 | OpenAlex | 10.1021/acsnano.3c09734 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389734782 | |||
| W4389732650 | The epidemiology of pediatric outpatient acute respiratory tract infections in the US: a multi-facility analysis of multiplex PCR testing from 2018 to 2023 | 2023-12-14 | OpenAlex | 10.1128/spectrum.03423-23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389732650 | |||
| W4389792586 | A careful approach to artificial intelligence: the struggles with epistemic responsibility of healthcare professionals | 2023-12-15 | OpenAlex | 10.1080/1369118x.2023.2289971 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389792586 | |||
| W4389785479 | Evaluation of Neuroprotective Activity of Sida Cordifolia Against β-AMYLOID Protein Induced Loss of Cognitive Functions in Swiss Albino Mice | 2023-12-15 | OpenAlex | 10.1039/9781837671090-00673 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389785479 | |||
| W4389802790 | Exploring the potential of Salmonella-mediated anti-sense RCAS1 RNA therapy in combatting aggressive breast cancer | 2023-12-15 | OpenAlex | 10.1016/j.omtn.2023.102089 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4389802790 | |||
| W4389832293 | Estrogen receptor positive breast cancer: contemporary nuances to sequencing therapy | 2023-12-16 | OpenAlex | 10.1007/s12032-023-02255-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389832293 | |||
| W4390111998 | Intelligent Conversational Agents for Personalized Health Diagnosis and Treatment: A Synergistic Approach of AI, ML, and Data Science and Robotics | 2023-12-16 | OpenAlex | 10.51219/urforum.2023.david-nkanta | Full text | Excluded | F1: The available publication is a one-page webinar overview and biography. It gives general NLP/ML, robotics and external-literature refresh aims without an operational primary system method or evaluation. | https://openalex.org/W4390111998 | https://doi.org/10.51219/URForum.2023.David-Nkanta | ||
| W4389847637 | Harmonizing the craft of crafting clinically endorsed small-molecule BCR-ABL tyrosine kinase inhibitors for the treatment of hematological malignancies | 2023-12-17 | OpenAlex | 10.1016/j.ejps.2023.106678 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389847637 | |||
| W4389895493 | Changing trends in phase 1 oncology clinical trials | 2023-12-18 | OpenAlex | 10.1016/j.conctc.2023.101239 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389895493 | |||
| W4389941551 | Phase to phase: Navigating drug combinations with hypomethylating agents in higher-risk MDS trials for optimal outcomes | 2023-12-18 | OpenAlex | 10.1016/j.ctrv.2023.102673 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389941551 | |||
| W4389944366 | What’s New in Pediatric Orthopaedics | 2023-12-19 | OpenAlex | 10.2106/jbjs.23.01141 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4389944366 | |||
| W4390053345 | Definition, epidemiology and characterization of sepsis | 2023-12-20 | OpenAlex | 10.18203/2394-6040.ijcmph20233852 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390053345 | |||
| W4390036136 | Goat-derived cell line (Capra hircus) TCh generated by karyological and morphological transformation of YаDK-04 CCL during subcultivation with lanthanide-treated bovine serum | 2023-12-20 | OpenAlex | 10.29326/2304-196x-2023-12-4-345-353 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4390036136 | |||
| W4389992087 | Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy | 2023-12-20 | OpenAlex | 10.1111/ene.16180 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4389992087 | |||
| W4390467480 | Tailoring treatment: a comprehensive review of precision medicine and biological therapies in inflammatory bowel disease | 2023-12-20 | OpenAlex | 10.51582/interconf.19-20.12.2023.043 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390467480 | |||
| W4389965975 | Unmet needs in β-thalassemia and the evolving treatment landscape | 2023-12-20 | OpenAlex | 10.1016/j.tracli.2023.12.003 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4389965975 | |||
| W4390070079 | Book of the Year Awards 2023 | 2023-12-21 | OpenAlex | 10.1097/01.naj.0001004968.26767.b1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390070079 | |||
| W4390110120 | Cryptococcosis in kidney transplant recipients: Current understanding and practices | 2023-12-22 | OpenAlex | 10.5527/wjn.v12.i5.120 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390110120 | |||
| W4390126153 | Editorial for “Early Identification of Pathologic Complete Response to Neoadjuvant Chemotherapy Using Multiphase DCE‐MRI by Siamese Network in Breast Cancer: A Longitudinal Multicenter Study” | 2023-12-22 | OpenAlex | 10.1002/jmri.29190 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390126153 | |||
| W4390114517 | Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma | 2023-12-22 | OpenAlex | 10.3390/cells13010034 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390114517 | |||
| W4404184536 | New perspectives in liver diseases with challenges | 2023-12-22 | OpenAlex | 10.1093/gastro/goae098 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404184536 | |||
| W4390112258 | Ocular graft versus host disease | 2023-12-22 | OpenAlex | 10.4103/ijo.ijo_2884_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390112258 | |||
| W4390142402 | Agency development of high school students in the process of professional self-determination | 2023-12-23 | OpenAlex | 10.17673/vsgtu-pps.2023.4.9 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4390142402 | |||
| W4390174532 | Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox | 2023-12-23 | OpenAlex | 10.3390/curroncol31010007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390174532 | |||
| W7171952726 | THE FUTURE OF PRECISION ONCOLOGY: CONVERGING FOUNDATION MODELS, AGENTIC AI, DIGITAL TWINS, AND MULTIMODAL CLINICAL INTELLIGENCE | 2023-12-23 | OpenAlex | 10.65713/ijaraiv13i1210 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7171952726 | |||
| W4390234108 | Australia and New Zealand consensus position statement: use of COVID‐19 therapeutics in patients with haematological malignancies | 2023-12-25 | OpenAlex | 10.1111/imj.16303 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390234108 | |||
| W7172030908 | DIGITAL TWIN INTELLIGENCE IN ONCOLOGY: AI-POWERED VIRTUAL PATIENTS FOR PERSONALIZED TREATMENT OPTIMIZATION | 2023-12-25 | OpenAlex | 10.65713/ijaraiv13i1214 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172030908 | |||
| W4390516672 | Molecularly Targeted Therapy for Urothelial Cancers | 2023-12-25 | OpenAlex | 10.18103/mra.v11i12.4788 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390516672 | |||
| W4390236400 | Real‐world treatment patterns in patients initiating third‐line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain | 2023-12-25 | OpenAlex | 10.1111/ejh.14161 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390236400 | |||
| W7217584192 | Review on Antibacterial efficacy of Tribal Acquaintance Medicinal Plants of Jaipur, (Rajasthan) Against Multidrug-Resistant Bacterial Uropathogens | 2023-12-25 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217584192 | ||||
| W4390242390 | What’s next: using infectious disease mathematical modelling to address health disparities | 2023-12-25 | OpenAlex | 10.1093/ije/dyad180 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390242390 | |||
| W4390535835 | A review of the contemporary use of inotropes in patients with heart failure | 2023-12-26 | OpenAlex | 10.1097/hco.0000000000001115 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390535835 | |||
| W4390233709 | Current evidence and therapeutic implication of PANoptosis in cancer | 2023-12-26 | OpenAlex | 10.7150/thno.91814 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390233709 | |||
| W4390501140 | Immunotherapy for transplantation of hepatocellular carcinoma: the next frontier in adjunctive therapy | 2023-12-26 | OpenAlex | 10.1097/mot.0000000000001133 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390501140 | |||
| W7171928766 | PREDICTIVE ONCOLOGY THROUGH FOUNDATION AI: INTEGRATING LONGITUDINAL CLINICAL DATA, MULTI-OMICS, AND DIGITAL TWINS | 2023-12-26 | OpenAlex | 10.65713/ijaraiv13i1219 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171928766 | |||
| W4394819846 | Team Physician Consensus Statement: Return to Sport/Return to Play and the Team Physician: A Team Physician Consensus Statement—2023 Update | 2023-12-26 | OpenAlex | 10.1249/mss.0000000000003371 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394819846; https://openalex.org/W4396674129 | |||
| W4390228828 | Updates in the treatment of asthma in pediatrics: A review for pharmacists | 2023-12-26 | OpenAlex | 10.1093/ajhp/zxad326 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390228828 | |||
| W4393076717 | Carbon nanomaterials for biomedical applications: A comprehensive review | 2023-12-27 | OpenAlex | 10.59400/n-c.v1i1.448 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393076717 | |||
| W4406193701 | Gen AI-Powered Clinical Guidelines: Automating the Future of Evidence-Based Care | 2023-12-27 | OpenAlex | 10.21275/sr23129145353 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406193701 | |||
| W4390270623 | Psychedelic Therapy: A Primer for Primary Care Clinicians – Part VII. Ketamine | 2023-12-27 | OpenAlex | 10.31234/osf.io/dtb6a | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390270623 | |||
| W4391345061 | The Real Crisis in Antimicrobial Resistance: Failure to Anticipate and Respond | 2023-12-27 | OpenAlex | 10.1093/cid/ciad758 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391345061 | |||
| W4390384800 | Exploiting nuclear-mitochondrial cross-talk in theranostics: Enhancing drug delivery and diagnostic precision | 2023-12-28 | OpenAlex | 10.1016/j.mito.2023.101839 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390384800 | |||
| W4390363230 | International Commentary of the Worldwide Survey of Fitness Trends | 2023-12-28 | OpenAlex | 10.1249/fit.0000000000000932 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390363230 | |||
| W4390339337 | Selected Abstracts | 2023-12-28 | OpenAlex | 10.1097/dcr.0000000000003218 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390339337 | |||
| W4390594928 | An Overview of Recent Advances in Anterior Cervical Decompression and Fusion Surgery | 2023-12-29 | OpenAlex | 10.52198/23.sti.43.ns1732 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390594928 | |||
| W4390410426 | Clinical frontiers of metabolic bone disorders: a comprehensive review | 2023-12-29 | OpenAlex | 10.20517/mtod.2023.38 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390410426 | |||
| W4390403329 | Microbes and Mental Illness: Past, Present, and Future | 2023-12-29 | OpenAlex | 10.3390/healthcare12010083 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390403329 | |||
| W4391277339 | The Present and Future Trend of Monoclonal Antibody | 2023-12-29 | OpenAlex | 10.54097/cy800q90 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391277339 | |||
| W4390411703 | Use of pembrolizumab among older adults with cancer in the United States, before and after FDA approval of its tumor‐agnostic indication | 2023-12-29 | OpenAlex | 10.1002/pds.5745 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390411703 | |||
| W4390728575 | A cross-sectional study of clinical a nd microbiological profile of urinary tract infections in children from tertiary care centre in Maharashtra | 2023-12-30 | OpenAlex | 10.47799/pimr.1103.07 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390728575 | |||
| W4390444495 | The Evaluation of Primary Brain Tumors: The Role of CT and MRI | 2023-12-30 | OpenAlex | 10.55041/ijsrem26929 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390444495 | |||
| W4390847723 | Cues from evolving insights about Cancer stem cells to tackle cancer metastases. | 2023-12-31 | OpenAlex | 10.46582/jsrm.1902006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390847723 | |||
| W7154855336 | INNOVATIONS IN DIABETES MANAGEMENT: A GLOBAL PERSPECTIVE | 2023-12-31 | OpenAlex | 10.71465/bhsr38 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154855336 | |||
| W4413225124 | IRDAI AND THE GROWTH OF HEALTH INSURANCE IN INDIA | 2023-12-31 | OpenAlex | 10.29121/shodhkosh.v4.i2.2023.6109 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4413225124 | |||
| W4390460465 | Subdural Empyema in Pediatric Bacterial Meningitis: A Case Report | 2023-12-31 | OpenAlex | 10.7759/cureus.51401 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390460465 | |||
| W4392091398 | The Role of Higher Education Institutes in Achieving the Gole of Developing | 2023-12-31 | OpenAlex | 10.31995/jgv.2023.v14is3.028 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392091398 | |||
| W4404967419 | ДОСЛІДЖЕННЯ ПЕРСПЕКТИВ МОДЕЛІ СТАКЕЛЬБЕРГА ТЕОРІЇ ІГОР У ХОЛІСТИЧНІЙ МЕДИЦИНІ | 2023-12-31 | OpenAlex | 10.31891/2307-5732-2023-329-6-61-63 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404967419 | |||
| W4401708435 | A BERT-Based Chatbot to Support Cancer Treatment Follow-Up | 2024-01-01 | OpenAlex | 10.1007/978-3-031-68639-9_4 | Full text | Excluded | F3: The implemented chatbot is a BERT span extractor fine-tuned once on fixed SQuAD examples. It predicts answer start/end positions in supplied context, without an LLM acting-agent mechanism; patient data are explicitly not stored. | https://openalex.org/W4401708435 | https://link.springer.com/chapter/10.1007/978-3-031-68639-9_4 | Publisher full HTML through existing Tohoku University entitlement; specified methods/evaluation sections read. | |
| W4401748407 | A Multi-Agent System Approach for Balance Disorder Treatment: Integrating Computer Vision and Gamification | 2024-01-01 | OpenAlex | 10.1109/access.2024.3448216 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4401748407 | |||
| W4405925137 | A Three-Layered AI-Oriented Approach for Intelligent Generation of Standardized Privacy Policies in Smart Healthcare Environments | 2024-01-01 | OpenAlex | 10.1007/978-3-031-78698-3_2 | Full text | Excluded | F5: Public publisher and author/repository routes did not provide full methods. The root agent also checked the publisher with the existing Tohoku University browser entitlement; only a subscription preview was available. LLM status, clinical-main focus and/or cross-case retention remain unresolved, rather than inferred absent from the abstract. | https://openalex.org/W4405925137 | https://link.springer.com/chapter/10.1007/978-3-031-78698-3_2 | Bibliographic information and available abstract/preview only; no full methods read. | |
| W4404703815 | A comprehensive review of amblyopia treatment | 2024-01-01 | OpenAlex | 10.22271/allresearch.2024.v10.i11d.12163 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404703815 | |||
| W4399205535 | A review of drug-induced liver injury with rash, eosinophilia, and systemic symptoms (DRESS) syndrome: Cutaneous manifestations, clinical features, and management | 2024-01-01 | OpenAlex | 10.1097/cld.0000000000000198 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399205535 | |||
| W4400281535 | A state-of-the-art update on hepatotoxicity: Introduction to the special series on drug-induced liver injury | 2024-01-01 | OpenAlex | 10.1097/cld.0000000000000212 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400281535 | |||
| W4403418671 | AI in an Uncertain World: Response to Krueger's Review of How to Stay Smart in a Smart World | 2024-01-01 | OpenAlex | 10.5406/19398298.137.1.06 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403418671 | |||
| W4396628746 | AI, women’s health care, and trust: Problems and prospects | 2024-01-01 | OpenAlex | 10.1016/b978-0-443-21889-7.00002-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396628746 | |||
| W4400873883 | ASCO 2024: Personal Insights and a Look into the Future from an International Expert Group | 2024-01-01 | OpenAlex | 10.1159/000539869 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400873883 | |||
| W4405374694 | Abstracts for oral presentations | 2024-01-01 | OpenAlex | 10.4103/njpt.njpt_65_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405374694 | |||
| W4404242415 | Advancements in HIV/AIDS Cure Research: Effects on Patient Adherence and Behavioral Trends in the General Population a Scoping Review | 2024-01-01 | OpenAlex | 10.51244/ijrsi.2024.1110029 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404242415 | |||
| W7118214797 | Advances in cardiovascular and thoracic anaesthesia: Perioperative management of complex cases | 2024-01-01 | OpenAlex | 10.33545/26643766.2024.v7.i1a.616 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118214797 | |||
| W4401007150 | Advancing evolutionary medicine in Northern Germany | 2024-01-01 | OpenAlex | 10.1093/emph/eoae013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401007150 | |||
| W4399547227 | Aldo-keto reductases: Role in cancer development and theranostics | 2024-01-01 | OpenAlex | 10.32604/or.2024.049918 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399547227 | |||
| W4390637892 | An Overview of Future Development Methods of Infectious Bronchitis Vaccines | 2024-01-01 | OpenAlex | 10.32598/ijvm.18.1.1005406 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390637892 | |||
| W4402006941 | An Update on Human Fungal Diseases: A Holistic Overview | 2024-01-01 | OpenAlex | 10.1007/978-981-97-5165-5_1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402006941 | |||
| W4400111980 | An abbreviated history of liver transplantation | 2024-01-01 | OpenAlex | 10.1097/cld.0000000000000244 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400111980 | |||
| W4394826410 | Anemia and Erythropoietin in HIV: A Multifaceted Review | 2024-01-01 | OpenAlex | 10.23880/hij-16000244 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394826410 | |||
| W4399854189 | Anesthesia and Cancer Recurrence | 2024-01-01 | OpenAlex | 10.1007/978-981-99-6339-3_36 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399854189 | |||
| W4391386515 | Anhang I – Einladungs-E-Mail | 2024-01-01 | OpenAlex | 10.5771/9783748941842-289 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391386515 | |||
| W4391386557 | Anhang II – Fragebogen | 2024-01-01 | OpenAlex | 10.5771/9783748941842-291 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391386557 | |||
| W4393323178 | Antibiotic Adjuvants and Their Synergistic Activity Against ESKAPE Pathogens | 2024-01-01 | OpenAlex | 10.1007/978-981-99-8799-3_13 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393323178 | |||
| W4401816967 | Antimicrobial Peptides and Their Applications | 2024-01-01 | OpenAlex | 10.1007/978-981-97-3413-9_9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401816967 | |||
| W4392744125 | Antimicrobial agent usage patterns and their role in preventing surgical site infections at a tertiary care teaching hospital: A comprehensive study | 2024-01-01 | OpenAlex | 10.5455/njppp.2024.14.020950202406032024 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392744125 | |||
| W4400046397 | Antimicrobial resistance: A looming threat to public health and global well-being | 2024-01-01 | OpenAlex | 10.4103/ijcfm.ijcfm_1_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400046397 | |||
| W4403682185 | Approach and Troubleshooting to Lower Limb Blocks | 2024-01-01 | OpenAlex | 10.1007/978-981-97-4098-7_9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403682185 | |||
| W4396601600 | Approach to immunotherapy for HCC in the liver transplant population | 2024-01-01 | OpenAlex | 10.1097/cld.0000000000000158 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396601600 | |||
| W4393972092 | Architecture of Life: Soviet Modernism and the Human Sciences | 2024-01-01 | OpenAlex | 10.1162/leon_r_02530 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393972092 | |||
| W4400166075 | Artificial Intelligence: The Future of Individualized and Effective Healthcare Approach for Psychosis | 2024-01-01 | OpenAlex | 10.1007/978-981-97-2577-9_10 | Full text | Excluded | F1: The reference chapter reviews AI/ML applications for psychosis rather than building/evaluating a primary adaptive LLM system. | https://openalex.org/W4400166075 | https://link.springer.com/chapter/10.1007/978-981-97-2577-9_10 | publisher abstract only | |
| W4402914889 | As Ground of Being, God Favors Good Over Bad Choices: Confucian Response to Wesley J. Wildman | 2024-01-01 | OpenAlex | 10.5406/21564795.45.1.04 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402914889 | |||
| W4404455018 | Association and Contribution of Dentistry in Creating and Sharing the Burden of Antibiotic-Resistant Microbial World | 2024-01-01 | OpenAlex | 10.1007/978-981-97-5272-0_14 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404455018 | |||
| W4396233827 | Basic Tools and Terminology for Endovascular Interventions | 2024-01-01 | OpenAlex | 10.1007/978-3-031-42735-0_5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396233827 | |||
| W4406800481 | Behavioral and Psychological Symptoms (BPSD) in Alzheimer’s Disease (AD): Development and Treatment | 2024-01-01 | OpenAlex | 10.1007/7854_2024_566 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406800481 | |||
| W4401468392 | Biosensors | 2024-01-01 | OpenAlex | 10.1016/b978-0-443-13394-7.00007-0 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4401468392 | |||
| W4400184821 | Biosimilars in Prostate Cancer | 2024-01-01 | OpenAlex | 10.1007/978-981-97-3001-8_6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400184821 | |||
| W4392476185 | Bloodstream infections: Epidemiology, risk factors, and resistance profiles in a university hospital: A five-year cross-sectional analysis | 2024-01-01 | OpenAlex | 10.4328/acam.22039 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392476185 | |||
| W7104034578 | Breakthrough coma: a severe myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) case report | 2024-01-01 | OpenAlex | 10.5327/cbn240264 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7104034578 | |||
| W4392252323 | Breast Cancer and Pregnancy: Challenges for Maternal and Newborn Successful Outcomes | 2024-01-01 | OpenAlex | 10.1007/16833_2024_209 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392252323 | |||
| W4391270378 | CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations | 2024-01-01 | OpenAlex | 10.1093/jlb/lsad030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391270378 | |||
| W4400493565 | Can Nanocrystals Help Create Our Dream Cosmetics? | 2024-01-01 | OpenAlex | 10.15212/bioi-2024-0014 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400493565 | |||
| W4393322500 | Carbocysteine as Adjuvant Therapy in Acute Respiratory Tract Infections in Patients without Underlying Chronic Conditions: Systematic Review and Meta-Analysis | 2024-01-01 | OpenAlex | 10.4236/ojrd.2024.142004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393322500 | |||
| W4392973790 | Changing and Evolution of Influenza Virus: Is It a Trivial Flu? | 2024-01-01 | OpenAlex | 10.1159/000538382 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392973790 | |||
| W7126297970 | Characterizing heterogeneity in Escherichia coli gene expression and its consequences for antimicrobial tolerance | 2024-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7126297970 | ||||
| W4410129900 | Chemotherapeutic Drugs: A Brief Introduction | 2024-01-01 | OpenAlex | 10.54615/2231-7805.6(11).321 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410129900 | |||
| W4402161939 | Chronology of Anticancer Drugs and Their Development | 2024-01-01 | OpenAlex | 10.1007/978-981-99-6263-1_51 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402161939; https://openalex.org/W4386973722 | |||
| W7207766990 | Civil Liability Arising from the Use of Intelligent Robots in the Field of Medical Science | 2024-01-01 | OpenAlex | 10.61838/jecjl.191 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7207766990 | |||
| W4391177205 | Clinical Practice Guidelines on using artificial intelligence and gadgets for mental health and well-being | 2024-01-01 | OpenAlex | 10.4103/indianjpsychiatry.indianjpsychiatry_926_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391177205 | |||
| W4392306271 | Comparative Analysis of Metformin and Imeglimin: Exploring Therapeutic Implications | 2024-01-01 | OpenAlex | 10.4103/bjem.bjem_2_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392306271 | |||
| W4407075101 | Competing Institutional Logics in the Health Information Exchange Field of US Healthcare Industry | 2024-01-01 | OpenAlex | 10.24251/hicss.2024.434 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407075101 | |||
| W4404620097 | Contemporary Strategies for Clinical Chemoprevention of Localized Prostate Cancer | 2024-01-01 | OpenAlex | 10.1177/10732748241302863 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404620097 | |||
| W4401025919 | Contributions of the Federal Council of Medicine to bioethics | 2024-01-01 | OpenAlex | 10.1590/1983-804220240001en | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401025919 | |||
| W7111927669 | Controlling the Supramolecular Assembly and Photophysical Properties of Atomically Precise Metal Chalcogenide and Noble Metal Nanoclusters | 2024-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7111927669 | ||||
| W4391377581 | Crohn’s & Colitis 360 Editorial Fellowship: The Inaugural Fellow’s Insights | 2024-01-01 | OpenAlex | 10.1093/crocol/otae002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391377581 | |||
| W4404854981 | DR. M.S. GUJRAL GOLD MEDAL/ DR. M.C. PANT GOLD MEDAL | 2024-01-01 | OpenAlex | 10.4103/jcrt.jcrt_2136_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404854981 | |||
| W4404756938 | Design and characterization of electrospun fibers for controlled delivery of antimicrobial peptides and proteins | 2024-01-01 | OpenAlex | 10.21248/gups.87878 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404756938 | |||
| W4392308643 | Diagnostic dilemma: Drug reaction with eosinophilia and systemic symptoms or erythema multiforme? | 2024-01-01 | OpenAlex | 10.4103/cmrp.cmrp_23_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392308643 | |||
| W4401148329 | Diagnostics Based on Microbial Enzymes | 2024-01-01 | OpenAlex | 10.1007/978-981-97-4235-6_4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401148329 | |||
| W4392477137 | Differentiated thyroid carcinoma: what the nonspecialists needs to know | 2024-01-01 | OpenAlex | 10.20945/2359-4292-2023-0375 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392477137 | |||
| W7139313875 | Diseño benigno de nanomateriales para procesos catalíticos y aplicaciones sostenibles | 2024-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7139313875 | ||||
| W7134234002 | EPIGENETICS AND ITS REFLECTIONS IN GLIOMAS | 2024-01-01 | OpenAlex | 10.5336/978-625-395-396-6_p10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134234002 | |||
| W7108223803 | Eaton Lambert myasthenic syndrome with cerebellar ataxia misdiagnosed as Guillain-Barré spectrum | 2024-01-01 | OpenAlex | 10.5327/cbn240597 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108223803 | |||
| W4391386510 | Einleitung | 2024-01-01 | OpenAlex | 10.5771/9783748941842-17 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391386510 | |||
| W4400902147 | Eldridge Cleaver's Spiritual Odyssey and Embrace of Mormonism | 2024-01-01 | OpenAlex | 10.5406/15549399.57.2.05 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400902147 | |||
| W7111879151 | Enhancing precision genome editing agents through directed evolution and protein engineering | 2024-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7111879151 | ||||
| W4400456310 | Entry-Level Occupational Therapy Education to Address Substance Use Disorders: Education in Screening, Brief Intervention, and Referral to Treatment (SBIRT) | 2024-01-01 | OpenAlex | 10.26681/jote.2024.080103 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400456310 | |||
| W7111488325 | Estimating the causal effects of dynamic strategies using observational data: applications to cancer survivors | 2024-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7111488325 | ||||
| W4399661142 | Ethics in hepatology: A professional and very personal journey | 2024-01-01 | OpenAlex | 10.1097/cld.0000000000000231 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399661142 | |||
| W4405962919 | Evaluation of Biomaterials Used in Guided Tissue Regeneration | 2024-01-01 | OpenAlex | 10.52533/johs.2024.41108 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405962919 | |||
| W4396837333 | Evaluation of respiratory viruses multiplex assay using RT-PCR | 2024-01-01 | OpenAlex | 10.35259/isi.biomang.2024_63921 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396837333 | |||
| W4396963342 | Evolving role of chemotherapy in gallbladder cancers: largest registry analysis of 2300 patients showing high progression and poor tolerance in “all-comers” | 2024-01-01 | OpenAlex | 10.1016/j.hpb.2024.03.932 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396963342 | |||
| W4390955127 | Evolving standards and future directions for systemic therapies in cervical cancer | 2024-01-01 | OpenAlex | 10.3802/jgo.2024.35.e65 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390955127 | |||
| W4403395578 | Examining the Hospital as a Complex Dynamical System: Using Agent-Based Modeling to Gain Insight into Potential Process Bottlenecks | 2024-01-01 | OpenAlex | 10.1007/978-3-031-66524-0_20 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403395578 | |||
| W4403501179 | Expert consensus on the use of third-generation EGFR-TKIs in EGFR-mutated advanced non-small cell lung cancer with various T790M mutations post-resistance to first-/second-generation EGFR-TKIs | 2024-01-01 | OpenAlex | 10.1177/17588359241289648 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403501179 | |||
| W4405197166 | Exploring Nanomedicine Ventures and Latest Developments in Clinical Trials | 2024-01-01 | OpenAlex | 10.1007/978-3-031-72467-1_16 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405197166 | |||
| W4404339800 | Exploring the Depths of Cryptic Aspergillosis: Species Variability, Clinical Spectrum, Diagnostic Quandaries and Therapeutic Options | 2024-01-01 | OpenAlex | 10.7860/jcdr/2024/74347.20287 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404339800 | |||
| W4399925490 | Exploring the Potential of Antibody-Drug Conjugates in Targeting Non-small Cell Lung Cancer Biomarkers | 2024-01-01 | OpenAlex | 10.1177/11795549241260534 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399925490 | |||
| W4402078544 | Exploring the Role of PROTACs for the Treatment of Breast Cancer | 2024-01-01 | OpenAlex | 10.1007/978-981-97-5077-1_12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402078544 | |||
| W4403855876 | Exploring the characteristics of conversational agents in chronic disease management interventions: A scoping review | 2024-01-01 | OpenAlex | 10.1177/20552076241277693 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4403855876 | |||
| W4416693140 | Exploring the medication use: a comparative study of HTLV-1 patients facing HAM/TSP and those without | 2024-01-01 | OpenAlex | 10.5327/cbn240783 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416693140 | |||
| W4405269461 | Extracellular Vesicles in Pregnancy: Functional Insights, Diagnostic Potential for Maternal–Fetal Disorders, and Therapeutic Implications | 2024-01-01 | OpenAlex | 10.1007/978-981-97-5536-3_13 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405269461 | |||
| W4404678542 | Extraction of Capsaicin: Formulation and Evaluation of a Transdermal Patch | 2024-01-01 | OpenAlex | 10.70593/978-81-981367-0-1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404678542 | |||
| W4396805641 | Eye anatomy, physiology, and ocular barriers | 2024-01-01 | OpenAlex | 10.1016/b978-0-323-99156-8.00023-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396805641 | |||
| W4403706535 | Feedback Reimagined: Generative AI and Conversational Avatars as Your New Training Partners | 2024-01-01 | OpenAlex | 10.1007/978-3-031-73427-4_13 | Full text | Excluded | F4: Generative avatars adapt feedback to the current trainee interaction; the retained learning is human skill acquisition, not an updated agent artifact reused on later cases. | https://openalex.org/W4403706535 | https://www.researchgate.net/publication/385211962_Feedback_Reimagined_Generative_AI_and_Conversational_Avatars_as_Your_New_Training_Partners | original public author-uploaded chapter, system description through evaluation | |
| W4390788174 | Fluorescence visualization for cancer DETECTION: EXPERIENCE and perspectives | 2024-01-01 | OpenAlex | 10.1016/j.heliyon.2024.e24390 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390788174 | |||
| W4400121365 | Fundamental approaches of drug discovery | 2024-01-01 | OpenAlex | 10.1016/b978-0-443-16013-4.00012-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400121365 | |||
| W4404610956 | Fungal Fighters: A Comprehensive Guide to Antifungal Therapies of the Past, Present, and Future | 2024-01-01 | OpenAlex | 10.1007/978-981-97-4909-6_2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404610956 | |||
| W4404837575 | GENITOURINARY | 2024-01-01 | OpenAlex | 10.4103/jcrt.jcrt_2124_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404837575 | |||
| W4404068097 | Gastrointestinal Disorders Associated with Autism Spectrum Disorder | 2024-01-01 | OpenAlex | 10.31550/1727-2378-2024-23-7-86-91 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404068097 | |||
| W4400088966 | Historical perspective on the therapeutic potential of cannabidiol | 2024-01-01 | OpenAlex | 10.1016/bs.irn.2024.03.008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400088966 | |||
| W4401979497 | Host-Directed Immunotherapy for Tuberculosis | 2024-01-01 | OpenAlex | 10.1007/978-981-97-1777-4_22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401979497 | |||
| W7134974532 | IDIOPATHIC GRANULOMATOUS MASTITIS | 2024-01-01 | OpenAlex | 10.5336/978-625-395-314-0_p161 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134974532 | |||
| W4392667483 | Immune Evasion in Cancer Is Regulated by Tumor-Asociated Macrophages (TAMs): Targeting TAMs | 2024-01-01 | OpenAlex | 10.1615/critrevoncog.2024053096 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392667483 | |||
| W7127221960 | Improving adverse event capture and reporting in oncology trials of systemic therapy to better inform assessment of treatment tolerability | 2024-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7127221960 | ||||
| W7126670665 | Improving the Standard of Care in Diabetic Kidney Disease | 2024-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126670665 | ||||
| W4404165114 | In Pursuit of the Perfect Turkey: The Snow Field Station, 1958–2008 | 2024-01-01 | OpenAlex | 10.5406/26428652.92.4.05 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404165114 | |||
| W4393121335 | In Vitro Carminative Activity of the Siddha Formulation T. Soolai Kudoram by Acid- Base Titration Method | 2024-01-01 | OpenAlex | 10.33745/ijzi.2024.v10i01.045 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393121335 | |||
| W4416865577 | Inclusion body myopathy with dysphagia and its expressive improvement with the use of immunoglobulin | 2024-01-01 | OpenAlex | 10.5327/cbn240953 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416865577 | |||
| W4390919882 | Indian clinical practice consensus guidelines for the management of very advanced head-and-neck squamous cell carcinoma: Update 2022 | 2024-01-01 | OpenAlex | 10.4103/crst.crst_124_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390919882 | |||
| W4391444710 | Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010–2020 | 2024-01-01 | OpenAlex | 10.1136/openhrt-2023-002515 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391444710 | |||
| W4394788204 | Integration of Artificial Intelligence in English Teaching | 2024-01-01 | OpenAlex | 10.37811/cli_w1046 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4394788204 | |||
| W4400002821 | Interventional radiology and the liver vasculature: A personal perspective | 2024-01-01 | OpenAlex | 10.1097/cld.0000000000000239 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400002821 | |||
| W4391146880 | Introducing NAR Molecular Medicine, a new journal in the Nucleic Acids Research family | 2024-01-01 | OpenAlex | 10.1093/narmme/ugad002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391146880 | |||
| W4401965423 | Introduction to Pharmacokinetics and Pharmacodynamic Studies of Novel Drug Delivery Systems | 2024-01-01 | OpenAlex | 10.1007/978-981-99-7858-8_1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401965423 | |||
| W4403545540 | Invasive Neurological and Multimodality Monitoring in the Neuro-ICU | 2024-01-01 | OpenAlex | 10.1007/978-3-031-62224-3_7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403545540 | |||
| W7112254985 | Investigating the Effects of Mycobacterium tuberculosis Bacterial Heterogeneity on Innate Immune Cell Tropism | 2024-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7112254985 | ||||
| W4393982432 | Investigation of early detection possibilities of sugar beet disease with machine learning algorithms based on multispectral reflection | 2024-01-01 | OpenAlex | 10.1051/e3sconf/202450803010 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393982432 | |||
| W4403637070 | Ischemic Stroke: Pathophysiology and Evolving Treatment Approaches | 2024-01-01 | OpenAlex | 10.1177/26331055241292600 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403637070 | |||
| W4391386637 | Kapitel 1 – Entstehung, Entwicklung und Bedeutung von Medizintourismus für das deutsche Gesundheitswesen | 2024-01-01 | OpenAlex | 10.5771/9783748941842-23 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391386637 | |||
| W4391386559 | Kapitel 2 – Korruption im Gesundheitswesen – Ausmaß, Auswirkungen und Maßnahmen | 2024-01-01 | OpenAlex | 10.5771/9783748941842-61 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391386559 | |||
| W4391386512 | Kapitel 3 – Rechtliche Würdigung der Zusammenarbeit von Patientenbetreuungsunternehmen und Medizineinrichtungen | 2024-01-01 | OpenAlex | 10.5771/9783748941842-103 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391386512 | |||
| W4391386527 | Kapitel 4 – Empirische Untersuchung der Zusammenarbeit | 2024-01-01 | OpenAlex | 10.5771/9783748941842-223 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391386527 | |||
| W4391386572 | Kapitel 5 – Abschließende Betrachtung und Fazit | 2024-01-01 | OpenAlex | 10.5771/9783748941842-281 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391386572 | |||
| W4391386520 | Kooperation und Korruption im Gesundheitswesen | 2024-01-01 | OpenAlex | 10.5771/9783748941842 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391386520 | |||
| W4391386532 | Literaturverzeichnis | 2024-01-01 | OpenAlex | 10.5771/9783748941842-305 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391386532 | |||
| W4400110857 | Liver biopsy: Archaic but resilient and many roads lead to Rome | 2024-01-01 | OpenAlex | 10.1097/cld.0000000000000247 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400110857 | |||
| W4400281649 | Liver fibrosis: Our evolving understanding | 2024-01-01 | OpenAlex | 10.1097/cld.0000000000000243 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400281649 | |||
| W4399880551 | Liver injury in patients with substance use disorder | 2024-01-01 | OpenAlex | 10.1097/cld.0000000000000220 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399880551 | |||
| W4390579210 | Looking to the Future of Early Detection in Cancer: Liquid Biopsies, Imaging, and Artificial Intelligence | 2024-01-01 | OpenAlex | 10.1093/clinchem/hvad196 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390579210 | |||
| W4391420154 | Management of chronic pleural tuberculosis and non-tuberculous empyema in the 21st century | 2024-01-01 | OpenAlex | 10.21037/shc-23-32 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391420154 | |||
| W4391955051 | Mapping the Earth's Embrace: Queer Life-Building in Mame-Diarra Niang's Éthérée | 2024-01-01 | OpenAlex | 10.1162/afar_a_00741 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391955051 | |||
| W4403181701 | Masks and Respirators for Non-medical Applications (Masks and Respirators Against Dust, Chemicals and Others) | 2024-01-01 | OpenAlex | 10.1007/978-981-97-6496-9_4 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403181701 | |||
| W4402469108 | Medical Education Transformation: Setting the Foundation | 2024-01-01 | OpenAlex | 10.59450/sipr1101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402469108 | |||
| W4399210238 | Metaplastic-EEG: Continuous Training on Brain-Signals | 2024-01-01 | OpenAlex | 10.1101/2024.05.29.24308178 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399210238 | |||
| W4401217969 | Middle of Nowhere (2012): Waiting Studies, Cinema, and Temporal Experience | 2024-01-01 | OpenAlex | 10.5406/19346018.76.3.03 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401217969 | |||
| W4394859409 | Minocycline and Photodynamic Priming Significantly Improve Chemotherapy Efficacy in Heterotypic Spheroids of Pancreatic Ductal Adenocarcinoma | 2024-01-01 | OpenAlex | 10.1016/j.jphotobiol.2024.112910 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4394859409 | |||
| W7135730409 | Molekulárne mechanizmy účinkov chemoterapeutických liečiv | 2024-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135730409 | ||||
| W4405554117 | Monkeypox: epidemiological situation, diagnostics, prevention, new challenges and problems of our time | 2024-01-01 | OpenAlex | 10.36488/cmac.2024.3.285-300 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405554117 | |||
| W4391317359 | Monoclonal Antibodies in Solid Organ Transplantation | 2024-01-01 | OpenAlex | 10.1007/978-3-031-30023-3_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391317359 | |||
| W4407270292 | Mucosal Protective Agents | 2024-01-01 | OpenAlex | 10.1007/978-3-031-69800-2_7 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4407270292 | |||
| W4402190567 | Multifaceted Potential of Photoacoustic Imaging for Preclinical Cancer Research | 2024-01-01 | OpenAlex | 10.1007/978-3-031-61411-8_14 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4402190567 | |||
| W4401879677 | Multilabel Decoupling Diagnosis for Compound Faults by Improved Deep Q-Network | 2024-01-01 | OpenAlex | 10.1109/tim.2024.3450088 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401879677 | |||
| W7202235706 | Mymensingh Shishu Hospital: a vision to ensure better healthcare for every child in Mymensingh | 2024-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202235706 | ||||
| W4404707044 | Nano-technological advancements in multimodal diagnosis and treatment | 2024-01-01 | OpenAlex | 10.3934/biophy.2024026 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404707044 | |||
| W4396909447 | Nanomaterials in the Development of Advanced Antimicrobial Agents | 2024-01-01 | OpenAlex | 10.1007/978-981-97-2023-1_16 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4396909447 | |||
| W4399680094 | Nanomedicine approaches for regenerative medicine | 2024-01-01 | OpenAlex | 10.1016/b978-0-443-19085-8.00016-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399680094 | |||
| W4400570975 | Nanotechnology in Cancer Diagnostics | 2024-01-01 | OpenAlex | 10.1007/978-981-16-1610-5_9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400570975 | |||
| W4400570838 | Nanotechnology in Diagnostic Imaging | 2024-01-01 | OpenAlex | 10.1007/978-981-16-1610-5_11 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400570838 | |||
| W4405347466 | Natural Products in Management of MDR | 2024-01-01 | OpenAlex | 10.1007/978-981-97-9634-2_2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405347466 | |||
| W4404493611 | Navigating the Landscape of Cancer-Induced Thrombocytopenia: Current Challenges and Emerging Advances | 2024-01-01 | OpenAlex | 10.1007/978-981-97-6270-5_14 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404493611 | |||
| W7108663650 | Neuro-chikungunya: a diagnostic challenge | 2024-01-01 | OpenAlex | 10.5327/cbn241158 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108663650 | |||
| W4393107569 | Neuromodulation in migraine | 2024-01-01 | OpenAlex | 10.1016/b978-0-12-823357-3.00003-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393107569 | |||
| W4404716551 | Neutropenic Sepsis | 2024-01-01 | OpenAlex | 10.1007/978-3-319-31738-0_81-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404716551; https://openalex.org/W4407944278 | |||
| W4416746530 | Optic neuritis secondary to bartonellosis (cat scratch disease by bartonella quintana): a case report | 2024-01-01 | OpenAlex | 10.5327/cbn241241 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416746530 | |||
| W4410025604 | Optimizing oral fluid-based surveillance for an evolving swine industry | 2024-01-01 | OpenAlex | 10.31274/td-20250502-133 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4410025604 | |||
| W4392812962 | Outcomes of Everolimus Plus Endocrine Therapy Following CDK4/6 Inhibitor Therapy for Metastatic Hormone Receptor- Positive Breast Cancer | 2024-01-01 | OpenAlex | 10.37047/jos.2023-100188 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392812962 | |||
| W4391893863 | Overview of ADME Science | 2024-01-01 | OpenAlex | 10.1016/b978-0-323-85704-8.00010-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391893863 | |||
| W4402115386 | Overview of Pharmacoproteomics and Its Clinical Applications | 2024-01-01 | OpenAlex | 10.1007/978-3-031-64021-6_1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402115386 | |||
| W4416745441 | Overview of bacterial meningitis in brazil: analysis of variables in the last five years | 2024-01-01 | OpenAlex | 10.5327/cbn241257 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416745441 | |||
| W4404855491 | PAIN AND PALLIATION | 2024-01-01 | OpenAlex | 10.4103/jcrt.jcrt_2132_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404855491 | |||
| W4393061467 | Pan-vascular disease: what we have done in the past and what we can do in the future? | 2024-01-01 | OpenAlex | 10.1097/cp9.0000000000000078 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393061467 | |||
| W4416746518 | Parechovirus encephalitis in a Brazilian adult: an extremely rare case report in the world | 2024-01-01 | OpenAlex | 10.5327/cbn241273 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416746518 | |||
| W4416746502 | Parkinsonism in bipolar mood disorder: a new look at an old problem | 2024-01-01 | OpenAlex | 10.5327/cbn241277 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416746502 | |||
| W4391325284 | Pazopanib-induced trismus in a young male with metastatic renal cell carcinoma: a case report and literature review | 2024-01-01 | OpenAlex | 10.1093/omcr/omad146 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391325284 | |||
| W4400088029 | Pediatric Pneumonia in China: New State of Alarm or Foreseeable Situation? | 2024-01-01 | OpenAlex | 10.58614/jahsm421 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400088029 | |||
| W4402724420 | Perception on Immune Checkpoint Inhibitor Vanquishing Standard Treatment Paradigm for Triple-negative Breast Cancer | 2024-01-01 | OpenAlex | 10.47278/book.cam/2024.454 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402724420 | |||
| W4404920748 | Perioperative Care | 2024-01-01 | OpenAlex | 10.1007/978-3-031-68578-1_1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404920748 | |||
| W4402613285 | Pharmacognosy: A fascinating research area having immense potential in drug development | 2024-01-01 | OpenAlex | 10.22271/phyto.2024.v13.i5b.15068 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402613285 | |||
| W4401322685 | Pharmacological Properties of Tapinarof in Mice as a Novel Topical Agent for Plaque Psoriasis | 2024-01-01 | OpenAlex | 10.1248/bpbreports.7.4_116 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401322685 | |||
| W4404073460 | Photoacoustic Imaging: Principles and Applications | 2024-01-01 | OpenAlex | 10.1007/978-3-031-61846-8_15 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404073460 | |||
| W4390699722 | Physician-made pericardium stent graft as a potential endovascular alternative for infectious aortic disease – an ex-vivo proof-of-concept study | 2024-01-01 | OpenAlex | 10.1177/00368504231221686 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390699722 | |||
| W4394738769 | Prevalence and antimicrobial resistance profile of Salmonella typhi infection in Iraq, 2019-2021. | 2024-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394738769 | ||||
| W4406296316 | Primary and secondary cardiovascular prevention: Recent advances. | 2024-01-01 | OpenAlex | 10.33963/v.phj.103997 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406296316 | |||
| W4392949566 | Psychedelics: The New Kid on the Block | 2024-01-01 | OpenAlex | 10.4103/aip.aip_195_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392949566 | |||
| W4394816033 | Publications! Where are we going? | 2024-01-01 | OpenAlex | 10.4103/jomfp.jomfp_77_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394816033 | |||
| W4391660669 | Pylephlebitis | 2024-01-01 | OpenAlex | 10.4322/acr.2024.473 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391660669 | |||
| W4392869809 | Pylephlebitis – an uncommon challenging entity | 2024-01-01 | OpenAlex | 10.4322/acr.2024.480 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392869809 | |||
| W7134990755 | RECENT DEVELOPMENTS IN PHOTOTHERMAL THERAPY-BASED CANCER TREATMENT | 2024-01-01 | OpenAlex | 10.5336/978-625-395-317-1_p77 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134990755 | |||
| W4399879076 | RNA biomarkers in cancer therapeutics: The promise of personalized oncology | 2024-01-01 | OpenAlex | 10.1016/bs.acc.2024.06.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399879076 | |||
| W4403941498 | Rear View | 2024-01-01 | OpenAlex | 10.14321/fourthgenre.26.2.0141 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403941498 | |||
| W4391643719 | Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Real-World Data from an HCV Elimination Model | 2024-01-01 | OpenAlex | 10.2139/ssrn.4716779 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391643719 | |||
| W4396609973 | Reflections on the Brain Conference 2024 | 2024-01-01 | OpenAlex | 10.1093/braincomms/fcae118 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396609973 | |||
| W4407262067 | Regulatory Aspects of Cancer Immunotherapy | 2024-01-01 | OpenAlex | 10.1007/978-981-97-7022-9_17 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407262067 | |||
| W4406197132 | Revascularization of Immature and Mature Teeth with Necrotic Pulp | 2024-01-01 | OpenAlex | 10.52533/johs.2024.41223 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406197132 | |||
| W4396711345 | Reversible central respiratory events induced by valproic acid treatment: A case report | 2024-01-01 | OpenAlex | 10.1177/2050313x241248386 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396711345 | |||
| W4394787995 | Robotic Treatment of Inflammatory Diseases | 2024-01-01 | OpenAlex | 10.1007/978-3-031-42257-7_14 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394787995 | |||
| W4393170553 | Role of Bioactive Compounds Synthesized by Extremophilic Microbes and Their Bioactivity | 2024-01-01 | OpenAlex | 10.1007/978-3-031-30037-0_54-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393170553; https://openalex.org/W4409953024 | |||
| W7132828114 | Role of Computational Drug Design in Modern Pharmacology | 2024-01-01 | OpenAlex | 10.54660/ijpis.2024.1.6.01-17 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7132828114 | |||
| W4406193772 | Role of Triple Antibiotic Paste in Regenerative Endodontics | 2024-01-01 | OpenAlex | 10.52533/johs.2024.41213 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406193772 | |||
| W4390543403 | SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024 | 2024-01-01 | OpenAlex | 10.4103/sjg.sjg_333_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390543403 | |||
| W4391176367 | Screening Queerness at Beyond the Blue Sky Mongolian Queer Film Festival | 2024-01-01 | OpenAlex | 10.1215/10642684-10920660 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391176367 | |||
| W4400168497 | Sepsis from SARS-COV2 Infection (COVID-19): Pathophysiology and Clinic of SARS-COV2 Infection and Sepsis | 2024-01-01 | OpenAlex | 10.1007/978-3-031-43891-2_10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400168497 | |||
| W4404073473 | Skin Disorders in Pregnancy | 2024-01-01 | OpenAlex | 10.1007/978-3-031-65300-1_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404073473 | |||
| W4406960545 | Small Molecule Inhibitors: Precision Tools Targeting Oncogenic Pathways for Therapeutic Intervention in Cancer | 2024-01-01 | OpenAlex | 10.1007/978-981-96-0301-5_12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406960545 | |||
| W4393170888 | Structure-Guided and Phage-Assisted Evolution of Therapeutic Antibodies to Reverse On-Target Point Mutation-Mediated Resistance | 2024-01-01 | OpenAlex | 10.1007/978-1-0716-3798-2_3 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393170888 | |||
| W4390700203 | Supramolecule-Mediated Delivery of Phytochemicals | 2024-01-01 | OpenAlex | 10.1007/978-981-99-5314-1_6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390700203 | |||
| W7130949277 | Surgery in Diabetic Retinopathy | 2024-01-01 | OpenAlex | 10.1007/978-3-031-29358-0_79-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130949277; https://openalex.org/W7214617060 | |||
| W4405999032 | Surgical Decision-Making in Hepatobiliary and Pancreatic Surgery | 2024-01-01 | OpenAlex | 10.1007/978-3-031-67391-7_17 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405999032 | |||
| W4409618354 | Sustainability in infection prevention and control – An Indian perspective | 2024-01-01 | OpenAlex | 10.4103/jpsic.jpsic_6_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409618354 | |||
| W4392236234 | Syntax Before Words—The Function-First Approach to the Evolution of Proto-Language | 2024-01-01 | OpenAlex | 10.2139/ssrn.4815379 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392236234 | |||
| W4393977284 | Systemic Therapy Options in VHL Disease | 2024-01-01 | OpenAlex | 10.1007/978-3-031-53858-2_10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393977284 | |||
| W4393286010 | Systemic Therapy for Breast Cancer | 2024-01-01 | OpenAlex | 10.1016/b978-0-323-93249-3.00009-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393286010 | |||
| W4403063255 | Tailoring treatment for locally advanced rectal cancer | 2024-01-01 | OpenAlex | 10.1016/j.ctarc.2024.100847 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403063255 | |||
| W4399364003 | Taking Action to Promote Diversity and Inclusion: One Program's Efforts Through Pathway Opportunities, Holistic Admissions, and Curricular Changes. | 2024-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399364003 | ||||
| W4406046899 | Talking Therapy: Knowledge and Power in American Psychiatric Nursing, by Kylie Smith | 2024-01-01 | OpenAlex | 10.5325/nursinghistory.32.0172 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406046899 | |||
| W4410508030 | Targeting Neutrophils in Pancreatic Cancer | 2024-01-01 | OpenAlex | 10.54615/2231-7805.24.s10.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410508030 | |||
| W4400659469 | The Disintegration of a Floating Ferrofluid Layer into an Ordered Drop System in a Vertical Magnetic Field | 2024-01-01 | OpenAlex | 10.32604/fdmp.2024.051053 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400659469 | |||
| W4390578330 | The Interpsychic: A Leading Actor in Interpersonal Relationships and in the Psychoanalytic Scene | 2024-01-01 | OpenAlex | 10.1007/978-3-031-44685-6_19 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390578330 | |||
| W4402651864 | The Rapidly Evolving Treatment Landscape of Metastatic Hormone-Sensitive Prostate Cancer | 2024-01-01 | OpenAlex | 10.1177/11795549241277181 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402651864 | |||
| W4390475738 | The key role of thrombosis: focus on acute coronary syndrome, venous thrombo-embolism, and atrial fibrillation | 2024-01-01 | OpenAlex | 10.1093/eurheartj/ehad835 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390475738 | |||
| W4400539985 | Theranostic nanogels: multifunctional agents for simultaneous therapeutic delivery and diagnostic imaging | 2024-01-01 | OpenAlex | 10.1039/d4nr01423e | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4400539985 | |||
| W4402722814 | Therapeutic Potential of Natural Pharmacological Agents (Flavonoids and Other Phenolic Compounds) Found in Plants | 2024-01-01 | OpenAlex | 10.1007/978-981-97-6706-9_17 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402722814 | |||
| W4404758931 | Therapeutic targeting of TNF-α and IL-17 in psoriasis: Mechanisms of action and clinical efficacy of biologic agents | 2024-01-01 | OpenAlex | 10.33545/26647184.2024.v6.i2a.37 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4404758931 | |||
| W4391386650 | Titelei/Inhaltsverzeichnis | 2024-01-01 | OpenAlex | 10.5771/9783748941842-1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391386650 | |||
| W4416361675 | Tocilizumab for cryptogenic fires with hemofagocytic syndrome: a case report | 2024-01-01 | OpenAlex | 10.5327/cbn241673 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416361675 | |||
| W4402402008 | Towards Model-driven Enhancement of Safety in Healthcare Robot Interactions | 2024-01-01 | OpenAlex | 10.1007/978-3-031-71333-0_6 | Full text | Excluded | F3: The described method is a static domain metamodel for healthcare-robot safety, not an LLM/VLM acting-agent system. | https://openalex.org/W4402402008 | https://link.springer.com/chapter/10.1007/978-3-031-71333-0_6 | publisher abstract only | |
| W4393323652 | Toxic effects of cancer therapies | 2024-01-01 | OpenAlex | 10.1016/b978-0-443-15842-1.00004-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393323652 | |||
| W4390968161 | Transarterial radioembolization and its impacts on colon cancer treatment and diagnosis | 2024-01-01 | OpenAlex | 10.1016/b978-0-443-13870-6.00007-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390968161 | |||
| W4400696051 | Transformation of conventional medical practices: an ethnographic investigation from Amppipal Gorkha, Nepal | 2024-01-01 | OpenAlex | 10.33545/26648679.2024.v6.i2a.87 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400696051 | |||
| W4403634603 | Transforming Healthcare with Artificial Intelligence: An Integrated Approach to Patent Analysis and Strategic Commercialization | 2024-01-01 | OpenAlex | 10.2139/ssrn.4995376 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403634603 | |||
| W4392454094 | Transforming the landscape of colorectal cancer treatment with immunotherapy: Evolution and future horizons | 2024-01-01 | OpenAlex | 10.1016/j.ctarc.2024.100807 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392454094 | |||
| W4402768062 | Treatment of Actinic Keratoses and Field Cancerization – Croatian perspective | 2024-01-01 | OpenAlex | 10.21857/mwo1vcrojy | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402768062 | |||
| W4396711507 | Treatment of multiple myeloma: What is the impact on T-cell function? | 2024-01-01 | OpenAlex | 10.1177/20406207241245194 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396711507 | |||
| W4407110862 | Treatment sequencing in metastatic colorectal cancer | 2024-01-01 | OpenAlex | 10.5114/wo.2024.146982 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407110862 | |||
| W4396725496 | Trends in drug poisoning hospitalizations over ten years in South Korea: mortality and length of hospital stay | 2024-01-01 | OpenAlex | 10.22514/sv.2024.053 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396725496 | |||
| W4390886319 | Understanding and Treating Acute Lung Injury: Exploring The Causes, How It Affects The Lungs, and Possible Medications | 2024-01-01 | OpenAlex | 10.53555/jaz.v45i1.3351 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390886319 | |||
| W4392105938 | Unleashing the Potential of Marine Algae in Cancer Prevention and Treatment Through Combination of Tradition and Innovation | 2024-01-01 | OpenAlex | 10.1007/16833_2024_212 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392105938 | |||
| W4393360803 | Unravelling the molecular basis of PARP inhibitor resistance in prostate cancer with homologous recombination repair deficiency | 2024-01-01 | OpenAlex | 10.1016/bs.ircmb.2024.03.004 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393360803 | |||
| W4398194344 | Use of biomarkers in clinical trials and future developments that will help identify novel biomarkers | 2024-01-01 | OpenAlex | 10.1016/bs.irn.2024.04.010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398194344 | |||
| W4393323352 | Viral Genome Sequencing and Its Significance in Latest Clinical and Research Findings | 2024-01-01 | OpenAlex | 10.1016/b978-0-443-13320-6.00001-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393323352 | |||
| W4404072413 | Virtual Laboratories for Diabetes Education on Artificial Pancreas | 2024-01-01 | OpenAlex | 10.1016/j.ifacol.2024.10.270 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404072413 | |||
| W4390989862 | WORKSHOP ABSTRACTS | 2024-01-01 | OpenAlex | 10.4103/0019-5545.394311 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390989862 | |||
| W4402914939 | Wildman's Effing Theodicy: The Problem of Suffering, the Ground of Being, and the Worship of Suchness | 2024-01-01 | OpenAlex | 10.5406/21564795.45.1.03 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4402914939 | |||
| W4390971478 | Yersinia pestis | 2024-01-01 | OpenAlex | 10.1016/b978-0-12-818619-0.00050-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390971478 | |||
| W4403113387 | [Novel therapies for MDS and future prospects]. | 2024-01-01 | OpenAlex | 10.11406/rinketsu.65.982 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403113387 | |||
| W4404753292 | Đợi Kiều | 2024-01-01 | OpenAlex | 10.1525/vs.2024.19.3-4.136 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404753292 | |||
| W4392665100 | 深层生物组织光学技术发展及其应用(特邀) | 2024-01-01 | OpenAlex | 10.3788/cjl231318 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392665100 | |||
| W4390699452 | A conversational artificial intelligence based web application for medical conversations: a prototype for a chatbot | 2024-01-02 | OpenAlex | 10.1101/2023.12.31.23300681 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4390699452 | |||
| W4390508381 | An adenine base editor variant expands context compatibility | 2024-01-02 | OpenAlex | 10.1038/s41587-023-01994-3 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4390508381 | |||
| W4390501811 | Biomedical Applications of Carbon Nanotubes | 2024-01-02 | OpenAlex | 10.1201/9781003396390-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390501811 | |||
| W4390488151 | Honeymoon phase in type 1 diabetes mellitus: A window of opportunity for diabetes reversal? | 2024-01-02 | OpenAlex | 10.12998/wjcc.v12.i1.9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390488151 | |||
| W4390508229 | Is it time to recommend cardiovascular protection for all? | 2024-01-02 | OpenAlex | 10.1097/hjh.0000000000003501 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390508229 | |||
| W4390541053 | Enactive interventions can enhance agency, health, and social relationships during childhood | 2024-01-03 | OpenAlex | 10.3389/fpsyg.2023.1245883 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390541053 | |||
| W7216357739 | Nano Formulation: A Promising Approach To Enhance The Bioavailability And Therapeutic Efficacy Of Herbal Drugs | 2024-01-03 | OpenAlex | 10.69980/redvet.v25i1.1789 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216357739 | |||
| W4390595730 | The role of disease registers in dermatology | 2024-01-03 | OpenAlex | 10.1093/bjd/ljae002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390595730 | |||
| W4390608073 | A study on Bacterial Infections Associated with Central Nervous System in Pakistani Population | 2024-01-04 | OpenAlex | 10.51846/jucmd.v3i1.2643 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390608073 | |||
| W4390597822 | Added Value of Contrast-enhanced US for Evaluation of Female Pelvic Disease | 2024-01-04 | OpenAlex | 10.1148/rg.230092 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390597822 | |||
| W4390561458 | Atypical femur fracture in a male without history of bisphosphonate use: a case report | 2024-01-04 | OpenAlex | 10.1186/s13256-023-04308-y | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390561458 | |||
| W4390574648 | Chapter 3: Clinical Trials of Sodium-Glucose Co-Transporter-2 Inhibitors for Treatment of Heart Failure | 2024-01-04 | OpenAlex | 10.1016/j.amjmed.2023.04.019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390574648 | |||
| W4390585358 | Editorial: Imaging techniques to predict outcomes in renal cancers | 2024-01-04 | OpenAlex | 10.3389/fonc.2023.1349703 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390585358 | |||
| W4390671327 | Marine Drug Discovery through Computer-Aided Approaches | 2024-01-04 | OpenAlex | 10.3390/books978-3-0365-9912-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390671327 | |||
| W4390589052 | The metallo-β-lactamases strike back: emergence of taniborbactam escape variants | 2024-01-04 | OpenAlex | 10.1128/aac.01510-23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390589052 | |||
| W4390589469 | Therapeutic Approaches to Targeting Androgen Receptor Splice Variants | 2024-01-04 | OpenAlex | 10.3390/cells13010104 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390589469 | |||
| W4390611138 | Cell death in cancer chemotherapy using taxanes | 2024-01-05 | OpenAlex | 10.3389/fphar.2023.1338633 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390611138 | |||
| W4390610873 | Editorial: Computing and artificial intelligence in digital therapeutics | 2024-01-05 | OpenAlex | 10.3389/fmed.2023.1330686 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390610873 | |||
| W7155193443 | El tratamiento informativo del sismo de Pisco del 2007 en los diarios El Comercio, La República y El Peruano | 2024-01-05 | OpenAlex | 10.26490/uncp.sl.2024.8.1.1928 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7155193443 | |||
| W4390893334 | A Fluid Approach to Type 2 Diabetes Management: Recent Advances in Medication Therapy from Tradition to Novelty | 2024-01-06 | OpenAlex | 10.36948/ijfmr.2024.v06i01.11140 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390893334 | |||
| W4390672389 | Biology and Development of DNA-Targeted Drugs, Focusing on Synthetic Lethality, DNA Repair, and Epigenetic Modifications for Cancer: A Review | 2024-01-06 | OpenAlex | 10.3390/ijms25020752 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390672389 | |||
| W4390675357 | Can removal of zombie cells revitalize the aging cardiovascular system? | 2024-01-08 | OpenAlex | 10.1093/eurheartj/ehad849 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390675357 | |||
| W4390658581 | Colin Jones: fox and hedgehog historian of France | 2024-01-08 | OpenAlex | 10.1093/fh/crad063 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4390658581 | |||
| W4390661381 | Green cardiovascular care: a call for sustainable transformation of cardiovascular practices | 2024-01-08 | OpenAlex | 10.1093/eurheartj/ehad844 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390661381 | |||
| W4390669516 | Remission of type 2 diabetes: always more questions, but enough answers for action | 2024-01-08 | OpenAlex | 10.1007/s00125-023-06069-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390669516 | |||
| W4390662645 | Role of Sodium-Glucose Co-Transporter-2 Inhibitor During Anthracycline Use: An Updated Review | 2024-01-08 | OpenAlex | 10.1097/crd.0000000000000638 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390662645 | |||
| W4390707033 | Annotations of LSE Research: Enhancing Accessibility and Promoting High Quality Biology Education Research | 2024-01-09 | OpenAlex | 10.1187/cbe.23-09-0171 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390707033 | |||
| W4390806935 | Decoding Online Teeth Whitening Videos: Navigating Social Media Complexities | 2024-01-09 | OpenAlex | 10.20944/preprints202401.0630.v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390806935 | |||
| W4390771765 | Editorial: New trends in the treatment of mood disorders | 2024-01-09 | OpenAlex | 10.3389/fpsyg.2023.1357198 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390771765 | |||
| W4390772085 | IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice | 2024-01-09 | OpenAlex | 10.21203/rs.3.rs-3728567/v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4390772085; https://openalex.org/W4398767308 | |||
| W4400022342 | Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa) | 2024-01-09 | OpenAlex | 10.17615/2m3x-kg35 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400022342 | |||
| W4391488959 | Mainstream health economics and the COVID-19 pandemic | 2024-01-09 | OpenAlex | 10.4324/9781003017110-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391488959 | |||
| W4391492701 | The growing link between microbes, mood and mental health | 2024-01-09 | OpenAlex | 10.1146/knowable-010924-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391492701 | |||
| W4406479861 | Artificial intelligence-powered drug discovery and development: Accelerating innovation | 2024-01-10 | OpenAlex | 10.70593/978-81-984306-1-8_10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406479861 | |||
| W4406482022 | Machine learning algorithms in personalized treatment planning | 2024-01-10 | OpenAlex | 10.70593/978-81-984306-1-8_3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406482022 | |||
| W4390716129 | Nanotechnology based Drug Delivery for Brain Targeting | 2024-01-10 | OpenAlex | 10.22214/ijraset.2024.57931 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390716129 | |||
| W4390692291 | Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies | 2024-01-10 | OpenAlex | 10.7759/cureus.52050 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390692291 | |||
| W4390830873 | Targeted Therapies in Cancer Treatment: Unveiling the Latest Breakthroughs and Promising Approaches | 2024-01-10 | OpenAlex | 10.55544/jrasb.2.6.26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390830873 | |||
| W4390739595 | A single center experience with a rare clinical entity of idiopathic granulomatous mastitis: Case series and review of the literature | 2024-01-11 | OpenAlex | 10.1016/j.ijscr.2024.109232 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390739595 | |||
| W4390734905 | Anaesthetic subspecialties and sustainable healthcare: a narrative review | 2024-01-11 | OpenAlex | 10.1111/anae.16169 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390734905 | |||
| W4390740703 | Clearing the air: a review of the effects of air pollution on dialysis outcomes | 2024-01-11 | OpenAlex | 10.1097/mnh.0000000000000968 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390740703 | |||
| W4390744022 | Driving down the carbon cost of peri‐operative care: old controversies, new topics, fresh perspectives and the future | 2024-01-11 | OpenAlex | 10.1111/anae.16217 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390744022 | |||
| W4390746382 | Editorial: Novel drug-designing approaches to combat antimicrobial resistance | 2024-01-11 | OpenAlex | 10.3389/fmolb.2023.1342702 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390746382 | |||
| W4390749734 | Effect of Different Disinfecting Agents on Surface Roughness and Color Stability of Heat-cure Acrylic Denture Material: An In Vitro Study | 2024-01-11 | OpenAlex | 10.5005/jp-journals-10024-3563 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390749734 | |||
| W4390741004 | Green Synthesis of Novel Silver Nanoparticles Using Salvia blepharophylla and Salvia greggii: Antioxidant and Antidiabetic Potential and Effect on Foodborne Bacterial Pathogens | 2024-01-11 | OpenAlex | 10.3390/ijms25020904 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4390741004 | |||
| W4390805762 | Quantification of Chemotherapy Drug Wastage and Incurred Financial Loss in Paediatric Cancer Care: A Cross-Sectional Study at a Tertiary Care Public Hospital in India | 2024-01-11 | OpenAlex | 10.7759/cureus.52076 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390805762 | |||
| W4390751219 | The Impact of Carrageenan on Pharmascience | 2024-01-11 | OpenAlex | 10.2174/0122150838266638231117180516 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390751219 | |||
| W4390824072 | A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines | 2024-01-12 | OpenAlex | 10.3390/cancers16020335 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390824072 | |||
| W4390827776 | Depth of Anesthesia and Nociception Monitoring: Current State and Vision For 2050 | 2024-01-12 | OpenAlex | 10.1213/ane.0000000000006860 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390827776 | |||
| W4390819650 | Perioperative Fluid and Vasopressor Therapy in 2050: From Experimental Medicine to Personalization Through Automation | 2024-01-12 | OpenAlex | 10.1213/ane.0000000000006672 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390819650 | |||
| W4390837523 | Spatial dispersal in chemostat systems with agent-based asymmetry | 2024-01-13 | OpenAlex | 10.1016/j.cnsns.2024.107847 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4390837523 | |||
| W4390857921 | Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome | 2024-01-14 | OpenAlex | 10.1186/s12967-023-04779-z | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4390857921 | |||
| W4390884625 | Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive Research | 2024-01-15 | OpenAlex | 10.1681/asn.0000000000000301 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390884625 | |||
| W4390877184 | Exploring the Effectiveness of Biological Therapy in Patients with Psoriasis: Body Image and Quality of Life | 2024-01-15 | OpenAlex | 10.3390/medicina60010160 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390877184 | |||
| W4390890119 | Physicians’ and Patients’ Expectations From Digital Agents for Consultations: Interview Study Among Physicians and Patients | 2024-01-15 | OpenAlex | 10.2196/49647 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4390890119 | |||
| W4390876505 | Tenapanor-A Novel Approach for Management of Hyperphosphatemia in End Stage Renal Disease: A Clinical Study Aggregate Review | 2024-01-15 | OpenAlex | 10.22270/jddt.v14i1.6336 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390876505 | |||
| W4390917114 | Editorial: Insights in precision medicine: 2022 | 2024-01-16 | OpenAlex | 10.3389/fmed.2023.1341175 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390917114 | |||
| W4390917719 | Ophthalmic implications of biological threat agents according to the chemical, biological, radiological, nuclear, and explosives framework | 2024-01-16 | OpenAlex | 10.3389/fmed.2023.1349571 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4390917719 | |||
| W4390928538 | MRI characteristics of chemotherapy-related central neurotoxicity: a pictorial review | 2024-01-17 | OpenAlex | 10.1186/s13244-023-01602-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390928538 | |||
| W4390978051 | Racial differences in treatment and survival among older patients with multiple myeloma | 2024-01-17 | OpenAlex | 10.1002/cam4.6915 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4390978051 | |||
| W4390952952 | Tularemia treatment: experimental and clinical data | 2024-01-17 | OpenAlex | 10.3389/fmicb.2023.1348323 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390952952 | |||
| W4390969818 | Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge | 2024-01-18 | OpenAlex | 10.1080/14787210.2024.2305854 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390969818 | |||
| W4390984747 | Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer | 2024-01-18 | OpenAlex | 10.3390/cancers16020412 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4390984747 | |||
| W4391024399 | An Era of Therapeutic Evolution and Revolution: Insights into Studies on Dupilumab, Tralokinumab, Lebrikizumab, Nemolizumab, Eblasakimab, and OX40/OX40L Agents (Rocatinlimab and Amlitelimab) in Moderate-to-Severe Atopic Dermatitis | 2024-01-19 | OpenAlex | 10.5772/intechopen.1004103 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391024399 | |||
| W4391021887 | Meeting at the precipice: Creative visualization in the treatment of trauma | 2024-01-19 | OpenAlex | 10.1080/24720038.2024.2302364 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391021887 | |||
| W4391022843 | Thamnostylum piriforme, a novel etiological agent of superficial mycosis | 2024-01-19 | OpenAlex | 10.1016/j.micpath.2024.106544 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4391022843 | |||
| W4391096700 | Combining low-dose regorafenib with pembrolizumab for patients with MSI-H colorectal cancer: REGPEM-CRC-01. | 2024-01-20 | OpenAlex | 10.1200/jco.2024.42.3_suppl.tps238 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391096700 | |||
| W4391070932 | SOHO State of the Art Updates and Next Questions: Will CAR-T Replace ASCT in NDMM | 2024-01-21 | OpenAlex | 10.1016/j.clml.2024.01.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391070932 | |||
| W4391105216 | The Efficacy and Safety of Transvaginal Ethanol Sclerotherapy in the Treatment of Endometrial Cysts—A Systematic Review | 2024-01-22 | OpenAlex | 10.3390/ijms25021337 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391105216 | |||
| W4391154193 | Act Local, Think Global: IR and Its Role in Immuno-Oncology in Hepatocellular Carcinoma | 2024-01-23 | OpenAlex | 10.1016/j.jvir.2023.10.008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391154193 | |||
| W4391580069 | PREBIOTICS AND PROBIOTICS: AN OVERVIEW ON MECHANISM OF ACTION AND THERAPEUTIC APPLICATIONS | 2024-01-23 | OpenAlex | 10.56735/saltjsrh.ms2404011016 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391580069 | |||
| W4391137182 | The Role of Cytokines in Activation of Tumour-promoting Pathways and Emergence of Cancer Drug Resistance | 2024-01-23 | OpenAlex | 10.2174/0115680266284527240118041129 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391137182 | |||
| W4391257346 | Editorial: Expert opinions in genitourinary oncology | 2024-01-24 | OpenAlex | 10.3389/fonc.2023.1360223 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391257346 | |||
| W4391173274 | Editorial: Optimizing the first-line treatment for metastatic colorectal cancer | 2024-01-24 | OpenAlex | 10.3389/fonc.2024.1366383 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391173274 | |||
| W4391171520 | G4-interacting ligands: paving the way for precision medicine and molecular diagnostics | 2024-01-24 | OpenAlex | 10.1080/07391102.2024.2306498 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391171520 | |||
| W4391172921 | RNA recombination: non-negligible factor for preventing emergence or reemergence of Senecavirus A | 2024-01-24 | OpenAlex | 10.3389/fvets.2024.1357179 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391172921 | |||
| W4391167626 | Sezary syndrome revealed by PD‐L1 blockade for tumor stage mycosis fungoides | 2024-01-24 | OpenAlex | 10.1002/jvc2.352 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391167626 | |||
| W4391227486 | A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence | 2024-01-25 | OpenAlex | 10.3389/fendo.2023.1266986 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391227486 | |||
| W4391217480 | Antibody–drug conjugates transform the outcome of individuals with low‐HER2‐expression advanced breast cancer | 2024-01-25 | OpenAlex | 10.1002/cncr.35205 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391217480 | |||
| W7119496071 | Cross-Border Healthcare Security: Challenges For Nursing Practice In The Era Of Globalized Health Data | 2024-01-25 | OpenAlex | 10.70082/c2xg2274 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119496071 | |||
| W4391219420 | Development of tumor-evolution-targeted anticancer therapeutic nanomedicineEVT | 2024-01-25 | OpenAlex | 10.1016/j.chempr.2023.12.019 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391219420 | |||
| W4391229427 | ERCC1 abundance is an indicator of DNA repair-apoptosis decision upon DNA damage | 2024-01-25 | OpenAlex | 10.1038/s41420-024-01817-7 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391229427 | |||
| W7221812053 | Empowering the sustainable development of the AI industry ecosystem with the "i7C" framework | 2024-01-25 | OpenAlex | 10.25405/ncl.34491117 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221812053 | |||
| W4391224124 | Health Informatics Workforce in the Digital Health Ecosystem | 2024-01-25 | OpenAlex | 10.3233/shti231160 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391224124 | |||
| W4391261076 | The Precision Oncology Approach to Molecular Cancer Therapeutics Targeting Oncogenic Signaling Pathways is a Means to an End | 2024-01-25 | OpenAlex | 10.31219/osf.io/wbp3q | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391261076 | |||
| W4391223854 | The contemporary nexus of medicines security and bioprospecting: a future perspective for prioritizing the patient | 2024-01-25 | OpenAlex | 10.1007/s13659-024-00431-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391223854 | |||
| W4391251979 | Cardiac Tamponade in ECMO: Infrequent but Important | 2024-01-26 | OpenAlex | 10.1053/j.jvca.2024.01.015 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391251979 | |||
| W4391317609 | Current Approaches to Worsening Heart Failure: Pathophysiological and Molecular Insights | 2024-01-26 | OpenAlex | 10.3390/ijms25031574 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391317609 | |||
| W4391260591 | Neuroprotection strategies in traumatic brain injury: Studying the effectiveness of different clinical approaches | 2024-01-26 | OpenAlex | 10.25259/sni_773_2023 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391260591 | |||
| W4391261002 | Which Patient Phenotype Is the Ideal Candidate for Hemoadsorption in Acute and Chronic Kidney Disease? | 2024-01-26 | OpenAlex | 10.1097/imna-d-24-00001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391261002 | |||
| W4391277386 | MR Imaging Techniques for Acute Ischemic Stroke and Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage | 2024-01-27 | OpenAlex | 10.1016/j.nic.2023.12.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391277386 | |||
| W7217592613 | Pengembangan Riset Terkini Pemanfaatan Tanaman Obat dalam Penemuan Obat Baru dan Mekanismenya dalam Pengobatan Penyakit: Pengembangan Riset Terkini Pemanfaatan Tanaman Obat dalam Penemuan Obat Baru dan Mekanismenya dalam Pengobatan Penyakit | 2024-01-27 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217592613 | ||||
| W4391292967 | Application of nanofiber-based drug delivery systems in improving anxiolytic effect of new 1,2,3-triazolo-1,4-benzodiazepine derivatives | 2024-01-28 | OpenAlex | 10.1016/j.ejps.2024.106712 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391292967 | |||
| W4391316094 | Book Illustrations | 2024-01-29 | OpenAlex | 10.4324/9781003094876-22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391316094 | |||
| W4391329340 | Ethical challenges for children undergoing surgery: Evaluation of graduate nursing students' learning | 2024-01-29 | OpenAlex | 10.26443/ijwpc.v11i1.406 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391329340 | |||
| W4391233082 | Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer | 2024-01-29 | OpenAlex | 10.1016/j.jconrel.2024.01.034 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4391233082 | |||
| W4391303575 | Real-world utilization patterns of radium-223 in metastatic prostate cancer in the United States: An administrative claims database study. | 2024-01-29 | OpenAlex | 10.1200/jco.2024.42.4_suppl.79 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391303575 | |||
| W4391325448 | Recent advances and future strategies in first-line treatment of ES-SCLC | 2024-01-29 | OpenAlex | 10.1016/j.ejca.2024.113581 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391325448 | |||
| W4396876390 | Symptoms-Disease Detecting Conversation Agent using Knowledge Graphs | 2024-01-29 | OpenAlex | 10.1145/3641142.3641165 | Full text | Excluded | F4: The GPT-3 DaVinci model is fine-tuned once on126 prompt–completion pairs generated from a fixed symptom–disease dataset and ChatGPT answers. A fixed knowledge graph guides within-dialogue questions. No retained execution-derived update or cross-case agent-learning loop is implemented. | https://openalex.org/W4396876390 | https://dl.acm.org/doi/10.1145/3641142.3641165 | Publisher online PDF pp3–4 and9, dataset/model/training and conclusion read through existing institutional access; no file archive/download. | |
| W4391302597 | Treatment (Rx) trends and attrition with lines of therapy in patients (pts) with advanced urothelial carcinoma (aUC). | 2024-01-29 | OpenAlex | 10.1200/jco.2024.42.4_suppl.562 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391302597 | |||
| W4391357728 | Challenges in acute postoperative pain management in thoracic surgery | 2024-01-30 | OpenAlex | 10.1016/j.bpa.2024.01.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391357728 | |||
| W4391375707 | PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic Landscape | 2024-01-30 | OpenAlex | 10.3390/life14020198 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391375707 | |||
| W4391349908 | The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs | 2024-01-30 | OpenAlex | 10.3390/ijms25031702 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391349908 | |||
| W4391377722 | BEST-CLI International Collaborative: planning a better future for patients with chronic limb-threatening ischaemia globally | 2024-01-31 | OpenAlex | 10.1093/bjs/znad413 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391377722 | |||
| W4391379892 | Getting rid of bed bugs: Trickier than ever | 2024-01-31 | OpenAlex | 10.1146/knowable-013124-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391379892 | |||
| W4391446177 | Lipolytic agents for submental fat reduction: Review | 2024-01-31 | OpenAlex | 10.1111/srt.13601 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4391446177 | |||
| W4391403375 | Real-World Evidence in Biliary Tract Cancer Treatment | 2024-01-31 | OpenAlex | 10.1097/01.cot.0001007188.58445.9a | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391403375 | |||
| W4391399497 | Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial | 2024-01-31 | OpenAlex | 10.1007/s10549-023-07231-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391399497 | |||
| W4404506519 | A Review: Novel Therapies for Advanced Clear Cell Renal Cell Carcinoma | 2024-02-01 | OpenAlex | 10.1177/24684570241288088 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404506519 | |||
| W4391443220 | Abstract A016: Positive ecological interaction between therapy-resistant and sensitive cells, mediated by stromal niche, slows the expansion of resistant subpopulations and promotes tumor heterogeneity | 2024-02-01 | OpenAlex | 10.1158/1538-7445.canevol23-a016 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391443220 | |||
| W4391443067 | Abstract A023: Integrating mathematical modeling and in vitro experiments to measure ecological interactions in cancer | 2024-02-01 | OpenAlex | 10.1158/1538-7445.canevol23-a023 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391443067 | |||
| W4391446459 | Abstract B056: Chronic hypoxia in TNBC breast cancer induces development of a novel population of CD24+/CD49b-high cells characterized by high expression of CST1 | 2024-02-01 | OpenAlex | 10.1158/1538-7445.advbc23-b056 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391446459 | |||
| W4391446155 | Abstract IA15: Single cell origins and targeting of genomic instability in breast cancers | 2024-02-01 | OpenAlex | 10.1158/1538-7445.advbc23-ia15 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391446155 | |||
| W4391450769 | Aortic Valve Embryology, Mechanobiology, and Second Messenger Pathways: Implications for Clinical Practice | 2024-02-01 | OpenAlex | 10.3390/jcdd11020049 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391450769 | |||
| W4391751598 | Approach to acute chest pain and acute coronary syndrome in adults | 2024-02-01 | OpenAlex | 10.4103/singaporemedj.smj-2023-039 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391751598 | |||
| W4391436383 | Clearing the Smoke: Underreporting of Smoking Status in Food and Drug Administration–Approved Bladder Cancer Therapeutic Trials | 2024-02-01 | OpenAlex | 10.1097/ju.0000000000003853 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391436383 | |||
| W4391787340 | Diagnosis and Treatment of Myelodysplastic Syndrome in the Era of Genetic Testing | 2024-02-01 | OpenAlex | 10.3904/kjm.2024.99.1.11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391787340 | |||
| W4392096963 | From the Editor—January 2024 AUA Publications Committee Meeting | 2024-02-01 | OpenAlex | 10.1097/ju9.0000000000000126 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392096963 | |||
| W4392391682 | Heparin: A Conventional Drug with A New Prototype | 2024-02-01 | OpenAlex | 10.47583/ijpsrr.2024.v84i02.019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392391682 | |||
| W4391443814 | Is ‘Immunity Debt’ Behind the RSV Surge? | 2024-02-01 | OpenAlex | 10.1097/01.eem.0001006968.81740.5e | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391443814 | |||
| W4391972957 | JISPPD Abstract supplement 2024 | 2024-02-01 | OpenAlex | 10.4103/jisppd.jisppd_59_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391972957 | |||
| W4391424698 | Mitochondrial targets in hyperammonemia: Addressing urea cycle function to improve drug therapies | 2024-02-01 | OpenAlex | 10.1016/j.bcp.2024.116034 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391424698 | |||
| W4394962235 | New anticoagulants in 2024: Development of factor XI and XIa inhibitors | 2024-02-01 | OpenAlex | 10.1684/abc.2024.1865 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394962235 | |||
| W4391442241 | Nuclear Cardiology | 2024-02-01 | OpenAlex | 10.1093/med/9780197521434.003.0001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391442241; https://openalex.org/W4391442048 | |||
| W4391447278 | Pathogenesis of COVID-19-Associated Mucormycosis: An Updated Evidence-Based Review | 2024-02-01 | OpenAlex | 10.1007/s12281-024-00484-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391447278 | |||
| W4391723567 | Phase I Studies: Innovations and Issues | 2024-02-01 | OpenAlex | 10.1016/j.clinthera.2024.01.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391723567 | |||
| W4391431161 | Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy | 2024-02-01 | OpenAlex | 10.1158/2767-9764.crc-23-0389 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391431161 | |||
| W4392788185 | Strategies to Achieve Evidence-Based Practice in Nursing | 2024-02-01 | OpenAlex | 10.4037/ccn2024359 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392788185 | |||
| W4391443966 | The Delicate Balance of Diagnosing GI Bleeding in the ED | 2024-02-01 | OpenAlex | 10.1097/01.eem.0001006952.99523.ee | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391443966 | |||
| W4391973331 | The evolutionary phylodynamics of human parechovirus A type 3 reveal multiple recombination events in South Korea | 2024-02-01 | OpenAlex | 10.1002/jmv.29477 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391973331 | |||
| W4391445254 | Tourette Syndrome and Tic Disorders | 2024-02-01 | OpenAlex | 10.1542/pir.2023-006014 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391445254 | |||
| W4391479897 | Contrast Echocardiography in Heart Failure: Update 2023 | 2024-02-02 | OpenAlex | 10.1007/s11897-024-00647-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391479897 | |||
| W4391465956 | Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs) | 2024-02-02 | OpenAlex | 10.1182/blood.2023021789 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391465956 | |||
| W4391485098 | Gesicles packaging dCas9-VPR ribonucleoprotein complexes can combine with vorinostat and promote HIV proviral transcription | 2024-02-02 | OpenAlex | 10.1016/j.omtm.2024.101203 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391485098 | |||
| W4391512658 | We have to cancel psychiatric nursing and forge a new way forward | 2024-02-02 | OpenAlex | 10.1111/inm.13301 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391512658 | |||
| W4391512773 | A review on trends in development and translation of omics signatures in cancer | 2024-02-03 | OpenAlex | 10.1016/j.csbj.2024.01.024 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391512773 | |||
| W4391508246 | Bibliometric Insights Into the Evolving Landscape of Antibiotic Resistance Research: Trends, Collaborations, and Key Foci (1965-2023) | 2024-02-03 | OpenAlex | 10.7759/cureus.53508 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391508246 | |||
| W4391511754 | How should newer therapeutic agents be incorporated into the treatment of patients with myasthenia gravis? | 2024-02-03 | OpenAlex | 10.1002/mus.28038 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4391511754 | |||
| W4391511685 | Mobilising Communities Prior to Healthcare Interventions: Reflections on the Role of Public Health Midwives Working With Vulnerable Communities of Sri Lanka | 2024-02-03 | OpenAlex | 10.1177/2752535x241232000 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391511685 | |||
| W7217111215 | Clinical Pharmacy in Transplant Medicine: Challenges and Innovations | 2024-02-04 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217111215 | ||||
| W4391522243 | Comparative Effectiveness of Oral Hypoglycemic Agents for Glycemic Control and Glycemic Variability in Patients with Type 2 Diabetes Mellitus: Using Flash Glucose Monitoring | 2024-02-04 | OpenAlex | 10.2174/0115733998267817231227102553 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391522243 | |||
| W4391522004 | Treatment of nonmelanoma skin cancer with pro‐differentiation agents and photodynamic therapy: Preclinical and clinical studies (Review) | 2024-02-04 | OpenAlex | 10.1111/php.13914 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4391522004 | |||
| W4391537317 | Anticoagulants for atrial fibrillation: from warfarin and DOACs to the promise of factor XI inhibitors | 2024-02-05 | OpenAlex | 10.3389/fcvm.2024.1352734 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391537317 | |||
| W4392734674 | CDA Formulations as Persuasive Good Cancer Drugs to Save Cancer Patients | 2024-02-05 | OpenAlex | 10.11648/ijcocr.20240901.13 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392734674 | |||
| W4391608654 | Cardiovascular disease burden in patients with urological cancers: The new discipline of uro‐cardio‐oncology | 2024-02-05 | OpenAlex | 10.1002/cai2.108 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391608654 | |||
| W4391566678 | Claudin 18.2 as a New Biomarker in Gastric Cancer—What Should We Know? | 2024-02-05 | OpenAlex | 10.3390/cancers16030679 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391566678 | |||
| W4391536119 | Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM) | 2024-02-05 | OpenAlex | 10.1038/s41408-024-00981-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391536119 | |||
| W4391563724 | Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis | 2024-02-05 | OpenAlex | 10.1016/j.mam.2024.101252 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391563724 | |||
| W4391542732 | Interstitial Lung Disease in Rheumatoid Arthritis: A Review | 2024-02-05 | OpenAlex | 10.7759/cureus.53632 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391542732 | |||
| W4391544246 | Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy | 2024-02-05 | OpenAlex | 10.1021/acsomega.3c06501 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391544246 | |||
| W4391563423 | CDC Laboratory Recommendations for Syphilis Testing, United States, 2024 | 2024-02-06 | OpenAlex | 10.15585/mmwr.rr7301a1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391563423 | |||
| W7221301301 | Capecitabine: A Promising Anticancer Drug: Review Article | 2024-02-06 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221301301 | ||||
| W4391577546 | Cracking the Genomic Code of CDK4/6 Inhibitor Resistance | 2024-02-06 | OpenAlex | 10.1158/1078-0432.ccr-23-3413 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391577546 | |||
| W4391795405 | Identification of ethyl-6-bromo-2((phenylthio)methyl)imidazo[1,2-a]pyridine-3-carboxylate as a narrow spectrum inhibitor of Streptococcus pneumoniae and its FtsZ | 2024-02-06 | OpenAlex | 10.1016/j.ejmech.2024.116196 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391795405 | |||
| W4391613784 | In defence of sociological description: A ‘world‐making’ perspective | 2024-02-06 | OpenAlex | 10.1111/1468-4446.13083 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391613784 | |||
| W4391579112 | Treatment of non-systemic juvenile idiopathic arthritis | 2024-02-06 | OpenAlex | 10.1038/s41584-024-01079-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391579112 | |||
| W4391598116 | Theranostic Innovation by Humane N-of-One Cancer Care in Real-World Patients | 2024-02-07 | OpenAlex | 10.1089/cbr.2023.0198 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391598116 | |||
| W4391651428 | Cdc42-driven endosomal cholesterol transport promotes collateral resistance in HER2-positive gastric cancer | 2024-02-08 | OpenAlex | 10.1016/j.canlet.2024.216702 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391651428 | |||
| W4391640675 | Data from Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium | 2024-02-08 | OpenAlex | 10.1158/2159-8290.c.7065317 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391640675; https://openalex.org/W4391640796; https://openalex.org/W4391640676 | |||
| W4391650316 | Editorial: Pathophysiology, treatment and rehabilitation of atherosclerosis-related diseases in geriatric population | 2024-02-08 | OpenAlex | 10.3389/fmed.2024.1358769 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391650316 | |||
| W4391650138 | Editorial: SARS-CoV-2: implications for maternal-fetal-infant and perinatal mortality, morbidity, pregnancy outcomes and well-being | 2024-02-08 | OpenAlex | 10.3389/fped.2024.1375501 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391650138 | |||
| W4391667818 | Editors’ Choice | 2024-02-08 | OpenAlex | 10.1097/ju.0000000000003838 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391667818 | |||
| W4391654988 | Hemoptysis caused by Parvimonas micra: case report and literature review | 2024-02-08 | OpenAlex | 10.3389/fpubh.2023.1307902 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391654988 | |||
| W4391685248 | An investment behavioral modeling framework for advancing power system transformation toward renewable energy integration | 2024-02-09 | OpenAlex | 10.1016/j.egycc.2024.100127 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391685248 | |||
| W4391691920 | Dual modality intravascular catheter system combining pulse-sampling fluorescence lifetime imaging and polarization-sensitive optical coherence tomography | 2024-02-09 | OpenAlex | 10.1364/boe.516515 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391691920 | |||
| W4391718508 | Orthopaedic Musculoskeletal Biologics Research Impacts Patient Care: The Second Annual Arthroscopy Orthobiologics Virtual Special Issue | 2024-02-09 | OpenAlex | 10.1016/j.arthro.2024.01.046 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391718508 | |||
| W4391855360 | Current advances in pharmacotherapy for schizophrenia | 2024-02-10 | OpenAlex | 10.5124/jkma.2024.67.2.96 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391855360 | |||
| W4394992348 | Perspectives of Women in Microscopy | 2024-02-10 | OpenAlex | 10.1093/mictod/qaae006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394992348 | |||
| W4391733033 | A computational fractional order model for optimal control of wearable healthcare monitoring devices for maternal health | 2024-02-11 | OpenAlex | 10.1016/j.health.2024.100308 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391733033 | |||
| W4391734029 | Exploring Future Horizons in Osteoarthritis Relief: Unveiling the Potential of Slow-Acting Drugs and Innovative Medications | 2024-02-11 | OpenAlex | 10.12775/jehs.2024.58.008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391734029 | |||
| W4391745430 | Data from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy | 2024-02-12 | OpenAlex | 10.1158/2767-9764.c.7070351.v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391745430; https://openalex.org/W4391754522 | |||
| W4391747178 | Preparation and in vitro evaluation of BBG-250 loaded liposomal formulation for anticancer potential | 2024-02-12 | OpenAlex | 10.1186/s43094-024-00581-w | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391747178 | |||
| W4392810364 | Arsenical Keratosis with Unusual Lung Involvement | 2024-02-13 | OpenAlex | 10.4103/idoj.idoj_160_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392810364 | |||
| W4391820054 | FakA impacts antiseptic susceptibility in Staphylococcus aureus and Enterococcus faecalis | 2024-02-13 | OpenAlex | 10.1101/2024.02.13.580087 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391820054 | |||
| W4391810908 | Promise and pitfalls of a natural killer cell signature for HCC detection in patients with HCV with sustained virological response | 2024-02-14 | OpenAlex | 10.1097/hep.0000000000000797 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391810908 | |||
| W4391815678 | Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias | 2024-02-14 | OpenAlex | 10.1007/s00392-024-02383-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391815678 | |||
| W4391837617 | Cost-effectiveness of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing and isolation strategies in nursing homes | 2024-02-15 | OpenAlex | 10.1017/ice.2024.9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391837617 | |||
| W4391883264 | Stereotactic ablative radiation therapy in metastatic prostate cancer | 2024-02-15 | OpenAlex | 10.1097/cco.0000000000001025 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391883264 | |||
| W4391880934 | Animal models in medical translation: the grand challenge of developing new treatments for human diseases | 2024-02-16 | OpenAlex | 10.3389/fmedt.2024.1367521 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391880934 | |||
| W7217738924 | Fluorouracil in Cancer Treatment: Unveiling its Crucial Role | 2024-02-16 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217738924 | ||||
| W4396691076 | Hepatocellular carcinoma: Advances in systemic therapies | 2024-02-16 | OpenAlex | 10.12688/f1000research.145493.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396691076 | |||
| W4391916405 | Perspective of nurses and community health agents on directly observed treatment of tuberculosis in a capital city in northern Brazil | 2024-02-16 | OpenAlex | 10.55905/revconv.17n.2-171 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4391916405 | |||
| W4391881055 | The Benefit of “Negative Thinking” in Transplant Tolerance Induction | 2024-02-16 | OpenAlex | 10.1097/tp.0000000000004933 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391881055 | |||
| W4395015745 | The Evolving Landscape of Dry Eye Disease Therapies | 2024-02-16 | OpenAlex | 10.19080/jojo.2024.10.555793 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395015745 | |||
| W4391874641 | The future of EUS | 2024-02-16 | OpenAlex | 10.1002/9781119697893.ch31 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391874641 | |||
| W4391915614 | Therapeutic targeting of cell transition: ready for clinical prime-time? | 2024-02-16 | OpenAlex | 10.1093/cvr/cvae029 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391915614 | |||
| W4391919254 | A survey on multi-agent reinforcement learning and its application | 2024-02-17 | OpenAlex | 10.1016/j.jai.2024.02.003 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4391919254 | |||
| W4391900134 | The principles of cardiac anaesthesia | 2024-02-17 | OpenAlex | 10.1016/j.mpaic.2023.11.017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391900134 | |||
| W4393337701 | First-in-human gene editing for lipid lowering: the initial results | 2024-02-18 | OpenAlex | 10.1093/cvr/cvae037 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393337701 | |||
| W4391965199 | Alert from Inner Mongolia: two bubonic plague cases reported in China | 2024-02-19 | OpenAlex | 10.1097/gh9.0000000000000411 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391965199 | |||
| W4391933262 | Recent advances on infrared thermography for ceramic tiles detachments diagnosis: literature review | 2024-02-19 | OpenAlex | 10.1007/s41024-024-00387-6 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391933262 | |||
| W4391930320 | Recent and anticipated novel drug approvals for 2024 | 2024-02-19 | OpenAlex | 10.1093/ajhp/zxae046 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391930320 | |||
| W4391954461 | Evaluation of 18F-AlF-labeled IF7 dimer as a promising molecular probe for tumor targeting PET imaging in mice | 2024-02-20 | OpenAlex | 10.1007/s10967-024-09391-z | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391954461 | |||
| W4392107799 | Rifampicin-resistant Tuberculosis: A Global Health Dilemma | 2024-02-20 | OpenAlex | 10.4103/aihb.aihb_15_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392107799 | |||
| W4391972286 | Topotaxis of active particles across long distances by sliding along obstacles | 2024-02-20 | OpenAlex | 10.1103/physrevresearch.6.013178 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4391972286 | |||
| W4392003340 | Ultrasound-Enhancing Agent and IV Administration in Cardiac Sonography: How Sonographers Play a Key Role in Positively Affecting Key Performance Indicators | 2024-02-20 | OpenAlex | 10.1177/87564793241230982 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392003340 | |||
| W4392017175 | Genotyping of UGT1A1 and DPYD polymorphisms in patients with colorectal cancer. A review | 2024-02-21 | OpenAlex | 10.26442/18151434.2023.4.202514 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392017175 | |||
| W4391991379 | The therapeutic potential of immunoengineering for systemic autoimmunity | 2024-02-21 | OpenAlex | 10.1038/s41584-024-01084-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4391991379 | |||
| W4407407562 | Adenosis / Atypical adenomatous hyperplasia of Prostate Gland. Review and Update | 2024-02-22 | OpenAlex | 10.31579/2767-7370/087 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407407562 | |||
| W7120697622 | As relações étnico-raciais em foco: o ensino de leitura do artigo de opinião como instrumento de empoderamento discursivo para transformação social | 2024-02-22 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7120697622 | ||||
| W4392079897 | Diverse mutant selection windows shape spatial heterogeneity in evolving populations | 2024-02-22 | OpenAlex | 10.1371/journal.pcbi.1011878 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392079897 | |||
| W4392109635 | Etiopathogenic Therapeutic Strategies in Behcet's Disease, with Ocular Complications | 2024-02-22 | OpenAlex | 10.9734/bpi/anums/v8/17572d | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392109635 | |||
| W4392084952 | MedLingua: A conceptual framework for a multilingual medical conversational agent | 2024-02-22 | OpenAlex | 10.1016/j.mex.2024.102614 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4392084952 | |||
| W4392040213 | Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management | 2024-02-22 | OpenAlex | 10.3390/jcm13051251 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392040213 | |||
| W4392038843 | Workforce Upskilling for Value-Based Healthcare | 2024-02-22 | OpenAlex | 10.4324/9781032685489-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392038843 | |||
| W4407424618 | APPLICATION OF AGENTIC AI AND CLINICAL REASONING MODELS IN CLINICAL WORKFLOW: A SYSTEMATIC IMPLEMENTATION STUDY OF DOCTORASSIST.AI | 2024-02-23 | OpenAlex | 10.53555/w7hr6r14 | Full text | Excluded | F3: The implemented DoctorAssist clinical-reasoning engine is described through Bayesian networks, causal models, pattern recognition and self-consistency checks. No LLM/VLM-based acting agent is documented. Claimed prospective outcomes are not evidence of an LLM agent. | https://openalex.org/W4407424618 | https://doi.org/10.53555/w7hr6r14 | ||
| W4392162963 | An Introduction to Reinforcement Learning and Its Application in Various Domains | 2024-02-23 | OpenAlex | 10.4018/979-8-3693-1738-9.ch001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392162963 | |||
| W4392102722 | Clinical characteristics, treatment patterns, and outcomes of cytotoxic cutaneous T‐cell lymphomas | 2024-02-23 | OpenAlex | 10.1002/ajh.27266 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392102722 | |||
| W4392132984 | Highlights of Research Activities in Advanced Materials at Wuhan University | 2024-02-23 | OpenAlex | 10.1002/adma.202313766 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392132984 | |||
| W4392111097 | Phototherapy for atopic dermatitis: Is the light still shining? | 2024-02-23 | OpenAlex | 10.1111/jdv.19766 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392111097 | |||
| W4392104517 | The role of maintenance therapy following autologous stem cell transplantation in newly diagnosed multiple myeloma: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT | 2024-02-23 | OpenAlex | 10.1111/bjh.19353 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392104517 | |||
| W4392243604 | A Review: Hospital Acquired Infection in Some Gram Negative Pathogenic Bacterial Strains | 2024-02-26 | OpenAlex | 10.22317/jcms.v10i1.1475 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392243604 | |||
| W4392162536 | Antibiotics for Patients With a Planned Re-Laparotomy for Intra-Abdominal Infection | 2024-02-26 | OpenAlex | 10.1089/sur.2023.255 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392162536 | |||
| W4392269126 | Asian Community of Glycoscience and Glycotechnology (ACGG) conference report 2023 | 2024-02-26 | OpenAlex | 10.1093/glycob/cwae017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392269126 | |||
| W4392157032 | B cell receptor signaling and associated pathways in the pathogenesis of chronic lymphocytic leukemia | 2024-02-26 | OpenAlex | 10.3389/fonc.2024.1339620 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392157032 | |||
| W4392359025 | Effect of an AI agent trained on a large language model (LLM) as an intervention for depression and anxiety symptoms in young adults: a 28-day randomized controlled trial (Preprint) | 2024-02-26 | OpenAlex | 10.2196/preprints.57766 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4392359025 | |||
| W4392159057 | Photonic neuromorphic architecture for tens-of-task lifelong learning | 2024-02-26 | OpenAlex | 10.1038/s41377-024-01395-4 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4392159057 | |||
| W4392163141 | Reflections on proposals for reform of the Individual Income Tax (IIT) in Brazil | 2024-02-26 | OpenAlex | 10.56238/sevened2024.003-042 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392163141 | |||
| W4392200482 | Microbial Spectrum of Keratitis at a Rural Tertiary Care Teaching Hospital | 2024-02-27 | OpenAlex | 10.7759/cureus.55055 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392200482 | |||
| W7119331913 | Uma análise foucaultiana da corrida no ambiente hospitalar: disputa de saberes, poderes e produção de verdades | 2024-02-27 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7119331913 | ||||
| W4392810226 | Advancements in Dermatological Imaging Modalities | 2024-02-28 | OpenAlex | 10.4103/idoj.idoj_852_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392810226 | |||
| W4392234644 | Advice From the Field: Practical Skills, Challenges, and How to Support Early Career Ecologists | 2024-02-28 | OpenAlex | 10.1002/bes2.2127 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392234644 | |||
| W4392236790 | Editorial: The role of cancer associated fibroblast (CAF) in EMT/metastasis in malignancies of epithelial tissues | 2024-02-28 | OpenAlex | 10.3389/fcell.2024.1384150 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392236790 | |||
| W4392232546 | Next-generation therapies for pancreatic cancer | 2024-02-28 | OpenAlex | 10.1080/17474124.2024.2322648 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392232546 | |||
| W7140306560 | SecOps Automation in IoT-Enabled Enterprises: Leveraging Gen AI | 2024-02-28 | OpenAlex | 10.5281/zenodo.19218912 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7140306560 | |||
| W4392293840 | A Clinical Review on Chronic Obstructive Pulmonary Disease | 2024-02-29 | OpenAlex | 10.14218/fim.2023.00026 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392293840 | |||
| W7215252723 | Acute Tonsillitis: Causes, and Management - A Comprehensive Review | 2024-02-29 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215252723 | ||||
| W4392282128 | Antimicrobial Susceptibility Patterns of Enterococcus Species and Molecular Detection of Enterococcus faecalis Isolated from Patients with Urinary Tract Infection in a Tertiary Care Hospital in Bangladesh | 2024-02-29 | OpenAlex | 10.1007/s12088-024-01216-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392282128 | |||
| W4392299049 | Development of Preventive Methods for Drug-induced Cardiotoxicity Using a Large-scale Medical Information Database | 2024-02-29 | OpenAlex | 10.1248/yakushi.23-00164-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392299049 | |||
| W4392303305 | Intra-host genetic diversity of SARS-CoV-2 Omicron variants in children | 2024-02-29 | OpenAlex | 10.1016/j.jinf.2024.106132 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392303305 | |||
| W4394780043 | Medication-Related Osteonecrosis of the Jaw – 2024 Update | 2024-02-29 | OpenAlex | 10.33425/2639-9490.1142 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394780043 | |||
| W4392284873 | Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy | 2024-02-29 | OpenAlex | 10.1097/ju.0000000000003892 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392284873 | |||
| W4392285035 | The Role of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapies in Early-Stage Breast Cancer: Current Practices, Treatment De-escalation, and Future Prospects | 2024-02-29 | OpenAlex | 10.7759/cureus.55230 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392285035 | |||
| W4394860870 | 29 Hospital admissions towards the end of life: an ethical exploration of decision making | 2024-03-01 | OpenAlex | 10.1136/spcare-2024-pcc.47 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394860870 | |||
| W4392597123 | A new frontier in imaging: natural ore-sourced superparamagnetic magnetite nanoparticles for multi-modal imaging | 2024-03-01 | OpenAlex | 10.1007/s13204-023-02993-1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392597123 | |||
| W4394739423 | A rare case of Takotsubo cardiomyopathy. | 2024-03-01 | OpenAlex | 10.26355/eurrev_202403_35619 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394739423 | |||
| W4392366027 | Abstract B032: Use of patient-derived organoids to model tumor evolution in response to chemotherapy | 2024-03-01 | OpenAlex | 10.1158/1557-3265.endo24-b032 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392366027 | |||
| W4392360060 | Editorial: Hepato-pancreato-biliary surgery: innovations, genomics, and prognostic management | 2024-03-01 | OpenAlex | 10.3389/fsurg.2024.1386870 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392360060 | |||
| W4393167294 | Editor’s view | 2024-03-01 | OpenAlex | 10.1093/ageing/afae063 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393167294 | |||
| W4396563265 | Engaging the Deeper Shifts: Content Expansion and Scientific Engagement | 2024-03-01 | OpenAlex | 10.1111/rsr.17069 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396563265 | |||
| W4392401562 | Environmental pollution’s toll on the heart: rethinking cardiovascular risk factors | 2024-03-01 | OpenAlex | 10.1093/ehjopen/oeae017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392401562 | |||
| W4392658768 | From theory to practice: The pragmatic value of applying systems thinking and complexity sciences in healthcare | 2024-03-01 | OpenAlex | 10.1111/jep.13979 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392658768 | |||
| W4392807689 | IMMUNOTHERAPY UTILIZATION PATTERNS IN METASTATIC BLADDER CANCER: ASSESSING INSURANCE STATUS AS A MODIFIABLE FACTOR ASSOCIATED WITH FAILURE TO RECEIVE NOVEL THERAPIES | 2024-03-01 | OpenAlex | 10.1016/j.urolonc.2024.01.102 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392807689 | |||
| W4392791503 | Inflammation, infection, and cardiovascular risk | 2024-03-01 | OpenAlex | 10.1016/s0140-6736(23)02877-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392791503; https://openalex.org/W4392791529; https://openalex.org/W4392791528; https://openalex.org/W4392791527 | |||
| W4392791547 | Inflammation, infection, and cardiovascular risk – Authors' reply | 2024-03-01 | OpenAlex | 10.1016/s0140-6736(23)02878-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392791547 | |||
| W4411498707 | MODEL BASED REINFORCEMENT LEARNING FOR ADAPTIVE HEALTHCARE DECISION SUPPORT SYSTEMS | 2024-03-01 | OpenAlex | 10.21917/ijdsml.2024.0129 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411498707 | |||
| W4393098934 | Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine | 2024-03-01 | OpenAlex | 10.1097/mjt.0000000000001721 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393098934 | |||
| W4392383680 | Pushing the boundaries of radiation technology for the management of central nervous system tumors | 2024-03-01 | OpenAlex | 10.1093/neuonc/noae002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392383680 | |||
| W4392564347 | Sporadic regional re-emergent cholera: a 19th century problem in the 21st century | 2024-03-01 | OpenAlex | 10.1093/jambio/lxae055 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392564347 | |||
| W4392352834 | The Undeniable Allure of New Drugs and Technology for SVT | 2024-03-01 | OpenAlex | 10.1097/01.eem.0001009616.98131.8d | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392352834 | |||
| W4394934839 | Update on chemotherapy modalities for retinoblastoma: Progress and challenges | 2024-03-01 | OpenAlex | 10.1016/j.apjo.2024.100061 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394934839 | |||
| W4392372814 | Abstract A010: Prostate-specific membrane antigen use in glioma management: past, present, and future | 2024-03-04 | OpenAlex | 10.1158/1538-7445.brain23-a010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392372814 | |||
| W4392377402 | Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review | 2024-03-04 | OpenAlex | 10.3390/ph17030334 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392377402 | |||
| W4392448524 | Medication-related osteonecrosis of the jaw: evolving research for multimodality medical management | 2024-03-05 | OpenAlex | 10.1007/s00520-024-08388-4 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4392448524 | |||
| W4392458279 | Metal-Organic Frameworks in Neural Regeneration | 2024-03-05 | OpenAlex | 10.1021/bk-2024-1463.ch010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392458279 | |||
| W4392471085 | Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib | 2024-03-05 | OpenAlex | 10.3390/cancers16051056 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392471085 | |||
| W4396863510 | Recent Developments in the Diagnosis and Management of Infectious Diseases | 2024-03-05 | OpenAlex | 10.21275/mr24316154029 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396863510 | |||
| W4392516015 | Editorial: Transcriptional and posttranscriptional homeostasis in inflammation and inflammatory diseases | 2024-03-06 | OpenAlex | 10.3389/fimmu.2024.1391199 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392516015 | |||
| W4392519878 | Editor’s Spotlight/Take 5: How Does ChatGPT Use Source Information Compared With Google? A Text Network Analysis of Online Health Information | 2024-03-06 | OpenAlex | 10.1097/corr.0000000000003006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392519878 | |||
| W4392501688 | Harnessing the Power of Stimuli‐Responsive Nanoparticles as an Effective Therapeutic Drug Delivery System | 2024-03-06 | OpenAlex | 10.1002/adma.202312939 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392501688 | |||
| W4392570934 | It’s About Blood Pressure Reduction and Control | 2024-03-06 | OpenAlex | 10.1093/ajh/hpae023 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392570934 | |||
| W4392519365 | Novel cardioprotective approaches in ischaemic heart disease | 2024-03-06 | OpenAlex | 10.1093/eurheartj/ehae058 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392519365 | |||
| W4392623318 | Therapy of moderate-to-severe plaque psoriasis | 2024-03-06 | OpenAlex | 10.21518/ms2024-043 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392623318 | |||
| W4392547733 | A Baby Step or a Real Giant Stride: Histomic Enabled by Artificial Intelligence to Predict Treatment Response in Pediatric Patients With Ulcerative Colitis | 2024-03-07 | OpenAlex | 10.1053/j.gastro.2024.03.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392547733 | |||
| W7216952197 | Chemical Profiling of Beta-Lactam and Derivatives for Antimicrobial Potential: A Computational Perspective | 2024-03-07 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7216952197 | ||||
| W4392553229 | Update for surgeons on novel induction treatments for acute severe inflammatory bowel disease associated colitis | 2024-03-07 | OpenAlex | 10.1111/ans.18924 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392553229 | |||
| W4392592167 | A complex molecular landscape to drug delivery concept for achieving precise therapy in psoriasis | 2024-03-08 | OpenAlex | 10.1016/j.medidd.2024.100183 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392592167 | |||
| W4392595400 | Intravenous Ketamine for Suicidal Behavior in Severe Depression with Psychotic Features | 2024-03-08 | OpenAlex | 10.4103/aip.aip_212_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392595400 | |||
| W4393991031 | Modification of Imperfect Cancer Drugs to Become Perfect Cancer Drugs to Save Cancer Patients | 2024-03-08 | OpenAlex | 10.14738/bjhmr.112.16531 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393991031 | |||
| W4392612028 | Nurses’ Ethical Obligations When Caring for Patients With Limited English Proficiency | 2024-03-08 | OpenAlex | 10.4037/aacnacc2024319 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392612028 | |||
| W4392616836 | PCSK9 inhibitors ameliorate arterial stiffness in ACS patients: evidences from mendelian randomization, cohort studies and basic experiments | 2024-03-08 | OpenAlex | 10.21203/rs.3.rs-4008037/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392616836 | |||
| W4392652581 | Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors | 2024-03-11 | OpenAlex | 10.1186/s12957-024-03335-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392652581 | |||
| W4392642097 | Quorum sensing in Mycobacteria: understanding the recognition machinery conundrum through an in-silico approach | 2024-03-11 | OpenAlex | 10.1101/2024.03.06.583649 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392642097 | |||
| W4394762433 | DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study | 2024-03-12 | OpenAlex | 10.1111/bjh.19392 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394762433 | |||
| W4392701856 | Editorial: The evolution in pharmacology of infectious diseases: 2022 | 2024-03-12 | OpenAlex | 10.3389/fphar.2024.1386077 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392701856 | |||
| W4392707060 | From cells to society: untangling the web of stress, inflammation, and social determinants of health | 2024-03-12 | OpenAlex | 10.3389/fsci.2024.1358784 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392707060 | |||
| W4392699881 | The MIRD Schema for Radiopharmaceutical Dosimetry: A Review | 2024-03-12 | OpenAlex | 10.2967/jnmt.123.265668 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392699881 | |||
| W4392710898 | The emerging role of extracellular vesicles in bronchopulmonary dysplasia | 2024-03-12 | OpenAlex | 10.1152/ajplung.00244.2023 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392710898 | |||
| W4392747517 | Landiolol for Treating Arrhythmias: A State-of-The-Art Review | 2024-03-13 | OpenAlex | 10.1097/crd.0000000000000687 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392747517 | |||
| W4392741906 | Living ethics: a stance and its implications in health ethics | 2024-03-13 | OpenAlex | 10.1007/s11019-024-10197-9 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392741906 | |||
| W4392807425 | Angiogenesis Inhibitor Drug-induced Benign Migratory Glossitis in a Patient of Juvenile-onset Recurrent Respiratory Papillomatosis under Maintenance Therapy | 2024-03-14 | OpenAlex | 10.5005/jp-journals-10005-2739 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392807425 | |||
| W4392886223 | Klotho in pregnancy and intrauterine development—potential clinical implications: a review from the European Renal Association CKD-MBD Working Group | 2024-03-14 | OpenAlex | 10.1093/ndt/gfae066 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392886223 | |||
| W4392997099 | COMPARATIVE EVALUATION OF SEVOFLURANE AND ISOFLURANE IN FAST TRACK ANAESTHESIA FOR VALVULAR CARDIAC SURGERY: A RANDOMIZED STUDY | 2024-03-15 | OpenAlex | 10.22159/ijcpr.2024v16i2.4023 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392997099 | |||
| W4392889873 | Activated carbon nanoparticles generated from coffee husk: A pioneering biomaterial for improving drug targeting in cancer | 2024-03-16 | OpenAlex | 10.1016/j.nanoso.2024.101134 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392889873 | |||
| W4392882692 | Epidemiology of perioperative anaphylaxis in France in 2017–2018: the 11th GERAP survey | 2024-03-16 | OpenAlex | 10.1016/j.bja.2024.01.044 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4392882692 | |||
| W4392968347 | 103rd American Association for Thoracic Surgery Presidential Address: Dreamers and pragmatists: A story of our past, present, and future | 2024-03-18 | OpenAlex | 10.1016/j.jtcvs.2024.01.044 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392968347 | |||
| W4394764315 | An epidermal growth factor receptor compound mutation of L858R with S768I in advanced non-small-cell lung cancer: a case report | 2024-03-18 | OpenAlex | 10.1186/s13256-024-04422-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394764315 | |||
| W4392916301 | Transformations in medical education: A prudential perspective | 2024-03-18 | OpenAlex | 10.1002/hcs2.86 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392916301 | |||
| W4392949451 | Flushing and Blushing | 2024-03-19 | OpenAlex | 10.1002/9781119709268.rook104 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392949451 | |||
| W4392971397 | Resurgence and atypical patterns of pertussis in China | 2024-03-19 | OpenAlex | 10.1016/j.jinf.2024.106140 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392971397 | |||
| W4392966589 | Transcutaneous electrical nerve stimulation vs. H-Wave® device stimulation—similar or different? | 2024-03-19 | OpenAlex | 10.3389/fpain.2024.1321148 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4392966589 | |||
| W4392972540 | Enhanced Compound Analysis Using Reactive Paper Spray Mass Spectrometry: Leveraging Schiff Base Reaction for Amino Acid Detection | 2024-03-20 | OpenAlex | 10.1021/acs.analchem.4c00215 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4392972540 | |||
| W4396589586 | On Vili Lehdonvirta’s Cloud Empires: How Digital Platforms Are Overtaking the State and How We Can Regain Control , Cambridge, MA, MIT Press, 2022 | 2024-03-20 | OpenAlex | 10.1093/ser/mwae023 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396589586 | |||
| W4411310291 | Agentic AI-Powered Data Quality Guardians for Regulated Industries | 2024-03-21 | OpenAlex | 10.60087/jaigs.v3i1.378 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4411310291 | |||
| W4393042174 | In Pursuit of Health Equity: A History of Latin American Social Medicine | 2024-03-21 | OpenAlex | 10.1215/00182168-11189730 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393042174 | |||
| W4393040951 | Navigating Lymphomas through BCR Signaling and Double-Hit Insights: Overview | 2024-03-21 | OpenAlex | 10.3390/hematolrep16010017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393040951 | |||
| W4393046179 | The Impact of microRNA SNPs on Breast Cancer: Potential Biomarkers for Disease Detection | 2024-03-21 | OpenAlex | 10.1007/s12033-024-01113-w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4393046179 | |||
| W4393096007 | Abstract 1230: MTX-531, a first-in-class pan-PI3K inhibitor spares hyperinsulinemia yielding durable tumor regressions and resilience to adaptive resistance | 2024-03-22 | OpenAlex | 10.1158/1538-7445.am2024-1230 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393096007 | |||
| W4393072823 | Abstract 1750: Decoding breast cancer: Unraveling subtype and model differences through multi-model single-cell RNA sequencing data integration | 2024-03-22 | OpenAlex | 10.1158/1538-7445.am2024-1750 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393072823 | |||
| W4393096169 | Abstract 2630: Identifying most promising combination therapies for immune suppressive breast cancer using a combined in vitro/in vivo approach | 2024-03-22 | OpenAlex | 10.1158/1538-7445.am2024-2630 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393096169 | |||
| W4393088175 | Abstract 3044: Novel agents with efficacy against germline mutant RUNX1 familial platelet disorder with myeloid malignancy (FPD-MM) | 2024-03-22 | OpenAlex | 10.1158/1538-7445.am2024-3044 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4393088175 | |||
| W4393093595 | Abstract 3470: Evaluation of the association between sickle cell disease and breast cancer using the All of Us Research Program dataset | 2024-03-22 | OpenAlex | 10.1158/1538-7445.am2024-3470 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4393093595 | |||
| W4393087488 | Deciphering the dynamics of methicillin-resistant Staphylococcus aureus biofilm formation: from molecular signaling to nanotherapeutic advances | 2024-03-22 | OpenAlex | 10.1186/s12964-024-01511-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393087488 | |||
| W4393086775 | Revolutionizing Antibacterial Surfaces: 3D Printed Nanoscale and Microscale Topographies through Two-Photon Polymerization | 2024-03-22 | OpenAlex | 10.4028/p-9mqipb | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393086775 | |||
| W4393127044 | Fanconi anemia neuroinflammatory syndrome: brain lesions and neurologic injury in Fanconi anemia | 2024-03-24 | OpenAlex | 10.1182/bloodadvances.2024012577 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4393127044 | |||
| W4393153186 | Haemophilia care in Asia: Learning from clinical practice in some Asian countries | 2024-03-24 | OpenAlex | 10.1111/hae.14998 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393153186 | |||
| W4393158299 | Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape | 2024-03-24 | OpenAlex | 10.3390/v16040498 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393158299 | |||
| W4396981082 | Therapeutic Efficacy of Cold Pressed Virgin Coconut Oil an Adjuvant to Conventional Therapy in Recurrent Aphthous Stomatitis -A Comparative Clinical Study | 2024-03-24 | OpenAlex | 10.33882/jida.15.35385 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396981082 | |||
| W4393183326 | Erosive Lesions in the Legs of an Elderly Woman | 2024-03-26 | OpenAlex | 10.4103/ijd.ijd_851_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4393183326 | |||
| W4393201479 | Innovative Combinations, Cellular Therapies and Bispecific Antibodies for Chronic Lymphocytic Leukemia: A Narrative Review | 2024-03-26 | OpenAlex | 10.3390/cancers16071290 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393201479 | |||
| W4393187156 | SOHO State of the Art Updates and Next Questions: Pre-emptive Therapy at Molecular Measurable Residual Disease Failure in Acute Myeloid Leukemia | 2024-03-26 | OpenAlex | 10.1016/j.clml.2024.03.009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393187156 | |||
| W4393231871 | Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia | 2024-03-27 | OpenAlex | 10.1007/s11899-024-00731-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393231871 | |||
| W4393246517 | Fate Took a Hand at Turning a Probing Mind to Oncology | 2024-03-27 | OpenAlex | 10.1097/01.cot.0001011480.13248.ec | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393246517 | |||
| W4393280296 | New biologics for food allergy | 2024-03-28 | OpenAlex | 10.1097/aci.0000000000000981 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393280296 | |||
| W4393280550 | Recent Advances in Material Technology for Leukemia Treatments | 2024-03-28 | OpenAlex | 10.1002/adma.202313955 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393280550 | |||
| W7216576415 | The Role of Radiologic Imaging in the Management of Sinusitis | 2024-03-28 | OpenAlex | 10.70082/axq05980 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216576415 | |||
| W4401396533 | Antimicrobial resistance as a global public health threat: the way forward | 2024-03-29 | OpenAlex | 10.21303/2504-5695.2024.003336 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401396533 | |||
| W4393332288 | Cardiomyopathies | 2024-03-29 | OpenAlex | 10.1016/b978-1-4557-0599-3.00057-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393332288 | |||
| W4393314173 | Revolutionizing lymph node metastasis imaging: the role of drug delivery systems and future perspectives | 2024-03-29 | OpenAlex | 10.1186/s12951-024-02408-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393314173 | |||
| W4393854310 | Topical retinoids: role and place in acne therapy | 2024-03-29 | OpenAlex | 10.30978/ujdvk2024-1-34 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393854310 | |||
| W4404641266 | Rare Primary and Combined Immunodeficiency Disease: A Case Report from Paediatric Emergency Reception of Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India | 2024-03-30 | OpenAlex | 10.24321/24559318202401 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404641266 | |||
| W4394722796 | Nano-Drone for T2 Turbo Spin Echo (TSE) MRI In Gastric Cancer Mice Model | 2024-03-31 | OpenAlex | 10.4283/jmag.2024.29.1.123 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4394722796 | |||
| W4394710133 | Abstracts of the Diabetes and Ramadan International Alliance (Virtual) Conference 2024, 12 to 13 January, 2024 | 2024-04-01 | OpenAlex | 10.1055/s-0044-1781437 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394710133 | |||
| W4395014102 | Assessing the performance of ChatGPT in psychiatry: A study using clinical cases from foreign medical graduate examination (FMGE) | 2024-04-01 | OpenAlex | 10.4103/indianjpsychiatry.indianjpsychiatry_919_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4395014102 | |||
| W4396801382 | Baclofen Abuse: Better To Be Suspicious Than To Be Cheated | 2024-04-01 | OpenAlex | 10.4103/aip.aip_18_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396801382 | |||
| W4404053592 | Combination of anti-TNFα therapy and surgical resection for severe chronic intestinal rejection: A case report | 2024-04-01 | OpenAlex | 10.1016/j.intf.2024.100025 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404053592 | |||
| W4396496093 | Current Perspectives on Small Bowel Tumors: Overview of Prevalence, Clinical Manifestations, and Treatment Approaches | 2024-04-01 | OpenAlex | 10.33192/smj.v76i4.267555 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396496093 | |||
| W4393947753 | Dental management of people with complex or rare inherited bleeding disorders | 2024-04-01 | OpenAlex | 10.1111/hae.15005 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4393947753 | |||
| W4393374783 | Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient | 2024-04-01 | OpenAlex | 10.1016/j.ijantimicag.2024.107163 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393374783 | |||
| W4400896203 | Emerging Significance and Clinical Application of Liquid Biopsy in Early Diagnosis and Monitoring of Cancer | 2024-04-01 | OpenAlex | 10.4103/jss.jss_129_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400896203 | |||
| W4400077717 | Fitting Things Together | 2024-04-01 | OpenAlex | 10.1215/00318108-11251691 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400077717 | |||
| W7216923368 | Inflammatory Bowel Disease-An Updated Review From Pediatrics Aspects. | 2024-04-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216923368 | ||||
| W4395034631 | Interplay of precision therapeutics and MD study: Calocybe indica's potentials against cervical cancer and its interaction with VEGF via octadecanoic acid | 2024-04-01 | OpenAlex | 10.1111/jcmm.18302 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4395034631 | |||
| W4393393640 | Kinetic coevolutionary models predict the temporal emergence of HIV-1 resistance mutations under drug selection pressure | 2024-04-01 | OpenAlex | 10.1073/pnas.2316662121 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393393640 | |||
| W4400047290 | Multiple Cerebral Infarctions after Treatment of Acquired Factor XIII Deficiency with Retroperitoneal Hematoma | 2024-04-01 | OpenAlex | 10.4103/jets.jets_7_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400047290 | |||
| W4401920524 | Neuroatypical “Moving Mirrors”: exploring the impact of camera movements on individuals with Autism Spectrum Disorders without intellectual disabilities. | 2024-04-01 | OpenAlex | 10.1192/j.eurpsy.2024.357 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401920524 | |||
| W4399878905 | New Music as Generalizable Tonal Predictions: Toward an Anti-Racist Framework | 2024-04-01 | OpenAlex | 10.1215/00222909-10974771 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4399878905 | |||
| W4395077519 | P024 Dermatomyositis, a blurred clinical picture | 2024-04-01 | OpenAlex | 10.1093/rheumatology/keae163.066 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4395077519 | |||
| W4395077102 | P122 Secular trends in prescription of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis: Experience from a UK regional centre (2016-2022) | 2024-04-01 | OpenAlex | 10.1093/rheumatology/keae163.163 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4395077102 | |||
| W4393385972 | Progress in Pharmacologic Management of Neuropsychiatric Syndromes in Neurodegenerative Disorders | 2024-04-01 | OpenAlex | 10.1001/jamaneurol.2024.0586 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393385972 | |||
| W4393389748 | Supporting Convergence Science | 2024-04-01 | OpenAlex | 10.1158/0008-5472.can-24-0618 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393389748 | |||
| W4395001749 | The evolving treatment landscape for BRAF-mutated non-small cell lung cancer | 2024-04-01 | OpenAlex | 10.21037/tlcr-24-117 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395001749 | |||
| W4394894343 | Transcatheter Aspiration and Mechanical Embolectomy of an Intracardiac Mass | 2024-04-01 | OpenAlex | 10.1016/j.jaccas.2024.102251 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394894343 | |||
| W4396968605 | USE OF SGLT2–INHIBITORS IN THE TREATMENT OF ANTHRACICLINE CARDIOTOXICITY | 2024-04-01 | OpenAlex | 10.1093/eurheartjsupp/suae036.433 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396968605 | |||
| W4393929794 | Endovascular embolization by a magnetic microfiberbot | 2024-04-03 | OpenAlex | 10.1093/nsr/nwae117 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393929794 | |||
| W4393987184 | The Sum of All Fears: the Figure of the Anti/Metaphysical Jew in Heidegger’s Black Notebooks (and beyond) | 2024-04-03 | OpenAlex | 10.1163/1477285x-12341354 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4393987184 | |||
| W4393985108 | Coalition of social learning and implementation theory in a federated model to advance practice change | 2024-04-04 | OpenAlex | 10.1111/wvn.12723 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393985108 | |||
| W4393941185 | Editorial Comment to Survival beyond cabazitaxel for metastatic castration‐resistant prostate cancer | 2024-04-04 | OpenAlex | 10.1111/iju.15458 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393941185 | |||
| W4400402565 | Evolution of In-vitro Diagnostics Methods | 2024-04-04 | OpenAlex | 10.60142/ijhti.v3i01.01 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400402565 | |||
| W4393946658 | Oral Psoriasis Therapies | 2024-04-04 | OpenAlex | 10.1016/j.det.2024.02.013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393946658 | |||
| W4393932047 | Real-World Data and Evidence in Lung Cancer: A Review of Recent Developments | 2024-04-04 | OpenAlex | 10.3390/cancers16071414 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393932047 | |||
| W4393987171 | Integrating reinforcement learning and serious games to support people with rare genetic diseases and neurodevelopmental disorders: outcomes on parents and caregivers | 2024-04-05 | OpenAlex | 10.3389/fpsyg.2024.1372769 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4393987171 | |||
| W4394012736 | Spectral Diffusion Analysis in Patients With High Risk for Prostate Cancer: A Feasibility Study | 2024-04-05 | OpenAlex | 10.1002/jmri.29354 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394012736 | |||
| W4393982625 | Stereotactic Neurosurgery: Deep Brain Stimulation, Focused Ultrasound, Therapeutic Radiosurgery, and Biological Therapies | 2024-04-05 | OpenAlex | 10.1016/b978-0-323-93273-8.00018-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393982625 | |||
| W4393986291 | The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults | 2024-04-05 | OpenAlex | 10.3389/fimmu.2024.1378432 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4393986291 | |||
| W4394573723 | Increase in the Number of Medical Requests for D-dimer during the First Wave of COVID-19: A Case Study of a University Hospital in the Metropolitan Region of the State of Rio de Janeiro | 2024-04-06 | OpenAlex | 10.9734/bpi/rudhr/v5/3328g | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394573723 | |||
| W4394579074 | Responsive Supramolecular Polymers for Diagnosis and Treatment | 2024-04-06 | OpenAlex | 10.3390/ijms25074077 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394579074 | |||
| W4403161553 | Sexually transmitted infections (STIs)/HIV linked to human papillomavirus (HPV) in precancerous lesions in Cameroonian women | 2024-04-06 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403161553 | ||||
| W4394571992 | Investigating How the Properties of Electrospun Poly(lactic acid) Fibres Loaded with the Essential Oil Limonene Evolve over Time under Different Storage Conditions | 2024-04-07 | OpenAlex | 10.3390/polym16071005 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394571992 | |||
| W4394060979 | Nitric oxide regulation of fetal and newborn lung development and function | 2024-04-07 | OpenAlex | 10.1016/j.niox.2024.04.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394060979 | |||
| W4394571688 | Essential thrombocythaemia: A contemporary approach with new drugs on the horizon | 2024-04-08 | OpenAlex | 10.1111/bjh.19403 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394571688 | |||
| W4394615531 | Progress in research and treatment of immune checkpoints in breast cancer | 2024-04-08 | OpenAlex | 10.32948/ajo.2024.04.06 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394615531 | |||
| W4394602690 | Cimetidine repurposed as a potential immunomodulatory agent against colorectal carcinoma: A systematic review | 2024-04-09 | OpenAlex | 10.1177/10781552241247007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394602690 | |||
| W4394598240 | Electro-clinical Variables Associated with Clobazam Response in Adults Presenting with Refractory Status Epilepticus: A Retrospective Study (P9-1.005) | 2024-04-09 | OpenAlex | 10.1212/wnl.0000000000205419 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394598240 | |||
| W4394855560 | Guillain-Barré Syndrome in a Patient Receiving Anti-Tumor Necrosis Factor for Crohn Disease: Coincidence or Consequence? | 2024-04-09 | OpenAlex | 10.12659/ajcr.943709 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394855560 | |||
| W4400728410 | Navigating the future of genitourinary cancer treatment: a decade of progress in image-guided surgery | 2024-04-09 | OpenAlex | 10.1097/js9.0000000000001438 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400728410 | |||
| W4394599058 | Trends in Management Practices of Seropositive Neuromyelitis Optica Spectrum Disorder: Lessons from a Multicenter Academic Cohort (P10-14.010) | 2024-04-09 | OpenAlex | 10.1212/wnl.0000000000204954 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394599058 | |||
| W4394683481 | Amphotericin B in the Era of New Antifungals: Where Will It Stand? | 2024-04-10 | OpenAlex | 10.3390/jof10040278 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394683481 | |||
| W4394719740 | Platelet Function in Mood Disorders: Interplay, Clinical Implications, and Future Perspectives – A Narrative Review | 2024-04-10 | OpenAlex | 10.4103/hm.hm-d-23-00066 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394719740 | |||
| W4394687232 | Rare genetic skeletal disorders: Evolving terminology, therapies, education and advocacy | 2024-04-10 | OpenAlex | 10.1016/j.jposna.2024.100057 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394687232 | |||
| W4394692587 | ‘It's like getting an Uber for sex’: social networking apps as spaces of risk and opportunity in the Philippines among men who have sex with men | 2024-04-10 | OpenAlex | 10.4324/9781032716855-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394692587 | |||
| W4394755169 | Chemical Strategies for the Detection and Elimination of Senescent Cells | 2024-04-11 | OpenAlex | 10.1021/acs.accounts.3c00794 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394755169 | |||
| W4394720828 | Dupilumab improves congenital ichthyosis | 2024-04-11 | OpenAlex | 10.1111/ddg.15358 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394720828 | |||
| W4394727612 | Metaverse: a new reality in surgery. Review | 2024-04-11 | OpenAlex | 10.17816/psaic1774 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394727612 | |||
| W7166444725 | Advancements in Multiple Sclerosis Research: From Pathogenesis to Novel Therapeutic Strategies | 2024-04-12 | OpenAlex | 10.61096/ijrpp.v13.iss2.2024.54-62 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166444725 | |||
| W4394741713 | Reinforcement Learning in Healthcare | 2024-04-12 | OpenAlex | 10.1002/9781394214068.ch15 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394741713 | |||
| W4394810127 | Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors | 2024-04-15 | OpenAlex | 10.1186/s12935-024-03315-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394810127 | |||
| W4394834842 | Database Decomposition to satisfy the Least Privilege Principle in Healthcare | 2024-04-15 | OpenAlex | 10.56394/aris2.v4i1.43 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4394834842 | |||
| W4394820383 | Evolving Understanding of Patients’ Experiences in Acute Care Trials Without Prospective Consent* | 2024-04-15 | OpenAlex | 10.1097/ccm.0000000000006221 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394820383 | |||
| W4396230980 | Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical and Translational Neuropsychiatry | 2024-04-15 | OpenAlex | 10.3390/books978-3-7258-0860-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396230980 | |||
| W4394823995 | The application of antibody-based agents in cancer therapy based on their mechanisms of action | 2024-04-15 | OpenAlex | 10.1016/j.fmre.2024.02.021 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394823995 | |||
| W4394884838 | Bonding Performance of Universal Adhesive in Different Etching Modes: A Review | 2024-04-16 | OpenAlex | 10.52403/ijhsr.20240446 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394884838 | |||
| W4394853364 | Editorial: Small molecules and smart drug delivery systems for combination cancer immunotherapy | 2024-04-16 | OpenAlex | 10.3389/fchem.2024.1412624 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394853364 | |||
| W4394796410 | Essential oils for clinical aromatherapy: A comprehensive review | 2024-04-16 | OpenAlex | 10.1016/j.jep.2024.118180 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394796410 | |||
| W4394840568 | Microsoft AI Expert: APA, MH Professionals Must Help Guide Future of AI and Mental Health | 2024-04-16 | OpenAlex | 10.1176/appi.pn.2024.05.5.10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394840568 | |||
| W4394846837 | Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs | 2024-04-16 | OpenAlex | 10.1177/03008916241246659 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394846837 | |||
| W4394933525 | Care of the critically ill begins in the emergency medicine setting | 2024-04-17 | OpenAlex | 10.1097/mej.0000000000001134 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394933525 | |||
| W4394874515 | Lipoarabinomannan modification as a source of phenotypic heterogeneity in host-adapted Mycobacterium abscessus isolates | 2024-04-17 | OpenAlex | 10.1073/pnas.2403206121 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4394874515 | |||
| W4394903386 | Rethinking European Integration in Times of Crisis | 2024-04-17 | OpenAlex | 10.5406/23300841.69.2.06 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4394903386 | |||
| W4394879091 | The Outcomes of Biologic Therapies for Fistulizing Crohn's Disease: A Systematic Review | 2024-04-17 | OpenAlex | 10.9734/jammr/2024/v36i55434 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394879091 | |||
| W4394975806 | Real World Experience of the First Cardio-Oncology Unit Implantation in Morocco | 2024-04-20 | OpenAlex | 10.9734/ca/2024/v13i2406 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4394975806 | |||
| W4395008750 | A Novel Pan-Proteome Array for High-Throughput Profiling of the Humoral Response to Treponema pallidum subsp. pallidum : a Pre-Clinical Study | 2024-04-21 | OpenAlex | 10.1101/2024.04.20.590429 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4395008750 | |||
| W4395695860 | Advancements in immunotherapy for glomerulonephritis: promising treatments on the horizon | 2024-04-22 | OpenAlex | 10.47391/jpma.10666 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395695860 | |||
| W4395005797 | Focus on current and emerging treatment options for glioma: A comprehensive review | 2024-04-22 | OpenAlex | 10.5306/wjco.v15.i4.482 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395005797 | |||
| W4395020302 | Global Use of Cryopreserved Platelets | 2024-04-22 | OpenAlex | 10.17945/kjbt.2024.35.1.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395020302 | |||
| W4394994129 | Kennedy Terminal Ulcers and Trombley-Brennan Terminal Tissue Injuries: Mystery Solved? | 2024-04-22 | OpenAlex | 10.1097/asw.0000000000000132 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4394994129 | |||
| W4395045826 | The current landscape for diabetes treatment: Preventing diabetes-associated CV risk | 2024-04-22 | OpenAlex | 10.1016/j.atherosclerosis.2024.117560 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395045826 | |||
| W4403034264 | Comparative Efficacy of 2% Hyperbaric Prilocaine vs 0.5% Hyperbaric Bupivacaine in Spinal Anesthesia for Urologic Endoscopy Procedures | 2024-04-23 | OpenAlex | 10.17116/pain20242203119 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403034264 | |||
| W4395048816 | Contrast transthoracic echocardiography in a patient with drug‐induced hypersensitivity syndrome with right atrial thrombus: A case report and mini review | 2024-04-23 | OpenAlex | 10.1002/pdi3.52 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4395048816 | |||
| W4395052228 | Engineered extracellular vesicles for cancer drug delivery and therapeutics | 2024-04-23 | OpenAlex | 10.1016/j.cophys.2024.100755 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395052228 | |||
| W4395043095 | Investigational drugs for the treatment of acromegaly: new agents to transform therapy | 2024-04-23 | OpenAlex | 10.1080/13543784.2024.2343056 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4395043095 | |||
| W4395116315 | Pseudoaneurysm formation following transarterial embolization of traumatic carotid-cavernous fistula with detachable balloon: An institutional cohort long-term study | 2024-04-24 | OpenAlex | 10.4329/wjr.v16.i4.94 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4395116315 | |||
| W4395068084 | Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn’s Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study | 2024-04-24 | OpenAlex | 10.1007/s12325-024-02825-w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4395068084 | |||
| W4395463712 | Genomic surveillance and pathogen intelligence | 2024-04-25 | OpenAlex | 10.3389/fsci.2024.1397048 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395463712 | |||
| W4395455414 | Severe cutaneous adverse reactions | 2024-04-25 | OpenAlex | 10.1038/s41572-024-00514-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395455414 | |||
| W4395464182 | The new SH3_T domain increases the structural and functional variability among SH3b-like CBDs from staphylococcal phage endolysins | 2024-04-25 | OpenAlex | 10.1101/2024.04.22.590666 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4395464182 | |||
| W4395467740 | Updates in the Management of Crohn's Disease | 2024-04-25 | OpenAlex | 10.1055/s-0044-1786382 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395467740 | |||
| W4395447651 | What’s New in Spine Surgery | 2024-04-25 | OpenAlex | 10.2106/jbjs.24.00133 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395447651 | |||
| W4395665919 | Advancements in Reinforcement Learning | 2024-04-26 | OpenAlex | 10.48175/ijarsct-17820 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395665919 | |||
| W4395666708 | Anti-inflammatory and anti-diabetic properties of indanone derivative isolated from Fernandoa adenophylla in vitro and in silico studies | 2024-04-26 | OpenAlex | 10.1038/s41598-024-59703-2 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4395666708 | |||
| W4395668839 | Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective | 2024-04-26 | OpenAlex | 10.1186/s11658-024-00571-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395668839 | |||
| W7135330925 | Health Effects of High Radon Environments in Central Europe | 2024-04-26 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135330925 | ||||
| W4395666880 | Infectious complications before and after pediatric liver transplantation | 2024-04-26 | OpenAlex | 10.1201/9781003341741-10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395666880 | |||
| W4395674649 | Journal of Population and Therapeutics and Clinical Pharmacology | 2024-04-26 | OpenAlex | 10.53555//jptcp.v29i04.5961 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395674649 | |||
| W4395702042 | Chikungunya Seroprevalence among Patients Presenting with Febrile illnesses in selected health facilities in Mt. Elgon region, Kenya | 2024-04-27 | OpenAlex | 10.1101/2024.04.26.24306414 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4395702042 | |||
| W4396220378 | Clinical Theranostics in Recurrent Gliomas: A Review | 2024-04-28 | OpenAlex | 10.3390/cancers16091715 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396220378 | |||
| W4396217159 | Current Landscape of Cancer Immunotherapy: Harnessing the Immune Arsenal to Overcome Immune Evasion | 2024-04-28 | OpenAlex | 10.3390/biology13050307 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396217159 | |||
| W4395957116 | Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials | 2024-04-28 | OpenAlex | 10.1016/j.clinre.2024.102357 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4395957116 | |||
| W4396222413 | A New Therapeutic Approach Utilizes Probiotics, Prebiotics, Synbiotics, Postbiotics, and Gut Microbiota | 2024-04-29 | OpenAlex | 10.20944/preprints202404.1866.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396222413 | |||
| W4396231581 | Alpha and Beta Radiation for Theragnostics | 2024-04-29 | OpenAlex | 10.1016/j.cpet.2024.03.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396231581 | |||
| W4396212909 | Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology | 2024-04-29 | OpenAlex | 10.1159/000539075 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396212909 | |||
| W4396231607 | EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer | 2024-04-29 | OpenAlex | 10.1016/j.eururo.2024.04.010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396231607; https://openalex.org/W7212033222 | |||
| W4396617110 | Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma—A Literature Review | 2024-04-29 | OpenAlex | 10.3390/curroncol31050188 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396617110 | |||
| W4396569073 | Advancements in understanding and addressing Alzheimer's disease: a comprehensive review | 2024-04-30 | OpenAlex | 10.18203/2320-6012.ijrms20241276 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396569073 | |||
| W4396497972 | Editorial: Future research questions for improving COPD diagnosis and care | 2024-04-30 | OpenAlex | 10.3389/fmed.2024.1411350 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396497972 | |||
| W4396528145 | Editorial: Neglected tropical diseases: tackling the challenges of a global world | 2024-04-30 | OpenAlex | 10.3389/ftox.2024.1417438 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396528145 | |||
| W4396518098 | Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology | 2024-04-30 | OpenAlex | 10.1016/j.esmoop.2024.103005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396518098 | |||
| W4396508390 | Innovations in Peripheral Nerve Regeneration | 2024-04-30 | OpenAlex | 10.3390/bioengineering11050444 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396508390 | |||
| W4398235135 | #1193 Tracking kidney cancer initiation via somatic mutation analysis of pre-cancer cells from Von Hippel Lindau cancer predisposition syndrome | 2024-05-01 | OpenAlex | 10.1093/ndt/gfae069.122 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4398235135 | |||
| W4398756018 | #2168 Lupus nephritis histopathological classification system: a questionnaire-based survey of the Renal Pathology Society (RPS) | 2024-05-01 | OpenAlex | 10.1093/ndt/gfae069.326 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4398756018 | |||
| W4398232439 | #2659 Clinical characteristics of patients with minimal change disease (MCD) that evolved to focal sclerosing glomerulosclerosis (FSGS) | 2024-05-01 | OpenAlex | 10.1093/ndt/gfae069.1272 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4398232439 | |||
| W4398233924 | #2982 Shifts in SGLT2 inhibitor initiation in CKD non-dialysis patients | 2024-05-01 | OpenAlex | 10.1093/ndt/gfae069.1505 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4398233924 | |||
| W4397007007 | 291P Perceptions of antibody drug conjugate (ADC)-induced nausea and vomiting: Results of a survey of healthcare providers at ESMO | 2024-05-01 | OpenAlex | 10.1016/j.esmoop.2024.103348 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4397007007 | |||
| W4396703565 | A review of recent advances in the use of complex metal nanostructures for biomedical applications from diagnosis to treatment | 2024-05-01 | OpenAlex | 10.1002/wnan.1959 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396703565 | |||
| W4403387187 | Actualizaciones clínicas en enfermedades pulmonares intersticiales: estrategias diagnósticas y terapéuticas avanzadas | 2024-05-01 | OpenAlex | 10.1016/j.rmclc.2024.05.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403387187 | |||
| W4399648443 | Antibody–Antibiotic Conjugates: A Comprehensive Review on Their Therapeutic Potentials Against BacterialInfections | 2024-05-01 | OpenAlex | 10.1002/jcla.25071 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399648443 | |||
| W4399385454 | Artificial intelligence and assisted reproductive technology: Applying a reproductive justice lens | 2024-05-01 | OpenAlex | 10.1177/13505068241258053 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399385454 | |||
| W4398784513 | British HIV Association guidelines on the management of opportunistic infection in people living with HIV : The clinical management of pulmonary opportunistic infections 2024 | 2024-05-01 | OpenAlex | 10.1111/hiv.13637 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398784513 | |||
| W4396801043 | Comparative evaluation of remineralization potential of novel bioactive agents on eroded enamel lesions: A single-blinded in vitro study | 2024-05-01 | OpenAlex | 10.4103/jcde.jcde_62_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396801043 | |||
| W4396598410 | Enhancing children's participation in dental research: A commentary | 2024-05-01 | OpenAlex | 10.1111/cdoe.12970 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396598410 | |||
| W4400292268 | Identification of Circular Patterns in Capsule Endoscopy Bubble Frames | 2024-05-01 | OpenAlex | 10.4103/jmss.jmss_50_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400292268 | |||
| W4401432341 | Oncogenic Driver Mutations in Nonsmall Cell Lung Cancer | 2024-05-01 | OpenAlex | 10.4103/pulmon.pulmon_20_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401432341 | |||
| W4396573738 | P58 An antiviral dilemma -- reflections on the pocapavir predicament | 2024-05-01 | OpenAlex | 10.1136/bmjpo-2024-nppg.68 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396573738 | |||
| W4396561140 | Pediatric Pulmonary Hypertension | 2024-05-01 | OpenAlex | 10.1542/pir.2023-006010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396561140 | |||
| W4406310622 | Role of co-trimoxazole in current medical practice | 2024-05-01 | OpenAlex | 10.4103/kleuhsj.kleuhsj_571_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406310622 | |||
| W4396591185 | Abstract PO2-10-08: Contemporary HER2-Positive MBC Treatment Recommendations Among Community Healthcare Professionals: Analysis of an Online Interactive Decision Support Tool | 2024-05-02 | OpenAlex | 10.1158/1538-7445.sabcs23-po2-10-08 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396591185 | |||
| W4396587707 | Abstract PO2-17-01: Impact of the introduction of CDK4/6 inhibitors on treatment duration in patients with HR+, HER2– advanced breast cancer: Final analysis of TreatER+ight, a Canadian prospective, real-world, observational study | 2024-05-02 | OpenAlex | 10.1158/1538-7445.sabcs23-po2-17-01 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396587707 | |||
| W4396587570 | Abstract PO2-20-10: Exceptional long-term disease control on pembrolizumab monotherapy in a patient with TMB-high PMS2-mutated MMR-deficient triple negative breast cancer brain metastasis | 2024-05-02 | OpenAlex | 10.1158/1538-7445.sabcs23-po2-20-10 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396587570 | |||
| W4396588269 | Abstract PO3-13-07: MUC1-C INTEGRATES CHRONIC ACTIVATION OF INTERFERON PATHWAYS WITH CHROMATIN REMODELING IN TREATMENT RESISTANCE OF TRIPLE-NEGATIVE BREAST CANCER | 2024-05-02 | OpenAlex | 10.1158/1538-7445.sabcs23-po3-13-07 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4396588269 | |||
| W4396588733 | Are we closer to a standard of care for Richter’s syndrome? Novel treatments on the horizon | 2024-05-02 | OpenAlex | 10.1080/17474086.2024.2350528 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396588733 | |||
| W4396577198 | Biomaterials-mediated radiation-induced diseases treatment and radiation protection | 2024-05-02 | OpenAlex | 10.1016/j.jconrel.2024.04.044 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396577198 | |||
| W4396597152 | Effectiveness of CAR-T treatment toward the potential risk of second malignancies | 2024-05-02 | OpenAlex | 10.3389/fimmu.2024.1384002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396597152 | |||
| W4396577541 | Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US | 2024-05-02 | OpenAlex | 10.1001/jamanetworkopen.2024.9417 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396577541 | |||
| W4396622858 | mRNA-based therapeutic strategies for cancer treatment | 2024-05-02 | OpenAlex | 10.1016/j.ymthe.2024.04.035 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396622858 | |||
| W4396613261 | A Review on Pharmacological Advancement of Ellagic Acid | 2024-05-03 | OpenAlex | 10.1177/0976500x241240634 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396613261 | |||
| W4396641162 | A modular simulation framework for organ allocation | 2024-05-03 | OpenAlex | 10.1016/j.healun.2024.04.063 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396641162 | |||
| W4396601853 | Application of Smart Materials in Dental Sciences | 2024-05-03 | OpenAlex | 10.1002/9781394186488.ch4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396601853 | |||
| W4396624115 | Evolving Characteristics of Gadolinium‐Based Contrast Agents for MR Imaging: A Systematic Review of the Importance of Relaxivity | 2024-05-03 | OpenAlex | 10.1002/jmri.29367 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4396624115 | |||
| W4396604365 | Neuroendovascular Rescue 2025 | 2024-05-03 | OpenAlex | 10.1016/j.ncl.2024.03.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396604365 | |||
| W4396606872 | Outcomes of Monoclonal Antibody Use in Patients with COVID-19 (Preprint) | 2024-05-03 | OpenAlex | 10.2196/preprints.60175 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396606872 | |||
| W4396623814 | Radiological and Molecular Analysis of Radioiodinated Anastrozole and Epirubicin as Innovative Radiopharmaceuticals Targeting Methylenetetrahydrofolate Dehydrogenase 2 in Solid Tumors | 2024-05-03 | OpenAlex | 10.3390/pharmaceutics16050616 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396623814 | |||
| W4396605818 | The evolving treatment landscape of metastatic urothelial cancer | 2024-05-03 | OpenAlex | 10.1038/s41585-024-00872-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396605818 | |||
| W4396640052 | Evaluating osteoporosis and bone quality in the aging spine: modern considerations for surgical management in the geriatric population | 2024-05-04 | OpenAlex | 10.1007/s11357-024-01171-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396640052 | |||
| W4396641648 | Harnessing Metal Nanoparticles: Revolutionizing Cancer Therapy Through Targeted Drug Delivery and Tumor Microenvironment Modulation | 2024-05-04 | OpenAlex | 10.1142/s1793292024300081 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396641648 | |||
| W4396634090 | Real-time and high-sensitive colorimetric sensor based on photonic crystal for amniotic fluid identification | 2024-05-04 | OpenAlex | 10.1016/j.microc.2024.110691 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396634090 | |||
| W4399291302 | Clinical Insights and Therapeutic Advancements: The Evolving Role of Magaldrate in Gastrointestinal Health | 2024-05-05 | OpenAlex | 10.21275/sr24314180539 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4399291302 | |||
| W4396673253 | Comparative Analysis of the Medical Equipment Management Process in Colombo Gampaha and Kaluthara Districts | 2024-05-06 | OpenAlex | 10.4038/sljma.v24i2.5433 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396673253 | |||
| W4396676305 | Kidney Failure in Pauci-immune Crescentic Glomerulonephritis: Rationale for Immunosuppression to Improve Kidney Outcome | 2024-05-06 | OpenAlex | 10.1007/s11926-024-01150-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396676305 | |||
| W4396705763 | Cancer drugs and acute kidney injury: new therapies and new challenges | 2024-05-07 | OpenAlex | 10.1097/mnh.0000000000001001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396705763 | |||
| W4396699972 | DEPLOYING ARTIFICIAL INTELLIGENCE INTO DAILY LIFE: ARTIFICIAL INTELLIGENCE FOR CYBER SECURITY WITH MORE OPPORTUNITIES | 2024-05-07 | OpenAlex | 10.58532/nbennurch336 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4396699972 | |||
| W4396700370 | Editorial: Combinational therapy and nanotechnologies in combating pathogenic microbes and antibiotic resistance | 2024-05-07 | OpenAlex | 10.3389/fphar.2024.1406043 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396700370 | |||
| W4396865966 | Focus on ischaemic heart disease: prevention with colchicine, role of the brain–heart axis, new therapeutic targets for ischaemia–reperfusion injury | 2024-05-07 | OpenAlex | 10.1093/eurheartj/ehae270 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396865966 | |||
| W4396694000 | GOLDIC Therapy Holds Promise as an Orthobiologic Agent: A Systematic Review of the Literature | 2024-05-07 | OpenAlex | 10.1007/s43465-024-01167-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396694000 | |||
| W4396693494 | Real‐world multicentre observational study of effectiveness and toxicity in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab | 2024-05-07 | OpenAlex | 10.1111/jdv.20066 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396693494 | |||
| W4402513718 | Advancing cervical cancer treatment: integrating immunotherapy with chemoradiotherapy | 2024-05-08 | OpenAlex | 10.1097/io9.0000000000000059 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402513718 | |||
| W4396720244 | CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition | 2024-05-08 | OpenAlex | 10.1158/1078-0432.ccr-24-0562 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4396720244 | |||
| W4396812850 | Exploring the Applications of Complex Adaptive Systems in the Real World: A Review | 2024-05-08 | OpenAlex | 10.2174/9789815179606124010009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396812850 | |||
| W4396758990 | Léiomyosarcome portal : une localisation extrêmement rare ! | 2024-05-08 | OpenAlex | 10.1016/j.ancard.2024.101759 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396758990 | |||
| W4396779231 | 3D bioprinted microneedles: merging drug delivery and scaffold science for tissue-specific applications | 2024-05-09 | OpenAlex | 10.1080/17425247.2024.2351928 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396779231 | |||
| W4396811386 | Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease | 2024-05-09 | OpenAlex | 10.1111/bjh.19519 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4396811386 | |||
| W7218071207 | Complete Pathological Response in Advanced Hepatocellular Carcinoma: Be Brave | 2024-05-09 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7218071207 | ||||
| W4396766573 | FcRn Inhibitor Therapies in Neurologic Diseases | 2024-05-09 | OpenAlex | 10.1007/s40263-024-01090-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396766573 | |||
| W4396760266 | From nature to nanomedicine: bioengineered metallic nanoparticles bridge the gap for medical applications | 2024-05-09 | OpenAlex | 10.1186/s11671-024-04021-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396760266 | |||
| W4396948232 | Blastocystis hominis-associated Acute Appendicular Peritonitis in a 9-Year-old Boy: A Case Report and a Comprehensive Review of the Literature | 2024-05-10 | OpenAlex | 10.1097/inf.0000000000004396 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396948232 | |||
| W4396837467 | Mechanistic and Clinical Chemoprevention | 2024-05-10 | OpenAlex | 10.1016/b978-0-323-95488-4.00058-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396837467 | |||
| W4396806733 | Report on Mortalities of Nile Tilapia (Oreochromis niloticus) Due to Tilapinevirus tilapiae and Co-infecting Bacteria in Winter Season | 2024-05-10 | OpenAlex | 10.18805/ijar.b-5297 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4396806733 | |||
| W4399542955 | Severe cases of SARS-CoV-2 in individuals with alcoholic liver disease and cirrhosis: Understanding the impediments to intensive care unit ventilation | 2024-05-10 | OpenAlex | 10.52768/jjgastro/1199 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399542955 | |||
| W4396869140 | A Grover-Like Skin Rash: A Potential Indicator of Underlying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection | 2024-05-12 | OpenAlex | 10.7759/cureus.60173 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396869140 | |||
| W4396859608 | Immunotherapy as a Complement to Surgical Management of Hepatocellular Carcinoma | 2024-05-12 | OpenAlex | 10.3390/cancers16101852 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396859608 | |||
| W4401231277 | Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases—a debate | 2024-05-13 | OpenAlex | 10.1093/jac/dkae158 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401231277 | |||
| W4396874003 | Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities | 2024-05-13 | OpenAlex | 10.1016/j.tips.2024.04.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396874003 | |||
| W4396869800 | Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutics | 2024-05-13 | OpenAlex | 10.31237/osf.io/ndsq5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396869800; https://openalex.org/W4403251548; https://openalex.org/W4401507524; https://openalex.org/W4399033746; https://openalex.org/W4400486943; https://openalex.org/W4401507150; https://openalex.org/W4406231709; https://openalex.org/W4409112112 | |||
| W4401766862 | Quality Indicators Common to All Gastrointestinal Endoscopic Procedures | 2024-05-13 | OpenAlex | 10.14309/ajg.0000000000002988 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401766862 | |||
| W4396901790 | Research hotspots and trends in biological agents for psoriasis: Visualization and bibliometric analysis | 2024-05-13 | OpenAlex | 10.1016/j.heliyon.2024.e31054 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396901790 | |||
| W4396857683 | Unraveling TAFRO Syndrome: An In-Depth Look at the Pathophysiology, Management, and Future Perspectives | 2024-05-13 | OpenAlex | 10.3390/biomedicines12051076 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396857683 | |||
| W4396898626 | Bibliometric Analysis of Clinical Trials on the Effect of Sugar Alcohol Consumption on Oral Health: Trends, Insights, and Future Directions (1967-2024) | 2024-05-14 | OpenAlex | 10.7759/cureus.60248 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396898626 | |||
| W4396902620 | Bringing global hematology research to the forefront | 2024-05-14 | OpenAlex | 10.1182/bloodadvances.2023011873 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396902620 | |||
| W4396886577 | Recent advances in interventional cardiology for coronary artery disease: a systematic literature review | 2024-05-14 | OpenAlex | 10.51798/sijis.v5isi1.767 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396886577 | |||
| W4396894102 | The times are changing: A primer on novel clinical trial designs and endpoints in critical care research | 2024-05-14 | OpenAlex | 10.1093/ajhp/zxae134 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396894102 | |||
| W4396917490 | Breast Cancer Brain Metastasis: A Comprehensive Review | 2024-05-15 | OpenAlex | 10.1200/op.23.00794 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396917490 | |||
| W4396937332 | CATH-2-derived antimicrobial peptide inhibits multidrug-resistant Escherichia coli infection in chickens | 2024-05-15 | OpenAlex | 10.3389/fcimb.2024.1390934 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4396937332 | |||
| W4396935697 | Emerging targeted therapies and strategies to overcome resistance in biliary tract cancers | 2024-05-15 | OpenAlex | 10.1016/j.critrevonc.2024.104388 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396935697 | |||
| W4402514497 | Enhancing surgical safety: the promise of plastic wound protectors in reducing surgical site infections in open abdominal surgeries | 2024-05-15 | OpenAlex | 10.1097/io9.0000000000000086 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402514497 | |||
| W4396962685 | Octreotide versus Terlipressin as Adjuvant to Endoscopic Variceal Band Ligation in Bleeding Oesophageal Varices: A Systematic Review and Meta-Analysis | 2024-05-15 | OpenAlex | 10.3390/gastroent15020028 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396962685 | |||
| W7132521793 | Ultragarsas su kontrastu | 2024-05-15 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7132521793 | ||||
| W4396950489 | A predictive algorithm for the analysis of AMR trends and healthcare decision support | 2024-05-16 | OpenAlex | 10.12688/wellcomeopenres.21289.1 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4396950489 | |||
| W4396978916 | A universal preference for animate agents in hominids | 2024-05-16 | OpenAlex | 10.1016/j.isci.2024.109996 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4396978916 | |||
| W4396952426 | Emerging treatments in HER2-positive advanced breast cancer: Keep raising the bar | 2024-05-16 | OpenAlex | 10.1016/j.xcrm.2024.101575 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4396952426 | |||
| W4396951441 | The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer | 2024-05-16 | OpenAlex | 10.1016/j.ctrv.2024.102761 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4396951441 | |||
| W4397012842 | Abstract IA016: The evolving role of immune-based treatment strategies in metastatic urothelial cancer | 2024-05-17 | OpenAlex | 10.1158/1557-3265.bladder24-ia016 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4397012842 | |||
| W4397000035 | Twin Prime Editing Mediated Exon Skipping/Reinsertion for Restored Collagen VII Expression in Recessive Dystrophic Epidermolysis Bullosa | 2024-05-17 | OpenAlex | 10.1016/j.jid.2024.04.013 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4397000035 | |||
| W4397016795 | Virtual health assistants: a grand challenge in health communications and behavior change | 2024-05-17 | OpenAlex | 10.3389/fdgth.2024.1418695 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4397016795 | |||
| W4397038890 | First study with positive cardiovascular outcome in obesity: Reflections on SELECT | 2024-05-18 | OpenAlex | 10.1002/agm2.12300 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4397038890 | |||
| W4397031223 | Safety of tofacitinib in IBD: A tricky puzzle | 2024-05-18 | OpenAlex | 10.1002/ueg2.12587 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4397031223 | |||
| W4397040060 | Urban people’s preferences for life-sustaining treatment or artificial nutrition and hydration in advance decisions | 2024-05-18 | OpenAlex | 10.1186/s12910-024-01060-w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4397040060 | |||
| W4397288956 | Panoramic view of artificial fruit ripening agents sensing technologies and the exigency of developing smart, rapid, and portable detection devices: A review | 2024-05-19 | OpenAlex | 10.1016/j.cis.2024.103199 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4397288956 | |||
| W4398142342 | Current understanding and management of CAR T cell-associated toxicities | 2024-05-20 | OpenAlex | 10.1038/s41571-024-00903-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398142342 | |||
| W4398132593 | Editorial: Urological cancer awareness month – 2022 | 2024-05-20 | OpenAlex | 10.3389/fruro.2024.1278688 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398132593 | |||
| W4398174265 | Heartfelt Healing: Charting New Trajectories in Postsurgical Pain | 2024-05-20 | OpenAlex | 10.1213/ane.0000000000006871 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398174265 | |||
| W4398131334 | IMPROVEMENT OF CAPILLAROSCOPY METHOD FOR STUDYING HUMAN MICROCIRCULATION | 2024-05-20 | OpenAlex | 10.31718/2077-1096.24.2.257 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4398131334 | |||
| W4407712937 | Nanocellulose for Sustainable Future Materials | 2024-05-20 | OpenAlex | 10.62422/978-81-970328-7-5-019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407712937 | |||
| W4398169305 | Painful Yellow-White Nodules Over Feet in an Alcoholic Male | 2024-05-20 | OpenAlex | 10.4103/idoj.idoj_588_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4398169305 | |||
| W4398182649 | A guide to prescribing systemic treatments for psoriasis during pregnancy, breastfeeding and in those trying to conceive: what does the current evidence suggest? | 2024-05-21 | OpenAlex | 10.1093/ced/llae209 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398182649 | |||
| W4398169320 | Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this? | 2024-05-21 | OpenAlex | 10.1080/17474086.2024.2357274 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398169320 | |||
| W4398175879 | Safety and tolerability of radiotherapy in combination with systemic targeted therapies for treatment of hepatocellular carcinoma: a narrative review | 2024-05-21 | OpenAlex | 10.21037/cco-23-140 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398175879 | |||
| W4398184113 | Use of topical methylene blue to image nuclear morphometry with a low-cost scanning darkfield microendoscope | 2024-05-21 | OpenAlex | 10.1117/1.jbo.29.5.050501 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4398184113 | |||
| W4398205666 | Evolving or immutable - phase I solid tumor trials in the era of precision oncology | 2024-05-22 | OpenAlex | 10.1007/s10637-024-01445-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398205666 | |||
| W4398204506 | Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options | 2024-05-22 | OpenAlex | 10.3390/ijms25115640 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398204506 | |||
| W4398254453 | Moving the needle for oncology dose optimization: A call for action | 2024-05-22 | OpenAlex | 10.1002/psp4.13157 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398254453; https://openalex.org/W4396869858 | |||
| W4398211556 | Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges | 2024-05-22 | OpenAlex | 10.4254/wjh.v16.i5.731 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398211556 | |||
| W4399123611 | Advances in Interferon Therapy for Myeloproliferative Neoplasms | 2024-05-23 | OpenAlex | 10.1097/01.cot.0001024068.38723.15 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399123611 | |||
| W4398241141 | COVID-19: the renaissance of science in the face of adversity | 2024-05-23 | OpenAlex | 10.3389/fsci.2024.1419497 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398241141 | |||
| W3035534707 | Comparison of antimicrobial susceptibility testing practices in 20 clinical microbiology laboratories in India | 2024-05-23 | OpenAlex | 10.4103/jacm.jacm_15_17 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W3035534707 | |||
| W4398252927 | Decontaminants Used After Biorisk Material Decontamination: Environmental Impact and the Role of Drones in Detection and Remediation of Resistance in Ecosystems | 2024-05-23 | OpenAlex | 10.58769/joinssr.1379496 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398252927 | |||
| W3130263631 | Editorial on antibiotic susceptibility testing | 2024-05-23 | OpenAlex | 10.4103/jacm.jacm_14_17 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W3130263631 | |||
| W4398235982 | Editorial: 2022 in review: allergen immunotherapy | 2024-05-23 | OpenAlex | 10.3389/falgy.2024.1431413 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398235982 | |||
| W4398780615 | Extracellular vesicles: A new frontier in the theranostics of cardiovascular diseases | 2024-05-23 | OpenAlex | 10.1002/ird3.77 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398780615 | |||
| W4398267803 | Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma? | 2024-05-23 | OpenAlex | 10.1093/jnci/djae099 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398267803 | |||
| W4398247096 | Multidisciplinary Standards and Evolving Therapies for Patients With Pancreatic Cancer | 2024-05-23 | OpenAlex | 10.1200/edbk_438598 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4398247096 | |||
| W4398267792 | Novel horizons in anticoagulation: the emerging role of factor XI inhibitors across different settings | 2024-05-23 | OpenAlex | 10.3324/haematol.2023.283682 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398267792 | |||
| W4398763615 | Evaluation of type 1 diabetes’ partial clinical remission after three years of heterologous adipose tissue derived stromal/stem cells transplantation associated with vitamin D supplementation | 2024-05-24 | OpenAlex | 10.1186/s13098-024-01302-2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4398763615 | |||
| W4398767383 | Exploring Acute Kidney Injury Following Aortic Dissection | 2024-05-24 | OpenAlex | 10.1097/crd.0000000000000717 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398767383 | |||
| W4399088753 | Exploring Nature's Pharmacy: A Comprehensive Review of Natural Products as Potential Sources of Therapeutic Agents | 2024-05-24 | OpenAlex | 10.46610/rrddd.2024.v06i01.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399088753 | |||
| W4398765703 | United Kingdom and Ireland Oesophagogastric Cancer Group Cancer Update 2023 | 2024-05-24 | OpenAlex | 10.1016/j.clon.2024.04.013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398765703 | |||
| W4399095709 | A Comprehensive Review on Evolving Landscape of Drug Therapies for Diabetes | 2024-05-25 | OpenAlex | 10.9734/bpi/mria/v4/11972f | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399095709 | |||
| W4399051956 | Dedication: JBMR‐A special edition recognizing James M. Anderson, M.D., Ph.D. | 2024-05-26 | OpenAlex | 10.1002/jbm.a.37733 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399051956 | |||
| W4399029949 | Middle Eastern Expert Opinion: Strategies for Successful Antifungal Stewardship Program Implementation in Invasive Fungal Infections | 2024-05-26 | OpenAlex | 10.7759/cureus.61127 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399029949 | |||
| W4399027514 | New therapies for unresectable or metastatic cutaneous eyelid and orbital melanoma | 2024-05-26 | OpenAlex | 10.1080/01676830.2024.2351514 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399027514 | |||
| W4404043317 | Challenges with Bruton’s Tyrosine Kinase Inhibitors Treatment | 2024-05-27 | OpenAlex | 10.19080/ctoij.2024.27.556203 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404043317 | |||
| W4399036015 | Investigating the disparities among drug categories in drug-induced dermatomyositis: A systematic review | 2024-05-27 | OpenAlex | 10.1016/j.semarthrit.2024.152478 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399036015 | |||
| W4399054612 | The physiology of evolution | 2024-05-27 | OpenAlex | 10.1113/jp284432 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4399054612 | |||
| W4399087787 | Correlation between Genomic Variants and Worldwide COVID-19 Epidemiology | 2024-05-28 | OpenAlex | 10.3390/jpm14060579 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399087787 | |||
| W4399079777 | Immunotherapy in Colorectal Cancer — Finding the Achilles’ Heel | 2024-05-28 | OpenAlex | 10.1056/evidra2300353 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399079777 | |||
| W4399076497 | Perturbed Lipid Metabolism Transduction Pathways in SARS-CoV-2 Infection and Their Possible Treating Nutraceuticals | 2024-05-28 | OpenAlex | 10.1080/27697061.2024.2359084 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399076497 | |||
| W4399101368 | Rho-Associated Protein Kinase Inhibitors and Primary Open-Angle Glaucoma | 2024-05-28 | OpenAlex | 10.1201/9781003522980-19 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399101368 | |||
| W4399091919 | Safe Administration of Medication in School: Policy Statement | 2024-05-28 | OpenAlex | 10.1542/peds.2024-066839 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399091919 | |||
| W4399077767 | Supplements and Performance-Enhancing Agents | 2024-05-28 | OpenAlex | 10.1201/9781003525561-7 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4399077767 | |||
| W4401367441 | The Science behind Ashwagandha: A Review of its Therapeutic Potential | 2024-05-28 | OpenAlex | 10.52711/0975-4385.2024.00022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401367441 | |||
| W4399093473 | When Should I Consider Anti-Vascular Endothelial Growth Factor Treatment for Retinopathy of Prematurity? | 2024-05-28 | OpenAlex | 10.1201/9781003523703-49 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399093473 | |||
| W4399077263 | Which Vaccines Should Patients With IBD Receive? | 2024-05-28 | OpenAlex | 10.1201/9781003523567-51 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399077263 | |||
| W4399118477 | Contemporary management of patients with advanced melanoma: Utility of an online interactive decision support tool to assess concordance of healthcare professional treatment patterns with expert recommendations. | 2024-05-29 | OpenAlex | 10.1200/jco.2024.42.16_suppl.e13548 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399118477 | |||
| W4399118501 | Opportunity cost of oncology subspecialist opinion. | 2024-05-29 | OpenAlex | 10.1200/jco.2024.42.16_suppl.e13578 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399118501 | |||
| W4399139847 | Theranostic Potential of Bacteriophages against Oral Squamous Cell Carcinoma | 2024-05-29 | OpenAlex | 10.2174/0115665232305905240521081553 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399139847 | |||
| W4399186145 | Editorial: Editor’s challenge in medical physics and imaging: quantitative medical imaging | 2024-05-30 | OpenAlex | 10.3389/fphy.2024.1434129 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399186145 | |||
| W4399166529 | Immunomodulators | 2024-05-30 | OpenAlex | 10.1201/9781003523017-19 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399166529 | |||
| W4399156690 | Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review | 2024-05-30 | OpenAlex | 10.1080/14737140.2024.2362192 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399156690 | |||
| W4399154984 | Physiologic Monitors and Patient Support Equipment | 2024-05-30 | OpenAlex | 10.4324/9781003522485-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399154984 | |||
| W4399176411 | The evolving landscape of tissue‐agnostic therapies in precision oncology | 2024-05-30 | OpenAlex | 10.3322/caac.21844 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399176411 | |||
| W4399157357 | The role of immunotherapy in urological cancers | 2024-05-30 | OpenAlex | 10.4081/aiua.2024.12307 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399157357 | |||
| W4399181395 | Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome | 2024-05-30 | OpenAlex | 10.1007/s11864-024-01217-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399181395 | |||
| W4399203309 | 28 Comparative analysis of the medical equipment management process in Colombo Gampaha and Kaluthara districts in Sri Lanka | 2024-05-31 | OpenAlex | 10.1136/leader-2024-fmlm.28 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399203309 | |||
| W4399204785 | Bispecific and multispecific antibodies in oncology: opportunities and challenges | 2024-05-31 | OpenAlex | 10.1038/s41571-024-00905-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399204785 | |||
| W4399215885 | Editorial: Metallodrugs in cancer therapy: past, present and new strategies | 2024-05-31 | OpenAlex | 10.3389/fchem.2024.1428502 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399215885 | |||
| W4399199518 | ‘The Doctor in Search of Herself’: women doctors’ autobiographies, second wave feminism, and the feminist women’s health movement, 1976-1987 | 2024-05-31 | OpenAlex | 10.1136/medhum-2023-012881 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4399199518 | |||
| W4402048195 | A message from the editor | 2024-06-01 | OpenAlex | 10.1111/jacf.12617 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402048195 | |||
| W4401327500 | A modular, open-label, phase I/IIa study to evaluate the safety, tolerability, pharmacokinetics (PKs) and anti-tumour activity of a first-in-class (FIC) specific dUTPase inhibitor CV6-168 combined with anti-cancer treatments in patients (pts) with advanced malignancies. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.tps3170 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401327500 | |||
| W4399263269 | ADVANCES IN COCRYSTALS OF ANTICANCER AGENTS: FORMULATION STRATEGIES AND THERAPEUTIC IMPLICATIONS | 2024-06-01 | OpenAlex | 10.22159/ijpps.2024v16i6.51044 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4399263269 | |||
| W4400272567 | AFT-50 EndoMAP: A phase IB/II multicohort study of targeted agents and/or immunotherapy for patients with recurrent or persistent endometrial cancer (EC). | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.tps5642 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400272567 | |||
| W4399574121 | Acute haemodynamic decompensation in the era of substrate-based ablation: rare but still worrisome | 2024-06-01 | OpenAlex | 10.1093/europace/euae144 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399574121 | |||
| W4399305325 | Adapting a prescreening program from VHIO to match molecular alterations in over 10,000 patients' tumors with targeted agents and immunotherapies in early clinical trials. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.e23071 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4399305325 | |||
| W4400367425 | An Unusual Case of Cycloheximide-Resistant Aspergillus Candidus Onychomycosis | 2024-06-01 | OpenAlex | 10.33425/2690-8077.1113 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400367425 | |||
| W4400109132 | Analysis of outcomes in resected early-stage non-small cell lung cancer (NSCLC) with rare targetable driver mutations. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.8052 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400109132 | |||
| W4400074661 | Applications of Artificial Intelligence in Prostate Cancer Care: A Path to Enhanced Efficiency and Outcomes | 2024-06-01 | OpenAlex | 10.1200/edbk_438516 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400074661 | |||
| W7127210042 | Be careful! A Portuguese project about critical thinking and information literacy to counteract disinformation in an academic context | 2024-06-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7127210042 | ||||
| W4400109051 | Cost analysis of targeted and immunotherapies in operable esophageal and non-small cell lung cancers. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.8051 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400109051 | |||
| W4400122498 | Efficacy and safety of regorafenib as a first-line agent alone or in combination with an immune checkpoint inhibitor for advanced hepatocellular carcinoma: a retrospective cohort study | 2024-06-01 | OpenAlex | 10.21037/jgo-24-315 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400122498 | |||
| W4399663261 | Emerging Novel Functional Imaging and Immunotherapy in Renal Cell Carcinoma and Current Treatment Sequencing Strategies After Immunotherapy | 2024-06-01 | OpenAlex | 10.1200/edbk_438658 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399663261 | |||
| W4399978861 | Feasibility of Wastewater‐based Public Health Monitoring Systems in Texas’ Small Rural Communities | 2024-06-01 | OpenAlex | 10.1111/j.1936-704x.2024.3406.x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399978861 | |||
| W4399323478 | Genomic alterations (GA) in ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) patients (pts) with metastatic breast cancer (MBC): Co-occurrence and prevalence along treatment course. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.1060 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399323478 | |||
| W4399603125 | Institutionalizing | 2024-06-01 | OpenAlex | 10.1093/ahr/rhae178 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4399603125 | |||
| W4400272476 | Knowledge and confidence gaps in differentiating PARP inhibitors among community oncology providers. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.e21002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400272476 | |||
| W4399592329 | Next generation imidazothiazole and imidazooxazole derivatives as potential drugs against brain-eating amoebae | 2024-06-01 | OpenAlex | 10.1007/s00436-024-08255-5 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4399592329 | |||
| W4399257825 | Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma | 2024-06-01 | OpenAlex | 10.1186/s13045-024-01560-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399257825 | |||
| W4399484353 | OP0085 CLINICAL FEATURES OF PATIENTS WITH SpA, WITH OR WITHOUT IBD: RESULTS FROM THE METEOR COHORT | 2024-06-01 | OpenAlex | 10.1136/annrheumdis-2024-eular.5211 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399484353 | |||
| W4399296224 | Obesity—A wicked challenge | 2024-06-01 | OpenAlex | 10.1111/1747-0080.12884 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399296224 | |||
| W4400193189 | P328 Autoimmune hepatitis management: an age-old problem | 2024-06-01 | OpenAlex | 10.1136/gutjnl-2024-bsg.410 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400193189 | |||
| W4399487185 | Patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) with BRAF V600E and/or K601E mutation status: A real-world view of effectiveness of lenvatinib monotherapy. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.6098 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399487185 | |||
| W4400063159 | Presence and Absence in Enemies, A Love Story: An Essay on Familism, Traditionalism, and Ultranationalism | 2024-06-01 | OpenAlex | 10.5325/pir.1.2.0002 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400063159 | |||
| W4399325190 | Radiosurgery to 5 or more newly diagnosed brain metastases in the systemic therapy era. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.2026 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399325190 | |||
| W4400264597 | Real-world cost of disease progression (PD) after frontline (1L) R-CHOP in diffuse large B-cell lymphoma (DLBCL): An analysis of a large US claims database. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.e19036 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400264597 | |||
| W4399323426 | Real-world treatment patterns, healthcare resource utilization and costs of care among newly-diagnosed patients with HR+/HER2- metastatic breast cancer. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.1073 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399323426 | |||
| W4399276479 | Sport, physical exercise and the body in modern France | 2024-06-01 | OpenAlex | 10.1093/fh/crae016 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4399276479 | |||
| W4400273172 | Stereotactic radiosurgery (SRS) for non-small cell lung cancer (NSCLC) in the oncogene-addicted era: A real-world UK tertiary center experience. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.e14011 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400273172 | |||
| W4399394681 | Survival outcomes for metastatic castration sensitive prostate cancer: Real world data from a Danish cohort 2016-2022. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.e17088 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399394681 | |||
| W4399280261 | Targeted interventions to address local challenges in HR+/HER2- and HER2+ breast cancer treatment in community-based settings. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.e23213 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399280261 | |||
| W4399519637 | The results of adding immunotherapy to chemotherapy in patients with small cell lung cancer: Registurk-Lung study—Real-world data. | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.e20006 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399519637 | |||
| W4401222866 | Therapeutic Patient Education for Severe Mental Disorders: A Systematic Review | 2024-06-01 | OpenAlex | 10.1192/bjo.2024.209 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401222866 | |||
| W4399275705 | US commercial health plan coverage dynamics in pulmonary arterial hypertension therapies | 2024-06-01 | OpenAlex | 10.18553/jmcp.2024.30.6.541 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399275705 | |||
| W4399394254 | Understanding patient and provider preferences in management of metastatic renal cell carcinoma (mRCC). | 2024-06-01 | OpenAlex | 10.1200/jco.2024.42.16_suppl.e16530 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399394254 | |||
| W4403177232 | Vitamin A-loaded decellularized kidney capsule promoted wound healing in rat | 2024-06-01 | OpenAlex | 10.1016/j.reth.2024.09.017 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403177232 | |||
| W4401753070 | Beyond the Stethoscope: Operationalizing Interactive Clinical Reasoning in Large Language Models via Proactive Information Seeking | 2024-06-03 | OpenAlex | 10.1109/ichi61247.2024.00090 | Full text | Excluded | F4: The complete published contribution is a single-page conference abstract. It describes within-consultation information seeking, self-reflection and expertise augmentation, without a documented retained experience update reused on later different cases. The related MediQ paper was not substituted for this report. | https://openalex.org/W4401753070 | https://ieeexplore.ieee.org/document/10628958 | Entire one-page published PDF read online; no additional methods or references are present. | |
| W4399282535 | Clinical landscape of macrophage-reprogramming cancer immunotherapies | 2024-06-03 | OpenAlex | 10.1038/s41416-024-02715-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399282535 | |||
| W4399294389 | Conference Abstracts - Case Reports | 2024-06-03 | OpenAlex | 10.4103/ghep.ghep_8_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399294389 | |||
| W4400423089 | Design and redesign journey of a drug for transthyretin amyloidosis | 2024-06-03 | OpenAlex | 10.4103/nrr.nrr-d-24-00056 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400423089 | |||
| W4399422636 | Family Health Strategy: Reflections focusing on community health workers | 2024-06-03 | OpenAlex | 10.56238/isevmjv3n3-009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399422636 | |||
| W4399445745 | Health Education: self-esteem as a topic for adolescents in a state school in Curitiba, state of Paraná | 2024-06-03 | OpenAlex | 10.22533/at.ed.1594492431054 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399445745 | |||
| W4398977540 | Replication Data for: Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutics | 2024-06-03 | OpenAlex | 10.7910/dvn/vxhebf | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4398977540 | |||
| W4399329605 | Editorial: Molecular diagnostic methods for bacteria and fungi detection | 2024-06-04 | OpenAlex | 10.3389/fcimb.2024.1430630 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399329605 | |||
| W4399323593 | Epidemiology of Pediatric Respiratory Tract Infections During the COVID-19 Era: A Retrospective Multicentric Study of Hospitalized Children in Lebanon Between October 2018 and March 2021 | 2024-06-04 | OpenAlex | 10.7759/cureus.61669 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399323593 | |||
| W4399361433 | Evolving Strategies for Use of Phytochemicals in Prevention and Long-Term Management of Cardiovascular Diseases (CVD) | 2024-06-04 | OpenAlex | 10.3390/ijms25116176 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399361433 | |||
| W4401687792 | Switching from ex vivo to in vivo: approaches and considerations for generating cell therapies directly in the patient upon in vivo gene delivery | 2024-06-04 | OpenAlex | 10.18609/cgti.2024.076 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401687792 | |||
| W4399364970 | Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-1 | 2024-06-05 | OpenAlex | 10.1007/s13205-024-04022-6 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4399364970 | |||
| W4399385680 | Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma: Nivolumab or brentuximab vedotin with the AVD regimen | 2024-06-05 | OpenAlex | 10.1002/pbc.31091 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399385680 | |||
| W4399354469 | Semaglutide for weight loss: unanswered questions | 2024-06-05 | OpenAlex | 10.3389/fendo.2024.1382814 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399354469 | |||
| W4401461276 | A COMPREHENSIVE CASE STUDY AND LITERATURE ANALYSIS ON THE EFFICACY OF ANTI-VEGF MEDICATION IN TREATING BRANCH RETINAL VEIN OCCLUSION | 2024-06-06 | OpenAlex | 10.15547/tjs.2024.01.013 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401461276 | |||
| W4399443177 | An Atypical Case of Hemolytic Uremic Syndrome Caused by Shiga Toxin Produced by Aeromonas spp. | 2024-06-06 | OpenAlex | 10.7759/cureus.61859 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399443177 | |||
| W4399544335 | Editorial: Quantitative bone imaging methods | 2024-06-06 | OpenAlex | 10.3389/fendo.2024.1411512 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399544335 | |||
| W4399386931 | Remission of Prediabetes and Diabetes | 2024-06-06 | OpenAlex | 10.3329/bjm.v35i20.73342 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399386931 | |||
| W4399390490 | Synergizing Nanomaterials and Artificial Intelligence in Advanced Optical Biosensors for Precision Antimicrobial Resistance Diagnosis | 2024-06-06 | OpenAlex | 10.1021/acssynbio.4c00070 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399390490 | |||
| W4399412981 | Transforming medical education: Conversational Generative Pre-trained Transformer’s (ChatGPT) integral role in simulation zones | 2024-06-06 | OpenAlex | 10.4103/ija.ija_196_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399412981 | |||
| W4399428149 | An AI-Powered Computer Vision Module for Social Interactive Agents | 2024-06-07 | OpenAlex | 10.1145/3657242.3658601 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4399428149 | |||
| W4399422462 | Current Approaches and Novel Agents in the Treatment of Chronic Lymphocytic Leukemia | 2024-06-07 | OpenAlex | 10.1200/op.23.00770 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4399422462 | |||
| W4399531095 | Editorial: Real-world data and real-world evidence in lung cancer | 2024-06-07 | OpenAlex | 10.3389/fonc.2024.1436077 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399531095 | |||
| W4399439031 | Navigating Europe's sustainable anaesthesia pathway | 2024-06-07 | OpenAlex | 10.1097/eja.0000000000001993 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399439031 | |||
| W4399433658 | Pediatric inflammatory multisystem syndrome or Kawasaki disease - continuous challenges in Pediatrics - case report | 2024-06-07 | OpenAlex | 10.37897/rjp.2024.2.2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399433658 | |||
| W4399460414 | Pathophysiology of dry eye disease and novel therapeutic agents | 2024-06-08 | OpenAlex | 10.4102/aveh.v83i1.874 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4399460414 | |||
| W4399475774 | Healthcare security in cloud‐based wireless sensor networks: Botnet attack detection via autoencoder‐aided goal‐based artificial intelligent agent | 2024-06-09 | OpenAlex | 10.1002/cpe.8152 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4399475774 | |||
| W4399504365 | Abstract A013: NF1 loss is syntetic lethal with Trastuzumab emtansine | 2024-06-10 | OpenAlex | 10.1158/1538-8514.synthleth24-a013 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4399504365 | |||
| W4399490563 | Improving Outcomes in Nosocomial Pneumonia: Recent Evidence and More Challenges | 2024-06-10 | OpenAlex | 10.3390/pathogens13060495 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399490563 | |||
| W4399488497 | Opening the Black Box of the Effects of Instructional Support on Collaborative Diagnostic Processes with Process Mining | 2024-06-10 | OpenAlex | 10.22318/cscl2024.740370 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399488497 | |||
| W4399479628 | Present and future of aptamers applications: A patent review. | 2024-06-10 | OpenAlex | 10.22541/au.171805150.08474596/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399479628 | |||
| W4399545315 | Access to novel therapies for Duchenne muscular dystrophy—Insights from expert treating physicians | 2024-06-11 | OpenAlex | 10.1002/cns3.20076 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399545315 | |||
| W4399596006 | An Aggressive Case of Cryoglobulinemia and Membranoproliferative Glomerulonephritis: A Case Report | 2024-06-11 | OpenAlex | 10.7759/cureus.62193 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399596006 | |||
| W4399544080 | Breast cancer epigenetics: current and evolving treatment | 2024-06-11 | OpenAlex | 10.1007/s12282-024-01601-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399544080 | |||
| W4399517991 | Fostering collaboration in simulations: How advanced learners benefit from collaboration scripts and reflection | 2024-06-11 | OpenAlex | 10.1016/j.learninstruc.2024.101912 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399517991 | |||
| W4399514102 | The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer | 2024-06-11 | OpenAlex | 10.20517/cdr.2023.120 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399514102 | |||
| W4403107797 | Immunotherapy in Gynecologic (Ovary, Endometrium and Servics) Cancer | 2024-06-12 | OpenAlex | 10.69860/nobel.9786053359388.15 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403107797 | |||
| W4399561820 | The role of urban and regional planning in the provision of social infrastructure | 2024-06-12 | OpenAlex | 10.4337/9781800883130.00034 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4399561820 | |||
| W4399668351 | Diagnosis and Medical Treatment of Acute and Chronic Idiopathic Pouchitis in Inflammatory Bowel Disease | 2024-06-13 | OpenAlex | 10.3390/medicina60060979 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399668351 | |||
| W4399604328 | Early Initiation of Guideline-Directed Medical Therapy for Heart Failure After Cardiac Surgery | 2024-06-13 | OpenAlex | 10.1016/j.athoracsur.2024.05.034 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399604328 | |||
| W4399656987 | Effects of Prenatal Nicotine Exposure on Short-Term and Long-Term Memory: A Literature Review | 2024-06-13 | OpenAlex | 10.26685/urncst.594 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4399656987; https://openalex.org/W4409486144 | |||
| W4399604392 | SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health | 2024-06-13 | OpenAlex | 10.1016/j.xkme.2024.100851 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399604392 | |||
| W4399687038 | The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease | 2024-06-13 | OpenAlex | 10.1080/17474086.2024.2366540 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4399687038 | |||
| W4399684168 | 883-P: Brain-Directed AAV-FGF21 Gene Therapy Reverses Type 2 Diabetes, Obesity, and Cognitive Decline | 2024-06-14 | OpenAlex | 10.2337/db24-883-p | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4399684168 | |||
| W4399776187 | Consenso de expertos basado en la evidencia: perfilamiento y manejo del carcinoma epitelial de ovario de alto grado avanzado | 2024-06-14 | OpenAlex | 10.18597/rcog.4094 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399776187 | |||
| W4399711267 | Optimizing anticoagulant therapy: is pharmacist-led intervention the best | 2024-06-14 | OpenAlex | 10.1093/ehjqcco/qcae047 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399711267 | |||
| W7120819989 | The lived experiences of childbearing in a basti : performing pregnancy and relationships in Jaipur, India | 2024-06-14 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7120819989 | ||||
| W4399689779 | The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials | 2024-06-14 | OpenAlex | 10.3389/fmed.2024.1384454 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399689779 | |||
| W4399701881 | A Rare Case of Gastric Metastasis from a Rare Case of Mucosal Malignant Melanoma | 2024-06-15 | OpenAlex | 10.3889/oamjms.2024.11917 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399701881 | |||
| W4399709466 | Peptic ulcer disease | 2024-06-15 | OpenAlex | 10.1016/s0140-6736(24)00155-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399709466 | |||
| W4404585908 | Silver Nanoparticle as a Modern Era in Antimicrobial Activity | 2024-06-15 | OpenAlex | 10.22270/ajprd.v11i3.1407 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404585908 | |||
| W4399755844 | Past, present and future of drug safety: Editorial | 2024-06-16 | OpenAlex | 10.1111/bcp.16140 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399755844 | |||
| W4399737484 | A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer | 2024-06-17 | OpenAlex | 10.1007/s13346-024-01648-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399737484 | |||
| W4399731858 | Advances in Evaluation of Electrode Insertion Trauma Induced Residual Hearing loss in Cochlear Implant Recipients and its significance- A Narrative Review | 2024-06-17 | OpenAlex | 10.1007/s12070-024-04801-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399731858 | |||
| W4399724811 | Epigenetic Fingerprints in IBD: From Methylation Patterns to Clinical Implications | 2024-06-17 | OpenAlex | 10.1093/ecco-jcc/jjae086 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399724811 | |||
| W4399836058 | Immunoengineering for autoimmune-kidney disease | 2024-06-18 | OpenAlex | 10.1093/ndt/gfae140 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399836058 | |||
| W4399773418 | Phage Therapy | 2024-06-18 | OpenAlex | 10.1201/9781003055211-54 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399773418 | |||
| W4399799615 | Editorial: aquaporins in health and disease | 2024-06-19 | OpenAlex | 10.1113/jp286369 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399799615 | |||
| W4399906584 | Kidney involvement in myelodysplastic syndromes | 2024-06-19 | OpenAlex | 10.1093/ckj/sfae185 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399906584 | |||
| W4400921354 | Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum | 2024-06-20 | OpenAlex | 10.1093/cid/ciae321 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400921354 | |||
| W4399872066 | Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non‐small cell lung cancer | 2024-06-20 | OpenAlex | 10.1002/ijc.35031 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399872066 | |||
| W4399858899 | Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia | 2024-06-20 | OpenAlex | 10.4081/btvb.2024.127 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399858899 | |||
| W4400657984 | Treatment approaches for older Hodgkin lymphoma patients | 2024-06-20 | OpenAlex | 10.1097/cco.0000000000001071 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400657984 | |||
| W4400657832 | What is the best salvage therapy for Hodgkin lymphoma? | 2024-06-20 | OpenAlex | 10.1097/cco.0000000000001073 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400657832 | |||
| W4399907221 | Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects | 2024-06-21 | OpenAlex | 10.3390/biom14070734 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399907221 | |||
| W4399890732 | From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy | 2024-06-21 | OpenAlex | 10.1186/s40168-024-01825-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399890732 | |||
| W4399895284 | Interstitial lung abnormalities evolving to histologically proven nonspecific interstitial pneumonia | 2024-06-21 | OpenAlex | 10.1016/b978-0-323-93522-7.00013-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399895284 | |||
| W4399892303 | Metformin: pioneering a path forward in knee osteoarthritis care? | 2024-06-21 | OpenAlex | 10.1097/ms9.0000000000002318 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399892303 | |||
| W4399881216 | Top advances of the year: Targeted therapy for lung cancer | 2024-06-21 | OpenAlex | 10.1002/cncr.35423 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399881216 | |||
| W4411040064 | Artificial Intelligence and Machine Learning | 2024-06-22 | OpenAlex | 10.71443/9788197282164 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411040064 | |||
| W4399925981 | Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine | 2024-06-22 | OpenAlex | 10.1016/j.ymthe.2024.06.029 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4399925981 | |||
| W4399948503 | The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations | 2024-06-22 | OpenAlex | 10.3390/cimb46070377 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4399948503 | |||
| W4399913503 | To Adapt or Not to Adapt ? Older Adults Enacting Agency in Dialogues with an Unknowledgeable Agent | 2024-06-22 | OpenAlex | 10.1145/3627043.3659562 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399913503 | |||
| W4399973055 | A Comprehensive Review of Simulation Technology: Development, Methods, Applications, Challenges and Future Trends | 2024-06-24 | OpenAlex | 10.62677/ijetaa.2405119 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399973055 | |||
| W4399981765 | Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates | 2024-06-24 | OpenAlex | 10.1016/j.pnpbp.2024.111069 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399981765 | |||
| W4400017011 | Cancer therapy in patients with reduced kidney function | 2024-06-24 | OpenAlex | 10.1093/ndt/gfae142 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400017011 | |||
| W4401018251 | Design and Fabrication of Multi-Functional Optical Microbots | 2024-06-24 | OpenAlex | 10.1109/ur61395.2024.10597446 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401018251 | |||
| W4399976399 | Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management | 2024-06-24 | OpenAlex | 10.1007/s11864-024-01215-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399976399 | |||
| W4399983790 | Navigating Acute Interstitial Nephritis: Clinical Insights and Emerging Challenges | 2024-06-24 | OpenAlex | 10.1097/imna-d-24-00017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399983790 | |||
| W4400045130 | Recent Analytical Methodologies for Determination of Anti-Viral COVID-19 Drugs: A Review | 2024-06-24 | OpenAlex | 10.21608/eajbsc.2024.361129 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400045130 | |||
| W4399982425 | Synthesis of high-performance antibacterial agent based on incorporated vancomycin into MOF-modified lignin nanocomposites | 2024-06-24 | OpenAlex | 10.1016/j.ijbiomac.2024.133339 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4399982425 | |||
| W4399994411 | It’s the End of the World and We Know It | 2024-06-25 | OpenAlex | 10.1215/00267929-11196175 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399994411 | |||
| W4400008222 | Narrative review on the evolving role of HER2/neu targeting in uterine serous cancers | 2024-06-25 | OpenAlex | 10.21037/atm-23-1465 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400008222 | |||
| W4400005506 | Optimizing salvage therapy for Hodgkin lymphoma: progress and future challenges | 2024-06-25 | OpenAlex | 10.1080/17474086.2024.2372325 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400005506 | |||
| W4400057561 | Point/counterpoint: Should we stop writing and reading letters of recommendation for residency selection? | 2024-06-25 | OpenAlex | 10.1002/jhm.13440 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400057561 | |||
| W4400018801 | Rotavirus: A micro review | 2024-06-25 | OpenAlex | 10.22541/au.171934170.09340648/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400018801 | |||
| W4400014375 | Splenic abscess and infective endocarditis | 2024-06-25 | OpenAlex | 10.1007/s15010-024-02322-w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400014375 | |||
| W4400092338 | Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer | 2024-06-26 | OpenAlex | 10.3390/ijms25136967 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400092338 | |||
| W4400038883 | Evolving treatment landscape in thymic epithelial tumors: From mechanism to therapy | 2024-06-26 | OpenAlex | 10.1016/j.bbcan.2024.189145 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400038883 | |||
| W4400063005 | Targeted Radiopharmaceutical Therapy for Bone Metastases | 2024-06-26 | OpenAlex | 10.1053/j.semnuclmed.2024.05.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400063005 | |||
| W4400100479 | The potential therapeutic applications of long non-coding RNAs | 2024-06-26 | OpenAlex | 10.20517/jtgg.2024.12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400100479 | |||
| W4400136564 | Comment on ‘Comprehensive toxicological screening of common drugs of abuse, new psychoactive substances, and cannabinoids in blood using supported liquid extraction and liquid chromatography–quadrupole time-of-flight mass spectrometry’ | 2024-06-27 | OpenAlex | 10.1093/jat/bkae057 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400136564 | |||
| W4400090559 | Involvement of Molecular Mechanism and Biological Activities of Pemirolast: A Therapeutic Review | 2024-06-27 | OpenAlex | 10.2174/0102506882308410240607053814 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400090559 | |||
| W4400073103 | Poland's strategic potential and capabilities to respond to CBRN threats | 2024-06-27 | OpenAlex | 10.13166/jms/188731 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400073103 | |||
| W4400094235 | Unveiling the enigma of acute kidney disease: predicting prognosis, exploring interventions, and embracing a multidisciplinary approach | 2024-06-27 | OpenAlex | 10.23876/j.krcp.23.289 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400094235 | |||
| W4400110912 | A mini-review of Vutrisiran and Eplontersen in hereditary transthyretin-mediated amyloidosis with polyneuropathy | 2024-06-28 | OpenAlex | 10.1097/md.0000000000038767 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400110912 | |||
| W4400123524 | European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transplantation | 2024-06-28 | OpenAlex | 10.1002/cyto.b.22195 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400123524 | |||
| W4400251172 | Glycopyrronium inhalation, bronchodilator reversibility assessment, and defining asthma: A new paradigm | 2024-06-28 | OpenAlex | 10.4103/lungindia.lungindia_461_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400251172 | |||
| W4400126139 | P006 Tumour necrosis factor-α-induced lupus panniculitis: one case report and literature review | 2024-06-28 | OpenAlex | 10.1093/bjd/ljae090.033 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400126139 | |||
| W4400128628 | Plasma therapy for traumatic brain injury: Rationale for a prospective randomized trial | 2024-06-28 | OpenAlex | 10.1111/trf.17928 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400128628 | |||
| W4400201943 | Advancements in First-Line Treatment of Metastatic Bladder Cancer: EV-302 and Checkmate-901 Insights and Future Directions | 2024-06-29 | OpenAlex | 10.3390/cancers16132398 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400201943 | |||
| W4399985863 | Opportunities for nanomaterials in enzyme therapy | 2024-06-29 | OpenAlex | 10.1016/j.jconrel.2024.06.035 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4399985863 | |||
| W7217302664 | Determinants of Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Therapy | 2024-06-30 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7217302664 | ||||
| W7118138708 | Role of Nursing in Preventing Missed Care: A Comprehensive Review | 2024-06-30 | OpenAlex | 10.22399/ijcesen.4651 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118138708 | |||
| W4400595252 | 2024-07-01 | OpenAlex | 10.1111/bjh.v205.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400595252 | ||||
| W4400453417 | 229 Involving change agents implementing a systematic approach to family involvement during patient hospitalization | 2024-07-01 | OpenAlex | 10.1136/bmjebm-2024-sdc.228 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4400453417 | |||
| W4400327380 | A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma | 2024-07-01 | OpenAlex | 10.1007/s11523-024-01074-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400327380 | |||
| W4402610812 | Advancing therapeutic strategies and future innovations in sickle cell disease management | 2024-07-01 | OpenAlex | 10.33545/pathol.2024.v7.i3e.2016 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402610812 | |||
| W4401431352 | Characterizing generative artificial intelligence applications: Text-mining-enabled technology roadmapping | 2024-07-01 | OpenAlex | 10.1016/j.jik.2024.100531 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401431352 | |||
| W4403251688 | Charting New Territories in Metastatic Prostate Cancer: A Convergence of Innovation and Hope | 2024-07-01 | OpenAlex | 10.1016/j.euf.2024.09.019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403251688 | |||
| W4400207978 | Cryptic enzymatic assembly of peptides armed with β-lactone warheads | 2024-07-01 | OpenAlex | 10.1038/s41589-024-01657-7 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400207978 | |||
| W7212213868 | Designing digital health futures | 2024-07-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7212213868 | ||||
| W4406224718 | Do we need phase 3 randomized clinical trials for oncology drug approvals? | 2024-07-01 | OpenAlex | 10.4103/ijc.ijc_819_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406224718 | |||
| W4402999309 | Dr. Ashok DB Vaidya: Scientist with a vision of Ayurvidya (1936–2024) | 2024-07-01 | OpenAlex | 10.4103/ijar.ijar_210_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402999309 | |||
| W4400893110 | E-036 Embozene versus onyx for middle meningeal artery embolization in chronic subdural hematoma | 2024-07-01 | OpenAlex | 10.1136/jnis-2024-snis.141 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400893110 | |||
| W4400215476 | Editorial: Artificial intelligence education & governance -human enhancive, culturally sensitive and personally adaptive HAI | 2024-07-01 | OpenAlex | 10.3389/frai.2024.1443386 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400215476 | |||
| W4402781149 | Effects of General Anesthesia on Noninvasively Measured Central and Peripheral Blood Pressure: A Prospective, Observational-based Cross-over Study | 2024-07-01 | OpenAlex | 10.4103/rcm.rcm_31_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402781149 | |||
| W4400201460 | Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms | 2024-07-01 | OpenAlex | 10.1002/phar.2950 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400201460 | |||
| W4400576974 | Evolving treatment paradigms for platinum-resistant ovarian cancer: An update narrative review | 2024-07-01 | OpenAlex | 10.1016/j.tjog.2024.05.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400576974 | |||
| W4400935989 | Familial Hypercholesterolemia: Can Continuing Medical Education Help Address Barriers to Screening in Children? | 2024-07-01 | OpenAlex | 10.1016/j.jacl.2024.04.064 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400935989 | |||
| W4405719790 | In the Dance of Growth and Advancements, the Future Unfolds with Boundless Potential | 2024-07-01 | OpenAlex | 10.4103/dljo.dljo_128_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405719790 | |||
| W4401384753 | Infections in Hematopoietic Stem Cell Transplant Recipients in India – Think Global, Act Local | 2024-07-01 | OpenAlex | 10.4103/cids.cids_48_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401384753 | |||
| W4402740244 | Investigator-initiated Clinical Trials for Neurological Diseases in Japan: Pipeline and Support Structures | 2024-07-01 | OpenAlex | 10.1016/j.neurot.2024.e00406 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402740244 | |||
| W7135825495 | Involving change agents implementing a systematic approach to family involvement during patient hospitalization | 2024-07-01 | OpenAlex | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7135825495 | ||||
| W4400219047 | Ketamine Can Be a Transformational Agent, but It Is Not Without Risk or Danger | 2024-07-01 | OpenAlex | 10.1097/01.eem.0001026356.60923.22 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4400219047 | |||
| W4400211131 | Long‐term outcomes in advanced anterior skull base malignancy: a single quaternary institution experience | 2024-07-01 | OpenAlex | 10.1111/ans.19144 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400211131 | |||
| W4401346493 | Models in Consciousness Research | 2024-07-01 | OpenAlex | 10.4103/jacs.jacs_120_24 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401346493 | |||
| W4400220149 | Modern paradigms in biologic sequencing of inflammatory bowel disease in Aotearoa New Zealand | 2024-07-01 | OpenAlex | 10.26635/6965.6613 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400220149 | |||
| W4400219478 | Neonatal Seizures | 2024-07-01 | OpenAlex | 10.1542/pir.2023-006016 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400219478 | |||
| W4400211233 | Optimisation during transition to dialysis commencement | 2024-07-01 | OpenAlex | 10.5694/mja2.52347 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400211233 | |||
| W4405457185 | Orthobiologics in Orthopaedics – Recent Advances | 2024-07-01 | OpenAlex | 10.4103/ijors.ijors_20_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405457185 | |||
| W4400560373 | Potential of neutrophil-to-eosinophil ratio as a new prognostic tool for patients with advanced renal cell carcinoma receiving first-line immuno-oncology combinations | 2024-07-01 | OpenAlex | 10.1136/bmjonc-2024-000481 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400560373 | |||
| W4401275685 | Retrospective Research of Cases of Oral Mucosal Diseases: Diagnosis and Management Trends | 2024-07-01 | OpenAlex | 10.4103/jpbs.jpbs_294_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401275685 | |||
| W4400355822 | SPL22 BIOLOGICAL HAZARDS IN THE WORKING ENVIRONMENT: A RISK OF PERMANENT RELEVANCE | 2024-07-01 | OpenAlex | 10.1093/occmed/kqae023.0033 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400355822 | |||
| W4400355842 | SS05 EMERGING AND CONTINUING BIOHAZARDS IN THE WORKPLACE | 2024-07-01 | OpenAlex | 10.1093/occmed/kqae023.0066 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400355842 | |||
| W4400215350 | Toward disrupting normalized incivility in our nursing workplaces | 2024-07-01 | OpenAlex | 10.1111/nin.12654 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400215350 | |||
| W4400308905 | Vulnerabilities mediating the Healthcare encounter: by an intersectional agency. | 2024-07-01 | OpenAlex | 10.1590/1413-81232024297.04352024 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400308905 | |||
| W4400305449 | Anaesthetic Challenge in a Child with Hurler’s Syndrome: Encouraging Experience with Neuraxial Blockade | 2024-07-02 | OpenAlex | 10.4038/slja.v32i2.9285 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400305449 | |||
| W4400259550 | Current Status on Management of Primary Plasma Cell Leukemia | 2024-07-02 | OpenAlex | 10.1007/s11912-024-01563-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400259550 | |||
| W4401035050 | Fire, Vulcanus , Archeus , and Alchemy: A Hybrid Close-Distant Reading of Paracelsus’s Thought on Active Agents | 2024-07-02 | OpenAlex | 10.1080/00026980.2024.2367396 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401035050 | |||
| W4400244350 | Immune thrombocytopenia (ITP): historical perspectives, pathophysiology, and treatment advances | 2024-07-02 | OpenAlex | 10.1007/s44337-024-00008-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400244350 | |||
| W4400257087 | Stem Cell Therapy as a Potential Treatment of Non-Alcoholic Steatohepatitis-Related End-Stage Liver Disease: A Narrative Review | 2024-07-02 | OpenAlex | 10.1007/s40778-024-00241-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400257087 | |||
| W4400420511 | The current state-of-the-art in pharmacotherapy for pulmonary sarcoidosis | 2024-07-02 | OpenAlex | 10.1080/14656566.2024.2377714 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400420511 | |||
| W4400231340 | The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is severely constrained by random peptide mixtures | 2024-07-02 | OpenAlex | 10.1371/journal.pbio.3002692 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400231340; https://openalex.org/W4392201389 | |||
| W4400935223 | The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke | 2024-07-02 | OpenAlex | 10.1080/14656566.2024.2385135 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400935223 | |||
| W4400291215 | Comment on: Community-acquired pneumonia: a US perspective on the guideline gap | 2024-07-03 | OpenAlex | 10.1093/jac/dkae208 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400291215 | |||
| W4401684277 | Molecularly Targeted Therapies In Breast Cancer: A Traditional Review | 2024-07-03 | OpenAlex | 10.55262/fabadeczacilik.1444169 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401684277 | |||
| W4400292208 | Moral agents as relational systems: The Contract-Based Model of Moral Cognition for AI | 2024-07-03 | OpenAlex | 10.31234/osf.io/52x74 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400292208 | |||
| W4400300014 | Pharmacological effects of bioactive agents in earthworm extract: A comprehensive review | 2024-07-03 | OpenAlex | 10.1002/ame2.12465 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4400300014 | |||
| W4400296595 | Who assesses what? | 2024-07-03 | OpenAlex | 10.4324/9781032648033-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400296595 | |||
| W4411001375 | Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality | 2024-07-04 | OpenAlex | 10.70070/ms7j8w64 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411001375 | |||
| W4400419097 | Intestinal Parasites from Past to Present: Taxonomy, Paleoparasitology, Geographic Distribution, Prevention and Control Strategies | 2024-07-04 | OpenAlex | 10.5772/intechopen.1005750 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400419097 | |||
| W4400311090 | Long-Axial Field-of-View PET Imaging in Patients with Lymphoma | 2024-07-04 | OpenAlex | 10.1016/j.cpet.2024.05.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400311090 | |||
| W4403176152 | Malaria and Molecular Diagnosis | 2024-07-04 | OpenAlex | 10.69860/nobel.9786053359524.2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403176152 | |||
| W4400325414 | Neonatal Opioid Withdrawal Syndrome and the Role of the Speech-Language Pathologist | 2024-07-04 | OpenAlex | 10.4324/9781003397267-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400325414 | |||
| W4400330578 | The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell Survival | 2024-07-04 | OpenAlex | 10.3390/cancers16132451 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400330578 | |||
| W4400314693 | Treatment modification patterns of glucose-lowering agents in Saudi Arabia: A retrospective real-world data analysis | 2024-07-04 | OpenAlex | 10.1016/j.diabres.2024.111770 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400314693 | |||
| W4400359621 | Current Surveillance and Treatment Guidelines for Thyroid Carcinoma | 2024-07-05 | OpenAlex | 10.1007/s40137-024-00421-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400359621 | |||
| W4400369260 | Editorial: Clinical challenges in pediatric transplant infectious diseases | 2024-07-05 | OpenAlex | 10.3389/fped.2024.1425983 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400369260 | |||
| W4400351500 | New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? | 2024-07-05 | OpenAlex | 10.3390/cancers16132466 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400351500 | |||
| W7218304494 | The Benefits of Oxymetazoline on Sensory Impairment in COVID-19 Patients | 2024-07-05 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7218304494 | ||||
| W4400425660 | The Role of the Dentist in Home Care for the Older People: A Narrative Review of the Literature | 2024-07-05 | OpenAlex | 10.12974/2311-8695.2024.12.03 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400425660 | |||
| W4400387274 | VIBRATO’s Symphony: Orchestrating Biomarker Harmony for Ritlecitinib in UC Therapy | 2024-07-05 | OpenAlex | 10.1093/ecco-jcc/jjae103 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400387274 | |||
| W4400387554 | Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia | 2024-07-06 | OpenAlex | 10.1007/s11899-024-00730-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400387554 | |||
| W4400404462 | PET imaging of gliomas: Status quo and quo vadis? | 2024-07-06 | OpenAlex | 10.1093/neuonc/noae078 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400404462 | |||
| W4400479214 | Biologics in Focus: A Comprehensive Review of Current Biological and Small Molecules Therapies for Crohn’s Disease in the United Arab Emirates (UAE) | 2024-07-07 | OpenAlex | 10.3390/gidisord6030043 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400479214 | |||
| W4400418891 | Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells | 2024-07-07 | OpenAlex | 10.3390/cancers16132478 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400418891 | |||
| W4401483763 | Interaction Behavior of Novel Chitosan-Pectin Complex of Ciclopiroxwith Human Galectin-3: Molecular Docking, Molecular Dynamic Simulation, In Silico Pharmacokinetics Studies | 2024-07-08 | OpenAlex | 10.48047/afjbs.6.si4.2024.951-963 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401483763 | |||
| W4400449172 | Evolving Paradigms in Sepsis Management: A Narrative Review | 2024-07-09 | OpenAlex | 10.3390/cells13141172 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400449172 | |||
| W4400474170 | Neurobiological alteration in agitation in Alzheimer’s disease and possible interventions | 2024-07-09 | OpenAlex | 10.3389/fpsyt.2024.1412901 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400474170 | |||
| W4400517698 | Proteomics for understanding progression to heart failure in chronic kidney disease: promising but still not there | 2024-07-09 | OpenAlex | 10.1093/eurheartj/ehae399 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400517698 | |||
| W4402842715 | A Comparative Clinical Study on the Effect of Tagar (Valleriana Wallichii Dc.) and Aswagandha (Withania Somnifera) in the Management of Preoperative Anxiety | 2024-07-10 | OpenAlex | 10.47070/ijapr.v12i6.3274 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402842715 | |||
| W4400512482 | Acne treatment: research progress and new perspectives | 2024-07-10 | OpenAlex | 10.3389/fmed.2024.1425675 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400512482 | |||
| W4401413351 | Aging-induced memory loss due to decreased N1-acetyl-5-methoxykynuramine, a melatonin metabolite, in the hippocampus: a potential prophylactic agent for dementia | 2024-07-10 | OpenAlex | 10.4103/nrr.nrr-d-24-00379 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401413351 | |||
| W4400513196 | Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma | 2024-07-10 | OpenAlex | 10.3389/fonc.2024.1401761 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400513196 | |||
| W4400501367 | Gene Editing with Artificial DNA Scissors | 2024-07-10 | OpenAlex | 10.1002/chem.202401621 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400501367 | |||
| W4400512214 | The Acari Hypothesis, IV: revisiting the role of hygiene in allergy | 2024-07-10 | OpenAlex | 10.3389/falgy.2024.1415124 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400512214 | |||
| W4400541121 | Bronchiolitis: Increased severity in the post‐COVID‐19 era | 2024-07-11 | OpenAlex | 10.1002/ppul.27172 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400541121 | |||
| W4400575791 | Colorimetric Study on Burnt Teeth and New Diagnostic Tool in Forensic Dental Identification: The Carbodent Scale | 2024-07-11 | OpenAlex | 10.3390/oral4030025 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400575791 | |||
| W4400558492 | Model‐Informed Reinforcement Learning for Enabling Precision Dosing Via Adaptive Dosing | 2024-07-11 | OpenAlex | 10.1002/cpt.3356 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400558492 | |||
| W4400558392 | Pharmacological Trends in the Management of Atopic Dermatitis: A Comprehensive Review | 2024-07-11 | OpenAlex | 10.7759/cureus.64302 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400558392 | |||
| W4400569878 | Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives | 2024-07-11 | OpenAlex | 10.3389/fonc.2024.1387345 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400569878 | |||
| W4400620968 | Assessing the impact of seismic scenarios and retrofits on community resilience using agent-based models | 2024-07-14 | OpenAlex | 10.1016/j.ijdrr.2024.104678 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400620968 | |||
| W4400614234 | Lithium and the risk of fractures in patients with bipolar disorder: A population-based cohort study | 2024-07-14 | OpenAlex | 10.1016/j.psychres.2024.116075 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400614234 | |||
| W4400617177 | SOHO State of the Art Updates and Next Questions | Contemporary Standard of Care Therapy for Richter's Transformation and Future Directions | 2024-07-14 | OpenAlex | 10.1016/j.clml.2024.07.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400617177 | |||
| W4400850943 | Antimicrobial Activity and Phytochemical analysis of Evolvulus alsinoides against HIV Secondary Pathogens | 2024-07-15 | OpenAlex | 10.22270/jddt.v14i7.6452 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400850943 | |||
| W4400662458 | Data from CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition | 2024-07-15 | OpenAlex | 10.1158/1078-0432.c.7348790.v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400662458; https://openalex.org/W4400661741 | |||
| W4400653783 | Executive Summary—Society of Critical Care Medicine Guideline and American Society of Health-System Pharmacists for the Prevention of Stress-Related Gastrointestinal Bleeding in Critically Ill Adults | 2024-07-15 | OpenAlex | 10.1097/ccm.0000000000006329 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400653783 | |||
| W4400696382 | Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS) | 2024-07-15 | OpenAlex | 10.1002/pbc.31189 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400696382 | |||
| W4400653801 | Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps | 2024-07-15 | OpenAlex | 10.1128/aac.00535-24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400653801 | |||
| W4400657117 | Targeted Therapy for Atopic Dermatitis: A Novel Approach | 2024-07-15 | OpenAlex | 10.2174/0115748855307501240607045747 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400657117 | |||
| W2275217505 | Acoustic characterization of ultrasound contrast microbubbles and echogenic liposomes: applications to imaging and drug-delivery | 2024-07-16 | OpenAlex | 10.58088/qjzj-yt77 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W2275217505 | |||
| W4401835091 | Advances and future directions in ROS1 fusion-positive lung cancer | 2024-07-16 | OpenAlex | 10.1093/oncolo/oyae205 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401835091 | |||
| W4400748370 | Different hyaluronan concentration determinate distinctive physicochemical and biological properties of the intra-articular gel but does not affect satisfactory clinical outcome | 2024-07-16 | OpenAlex | 10.1016/j.jorep.2024.100445 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400748370 | |||
| W4400695519 | Editorial: Is there still room for pharmacogenetics in 2023? The cases of infectious diseases and oncology | 2024-07-16 | OpenAlex | 10.3389/fphar.2024.1457733 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400695519 | |||
| W4400689312 | Equal Societies, Autonomous Lives: Reconciling social equality and relational autonomy | 2024-07-16 | OpenAlex | 10.1111/josp.12579 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400689312 | |||
| W4400694279 | Physical and mechanical properties of cellulose based hemostatic agents: an in vitro comparison | 2024-07-16 | OpenAlex | 10.1007/s12553-024-00892-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400694279 | |||
| W4400722243 | New Perspectives on Risk Assessment and Anticoagulation in Elective Spine Surgery Patients: The Impact of Ultra-Minimally Invasive Endoscopic Surgery Techniques on Patients with Cardiac Disease | 2024-07-17 | OpenAlex | 10.3390/jpm14070761 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400722243 | |||
| W4400773751 | Comment on: Where are we now in biologic drugs for myositis? | 2024-07-18 | OpenAlex | 10.1093/rheumatology/keae363 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400773751 | |||
| W4400780239 | Editorial: A contemporary look at allergic rhinitis treatments: where are we heading? | 2024-07-18 | OpenAlex | 10.3389/falgy.2024.1459032 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400780239 | |||
| W4400810659 | The Clinical Meaning of Withdrawal with Antidepressant Drugs | 2024-07-18 | OpenAlex | 10.1159/000540033 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400810659 | |||
| W4400772490 | The Evolving Use of Gold Nanoparticles as a Possible Reversal Agent for the Symptoms of Neurodegenerative Diseases: A Narrative Review | 2024-07-18 | OpenAlex | 10.7759/cureus.64846 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4400772490 | |||
| W4403321160 | A human motivation driven based user-activity recommending service using AIGC and self-supervised agent cluster with debating scheme | 2024-07-19 | OpenAlex | 10.1145/3691720.3691807 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403321160 | |||
| W4400824496 | Editorial: Natural and synthetic microbiology for the production of novel biomolecules for applications in the areas of food, fuel, farming, pharma and environment | 2024-07-19 | OpenAlex | 10.3389/fmicb.2024.1458803 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400824496 | |||
| W4405808122 | Outsourcing Public Services | 2024-07-19 | OpenAlex | 10.46692/9781529212877.002 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405808122 | |||
| W4400837594 | Smart sanitization on a budget: revolutionizing public transport hygiene post-COVID | 2024-07-19 | OpenAlex | 10.3389/fpubh.2024.1437499 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400837594 | |||
| W4400823397 | Some virulence genes are associated with antibiotic susceptibility in Enterobacter cloacae complex | 2024-07-19 | OpenAlex | 10.1186/s12879-024-09608-2 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400823397 | |||
| W4401064697 | The Clinical Utility of Botulinum Toxin in the Field of Otolaryngology | 2024-07-21 | OpenAlex | 10.3342/kjorl-hns.2024.00227 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401064697 | |||
| W4400872030 | A review of novel endothelin antagonists and overview of non-steroidal mineralocorticoid antagonists for treating resistant hypertension: An update | 2024-07-22 | OpenAlex | 10.1016/j.ejphar.2024.176752 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400872030 | |||
| W4400889004 | Challenges for emergency departments: Anti‐amyloid therapy and amyloid‐related imaging abnormalities in persons with dementia | 2024-07-22 | OpenAlex | 10.1111/jgs.19099 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400889004 | |||
| W4400930638 | Dilemmas of dating: The case of aprioristic sexual lookism | 2024-07-22 | OpenAlex | 10.1111/josp.12585 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4400930638 | |||
| W4400881015 | Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease | 2024-07-22 | OpenAlex | 10.2215/cjn.0000000000000540 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400881015 | |||
| W4400871112 | The new oral SERDs in endocrine-resistant breast cancer: who will benefit the most? | 2024-07-22 | OpenAlex | 10.1016/j.annonc.2024.05.542 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400871112 | |||
| W4400932585 | Navigating the Evolving Roles of GLP-1 Agonists Safely and Effectively | 2024-07-23 | OpenAlex | 10.1093/asj/sjae166 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400932585 | |||
| W4400953109 | Recent Advances on Pt-Based Compounds for Theranostic Applications | 2024-07-23 | OpenAlex | 10.3390/molecules29153453 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400953109 | |||
| W4402153039 | Role of magnesium sulfate in pregnancy: A comprehensive review of benefits and risks | 2024-07-23 | OpenAlex | 10.31893/multirev.2024094 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402153039 | |||
| W4401364395 | The evolving landscape of polycythemia vera therapies | 2024-07-23 | OpenAlex | 10.1080/14656566.2024.2387681 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401364395 | |||
| W4400963680 | IL-2 based cancer immunotherapies: an evolving paradigm | 2024-07-24 | OpenAlex | 10.3389/fimmu.2024.1433989 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400963680 | |||
| W4400974168 | NANN Neonatal Peripherally Inserted Central Catheters | 2024-07-24 | OpenAlex | 10.1097/anc.0000000000001182 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400974168 | |||
| W4400959993 | Recent Updates in the Diagnosis and Management of Kidney Diseases in Multiple Myeloma | 2024-07-24 | OpenAlex | 10.25259/ijn_491_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400959993 | |||
| W4401715999 | AntiFormer: graph enhanced large language model for binding affinity prediction | 2024-07-25 | OpenAlex | 10.1093/bib/bbae403 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401715999 | |||
| W4400983858 | Biofilm Production and Its Implications in Pediatrics | 2024-07-25 | OpenAlex | 10.3390/microorganisms12081522 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400983858 | |||
| W4401000360 | Editorial: Recent advances in childhood vascular tumors | 2024-07-25 | OpenAlex | 10.3389/fonc.2024.1465155 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401000360 | |||
| W4401001153 | Editorial: lncRNAs: application in immunotherapy, radiotherapy, and chemotherapy | 2024-07-25 | OpenAlex | 10.3389/fcell.2024.1438773 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401001153 | |||
| W4400994068 | Evolution of Treatment Strategies for Gestational Trophoblastic Neoplasia: Chemotherapy, Immunotherapy, and Molecular Targeted Therapy | 2024-07-25 | OpenAlex | 10.1007/s11864-024-01235-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400994068 | |||
| W4401019125 | Meeting the Health Needs of Society Through Curricular Innovation in Physical Therapist Education: Examples From 3 Entry-Level Programs | 2024-07-25 | OpenAlex | 10.1097/jte.0000000000000359 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401019125 | |||
| W4401038695 | Occupational health nursing and political action | 2024-07-25 | OpenAlex | 10.1111/inr.13030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401038695 | |||
| W4400980781 | The Potential Use of Naturally Derived Materials for Nanoparticle Synthesis as Potential Anti-biofilms and Anti-virulence Drugs to Prevent Mono or Polymicrobial Diseases | 2024-07-25 | OpenAlex | 10.22541/au.172192045.50188569/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400980781 | |||
| W4400974247 | Unveiling DprE1 as a Key Target in the Fight against Tuberculosis: Insights and Perspectives on Developing Novel Antimicrobial Agents | 2024-07-25 | OpenAlex | 10.3390/biomed4030018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400974247 | |||
| W4400974296 | What’s New in Osteoporosis: Emphasis on the Aging Athlete | 2024-07-25 | OpenAlex | 10.2106/jbjs.24.00644 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4400974296 | |||
| W4401037293 | A narrative review on perioperative systemic therapy in non-small cell lung cancer | 2024-07-26 | OpenAlex | 10.37349/etat.2024.00256 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401037293 | |||
| W4403144247 | Acute Generalized Exanthematous Pustulosis (AGEP) Unveiled | 2024-07-26 | OpenAlex | 10.70552/pjaai.24.1.9871 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403144247 | |||
| W4401023468 | Prevalence of Staphylococcus aureus Infections in the Implantation of Orthopedic Devices in a Third-Level Hospital: An Observational Cohort Study | 2024-07-26 | OpenAlex | 10.3390/pathogens13080620 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401023468 | |||
| W4401035315 | Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide | 2024-07-26 | OpenAlex | 10.1080/17474086.2024.2382897 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401035315 | |||
| W4401029882 | Treatment patterns and outcomes in KRAS‐positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study | 2024-07-26 | OpenAlex | 10.1016/j.lungcan.2024.107898 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401029882 | |||
| W4401056948 | Reply to: Comment on “Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease” | 2024-07-27 | OpenAlex | 10.1016/j.ctro.2024.100826 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401056948 | |||
| W4403193758 | Evolving Treatment Landscape in Endometrial Cancer | 2024-07-28 | OpenAlex | 10.36000/hbt.oh.2024.20.149 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403193758 | |||
| W4401081185 | Disease‐burden‐adapted immunotherapy protocol for primary refractory or high‐risk relapsed pediatric acute lymphoblastic leukemia | 2024-07-29 | OpenAlex | 10.1002/hem3.111 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401081185 | |||
| W4401096121 | Mapping the Landscape of Clinical Trials on Oral Biofilm: A Bibliometric Analysis | 2024-07-29 | OpenAlex | 10.3329/bjms.v23i3.75013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401096121 | |||
| W4401068363 | Physician Humility: A Review and Call to Revive Virtue in Medicine | 2024-07-29 | OpenAlex | 10.7326/m24-0842 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401068363 | |||
| W4401186286 | The many faces of brucellosis: diagnostic and management approach | 2024-07-29 | OpenAlex | 10.1097/qco.0000000000001045 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401186286 | |||
| W4401114072 | Advances in primary glomerulonephritis | 2024-07-30 | OpenAlex | 10.12968/hmed.2024.0044 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401114072 | |||
| W4401118005 | Allergic Fungal Infections | 2024-07-30 | OpenAlex | 10.1201/9781032642864-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401118005 | |||
| W4401116868 | Antifungal Therapies and Drug Resistance | 2024-07-30 | OpenAlex | 10.1201/9781032642864-10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401116868 | |||
| W4401152819 | Commentary: AI-based preeclampsia detection and prediction with electrocardiogram data | 2024-07-30 | OpenAlex | 10.3389/fcvm.2024.1437369 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401152819 | |||
| W4401234955 | Comparison of shear bond strength between 7th and 8th generation bonding agents in flowable composite resin | 2024-07-30 | OpenAlex | 10.30574/wjarr.2024.23.1.2289 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401234955 | |||
| W4401434712 | HELICOBACTER PYLORI: FROM DISCOVERY TO MODERN-DAY TREATMENTS | 2024-07-30 | OpenAlex | 10.61796/jmgcb.v1i7.796 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401434712 | |||
| W4416287392 | Nursing and Radiology Teams Collaboration to Enhance Patient Safety During Imaging Procedures | 2024-07-30 | OpenAlex | 10.22399/ijcesen.4285 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416287392 | |||
| W4401126512 | Serum globulin trajectory discovery and prediction in systemic lupus erythematosus: Results from a real‐world observational cohort study | 2024-07-30 | OpenAlex | 10.1111/1756-185x.15278 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401126512 | |||
| W4403416051 | Tropical Excursion With Ensuing Mental Ulceration | 2024-07-30 | OpenAlex | 10.1093/cid/ciae283 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403416051 | |||
| W4401118131 | Unraveling the World of Human Fungal Infections | 2024-07-30 | OpenAlex | 10.1201/9781032642864-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401118131 | |||
| W4401194511 | Addressing AMR and planetary health in primary care: the potential of general practitioners as change agents | 2024-07-31 | OpenAlex | 10.3389/fpubh.2024.1383423 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401194511 | |||
| W4401166925 | An analysis of the trends in the usage of Pharmaceutical Benefits Scheme-subsidised cancer drugs in Australia from 2012 to 2022 | 2024-07-31 | OpenAlex | 10.1007/s00432-024-05889-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401166925 | |||
| W4401594750 | DEXMEDETOMIDINE: A VERSATILE, MULTITASKING ANESTHETIC AGENT FOR PERIOPERATIVE MANAGEMENT, A NARRATIVE REVIEW | 2024-07-31 | OpenAlex | 10.21474/ijar01/19188 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401594750 | |||
| W4401544080 | Hormonal Therapy and Endometrial Cancer: Latest Advancements | 2024-07-31 | OpenAlex | 10.54393/pbmj.v7i07.1121 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401544080 | |||
| W4401160325 | Malignant Hyperthermia Simulation | 2024-07-31 | OpenAlex | 10.1016/j.jopan.2024.06.006 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401160325 | |||
| W4401179304 | Recent Advances in the Management of Non-rheumatic Atrial Fibrillation: A Comprehensive Review | 2024-07-31 | OpenAlex | 10.7759/cureus.65835 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401179304 | |||
| W4401646362 | 3056 Everything is connected to everything else | 2024-08-01 | OpenAlex | 10.1136/bmjno-2024-anzan.67 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401646362 | |||
| W7203512914 | Coupled Flow and Transport in an Organ and its Vasculature | 2024-08-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203512914 | ||||
| W4401954128 | Evolving patterns in systemic treatment utilization and survival among older patients with advanced cutaneous melanoma | 2024-08-01 | OpenAlex | 10.1002/cam4.70131 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401954128 | |||
| W4401330964 | Is Rapid Bedside Echocardiography in Septic Shock Possible?* | 2024-08-01 | OpenAlex | 10.1097/pcc.0000000000003538 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401330964 | |||
| W4406455323 | Melatonin: Evolving Physiological Understanding and Potential Therapeutic Role in Pain Medicine Including Intervertebral Disc Degeneration | 2024-08-01 | OpenAlex | 10.36076/ppj.2024.7.273 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406455323; https://openalex.org/W4401237344 | |||
| W7169745981 | Molecular characterisation of porcine circoviruses in Malaysia and development of a PCV type 3 diagnostic tool | 2024-08-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7169745981 | ||||
| W4401835554 | P05 A targeted antimicrobial pharmacy technician ward service improves stewardship and patient-centred care and safety of commonly prescribed higher risk antimicrobials in the acute hospital setting | 2024-08-01 | OpenAlex | 10.1093/jacamr/dlae136.009 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401835554 | |||
| W4401827532 | P28 An analysis of the appropriateness of antimicrobial prescribing at a tertiary centre: reflections from the National Point Prevalence Survey | 2024-08-01 | OpenAlex | 10.1093/jacamr/dlae136.032 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401827532 | |||
| W4401973442 | Participating together in CP-ACHIEVE: Experiences, opportunities and reflections from a collaborative research team of people with lived experience of cerebral palsy and health care professionals | 2024-08-01 | OpenAlex | 10.1177/09075682241269682 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401973442 | |||
| W4401232754 | Recent Advances in Liver Transplantation for Hepatocellular Carcinoma | 2024-08-01 | OpenAlex | 10.1007/s11864-024-01247-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401232754 | |||
| W4404556438 | Torture, Imperial Citizenship, and Embodied Reading | 2024-08-01 | OpenAlex | 10.1215/00295132-11186650 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404556438 | |||
| W4401260700 | An overview of the development of pharmacotherapeutics targeting SARS-CoV-2 | 2024-08-02 | OpenAlex | 10.1016/j.drudis.2024.104126 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401260700 | |||
| W4401240985 | BMScope: A scoping review to chart the evolving clinical study landscape in brain and leptomeningeal metastasis | 2024-08-02 | OpenAlex | 10.1093/neuonc/noae140 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401240985 | |||
| W4401256224 | Evolving approaches in advanced gallbladder cancer with complete pathological response using chemo‑immunotherapy: A case report | 2024-08-02 | OpenAlex | 10.3892/ol.2024.14606 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401256224 | |||
| W4416279869 | Giant Cell Arteritis or Formerly Known as Horton's Disease When the Puzzle is Complete: A Case Report | 2024-08-02 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416279869 | ||||
| W4401277152 | Nephrology: a flourishing field with plentiful emerging topics | 2024-08-02 | OpenAlex | 10.3389/fmed.2024.1463540 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401277152 | |||
| W4401311711 | Use of Artificial Intelligence in the Mental Health Space | 2024-08-04 | OpenAlex | 10.58445/rars.1382 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401311711 | |||
| W4401363866 | 36 Real-world treatment patterns and clinical outcomes of metastatic renal cell carcinoma patients post immune-oncology (IO) and Vascular Endothelial Growth Factor (VEGF) receptor targeted therapies | 2024-08-05 | OpenAlex | 10.1093/oncolo/oyae181.037 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401363866 | |||
| W4401345849 | Advanced, recurrent, and persistent cervical cancer management: in the era of immunotherapy | 2024-08-05 | OpenAlex | 10.3389/fonc.2024.1392639 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401345849 | |||
| W4401337477 | Behçet disease: epidemiology, classification criteria and treatment modalities | 2024-08-05 | OpenAlex | 10.1080/1744666x.2024.2388693 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401337477 | |||
| W4401373511 | Smouldering COVID ‐19 XBB .1.5. subvariant pneumonitis: a case report | 2024-08-05 | OpenAlex | 10.5694/mja2.52403 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401373511 | |||
| W4401385423 | ASHP Statement on the Community Pharmacist’s Role in the Care Continuum | 2024-08-06 | OpenAlex | 10.1093/ajhp/zxae176 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401385423; https://openalex.org/W4412106503 | |||
| W4401374210 | Editorial: Insights in intensive care cardiovascular medicine: 2022 | 2024-08-06 | OpenAlex | 10.3389/fcvm.2024.1446904 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401374210 | |||
| W4401374204 | Editorial: The ethics of speech ownership in the context of neural control of augmented assistive communication | 2024-08-06 | OpenAlex | 10.3389/fnhum.2024.1468938 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401374204 | |||
| W4401374567 | Editorial: Therapeutics in pulmonary arterial hypertension | 2024-08-06 | OpenAlex | 10.3389/fcvm.2024.1463305 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401374567 | |||
| W4401380136 | Refinement in animal experimentation: calling time on the use of chloral hydrate for non‐recovery procedures and euthanasia | 2024-08-06 | OpenAlex | 10.1113/jp286687 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401380136 | |||
| W4410375083 | Compliance-as-Code 2.0: Orchestrating Regulatory Operations with Agentic AI | 2024-08-07 | OpenAlex | 10.60087/jaigs.v5i1.366 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4410375083 | |||
| W4401454537 | Post-Metastasectomy Adjuvant Therapy in Patients with Renal Cell Carcinoma: A Systematic Review | 2024-08-07 | OpenAlex | 10.3233/kca-240006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401454537 | |||
| W4401438032 | The Evolving Role of Checkpoint Inhibitors in Multiple Myeloma | 2024-08-08 | OpenAlex | 10.1016/j.clml.2024.08.004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401438032 | |||
| W4401425392 | The PANORAMIC study of COVID-19 treatments in primary care: a review and learning exercise | 2024-08-08 | OpenAlex | 10.3310/nihropenres.1115237.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401425392 | |||
| W4401544778 | Use of Neuromuscular Blocking and Antagonism Agents across the Spectrum of Renal Impairment Undergoing Major Inpatient Surgery: A Single-center Retrospective Observational Cohort Study | 2024-08-08 | OpenAlex | 10.1097/aln.0000000000005079 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401544778 | |||
| W4401449817 | Anticoagulation in Chronic Kidney Disease | 2024-08-09 | OpenAlex | 10.1007/s40265-024-02077-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401449817 | |||
| W4401448826 | Antifungal Susceptibility Pattern of Candida Species among Cancer Patients Attending B.P Koirala Memorial Cancer Hospital, Chitwan | 2024-08-09 | OpenAlex | 10.21203/rs.3.rs-4694992/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401448826 | |||
| W4401455831 | Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management | 2024-08-09 | OpenAlex | 10.1007/s00125-024-06242-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401455831 | |||
| W4401470725 | Editorial: High-level antimicrobial resistance or hypervirulence in emerging and re-emerging “super-bug” foodborne pathogens: detection, mechanism, and dissemination from omics insights | 2024-08-09 | OpenAlex | 10.3389/fmicb.2024.1459601 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401470725 | |||
| W4401474168 | Radiolabeled Somatostatin Analogs for Cancer Imaging | 2024-08-09 | OpenAlex | 10.1053/j.semnuclmed.2024.07.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401474168 | |||
| W4401474117 | Small-molecule in cancer immunotherapy: Revolutionizing cancer treatment with transformative, game-changing breakthroughs | 2024-08-09 | OpenAlex | 10.1016/j.bbcan.2024.189170 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401474117 | |||
| W4401500729 | Bringing Geroscience into the Mainstream: From Education to Clinical Practice, What Will It Take? | 2024-08-10 | OpenAlex | 10.1093/gerona/glae020 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401500729 | |||
| W4401495938 | Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy | 2024-08-11 | OpenAlex | 10.1007/s12672-024-01195-7 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4401495938 | |||
| W4401515145 | Anesthesia Management in Emergency and Trauma Surgeries: A Narrative Review | 2024-08-12 | OpenAlex | 10.7759/cureus.66687 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401515145 | |||
| W4412821259 | Emerging Monoclonal Antibody–Drug Conjugates In Cancer Therapy: A Comprehensive Review Of Design, Mechanisms, And Clinical Advances | 2024-08-12 | OpenAlex | 10.53555/ajbr.v27i2.8216 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412821259 | |||
| W4401514910 | Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine | 2024-08-12 | OpenAlex | 10.3390/ph17081059 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401514910 | |||
| W4401517043 | Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm | 2024-08-12 | OpenAlex | 10.1038/s41408-024-01109-4 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4401517043 | |||
| W4401504838 | Quality Measurement in Oncology: Time to Take the Next Step! | 2024-08-12 | OpenAlex | 10.1200/op.24.00348 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401504838 | |||
| W4401521466 | Survey of community pharmacists’ opinions on drug scheduling in Ontario and Québec | 2024-08-12 | OpenAlex | 10.1080/20523211.2024.2385936 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401521466 | |||
| W4401515465 | Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma | 2024-08-12 | OpenAlex | 10.1038/s41408-024-01114-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401515465 | |||
| W4401503612 | Unveiling the nexus: Long non-coding RNAs and the PI3K/Akt pathway in oral squamous cell carcinoma | 2024-08-12 | OpenAlex | 10.1016/j.prp.2024.155540 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401503612 | |||
| W4401517079 | Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways | 2024-08-12 | OpenAlex | 10.1038/s41467-024-51046-w | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401517079 | |||
| W4401529517 | At the Cutting Edge: Novel Agents in Hodgkin Lymphoma and the Evolving Role of Radiation Therapy | 2024-08-13 | OpenAlex | 10.1016/j.ijrobp.2024.04.021 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4401529517 | |||
| W4401554310 | Hydroxyurea in the sickle cell disease modern era | 2024-08-13 | OpenAlex | 10.1080/17512433.2024.2390915 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401554310 | |||
| W4401603717 | NK cell based immunotherapy against oral squamous cell carcinoma | 2024-08-13 | OpenAlex | 10.3389/fimmu.2024.1440764 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401603717 | |||
| W4401593691 | Pemivibart is less active against recent SARS-CoV-2 JN.1 sublineages | 2024-08-13 | OpenAlex | 10.1101/2024.08.12.607496 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401593691 | |||
| W4401548844 | Transforming Disease Surveillance through Artificial Intelligence | 2024-08-13 | OpenAlex | 10.4103/ijcm.ijcm_459_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401548844 | |||
| W4401628988 | Patient and Caregiver Insights from Social Media into the Disease Burden of Myelodysplastic Syndrome With A Sub-Cohort View of High-risk Patients (Preprint) | 2024-08-15 | OpenAlex | 10.2196/preprints.65460 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401628988 | |||
| W4401618447 | Use of a Cyclic α-Alkylidene-β-Diketone as a Cleavable Linker Strategy for Antibody-Drug Conjugates | 2024-08-15 | OpenAlex | 10.1021/jacs.4c04567 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401618447 | |||
| W4401646203 | Evolution of Prevention of HIV: A Personal Journey | 2024-08-16 | OpenAlex | 10.1097/olq.0000000000002046 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401646203 | |||
| W4401642506 | From the Cold Chain to Point-of Care Tests for Chlamydia and Gonorrhea: Personal Reflections | 2024-08-16 | OpenAlex | 10.1097/olq.0000000000002026 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401642506 | |||
| W4401643184 | Sexually Transmitted Diseases at 50: Historical Notes | 2024-08-16 | OpenAlex | 10.1097/olq.0000000000001998 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401643184 | |||
| W4401632650 | Site-Selective Antibody Conjugation with Dibromopyrazines | 2024-08-16 | OpenAlex | 10.1021/acs.bioconjchem.4c00296 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401632650 | |||
| W4401642742 | The Intimate Interface of HIV and Sexually Transmitted Infections Over 40 Years | 2024-08-16 | OpenAlex | 10.1097/olq.0000000000002012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401642742 | |||
| W4401640980 | The role of cation-exchange resins in hyperkalemia management | 2024-08-16 | OpenAlex | 10.1016/j.mjafi.2024.07.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401640980 | |||
| W4401646838 | Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN ‐ FRT expert consensus | 2024-08-16 | OpenAlex | 10.1111/jdv.20287 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401646838 | |||
| W4401665028 | Evolving immunotherapeutic solutions for triple-negative breast carcinoma | 2024-08-17 | OpenAlex | 10.1016/j.ctrv.2024.102817 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401665028 | |||
| W7214114240 | Machine Learning for Renewable Energy Forecasting and Smart Grid Optimization | 2024-08-17 | OpenAlex | 10.63544/a6kts575 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7214114240 | |||
| W4401704641 | Lupus Nephritis from Pathogenesis to New Therapies: An Update | 2024-08-18 | OpenAlex | 10.3390/ijms25168981 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401704641 | |||
| W7217302962 | Renal Cell Carcinomas: Radiotherapy, Clinical Application, Radio-Sensitivity and Dose-Response | 2024-08-18 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217302962 | ||||
| W4401714261 | A Novel Approach to Noncompressible Torso Hemorrhage Using a Silicone-Based Polymer Universal Combat Matrix | 2024-08-19 | OpenAlex | 10.1093/milmed/usae085 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401714261 | |||
| W4401735115 | Chapter 1 Nanocarrier drug delivery System: recent advancement and future potential | 2024-08-19 | OpenAlex | 10.1515/9783111320847-001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401735115 | |||
| W4401714272 | Foreword | 2024-08-19 | OpenAlex | 10.1093/milmed/usae145 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401714272; https://openalex.org/W4416427962 | |||
| W4401690813 | Reassessing the management of uncomplicated urinary tract infection: A retrospective analysis using machine learning causal inference | 2024-08-19 | OpenAlex | 10.1101/2024.08.18.24312104 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401690813 | |||
| W4401701586 | Soft nanoferrites for cancer diagnosis | 2024-08-19 | OpenAlex | 10.1201/9781003517139-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401701586 | |||
| W4401975416 | Advancement in Mechanistic Alteration of IGFs Family of Receptors to Target Prostate and Cervical Cancer: An Updated Review | 2024-08-20 | OpenAlex | 10.2174/0115733947302362240807105327 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401975416 | |||
| W4402207347 | Assessment of the knowledge of healthcare workers on monkeypox in Nigeria | 2024-08-20 | OpenAlex | 10.3205/dgkh000493 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402207347 | |||
| W4401715793 | Consideration of the Root Causes in Candidate Attrition During Oncology Drug Development | 2024-08-20 | OpenAlex | 10.1002/cpdd.1464 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401715793 | |||
| W4401745694 | Telemedicine in the post-COVID era: balancing accessibility, equity, and sustainability in primary healthcare | 2024-08-21 | OpenAlex | 10.3389/fdgth.2024.1432871 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401745694 | |||
| W4401732558 | Were deaths recorded in Brazil due to cystic fibrosis or pulmonary fibrosis? A data-based analysis | 2024-08-21 | OpenAlex | 10.3389/fmed.2024.1459785 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401732558 | |||
| W4401758439 | Contemporary treatment options in heart failure with preserved ejection fraction | 2024-08-22 | OpenAlex | 10.1093/ehjci/jeae201 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401758439 | |||
| W4401741836 | From Soft Microgel Assemblies to Advanced Healthcare Materials | 2024-08-22 | OpenAlex | 10.1002/adhm.202402905 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401741836 | |||
| W4401755392 | Imaging in Erdheim-Chester Disease | 2024-08-22 | OpenAlex | 10.1148/rg.240011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401755392 | |||
| W4401828575 | What’s New in Shoulder and Elbow Surgery | 2024-08-22 | OpenAlex | 10.2106/jbjs.24.00812 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401828575; https://openalex.org/W4414007880 | |||
| W4401799173 | Formulation of Bacteriophage for Inhalation to Treat Multidrug-Resistant Pulmonary Infections | 2024-08-23 | OpenAlex | 10.14356/kona.2025016 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401799173 | |||
| W4401823827 | Green Nanomaterials for Sustainable Targeted Drug Delivery Systems | 2024-08-23 | OpenAlex | 10.1201/9781003501572-11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401823827 | |||
| W4401811574 | Immunotherapy for breast cancer: New strategies to enhance the patient selection and overcome therapeutic resistance | 2024-08-23 | OpenAlex | 10.1016/b978-0-443-13376-3.00008-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401811574 | |||
| W4401835422 | Molecular Mechanism and Actions of Antifungal Drugs Using Trichosporon Fungal Species | 2024-08-23 | OpenAlex | 10.22214/ijraset.2024.64031 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401835422 | |||
| W4401820878 | Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors | 2024-08-23 | OpenAlex | 10.4166/kjg.2024.060 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401820878 | |||
| W4401798070 | Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer | 2024-08-23 | OpenAlex | 10.1038/s41571-024-00935-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401798070 | |||
| W4401802667 | Recompensation of Chronic Hepatitis C–Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program | 2024-08-23 | OpenAlex | 10.1053/j.gastro.2024.08.018 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401802667 | |||
| W4401853322 | Heart Failure in Older People Part 1: Disease State Review and Lifestyle Interventions | 2024-08-24 | OpenAlex | 10.4140/tcp.n.2024.325 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401853322 | |||
| W4401865444 | An Evolving Landscape: New Therapies for Metastatic Colorectal Cancer | 2024-08-25 | OpenAlex | 10.1016/j.clcc.2024.08.003 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401865444 | |||
| W4407838366 | Investigating the Anti-Allergic, Bronchoprotective, and Antioxidant Activities of Psidium guajava Extract in Experimental Animals: A Comprehensive Study | 2024-08-25 | OpenAlex | 10.61920/jimp.v1i02.25 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4407838366 | |||
| W4401891142 | A Narrative Review on Recombinant Human Bone Morphogenetic Protein 2: Where Are We Now? | 2024-08-26 | OpenAlex | 10.7759/cureus.67785 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401891142 | |||
| W4403007871 | Current Treatment Process and Challenges for Spinal Muscular Atrophy (SMA) | 2024-08-26 | OpenAlex | 10.52711/0974-360x.2024.00580 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403007871 | |||
| W4401963974 | Prilocaine vs bupivacaine in spinal anesthesia for urologic endoscopy: clinical trials & historical overview | 2024-08-26 | OpenAlex | 10.24884/2078-5658-2024-21-4-50-59 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401963974 | |||
| W4401930103 | Editorial: Cancer and inflammatory diseases research: from the basics to the precision medicine | 2024-08-27 | OpenAlex | 10.3389/fphar.2024.1477963 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401930103 | |||
| W4401929261 | Hepatocellular carcinoma imaging: Exploring traditional techniques and emerging innovations for early intervention | 2024-08-27 | OpenAlex | 10.1016/j.medntd.2024.100327 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401929261 | |||
| W4401905048 | Therapeutics in hospitalised adult patients with COVID-19 | 2024-08-27 | OpenAlex | 10.1183/2312508x.10020423 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401905048 | |||
| W4401970844 | Bacterial pathogens associated with community-acquired pneumonia in children aged from 28 days to 10 years admitted in Dakahlia Governorate hospitals: a cross-sectional study | 2024-08-28 | OpenAlex | 10.21203/rs.3.rs-4773221/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401970844 | |||
| W4402012315 | CAR-T cell therapy in relapsed or refractory multiple myeloma and access in Turkey | 2024-08-28 | OpenAlex | 10.3389/fmed.2024.1413825 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402012315 | |||
| W4402025816 | Emerging lactic acid bacteria bacteriocins as anti-cancer and anti-tumor agents for human health | 2024-08-28 | OpenAlex | 10.1016/j.heliyon.2024.e37054 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4402025816 | |||
| W4401954303 | Loss of glycerol catabolism confers carbon-source-dependent artemisinin resistance in Mycobacterium tuberculosis | 2024-08-28 | OpenAlex | 10.1128/aac.00645-24 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4401954303 | |||
| W4403677619 | Property-Based Transparency: a New Utility Definition* | 2024-08-28 | OpenAlex | 10.1109/case59546.2024.10711688 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403677619; https://openalex.org/W4404433761 | |||
| W4401947322 | Translating biological insights into improved management of endometrial cancer | 2024-08-28 | OpenAlex | 10.1038/s41571-024-00934-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401947322 | |||
| W4401992551 | Who Cares for Black Women in Health and Health Care | 2024-08-28 | OpenAlex | 10.52843/cassyni.lw6tm5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401992551 | |||
| W4401954680 | “What got you here, won’t get you there”: Students as leaders of the change we need | 2024-08-28 | OpenAlex | 10.1177/08404704241259917 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401954680 | |||
| W4401979646 | Becoming agents for genomic change: genetic counsellors’ views of patient care and implementation influences when genomics is mainstreamed | 2024-08-29 | OpenAlex | 10.1038/s41431-024-01686-9 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4401979646 | |||
| W4402015362 | Comparison of sinonasal symptoms in upper respiratory tract infections during the infectious diseases season of November 2023 to March 2024—a cross-sectional study | 2024-08-29 | OpenAlex | 10.3389/fmed.2024.1447467 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402015362 | |||
| W4402003061 | Considering the Future of Geroscience: Goals and Opportunities Stemming From the Fourth Geroscience Summit | 2024-08-29 | OpenAlex | 10.1093/gerona/glae179 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402003061 | |||
| W4401986271 | The treatment landscape of triple-negative breast cancer | 2024-08-29 | OpenAlex | 10.1007/s12032-024-02456-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4401986271 | |||
| W4402034457 | BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing | 2024-08-30 | OpenAlex | 10.1038/s41416-024-02827-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402034457 | |||
| W4402072212 | Editorial: Spiroplasma, Mycoplasma, Phytoplasma, and other genome-reduced and wall-less mollicutes: their genetics, genomics, mechanics, interactions and symbiosis with insects, other animals and plants | 2024-08-30 | OpenAlex | 10.3389/fmicb.2024.1477536 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402072212 | |||
| W4402035534 | Nutrition Considerations in the Intensive Care Unit | 2024-08-30 | OpenAlex | 10.4037/aacnacc2024643 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402035534 | |||
| W4402055660 | The Most Disruptive Near-Term Use of AI in Cancer Care: Patient Empowerment Through Software Agents | 2024-08-30 | OpenAlex | 10.1089/aipo.2024.0027 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4402055660 | |||
| W4402051052 | Updates on the Management of Autoimmune Bullous Diseases | 2024-08-30 | OpenAlex | 10.4103/idoj.idoj_740_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402051052 | |||
| W4401895717 | Metastatic pheochromocytoma and paraganglioma: Integrating tumor biology in clinical practice | 2024-08-31 | OpenAlex | 10.1016/j.mce.2024.112344 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401895717 | |||
| W4413337398 | Pharmacokinetics and Pharmacodynamics of Glyburide: Insights for Optimizing Treatment in Type 2 Diabetes | 2024-08-31 | OpenAlex | 10.15416/ijcp.2024.13.2.48713 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413337398 | |||
| W4402558495 | 1285P Deep learning prediction of response to advanced-generation ALK inhibitors (aALKi) in ALK-rearranged advanced NSCLC (aNSCLC) patients using digital pathology | 2024-09-01 | OpenAlex | 10.1016/j.annonc.2024.08.1342 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402558495 | |||
| W4402704921 | 1661TiP SEGNO: An exploratory study of the safety and efficacy of genomic biomarker-guided neoadjuvant therapy for locally advanced and oligometastatic prostate cancer | 2024-09-01 | OpenAlex | 10.1016/j.annonc.2024.08.1742 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402704921 | |||
| W7201606461 | Biyogörüntüleme ve biyosensing için genetik olarak tasarlanmış mikroplar | 2024-09-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7201606461 | ||||
| W4402114371 | Case 2: Worsening Anxiety in an Adolescent: The Role of Anchoring Bias | 2024-09-01 | OpenAlex | 10.1542/pir.2022-005947 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402114371 | |||
| W4403454583 | Challenging the efficacy and safety of clopidogrel versus aspirin monotherapy in secondary prevention of coronary artery disease: a comprehensive review | 2024-09-01 | OpenAlex | 10.56808/3027-7922.2968 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403454583 | |||
| W4402895350 | Deciphering the Dynamics of EGFR-TKI Resistance in Lung Cancer: Insights from Bibliometric Analysis | 2024-09-01 | OpenAlex | 10.2147/dddt.s478910 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402895350 | |||
| W4403810861 | Developments in good practice in medically assisted procreation: new rules and management of viral risks | 2024-09-01 | OpenAlex | 10.1684/mte.2024.1015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403810861 | |||
| W4406376913 | Driving outperformance: The power and potential of economic profit | 2024-09-01 | OpenAlex | 10.1111/jacf.12637 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4406376913 | |||
| W4402768124 | E14 Adjusting RA to kids | 2024-09-01 | OpenAlex | 10.1136/rapm-2024-esra.571 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402768124 | |||
| W4402888315 | Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach | 2024-09-01 | OpenAlex | 10.1002/jex2.70011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402888315 | |||
| W4402288441 | From Research to Practice: The Latest Data on Evolving Treatments for Chronic Spontaneous Urticaria. | 2024-09-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402288441 | ||||
| W4404086842 | Insights and perspectives: EUS in post-liver transplantation care | 2024-09-01 | OpenAlex | 10.1097/eus.0000000000000084 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404086842 | |||
| W4402378671 | Long‐term persistence of mitochondrial dysfunctions after viral infections and antiviral therapies: A review of mechanisms involved | 2024-09-01 | OpenAlex | 10.1002/jmv.29886 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402378671 | |||
| W4406310573 | New dimensions of oral potentially malignant disorders: Navigating the future | 2024-09-01 | OpenAlex | 10.4103/kleuhsj.kleuhsj_480_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406310573 | |||
| W4402106272 | New strategies in soft tissue sarcoma treatment | 2024-09-01 | OpenAlex | 10.1186/s13045-024-01580-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402106272 | |||
| W4402118374 | Original Sin in the Context of Lonergan's Soteriology | 2024-09-01 | OpenAlex | 10.1111/heyj.14347 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4402118374 | |||
| W4404164497 | Our Experiences and Learnings in Diagnosing MODY from Non-Institutional-Based Diabetes Care Clinics | 2024-09-01 | OpenAlex | 10.4103/ijem.ijem_361_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404164497 | |||
| W4402798056 | P.157: Successful ABO i Renal Transplantation in UAE. | 2024-09-01 | OpenAlex | 10.1097/01.tp.0001067472.01188.34 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402798056 | |||
| W4402817904 | P.245: Challenges and outcomes with kidney re-transplantation. | 2024-09-01 | OpenAlex | 10.1097/01.tp.0001067796.66340.9c | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402817904 | |||
| W4402395680 | Re: Posterior urethral stenosis: Contemporary management options | 2024-09-01 | OpenAlex | 10.1002/uro2.81 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402395680 | |||
| W4402627247 | Recent advances in immunotherapy for pancreatic cancer: a narrative review | 2024-09-01 | OpenAlex | 10.21037/dmr-24-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402627247 | |||
| W4402373594 | SP6.3 - Comparison of three new wireless non-radiation techniques for localization of non-palpable breast cancer - an updated systematic review and pooled meta-analysis | 2024-09-01 | OpenAlex | 10.1093/bjs/znae197.068 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402373594 | |||
| W4402397851 | Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer | 2024-09-01 | OpenAlex | 10.1016/j.tjog.2024.07.014 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402397851 | |||
| W4403527786 | Surgical Applications for Bone Marrow Aspirate Concentrate | 2024-09-01 | OpenAlex | 10.1016/j.arthro.2024.05.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403527786 | |||
| W4405424409 | The “Brave New World” of biosimilars: Look before you leap! | 2024-09-01 | OpenAlex | 10.4103/kjo.kjo_130_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405424409 | |||
| W4402818559 | V-212.5: Candida colonization and candidemia among pediatrics solid organ transplantation: A one year experience. | 2024-09-01 | OpenAlex | 10.1097/01.tp.0001066804.63088.e9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402818559 | |||
| W4402624699 | VR Environments | 2024-09-01 | OpenAlex | 10.1162/pajj_a_00739 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4402624699 | |||
| W4406081512 | Vitiligo | 2024-09-01 | OpenAlex | 10.4103/pigmentinternational_82_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406081512 | |||
| W4402139035 | Advances in Primary Stabbing Headache: Diagnostic Criteria, Epidemiological Insights, and Tailored Treatment Approaches | 2024-09-02 | OpenAlex | 10.62087/hpr.2024.0018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402139035 | |||
| W4402198242 | Bladder sparing options for muscle-invasive bladder cancer | 2024-09-02 | OpenAlex | 10.1097/mou.0000000000001220 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402198242 | |||
| W4402147005 | Medical and neurologic management of brain tumor patients | 2024-09-02 | OpenAlex | 10.1097/wco.0000000000001315 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402147005 | |||
| W4402312999 | Pediatric Arteriovenous Malformations of the Neck: A Case Presentation and Review of Literature | 2024-09-02 | OpenAlex | 10.36347/sjmcr.2024.v12i09.004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402312999 | |||
| W4402138176 | Sustainable Therapeutic Approaches with Nanophotocatalyst | 2024-09-02 | OpenAlex | 10.1002/9781394212767.ch14 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402138176 | |||
| W4402191222 | Does Eosinophil Heterogeneity Translate into Functional Diversity? A Review of the Evolving Paradigm of Eosinophil Heterogeneity in Asthma | 2024-09-03 | OpenAlex | 10.3390/biomedicines12092011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402191222 | |||
| W4402193334 | Mpox treatment evolution: past milestones, present advances, and future directions | 2024-09-03 | OpenAlex | 10.1007/s00210-024-03385-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402193334 | |||
| W4402190609 | Protection, Mobility, & Comfort: The Effects of Global Pandemics on Women's Dress | 2024-09-03 | OpenAlex | 10.32920/26871493 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4402190609; https://openalex.org/W4402195296 | |||
| W7219042703 | GERIATRIC ANESTHESIA: EVALUATING THE IMPACT OF AGE-RELATED PHYSIOLOGICAL CHANGES ON ANAESTHETIC PRACTICES | 2024-09-04 | OpenAlex | 10.33508/jwmj.v6i3.5764 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7219042703 | |||
| W4402326715 | Editorial: Theranostics as a driving force in nuclear medicine | 2024-09-06 | OpenAlex | 10.3389/fonc.2024.1468357 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402326715 | |||
| W4402369378 | Emerging potential of progranulin-dependent SorCS2 signaling in healthy and diseased nervous systems | 2024-09-06 | OpenAlex | 10.4103/nrr.nrr-d-24-00734 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402369378 | |||
| W4402323764 | Immunomodulation in Non-traditional Therapies for Methicillin-resistant Staphylococcus aureus (MRSA) Management | 2024-09-06 | OpenAlex | 10.1007/s00284-024-03875-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402323764 | |||
| W4402321770 | Maintenance Therapy in Acute Myeloid Leukemia | 2024-09-06 | OpenAlex | 10.1097/coc.0000000000001140 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402321770 | |||
| W4402328958 | A Novel Use of Terbutaline: Persistent Genital Arousal Disorder in the Emergency Department | 2024-09-07 | OpenAlex | 10.1016/j.jemermed.2024.08.023 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402328958 | |||
| W4402332408 | Imaging recommendations for soft-tissue sarcomas: model guidelines from diagnosis to post-treatment follow-up | 2024-09-07 | OpenAlex | 10.1016/j.crad.2024.08.023 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402332408 | |||
| W4402341052 | Extracellular vesicles in pulmonary infection: From pathophysiology to theranostic technologies | 2024-09-08 | OpenAlex | 10.1016/j.cej.2024.155585 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402341052 | |||
| W4402341744 | Toxin inhibition: Examining tetracyclines, clindamycin, and linezolid | 2024-09-08 | OpenAlex | 10.1093/ajhp/zxae251 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402341744 | |||
| W4402380415 | Editorial: Green Veterinary Pharmacology and Toxicology: a “One Health” Approach milestone | 2024-09-09 | OpenAlex | 10.3389/fvets.2024.1476877 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402380415 | |||
| W4402357554 | Innovative Endovascular Management of Giant Superficial Temporal Artery Pseudoaneurysm Presented With Periorbital Ulcerative Mass | 2024-09-09 | OpenAlex | 10.1097/scs.0000000000010594 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402357554 | |||
| W4402412143 | Journal-related Activities and Other Special Activities at the 2024 American Society of Anesthesiologists Meeting | 2024-09-09 | OpenAlex | 10.1097/aln.0000000000005165 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402412143 | |||
| W4402364542 | Navigating dry eye relief: Meibo’s approach to controlling tear evaporation | 2024-09-09 | OpenAlex | 10.1097/ms9.0000000000002550 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402364542 | |||
| W4402409201 | Navigating the Maze: A Mini-Guide for the Management and Therapy of Metabolic Dysfunction-associated Steatotic Liver Disease | 2024-09-09 | OpenAlex | 10.58931/cpct.2024.2232 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402409201 | |||
| W4402395751 | Anticipating Viral Challenges: A Perspective on Phytochemicals against Existing and Emerging Viruses | 2024-09-10 | OpenAlex | 10.2174/0122113525312781240819105116 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402395751 | |||
| W4402422896 | Editorial: From interventional pearls to pioneering technologies in transcatheter treatment of congenital heart defects | 2024-09-10 | OpenAlex | 10.3389/fcvm.2024.1484393 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402422896 | |||
| W4402452511 | Emerging Therapies for Non-Alcoholic Steatohepatitis (NASH): A Comprehensive Review of Pharmacological and Non-Pharmacological Approaches | 2024-09-10 | OpenAlex | 10.7759/cureus.69129 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402452511 | |||
| W4402423975 | Epidemiology of pulmonary embolism diagnosis and management among United States emergency departments over an eight-year period | 2024-09-10 | OpenAlex | 10.1016/j.ajem.2024.09.016 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402423975 | |||
| W4402421583 | INDOMETHACIN: A MIRACLE DRUG TO TREAT A RANGE OF AILMENTS WITH A RESTORATIVE AND SYNERGISTIC IMPACT | 2024-09-10 | OpenAlex | 10.22541/au.172594809.99819066/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402421583 | |||
| W4402430424 | Liver disorders in substance abusers | 2024-09-10 | OpenAlex | 10.14744/hf.2024.2024.0012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402430424 | |||
| W4402442117 | Nonhealing vulvar ulcer associated with hyperkeratotic depigmented plaques | 2024-09-11 | OpenAlex | 10.1097/jw9.0000000000000178 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402442117 | |||
| W4402498966 | Revolutionizing Ophthalmic Care: A Review of Ocular Hydrogels from Pathologies to Therapeutic Applications | 2024-09-11 | OpenAlex | 10.1080/02713683.2024.2396385 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402498966 | |||
| W4402460438 | The evolution of heteroresistance via small colony variants in Escherichia coli following long term exposure to bacteriostatic antibiotics | 2024-09-11 | OpenAlex | 10.1038/s41467-024-52166-z | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4402460438 | |||
| W4402499278 | Changes in the clinical features, treatments, and outcomes of patients with systemic light chain (AL) amyloidosis in Western China, 2010–2022: A multicenter, retrospective, real-world study | 2024-09-12 | OpenAlex | 10.1097/cm9.0000000000003290 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402499278 | |||
| W4402514733 | Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance | 2024-09-13 | OpenAlex | 10.1038/s41571-024-00939-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402514733 | |||
| W4402524263 | Radiotherapeutic advances in the management of glioblastoma | 2024-09-13 | OpenAlex | 10.1007/s11060-024-04824-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402524263 | |||
| W4402512757 | Yao Syndrome: An Overview of Genotypic Associations, Clinical Manifestations, Diagnosis, and Treatment | 2024-09-13 | OpenAlex | 10.1159/000540188 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402512757 | |||
| W4402754860 | Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral Small Molecules | 2024-09-14 | OpenAlex | 10.3390/antib13030076 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402754860 | |||
| W4402554757 | Anti-CD38 Monoclonals for Treatment of Antibody-mediated Rejection in Renal Allografts | 2024-09-16 | OpenAlex | 10.1097/tp.0000000000005206 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402554757 | |||
| W4402811020 | Editorial: The role of evidence-based medicine and value-based medicine in clinical practice to enhance mental health | 2024-09-16 | OpenAlex | 10.3389/fpubh.2024.1487305 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402811020 | |||
| W4402653058 | Review on Updated Management of Prurigo Nodularis (PN) | 2024-09-16 | OpenAlex | 10.36348/sjm.2024.v09i09.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402653058; https://openalex.org/W7168021626 | |||
| W4402614090 | An evaluation of durvalumab across the spectrum of urothelial carcinoma | 2024-09-18 | OpenAlex | 10.1080/14737140.2024.2405104 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402614090 | |||
| W4402611321 | Diagnosis and Management of Immune Thrombocytopenia in Paediatrics: A Comprehensive Review | 2024-09-18 | OpenAlex | 10.7759/cureus.69635 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402611321 | |||
| W4402592254 | Ex-vivo mouse precision cut tumour slices for modelling hepatocellular carcinoma; A 3Rs solution for at-scale drug screening | 2024-09-18 | OpenAlex | 10.1101/2024.09.16.613213 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4402592254 | |||
| W4402601219 | Functionalized PLGA-Based Nanoparticles with Anti-HSV-2 Human Monoclonal Antibody: A Proof of Concept for Early Diagnosis and Targeted Therapy | 2024-09-18 | OpenAlex | 10.3390/pharmaceutics16091218 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402601219 | |||
| W4402643486 | Combined use of radiotherapy and tyrosine kinase inhibitors in the management of metastatic non-small cell lung cancer: A literature review | 2024-09-19 | OpenAlex | 10.1016/j.critrevonc.2024.104520 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402643486 | |||
| W4405800299 | Contemporary insights into the collagen-stimulating mechanism of polylactic acid: a new paradigm in dermal fillers using poly-L-lactic acid fillers | 2024-09-19 | OpenAlex | 10.54724/lc.2024.e10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405800299 | |||
| W4402640743 | Immunological Advancements In Hand Eczema Treatment: Progress With Small Molecules and Biologics | 2024-09-19 | OpenAlex | 10.1007/s40521-024-00374-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402640743 | |||
| W4402647582 | Modern Therapy of Chronic Myeloid Leukaemia | 2024-09-19 | OpenAlex | 10.5772/intechopen.115458 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402647582 | |||
| W4402641535 | Principles of lipid nanoparticle design for mRNA delivery | 2024-09-19 | OpenAlex | 10.1002/bmm2.12116 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402641535 | |||
| W7201223881 | Recent advances in pharmacothrapy of colorectal cancer | 2024-09-19 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7201223881 | ||||
| W4402694600 | Harnessing artificial intelligence for breakthroughs in lung cancer management: are we ready for the future? | 2024-09-20 | OpenAlex | 10.3389/fonc.2024.1450568 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402694600 | |||
| W4402772110 | Lessons Learned from the Zika Virus Epidemics: A Mounting Demand for Adopting Public Health Informatics Tools and Technologies for Epidemiological Surveillance and Outbreak Containment | 2024-09-20 | OpenAlex | 10.1007/s40475-024-00330-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402772110 | |||
| W4402709853 | NOVOS ANTIDIABÉTICOS E PERSPECTIVAS NO MANEJO DA HIPERGLICEMIA CRÔNICA | 2024-09-20 | OpenAlex | 10.51473/rcmos.v1i1.2024.613 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402709853 | |||
| W4402674365 | Self-Improved Language Production in Nonfluent Aphasia Through Automated Recursive Self-Feedback | 2024-09-20 | OpenAlex | 10.1044/2024_ajslp-23-00320 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402674365 | |||
| W4402844157 | Synthesis and antimicrobial activity of hybrid peptides as dual inhibitor of intracellular targets in ESKAPE pathogens | 2024-09-20 | OpenAlex | 10.17952/37eps.2024.p2150 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4402844157 | |||
| W4402709153 | Abstract C054: Current anticancer drugs differentially impact Black and White prostate cancer cell lines | 2024-09-21 | OpenAlex | 10.1158/1538-7755.disp24-c054 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4402709153 | |||
| W4402750809 | An Overview of the Recent Advances in Antimicrobial Resistance | 2024-09-21 | OpenAlex | 10.3390/microorganisms12091920 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402750809 | |||
| W4402711151 | Chemotherapy of Malignancy-II | 2024-09-21 | OpenAlex | 10.58532/nbennurphch17 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402711151 | |||
| W4402715408 | Advancements in Topical Treatments for Acne Vulgaris: A Comprehensive Review of Efficacy, Safety, and Patient Satisfaction | 2024-09-22 | OpenAlex | 10.61853/6zczv952 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402715408 | |||
| W4402760383 | 9 Nanotoxicity prediction in nanotechnology-driven drugs using QSPR modeling | 2024-09-23 | OpenAlex | 10.1515/9783111208671-009 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4402760383 | |||
| W4402724640 | Advancements in cholangiocarcinoma: evolving strategies for diagnosis, treatment, and palliation over three decades | 2024-09-23 | OpenAlex | 10.21037/cco-23-144 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4402724640 | |||
| W4402731407 | Advances in nephroprotection: the therapeutic role of selenium, silver, and gold nanoparticles in renal health | 2024-09-23 | OpenAlex | 10.1007/s11255-024-04212-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402731407 | |||
| W4402730915 | Erdosteine in Chronic Obstructive Pulmonary Disease – Evidence and Current Role | 2024-09-23 | OpenAlex | 10.4103/jalh.jalh_21_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402730915 | |||
| W4402741146 | Recurrent acute myocardial and renal infarction with aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome: a case report | 2024-09-23 | OpenAlex | 10.1093/ehjcr/ytae526 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402741146 | |||
| W4402802387 | CARDIOMIOPATIA INDUZIDA POR QUIMIOTERAPIA: UMA REVISÃO INTEGRATIVA SOBRE MECANISMOS, DIAGNÓSTICO E TRATAMENTO | 2024-09-24 | OpenAlex | 10.69849/revistaft/ma10202409241436 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402802387 | |||
| W4402772092 | Commentary on “Preoperative Chemotherapy Response and Survival in Patients With Colorectal Cancer Peritoneal Metastases” | 2024-09-24 | OpenAlex | 10.1002/jso.27929 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402772092 | |||
| W4407729972 | Living conditions, working conditions, professional development and self-identity in Chinese rural primary school teachers: A chain-mediating model | 2024-09-24 | OpenAlex | 10.46690/elder.2024.04.03 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4407729972 | |||
| W4402763358 | Milestone achieved: FDA approves nivolumab in combination with cisplatin and gemcitabine for metastatic urothelial carcinoma | 2024-09-24 | OpenAlex | 10.1097/ms9.0000000000002601 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402763358 | |||
| W4402794043 | Multiple Sclerosis and COVID-19: An Overview on Risk, Severity, and Association With Disease Modifying Therapies | 2024-09-24 | OpenAlex | 10.1177/26331055241265668 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402794043 | |||
| W4402786461 | The Role of Nanomaterials in Diagnosis and Targeted Drug Delivery | 2024-09-24 | OpenAlex | 10.1002/cbdv.202401581 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402786461 | |||
| W4402847570 | Advancements in Pyrazine Derivatives as Anticancer Agents: A Comprehensive Review (2010-2024) | 2024-09-25 | OpenAlex | 10.2174/0118715206333399240912071555 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4402847570 | |||
| W4402861686 | Disrupting the activity of endogenous gas neurotransmitters: a therapeutic strategy using engineered metal–organic frameworks for cancer | 2024-09-25 | OpenAlex | 10.4103/mgr.medgasres-d-24-00046 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402861686 | |||
| W4402814805 | Editorial: Internet pharmacies and the online pharmacy market: trends, perspectives and challenges | 2024-09-25 | OpenAlex | 10.3389/fphar.2024.1489396 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402814805 | |||
| W4402828241 | Management of von Willebrand disease for orthognathic surgery: Evidenced-based recommendations and scoping review of the literature | 2024-09-25 | OpenAlex | 10.1016/j.adoms.2024.100498 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402828241 | |||
| W4402825008 | Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions | 2024-09-25 | OpenAlex | 10.1016/j.euo.2024.09.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402825008 | |||
| W4402841314 | Performance evaluation of image co-registration methods in photoacoustic mesoscopy of the vasculature | 2024-09-25 | OpenAlex | 10.1088/1361-6560/ad7fc7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402841314 | |||
| W4402846669 | Rabies virus as vector for development of vaccine: pros and cons | 2024-09-25 | OpenAlex | 10.3389/fvets.2024.1475431 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402846669 | |||
| W4402849875 | S. Todd Lowry (1927–2023) | 2024-09-25 | OpenAlex | 10.1215/00182702-11540302 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402849875 | |||
| W4402829862 | Strategies to optimize initial P2Y12 inhibitor therapy in STEMI patients | 2024-09-25 | OpenAlex | 10.1016/j.carrev.2024.09.012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402829862 | |||
| W4402815455 | Targeted Therapies in Pancreatic Cancer: A New Era of Precision Medicine | 2024-09-25 | OpenAlex | 10.3390/biomedicines12102175 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402815455 | |||
| W4402894782 | Editorial: Insights and implications of mechanisms shaping glioma immune landscape, immunotherapy resistance, and relevant translational research | 2024-09-26 | OpenAlex | 10.3389/fonc.2024.1485761 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402894782 | |||
| W4402884616 | Medical Management of Acute Stroke based on Japan Stroke Society Guidelines and the Japan Stroke Data Bank | 2024-09-26 | OpenAlex | 10.5551/jat.rv22027 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402884616 | |||
| W4402873358 | THE THREAT OF CBRN TERRORISM: AN OVERVIEW AND IMPROVISED USE OF CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR MATERIALS | 2024-09-26 | OpenAlex | 10.5604/01.3001.0054.7565 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4402873358 | |||
| W4402907157 | A Novel Localized Student-Teacher LLM for Enhanced Toxicity Extraction in Radiation Oncology | 2024-09-27 | OpenAlex | 10.1016/j.ijrobp.2024.07.1392 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402907157 | |||
| W4402907482 | Adjuvant Primary Site Radiation Therapy for Melanoma in the Immunotherapy Era | 2024-09-27 | OpenAlex | 10.1016/j.ijrobp.2024.07.2220 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402907482 | |||
| W4402935626 | Assessing organ function in the critically ill patient | 2024-09-27 | OpenAlex | 10.1097/jtccm-d-24-00038 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402935626 | |||
| W4402928626 | Recent Advances in Nanomedicine: Enhancing Drug Delivery and Diagnosis through Nanotechnology | 2024-09-27 | OpenAlex | 10.47392/irjaem.2024.0443 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402928626 | |||
| W4402948599 | A Five-Year Trend Analysis of Antibacterial Resistance Patterns Among Non-fermenting Gram-Negative Bacilli: A Retrospective Study From the ICU Settings of a Tertiary Care Hospital | 2024-09-28 | OpenAlex | 10.7759/cureus.70375 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402948599 | |||
| W4403038995 | Diagnosis and treatment of pneumocystis pneumonia - a review article | 2024-09-28 | OpenAlex | 10.55214/25768484.v8i6.2032 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403038995 | |||
| W4403068458 | Monkeypox: A comprehensive review of virology, epidemiology, and global health implications | 2024-09-28 | OpenAlex | 10.21608/mid.2024.317587.2187 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403068458 | |||
| W4402956737 | Evidence for the evolving role of neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer | 2024-09-29 | OpenAlex | 10.37349/etat.2024.00273 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402956737 | |||
| W4402988649 | Insights from Clinical Trials: Evidence-Based Recommendations for Induction Treatment of Newly Diagnosed Transplant-Eligible Multiple Myeloma | 2024-09-29 | OpenAlex | 10.3390/antib13040080 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402988649 | |||
| W4403196675 | A Review on Applications of Photodynamic Therapy in Oral and Maxillofacial Surgery | 2024-09-30 | OpenAlex | 10.53555/ajbr.v27i3s.1560 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403196675 | |||
| W4402995824 | An Uncommon Clinical Mystery: Systemic Lupus Erythematosus Masquerading as Aseptic Meningitis in a Male Patient | 2024-09-30 | OpenAlex | 10.7759/cureus.70484 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4402995824 | |||
| W4406231789 | CDA Formulations as the Only Option Capable of Reducing Cancer Mortality | 2024-09-30 | OpenAlex | 10.33425/2833-0390.1035 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4406231789 | |||
| W4403044114 | COPD : The forgotten cardiovascular risk | 2024-09-30 | OpenAlex | 10.1111/resp.14837 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403044114 | |||
| W4402995695 | Graphene Quantum Dots from Natural Carbon Sources for Drug and Gene Delivery in Cancer Treatment | 2024-09-30 | OpenAlex | 10.3390/ijms251910539 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4402995695 | |||
| W7224069612 | Plane Warts: Clinical Features, Pathogenesis, Diagnostic Modalities, and Emerging Immunotherapeutic Approaches | 2024-09-30 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224069612 | ||||
| W4403014004 | Polymer-Based Antimicrobial Peptide Mimetics for Treating Multi-drug Resistant Infections: Therapy and Toxicity Evaluation | 2024-09-30 | OpenAlex | 10.1007/s10989-024-10648-0 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403014004 | |||
| W7118123056 | Role of Clinical Laboratories in Early Detection of Sepsis | 2024-09-30 | OpenAlex | 10.22399/ijcesen.4643 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118123056 | |||
| W4400397773 | TOWARDS RIEMANNIAN EEG CLASSIFIERS TO DETECT AWAKE AND ANESTHETIZED STATES USING MEDIAN NERVE STIMULATION | 2024-09-30 | OpenAlex | 10.3217/978-3-99161-014-4-017 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4400397773 | |||
| W4403096463 | Treatment Paradigms in Radiation Maculopathy Treatment: What’s Next? | 2024-09-30 | OpenAlex | 10.18103/mra.v12i9.5708 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403096463 | |||
| W4403153141 | 7856 In Pursuit of Solutions: Exploring Novel Therapeutic Strategies in the Treatment of a Rare, Aggressive Macroprolactinoma Post-Temozolomide: A Case Report | 2024-10-01 | OpenAlex | 10.1210/jendso/bvae163.1245 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403153141 | |||
| W4404500269 | Abstracts of ICRR-HHE-2024 and 4th Biennial Meeting of the Society for Radiation Research | 2024-10-01 | OpenAlex | 10.4103/jrcr.jrcr_53_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404500269 | |||
| W4405782678 | Advancing glaucoma management: Innovation, collaboration, and future directions | 2024-10-01 | OpenAlex | 10.4103/sjopt.sjopt_329_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405782678 | |||
| W4403914937 | Antibody-Drug Conjugates in Breast Cancer: Toward a Molecular Perspective Into Clinical Practice | 2024-10-01 | OpenAlex | 10.1200/po.24.00173 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403914937 | |||
| W4403070611 | B-198 Rapid Molecular Detection of Respiratory Infections in Brazilian Hospitals and Outpatient Units: Insights from the Diagnostic Medicine and Health Network | 2024-10-01 | OpenAlex | 10.1093/clinchem/hvae106.558 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403070611 | |||
| W4403938916 | Can Blood Gene Expression Profile and Donor-Derived Cellfree DNA Guide Postrejection Management among Kidney Transplant Recipients? | 2024-10-01 | OpenAlex | 10.34067/kid.0000000570 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403938916 | |||
| W4403833327 | Current and Future State of Hyperphosphatemia Management | 2024-10-01 | OpenAlex | 10.1681/asn.20241m3ghe0m | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403833327 | |||
| W4403831385 | Demystifying the Atypical Presentation of Complement-Mediated Thrombotic Microangiopathy | 2024-10-01 | OpenAlex | 10.1681/asn.20247861nh0b | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403831385 | |||
| W4403005353 | Dentistry and Pharmaceutical Science: An Evolving Synergy for Oral Health Optimization | 2024-10-01 | OpenAlex | 10.61615/jmccr/2024/oct027141002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403005353 | |||
| W4403824647 | Design and Synthesis of Six‐Armed Antimicrobial Polymer to Battle Against Nosocomial Pathogens | 2024-10-01 | OpenAlex | 10.1002/pat.6606 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403824647 | |||
| W4403568742 | EVALUATION OF DARATUMUMAB, BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (D-VRD) INDUCTION FOLLOWED BY DARATUMUMAB AND LENALIDOMIDE (DR) MAINTENANCE IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS IN BRAZIL | 2024-10-01 | OpenAlex | 10.1016/j.htct.2024.09.873 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403568742 | |||
| W7216928870 | Ethical Considerations in Respiratory Therapy and Nursing Practice: Balancing Patient Autonomy and Care | 2024-10-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216928870 | ||||
| W4403046700 | Future applications of host direct therapies for infectious disease treatment | 2024-10-01 | OpenAlex | 10.3389/fimmu.2024.1436557 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403046700 | |||
| W4403107141 | Heart Failure in Older People Part 2: Guideline-Directed Medical Therapy | 2024-10-01 | OpenAlex | 10.4140/tcp.n.2024.360 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403107141 | |||
| W4405807106 | Keratoconus | 2024-10-01 | OpenAlex | 10.4103/tjosr.tjosr_154_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405807106 | |||
| W4403831428 | Lupus Nephritis Histopathological Classification System: A Questionnaire-Based Survey of the Renal Pathology Society (RPS) | 2024-10-01 | OpenAlex | 10.1681/asn.2024nzrsxw8e | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403831428 | |||
| W4403531656 | Optimizing CT Protocols: Advanced Dose Reduction and Contrast Media Strategies for Personalized Patient Care – Today's Innovations and Tomorrow's Horizons | 2024-10-01 | OpenAlex | 10.1016/j.jmir.2024.101456 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403531656 | |||
| W4403518742 | P17.02.B BMSCOPE: A SCOPING REVIEW TO CHART THE EVOLVING CLINICAL STUDY LANDSCAPE IN BRAIN AND LEPTOMENINGEAL METASTASIS | 2024-10-01 | OpenAlex | 10.1093/neuonc/noae144.289 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403518742 | |||
| W4403811629 | Peritonitis Trends and Patient Outcomes in Peritoneal Dialysis from a Portuguese Center: Decades of Data Unlocked | 2024-10-01 | OpenAlex | 10.1681/asn.2024bbz8751w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403811629 | |||
| W4403830980 | Renal Crystal-Storing Histiocytosis: Transition from Monoclonal Gammopathy of Unknown Significance to Monoclonal Gammopathy of Renal Significance | 2024-10-01 | OpenAlex | 10.1681/asn.2024v77cjdgh | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403830980 | |||
| W4403721693 | S1939 The Evolving Landscape of Drug Induced Liver Injury (DILI): Tracking New Drug Culprits | 2024-10-01 | OpenAlex | 10.14309/01.ajg.0001037124.81921.b2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403721693 | |||
| W4403726730 | S3064 Gastografin Enema to the Rescue of the Glorious Cecal Bascule | 2024-10-01 | OpenAlex | 10.14309/01.ajg.0001041624.40531.77 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403726730 | |||
| W4403721934 | S4093 Novel Hemostatic Gel and Powder as Rescue Agents for Arterial Bleeding Related to Lumen Apposing Metal Stent Placement | 2024-10-01 | OpenAlex | 10.14309/01.ajg.0001045740.45614.a5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403721934 | |||
| W4403719853 | S4739 Unmasking the Chameleon: A Case of Systemic Amyloidosis with Gastrointestinal and Cardiac Involvement | 2024-10-01 | OpenAlex | 10.14309/01.ajg.0001048324.86372.57 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403719853 | |||
| W4403063076 | Scorpionism in a fibromyalgia patient: First report | 2024-10-01 | OpenAlex | 10.4103/sja.sja_233_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403063076 | |||
| W4403568577 | THE DYNAMIC OF MDS DIAGNOSIS: FROM MULTI-LINEAGE DYSPLASIA AND HIGH BLASTS TO LMMC - A CASE REPORT | 2024-10-01 | OpenAlex | 10.1016/j.htct.2024.09.757 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403568577 | |||
| W4403461043 | The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALL | 2024-10-01 | OpenAlex | 10.6004/jnccn.2024.7065 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403461043 | |||
| W4403812702 | The effect of Trimetazidine on the left ventricular global longitudinal strain assessed by cardiac magnetic resonance in stable angina patients with previous myocardial infarction and left ventricular | 2024-10-01 | OpenAlex | 10.1093/eurheartj/ehae666.831 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403812702 | |||
| W4403213910 | The emerging role of bacterial extracellular vesicles in human cancers | 2024-10-01 | OpenAlex | 10.1002/jev2.12521 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403213910 | |||
| W7118204591 | The future of ambulatory anaesthesia: Current trends and emerging techniques | 2024-10-01 | OpenAlex | 10.33545/26643766.2024.v7.i4a.621 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118204591 | |||
| W4404018330 | The history of cytoreduction and HIPEC: Heating up or just blowing smoke? | 2024-10-01 | OpenAlex | 10.1002/jso.27802 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404018330 | |||
| W4405666031 | Unlocking the “Golden” potential of brachytherapy at the nanoscale: Is the era of nano-brachytherapy near? | 2024-10-01 | OpenAlex | 10.4103/jcrt.jcrt_1760_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405666031 | |||
| W4403053761 | Brazilian community health agents and qualitative primary healthcare information | 2024-10-02 | OpenAlex | 10.32920/27156453 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4403053761; https://openalex.org/W4403058217 | |||
| W4403110384 | Inhibitory Potential of Silychrystin on ERR‐γ, Keap‐1, and NF‐κB Proteins in Acute Pancreatitis Explored Through Molecular Docking and Molecular Dynamics Simulation | 2024-10-02 | OpenAlex | 10.1002/slct.202404305 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403110384 | |||
| W4403195240 | CAR-T cell therapy in evolving therapeutic landscape of relapsed or refractory primary mediastinal b-cell lymphoma (PMBCL): challenges and aspirations — two case reports | 2024-10-03 | OpenAlex | 10.5603/hicp.98832 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403195240 | |||
| W4403097783 | Fungal lung disease | 2024-10-03 | OpenAlex | 10.1183/13993003.00803-2024 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403097783 | |||
| W4403088032 | Linear IgA bullous dermatosis in a latin adolescent treated with cyclosporine and prednisone | 2024-10-03 | OpenAlex | 10.24875/bmhim.24000043 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403088032 | |||
| W4403095665 | Revisiting the clinical encounter II | 2024-10-03 | OpenAlex | 10.4324/9780367824051-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403095665 | |||
| W4403097772 | Role of AI in smart robotic systems | 2024-10-03 | OpenAlex | 10.1201/9781003537083-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403097772 | |||
| W4403112258 | A Modern Epidemic of Dermatology Quackery in India | 2024-10-04 | OpenAlex | 10.4103/idoj.idoj_907_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403112258 | |||
| W4403276089 | Antimicrobial Peptides in the Fight Against Drug-Resistant Superbug Infections | 2024-10-04 | OpenAlex | 10.20944/preprints202410.0241.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403276089 | |||
| W4411001396 | Antiviral treatment of COVID-19 | 2024-10-04 | OpenAlex | 10.70070/3kv7z420 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411001396 | |||
| W4403143075 | Editorial: Future frontiers in the management of metastatic colorectal cancer | 2024-10-04 | OpenAlex | 10.3389/fonc.2024.1486653 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403143075 | |||
| W4403119668 | Hybrid Approaches | 2024-10-04 | OpenAlex | 10.1002/9781394272587.ch13 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403119668 | |||
| W4403117069 | Infection risk with JAK inhibitors in dermatoses: a meta‐analysis | 2024-10-04 | OpenAlex | 10.1111/ijd.17501 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403117069 | |||
| W4403139045 | THE SUPPLY OF MEDICINES AS EXAMPLE OF A RE-DESIGN OF THE DISTRIBUTION NETWORK | 2024-10-04 | OpenAlex | 10.52152/dmn10962 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403139045 | |||
| W4403147856 | Large descending colon alveolar soft part sarcoma with ASPL-TFE3 fusion gene: Case report and review of the literature | 2024-10-05 | OpenAlex | 10.1016/j.ijscr.2024.110390 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403147856 | |||
| W4403151441 | Acute Pain Management Following Mandibular Third Molar Exodontia: A Bibliometric Analysis of Randomized Controlled Trials | 2024-10-06 | OpenAlex | 10.1016/j.identj.2024.09.018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403151441 | |||
| W7206557353 | Cell wall lipopeptide structure of ancestral strains of Mycobacterium avium subsp. paratuberculosis | 2024-10-07 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7206557353 | ||||
| W4403237120 | Could H5N1 bird flu virus be the cause of the next human pandemic? | 2024-10-08 | OpenAlex | 10.3389/fmicb.2024.1477738 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403237120 | |||
| W4403237527 | Editorial: Exploring the links between social connections, care and integration | 2024-10-08 | OpenAlex | 10.3389/fhumd.2024.1501897 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403237527 | |||
| W4403209671 | Exploring chitosan nanoparticles for enhanced therapy in neurological disorders: a comprehensive review | 2024-10-08 | OpenAlex | 10.1007/s00210-024-03507-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403209671 | |||
| W4403213288 | Ritonavir’s Evolving Role: A Journey from Antiretroviral Therapy to Broader Medical Applications | 2024-10-08 | OpenAlex | 10.3390/curroncol31100450 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4403213288 | |||
| W4403254705 | Exploration of the Synthesis, Properties, and Biological Applications of B-CDs Materials | 2024-10-09 | OpenAlex | 10.22541/au.172846628.85457688/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403254705 | |||
| W4403252809 | Full Genome Characterization of the First Oropouche Virus Isolate Imported in Europe from Cuba | 2024-10-09 | OpenAlex | 10.3390/v16101586 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403252809 | |||
| W4403248059 | Leukemic occult infiltrative optic neuropathy presenting as optic neuritis: a case report | 2024-10-09 | OpenAlex | 10.1186/s12886-024-03717-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403248059 | |||
| W4403286432 | Cellulose nanocrystal based electrospun nanofiber for biomedical applications–A review | 2024-10-10 | OpenAlex | 10.1016/j.carbpol.2024.122838 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403286432 | |||
| W4403319163 | Efficacy of Nitrofurantoin in Treating Urinary Tract Infections | 2024-10-10 | OpenAlex | 10.48175/ijarsct-19818 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403319163 | |||
| W4403301805 | From Bench to Bedside: A Team’s Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma | 2024-10-10 | OpenAlex | 10.3390/jcm13206036 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403301805 | |||
| W4403285387 | Response to deucravacitinib in psoriasis patients with prior biologic therapy failures: A retrospective study | 2024-10-10 | OpenAlex | 10.1016/j.jaad.2024.09.060 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403285387 | |||
| W4403308940 | Surgeon preferences for self-treatment in locally advanced non–small cell lung cancer: Would we practice what we preach? | 2024-10-10 | OpenAlex | 10.1016/j.jtcvs.2024.05.029 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403308940 | |||
| W4403293231 | The role of nutrition-related clinical trials in informing dietary recommendations for health and treatment of diseases | 2024-10-10 | OpenAlex | 10.1016/j.jacl.2024.09.010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403293231 | |||
| W4403332715 | Blame it on ... Anesthesia? | 2024-10-11 | OpenAlex | 10.1097/aln.0000000000005202 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403332715 | |||
| W4403357857 | Efficacy and safety of inhaled molecular hydrogen therapy in patients with respiratory failure due to chronic obstructive pulmonary disease exacerbation in post-COVID period | 2024-10-11 | OpenAlex | 10.18093/0869-0189-2024-34-5-655-667 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403357857 | |||
| W4403316616 | Future perspectives and challenges for biomaterials in cancer precision medicine | 2024-10-11 | OpenAlex | 10.1016/b978-0-323-85661-4.00008-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403316616 | |||
| W4403335118 | Lack of progress in cancer-related outcomes after liver transplantation: Mitigating risk and identifying future needs to move this needle | 2024-10-11 | OpenAlex | 10.1097/lvt.0000000000000509 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403335118 | |||
| W4403286988 | Novel Therapies for Primary Central Nervous System Lymphomas | 2024-10-11 | OpenAlex | 10.1007/s11910-024-01376-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403286988 | |||
| W4407949541 | Developing Global Competences and Values for Sustainable Development for Interdisciplinary Students Through a COIL Experience Between Chile and Colombia | 2024-10-13 | OpenAlex | 10.1109/fie61694.2024.10893415 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4407949541 | |||
| W4403380486 | A Comprehensive Review on Repurposing the Nanocarriers for the Treatment of Parkinson’s Disease: An Updated Patent and Clinical Trials | 2024-10-14 | OpenAlex | 10.2174/0118715273323074241001071645 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403380486 | |||
| W4403438235 | Atypical Presentation of Adult-Onset Hydroa Vacciniforme with Direct Immunofluorescence Positivity—A Case Report | 2024-10-14 | OpenAlex | 10.4103/idoj.idoj_927_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403438235 | |||
| W4403383598 | Current therapeutic overview and future perspectives regarding the treatment of psoriasis | 2024-10-14 | OpenAlex | 10.1016/j.intimp.2024.113388 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403383598 | |||
| W4403381048 | Hypertrophic Cardiomyopathy as a Form of Heart Failure with Preserved Ejection Fraction: Diagnosis, Drugs, and Procedures | 2024-10-14 | OpenAlex | 10.15420/usc.2023.21 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403381048 | |||
| W4403382210 | Pathogenesis of Atherothrombotic Events: From Lumen to Lesion and Beyond | 2024-10-14 | OpenAlex | 10.1161/circulationaha.124.070087 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403382210 | |||
| W4403384263 | Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United States | 2024-10-14 | OpenAlex | 10.1016/j.bneo.2024.100047 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403384263 | |||
| W4403438980 | Slow-Flow Venous Malformation of Vulva in a Pre-menarcheal Girl | 2024-10-14 | OpenAlex | 10.4103/idoj.idoj_886_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403438980 | |||
| W4403463121 | Emergence of Transdermal Drug Delivery Technologies: A Historical Synopsis and Systematic Review on Microneedles | 2024-10-15 | OpenAlex | 10.70389/pjs.100019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403463121 | |||
| W4403412963 | Innovative Psychedelic Therapies: Harnessing 5-MeO-DMT and DMT for Mental Health Treatment | 2024-10-15 | OpenAlex | 10.1021/acsmedchemlett.4c00490 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403412963 | |||
| W4403426102 | Severe, rapidly evolving infective endocarditis as a complication of elective surgery: a case report | 2024-10-15 | OpenAlex | 10.24969/hvt.2024.521 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403426102 | |||
| W4403441543 | “Out With the Old, In With the New”: Donor Risk Evolution Is Upon Us | 2024-10-15 | OpenAlex | 10.1097/tp.0000000000005250 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403441543 | |||
| W4403474999 | Editorial: Recent advancements in mycobacterial diseases research | 2024-10-16 | OpenAlex | 10.3389/fmicb.2024.1504449 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403474999 | |||
| W4403474452 | Optimizing Microarray Gene Selection in Colon Cancer: An Enhanced Metaheuristic Algorithm for Feature Selection | 2024-10-16 | OpenAlex | 10.1007/978-3-031-73420-5_7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403474452 | |||
| W4403543501 | Otolaryngology | 2024-10-16 | OpenAlex | 10.1097/xcs.0000000000001174 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403543501 | |||
| W4403457388 | The history of sclerosant foams: persons, techniques, patents and medical improvements | 2024-10-16 | OpenAlex | 10.1201/9781003579779-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403457388 | |||
| W4403543509 | Vascular Surgery | 2024-10-16 | OpenAlex | 10.1097/xcs.0000000000001183 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403543509 | |||
| W4403625741 | Breast Cancer | 2024-10-17 | OpenAlex | 10.1017/9781009279864.014 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403625741; https://openalex.org/W7160384760; https://openalex.org/W4408156349 | |||
| W4403497629 | Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovations | 2024-10-17 | OpenAlex | 10.3324/haematol.2024.286061 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403497629 | |||
| W4403510167 | Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey | 2024-10-17 | OpenAlex | 10.1038/s41391-024-00906-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403510167 | |||
| W4403540544 | Abstracts for the ISEE Asia and Western Pacific (AWPC) Chapter | 2024-10-18 | OpenAlex | 10.1097/ee9.0000000000000345 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403540544 | |||
| W4403524154 | In vitro maturation of oocytes: what is already known? | 2024-10-18 | OpenAlex | 10.1093/biolre/ioae147 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403524154 | |||
| W4403544061 | Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance | 2024-10-18 | OpenAlex | 10.1097/hep.0000000000001112 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403544061 | |||
| W4403561954 | Nanobodies: From High-Throughput Identification to Therapeutic Development | 2024-10-19 | OpenAlex | 10.1016/j.mcpro.2024.100865 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403561954 | |||
| W4403553771 | Potential role of heteroplasmic mitochondrial DNA mutations in modulating the subtype-specific adaptation of oral squamous cell carcinoma to cisplatin therapy | 2024-10-19 | OpenAlex | 10.1007/s12672-024-01445-8 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403553771 | |||
| W4403572987 | Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerations | 2024-10-19 | OpenAlex | 10.1093/nop/npae076 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403572987 | |||
| W4411001735 | 2024-10-20 | OpenAlex | 10.70070/0yygg348 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411001735 | ||||
| W4403617076 | A real-world study on the clinicopathological profile, treatment outcomes and health-related quality of life, anxiety and depression among patients with desmoid tumor at two tertiary care centers in India | 2024-10-21 | OpenAlex | 10.3389/fonc.2024.1382856 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403617076 | |||
| W4403602871 | Nanomaterial-Enhanced Microneedles: Emerging Therapies for Diabetes and Obesity | 2024-10-21 | OpenAlex | 10.3390/pharmaceutics16101344 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403602871 | |||
| W4403649612 | Blinatumomab use in patients with CD19 positive B-ALL and hepatic dysfunction | 2024-10-22 | OpenAlex | 10.1080/10428194.2024.2416018 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403649612 | |||
| W4403619467 | Proteostasis failure: at the intersection between aging and Alzheimer’s disease | 2024-10-22 | OpenAlex | 10.4103/nrr.nrr-d-24-00658 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403619467 | |||
| W4403658944 | The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma | 2024-10-22 | OpenAlex | 10.3389/fonc.2024.1392653 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403658944 | |||
| W4403689449 | Evolving Treatment Landscape for Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma | 2024-10-23 | OpenAlex | 10.1007/s11912-024-01607-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403689449 | |||
| W4403679193 | Membranes to Improve Amperometric Sensor Characteristics | 2024-10-23 | OpenAlex | 10.1201/9781003575177-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403679193 | |||
| W4403688002 | Potential Anti-tumor Effects and Apoptosis-inducing Mechanisms of Saponins: A Review | 2024-10-23 | OpenAlex | 10.2174/0115680266315197241015101801 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403688002 | |||
| W4403683396 | Review: Known, Emerging, and Remerging Pharyngitis Pathogens | 2024-10-23 | OpenAlex | 10.1093/infdis/jiae391 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403683396 | |||
| W4403719285 | Usage of Bacterial Whole Genome Sequencing: Outbreaks and Beyond in Pediatric Patients | 2024-10-23 | OpenAlex | 10.1097/inf.0000000000004588 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403719285 | |||
| W4403731690 | Functional evolution and functional biodiversity: 150 years of déjà vu or new physiology of evolution? | 2024-10-24 | OpenAlex | 10.3389/fcell.2024.1485089 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403731690 | |||
| W4403846753 | Nanotherapeutics as Antibacterial and Antiviral Agents: Approach beyond Antibiotics | 2024-10-24 | OpenAlex | 10.2174/9789815256505124010004 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4403846753 | |||
| W4403716976 | The Impact of Anesthesia on Dermatological Outcomes: A Narrative Review | 2024-10-24 | OpenAlex | 10.7759/cureus.72321 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403716976 | |||
| W4403710250 | Ticagrelor Therapy Modifications after Acute Coronary Syndrome: An Ever-Evolving Issue | 2024-10-24 | OpenAlex | 10.1055/a-2448-7029 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403710250 | |||
| W4403777036 | Using Poetic Assemblage to Trouble Stigma Associated With Perinatal Drug Use | 2024-10-24 | OpenAlex | 10.1177/00914509241293256 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403777036 | |||
| W4403772814 | Antibody-drug conjugates | 2024-10-25 | OpenAlex | 10.1016/b978-0-443-13466-1.00003-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403772814 | |||
| W4403767719 | Clinical challenges and research perspectives in liver transplant oncology | 2024-10-25 | OpenAlex | 10.1097/cm9.0000000000003339 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403767719 | |||
| W4403747999 | Editorial: Graft preservation | 2024-10-25 | OpenAlex | 10.3389/fcvm.2024.1478730 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403747999 | |||
| W4403752414 | The Relationship between Cerebral Autoregulation Dysfunction and Memory Impairment in Cardiac Surgery Patients | 2024-10-25 | OpenAlex | 10.1053/j.jvca.2024.09.101 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403752414 | |||
| W4403778046 | Ultrasound-guided intra-tumoral administration of directly-injected therapies: a review of the technical and logistical considerations | 2024-10-25 | OpenAlex | 10.1186/s40644-024-00763-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403778046 | |||
| W4403759109 | Volumetric Ultrasound Localization Microscopy | 2024-10-25 | OpenAlex | 10.1109/tuffc.2024.3485556 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403759109 | |||
| W4403969939 | EXPLORING AI-POWERED CHATBOTS FOR CUSTOMER SERVICE ENHANCEMENT | 2024-10-27 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403969939 | ||||
| W7215717412 | Estrategias didácticas para potenciar la evaluación formativa en estudiantes de quinto año de la EGB | 2024-10-27 | OpenAlex | 10.51736/r8veq766 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7215717412 | |||
| W4405571048 | From cardiorenal to cardiovascular–kidney–metabolic syndromes | 2024-10-28 | OpenAlex | 10.1093/eurheartj/ehae775 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405571048 | |||
| W4403827784 | Navigating the Labyrinth; Current Trends in Distal Urethritis Management | 2024-10-28 | OpenAlex | 10.1007/s11884-024-00762-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403827784 | |||
| W4403835175 | On Call: A Doctor’s Journey in Public Service | 2024-10-28 | OpenAlex | 10.1097/aln.0000000000005235 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403835175 | |||
| W4403806908 | The role of DC subgroups in the pathogenesis of asthma | 2024-10-28 | OpenAlex | 10.3389/fimmu.2024.1481989 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403806908 | |||
| W4409448850 | Transplanting the unexpected: what happens when donors have coronary artery disease? | 2024-10-28 | OpenAlex | 10.1097/io9.0000000000000230 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409448850 | |||
| W4403852427 | Evolving Patient-Centred Therapies for Metastatic NSCLC | 2024-10-29 | OpenAlex | 10.33590/emjoncol/rhir5662 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4403852427 | |||
| W4404111482 | Generative AI as Third Agent: LLMs and the Transformation of the Clinician-Patient Relationship (Preprint) | 2024-10-29 | OpenAlex | 10.2196/preprints.68146 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4404111482 | |||
| W4403875881 | Melanocortin 4 receptor mutation in obesity | 2024-10-29 | OpenAlex | 10.5493/wjem.v14.i4.99239 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403875881 | |||
| W4403976533 | Therapeutic Advancements in Anemia of Chronic Kidney Disease and End Stage Kidney Disease | 2024-10-29 | OpenAlex | 10.18103/mra.v12i10.5815 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403976533 | |||
| W4403918132 | Computer-Assisted Analysis of Myelography | 2024-10-30 | OpenAlex | 10.4018/979-8-3693-5226-7.ch006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403918132 | |||
| W4403912094 | Editorial: Brain injury in spontaneous intracerebral hemorrhage: from bench to bedside | 2024-10-30 | OpenAlex | 10.3389/fstro.2024.1501662 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403912094 | |||
| W4403911815 | Editorial: The role of sphingolipid metabolism in endocrine diseases | 2024-10-30 | OpenAlex | 10.3389/fendo.2024.1506971 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403911815 | |||
| W4403894443 | Effects of sodium-dependent glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus and asymptomatic heart failure | 2024-10-30 | OpenAlex | 10.4330/wjc.v16.i11.665 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403894443 | |||
| W4403968087 | Intra-arterial chemoembolization as a component of neoadjuvant treatment of rectal cancer. Literature review | 2024-10-30 | OpenAlex | 10.18699/ssmj20240501 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403968087 | |||
| W4403978481 | Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment | 2024-10-30 | OpenAlex | 10.3390/jcm13216537 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403978481 | |||
| W4403912962 | On Multimodal Emotion Recognition for Human-Chatbot Interaction in the Wild | 2024-10-30 | OpenAlex | 10.1145/3678957.3685759 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4403912962 | |||
| W4403898719 | Prostate cancer | 2024-10-30 | OpenAlex | 10.1016/b978-0-443-13825-6.00103-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403898719 | |||
| W4403909115 | REVIEW ON EFFLUX PUMP BLOCKER FOR DRUG RESISTANCE BACTERIA | 2024-10-30 | OpenAlex | 10.53555/0tg8ps18 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403909115 | |||
| W4403985811 | Association of Liver Damage and Quasispecies Maturity in Chronic HCV Patients: The Fate of a Quasispecies | 2024-10-31 | OpenAlex | 10.3390/microorganisms12112213 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403985811 | |||
| W4403942235 | Clinician-Researcher Leads Young Investigators to Emergence & Success | 2024-10-31 | OpenAlex | 10.1097/01.cot.0001083624.57191.8a | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403942235 | |||
| W4403952896 | Impact of a Service Learning Curriculum that Emphasizes Bidirectional Learning on Medical Students’ Professional Identity Formation | 2024-10-31 | OpenAlex | 10.1007/s40670-024-02202-w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403952896 | |||
| W4403939031 | The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease | 2024-10-31 | OpenAlex | 10.3390/biom14111393 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403939031 | |||
| W4404445502 | 2024-11-01 | OpenAlex | 10.1111/php.v100.6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404445502 | ||||
| W4404065264 | 1132 Enhancing melanoma therapy efficacy by protecting EZH2 activity in T cells | 2024-11-01 | OpenAlex | 10.1136/jitc-2024-sitc2024.1132 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404065264 | |||
| W4404064380 | 1388 Characterization of the DDLPS TIME reveals distinct immune heterogeneity and T cell terminal exhaustion | 2024-11-01 | OpenAlex | 10.1136/jitc-2024-sitc2024.1388 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404064380 | |||
| W4403977866 | Atypical Presentation of Rapidly Progressive Cutaneous Metastases of Clear Cell Renal Carcinoma: A Case Report | 2024-11-01 | OpenAlex | 10.3390/medicina60111797 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4403977866 | |||
| W4404148524 | Battling Kyasanur forest disease: the race for robust and long-lasting Kyasanur forest disease vaccine | 2024-11-01 | OpenAlex | 10.1097/gh9.0000000000000496 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404148524 | |||
| W4404562102 | Celebrating the Discovery of Insulin and Pressure Injury Awareness Day, and Reexamining Irritant Contact Dermatitis Due to Incontinence | 2024-11-01 | OpenAlex | 10.1097/asw.0000000000000231 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404562102 | |||
| W4404519624 | Contemporary State-of-the-Art PCI of Left Main Coronary Artery Disease | 2024-11-01 | OpenAlex | 10.1161/circinterventions.124.014026 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404519624 | |||
| W4403982992 | Current approaches for the treatment of chronic respiratory disorders and limitations | 2024-11-01 | OpenAlex | 10.1016/b978-0-443-27345-2.00002-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403982992 | |||
| W4404996023 | Disrupting Bacterial Biofilms to Combat Dental Diseases Using Nanotechnology in Oral Healthcare | 2024-11-01 | OpenAlex | 10.25163/angiotherapy.81110010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404996023 | |||
| W4404256954 | EPCO-39. MULTIOMIC AND CLINICAL ANALYSIS OF MULTIPLY RECURRENT MENINGIOMAS REVEALS RISK FACTORS, UNDERLYING BIOLOGY, AND INSIGHTS INTO EVOLUTION | 2024-11-01 | OpenAlex | 10.1093/neuonc/noae165.0038 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404256954 | |||
| W4403982984 | Emerging therapeutics in the treatment of chronic respiratory disorders | 2024-11-01 | OpenAlex | 10.1016/b978-0-443-27345-2.00003-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403982984 | |||
| W4404837688 | Evolving occupational health needs for the adult social care workforce due to changing migration patterns: a cross-sectional study | 2024-11-01 | OpenAlex | 10.1016/s0140-6736(24)02042-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404837688 | |||
| W4404237704 | INNV-18. FOCUS ON CURRENT AND EMERGING TREATMENT OPTIONS FOR GLIOMA: A COMPREHENSIVE REVIEW | 2024-11-01 | OpenAlex | 10.1093/neuonc/noae165.0681 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404237704 | |||
| W4405592825 | Magicking into Being | 2024-11-01 | OpenAlex | 10.1215/00138282-11343951 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405592825 | |||
| W4404459287 | Multilocular Cystic Renal Neoplasia of Low-grade Malignant Potential: Evolving Diagnostic Criteria: A Case Report with Review of Literature | 2024-11-01 | OpenAlex | 10.4103/mjdrdypu.mjdrdypu_811_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404459287 | |||
| W4404160229 | Nanobubble Contrast Enhanced Ultrasound Imaging: A Review | 2024-11-01 | OpenAlex | 10.1002/wnan.2007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404160229 | |||
| W4403982787 | Natural product-based compounds for chronic respiratory disorders | 2024-11-01 | OpenAlex | 10.1016/b978-0-443-27345-2.00010-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4403982787 | |||
| W4404080066 | P43 Unmasking posterior reversible encephalopathy syndrome: a hidden threat in juvenile lupus | 2024-11-01 | OpenAlex | 10.1093/rap/rkae117.074 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404080066 | |||
| W4404486806 | Practice paper 3 | 2024-11-01 | OpenAlex | 10.1201/9781003579731-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404486806 | |||
| W4405666118 | Windows to Worlds: Eduardo Jiménez de Aréchaga’s Teachings at the Hague Academy | 2024-11-01 | OpenAlex | 10.1093/ejil/chae060 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405666118 | |||
| W4404063372 | Decoding PARP Inhibitor Resistance in Ovarian Cancer: Molecular Insights and Emerging Therapeutic Strategies | 2024-11-03 | OpenAlex | 10.23958/ijirms/vol09-i11/1995 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404063372 | |||
| W4404010990 | Examining Scientific Inquiry of Queerness in Medical Education: A Queer Reading | 2024-11-03 | OpenAlex | 10.1080/10401334.2024.2422381 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404010990 | |||
| W4404052680 | Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma | 2024-11-04 | OpenAlex | 10.3389/fonc.2024.1490202 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404052680 | |||
| W4404086985 | Social and ethical impact of emotional AI advancement: the rise of pseudo-intimacy relationships and challenges in human interactions | 2024-11-04 | OpenAlex | 10.3389/fpsyg.2024.1410462 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404086985 | |||
| W4405047681 | A Phase 2 Study of Loncastuximab Tesirine Plus Mosunetuzumab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma | 2024-11-05 | OpenAlex | 10.1182/blood-2024-198727 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405047681 | |||
| W4405042242 | Acalabrutinib, Umbralisib and Ublituximab Regimen (AU2) Demonstrates High Response Rate and Undetectable Molecular Minimal Residual Disease (MRD) in Patients (pts) with De Novo Mantle Cell Lymphoma (MCL) | 2024-11-05 | OpenAlex | 10.1182/blood-2024-200963 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405042242 | |||
| W4405046044 | Association of Hypometilating Agents + Venetoclax in the Treatment of Secondary Acute Myeloid Leukemias Evolved from Chronic Myelomonocytic Leukemia | 2024-11-05 | OpenAlex | 10.1182/blood-2024-207060 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4405046044 | |||
| W4405051381 | Characterizing Treatment Patterns in Multiple Myeloma Patients with High-Risk Cytogenetics: A 15-Year-Study | 2024-11-05 | OpenAlex | 10.1182/blood-2024-211572 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405051381 | |||
| W4405041570 | Circulating Biomarkers and CD8+ T-Cell Subpopulations Reveal Evolving Phases of Immune Response in Patients Receiving Mosunetuzumab for Previously Untreated B-Cell Lymphoma | 2024-11-05 | OpenAlex | 10.1182/blood-2024-193023 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405041570 | |||
| W4405038320 | Clinical Outcomes of Lymphoplasmacytic Lymphoma / Waldenstrom Macroglobulinemia (LPL/WM) in the Targeted Therapy Era: A US Multicenter Retrospective Analysis | 2024-11-05 | OpenAlex | 10.1182/blood-2024-199278 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405038320 | |||
| W4405041120 | Cytomegalovirus Infections Following CAR T-Cell Therapy: A Systematic Review and Meta-Analysis | 2024-11-05 | OpenAlex | 10.1182/blood-2024-208855 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405041120 | |||
| W4405039102 | Daratumumab Versus Lenalidomide As Maintenance Therapy in Newly Diagnosed Multiple Myeloma - Interim Efficacy Results of a Randomized Clinical Trial | 2024-11-05 | OpenAlex | 10.1182/blood-2024-208094 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405039102 | |||
| W4404067405 | Drug resistance and possible therapeutic options against influenza A virus infection over past years | 2024-11-05 | OpenAlex | 10.1007/s00203-024-04181-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404067405 | |||
| W4404086800 | Editorial: Education in obstetrics and gynecology | 2024-11-05 | OpenAlex | 10.3389/fmed.2024.1490673 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404086800 | |||
| W4405043362 | Effect of Prior Treatments on the Clinical Activity of Imetelstat in Transfusion-Dependent Patients with Erythropoiesis-Stimulating Agent, Relapsed or Refractory/Ineligible Lower-Risk Myelodysplastic Syndromes | 2024-11-05 | OpenAlex | 10.1182/blood-2024-203612 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4405043362 | |||
| W4405055039 | Efficacy of Isatuximab Combination Regimens in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials | 2024-11-05 | OpenAlex | 10.1182/blood-2024-209018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405055039 | |||
| W4405048623 | Evaluation of Measurable Residual Disease Assessment Dynamics in Hairy Cell Leukemia Clinical Trials from 1980 to 2020 | 2024-11-05 | OpenAlex | 10.1182/blood-2024-209169 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405048623 | |||
| W4405041198 | Evolution of Treatment Patterns and Sequencing in Mantle Cell Lymphoma (MCL) in Spain and Their Impact on Survival. the Geltamo-MCL-2022 Study | 2024-11-05 | OpenAlex | 10.1182/blood-2024-209936 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405041198 | |||
| W4404075705 | Exploring Dentists’ Preferences in Selecting Adhesive Systems: A Survey Analysis | 2024-11-05 | OpenAlex | 10.3390/app142210119 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404075705 | |||
| W4405041211 | Frontline Treatment Patterns in Patients with Newly Diagnosed Multiple Myeloma - Real-World Evidence from a Large Community-Based Oncology Practice Network in the US | 2024-11-05 | OpenAlex | 10.1182/blood-2024-204730 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405041211 | |||
| W4405040452 | Impact of Co-Mutations, Monocytic Differentiation, and Choice of Hypomethylating Agent Combined with Venetoclax on the Predictive Value of Molecular Prognostic Risk Signature in Newly Diagnosed AML Patients | 2024-11-05 | OpenAlex | 10.1182/blood-2024-194259 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405040452 | |||
| W4405041272 | Impact of Emicizumab on Mental Liberation in Adult Patients with Severe and Moderate Factor VIII Deficiency | 2024-11-05 | OpenAlex | 10.1182/blood-2024-205287 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405041272 | |||
| W4405041247 | Impact of Novel Therapies on Survival in Chronic Lymphocytic Leukemia: Insights from SEER Database | 2024-11-05 | OpenAlex | 10.1182/blood-2024-209219 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405041247 | |||
| W4405043102 | Implications of MRD Progression in Newly Diagnosed Multiple Myeloma (NDMM) Treated with Quadruplet Therapy and Autologous Stem Cell Transplantation | 2024-11-05 | OpenAlex | 10.1182/blood-2024-201914 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405043102 | |||
| W4405045299 | MRD-Driven Time-Limited Therapy of Acalabrutinib and Lenalidomide Plus Rituximab (ALR) or Obinutuzumab (ALO) in Patients with Treatment-Naïve Mantle Cell Lymphoma: Phase 2 Trial Outcomes with MRD and cfDNA Analyses | 2024-11-05 | OpenAlex | 10.1182/blood-2024-204495 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405045299 | |||
| W4405038859 | Modified Delphi Process to Develop Best Practice Recommendations for Myelofibrosis Management in Routine Clinical Practice in the Asia-Pacific Region (The APAC-MF Alliance) | 2024-11-05 | OpenAlex | 10.1182/blood-2024-201402 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405038859 | |||
| W4404699851 | Navigating Complexity: Chatbot Router Agents as a Key to Improved User Engagement in Healthcare | 2024-11-05 | OpenAlex | 10.21275/sr241120062953 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4404699851 | |||
| W4405052145 | Open Label Single Arm Study to Assess the Implementation of Home Based Daratumumab Administration in Patients Being Treated for Multiple Myeloma | 2024-11-05 | OpenAlex | 10.1182/blood-2024-206031 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405052145 | |||
| W4404062203 | Oral antimicrobial agents in patients with short bowel syndrome: worth a try!—authors’ response | 2024-11-05 | OpenAlex | 10.1093/jac/dkae402 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4404062203 | |||
| W4405039526 | Outcomes of Relapsed and Refractory Multiple Myeloma with the Evolving Standard of Care | 2024-11-05 | OpenAlex | 10.1182/blood-2024-193255 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405039526 | |||
| W4405049141 | Overall Survival of Patients with Chronic Lymphocytic Leukemia Treated with Frontline Bruton's Tyrosine Kinase Inhibitors: An Analysis of the United States Veterans Health Administration Database | 2024-11-05 | OpenAlex | 10.1182/blood-2024-201206 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405049141 | |||
| W4405047781 | Phase II Trial of Axicabagene Ciloleucel and Glofitamab As Second-Line Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma | 2024-11-05 | OpenAlex | 10.1182/blood-2024-205196 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405047781 | |||
| W4404054720 | Potential health risks of hypomagnetic field for manned deep-space explorations | 2024-11-05 | OpenAlex | 10.1093/nsr/nwae395 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404054720 | |||
| W4405048117 | Practice Patterns Inform Patient-Centered Approaches for the Integration of BTK Inhibitors in Frontline Mantle Cell Lymphoma | 2024-11-05 | OpenAlex | 10.1182/blood-2024-208930 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405048117 | |||
| W4405040615 | Real World First-Line Treatment Strategies and Outcomes in TP53 Mutated and Unmutated Mantle Cell Lymphoma | 2024-11-05 | OpenAlex | 10.1182/blood-2024-194601 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405040615 | |||
| W4405096152 | Real-World Patient Characteristics and Treatment Patterns in Patients with Chronic Graft-Versus-Host Disease Receiving Belumosudil in the United States | 2024-11-05 | OpenAlex | 10.1182/blood-2024-208047 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405096152 | |||
| W4405041003 | Real-World Treatment Patterns and Clinical Outcomes Among Patients with Diffuse Large B-Cell Lymphoma in a US Healthcare Claims Database | 2024-11-05 | OpenAlex | 10.1182/blood-2024-203289 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405041003 | |||
| W4405092567 | Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Waldenstrӧm Macroglobulinemia: A Retrospective Analysis of US Claims Data | 2024-11-05 | OpenAlex | 10.1182/blood-2024-208443 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405092567 | |||
| W4405048306 | Reduced Intensity Therapy for Primary Central Nervous System Post-Transplant Lymphoproliferative Disorders (PTLD) Is Associated with Preserved Survival Outcomes: A Twenty-Year Single-Institutional Experience | 2024-11-05 | OpenAlex | 10.1182/blood-2024-193519 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405048306 | |||
| W4405042500 | Representation of Women As Leaders of Hemato-Oncology Clinical Trials | 2024-11-05 | OpenAlex | 10.1182/blood-2024-209863 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405042500 | |||
| W4405048062 | Survival Outcomes in Elderly Patients with Non-Hodgkin Lymphoma: A Retrospective Comparative Study of Standard Chemotherapy Versus Novel Agent | 2024-11-05 | OpenAlex | 10.1182/blood-2024-199867 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4405048062 | |||
| W4405042597 | The Effects of an Online Curriculum Based Approach to CME on Hematologist/Oncologists' Ability to Treat Patients with BTK Inhibitors for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma | 2024-11-05 | OpenAlex | 10.1182/blood-2024-209529 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405042597 | |||
| W4405046652 | The Evolution of Treatment Patterns for Chronic Lymphocytic Leukemia (CLL): Trends in the US Community Oncology Setting from 2015 to 2024 | 2024-11-05 | OpenAlex | 10.1182/blood-2024-210905 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405046652 | |||
| W4405046872 | The Evolution of Treatments and Outcomes for Real-World Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in a Chinese National Medical Center: Over 10 Years of Experience with 370 Patients | 2024-11-05 | OpenAlex | 10.1182/blood-2024-207401 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405046872 | |||
| W4405049921 | The Evolving Treatment Paradigms and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Receive Autologous Stem Cell Transplantation in China: A Real-World Observational Study | 2024-11-05 | OpenAlex | 10.1182/blood-2024-202198 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405049921 | |||
| W4405673258 | Towards Role Definition in Agile AI-based System Development: Perspectives and Reflections | 2024-11-05 | OpenAlex | 10.1145/3701625.3701661 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405673258 | |||
| W4405053198 | Treatment Patterns and Attitudes Among US-Based Physicians in Using BTK Inhibitors to Treat Relapsed/Refractory CLL and MCL | 2024-11-05 | OpenAlex | 10.1182/blood-2024-208406 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405053198 | |||
| W4405053714 | Treatment-Related and De Novo Ccus Have Similar Molecular Features and Risk of Progression to Myeloid Malignancies | 2024-11-05 | OpenAlex | 10.1182/blood-2024-201062 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405053714 | |||
| W4405046661 | Trial in Progress: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination with Azacitidine in Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes (AK117-205) | 2024-11-05 | OpenAlex | 10.1182/blood-2024-200541 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405046661 | |||
| W4405046964 | “I'd Go on a Hike with My Kids... That Would Make Me Feel so Happy.” Recognizing What People with Hemophilia B Identify As Meaningful When Considering Their Personal Goals and the Potential for Gene Therapy | 2024-11-05 | OpenAlex | 10.1182/blood-2024-194479 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405046964 | |||
| W4404127590 | Menadione reduces the expression of virulence- and colonisation-associated genes in Helicobacter pylori | 2024-11-07 | OpenAlex | 10.1101/2024.11.07.622476 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404127590 | |||
| W4404135913 | Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies | 2024-11-07 | OpenAlex | 10.3390/pathogens13110975 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404135913 | |||
| W4404128364 | Nanoparticles based image-guided thermal therapy and temperature feedback | 2024-11-07 | OpenAlex | 10.1039/d4tb01416b | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404128364 | |||
| W4404146498 | Research progress of nitroxide radical-based MRI contrast agents: from structure design to application | 2024-11-07 | OpenAlex | 10.1039/d4tb02272f | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404146498 | |||
| W4404141603 | Role of Avacopan on Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis | 2024-11-07 | OpenAlex | 10.3390/jcm13226676 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404141603 | |||
| W4404171571 | "Unveiling onychomycosis: Pathogenesis, diagnosis, and innovative treatment strategies" | 2024-11-08 | OpenAlex | 10.1016/j.micpath.2024.107111 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404171571 | |||
| W4404166538 | Evaluating clinical utility of comprehensive genomic profiling—challenges and opportunities | 2024-11-08 | OpenAlex | 10.1093/jnci/djae237 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404166538 | |||
| W4404191748 | Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review | 2024-11-08 | OpenAlex | 10.1007/s11912-024-01593-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404191748 | |||
| W4404188576 | Linagliptin In Managing Type 2 Diabetes With Renal Impairment: Insights From Indian Nephrologists | 2024-11-08 | OpenAlex | 10.36478/makrjms.2024.11.468.472 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404188576 | |||
| W4404191292 | Sodium-Selective Channelrhodopsins | 2024-11-08 | OpenAlex | 10.3390/cells13221852 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404191292 | |||
| W4404672850 | A Look at Advancements in Thyroid Cancer Research & Treatment | 2024-11-11 | OpenAlex | 10.1097/01.cot.0001095604.80771.c5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404672850 | |||
| W4404228825 | Photothermally Active Quantum Dots in Cancer Imaging and Therapeutics: Nanotheranostics Perspective | 2024-11-11 | OpenAlex | 10.1021/acsabm.4c01190 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404228825 | |||
| W4404247033 | Reflective Tool on Advanced Access to Support Primary Healthcare Teams: Development and Validation of an Online Questionnaire | 2024-11-11 | OpenAlex | 10.1111/jep.14232 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404247033 | |||
| W4404290339 | Systemic therapy for non–clear cell renal cell carcinomas: A systematic review | 2024-11-11 | OpenAlex | 10.1177/10781552241289920 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404290339 | |||
| W4404341238 | Abstract 4138722: Large Language Model based multi-agent Transcatheter Aortic Valve Implantation team to augment multidisciplinary meetings - proof of concept. | 2024-11-12 | OpenAlex | 10.1161/circ.150.suppl_1.4138722 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W4404341238 | |||
| W4404363802 | Abstract 4139853: Altering Cardiovascular Mortality in HFpEF with SGLT2i or ARNI — A Head-to-Head Analysis | 2024-11-12 | OpenAlex | 10.1161/circ.150.suppl_1.4139853 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404363802 | |||
| W4404266246 | Pharmacokinetic evaluation of bictegravir + emtricitabine + tenofovir alafenamide in HIV treatment | 2024-11-12 | OpenAlex | 10.1080/17425255.2024.2428820 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404266246 | |||
| W4404511173 | 2-Deoxy-D-Glucose and its Derivatives: Dual Role in Diagnostics and Therapeutics | 2024-11-13 | OpenAlex | 10.2174/9789815305159124010009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404511173 | |||
| W4404511092 | 2-Deoxy-D-Glucose as a Potential Antiviral and Anti-COVID-19 Drug | 2024-11-13 | OpenAlex | 10.2174/9789815305159124010010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404511092 | |||
| W7215637385 | AN EVALUATION OF LOCAL ANESTHESIA SYSTEM TOXICITY: THE IMPLICATIONS AND REMEDIES | 2024-11-13 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215637385 | ||||
| W4404329068 | Developing teamwork: transitioning between stages in human-agent collaboration | 2024-11-13 | OpenAlex | 10.3389/fcomp.2024.1455903 | Full text | Excluded | F3: The calendar-planning agent is an Android Java finite-state machine with scripted dialogue scenarios (§4.3). A large language model is explicitly proposed for a future version (§6). | https://openalex.org/W4404329068 | https://www.frontiersin.org/journals/computer-science/articles/10.3389/fcomp.2024.1455903/full | ||
| W4404339957 | Editorial: Advanced green polymers for medical purpose – trends and challenges in the circular economy | 2024-11-13 | OpenAlex | 10.3389/fbioe.2024.1511632 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404339957 | |||
| W4404428304 | Development of Idiopathic Pulmonary Fibrosis and its Pathogenic Inhibition by Drugs: An Overview | 2024-11-14 | OpenAlex | 10.9734/bpi/prrat/v8/2886 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404428304 | |||
| W4404368400 | The Use of Text Mining to Obtain a Historical Overview of Research on Therapeutic Drug Monitoring | 2024-11-14 | OpenAlex | 10.1248/bpb.b24-00319 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404368400 | |||
| W4404355112 | Audio-diary reflections after community focus groups to address local racial inequities in the neonatal intensive care unit | 2024-11-15 | OpenAlex | 10.1038/s41372-024-02176-y | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404355112 | |||
| W4408287644 | Functionalized Phytosomes and Liposomes: Innovations in Crossing the Blood-Brain Barrier for Neurodegenerative Disease Therapy | 2024-11-15 | OpenAlex | 10.1007/978-981-97-7445-6_35 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408287644 | |||
| W7198083471 | Natural predators of Yersinia : Characterization and genomic analysis of bacteriophages that infect Yersinia | 2024-11-15 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7198083471 | ||||
| W4404415192 | Navigating the complexity of BRAF mutations in non-small cell lung cancer: current insights and future prospects | 2024-11-15 | OpenAlex | 10.5826/mrm.2024.992 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404415192 | |||
| W4404525679 | Trends and implications of antimicrobial resistance in Pseudomonas aeruginosa: Insights from a 19-year study in Zhejiang Province | 2024-11-15 | OpenAlex | 10.1097/md.0000000000040606 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404525679 | |||
| W4408287668 | Two-Dimensional Nanomaterials in Nanomedicine and Point-of-Care Diagnosis | 2024-11-15 | OpenAlex | 10.1007/978-981-97-7445-6_41 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408287668 | |||
| W4404392893 | Unmet Need in Non–muscle-invasive Bladder Cancer Failing Bacillus Calmette-Guérin Therapy: A Systematic Review and Cost-effectiveness Analyses from the International Bladder Cancer Group | 2024-11-15 | OpenAlex | 10.1016/j.euo.2024.10.012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404392893 | |||
| W4404443880 | Lessons Learned From Clinical Trials of Immunotherapeutics for COVID‐19 | 2024-11-16 | OpenAlex | 10.1111/imr.13422 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404443880 | |||
| W4404446591 | ESPOROTRICOSE FELINA | 2024-11-17 | OpenAlex | 10.69849/revistaft/fa10202411170227 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404446591 | |||
| W4404450071 | First-line treatments for advanced or recurrent endometrial cancer: Systematic literature review of clinical evidence | 2024-11-17 | OpenAlex | 10.1016/j.critrevonc.2024.104555 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404450071 | |||
| W4404536119 | Response to Carboplatin and Paclitaxel in the treatment of hereditary breast ovarian cancer syndrome (HBOC): a case report | 2024-11-17 | OpenAlex | 10.47391/jpma.20059 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404536119 | |||
| W4406764073 | Validation of Gelatin Layering for Ultrasound Power Transfer and Backscatter Communication | 2024-11-17 | OpenAlex | 10.1115/imece2024-143324 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4406764073 | |||
| W4404492746 | Beyond anti-inflammatory strategies: addressing immunosuppression with nanomaterials in sepsis treatment | 2024-11-18 | OpenAlex | 10.3389/fimmu.2024.1500734 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404492746 | |||
| W4404522802 | Beyond Antivirals: Alternative Therapies for Long COVID | 2024-11-19 | OpenAlex | 10.3390/v16111795 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404522802 | |||
| W4404529338 | Clinical characteristics and risk factors of infection in initially treated patients with multiple myeloma during the induction period | 2024-11-19 | OpenAlex | 10.1016/j.jiac.2024.11.012 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404529338 | |||
| W4404506245 | Myasthenia gravis: The evolving therapeutic landscape | 2024-11-19 | OpenAlex | 10.1016/j.ensci.2024.100541 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404506245 | |||
| W4404588710 | Norepinephrine Transporter–Targeted Cancer Theranostics—New Horizons | 2024-11-19 | OpenAlex | 10.1097/rlu.0000000000005567 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404588710 | |||
| W4404519839 | Pharmacotherapy of Acute Lymphoblastic Leukemia in Pediatric Patients: A Review of Efficacy and Adverse Effects | 2024-11-19 | OpenAlex | 10.32677/ijch.v11i8.4821 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404519839 | |||
| W4404500638 | Systemic approaches in biliary tract cancers: a review in the era of multidirectional precision medicine | 2024-11-19 | OpenAlex | 10.1080/14656566.2024.2432488 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404500638 | |||
| W4404595453 | Anti-Diabetic Therapies and Cancer: From Bench to Bedside | 2024-11-20 | OpenAlex | 10.3390/biom14111479 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404595453 | |||
| W4404579811 | Clinical implications of mineralocorticoid receptor overactivation | 2024-11-20 | OpenAlex | 10.1093/ckj/sfae346 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404579811 | |||
| W4404567319 | Epidemiological Trends of Mucormycosis in Europe, Comparison with Other Continents | 2024-11-20 | OpenAlex | 10.1007/s11046-024-00907-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404567319 | |||
| W4404545052 | Impact of occupational exposures in patients with chronic obstructive pulmonary disease: current understanding and knowledge gaps | 2024-11-20 | OpenAlex | 10.1097/mcp.0000000000001141 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404545052 | |||
| W4404808492 | Key Strategies to Foster Effective Champions for Continuous Quality Improvement in Primary Healthcare Clinics | 2024-11-20 | OpenAlex | 10.1370/afm.22.s1.6490 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404808492 | |||
| W4404589880 | The Inappropriate Use of GLP-1 Analogs: Reflections from Pharmacoepidemiology | 2024-11-20 | OpenAlex | 10.3390/pharma3040025 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404589880 | |||
| W4404540484 | The tigecycline resistance mechanisms in Gram-negative bacilli | 2024-11-20 | OpenAlex | 10.3389/fcimb.2024.1471469 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404540484 | |||
| W4404603425 | AI-powered contrast-free cardiovascular magnetic resonance imaging for myocardial infarction | 2024-11-21 | OpenAlex | 10.3389/fcvm.2024.1457498 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404603425 | |||
| W4408074350 | Coaching: An Effective Approach to Facilitate Performance, Learning and Advancement of Medical Students | 2024-11-21 | OpenAlex | 10.32592/rmegums.16.4.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408074350 | |||
| W4404555038 | Focus on the evolving methodologies of trials, on inflammation in atherosclerotic cardiovascular disease, and on abdominal aortic aneurysms | 2024-11-21 | OpenAlex | 10.1093/eurheartj/ehae789 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404555038 | |||
| W4404589354 | Immune checkpoint inhibition of metastatic melanoma: achieving high efficacy in the face of high toxicity | 2024-11-21 | OpenAlex | 10.1080/17512433.2024.2431513 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404589354 | |||
| W4404592347 | Optimal Management of Patients with Moderate-to-Severe Inflammatory Bowel Disease | 2024-11-21 | OpenAlex | 10.3390/jcm13237026 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404592347 | |||
| W7133486790 | Prophylactic cerebrospinal fluid drainage in aortic surgery: enhancing neurological outcomes | 2024-11-21 | OpenAlex | 10.1097/io9.0000000000000212 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133486790 | |||
| W4404553702 | The journey of antibody-drug conjugates for revolutionizing cancer therapy: A review | 2024-11-21 | OpenAlex | 10.1016/j.bmc.2024.118010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404553702 | |||
| W4404633978 | Let's Agree to Disagree: Reflections From the Smoldering Multiple Myeloma Session at the International Myeloma Society Study Summit | 2024-11-22 | OpenAlex | 10.1016/j.clml.2024.11.009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404633978 | |||
| W4404618573 | Nanoparticles for Biomedical Imaging | 2024-11-22 | OpenAlex | 10.1201/9781003432661-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404618573 | |||
| W4404634064 | Networked Control Theory | 2024-11-22 | OpenAlex | 10.1016/b978-0-443-14081-5.00059-3 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404634064 | |||
| W4404616258 | Pharmacologic Approaches to Bleeding | 2024-11-22 | OpenAlex | 10.1016/b978-0-323-96014-4.00064-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404616258 | |||
| W4404644230 | Basics of vasomotor symptoms | 2024-11-23 | OpenAlex | 10.1097/gme.0000000000002479 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404644230 | |||
| W4404645533 | Pharmacists leading the way in infectious diseases education, research, and patient care | 2024-11-23 | OpenAlex | 10.1093/ajhp/zxae361 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404645533 | |||
| W4404705347 | Applications and Efficacy of Minoxidil in Dermatology | 2024-11-24 | OpenAlex | 10.1002/ski2.472 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404705347 | |||
| W4404666587 | Clinical and biological advances of critical complications in acute myeloid leukemia | 2024-11-24 | OpenAlex | 10.1080/10428194.2024.2425051 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404666587 | |||
| W4404691743 | Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents | 2024-11-24 | OpenAlex | 10.3390/biology13120967 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4404691743 | |||
| W4404697656 | Deliberate Releases of Biological Agents of Zoonosis | 2024-11-25 | OpenAlex | 10.1079/9781800622852.0003 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4404697656 | |||
| W4404729363 | In-vitro Cell Culture: A Promising Technology in the Advancement of Science and Research as a Solution to Human and Animal Health Issues | 2024-11-25 | OpenAlex | 10.18805/ijar.b-5325 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404729363 | |||
| W4404740353 | Humans and great apes visually track event roles in similar ways | 2024-11-26 | OpenAlex | 10.1371/journal.pbio.3002857 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404740353; https://openalex.org/W7112205860 | |||
| W4404742767 | The evolving landscape of antiemetic prophylaxis for chemotherapy-induced nausea and vomiting: inspiration from cisplatin-based antiemetic and non-antiemetic trials | 2024-11-26 | OpenAlex | 10.1007/s00520-024-09035-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404742767 | |||
| W4404728343 | The role of silver diamine fluoride as dental caries preventive and arresting agent: a systematic review and meta-analysis | 2024-11-26 | OpenAlex | 10.3389/froh.2024.1492762 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404728343 | |||
| W4404853474 | Animal Disease Surveillance: History of Zoonotic Viruses and Bacteria and Diagnostics | 2024-11-27 | OpenAlex | 10.5772/intechopen.1008157 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404853474 | |||
| W4404756353 | Novel Strategies for Lung Cancer Interventional Diagnostics | 2024-11-27 | OpenAlex | 10.3390/jcm13237207 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404756353 | |||
| W4404880528 | Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review | 2024-11-27 | OpenAlex | 10.1093/bjs/znae284 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404880528 | |||
| W4404759520 | YY1 downregulation underlies therapeutic response to molecular targeted agents | 2024-11-27 | OpenAlex | 10.1038/s41419-024-07239-8 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4404759520 | |||
| W4405009254 | CDA Formulations: Potentially the Standard Care of Breast, Lung and Liver Cancers | 2024-11-28 | OpenAlex | 10.11648/j.ijcocr.20240903.12 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405009254 | |||
| W4404815792 | Context is key: ethical considerations related to consent and study design in acute cardiac care research | 2024-11-28 | OpenAlex | 10.1093/ehjacc/zuae125 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404815792 | |||
| W4404870526 | A Review of Current and Future Antibody Drug Conjugates in Breast Cancer | 2024-11-29 | OpenAlex | 10.1007/s11864-024-01276-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404870526 | |||
| W4404866133 | An Evolving Role of Antitumor Activity of Zoledronic Acid in Breast Cancer | 2024-11-29 | OpenAlex | 10.47275/2690-5663-136 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404866133 | |||
| W4404866606 | Editorial: Drug discovery and development explained: introductory notes for the general public | 2024-11-29 | OpenAlex | 10.3389/fddsv.2024.1528467 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404866606 | |||
| W4404861358 | Enhancing Alzheimer’s disease classification through split federated learning and GANs for imbalanced datasets | 2024-11-29 | OpenAlex | 10.7717/peerj-cs.2459 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404861358 | |||
| W4404853648 | From Barbers to Bots: A Surgeon’s Odyssey | 2024-11-29 | OpenAlex | 10.4103/jmms.jmms_120_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404853648 | |||
| W4404799612 | GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis | 2024-11-29 | OpenAlex | 10.3748/wjg.v30.i48.5205 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404799612 | |||
| W4404859652 | Governing the private scales of families and homes: Visiting nurses and Turkey's mobilization of consumptive care | 2024-11-29 | OpenAlex | 10.1016/j.jhg.2024.11.011 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404859652 | |||
| W4404875629 | Immunological exosomes: An upcoming cue for disease management | 2024-11-29 | OpenAlex | 10.1016/b978-0-443-29052-7.00011-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404875629 | |||
| W4404864062 | Novel approaches for preventing COVID-19 infection in immunocompromised patients with hematologic malignancies | 2024-11-29 | OpenAlex | 10.1080/17474086.2024.2436973 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404864062 | |||
| W4404882951 | Bestie da domare: retoriche e moralizzazioni del vaccino nell’Inghilterra dell’Ottocento | 2024-11-30 | OpenAlex | 10.54103/2035-7680/27286 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404882951 | |||
| W4404919775 | Novel Therapies in the Perioperative Management of Localized Gastric Cancer: Current Perspectives and Future Directions | 2024-11-30 | OpenAlex | 10.14295/aimj.v8i16.210 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404919775 | |||
| W4404844300 | Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative Advanced Breast Cancer – A Clinical Review | 2024-11-30 | OpenAlex | 10.1007/s11864-024-01259-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404844300 | |||
| W4414352215 | A Rotten Crowd: America, Wealth, and One Hundred Years of The Great Gatsby, Odyssey of a Wandering Mind: The Strange Tale of Sara Mayfield, Author, Chasing The Great Gatsby: Freddie Welsh’s Saga and The Great Gatsby | 2024-12-01 | OpenAlex | 10.5325/fscotfitzrevi.22.0230 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414352215 | |||
| W4406861038 | A look back at the Virology Departmental Days of the Institut Pasteur (Le Touquet, May 13–15, 2024) | 2024-12-01 | OpenAlex | 10.1093/jmcb/mjae052 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406861038 | |||
| W4404995488 | Antibiotic Target Attainment: What Are We Aiming for?* | 2024-12-01 | OpenAlex | 10.1097/pcc.0000000000003630 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404995488 | |||
| W4405956781 | CARBON-DOTs: A Breakthrough Weapon in the Fight Against Infectious Diseases - A Review | 2024-12-01 | OpenAlex | 10.9790/9622-141297118 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405956781 | |||
| W4404880168 | Delayed Puberty and Incidental Hypertension in a 14-year-old Girl | 2024-12-01 | OpenAlex | 10.1542/pir.2023-005971 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404880168 | |||
| W4405222638 | Metabolic orchestration of drug-tolerant persister cells in cancer | 2024-12-01 | OpenAlex | 10.1093/lifemedi/lnae040 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405222638 | |||
| W7155444830 | NOVEL DRUG DELIVERY SYSTEM FROM FUNDAMENTAL PRINCIPLES TO ADVANCED APPLICATIONS | 2024-12-01 | OpenAlex | 10.58532/nddsfpaav4b10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155444830 | |||
| W4405746630 | NOVEL MAINTENANCE THERAPIES IN ACUTE MYELOID LEUKEMIA: PROLONGING REMISSION AND IMPROVING OUTCOMES | 2024-12-01 | OpenAlex | 10.1016/j.htct.2024.11.092 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405746630 | |||
| W4414366849 | Nanoparticles for Advanced Drug Delivery Systems: Innovations, Applications, and Future Perspectives in Nanomedicine | 2024-12-01 | OpenAlex | 10.69626/bba.2024.0003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414366849 | |||
| W4405230090 | P100 A systematic review and meta-analysis of the prevalence of comorbidity amongst people with palmoplantar pustulosis | 2024-12-01 | OpenAlex | 10.1093/bjd/ljae360.130 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405230090 | |||
| W4405833661 | Practical insights into bispecific antibody therapy in multiple myeloma | 2024-12-01 | OpenAlex | 10.1080/14737140.2024.2445145 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405833661 | |||
| W4405168550 | S64 Caught Between a Cough and a Hard Place: A Crohn’s Conundrum with a Broncho-Esophageal Twist | 2024-12-01 | OpenAlex | 10.14309/01.ajg.0001082788.22386.b2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405168550 | |||
| W4405852331 | Safeguarding the Heart in Cancer Therapy: Balancing Cardioprotection with Treatment Efficacy | 2024-12-01 | OpenAlex | 10.4103/jpbs.jpbs_1408_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405852331 | |||
| W4404902402 | Targeted and cytotoxic inhibitors used in the treatment of breast cancer | 2024-12-01 | OpenAlex | 10.1016/j.phrs.2024.107534 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404902402 | |||
| W7212248062 | The Uptake Mechanisms of Extracellular Vesicles by Target Cells and Their Applications in Disease Diagnosis and Treatment | 2024-12-01 | OpenAlex | 10.16476/j.pibb.2024.0156 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212248062 | |||
| W4407064465 | The impact of antidiabetic medications on COVID-19 outcomes in diabetic patients: an overview | 2024-12-01 | OpenAlex | 10.61186/phypha.28.4.363 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407064465 | |||
| W4404908616 | Atypical Cerebral Carcinoids Treated with Hippocampal-Sparing Whole Brain Radiotherapy | 2024-12-02 | OpenAlex | 10.7759/cureus.74997 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4404908616 | |||
| W4404918206 | Bridging the Industry-Higher Education Gap with Critical Design Futures Thinking and GenAI for Innovation | 2024-12-02 | OpenAlex | 10.1201/9781003469551-11 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404918206 | |||
| W4405157169 | Comparison between The Efficacy of Concurrent Chemo-Radiation with Gemcitabine Followed by Intracavitary Radiotherapy in Patients with Locally Advanced Cervical Carcinoma | 2024-12-02 | OpenAlex | 10.55561/ajhr.v3i3.193 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405157169; https://openalex.org/W4402315952 | |||
| W4404908094 | Kidney-sparing approach for upper tract urothelial carcinoma: An update on current evidence | 2024-12-02 | OpenAlex | 10.1016/j.ajur.2024.08.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404908094 | |||
| W4404914206 | Modulation of Brain Kynurenic Acid by N-Acetylcysteine Prevents Cognitive Impairment and Muscular Weakness Induced by Cisplatin in Female Rats | 2024-12-02 | OpenAlex | 10.3390/cells13231989 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4404914206 | |||
| W4408956980 | Not the Usual Suspect | 2024-12-02 | OpenAlex | 10.1093/cid/ciae590 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408956980 | |||
| W4404902741 | Thiazolidinedione derivatives in cancer therapy: exploring novel mechanisms, therapeutic potentials, and future horizons in oncology | 2024-12-02 | OpenAlex | 10.1007/s00210-024-03661-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404902741 | |||
| W4406271271 | Autonomous Pharmaceutical Care with Large Language Models | 2024-12-03 | OpenAlex | 10.1109/bibm62325.2024.10822302 | Full text | Included | Included: Clinician edits and prompts are persistently encoded into an experience store and reused for later similar pharmaceutical-care cases. | https://openalex.org/W4406271271 | https://ieeexplore.ieee.org/document/10822302 | ||
| W4404967078 | Evolving Applications of Conversational Agents in Healthcare: A Literature Review | 2024-12-03 | OpenAlex | 10.1007/978-3-031-78090-5_12 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4404967078 | |||
| W4404955905 | Evolving Treatment Strategies for Systemic Lupus Erythematosus in Clinical Practice: A Narrative Review | 2024-12-03 | OpenAlex | 10.7759/cureus.75062 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4404955905 | |||
| W4406091184 | Front-line Treatment of Older Patients with Hodgkin Lymphoma | 2024-12-03 | OpenAlex | 10.58931/cht.2024.3358 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406091184 | |||
| W7131328535 | Nanobubbles combined with p53 encoding pDNA for colorretal cancer treatment | 2024-12-04 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7131328535 | ||||
| W4404994209 | Perspectives on Microbiome Therapeutics in Infectious Diseases: A Comprehensive Approach Beyond Immunology and Microbiology | 2024-12-04 | OpenAlex | 10.3390/cells13232003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4404994209 | |||
| W4405008822 | Point‐of‐care ultrasound differentiated the cause of proteinuria in a patient with lung cancer | 2024-12-04 | OpenAlex | 10.1002/sono.12488 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405008822 | |||
| W4405040754 | Advances in the Management of Hemophilia and Bleeding Disorders: Achievements and Perspectives | 2024-12-05 | OpenAlex | 10.1055/s-0044-1800835 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405040754 | |||
| W4405025868 | Editorial: The role of nutritional strategies in the regulation of gut microbiota and host immune system | 2024-12-05 | OpenAlex | 10.3389/fmicb.2024.1501596 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405025868 | |||
| W4405040628 | Precision Medicine in Rare Bleeding Disorders | 2024-12-05 | OpenAlex | 10.1055/s-0044-1800833 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405040628 | |||
| W4405165853 | Prevalence and Antibiotic Resistance Patterns of Neonatal Bloodstream Pathogens in Tertiary Care Hospitals: A Retrospective Analysis | 2024-12-05 | OpenAlex | 10.3329/bjmm.v18i1.76965 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405165853 | |||
| W4405061040 | Role of Multi-Agent System in Reducing Failure Probabilities in Production System | 2024-12-05 | OpenAlex | 10.4018/979-8-3693-6230-3.ch007 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4405061040 | |||
| W4405106084 | Anti-Amyloid Drugs for Alzheimer’s Disease: Considering the Role of Depression | 2024-12-06 | OpenAlex | 10.1159/000541783 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405106084 | |||
| W4405127048 | BV and beyond: how to incorporate novel agents into PTCL management | 2024-12-06 | OpenAlex | 10.1182/hematology.2024000530 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4405127048 | |||
| W4405109019 | Insights on treatment of adult ITP: algorithm for management and role of multimodal therapy | 2024-12-06 | OpenAlex | 10.1182/hematology.2024000594 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405109019 | |||
| W4405108491 | On the horizon: upcoming new agents for the management of ITP | 2024-12-06 | OpenAlex | 10.1182/hematology.2024000596 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4405108491 | |||
| W4405108045 | Recent Advances in the Management of Acute Severe Ulcerative Colitis | 2024-12-06 | OpenAlex | 10.3390/jcm13237446 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405108045 | |||
| W4405108875 | Sequencing bispecific antibodies and CAR T cells for FL | 2024-12-06 | OpenAlex | 10.1182/hematology.2024000667 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405108875 | |||
| W4405154575 | Shock Patients and Enteral Nutrition? | 2024-12-06 | OpenAlex | 10.54097/2frt1b93 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405154575 | |||
| W4405108979 | When should we use it? The role of brentuximab vedotin in 2024 | 2024-12-06 | OpenAlex | 10.1182/hematology.2024000668 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405108979 | |||
| W4405109152 | Your chemo is no good here: management of high-risk MCL | 2024-12-06 | OpenAlex | 10.1182/hematology.2024000658 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405109152 | |||
| W4405166232 | Exploring the nexus between medical gases and ion channel function: implications for therapeutic innovation | 2024-12-07 | OpenAlex | 10.4103/mgr.medgasres-d-24-00076 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405166232 | |||
| W4405128914 | Getting your message across? The evolution of leader vision and managed pluralisation of leadership | 2024-12-07 | OpenAlex | 10.1177/00187267241301720 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405128914 | |||
| W4405133536 | The psychological impact of reopening after COVID-19 lockdowns in China: Threat perception, affect and moral conflict | 2024-12-07 | OpenAlex | 10.1016/j.socscimed.2024.117611 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405133536 | |||
| W4405170909 | Abstract IA011: Strategies to close the translational gap for nanoscale drug delivery systems | 2024-12-09 | OpenAlex | 10.1158/1538-8514.cancerchem24-ia011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405170909 | |||
| W4405196929 | Current Advances in Viral Nanoparticles for Biomedicine | 2024-12-09 | OpenAlex | 10.1021/acsnano.4c13146 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405196929 | |||
| W4405201443 | Editorial: Genetic and cellular heterogeneity in tumors | 2024-12-09 | OpenAlex | 10.3389/fcell.2024.1519539 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405201443 | |||
| W4405201683 | Editorial: Mathematical modeling of diseases at population-level and cellular-level | 2024-12-09 | OpenAlex | 10.3389/fams.2024.1534439 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405201683 | |||
| W4405212145 | Enhanced recovery revisited: what day case hysterectomies can learn from Team GB elite athletes | 2024-12-09 | OpenAlex | 10.1111/tog.12958 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405212145 | |||
| W4405209782 | Physician Assistant Students as Agents of Change through Service-Learning Opportunities | 2024-12-09 | OpenAlex | 10.53309/2164-7666.1470 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4405209782 | |||
| W4408860084 | Quantitative Review of Conversational Agents in E-Health Using NLP and AI | 2024-12-09 | OpenAlex | 10.1109/gcet64327.2024.10934583 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4408860084 | |||
| W4405215143 | Editorial: Emerging trends and advances in the socioeconomic applications of beneficial microbes | 2024-12-10 | OpenAlex | 10.3389/fmicb.2024.1523569 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405215143 | |||
| W4405225816 | Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study | 2024-12-10 | OpenAlex | 10.1182/bloodadvances.2024013838 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405225816 | |||
| W4405235514 | Inhaled Anesthetics: Beyond the Operating Room | 2024-12-10 | OpenAlex | 10.3390/jcm13247513 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405235514 | |||
| W4407348885 | Landscape of Bacterial Enteric Disease and Traveler´s Diarrhea in South America | 2024-12-10 | OpenAlex | 10.1093/infdis/jiae594 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407348885 | |||
| W4405219749 | Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy | 2024-12-10 | OpenAlex | 10.1007/s10557-024-07652-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405219749 | |||
| W4405215300 | Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity | 2024-12-10 | OpenAlex | 10.3389/fimmu.2024.1490129 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405215300 | |||
| W4405233512 | Understanding tissue injury and remodelling in eosinophilic oesophagitis: development towards personalised medicine | 2024-12-10 | OpenAlex | 10.1136/gutjnl-2024-333994 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405233512 | |||
| W4405263688 | Editorial: Advances in targeted therapy and biomarker research for endocrine-related cancers | 2024-12-11 | OpenAlex | 10.3389/fendo.2024.1533623 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405263688 | |||
| W4405257039 | Editorial: Data governance in African health research: ELSI challenges and solutions | 2024-12-11 | OpenAlex | 10.3389/fphar.2024.1525434 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405257039 | |||
| W4405283320 | MDMA for PTSD and beyond: a new paradigm brings hope | 2024-12-11 | OpenAlex | 10.3389/fnhum.2024.1475013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405283320 | |||
| W4405347145 | Pharmacology and mechanisms of apigenin in preventing osteoporosis | 2024-12-11 | OpenAlex | 10.3389/fphar.2024.1486646 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405347145 | |||
| W4405367347 | Vasoactive Agents in Burn Patients: Perspectives on Angiotensin-II | 2024-12-11 | OpenAlex | 10.1093/jbcr/irae208 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4405367347 | |||
| W7171937448 | ADAPTIVE FOUNDATION MODELS IN ONCOLOGY: CONTINUOUS LEARNING FOR PERSONALIZED CANCER MANAGEMENT | 2024-12-12 | OpenAlex | 10.65713/ijaraiv14i1203 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171937448 | |||
| W4405321016 | Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 2024 | 2024-12-12 | OpenAlex | 10.1016/j.semradonc.2024.08.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405321016 | |||
| W4405338882 | Editorial: The future of third molar surgery | 2024-12-12 | OpenAlex | 10.3389/froh.2024.1512305 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405338882 | |||
| W4405384683 | Evaluation of Biomaterials in Periodontal Regeneration: A Literature Review | 2024-12-12 | OpenAlex | 10.7759/cureus.75618 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405384683 | |||
| W4405393682 | SurfR: Riding the wave of RNA-seq data with a comprehensive bioconductor package to identify surface protein-coding genes | 2024-12-12 | OpenAlex | 10.1093/bioadv/vbae201 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405393682 | |||
| W7171964303 | AUTONOMOUS ONCOLOGY SYSTEMS: FOUNDATION MODELS FOR REAL-TIME CLINICAL INTELLIGENCE AND PERSONALIZED CANCER CARE | 2024-12-13 | OpenAlex | 10.65713/ijaraiv14i1209 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171964303 | |||
| W7172012214 | FUTURE CANCER INTELLIGENCE: CONVERGING FOUNDATION AI, DIGITAL TWINS, MULTIMODAL LEARNING, AND PRECISION ONCOLOGY | 2024-12-14 | OpenAlex | 10.65713/ijaraiv14i1210 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172012214 | |||
| W7171970226 | INTELLIGENT DIGITAL TWINS IN ONCOLOGY: REAL-TIME VIRTUAL PATIENT MODELING FOR PERSONALIZED THERAPEUTIC DECISION-MAKING | 2024-12-14 | OpenAlex | 10.65713/ijaraiv14i1212 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171970226 | |||
| W4409684107 | DIAGNOSTIC ACCURACY OF PI-RADS FOR PROSTATIC MALIGNANCY; NON-INVASIVE ASSESSMENT OF THE PROSTATE GLAND | 2024-12-16 | OpenAlex | 10.55519/jamc-s4-13563 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409684107 | |||
| W7171983307 | DIGITAL TWIN–ENABLED PRECISION ONCOLOGY: INTEGRATING LONGITUDINAL PATIENT DATA, MULTI-OMICS, AND ARTIFICIAL INTELLIGENCE | 2024-12-16 | OpenAlex | 10.65713/ijaraiv14i1218 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171983307 | |||
| W4405441202 | Editorial: Drug allergy in children | 2024-12-16 | OpenAlex | 10.3389/falgy.2024.1530907 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405441202 | |||
| W4405433575 | Large Language Models Applied to Health Care Tasks May Improve Clinical Efficiency, Value of Care Rendered, Research, and Medical Education | 2024-12-16 | OpenAlex | 10.1016/j.arthro.2024.12.010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405433575 | |||
| W4405534906 | Novel immunotherapy for multiple solid cancers using an Anti-HVEM blocking monoclonal antibody | 2024-12-16 | OpenAlex | 10.1101/2024.12.16.627913 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405534906 | |||
| W4405426375 | Sequelae of B-Cell Depleting Therapy: An Immunologist’s Perspective | 2024-12-16 | OpenAlex | 10.1007/s40259-024-00696-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405426375 | |||
| W4405426766 | Surrogate Clinical End Points in Studies of APOL1-Associated Kidney Disease: Just in Time | 2024-12-16 | OpenAlex | 10.2215/cjn.0000000628 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405426766 | |||
| W4405457840 | Computer-aided Drug Design: Innovation and its Application in Reshaping Modern Medicine | 2024-12-17 | OpenAlex | 10.2174/0129503752321279241126091807 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405457840 | |||
| W4405459452 | Immunoconjugates as an Efficient Platform for Drug Delivery: A Resurgence of Natural Products in Targeted Antitumor Therapy | 2024-12-17 | OpenAlex | 10.3390/ph17121701 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405459452 | |||
| W4405491993 | Multi-target directed ligands inspired natural products as an effective approach for the treatment of complex chronic health disorders | 2024-12-17 | OpenAlex | 10.1016/j.bioorg.2024.108075 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405491993 | |||
| W4405556048 | Cancer Therapy-Related Skin Change | 2024-12-18 | OpenAlex | 10.1007/978-3-031-53888-9_72-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405556048 | |||
| W4405511092 | The complement system in clinical oncology: Applications, limitations and challenges | 2024-12-18 | OpenAlex | 10.1016/j.smim.2024.101921 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405511092 | |||
| W4405523030 | The double life of glucose metabolism: brain health, glycemic homeostasis, and your patients with type 2 diabetes | 2024-12-18 | OpenAlex | 10.1186/s12916-024-03763-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405523030 | |||
| W4411624623 | What does your Packet Capture say? | 2024-12-18 | OpenAlex | 10.1145/3703323.3704278 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4411624623 | |||
| W4406478004 | Innovations in toxicological research: Advancing knowledge for a safer tomorrow | 2024-12-19 | OpenAlex | 10.70593/978-81-982935-0-3_4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406478004 | |||
| W4405586574 | State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes | 2024-12-19 | OpenAlex | 10.1080/21645515.2024.2440165 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405586574 | |||
| W4405578644 | Updates in Management of Unresectable Stage III Non Small Cell Lung Cancer: A Radiation Oncology Perspective | 2024-12-19 | OpenAlex | 10.3390/cancers16244233 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405578644 | |||
| W4405643223 | A Tachyplesin Antimicrobial Peptide from Theraphosidae Spiders with Potent Antifungal Activity Against Cryptococcus neoformans | 2024-12-20 | OpenAlex | 10.3390/microorganisms12122648 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405643223 | |||
| W4405625819 | Advanced transdermal drug delivery system: A comprehensive review of microneedle technologies, novel designs, diverse applications, and critical challenges | 2024-12-20 | OpenAlex | 10.1016/j.ijpharm.2024.125118 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405625819 | |||
| W4405646477 | Practices of Resistance and Nursing | 2024-12-20 | OpenAlex | 10.1111/nup.70010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405646477 | |||
| W4405661887 | Central command suite: futureproofing next-generation surgical environments to embrace the digital operating room | 2024-12-21 | OpenAlex | 10.1007/s11548-024-03278-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405661887 | |||
| W4405778249 | Efficacy and safety of lorlatinib as first-line treatment for advanced ALK-mutated non-small cell lung cancer: A clinical case study | 2024-12-21 | OpenAlex | 10.21518/ms2024-538 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405778249 | |||
| W4405659674 | Screening and identification of antimicrobial peptides from the gut microbiome of cockroach Blattella germanica | 2024-12-21 | OpenAlex | 10.1186/s40168-024-01985-9 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405659674 | |||
| W4405685687 | Risk-adapted treatment for multiple myeloma: assessing the current potential and a roadmap for the future | 2024-12-22 | OpenAlex | 10.1080/10428194.2024.2443550 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405685687 | |||
| W4405693735 | Symposium introduction: The political economy of corruption | 2024-12-22 | OpenAlex | 10.1002/soej.12753 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405693735 | |||
| W4405699694 | Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine | 2024-12-22 | OpenAlex | 10.3390/cells13242126 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405699694 | |||
| W4405706134 | A Comprehensive Literature Review of Osteoporosis Treatment and Fracture Outcomes | 2024-12-23 | OpenAlex | 10.70070/rs5yc355 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405706134 | |||
| W4405694164 | Editorial: Exosome-mediated intercellular communications: immune stimulation and suppression | 2024-12-23 | OpenAlex | 10.3389/fimmu.2024.1540484 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405694164 | |||
| W4405726885 | From fibrosis to granuloma: drug induced systemic sarcoidosis-like reaction after rituximab in a patient with primary Sjögren’s syndrome | 2024-12-23 | OpenAlex | 10.12890/2024_005070 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405726885 | |||
| W4406232215 | Limonene as a Multi-Target Antibiofilm and Quorum Sensing Inhibitor Against Pseudomonas aeruginosa | 2024-12-23 | OpenAlex | 10.51152/jbarbiomed.v10i1.245 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4406232215 | |||
| W4405703421 | Phage-mediated virulence loss and antimicrobial susceptibility in carbapenem-resistant Klebsiella pneumoniae | 2024-12-23 | OpenAlex | 10.1128/mbio.02957-24 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4405703421 | |||
| W4405737761 | A Systematic Review on the Effectiveness and Safety of Combining Biostimulators with Botulinum Toxin, Dermal Fillers, and Energy-Based Devices | 2024-12-24 | OpenAlex | 10.1007/s00266-024-04627-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405737761 | |||
| W4405732463 | A comprehensive review on nanoparticle-based photo acoustic: current application and future prospective | 2024-12-24 | OpenAlex | 10.1186/s11671-024-04173-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405732463 | |||
| W4405740444 | Complex Regional Pain Syndrome: Diagnosis, Pathophysiology, and Treatment Approaches | 2024-12-24 | OpenAlex | 10.7759/cureus.76324 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405740444 | |||
| W4405753421 | How I treat AML relapse after allogeneic HSCT | 2024-12-24 | OpenAlex | 10.1182/blood.2024025705 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405753421 | |||
| W4405737072 | Retina/posterior segment disorders – A colossal subspecialty | 2024-12-24 | OpenAlex | 10.4103/ijo.ijo_3036_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405737072 | |||
| W4405762001 | Tumor Shrinkage can be a Promising Diagnosis Toward Remissionor can also be an Ominous Diagnosis Toward Fatality | 2024-12-24 | OpenAlex | 10.47363/jcrr/2024(6)204 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405762001 | |||
| W4405775229 | Evolving strategies in cervical cancer therapy: A comprehensive review navigating from molecular insights to regulatory challenges | 2024-12-25 | OpenAlex | 10.1016/j.jddst.2024.106568 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405775229 | |||
| W4405843455 | Anionic polysaccharides as delivery carriers for cancer therapy and theranostics: An overview of significance | 2024-12-26 | OpenAlex | 10.1016/j.ijbiomac.2024.139211 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405843455 | |||
| W4405815586 | INFECTIOUS DISEASES IN CHILDREN AND THE REFLECTION ON THE VARIOUS COMMONLY USED ANTIBIOTIC AGENTS | 2024-12-26 | OpenAlex | 10.53555/cz0m2e18 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4405815586 | |||
| W7220252912 | Infection management in hematological malignancies: Febril neutropenia | 2024-12-26 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220252912 | ||||
| W4405821569 | Phosphodiesterase Inhibitors for Diabetes: From Mechanistic Insights to Therapeutic Innovations | 2024-12-26 | OpenAlex | 10.2174/0102506882344901241218070917 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405821569 | |||
| W4405806795 | Vitreous: From Molecules and Cells to Clinical Applications | 2024-12-26 | OpenAlex | 10.1016/b978-0-443-13820-1.00003-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405806795 | |||
| W4405861505 | DRUG AND CARDIAC RESYNCHRONIZATION THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE (LITERATURE REVIEW) | 2024-12-28 | OpenAlex | 10.26787/nydha-2686-6838-2024-26-12-35-45 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405861505 | |||
| W4416028665 | Agentic AI for Regulatory Intelligence: Designing Scalable Compliance Lifecycle Systems in Multinational Tech Enterprises | 2024-12-29 | OpenAlex | 10.38124/ijsrmt.v3i12.934 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416028665 | |||
| W4405872800 | Technical, social, psychological and ethical aspects of human-robot collaboration: a case study of the 'Robin Heart' medical robot | 2024-12-29 | OpenAlex | 10.13166/jms/197008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405872800 | |||
| W4405880306 | A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique” | 2024-12-30 | OpenAlex | 10.14245/ns.2449382.691 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405880306 | |||
| W4405903965 | Assessment of cardio-oncology knowledge and practice among healthcare providers in Saudi Arabia: a comprehensive nationwide survey | 2024-12-30 | OpenAlex | 10.1186/s40959-024-00299-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405903965 | |||
| W4406594927 | Clostridioides difficile Infection: A Review of Emerging Practices for Infection Treatment and Prevention of Recurrence | 2024-12-30 | OpenAlex | 10.14218/jtg.2024.00022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406594927 | |||
| W4406104934 | Giant Frontal Brain Abscess Due to Streptococcus Viridans in an 8-Year-Old Patient: Case Report | 2024-12-30 | OpenAlex | 10.11648/j.ajp.20241004.23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406104934 | |||
| W4405893067 | How Do We Treat Patients With Advanced Hepatocellular Carcinoma? | 2024-12-30 | OpenAlex | 10.1097/01.cot.0001097204.55713.71 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405893067 | |||
| W4405893525 | Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutic | 2024-12-30 | OpenAlex | 10.22541/au.173557639.91035402/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405893525; https://openalex.org/W4406202331 | |||
| W4405930215 | Psychotropic Drugs in Dermatology Part 1: Anti-depressants and Mood Stabilisers | 2024-12-30 | OpenAlex | 10.4103/ijd.ijd_792_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405930215 | |||
| W4405923677 | Reflections on the Potential of Applying Artificial Intelligence (AI) and Machine Learning (ML) for Screening Topical Hemostatic Agents Based on Inorganic Solids for Hemorrhage Control | 2024-12-30 | OpenAlex | 10.31875/2410-4701.2024.11.11 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4405923677 | |||
| W4405912567 | Rhinitis in Primary Care | 2024-12-30 | OpenAlex | 10.1016/j.pop.2024.09.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405912567 | |||
| W4405886157 | Successful Management of Streptococcal Pneumoniae-induced Severe Community-acquired Pneumoniae Complicated by Myocarditis: A Rare Case Report Utilizing Venoarterial Extracorporeal Membrane Oxygenation and Steroid Therapy | 2024-12-30 | OpenAlex | 10.5005/jp-journals-11006-0144 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4405886157 | |||
| W7172000061 | TOWARDS AN INTELLIGENT CANCER LEARNING HEALTH SYSTEM: FOUNDATION AI MODELS FOR ADAPTIVE AND PERSONALIZED ONCOLOGY | 2024-12-30 | OpenAlex | 10.65713/ijaraiv14i1230 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172000061 | |||
| W4407159386 | Transformational journey in ileo-pouch anal anastomosis surgery for ulcerative colitis | 2024-12-30 | OpenAlex | 10.1093/bjsopen/zrae157 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407159386 | |||
| W4407775463 | Walking towards Green Hospitals: innovation and commitment for a healthy future in Latin America | 2024-12-30 | OpenAlex | 10.31579/2690-8808/235 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407775463 | |||
| W7125587842 | A Narrative Review of the Interdisciplinary Management of Acute Poisonings and Overdoses: From Bedside to Laboratory to Antidote | 2024-12-31 | OpenAlex | 10.64483/202412562 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125587842 | |||
| W4407049428 | Advanced Applications of Phytosomes in Cancer Therapy: Innovations, Challenges, and Future Perspectives | 2024-12-31 | OpenAlex | 10.61554/ijnrph.v2i2.2024.101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407049428 | |||
| W4405929101 | An Overview of Pediatric Hemolytic Uremic Syndrome | 2024-12-31 | OpenAlex | 10.1542/pir.2023-006333 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405929101 | |||
| W4405978829 | Evolving Evidence Practices in Acute Stroke Care | 2024-12-31 | OpenAlex | 10.29173/ijcc1041 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405978829 | |||
| W4405950588 | Unveiling the chemistry of antibody conjugation for enhanced PET imaging: Current trends and future directions | 2024-12-31 | OpenAlex | 10.1016/j.bioorg.2024.108115 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405950588 | |||
| W4406018249 | Updates in the Management of Richter Transformation | 2024-12-31 | OpenAlex | 10.3390/cancers17010095 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406018249 | |||
| W4412714011 | 2025-01-01 | OpenAlex | 10.46998/ijcmcr.54.3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412714011 | ||||
| W4414078728 | 22 - A decade of incontinence and outflow obstruction surgery: current trends from the hospital episode statistics database | 2025-01-01 | OpenAlex | 10.1016/j.cont.2025.101946 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414078728 | |||
| W4413808907 | 2D/3D Ultrasound Imaging of Urethral Bulking Materials | 2025-01-01 | OpenAlex | 10.1007/978-3-031-92486-6_11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413808907 | |||
| W7138879975 | A New Era in Atherosclerosis Prevention and Treatment | 2025-01-01 | OpenAlex | 10.4103/aptj.aptj_15_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138879975 | |||
| W4415847378 | A Review on Novel Applications of Nanoparticles in Pediatric Oncology | 2025-01-01 | OpenAlex | 10.32604/or.2025.069101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415847378 | |||
| W7133574642 | A Unified Framework for Collaborative Knowledge Graph Construction, Editing, and Distribution | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7133574642 | ||||
| W4409904020 | A comprehensive introduction on biogenic nanoparticles: fabrication, implementation, and environmental concern | 2025-01-01 | OpenAlex | 10.1016/b978-0-443-33819-9.00005-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409904020 | |||
| W4413825080 | A comprehensive review of the multisystem benefits of antidiabetic drugs in aging beyond glycemic control | 2025-01-01 | OpenAlex | 10.1016/j.tma.2025.08.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413825080 | |||
| W7118890792 | A neurological challenge: primary angiitis of the central nervous system in a young woman | 2025-01-01 | OpenAlex | 10.5327/1516-3180.cpn.1260 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7118890792 | |||
| W7116749006 | A socio-hydrological agent-based model of farmer adaptation to groundwater salinity stress in an arid region of Iran | 2025-01-01 | OpenAlex | 10.2139/ssrn.5944155 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7116749006 | |||
| W4409957407 | A state-of-the-art view: G-quadruplex-targeting for platinum complexes’ treatment of tumors | 2025-01-01 | OpenAlex | 10.1039/d5cb00024f | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409957407 | |||
| W4411152587 | AI Agents in Healthcare | 2025-01-01 | OpenAlex | 10.1007/978-3-031-90026-6_10 | Title/abstract | Excluded | E5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established. | https://openalex.org/W4411152587 | |||
| W7124939968 | AI in Personnel Training and Development from Pre- to Post-ChatGPT: A Systematic Review | 2025-01-01 | OpenAlex | 10.17605/osf.io/2qmge | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124939968 | |||
| W7117533694 | AI-Driven Security Automation for Continuous Compliance Monitoring in Regulated Cloud Environments | 2025-01-01 | OpenAlex | 10.63282/3050-9246.ijetcsit-v6i2p112 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7117533694 | |||
| W4415679058 | ATLAS: History and Evolution of Health Professions in Puerto Rico (1952–2022). Medical Doctors — Vol. 1 | 2025-01-01 | OpenAlex | 10.2139/ssrn.5675442 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415679058 | |||
| W4409303524 | Abscess Angiofibroma of the Rectus Abdominis Muscle: About a Case at the Bouaké University Hospital | 2025-01-01 | OpenAlex | 10.4236/ss.2025.164020 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409303524 | |||
| W4406255861 | Acute Generalized Exanthematous Pustulosis Induced by Hyaluronic Acid Knee Injection: A Case Report | 2025-01-01 | OpenAlex | 10.1016/j.jen.2024.08.005 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406255861 | |||
| W4411852503 | Addressing residual neuromuscular blockade: A key to achieving ERAS goals in cardiac surgery | 2025-01-01 | OpenAlex | 10.4103/theiaforum.theiaforum_51_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411852503 | |||
| W4410888816 | Advancements in Protein Kinase Inhibitors: From Discovery to Clinical Applications | 2025-01-01 | OpenAlex | 10.34133/research.0747 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410888816 | |||
| W4416753324 | Advances and future perspectives in chimeric antigen receptor T-cell and bispecific antibody therapies for multiple myeloma | 2025-01-01 | OpenAlex | 10.3960/jslrt.25038 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416753324 | |||
| W4414188522 | Agentic AI Meets Data Engineering: Toward Self-Directed, Interpretable, and Balanced Pipelines | 2025-01-01 | OpenAlex | 10.70153/ijcmi/2025.17202 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414188522 | |||
| W4409417630 | Agentic AI in Healthcare: Diagnosis and Treatment | 2025-01-01 | OpenAlex | 10.2139/ssrn.5214492 | Title/abstract | Excluded | E5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established. | https://openalex.org/W4409417630 | |||
| W4414550633 | Agentic AI in XML-Based Information Retrieval Systems for Collaboration and Decision Support | 2025-01-01 | OpenAlex | 10.1007/978-3-031-89424-4_14 | Full text | Excluded | F2: The XML retrieval method evaluates general multimedia/IMDB records; healthcare is one example industry, so existing P2 applies. | https://openalex.org/W4414550633 | https://link.springer.com/chapter/10.1007/978-3-031-89424-4_14 | publisher abstract and dataset note, not full methods | |
| W4411995908 | Agentic AI: A Comprehensive Survey of Technologies, Applications, and Societal Implications | 2025-01-01 | OpenAlex | 10.1109/access.2025.3585609 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4411995908 | |||
| W4406728221 | Agentic AI: Autonomous Intelligence for Complex Goals—A Comprehensive Survey | 2025-01-01 | OpenAlex | 10.1109/access.2025.3532853 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4406728221 | |||
| W4410294045 | Agentic Artificial Intelligence in Public Administration: Foundations, Applications, and Governance | 2025-01-01 | OpenAlex | 10.2139/ssrn.5249100 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4410294045 | |||
| W4416034803 | Agentic Medical Knowledge Graphs Enhance Medical Question Answering: Bridging the Gap Between LLMs and Evolving Medical Knowledge | 2025-01-01 | OpenAlex | 2502.13010 | 10.18653/v1/2025.findings-emnlp.679 | Full text | Excluded | F4: AMG-RAG grows a persistent graph from external textbooks/search results. §3.3 and §4.1 describe query-triggered coverage expansion and background literature refresh, without an experience-derived case-outcome update reused on later cases. | https://openalex.org/W4416034803 | https://aclanthology.org/2025.findings-emnlp.679.pdf | |
| W7119299327 | Agents of Change: Self-Reflection and Queer Prosociality among Trans and Nonbinary People | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7119299327 | ||||
| W4415878955 | Alyse Gregory: Finding her “Voice” through Woman's Suffrage | 2025-01-01 | OpenAlex | 10.5406/26395991.64.2.11 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415878955 | |||
| W7128755679 | An Efficient and Effective Electromagnetic Rewarming Platform for Cryopreservation of Large-Volume Biomaterials | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7128755679 | ||||
| W4414830170 | An Overview of Chronic Spontaneous Urticaria: Diagnosis, Management, and Treatment | 2025-01-01 | OpenAlex | 10.4168/aair.2025.17.5.531 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414830170 | |||
| W4408924216 | An overview of medical care and diagnostic aspects of rheumatoid arthritis | 2025-01-01 | OpenAlex | 10.33545/comed.2025.v8.i1.b.374 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4408924216 | |||
| W4411026481 | Anesthesia for Patients with Motor Neuron Disease – Many Pitfalls | 2025-01-01 | OpenAlex | 10.4103/jica.jica_16_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411026481 | |||
| W4413408373 | Antibiotics and antiviral agents | 2025-01-01 | OpenAlex | 10.1016/b978-0-443-27461-9.00012-3 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4413408373 | |||
| W4410736413 | Antithrombotic Therapy for Acute Coronary Syndrome | 2025-01-01 | OpenAlex | 10.5797/jnet.ra.2024-0102 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410736413 | |||
| W4412916341 | Aptamers: A Novel Class of Targeted Therapeutics | 2025-01-01 | OpenAlex | 10.1007/978-981-96-8387-1_3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412916341 | |||
| W4413192759 | Artificial Intelligence as a Digital Species: Opportunities, Risks, and the Human Challenge – A Conversation with Mustafa Suleyman | 2025-01-01 | OpenAlex | 10.2139/ssrn.5368626 | Title/abstract | Excluded | E1: Title identifies a conversation/interview; no primary adapting agent study. | https://openalex.org/W4413192759 | |||
| W4417317890 | Assessment of Efficacy and Safety of Tislelizumab for Esophageal Squamous Cell Carcinoma | 2025-01-01 | OpenAlex | 10.70844/jmhrp.2025.2.2.43 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417317890 | |||
| W4410106808 | Autonomous Self-Healing Grid Transformers with GenAI and LLM Optimization: Toward Limited Human Intervention | 2025-01-01 | OpenAlex | 10.2139/ssrn.5220392 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4410106808 | |||
| W4408024359 | Beyond Moral Fundamentalism | 2025-01-01 | OpenAlex | 10.5406/19446489.20.1.01 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4408024359 | |||
| W7108337014 | Beyond Static Products: Rethinking Regulatory Hurdles and "Significant Change" in Digital Mental Health Technologies Across India, the EU/UK, and the United States | 2025-01-01 | OpenAlex | 10.2139/ssrn.5824142 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7108337014 | |||
| W4408580977 | Beyond the Tumor: Cutaneous Manifestations of Paraneoplastic Syndromes | 2025-01-01 | OpenAlex | 10.4236/jbm.2025.133018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408580977 | |||
| W4406591636 | Bilateral aqueous misdirection following cataract surgery: A case report | 2025-01-01 | OpenAlex | 10.1111/aos.17293 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406591636 | |||
| W4409256865 | Biofilms and Their Increasing Trend in AMR Patterns in Integrated Farming Systems | 2025-01-01 | OpenAlex | 10.1007/978-981-96-1885-9_18 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4409256865 | |||
| W4406731360 | Biologic Therapy and Cardiometabolic Risk in Psoriasis: A Retrospective Review | 2025-01-01 | OpenAlex | 10.1007/s13555-024-01327-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406731360 | |||
| W4412491899 | Burn Debridment - Approach and Review. | 2025-01-01 | OpenAlex | 10.12865/chsj.51.01.01 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412491899 | |||
| W7133538487 | CORONARY VENOUS DISEASES TREATMENT AND PHARMACOLOGICAL INNOVATIONS | 2025-01-01 | OpenAlex | 10.5336/978-625-395-700-1_p119 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133538487 | |||
| W4412781839 | Capivasertib/Fulvestrant in patients with HR+, HER2-low or HER2-negative locally advanced or metastatic breast cancer | 2025-01-01 | OpenAlex | 10.1177/17588359251358947 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412781839 | |||
| W4415997772 | Cardiovascular Effects of GLP-1 Analogues | 2025-01-01 | OpenAlex | 10.1007/978-3-032-01700-0_15 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415997772 | |||
| W4407140791 | Challenges and Opportunities for Nanotechnology to Enhance Food Safety of Fresh Vegetables in Chile | 2025-01-01 | OpenAlex | 10.1007/978-3-031-70745-2_14 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4407140791 | |||
| W4416240721 | Chemical Peels: Indications and Use in Various Skin Types | 2025-01-01 | OpenAlex | 10.1007/978-981-97-9754-7_10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416240721 | |||
| W4409524158 | Chemotherapy in Breast Cancer | 2025-01-01 | OpenAlex | 10.1007/978-981-97-9847-6_15 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409524158 | |||
| W7125817509 | Chemotherapy-induced osteoporosis in pediatric oncology: pathophysiology and treatment | 2025-01-01 | OpenAlex | 10.5114/pedm.2025.158551 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125817509 | |||
| W7213390217 | Chinese-speaking Immigrants' Experience Navigating Ireland’s 2022 Regularisation of Long-Term Undocumented Migrants Scheme | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213390217 | ||||
| W4410132433 | Chronic Kidney Disease - Evolving Treatments | 2025-01-01 | OpenAlex | 10.71431/ijrpas.2025.4310 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410132433 | |||
| W7133022531 | Classification and Analysis of Differential Mobility Spectrometry Measurements | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7133022531 | ||||
| W4409001771 | Clinical Application of Artificial Intelligence in Breast MRI | 2025-01-01 | OpenAlex | 10.3348/jksr.2025.0012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409001771 | |||
| W4410311201 | Clinical Applications of Exosomes | 2025-01-01 | OpenAlex | 10.1007/978-981-96-1261-1_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410311201 | |||
| W7106234027 | Clinical Evaluation of Patients Proposed for Hyperbaric Oxygen Therapy and Contraindications | 2025-01-01 | OpenAlex | 10.1007/978-3-032-06346-5_20 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7106234027 | |||
| W4414730701 | Clinical Validations of Localized Cancer Nanomedicine | 2025-01-01 | OpenAlex | 10.1007/978-981-95-0938-6_7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414730701 | |||
| W4406298756 | Clinical practice guidelines on the assessment and management of cognitive impairment in major depressive disorder | 2025-01-01 | OpenAlex | 10.4103/indianjpsychiatry.indianjpsychiatry_563_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406298756 | |||
| W4406298779 | Clinical practice guidelines – An overview of cognitive remediation for various neuropsychiatric disorders | 2025-01-01 | OpenAlex | 10.4103/indianjpsychiatry.indianjpsychiatry_1191_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406298779 | |||
| W4411449569 | Clostridioides Difficile Infection in Colorectal Cancer: Risk Factors, Clinical Outcomes, and Evolving Strategies for Optimal Management | 2025-01-01 | OpenAlex | 10.2139/ssrn.5292438 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411449569 | |||
| W7114912027 | CloudPedagogy AI Capability Framework (2026 Edition) | 2025-01-01 | OpenAlex | 10.6084/m9.figshare.30865790 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7114912027 | |||
| W4406298762 | Cognitive impairment in alcohol use disorder and clinical practice guidelines for management of long-stay alcohol use disorder patients | 2025-01-01 | OpenAlex | 10.4103/indianjpsychiatry.indianjpsychiatry_692_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406298762 | |||
| W4414167322 | Comparative effectiveness of perioperative strategies for resectable gastric and gastroesophageal junction cancer: a Bayesian network meta-analysis | 2025-01-01 | OpenAlex | 10.62347/eckt5511 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414167322 | |||
| W4414394578 | Comparative evaluation of different re-mineralizing agents for enamel protection after pH-cycling | 2025-01-01 | OpenAlex | 10.5114/jos.2025.154418 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414394578 | |||
| W7127702323 | Composition, Assembly, Function, and Post-Translational Modification of the Apical Complex in Toxoplasma gondii: Insights into Regulation of Motility and Invasion | 2025-01-01 | OpenAlex | 10.13097/archive-ouverte/unige:191222 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7127702323 | |||
| W4414786159 | Comunicação da PrEP e da PEP no Brasil: exploração dos sentidos de peças comunicacionais e análise das concepções de agentes governamentais | 2025-01-01 | OpenAlex | 10.1590/0102-311xpt100524 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414786159 | |||
| W4406735229 | Connecting Wound Bed Preparation 2024, Therapeutic Index, and Covert and Overt Infection | 2025-01-01 | OpenAlex | 10.1097/asw.0000000000000267 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406735229 | |||
| W4408024388 | Consequentialism in the Work of John Dewey and Peter Singer: Considering the Case of Effective Altruism | 2025-01-01 | OpenAlex | 10.5406/19446489.20.1.04 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4408024388 | |||
| W4416684670 | Constructing an Application Framework for Educational AI Agents to Promote Deep Integration of Teacher TPACK | 2025-01-01 | OpenAlex | 10.4236/jcc.2025.1311013 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416684670 | |||
| W4411049353 | Contemporary Approaches to Combat Cardiac Fibrosis: From Immune Cell Modulation to Therapeutic Advancements | 2025-01-01 | OpenAlex | 10.2139/ssrn.5274697 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411049353 | |||
| W7115914616 | Cooperation in a Dynamic Network | 2025-01-01 | OpenAlex | 10.2139/ssrn.5933281 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7115914616 | |||
| W4408645701 | Current Developments, Challenges, and Future Standpoints Corresponding to Antibacterial Agents with Special Reference to Polyhydroxyalkanoates (PHAs) | 2025-01-01 | OpenAlex | 10.1007/978-981-96-2022-7_8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408645701 | |||
| W4411549361 | DISEASE DIAGNOSIS USING RAG LLM WITH SMART PROMPT ENGINEERING | 2025-01-01 | OpenAlex | 10.31979/etd.azur-9jbv | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4411549361 | |||
| W7131101566 | DYSESTHESIA | 2025-01-01 | OpenAlex | 10.5336/978-625-395-759-9_p281 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131101566 | |||
| W7106003846 | Data Augmentation, Explainable AI, and Conversational Diagnosis via Large Language Models: A Path Towards a Real Automated Clinical Mental Disorder Diagnosis | 2025-01-01 | OpenAlex | 10.7939/83339 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7106003846 | |||
| W4415205345 | Dementia Care and Generative Artificial Intelligence | 2025-01-01 | OpenAlex | 10.1007/978-3-031-40858-8_528-1 | Full text | Excluded | F1: This is an encyclopedia literature/reference entry, not a primary adaptive-agent study. | https://openalex.org/W4415205345 | https://link.springer.com/rwe/10.1007/978-3-031-40858-8_528-1 | publisher abstract and bibliographic version information only | |
| W4411789634 | Demographic and Clinical Characteristics of Pediatric Poisoning: A 20-Year Retrospective Analysis with Literature Review | 2025-01-01 | OpenAlex | 10.29228/ejhh.82491 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411789634 | |||
| W7116708953 | Descriptive Epidemiology of Klebsiella spp. Urinary Tract Infections in Central Africa | 2025-01-01 | OpenAlex | 10.1155/bmri/9558259 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7116708953 | |||
| W7199328993 | Development of multilayered protection systems against chemical, radiological, and biological hazards for military personnel | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7199328993 | ||||
| W4409932645 | Dietary Fiber and Cancer Management: A Twenty‐Five‐Year Bibliometric Review of Research Trends and Directions | 2025-01-01 | OpenAlex | 10.1155/bmri/5086946 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409932645 | |||
| W7141661283 | Discovery and in vitro functional characterization of marine-derived and synthetic multifunctional peptides with therapeutic potential against cancer and microbial infections | 2025-01-01 | OpenAlex | 10.18725/oparu-59644 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7141661283 | |||
| W7206417086 | Diseases of the Eye | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7206417086 | ||||
| W4406598659 | Distribution and Resistance Profile of Klebsiella pneumoniae Strains at the Yaoundé Central Hospital: Analysis and Implications | 2025-01-01 | OpenAlex | 10.4236/aim.2025.151002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406598659 | |||
| W7128209144 | Drug discovery and development process: An evolving scientific journey | 2025-01-01 | OpenAlex | 10.33545/26646536.2025.v7.i2a.129 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128209144 | |||
| W4416563226 | Drug-Induced Lung Injury | 2025-01-01 | OpenAlex | 10.1007/978-981-96-7810-5_78 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416563226 | |||
| W4413165705 | Dynamic Resource Allocation with Stochastic Agent Flows | 2025-01-01 | OpenAlex | 10.2139/ssrn.5373671 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4413165705 | |||
| W4411020523 | Efficacy of a Chatbot (Chatgpt-4) Compared to a Human Conversational Agent for Reducing Procrastination: A Randomized Controlled Pilot-Trial | 2025-01-01 | OpenAlex | 10.2139/ssrn.5281283 | Full text | Excluded | F4: The trial evaluates fixed ChatGPT4 session prompts without tuning/adaptation. Human pretrial prompt development is separate from the evaluated trial; no retained cross-case agent learning is tested. | https://openalex.org/W4411020523 | https://journals.sagepub.com/doi/10.1177/20552076261450336 | SSRN original abstract and retitled published paper full Methods; no supplementary files downloaded | |
| W4414194208 | Electrospun Mucoadhesive Film Loaded with Polycaprolactone Nanocarriers for Sustained Delivery of Deferasirox through Buccal Mucosa | 2025-01-01 | OpenAlex | 10.2139/ssrn.5481998 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414194208 | |||
| W4412804375 | Electrospun chitosan nanofibers for regenerative wound healing: from molecular design to functional scaffolds | 2025-01-01 | OpenAlex | 10.1039/d5tb01405k | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412804375 | |||
| W7126323659 | Enclosing the Insane: The Pharmakon Behind Asylum Architecture | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126323659 | ||||
| W4411864383 | Engaging patients and caregivers: transforming healthcare together | 2025-01-01 | OpenAlex | 10.1093/ijcoms/lyaf007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411864383 | |||
| W4409494283 | Enhancing LLM Reasoning Capabilities Through Brokered Multi-Expert Reflection | 2025-01-01 | OpenAlex | 10.1109/access.2025.3561693 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4409494283 | |||
| W7147467563 | Evaluation of Patient with Peripheral Arterial Disease: General Surgeons’ Perspective | 2025-01-01 | OpenAlex | 10.4103/sd.sd_3_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147467563 | |||
| W4415282964 | Evolutionary engineering and molecular characterization of an antimycin A-resistant Saccharomyces cerevisiae strain: the key role of pleiotropic drug resistance ( PDR1 ) | 2025-01-01 | OpenAlex | 10.1093/femsyr/foaf062 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415282964 | |||
| W7110776913 | Evolving functions of plasters and patches in health care: The historical progress of classical medical devices | 2025-01-01 | OpenAlex | 10.23750/abm.v96i5.17290 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7110776913 | |||
| W4409023368 | Expanding the Role of Novel Therapeutics in Cardiometabolic Syndrome: Beyond Heart Failure and Diabetes | 2025-01-01 | OpenAlex | 10.51789/cmsj.2025.5.e4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409023368 | |||
| W7135577050 | Exploring the Future Trajectory of AI-Powered Hearables: Industry Perspectives on Emerging Capabilities | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135577050 | ||||
| W4416553257 | Exploring the Ocean for Oncology: Natural Compounds from Marine Organisms in Cancer Treatment | 2025-01-01 | OpenAlex | 10.52756/lbsopf.2025.v04.010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416553257 | |||
| W7169574941 | Exploring the evolution of multidrug resistance patterns in ESKAPEE pathogens using association mining: Key to antibiotic stewardship? | 2025-01-01 | OpenAlex | 10.12688/wellcomeopenres.24103.3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169574941; https://openalex.org/W7130642010; https://openalex.org/W4413426508 | |||
| W4414284296 | FRAME MODELING OF THE DOUBT /СОМНЕНИЕ/ CONCEPT (based on materials from Russian-language electronic media of Ukraine) | 2025-01-01 | OpenAlex | 10.17721/studling2025.26.45-62 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414284296 | |||
| W7131118025 | FUTURE ROLES OF ARTIFICIAL INTELLEGENCE IN COLLABORATION WITH HEALTHCARE PROFESSIONALS | 2025-01-01 | OpenAlex | 10.5336/978-625-395-760-5_p235 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131118025 | |||
| W4410121570 | Follicular Non-Hodgkin's Lymphoma (FL) heterogeneity, management and perspectives | 2025-01-01 | OpenAlex | 10.32440/ar.2025.142.01.rev04 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410121570 | |||
| W7128539339 | Food anaphylaxis and emerging allergens — beyond current regulations | 2025-01-01 | OpenAlex | 10.26416/aler.9.4.2025.11335 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128539339 | |||
| W4407554468 | From Simple Scripts to Sentient Conversations: Tracing NLP's Influence on Chatbot Development | 2025-01-01 | OpenAlex | 10.52783/eel.v15i1.2567 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407554468 | |||
| W4413315499 | From “Taking” to Beyond: Diachronic Change in the Multifunctionality of the Na-Construction of Chinese | 2025-01-01 | OpenAlex | 10.2139/ssrn.5397524 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4413315499 | |||
| W7127253506 | Fully moral artificial agents: future or fiction | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7127253506 | ||||
| W4416453879 | Fundamentals of Ultrasonic Diagnosis and Common Ultrasound Techniques in Female Reproduction | 2025-01-01 | OpenAlex | 10.1007/978-981-95-1373-4_2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416453879 | |||
| W4409830039 | Future Perspectives: Metabolic Imaging, Theranostics, and Radiomics | 2025-01-01 | OpenAlex | 10.1007/978-3-031-77061-6_4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409830039 | |||
| W4405963974 | GLP-1 receptor agonism in cardiovascular disease prevention | 2025-01-01 | OpenAlex | 10.32948/ajpt.2024.11.22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4405963974 | |||
| W4407154086 | Gallery Artists | 2025-01-01 | OpenAlex | 10.1162/leon_a_02658 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4407154086 | |||
| W7104096400 | Global Anesthesia Drugs Market Analysis (2024–2030) | 2025-01-01 | OpenAlex | 10.6084/m9.figshare.30518942.v2 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7104096400; https://openalex.org/W7103991406 | |||
| W4415145500 | Glycoprotein IIb/IIIa Antagonists | 2025-01-01 | OpenAlex | 10.1007/978-3-031-96360-5_3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415145500 | |||
| W4408477905 | Guts for Self-Eating: Role of Autophagy in Gastrointestinal Health and Disease | 2025-01-01 | OpenAlex | 10.1016/j.gastha.2025.100654 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408477905 | |||
| W7133312717 | Handling Communist Captives: U.S. Military Authorities and the Treatment of Enemy POWs during the Korean War | 2025-01-01 | OpenAlex | 10.1162/jcws.a.39 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7133312717 | |||
| W4416987346 | Harnessing GLP‐1 Receptor Agonists for Obesity Treatment: Prospects and Obstacles on the Horizon | 2025-01-01 | OpenAlex | 10.1155/jobe/9919810 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416987346 | |||
| W4416794021 | Harnessing the extinction vortex against acute lymphoblastic leukemia | 2025-01-01 | OpenAlex | 10.1093/emph/eoaf035 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416794021 | |||
| W4412683869 | Harnessing the medicinal benefits of silkworm, Bombyx mori | 2025-01-01 | OpenAlex | 10.33545/26174693.2025.v9.i7sh.4942 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412683869 | |||
| W4409834069 | HbA1c reduction strategies: An overview of pharmacological interventions | 2025-01-01 | OpenAlex | 10.4103/njpt.njpt_72_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409834069 | |||
| W4417200037 | Health empowerment through the convergence of Wearables, Smartphone-Driven Health Devices, and Artificial Intelligence -A Scoping Review | 2025-01-01 | OpenAlex | 10.2139/ssrn.5890362 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417200037 | |||
| W4408957953 | Hepatic Arterial Infusion Chemotherapy for Intrahepatic Cholangiocarcinoma | 2025-01-01 | OpenAlex | 10.1007/978-3-031-74935-3_16 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408957953 | |||
| W4408958057 | Hepatic Arterial Infusion Drugs and Dosing | 2025-01-01 | OpenAlex | 10.1007/978-3-031-74935-3_11 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408958057 | |||
| W4409983039 | Heterogeneous Multi-Agent Framework for Dynamic Generalized Category Discovery | 2025-01-01 | OpenAlex | 10.1137/1.9781611978520.33 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4409983039 | |||
| W4406567183 | History of the human viral infection and their clinical manifestation | 2025-01-01 | OpenAlex | 10.1016/b978-0-443-15283-2.00001-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406567183 | |||
| W7107862142 | How do lipopeptides interact with the model fungal membrane? | 2025-01-01 | OpenAlex | 10.5286/isis.e.rb2520355-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7107862142; https://openalex.org/W7107874444 | |||
| W7114594275 | ICCCC 2025 Outcome Document | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7114594275 | ||||
| W7133352727 | INTRODUCTION TO UROGYNECOLOGY | 2025-01-01 | OpenAlex | 10.5336/978-625-395-710-0_p3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133352727 | |||
| W4411349489 | Imagining the work of community health workers: notes for a discussion on territory, health and care | 2025-01-01 | OpenAlex | 10.1590/s0104-12902025230415en | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411349489 | |||
| W4413457855 | Immunomodulation and Thrombolytic Approaches in the Management of Deep Vein Thrombosis and Pulmonary Embolism | 2025-01-01 | OpenAlex | 10.26502/fccm.92920456 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413457855 | |||
| W4416239281 | Impact of Comorbidities on Treatments and Outcomes of Systemic Sclerosis–Associated Pulmonary Arterial Hypertension | 2025-01-01 | OpenAlex | 10.1155/carj/5021789 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416239281 | |||
| W4409831195 | In Vivo Infiltration Techniques for Nanoparticle Delivery | 2025-01-01 | OpenAlex | 10.1007/978-3-031-81896-7_17 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409831195 | |||
| W7114924896 | Inflammation as a Modifiable Driver of Ischemic Heart Disease: Mechanisms, Clinical Risks, and Evolving Therapeutic Options | 2025-01-01 | OpenAlex | 10.64149/j.carcinog.24.10s.488-501 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7114924896 | |||
| W4411101028 | Innovations in cardio-oncology research | 2025-01-01 | OpenAlex | 10.1016/b978-0-443-29829-5.00016-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411101028 | |||
| W4415763514 | Innovations in intelligent automation and evolving human-Robot Interaction | 2025-01-01 | OpenAlex | 10.2991/978-94-6463-858-5_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415763514 | |||
| W7154834318 | Insecticide resistance patterns in major mosquito vectors and their impact on vector control strategies | 2025-01-01 | OpenAlex | 10.22271/23487941.2025.v12.i1a.904 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7154834318 | |||
| W7119559344 | Integrating Large Language Models in Physiotherapy : A Design Study of Interaction and Workflows | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7119559344 | ||||
| W4413240765 | Integrative strategies in breast cancer therapy: Conventional approaches, emerging advances, and future challenges | 2025-01-01 | OpenAlex | 10.1016/j.aspetd.2025.100012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413240765 | |||
| W7117972744 | Interactive Healthcare Solutions: NLP Systems with Personalized Conversational Agents and Long-Term Memory | 2025-01-01 | OpenAlex | 10.1007/978-3-031-87372-0_44 | Full text | Excluded | F5: Public publisher and author/repository routes did not provide full methods. The root agent also checked the publisher with the existing Tohoku University browser entitlement; only a subscription preview was available. LLM status, clinical-main focus and/or cross-case retention remain unresolved, rather than inferred absent from the abstract. | https://openalex.org/W7117972744 | https://link.springer.com/chapter/10.1007/978-3-031-87372-0_44 | Bibliographic information and available abstract/preview only; no full methods read. | |
| W4415423147 | Interdisciplinary Dialogues for the Twentieth Anniversary of the SZJSZK | 2025-01-01 | OpenAlex | 10.15170/ttk-szjszk-2025b | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415423147 | |||
| W4409562829 | Interstitial Lung Diseases - Registries are the Need of the Hour | 2025-01-01 | OpenAlex | 10.4103/pulmon.pulmon_3_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409562829 | |||
| W4413475442 | Intravenous Infusions for Sedation: Rationale, State of the Art, and Future Trends | 2025-01-01 | OpenAlex | 10.1007/978-3-031-68468-5_36 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413475442 | |||
| W4416272911 | Intrinsic Participatory Governance of Autonomous Agents: Runtime Oversight and Orientation through Embedded Steward Agents | 2025-01-01 | OpenAlex | 10.2139/ssrn.5651771 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4416272911 | |||
| W4406592272 | Introduction | 2025-01-01 | OpenAlex | 10.1016/b978-0-443-26787-1.00001-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406592272; https://openalex.org/W4367179063; https://openalex.org/W4390348278; https://openalex.org/W7164887387; https://openalex.org/W7131820512; https://openalex.org/W4410593498 | |||
| W4412645672 | Introduction to Biosafety and Biosecurity in the Context of Biorisk Assessment and Management in Biomedical and Clinical Laboratory Settings | 2025-01-01 | OpenAlex | 10.47278/book.hh/2025.373 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412645672 | |||
| W4410160560 | Introduction to Social Robotics: An Intersection of Robotics and Society | 2025-01-01 | OpenAlex | 10.1007/978-3-319-77267-7_7 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4410160560 | |||
| W4412837552 | Ionic Liquids as Versatile Greener Media: Synthesis and Stabilization of Metal Nanoparticles and Their Remarkable Biological Applications | 2025-01-01 | OpenAlex | 10.2139/ssrn.5374917 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412837552 | |||
| W4417257131 | Japan–Korea collaboration on biophysical techniques for drug discovery in infectious diseases: Toward future pandemic preparedness | 2025-01-01 | OpenAlex | 10.2142/biophysico.bppb-v22.s003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417257131 | |||
| W4408899333 | Kaposi’s sarcoma occurring in a glioblastoma multiforme on temozolomide | 2025-01-01 | OpenAlex | 10.4103/ds.ds-d-24-00095 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408899333 | |||
| W4412896833 | Ketamine and Esketamine for the Treatment of Refractory Status Epilepticus Induced by Organophosphorus Compounds | 2025-01-01 | OpenAlex | 10.1007/978-1-0716-4599-4_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412896833 | |||
| W7110669692 | La Emptiness Machine: Derechos Fundamentales para la Inteligencia Artificial y la Evolución de la Conciencia: Un Análisis Interdisciplinario a la Luz del Project Sid de Altera AI | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7110669692 | ||||
| W7119473485 | Leukemia epidemiology in China: Burden, trends and determinants in the 21st century | 2025-01-01 | OpenAlex | 10.21147/j.issn.1000-9604.2025.06.03 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119473485 | |||
| W4410392312 | Liability for AI Agents | 2025-01-01 | OpenAlex | 10.2139/ssrn.5236649 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4410392312 | |||
| W4406655101 | Los cursos de didácticas en Educación Especial: sus cambios a lo largo de los 50 años de la carrera en la Universidad de Costa Rica | 2025-01-01 | OpenAlex | 10.15517/aie.v25i1.60551 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4406655101 | |||
| W4409050795 | Lung cancer: Current status of preclinical research | 2025-01-01 | OpenAlex | 10.1016/b978-0-443-31656-2.00005-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409050795 | |||
| W7133300455 | MANAGEMENT OF METASTATIC BREAST CANCER | 2025-01-01 | OpenAlex | 10.5336/978-625-395-705-6_p145 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133300455 | |||
| W4417293947 | MICROBUBBLES IN MOTION: THE EVOLVING LANDSCAPE OF ULTRASOUND CONTRAST AGENTS FOR DIAGNOSTICS AND THERAPEUTICS | 2025-01-01 | OpenAlex | 10.1016/j.ultrasmedbio.2025.10.080 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4417293947 | |||
| W4411285726 | Management of Advanced Heart Failure in Cardiac Amyloidosis | 2025-01-01 | OpenAlex | 10.1007/978-3-031-88342-2_11 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411285726 | |||
| W4415916084 | Managing atopic dermatitis with antioxidant treatment emollients: A narrative review and consensus statements | 2025-01-01 | OpenAlex | 10.12932/ap-060225-2027 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415916084 | |||
| W7114001483 | Memory as Baseline Deviation: Toward a Relational Predictive Processing Framework | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7114001483 | ||||
| W4407252977 | Meningiomas Following the Previous Cancer Therapies: Brief Report | 2025-01-01 | OpenAlex | 10.4103/ni.ni_670_22 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407252977 | |||
| W4410517385 | Metabolism Prediction: Identification of Potential Sites of Metabolism in Lead Molecules | 2025-01-01 | OpenAlex | 10.1007/978-981-96-4154-3_17 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410517385 | |||
| W4412092747 | Molecular Diagnostics and Therapeutic Approaches in Zoonotic Infections | 2025-01-01 | OpenAlex | 10.51584/ijrias.2025.10060054 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412092747 | |||
| W4410765323 | Molecularly driven therapies in the treatment of primary brain tumors | 2025-01-01 | OpenAlex | 10.1016/bs.acr.2025.05.005 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410765323 | |||
| W7211874267 | Multi-Agent Coordination for Operating Room Turnover: A Constraint-Based Optimization Blueprint | 2025-01-01 | OpenAlex | 10.68159/i129739920 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7211874267 | |||
| W4412379950 | Multidimensional heterogeneous integration of two-dimensional materials and artificial visual systems: Frontier innovations and paradigm-shifting advancements | 2025-01-01 | OpenAlex | 10.7498/aps.74.20250703 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4412379950 | |||
| W7131732636 | Multimodal and Agentic AI for Cognitive Accessibility and Linguistic Preservation | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7131732636 | ||||
| W4406595619 | Myopia control in the community (optical interventions, biometry, protocol) | 2025-01-01 | OpenAlex | 10.1111/aos.16896 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406595619 | |||
| W4415804950 | NANOSPONGES AS A REVOLUTIORNARY PLATFORM IN DELIVERY OF DRUGS | 2025-01-01 | OpenAlex | 10.56975/ijsdr.v10i10.305470 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415804950 | |||
| W7133936532 | NONINVASIVE CARDIAC MONITORING IN CRITICALLY ILL CHILD | 2025-01-01 | OpenAlex | 10.5336/978-625-395-599-1_p13 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133936532 | |||
| W4410969082 | Nanopaints in medical applications | 2025-01-01 | OpenAlex | 10.1016/b978-0-443-26512-9.00017-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410969082 | |||
| W4411548164 | Nanosystem Equipped with a Sonosensitizer for Combined Chemotherapy and Sonodynamic Therapy for Melanoma Treatment | 2025-01-01 | OpenAlex | 10.2139/ssrn.5294156 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411548164 | |||
| W4412645691 | Nanotechnology and the Future of Medical Imaging: Enhancing Diagnostic Accuracy | 2025-01-01 | OpenAlex | 10.47278/book.hh/2025.441 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4412645691 | |||
| W4413437842 | Nasal staphylococcal microbiota of healthy hosts, their antimicrobial resistance and virulence determinants: Implications for One Health | 2025-01-01 | OpenAlex | 10.1016/b978-0-443-33351-4.00013-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413437842 | |||
| W4406582748 | National educational policy 2020: Transforming nursing profession | 2025-01-01 | OpenAlex | 10.33545/26649187.2025.v7.i1a.78 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406582748 | |||
| W7131738518 | Negotiating Health Equity in Aotearoa New Zealand: A Constructivist Grounded Theory of IQNs’ Balancing Perspectives and Reconciling a New Understanding | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7131738518 | ||||
| W7117952837 | Nelson’s Syndrome after bilateral adrenalectomy: A comprehensive review of pathogenesis, diagnosis, and treatment approaches | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117952837 | ||||
| W4416362829 | Nephrology | 2025-01-01 | OpenAlex | 10.1007/978-3-032-12399-2_6 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4416362829 | |||
| W7115978551 | Network-Agnostic Computational Approaches for Modelling and Validating Evolving Complex Systems | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7115978551 | ||||
| W4410874813 | Neurophysiological and Neuroanatomical Background of Spasticity: Surgical Implication for Dorsal Rhizotomy in Cerebral Palsy | 2025-01-01 | OpenAlex | 10.1007/978-3-031-86441-4_3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410874813 | |||
| W7118005039 | Neuroprotection: Quest for the Holy Grail | 2025-01-01 | OpenAlex | 10.1007/978-981-95-4419-6_17 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7118005039 | |||
| W4416152631 | New Insights in Septic Encephalopathy | 2025-01-01 | OpenAlex | 10.1007/978-3-032-01024-7_5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416152631 | |||
| W4408508226 | New insights into atherosclerotic cardiovascular disease through the lens of metabolism: expanding our approach | 2025-01-01 | OpenAlex | 10.1097/cp9.0000000000000112 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408508226 | |||
| W4409181312 | Nonresolving Pneumonia: A Curious Case | 2025-01-01 | OpenAlex | 10.22259/2639-362x.0801001 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409181312 | |||
| W4413424457 | Novel Immune Modulatory Agents in the Treatment of Non-small Cell Lung Cancer | 2025-01-01 | OpenAlex | 10.1007/978-3-031-97242-3_8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413424457 | |||
| W4414693968 | Nucleoid-associated Proteins Shape the Regulation of Virulence Factors and Defense Elements in Vibrio cholerae | 2025-01-01 | OpenAlex | 10.7302/25791 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414693968 | |||
| W4416310371 | Nursing Management | 2025-01-01 | OpenAlex | 10.18231/978-93-48565-32-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416310371 | |||
| W4410825675 | Off-Label Use of Bispectral Index to Grade Conditions Other Than Depth of Anesthesia | 2025-01-01 | OpenAlex | 10.1007/978-3-031-88260-9_8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410825675 | |||
| W4408150473 | One Health: A Collaborative Approach in Bridging Human, Animal, and Environmental Health | 2025-01-01 | OpenAlex | 10.4103/amhs.amhs_295_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408150473 | |||
| W7114946748 | Optimising the Customer Experience in Healthcare SaaS Support: Balancing Service Quality and Security | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7114946748 | ||||
| W4412633375 | Overview of Military Operations in Response to Domestic Emergencies, Global Pandemics, and Civil-Military Relations | 2025-01-01 | OpenAlex | 10.1007/978-3-031-86741-5_1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412633375 | |||
| W4406354715 | Oxidation of A-Hydroxy Acids by D-2-Hydroxyglutarate Dehydrogenase Enzymes | 2025-01-01 | OpenAlex | 10.2139/ssrn.5078069 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406354715 | |||
| W4406704815 | P0211 Characterization of drug-specific CD4+ T cells in patients with inflammatory bowel diseases | 2025-01-01 | OpenAlex | 10.1093/ecco-jcc/jjae190.0385 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406704815 | |||
| W4406703389 | P0618 A Network Meta-analysis to Compare the Efficacy of Advanced Treatments for Biological-Experienced Patients with Ulcerative Colitis | 2025-01-01 | OpenAlex | 10.1093/ecco-jcc/jjae190.0792 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406703389 | |||
| W4406699886 | P0919 Correlation between trough levels of risankizumab and clinical and biological remission in patients with moderate to severe Crohn’s disease: a retrospective multicenter study (RISE-CD) | 2025-01-01 | OpenAlex | 10.1093/ecco-jcc/jjae190.1093 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406699886 | |||
| W4406700140 | P1022 ChatGPT in the management of Inflammatory Bowel Disease, a future or a present reality? | 2025-01-01 | OpenAlex | 10.1093/ecco-jcc/jjae190.1196 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406700140 | |||
| W4414651538 | PARP Inhibitors-Associated Adverse Effects Across Multiple Organ Systems: A Review of Case Reports from 2022 to 2025 | 2025-01-01 | OpenAlex | 10.70251/hyjr2348.35407422 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414651538 | |||
| W7133337907 | Patient-facing artificial intelligence for diabetes self-management in the large language model era: an integrative review | 2025-01-01 | OpenAlex | 10.17605/osf.io/prf53 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133337907 | |||
| W4415631890 | Peptides in the clinic today: The leading families and their applications | 2025-01-01 | OpenAlex | 10.1016/bs.mie.2025.09.012 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415631890 | |||
| W4411085814 | Persistent Spread of Carbapenemase-Producing Klebsiella Pneumoniae in Acute Care Hospitals in 36 European Countries: Results from the Survey of Carbapenem- and/or Colistin-Resistant Enterobacterales (CCRE Survey), 2019 | 2025-01-01 | OpenAlex | 10.2139/ssrn.5275521 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411085814 | |||
| W7155387120 | Pharmacologic Management of Chronic Obstructive Pulmonary Disease: A review of the literature | 2025-01-01 | OpenAlex | 10.18103/mra.v14i1.7424 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155387120 | |||
| W4411148208 | Pharmacological Maintenance Therapies After Allogeneic Hematopoietic Cell Transplantation | 2025-01-01 | OpenAlex | 10.1007/978-3-031-84988-6_11 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411148208 | |||
| W4414025553 | Pharmacological Management of Acute Agitation and Violent Behavior in Psychiatric Settings | 2025-01-01 | OpenAlex | 10.4306/jknpa.2025.64.3.109 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414025553 | |||
| W4414548903 | Pharmacotherapies in Prevention of Myocardial Oxidative Stress Mediated by Anthracyclines, Taxanes, and Alkylating Agents | 2025-01-01 | OpenAlex | 10.1007/978-3-031-97517-2_6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414548903 | |||
| W4411177287 | Photoactivated Radiochemistry for the Construction of 18F- and 11C-Labeled Compounds | 2025-01-01 | OpenAlex | 10.1007/978-3-031-84632-8_13 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411177287 | |||
| W4411923958 | Photon-Counting CT in Emergency Radiology | 2025-01-01 | OpenAlex | 10.1007/978-3-031-85078-3_6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411923958 | |||
| W7131363281 | Pioneering Approaches to Transform Women’s Health: Experiences from Human Immunodeficiency Virus Research in Southern Africa | 2025-01-01 | OpenAlex | 10.4103/abmj.abmj_29_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131363281 | |||
| W4408471201 | Place of New Generation Sulfonylurea: Gliclazide in the Evolving Landscape of Type 2 Diabetes Management | 2025-01-01 | OpenAlex | 10.54457/dr.202501003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408471201 | |||
| W7108069335 | Polymyxin B Revisited: Structural Insights, Clinical Resurgence, and Emerging Strategies Against Multidrug-Resistant GramNegative Infections. | 2025-01-01 | OpenAlex | 10.5281/zenodo.17766962 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7108069335; https://openalex.org/W7107967283 | |||
| W4414128254 | Precision therapeutics for Alzheimer’s disease | 2025-01-01 | OpenAlex | 10.1016/bs.pbr.2025.08.011 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414128254 | |||
| W4413776550 | Predicting Parkinson’s Disease with Explainability: A Hybrid Deep Learning Approach Utilizing Voice Dataset | 2025-01-01 | OpenAlex | 10.1007/978-3-031-94950-0_10 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413776550 | |||
| W7107947094 | Preeclampsia: Advances in Prediction, Prevention, and Management of a Critical Maternal–Fetal Disorder | 2025-01-01 | OpenAlex | 10.5281/zenodo.17748833 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7107947094; https://openalex.org/W7108070598 | |||
| W4411300266 | Preventing Surgical Site Infections, Skin Microbiome Dysbiosis – The Fourth Dimension of Surgical Site Infection Epidemiological Quad | 2025-01-01 | OpenAlex | 10.4103/ijcs.ijcs_12_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411300266 | |||
| W7111350230 | Production and characterization of endogenous receptor ligands for gene delivery | 2025-01-01 | OpenAlex | 10.3929/ethz-c-000789217 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7111350230 | |||
| W4413475436 | Proportionate Sedation in Pediatric Palliative Care | 2025-01-01 | OpenAlex | 10.1007/978-3-031-68468-5_40 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413475436 | |||
| W4409530560 | Pros and Cons of Nanomedicine While Targeting Inflammatory Diseases | 2025-01-01 | OpenAlex | 10.1007/978-981-96-2112-5_18 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409530560 | |||
| W4410326139 | Radiation Synovectomy: An Enticing Treatment Option for Inflammatory Joint Pain | 2025-01-01 | OpenAlex | 10.1155/prm/8887391 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410326139 | |||
| W4410972028 | Radiotherapeutics in prostate cancer therapy | 2025-01-01 | OpenAlex | 10.1016/b978-0-443-23585-6.00012-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410972028 | |||
| W7117988374 | Reality of Regulatory Failure and the Limit of Regulatory Reform | 2025-01-01 | OpenAlex | 10.1007/978-3-032-10713-8_6 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7117988374 | |||
| W7171711549 | Recent Trends in Biomedical and Applied Biological Sciences | 2025-01-01 | OpenAlex | 10.5281/zenodo.21673714 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171711549 | |||
| W7115935623 | Reckoning with AI agents | 2025-01-01 | OpenAlex | 10.5287/ora-ppgrbwpva | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7115935623 | |||
| W4407121857 | Redefining Perioperative Care: The Pivotal Role of Anesthesiologists in Enhanced Recovery After Surgery (ERAS) Protocols | 2025-01-01 | OpenAlex | 10.51542/ijscia.v6i1.16 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407121857 | |||
| W4411620424 | Reinforcement Learning in Dynamic Environments: Challenges and Future Directions | 2025-01-01 | OpenAlex | 10.63282/3050-9262.ijaidsml-v6i1p102 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411620424; https://openalex.org/W4411577658 | |||
| W4412814860 | Research Progress on Traditional Uses, Chemical Composition, Pharmacological Actions, and Clinical Applications of Ginseng-Containing Sijunzi Decoction | 2025-01-01 | OpenAlex | 10.1142/s0192415x25500636 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412814860 | |||
| W4414510742 | Resistant Hypertension: Emerging Therapies And Future Directions | 2025-01-01 | OpenAlex | 10.64149/j.carcinog.24.6s.346-351 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414510742 | |||
| W4414108043 | Responsible RAG Systems in Practice: Lessons from Commercial and Pharma Use Case | 2025-01-01 | OpenAlex | 10.2139/ssrn.5467706 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414108043 | |||
| W4413242577 | Retinal Venous Occlusions | 2025-01-01 | OpenAlex | 10.1007/978-3-031-29358-0_26-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413242577; https://openalex.org/W7214667853 | |||
| W4407251538 | Revisiting the Role of miRNAs in Neuropathology | 2025-01-01 | OpenAlex | 10.4103/neurol-india.neurol-india-d-24-00920 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407251538 | |||
| W7118835957 | Revisiting the role of iron in ferroptosis | 2025-01-01 | OpenAlex | 10.70401/fos.2025.0009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118835957 | |||
| W4416508247 | Rewriting the script of health and disease: The evolving era of molecular medicine and precision medicine | 2025-01-01 | OpenAlex | 10.4103/ijpmmm.ijpmmm_1_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416508247 | |||
| W7103889777 | Robotics and AI in Telepharmacy: A Critical Review of Their Role in Revolutionizing Pharmaceutical Care | 2025-01-01 | OpenAlex | 10.5281/zenodo.17511640 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7103889777 | |||
| W7223144344 | Rog Pratirodhak Shamta ki Ayurvedic Sankalpana | 2025-01-01 | OpenAlex | 10.5281/zenodo.23527946 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223144344 | |||
| W7130543730 | SECOND AND SUBSEQUENT-LINE SYSTEMIC THERAPY FOR METASTATIC COLORECTAL CANCER | 2025-01-01 | OpenAlex | 10.5336/978-625-395-770-4_p105 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130543730 | |||
| W4415736012 | Scalable Hybrid Memory System for Long-Term Conversational Assistants in Healthcare | 2025-01-01 | OpenAlex | 10.1007/978-3-032-05925-3_1 | Full text | Excluded | F5: Public publisher and author/repository routes did not provide full methods. The root agent also checked the publisher with the existing Tohoku University browser entitlement; only a subscription preview was available. LLM status, clinical-main focus and/or cross-case retention remain unresolved, rather than inferred absent from the abstract. | https://openalex.org/W4415736012 | https://link.springer.com/chapter/10.1007/978-3-032-05925-3_1 | Bibliographic information and available abstract/preview only; no full methods read. | |
| W4416705758 | Secure web based chat platform with advanced network security | 2025-01-01 | OpenAlex | 10.1063/5.0309354 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416705758 | |||
| W4416912180 | Sedated behind bars: the inappropriate use of psychiatric medications in Italy’s incarcerated populations | 2025-01-01 | OpenAlex | 10.15406/jpcpy.2025.16.00833 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416912180 | |||
| W4413475447 | Sedation in the Pediatric Intensive Care Unit: Current Practice in Europe | 2025-01-01 | OpenAlex | 10.1007/978-3-031-68468-5_18 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413475447 | |||
| W4413248662 | Self-Evolving LLM Ecosystems for Precision Medicine | 2025-01-01 | OpenAlex | 10.17762/ijisae.v13i1s.7793 | Full text | Excluded | F3: The implemented TreatmentAgent is a Random Forest retrained on increasing data subsets. The purported LLM-agent feedback is explicitly a rule-based simulator; §VII identifies an actual LLM multi-agent system as future work. | https://openalex.org/W4413248662 | https://ijisae.org/index.php/IJISAE/article/view/7793 | ||
| W4412190916 | Semiconducting polymer nanoparticles for combinational cancer immunotherapy | 2025-01-01 | OpenAlex | 10.32657/10356/200340 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412190916 | |||
| W4408098381 | Senotherapeutics: Milestones, innovations, and future prospects | 2025-01-01 | OpenAlex | 10.1016/bs.apha.2025.01.021 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408098381 | |||
| W4415532763 | Side effects of antihypertensive agents: Calcium channel blockers, loop diuretics, alpha-2 agonists, beta-blockers, and vasodilators | 2025-01-01 | OpenAlex | 10.1016/bs.seda.2025.09.001 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415532763 | |||
| W4415358445 | Simulation of Human Decision-Making in High-Stakes Crisis Scenarios | 2025-01-01 | OpenAlex | 10.2139/ssrn.5524081 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4415358445 | |||
| W7203613446 | Sirolimus in contemporary medicine: from immunosuppression to precision therapeutics – part 1 | 2025-01-01 | OpenAlex | 10.5114/pcard.2025.163965 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203613446 | |||
| W4417150757 | Spinal Cervical Meningiomas: An Integrative Review of Molecular Pathogenesis, Evolving Surgical Procedures, and Pathway to Personalized Management | 2025-01-01 | OpenAlex | 10.52533/johs.2025.51104 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417150757 | |||
| W4408132647 | Spleen Infarction in Plasmodium Infection | 2025-01-01 | OpenAlex | 10.37184/lnjpc.2707-3521.7.48 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408132647 | |||
| W4407020607 | Sports nutrition: boosting performance with functional foods | 2025-01-01 | OpenAlex | 10.1016/b978-0-443-28862-3.00008-x | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4407020607 | |||
| W4416202668 | Strategies for hyperkalemia management in dialysis patients: A systematic review | 2025-01-01 | OpenAlex | 10.1515/med-2025-1301 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416202668 | |||
| W7106698763 | Structural and Magnetic Properties of Biocompatible Iron Oxide Nanoparticles for Medical Applications | 2025-01-01 | OpenAlex | 10.34734/fzj-2025-03970 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7106698763 | |||
| W7133333758 | Structure-exploiting uncertainty quantification and control : Bayesian inference and Itô SDE methods from MRI segmentation to autonomous sensing | 2025-01-01 | OpenAlex | 10.18154/rwth-2026-00164 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133333758 | |||
| W4412363281 | Surface modification of polyetheretherketone for boosted osseointegration: A review. | 2025-01-01 | OpenAlex | 10.12336/bmt.24.00052 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412363281 | |||
| W4414527816 | Surgical Management for Transitional Cell Carcinoma of the Upper Tract | 2025-01-01 | OpenAlex | 10.1007/978-3-031-97599-8_19 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414527816 | |||
| W4415652785 | Sustainability in Dental Education | 2025-01-01 | OpenAlex | 10.1007/978-981-97-0275-6_33-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415652785 | |||
| W7126642970 | T cell evolution in the blood and organs during acute graft-versus-host disease | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126642970 | ||||
| W4412645413 | Tailored Tissue Plasminogen Factor Injection via Subdural Catheter for Subacute Subdural Hematoma in an Elderly Patient: A Case Report and Literature Review | 2025-01-01 | OpenAlex | 10.13004/kjnt.2025.21.e25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412645413 | |||
| W7117453040 | The AI-Enhanced Intelligent Business Diagnostics for Predictive Assessment of Organizational Resilience in Digital Transformation | 2025-01-01 | OpenAlex | 10.32983/2222-4459-2025-10-560-569 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7117453040 | |||
| W7133197319 | The Avant-Garde and the Administrator | 2025-01-01 | OpenAlex | 10.14321/jstudradi.19.2.0033 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7133197319 | |||
| W7106244358 | The Difficulties of Philosophical Advice | 2025-01-01 | OpenAlex | 10.1007/978-3-031-97293-5_10 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7106244358 | |||
| W7110539710 | The Digital Environment of the University: Issues in the Development of Teachers’ Digital Competencies | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7110539710 | ||||
| W7162753329 | The Evolving Role of Sodium-Glucose Linked Transporter-2 (SGLT2) Inhibitors in Heart Failure Management: A Paradigm Shift | 2025-01-01 | OpenAlex | 10.59462/3071-2335.3.1.105 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162753329; https://openalex.org/W7124733884 | |||
| W7128115553 | The Forced Sterilization of Quechua-Speaking Women in Peru: The Role of Epistemic injustice in The Perpetration of Genocide | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128115553 | ||||
| W4411204129 | The Impact of Artificial Intelligence Innovations on Diverse Careers and Industries | 2025-01-01 | OpenAlex | 10.2139/ssrn.5215902 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4411204129 | |||
| W4406735397 | The Infection—Inflammation Challenges to Skin and Wound Care | 2025-01-01 | OpenAlex | 10.1097/asw.0000000000000266 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406735397 | |||
| W7107993207 | The Nurse’s Role in Communication with the Conscious Critically Ill Patient in the Emergency Department: Scoping Review Protocol | 2025-01-01 | OpenAlex | 10.17605/osf.io/d3gku | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7107993207 | |||
| W4414171077 | The Origin and Practice of Public Health | 2025-01-01 | OpenAlex | 10.1007/978-981-96-6650-8_2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414171077 | |||
| W4413006904 | The Patient Leader | 2025-01-01 | OpenAlex | 10.1007/978-3-031-51650-4_17-1 | Full text | Excluded | F1: This conceptual encyclopedia entry concerns human patient leadership, rather than a built/evaluated LLM system. | https://openalex.org/W4413006904 | https://link.springer.com/rwe/10.1007/978-3-031-51650-4_17-1 | publisher abstract only | |
| W7104671626 | The Role and Dynamics of Working Alliance as a Change Factor in a Digital Personality Intervention | 2025-01-01 | OpenAlex | 10.17605/osf.io/uzewv | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7104671626 | |||
| W4406124968 | The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancer | 2025-01-01 | OpenAlex | 10.1177/17588359241308784 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406124968 | |||
| W7133457441 | The physician as a moral and social agent: reflections and contradictions of their normative identity and contemporary medical practice | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7133457441 | ||||
| W7163513341 | The scope of antivascular endothelial growth factor injections: Past achievements, present challenges, and future directions | 2025-01-01 | OpenAlex | 10.4103/odjo.odjo_6_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163513341 | |||
| W4412840684 | Therapeutic potential of pharmacoepigenetics in cholangiocarcinoma | 2025-01-01 | OpenAlex | 10.1016/b978-0-443-18722-3.00037-2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412840684 | |||
| W4414676053 | Thermotropic liquid crystals for precision drug delivery and diagnostics: Molecular design, characterization, and clinical translation | 2025-01-01 | OpenAlex | 10.7324/japs.2025.255035 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414676053 | |||
| W4407816273 | Total synthetic studies on potent compounds as anti-prostate cancer agents | 2025-01-01 | OpenAlex | 10.1016/b978-0-443-21842-2.00012-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407816273 | |||
| W4408999273 | Trends in prescribing dipeptidyl peptidase-IV-based therapy for type 2 diabetes mellitus and determining factors associated with its utilization | 2025-01-01 | OpenAlex | 10.4103/mgmj.mgmj_74_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408999273 | |||
| W4410706192 | Tropane Alkaloids: Biosimilar and Biopharmaceutics | 2025-01-01 | OpenAlex | 10.1007/978-981-96-5805-3_8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410706192 | |||
| W7106294281 | Trustworthy and Ethical AI for Intrusion Detection in Healthcare IoT (IoMT) Systems: An Agentic Decision Loop Framework | 2025-01-01 | OpenAlex | 10.6084/m9.figshare.30686600 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7106294281 | |||
| W7126675610 | U.S. Rural-Urban Breast Cancer Screening Inequities: Leveraging Contextual Heterogeneity to Identify Solutions | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126675610 | ||||
| W4411207312 | Unified Data Quality Frameworks for Real-Time ML Pipelines: Bridging DataOps, MLOps, and Streaming Architectures | 2025-01-01 | OpenAlex | 10.2139/ssrn.5216257 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4411207312 | |||
| W4407201109 | Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present, and Future of Antibody-Drug Conjugate Development in Advanced Urothelial Carcinoma | 2025-01-01 | OpenAlex | 10.1200/edbk-25-471924 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407201109 | |||
| W4416300826 | Use of intravenous lipid emulsions in drug-induced toxicities: a 2025 narrative review | 2025-01-01 | OpenAlex | 10.1186/s13613-025-01601-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416300826 | |||
| W4409567626 | Vaping: The emerging epidemic and its psychiatric implications in India | 2025-01-01 | OpenAlex | 10.4103/ipj.ipj_465_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409567626 | |||
| W7118010167 | Vernal KeratoConjunctivitis VKC and Atopic KeratoConjunctivitis AKC | 2025-01-01 | OpenAlex | 10.1007/978-3-031-65422-0_29 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7118010167 | |||
| W7137959530 | What a Difference a Couple Hundred Million Years Can Make | 2025-01-01 | OpenAlex | 10.5406/19398298.138.4.07 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7137959530 | |||
| W4408915722 | What’s new in critical illness and injury science? Keeping up with Moore’s law – Are we ready for the intensive care units of tomorrow? | 2025-01-01 | OpenAlex | 10.4103/ijciis.ijciis_27_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408915722 | |||
| W4413308161 | Where Do We Stand in Motion Sickness and a Holistic Approach to Motion Sickness: Etiology, Diagnosis, and Treatment | 2025-01-01 | OpenAlex | 10.24179/kbbbbc.2025-109668 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413308161 | |||
| W7108080932 | Working alliance, mental health, and future thinking in volunteering | 2025-01-01 | OpenAlex | 10.17605/osf.io/7mnjv | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108080932 | |||
| W4406315880 | Xanthene-based NIR organic phototheranostics agents: design strategies and biomedical applications | 2025-01-01 | OpenAlex | 10.1039/d4tb02480j | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4406315880 | |||
| W7167746698 | [Anxiolytics and mood stabilizers in modern psychopharmacological practice with an emphasis to specific patient populations]. | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167746698 | ||||
| W7112975613 | Αντιθρομβωτική αγωγή στις ενδαγγειακές επεμβάσεις επαναιμάτωσης στην Περιφερική Αρτηριακή Νόσο (ΠΑΝ) | 2025-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7112975613 | ||||
| W7162317117 | นกวทยาศาสตรการกฬากบพลวตสงคมสงวยไทย: บทบาท ความทาทาย และขอเสนอเชงระบบ | 2025-01-01 | OpenAlex | 10.58837/chula.jssh.26.2.2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162317117 | |||
| W4408593539 | “I’d go on a hike with my kids… that would make me feel so happy.” Recognising what people with haemophilia B identify as meaningful when considering personal goals and the potential for gene therapy | 2025-01-01 | OpenAlex | 10.2478/jhp-2025-0001 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408593539 | |||
| W4406296478 | Advancing treatments for transthyretin amyloid cardiomyopathy: Innovations in RNA silencing, gene editing, TTR stabilization, and degradation | 2025-01-02 | OpenAlex | 10.33963/v.phj.104054 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406296478 | |||
| W4405986360 | Evolving Strategies for Respiratory Syncytial Virus (RSV): A Review Article of Preventive Agents and Vaccines for RSV | 2025-01-02 | OpenAlex | 10.1177/10600280241302085 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4405986360 | |||
| W4407981217 | Unveiling patienthood in psychiatric care: an ethnographic study in Nigeria | 2025-01-02 | OpenAlex | 10.1080/13648470.2025.2453366 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407981217 | |||
| W4406062881 | Lessons from COVID-19 in Taiwan's long-term care facilities: A narrative review | 2025-01-04 | OpenAlex | 10.1016/j.jfma.2024.12.033 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406062881 | |||
| W4406062797 | Modern insights of nanotheranostics in the glioblastoma: An updated review | 2025-01-04 | OpenAlex | 10.1016/j.bbadis.2024.167653 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406062797 | |||
| W4406077943 | PCSK9 V474I germline variant drives breast cancer metastasis | 2025-01-04 | OpenAlex | 10.1093/lifemeta/loae041 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406077943 | |||
| W4406075572 | A Day in the Life of an MSL Powered by AI: Combining AI Technologies to Transform Training | 2025-01-05 | OpenAlex | 10.70792/jngr5.0.v1i2.70 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406075572 | |||
| W7220539347 | Advancements in Drug Delivery Systems: A Comprehensive Review | 2025-01-05 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220539347 | ||||
| W4406080863 | Paroxysmal sympathetic hyperactivity: A common consequence of traumatic brain injury | 2025-01-05 | OpenAlex | 10.1016/j.autneu.2024.103238 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406080863 | |||
| W4406069941 | Penicillamine-induced decomposition of copper sulfide nanocrystals after microbial infection treatment | 2025-01-05 | OpenAlex | 10.1016/j.cej.2024.159195 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406069941 | |||
| W4406083094 | Editorial: The application of bioactive materials in bone repair | 2025-01-06 | OpenAlex | 10.3389/fbioe.2024.1539142 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406083094 | |||
| W4406094333 | Global forces and local impacts: megatrends in regional development | 2025-01-06 | OpenAlex | 10.1093/cjres/rsae047 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406094333 | |||
| W4406082914 | Synergistic integration of remote sensing and soil metagenomics data: advancing precision agriculture through interdisciplinary approaches | 2025-01-06 | OpenAlex | 10.3389/fsufs.2024.1499973 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406082914 | |||
| W4406119785 | A Comprehensive Literature Review of Effect of Mineralocorticoid Receptor Blockers on Chronic Kidney Disease | 2025-01-07 | OpenAlex | 10.70070/xfwn1344 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406119785 | |||
| W4406129006 | Grand challenge in biosafety and biosecurity | 2025-01-07 | OpenAlex | 10.3389/fbioe.2024.1538723 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406129006 | |||
| W4406146744 | Immunotherapy in Ophthalmic Oncology: Current Trends and Future Directions | 2025-01-07 | OpenAlex | 10.3390/jcto3010001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406146744 | |||
| W4406123507 | Post-stroke lives in Dutch nursing homes | 2025-01-07 | OpenAlex | 10.5463/thesis.545 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406123507 | |||
| W4406188251 | Altered kidney function in fatty liver disease: confronting the “MAFLD-renal syndrome” | 2025-01-08 | OpenAlex | 10.3389/fcdhc.2024.1539117 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406188251 | |||
| W4406183349 | Folliculocentric Atrophic Papules in a 12‐Year‐Old Boy | 2025-01-08 | OpenAlex | 10.1111/pde.15795 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406183349 | |||
| W4406188259 | Healthy gut microbiomes are host-controllable microbiomes | 2025-01-08 | OpenAlex | 10.3389/fmicb.2024.1497083 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406188259 | |||
| W4406221957 | Benzimidazole Derivatives in Breast Cancer: Target-Specific Therapeutic Breakthroughs | 2025-01-09 | OpenAlex | 10.2174/0115680266336395241115092048 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406221957 | |||
| W4406219691 | Comparative study of management strategies for immune checkpoint inhibitor‐induced inflammatory arthritis: rheumatologists versus oncologists | 2025-01-09 | OpenAlex | 10.1111/imj.16629 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406219691 | |||
| W4406230668 | Immunological pathogenesis and treatment progress of adenovirus pneumonia in children | 2025-01-09 | OpenAlex | 10.1186/s13052-024-01836-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406230668 | |||
| W4406199551 | Kidney Disease and Hematopoietic Stem Cell Transplantation | 2025-01-09 | OpenAlex | 10.34067/kid.0000000692 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406199551 | |||
| W4406207352 | Multiple actinic keratoses treated with oral capecitabine | 2025-01-09 | OpenAlex | 10.1093/ced/llaf017 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406207352 | |||
| W4406398641 | Automation and orchestration in hybrid clouds | 2025-01-10 | OpenAlex | 10.70593/978-81-984306-5-6_9 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4406398641 | |||
| W4406402713 | Introduction to hybrid cloud paradigms: Bridging public and private clouds | 2025-01-10 | OpenAlex | 10.70593/978-81-984306-5-6_1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4406402713 | |||
| W4406249372 | Treatment of metastatic urothelial carcinoma in the United Kingdom, France, Germany, Italy, and Spain | 2025-01-10 | OpenAlex | 10.1080/14796694.2024.2445498 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406249372 | |||
| W4406287294 | Editorial: Molecular MRD testing in patients with acute myeloid leukemia | 2025-01-11 | OpenAlex | 10.1038/s41409-024-02493-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406287294 | |||
| W4406292220 | Current Strategies and Future Dimensions in the Development of KRAS Inhibitors for Targeted Anticancer Therapy | 2025-01-12 | OpenAlex | 10.1002/ddr.70042 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406292220 | |||
| W4406116350 | [Annual therapeutic advances in advanced non-small cell lung cancer in 2024]. | 2025-01-12 | OpenAlex | 10.3760/cma.j.cn112147-20241103-00655 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406116350 | |||
| W4406116271 | [Clinical update in critical care of pulmonary medicine 2024]. | 2025-01-12 | OpenAlex | 10.3760/cma.j.cn112147-20241010-00590 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406116271 | |||
| W4406332302 | Nuclear Medicine and Molecular Imaging in Urothelial Cancer: Current Status and Future Directions | 2025-01-13 | OpenAlex | 10.3390/cancers17020232 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406332302 | |||
| W4406337627 | The wonders of anticoagulation | 2025-01-13 | OpenAlex | 10.3389/fcvm.2024.1517109 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406337627 | |||
| W4406405725 | Treatment consensus for locally advanced cervical cancer | 2025-01-13 | OpenAlex | 10.36922/arnm.4032 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406405725 | |||
| W4406364203 | Beyond nutrition: The emerging therapeutic potential landscape of breast milk-derived extracellular vesicles | 2025-01-14 | OpenAlex | 10.1016/j.nutres.2025.01.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406364203 | |||
| W4406387486 | Evolution of leadership roles in international nursing | 2025-01-14 | OpenAlex | 10.1097/nmg.0000000000000222 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406387486 | |||
| W4406379776 | Highly pathogenic bovine viral diarrhea virus BJ-11 unveils genetic evolution related to virulence in calves | 2025-01-14 | OpenAlex | 10.3389/fmicb.2024.1540358 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4406379776 | |||
| W4406363977 | Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic | 2025-01-14 | OpenAlex | 10.1097/hep.0000000000001227 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406363977 | |||
| W4406379831 | The evolving therapeutic landscape in atopic dermatitis | 2025-01-14 | OpenAlex | 10.37349/eaa.2025.100966 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406379831 | |||
| W4406387434 | Unlocking organizational excellence | 2025-01-14 | OpenAlex | 10.1097/nmg.0000000000000223 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406387434 | |||
| W4406399624 | Advancements in Cancer Therapeutics: Emerging Agents and Combination Strategies in Drug Discovery | 2025-01-15 | OpenAlex | 10.2174/012212697x361870250113043318 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406399624 | |||
| W4406409261 | Endodontics at the Bio-Futuristic Frontier: Integrating High-Resolution Imaging, Regenerative Therapies, and Nanotechnology for Next-Generation Care | 2025-01-15 | OpenAlex | 10.20944/preprints202501.1077.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406409261 | |||
| W4406480282 | Military influences on the evolution of clinical trials throughout history | 2025-01-15 | OpenAlex | 10.1177/17407745241309054 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406480282 | |||
| W4406388105 | Recurrent HCC after liver transplantation: Small steps, while awaiting a breakthrough | 2025-01-15 | OpenAlex | 10.1097/lvt.0000000000000571 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406388105 | |||
| W4410627614 | The Ethical Choice | 2025-01-15 | OpenAlex | 10.7591/cornell/9781501779633.003.0005 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4410627614 | |||
| W4406419353 | The Landmark Series: The Future of Pancreatic Cancer Clinical Trials | 2025-01-15 | OpenAlex | 10.1245/s10434-024-16840-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406419353 | |||
| W4406467760 | Antithrombotic use in retinal artery occlusion: A narrative review | 2025-01-16 | OpenAlex | 10.1002/kjm2.12938 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406467760 | |||
| W4406479142 | Endodontic management of a multi-rooted tooth as a foundation dentist | 2025-01-16 | OpenAlex | 10.5348/100048z07am2025cr | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406479142 | |||
| W4406520113 | On the formation and stability mechanisms of diverse lipid-based nanostructures for drug delivery | 2025-01-17 | OpenAlex | 10.1016/j.cis.2025.103402 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406520113 | |||
| W4406502162 | Pinnipeds (Seals and Sea Lions) | 2025-01-17 | OpenAlex | 10.1002/9781119539278.ch40 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4406502162 | |||
| W4412048536 | A Review on Febuxostat as Uric Acid Lowering Agent | 2025-01-18 | OpenAlex | 10.30904/j.ajmps.2025.4761 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4412048536 | |||
| W4406587382 | Digital and Social Determinants of Consumer Decision Making in OTC Pharmaceuticals | 2025-01-18 | OpenAlex | 10.59075/7rfg0c24 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4406587382 | |||
| W4406557108 | Intra-articular injections for the management of knee osteoarthritis | 2025-01-18 | OpenAlex | 10.1016/j.mporth.2024.12.001 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406557108 | |||
| W4406551549 | Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges | 2025-01-18 | OpenAlex | 10.1186/s12943-024-02214-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406551549 | |||
| W4406559811 | Review on application of silk fibroin hydrogels in the management of wound healing | 2025-01-18 | OpenAlex | 10.1016/j.ijbiomac.2025.140082 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406559811 | |||
| W4406627975 | General Anesthesia in Cardiac Surgery: A Narrative Review for Evolving Techniques and Patient-Centered Best Practices | 2025-01-19 | OpenAlex | 10.20428/yjms.v19i2.2696 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406627975 | |||
| W4406615068 | Anticoagulation Management During ECMO: Narrative Review | 2025-01-20 | OpenAlex | 10.1016/j.jhlto.2025.100216 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406615068 | |||
| W4406616254 | Genomic detection of Panton-Valentine Leucocidins encoding genes, virulence factors and distribution of antiseptic resistance determinants among Methicillin-resistant S. aureus isolates from patients attending regional referral hospitals in Tanzania | 2025-01-20 | OpenAlex | 10.1186/s12920-025-02085-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406616254 | |||
| W4406678415 | Brucellosis, the Forgotten Endemic: A Clinical Case Report | 2025-01-21 | OpenAlex | 10.7759/cureus.77761 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406678415 | |||
| W4406682093 | Editorial: Biodegradable polymers for biomedical applications - volume III | 2025-01-21 | OpenAlex | 10.3389/fmats.2025.1551590 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406682093 | |||
| W4406689876 | SOHO State of the Art Updates and Next Questions: Combination Therapy in Chronic Myeloid Leukemia in Chronic Phase | 2025-01-21 | OpenAlex | 10.1016/j.clml.2025.01.004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406689876 | |||
| W4406710466 | Challenges and solutions in soft tissue grafting for receding gums | 2025-01-22 | OpenAlex | 10.18203/2394-6040.ijcmph20250040 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406710466 | |||
| W4406705925 | Diagnostic Accuracy of Breath Tests to Detect Pulmonary Tuberculosis: A Systematic Review | 2025-01-22 | OpenAlex | 10.1007/s00408-024-00779-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406705925 | |||
| W4406711298 | Evolving Immunotherapy Strategies in Gastrointestinal Neuroendocrine Neoplasms | 2025-01-22 | OpenAlex | 10.1007/s11864-024-01283-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406711298 | |||
| W4406722981 | Niosomal Encapsulation of Anti-cancer Peptides: A Revolutionary Strategy in Cancer Therapy | 2025-01-22 | OpenAlex | 10.2174/0113892010344931241220042746 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406722981 | |||
| W4406704291 | Recent Advancements in Strategies for Delivery of Neuro-Nutraceuticals to the Brain | 2025-01-22 | OpenAlex | 10.1201/9781003570585-13 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406704291 | |||
| W4406884244 | A Study on the Response of Concurrent Chemoradiation with Gemcitabine Versus Cisplatin in Patients with Locally Advanced Cervical Carcinoma | 2025-01-23 | OpenAlex | 10.62225/2583049x.2025.5.1.3678 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406884244 | |||
| W4406762397 | Consensus guidelines for the management of treatment-naïve chronic lymphocytic leukaemia in Singapore (2024) | 2025-01-23 | OpenAlex | 10.47102/annals-acadmedsg.2024174 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406762397 | |||
| W4406746144 | Learning from HIV and drug policy failures: reflections from clinical practice and research in Edinburgh | 2025-01-23 | OpenAlex | 10.1108/dhs-09-2024-0031 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406746144 | |||
| W4406741801 | Novel hemostatic gel and powder as rescue agents for arterial bleeding related to lumen-apposing metal stent placement | 2025-01-23 | OpenAlex | 10.1055/a-2512-4496 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406741801 | |||
| W4406753788 | Potential for application of direct thrombin inhibitors isolated from Euphorbia resinifera O.Berg latex in fibrin clot formation | 2025-01-23 | OpenAlex | 10.1016/j.jchromb.2025.124480 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406753788 | |||
| W4406713987 | Unlocking exosome therapeutics: The critical role of pharmacokinetics in clinical applications | 2025-01-23 | OpenAlex | 10.1016/j.tice.2025.102749 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406713987 | |||
| W4406786470 | An overview of uses and effectiveness of intracanal medicaments in endodontics | 2025-01-24 | OpenAlex | 10.18203/2394-6040.ijcmph20250064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406786470 | |||
| W4406826144 | Apoptosis in Cancer Biology and Therapy | 2025-01-24 | OpenAlex | 10.1146/annurev-pathmechdis-051222-115023 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406826144 | |||
| W4406741667 | Debate on first-line treatment strategies in advanced non-small cell lung cancer with EGFR mutation: An expert panel meeting by the Italian Association of Thoracic Oncology (AIOT) | 2025-01-24 | OpenAlex | 10.1016/j.lungcan.2025.108100 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406741667 | |||
| W4406808518 | Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations | 2025-01-24 | OpenAlex | 10.3389/frhem.2025.1548984 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406808518 | |||
| W4406989715 | Emerging and Re-Emerging Bacterial Infections: An Overview | 2025-01-24 | OpenAlex | 10.4314/sokjmls.v9i4.18 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406989715 | |||
| W4406805081 | Sodium-Glucose-Cotransporter-2 Inhibitor Therapy and Intermitted Fasting in Cardiorenal Syndrome: The Role of Glucose-Mediated Oxidative Stress | 2025-01-24 | OpenAlex | 10.3390/jcm14030746 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406805081 | |||
| W4406914804 | Reflections on Methods, Therapeutic Alliance, and Possibilities for Psychotherapy Integration in the RFP-C Cases of "Jack" and "Oliver" | 2025-01-26 | OpenAlex | 10.55818/pcsp.v21i1.2179 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406914804 | |||
| W4406850014 | Editorial: Nanomaterial and nanostructures for cancer and pathogenic infection diagnosis and therapy | 2025-01-27 | OpenAlex | 10.3389/fnano.2025.1552196 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406850014 | |||
| W4406875266 | Endocarditis Caused by Bartonella quintana: A Case Report | 2025-01-27 | OpenAlex | 10.7759/cureus.78055 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406875266 | |||
| W7133239105 | INTEGRATION OF BIOSIMILAR THERAPIES IN ONCOLOGY AND HEMATOLOGY: REGULATORY, CLINICAL, AND PRACTICAL PERSPECTIVES | 2025-01-27 | OpenAlex | 10.5281/zenodo.18837011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133239105 | |||
| W4406853362 | TH Open—Editor's Highlights of 2024 | 2025-01-27 | OpenAlex | 10.1055/a-2513-4445 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406853362 | |||
| W4406875231 | The Effectivity of 15% TCA Superficial Chemical Peeling to Treat Comedos and Papulo-Pustules Acne Vulgaris | 2025-01-27 | OpenAlex | 10.61440/jidt.2024.v2.23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406875231 | |||
| W4406914260 | Integrating Sentiment Analysis and Reinforcement Learning for Equitable Disaster Response: A Novel Approach | 2025-01-28 | OpenAlex | 10.3390/su17031072 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4406914260 | |||
| W4406896812 | Pillar[6]MaxQ and Sugammadex Enhance Recovery From Rocuronium- and Vecuronium-Mediated Neuromuscular Blockade With Similar Effects in Isoflurane-Anesthetized Rats | 2025-01-28 | OpenAlex | 10.1213/ane.0000000000007336 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406896812 | |||
| W4407240252 | Rectal cancer surgery: radiology roadmaps | 2025-01-28 | OpenAlex | 10.1093/bjs/znae270 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407240252 | |||
| W4406917465 | Understanding dynamics to Streamline Access: Systems Engineering and Agent-Based Probabilistic Modelling in Memory Assessment Services | 2025-01-28 | OpenAlex | 10.21203/rs.3.rs-5898259/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406917465 | |||
| W4406893695 | Xylazine: An Emerging Threat in Obstetrics | 2025-01-28 | OpenAlex | 10.1016/j.jogc.2025.102773 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406893695 | |||
| W4412962579 | Comprehensive Review of Diabetes Mellitus: Current Perspectives, Challenges, and Emerging Frontiers | 2025-01-29 | OpenAlex | 10.61096/ijrpp.v14.iss1.2025.67-76 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412962579 | |||
| W4406933783 | Optimizing Osimertinib for NSCLC: Targeting Resistance and Exploring Combination Therapeutics | 2025-01-29 | OpenAlex | 10.3390/cancers17030459 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406933783 | |||
| W4406960218 | P-1066. Quorum Sensing Coordinates Phage Defense Mechanisms in Pseudomonas aeruginosa | 2025-01-29 | OpenAlex | 10.1093/ofid/ofae631.1254 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406960218 | |||
| W4406940777 | P-1141. Antibiotic administration for Staphylococcus aureus infections in US children's hospitals, 2015-2023 | 2025-01-29 | OpenAlex | 10.1093/ofid/ofae631.1328 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4406940777 | |||
| W4406930089 | The Potential of Cyperus rotundus L. As a Natural Hair Removal Agent: A Review of Traditional and Modern Applications | 2025-01-29 | OpenAlex | 10.1002/der2.70020 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406930089; https://openalex.org/W4412675879 | |||
| W4406999926 | An update on newer antifungals | 2025-01-30 | OpenAlex | 10.1080/14787210.2025.2461566 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406999926 | |||
| W4407134844 | Civil Identity of the Population of the New Subjects of the Russian Federation: Problems, Politics, Technologies | 2025-01-30 | OpenAlex | 10.56654/ropi-2024-4(13)-130-147 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4407134844 | |||
| W4406972051 | Clinical application of biological agents in rheumatoid arthritis | 2025-01-30 | OpenAlex | 10.1016/j.trim.2025.102187 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4406972051 | |||
| W7158442320 | Comment l'approche santé planétaire influence-t-elle le rapport des patient•e•s à l'alimentation ? Exploration d'un dispositif de soin mis en place dans un centre de santé communautaire et planétaire | 2025-01-30 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7158442320 | ||||
| W4407154356 | Diseases of the Eye - Novel Investigations and Treatments | 2025-01-30 | OpenAlex | 10.5772/intechopen.1004495 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407154356 | |||
| W4406996600 | Evolving concepts in sepsis: we are making progress! | 2025-01-30 | OpenAlex | 10.3389/fsci.2025.1558161 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406996600 | |||
| W4406984555 | From Google Gemini to OpenAI Q* (Q-Star): A Survey on Reshaping the Generative Artificial Intelligence (AI) Research Landscape | 2025-01-30 | OpenAlex | 2312.10868 | 10.3390/technologies13020051 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406984555 | ||
| W4406979843 | Updates in chronic cholestatic liver diseases: Indian expert recommendations for diagnosing and managing complex cases | 2025-01-30 | OpenAlex | 10.18203/2320-6012.ijrms20250286 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4406979843 | |||
| W4408581964 | Agentic Retrieval-Augmented Generation: Advancing AI-Driven Information Retrieval and Processing | 2025-01-31 | OpenAlex | 10.14445/22312803/ijctt-v73i1p111 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4408581964 | |||
| W7130532827 | An Image-Based Facial Emotion Detection Chatbot | 2025-01-31 | OpenAlex | 10.64701/ijrc/345/8920 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7130532827 | |||
| W4408579743 | Efficacy, Safety, and Tolerance of Split Dose Oral Sulfate Solution Versus Split-Dose Polyethylene Glycol Versus Single Dose Polyethylene Glycol for Colonoscopy Preparation: A Prospective Randomized Study | 2025-01-31 | OpenAlex | 10.34172/mejdd.2025.403 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408579743 | |||
| W4407040799 | Epigenetic Therapy in Hormone Positive Breast Cancer: The Role of PIK3CA | 2025-01-31 | OpenAlex | 10.1007/s12609-024-00566-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407040799 | |||
| W4407342365 | MISUSE OF ARTIFICIAL INTELLIGENCE IN MEDICAL PRACTICE: A CASE REPORT | 2025-01-31 | OpenAlex | 10.21474/ijar01/20251 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4407342365 | |||
| W4407011960 | Pediatric AML: state of the Art and Future Directions | 2025-01-31 | OpenAlex | 10.1080/08880018.2025.2453861 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407011960 | |||
| W4407012007 | Pediatric Intestinal Pseudo-Obstruction: A Review | 2025-01-31 | OpenAlex | 10.1542/pir.2024-006523 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407012007 | |||
| W4410544256 | A Review Articles on Pharmacovigilance: Protecting Public Health through Effective, Monitoring Drug Safety | 2025-02-01 | OpenAlex | 10.35629/4494-100225412547 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410544256 | |||
| W4407387480 | AI-POWERED CHATBOTS IN PSYCHIATRY: A CRITICAL EVALUATION OF CHATGPT'S SLEEP AID GUIDANCE | 2025-02-01 | OpenAlex | 10.1093/ijnp/pyae059.431 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407387480 | |||
| W4407061169 | Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma | 2025-02-01 | OpenAlex | 10.1007/s11864-025-01293-w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407061169 | |||
| W4407100572 | Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies | 2025-02-01 | OpenAlex | 10.2147/ijn.s457393 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407100572 | |||
| W4407927757 | Application of Artificial Intelligence Generated Content in Medical Examinations | 2025-02-01 | OpenAlex | 10.2147/amep.s492895 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407927757 | |||
| W4407460947 | Atopic dermatitis | 2025-02-01 | OpenAlex | 10.1016/s0140-6736(24)02519-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407460947 | |||
| W4407219011 | Clinical Characteristics and Optimization of Empirical Antimicrobial Therapy for Febrile Neutropenia in Patients With Hematologic Malignancies | 2025-02-01 | OpenAlex | 10.2147/idr.s493670 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407219011 | |||
| W4407249264 | CrossMoDA Computational Competition: Evolution of Cross-Modality Domain Adaptation Techniques for Vestibular Schwannoma and Cochlea Segmentation from 2021 to 2023 | 2025-02-01 | OpenAlex | 10.1055/s-0045-1803943 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407249264 | |||
| W4407454670 | Designing and Evaluating an Ensemble Reasoning-based Clinical Decision Support System | 2025-02-01 | OpenAlex | 10.3724/2096-7004.di.2025.0001 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407454670 | |||
| W4408019495 | Early Steroid Withdrawal in Kidney Transplant Recipients: COMMENTARY | 2025-02-01 | OpenAlex | 10.34067/kid.0000000571 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408019495 | |||
| W4407238545 | Early investigational agents for the treatment of rosacea: drugs in phase I and II clinical development | 2025-02-01 | OpenAlex | 10.1080/13543784.2025.2463093 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4407238545 | |||
| W4407597745 | Evolutionary adaptation to hyperstable microtubules selectively targets tubulins and is empowered by the spindle assembly checkpoint | 2025-02-01 | OpenAlex | 10.1016/j.celrep.2025.115323 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407597745 | |||
| W4407056997 | From Epidemics to Pandemics: Over a Decade of Strengthening SARInet Laboratory Surveillance and Response for Respiratory Viruses in the Americas | 2025-02-01 | OpenAlex | 10.1093/infdis/jiaf046 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407056997 | |||
| W4408420878 | From the Masterclasses in Dermatology 2024 Meeting: Updates in Psoriasis Treatments. | 2025-02-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408420878 | ||||
| W4407223454 | Metabolic dysfunction and insulin sensitizers in acute and chronic disease | 2025-02-01 | OpenAlex | 10.1080/13543784.2025.2463086 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407223454 | |||
| W4410019203 | NEXT-GENERATION ANTIOXIDANTS: SHOULD WE TARGET PEROXIREDOXINS? | 2025-02-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410019203 | ||||
| W4413971651 | Netherton Syndrome: A Comprehensive Literature Review of Pathogenesis, Clinical Manifestations, and Therapeutic Strategies. | 2025-02-01 | OpenAlex | 10.34763/jmotherandchild.20252901.d-25-00014 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413971651 | |||
| W4407065633 | Opportunities in the translational pipeline for pediatric brain cancer therapies | 2025-02-01 | OpenAlex | 10.1038/s41390-025-03847-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407065633 | |||
| W4407462558 | Phytochemical insights into flavonoids in cancer: Mechanisms, therapeutic potential, and the case of quercetin | 2025-02-01 | OpenAlex | 10.1016/j.heliyon.2025.e42682 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407462558 | |||
| W4407059899 | Radiotheranostic landscape: A review of clinical and preclinical development | 2025-02-01 | OpenAlex | 10.1007/s00259-025-07103-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407059899 | |||
| W4408738234 | Role of Sodium-Glucose Co-Transporter 2 Inhibitors in Chronic Kidney Disease Management | 2025-02-01 | OpenAlex | 10.47583/ijpsrr.2025.v85i02.012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408738234 | |||
| W4407945332 | Vaccines in Pregnancy: An Update on Recommendations From CDC 's Advisory Committee on Immunization Practices | 2025-02-01 | OpenAlex | 10.1002/bdr2.2459 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407945332 | |||
| W4407070054 | Single-cell transcriptomics analysis reveals dynamic changes and prognostic signature in tumor microenvironment of PDAC | 2025-02-02 | OpenAlex | 10.1038/s41598-025-86950-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407070054 | |||
| W4407101960 | Current and Evolving Concepts in the Management of Complex Regional Pain Syndrome: A Narrative Review | 2025-02-03 | OpenAlex | 10.3390/diagnostics15030353 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407101960 | |||
| W4410701512 | Deciphering Rheumatoid Arthritis: A Detailed Review of Clinical Features, Disease Progression, and T | 2025-02-03 | OpenAlex | 10.19080/oajt.2025.06.555686 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410701512 | |||
| W4407114205 | Evolving Field of Immunotherapy: Pioneering New Paths in Small-Cell Lung Cancer | 2025-02-03 | OpenAlex | 10.1200/op-24-00862 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407114205 | |||
| W4407095158 | The evolving landscape of NF gene therapy: Hurdles and opportunities | 2025-02-03 | OpenAlex | 10.1016/j.omtn.2025.102475 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407095158 | |||
| W4407142891 | ANTIBIOTIC RESISTANCE: A GLOBAL THREAT AND PATHWAYS TO SOLUTIONS | 2025-02-04 | OpenAlex | 10.26212/2227-1937.2025.18.39.013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407142891 | |||
| W4407147603 | Breaking the Mold: Advances and Hurdles in Antifungal Resistance Management for Dermatophytes | 2025-02-04 | OpenAlex | 10.2174/0127724328328331241217194034 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407147603 | |||
| W4407113862 | Editorial: New insights into intracellular pathways and therapeutic targets in CNS diseases | 2025-02-04 | OpenAlex | 10.3389/fncel.2025.1559821 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407113862 | |||
| W4407132230 | Overview of systemic anticancer treatments: conventional cytotoxics | 2025-02-04 | OpenAlex | 10.1136/dtb.2023.000059 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407132230 | |||
| W4407138586 | Paul DafyddJones, Patience—A Theological Exploration: Part One, From Creation to Christ. London: T&T Clark, 2022, 632pp. $46.95 | 2025-02-04 | OpenAlex | 10.1111/ijst.12742 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407138586 | |||
| W4408069369 | Uterine Artery Embolization: A Growing Pillar of Gynecological Intervention | 2025-02-04 | OpenAlex | 10.26502/jrci.2809105 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408069369 | |||
| W4407181767 | Editorial: Updates on the management of glioblastoma | 2025-02-05 | OpenAlex | 10.3389/fonc.2025.1526669 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407181767 | |||
| W4407181198 | Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy | 2025-02-05 | OpenAlex | 10.3389/fpsyg.2025.1505894 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407181198 | |||
| W4407209734 | Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet | 2025-02-06 | OpenAlex | 10.1182/bloodadvances.2024013744 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407209734 | |||
| W4407230179 | The data scientist as a mainstay of the tumor board: global implications and opportunities for the global south | 2025-02-06 | OpenAlex | 10.3389/fdgth.2025.1535018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407230179 | |||
| W4407254035 | A comprehensive analysis of percutaneous liver biopsy characteristics and pathological manifestations in a large patient cohort (2009–2024) | 2025-02-07 | OpenAlex | 10.1186/s12876-025-03646-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407254035 | |||
| W4407237220 | Culture | 2025-02-07 | OpenAlex | 10.4324/9781003600237-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407237220 | |||
| W4407242258 | HER2-targeted therapies: Unraveling their role in biliary tract cancers | 2025-02-07 | OpenAlex | 10.1016/j.critrevonc.2025.104655 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407242258 | |||
| W4407253501 | Key tips to shift student perspectives through transformative learning in medical education | 2025-02-07 | OpenAlex | 10.1186/s12909-025-06754-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407253501 | |||
| W4407294050 | Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives | 2025-02-08 | OpenAlex | 10.3390/jcm14041079 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407294050 | |||
| W4407264549 | Journal of Population Therapeutics and Clinical Pharmacology | 2025-02-08 | OpenAlex | 10.53555//sbcmpj45 | Full text | Excluded | F5: The indexed title is a journal name and malformed DOI. Its linked PDF was verified as a different DoctorAssist paper and retained under that actual identity. The intended study behind this corrupt index record could not be identified, so the mismatched text was not used to infer eligibility. | https://openalex.org/W4407264549; https://openalex.org/W4409552601; https://openalex.org/W4403908921 | https://openalex.org/W4407264549 | Metadata and mismatched PDF identity checked; see fulltext/SOURCE_IDENTITY_CORRECTIONS.json. Intended full text unavailable. | |
| W4407287700 | Multi-lineage transcriptional and cell communication signatures define evolving personalized mechanisms that initiate and perpetuate rheumatoid arthritis | 2025-02-09 | OpenAlex | 10.1101/2025.02.08.619913 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407287700 | |||
| W4407612505 | The Potential Therapeutic Advantages of Using Nanotechnology in the Treatment of Liver Fibrosis: A Review | 2025-02-09 | OpenAlex | 10.21608/eajbsz.2025.410264 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407612505 | |||
| W4407319312 | Acceptability of a Conversational Agent-led Digital Program for Anxiety: A Mixed-Methods Study of Patient Perspectives | 2025-02-10 | OpenAlex | 10.31234/osf.io/g3dhy_v1 | Full text | Excluded | F3: The evaluated anxiety intervention uses tree-based dialogue, NLP intent recognition and clinician-written responses. Future generative-AI discussion does not make the tested agent an LLM. | https://openalex.org/W4407319312 | https://humanfactors.jmir.org/2025/1/e76377/ | published full Methods and intervention description; archived preprint abstract | |
| W4408175982 | Cancer attributable to occupational factors: a focus on primary prevention | 2025-02-10 | OpenAlex | 10.5124/jkma.2025.68.2.121 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408175982 | |||
| W4407306288 | Comparative Analysis Between Radiofrequency Ablation Techniques and Ultrasound-Guided Nerve Blocks in the Treatment of Postherpetic Neuralgia | 2025-02-10 | OpenAlex | 10.24857/rgsa.v19n2-012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407306288 | |||
| W4407293518 | Editorial: Ovarian cancer targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more, volume II | 2025-02-10 | OpenAlex | 10.3389/fphar.2025.1552652 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407293518 | |||
| W4407343983 | Editorial: Revealing the role of mitochondrial gene defects in tumor progression and developing mitochondrial-targeted drugs | 2025-02-10 | OpenAlex | 10.3389/fonc.2025.1553496 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407343983 | |||
| W4407344818 | Post-Covid-19 Pulmonary Fibrosis: Pathogenesis, Risk Factors, Diagnosis, And Emerging Therapeutic Strategies | 2025-02-10 | OpenAlex | 10.55041/ijsrem41401 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407344818 | |||
| W4407319487 | Proline mitigates antibiotic resistance evolution induced by ciprofloxacin at environmental concentrations | 2025-02-10 | OpenAlex | 10.1016/j.jhazmat.2025.137561 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407319487 | |||
| W4408924946 | RETRACTED: Arteriovenous Fistula Creation for Hemodialysis in Patients with End-Stage Renal Disease with and Without Surgical Drain: A Randomized Control Trial | 2025-02-10 | OpenAlex | 10.58742/bmj.v3i2.170 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4408924946 | |||
| W4407700162 | Survival outcomes based on line of therapy and treatment trends with cabazitaxel in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). | 2025-02-10 | OpenAlex | 10.1200/jco.2025.43.5_suppl.162 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407700162 | |||
| W7215782472 | Transforming Emergency Care: The Strategic Role of Paramedics in Improving Survival and System Efficiency | 2025-02-10 | OpenAlex | 10.70082/rb3g2w54 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215782472 | |||
| W4407701368 | Treatment (Rx) patterns and attrition rates in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). | 2025-02-10 | OpenAlex | 10.1200/jco.2025.43.5_suppl.75 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407701368 | |||
| W4407363485 | Brain metastases from lung cancer: recent advances and novel therapeutic opportunities | 2025-02-11 | OpenAlex | 10.1007/s12672-025-01873-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407363485 | |||
| W4412962727 | Contemporary Strategies In The Pharmacological Management Of Hypertension | 2025-02-11 | OpenAlex | 10.61096/ijrpp.v14.iss1.2025.111-118 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412962727 | |||
| W4407379085 | Editorial: Understanding biofilms: recent trends and developments | 2025-02-11 | OpenAlex | 10.3389/fcimb.2025.1566230 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407379085 | |||
| W4407351475 | Stress adaptation under in vitro evolution influences survival and metabolic phenotypes of clinical and environmental strains of Vibrio cholerae El-Tor | 2025-02-11 | OpenAlex | 10.1128/spectrum.01211-24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407351475 | |||
| W4407411161 | A Medicinal Chemistry Perspective on Protein Tyrosine Phosphatase Nonreceptor Type 2 in Tumor Immunology | 2025-02-12 | OpenAlex | 10.1021/acs.jmedchem.4c01802 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407411161 | |||
| W4407410660 | Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management | 2025-02-12 | OpenAlex | 10.1002/ajh.27625 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407410660 | |||
| W4407857873 | Advances in Nanoparticle-Based Drug Delivery Systems: Enhancing Targeted Therapeutic Efficacy in Pharmaceutical Science and Technologycrete Technology | 2025-02-12 | OpenAlex | 10.52783/jns.v14.1717 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407857873 | |||
| W4407393149 | Antimicrobial peptides in Clarias batrachus epidermal mucus: Characterization and therapeutic potential | 2025-02-12 | OpenAlex | 10.1016/j.fsi.2025.110191 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407393149 | |||
| W4407419963 | Disruption of zinc homeostasis reverses tigecycline resistance in Klebsiella pneumoniae | 2025-02-12 | OpenAlex | 10.3389/fcimb.2025.1458945 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407419963 | |||
| W4407358058 | Zinc pyrithione inhibits blood-stage parasites of Plasmodium falciparum and its combinatorial effect with dihydro-artemisinin and chloroquine in culture | 2025-02-12 | OpenAlex | 10.1016/j.parint.2025.103041 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407358058 | |||
| W4407450852 | A single approach, multiple insights: Harnessing spatial transcriptomics and proteomics to identify novel therapeutic targets of alcohol‐associated hepatitis | 2025-02-13 | OpenAlex | 10.1111/acer.70007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407450852 | |||
| W4407424587 | AGENTIC AI FOR PREDICTING AND PREVENTING DATA DRIFT | 2025-02-13 | OpenAlex | 10.56726/irjmets67596 | Full text | Excluded | F3: The implemented pipeline trains an RNN on an 80/20 UCI HAR sensor split, detects drift through statistical tests/moving averages and recalibrates RNN parameters. It does not implement an LLM/VLM acting agent. | https://openalex.org/W4407424587 | https://doi.org/10.56726/IRJMETS67596 | ||
| W4407548551 | Antimicrobial Lock Therapy in Clinical Practice: A Scoping Review | 2025-02-13 | OpenAlex | 10.3390/microorganisms13020406 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407548551 | |||
| W4407546672 | Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and its Mutated Variants: Challenges and Future Directions | 2025-02-13 | OpenAlex | 10.1177/0976500x251316939 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407546672 | |||
| W4407529712 | Perceptions of members of ethics committees of medical institutions in India on controlled human infection studies (CHIS) following a sensitization workshop: a systematic survey | 2025-02-13 | OpenAlex | 10.1007/s40592-025-00231-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407529712 | |||
| W4407530851 | Phytochemicals and bioenhancers: tackling antibiotic resistance in the era of emerging microbial threats | 2025-02-13 | OpenAlex | 10.1080/00207233.2025.2464469 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407530851 | |||
| W4407514595 | Towards optimization in the use of hemostatic agents and blood products in the early treatment of patients with traumatic brain injury (TBI) | 2025-02-13 | OpenAlex | 10.1097/aco.0000000000001465 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4407514595 | |||
| W4408099196 | Yesil o1 Pro: Evidence-Based AI Model for Health and Benchmarking in Clinical Decision Support (Preprint) | 2025-02-14 | OpenAlex | 10.2196/preprints.72646 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4408099196 | |||
| W7130506376 | Third and Later Line Therapy in Metastatic Colorectal Cancer – Current Landscape and Future Perspectives | 2025-02-15 | OpenAlex | 10.53011/jmro.2025.02.03 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130506376 | |||
| W4407711959 | Advances in Lipid Nanoparticle‐Based Disease Treatment | 2025-02-17 | OpenAlex | 10.1002/cmdc.202400938 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407711959 | |||
| W4407616257 | Antiphospholipid syndrome in pregnancy: A comprehensive review | 2025-02-17 | OpenAlex | 10.5499/wjr.v12.i2.103837 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407616257 | |||
| W4407669013 | Editorial: Understanding bladder tumor microenvironment to optimize immunotherapy | 2025-02-17 | OpenAlex | 10.3389/fimmu.2025.1566407 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407669013 | |||
| W4407679662 | HIV diagnosis during acute infection: implications of long-acting preexposure prophylaxis and other evolving challenges | 2025-02-17 | OpenAlex | 10.1097/coh.0000000000000919 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407679662 | |||
| W4407640629 | Investigating the Application of Pomegranate-Loaded Chitosan Nanoparticles as Contrast Agents for Enhancing Breast Cancer Detection via Diffuse Reflectance Spectroscopy | 2025-02-17 | OpenAlex | 10.3390/chemosensors13020073 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407640629 | |||
| W4407667626 | Mitochondrial targeted therapies in MAFLD | 2025-02-17 | OpenAlex | 10.1016/j.bbrc.2025.151498 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407667626 | |||
| W4407716594 | Editorial: Case reports in intensive care medicine 2023 | 2025-02-18 | OpenAlex | 10.3389/fmed.2025.1563533 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407716594 | |||
| W4407680962 | Isatuximab-containing regimens for the treatment of patients with newly diagnosed multiple myeloma: A literature review and a clinical case | 2025-02-18 | OpenAlex | 10.26442/18151434.2024.4.203086 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407680962 | |||
| W4407685106 | Recent Human Metapneumovirus Outbreak in East Asia: The Time to Shift Immunological Gears is Now | 2025-02-18 | OpenAlex | 10.20944/preprints202501.0759.v5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407685106; https://openalex.org/W4406318641; https://openalex.org/W4406744588; https://openalex.org/W4407037135; https://openalex.org/W4407037180 | |||
| W4407699612 | Temporal Trends in the Use of Biological Agents in Patients with Inflammatory Bowel Disease: Real-World Data from a Tertiary Inflammatory Bowel Disease Greek Center During a 5-Year Period | 2025-02-18 | OpenAlex | 10.3390/jcm14041357 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407699612 | |||
| W4407693880 | The fifth edition of the WHO classification of mature T cell, NK cell and stroma-derived neoplasms | 2025-02-18 | OpenAlex | 10.1136/jcp-2025-210074 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407693880 | |||
| W4407798514 | Hemostatic Biopolymers: A Natural Approach for Revolutionizing Blood Loss Control | 2025-02-19 | OpenAlex | 10.1080/25740881.2025.2461626 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407798514 | |||
| W4407748488 | Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics | 2025-02-19 | OpenAlex | 10.1080/17474124.2025.2469832 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407748488 | |||
| W7221297612 | FAST DISSOLVING FILMS: A NOVEL APPROACH TO ORAL DRUG DELIVERY | 2025-02-20 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221297612 | ||||
| W4407786635 | Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma | 2025-02-20 | OpenAlex | 10.3390/cancers17050715 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407786635 | |||
| W4407835571 | Bridging the Gaps in CMV Management in Transplantation: Lessons From Resource‐Limited Settings | 2025-02-21 | OpenAlex | 10.1111/tid.70009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407835571 | |||
| W4407839683 | Multicenter Real-World Study: 432 Patients with Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer | 2025-02-21 | OpenAlex | 10.3390/curroncol32030119 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407839683 | |||
| W4407855804 | 2024: The Year in Cardiovascular Disease - The Year of Lipoprotein(a) – Research Advances and New Findings. | 2025-02-22 | OpenAlex | 10.5114/aoms/202213 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407855804 | |||
| W4407853687 | Polyextremotolerant, opportunistic, and melanin-driven resilient black yeast Exophiala dermatitidis in environmental and clinical contexts | 2025-02-22 | OpenAlex | 10.1038/s41598-025-88595-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407853687 | |||
| W4408068988 | CD105 in the Progression and Therapy of Colon Cell Carcinoma | 2025-02-23 | OpenAlex | 10.2174/9789815305906125010007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408068988 | |||
| W4407903031 | Deep Reinforcement Learning: A Chronological Overview and Methods | 2025-02-24 | OpenAlex | 10.3390/ai6030046 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407903031 | |||
| W4407876589 | Multifaceted role of heparin in oncology: from anticoagulation to anticancer mechanisms and clinical implications | 2025-02-24 | OpenAlex | 10.1007/s12672-025-01985-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407876589 | |||
| W4407896532 | Re-conceptualizing structural damage in chronic calcium pyrophosphate crystal inflammatory arthritis through ultrasonography: a pictorial essay | 2025-02-24 | OpenAlex | 10.37349/emd.2025.100786 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407896532 | |||
| W4408143830 | A Unified Framework for Self-Learning AI: Reinforcement Learning, Neural Search, and Adaptive Evolution | 2025-02-25 | OpenAlex | 10.5120/ijca2025924503 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4408143830 | |||
| W4407925178 | Editorial: Methods in predictive toxicology 2023 | 2025-02-25 | OpenAlex | 10.3389/fphar.2025.1556352 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407925178 | |||
| W4407944435 | Recent Advances in the Development and Efficacy of Anti-Cancer Vaccines—A Narrative Review | 2025-02-25 | OpenAlex | 10.3390/vaccines13030237 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407944435 | |||
| W4407986082 | Safety of Hydroxychloroquine for COVID-19 Prophylaxis in Healthcare Workers: A Cross-Sectional Study | 2025-02-25 | OpenAlex | 10.7759/cureus.79660 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407986082 | |||
| W4407932534 | Second-Person Authenticity and the Mediating Role of AI: A Moral Challenge for Human-to-Human Relationships? | 2025-02-25 | OpenAlex | 10.1007/s13347-025-00857-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407932534 | |||
| W4407919242 | Tabetic arthropathy of the knee: A case report | 2025-02-25 | OpenAlex | 10.1016/j.radcr.2024.11.074 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407919242 | |||
| W4407942782 | The potential of natural herbal plants in the treatment and prevention of non-small cell lung cancer: An encounter between ferroptosis and mitophagy | 2025-02-25 | OpenAlex | 10.1016/j.jep.2025.119555 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407942782 | |||
| W4407937902 | Using Everyday Ethics to Address Bias and Racism in Clinical Care | 2025-02-25 | OpenAlex | 10.4037/aacnacc2025307 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407937902 | |||
| W4407980661 | APPLICATION AND PROGRESS OF CT ANGIOGRAPHY–X-RAY IMAGE FUSION TECHNOLOGY IN ENDOVASCULAR SURGERY: A LITERATURE REVIEW | 2025-02-26 | OpenAlex | 10.61784/jpmr3028 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407980661 | |||
| W4407957615 | Enhancing vaginal drug delivery: the nanoemulsion gel strategy | 2025-02-26 | OpenAlex | 10.1515/znc-2024-0239 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407957615 | |||
| W4407928906 | Nanotechnology in Immunology | 2025-02-26 | OpenAlex | 10.1201/9781003472155-13 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4407928906 | |||
| W4408293808 | Occupational Risk Management in the Context of Emerging Infections | 2025-02-26 | OpenAlex | 10.1097/jom.0000000000003372 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408293808 | |||
| W4408010750 | Demystifying the Role of Immuno PET-CT in Non-Small Cell Lung Cancer: Clinical Value and Research Trends | 2025-02-27 | OpenAlex | 10.1053/j.semnuclmed.2025.02.004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408010750 | |||
| W4408021671 | Elevated C-reactive protein and cardiovascular risk | 2025-02-27 | OpenAlex | 10.1097/hco.0000000000001215 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408021671 | |||
| W4407991953 | Evolutionary trajectory of bacterial resistance to antibiotics and antimicrobial peptides in Escherichia coli | 2025-02-27 | OpenAlex | 10.1128/msystems.01700-24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4407991953 | |||
| W4408038816 | HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS | 2025-02-27 | OpenAlex | 10.4084/mjhid.2025.026 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408038816 | |||
| W4409659768 | Interactive Agent Foundation Model: A Meta-Learning Strategy | 2025-02-27 | OpenAlex | 10.1109/isacc65211.2025.10969383 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4409659768 | |||
| W4408003040 | Magnesium: A Micronutrient for Brain Health | 2025-02-27 | OpenAlex | 10.4103/aihb.aihb_32_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408003040 | |||
| W4408041177 | Editorial: Minimal intervention dentistry for dental caries management | 2025-02-28 | OpenAlex | 10.3389/froh.2025.1565605 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408041177 | |||
| W4408046592 | Evaluation of the performance of the QIAstat-Dx® Gastrointestinal Panel 2 for the detection of pathogens from stool at a diagnostic laboratory in South Africa | 2025-02-28 | OpenAlex | 10.1016/j.ijid.2024.107586 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408046592 | |||
| W4408089628 | Negative Hyperselection in Metastatic Colorectal Cancer for First-Line Anti-EGFR Therapy: A Narrative Review | 2025-02-28 | OpenAlex | 10.3390/ijms26052216 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408089628 | |||
| W7143295924 | The Role of Nanotechnology in Drug Delivery Systems | 2025-02-28 | OpenAlex | 10.71465/aljb3340 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143295924 | |||
| W4408046360 | Universal PCR assays to detect Candida FKS and ERG11 mutations | 2025-02-28 | OpenAlex | 10.1016/j.ijid.2024.107757 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408046360 | |||
| W4408217997 | 17P KBA1413: An antibody derived from a cured AML patient, recognizes a unique glycoepitope shared by AML, MDS and several solid cancer cells | 2025-03-01 | OpenAlex | 10.1016/j.esmoop.2025.104173 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408217997 | |||
| W4409514643 | Advances in Medical Toxicology: Innovative Approaches for Poisoning and Overdose Management | 2025-03-01 | OpenAlex | 10.22377/ajp.v19i01.6050 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409514643 | |||
| W4408077931 | An updated review of intra-arterial chemotherapy for retinoblastoma | 2025-03-01 | OpenAlex | 10.1016/j.rxeng.2025.02.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408077931 | |||
| W4410011499 | Antibacterial Effectiveness of Zinc Oxide and Magnesium Oxide Nanoparticles Against Enterococcus faecalis: An In Vitro Study | 2025-03-01 | OpenAlex | 10.4103/jioh.jioh_164_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410011499 | |||
| W4409363278 | Beyond Angina: Unlocking the Multifaceted Therapeutic Potential of Trimetazidine | 2025-03-01 | OpenAlex | 10.2174/277243282003250219160900 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409363278 | |||
| W4408144328 | Code ICH: Giving Patients with Intracerebral Hemorrhage a Fighting Chance | 2025-03-01 | OpenAlex | 10.1097/01.eem.0001108576.15828.5e | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408144328 | |||
| W4408957435 | Cognitive Sequelae of COVID ‐19: Mechanistic Insights and Therapeutic Approaches | 2025-03-01 | OpenAlex | 10.1111/cns.70348 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408957435 | |||
| W4408981764 | Editorial | 2025-03-01 | OpenAlex | 10.1097/us9.0000000000000072 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408981764; https://openalex.org/W4402305831 | |||
| W4411693485 | Emerging bladder-sparing treatments for high risk non-muscle invasive bladder cancer | 2025-03-01 | OpenAlex | 10.1177/23523735251348842 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411693485 | |||
| W4408079443 | Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review | 2025-03-01 | OpenAlex | 10.1186/s12885-025-13749-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408079443 | |||
| W4409217804 | Fifty Years of Teaching Operative Dentistry – My Reflections | 2025-03-01 | OpenAlex | 10.2341/1559-2863-50-2-119 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409217804 | |||
| W4408683314 | Generation of Spatial Structure of Urban Parks Based on Spatial Analysis of Agent-Based Models | 2025-03-01 | OpenAlex | 10.3724/j.fjyl.202408030430 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4408683314 | |||
| W4408375277 | Highlights from the breakout session: outcome predictors in small, large and variable vessel vasculitis | 2025-03-01 | OpenAlex | 10.1093/rheumatology/keae502 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408375277 | |||
| W4409324827 | Metalloproteins in emerging pathogens | 2025-03-01 | OpenAlex | 10.1063/4.0000578 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409324827 | |||
| W4408750632 | Modern Approach to Manage Patients With Kaposi Sarcoma | 2025-03-01 | OpenAlex | 10.1002/jmv.70294 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408750632 | |||
| W4408059583 | Monoclonal Antibody Therapies for Children | 2025-03-01 | OpenAlex | 10.1542/pir.2024-006452 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408059583 | |||
| W4408901596 | Sedation practices of Greek gastroenterologists: developments in the last decade | 2025-03-01 | OpenAlex | 10.1055/s-0045-1805688 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408901596 | |||
| W4408127164 | The Adulterant Era of the Opioid Epidemic | 2025-03-01 | OpenAlex | 10.1097/01.eem.0001108572.00041.aa | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408127164 | |||
| W4409315159 | [Practice guideline on the prevention and treatment of central line associated bloodstream infection in 2025]. | 2025-03-01 | OpenAlex | 10.3760/cma.j.cn121430-20250301-00199 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409315159 | |||
| W4408228018 | Advances in Asthma Management: Integrating Biologics, Personalized Medicine, and Lessons from the COVID-19 Era | 2025-03-02 | OpenAlex | 10.36948/ijfmr.2025.v07i02.37923 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408228018 | |||
| W4410038274 | Digital narcissism: Psychoanalytic mechanisms of personality manifestation in social media and their impact on psychological well-being | 2025-03-02 | OpenAlex | 10.52534/msu-pp1.2025.104 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410038274 | |||
| W4408102588 | Corrigendum: Early detection of chemotherapy-induced cardiotoxicity in breast cancer patients: a comprehensive analysis using speckle tracking echocardiography | 2025-03-03 | OpenAlex | 10.3389/fcvm.2025.1548119 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4408102588 | |||
| W4408216702 | Infection-Simulator, Immunostimulatory and Immunomodulatory Effects of Interferons I and III in Biological Systems: A New Era in Vaccinology and Therapeutics Possible? | 2025-03-03 | OpenAlex | 10.20944/preprints202212.0155.v8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408216702; https://openalex.org/W7133901321 | |||
| W4408098277 | Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide | 2025-03-03 | OpenAlex | 10.1200/op-24-00872 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408098277 | |||
| W4408121864 | Mycoplasma pneumoniae-Induced Erythema Multiforme in an 11-Year-Old Boy: Diagnostic and Therapeutic Challenges | 2025-03-03 | OpenAlex | 10.7759/cureus.79944 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408121864 | |||
| W4408082123 | Unlocking the therapeutic potential of antibody–drug conjugates in targeting molecular biomarkers in non-small cell lung cancer | 2025-03-03 | OpenAlex | 10.1186/s43046-025-00264-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408082123 | |||
| W4408180730 | Use of broadly neutralizing antibodies in pediatric HIV for treatment and remission | 2025-03-03 | OpenAlex | 10.1097/coh.0000000000000927 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408180730 | |||
| W4408123260 | Advances in Therapy of Adult Patients with Acute Lymphoblastic Leukemia | 2025-03-04 | OpenAlex | 10.3390/cells14050371 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408123260 | |||
| W4408148200 | Evolution of coronary stents: innovations, antithrombotic strategies and future directions | 2025-03-04 | OpenAlex | 10.1136/heartjnl-2024-324744 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408148200 | |||
| W4408126678 | From Dose-Finding to Dose-Optimization in Early-Phase oncology clinical trials | 2025-03-04 | OpenAlex | 10.1016/j.ctrv.2025.102906 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408126678 | |||
| W4408152860 | Integrative learning through student-led transdisciplinary investigation of Belgium’s COVID-19 pandemic preparedness | 2025-03-04 | OpenAlex | 10.21203/rs.3.rs-5932329/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408152860 | |||
| W4408150199 | Tissue-engineered and cell-based therapies for cartilage defects | 2025-03-04 | OpenAlex | 10.17816/gc640858 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408150199 | |||
| W4408093197 | Transarterial Chemoembolization: A Consistent and Continuously Evolving Therapy for Hepatocellular Carcinoma | 2025-03-04 | OpenAlex | 10.1016/j.jceh.2025.102538 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408093197 | |||
| W4408226933 | Agentic Workflows in Healthcare: Advancing Clinical Efficiency through AI Integration | 2025-03-05 | OpenAlex | 10.32628/cseit25112396 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4408226933 | |||
| W4408158687 | Editorial: Unveiling biomarkers and mechanisms in the tumor-immune nexus | 2025-03-05 | OpenAlex | 10.3389/fimmu.2025.1581492 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408158687 | |||
| W4408208475 | Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing | 2025-03-06 | OpenAlex | 10.20517/cdr.2024.180 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408208475 | |||
| W4408202367 | Myeloid cells: key players in tumor microenvironments | 2025-03-06 | OpenAlex | 10.1007/s11684-025-1124-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408202367 | |||
| W4408244433 | Therapeutic Strategies for Relapsed or Refractory B‐Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal Antibodies | 2025-03-06 | OpenAlex | 10.1111/ejh.14405 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408244433 | |||
| W4408537408 | Cytotoxic Agents Can Cure Cancer, but Can Also Kill Cancer Patients | 2025-03-07 | OpenAlex | 10.11648/j.ijcocr.20251001.14 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4408537408 | |||
| W4408226040 | Global research trends on DPP-4 inhibitors and cardiovascular outcomes: a comprehensive bibliometric analysis | 2025-03-07 | OpenAlex | 10.1097/ms9.0000000000003089 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408226040 | |||
| W4408229670 | Pharmacogenomics in Solid Tumors: A Comprehensive Review of Genetic Variability and Its Clinical Implications | 2025-03-07 | OpenAlex | 10.3390/cancers17060913 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408229670 | |||
| W4408168251 | Precision Treatment of IgA Nephropathy Based on a New Framework: Angiorenal Protection, Immunity Inhibition, B-Cell/Plasma-Cell Modulation, and Complement Inhibition | 2025-03-07 | OpenAlex | 10.1159/000544998 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408168251 | |||
| W4408168108 | The Need for Concurrent Chemoimmunotherapy in Pediatric B-Cell Lymphoblastic Leukemia | 2025-03-07 | OpenAlex | 10.1159/000545028 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408168108 | |||
| W4408226838 | “She’s Always Made Sure That We Had Black Doctors, Particularly Women Doctors If We Could… and How It Can Sometimes Be the Difference Between Life and Death.” Black College Women’s Reflections On Medical Racism As a Social Determinant of Health | 2025-03-07 | OpenAlex | 10.1007/s40615-025-02366-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408226838 | |||
| W7117147020 | Targeted Therapeutics for Cancer Treatment: A Review of Kinase Inhibitors, Angiogenesis Inhibitors, and Other Molecularly targeted Agents | 2025-03-09 | OpenAlex | 10.51470/bf.2025.5.1.09 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117147020 | |||
| W4408286679 | What the clinician should know when ordering a mast cell tryptase test | 2025-03-10 | OpenAlex | 10.1016/j.anai.2025.03.003 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408286679 | |||
| W4408306639 | Book Review | 2025-03-11 | OpenAlex | 10.1097/naq.0000000000000659 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408306639 | |||
| W4408283515 | MYC networks associate with decreased CD8 T-cell presence in diffuse large B-cell lymphoma and may be addressed by the synergistic combination of AZD4573 and Selinexor – a preliminary analysis | 2025-03-11 | OpenAlex | 10.1007/s00277-025-06298-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408283515 | |||
| W4408162019 | Sulfonamides as a Promising Scaffold in Drug Discovery: An Insightful Review on FDA‐Approved Molecules, Synthesis Strategy, Medical Indication, and Their Binding Mode | 2025-03-11 | OpenAlex | 10.1002/cbdv.202403434 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408162019 | |||
| W4408302947 | The Analytical Gaze of Operators and Facilitators in Healthcare Simulations: Technologies, Agency and the Evolution of Instructional Expertise | 2025-03-11 | OpenAlex | 10.3390/educsci15030347 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408302947 | |||
| W4408342948 | The Discovery of Gadopiclenol: An Example of Rational Drug Design? | 2025-03-11 | OpenAlex | 10.1097/rli.0000000000001169 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408342948 | |||
| W4408387767 | Therapeutic advances in chronic lymphocytic leukemia: A focus on molecular pathogenesis, targeted therapies, and supportive care | 2025-03-11 | OpenAlex | 10.1093/ajhp/zxaf058 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408387767 | |||
| W4408352269 | A Self-Evolving Framework for Multi-Agent Medical Consultation Based on Large Language Models | 2025-03-12 | OpenAlex | 10.1109/icassp49660.2025.10889517 | Full text | Included | Included: Correct consultations and error abstractions from training cases are stored in two knowledge bases and retrieved for later different consultations. | https://openalex.org/W4408352269 | https://ieeexplore.ieee.org/document/10889517 | ||
| W4408364649 | Editorial for “Evaluating the Diagnostic Performance of MR Cytometry Imaging in Differentiating Benign and Malignant Breast Tumors” | 2025-03-12 | OpenAlex | 10.1002/jmri.29767 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408364649 | |||
| W4408360841 | Menadione reduces the expression of virulence- and colonization-associated genes in Helicobacter pylori | 2025-03-12 | OpenAlex | 10.1099/mic.0.001539 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408360841 | |||
| W4408408254 | Continuum-based postoperative nausea and vomiting prophylaxis protocol: Development and real-world implementation checklist | 2025-03-13 | OpenAlex | 10.4103/ija.ija_1227_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408408254 | |||
| W4408408252 | Do not resuscitate, but only anaesthetise! | 2025-03-13 | OpenAlex | 10.4103/ija.ija_1302_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408408252 | |||
| W4408419259 | Editorial: Metabolomics perspectives for clinical medicine, volume II | 2025-03-13 | OpenAlex | 10.3389/fmolb.2025.1577050 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408419259 | |||
| W4408622983 | Griseofulvin: A Comprehensive Review of its Antifungal, Pharmacological, and Clinical Implications | 2025-03-13 | OpenAlex | 10.21608/aijp.2025.356963.1003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408622983 | |||
| W4408460257 | Prostate Cancer Playback: Highlights of 2024 | 2025-03-13 | OpenAlex | 10.33590/emjurol/iieq4765 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408460257 | |||
| W4408629583 | Recent Advances in Green Synthesis, Chemical-Physics Characterizations, and Biological Adeptness of Selenium and Silver Nanoparticles for Medical Application | 2025-03-13 | OpenAlex | 10.70593/978-93-49307-47-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408629583 | |||
| W7218208767 | AI, Robotics, and Next-Generation Biologic Therapies in Orthopedic Regeneration: The Future of Autonomous Musculoskeletal Healing | 2025-03-15 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7218208767 | ||||
| W7220347517 | Reinforcement Learning Enhanced AI-AugETM for Adaptive Real-Time Dose Adjustment in Oncology Phase I Trials | 2025-03-15 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220347517 | ||||
| W4409118862 | Targeting ROS1 rearrangements in non–small cell lung cancer: Current insights and future directions | 2025-03-15 | OpenAlex | 10.1002/cncr.35784 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409118862 | |||
| W4408479174 | The evolving epidemiology of antimicrobial resistance of ESKAPE pathogens isolated in the intensive care unit of a Greek university hospital | 2025-03-15 | OpenAlex | 10.1016/j.diagmicrobio.2025.116804 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408479174 | |||
| W4408492944 | Current androgen receptor antagonists under investigation for resistant prostate cancer: progress and challenges | 2025-03-16 | OpenAlex | 10.1080/14737140.2025.2481141 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408492944 | |||
| W4408536231 | Facile One‐Pot Assembly of a Versatile Photoactive Nanozyme for Highly Efficient Antibacterial Therapy | 2025-03-16 | OpenAlex | 10.1002/smll.202500895 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408536231 | |||
| W4411447120 | AI-enabled Cybersecurity using Synthetic Data | 2025-03-17 | OpenAlex | 10.1109/percomworkshops65533.2025.00055 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4411447120 | |||
| W4408536786 | Combining immune checkpoints with TNFSF agonists: a new horizon for cancer and autoimmune therapies | 2025-03-17 | OpenAlex | 10.3389/fimmu.2025.1557176 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408536786 | |||
| W4408508055 | Editorial: Exploring anesthetic risk: challenges and solutions in veterinary medicine | 2025-03-17 | OpenAlex | 10.3389/fvets.2025.1587332 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408508055 | |||
| W4408580150 | Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients | 2025-03-18 | OpenAlex | 10.1093/pnasnexus/pgaf085 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408580150 | |||
| W4408546462 | Editorial: Reviews in veterinary neurology and neurosurgery | 2025-03-18 | OpenAlex | 10.3389/fvets.2025.1583995 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408546462 | |||
| W4408579038 | Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma in 2025 | 2025-03-18 | OpenAlex | 10.1016/j.jceh.2025.102547 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408579038 | |||
| W4408545370 | Immunotherapy and Immune Checkpoint Inhibitors | 2025-03-18 | OpenAlex | 10.1201/9781032704517-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408545370 | |||
| W4408647188 | Advancement in the Management of Synchronous Colorectal Liver Metastasis: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities | 2025-03-19 | OpenAlex | 10.7759/cureus.80860 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408647188 | |||
| W4408603348 | Fourier ptychographic microscopy (FPM): a versatile label-free multimodal imaging tool, review and perspectives | 2025-03-19 | OpenAlex | 10.1117/12.3045309 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408603348 | |||
| W4408628370 | Multiple sclerosis in China: the current state of diagnosis and management | 2025-03-19 | OpenAlex | 10.1097/wco.0000000000001359 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408628370 | |||
| W4408646534 | Rethinking How We Define and Treat Periprosthetic Joint Infection | 2025-03-19 | OpenAlex | 10.2106/jbjs.24.01549 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408646534 | |||
| W4408609354 | TPNET: A Time-Sensitive Small Sample Multimodal Network for Cardiotoxicity Risk Prediction | 2025-03-19 | OpenAlex | 10.1109/jbhi.2025.3552819 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408609354 | |||
| W4408613199 | Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges | 2025-03-19 | OpenAlex | 10.1002/cncr.35806 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408613199 | |||
| W4408773376 | Use of Antiplatelet Agents in Canadian Patients: A Reflection of the 2023 Antiplatelet Guidelines | 2025-03-19 | OpenAlex | 10.58931/cct.2025.115 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4408773376 | |||
| W4408665745 | Antibody-drug conjugates in breast cancer: current evidence and future directions | 2025-03-20 | OpenAlex | 10.1186/s40164-025-00632-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408665745 | |||
| W4408657519 | Evolving antimicrobial resistance of extensively drug-resistant Gram-negative severe infections associated with conflict wounds in Ukraine: an observational study | 2025-03-20 | OpenAlex | 10.1016/j.lanepe.2025.101274 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408657519 | |||
| W4408658427 | Hypophosphatasia: Clinical Clues and Management Considerations | 2025-03-20 | OpenAlex | 10.7759/cureus.80894 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408658427 | |||
| W4408674915 | Pharmacological advances and therapeutic applications of niclosamide in cancer and other diseases | 2025-03-20 | OpenAlex | 10.1016/j.ejmech.2025.117527 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408674915 | |||
| W4408667656 | Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer | 2025-03-20 | OpenAlex | 10.1016/j.ctrv.2025.102924 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408667656 | |||
| W4408717796 | Preliminary Study Concerning the Adaptation of a Periodontal Dressing Material to the Inclusion of Therapeutic Agents | 2025-03-20 | OpenAlex | 10.24425/amm.2025.152562 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4408717796 | |||
| W4408724219 | A Reflection on the Use of Molecular Simulation to Respond to SARS-CoV-2 Pandemic Threats | 2025-03-21 | OpenAlex | 10.1021/acs.jpclett.4c03654 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408724219 | |||
| W4408732625 | Advances in radiation therapy for HCC: Integration with liver-directed treatments | 2025-03-21 | OpenAlex | 10.1097/hc9.0000000000000653 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408732625 | |||
| W4408745458 | Characteristics of Australian and New Zealand patients with chronic lymphocytic leukaemia: a lymphoma and related diseases registry report | 2025-03-21 | OpenAlex | 10.1111/imj.70037 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408745458 | |||
| W4408683420 | Editorial: Rehabilitation and alternative medicine in the healthcare for chronic rheumatic pain disorders | 2025-03-21 | OpenAlex | 10.3389/fmed.2025.1586105 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408683420 | |||
| W4409116742 | Fever in the Returning Pediatric Traveler | 2025-03-21 | OpenAlex | 10.1097/inf.0000000000004783 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409116742 | |||
| W4408808788 | Focus on old and emerging risk factors: familial hypercholesterolaemia, lipoprotein(a), and skeletal muscle adiposity | 2025-03-21 | OpenAlex | 10.1093/eurheartj/ehaf124 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408808788 | |||
| W4408682422 | Remimazolam – expectations and concerns | 2025-03-21 | OpenAlex | 10.4097/kja.25170 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408682422 | |||
| W4408803303 | Whole-Genome Sequencing, Annotation and Phenotypic Taxonomic Confirmation of a Multidrug-Resistant Escherichia coli Strain Isolated from the Blood of a Sepsis Patient | 2025-03-22 | OpenAlex | 10.1101/2025.03.21.644136 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408803303 | |||
| W4408746713 | Liposomes as immunotherapeutic carriers: A game-changer in cancer therapy | 2025-03-23 | OpenAlex | 10.1016/j.jddst.2025.106847 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408746713 | |||
| W4408842881 | A Case of Spondyloarthritis with Fulminant Extra-articular Features and Renal Amyloidosis and Difficulties in its Phenotypical Classification | 2025-03-24 | OpenAlex | 10.4103/jme.jme_171_23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408842881 | |||
| W4408808862 | Drug delivery systems incorporating bile salts: advancements since the conception of bilosomes | 2025-03-24 | OpenAlex | 10.1080/20415990.2025.2469488 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408808862 | |||
| W4408771855 | Towards AI-Powered Applications: The Development of a Personalised LLM for HRI and HCI | 2025-03-24 | OpenAlex | 10.3390/s25072024 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4408771855 | |||
| W4408885066 | Active glomerular inflammation versus chronicity and fibrosis: the role of targeted therapies in IgA nephropathy | 2025-03-25 | OpenAlex | 10.1093/ndt/gfaf059 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408885066 | |||
| W4408811224 | Addition of a short HIV-1 fusion-inhibitory peptide to PRO 140 antibody dramatically increases its antiviral breadth and potency | 2025-03-25 | OpenAlex | 10.1128/jvi.02018-24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408811224 | |||
| W4408925669 | Advances in Botulinum Toxin Applications: Enhancing Wound Healing and Optimizing Scar Management | 2025-03-25 | OpenAlex | 10.1007/s13671-025-00466-y | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408925669 | |||
| W4408821401 | Has-miR-30c-1-3p inhibits macrophage autophagy and promotes Mycobacterium tuberculosis survival by targeting ATG4B and ATG9B | 2025-03-25 | OpenAlex | 10.1038/s41598-025-94452-w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408821401 | |||
| W4408818284 | Highlights of the Issue | 2025-03-25 | OpenAlex | 10.70777/si.v2i1.14075 | Title/abstract | Excluded | E1: Editorial/issue highlights summarizing other publications, not an original adapting agent study. | https://openalex.org/W4408818284 | |||
| W4408884794 | Update 2025: Management of Non‑Small-Cell Lung Cancer | 2025-03-25 | OpenAlex | 10.1007/s00408-025-00801-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408884794 | |||
| W4408847435 | CDA Formulations as Superb and Excellent Cancer Drugs to Save Cancer Patients | 2025-03-26 | OpenAlex | 10.47363/jcrr/2025(8)209 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408847435 | |||
| W4408900448 | Deep Neuromuscular Blockade During General Anesthesia: Advantages, Challenges, and Future Directions | 2025-03-26 | OpenAlex | 10.3390/anesthres2020008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408900448 | |||
| W4408855038 | Guidelines for the evolving landscape of liver disease: From viral hepatitis to MAFLD | 2025-03-26 | OpenAlex | 10.1097/cm9.0000000000003616 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408855038 | |||
| W4408866876 | Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial | 2025-03-26 | OpenAlex | 10.1016/j.cct.2025.107887 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408866876 | |||
| W4408913877 | Recent advances in therapeutic strategies for non-small cell lung cancer | 2025-03-26 | OpenAlex | 10.1186/s13045-025-01679-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408913877 | |||
| W4408972749 | Writing a Letter of Recommendation Without Bias | 2025-03-26 | OpenAlex | 10.5435/jaaos-d-24-00827 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408972749 | |||
| W4408890515 | Future Perspectives of Spinel Nano-Ferrites | 2025-03-27 | OpenAlex | 10.1201/9781003568940-19 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408890515 | |||
| W4408859007 | Семиотика буквы в современном искусстве: шрифтовой биохакинг Одеда Эзера | 2025-03-27 | OpenAlex | 10.23951/2312-7899-2025-1-70-92 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4408859007 | |||
| W4408923764 | A Case of Cutaneous Fungal Infection Following the Administration of Dupilumab | 2025-03-28 | OpenAlex | 10.7759/cureus.81349 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408923764 | |||
| W4408957580 | Aseptic meningitis: a foundation review | 2025-03-28 | OpenAlex | 10.1097/qco.0000000000001105 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408957580 | |||
| W4408987062 | Demystifying Cell and Gene Therapy Orchestration in Supply Chain Technical Operations | 2025-03-28 | OpenAlex | 10.32628/cseit25112731 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408987062 | |||
| W4408943766 | Integrative Design of ADAMTS Partial Agonists within a Multi-Hallmark Therapeutic Framework: The Beginning of Paving the Way Toward a Functional Cure for Neurodegenerative Disorders | 2025-03-28 | OpenAlex | 10.26434/chemrxiv-2025-4n2nb-v3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408943766 | |||
| W4408939628 | Prospective Implications of Autologous Platelet-Rich Plasma in Tissue Engineering and Organ Rejuvenation | 2025-03-28 | OpenAlex | 10.1201/9781003611509-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408939628 | |||
| W4408932095 | Surgical Site Infection Rates by Specialty for Patients Who Undergo Sacral Neuromodulation Surgery | 2025-03-28 | OpenAlex | 10.1097/aog.0000000000005851.101 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408932095 | |||
| W4408918824 | Synthesis, bioactivity, and molecular docking studies: novel arylpiperazine derivatives as potential new-resistant AR antagonists | 2025-03-28 | OpenAlex | 10.3389/fchem.2025.1557275 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408918824 | |||
| W4408925074 | The First Report of a Pulmonary Abscess Due to Streptococcus intermedius in Rabbits in Romania | 2025-03-28 | OpenAlex | 10.3390/microorganisms13040769 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4408925074 | |||
| W4409962087 | Towards personalized therapy for atrial fibrillation: the rhythmic climbing of dronedarone | 2025-03-28 | OpenAlex | 10.1093/europace/euaf079 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409962087 | |||
| W4409277631 | Approaches To Managing Relapsed Myeloma: Switching Drug Class or Retreatment With Same Drug Class? | 2025-03-29 | OpenAlex | 10.1007/s12288-025-02008-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409277631 | |||
| W4408962942 | Statistical Study of Bacterial Urinary Tract Infections for the Period 2019 to 2023 | 2025-03-29 | OpenAlex | 10.29196/jubpas.v33i1.5645 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4408962942 | |||
| W4408984764 | WITHDRAWN | 2025-03-30 | OpenAlex | 10.31237/osf.io/qs37b_v1 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4408984764; https://openalex.org/W4412830963; https://openalex.org/W4415660100; https://openalex.org/W4411008130 | |||
| W4409026417 | A case of acute exudative polymorphous vitelliform maculopathy successfully treated with systemic steroid | 2025-03-31 | OpenAlex | 10.4103/tjo.tjo-d-24-00140 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409026417 | |||
| W4409086174 | Alpha radioligand therapy in neuroendocrine neoplasms: current landscape and spotlight on RYZ101 | 2025-03-31 | OpenAlex | 10.1080/14796694.2025.2485650 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409086174 | |||
| W4409550619 | Development of Monoclonal Antibody Application in Cancer Therapy: The Roles of ADCC, CDC, ADCP, and ADC | 2025-03-31 | OpenAlex | 10.7841/ksbbj.2025.40.1.22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409550619 | |||
| W4409021950 | Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2 -mutated post-MPN AML | 2025-03-31 | OpenAlex | 10.1182/blood.2024027117 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409021950 | |||
| W4408999553 | Etiological characteristics of 3,691 cases of microbial keratitis: an 8-year longitudinal study | 2025-03-31 | OpenAlex | 10.1128/spectrum.02630-24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4408999553 | |||
| W7204664917 | Large Language Model-Based Academic Writing Support Framework for University English Learners | 2025-03-31 | OpenAlex | 10.67050/ijee/v14i1/ijee251014 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204664917 | |||
| W7115566030 | Study of Biological Properties of Ethnobotanically Important Plants of Tehsil Kotmomin | 2025-03-31 | OpenAlex | 10.53762/grjnst.03.01.29 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7115566030 | |||
| W4409184343 | Systematic literature review related to the theoretical knowledge base for non-invasive monitoring of the biomechanical and viscoelastic properties of the myotendinous complex in patients with complete tetraplegia following cervical spinal cord injury | 2025-03-31 | OpenAlex | 10.12680/balneo.2025.798 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409184343 | |||
| W4409136939 | The review of modern prospects for the pharmacological treatment of obesity and its complications – The role of GLP- 1, GLP1 / GIP, GLP1 / GIP / GCG receptor agonists | 2025-03-31 | OpenAlex | 10.54905/disssi.v29i157.e50ms3543 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409136939 | |||
| W4410554647 | Addressing the Critical Gap in Biological Therapies for Inflammatory Bowel Disease in Syria | 2025-04-01 | OpenAlex | 10.1055/s-0045-1809039 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410554647 | |||
| W4411715018 | Advances in Oral Cancer Diagnosis and Treatment | 2025-04-01 | OpenAlex | 10.4103/jiaomr.jiaomr_140_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411715018 | |||
| W4409117539 | Biomarkers in Alzheimer’s disease: Emerging trends and clinical implications | 2025-04-01 | OpenAlex | 10.1097/cm9.0000000000003579 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409117539 | |||
| W4410875309 | Bridging pandemic and oncology challenges: Surface-enhanced Raman spectroscopy in the fight against COVID-19 and cancer | 2025-04-01 | OpenAlex | 10.1177/00368504251342977 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410875309 | |||
| W7215947998 | CURRENT TRENDS IN AXIAL SPONDYLOARTHRITIS MANAGEMENT: A STATE-OF-THE-ART REVIEW OF TREATMENT OPTIONS | 2025-04-01 | OpenAlex | 10.55640/irjmshc-v02i04-01 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215947998 | |||
| W4409632480 | Care of the bedridden patient | 2025-04-01 | OpenAlex | 10.4103/singaporemedj.smj-2022-123 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409632480 | |||
| W4410640435 | Chemotherapy hypersensitivity: Current insights and novel desensitization strategies | 2025-04-01 | OpenAlex | 10.1016/j.jahd.2025.100042 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410640435 | |||
| W4409207563 | Chemotherapy-Induced Bone Marrow Suppression: A Bibliometrics Analysis | 2025-04-01 | OpenAlex | 10.2147/jmdh.s507187 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409207563 | |||
| W4409818420 | Comparative Evaluation of Typical Antipsychotic Haloperidol with Atypical Antipsychotics Olanzapine, Risperidone and Aripiprazole in the Treatment of Stable Schizophrenia in a Tertiary Care Teaching Hospital at Dehradun, Uttarakhand, India: A Randomised Clinical Trial | 2025-04-01 | OpenAlex | 10.7860/jcdr/2025/77295.20888 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409818420; https://openalex.org/W4409778303 | |||
| W4409485262 | Con: Artificial Intelligence in Manuscript Writing: Pitfalls and Ethical Concerns the Authors Should Be Aware | 2025-04-01 | OpenAlex | 10.4103/aca.aca_9_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409485262 | |||
| W4411461093 | Diagnostic and therapeutic challenges in Non-Alcoholic Fatty Liver Disease (NAFLD) | 2025-04-01 | OpenAlex | 10.22271/27069567.2025.v7.i2b.632 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411461093 | |||
| W7117253470 | Diarrheagenic Escherichia Coli among students in the Ashanti Region of Ghana | 2025-04-01 | OpenAlex | 10.26355/mhd_20254_1189 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117253470 | |||
| W4409898580 | E031 Scleromyxedema: a scleroderma mimic | 2025-04-01 | OpenAlex | 10.1093/rheumatology/keaf142.268 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409898580 | |||
| W4409039016 | Effect of Operative Plane on Anesthetic Requirements in Tissue Expander Breast Reconstruction Patients | 2025-04-01 | OpenAlex | 10.1097/sap.0000000000004256 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409039016 | |||
| W4409147698 | Efficacy and Safety of Quadruplet Therapy in Newly Diagnosed Transplant‐Eligible Multiple Myeloma: A Systematic Review and Meta‐Analysis | 2025-04-01 | OpenAlex | 10.1002/cnr2.70171 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409147698 | |||
| W4410862602 | Evolving frontiers in dermatologic science and clinical care | 2025-04-01 | OpenAlex | 10.4103/ds.v43-2_editorial | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4410862602 | |||
| W4411972589 | Integrating Positron Emission Tomography Combined with Computed Tomography Imaging into Advanced Radiation Therapy Planning: Clinical Applications, Innovations, and Challenges | 2025-04-01 | OpenAlex | 10.4103/jmp.jmp_34_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411972589 | |||
| W4414181637 | Molecular Mechanisms of Hypericin and Hyperforin in Modulating Mammalian Neurotransmitter Systems: A Review | 2025-04-01 | OpenAlex | 10.1192/j.eurpsy.2025.1682 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414181637 | |||
| W4411713775 | Outpatient Parenteral Antibiotic Therapy: A Cornerstone of Modern Health Care | 2025-04-01 | OpenAlex | 10.4103/cids.cids_71_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411713775 | |||
| W4410012986 | Pharmacology: The Powerhouse of Drug Discovery and Therapy | 2025-04-01 | OpenAlex | 10.21275/sr25422213107 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410012986 | |||
| W4410371036 | Plain Roentgenography in Diagnosing Neonatal Gastrointestinal Emergencies | 2025-04-01 | OpenAlex | 10.4103/ipcares.ipcares_88_25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410371036 | |||
| W4409107933 | Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer | 2025-04-01 | OpenAlex | 10.2147/itt.s495751 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409107933 | |||
| W7140030750 | Social Protection in Complex Information Environments: Discussion on Social Resilience through Information Anesthesia and Cushioning to Mitigate Information Shocks | 2025-04-01 | OpenAlex | 10.5281/zenodo.19165111 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7140030750 | |||
| W4409212125 | The Company of Biologists Workshops: supporting our community and inspiring new science | 2025-04-01 | OpenAlex | 10.1242/dev.204708 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409212125 | |||
| W4409395535 | The Rise of AI Agents: Transforming Enterprise Automation | 2025-04-01 | OpenAlex | 10.35629/5252-0704132139 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4409395535 | |||
| W4409840176 | The Role of LLM Agent Apps in Conversational AI | 2025-04-01 | OpenAlex | 10.63345/ijrmeet.org.v13.i4.12 | Title/abstract | Excluded | E1: Survey/taxonomy or discussion of existing applications; not a newly built or evaluated adapting clinical agent. | https://openalex.org/W4409840176 | |||
| W4411550198 | The rapidly emerging field of RNA therapies for cardiovascular disease | 2025-04-01 | OpenAlex | 10.1097/cp9.0000000000000121 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411550198 | |||
| W4409157970 | Trends in Atopic Dermatitis Management: A NAMCS Retrospective Analysis (2013-2019) | 2025-04-01 | OpenAlex | 10.62186/001c.133837 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409157970 | |||
| W4409131710 | Verifiable and secure data sharing in crowdsourcing-based healthcare | 2025-04-01 | OpenAlex | 10.1007/s11227-025-07185-y | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409131710 | |||
| W4409100563 | A Survey of the Model Context Protocol (MCP): Standardizing Context to Enhance Large Language Models (LLMs) | 2025-04-02 | OpenAlex | 10.20944/preprints202504.0245.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409100563 | |||
| W4409081366 | Bioinspired Suction-Driven Strategies with Nanoscale Skin-Controllable Adhesive Architectures for Efficient Liquid Formulated Transdermal Patches | 2025-04-02 | OpenAlex | 10.1021/acsnano.5c00585 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409081366 | |||
| W7215238945 | Caracterización clínica-epidemiológica de las Bronquiolitis en pacientes pediátricos. Hospital General docente “Héroes del Baire”. Isla de la Juventud. | 2025-04-02 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7215238945 | ||||
| W4409111735 | Critical medications in cardiology: strategic policy of the European Medicines Agency | 2025-04-02 | OpenAlex | 10.1093/eurheartj/ehaf134 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409111735 | |||
| W4409067181 | Editorial: Five-membered ring heterocyclic compounds as anticancer drug candidates | 2025-04-02 | OpenAlex | 10.3389/fchem.2025.1599140 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409067181 | |||
| W4409091111 | Evaluating large language models and agents in healthcare: key challenges in clinical applications | 2025-04-02 | OpenAlex | 10.1016/j.imed.2025.03.002 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4409091111 | |||
| W4409143598 | Recent Advances in the Diagnosis and Treatment of Paediatric Endocrine Disorders | 2025-04-03 | OpenAlex | 10.1111/jpc.70047 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409143598 | |||
| W4409148416 | Updates in Diagnosis and Treatment of Immune Checkpoint Inhibitor Myocarditis | 2025-04-03 | OpenAlex | 10.1007/s11886-025-02232-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409148416 | |||
| W4409121205 | Updates on Glomerular Diseases: A Summary of Inaugural GlomCon Hawaii 2024 | 2025-04-03 | OpenAlex | 10.1159/000543863 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409121205 | |||
| W4409188381 | Aggressive B‐cell non‐Hodgkin lymphoma | 2025-04-04 | OpenAlex | 10.1002/9781119706687.ch27 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409188381 | |||
| W4409188412 | Childhood acute lymphoblastic leukaemia | 2025-04-04 | OpenAlex | 10.1002/9781119706687.ch22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409188412 | |||
| W4409118780 | Clostridioides difficile in feral horse populations in Australia | 2025-04-04 | OpenAlex | 10.1128/aem.02114-24 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4409118780 | |||
| W4409176255 | Editorial: Onconephrology: evolving concepts and challenges | 2025-04-04 | OpenAlex | 10.3389/fneph.2025.1585605 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409176255 | |||
| W4409184040 | Floral extracts promising avenue for sustainable approach for nanoparticles: an updated review | 2025-04-04 | OpenAlex | 10.1007/s41204-025-00423-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409184040 | |||
| W4409329418 | Proposing Bromo-Epi-Androsterone (BEA) for Stiff Person Syndrome (SPS) | 2025-04-05 | OpenAlex | 10.3390/microorganisms13040824 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409329418 | |||
| W4409197383 | Ablation Medical Devices with Chemical Technologies: Engineering aspects, System, Mechanism, and Future Directions. | 2025-04-06 | OpenAlex | 10.36948/ijfmr.2025.v07i02.39465 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409197383 | |||
| W7113491913 | The use of Artificial intelligence in Tuberculosis | 2025-04-06 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7113491913 | ||||
| W4409275602 | 40 years after the discovery of Helicobacter Pylori : Performing optimized “subtraction” for clinical eradication | 2025-04-07 | OpenAlex | 10.1002/imo2.70017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409275602 | |||
| W4409211432 | AI-Driven Avatars for Smarter Decisions: Reducing Bias and Strengthening Critical Thinking | 2025-04-07 | OpenAlex | 10.3991/ijac.v18i2.52589 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4409211432 | |||
| W4409237434 | Comprehensive Management and Treatment Insights in Disseminated Central Nervous System and Skin Infection by Fusarium Species in Myelodysplastic Syndrome: A Case Report (P10-10.006) | 2025-04-07 | OpenAlex | 10.1212/wnl.0000000000211846 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409237434 | |||
| W4409270619 | Evolving dermatological complaints following the 2023 Turkey and Syria earthquake: insights from a disaster-affected region | 2025-04-07 | OpenAlex | 10.1007/s00403-025-04195-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409270619 | |||
| W4409210173 | Immune-Based Strategies for Pancreatic Cancer in the Adjuvant Setting | 2025-04-07 | OpenAlex | 10.3390/cancers17071246 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409210173 | |||
| W7160243636 | KETAMINE USE AND REGULATORY PRACTICES IN GHANA: INSIGHTS INTO ANESTHETIC AND ANALGESIC APPLICATIONS | 2025-04-07 | OpenAlex | 10.5281/zenodo.20038345 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160243636 | |||
| W4409212942 | Myeloproliferative neoplasms | 2025-04-07 | OpenAlex | 10.1016/j.mpmed.2025.02.006 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409212942 | |||
| W7200542602 | THE IMPACT OF THERAPEUTIC INTERVENTIONS ON THE PATHOGENESIS OF THYROID EYE DISEASE | 2025-04-07 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7200542602 | ||||
| W4409233526 | The Importance of Correct Diagnosis of Transthyretin Amyloid Cardiomyopathy | 2025-04-07 | OpenAlex | 10.1159/000544942 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409233526 | |||
| W4409213543 | Theranostics in Hematological Malignancies: Cutting-Edge Advances in Diagnosis and Targeted Therapy | 2025-04-07 | OpenAlex | 10.3390/cancers17071247 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409213543 | |||
| W4409240101 | 1,3,4-Oxadiazole-based EGFR inhibitors as anticancer therapeutics: SAR study and binding mode of interaction analysis | 2025-04-08 | OpenAlex | 10.1016/j.ejmcr.2025.100265 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409240101 | |||
| W4409270598 | Advances and future outlook in clinical trials for treating systemic sclerosis-interstitial lung disease | 2025-04-08 | OpenAlex | 10.1080/17476348.2025.2490729 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409270598 | |||
| W4409299877 | Advances in Current Treatment Paradigms for Metastatic Hormone-Sensitive Prostate Cancer | 2025-04-08 | OpenAlex | 10.3390/jcm14082565 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409299877 | |||
| W4409277394 | Editorial: Metabolomics in personalized cancer medicine | 2025-04-08 | OpenAlex | 10.3389/fmolb.2025.1593877 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409277394 | |||
| W4409328138 | Induction Treatment for HIV-Associated Cryptococcal Meningitis: Where Have We Been and Where Are We Going? | 2025-04-08 | OpenAlex | 10.3390/microorganisms13040847 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409328138 | |||
| W4409265123 | The hepatitis B virus surface antigen: An evolved perfection and its unresolved mysteries | 2025-04-08 | OpenAlex | 10.1016/j.virol.2025.110527 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409265123 | |||
| W4409328066 | Delayed Diagnosis and Evolving Trends in Gastric Cancer During and After COVID-19: A Comparative Study of Staging, Helicobacter pylori Infection and Bleeding Risk in Western Romania | 2025-04-09 | OpenAlex | 10.3390/diagnostics15080950 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409328066 | |||
| W4409310283 | Digital Ethics | 2025-04-09 | OpenAlex | 10.1002/9781394372409.ch1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409310283 | |||
| W4409289636 | Emerging Viral Infections (ZIKV, SARS‐CoV‐2, and MPXV) and Depression: Ketamine and (S, R)‐Ketamine as Promising Antidepressants | 2025-04-09 | OpenAlex | 10.1002/rmv.70036 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409289636 | |||
| W4409290644 | How does antifungal resistance vary in Candida (Candidozyma) auris and its clades? Quantitative and qualitative analyses and their clinical implications | 2025-04-09 | OpenAlex | 10.1016/j.cmi.2025.04.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409290644 | |||
| W4409376618 | Clinical Strategies for the Chemoprevention of Localized Prostate Cancer | 2025-04-10 | OpenAlex | 10.9734/bpi/msraa/v1/4818 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409376618 | |||
| W4409339259 | Immunotherapy for Renal Cell Carcinoma—What More is to Come? | 2025-04-10 | OpenAlex | 10.1007/s11523-025-01143-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409339259 | |||
| W4409325619 | MIOCARDITE INFECCIOSA: ATUALIZAÇÕES EM DIAGNÓSTICO, MANEJO CLÍNICO E PERSPECTIVAS TERAPÊUTICAS | 2025-04-10 | OpenAlex | 10.69849/revistaft/dt10202504102301 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409325619 | |||
| W4409344912 | Mapping the future: bibliometric insights into ferroptosis and diabetic nephropathy | 2025-04-10 | OpenAlex | 10.3389/fphys.2025.1516466 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409344912 | |||
| W4409345128 | Preventing common mental health problems in war-affected populations: the role of digital interventions | 2025-04-10 | OpenAlex | 10.3389/fdgth.2025.1586030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409345128 | |||
| W4409334244 | Rituximab, Apremilast, and Upadacitinib as Selected Biosimilar and Targeted Synthetic Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action: Their Current Use in Slowing Down the Progression of Disease | 2025-04-10 | OpenAlex | 10.3390/jcm14082605 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409334244 | |||
| W4409358600 | Barriers to allogeneic stem cell transplantation in responding patients with TP53-mutated acute myeloid leukemia | 2025-04-11 | OpenAlex | 10.1038/s41409-025-02590-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409358600 | |||
| W4409320212 | Current update on pharmacological strategies of penile cancer | 2025-04-11 | OpenAlex | 10.1080/14656566.2025.2492335 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409320212 | |||
| W4409370714 | Non-surgical endodontics: contemporary biomechanical preparation of the root canal system | 2025-04-11 | OpenAlex | 10.1038/s41415-025-8599-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409370714 | |||
| W4409369771 | Nucleolar immunohistochemical expression of H3K27me3 in a pediatric cerebellar lesion: A true or false positive? | 2025-04-11 | OpenAlex | 10.4103/tcmj.tcmj_289_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409369771 | |||
| W4409391043 | Dual Antiplatelet Therapy: Unlocking the Future of Cardiovascular Disease Management | 2025-04-12 | OpenAlex | 10.22214/ijraset.2025.68412 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409391043 | |||
| W4410876417 | Integrating infectious diseases into life course epidemiology | 2025-04-12 | OpenAlex | 10.1093/ije/dyaf059 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410876417 | |||
| W4409383441 | The evolving landscape of biomarkers for systemic therapy in advanced hepatocellular carcinoma | 2025-04-12 | OpenAlex | 10.1186/s40364-025-00774-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409383441 | |||
| W4409556701 | Thyroid Abscess due to Salmonella: Rare Entity of Unpredictable Severity | 2025-04-12 | OpenAlex | 10.36346/sarjap.2025.v06i02.003 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409556701 | |||
| W4409397769 | Mycophenolate Mofetil Use for Inflammatory Bowel Disease | 2025-04-13 | OpenAlex | 10.71079/aside.gi.04142552 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409397769 | |||
| W4409589563 | Management of CRE Infection with a Focus on New Antimicrobial Agents | 2025-04-14 | OpenAlex | 10.29011/2577-1515.100273 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4409589563 | |||
| W4411276970 | Evolving Strategies in Targeted Drug Delivery for Optimized Cancer Therapy: A Comprehensive Review | 2025-04-15 | OpenAlex | 10.37285/ijpsn.2025.18.2.12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411276970 | |||
| W4409479478 | Exploring the efficacy and safety of lecanemab in the management of early Alzheimer’s disease: A systematic review of clinical evidence | 2025-04-15 | OpenAlex | 10.1177/13872877251331640 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409479478 | |||
| W4409454628 | Glucocorticoids-induced remission followed by rituximab as maintenance therapy for podocytopathy with minimal change lesions in adults | 2025-04-15 | OpenAlex | 10.1093/ndt/gfaf050 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409454628 | |||
| W4409478839 | Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology | 2025-04-15 | OpenAlex | 10.3322/caac.70001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409478839 | |||
| W4409461755 | Prevalence of New Delhi Metallo-β-lactamase (blaNDM) gene in a selected population of drug-resistant clinical isolates | 2025-04-15 | OpenAlex | 10.1007/s11033-025-10446-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409461755 | |||
| W4409504825 | ESTUDO SOBRE OS PROCESSOS DE MEDICALIZAÇÃO E DESMEDICALIZAÇÃO NO CAMPO DA SAÚDE MENTAL | 2025-04-16 | OpenAlex | 10.16891/2317-434x.v13.e5.a2025.id2243 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409504825 | |||
| W4409516525 | Editorial: Autophagy and lung cancer therapy: targeted drug development and new emerging technology | 2025-04-16 | OpenAlex | 10.3389/fphar.2025.1599548 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409516525 | |||
| W4409516558 | Editorial: Multi-omics application in exploring potential biomarkers targeting resistance of anti-cancer drugs | 2025-04-16 | OpenAlex | 10.3389/fphar.2025.1594064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409516558 | |||
| W7215201955 | MODERN CLASSIFICATION OF PYODERMA AND THE IMPORTANCE OF ANTISEPTIC AGENTS | 2025-04-16 | OpenAlex | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7215201955 | ||||
| W4409957345 | Swarm Intelligence for Dynamic and Multi-Scale Toxicity Prediction in Drug Discovery | 2025-04-16 | OpenAlex | 10.47392/irjaem.2025.0195 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409957345 | |||
| W4409511931 | Targeting Lung Cancer with Precision: The ADC Therapeutic Revolution | 2025-04-16 | OpenAlex | 10.1007/s11912-025-01655-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409511931 | |||
| W4409483880 | The History of Dermal Fillers in Dermatologic Surgery | 2025-04-16 | OpenAlex | 10.1097/dss.0000000000004650 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409483880 | |||
| W4409552526 | BONE & BONE MATRIX BUILDERS: KEY FRONTIERS IN OSTEOPOROSIS MANAGEMENT | 2025-04-17 | OpenAlex | 10.53555/z9drvn04 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409552526 | |||
| W7110625596 | Dysregulation of tryptophan biosynthesis as a putative treatment approach for nontypeable Haemophilus influenzae, a causative agent of otitis media | 2025-04-17 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7110625596 | ||||
| W4409564986 | From Biopower to Embodiment: Reconfiguring Healthcare Beyond the Pandemic of Medicalization | 2025-04-18 | OpenAlex | 10.31584/psumj.2025277717 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4409564986 | |||
| W4409587022 | Guidelines for the Storage, Isolation, and Characterization of Extracellular Vesicle Research | 2025-04-18 | OpenAlex | 10.52927/jdcr.2025.13.1.9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409587022 | |||
| W4409617137 | Role of Insect-Derived Antimicrobial Peptides in Overcoming Multidrug-Resistant Infections | 2025-04-18 | OpenAlex | 10.36948/ijfmr.2025.v07i02.41583 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409617137 | |||
| W4409591330 | An evaluation of epcoritamab as a treatment for relapsed or refractory follicular lymphoma | 2025-04-19 | OpenAlex | 10.1080/14737140.2025.2492787 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409591330 | |||
| W4409605614 | Desmoplastic small round cell tumor: an update of current management practices | 2025-04-20 | OpenAlex | 10.1186/s43046-025-00276-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409605614 | |||
| W4409763365 | Kuzey Kıbrıs’tan İzole Edilen Kutanöz Layşmanyazis ve Kanin Layşmanyazis Suşlarının Moleküler Karakterizasyonu ve Fare Modellerinde Klinik Yansımaları | 2025-04-20 | OpenAlex | 10.5578/mb.202502149 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409763365 | |||
| W4409689386 | Abstract 1087: The evolving landscape of cancer transcriptomics data | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-1087 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409689386 | |||
| W4409628033 | Abstract 1228: High throughput phenotyping and drug discovery using the TumorGraft3D co-culture platform and flow cytometry | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-1228 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409628033 | |||
| W4409624675 | Abstract 1245: Delaying resistance to Gefitinib in EGFR+ NSCLC through optimized treatment scheduling: an integrated experimental-theoretical approach | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-1245 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409624675 | |||
| W4409628153 | Abstract 1705: MUC1-C is a target for antibody-drug conjugate treatment of MRTX1133-resistant KRAS G12D mutant pancreatic ductal adenocarcinomas | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-1705 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409628153 | |||
| W4409627530 | Abstract 1805: Dual-payload TME-activated ADC platform | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-1805 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409627530 | |||
| W4409689102 | Abstract 2128: Uncovering the multiple therapeutic mechanisms of trastuzumab deruxtecan (T-DXd): effective extracellular payload release and immunomodulatory stimulation | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-2128 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409689102 | |||
| W4409627001 | Abstract 2197: Uncovering immune evasion in EGFR-mutant and treatment resistant NSCLC: insights from a novel mouse model | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-2197 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409627001 | |||
| W4409689833 | Abstract 2486: Decoding tumor evolution through fitness landscapes of aneuploid cells | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-2486 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409689833 | |||
| W4409634351 | Abstract 2627: Integrated multi-omics analyses discovers lineage plasticity in desmoplastic small round cell tumors | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-2627 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409634351 | |||
| W4409627422 | Abstract 2902: Systematic mapping of chemo-genomic interactions between DNA damaging agents and DNA damage repair genes with targeted CRISPR knockout screening | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-2902 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409627422 | |||
| W4409634389 | Abstract 4446: Collateral drug screening throughout the evolution of osteosarcoma drug resistance | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-4446 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409634389 | |||
| W4409633637 | Abstract 4564: Enhancing circulating tumor DNA recovery and liquid biopsy sensitivity with precision liposomal priming agents | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-4564 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409633637 | |||
| W4409631364 | Abstract 4864: The dysregulated YY1-EZH2-RKIP axis in cancer and immune evasion | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-4864 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409631364 | |||
| W4409631647 | Abstract 5187: Characterization and prediction of drug responses in NF1 patient-derived tumor organoids through multiplex phenotypic profiling | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-5187 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409631647 | |||
| W4409632611 | Abstract 5808: Differential clinical outcomes of immune vs non-immune based therapeutics in gastrointestinal malignancies: A retrospective, single center experience of early phase studies | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-5808 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409632611 | |||
| W4409652522 | Abstract 7495: The evolving ECM architecture shapes unique evolutionary trajectories of breast tumor immune escape and elimination | 2025-04-21 | OpenAlex | 10.1158/1538-7445.am2025-7495 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409652522 | |||
| W4409648155 | Alopecia Areata: Pathogenesis, Diagnosis, and Therapies | 2025-04-21 | OpenAlex | 10.1002/mco2.70182 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409648155 | |||
| W7110480573 | Digital Thread: Bridging Macro–Micro Services in System-of-Systems | 2025-04-21 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7110480573 | ||||
| W4409626453 | Does Chemotherapy-Induced Peripheral Neuropathy Fall Within the Spectrum of Complex Regional Pain Syndrome? A Narrative Review | 2025-04-21 | OpenAlex | 10.1007/s11916-025-01390-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409626453 | |||
| W4409805299 | Updates in immunomodulator therapy in ocular surface inflammatory diseases | 2025-04-21 | OpenAlex | 10.1097/icu.0000000000001140 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409805299 | |||
| W7120316457 | Bridging the Human-in-the-Loop Gap in Robotics Through Language: A Multimodal Agentic AI for Scaling Human Supervision in Autonomous Systems | 2025-04-22 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7120316457 | ||||
| W4409657923 | Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer | 2025-04-22 | OpenAlex | 10.36401/jipo-24-36 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409657923 | |||
| W4409712688 | Editorial: Microbiome in an immunocompromised host- a jungle of challenges or a glacier of hidden opportunities? | 2025-04-23 | OpenAlex | 10.3389/fcimb.2025.1569842 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409712688 | |||
| W4409710415 | Editorial: Rare hematological malignancies | 2025-04-23 | OpenAlex | 10.3389/fcell.2025.1600063 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409710415 | |||
| W4409704743 | PSMA-based Therapies and Novel Therapies in Advanced Prostate Cancer: The Now and the Future | 2025-04-23 | OpenAlex | 10.1007/s11864-025-01317-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409704743 | |||
| W4417286171 | Registro multicéntrico prospectivo de pacientes hospitalizados por síndrome coronario agudo sin elevación del segmento ST en centros de alta complejidad. Resultados intrahospitalarios y evolución a 6 meses (Buenos Aires I) | 2025-04-23 | OpenAlex | 10.7775/rac.v88i4.669 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417286171 | |||
| W4409729826 | Treatment Sequencing in Metastatic HR+/HER2− Breast Cancer: A Delphi Consensus | 2025-04-23 | OpenAlex | 10.3390/cancers17091412 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409729826 | |||
| W4409695091 | Tumor Treating Fields (TTFields) Therapy in Unresectable Pleural Mesothelioma: Overview of Efficacy, Safety, and Future Outlook | 2025-04-23 | OpenAlex | 10.1007/s11864-025-01320-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409695091 | |||
| W4409732983 | Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the Future | 2025-04-24 | OpenAlex | 10.1007/s13300-025-01738-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409732983 | |||
| W4409735046 | Clinicopathologic correlation case 2: multifocal, symptomatic oral mucosal lesions | 2025-04-24 | OpenAlex | 10.1016/j.oooo.2025.01.721 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409735046 | |||
| W4410016853 | Comprehensive pharmacy-based investigational drug service: A 40-year update | 2025-04-24 | OpenAlex | 10.1093/ajhp/zxaf104 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410016853 | |||
| W4409747090 | Corrigendum: Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting | 2025-04-24 | OpenAlex | 10.3389/fphar.2025.1591443 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4409747090 | |||
| W4409747088 | Editorial: The role of ubiquitination in disease development, progression, and prognosis | 2025-04-24 | OpenAlex | 10.3389/fimmu.2025.1595755 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409747088 | |||
| W4409763210 | Functionalization of Implantable Systems for Controlled Drug Delivery and Beyond | 2025-04-24 | OpenAlex | 10.1007/s40883-025-00401-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409763210 | |||
| W4409737282 | Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma | 2025-04-24 | OpenAlex | 10.1001/jamaoto.2025.0410 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409737282 | |||
| W4409737578 | Q&A: Louis Staudt on Molecular Classification of Cancer | 2025-04-24 | OpenAlex | 10.1158/2643-3230.bcd-25-0133 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409737578 | |||
| W4412567825 | Self-Organizing Microservice Composition for IoT-Enabled Neonatal Monitoring | 2025-04-24 | OpenAlex | 10.1109/amathe65477.2025.11081365 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412567825 | |||
| W4409821428 | Abstract SY37-02: Adapting radiotherapy to cancer immunotherapy | 2025-04-25 | OpenAlex | 10.1158/1538-7445.am2025-sy37-02 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409821428 | |||
| W4409820726 | Abstract SY43-01: Translating adaptive therapy to ovarian cancer patients | 2025-04-25 | OpenAlex | 10.1158/1538-7445.am2025-sy43-01 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409820726 | |||
| W4409798427 | Case to Vignette: A Framework to Elevate Narrative by Embracing Vignette-Based Learning in Medicine | 2025-04-25 | OpenAlex | 10.1007/s11606-025-09531-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409798427 | |||
| W4409825526 | Editorial: Targeting neuroinflammation for novel therapeutics in neurodegenerative diseases | 2025-04-25 | OpenAlex | 10.3389/fphar.2025.1602495 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409825526 | |||
| W4409788590 | Entheogen: an evolutionary medicine for neuropsychiatric disorders | 2025-04-25 | OpenAlex | 10.1093/nsr/nwaf168 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409788590 | |||
| W4409816017 | Exploring pyridinium-based inhibitors of cholinesterases: A review of synthesis, efficacy, and structural insights | 2025-04-25 | OpenAlex | 10.1016/j.ejmcr.2025.100270 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409816017 | |||
| W7164143015 | Health Informatics-Based Telecounseling Innovation in Mental Health Services | 2025-04-25 | OpenAlex | 10.57185/3e3z2n84 | Full text | Excluded | F3: The evaluated platform provides practitioner-delivered video telecounseling, messaging and symptom monitoring. The Methods describes practitioner training and6–12 counseling sessions, not an implemented LLM acting-agent system. General AI background statements do not establish an LLM intervention. | https://openalex.org/W7164143015 | https://healthinformaticsjournal.al-makkipublisher.com/index.php/hij/article/view/78/74 | Publisher PDF.js online text, abstract and Methods/Results pp215–220 read; no file archive/download. Landing-page abstract is mistakenly a bibliography, so actual PDF text was used. | |
| W4409787552 | Innovative therapeutics for renoprotection: Where we are | 2025-04-25 | OpenAlex | 10.1016/j.pharmr.2025.100060 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409787552 | |||
| W4409805671 | Programmed wound healing in aged skin may be enhanced by mesenchymal cell loaded gene-activated scaffolds | 2025-04-25 | OpenAlex | 10.1063/5.0240504 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409805671 | |||
| W4409819469 | Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Renal Cell Carcinoma Post-Immune-Oncology and Vascular Endothelial Growth Factor Receptor Targeted Therapies | 2025-04-25 | OpenAlex | 10.3390/cancers17091434 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409819469 | |||
| W7133239314 | The 5 Pillars of Grace: A Formal Architecture for Recursive Reflective Coherence | 2025-04-25 | OpenAlex | 10.5281/zenodo.18838931 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7133239314 | |||
| W4409843897 | Case Series on Comparison Between Dexmedetomidine and Propofol as Preanaesthetic Medication in Awake Fibreoptic Intubation | 2025-04-26 | OpenAlex | 10.21275/sr25421185220 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409843897 | |||
| W4409835012 | The emerging role of proactive therapy in atopic dermatitis and psoriasis | 2025-04-26 | OpenAlex | 10.12775/jehs.2025.80.59456 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409835012 | |||
| W4409852851 | Tackling CMV in Transplant Recipients: Past, Present, and Future | 2025-04-27 | OpenAlex | 10.1007/s40121-025-01159-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409852851 | |||
| W4409864478 | A Paradigm Shift in Health Surveillance: Preparing for the Future of Longevity | 2025-04-28 | OpenAlex | 10.3389/ijph.2025.1607760 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409864478 | |||
| W4409896338 | Antimicrobial peptides: evolving soldiers in the battle against drug-resistant superbugs | 2025-04-28 | OpenAlex | 10.1007/s11033-025-10533-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409896338 | |||
| W4409871280 | Difficult Decisions in the Multidisciplinary Treatment of Resectable Non-small Cell Lung Cancer | 2025-04-28 | OpenAlex | 10.1245/s10434-025-17345-2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409871280 | |||
| W4409889608 | Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings | 2025-04-28 | OpenAlex | 10.3389/fphar.2025.1607362 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409889608 | |||
| W4409890179 | Evolution of carbapenemase activity in the class C β-lactamase ADC-1 | 2025-04-28 | OpenAlex | 10.1128/mbio.00185-25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409890179 | |||
| W4409884340 | Life Already Knows How to Heal: A Conceptual Shift Toward Self-Terminating Regenerative Loops | 2025-04-28 | OpenAlex | 10.22541/au.174585849.98938164/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409884340 | |||
| W4409887304 | Long-Chain Hydrocarbons in the Mucous Layer of the Galleria mellonella Insect Eggs as Potential Antibacterial Agents against Multidrug-Resistant Bacteria | 2025-04-28 | OpenAlex | 10.1021/acsomega.5c00938 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409887304 | |||
| W4409948928 | Synergizing Intelligence: A Comparative Study of Robotics Components and AI Integration | 2025-04-28 | OpenAlex | 10.71097/ijsat.v16.i2.4102 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409948928 | |||
| W4409908586 | Targeting the Senescent Tumor Microenvironment to Sensitize Immunotherapy | 2025-04-28 | OpenAlex | 10.54097/te6m0d54 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409908586 | |||
| W4409875609 | Trojan Horse-Like Vehicles for CRISPR-Cas Delivery: Engineering Extracellular Vesicles and Virus-Like Particles for Precision Gene Editing in Cystic Fibrosis | 2025-04-28 | OpenAlex | 10.1089/hum.2024.258 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409875609 | |||
| W4409995640 | AMRrounds: Carbapenem-resistant Acinetobacter baumannii in the intensive care unit—when resistance meets severity | 2025-04-29 | OpenAlex | 10.1093/jacamr/dlaf067 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409995640 | |||
| W4409958056 | Editorial: Smart devices for personalized nutrition and healthier lifestyle behavior change | 2025-04-29 | OpenAlex | 10.3389/fnut.2025.1604314 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409958056 | |||
| W4409993782 | Enhancing Pain Management: The Role of Superior Hypogastric Plexus Block in Chronic Pelvic Pain Treatment | 2025-04-29 | OpenAlex | 10.4103/jpbs.jpbs_1805_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409993782 | |||
| W4409954291 | Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease | 2025-04-29 | OpenAlex | 10.1016/j.cjca.2025.03.037 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409954291 | |||
| W4409908271 | VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder – A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape | 2025-04-29 | OpenAlex | 10.1016/j.jaut.2025.103425 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409908271 | |||
| W4409972358 | A Current Review of Generative AI in Medicine: Core Concepts, Applications, and Current Limitations | 2025-04-30 | OpenAlex | 10.1007/s12178-025-09961-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409972358 | |||
| W7135216246 | AI-Powered Predictive Health Risk Management in Insurance Plans: A Multi-Agent System Approach for Personalized Policy Customization | 2025-04-30 | OpenAlex | 10.47363/jcbr/icbr2025/2025(7)8 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7135216246 | |||
| W4411242906 | Antiplatelet Therapy in Cardiovascular Diseases | 2025-04-30 | OpenAlex | 10.37022/jis.v8i1.103 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411242906 | |||
| W4409964731 | Biotechnological Applications of Biogenic Nanomaterials from Red Seaweed: A Systematic Review (2014–2024) | 2025-04-30 | OpenAlex | 10.3390/ijms26094275 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409964731 | |||
| W4410082209 | Clinical Trials for Curing Chronic Hepatitis B: A Comprehensive Analysis of Design Principles and Their Impact on Trial Performance | 2025-04-30 | OpenAlex | 10.20944/preprints202504.2575.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410082209 | |||
| W4409907579 | Evolution of pain management in lung cancer surgery: from opioid-based to personalized analgesia | 2025-04-30 | OpenAlex | 10.17085/apm.25240 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409907579 | |||
| W4410465386 | Intelligent AI Agents for Fraud and Abuse Detection: Leveraging Machine Learning, NLP, and Behavioural Analytics for Enhanced Security | 2025-04-30 | OpenAlex | 10.14445/23488387/ijcse-v12i4p103 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4410465386 | |||
| W7169858612 | Ketamine Therapy in Psychiatry: A Comprehensive Review | 2025-04-30 | OpenAlex | 10.21088/jpn.2277.9035.14125.5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169858612; https://openalex.org/W7169873636 | |||
| W4409964916 | Microbial contamination and pharmaceutical stability in space environment: addressing dual challenge with innovative technologies and sustainable practices | 2025-04-30 | OpenAlex | 10.3389/frspt.2025.1553854 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409964916 | |||
| W4409975401 | The challenges and prospects of intercultural adult education | 2025-04-30 | OpenAlex | 10.3389/feduc.2025.1467341 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409975401 | |||
| W4409999833 | Updates in Gastroesophageal Reflux Disease Management: From Proton Pump Inhibitors to Dietary and Lifestyle Modifications | 2025-04-30 | OpenAlex | 10.3390/gidisord7020033 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409999833 | |||
| W4410009804 | A case report of PLEVA after Herpes Zoster infection: is there a correlation? | 2025-05-01 | OpenAlex | 10.4103/jewd.jewd_79_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410009804 | |||
| W4411749593 | Academic Contributions and Field Advances of the International Takotsubo Registry: A Comment from Multidimensional Perspectives | 2025-05-01 | OpenAlex | 10.4103/hm.hm-d-25-00048 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411749593 | |||
| W4410991138 | Advances in Systemic and Immunotherapies for Human Papillomavirus–Mediated Oropharyngeal Cancers | 2025-05-01 | OpenAlex | 10.1097/ppo.0000000000000766 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410991138 | |||
| W4410406058 | BRUGADA TYPE 1 PHENOTYPE AND CARDIAC ARREST FOLLOWING COCAINE ABUSE | 2025-05-01 | OpenAlex | 10.1093/eurheartjsupp/suaf076.140 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410406058 | |||
| W7165502919 | Evaluation Of Treatment Outcomes And Prognostic Factors In Managing Children With Steroid Sensitive Nephrotic Syndrome In Malaysia | 2025-05-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165502919 | ||||
| W4410453118 | Evolving Resistance Patterns: A Retrospective Five-year Study of Urinary Pathogens and Antibiotic Efficacy | 2025-05-01 | OpenAlex | 10.7860/jcdr/2025/74833.20985 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410453118 | |||
| W4410017743 | Focus on somatic mutations and cardiovascular risk, upper extremity artery disease, drug-coated balloons, and new therapeutic targets for restenosis | 2025-05-01 | OpenAlex | 10.1093/eurheartj/ehaf221 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410017743 | |||
| W4410761087 | From Past to Present: The Evolution of Pharmacologic Therapies for Eosinophilic Esophagitis. | 2025-05-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410761087 | ||||
| W4409994026 | Front-line Treatment of B-cell Acute Lymphoblastic Leukemia in Canada: Current Strategies and Evolving Paradigms | 2025-05-01 | OpenAlex | 10.58931/cht.2025.4165 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409994026 | |||
| W4411652260 | Governance of Direct‐to‐User Digital Mental Health Tools: Emphasizing Transparency over Paternalism | 2025-05-01 | OpenAlex | 10.1002/hast.5009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411652260 | |||
| W4410603768 | LEGACY OF STATINS IN CARDIOVASCULAR DISEASE | 2025-05-01 | OpenAlex | 10.1097/01.hjh.0001117416.83554.c7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410603768 | |||
| W4410011153 | Let Doctors Be Doctors: Defending Physician Autonomy in Cancer Care | 2025-05-01 | OpenAlex | 10.1097/01.cot.0000000000000064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410011153 | |||
| W4409963130 | Longitudinal surveillance of the molecular evolution of methicillin-resistant Staphylococcus aureus isolates from pediatric patients in Shanghai, China, from 2013 to 2022 | 2025-05-01 | OpenAlex | 10.1128/msystems.00371-25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409963130 | |||
| W4410498836 | Management of anaemia in critically ill adults | 2025-05-01 | OpenAlex | 10.4103/singaporemedj.smj-2024-005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410498836 | |||
| W4410467870 | Multi-agent AI Systems for Adaptive, Culturally-Concordant Care Routing in Postpartum Depression Across Medicaid-Dependent Populations | 2025-05-01 | OpenAlex | 10.55248/gengpi.6.0525.1645 | Full text | Excluded | F3: The described postpartum screening, triage, referral and feedback architecture uses clinical risk scoring, conventional NLP, supervised/unsupervised and federated learning. No LLM/VLM acting agent is implemented. | https://openalex.org/W4410467870 | https://doi.org/10.55248/gengpi.6.0525.1645 | ||
| W4410275666 | Racing Against Time: Pulmonary Mucormycosis in a Kidney Transplant Recipient Under Experimental Anti-rejection Therapy | 2025-05-01 | OpenAlex | 10.1164/ajrccm.2025.211.abstracts.a6718 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410275666 | |||
| W4409993751 | Richter Transformation in the Canadian Landscape: Clinical Perspectives and Emerging Trends | 2025-05-01 | OpenAlex | 10.58931/cht.2025.4163 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409993751 | |||
| W4410016396 | SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application | 2025-05-01 | OpenAlex | 10.4093/dmj.2025.0220 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4410016396 | |||
| W4410276685 | Shedding Light on HPV-Driven Lung Cancer: A Case of in Situ Squamous Cell Carcinoma Treated With Bronchoscopic Photodynamic Therapy | 2025-05-01 | OpenAlex | 10.1164/ajrccm.2025.211.abstracts.a7809 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410276685 | |||
| W4410880256 | Talking about obesity in the OB-GYN clinic | 2025-05-01 | OpenAlex | 10.1097/gme.0000000000002594 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410880256 | |||
| W4409978716 | The Spectrum of Influenza-Associated Acute Necrotizing Encephalopathy of Childhood: A Case Series | 2025-05-01 | OpenAlex | 10.1016/j.pediatrneurol.2025.04.012 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4409978716 | |||
| W4410275600 | Trends in Management and Short-Term Outcomes of Patients With Pulmonary Embolism and Hemodynamic Instability: Baseline Characteristics, Treatment Decisions, and Clinical Outcomes | 2025-05-01 | OpenAlex | 10.1164/ajrccm.2025.211.abstracts.a6505 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410275600 | |||
| W4411750394 | Type 5 Diabetes- The Rejuvenated Spirit from a Ghost of the Past | 2025-05-01 | OpenAlex | 10.4103/ijem.ijem_404_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411750394 | |||
| W4410895884 | Updates to Systemic Therapy for Differentiated Thyroid Cancer | 2025-05-01 | OpenAlex | 10.6004/jnccn.2025.5015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410895884 | |||
| W4410082204 | Antibody-Drug Conjugates (ADCs) and Indications in Autoimmune Disorders | 2025-05-02 | OpenAlex | 10.20944/preprints202505.0090.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410082204 | |||
| W4410020726 | Enhancing Efficiency in Manufacturing through Automated AI Agent-Based Bearing Defect Diagnostic System | 2025-05-02 | OpenAlex | 10.4271/2025-01-0158 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4410020726 | |||
| W4410182386 | Enterococci: An Evolving Threat of Multidrug Resistance and Linezolid Resistance in the Clinical Era | 2025-05-02 | OpenAlex | 10.21608/zumj.2025.374424.3903 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4410182386 | |||
| W4410028148 | Evolving dynamics in clinical trials for oral cancer: Trends, treatment modalities, and future directions | 2025-05-02 | OpenAlex | 10.1016/j.oraloncology.2025.107333 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410028148 | |||
| W4410188843 | Hypertensive Pregnancy Disorders: From Mechanisms to Management | 2025-05-02 | OpenAlex | 10.1093/ajh/hpaf080 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410188843 | |||
| W4410034200 | Medical and surgical management of neovascular glaucoma | 2025-05-02 | OpenAlex | 10.1097/icu.0000000000001151 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410034200 | |||
| W4410062709 | Successful treatment of terbinafine-resistant Trichophyton indotineae with fluconazole and resveratrol: A novel approach | 2025-05-02 | OpenAlex | 10.4103/ds.ds-d-24-00224 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410062709 | |||
| W4410019752 | The Evolution of Fluorescein into A Potential Theranostic Tool | 2025-05-02 | OpenAlex | 10.1002/chem.202501513 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410019752 | |||
| W4410068624 | High-Volume Hemodiafiltration: Expanding the Evidence Beyond Randomized Trials—A Critical Perspective on the 2025 EuDial Consensus | 2025-05-03 | OpenAlex | 10.3390/jcm14093174 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410068624 | |||
| W4410071122 | Refractory/Relapsed Classic Hodgkin Lymphoma Mimicking Disseminated Tuberculosis | 2025-05-03 | OpenAlex | 10.3390/hemato6020012 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410071122 | |||
| W4410081075 | Current treatment landscape for patients with non–small cell lung cancer with common EGFR mutations | 2025-05-05 | OpenAlex | 10.1016/j.resinv.2025.04.021 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410081075 | |||
| W4410083412 | Mandimycin: A phospholipid-targeting natural polyene macrolide overcoming multidrug resistance in invasive fungal infections | 2025-05-05 | OpenAlex | 10.1016/j.aac.2025.04.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410083412 | |||
| W4410127187 | Ethical Intrusion: The Strategic Role of Ethical Hacking in the Modern Cybersecurity Framework | 2025-05-06 | OpenAlex | 10.55041/ijsrem47045 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4410127187 | |||
| W4410134567 | Knowledge gaps in the 2024 consensus statement on atrial fibrillation ablation | 2025-05-06 | OpenAlex | 10.1093/eurheartj/ehaf175 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410134567 | |||
| W4410124837 | Management of Acute Respiratory Distress Syndrome (ARDS): A Review of Current Ventilatory and Pharmacological Strategies | 2025-05-06 | OpenAlex | 10.12775/jehs.2025.81.59770 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410124837 | |||
| W4410106945 | New Targets for Imaging in Nuclear Medicine | 2025-05-06 | OpenAlex | 10.1053/j.semnuclmed.2025.04.004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410106945 | |||
| W7117882553 | Proposing a RAG-Based System for Context-Aware Healthcare Monitoring | 2025-05-06 | OpenAlex | 10.5281/zenodo.18106766 | Full text | Excluded | F4: Dynamic RAG and current-patient monitoring change consultation state; no experience-derived cross-patient update is retained. Agent-policy learning is expressly future work. | https://openalex.org/W7117882553 | https://www.ijert.org/research/proposing-a-rag-based-system-for-context-aware-healthcare-monitoring-IJERTV14IS040466.pdf | original publisher complete article text, methods/simulation/conclusion | |
| W4410130751 | Recent Advances in Diagnostics and Therapeutic Interventions for Drug-Resistant Malaria | 2025-05-06 | OpenAlex | 10.1021/acsinfecdis.4c00962 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410130751 | |||
| W4410183135 | AI with agency: a vision for adaptive, efficient, and ethical healthcare | 2025-05-07 | OpenAlex | 10.3389/fdgth.2025.1600216 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410183135 | |||
| W4410138052 | Editorial Comment on “Is Docetaxel Essential for Darolutamide‐Based Metastatic Hormone‐Sensitive Prostate Cancer Therapy?” | 2025-05-07 | OpenAlex | 10.1111/iju.70093 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410138052 | |||
| W4410183190 | Editorial: Insights in consciousness research, volume II | 2025-05-07 | OpenAlex | 10.3389/fpsyg.2025.1602845 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410183190 | |||
| W4410157879 | Providing Task Execution Capabilities in LLM-Based Conversational Assistants | 2025-05-07 | OpenAlex | 10.5753/sbsi.2025.246626 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4410157879 | |||
| W4410157228 | The Evolving Role of Immunotherapy for Gastroesophageal Malignancies | 2025-05-07 | OpenAlex | 10.1245/s10434-025-17386-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410157228 | |||
| W4410155196 | Tomographic evaluation of apexogenesis with human treated dentin matrix in young permanent molars: a split-mouth randomized controlled clinical trial | 2025-05-07 | OpenAlex | 10.1186/s12903-025-05997-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410155196 | |||
| W7215428849 | ACUTE BRONCHITIS IN CHILDREN | 2025-05-08 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215428849 | ||||
| W4410211284 | AI-Powered Data Observability & Governance Agent for Cloud Analytics: Transforming Enterprise Data Management | 2025-05-08 | OpenAlex | 10.32996/jcsts.2025.7.3.88 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4410211284 | |||
| W4410306061 | Antioxidant nanozymes: current status and future perspectives in spinal cord injury treatments | 2025-05-08 | OpenAlex | 10.7150/thno.114836 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410306061 | |||
| W4410185863 | Editorial: Designing and evaluating digital health interventions | 2025-05-08 | OpenAlex | 10.3389/fdgth.2025.1612380 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410185863 | |||
| W4410215665 | Editorial: SLC12A5-dependent neurological disorders | 2025-05-08 | OpenAlex | 10.3389/fnmol.2025.1611682 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410215665 | |||
| W4410193934 | Guidelines on Management of Multiple Myeloma in the Relapsed/Refractory Setting: The Saudi Myeloma Working Group Guideline | 2025-05-08 | OpenAlex | 10.1016/j.clml.2025.05.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410193934 | |||
| W4410203266 | Humanistic values of the physician in the era of artificial intelligence | 2025-05-08 | OpenAlex | 10.1016/j.hjc.2025.04.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410203266 | |||
| W7164534485 | The Complete Patient: AI, Clinical Intelligence, and the Future of Predictive Medicine BY Srivenkata Gantikota | 2025-05-08 | OpenAlex | 10.5281/zenodo.20658360 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164534485 | |||
| W4410279569 | XPS Monitoring of Calcarenite Building Walls Long Exposed Outdoor. Estimation of Deterioration Trend from the Time Sequence of Curve-Fitted Spectra and PCA Exploration of the Large Dataset | 2025-05-08 | OpenAlex | 10.20944/preprints202505.0518.v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4410279569 | |||
| W4410232643 | Advances in COVID-19 Therapeutics: Exploring the role of lectins and protease inhibitors | 2025-05-09 | OpenAlex | 10.1016/j.micpath.2025.107687 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410232643 | |||
| W4410246253 | Current anti-inflammatory strategies for treatment of heart failure: From innate to adaptive immunity | 2025-05-09 | OpenAlex | 10.1016/j.phrs.2025.107761 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410246253 | |||
| W4410241116 | Effectiveness and Toxicity of Anticancer Agents in Older Australian Patients: A Retrospective Analysis | 2025-05-09 | OpenAlex | 10.1111/ajco.14186 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4410241116 | |||
| W4410243325 | Endoscopic management of upper non-variceal and lower gastrointestinal bleeding: Where do we stand? | 2025-05-09 | OpenAlex | 10.4253/wjge.v17.i5.105580 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410243325 | |||
| W4410257802 | Real-World Advances in Metastatic Pancreatic Cancer Treatment in the Pre-Molecular Era: A Retrospective Single-Center Analysis 2010–2018 | 2025-05-10 | OpenAlex | 10.1159/000546307 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410257802 | |||
| W4410907305 | Recent advances in the pharmacological treatment of obesity | 2025-05-10 | OpenAlex | 10.5124/jkma.25.0058 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410907305 | |||
| W4410280183 | SGLT2 inhibitors across the acute cardiac care spectrum: insights and perspectives | 2025-05-11 | OpenAlex | 10.1080/14796678.2025.2503666 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410280183 | |||
| W4410288328 | A Machine Learning–Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia | 2025-05-12 | OpenAlex | 10.1158/0008-5472.can-24-3840 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410288328 | |||
| W4410327766 | Artificial intelligence will change the research environment in dental medicine dramatically: will algorithms replace literature reviews in the near future? | 2025-05-12 | OpenAlex | 10.1093/dmfr/twaf041 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410327766 | |||
| W4410285343 | Editorial: venom collection | 2025-05-12 | OpenAlex | 10.1038/s41598-024-76017-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410285343 | |||
| W4411737214 | Exploring the Anticoagulant Mechanisms in Complementary and Alternative Medicines and Pharmacokinetics and Pharmacodynamics of Novel Oral Anticoagulants | 2025-05-12 | OpenAlex | 10.63682/jns.v14i7.5706 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411737214 | |||
| W4410308545 | The Journey and Evaluation of Chemical Water Shut-Off Treatments in Carbonate Reservoirs: A Case Study from Northern Oman | 2025-05-12 | OpenAlex | 10.2118/224978-ms | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4410308545 | |||
| W4410332175 | Diagnostic and clinical management of Candida auris infections in immunocompromised patients | 2025-05-13 | OpenAlex | 10.1080/14787210.2025.2505567 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4410332175 | |||
| W4411301257 | Health Promoting Campuses: a time for global reflection and renewed action | 2025-05-13 | OpenAlex | 10.1093/heapro/daaf086 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411301257 | |||
| W4410335270 | Immunologische Aspekte nach der Lungentransplantation | 2025-05-13 | OpenAlex | 10.1055/a-2590-9933 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410335270 | |||
| W4410345378 | Innovative Strategies in the Diagnosis and Treatment of Liver Cirrhosis and Associated Syndromes | 2025-05-13 | OpenAlex | 10.3390/life15050779 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410345378 | |||
| W4410370580 | Changes in postural stability induced by a ball-and-board game designed from a systems perspective | 2025-05-14 | OpenAlex | 10.1186/s13102-025-01110-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410370580 | |||
| W4410379924 | Creating health systems citizens: enhanced professional identity formation through a para-curricular distinction track in health systems transformation and leadership | 2025-05-14 | OpenAlex | 10.1186/s12909-025-07108-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410379924 | |||
| W4410355405 | Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy Sequencing | 2025-05-14 | OpenAlex | 10.1200/edbk-25-100053 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410355405 | |||
| W4410360695 | Dynamic Fairness Calibration for Real-Time Decision Systems using Multi-Objective Reinforcement Learning | 2025-05-14 | OpenAlex | 10.36227/techrxiv.174723862.23255200/v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4410360695 | |||
| W4410429461 | From Nobel-winning antiparasitic to antiviral pandemic candidate: A bibliometric analysis of ivermectin’s decades of veterinary and human protection | 2025-05-14 | OpenAlex | 10.53894/ijirss.v8i3.7031 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410429461 | |||
| W4410349227 | Navigating the dynamic landscape of lower-risk MDS: Advances and emerging insights | 2025-05-14 | OpenAlex | 10.1016/j.blre.2025.101301 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410349227 | |||
| W4410361787 | SOHO State of the Art Updates and Next Questions | The Evolving Landscape of Prognostic Models in Chronic Lymphocytic Leukemia | 2025-05-14 | OpenAlex | 10.1016/j.clml.2025.05.010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410361787 | |||
| W4410379720 | Skin and systemic infections in children with atopic dermatitis: review of the current evidence | 2025-05-14 | OpenAlex | 10.3389/fped.2025.1513969 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410379720 | |||
| W4410349010 | The critical role of platelets in venous thromboembolism: Pathogenesis, clinical status, and emerging therapeutic strategies | 2025-05-14 | OpenAlex | 10.1016/j.blre.2025.101302 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410349010 | |||
| W4410411907 | Editorial: Marine algal bioactive molecules for food and pharmaceutical applications | 2025-05-15 | OpenAlex | 10.3389/fmars.2025.1598329 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410411907 | |||
| W4410396234 | Evolving incretin-based therapies in Japan: optimizing treatment strategies for diverse clinical and socioeconomical profiles in type 2 diabetes | 2025-05-15 | OpenAlex | 10.1007/s13340-025-00818-w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410396234 | |||
| W4411112290 | How GenAI Agents Are Transforming Legacy Application Modernization | 2025-05-15 | OpenAlex | 10.37745/ejcsit.2013/vol13n366271 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4411112290 | |||
| W4410411595 | Long-Acting Extracellular Vesicle-Based Biologics in Osteoarthritis Immunotherapy | 2025-05-15 | OpenAlex | 10.3390/bioengineering12050525 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410411595 | |||
| W4410546461 | New Drugs and New Modes of Administration in Pediatric Anesthesia | 2025-05-15 | OpenAlex | 10.36347/sasjm.2025.v11i05.018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410546461 | |||
| W4410453444 | Pharmacists and Community-Based Pharmacies in an Expanded Role in Patient Care and Public Health in The U.S. | 2025-05-15 | OpenAlex | 10.31926/but.ms.2025.67.18.1.3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410453444 | |||
| W4410386174 | The rise of quality agents: How AI is eliminating bad data at scale | 2025-05-15 | OpenAlex | 10.30574/wjarr.2025.26.2.1694 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4410386174 | |||
| W4410445250 | Evolving therapeutic strategies for severe fever with thrombocytopenia syndrome: from past to future | 2025-05-16 | OpenAlex | 10.1177/20499361251340786 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410445250 | |||
| W4410430358 | From prompt to platform: an agentic AI workflow for healthcare simulation scenario design | 2025-05-16 | OpenAlex | 10.1186/s41077-025-00357-z | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W4410430358 | |||
| W4410453671 | Spatiotemporal imaging of immune dynamics: rethinking drug efficacy evaluation in cancer immunotherapy | 2025-05-16 | OpenAlex | 10.3389/fimmu.2025.1609606 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410453671 | |||
| W4410386183 | Temporal Trends in Multiple Myeloma Mortality and Their Relationship to Evolving Treatment Strategies: A Retrospective Analysis Using SEER Data | 2025-05-16 | OpenAlex | 10.21203/rs.3.rs-6624519/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410386183 | |||
| W4410438745 | The Role of Somatostatin in the Gastrointestinal Tract | 2025-05-16 | OpenAlex | 10.3390/biology14050558 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410438745 | |||
| W4410430994 | Tumour and microenvironment crosstalk in NSCLC progression and response to therapy | 2025-05-16 | OpenAlex | 10.1038/s41571-025-01021-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410430994 | |||
| W4411617543 | Dissemination of a Controversial COVID-19 ‘Miracle Cure’ on Twitter: The Case of Chlorine Dioxide | 2025-05-17 | OpenAlex | 10.9734/bpi/nicass/v3/5587 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4411617543 | |||
| W4410501223 | AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review | 2025-05-19 | OpenAlex | 10.1016/j.cgh.2025.02.015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410501223 | |||
| W4410522795 | Anthraquinone-Based Nanomaterials: Emerging Strategies in Cancer Therapy | 2025-05-19 | OpenAlex | 10.2174/9789815313987125030009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410522795 | |||
| W4410477749 | Editorial: Exploring new therapeutic frontiers in Glaucoma: from molecular targets to patient outcomes | 2025-05-19 | OpenAlex | 10.3389/fphar.2025.1624534 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410477749 | |||
| W4410507967 | Prognostic Factors of Renal Survival among Chronic Kidney Disease Patients in Tertiary Care Centre in Kelantan, Malaysia | 2025-05-19 | OpenAlex | 10.32802/asmscj.2025.1554 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410507967 | |||
| W4410493987 | Progress through Persistence — Turning the Page in Pulmonary Fibrosis Clinical Trials | 2025-05-19 | OpenAlex | 10.1056/nejme2505760 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410493987 | |||
| W4410504961 | Trends in Lipid‐Lowering Agent Consumption in Croatia: A 25‐Year Observational Study | 2025-05-19 | OpenAlex | 10.1002/prp2.70122 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410504961 | |||
| W4410513216 | ADVANCES IN TARGETED THERAPIES AND IMMUNOMODULATORY STRATEGIES IN LUPUS | 2025-05-20 | OpenAlex | 10.3899/jrheum.2025-0390.pv249 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410513216 | |||
| W4410520741 | Advanced Therapies for Inflammatory Bowel Disease and Risk of Skin Cancer: What’s New? | 2025-05-20 | OpenAlex | 10.3390/cancers17101710 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410520741 | |||
| W4410529622 | Advances in Radiation Therapy for Anal Cancer | 2025-05-20 | OpenAlex | 10.1055/s-0045-1806853 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410529622 | |||
| W4410524126 | Editorial: The integration of clinical veterinary anatomy and diagnostic imaging | 2025-05-20 | OpenAlex | 10.3389/fvets.2025.1602545 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410524126 | |||
| W4410512989 | IMAGING INSIGHTS INTO JC VIRUS-ASSOCIATED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN NEUROPSYCHIATRIC LUPUS: A CASE REPORT | 2025-05-20 | OpenAlex | 10.3899/jrheum.2025-0390.pv283 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410512989 | |||
| W4410530697 | Neurofibromatosis Type 1 : A General Review | 2025-05-20 | OpenAlex | 10.3340/jkns.2025.0073 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410530697 | |||
| W4410542930 | Pharmacological Strategies and Investigational Drugs for Emerging and Re-Emerging Diseases of Viral Origin | 2025-05-20 | OpenAlex | 10.1201/9781032721811-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410542930 | |||
| W4410546895 | Bdellovibrio bacteriovorus: a “magic weapon” against bacterial pathogens | 2025-05-21 | OpenAlex | 10.1186/s13213-025-01794-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410546895 | |||
| W4410840692 | COMPARISON BETWEEN TIVA AND INHALATIONAL ANESTHETICS, RISKS AND BENEFITS | 2025-05-21 | OpenAlex | 10.71000/77q6m886 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410840692 | |||
| W4410605324 | Corrigendum: Autonomy support in telehealth: an evolutionary concept analysis | 2025-05-21 | OpenAlex | 10.3389/fpubh.2025.1610264 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4410605324 | |||
| W4410571496 | Emerging immunotherapy and tumor microenvironment for advanced sarcoma: a comprehensive review | 2025-05-21 | OpenAlex | 10.3389/fimmu.2025.1507870 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410571496 | |||
| W4411264801 | Organoids in motion: biohybrid robotics futures | 2025-05-21 | OpenAlex | 10.1097/mm9.0000000000000018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411264801 | |||
| W4410581274 | Preclinical approach of two novel tetrahydroquinoline derivatives targeting GPER and Bcl-2 for anti-glioblastoma therapy | 2025-05-21 | OpenAlex | 10.1038/s41598-025-02186-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410581274 | |||
| W4410555903 | Where are the birthing women? Rethinking agency, culture, and explanation in evolutionary psychology | 2025-05-21 | OpenAlex | 10.1080/09515089.2025.2508941 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4410555903 | |||
| W4410609506 | A Decade of Clinical Experience with DARPins in Oncology and Virology: A Systematic Review | 2025-05-22 | OpenAlex | 10.1101/2025.05.21.25328103 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410609506 | |||
| W4410591577 | Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos | 2025-05-22 | OpenAlex | 10.1161/circresaha.125.325602 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410591577 | |||
| W4410612359 | Cellular Therapy for Advanced Melanoma | 2025-05-22 | OpenAlex | 10.1016/j.suc.2025.03.004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410612359 | |||
| W4410616544 | Navigating a paradigm shift in the treatment of CNS demyelinating diseases in a middle-income country | 2025-05-22 | OpenAlex | 10.1016/j.msard.2025.106544 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410616544 | |||
| W4410698651 | Advanced combination therapy in inflammatory bowel disease | 2025-05-23 | OpenAlex | 10.1016/j.jbspin.2025.105922 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410698651 | |||
| W4410706484 | Co-Clinical Trial: An Innovative Platform for Drug Development | 2025-05-23 | OpenAlex | 10.32553/ijmsdr.v9i3.1053 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410706484 | |||
| W4412022016 | Green Synthesis And Antimicrobial Activity Of Vanadium Oxide Nanoparticles Using Nyctanthes Arbortristis Aqueous Leaf Extract | 2025-05-23 | OpenAlex | 10.64252/1swpr633 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412022016 | |||
| W4410696209 | Incretin-Based Therapies: A Paradigm Shift in Blood Pressure Management? | 2025-05-23 | OpenAlex | 10.1161/hypertensionaha.125.25112 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410696209 | |||
| W4410746940 | LOOP-MEDIATED ISOTHERMAL AMPLIFICATION METHOD - PERSPECTIVE TOOL IN VETERINARY MEDICINE | 2025-05-23 | OpenAlex | 10.20544/aisc.1.2.25.p09 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410746940 | |||
| W4410629910 | SAGE: Self-evolving Agents with Reflective and Memory-augmented Abilities | 2025-05-23 | OpenAlex | 10.1016/j.neucom.2025.130470 | Full text | Excluded | F2: SAGE is a general agent/memory framework evaluated on AgentBench, long-text QA and general tasks; healthcare is an application claim, not the primary evaluated domain. Fixed P2 applies. | https://openalex.org/W4410629910 | https://www.sciencedirect.com/science/article/pii/S0925231225011427 | ||
| W4410698680 | SOHO State of the Art Updates and Next Questions | Does Limited Stage Diffuse Large B-cell Lymphoma Matter? | 2025-05-23 | OpenAlex | 10.1016/j.clml.2025.05.018 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410698680 | |||
| W4410633223 | Theragnostic applications of cyclodextrin-enhanced photothermal therapy in cancer management | 2025-05-23 | OpenAlex | 10.1016/j.carbpol.2025.123793 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410633223 | |||
| W4410635598 | Theranostic: A Primer for Radiologists | 2025-05-23 | OpenAlex | 10.1177/08465371251338032 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410635598 | |||
| W4410708357 | A Review on AI-Powered Conversational Agents for Psychotherapy: Techniques, Tools, and Ethical Perspectives- Inner Me | 2025-05-24 | OpenAlex | 10.22214/ijraset.2025.71307 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410708357 | |||
| W4410713994 | Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer | 2025-05-24 | OpenAlex | 10.1016/j.jncc.2025.04.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410713994 | |||
| W4410708945 | The evolving role of HER2 in gynecologic oncology and clinical trial design: A gynecologic pathologist's perspective | 2025-05-24 | OpenAlex | 10.1016/j.ygyno.2025.05.017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410708945 | |||
| W4410721714 | High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies | 2025-05-25 | OpenAlex | 10.3390/cells14110776 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410721714 | |||
| W4410717265 | Transforming the landscape of cancer treatment with seven promising novel therapies: evolution and future perspectives | 2025-05-25 | OpenAlex | 10.1016/j.medp.2025.100087 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410717265 | |||
| W4410740974 | Anti-Human Epidermal Growth Factor Receptor-2 Therapies in Biliary Tract Cancers: A Meta-Analysis on Disease Location, Human Epidermal Growth Factor Receptor-2 Status, and Survival Outcomes | 2025-05-26 | OpenAlex | 10.1159/000545308 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410740974 | |||
| W4410759318 | B-cell lymphoma: Advances in pathogenesis, diagnosis, and targeted therapies | 2025-05-26 | OpenAlex | 10.1016/j.prp.2025.156036 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410759318 | |||
| W4410866745 | Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management | 2025-05-26 | OpenAlex | 10.3390/ph18060800 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410866745 | |||
| W7127430772 | Intelligent Systems in Health: Historical Evolution, Current Development and Future Perspectives | 2025-05-26 | OpenAlex | 10.1109/ccece64018.2025.11364518 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127430772 | |||
| W4410927362 | Nanosponges: In-sights into Fabrication, Design, Drug delivery and its Evolving Challenges | 2025-05-26 | OpenAlex | 10.71097/ijsat.v16.i2.5574 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410927362 | |||
| W4410740895 | PSMA PET Imaging in the Management of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radioligand Therapy | 2025-05-26 | OpenAlex | 10.1007/s11523-025-01151-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410740895 | |||
| W4410779171 | Anti-bacterial activity of dermcidin in human platelets: suppression of methicillin-resistant Staphylococcus aureus growth | 2025-05-27 | OpenAlex | 10.1128/spectrum.03273-24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410779171 | |||
| W7128625546 | Development of synthetic RNA-targeting catalysts from biostable nucleic acid analogues | 2025-05-27 | OpenAlex | 10.17863/cam.126840 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128625546 | |||
| W4410780157 | Role of Pharmacology in Dentistry: A Review of Analgesics, Antibiotics, and Local Anesthetics | 2025-05-27 | OpenAlex | 10.7759/cureus.84889 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410780157 | |||
| W4410775087 | Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study | 2025-05-27 | OpenAlex | 10.1016/j.leukres.2025.107719 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410775087 | |||
| W4410795562 | A multicenter, prospective, non-interventional study to investigate the treatment patterns of neratinib in human epidermal growth factor receptor 2 positive (HER2+) early breast cancer (EBC) in China: Updated interim analysis from the NER-Tree study. | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e12507 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410795562 | |||
| W4410822489 | Actionability landscape and biomarker utility in a colorectal cancer alliance cohort: Initial results from the Know Your Biomarker program. | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e15605 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410822489 | |||
| W4410810994 | Artificial intelligence for contextual well-being: Protocol for an exploratory sequential mixed methods study with medical students as a social microcosm | 2025-05-28 | OpenAlex | 10.1371/journal.pone.0321426 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410810994 | |||
| W4410821537 | Biomarkertesting in metastatic colorectal cancer (mCRC): 2015-2024 trends in the United States (US) community oncology setting. | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e15573 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410821537 | |||
| W4410812085 | Chemotherapy and supportive care practice patterns among older adults with metastatic pancreatic cancer. | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e16373 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410812085; https://openalex.org/W4415252437 | |||
| W4410814891 | Dynamic Arterial Lactate Values Are Associated with 30-Day Mortality in Patients with Acute Myocardial Infarction and Cardiogenic Shock on Intra-Aortic Balloon Pump Circulatory Support | 2025-05-28 | OpenAlex | 10.1159/000545746 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410814891 | |||
| W4410836799 | Editorial: Advancement in malaria treatment | 2025-05-28 | OpenAlex | 10.3389/fcimb.2025.1628923 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410836799 | |||
| W4410802781 | Evaluating the benefit-risk balance of second-line therapies for HR+/HER2- metastatic breast cancer: A comparative analysis using ASCO VF and ESMO MCBS frameworks. | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e13100 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410802781 | |||
| W4410813411 | Evaluating uptake of targeted agents by race/ethnicity in patients receiving first-line treatment for chronic lymphocytic leukemia (CLL). | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e13741 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410813411 | |||
| W4410807847 | Exploring variables associated with prolonged survival in AML with TP53 aberration. | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e18519 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410807847 | |||
| W4410809335 | Genetic characteristics and clinical outcomes of driver mutant oligometastatic non small cell lung cancer treated with combination definitive chemoradiotherapy and targeted systemic therapy. | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e20676 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410809335 | |||
| W4410809262 | Immunoprevention of non-viral cancers: challenges and strategies for early intervention | 2025-05-28 | OpenAlex | 10.1186/s12935-025-03817-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410809262 | |||
| W4413178475 | LLM-Guided Hybrid Architecture for Autonomous Fire Response: Dialog-Driven Planning in Space and Disaster Missions | 2025-05-28 | OpenAlex | 10.1109/aiiot65859.2025.11105239 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4413178475 | |||
| W4410830909 | Management of Metastatic Hormone Receptor-Positive Breast Cancer Beyond CDK4/6 Inhibitors | 2025-05-28 | OpenAlex | 10.1007/s11912-025-01689-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410830909 | |||
| W4410837540 | Navigating the regulatory landscape: The emergence of AI-powered compliance agents | 2025-05-28 | OpenAlex | 10.30574/wjarr.2025.26.2.1923 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4410837540 | |||
| W4410806813 | NeuroGenesis Nexus: A Theoretical Framework for Nano-Enhanced, Stem Cell-Integrated Brain-Computer Interfaces for Neural Restoration | 2025-05-28 | OpenAlex | 10.31219/osf.io/9hck6_v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410806813 | |||
| W4410821341 | Prognostic profiling of hormone receptor–positive, HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) treated with CDK4/6 inhibitors beyond progression (BP): A synthetic control arm biomarker analysis. | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e13068 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410821341 | |||
| W4410823158 | Real-world outcomes for dMMR/MSI-H colorectal cancer: Navigating rapidly evolving oncologic practices in a community hospital. | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e15519 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410823158 | |||
| W4411170269 | Remimazolam in neuroanesthesia | 2025-05-28 | OpenAlex | 10.1097/aco.0000000000001524 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411170269 | |||
| W4410805265 | Systematic review of BCMA-targeted therapies in relapsed/refractory (R/R) multiple myeloma (MM). | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e19528 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410805265 | |||
| W4410822353 | Targeting HER3 in NSCLC: Leveraging continuing education to bridge the gaps between evidence and practice. | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e20055 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410822353 | |||
| W4410827368 | Targets for Molecular Imaging of Neuroendocrine Tumors (NETs): An Overview and Update | 2025-05-28 | OpenAlex | 10.1053/j.semnuclmed.2025.04.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410827368 | |||
| W7204470294 | The Battle Against Emerging Viruses | 2025-05-28 | OpenAlex | 10.4018/979-8-3693-9276-8.ch007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204470294 | |||
| W4410809324 | Variations in PSMA PET utilization, PSA testing, and urologist involvement in advanced castrate resistant prostate cancer: Comparing academic and community practices in the US. | 2025-05-28 | OpenAlex | 10.1200/jco.2025.43.16_suppl.e17075 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410809324 | |||
| W4410857663 | AI Will Offer New Opportunities for Transplantation: Are We Ready? | 2025-05-29 | OpenAlex | 10.1097/txd.0000000000001820 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410857663 | |||
| W4410859914 | Changes in Medical Management of Inflammatory Bowel Disease and Reducing Surgical Risk: Investigating Causality Through the Bradford-Hill Criteria | 2025-05-29 | OpenAlex | 10.3390/jcm14113824 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410859914 | |||
| W4410872210 | Intelligent Automation for Streamlining Prior Authorization Workflows Integrated with EHRs Using Agentic AI | 2025-05-29 | OpenAlex | 10.32996/jcsts.2025.7.5.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410872210 | |||
| W4410849807 | Precision paradigm in breast cancer management: A mini review | 2025-05-29 | OpenAlex | 10.1016/j.senol.2025.100703 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410849807 | |||
| W4410840797 | Syndromic Testing in the Pandemic Era and Beyond: Rapid Detection for Respiratory Infections in Istanbul | 2025-05-29 | OpenAlex | 10.3390/v17060776 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410840797 | |||
| W4410859268 | T-Cell Engager Therapy in Prostate Cancer: Molecular Insights into a New Frontier in Immunotherapy | 2025-05-29 | OpenAlex | 10.3390/cancers17111820 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410859268 | |||
| W4410849502 | Taking a Bite Out of Small Cell Lung Cancer By Leveraging Precision-Directed Delta-Like Ligand-3 Therapies | 2025-05-29 | OpenAlex | 10.1200/edbk-25-472794 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410849502 | |||
| W4410869689 | The evolution of generative AI in conversational systems: advancing chatbots and CCAI for Next-Gen Business Intelligence | 2025-05-29 | OpenAlex | 10.30574/gjeta.2025.23.2.0161 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410869689; https://openalex.org/W7107949065 | |||
| W4411777759 | Uncertain Terrain | 2025-05-29 | OpenAlex | 10.1093/cid/ciaf283 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411777759 | |||
| W4410884716 | Conformance to the National List of Essential Medicines 2022 in a government tertiary care hospital | 2025-05-30 | OpenAlex | 10.1016/j.jhqr.2025.101141 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410884716 | |||
| W4410902811 | Harnessing Machine Learning for Agnostic Biodetection | 2025-05-30 | OpenAlex | 10.1089/hs.2024.0075 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410902811 | |||
| W4410877446 | Refining outcome measures in multiple sclerosis clinical trials: A call to action | 2025-05-30 | OpenAlex | 10.1016/j.msard.2025.106558 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410877446 | |||
| W4410893230 | Strategies for Ovarian Cancer After PARP Inhibitor Maintenance | 2025-05-30 | OpenAlex | 10.1097/01.cot.0000000000000070 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410893230 | |||
| W7169792916 | The Immunomodulatory Potential of Normothermic Liver Perfusion: Reconditioning the Graft's Immune Profile Before Transplantation | 2025-05-30 | OpenAlex | 10.26524/amr.2025.3.5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169792916 | |||
| W4411682089 | A Comparative Study of Veterans’ Affairs Systems in Korea and the United States | 2025-05-31 | OpenAlex | 10.35227/hylr.2025.5.36.2.3 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4411682089 | |||
| W4410958620 | A Review: Topical Gels for Localized Drug Delivery | 2025-05-31 | OpenAlex | 10.22214/ijraset.2025.71847 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410958620 | |||
| W4410909202 | Advances in biomaterials for wound care management: Insights from recent developments | 2025-05-31 | OpenAlex | 10.1016/j.cis.2025.103563 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410909202 | |||
| W4411622915 | Advancing hepatic augmentation for safer hepatic surgery: insights into portal and hepatic vein embolization strategies | 2025-05-31 | OpenAlex | 10.1093/bjs/znaf115 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411622915 | |||
| W4410922768 | Aerosol Measurements and Decadal Changes: The Role of Climatic Changes and How It Reflects in Respiratory Allergies and Asthma | 2025-05-31 | OpenAlex | 10.1111/all.16602 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410922768 | |||
| W4410929733 | Global Multidisciplinary Collaboration in Therapeutic Cannabis Research, Regulatory and Pharmaceutical Challenges | 2025-05-31 | OpenAlex | 10.26538/tjnpr/v9i5.52 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410929733 | |||
| W4411470051 | Hybrid Lipid Nanoparticles in Diabetes Management and Pancreatic Islet Regeneration | 2025-05-31 | OpenAlex | 10.71443/9789349552852-08 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411470051 | |||
| W4410909637 | Infectious disease risk after the October 2024 flash flood in Valencia, Spain: Disaster evolution, strategic scenario analysis, and extrapolative baseline for a One Health assessment | 2025-05-31 | OpenAlex | 10.1016/j.onehlt.2025.101093 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410909637 | |||
| W4411076644 | Power, Discourse, and the Formation of Subjectivity in Alias Grace | 2025-05-31 | OpenAlex | 10.17754/mesk.69.2.71 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4411076644 | |||
| W4411648849 | Progress in prevention and treatment of peritoneal metastases by cytoreductive surgery | 2025-05-31 | OpenAlex | 10.1093/bjs/znaf081 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411648849 | |||
| W4411076887 | “Study on Moral Patiency in Ted Chiang’s “The Lifecycle of Software Objects” | 2025-05-31 | OpenAlex | 10.17754/mesk.69.2.27 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4411076887 | |||
| W4411428084 | ABS0046 THE EVOLVING ROLE OF JANUS KINASE INHIBITORS (JAKI) IN RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMDS): AN INTERNATIONAL DELPHI STUDY | 2025-06-01 | OpenAlex | 10.1016/j.ard.2025.06.862 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411428084 | |||
| W4411409950 | ABS1155 COMPARATIVE EFFICACY AND SAFETY OF TOFACITINIB AND TNF INHIBITORS IN RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS | 2025-06-01 | OpenAlex | 10.1016/j.ard.2025.06.1795 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411409950 | |||
| W4411400377 | ABS1232-PARE PATIENT EMPOWERMENT SESIONS: BUILDING KNOWLEDGE AND EMPOWERMENT AMONG RHEUMATOID ARTHRITIS PATIENTS | 2025-06-01 | OpenAlex | 10.1016/j.ard.2025.06.1342 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411400377 | |||
| W4410928316 | Achilles Tendinopathy: Epidemiology, Diagnosis, and Treatment Strategies – A Review | 2025-06-01 | OpenAlex | 10.12775/qs.2025.42.60456 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410928316 | |||
| W4411482795 | After a CDK4/6 Inhibitor: State of the Art in Hormone Receptor–Positive Metastatic Breast Cancer | 2025-06-01 | OpenAlex | 10.1200/edbk-25-473372 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411482795 | |||
| W4415260876 | Amiloidosi cardiaca: nuove prospettive terapeutiche | 2025-06-01 | OpenAlex | 10.17473/1971-6818-2025-2-10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415260876 | |||
| W4411139165 | Antimicrobial resistance and antimicrobial stewardship: an update | 2025-06-01 | OpenAlex | 10.33235/wpr.33.2.79-96 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411139165 | |||
| W4411204464 | Artificial Environments in Experimental Biology | 2025-06-01 | OpenAlex | 10.1525/hsns.2025.55.3.287 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411204464 | |||
| W4411054725 | Congenital Pseudarthrosis of the Tibia: A Comprehensive Literature Review | 2025-06-01 | OpenAlex | 10.2106/jbjs.rvw.25.00035 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411054725 | |||
| W4411198675 | Current Practice of Nuclear Medicine in Iran | 2025-06-01 | OpenAlex | 10.1097/nm9.0000000000000034 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411198675 | |||
| W4411610387 | Drug-Induced Uveitis: Patterns, Pathogenesis and Clinical Implications | 2025-06-01 | OpenAlex | 10.2147/opto.s492202 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411610387 | |||
| W4411388820 | Editorial: New Target for Skin Cancer | 2025-06-01 | OpenAlex | 10.1111/exd.70127 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411388820 | |||
| W4411227662 | Measurable residual disease monitoring in acute myeloid leukaemia: Techniques, timing and therapeutic implications | 2025-06-01 | OpenAlex | 10.1053/j.seminhematol.2025.06.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411227662 | |||
| W4410968780 | New pieces to the jigsaw of antiplatelet treatment after acute coronary syndrome, and a focus on leadless pacing | 2025-06-01 | OpenAlex | 10.1093/eurheartj/ehaf320 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410968780 | |||
| W4411431459 | OP0133 COMPREHENSIVE ANALYSIS UNVEILS POTENTIAL MECHANISMS OF MMP9 AND RNASET2 IN RHEUMATOID ARTHRITIS THROUGH GENOME-WIDE ASSOCIATION STUDIES, MENDELIAN RANDOMIZATION, AND SINGLE-CELL TRANSCRIPTOMIC | 2025-06-01 | OpenAlex | 10.1016/j.ard.2025.05.155 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411431459 | |||
| W4411417751 | OP0317 ULTRASONOGRAPHIC FINDINGS IN PATIENTS WITH SEVERE DISEASE AND REFRACTORY MYOSITIS IN A COHORT OF PATIENTS WITH INFLAMMATORY MYOPATHIES | 2025-06-01 | OpenAlex | 10.1016/j.ard.2025.05.319 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411417751 | |||
| W4411194742 | Operational Modes and Technical Points for Empowering Urban Park Green Spaces by Digital Technology | 2025-06-01 | OpenAlex | 10.3724/j.fjyl.la20240175 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4411194742 | |||
| W4411421124 | POS0523 Analysis of prescription pattern of biological and synthetic targeted disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis | 2025-06-01 | OpenAlex | 10.1016/j.ard.2025.05.905 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411421124 | |||
| W4411059261 | Respiratory Support for Bronchiolitis Management in the PICU: What We Now Know and What We Want to Know | 2025-06-01 | OpenAlex | 10.1097/pcc.0000000000003765 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411059261 | |||
| W4411937062 | Rewriting the prognosis of multiple sclerosis in Brazil: a 25-year perspective on evolving diagnostic criteria | 2025-06-01 | OpenAlex | 10.1055/s-0045-1809937 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4411937062 | |||
| W4411534009 | SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development | 2025-06-01 | OpenAlex | 10.1136/jitc-2024-010739 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411534009 | |||
| W4411169226 | Speaking to Power With Power: Advocating for Your Profession | 2025-06-01 | OpenAlex | 10.1200/edbk-25-471872 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411169226 | |||
| W4410909239 | The Evidence of Us | 2025-06-01 | OpenAlex | 10.4037/ccn2025590 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410909239 | |||
| W4411695050 | The Origin and Development of Genetic Therapies | 2025-06-01 | OpenAlex | 10.1093/med/9780197689974.001.0001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411695050 | |||
| W4410985027 | The pursuit of precision in cardiogenic shock: navigating promise, pitfalls, and a path forward | 2025-06-01 | OpenAlex | 10.1093/ehjacc/zuaf080 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410985027 | |||
| W4412201296 | Traditional Chinese Medicine + artificial intelligence: Wuzhen consensus | 2025-06-01 | OpenAlex | 10.1097/hm9.0000000000000163 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412201296 | |||
| W4410944603 | A Case of Refractory Hidradenitis Suppurativa Successfully Treated With Upadacitinib | 2025-06-02 | OpenAlex | 10.7759/cureus.85255 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410944603 | |||
| W4410956945 | Disulfidptosis in pediatric AML: a multi-omics approach to risk stratification and potential therapeutic strategy | 2025-06-02 | OpenAlex | 10.1186/s12935-025-03824-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410956945 | |||
| W4410940002 | Editorial: Community series in emerging insights in controlling autoimmunity, volume II | 2025-06-02 | OpenAlex | 10.3389/fimmu.2025.1613858 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410940002 | |||
| W4410954038 | Efficient and accurate simulation of infectious diseases on adaptive networks | 2025-06-02 | OpenAlex | 10.1371/journal.pcsy.0000049 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4410954038 | |||
| W4410944960 | Self-HealAI: Architecting Autonomous Cognitive Self-Repair | 2025-06-02 | OpenAlex | 10.20944/preprints202506.0063.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4410944960 | |||
| W4413851646 | Swarm intelligence in project management decision sciences: Enhancing resource, allocation, decision making and team collaboration | 2025-06-02 | OpenAlex | 10.23954/osj.v10i1.3708 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4413851646 | |||
| W4414094720 | Ketamine for the Critically Ill: Case Series and Clinical Reflections | 2025-06-03 | OpenAlex | 10.31579/2835-7957/111 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4414094720 | |||
| W7125194221 | Dataset and Analysis for "The Limits of Naturalness: User Perceptions of Interactional Language in Human-Computer Interaction" | 2025-06-04 | OpenAlex | 10.5281/zenodo.18329845 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7125194221 | |||
| W4411041169 | Editorial: Current trends in targeted and non-targeted metabolomics in analytical toxicology | 2025-06-04 | OpenAlex | 10.3389/fmolb.2025.1614399 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411041169 | |||
| W4411021215 | Inorganic nanoparticle-based cancer immunotheranostics | 2025-06-04 | OpenAlex | 10.1016/j.ccr.2025.216848 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411021215 | |||
| W4411011009 | What Child Neurologists Need to Know About Pediatric Glioma | 2025-06-04 | OpenAlex | 10.1016/j.pediatrneurol.2025.05.029 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411011009 | |||
| W4411045730 | An urgent need for diagnostic tools to address global mpox public health emergencies | 2025-06-05 | OpenAlex | 10.1128/jcm.01321-24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411045730 | |||
| W4411046612 | Emerging role of peroxisome proliferator-activated receptor agonists in the treatment of cholestatic liver disease | 2025-06-05 | OpenAlex | 10.1097/mog.0000000000001109 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411046612 | |||
| W4411055812 | Essential Interstitial Lung Disease Management for the Primary Care Provider | 2025-06-05 | OpenAlex | 10.58931/cpct.2025.3138 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411055812 | |||
| W4411076412 | Grasping Problems at the Nanoscale: Predicting the TCR Peptide Binding in T Cell Therapy for Cancer | 2025-06-05 | OpenAlex | 10.36227/techrxiv.174909883.34734268/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411076412 | |||
| W4411362454 | Infection Prevention and Control | 2025-06-05 | OpenAlex | 10.1017/9781009052733.019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411362454 | |||
| W4411075207 | Metabolic resilience: liraglutide’s potential in alleviating depressive symptoms | 2025-06-05 | OpenAlex | 10.1007/s11033-025-10641-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411075207 | |||
| W4411121675 | Reasoning About Responsibility in Autonomous Systems: Navigating the Challenges and Charting Future Directions | 2025-06-05 | OpenAlex | 10.71346/utj.v1i2.21 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411121675 | |||
| W4411057561 | The Trinity of Cancer, Climate, and Care: Why Oncology Needs an Ecological Lens | 2025-06-05 | OpenAlex | 10.1097/cr9.0000000000000075 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411057561 | |||
| W4411101924 | Editorial: Applications of AI in autonomous, surveillance, and robotic systems | 2025-06-06 | OpenAlex | 10.3389/frobt.2025.1616634 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411101924 | |||
| W4411107889 | Editorial: Mental health recovery: engaging and empowering people living with mental illness and their families | 2025-06-06 | OpenAlex | 10.3389/fpsyt.2025.1633178 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411107889 | |||
| W4411101304 | Improving the Dosing Schedules of Targeted Anticancer Agents | 2025-06-06 | OpenAlex | 10.3390/ph18060848 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4411101304 | |||
| W4411088841 | Mapping the trajectory of psychotic symptoms and their interaction with antipsychotic treatment: a longitudinal network intervention study | 2025-06-06 | OpenAlex | 10.1101/2025.05.28.25328478 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411088841 | |||
| W4411104123 | New insights into the treatment of asthma complicated by allergic bronchopulmonary aspergillosis | 2025-06-06 | OpenAlex | 10.1080/17476348.2025.2517302 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411104123 | |||
| W4411522290 | Pediatric Leukemia: Advances in Diagnosis and Treatment Strategies | 2025-06-06 | OpenAlex | 10.47275/2379-6707-122 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411522290 | |||
| W4411090383 | Sequencing of antibody drug conjugates in breast cancer: Evidence gap and future directions | 2025-06-06 | OpenAlex | 10.1016/j.bbcan.2025.189369 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411090383 | |||
| W7216233097 | AI Agents for Real-Time Operational Decision Making: Embedding Intelligence in Data Pipelines | 2025-06-07 | OpenAlex | 10.32996/jcsts.2025.7.5.99 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7216233097 | |||
| W7214154634 | Cardiovascular Pharmacology: Contemporary Drug Classes and Novel Peptides | 2025-06-09 | OpenAlex | 10.61096/978-81-981372-2-7_2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214154634 | |||
| W4411156465 | Myelofibrosis: Treatment Options After Ruxolitinib Failure | 2025-06-09 | OpenAlex | 10.3390/curroncol32060339 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411156465 | |||
| W4411131458 | Nanomedicine in Cancer Therapeutics: Current Perspectives from Bench to Bedside | 2025-06-09 | OpenAlex | 10.1186/s12943-025-02368-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411131458 | |||
| W7214228329 | Respiratory System Therapeutics | 2025-06-09 | OpenAlex | 10.61096/978-81-981372-2-7_5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214228329 | |||
| W4411133193 | The role of L-DOPA in neurological and neurodegenerative complications: a review | 2025-06-09 | OpenAlex | 10.1007/s11010-025-05324-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411133193 | |||
| W4411167876 | Advances in the understanding and management of multiple sclerosis phenotypes | 2025-06-10 | OpenAlex | 10.1016/j.hsr.2025.100232 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411167876 | |||
| W4411191659 | Editorial: Current evidence on epidemiology and management of infections in critically ill patients | 2025-06-10 | OpenAlex | 10.3389/fpubh.2025.1584879 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411191659 | |||
| W4411186482 | Evolving Treatment Strategies for Neuropathic Pain: A Narrative Review | 2025-06-10 | OpenAlex | 10.3390/medicina61061063 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411186482 | |||
| W4411379988 | Introduction to Medical Toxicology | 2025-06-10 | OpenAlex | 10.69613/tnkdfs94 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411379988 | |||
| W4411186360 | Nanoparticles as Antimicrobial Agents: A Promising Solution Against Multidrug Resistance | 2025-06-10 | OpenAlex | 10.26524/nr.8.5 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4411186360 | |||
| W4417314731 | Uropathogens And Their Evolving Antimicrobial Resistance Patterns In Urinary Tract Infections: A Study From A Tertiary Care Hospital In Dhaka, Bangladesh | 2025-06-10 | OpenAlex | 10.70135/seejph.vi.6712 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417314731 | |||
| W7134037734 | Community-Acquired Necrotizing Pneumonia due to Panton-Valentine Leukocidin-Producing Methicillin-Sensitive Staphylococcus aureus | 2025-06-11 | OpenAlex | 10.60591/crspmi.455 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134037734 | |||
| W4411193586 | Consigning the Mapleson F Circuit to Anaesthesia’s historical archives | 2025-06-11 | OpenAlex | 10.4103/ija.ija_440_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411193586 | |||
| W4411221803 | Editorial: Applications of AI, machine learning, computational medicine, and bioinformatics in respiratory pharmacology | 2025-06-11 | OpenAlex | 10.3389/fphar.2025.1602941 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411221803 | |||
| W4411221953 | Editorial: Bacteria-host interactions: from infection to carcinogenesis | 2025-06-11 | OpenAlex | 10.3389/fcimb.2025.1634299 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411221953 | |||
| W4411222010 | Editorial: Drug repurposing to fight resistant fungal species: Recent developments as novel therapeutic strategies | 2025-06-11 | OpenAlex | 10.3389/fcimb.2025.1633037 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411222010 | |||
| W4411216126 | Immune Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma (ccRCC) | 2025-06-11 | OpenAlex | 10.3390/ijms26125577 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411216126 | |||
| W4411193972 | Microbial Collagenases | 2025-06-11 | OpenAlex | 10.1201/9781003473008-13 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411193972 | |||
| W4411194003 | Microbial Enzyme Therapeutics as Anti-Inflammatory Agents | 2025-06-11 | OpenAlex | 10.1201/9781003473008-5 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4411194003 | |||
| W4411211870 | Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies | 2025-06-11 | OpenAlex | 10.3390/scipharm93020026 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411211870 | |||
| W4412537410 | Reinforcement Learning-Driven Multi-Modal Sentiment Analysis for Personalized Drug Recommendations | 2025-06-11 | OpenAlex | 10.1109/icssas66150.2025.11080957 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412537410 | |||
| W4411215483 | Sugammadex for Neuromuscular Blockade Reversal: A Narrative Review | 2025-06-11 | OpenAlex | 10.3390/jcm14124128 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411215483 | |||
| W7201969175 | Synthetic Lethality: Revisting Precision Oncology Through Functional Susceptibilities | 2025-06-11 | OpenAlex | 10.19080/ctoij.2025.29.556255 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7201969175 | |||
| W4411224561 | Prescribing sleep, provoking harm? rethinking Z-drugs in heart failure | 2025-06-12 | OpenAlex | 10.1093/eurjpc/zwaf277 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411224561 | |||
| W4411238508 | Reflexionen zur Implementierung bevölkerungsweiter Maßnahmen zur Verhältnisprävention nichtübertragbarer Erkrankungen | 2025-06-12 | OpenAlex | 10.1007/s00103-025-04078-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411238508 | |||
| W4411230315 | Thrombotic Microangiopathy After Kidney Pancreas Transplant Managed With Eculizumab and a Calcineurin Inhibitor-free Basiliximab/Belatacept Maintenance Regimen: Between a Rock and a Hard Place | 2025-06-12 | OpenAlex | 10.1097/txd.0000000000001825 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411230315 | |||
| W4411291162 | 1304-P: Trends in Use of Medications for Multifactorial Cardiovascular Risk Factor Intervention in Adults with Diabetes in Hong Kong, 2002–2019 | 2025-06-13 | OpenAlex | 10.2337/db25-1304-p | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411291162 | |||
| W4411286203 | Abstract P1-04-03: Model-predicted Neurokinin-1 (NK1) Receptor Occupancy of Netupitant versus Aprepitant Over an Extended Time Period: Implications for Controlling Nausea and Vomiting Associated with Antibody-Drug Conjugates (ADCs) | 2025-06-13 | OpenAlex | 10.1158/1557-3265.sabcs24-p1-04-03 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411286203 | |||
| W4411292190 | Abstract P1-12-27: Clinical Case Vignette: Estrogen Receptor Targeting PET Imaging to Monitor Treatment Response to Endocrine Therapy in Lobular Breast Cancer | 2025-06-13 | OpenAlex | 10.1158/1557-3265.sabcs24-p1-12-27 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411292190 | |||
| W4411285790 | Abstract P4-10-08: Impact of an Online Educational Activity on Oncologists’ Knowledge and Confidence Regarding the Management of HR-Positive/HER2-Negative Metastatic Breast Cancer | 2025-06-13 | OpenAlex | 10.1158/1557-3265.sabcs24-p4-10-08 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411285790 | |||
| W4411290286 | Abstract RF1-04: Long-Term Follow-up and updated analysis from S0221, Comparing Alternative Dose-Schedules of Adjuvant Anthracycline/Taxane Therapy in High-Risk Early Breast Cancer | 2025-06-13 | OpenAlex | 10.1158/1557-3265.sabcs24-rf1-04 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411290286 | |||
| W4411284042 | Advances in Complement Inhibitory Strategies for the Treatment of Glomerular Disease: A Rapidly Evolving Field | 2025-06-13 | OpenAlex | 10.3390/jcm14124204 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411284042 | |||
| W4411281257 | Comprehensive review of fungal pathogenesis and antifungal therapeutics | 2025-06-13 | OpenAlex | 10.1007/s44337-025-00297-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411281257 | |||
| W4411292521 | Editorial: Multi-target drug discovery and design for complex health disorders | 2025-06-13 | OpenAlex | 10.3389/fphar.2025.1633600 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411292521 | |||
| W4411389844 | Histotechnology of Mineralised Tissues: Principles and Practical Approaches for Clinical and Research Applications | 2025-06-13 | OpenAlex | 10.9734/bpi/msraa/v6/5724 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411389844 | |||
| W4411255865 | Novel Drug Strategies in Kidney Transplantation | 2025-06-13 | OpenAlex | 10.1007/s40472-025-00479-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411255865 | |||
| W4411278169 | SIU-ICUD: Management of Lymph Node–Positive Prostate Cancer | 2025-06-13 | OpenAlex | 10.3390/siuj6030046 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411278169 | |||
| W4417331001 | 184185Chapter 10 Revolutionizing interaction with AI-driven enhancements in AR and VR | 2025-06-14 | OpenAlex | 10.1515/9783111388588-010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417331001 | |||
| W4411312298 | Adjunctive β-lactams for Staphylococcus aureus bacteremia: a narrative review | 2025-06-14 | OpenAlex | 10.1177/20499361251343969 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411312298 | |||
| W4411307910 | Analyzing clinical trials on diabetic retinopathy: Insights from the Clinical Trials Registry - India | 2025-06-14 | OpenAlex | 10.4103/picr.picr_69_25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411307910 | |||
| W4411301022 | Anti-tissue factor pathway inhibitors for hemophilia: are these treatments the answer to overcoming current treatment limitations? | 2025-06-14 | OpenAlex | 10.1080/17474086.2025.2519002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411301022 | |||
| W4411352598 | Biological Potential of Extremophilic Filamentous Fungi for the Production of New Compounds with Antimicrobial Effect | 2025-06-14 | OpenAlex | 10.3390/fermentation11060347 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411352598 | |||
| W4411394319 | Rich Data Versus Quantity of Data in Code Generation AI: A Paradigm Shift for Healthcare | 2025-06-15 | OpenAlex | 10.30953/bhty.v8.396 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411394319 | |||
| W4411336082 | Building the TacMed Chatbot to Support Medical Education in Low-Resource Settings: A Low-Code Platform Approach | 2025-06-16 | OpenAlex | 10.55157/conductscience-proceedings.v2i1.05 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411336082 | |||
| W4411327200 | Current trends in neurocritical care: a comprehensive review | 2025-06-16 | OpenAlex | 10.18700/jnc.240034 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411327200 | |||
| W4411442528 | Mutation in Media and Popular Culture | 2025-06-16 | OpenAlex | 10.5204/mcj.3182 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411442528 | |||
| W4411742526 | Optimizing Insulin Dosing and Predicting Glucose Levels for Type 1 Diabetes Management Using Reinforcement Learning (Preprint) | 2025-06-16 | OpenAlex | 10.2196/preprints.79195 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411742526 | |||
| W4411340876 | The resurrection of apomorphine: A dopamine analogue comparable in potency to L-DOPA | 2025-06-16 | OpenAlex | 10.1016/j.parkreldis.2025.107923 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411340876 | |||
| W4411363063 | Early Emicizumab Treatment in Acquired Hemophilia A: Impact on Bypassing Agent Use and Length of Hospitalization in an Australian Single-Center Cohort | 2025-06-17 | OpenAlex | 10.1055/a-2622-3483 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411363063 | |||
| W4411671259 | Editorial: Hepatocellular carcinoma: from diagnostic approaches to surgical and systemic therapies | 2025-06-17 | OpenAlex | 10.3389/fmed.2025.1633587 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411671259 | |||
| W4411370492 | Evolution of Treatment for Autoimmune Pancreatitis: Recent Advancements | 2025-06-17 | OpenAlex | 10.1007/s11938-025-00476-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411370492 | |||
| W4411715193 | Lipid-lowering agents in solid organ transplant recipients | 2025-06-17 | OpenAlex | 10.1093/ndt/gfaf104 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4411715193 | |||
| W4411401497 | An Overview of Advancements in the Bone Metastases in Endocrine Cancers: From Molecular Insights to Clinical Applications | 2025-06-18 | OpenAlex | 10.47275/2690-5663-145 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411401497 | |||
| W4411395258 | Integrating Hematopoietic Stem Cell Transplantation (HSCT) and Targeted Antibody-Drug Conjugates (ADCs) in Leukemia Treatment: Current Landscape, Translational Advances, and Emerging Therapeutic Horizons | 2025-06-18 | OpenAlex | 10.33425/2689-1069.1064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411395258 | |||
| W4416742947 | Noise, doubt, empathy or surprise? A qualitative collective self-study exploring the phenomenon of disruption in clinical trials | 2025-06-18 | OpenAlex | 10.56883/aijmt.2025.616 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416742947 | |||
| W4411458140 | Surgical Management of Oligometastatic Non-Small Cell Lung Cancer | 2025-06-18 | OpenAlex | 10.3390/cancers17122040 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411458140 | |||
| W4411416824 | Think FAST: a novel framework to evaluate fidelity, accuracy, safety, and tone in conversational AI health coach dialogues | 2025-06-18 | OpenAlex | 10.3389/fdgth.2025.1460236 | Full text | Included | Included: Human review of prior service conversations leads to retained shared task-component refinements used by the clinical conversational agent. | https://openalex.org/W4411416824 | https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2025.1460236/full | ||
| W4411395624 | Thymic epithelial tumors: what’s new and what’s next? | 2025-06-18 | OpenAlex | 10.1016/j.esmorc.2025.100024 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411395624 | |||
| W4411420584 | Use of Daptomycin to Manage Severe MRSA Infections in Humans | 2025-06-18 | OpenAlex | 10.3390/antibiotics14060617 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411420584 | |||
| W7162372042 | Αξιολόγηση αναλυτικού αλγόριθμου ανακατασκευής εικόνας σε δυναμική απεικόνιση τομογραφίας εκπομπής ποζιτρονίου μικρών ζώων | 2025-06-18 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162372042 | ||||
| W4411434799 | 2025 Southeastern Surgical Congress Presidential Address: Leadership and Innovation in Surgery: A Vision for the Future | 2025-06-19 | OpenAlex | 10.1177/00031348251350999 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411434799 | |||
| W4411448740 | Current landscape of frontline and relapsed follicular lymphoma trials | 2025-06-19 | OpenAlex | 10.1016/j.bneo.2025.100131 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411448740 | |||
| W4411452673 | NMR Relaxometry Across Time: From Early Insights to Emerging Directions | 2025-06-19 | OpenAlex | 10.1002/mrc.70002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411452673 | |||
| W4412098131 | Squamous Cell Carcinoma of the Scalp: A Case Report | 2025-06-19 | OpenAlex | 10.36347/sjmcr.2025.v13i06.042 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412098131 | |||
| W4415159087 | The Convergence of Emerging Technologies and AI-Driven Autonomous Cybersecurity in Smart Digital Ecosystems | 2025-06-19 | OpenAlex | 10.1109/smartblock4health64843.2025.11189602 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415159087 | |||
| W4411464535 | Understanding therapy-related AML: genetic insights and emerging strategies for high-risk patients | 2025-06-19 | OpenAlex | 10.3389/frhem.2025.1609642 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411464535 | |||
| W7160683984 | Yeni nesil hücresel ağlarda yapay zeka destekli dinamik öncelikli kaynak tahsisi | 2025-06-19 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160683984 | ||||
| W4411544131 | Anti-CASPR2 meningoencephalitis with thickened dura mater induced by various infections: A case report and literature review | 2025-06-20 | OpenAlex | 10.1097/md.0000000000042873 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411544131 | |||
| W4412724959 | Challenges and advances in the management of antineutrophil cytoplasmic antibody vasculitis in 2025 | 2025-06-20 | OpenAlex | 10.1097/mnh.0000000000001094 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412724959 | |||
| W4411528344 | EAISE: A Simulation Environment for Self-Evolving Embodied AI with Mirror Testing and Multi-Agent Diagnostics | 2025-06-20 | OpenAlex | 10.20944/preprints202506.1700.v1 | Title/abstract | Excluded | E2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task. | https://openalex.org/W4411528344 | |||
| W4415003882 | Enhancing Medical Lung X-Ray Diagnosis Through Multi-Agent Vision-Language Model Collaboration | 2025-06-20 | OpenAlex | 10.1109/caibda65784.2025.11182822 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W4415003882 | |||
| W4411487901 | From Headache to Heart Health: Investigating the Migraine–Cardiovascular Disease Connection | 2025-06-20 | OpenAlex | 10.1007/s40120-025-00785-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411487901 | |||
| W7207511585 | Investigating the Combined Efficacy of Targeted Therapy and Immune Checkpoint Blockade in Anaplastic Thyroid Carcinoma | 2025-06-20 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7207511585 | ||||
| W4411754089 | Poly- L- Lactic Acid in Aesthetic Dermatology: A Decade Beyond Volume Restoration Toward Regenerative Biostimulation | 2025-06-20 | OpenAlex | 10.1093/asj/sjaf121 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411754089 | |||
| W4411847040 | Rituximab-induced persistent hypogammaglobulinemia in children with nephrotic syndrome: common or rare? | 2025-06-20 | OpenAlex | 10.1093/ndt/gfaf103 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411847040 | |||
| W4414355074 | The Role of AI, Generative AI, AI Agents, RAG in Advancing Affordable Healthcare Systems | 2025-06-20 | OpenAlex | 10.26562/ijirae.2025.v1206.02 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4414355074 | |||
| W4411763924 | The hidden curriculum: a theoretical exploration in pharmacy education | 2025-06-20 | OpenAlex | 10.1093/ijpp/riaf043 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411763924 | |||
| W4411485496 | Virulence Factors and Molecular Identification of Candida Species Causing Candidemia in Honduras | 2025-06-20 | OpenAlex | 10.3390/jof11070470 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411485496 | |||
| W4411515056 | Conversational GenAI agents in mobile health and fitness apps | 2025-06-21 | OpenAlex | 10.30574/wjaets.2025.15.3.1100 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4411515056 | |||
| W4411569371 | Focus on PD-1/PD-L1-Targeting Antibodies in Colorectal Cancer: Are There Options Beyond Dostarlimab, Nivolumab, and Pembrolizumab? A Comprehensive Review | 2025-06-21 | OpenAlex | 10.3390/molecules30132686 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411569371 | |||
| W4411516751 | Recurrent Chyluria Revisited: Lymphangiographic Diagnosis of Pyelolymphatic Fistula With Insights on Endolymphatic Interventions | 2025-06-21 | OpenAlex | 10.7759/cureus.86470 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411516751 | |||
| W4411528290 | A Self-Correcting Multi-Agent Framework for Language-Based Physics Simulation and Explanation | 2025-06-22 | OpenAlex | 10.31224/4723 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4411528290 | |||
| W4411529782 | COVID-19 management in patients with comorbid conditions | 2025-06-22 | OpenAlex | 10.5501/wjv.v14.i2.102674 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411529782 | |||
| W4411522285 | From “time is brain” to “time is collaterals”: updates on the role of cerebral collateral circulation in stroke | 2025-06-22 | OpenAlex | 10.1007/s11239-025-03135-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411522285 | |||
| W4411569029 | Management of Advanced Ovarian Cancer: Current Clinical Practice and Future Perspectives | 2025-06-22 | OpenAlex | 10.3390/biomedicines13071525 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411569029 | |||
| W4411607063 | Sphenopalatine Ganglion Blocks in Headache Management: A Review | 2025-06-22 | OpenAlex | 10.3390/brainsci15070672 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411607063 | |||
| W4411558443 | Systemic Therapy for Unresectable Hepatocellular Carcinoma: Current Landscape and Future Directions | 2025-06-22 | OpenAlex | 10.3390/ijms26135994 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411558443 | |||
| W4415180812 | Architecting Secure Smart Infrastructures with AI Microservices and Autonomous Agents: A State-of-the-Art Review and Healthcare Use Case | 2025-06-23 | OpenAlex | 10.1109/blackseacom65655.2025.11193935 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4415180812 | |||
| W4411545358 | Evolving Options and Views on Anal Dysplasia | 2025-06-23 | OpenAlex | 10.1055/s-0045-1809904 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411545358 | |||
| W4411563787 | Gastric cancer: from biomarkers to functional precision medicine | 2025-06-23 | OpenAlex | 10.1016/j.molmed.2025.05.007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411563787 | |||
| W4411548606 | Internal Balance and Behavior: An Interdisciplinary Reading from Maimonides and Neurophysiology | 2025-06-23 | OpenAlex | 10.22541/au.175070787.71694259/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411548606 | |||
| W4411567810 | JAK2 Inhibitors and Emerging Therapies in Graft-Versus-Host Disease: Current Perspectives and Future Directions | 2025-06-23 | OpenAlex | 10.3390/biomedicines13071527 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411567810 | |||
| W4411532925 | New treatments in atopic dermatitis update | 2025-06-23 | OpenAlex | 10.1016/j.anai.2025.06.020 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411532925 | |||
| W4411548645 | The Evolution and Diversification of Proteasome Inhibitors in Cancer and Beyond | 2025-06-23 | OpenAlex | 10.26434/chemrxiv-2025-v5w42 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411548645 | |||
| W7112442365 | The Only Constant Is Change: The Role of Genetic Diversification in Cancer and Beyond | 2025-06-23 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7112442365 | ||||
| W4411593067 | A new era for radium-223? Optimizing treatment by balancing efficacy and toxicity through combination therapies | 2025-06-24 | OpenAlex | 10.1016/j.critrevonc.2025.104819 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411593067 | |||
| W4411605124 | Cardio-Oncology: Cardiovascular Risk and Surveillance in Cancer Therapy | 2025-06-24 | OpenAlex | 10.58830/ozgur.pub780.c3259 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411605124 | |||
| W4411597762 | Clinical trials for neuropsychiatric syndromes in major and mild neurocognitive disorders: A CONSORT-based approach | 2025-06-24 | OpenAlex | 10.1016/j.inpsyc.2025.100107 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411597762 | |||
| W4411582670 | Covalent organic frameworks: Prospects and potential in tumor diagnosis and therapy | 2025-06-24 | OpenAlex | 10.1016/j.cej.2025.165302 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411582670 | |||
| W7220587139 | EDUCAÇÃO EM SAÚDE E PREVENÇÃO DE INFECÇÕES EM ACADEMIAS: REFLEXÕES A PARTIR DE UM PROJETO INTEGRADOR NO CURSO DE MEDICINA: INFECTION PREVENTION IN FITNESS CENTERS: REFLECTIONS FROM A MEDICAL SCHOOL INTEGRATIVE PROJECT | 2025-06-24 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220587139 | ||||
| W4411742347 | Evolutionary Perspective of Drug Eluting Stents: From Thick Polymer to Polymer-Free Approach | 2025-06-24 | OpenAlex | 10.69968/ijisem.2025v4i2379-389 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411742347 | |||
| W4412972828 | Falling Behind In The Fight: The Persistent And Evolving Threat Of Pseudomonas Aeruginosa In Healthcare And Ecosystems | 2025-06-24 | OpenAlex | 10.64252/a9ggyc08 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4412972828 | |||
| W4411613535 | GLP-1RA may open a new era for MASLD treatment: Editorial on “Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study” | 2025-06-24 | OpenAlex | 10.3350/cmh.2025.0628 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411613535 | |||
| W7217113988 | In dialogue with the vampire: influence of Bram Stoker’s Dracula on twentieth and twenty-first century vampire tropes | 2025-06-24 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7217113988 | ||||
| W4411597957 | Indirect comparison of TPF and GP induction chemotherapy regimens in nasopharyngeal carcinoma: a data-driven reassessment before the transition to induction chemoimmunotherapy | 2025-06-24 | OpenAlex | 10.1093/oncolo/oyaf175 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411597957 | |||
| W4411651582 | Metabolic syndrome adversely impacts mortality from steatotic liver disease | 2025-06-24 | OpenAlex | 10.1093/eurjpc/zwaf364 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411651582 | |||
| W4411586371 | Pharmacologic options for the treatment of overweight and obesity | 2025-06-24 | OpenAlex | 10.1097/gme.0000000000002573 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411586371 | |||
| W7215268539 | Pharmacological Strategies in the Management of Chronic Heart Failure: Advances and Clinical Perspectives | 2025-06-24 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215268539 | ||||
| W4411580454 | Re-evaluation of penicillin and ceftriaxone MIC results to predict susceptibility to the oral cephalosporin, cefpodoxime, in Streptococcus pneumoniae clinical isolates from the United States according to CLSI guidelines (2019–2021) | 2025-06-24 | OpenAlex | 10.1128/jcm.00027-25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411580454 | |||
| W4411580535 | SGLT2 inhibitors as metabolic modulators: beyond glycemic control in type 2 diabetes | 2025-06-24 | OpenAlex | 10.3389/fendo.2025.1601633 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411580535 | |||
| W4411575833 | The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types | 2025-06-24 | OpenAlex | 10.1038/s43018-025-00990-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411575833 | |||
| W4411606918 | Zinc-dependent mechanisms of reparative regeneration: theoretical aspects and translational perspectives | 2025-06-24 | OpenAlex | 10.17816/rcf660184 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411606918 | |||
| W4411626590 | Agentic Artificial Intelligence: The Power to Change Medicine and Our World | 2025-06-25 | OpenAlex | 10.1016/j.jacr.2025.06.032 | Title/abstract | Excluded | E5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established. | https://openalex.org/W4411626590 | |||
| W4411918282 | Antiplatelet Therapy in Heart Disease | 2025-06-25 | OpenAlex | 10.31083/rcm36522 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411918282 | |||
| W7219366835 | Assessment of Antidiabetic Potential Using Melia azedarach fruit Extract | 2025-06-25 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7219366835 | ||||
| W4411639641 | Carbon-Dot-Zn 2+ Assembly Hybrid Multifunctional Hydrogels for Synergistically Monitoring Local Glucose and Repairing Diabetic Wound | 2025-06-25 | OpenAlex | 10.1021/acsami.5c06293 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411639641 | |||
| W4411662119 | Changing landscape of first-line treatment for locally advanced or metastatic urothelial carcinoma: the progression from platinum-based chemotherapy to platinum-free therapy | 2025-06-25 | OpenAlex | 10.3389/fimmu.2025.1604395 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411662119 | |||
| W4411626614 | Clinical trial landscape for pneumonia: Evolving agents against bacterial pathogens | 2025-06-25 | OpenAlex | 10.1016/j.ijid.2025.107965 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4411626614 | |||
| W4411627122 | Monoclonal antibodies: their place in applied medicine and their role in the newest infectious disease – history, present, and future. Literature review | 2025-06-25 | OpenAlex | 10.3897/pharmacia.72.e159772 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411627122 | |||
| W7220128781 | Negotiating Trust, Identity, and Responsibility: Clinicians’ Experiences with AI-Assisted Diagnosis in Digital Healthcare Settings | 2025-06-25 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220128781 | ||||
| W4411642284 | Tenecteplase: expanding horizons in thrombolytic therapy across various clinical indications | 2025-06-25 | OpenAlex | 10.1136/heartjnl-2024-325249 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411642284 | |||
| W4411700885 | The Evolving Role of Chemotherapy in the Management of Pleural Malignancies: Current Evidence and Future Directions | 2025-06-25 | OpenAlex | 10.3390/cancers17132143 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411700885 | |||
| W4411918249 | Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation: A Review of the Literature and Current Guidelines | 2025-06-26 | OpenAlex | 10.31083/rcm39233 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411918249 | |||
| W4411699079 | Editorial: Application of PKPD modeling in drug discovery and development | 2025-06-26 | OpenAlex | 10.3389/fphar.2025.1614689 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411699079 | |||
| W4411690558 | Efficacy and safety of obinutuzumab in active lupus nephritis | 2025-06-26 | OpenAlex | 10.1093/ckj/sfaf161 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411690558 | |||
| W4411680704 | Incorporating novel therapies into the treatment of older patients with classic Hodgkin lymphoma | 2025-06-26 | OpenAlex | 10.1080/17474086.2025.2526685 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411680704 | |||
| W4411682894 | Ivabradine: Evolving role as an antiarrhythmic agent | 2025-06-26 | OpenAlex | 10.1016/j.hrthm.2025.06.039 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4411682894 | |||
| W4411674565 | The microbiome of the sucking louse Linognathus stenopsis (Phthiraptera, Anoplura, Linognathiidae) | 2025-06-26 | OpenAlex | 10.1093/jme/tjaf060 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4411674565 | |||
| W4412037355 | ‘4 Ss’ for successful blood pressure control | 2025-06-26 | OpenAlex | 10.1097/hjh.0000000000004054 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412037355 | |||
| W4411730060 | Bipolar disorder: Systematic review of approved psychiatric medications (2008–2024) and pipeline Phase-3 medications | 2025-06-27 | OpenAlex | 10.1016/j.jad.2025.119778 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411730060 | |||
| W4411716778 | Contributors | 2025-06-27 | OpenAlex | 10.1215/00265667-11859149 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411716778 | |||
| W4411732856 | HX01 Avicenna: an influence on modern dermatology | 2025-06-27 | OpenAlex | 10.1093/bjd/ljaf085.464 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411732856 | |||
| W4411732744 | HX22 Shining a light on dermatology | 2025-06-27 | OpenAlex | 10.1093/bjd/ljaf085.485 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411732744 | |||
| W4411733549 | HX24 Battle scars: the role of dermatology in war, both past and present | 2025-06-27 | OpenAlex | 10.1093/bjd/ljaf085.487 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411733549 | |||
| W4411715869 | Leading Lung Cancer Experts Highlight Hot Topics in Immunotherapy | 2025-06-27 | OpenAlex | 10.1097/01.cot.0000000000000116 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411715869 | |||
| W4411739427 | Low-intensity behavioral activation smartphone app to support low mood: description, engagement and log data analysis | 2025-06-27 | OpenAlex | 10.20935/mhealthwellb7785 | Full text | Excluded | F4: The behavior-activation app retains personal activity/progress logs for the same user. Analysis of those logs informs future product development, without an implemented shared cross-case agent update (P1). | https://openalex.org/W4411739427 | https://doi.org/10.20935/MHealthWellB7785 | original publisher full Methods and app/agent description | |
| W4413321990 | Super-Ellipse Control Barrier Functions for Enhanced Obstacle Avoidance in Complex Multi-Agent Environments | 2025-06-27 | OpenAlex | 10.1109/icras65818.2025.11108843 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4413321990 | |||
| W4411711107 | Targeting p53 activation: Recent therapeutic advances in cancer and diabetic macular edema | 2025-06-27 | OpenAlex | 10.1016/j.ejmech.2025.117909 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411711107 | |||
| W4412389924 | The Evolving Role of Alkylating Agents in Multiple Myeloma: From the Past and Present to Next-Generation Peptide Drug Conjugates | 2025-06-27 | OpenAlex | 10.36000/hbt.oh.2025.24.180 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4412389924 | |||
| W4411744728 | Artificial Intelligence in Healthcare: A Systematic Review of Virtual Healthcare Assistants | 2025-06-28 | OpenAlex | 10.9734/ajpas/2025/v27i7776 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411744728 | |||
| W4411746524 | Histamine dihydrochloride and low-dose interleukin-2 in an emerging landscape of relapse prevention in acute myeloid leukemia | 2025-06-28 | OpenAlex | 10.1177/20406207251351086 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411746524 | |||
| W4413345543 | Molecular mechanisms and genetic features of cholangiocarcinoma: implications for targeted therapeutic strategies | 2025-06-28 | OpenAlex | 10.1093/pcmedi/pbaf021 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413345543 | |||
| W4411776219 | BRUTON’S TYROSINE KINASE (BTK) MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A CLINICAL VIEW. | 2025-06-29 | OpenAlex | 10.4084/mjhid.2025.053 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411776219 | |||
| W7128528194 | Beyond Traditional AI: A Comprehensive Study of Agentic Frameworks and Their Impact | 2025-06-29 | OpenAlex | 10.38124/ijsrmt.v4i6.1044 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7128528194 | |||
| W4411842761 | Integrating 5PL Frameworks with Drone-Based Last-Mile Delivery: A Model for Future-Ready Logistics | 2025-06-29 | OpenAlex | 10.55121/tdr.v3i1.449 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4411842761 | |||
| W4414723260 | CDA Formulations to Remove Cancer as the Top Killers of Many Asian Countries | 2025-06-30 | OpenAlex | 10.70818/apjcr.v02i02.028 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414723260 | |||
| W7217065476 | CLINICAL OUTCOMES OF IMMUNOTHERAPY IN STAGE IV NON-SMALL CELL LUNG CANCER PATIENTS | 2025-06-30 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7217065476 | ||||
| W4411802175 | Clinical Insights and Therapeutic Strategies for the Treatment of Interstitial Lung Disease in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Trends and Future Directions | 2025-06-30 | OpenAlex | 10.3390/jcm14134631 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411802175 | |||
| W4413403801 | Efficacy of Disinfectants Against Pathogenic Bacteria in Intensive Care Units of Abadan and Khorramshahr Hospitals, Iran | 2025-06-30 | OpenAlex | 10.34172/ajcmi.3617 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413403801 | |||
| W4411780233 | Escitalopram-associated Cutaneous Reactions: Insights from a Case Series | 2025-06-30 | OpenAlex | 10.4103/jopsys.jopsys_57_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411780233 | |||
| W4413067785 | Intelligent Agents for Healthcare Complaint Management: Ensuring Compliance with HIPAA and Medicare Standards | 2025-06-30 | OpenAlex | 10.14445/22312803/ijctt-v73i6p111 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4413067785 | |||
| W4413869062 | OVERVIEW OF CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CLOSTRIDIODIOIDES DIFFICILE-ASSOCIATED INFECTION | 2025-06-30 | OpenAlex | 10.32345/2664-4738.2.2025.18 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413869062 | |||
| W4411834249 | Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial | 2025-06-30 | OpenAlex | 10.1038/s41375-025-02674-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411834249 | |||
| W4411953220 | Pulmonary aspergillosis in patients with asthma | 2025-06-30 | OpenAlex | 10.3855/jidc.20711 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411953220 | |||
| W4411788278 | Therapeutic horizons in metabolic dysfunction–associated steatohepatitis | 2025-06-30 | OpenAlex | 10.1172/jci186425 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411788278 | |||
| W7217371811 | Transformative learning as a catalyst for People Living with HIV (PLHIV): A qualitative conceptual framework | 2025-06-30 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217371811 | ||||
| W4414928440 | A clinical viewpoint on the EASO grade-based pharmacological algorithm for obesity management | 2025-07-01 | OpenAlex | 10.1093/obendo/wjaf010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414928440 | |||
| W4412627974 | A rare complication of DRESS syndrome in the treatment of cardiac device-related lead thrombus and infective endocarditis | 2025-07-01 | OpenAlex | 10.1016/j.clinme.2025.100353 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412627974 | |||
| W4413641306 | Antimicrobial resistance: A call to action for the medical community | 2025-07-01 | OpenAlex | 10.4103/cmrp.cmrp_101_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413641306 | |||
| W4411864374 | Cardiovascular risk management beyond statins: review of new therapies available in Italy | 2025-07-01 | OpenAlex | 10.1186/s43044-025-00660-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411864374 | |||
| W4412915040 | Co-creating Value in Mental Health: A Business Development Perspective on Mental Health Professionals’ Partnerships with Social Media and Artificial Intelligence Platforms in India | 2025-07-01 | OpenAlex | 10.4103/jmhhb.jmhhb_77_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412915040 | |||
| W4414578881 | Current state and future of nonsurgical management of metastatic liver tumors | 2025-07-01 | OpenAlex | 10.4103/jcrt.jcrt_192_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414578881 | |||
| W4411963290 | Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast] | 2025-07-01 | OpenAlex | 10.2147/blctt.s549780 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411963290 | |||
| W4411991822 | Deep learning-based multimodal data fusion in bone tumor management: Advances in clinical decision support | 2025-07-01 | OpenAlex | 10.1016/j.intonc.2025.06.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411991822 | |||
| W4411846202 | Emerging therapeutic agents in multiple myeloma: highlights from the 2024 ASH annual meeting | 2025-07-01 | OpenAlex | 10.1186/s40364-025-00803-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411846202 | |||
| W4413236670 | Evasion of complement and amyloid-beta by the neurotropic pathogen Borrelia burgdorferi in human 3D cultures | 2025-07-01 | OpenAlex | 10.1016/j.imbio.2025.152928 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413236670 | |||
| W7163029007 | Green-synthesized titanium dioxide nanoparticles via spirulina extract: X-ray diffraction profiling and radiological imaging prospects | 2025-07-01 | OpenAlex | 10.33545/26644436.2025.v8.i3c.548 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163029007 | |||
| W4412885553 | International Journal of Healthcare Quality, Patient Centeredness, and Safety (IJHQPCS) | 2025-07-01 | OpenAlex | 10.4103/ijhqpcs.ijhqpcs_43_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412885553 | |||
| W4414436704 | International law and the challenge of populism | 2025-07-01 | OpenAlex | 10.1093/lril/lraf018 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414436704 | |||
| W4413820200 | Journal Club: Quarterly Round-up of Notable Articles (June 2025 to July 2025) | 2025-07-01 | OpenAlex | 10.4103/cids.cids_24_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413820200 | |||
| W4413473810 | Liposomal Medicine Drug Delivery Systems from Concept to Clinical Operation | 2025-07-01 | OpenAlex | 10.47583/ijpsrr.2025.v85i7.009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413473810 | |||
| W4412556093 | Lytic bacteriophages as alternative to overcoming antibiotic-resistant biofilms formed by clinically significant bacteria | 2025-07-01 | OpenAlex | 10.1177/20499361251356057 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412556093 | |||
| W4413969931 | MASLD Pharmacotherapy: Current Standards, Emerging Treatments, and Practical Guidance for Indian Physicians | 2025-07-01 | OpenAlex | 10.59556/japi.73.1058 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413969931 | |||
| W4412443092 | MSR7 Transforming Regulatory Intelligence With AI Driven Methodologies in HEOR | 2025-07-01 | OpenAlex | 10.1016/j.jval.2025.04.1160 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4412443092 | |||
| W4413141291 | Machine Learning and Artificial Intelligence in Nanomedicine | 2025-07-01 | OpenAlex | 10.1002/wnan.70027 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413141291 | |||
| W7139129275 | Metabolic Liver Disease and Obesity at a Therapeutic Crossroads: From Lifestyle Interventions to Incretin-based Pharmacotherapy | 2025-07-01 | OpenAlex | 10.4103/aptj.aptj_26_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139129275 | |||
| W4416534812 | Monoclonal antibodies in 2025: From milestones to new frontiers | 2025-07-01 | OpenAlex | 10.4103/ijc.ijc_9_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416534812 | |||
| W4412124266 | Moving the needle on immune checkpoint inhibitors with novel targets: are we being TIMid or LAGging behind? | 2025-07-01 | OpenAlex | 10.1093/oncolo/oyaf145 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412124266 | |||
| W4411895246 | Neoadjuvant treatment patterns and biomarker selection in muscle-invasive bladder cancer | 2025-07-01 | OpenAlex | 10.1007/s12672-025-02796-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411895246 | |||
| W4411900738 | New Tools and Targets: Optimizing Emergency Care for Neurotrauma Patients | 2025-07-01 | OpenAlex | 10.1097/01.eem.0000000000000059 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411900738 | |||
| W4411856165 | New horizons in systemic sclerosis treatment: advances and emerging therapies in 2025 | 2025-07-01 | OpenAlex | 10.1136/rmdopen-2025-005776 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411856165 | |||
| W4412901535 | New progress and challenges of targeted therapies for breast cancer | 2025-07-01 | OpenAlex | 10.21037/apm-25-30 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412901535 | |||
| W7129343124 | Next-Generation Therapeutics for Perianal Fistulizing Crohn’s Disease: The Anticipated Impact of IL-23 Inhibitors | 2025-07-01 | OpenAlex | 10.4103/hjhs.hjhs_50_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129343124 | |||
| W7155520803 | Oncologic Surgery in the Era of Targeted Therapy: Beyond the Scalpel | 2025-07-01 | OpenAlex | 10.4103/sd.sd_2_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155520803 | |||
| W7124655394 | Orthopaedic oncology: Innovative treatment modalities for bone tumours in children | 2025-07-01 | OpenAlex | 10.22271/27078345.2025.v7.i2b.323 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124655394 | |||
| W4412403511 | P37 Retrospective analysis of the microbiological structure of pathogens in severe lung lesions. | 2025-07-01 | OpenAlex | 10.1093/jacamr/dlaf118.044 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412403511 | |||
| W4412976953 | Pyrimidine‐Based Scaffolds: Emerging Frontiers in Antimicrobial Drug Discovery | 2025-07-01 | OpenAlex | 10.1002/slct.202500907 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412976953 | |||
| W4412507742 | Research Trends and Knowledge Mapping of Opioid-Free Anesthesia: A Global Bibliometric Analysis | 2025-07-01 | OpenAlex | 10.2147/jmdh.s533687 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412507742 | |||
| W4417185328 | Response to “Pemphigus vulgaris and lichen planus pigmentosus in an HIV-positive patient” | 2025-07-01 | OpenAlex | 10.4103/ijstd.ijstd_62_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417185328 | |||
| W4411851797 | Shaping the Future of Stroke Management: Latest Innovations and Discoveries | 2025-07-01 | OpenAlex | 10.32894/kjms.2025.161005.1162 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411851797 | |||
| W4414022688 | Strategies employed by tumor cells to evade immune surveillance and immunotherapeutic interventions: A comprehensive review | 2025-07-01 | OpenAlex | 10.22271/letters.2025.v5.i2b.146 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414022688 | |||
| W4412109964 | Surgical audience focused on multimodality treatment for lung cancer | 2025-07-01 | OpenAlex | 10.1093/icvts/ivaf151 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412109964 | |||
| W4411993998 | Targeted Therapy in NSCLC: A Comprehensive Review of Molecular Drivers and Treatment Strategies | 2025-07-01 | OpenAlex | 10.12775/qs.2025.43.61191 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411993998 | |||
| W7134057618 | The Excesses of Cosmetic Medicine | 2025-07-01 | OpenAlex | 10.4103/ijt.ijt_4_24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134057618 | |||
| W7115184572 | The Rise of Dalbavancin in MRSA and Skin Infections – A Review of Therapeutic Benefits | 2025-07-01 | OpenAlex | 10.33545/26647613.2025.v7.i2h.158 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7115184572 | |||
| W4414045740 | The evolving landscape of generative AI: Architectures, Applications, and ethical governance in 2024-2025 | 2025-07-01 | OpenAlex | 10.33545/27075923.2025.v6.i2a.96 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414045740 | |||
| W4412519729 | The role of ocular pathology and ocular microbiology in ophthalmology | 2025-07-01 | OpenAlex | 10.4103/hjo.hjo_2_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412519729 | |||
| W4413194176 | Transforming sarcoma treatment: The role of genomic profiling and immunotherapy | 2025-07-01 | OpenAlex | 10.4103/crst.crst_44_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413194176 | |||
| W4412631614 | Treatment of Chronic Migraine and Medication Overuse Headache | 2025-07-01 | OpenAlex | 10.1093/med/9780190888770.003.0021 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412631614 | |||
| W4412473749 | Ultrasound-guided strategies in ulcerative colitis: early prediction and targeting | 2025-07-01 | OpenAlex | 10.1093/ecco-jcc/jjaf113 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412473749 | |||
| W4412693824 | Understanding and Managing Antineoplastic and Antiretroviral Therapy | 2025-07-01 | OpenAlex | 10.1093/med/9780197812631.003.0026 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412693824; https://openalex.org/W4386613523 | |||
| W7133510588 | Unmasking Nature’s Deceit: A Systematic Review of Biological Deception Across Pathogens, Viruses, and Genetic Systems | 2025-07-01 | OpenAlex | 10.25163/microbbioacts.8110417 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133510588 | |||
| W4413941935 | Unveiling the Leptomeningeal Labyrinth: Insights Into Outer Pial Layer and Subarachnoid Lymphoid Interface | 2025-07-01 | OpenAlex | 10.4103/njca.njca_143_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413941935 | |||
| W4411945774 | A promising leap in treating large granular lymphocytic leukemia: reflections on a Multicenter Phase II Study of thalidomide-based therapy | 2025-07-02 | OpenAlex | 10.1097/bs9.0000000000000239 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411945774 | |||
| W7221774847 | ESG IMPACT Environment, Social, and Governance | 2025-07-02 | OpenAlex | 10.20473/aup.1566 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221774847 | |||
| W4411968118 | Harnessing the power of nanotechnology and intelligent wound dressings to transform sports injury recovery and healing | 2025-07-02 | OpenAlex | 10.1016/j.jddst.2025.107240 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411968118 | |||
| W4411932834 | Proline-Mediated Enhancement in Evolvability of Disulfide-Rich Peptides for Discovering Protein Binders | 2025-07-02 | OpenAlex | 10.1021/jacs.5c07075 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4411932834 | |||
| W4412004157 | An organizational theory for multi-agent interactions integrating human agents, LLMs, and specialized AI | 2025-07-03 | OpenAlex | 10.1007/s10791-025-09667-2 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4412004157 | |||
| W4411947812 | Editorial: Community series in trends in neuroimmunology: cross-talk between brain-resident and peripheral immune cells in both health and disease, volume II | 2025-07-03 | OpenAlex | 10.3389/fimmu.2025.1644278 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411947812 | |||
| W4412009832 | Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies | 2025-07-03 | OpenAlex | 10.3390/cancers17132228 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412009832 | |||
| W4411984265 | Kikuchi-Fujimoto in the light of the COVID-19: infection and vaccination. A systematic review | 2025-07-03 | OpenAlex | 10.1007/s10067-025-07548-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4411984265 | |||
| W4415686329 | Mezigdomide for multiple myeloma: a focus on phase 2 trial data | 2025-07-03 | OpenAlex | 10.1080/14728214.2025.2575570 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415686329 | |||
| W4412091366 | Narcotics through time: exploring historical origins, synthetic advances, and clinical progress | 2025-07-03 | OpenAlex | 10.1080/17568919.2025.2527606 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412091366 | |||
| W4412017190 | Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC | 2025-07-04 | OpenAlex | 10.1007/s15010-025-02575-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412017190 | |||
| W4412013832 | Ghrelin peptide in heart failure: when is showtime? | 2025-07-04 | OpenAlex | 10.3389/fcvm.2025.1574521 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412013832 | |||
| W4412727974 | Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan | 2025-07-04 | OpenAlex | 10.1097/mnh.0000000000001101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412727974 | |||
| W4412042075 | [177Lu]Lu-FAPI Radioligand Therapy: Emerging Horizons and Clinical Promise in Solid Tumors: A Comprehensive Review | 2025-07-04 | OpenAlex | 10.1053/j.semnuclmed.2025.06.010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412042075 | |||
| W4412054607 | Mechanisms and Therapeutic Applications of β‐Cyclodextrin in Drug Solubilisation and Delivery Systems | 2025-07-05 | OpenAlex | 10.1002/cbdv.202500359 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412054607 | |||
| W4412056870 | Role of Interventional Radiology as the First-line Management in Unruptured Giant Hepatic Hemangiomas | 2025-07-05 | OpenAlex | 10.4103/jmms.jmms_76_25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412056870 | |||
| W4412149489 | Theory and Mechanism in Novel Drug Delivery Technologies | 2025-07-05 | OpenAlex | 10.59646/ddt/400 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412149489 | |||
| W7106320633 | 251Chapter 8 Clinical frontiers and regulatory status of micro/nanoemulsions | 2025-07-07 | OpenAlex | 10.1515/9783111593654-009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7106320633 | |||
| W7218051725 | Computer Aided Drug Discovery Driven Approaches for Discovery of Antimicrobial Agents | 2025-07-07 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7218051725 | ||||
| W4412069514 | Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: a comprehensive literature review of a rare retinal vasculopathy | 2025-07-07 | OpenAlex | 10.1186/s12886-025-04236-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412069514 | |||
| W4412091127 | Non-Invasive Caries Control: Role of Silver Diamine Fluoride in Arresting Early Childhood Caries - A Narrative Review | 2025-07-07 | OpenAlex | 10.21275/sr25703101306 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412091127 | |||
| W4412202495 | Perspective Chapter: Metabolic Dysfunction-Associated Steatotic Liver Disease as an Emerging Cardiovascular Risk Factor – Pathophysiology, Implications and Clinical Perspectives | 2025-07-07 | OpenAlex | 10.5772/intechopen.1011513 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412202495 | |||
| W4413679715 | AI Agents for Clinical Data Assessment: Enhancing Decision-Making with Human-AI Collaboration | 2025-07-08 | OpenAlex | 10.1109/compsac65507.2025.00296 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4413679715 | |||
| W4412154795 | Alisertib and Barasertib Induce Cell Cycle Arrest and Mitochondria-Related Cell Death in Multiple Myeloma with Enhanced Efficacy Through Sequential Combination with BH3-Mimetics and Panobinostat | 2025-07-09 | OpenAlex | 10.3390/cancers17142290 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412154795 | |||
| W4412182432 | A Historical Revision on The Evolution of Purpura Fulminans Management Since 1995 | 2025-07-10 | OpenAlex | 10.20944/preprints202507.0923.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412182432 | |||
| W4412172829 | AI-Facilitated Cognitive Reappraisal via Socrates 2.0: A Mixed Methods Feasibility Study (Preprint) | 2025-07-10 | OpenAlex | 10.2196/preprints.80461 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4412172829 | |||
| W4412161602 | Current Application of Mineralocorticoid Antagonist (MRA) in Heart Failure and CKD: Does Non-Steroidal Drug Add Novel Insights | 2025-07-10 | OpenAlex | 10.3390/biomedicines13071693 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412161602 | |||
| W4412177655 | Cytomorphology of Renal Hydatid Cyst Mimicking as Simple Renal Cyst | 2025-07-10 | OpenAlex | 10.1111/cyt.70008 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412177655 | |||
| W4412182975 | Lipid-mediated GPR32 signaling reprograms macrophage metabolism to impair anti-tuberculous immunity | 2025-07-10 | OpenAlex | 10.1101/2025.07.07.663524 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412182975 | |||
| W4412166231 | Nanocarriers in Cancer Immunotherapy | 2025-07-10 | OpenAlex | 10.1201/9781003473183-14 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412166231 | |||
| W4412154774 | Precision medicine and the expanding perioperative role by Anaesthesiologists | 2025-07-10 | OpenAlex | 10.4103/ija.ija_581_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412154774 | |||
| W4412154766 | Recent Progress of Nanomedicine for the Synergetic Treatment of Radiotherapy (RT) and Photothermal Treatment (PTT) | 2025-07-10 | OpenAlex | 10.3390/cancers17142295 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412154766 | |||
| W7224051053 | Toque Afetivo, Corregulação Emocional e Satisfação Conjugal - Um Estudo Qualitativo Diádico | 2025-07-10 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224051053 | ||||
| W4412913498 | What is Your Suspected Diagnosis? A Challenging Case of Unilateral Ptosis with Eyelid Edema in a Pediatric Patient | 2025-07-10 | OpenAlex | 10.52338/jocp.2025.4930 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412913498 | |||
| W4412201742 | XPS Monitoring of Calcarenite Building Walls Long Exposed Outdoors: Estimation of Deterioration Trend from the Time Sequence of Curve-Fitted Spectra and PCA Exploration of the Large Dataset | 2025-07-10 | OpenAlex | 10.3390/app15147741 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4412201742 | |||
| W7106536719 | DERIVATIVES OF INDOLE | 2025-07-11 | OpenAlex | 10.58532/nbennurfrt36 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7106536719 | |||
| W4412350512 | Immunomodulation in Autoimmune Disorders | 2025-07-11 | OpenAlex | 10.1002/9781394313785.ch9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412350512 | |||
| W4412188141 | Solving Mazes of Organelle‐Targeted Therapies with DNA Nanomachines | 2025-07-11 | OpenAlex | 10.1002/adma.202508047 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412188141 | |||
| W4412200834 | THE MANIFESTATION OF PHARMACOGENETIC AND CLINICAL PERSPECTIVES ON MEDICATION-ASSOCIATED EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS): A COMPREHENSIVE EVALUATION OF IMPLICATED AGENTS, RISK FACTORS, AND TREATMENT MANAGEMENTS STRATEGIES IN GENERAL | 2025-07-11 | OpenAlex | 10.52340/gs.2025.07.03.14 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412200834 | |||
| W4412362022 | African Footballers and Their Role in Community Development and Cultural Activism | 2025-07-12 | OpenAlex | 10.62154/ajsps.2025.04.01013 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4412362022 | |||
| W7217818403 | Review of Clinical Advances and Challenges in Managing Wet Age-Related Macular Degeneration | 2025-07-13 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217818403 | ||||
| W4412379163 | Building trust in the age of human-machine interaction: insights, challenges, and future directions | 2025-07-14 | OpenAlex | 10.3389/frobt.2025.1535082 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412379163 | |||
| W4412390413 | Optimizing Adjuvant Care in Early Breast Cancer: Multidisciplinary Strategies and Innovative Models from Canadian Centers | 2025-07-14 | OpenAlex | 10.3390/curroncol32070402 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412390413 | |||
| W7220616700 | ROLE OF MOLECULAR DIAGNOSTICS IN EARLY DETECTION OF INFECTIOUS DISEASES | 2025-07-14 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220616700 | ||||
| W4412425712 | Adaptive laboratory-evolved MRSA with PPEF manifests cross-susceptibility to oxacillin and hypersensitivity to ciprofloxacin | 2025-07-15 | OpenAlex | 10.1128/spectrum.02974-24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412425712 | |||
| W4412417730 | Data from A Machine Learning–Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia | 2025-07-15 | OpenAlex | 10.1158/0008-5472.c.7928375 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412417730 | |||
| W4412460706 | Humans learn to trace meaningful relationships with their eyes | 2025-07-15 | OpenAlex | 10.1167/jov.25.9.1782 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412460706 | |||
| W4412392677 | Interpretable Ensemble Learning Predicts Antibiotic Resistance in Treponema denticola Using Expert Classifiers | 2025-07-15 | OpenAlex | 10.1016/j.identj.2025.100884 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412392677 | |||
| W4412926972 | Research Trends in Virtual Assistants | 2025-07-15 | OpenAlex | 10.14429/djlit.21022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412926972 | |||
| W4412425714 | Rheumatologists’ Adherence to EULAR Recommendations for Systemic Sclerosis Treatment: Experience of a Single Center in Serbia | 2025-07-15 | OpenAlex | 10.3390/jcm14144994 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412425714 | |||
| W4412420271 | The role of the endocannabinoid system in the mechanism of action of nonopioid analgesics | 2025-07-15 | OpenAlex | 10.1016/j.ejphar.2025.177946 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412420271 | |||
| W4412439706 | The treatment of marginal zone lymphoma | 2025-07-15 | OpenAlex | 10.1182/blood.2024028269 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412439706 | |||
| W4412458919 | A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients | 2025-07-16 | OpenAlex | 10.1016/j.esmoop.2025.105514 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412458919 | |||
| W4412477450 | Clinical use of biologics in juvenile idiopathic arthritis: lessons learned from real-world studies | 2025-07-16 | OpenAlex | 10.1080/14712598.2025.2536351 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412477450 | |||
| W4412488577 | Emerging treatment options for adrenocortical carcinoma | 2025-07-16 | OpenAlex | 10.1097/med.0000000000000921 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412488577 | |||
| W4412467665 | Evolving treatment strategies in meningioma: from traditional approaches to emerging therapies | 2025-07-16 | OpenAlex | 10.1097/ms9.0000000000003556 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412467665 | |||
| W4412465758 | Genetic improvement of a synthetic microbiota: a step further? | 2025-07-16 | OpenAlex | 10.3389/fmicb.2025.1619874 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412465758 | |||
| W4412470842 | Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management | 2025-07-16 | OpenAlex | 10.3390/jcdd12070270 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412470842 | |||
| W4412483375 | RETRACTED: Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine | 2025-07-16 | OpenAlex | 10.1053/j.semnuclmed.2025.06.005 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4412483375 | |||
| W4413319439 | Artificial Moral Agents: Should Machines Take Ethical Responsibility? | 2025-07-17 | OpenAlex | 10.1109/arso64737.2025.11124921 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4413319439 | |||
| W4412957150 | Editorial: Insights in emotion science | 2025-07-17 | OpenAlex | 10.3389/fpsyg.2025.1643052 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412957150 | |||
| W4412855918 | Emerging B and plasma cell-targeting immune therapies in idiopathic inflammatory myopathies | 2025-07-17 | OpenAlex | 10.3389/fimmu.2025.1581323 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412855918 | |||
| W4412823337 | Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift | 2025-07-17 | OpenAlex | 10.15420/cfr.2024.33 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412823337 | |||
| W7202417829 | Mechanistic investigation of PBT2-induced metal ion disruption in methicillin-resistant Staphylococcus aureus | 2025-07-17 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202417829 | ||||
| W4412519673 | Practice Points and Practice Reflections as the Key to Knowledge Translation | 2025-07-17 | OpenAlex | 10.1097/asw.0000000000000330 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412519673 | |||
| W4412650757 | Specialty grand challenge: existing issues and emerging frontiers in renal endocrinology | 2025-07-17 | OpenAlex | 10.3389/fendo.2025.1651141 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412650757 | |||
| W4412488244 | The Challenge of Treating Anti-PD-1-Resistant Advanced Melanoma | 2025-07-17 | OpenAlex | 10.1007/s40257-025-00969-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412488244 | |||
| W4412650176 | Unveiling the power of polymeric nanoparticles: Pioneering advances in breast cancer treatment | 2025-07-17 | OpenAlex | 10.1016/j.cis.2025.103606 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412650176 | |||
| W4412650765 | AI Agents, Automaticity, and Value Alignment in Health Care | 2025-07-18 | OpenAlex | 10.1056/aip2401165 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4412650765 | |||
| W4412521715 | Bridging theory and practice: Enhancing pharmacology education through simulation-based learning and statistical analysis training | 2025-07-18 | OpenAlex | 10.1016/j.cptl.2025.102440 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412521715 | |||
| W7164191666 | Contemporary Advances in Heart Failure Treatment: From Medications to Regenerative Therapy | 2025-07-18 | OpenAlex | 10.70146/msv02i03.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164191666 | |||
| W4412521406 | Evolving roles of MET as a therapeutic target in NSCLC and beyond | 2025-07-18 | OpenAlex | 10.1038/s41571-025-01051-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412521406 | |||
| W7164650926 | Novel Trends in the Management of Type 2 Diabetes: Beyond Glycaemic Control to Cardiovascular Protection | 2025-07-18 | OpenAlex | 10.70146/msv02i03.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164650926 | |||
| W4412523390 | Overcoming regulatory barriers to the implementation of AI agents in healthcare | 2025-07-18 | OpenAlex | 10.1038/s41591-025-03841-1 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4412523390 | |||
| W4412785499 | Pharmacologic Disruption: How Emerging Weight Loss Therapies Are Challenging Bariatric Surgery Guidelines | 2025-07-18 | OpenAlex | 10.3390/medicina61071292 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412785499 | |||
| W4413268929 | Results of a single-center rertrospective study combyning DMD treatment in patients with type 2 diabetes mellitus | 2025-07-18 | OpenAlex | 10.1016/j.atherosclerosis.2025.119947 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413268929 | |||
| W4412517689 | Advances and Challenges in Immunotherapy for Metastatic Uveal Melanoma: Clinical Strategies and Emerging Targets | 2025-07-19 | OpenAlex | 10.3390/jcm14145137 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412517689 | |||
| W4412519235 | Mapping the Global Research on Drug–Drug Interactions: A Multidecadal Evolution Through AI-Driven Terminology Standardization | 2025-07-19 | OpenAlex | 10.3390/bioengineering12070783 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412519235 | |||
| W4412496557 | Emerging innovations in ophthalmic drug delivery for diabetic retinopathy: a translational perspective | 2025-07-20 | OpenAlex | 10.1007/s13346-025-01925-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412496557 | |||
| W4412500939 | Retinopathy of Prematurity - a literature review | 2025-07-20 | OpenAlex | 10.12775/jehs.2025.83.61815 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412500939 | |||
| W4412517419 | The Changing Landscape of Antibiotic Treatment: Reevaluating Treatment Length in the Age of New Agents | 2025-07-20 | OpenAlex | 10.3390/antibiotics14070727 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412517419 | |||
| W4412524273 | Architecting Adaptive RPA: Integrating Reinforcement Learning for Intelligent Process Automation | 2025-07-21 | OpenAlex | 10.32996/jcsts.2025.7.7.84 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4412524273 | |||
| W4412616694 | Contemporary challenges in the clinical diagnosis and treatment of Mycoplasma pneumoniae infections in the paediatric population | 2025-07-21 | OpenAlex | 10.15557/pimr.2025.0016 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412616694 | |||
| W4412513249 | Current Application Status and Trends in Paravertebral Block for Thoracic Surgery: A 2004–2024 Bibliometric Analysis | 2025-07-21 | OpenAlex | 10.9734/cjast/2025/v44i74579 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412513249 | |||
| W4412519406 | Immunomodulatory Effects of RAAS Inhibitors: Beyond Hypertension and Heart Failure | 2025-07-21 | OpenAlex | 10.3390/biomedicines13071779 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412519406 | |||
| W4412519854 | Immunosuppressants/Immunomodulators and Malignancy | 2025-07-21 | OpenAlex | 10.3390/jcm14145160 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412519854 | |||
| W4412507061 | Should Systematic HSV Serological Screening of Donors Be Implemented to Manage Mismatched HSV D+/R− Liver Transplants? | 2025-07-21 | OpenAlex | 10.3389/ti.2025.14835 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412507061 | |||
| W4412570693 | Advances in minimally invasive diagnostic techniques for pulmonary diseases | 2025-07-22 | OpenAlex | 10.23736/s2724-5691.25.10867-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412570693 | |||
| W4412556691 | Effectiveness, treatment pattern, and safety of ustekinumab in treating bio-naïve patients with Crohn’s disease in the real-world clinical setting in China | 2025-07-22 | OpenAlex | 10.1097/cm9.0000000000003694 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412556691 | |||
| W4412553116 | Maximizing the Longevity and Volume Retention of Fat Grafts: Advances in Clinical Practice | 2025-07-22 | OpenAlex | 10.7759/cureus.88493 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412553116 | |||
| W4412550956 | P-MedAgent:Medical diagnostics based on LLM programmable CoT | 2025-07-22 | OpenAlex | 10.21203/rs.3.rs-6621627/v1 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4412550956 | |||
| W4412571361 | Trends of obesity management in adults: an analysis across guidelines in China and in Europe | 2025-07-22 | OpenAlex | 10.1093/pcmedi/pbaf018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412571361 | |||
| W4412543890 | UNVEILING THE EXPANDING CLINICAL HORIZONS OF BOTULINUM TOXIN ACROSS MEDICAL SPECIALITIES | 2025-07-22 | OpenAlex | 10.31435/ijitss.3(47).2025.3485 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412543890 | |||
| W4412592712 | Back to the Future—Cardiovascular Imaging From 1966 to Today and Tomorrow | 2025-07-23 | OpenAlex | 10.1097/rli.0000000000001219 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412592712 | |||
| W4412616241 | Checkpoint blockade immunotherapy for multiple recurrences of radiation-induced maxillary sinus sarcoma: A case report | 2025-07-23 | OpenAlex | 10.1177/09287329251358636 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412616241 | |||
| W4412583500 | Editorial: Current trends in muscle diseases and their treatment strategies | 2025-07-23 | OpenAlex | 10.3389/fcell.2025.1660074 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412583500 | |||
| W4413004429 | Evolving management of sarcoidosis in the real world | 2025-07-23 | OpenAlex | 10.1097/mcp.0000000000001204 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413004429 | |||
| W4412596199 | Mutations in transcription factors that confer fluconazole resistance also confer reduced susceptibility to manogepix in Candida auris ( Candidozyma auris ), Candida albicans , Candida parapsilosis , and Candida glabrata ( Nakaseomyces glabratus ) | 2025-07-23 | OpenAlex | 10.1128/aac.00680-25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412596199 | |||
| W7116597701 | Noma in Mozambique. Epidemiological efforts to uncover a neglected disease | 2025-07-23 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7116597701 | ||||
| W4412603346 | Polypill: Shifting Paradigm from Concept to Practice in the Prevention of Myocardial Infarction | 2025-07-23 | OpenAlex | 10.1159/000547098 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412603346 | |||
| W4412584224 | Profiling opnurasib (JDQ-443) for the treatment of non-small cell lung cancer (NSCLC) | 2025-07-23 | OpenAlex | 10.1080/14656566.2025.2536352 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412584224 | |||
| W4412595292 | [Consensus on recurrence risk and clinical management of HR+/HER-2- early breast cancer (2025 edition)]. | 2025-07-23 | OpenAlex | 10.3760/cma.j.cn112152-20250524-00240 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412595292 | |||
| W4412626395 | Agentic AI in radiology: emerging potential and unresolved challenges | 2025-07-24 | OpenAlex | 10.1093/bjr/tqaf173 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4412626395 | |||
| W4412648912 | Blood Cadmium and Preterm Birth: A Systems Toxicology Review of Molecular Mechanisms, Placental Disruption, and Translational Obstetric Implications | 2025-07-24 | OpenAlex | 10.24198/obgynia.v8i2.949 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412648912 | |||
| W4412645254 | Editorial: Natural remedies repositioned: advancing drug discovery for infectious diseases | 2025-07-24 | OpenAlex | 10.3389/fphar.2025.1655921 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412645254 | |||
| W4412645361 | Editorial: New trends in vascular biology 2024 | 2025-07-24 | OpenAlex | 10.3389/fcvm.2025.1649558 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412645361 | |||
| W4412648158 | Ensifentrine Plus a Long-Acting Muscarinic Antagonist in COPD: A Trifunctional Dual Bronchodilation Perspective | 2025-07-24 | OpenAlex | 10.1007/s40265-025-02213-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412648158 | |||
| W4412643022 | Evolving Anesthesia Strategies for Enhanced Recovery in Gastrectomy | 2025-07-24 | OpenAlex | 10.63096/medtigo3067123 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412643022 | |||
| W4412620739 | Redefining Psoriasis Therapy: The Emerging Role of Polymeric Nanocarriers in Precision Dermatology | 2025-07-24 | OpenAlex | 10.1007/s44174-025-00473-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412620739 | |||
| W4412911047 | Advances and Challenges in the Management of Myelodysplastic Syndromes | 2025-07-25 | OpenAlex | 10.3390/cancers17152469 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412911047 | |||
| W4412653916 | Are there differences in efficacy and safety between local and imported direct-acting antiviral agents for hepatitis C in China? | 2025-07-25 | OpenAlex | 10.1186/s40249-025-01344-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412653916 | |||
| W4412925087 | Editorial: Endocrine insights into heart disease | 2025-07-25 | OpenAlex | 10.3389/fendo.2025.1664575 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412925087 | |||
| W4412925966 | Emerging therapeutic approaches in graves’ ophthalmopathy: an update on pharmacological interventions | 2025-07-25 | OpenAlex | 10.3389/fimmu.2025.1647602 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412925966 | |||
| W4412698183 | Empowering Women for Zoonotic Malaria Prevention: A Protocol for a Community-Based Participatory Research in Rural Communities (Preprint) | 2025-07-25 | OpenAlex | 10.2196/preprints.81083 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412698183 | |||
| W4412856378 | Evolving therapeutic landscape of primary biliary cholangitis: A review | 2025-07-25 | OpenAlex | 10.4254/wjh.v17.i7.107223 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412856378 | |||
| W4412925204 | From data-driven cities to data-driven tumors: dynamic digital twins for adaptive oncology | 2025-07-25 | OpenAlex | 10.3389/frai.2025.1624877 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412925204 | |||
| W4412924848 | Immune surveillance as a pharmacological target in the early stages of cancer | 2025-07-25 | OpenAlex | 10.3389/fmolb.2025.1643024 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412924848 | |||
| W4412924967 | Incentivising cooperation by judging a group’s performance by its weakest member in neuroevolution and reinforcement learning | 2025-07-25 | OpenAlex | 10.3389/frobt.2025.1599676 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4412924967 | |||
| W4412833338 | Metformin Beyond Diabetes: A Precision Gerotherapeutic and Immunometabolic Adjuvant for Aging and Cancer | 2025-07-25 | OpenAlex | 10.3390/cancers17152466 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412833338 | |||
| W4412855741 | Microbiome dysbiosis and immune checkpoint inhibitors: Dual targets in Hepatocellular carcinoma management | 2025-07-25 | OpenAlex | 10.4254/wjh.v17.i7.106810 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412855741 | |||
| W4413218094 | Neurological symptoms and MRI changes post-sugammadex reversal | 2025-07-25 | OpenAlex | 10.12746/swjm.v13i56.1493 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413218094 | |||
| W4412732884 | Obstetric and Neonatal Outcomes among Patients with Obstetric Antiphospholipid Antibody Syndrome: A Prospective Observational Study Comparing Patients Receiving Conventional Therapy (LMWH + Aspirin) and Patients Receiving Additional Hydroxychloroquine | 2025-07-25 | OpenAlex | 10.5005/jp-journals-10006-2690 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412732884 | |||
| W4412713867 | Target practice: Opportunities for therapeutic intervention in CHIP and CCUS | 2025-07-25 | OpenAlex | 10.1016/j.blre.2025.101323 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412713867 | |||
| W4412676567 | Real-world utilization of Bruton tyrosine kinase inhibitors in relapsed/refractory chronic lymphocytic leukemia in Australia | 2025-07-27 | OpenAlex | 10.1080/10428194.2025.2533498 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412676567 | |||
| W4412682022 | Challenges in Modelling the Cost Effectiveness of Pharmacotherapies for Obesity | 2025-07-28 | OpenAlex | 10.1007/s40273-025-01520-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412682022 | |||
| W4412728042 | Pharmacology and Regulation of Appetite and Food Intake | 2025-07-28 | OpenAlex | 10.1002/prp2.70101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412728042 | |||
| W4412679302 | Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis | 2025-07-28 | OpenAlex | 10.26599/nr.2025.94907639 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412679302 | |||
| W4412738118 | The rise of superbugs: Confronting antimicrobial resistance in Pakistan | 2025-07-28 | OpenAlex | 10.47391/jpma.23220 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412738118 | |||
| W4412855603 | Unpublished overall survival confounders in immunomodulatory agent registrational trials | 2025-07-28 | OpenAlex | 10.1016/s1470-2045(25)00296-7 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4412855603 | |||
| W4412685784 | VEXAS: A review of current understandings and emerging treatment strategies | 2025-07-28 | OpenAlex | 10.3389/fimmu.2025.1644404 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412685784 | |||
| W4412703144 | What’s New in Hip Surgery | 2025-07-28 | OpenAlex | 10.2106/jbjs.25.00532 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412703144 | |||
| W4412712908 | A new era at BJR | 2025-07-29 | OpenAlex | 10.1093/bjr/tqaf185 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412712908 | |||
| W4412785020 | Bridging the gap for diverse applications of parasites as advanced cancer therapeutics: current progress and future directions | 2025-07-29 | OpenAlex | 10.1186/s13027-025-00679-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412785020 | |||
| W4412712751 | Cardiac Myosin Inhibitors in the Treatment of Hypertrophic Cardiomyopathy: Clinical Trials and Future Challenges | 2025-07-29 | OpenAlex | 10.3390/biom15081098 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412712751 | |||
| W4412729047 | Editorial: Upping the heat: capsaicin for human health | 2025-07-29 | OpenAlex | 10.3389/fnut.2025.1665722 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412729047 | |||
| W4413301636 | Integrating Computational and Experimental Approaches in 21st Century Drug Design | 2025-07-29 | OpenAlex | 10.21590/jddhs.02.02.04 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413301636 | |||
| W4412710812 | Unraveling the 2023 cholera outbreak in Rourkela municipal corporation of Odisha, India: Antibiotic resistance, virulence factors, and water contamination insights | 2025-07-29 | OpenAlex | 10.1016/j.ijmmb.2025.100944 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412710812 | |||
| W4412739026 | Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS syndrome management | 2025-07-30 | OpenAlex | 10.1016/j.retram.2025.103533 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412739026 | |||
| W4412765678 | Editorial: Immunoregulatory cells: balancing immune responses during pathogen infections | 2025-07-30 | OpenAlex | 10.3389/fimmu.2025.1664401 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412765678 | |||
| W4412758316 | Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis | 2025-07-30 | OpenAlex | 10.1080/17474124.2025.2537192 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412758316 | |||
| W4412748027 | Stem Cell Applications in Pediatric Urology | 2025-07-30 | OpenAlex | 10.4018/979-8-3693-8829-7.ch008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412748027 | |||
| W4412750762 | The Evolving Role of Stem Cells in Oral Health and Regeneration: A Systematic Review | 2025-07-30 | OpenAlex | 10.3390/surgeries6030065 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412750762 | |||
| W4412816409 | Topical hemostatic agents in endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review | 2025-07-30 | OpenAlex | 10.1055/a-2646-7556 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412816409 | |||
| W4412929278 | AI-Augmented Data Quality Validation in P&C Insurance: A Hybrid Framework Using Large Language Models and Rule-Based Agents | 2025-07-31 | OpenAlex | 10.22399/ijcesen.3613 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4412929278 | |||
| W4412793621 | Advancements and Challenges in the Preoperative Management of Pheochromocytoma in a Low- and Middle-Income Country (LMIC): A Nationwide Survey | 2025-07-31 | OpenAlex | 10.7759/cureus.89145 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412793621 | |||
| W7220348624 | Agentic Digital Twins: Self-Evolving Models for Autonomous Systems | 2025-07-31 | OpenAlex | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7220348624 | ||||
| W4412775731 | Beneath the surface in autoimmune hemolytic anemia: pathogenetic networks, therapeutic advancements and open questions | 2025-07-31 | OpenAlex | 10.3389/fimmu.2025.1624667 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412775731 | |||
| W4412774080 | Editorial: Advanced therapeutic strategies in digestive and circulatory health: nanomedicine and beyond | 2025-07-31 | OpenAlex | 10.3389/fphar.2025.1666774 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412774080 | |||
| W4412793509 | Epidemiology of community acquired and health care assocİated infective endocarditis and 28 day mortality risk factors: a university hospital study | 2025-07-31 | OpenAlex | 10.1186/s12879-025-11386-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412793509 | |||
| W4412845098 | GLP-1 Receptor Agonist Use in Patients Undergoing Distal Radius Fracture Surgery: A Retrospective Review of Perioperative Considerations | 2025-07-31 | OpenAlex | 10.7759/cureus.89183 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412845098 | |||
| W4412788487 | Streptococcus pneumoniae β-lactam resistance: epidemiological trends, molecular drivers, and innovative control strategies in the post-pandemic era | 2025-07-31 | OpenAlex | 10.1128/cmr.00082-25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412788487 | |||
| W4412791006 | Targeted therapy in acute myeloid leukemia: Resistance and overcoming strategy | 2025-07-31 | OpenAlex | 10.1016/j.drup.2025.101286 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412791006 | |||
| W4412887278 | A Comprehensive Review of the Latest Approaches to Managing Hypercholesterolemia: A Comparative Analysis of Conventional and Novel Treatments: Part II | 2025-08-01 | OpenAlex | 10.3390/ph18081150 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412887278 | |||
| W4413403770 | A narrative review of immunotherapy for non-small cell lung cancer: current progress, sensitization approaches, and synergistic strategies | 2025-08-01 | OpenAlex | 10.21037/tlcr-2025-754 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413403770 | |||
| W7128523959 | Active cyber defense using intelligent agents in cloud-edge based applications | 2025-08-01 | OpenAlex | 10.32469/10355/110389 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7128523959 | |||
| W4412881422 | Advanced Nanotheranostics: Evolving Strategies in Cancer Therapy and Diagnosis | 2025-08-01 | OpenAlex | 10.61554/ijnrph.v3i1.2025.170 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4412881422 | |||
| W4412822306 | Advancing engineering design strategies for targeted cancer nanomedicine | 2025-08-01 | OpenAlex | 10.1038/s41568-025-00847-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412822306 | |||
| W4417487935 | BCMA biology and therapeutic targeting in multiple myeloma: From ligand signaling to antigen escape | 2025-08-01 | OpenAlex | 10.1053/j.seminhematol.2025.12.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417487935 | |||
| W4414679323 | Best practices for screening, testing, diagnosing, and treating patients with hepatitis D (delta) virus based on global expert review and recent guidelines | 2025-08-01 | OpenAlex | 10.1177/13596535251349380 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414679323 | |||
| W4414065294 | Blockchain-anchored Reinforcement Learning Collectives with Tokenized Ecosystem Optimization for Trustless, Bias-Free Adaptation of Complex Systems. | 2025-08-01 | OpenAlex | 10.55248/gengpi.6.0825.3131 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414065294 | |||
| W4412805699 | Congenital Lymphatic Malformations | 2025-08-01 | OpenAlex | 10.1542/neo.26-8-048 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412805699 | |||
| W4413351069 | Current paradigms in the management of inflammatory bowel disease | 2025-08-01 | OpenAlex | 10.4103/singaporemedj.smj-2025-078 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413351069 | |||
| W4413113533 | Dynamics that predispose, enable, and reinforce commercial tobacco-related health disparities: Introduction to a Monograph | 2025-08-01 | OpenAlex | 10.1093/jncimonographs/lgaf034 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413113533 | |||
| W4412846616 | Editorial: Biosecurity of infectious diseases in veterinary medicine | 2025-08-01 | OpenAlex | 10.3389/fvets.2025.1665683 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412846616 | |||
| W4412817380 | Editorial: Expanding CAR-T cell therapy — breakthroughs from cancer to autoimmune diseases | 2025-08-01 | OpenAlex | 10.3389/fimmu.2025.1649045 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412817380 | |||
| W4412881421 | Emerging Nanoparticle Drug Delivery Approaches for the Treatment of Alzheimer’s Disease: A Review | 2025-08-01 | OpenAlex | 10.61554/ijnrph.v3i1.2025.171 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412881421 | |||
| W4412859749 | Expanding Treatment Horizons with Chemical Agents and Drug Adjuvants in Odontogenic Keratocyst: A Comprehensive Review | 2025-08-01 | OpenAlex | 10.7860/jcdr/2025/78674.21362 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412859749 | |||
| W4414276532 | Focused Pharmacovigilance of Neuropsychiatry Drugs in A Tertiary Care Hospital, India | 2025-08-01 | OpenAlex | 10.21276/amit.2025.v12.i2.11 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414276532 | |||
| W4413547113 | Impact of Artemisinin derivatives in patient-derived tissue cultures of NSCLC in combined treatment with cisplatin | 2025-08-01 | OpenAlex | 10.1055/s-0045-1809736 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413547113 | |||
| W4416331990 | Lauren Benton. They Called It Peace: Worlds of Imperial Violence | 2025-08-01 | OpenAlex | 10.1093/ejil/chaf053 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416331990 | |||
| W4412834865 | Learning from nature: how correlated multimodal imaging enhances our understanding of light-biological surface interactions | 2025-08-01 | OpenAlex | 10.1117/12.3067880 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4412834865 | |||
| W4413369610 | Mapping Key Nodes and Global Trends in AI and Large Language Models for Medical Education: A Bibliometric Study | 2025-08-01 | OpenAlex | 10.2147/amep.s538362 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413369610 | |||
| W4412805672 | Mismatch between pre-clinical cardio-oncology and clinical oncology research | 2025-08-01 | OpenAlex | 10.1093/eurheartjsupp/suaf083.230 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412805672 | |||
| W4412846868 | Narrowing of the ventral CA1 excitability margin in schizophrenia, depression and PTSD | 2025-08-01 | OpenAlex | 10.31219/osf.io/e4cwb_v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412846868 | |||
| W4412835947 | Pendekatan Integratif dalam Manajemen Dengue | 2025-08-01 | OpenAlex | 10.56951/699q0n64 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412835947 | |||
| W4413796801 | Pharmacological Management of Immune Thrombocytopenic Purpura (ITP): A Review | 2025-08-01 | OpenAlex | 10.55248/gengpi.6.0825.3022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413796801 | |||
| W4415634196 | Processing neuroimaging data for research purposes: Open Science, FAIR data, and the GDPR | 2025-08-01 | OpenAlex | 10.1093/idpl/ipaf020 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415634196 | |||
| W4413336181 | Progress in Nanocarriers‐Based Approaches for the Delivery of Tyrosine Kinase Inhibitors in Bone Cancer: Trends and Prospects | 2025-08-01 | OpenAlex | 10.1002/iub.70052 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413336181 | |||
| W7219563765 | Rasakalpa And Pottali Kalpana In Rasashastra: A Scientific Review Of Their Preparation And Curative Potential | 2025-08-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7219563765 | ||||
| W7163207877 | Speakers’ Presentations | 2025-08-01 | OpenAlex | 10.4103/jmhit.jmhit_37_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163207877 | |||
| W4412957992 | The Blurred Lines Between New Psychoactive Substances and Potential Chemical Weapons | 2025-08-01 | OpenAlex | 10.3390/toxics13080659 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412957992 | |||
| W4413309314 | The penis speaks, but are we listening: the role of early trauma in understanding male sexual dysfunction | 2025-08-01 | OpenAlex | 10.1093/sexmed/qfaf058 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413309314 | |||
| W4414625036 | The role of uropathogenic Escherichia coli virulence factors in the development of urinary tract infection | 2025-08-01 | OpenAlex | 10.25122/jml-2024-0396 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414625036 | |||
| W4412805856 | Tracheobronchomalacia in an Infant With Severe Bronchopulmonary Dysplasia | 2025-08-01 | OpenAlex | 10.1542/neo.26-8-049 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412805856 | |||
| W4412887742 | Urinary Multidrug-Resistant Klebsiella pneumoniae: Essential Oil Countermeasures in a One Health Case Report | 2025-08-01 | OpenAlex | 10.3390/microorganisms13081807 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412887742 | |||
| W4413373977 | What’s New and What’s Next in Fecal Microbiota Transplantation? | 2025-08-01 | OpenAlex | 10.2147/btt.s486372 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413373977 | |||
| W4412852804 | Small dense low-density lipoprotein cholesterol as a risk marker for peripheral artery disease | 2025-08-02 | OpenAlex | 10.1093/eurjpc/zwaf490 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412852804 | |||
| W4412890788 | Focused Modulation of Brain Activity: A Narrative Review | 2025-08-03 | OpenAlex | 10.3390/biomedicines13081889 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412890788 | |||
| W4412874384 | Metformin-Associated Lactic Acidosis (MALA): When a Common Drug Turns Catastrophic | 2025-08-03 | OpenAlex | 10.7759/cureus.89292 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412874384 | |||
| W4412877886 | Unraveling Liver Cirrhosis: Bridging Pathophysiology to Innovative Therapeutics | 2025-08-03 | OpenAlex | 10.1111/jgh.70037 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412877886 | |||
| W4413875696 | Auditing AI Access to Electronic Health Records: HIPAA Compliance, Challenges, Solutions, and Future Directions | 2025-08-04 | OpenAlex | 10.32996/jcsts.2025.7.8.51 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413875696 | |||
| W4412889158 | Cardiovascular-Kidney-Metabolic healthcare framework: Perspective from Hong Kong | 2025-08-04 | OpenAlex | 10.1097/cm9.0000000000003748 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412889158 | |||
| W4412944008 | Gene Therapy for the Treatment of Osteoarthritis: Advances and Prospective | 2025-08-04 | OpenAlex | 10.2174/0113816128384412250709130211 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412944008 | |||
| W4412931265 | New frontiers in prostate cancer treatment from systemic therapy to targeted therapy | 2025-08-04 | OpenAlex | 10.1038/s44321-025-00282-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412931265 | |||
| W4412938501 | Recent Advances in Bioink Research for Biomedical Applications | 2025-08-04 | OpenAlex | 10.1007/s44174-025-00478-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412938501 | |||
| W7216223140 | Recent Trends In Neuroanaesthesia- A Review. | 2025-08-04 | OpenAlex | 10.64252/ae312781 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216223140 | |||
| W4412934724 | Serovars and antimicrobial resistance profiles of Actinobacillus pleuropneumoniae isolates from clinical-case pigs in Taiwan | 2025-08-04 | OpenAlex | 10.1186/s12917-025-04878-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4412934724 | |||
| W4413105150 | A tale of two TROP-2 antibody-drug conjugates: a comparative saga of datopotamab deruxtecan and sacituzumab govitecan | 2025-08-05 | OpenAlex | 10.1093/oncolo/oyaf251 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413105150 | |||
| W4413462091 | Design, Classification, and Therapeutic Applications of Prodrugs in Modern Drug Development | 2025-08-05 | OpenAlex | 10.69613/2mqr8d80 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413462091 | |||
| W4412991198 | The future of anesthesia education: incorporating technology for safer practices | 2025-08-05 | OpenAlex | 10.1097/aco.0000000000001559 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412991198 | |||
| W4412891677 | Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor types | 2025-08-05 | OpenAlex | 10.1016/j.diii.2025.07.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4412891677; https://openalex.org/W7172218397 | |||
| W4413004787 | Combination therapies in the treatment of prostate cancer | 2025-08-06 | OpenAlex | 10.5603/ocp.104112 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413004787 | |||
| W4413000545 | Coxiella burnetii: Emerging threats, molecular insights, and advances in diagnosis and control measures | 2025-08-06 | OpenAlex | 10.1016/j.mimet.2025.107213 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413000545 | |||
| W4413006943 | Reduced-intensity conditioning for allogeneic transplantation in classical Hodgkin lymphoma | 2025-08-06 | OpenAlex | 10.1080/17474086.2025.2545336 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413006943 | |||
| W4413034472 | A multi-agent continual learning framework for skin cancer detection leveraging crowdsourced dermoscopic images | 2025-08-07 | OpenAlex | 10.30574/wjarr.2025.27.2.2863 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4413034472; https://openalex.org/W7105802898 | |||
| W4414380247 | Rethinking Safety Assessment of Rotavirus Vaccination in Biologic-Exposed Infants: Methodological Nuances Matter | 2025-08-07 | OpenAlex | 10.1093/ibd/izaf201 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414380247 | |||
| W4413051451 | Social justice and social media: How medical schools display critical consciousness online | 2025-08-07 | OpenAlex | 10.1371/journal.pdig.0000981 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413051451 | |||
| W4413035316 | Transthyretin Amyloid Cardiomyopathy: Diagnosis and Management | 2025-08-07 | OpenAlex | 10.1007/s12170-025-00771-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413035316 | |||
| W4413101179 | Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group | 2025-08-08 | OpenAlex | 10.46989/001c.141401 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413101179 | |||
| W4414532274 | ESC consensus statement on stroke risk management in carotid atherosclerotic disease: 10 key points | 2025-08-08 | OpenAlex | 10.1093/eurheartj/ehaf614 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414532274 | |||
| W4413256237 | Editorial: The pharmacological effects and mechanisms of drugs against human diseases by modulating redox homeostasis - volume II | 2025-08-08 | OpenAlex | 10.3389/fphar.2025.1665486 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413256237 | |||
| W4413256082 | Opportunities, obstacles and challenges of nano-immunotherapy in melanoma | 2025-08-08 | OpenAlex | 10.3389/fimmu.2025.1611423 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413256082 | |||
| W4413119192 | The impact of metabolic dysfunction-associated steatotic liver disease (MASH) on the high risk of cardiovascular disease in CKD: interconnections and management | 2025-08-08 | OpenAlex | 10.1093/ckj/sfaf260 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413119192 | |||
| W4413255974 | Ticks and tick-borne diseases in the northern hemisphere affecting humans | 2025-08-08 | OpenAlex | 10.3389/fmicb.2025.1632832 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413255974 | |||
| W4413225696 | Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base (2025) | 2025-08-09 | OpenAlex | 10.3390/pharmaceutics17081036 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413225696 | |||
| W4413094001 | Optimizing treatment for metastatic castration‐resistant prostate cancer: Food and Drug Administration‐approved therapies, emerging strategies, and biomarker‐driven approaches | 2025-08-09 | OpenAlex | 10.1002/cncr.70037 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413094001 | |||
| W4413223210 | Recent Advances in the Management of EGFR-Mutated Advanced Non-Small Cell Lung Cancer—A Narrative Review | 2025-08-09 | OpenAlex | 10.3390/curroncol32080448 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413223210 | |||
| W4413110359 | Trends in nephrology: kidney metabolism as a therapeutic target | 2025-08-09 | OpenAlex | 10.1093/ndt/gfaf155 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413110359 | |||
| W4413212892 | Advancements and Challenges in 3D Printing for Wound Healing: Current Trends and Future Prospects | 2025-08-11 | OpenAlex | 10.1007/s40883-025-00470-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413212892 | |||
| W4413100643 | Allogeneic Transplant for CMML | 2025-08-11 | OpenAlex | 10.1007/s11899-025-00754-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413100643 | |||
| W4413117548 | Assessing the current medicolegal landscape in orthopedic sports medicine surgery—patient-centered communication and multidisciplinary approaches matter: A consensus statement | 2025-08-11 | OpenAlex | 10.1016/j.jisako.2025.100993 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413117548 | |||
| W4413142294 | Confirm presence of metallo-β-lactamase-producing Gram-negative bacteria to inform treatment of infection, although clinical data are limited for current and emerging treatment options | 2025-08-11 | OpenAlex | 10.1007/s40267-025-01173-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413142294 | |||
| W4413221620 | Correction: Experimental models for developing oncolytic virotherapy for metastatic prostate cancer | 2025-08-11 | OpenAlex | 10.3389/fimmu.2025.1665709 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4413221620 | |||
| W4414018199 | Management of MDR/XDR severe infections in the critically ill | 2025-08-11 | OpenAlex | 10.1097/mcc.0000000000001307 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414018199 | |||
| W7216492788 | Paper For International Journal Of Environmental Sciences-Special Issue 2025 Investigating How To Design Agentic AI Systems That Effectively Augment Human Capabilities And Enhance Human-AI Teamwork | 2025-08-11 | OpenAlex | 10.64252/ersdfx86 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7216492788 | |||
| W4413109381 | Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers | 2025-08-11 | OpenAlex | 10.1002/bcp.70196 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4413109381 | |||
| W4413206429 | Beyond personalization: autonomy and agency in intelligent systems education | 2025-08-12 | OpenAlex | 10.3389/feduc.2025.1610239 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413206429 | |||
| W4415877204 | COVID-19 and HIV—Interaction, clinical course, outcome, and prognosis | 2025-08-12 | OpenAlex | 10.14748/ngfcp473 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415877204 | |||
| W4413183848 | Evaluating Public Awareness and Perceptions of the Romanian National Immunization Program: Implications for Strengthening Population Immunity | 2025-08-12 | OpenAlex | 10.20944/preprints202508.0856.v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413183848 | |||
| W4409445108 | Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium | 2025-08-12 | OpenAlex | 10.64719/pb.4531 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4409445108 | |||
| W4413189400 | Paediatric Focal Segmental Glomerulosclerosis (FSGS): From Bench to Bedside and Beyond | 2025-08-12 | OpenAlex | 10.3390/sclerosis3030029 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413189400 | |||
| W142241586 | The Emergence of the Bipolar Spectrum: Validation along Clinical-Epidemiologic and Familial-Genetic Lines | 2025-08-12 | OpenAlex | 10.64719/pb.4142 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W142241586 | |||
| W4413187355 | Top 10 academic advances in traditional Chinese medicine in 2024 | 2025-08-12 | OpenAlex | 10.1097/st9.0000000000000074 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413187355 | |||
| W4413161801 | Advances in Sclerosants for Low-Flow Vascular Malformations | 2025-08-13 | OpenAlex | 10.1016/j.avsg.2025.07.049 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413161801 | |||
| W4413160350 | Antimicrobial Nanoparticles Against Superbugs: Mechanistic Insights, Biomedical Applications, and Translational Frontiers | 2025-08-13 | OpenAlex | 10.3390/ph18081195 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413160350 | |||
| W4413113475 | Deceased donor blood transfusion in emergency resuscitation: A scoping review of historical evidence for military and mass casualty applications | 2025-08-13 | OpenAlex | 10.1111/trf.18366 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413113475 | |||
| W4413178345 | OncoAID: an open access targeted anti-cancer drugs database | 2025-08-13 | OpenAlex | 10.3389/fphar.2025.1588191 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413178345 | |||
| W4413111631 | Oral Semaglutide: A Step Forward in Cardiovascular Risk Management for Type 2 Diabetes | 2025-08-13 | OpenAlex | 10.2174/011871529x421551250801194823 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413111631 | |||
| W4413150383 | Posterior reversible encephalopathy syndrome: evolving insights in diagnosis, management, and outcomes | 2025-08-13 | OpenAlex | 10.1016/s1474-4422(25)00232-7 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4413150383 | |||
| W4413181537 | Redefining communication in mental healthcare: generative AI for neurodivergent equity and non-verbal autistic inclusion | 2025-08-13 | OpenAlex | 10.3389/fpsyt.2025.1611101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413181537 | |||
| W4413417222 | Antibody-Drug Conjugates in Breast Cancer: Current Landscape and Future Targets | 2025-08-14 | OpenAlex | 10.58931/cot.2025.2235 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413417222 | |||
| W4413139641 | Glucagon-Like Peptide-1 Receptor Agonists in Gynecologic Surgery | 2025-08-14 | OpenAlex | 10.1097/aog.0000000000006035 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413139641 | |||
| W4413258141 | Novel Dual and Triple Agonists Targeting GLP-1, GIP, Glucagon, and GDF15 for Type 2 Diabetes and Obesity Management | 2025-08-14 | OpenAlex | 10.1210/endocr/bqaf130 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413258141 | |||
| W4414001974 | Pathophysiological Insights and Clinical Management Strategies for Interstitial Lung Diseases | 2025-08-14 | OpenAlex | 10.4062/biomolther.2025.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414001974 | |||
| W7220724655 | Safety and Efficacy of Peptide-Based Therapeutics in Health Sciences: From Bench to Bedside | 2025-08-14 | OpenAlex | 10.34297/ajbsr.2025.28.003647 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220724655 | |||
| W7216154411 | The Evolution of Cognitive Partnership: A Taxonomic Framework for Human-AI Collaboration Modalities | 2025-08-14 | OpenAlex | 10.32996/jcsts.2025.7.8.113 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216154411 | |||
| W4413142584 | Treatment of NSCLC after chemoimmunotherapy — are we making headway? | 2025-08-14 | OpenAlex | 10.1038/s41571-025-01061-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413142584 | |||
| W4413380618 | Artificial Intelligence Agent-Enabled Predictive Maintenance: Conceptual Proposal and Basic Framework | 2025-08-15 | OpenAlex | 10.3390/computers14080329 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4413380618 | |||
| W4413467640 | Automated Literature Screening for Hepatocellular Carcinoma Treatment Through Integration of 3 Large Language Models: Methodological Study | 2025-08-15 | OpenAlex | 10.2196/76252 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4413467640 | |||
| W4413378211 | Efficacy of Biologic Agents and Small Molecules for Endoscopic Improvement and Mucosal Healing in Patients with Moderate-to-Severe Ulcerative Colitis: Systematic Review and Meta-Analysis | 2025-08-15 | OpenAlex | 10.3390/jcm14165789 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413378211 | |||
| W4413139545 | Treatment Optimization and Management of AEs with Enfortumab Vedotin + Pembrolizumab for Untreated Locally Advanced/Metastatic Urothelial Cancer: A Podcast | 2025-08-15 | OpenAlex | 10.1007/s40487-025-00369-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413139545 | |||
| W4413330517 | Comprehensive Review on Carcinoma of the Gallbladder: Epidemiology, Pathogenesis, Diagnosis, and Contemporary Management Strategies | 2025-08-16 | OpenAlex | 10.36347/sasjs.2025.v11i08.008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413330517 | |||
| W4413452275 | Diagnostic Role of Radiology in Acute Gastrointestinal Bleeding: A Comprehensive Review | 2025-08-16 | OpenAlex | 10.7759/cureus.90219 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4413452275 | |||
| W4413279423 | Mechanisms and Genetic Drivers of Resistance of Insect Pests to Insecticides and Approaches to Its Control | 2025-08-16 | OpenAlex | 10.3390/toxics13080681 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4413279423 | |||
| W4413270789 | Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithms | 2025-08-16 | OpenAlex | 10.1038/s41408-025-01346-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413270789 | |||
| W4413293740 | Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape | 2025-08-16 | OpenAlex | 10.3390/ph18081212 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413293740 | |||
| W4413376755 | Redefining Risk, Biomarkers, and Precision Therapy for Hereditary Ovarian Cancer: A Review | 2025-08-16 | OpenAlex | 10.1021/acsomega.5c05260 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413376755 | |||
| W4413279968 | Acceptability of a Conversational Agent–Led Digital Program for Anxiety: Mixed Methods Study of User Perspectives | 2025-08-18 | OpenAlex | 10.2196/76377 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413279968 | |||
| W7217081993 | Efficacy of Targeted Drug Therapies in Conjunction with Surgical Treatment for Thyroid Cancer: A Meta-Analysis | 2025-08-18 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217081993 | ||||
| W4413274368 | Evolving tumor microenvironment: Driving cancer initiation and progression in cardiovascular diseases | 2025-08-18 | OpenAlex | 10.1016/j.isci.2025.113387 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413274368 | |||
| W4413279375 | Post anaesthesia cognitive outcomes in propofol vs. ketamine sedation for colonoscopy: a retrospective cohort study | 2025-08-18 | OpenAlex | 10.1007/s44254-025-00125-2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413279375 | |||
| W4413286593 | Reconstructing the Antibiotic Pipeline: Natural Alternatives to Antibacterial Agents | 2025-08-18 | OpenAlex | 10.3390/biom15081182 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4413286593 | |||
| W4413272048 | Research Progress of Platinum-Based Complexes in Lung Cancer Treatment: Mechanisms, Applications, and Challenges | 2025-08-18 | OpenAlex | 10.3390/ijms26167958 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413272048 | |||
| W4413305165 | Synergistic application of antibiotics and hyperbaric oxygen therapy | 2025-08-18 | OpenAlex | 10.4103/mgr.medgasres-d-25-00086 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413305165 | |||
| W4413292011 | The sustainability of hypercholesterolemia treatment: New drugs have made such therapy more expensive | 2025-08-18 | OpenAlex | 10.1016/j.hipert.2025.05.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413292011 | |||
| W4413308624 | HER2/neu as a Signaling and Therapeutic Marker in Uterine Serous Carcinoma | 2025-08-19 | OpenAlex | 10.3390/cells14161282 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413308624 | |||
| W4413307834 | Hodgkin lymphoma: evolving treatment strategies for elderly patients and patients in first relapse | 2025-08-19 | OpenAlex | 10.1007/s12254-025-01062-3 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4413307834 | |||
| W4413324737 | N-acetilcisteína: 50 años del descubrimiento de un antídoto que ha cambiado el pronóstico de la intoxicación por paracetamol | 2025-08-19 | OpenAlex | 10.1016/j.farma.2025.07.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413324737 | |||
| W4413318512 | Schizophrenia and psychosis in children and adolescents: An inspiring journey of scientific progress and the rich influences of history and religion | 2025-08-19 | OpenAlex | 10.1016/j.disamonth.2025.101983 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413318512 | |||
| W4413342471 | Challenging the Dogma: Reversal of End-Stage Liver Fibrosis with Tirzepatide in MASH Cirrhosis | 2025-08-20 | OpenAlex | 10.3390/transplantology6030025 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413342471 | |||
| W4413372506 | Safety of antibody-drug conjugates in gynecologic cancers: current evidence and management approaches | 2025-08-20 | OpenAlex | 10.1016/j.ijgc.2025.102117 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413372506 | |||
| W4413404306 | State‐of‐the‐art management of Dravet syndrome | 2025-08-20 | OpenAlex | 10.1111/dmcn.16475 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413404306 | |||
| W4413352530 | Tremelimumab for the treatment of hepatocellular carcinoma | 2025-08-20 | OpenAlex | 10.1080/14712598.2025.2550711 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413352530 | |||
| W4413358587 | “Super-Responders” to Liraglutide Monotherapy and the Growing Evidence of Efficacy of GLP-1 Analogues in Obesity Management: A Longitudinal Prospective Cohort Study | 2025-08-20 | OpenAlex | 10.3390/obesities5030063 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413358587 | |||
| W4413376077 | Agnostic Biomarkers and Molecular Signatures in Colorectal Cancer—Guiding Chemotherapy and Predicting Response | 2025-08-21 | OpenAlex | 10.3390/biomedicines13082038 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413376077 | |||
| W7106314814 | Geographies of Trust: AI, Biomedicine, and the Next Era of Federated and Visiting Data Models | 2025-08-21 | OpenAlex | 10.5281/zenodo.17662085 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7106314814; https://openalex.org/W7106679943 | |||
| W4413403477 | Versatile Application of Calixarenes and Their Derivatives: From Drug Delivery to Industrial Catalysis and Environmental Remediation | 2025-08-21 | OpenAlex | 10.1080/10408347.2025.2538731 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413403477 | |||
| W4414018707 | Acute myeloid leukemia: a comprehensive update | 2025-08-22 | OpenAlex | 10.1097/moh.0000000000000897 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414018707 | |||
| W4413621242 | Antibody–drug conjugates for non-muscle invasive bladder cancer: current status and future development | 2025-08-22 | OpenAlex | 10.1097/mou.0000000000001330 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413621242 | |||
| W4413448295 | Beyond neuronal loss: epigenetic signatures bridging immune activation and sleep dysfunction in narcolepsy type 1 | 2025-08-22 | OpenAlex | 10.1093/sleep/zsaf253 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4413448295 | |||
| W4413437046 | Editorial: Case reports in autoimmune and autoinflammatory disorders | 2025-08-22 | OpenAlex | 10.3389/fimmu.2025.1655791 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413437046 | |||
| W4413430348 | Ethical frameworks for automated vehicles: a systematic analysis and design | 2025-08-22 | OpenAlex | 10.1007/s43681-025-00803-8 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4413430348 | |||
| W4413431220 | In conversation with Małgorzata Kosla | 2025-08-22 | OpenAlex | 10.1111/febs.70227 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413431220 | |||
| W4413435117 | Peritoneal Dialysis -Associated Fibrosis: Emerging Mechanisms and Therapeutic Opportunities | 2025-08-22 | OpenAlex | 10.3389/fphar.2025.1635624 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413435117 | |||
| W4413411488 | Real-World Systemic Treatment Patterns, Survival Outcomes, and Prognostic Factors in Advanced Hepatocellular Carcinoma: A 15-Year Experience from a Low-Resource Setting | 2025-08-22 | OpenAlex | 10.3390/cancers17172729 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413411488 | |||
| W4413772349 | Shaping the future on a solid tradition | 2025-08-22 | OpenAlex | 10.1093/eurheartj/ehaf693 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413772349 | |||
| W4413425517 | The evolving landscape of rheumatic drugs and their indications in paediatric and adolescent care | 2025-08-22 | OpenAlex | 10.1093/rheumatology/keaf455 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413425517 | |||
| W4413446943 | ASHP Statement on Artificial Intelligence in Pharmacy | 2025-08-23 | OpenAlex | 10.1093/ajhp/zxaf107 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413446943 | |||
| W7201967545 | Article Review: The Enchanting Versatile Applications of Pregabalin and Its Abuse Liability | 2025-08-23 | OpenAlex | 10.67735/scms.2025.02.0124 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7201967545 | |||
| W4413480834 | Cannabidiol in Skin Health: A Comprehensive Review of Topical Applications in Dermatology and Cosmetic Science | 2025-08-23 | OpenAlex | 10.3390/biom15091219 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413480834 | |||
| W7217757602 | Explainable Multi Agent Architectures Using AI and Cloud for Cross Jurisdictional Healthcare Fraud Detection | 2025-08-23 | OpenAlex | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7217757602 | ||||
| W4414536597 | RecOVARY? Using anti-Müllerian hormone to predict ovarian function after anti-HER2 therapy for early breast cancer | 2025-08-23 | OpenAlex | 10.1093/jnci/djaf247 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414536597 | |||
| W4413471008 | Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML | 2025-08-23 | OpenAlex | 10.1007/s11864-025-01351-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413471008 | |||
| W4413480481 | Biologics as Therapeutical Agents Under Perspective Clinical Studies for Alzheimer’s Disease | 2025-08-24 | OpenAlex | 10.3390/molecules30173479 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4413480481 | |||
| W7171327967 | Building Compliant Data Pipelines in Regulated Sectors: A Privacy-First Engineering Approach | 2025-08-24 | OpenAlex | 10.5281/zenodo.21605348 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171327967; https://openalex.org/W7162445270 | |||
| W4413480683 | Precision Medicine in Orthobiologics: A Paradigm Shift in Regenerative Therapies | 2025-08-24 | OpenAlex | 10.3390/bioengineering12090908 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413480683 | |||
| W4413480682 | Threat of non-traditional agents: a new frontier in chemical weapons concerns? | 2025-08-24 | OpenAlex | 10.1136/military-2025-003101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413480682 | |||
| W4414684312 | Transthyretin amyloid cardiomyopathy: from cause to novel treatments | 2025-08-24 | OpenAlex | 10.1093/eurheartj/ehaf667 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414684312 | |||
| W4413535390 | Advances and Future Perspectives for the Management of Non‐Small Cell Lung Cancer in Australia: A Narrative Review | 2025-08-25 | OpenAlex | 10.1111/ajco.70001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413535390 | |||
| W4414015691 | Atopic Dermatitis Pathogenesis And Management: A Review Article | 2025-08-25 | OpenAlex | 10.54293/smhj.v5i3.145 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414015691 | |||
| W4414895536 | Breadth of Depth of Bacteriophage Antibacterial Activity | 2025-08-25 | OpenAlex | 10.54026/ars/1032 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414895536; https://openalex.org/W4413329151 | |||
| W4413601308 | Compliance and Quality Assurance Framework for Multidisciplinary Nursing Leadership in Acute Care | 2025-08-25 | OpenAlex | 10.47191/etj/v10i08.40 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413601308 | |||
| W4413569229 | Lichen Simplex Chronicus: Clinical Perspectives and Emerging Therapeutic Strategies | 2025-08-25 | OpenAlex | 10.1007/s40257-025-00979-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413569229 | |||
| W4413698536 | A Tree-Based Search Algorithm with Global Pheromone and Local Signal Guidance for Scientific Chart Reasoning | 2025-08-26 | OpenAlex | 10.3390/math13172739 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4413698536 | |||
| W4416233439 | Algorithm Design of Reinforcement Learning in Smart Elderly Care Resource Allocation Prediction | 2025-08-26 | OpenAlex | 10.1109/cipae66821.2025.00201 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416233439 | |||
| W4413612608 | Dietary Amino Acids and Amelioration of Liver Ischemia-reperfusion Injury | 2025-08-26 | OpenAlex | 10.1097/tp.0000000000005511 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4413612608 | |||
| W4413612268 | Editorial: Challenges and advances in carcinomatous meningitis treatment | 2025-08-26 | OpenAlex | 10.3389/fonc.2025.1672755 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413612268 | |||
| W4413641589 | Healthcare Innovation as a Complex Adaptive System | 2025-08-26 | OpenAlex | 10.1201/9781003513834-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413641589 | |||
| W4413619680 | Investigational agents for pancreatic neuroendocrine tumors: what clinical progress have we seen in the last 5 years? | 2025-08-26 | OpenAlex | 10.1080/13543784.2025.2552847 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4413619680 | |||
| W4413734435 | MRI Contrast Agents for Glioma Diagnosis (2015–2024): A Bibliometric and Visual Analysis of Research Trends and Emerging Directions | 2025-08-26 | OpenAlex | 10.1002/apj.70095 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4413734435 | |||
| W4413627720 | Novel Therapeutic Development for Nasopharyngeal Carcinoma | 2025-08-26 | OpenAlex | 10.3390/curroncol32090479 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413627720 | |||
| W4413638592 | Recent advances in the functionalities of macrocycles in bone diseases | 2025-08-26 | OpenAlex | 10.36227/techrxiv.175624482.26463371/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413638592 | |||
| W4413746042 | Expanding the boundaries of regenerative endodontics to mature teeth with pulp necrosis | 2025-08-27 | OpenAlex | 10.4103/sej.sej_31_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413746042 | |||
| W4413756600 | From visual question answering to intelligent AI agents in ophthalmology | 2025-08-27 | OpenAlex | 10.1136/bjo-2024-326097 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4413756600 | |||
| W4413744076 | Mindful Ethical Practice and Resilience Academy (MEPRA) | 2025-08-27 | OpenAlex | 10.1097/nmg.0000000000000287 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413744076 | |||
| W4413773191 | “Dusting Off the Cobwebs”: Rethinking How We Use New Antibiotics | 2025-08-27 | OpenAlex | 10.3390/antibiotics14090862 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413773191 | |||
| W4413832267 | A Comprehensive Overview of Candida albicans as the Leading Pathogen in Vulvovaginal Candidiasis | 2025-08-28 | OpenAlex | 10.3390/jof11090632 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413832267 | |||
| W7216398116 | Accelerating Cloud Modernization with Agentic AI | 2025-08-28 | OpenAlex | 10.32996/jcsts.2025.7.9.4 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7216398116 | |||
| W4413775387 | Aspartate potentiates tobramycin against multidrug-resistant Edwardsiella tarda through enhancing proton motive force and membrane permeability | 2025-08-28 | OpenAlex | 10.1128/msystems.00794-25 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4413775387 | |||
| W4413794292 | Beyond the Eye: Glaucoma and the Brain | 2025-08-28 | OpenAlex | 10.3390/brainsci15090934 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413794292 | |||
| W4413781539 | CML-792: Complex Case Report Involving Polycythemia Vera, Myelofibrosis, Chronic Myeloid Leukemia, and Merkel Cell Carcinoma | 2025-08-28 | OpenAlex | 10.1016/s2152-2650(25)01958-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413781539 | |||
| W4413788276 | Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation Agents | 2025-08-28 | OpenAlex | 10.1007/s40256-025-00757-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413788276 | |||
| W4413776861 | Development of a Conversational Artificial Intelligence–Based Web Application for Medical Consultations: Prototype Study | 2025-08-28 | OpenAlex | 10.2196/56090 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4413776861 | |||
| W4413799319 | Editorial: Fighting microbial biofilms: novel therapeutics and antibiofilm strategies | 2025-08-28 | OpenAlex | 10.3389/fcimb.2025.1680391 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413799319 | |||
| W4413799068 | Editorial: Synergistic advances in gene technology, nanobiotechnology, and photonic innovations for next-generation diagnostics and therapeutics | 2025-08-28 | OpenAlex | 10.3389/fbioe.2025.1685142 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413799068 | |||
| W4413832935 | Evolving Paradigms in Acute Myeloid Leukemia: Personalized Approaches to Therapy Across Age and Risk Groups | 2025-08-28 | OpenAlex | 10.3390/cancers17172824 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413832935 | |||
| W4413781581 | MDS-1451: Evolving Mortality Trends in Myelodysplastic Syndromes Among Older US Adults: A 25-Year Nationwide Joinpoint Analysis | 2025-08-28 | OpenAlex | 10.1016/s2152-2650(25)02079-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413781581 | |||
| W4413810531 | MDS-961: MDS-RS Evolving From Hereditary Sideroblastic Anemia: A Diagnostically Challenging Case With Multisystem Involvement | 2025-08-28 | OpenAlex | 10.1016/s2152-2650(25)02048-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413810531 | |||
| W4413790795 | MM-174: Sequential Myelomatous Pleural and Pericardial Effusions in Multiple Myeloma: A Case Report Demonstrating Extended Survival with Teclistamab | 2025-08-28 | OpenAlex | 10.1016/s2152-2650(25)02571-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413790795 | |||
| W4414018714 | Predicting response to renal denervation: aortic distensibility as a piece of the puzzle | 2025-08-28 | OpenAlex | 10.1097/hjh.0000000000004103 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414018714 | |||
| W4413803336 | Breakpoint drift: a hidden confounder in antimicrobial resistance surveillance? | 2025-08-29 | OpenAlex | 10.3389/fmicb.2025.1674968 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413803336 | |||
| W4413803852 | Editorial: Tuberculosis: recent updates in basic research, drug discovery and treatment | 2025-08-29 | OpenAlex | 10.3389/fmed.2025.1668254 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413803852 | |||
| W4413828318 | Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review | 2025-08-29 | OpenAlex | 10.3390/jcm14176119 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413828318 | |||
| W4413920693 | IUC24406-81 ARTA-ATTACK study: assessment of sarcopenia, frailty, and neurocognitive impairment in patients with prostate cancer treated with androgen receptor-targeted agents: a prospective multicenter observational cohort study | 2025-08-29 | OpenAlex | 10.1093/oncolo/oyaf248.029 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413920693 | |||
| W4413817198 | Menopause Step-by-Step: must-know studies | 2025-08-29 | OpenAlex | 10.1097/gme.0000000000002632 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413817198 | |||
| W4413833096 | Nanotechnology-based approaches for vitiligo | 2025-08-29 | OpenAlex | 10.1016/b978-0-443-36326-9.00001-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413833096 | |||
| W4413834681 | Neuro-immune interactions in coronary microvascular disease: mechanisms and therapeutic prospect | 2025-08-29 | OpenAlex | 10.3389/fimmu.2025.1631083 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413834681 | |||
| W4413816582 | Staggered use of sodium nitroprusside and levosimendan in a patient with refractory cardiogenic shock: a case report | 2025-08-29 | OpenAlex | 10.1093/ehjcr/ytaf430 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413816582 | |||
| W7214957210 | Microbes in Action: Powering Sustainable Fermentation for Food, Pharma, and Bioeconomy | 2025-08-30 | OpenAlex | 10.22037/afb.v12i1.49836 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214957210 | |||
| W4413846401 | Modeling Vaccine Hesitancy in a Dynamic World: Integrating Misinformation, Behavioral Shocks, and Policy Interventions in a Game-Theoretic Framework | 2025-08-30 | OpenAlex | 10.58445/rars.2995 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413846401 | |||
| W4413915282 | The Prevalence and Drug Susceptibility of Candida Species and an Analysis of Risk Factors for Oral Candidiasis—A Retrospective Study | 2025-08-30 | OpenAlex | 10.3390/antibiotics14090876 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413915282 | |||
| W7115702937 | Therapeutic Potential of Autologous Fibrin Glue in Regenerative Dentistry: A Review | 2025-08-30 | OpenAlex | 10.5281/zenodo.17949866 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7115702937 | |||
| W4413845841 | Vogt-Koyanagi-Harada Diseases Diagnosis by Means of Ocular Multimodal Imaging: A Case Report | 2025-08-30 | OpenAlex | 10.9734/or/2025/v20i5472 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413845841 | |||
| W4414522845 | A Study on the Derivation of New Meanings in ‘Shua N’-Type Constructions under Prototype Category Theory | 2025-08-31 | OpenAlex | 10.25021/jcll.2025.8.153.99 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414522845 | |||
| W4413929327 | Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases Offers 60% Five-Year Overall Survival for Low-Volume Disease | 2025-08-31 | OpenAlex | 10.3390/gidisord7030057 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413929327 | |||
| W4413857369 | FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON | 2025-08-31 | OpenAlex | 10.4084/mjhid.2025.057 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413857369 | |||
| W4414624754 | Streamline automated biomedical discoveries with agentic bioinformatics | 2025-08-31 | OpenAlex | 10.1093/bib/bbaf505 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4414624754 | |||
| W4414258122 | Structural Violence and Medical Racism in Mojisola Adebayo’s Family Tree | 2025-08-31 | OpenAlex | 10.29163/jmed.2025.8.38.2.135 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414258122 | |||
| W4414218181 | 117 Rethinking health: mobilising the future health workforce from sick-care to systems change | 2025-09-01 | OpenAlex | 10.1136/ebm-2025-pod.117 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414218181 | |||
| W4414801536 | 179PMethodology of the CINRG expanded Duchenne natural history study (eDNHS): assessing disease progression in the era of glucocorticoid and gene therapy treatments | 2025-09-01 | OpenAlex | 10.1016/j.nmd.2025.105532 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414801536 | |||
| W4413870721 | 63259 Is it time to change the concept of difficult-to-treat areas?: Reflections on the POSITIVE study | 2025-09-01 | OpenAlex | 10.1016/j.jaad.2025.05.943 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413870721 | |||
| W4416357885 | A Preferential Option for the Fugitive | 2025-09-01 | OpenAlex | 10.1111/rsr.18122 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416357885 | |||
| W4414245290 | Abstracts | 2025-09-01 | OpenAlex | 10.1111/anae.16748 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414245290; https://openalex.org/W7135183324; https://openalex.org/W4401634471; https://openalex.org/W4313649927 | |||
| W4414040604 | Advances in Care for Burn and Hypertrophic Scar | 2025-09-01 | OpenAlex | 10.1097/sap.0000000000004448 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414040604 | |||
| W4414676388 | Advances in the medical management of esophageal cancer: an updated narrative review | 2025-09-01 | OpenAlex | 10.21037/aoe-25-16 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414676388 | |||
| W4413869512 | Analytical Performance Disclosure in JCV PCR: An Overdue Standard | 2025-09-01 | OpenAlex | 10.22541/au.175670486.65949584/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413869512 | |||
| W4413905048 | Association of Anti-VEGF Therapy with Reported Ocular Adverse Events | 2025-09-01 | OpenAlex | 10.1016/j.oret.2025.08.018 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413905048 | |||
| W4413885826 | Breaking barriers in HIV management: the rise of long-acting lenacapavir | 2025-09-01 | OpenAlex | 10.1097/ms9.0000000000003775 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413885826 | |||
| W4414333304 | Clinical Utility of PCR in Complicated Urinary Tract Infections: A Paradigm Shift in Diagnostics and Management | 2025-09-01 | OpenAlex | 10.1097/ju9.0000000000000353 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414333304 | |||
| W7108474156 | Consortium for Infection- and Immune-Mediated Movement Disorders in India: A Call to Action for Collaborative Discovery and Care | 2025-09-01 | OpenAlex | 10.4103/aomd.aomd_63_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7108474156 | |||
| W4414011431 | Design of LONGEVITI (LIVinG with chrONIc cancEr Therapies): A Narrative Arts-Based Study of Living with Advanced Cancers Treated with Targeted Therapy | 2025-09-01 | OpenAlex | 10.1177/16094069251376201 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414011431 | |||
| W7129504299 | Disease-Modifying Therapies in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy | 2025-09-01 | OpenAlex | 10.1016/j.oto.2026.101215 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129504299 | |||
| W4413893920 | Downy Mildew Disease in Crops: A Comprehensive Review | 2025-09-01 | OpenAlex | 10.9734/ajahr/2025/v12i3403 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413893920 | |||
| W4413868574 | Editorial: Natural products and nanotechnology: next-generation therapies for infectious diseases | 2025-09-01 | OpenAlex | 10.3389/fphar.2025.1682331 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413868574 | |||
| W4413873059 | Editorial: Towards HRI of everyday life | 2025-09-01 | OpenAlex | 10.3389/frobt.2025.1657518 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413873059 | |||
| W7117368930 | Epigenetics in disease prevention, cure, and treatment: Role of histone modifiers in immune modulation | 2025-09-01 | OpenAlex | 10.4103/ijpmmm.ijpmmm_12_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117368930 | |||
| W4415022204 | Evolving insights into viral hepatitis: Advances, evidence, and expert perspectives from the ESCMID Study Group for Viral Hepatitis (ESGVH) – Part 2: hepatitis B, C, and delta | 2025-09-01 | OpenAlex | 10.18683/germs.2025.1473 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415022204 | |||
| W4417201157 | From Degenerative Pathology to Regenerative Therapy: Redefining the Pain Physician’s Role | 2025-09-01 | OpenAlex | 10.4103/ijpn.ijpn_179_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417201157 | |||
| W4414406768 | Glucagon-like Peptide-1 Receptor Agonists: Multifaceted Agents for Cardiovascular Risk Reduction in Diabetes | 2025-09-01 | OpenAlex | 10.4103/jmr.jmr_48_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414406768 | |||
| W4413877672 | Image‐guided therapies for uterine fibroids | 2025-09-01 | OpenAlex | 10.1002/ijgo.70493 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413877672 | |||
| W4415356706 | Infectious Disease: Evolution, Mechanism and Global Health | 2025-09-01 | OpenAlex | 10.1242/dmm.052701 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415356706 | |||
| W4413922439 | Inflammation-Responsive Hydrogels in Perioperative Pain and Wound Management: Design Strategies and Emerging Potential | 2025-09-01 | OpenAlex | 10.3390/gels11090691 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413922439 | |||
| W4413920554 | Interaction with an AI Chatbot in Audiology Education as a Critical Learning Agent | 2025-09-01 | OpenAlex | 10.1097/01.hj.0001167888.15634.ca | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W4413920554 | |||
| W4414032129 | Iron and Manganese Azooxime Complexes as Anti‐Microbial Agents Against Antibiotics Resistant Wild Bacteria From Hospital Drainage | 2025-09-01 | OpenAlex | 10.1111/jcmm.70826 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414032129 | |||
| W4413893866 | Lipoprotein(a): what clinicians need to know | 2025-09-01 | OpenAlex | 10.4081/cardio.2025.80 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413893866 | |||
| W4415568730 | Long-term Management of Graves’ Disease: Balancing Clinical Effectiveness, Safety Considerations, and Patient-focused Treatment | 2025-09-01 | OpenAlex | 10.4103/bjem.bjem_33_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415568730 | |||
| W4414167198 | Mechanisms, Clinical Trials, and New Treatments for BCG ‐Unresponsive in Nonmuscle Invasive Bladder Cancer | 2025-09-01 | OpenAlex | 10.1002/cam4.71243 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414167198 | |||
| W4414452578 | Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025) | 2025-09-01 | OpenAlex | 10.1002/ardp.70102 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414452578 | |||
| W4415449761 | New Sincerity: American Fiction in the Neoliberal Age by Adam Kelly | 2025-09-01 | OpenAlex | 10.1215/0041462x-11983380 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415449761 | |||
| W4414382447 | New directions in childhood obesity treatment – A path forward or wishful thinking? | 2025-09-01 | OpenAlex | 10.1016/j.jacl.2025.05.010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414382447 | |||
| W4414382359 | Oncolytic viruses as anticancer agents: clinical progress and remaining challenges | 2025-09-01 | OpenAlex | 10.1016/s0140-6736(25)01206-1 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4414382359 | |||
| W4414074752 | P06-13 Rivastigmine, Donepezil, and Memantine as Cognitive Enhancers in Neurodoping Practices and Their Implications in Clinical Toxicology | 2025-09-01 | OpenAlex | 10.1016/j.toxlet.2025.07.250 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414074752 | |||
| W4414873892 | Persistent foreign body granuloma developing on the face following embolization agent and stent placement: A rare case report | 2025-09-01 | OpenAlex | 10.54029/2025ktw | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414873892 | |||
| W4414409994 | Principles, applications and projections of ultrasound contrast | 2025-09-01 | OpenAlex | 10.32440/ar.2025.142.02.rev07 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414409994 | |||
| W7105698846 | Reasons of Passive social adjustment of the people in Khalil Mutran's poetry | 2025-09-01 | OpenAlex | 10.22075/lasem.2025.38091.1490 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7105698846 | |||
| W4417201145 | Regeneration in Pain Medicine: Between Expectation and Evidence | 2025-09-01 | OpenAlex | 10.4103/ijpn.ijpn_201_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417201145 | |||
| W4414894985 | Relaxivity and Cytotoxicity Studies of Efficient Imaging Probes of Metalloporphyrins (A Mini-Review) | 2025-09-01 | OpenAlex | 10.1134/s1070363225601863 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414894985 | |||
| W4414033858 | Rheumatoid Arthritis Therapy Based on B Cells | 2025-09-01 | OpenAlex | 10.2147/dddt.s527687 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414033858 | |||
| W4414033605 | Skinspan: A Holistic Roadmap for Extending Skin Longevity With Evidence‐Based Interventions | 2025-09-01 | OpenAlex | 10.1111/jocd.70432 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414033605 | |||
| W4413890437 | Smart biomaterials in dentistry: A review on the role of cellulose and other biological macromolecules in infection control | 2025-09-01 | OpenAlex | 10.1016/j.ijbiomac.2025.147293 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413890437 | |||
| W4414889414 | Synergistic Innovative Therapies in Dermatology: Integrating Platelet Derivatives, Biomaterials, and Exogenous Bioactive Substances for Enhancing Skin Repair and Regeneration | 2025-09-01 | OpenAlex | 10.2147/dddt.s546097 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414889414 | |||
| W4414811882 | The Emerging Role of Oncodermatology in a Hemato-Oncology Unit in a Tertiary Hospital | 2025-09-01 | OpenAlex | 10.36849/jdd.8965 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414811882 | |||
| W4414533027 | The Evolution of Knifeless Microcolumn Fat Injection in 1362 Patients: Emphasizing Longevity of Results and Optimal Contour | 2025-09-01 | OpenAlex | 10.1097/gox.0000000000007118 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414533027 | |||
| W4414340976 | The Evolution, Safety, and Public Perception of Sunscreens: A Historical and Contemporary Review | 2025-09-01 | OpenAlex | 10.1111/phpp.70055 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414340976 | |||
| W4414574139 | The Role of Postoperative Radiotherapy Based on Nomogram Risk Stratification Model in De Novo Metastatic Breast Cancer | 2025-09-01 | OpenAlex | 10.1016/j.ijrobp.2025.06.2536 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414574139 | |||
| W4413902256 | Cognitive alignment in cardiovascular AI: designing predictive models that think with, not just for, clinicians | 2025-09-02 | OpenAlex | 10.3389/fcvm.2025.1651324 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413902256 | |||
| W4413948508 | FDA approval of imetelstat: a new era in the treatment of lower-risk myelodysplastic syndrome | 2025-09-02 | OpenAlex | 10.1097/ms9.0000000000003808 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413948508 | |||
| W4414042715 | Investigational agents for ischaemic cardiomyopathy treatment: preclinical and early phase insights | 2025-09-02 | OpenAlex | 10.1080/13543784.2025.2558655 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414042715 | |||
| W4413995866 | Personalized therapy in metastatic colorectal cancer: biomarker-driven use of biologics | 2025-09-02 | OpenAlex | 10.1080/14712598.2025.2556911 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413995866 | |||
| W4413900987 | Riboflavin in neurological diseases: therapeutic advances, metabolic insights, and emerging genetic strategies | 2025-09-02 | OpenAlex | 10.3389/fneur.2025.1663136 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413900987 | |||
| W4413939408 | 3D human epithelial models: a promising platform for studying Candida infections and novel antifungal therapeutic options | 2025-09-03 | OpenAlex | 10.3389/fcimb.2025.1680261 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413939408 | |||
| W4415834195 | A Scoping Review on Recent Advances in Antidiabetic Medications: From GLP-1 Receptor Agonists to Dual and Triple Agonists | 2025-09-03 | OpenAlex | 10.63623/8cv4gh26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415834195 | |||
| W4414478200 | Health promotion in the algorithmic age: recognizing the information environment as a determinant of health | 2025-09-03 | OpenAlex | 10.1093/heapro/daaf166 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414478200 | |||
| W4416443392 | Integration of basic sciences across the medical school curriculum: Innovative use of AI-powered interactive basic science nodes | 2025-09-03 | OpenAlex | 10.21955/mep.1115704.1 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4416443392 | |||
| W4413952971 | LHX2 Rewires the Metabolic and Epigenetic Landscape to Drive Tumor Progression in Prostate Cancer | 2025-09-03 | OpenAlex | 10.1158/0008-5472.can-25-0587 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4413952971 | |||
| W4413959791 | Obstructive hydrocephalus due to high-volume liquid embolic agent embolization for management of pediatric arteriovenous malformations: illustrative case | 2025-09-03 | OpenAlex | 10.1007/s00381-025-06936-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4413959791 | |||
| W4413951564 | Present and Future Perspectives in the Treatment of Liver Fibrosis | 2025-09-03 | OpenAlex | 10.3390/ph18091321 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413951564 | |||
| W4413961399 | Psychedelics and mental health: reimagining care through science, insight, and compassion | 2025-09-03 | OpenAlex | 10.3389/fphar.2025.1649929 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413961399 | |||
| W4413954738 | Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy—Implications for Radiopharmaceutical Repurposing (Beyond Oncology) | 2025-09-03 | OpenAlex | 10.3390/pharmaceutics17091159 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413954738 | |||
| W4413963432 | Viral oncogenesis and immune remodeling: Decoding the therapeutic potential of immune checkpoint inhibitors in virus-associated cancers | 2025-09-03 | OpenAlex | 10.1016/j.biopha.2025.118515 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413963432 | |||
| W4413989226 | Guest editorial: The role of accounting and management control systems (MCS) in organisations' sustainability performance | 2025-09-04 | OpenAlex | 10.1108/jaar-08-2025-489 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413989226 | |||
| W4414504442 | Navigating the future of artificial intelligence technologies for improving the care of older adults | 2025-09-04 | OpenAlex | 10.1093/geroni/igaf092 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414504442 | |||
| W4413998543 | The role of everolimus in malignant bone tumor therapy: Molecular mechanisms, preclinical evidence, and advances in clinical applications | 2025-09-04 | OpenAlex | 10.3389/or.2025.1630239 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4413998543 | |||
| W4414037161 | Advancements in Multi-Agent Large Language Model Systems for Next-Generation AI | 2025-09-05 | OpenAlex | 10.4018/979-8-3373-1419-8.ch002 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4414037161 | |||
| W4414011238 | Advances in treatment strategies for low-grade serous ovarian cancer | 2025-09-05 | OpenAlex | 10.1016/j.ctrv.2025.103019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414011238 | |||
| W4414221927 | Checkpoint Inhibitor Pneumonitis: Updates in Management | 2025-09-05 | OpenAlex | 10.18103/mra.v13i7.6740 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414221927 | |||
| W4414018955 | From Pandemic to Persistence: Obesity, Immunity, and Next-Gen COVID-19 Vaccines | 2025-09-05 | OpenAlex | 10.38124/ijisrt/25aug1400 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414018955 | |||
| W4414011759 | Movements During Intended General Anesthesia and Psychologically Traumatic Accidental Awareness: Explanatory Role of the “Efference Copy Network” | 2025-09-05 | OpenAlex | 10.1213/ane.0000000000007722 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414011759 | |||
| W4414011273 | Multimodality curative-intent treatment in NSCLC: an unprecedented era of change 2017–2025 | 2025-09-05 | OpenAlex | 10.1136/thorax-2025-223096 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414011273 | |||
| W4414047714 | Squamous Cell Lung Cancer: Review of Biochemical Aspects, Cellular Signals, and Pharmacological Treatments | 2025-09-05 | OpenAlex | 10.21608/ejchem.2025.400356.11995 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414047714 | |||
| W4415171184 | The Current Clinical Application Status and Pharmacological Mechanism of Aspirin | 2025-09-05 | OpenAlex | 10.54097/5hr7dp28 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415171184 | |||
| W4414017655 | The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe? | 2025-09-05 | OpenAlex | 10.3390/biom15091284 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414017655 | |||
| W4414032743 | Climbing to the Summit of Guideline Directed Therapy of Heart Failure:A Slippery Slope | 2025-09-06 | OpenAlex | 10.1016/j.amjcard.2025.09.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414032743 | |||
| W7217628628 | Marginal Adaptation of Eggshell Powder Coalesced Calcium Hydroxide Sealer Using SEM; An In-Vitro Study | 2025-09-06 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7217628628 | ||||
| W4414043654 | Artificial intelligence in allergy and immunology: Recent developments, implementation challenges, and the road toward clinical impact | 2025-09-07 | OpenAlex | 10.1016/j.jaci.2025.08.022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414043654 | |||
| W4414307063 | Atypical Breast Abscess in Pregnancy: A Case of E. coli and E. faecalis Co-Infection | 2025-09-07 | OpenAlex | 10.25251/x1s3j845 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414307063 | |||
| W4414072461 | Large language models in nephrology: applications and challenges in chronic kidney disease management | 2025-09-07 | OpenAlex | 10.1080/0886022x.2025.2555686 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414072461 | |||
| W4415222868 | A Minimal Overlay-Based Framework for Transitioning Legacy Infrastructure to Zero Trust | 2025-09-08 | OpenAlex | 10.1109/cns66487.2025.11195028 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415222868 | |||
| W4414068751 | Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo | 2025-09-08 | OpenAlex | 10.3390/biomedicines13092192 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414068751 | |||
| W4414072759 | Navigating an evolving microbial landscape: emerging antimicrobial resistance trends and precision stewardship in Tianjin tertiary hospitals (2021–2023) | 2025-09-08 | OpenAlex | 10.3389/fcimb.2025.1629038 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414072759 | |||
| W4414096166 | Richter Transformation in Chronic Lymphocytic Leukemia: Current Treatment Challenges and Evolving Therapies | 2025-09-08 | OpenAlex | 10.3390/ijms26178747 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414096166 | |||
| W4414059396 | Targeting CD20 for B-cell Depletion in Autoimmune Kidney Disease: Next Generation | 2025-09-08 | OpenAlex | 10.1007/s40259-025-00742-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414059396 | |||
| W7124828812 | 261Chapter 12 Future Directions and Emerging Trends in Computational Optimization Related to Data Science and Machine Learning | 2025-09-09 | OpenAlex | 10.1515/9783112219430-012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124828812 | |||
| W4415463937 | Case report of refractory Hodgkin lymphoma with subsequent transformation to diffuse large B-cell lymphoma: A diagnostic and therapeutic challenge | 2025-09-09 | OpenAlex | 10.22146/inajbcs.v57i3.supplement.24345 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415463937 | |||
| W4414148772 | Editorial: Formation of immunological niches in tumor microenvironments: mechanisms and therapeutic potential | 2025-09-09 | OpenAlex | 10.3389/fonc.2025.1675697 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414148772 | |||
| W4414145626 | Evolving Paradigms in Psoriasis Treatment: Bridging Traditional Therapies with Technological Innovations | 2025-09-09 | OpenAlex | 10.52504/001c.143492 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414145626 | |||
| W4414147301 | From Haemorrhagic Shock to Years of Survival: A Case Report of PIK3CA-Mutated Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Metastatic Breast Cancer With Satellite Lesions | 2025-09-09 | OpenAlex | 10.7759/cureus.91888 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414147301 | |||
| W4414210746 | Pharmacological Culprits of Hyperhidrosis: An Updated Review of Incidence, Mechanisms, and Management | 2025-09-09 | OpenAlex | 10.1002/der2.70052 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414210746 | |||
| W4414084718 | Rickettsia lanei, sp. nov. (Rickettsiales: Rickettsiaceae), a Newly Recognized Pathogen of Humans Associated with the Rabbit Tick, Haemaphysalis leporispalustris (Acari: Ixodidae) | 2025-09-09 | OpenAlex | 10.4269/ajtmh.25-0134 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414084718 | |||
| W4414082095 | Statins in Acute Ischemic Stroke: Mechanisms, Resistance, and Precision Strategies for Neurovascular and Cognitive Protection | 2025-09-09 | OpenAlex | 10.1007/s40263-025-01222-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414082095 | |||
| W4414148523 | Targeting the neuroimmune axis in glioblastoma: emerging strategies for precision immunotherapy | 2025-09-09 | OpenAlex | 10.3389/fimmu.2025.1661327 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414148523 | |||
| W4414089354 | The Contextual-Experiential Approach in ELT | 2025-09-09 | OpenAlex | 10.20944/preprints202509.0736.v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414089354 | |||
| W4414214943 | The Evolving Landscape of microRNAs in Cholangiocarcinoma and Pancreatic Cancer | 2025-09-09 | OpenAlex | 10.3390/diagnostics15182285 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414214943 | |||
| W4414143862 | Toward Weight-level Self-improving Agents with Meta-knowledge Discovery | 2025-09-09 | OpenAlex | 10.36227/techrxiv.175744083.37752625/v1 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4414143862 | |||
| W4414094307 | Approved and emerging therapies for glucocorticoid-refractory chronic graft-versus-host disease | 2025-09-10 | OpenAlex | 10.1016/j.coi.2025.102654 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414094307 | |||
| W4414091343 | Balancing Host Defense and Viral Tolerance for the Development of Next-Generation Broad-Spectrum Antiviral Agents | 2025-09-10 | OpenAlex | 10.3390/pathogens14090911 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414091343 | |||
| W4414086641 | Editorial: Beyond traditional antibiotics: innovations in biologics, chemical modulators, and microbiome manipulation | 2025-09-10 | OpenAlex | 10.3389/fphar.2025.1679268 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414086641 | |||
| W4415708602 | Enhancing Security in Internet of Medical Things (IoMT) using Reinforcement Learning and Federated Learning Approaches | 2025-09-10 | OpenAlex | 10.1109/icesc65114.2025.11212310 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415708602 | |||
| W4414091769 | Feasibility of a reduced gadolinium dose protocol for MRI-guided radiotherapy in glioblastoma | 2025-09-10 | OpenAlex | 10.2340/1651-226x.2025.44022 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414091769 | |||
| W7125585221 | Federated Cognitive Infrastructure with Reinforcement Learning-Driven Governance: An Adaptive, Privacy-Preserving Architecture for Regulated AI Systems | 2025-09-10 | OpenAlex | 10.1109/resgenxai64788.2025.11344027 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7125585221 | |||
| W4415709048 | Hybrid Reinforcement Learning and Supervised Learning for Fault Detection and Tolerance in Cyber-Physical Systems | 2025-09-10 | OpenAlex | 10.1109/icesc65114.2025.11212250 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415709048 | |||
| W4414269335 | INJECTABLE FILLERS AND THE ORAL MICROENVIRONMENT: FROM MUCOSAL REACTIONS TO IMPLANT HEALING FAILURE: A NARRATIVE REVIEW | 2025-09-10 | OpenAlex | 10.71000/d4qxe542 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414269335 | |||
| W4414085335 | Nasal microbiome inhabitants with anti- Staphylococcus aureus activity | 2025-09-10 | OpenAlex | 10.1128/spectrum.01024-25 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414085335 | |||
| W4414095464 | Resistance Mutations in CLL: Genetic Mechanisms Shaping the Future of Targeted Therapy | 2025-09-10 | OpenAlex | 10.3390/genes16091064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414095464 | |||
| W4414129273 | A Comprehensive Review of Digestive Endoscopy-Associated Infections: Bacterial Pathogens, Host Susceptibility, and the Impact of Viral Hepatitis | 2025-09-11 | OpenAlex | 10.3390/microorganisms13092128 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414129273 | |||
| W4414134286 | Anti-infective Drug Discovery: Harnessing Multimechanistic Molecules and Emergent Properties to Defeat Pathogenic Complexity | 2025-09-11 | OpenAlex | 10.1021/acs.jmedchem.5c02312 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414134286 | |||
| W4414239902 | Are Nurses Free to Be Moral Agents? Revisiting the Moral Foundation of Nursing in Uncertain Times | 2025-09-11 | OpenAlex | 10.1097/ans.0000000000000591 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414239902 | |||
| W4414114230 | Comprehensive Update on Keloid Management | 2025-09-11 | OpenAlex | 10.1055/a-2698-3574 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414114230 | |||
| W4414138882 | Editorial: Management of rare oncological cases | 2025-09-11 | OpenAlex | 10.3389/fonc.2025.1668671 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414138882 | |||
| W4414262332 | Editorial: Refractory and relapsed hemophagocytic lymphohistiocytosis in pediatric population: targeted therapy | 2025-09-12 | OpenAlex | 10.3389/fonc.2025.1691878 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414262332 | |||
| W4414146564 | Engineering the Colloidal Properties of Iron Oxide Nanoparticles for High T1 MRI Contrast at 64 mT | 2025-09-12 | OpenAlex | 10.1021/acsanm.5c03154 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414146564 | |||
| W4414306964 | Guided multi-agent AI invents highly accurate, uncertainty-aware transcriptomic aging clocks | 2025-09-12 | OpenAlex | 10.1101/2025.09.08.674588 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4414306964 | |||
| W7128739377 | Integrating Generative AI into Digital Transformation: A Unified Pilot-to-Production Framework for Key Economic Sectors | 2025-09-12 | OpenAlex | 10.1109/icerect65215.2025.11376210 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7128739377 | |||
| W4414261641 | Transforming the Management of Oligometastatic Non-Small Cell Lung Cancer in the Era of Immunotherapy and Targeted Therapy | 2025-09-12 | OpenAlex | 10.3390/cancers17182982 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414261641 | |||
| W4414084864 | [Immunomodulatory therapy in severe pneumonia: a double-edged sword in determining clinical outcomes]. | 2025-09-12 | OpenAlex | 10.3760/cma.j.cn112147-20250505-00247 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414084864 | |||
| W4414263891 | Immunotherapy in gastric adenocarcinoma – a rapidly evolving treatment landscape | 2025-09-13 | OpenAlex | 10.1016/j.critrevonc.2025.104941 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414263891 | |||
| W4414260872 | Near-Infrared Fluorescence Imaging in General Surgery: Applications in Vascularization, Tumor Margin Detection, and Biliary Anatomy | 2025-09-13 | OpenAlex | 10.7759/cureus.92194 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414260872 | |||
| W4414162510 | Review of anti-amyloid-beta (Aβ) monoclonal antibodies for the treatment of Alzheimer’s disease | 2025-09-13 | OpenAlex | 10.1080/17512433.2025.2556122 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414162510 | |||
| W7133230893 | Ulcerative Colitis in the Modern Era: Pathogenesis, Evolving Therapies and Future Directions | 2025-09-13 | OpenAlex | 10.52794/hujpharm.1781660 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133230893 | |||
| W4414168300 | What’s new in IBD research? Refining the agenda: Outcomes, patient-centered care, and technology | 2025-09-13 | OpenAlex | 10.1016/j.dld.2025.08.084 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414168300 | |||
| W4414346979 | Genes, long non-coding RNAs, and nucleic-acid based therapies: how genetics is changing the present and future of cardiovascular diseases | 2025-09-14 | OpenAlex | 10.1093/eurheartj/ehaf650 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414346979 | |||
| W4414204616 | The Cardiovascular Effects of Inflammatory Bowel Disease Therapy with Biologics and Small Molecules: A Comprehensive Review | 2025-09-14 | OpenAlex | 10.3390/jcm14186476 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414204616 | |||
| W4414263322 | AI Agents and Autonomy | 2025-09-15 | OpenAlex | 10.1201/9781003651963-8 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4414263322 | |||
| W7124461357 | Data Foundations in CADD: Structural Databases, Descriptors and Force Fields | 2025-09-15 | OpenAlex | 10.61096/978-81-990998-7-6_2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124461357 | |||
| W7214160479 | Dermatologic Therapeutics | 2025-09-15 | OpenAlex | 10.61096/978-81-981372-2-7_13 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214160479 | |||
| W4414255382 | Multifunctional Nanocarrier Drug Delivery Systems: From Diverse Design to Precise Biomedical Applications | 2025-09-15 | OpenAlex | 10.1002/adhm.202502178 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414255382 | |||
| W7214232192 | Musculoskeletal and Bone Disorders | 2025-09-15 | OpenAlex | 10.61096/978-81-981372-2-7_15 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214232192 | |||
| W7214230122 | Ophthalmic and Otologic Pharmacology | 2025-09-15 | OpenAlex | 10.61096/978-81-981372-2-7_14 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214230122 | |||
| W4414257611 | Pharmaceutical Skin Care: Skin Structure, Barrier Function, and Advanced Drug Delivery Modes | 2025-09-15 | OpenAlex | 10.22270/jddt.v15i9.7364 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414257611 | |||
| W4414167929 | Silent damage, early signals: A narrative review of the evolving role of cardiac biomarkers in oncology-driven cardiotoxicity | 2025-09-15 | OpenAlex | 10.1177/10815589251382263 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414167929 | |||
| W4414226918 | CURRENT PERSPECTIVES ON THE MANAGEMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE IN PEDIATRIC TRANSPLANTATION | 2025-09-16 | OpenAlex | 10.31435/ijitss.3(47).2025.3734 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414226918 | |||
| W4414243609 | Glucagon-Like Peptide-1 Receptor Agonists in Neurodegenerative Diseases: A Comprehensive Review | 2025-09-16 | OpenAlex | 10.7759/cureus.92441 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414243609 | |||
| W4414340969 | Indole therapeutics: Latest FDA updates, ongoing trials, and future directions | 2025-09-16 | OpenAlex | 10.1016/j.drudis.2025.104471 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414340969 | |||
| W7203573298 | Systems-Level Modeling of Cancer Evolution | 2025-09-16 | OpenAlex | 10.5281/zenodo.19549926 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7203573298 | |||
| W4414276143 | Beyond Antihistamines: How Biologic and Small‐Molecule Therapies Are Transforming Chronic Spontaneous Urticaria Care in Adults | 2025-09-17 | OpenAlex | 10.1007/s40261-025-01480-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414276143 | |||
| W4414295529 | Current Clinical Trial Landscape of Gastroenteropancreatic Neuroendocrine Tumors: A New Era of Landmark Trials | 2025-09-17 | OpenAlex | 10.3390/jcm14186522 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414295529 | |||
| W4414334298 | Decoding Cancer Stem Cells: A Game Change in Oncology Therapeutics | 2025-09-17 | OpenAlex | 10.22259/2638-5074.0501004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414334298 | |||
| W4414299616 | Editorial: Biotic pest disturbance - risk, evaluation, and management in forest ecosystems | 2025-09-17 | OpenAlex | 10.3389/ffgc.2025.1665993 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414299616 | |||
| W4414290874 | Editorial: Insights in pediatric nephrology | 2025-09-17 | OpenAlex | 10.3389/fped.2025.1671358 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414290874 | |||
| W4414299604 | From tools to co-learners: entangled humanism and the co-evolution of intelligence in AI education | 2025-09-17 | OpenAlex | 10.3389/feduc.2025.1632990 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414299604 | |||
| W4414257778 | Reversible cerebral vasoconstriction syndrome: not just a “reversible” condition. Retrospective observational study and literature review | 2025-09-17 | OpenAlex | 10.1016/j.hest.2025.09.003 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414257778 | |||
| W4414451204 | Updates in endoscopic hemostasis for nonvariceal gastroduodenal bleeding | 2025-09-17 | OpenAlex | 10.1097/mog.0000000000001133 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414451204 | |||
| W4414328437 | Chemopreventive Effect of Lupeol and Lupeol Nanoparticles | 2025-09-18 | OpenAlex | 10.1201/9781003600022-5 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414328437 | |||
| W4414340090 | Emotional AI and the rise of pseudo-intimacy: are we trading authenticity for algorithmic affection? | 2025-09-18 | OpenAlex | 10.3389/fpsyg.2025.1679324 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414340090 | |||
| W4414331919 | The Nitrite-Amines Nexus in Nitrosamine Formation: Mechanisms, Mutagenic Implications, Regulations, and Root Causes in Medicines | 2025-09-18 | OpenAlex | 10.2174/0115680266379308250827055006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414331919 | |||
| W7213995300 | Enigmas que se inventam quando a ayahuasca e a clínica se encontram: “Fale de mim para os acadêmicos” | 2025-09-19 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213995300 | ||||
| W4414381644 | GoCa: Trustworthy Multi-modal RAG with Explicit Thinking Distillation for Reliable Decision-Making in Med-LVLMs | 2025-09-19 | OpenAlex | 10.1007/978-3-032-05185-1_25 | Full text | Excluded | F4: Fixed GPT4o-mini agents critique/refine each example to build a fixed offline preference corpus. LLaVA-Med then receives DPO and CoT-DPO; no interactive clinical-agent training loop or retained cross-case execution-derived agent artifact is documented. | https://openalex.org/W4414381644 | https://papers.miccai.org/miccai-2025/paper/0421_paper.pdf | official MICCAI original accepted manuscript, complete methods and experiments; official repository observed empty | |
| W4414377132 | Hypertension Unraveled: From Mechanisms to Modern Management | 2025-09-19 | OpenAlex | 10.38124/ijisrt/25sep335 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414377132 | |||
| W4414351537 | Management of Type 2 Diabetes Mellitus in Native Americans and Alaska Natives: A Systematic Review | 2025-09-19 | OpenAlex | 10.1007/s40615-025-02668-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414351537 | |||
| W4414346950 | Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium | 2025-09-19 | OpenAlex | 10.1200/po-25-00377 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414346950 | |||
| W4414378535 | Reimagining mental health: the role of artificial intelligence and brain computer interfaces in advancing mental health care | 2025-09-19 | OpenAlex | 10.18203/2394-6040.ijcmph20252940 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414378535 | |||
| W4414346325 | Ripretinib in Advanced Gastrointestinal Stromal Tumors: A Case Series and Literature Review from a Tertiary Cancer Center in India | 2025-09-19 | OpenAlex | 10.1055/s-0045-1811940 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414346325 | |||
| W4414366109 | Treating and triggering hyperinflammation: tackling hemophagocytic lymphohistiocytosis and HLH-like syndromes in the pediatric cell therapy and critical care setting | 2025-09-19 | OpenAlex | 10.3389/fonc.2025.1631557 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414366109 | |||
| W4414353081 | Tumor Microenvironment and Its Role in Cancer Progression: An Integrative Review | 2025-09-19 | OpenAlex | 10.7759/cureus.92707 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414353081 | |||
| W4414376826 | A Brief Overview on Multi-component Synthesis of Tri- and Tetra-substituted Imidazoles | 2025-09-20 | OpenAlex | 10.9734/ajocs/2025/v15i5394 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414376826 | |||
| W4414787079 | Artificial Intelligence in Health Promotion: Computational Literature Review and Framework Development (Preprint) | 2025-09-20 | OpenAlex | 10.2196/preprints.84492 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414787079 | |||
| W4414418287 | Harmony | 2025-09-22 | OpenAlex | 10.1007/978-3-032-06004-4_10 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4414418287 | |||
| W4414401476 | Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacy | 2025-09-22 | OpenAlex | 10.3389/fonc.2025.1649493 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414401476 | |||
| W4414421921 | M$$^3$$Builder: A Multi-agent System for Automated Machine Learning in Medical Imaging | 2025-09-22 | OpenAlex | 2502.20301 | 10.1007/978-3-032-06004-4_12 | Full text | Excluded | F4: M3Builder refines code from compiler feedback within the current model-building request, with initially empty code/feedback for the task. The output is a trained medical-imaging model; later use by another medical agent is proposed, without a demonstrated retained experience/skill update reused by the agent on different requests. | https://openalex.org/W4414421921 | https://doi.org/10.1007/978-3-032-06004-4_12 | |
| W4414404481 | Modern Approaches to treatment of peptic ulcer in the practice of GPs from point of view of evidence - based medicine | 2025-09-22 | OpenAlex | 10.58676/sjmas.v3i6.134 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414404481 | |||
| W4414407028 | Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review | 2025-09-22 | OpenAlex | 10.3390/jcm14186686 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414407028 | |||
| W4414406058 | Refining the Difficult-to-Treat ABPA Phenotype: Towards Mechanistic Insights and Stratified Therapies | 2025-09-22 | OpenAlex | 10.22541/au.175856319.93691472/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414406058 | |||
| W4414380291 | Septic shock: Past, present, and perspectives | 2025-09-22 | OpenAlex | 10.1016/j.jcrc.2025.155269 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414380291 | |||
| W4414446754 | Antibody-drug conjugates in metastatic urothelial cancer: Highway to heaven | 2025-09-23 | OpenAlex | 10.5306/wjco.v16.i9.106646 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414446754 | |||
| W4414449013 | Diagnostic capabilities of cone-beam computed tomography with sialography | 2025-09-23 | OpenAlex | 10.17116/rosstomat20251803141 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414449013 | |||
| W4414563664 | Evolutionary Double-Bind Treatment Using Radiation Therapy and Natural Killer Cell-Based Immunotherapy in Prostate Cancer | 2025-09-23 | OpenAlex | 10.1016/j.ijrobp.2025.09.034 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414563664 | |||
| W4414420891 | Evolving perspectives on blood transfusion in obstetric hemorrhage: a narrative review | 2025-09-23 | OpenAlex | 10.4097/kja.25413 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414420891 | |||
| W4414437833 | FDA and EMA approval of datopotamab-deruxtecan: A paradigm shift in breast cancer drug evaluation? | 2025-09-23 | OpenAlex | 10.1016/j.breast.2025.104589 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414437833 | |||
| W4414443225 | Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape | 2025-09-23 | OpenAlex | 10.1080/14728214.2025.2565189 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414443225 | |||
| W4414451293 | Hypoxia-Induced Metabolic Reprogramming in the Renal Tubules of Patients with Diabetic Kidney Disease and the Associated Traditional Chinese Medicine Intervention Strategies | 2025-09-23 | OpenAlex | 10.1097/imna-d-25-00019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414451293 | |||
| W7104580380 | Integrative targeting of Bruton’s Tyrosine Kinase (BTK) and fibroblast growth factor receptor (FGFR) in lung cancer: A paradigm shift in precision oncology | 2025-09-23 | OpenAlex | 10.51470/bca.2025.25.2.1195 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7104580380 | |||
| W4414436104 | Leptomeningeal Metastasis, an Evolving Frontier for Radiation Oncology | 2025-09-23 | OpenAlex | 10.1016/j.ijrobp.2025.08.002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414436104 | |||
| W4414578897 | Phytotherapy as an adjunct to the treatment of rheumatoid arthritis - a systematic review of clinical trials | 2025-09-23 | OpenAlex | 10.1016/j.phymed.2025.157285 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414578897 | |||
| W4414444748 | Remimazolam in pediatric anesthesia: a systematic review for clinical decision-making | 2025-09-23 | OpenAlex | 10.3389/fped.2025.1662752 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414444748 | |||
| W7151583044 | Bio-Cybersecurity with AI | 2025-09-24 | OpenAlex | 10.1109/icosec67334.2025.11459645 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7151583044 | |||
| W4414462427 | Detection and characterization of heteroresistance to chloramphenicol in Klebsiella pneumoniae isolates | 2025-09-24 | OpenAlex | 10.1186/s12866-025-04266-z | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414462427 | |||
| W4414502467 | Discussion: Comparative Study of Inflammatory and Fibrotic Reactions Induced by Silicone Implants with Different Hardness | 2025-09-24 | OpenAlex | 10.1097/prs.0000000000012146 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414502467 | |||
| W4414519697 | Excoriation disorder: Etiopathogenesis, prevalence, symptoms, treatment | 2025-09-24 | OpenAlex | 10.18510/hssr.2025.13219 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414519697 | |||
| W7225007391 | Global Pharmacovigilance Trends 2025 and Beyond Leveraging AI, Real-Time Monitoring, and Predictive Analytics for Advanced Drug Safety | 2025-09-24 | OpenAlex | 10.5281/zenodo.23836218 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225007391 | |||
| W4414624984 | Laxative logic: when lifestyle is not enough | 2025-09-24 | OpenAlex | 10.1097/mog.0000000000001137 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414624984 | |||
| W4414472051 | New drugs for the management of tuberculosis | 2025-09-24 | OpenAlex | 10.1097/qco.0000000000001156 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414472051 | |||
| W4414564378 | Quantifying the carbon footprint of canine breed-specific surgical care in a veterinary referral setting | 2025-09-24 | OpenAlex | 10.1016/j.tvjl.2025.106451 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414564378 | |||
| W4414473342 | Sustainable Synthesis of Silver Nanoparticles (Chemical vs Biological) and Their Antimicrobial Activity against Clinical Pathogens | 2025-09-24 | OpenAlex | 10.1021/acsomega.5c05917 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414473342 | |||
| W4414471562 | Understanding idiopathic hypersomnia: diagnosis, pathophysiology, and management | 2025-09-24 | OpenAlex | 10.1097/mcp.0000000000001221 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414471562 | |||
| W4414500953 | A Mechanistic Framework for Repurposing FDA-Approved Drugs to Combat Antimicrobial Resistance: The Case of Staphylococcus aureus | 2025-09-25 | OpenAlex | 10.1146/annurev-pharmtox-062624-014243 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414500953 | |||
| W4414516950 | Allergy and dermatology US treatment guidelines review for adults with atopic dermatitis | 2025-09-25 | OpenAlex | 10.1016/j.jacig.2025.100569 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414516950 | |||
| W4414532092 | Cardiac imaging in oncology: the detection of cardiotoxicity | 2025-09-25 | OpenAlex | 10.1136/heartjnl-2024-323864 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414532092 | |||
| W4414493967 | Emerging EGFR-Targeted Therapy in Head and Neck Cancer | 2025-09-25 | OpenAlex | 10.1001/jamaoncol.2025.3136 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414493967 | |||
| W4414519222 | Intra-nasal Nano drug delivery system: a non-invasive gateway to the brain | 2025-09-25 | OpenAlex | 10.70593/978-93-7185-149-7_6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414519222 | |||
| W4414756353 | JAK-STAT Inhibitors: A Game Changer, from Rheumatology to Gastroenterology | 2025-09-25 | OpenAlex | 10.18103/mra.v13i9.6935 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414756353 | |||
| W7220116180 | MANAGEMENT AND PREVENTION OF POST-VIRAL PULMONARY FIBROSIS IN CHILDREN: CURRENT APPROACHES AND FUTURE PERSPECTIVES | 2025-09-25 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220116180 | ||||
| W7151311435 | Mnestic functions restoration due to chronic brain ischemia pathogenetically oriented pharmacocorrection as a condition to enhance cerebral resistance | 2025-09-25 | OpenAlex | 10.12775/jehs.2025.85.70620 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7151311435 | |||
| W4414519107 | Navigating uncertainty in human interaction: A management science approach using Bayesian games in therapy | 2025-09-25 | OpenAlex | 10.1016/j.omega.2025.103430 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414519107 | |||
| W4414498121 | Novel therapies in osteoporosis – Clinical update – 2025 | 2025-09-25 | OpenAlex | 10.1016/j.berh.2025.102100 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414498121 | |||
| W4414756377 | SLFN12 and Triple Negative Breast Cancer: Unlocking New Possibilities in Chemotherapy Response | 2025-09-25 | OpenAlex | 10.18103/mra.v13i9.6947 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414756377 | |||
| W4414520712 | Scientometric analysis of glioblastoma and blood-brain barrier research (1995−2024): evolving trends and therapeutic challenges | 2025-09-25 | OpenAlex | 10.3389/fonc.2025.1649414 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414520712 | |||
| W4414494912 | Taiwan expert consensus on the clinical integration of antibody-drug conjugates in advanced breast cancer | 2025-09-25 | OpenAlex | 10.1016/j.soi.2025.100193 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414494912 | |||
| W7167069604 | The Role of Ivabradine in Heart Failure with Reduced Ejection Fraction: A Comprehensive Review | 2025-09-25 | OpenAlex | 10.47191/ijmscrs/v5-i09-22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167069604 | |||
| W7112259736 | Acide hyaluronique : 90 ans d’innovation médicale : histoire, applications thérapeutiques et perspectives d’innovation en santé et biotechnologie | 2025-09-26 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7112259736 | ||||
| W4414532305 | Advancing Bladder Cancer Management: The Role of Neoadjuvant and Adjuvant Therapies and Biomarkers in Muscle Invasive Bladder Cancer | 2025-09-26 | OpenAlex | 10.1007/s11864-025-01355-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414532305 | |||
| W4414556370 | How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach | 2025-09-26 | OpenAlex | 10.1097/qco.0000000000001151 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414556370 | |||
| W4414531436 | Impact of two-level filtering organization on population’s accessibility to an emergency medical communication centre | 2025-09-26 | OpenAlex | 10.1186/s12873-025-01310-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414531436 | |||
| W4414540283 | Melflufen Approved in EU, Withdrawn in U.S. for Multiple Myeloma | 2025-09-26 | OpenAlex | 10.1097/01.cot.0000000000000165 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414540283 | |||
| W4415138188 | Microneedles: A Promising Therapeutic Strategy for Next-Generation Drug Delivery, Diagnosis and Biosensing | 2025-09-26 | OpenAlex | 10.53941/mmr.2025.100005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415138188 | |||
| W4414553437 | Monoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions | 2025-09-26 | OpenAlex | 10.3390/ijms26199398 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414553437 | |||
| W4414531473 | Surveillance of respiratory viruses in severe acute respiratory infections in Southern Brazil, 2023–2024 | 2025-09-26 | OpenAlex | 10.1186/s12879-025-11458-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414531473 | |||
| W4414514977 | Targeting the crosstalk of metabolism reprogramming and replication stress: novel strategy to combat cancer | 2025-09-26 | OpenAlex | 10.1007/s12032-025-03053-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414514977 | |||
| W4414586676 | Acanthamoeba keratitis: from pathophysiology to prevention – a contemporary clinical perspective | 2025-09-27 | OpenAlex | 10.51329/mehdiophthal1528 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414586676 | |||
| W4416635934 | Evolution of Treatment Patterns and Their Impact on Disease Progression in Systemic Sclerosis-associated ILD | 2025-09-27 | OpenAlex | 10.1183/13993003.congress-2025.oa1155 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416635934 | |||
| W4414591202 | Glypican-3: Novel Theranostic Agent for Hepatocellular Carcinoma | 2025-09-27 | OpenAlex | 10.1053/j.semnuclmed.2025.09.004 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4414591202 | |||
| W7119504461 | Treatment Diversification to Address the Continued Rise of Antimicrobial Resistance in Neisseria gonorrhoeae | 2025-09-27 | OpenAlex | 10.1093/cid/ciaf531 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119504461 | |||
| W7160658432 | Using Biomarkers in Dose-Finding Designs in Oncology | 2025-09-27 | OpenAlex | 10.17863/cam.129863 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160658432 | |||
| W4414661006 | Individualizing SGLT2 inhibitors cardiovascular benefit in patients with type 2 diabetes: target trial emulation meets machine learning | 2025-09-28 | OpenAlex | 10.1093/eurjpc/zwaf625 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414661006 | |||
| W4414583623 | The comet assay: A contemporary approach for detecting genomic instability | 2025-09-28 | OpenAlex | 10.1016/j.dnarep.2025.103899 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414583623 | |||
| W4416184344 | A Reflective Architecture for LLM-Based Systems | 2025-09-29 | OpenAlex | 10.1109/acsos-c66519.2025.00029 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416184344 | |||
| W4414601807 | ASO Author Reflections: Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma | 2025-09-29 | OpenAlex | 10.1245/s10434-025-18456-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414601807 | |||
| W4416074774 | Designing a novel peer-based decision aid to address perceived risk for HIV and PrEP interest among Black sexual minority men | 2025-09-29 | OpenAlex | 10.1093/her/cyaf045 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416074774 | |||
| W4414602824 | Epidemiology of poisoning in elderly Iranians: a narrative review with global context | 2025-09-29 | OpenAlex | 10.1186/s12245-025-00989-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414602824 | |||
| W4414611849 | Erythema ab igne—A Potential Cutaneous Marker of Chronic Heat Use in Patients with Endometriosis: A Narrative Literature Review and a Case Report | 2025-09-29 | OpenAlex | 10.3390/life15101533 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414611849 | |||
| W4414616041 | Evolving MET-Directed Therapies in NSCLC: From Present Treatment to Innovative Future Approaches | 2025-09-29 | OpenAlex | 10.58502/dtt.25.0007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414616041 | |||
| W7106259168 | Recent Advances in Cardiothoracic Anaesthesia: A Scoping Review of Innovations, Outcomes, and Future Directions | 2025-09-29 | OpenAlex | 10.82223/nja.vol2no2.48 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7106259168 | |||
| W4414587493 | Revolutionizing Dental Therapy: A Comprehensive Review on the Innovative Use of Natural Extracts in Tooth Care and Treatment | 2025-09-29 | OpenAlex | 10.2174/0122150838410159250909103512 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414587493 | |||
| W4414791201 | Shining light on immunotherapy in metastatic urothelial carcinoma: trends and prospects | 2025-09-29 | OpenAlex | 10.1097/mm9.0000000000000025 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414791201 | |||
| W4415544537 | Artificial intelligence and pharmacy practice research: call to action | 2025-09-30 | OpenAlex | 10.1093/ijpp/riaf096 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415544537 | |||
| W4414794464 | Cross-Species Boundaries and Human Rights: Legal and Ethical Reflections on Xenotransplantation | 2025-09-30 | OpenAlex | 10.12681/bioeth.42845 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414794464 | |||
| W4414677558 | Editorial: Understanding the role of microbiome in alteration of cellular metabolism and cancer development | 2025-09-30 | OpenAlex | 10.3389/fcimb.2025.1686038 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414677558 | |||
| W4414679003 | Experience-guided multi-agent interpretable framework for radiology report summarization | 2025-09-30 | OpenAlex | 10.1016/j.cmpb.2025.109078 | Full text | Included | Included: Clinical report-derived rules are iteratively selected and refined, retained and applied to different held-out radiology reports. | https://openalex.org/W4414679003 | https://www.sciencedirect.com/science/article/abs/pii/S016926072500495X | ||
| W4414621592 | Fibrinolytic Therapy for Thromboembolic Diseases | 2025-09-30 | OpenAlex | 10.1016/j.jacc.2025.07.061 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414621592 | |||
| W4414674387 | First Large‐Scale Breakdown of Yr15 Resistance to Wheat Yellow Rust ( Puccinia striiformis f. sp. tritici ) Recorded Globally | 2025-09-30 | OpenAlex | 10.1002/ndr2.70067 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414674387 | |||
| W4414659630 | In Reply: Stereotactic Radiosurgery Dose Reduction for Melanoma Brain Metastases Patients on Immunotherapy or Targeted Therapy: A Single-Center Experience | 2025-09-30 | OpenAlex | 10.1227/neu.0000000000003796 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414659630 | |||
| W4414659658 | Letter: Stereotactic Radiosurgery Dose Reduction for Melanoma Brain Metastases Patients on Immunotherapy or Target Therapy: A Single-Center Experience | 2025-09-30 | OpenAlex | 10.1227/neu.0000000000003795 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414659658 | |||
| W4414751896 | Novel agents and evolving strategies for anemia management in lower-risk myelodysplastic syndromes | 2025-09-30 | OpenAlex | 10.1007/s44313-025-00099-x | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4414751896 | |||
| W4414669466 | Perinatal Management and Clinical Outcomes of Hereditary Angioedema in Japan: A Case Series and Comprehensive Literature Review | 2025-09-30 | OpenAlex | 10.1111/1346-8138.17979 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414669466 | |||
| W4414668654 | Role of Antibody Therapy in Recurrent and Metastatic Cervical Cancer Treatment: A Review of the Literature | 2025-09-30 | OpenAlex | 10.38124/ijisrt/25sep1217 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414668654 | |||
| W4414757098 | The evolving threat of antimicrobial resistance in surgical site infections: Mechanisms, epidemiology, and innovative mitigation strategies | 2025-09-30 | OpenAlex | 10.53771/ijbpsa.2025.10.1.0072 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414757098 | |||
| W4415426551 | #2789 Rituximab in treating steroid-sensitive nephrotic syndrome in children—experience from Uzbekistan | 2025-10-01 | OpenAlex | 10.1093/ndt/gfaf116.0235 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415426551 | |||
| W4415423311 | #2935 Real-world treatment patterns of patients with immunoglobulin a nephropathy (IgAN) in the United States | 2025-10-01 | OpenAlex | 10.1093/ndt/gfaf116.1141 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415423311 | |||
| W4414950869 | 21 News and views: Exciting new approaches in therapy, double-hit therapies, JAK inhibitors | 2025-10-01 | OpenAlex | 10.1136/lupus-2025-la.21 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414950869 | |||
| W4414749313 | A Comprehensive Approach to Myasthenia Gravis With Thymoma: A Case Report Highlighting Management of Myasthenic Crisis and Post‐Crisis Care | 2025-10-01 | OpenAlex | 10.1002/ccr3.71063 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414749313 | |||
| W4415077887 | A Comprehensive Review of Treatment Outcomes in Lichen Planus Pigmentosus | 2025-10-01 | OpenAlex | 10.4103/cdr.cdr_115_23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415077887 | |||
| W4415079737 | A Legacy of Safeguarding Health: Saudi Arabia’s Remarkable Commitment to a Disease-free Hajj and the Role of Vision 2030 | 2025-10-01 | OpenAlex | 10.4103/jnsm.jnsm_120_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415079737 | |||
| W4416864911 | A New Era in Kidney Disease Treatment? Rapid Adoption of SGLT2 Inhibitors and GLP-1 Receptor Agonists Signals Shifting Paradigms | 2025-10-01 | OpenAlex | 10.1681/asn.2025wtenjrxa | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416864911 | |||
| W7121612039 | A bibliometric analysis of human-agent collaboration in empathetic social agents: trends, influences, and research frontiers | 2025-10-01 | OpenAlex | 10.24191/mij.v6i2.9613 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7121612039 | |||
| W4416066705 | APOL1 Genetic Testing, Family History of Hypertension and Kidney Disease, and Renal Risk Variant Distributions in a Midwestern US Cohort | 2025-10-01 | OpenAlex | 10.1681/asn.2025js7asnhr | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416066705 | |||
| W4414766569 | Adulteration of Sports Supplements with Anabolic Steroids—From Innocent Athlete to Vicious Cheater | 2025-10-01 | OpenAlex | 10.3390/nu17193146 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414766569 | |||
| W7124698916 | Algorithmic Oracles and Humanistic Dilemmas: Philosophical Reflections on Large Language Models in Medical Artificial Intelligence | 2025-10-01 | OpenAlex | 10.12014/j.issn.1002-0772.2025.20.01 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124698916 | |||
| W7127085056 | Antibody-Drug Conjugates (ADCs) for Breast Cancer Therapeutic Landscape: Concept and Mechanisms of Action | 2025-10-01 | OpenAlex | 10.4103/hemoncstem.hemoncstem-d-24-00042 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127085056 | |||
| W7108708921 | Are We Overusing Anti-vascular Endothelial Growth Factor? – Reflections on Treatment Burden and Real-World Outcomes | 2025-10-01 | OpenAlex | 10.4103/dljo.dljo_225_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7108708921 | |||
| W4416864915 | Bridging the Gap: Accelerating Slow Uptake of Novel CKD Therapies with Structured Optimization Clinics | 2025-10-01 | OpenAlex | 10.1681/asn.2025hcn1520q | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416864915 | |||
| W4414735231 | CARDIOTOXICITY OF ONCOLOGICAL THERAPIES AND THEIR IMPACT ON RENAL AND METABOLIC FUNCTION | 2025-10-01 | OpenAlex | 10.70779/aijshs.v4i10.342 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414735231 | |||
| W4415670271 | COMPARATIVE EFFECTIVENESS OF BRUTON`S TYROSINE KINASE INHIBITORS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A SYSTEMATIC REVIEW | 2025-10-01 | OpenAlex | 10.1016/j.htct.2025.104356 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415670271 | |||
| W7117451763 | Cardio-oncology at the crossroads of discovery, training, and global impact | 2025-10-01 | OpenAlex | 10.1097/cp9.0000000000000145 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117451763 | |||
| W4414781967 | Considerations in the Diagnoses and Management of Hepatic Disease in Older Adults | 2025-10-01 | OpenAlex | 10.14309/ajg.0000000000003641.07 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414781967 | |||
| W7124236313 | Distributed Adaptive Multi-Drone Coordination At Scale | 2025-10-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7124236313 | ||||
| W4415597376 | Evolving Landscape of Parenteral Anticancer Therapy–Associated Lung Toxicity: Incidence, Monitoring, and Management | 2025-10-01 | OpenAlex | 10.1200/oa-25-00105 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415597376 | |||
| W7132679111 | Evolving Paradigms in Pediatric Hemophilia Care: Advances, Challenges, AND GLOBAL Disparities | 2025-10-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7132679111 | ||||
| W4416124619 | Faculty and Consultants Independent Presentations | 2025-10-01 | OpenAlex | 10.4103/jiag.jiag_87_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416124619 | |||
| W4414690535 | Finding Bearings in the Fog: Optic Nerve Sheath Ultrasound for Pediatric ICP | 2025-10-01 | OpenAlex | 10.1097/01.eem.0000000000000124 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414690535 | |||
| W4415606668 | Flower of Endurance: An Ethnography of Opium’s Untold Role in Iran’s Capitalist Margins | 2025-10-01 | OpenAlex | 10.1017/irn.2025.10103 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415606668 | |||
| W4415191460 | Forging forward: SG60 and Changi General Hospital at 90 | 2025-10-01 | OpenAlex | 10.4103/singaporemedj.smj-2025-122 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415191460 | |||
| W4414782178 | Gastro-Esophageal Disorders of the Geriatric Population | 2025-10-01 | OpenAlex | 10.14309/ajg.0000000000003641.05 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414782178 | |||
| W4416845509 | Hepatorenal Syndrome – Acute Kidney Injury (HRS-AKI): Advances in Definition, Diagnosis and Management: Review Article | 2025-10-01 | OpenAlex | 10.21608/ejhm.2025.467718 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416845509 | |||
| W7104309269 | Herbo-metallic Preparations: An Ethnopharmacological Bridge Between Traditional Wisdom and Modern Medical Science | 2025-10-01 | OpenAlex | 10.5281/zenodo.17543495 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7104309269 | |||
| W4414700283 | Management of Retinopathy of Prematurity in the Anti-VEGF Era: Consensus and Recommendations From the Taiwan Pediatric Retina (TPR) Group | 2025-10-01 | OpenAlex | 10.1016/j.ajo.2025.09.050 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414700283 | |||
| W7131346924 | Metabolic sabotage: The insulin–cancer conspiracy | 2025-10-01 | OpenAlex | 10.4103/jcsr.jcsr_90_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131346924 | |||
| W7117364304 | Neurosurgical management of intracerebral hemorrhage in anticoagulated patients: Outcomes and reversal strategies | 2025-10-01 | OpenAlex | 10.4103/bc.bc_175_25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117364304 | |||
| W4415731562 | Objective Evaluation of Small Bowel Visualization Quality in Wireless Capsule Endoscopy Images Using Generative Adversarial Network | 2025-10-01 | OpenAlex | 10.4103/abr.abr_381_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415731562 | |||
| W4414793988 | P018 Pharmacotherapy for OSA: a critical review of randomised placebo-controlled trials | 2025-10-01 | OpenAlex | 10.1093/sleepadvances/zpaf053.078 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414793988 | |||
| W4415519429 | P2.10.02 Developments in Treatment of Non-Small Cell Lung Cancer and Their Implications for National Practice.Registurk-Lung National Registry Study | 2025-10-01 | OpenAlex | 10.1016/j.jtho.2025.09.696 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415519429 | |||
| W4414732526 | Pharmacology in Congenital Diaphragmatic Hernia: A Focus on Cardiovascular Management | 2025-10-01 | OpenAlex | 10.1542/neo.26-10-060 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414732526 | |||
| W4414782144 | Practical Advice for the Management of Older Adults With Inflammatory Bowel Disease | 2025-10-01 | OpenAlex | 10.14309/ajg.0000000000003641.03 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414782144 | |||
| W7117472690 | Prevalence Of Fluroquinolone Resistant Escherichia coli Isolates From Urine Samples | 2025-10-01 | OpenAlex | 10.21608/ejmr.2024.306500.1651 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117472690 | |||
| W4416842028 | Preventive Gastroenterology: An Ounce of Prevention or Pounds of Cure to Curb Gastrointestinal Diseases | 2025-10-01 | OpenAlex | 10.4103/jme.jme_188_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416842028 | |||
| W7108213273 | Progression of ANCA-Associated Vasculitis with Multiorgan Involvement Despite Immunosuppressive Therapy | 2025-10-01 | OpenAlex | 10.1681/asn.202590gtq906 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108213273 | |||
| W4415670474 | RECENT ADVANCES IN THE FIELD OF HEMOPHILIA DIAGNOSIS AND TREATMENT | 2025-10-01 | OpenAlex | 10.1016/j.htct.2025.104970 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415670474 | |||
| W4414893301 | Real-world treatment patterns, procedures, and subgroup variation in lung cancer–associated malignant pleural effusion. | 2025-10-01 | OpenAlex | 10.1200/op.2025.21.10_suppl.582 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414893301 | |||
| W4415749856 | Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents | 2025-10-01 | OpenAlex | 10.1200/oa-25-00096 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4415749856 | |||
| W4415718106 | Recent advancements in systemic therapy for biliary tract cancers: a literature review | 2025-10-01 | OpenAlex | 10.21037/jgo-2025-83 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415718106 | |||
| W4415992794 | Reducing Occupational Hazards in Forensic Autopsy: A Novel Approach to Brain Removal via Craniotomy | 2025-10-01 | OpenAlex | 10.1177/09710973251389338 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415992794 | |||
| W4414893201 | Rethinking systemic anti-cancer therapy in the last 14 days of life in the era of oral oncology. | 2025-10-01 | OpenAlex | 10.1200/op.2025.21.10_suppl.466 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414893201 | |||
| W4416030621 | S1080 Transforming EoE Care in the Littles: Education on Early Adoption of Novel EoE Therapy | 2025-10-01 | OpenAlex | 10.14309/01.ajg.0001131780.39542.b1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416030621 | |||
| W7111006547 | S1597 The Changing Landscape of Biologic Therapy in IBD: How Patient Preference for Subcutaneous Formulations Are Reshaping Ambulatory Infusion Centers (AIC): Single Center Survey Results From a High-Volume Community-Based AIC | 2025-10-01 | OpenAlex | 10.14309/01.ajg.0001133848.86967.d7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7111006547 | |||
| W7111128727 | S1720 Comparative Effectiveness of JAK Inhibitors vs Traditional Therapies in Moderate-to-Severe Ulcerative Colitis | 2025-10-01 | OpenAlex | 10.14309/01.ajg.0001134340.09488.99 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7111128727 | |||
| W4417197428 | S2043 Efficacy of Advanced Therapies for Naïve and Experienced Patients for Moderately-to-Severely Active Ulcerative Colitis: A Bayesian Network Meta-Analysis | 2025-10-01 | OpenAlex | 10.14309/01.ajg.0001135632.61091.90 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417197428 | |||
| W4415540618 | S3700 Squamous Cell Carcinoma of the Sigmoid Colon: A Rare Late Presentation of Metastatic Urothelial Cancer With Squamous Differentiation of the Bladder | 2025-10-01 | OpenAlex | 10.14309/01.ajg.0001142260.53899.89 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415540618 | |||
| W4415540662 | S3721 A Rare Case of Solitary Mesenteric Plexiform Neurofibroma | 2025-10-01 | OpenAlex | 10.14309/01.ajg.0001142344.65711.17 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415540662 | |||
| W4417171120 | S4943 Acute Fibrostenotic and Fistulizing Ileal Crohn’s Disease: Timing of Biologic Therapy in the Setting of Obstruction and Infection | 2025-10-01 | OpenAlex | 10.14309/01.ajg.0001147232.59573.0c | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417171120 | |||
| W4417202610 | S5570 Perplexing Severe Cholestasis in the Post-Partum Period | 2025-10-01 | OpenAlex | 10.14309/01.ajg.0001149740.92828.35 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417202610 | |||
| W4417202343 | S5620 Vanishing Bile Duct Syndrome Following Oxaliplatin-Based Chemotherapy: A Rare Hepatotoxic Complication | 2025-10-01 | OpenAlex | 10.14309/01.ajg.0001149940.56281.24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417202343 | |||
| W7114767742 | S5880 Challenging the Dogma: Reversal of End-Stage Liver Fibrosis With Tirzepatide in MASH Cirrhosis | 2025-10-01 | OpenAlex | 10.14309/01.ajg.0001150980.09519.07 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7114767742 | |||
| W4416030800 | S964 Trends in Incidence, Survival, and Emerging Therapies in Esophageal Cancer: A SEER-Based Analysis From 2000 to 2021 | 2025-10-01 | OpenAlex | 10.14309/01.ajg.0001131316.51280.0a | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416030800 | |||
| W4415453055 | SAT-302 Acquired Resistance to Breast Cancer Therapy is a Dynamic Multi-step Evolutionary Process | 2025-10-01 | OpenAlex | 10.1210/jendso/bvaf149.2445 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415453055 | |||
| W4415453519 | SUN-210 The role of transcriptional reprogramming and genomic alterations in the transition from chemo-sensitive to chemoresistant triple-negative breast cancer | 2025-10-01 | OpenAlex | 10.1210/jendso/bvaf149.1868 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415453519 | |||
| W4416266758 | SY18-3 Innovation in antibody-drug conjugates | 2025-10-01 | OpenAlex | 10.1016/j.annonc.2025.08.064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416266758 | |||
| W4416266820 | SY20-4 Treatment strategies for MSI-H gastric cancer | 2025-10-01 | OpenAlex | 10.1016/j.annonc.2025.08.066 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416266820 | |||
| W4415420923 | Targeting Heart Disease in Cardiovascular–Kidney–Metabolic Syndrome: A Review of Novel Therapeutic Approaches with Prognostic and Quality-of-Life Impact | 2025-10-01 | OpenAlex | 10.55453/rjmm.2025.128.6.9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415420923 | |||
| W4415910895 | Targeting Prostate Cancer with Lipid Nanoparticles: A Comprehensive Review of Current Advances and Future Prospects | 2025-10-01 | OpenAlex | 10.21608/erurj.2025.384731.1280 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415910895 | |||
| W4416821219 | The Role of Anti-vascular Endothelial Growth Factor (anti-VEGF) in Retinopathy of Prematurity (ROP) | 2025-10-01 | OpenAlex | 10.4103/tjosr.tjosr_136_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416821219 | |||
| W4414703159 | The crossroads of Amantadine from antiviral to neurotherapeutic: Bibliometric mapping of six decades of therapeutic evolution | 2025-10-01 | OpenAlex | 10.7324/japs.2025.v15.i12.16 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414703159 | |||
| W7131359424 | The human element – Overcoming cognitive biases in antimicrobial prescribing | 2025-10-01 | OpenAlex | 10.4103/jcsr.jcsr_157_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131359424 | |||
| W7154597366 | Time to Thrombolysis in Left-sided Prosthetic Valve Thrombosis: Reaffirming the Critical Window | 2025-10-01 | OpenAlex | 10.4103/heartviews.heartviews_146_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154597366 | |||
| W4414713506 | Unraveling angioedema: diagnostic challenges and emerging therapies | 2025-10-01 | OpenAlex | 10.3389/fimmu.2025.1681763 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414713506 | |||
| W4414646521 | Vascular Access and Complications in Critical Illness | 2025-10-01 | OpenAlex | 10.4037/ccn2025483 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414646521 | |||
| W4415474462 | Venous Thromboembolism Prophylaxis in Nephrotic Syndrome: Survey of Real-World Physician Practice | 2025-10-01 | OpenAlex | 10.1681/asn.2025y96n40hc | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415474462 | |||
| W7124227316 | [Unusual presentation of Crohn disease associated with hemophagocytic lymphohistiocytosis syndrome: a case report]. | 2025-10-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7124227316 | ||||
| W7114914348 | “Less is More” – We Need to Think of the Patients First | 2025-10-01 | OpenAlex | 10.4103/ijkd.ijkd_70_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7114914348 | |||
| W4414753181 | Challenges in the management of multidrug-resistant Gram-negative bacterial meningitis in children: a decade of clinical insights | 2025-10-02 | OpenAlex | 10.1186/s12887-025-06098-2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414753181 | |||
| W4414747686 | Editorial: Immunometabolic alterations linked to affective disorders and other mental illnesses | 2025-10-02 | OpenAlex | 10.3389/fpsyg.2025.1699733 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414747686 | |||
| W4416249176 | Emerging therapeutic strategies in immune thrombocytopenia: an expert evaluation of the evolving treatment landscape | 2025-10-02 | OpenAlex | 10.1080/14728214.2025.2590155 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416249176 | |||
| W4414748623 | From Bench to Brain: Translating EV and Nanocarrier Research into Parkinson’s Disease Therapies | 2025-10-02 | OpenAlex | 10.3390/biology14101349 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414748623 | |||
| W4414771870 | Rapidly and reproducibly building a comprehensive catalogue of resistance-associated variants for M. tuberculosis | 2025-10-02 | OpenAlex | 10.1101/2025.10.02.679941 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414771870 | |||
| W4414757021 | The evolving chemistry of cADPR analogues: from marine discovery to calcium signaling tools | 2025-10-02 | OpenAlex | 10.1016/j.bioorg.2025.109055 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414757021 | |||
| W4415196913 | Belantamab mafodotin for the treatment of multiple myeloma | 2025-10-03 | OpenAlex | 10.1080/14712598.2025.2576502 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415196913 | |||
| W4414771250 | Case Report: Could genetic factors influence the outcomes of first-line enfortumab vedotin plus pembrolizumab therapy in patients with metastatic urothelial carcinoma? Two cases of patients harbouring a BRCA mutation | 2025-10-03 | OpenAlex | 10.3389/fonc.2025.1648230 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414771250 | |||
| W4414777758 | Discovery and artificial intelligence-guided mechanistic elucidation of a narrow-spectrum antibiotic | 2025-10-03 | OpenAlex | 10.1038/s41564-025-02142-0 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4414777758 | |||
| W7104398205 | Discretizaton Theory for Hybrid Intelligence Systems | 2025-10-03 | OpenAlex | 10.5281/zenodo.17553462 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7104398205 | |||
| W7135195843 | Eravacycline: from clinical trials to its potential place in everyday therapy | 2025-10-03 | OpenAlex | 10.1097/qco.0000000000001157 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135195843 | |||
| W7131761895 | Factors that help medical students recognize role models in Bolan medical college, Quetta : A qualitative study | 2025-10-03 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7131761895 | ||||
| W4414790319 | Novel Treatment Approaches in Recurrent/Metastatic Squamous Head and Neck Cancer | 2025-10-03 | OpenAlex | 10.1016/j.otc.2025.08.009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414790319 | |||
| W4414940158 | Obesity and hypertension new insights in management | 2025-10-03 | OpenAlex | 10.1097/hco.0000000000001261 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414940158 | |||
| W4414792989 | Spinal Cord Infarction Presenting as Cauda Equina Syndrome With Concurrent Pulmonary Embolism: A Case Report | 2025-10-03 | OpenAlex | 10.7759/cureus.93778 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414792989 | |||
| W4414781757 | Surgical Oncology | 2025-10-03 | OpenAlex | 10.1097/xcs.0000000000001569 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414781757 | |||
| W4415479867 | The Evolution of Agentic AI: From Rule-Based Systems to Autonomous Agents | 2025-10-03 | OpenAlex | 10.71097/ijsat.v16.i4.5112 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4415479867 | |||
| W4414808625 | A Trust-Aware Architecture for Personalized Digital Health: Integrating Blueprint Personas and Ontology-Based Reasoning | 2025-10-04 | OpenAlex | 10.1007/s10916-025-02255-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414808625 | |||
| W4414801289 | Anti-inflammatory agents for the management of COPD - Quo Vadis? | 2025-10-04 | OpenAlex | 10.1016/j.rmed.2025.108396 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4414801289 | |||
| W4414801782 | Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study | 2025-10-04 | OpenAlex | 10.1016/j.ejca.2025.116034 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414801782 | |||
| W4414802301 | Evolving Strategies in the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Narrative Review of Locoregional and Surgical Therapies | 2025-10-04 | OpenAlex | 10.1016/j.tvir.2025.101081 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414802301 | |||
| W4414850873 | Hormonal Therapy Patterns in Older Men with Prostate Cancer in the United States, 2010–2019 | 2025-10-04 | OpenAlex | 10.3390/cancers17193231 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414850873 | |||
| W4415588220 | A Review on Nitrosamine Impurities in Pharmaceutical Products | 2025-10-05 | OpenAlex | 10.69613/qn1fmm61 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415588220 | |||
| W4414833856 | Host Modulation in Periodontology: Redefining Therapy Beyond Scaling and Root Planing | 2025-10-05 | OpenAlex | 10.7759/cureus.93880 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414833856 | |||
| W4414934249 | Privileged scaffold repurposed: the evolving role of quinolone derivatives in antiviral therapy | 2025-10-05 | OpenAlex | 10.1016/j.bmcl.2025.130427 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414934249 | |||
| W4415816031 | Agentic Artificial Intelligence for Prior Authorization Workflows in Healthcare | 2025-10-06 | OpenAlex | 10.32996/jcsts.2025.7.10.11 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4415816031 | |||
| W4414873593 | Cardiopulmonary Collaboration in Respiratory Care: Shifting the Paradigm | 2025-10-06 | OpenAlex | 10.58931/crt.2025.1214 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414873593 | |||
| W4414861571 | Editorial: Climate mobility modeling: methodological advances and future prospects | 2025-10-06 | OpenAlex | 10.3389/fclim.2025.1704343 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414861571 | |||
| W4414857512 | Fertility-Sparing Practices in Uterine Malignancies: A Literature Review | 2025-10-06 | OpenAlex | 10.1177/10424067251384464 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414857512 | |||
| W4414860703 | Pharma’s subtle conditioning in clinical medicine | 2025-10-06 | OpenAlex | 10.1016/j.ejim.2025.106537 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414860703 | |||
| W4414838803 | Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma | 2025-10-06 | OpenAlex | 10.36401/jipo-25-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4414838803 | |||
| W4414841762 | Recent Updates in the Management of Chronic Hypertension in Pregnancy | 2025-10-06 | OpenAlex | 10.1007/s13669-025-00437-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414841762 | |||
| W4415464670 | Treatment Options for HR-Positive, HER2-Negative Advanced Breast Cancer: Focus on Capivasertib | 2025-10-06 | OpenAlex | 10.36000/hbt.oh.2025.25.188 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415464670 | |||
| W4414982871 | Updates in Pet Reptile Infectious Diseases | 2025-10-06 | OpenAlex | 10.1016/j.cvex.2025.07.007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414982871 | |||
| W4414934216 | When LLMs Recognize Your Space: Research on Experiences with Spatially Aware LLM Agents | 2025-10-06 | OpenAlex | 10.1109/tvcg.2025.3616809 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W4414934216 | |||
| W4415409151 | Carrying the torch of Nightingale”™s legacy into health reform: A nursing perspective | 2025-10-07 | OpenAlex | 10.31603/jhns.v12i2.14199 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415409151 | |||
| W4414886389 | Conventional and precision medicine: opposites or complementary ends? | 2025-10-07 | OpenAlex | 10.3389/fsci.2025.1701495 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414886389 | |||
| W7103903965 | Double Trouble: Lynch Syndrome and KRAS Mutation in a Young Male With Stage IV Colon Adenocarcinoma | 2025-10-07 | OpenAlex | 10.48448/3dwb-1777 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7103903965 | |||
| W4414918616 | Editorial: Chatbots as humanlike text generators: friend or foe? | 2025-10-07 | OpenAlex | 10.3389/fhumd.2025.1706740 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414918616 | |||
| W7103890214 | First Look: NSCLC Genetic Mutations in a Previously Uncharacterized South Carolina Cohort | 2025-10-07 | OpenAlex | 10.48448/x8fw-cf55 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7103890214 | |||
| W7103885821 | Systems Genetics Approach for Repurposing FDA-Approved Drugs against Early-stage Human Pancreatic Ductal Adenocarcinoma | 2025-10-07 | OpenAlex | 10.48448/e4n8-xz78 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7103885821 | |||
| W7103893352 | Systems Genetics Approach for Repurposing FDA-Approved Drugs against Late-stage Human Pancreatic Ductal Adenocarcinoma | 2025-10-07 | OpenAlex | 10.48448/kda4-9558 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7103893352 | |||
| W7103890386 | Unmasking Latent Autoimmune Diabetes: A case that challenges Type 2 Diabetes | 2025-10-07 | OpenAlex | 10.48448/12vv-w090 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7103890386 | |||
| W4414964369 | Barney Brooks: The Unrecognized Hero behind 100 Years of Peripheral Angiography | 2025-10-08 | OpenAlex | 10.4103/ijves.ijves_58_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414964369 | |||
| W4414941308 | Cirrhotic portal vein thrombosis as a vascular rather than a thrombotic disorder | 2025-10-08 | OpenAlex | 10.1097/hep.0000000000001565 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414941308 | |||
| W4414925296 | Editorial: Opportunities and challenges in drug repurposing | 2025-10-08 | OpenAlex | 10.3389/fphar.2025.1709217 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414925296 | |||
| W7117258820 | Enhancing Personal Healthcare through AI-Driven DNA Analysis and Public Health Data Integration | 2025-10-08 | OpenAlex | 10.1109/itis67966.2025.11308844 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7117258820 | |||
| W7167257387 | Imposter Syndrome or a Wrong Diagnosis? - Exploring the Experiences of Graduate Teaching Assistants | 2025-10-08 | OpenAlex | 10.82191/pp.114 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167257387 | |||
| W4415171558 | SPECTROCOLORIMETRIC ASSESSMENT OF THE DEGREE OF GINGIVAL INFLAMMATION IN PATIENTS WITH PERIIMPLANTITIS DURING THERAPEUTIC AND PREVENTIVE MEASURES | 2025-10-08 | OpenAlex | 10.24061/2413-4260.xv.3.57.2025.20 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415171558 | |||
| W4414997971 | Beyond Ursodeoxycholic Acid: A Comprehensive Review of Second-Line Agents in Primary Biliary Cholangitis | 2025-10-09 | OpenAlex | 10.7759/cureus.94172 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414997971 | |||
| W4415044513 | Clinical Advances in Extracellular Volume Measurement by Cardiac Computed Tomography and Magnetic Resonance Imaging: Current Status and Future Perspectives | 2025-10-09 | OpenAlex | 10.20944/preprints202510.0729.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415044513 | |||
| W4414983299 | Harnessing the potential of graphene quantum dots in emerging biomedical applications: interaction mechanisms, multifunctional roles, and future perspectives | 2025-10-09 | OpenAlex | 10.1088/2752-5724/ae03db | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414983299 | |||
| W4414979213 | Revisiting Neoadjuvant Chemotherapy in Cisplatin-eligible Muscle-invasive Bladder Cancer | 2025-10-09 | OpenAlex | 10.1016/j.euo.2025.09.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414979213 | |||
| W4414981584 | Risk of Herpes Zoster and Opportunistic Infections with Treatments for Autoimmune Rheumatic Disease | 2025-10-09 | OpenAlex | 10.1007/s40674-025-00235-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4414981584 | |||
| W4415002106 | The Role of Osteoporosis in Spine Surgery and Current Management Strategies: A Review | 2025-10-09 | OpenAlex | 10.1007/s11914-025-00930-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415002106 | |||
| W4415161108 | Brighter days ahead: the shifting landscape of IBD therapy | 2025-10-10 | OpenAlex | 10.1097/mog.0000000000001139 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415161108 | |||
| W7216987359 | COMPREHENSIVE INSIGHTS INTO ORAL CANCERS & TUMORS: DIAGNOSTIC ADVANCEMENTS, MICROBIAL ASSOCIATIONS, & THERAPEUTIC STRATEGIES | 2025-10-10 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216987359 | ||||
| W4415050775 | Euthanasia Techniques in Companion Animals | 2025-10-10 | OpenAlex | 10.1002/9781394266098.ch12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415050775 | |||
| W4415033085 | Further Considerations on the Clinical Evaluation of Sotagliflozin in Type 1 Diabetes with CKD | 2025-10-10 | OpenAlex | 10.1681/asn.0000000867 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415033085 | |||
| W7225014999 | Global Healthcare & Medical AI 2026 and Beyond Advanced AI Tools & Innovations Shaping the Future of Clinical Decision Making & patient Outcomes. | 2025-10-10 | OpenAlex | 10.5281/zenodo.23830310 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7225014999 | |||
| W4415017963 | Herbal approaches for the treatment of glioblastoma | 2025-10-10 | OpenAlex | 10.1016/b978-0-443-33319-4.00008-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415017963 | |||
| W4415018143 | New galenic formulations of melatonin and therapeutic applications | 2025-10-10 | OpenAlex | 10.1016/b978-0-443-30240-4.00013-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415018143 | |||
| W4415148148 | Od broni chemicznej do chemioterapii. Badania polskich lekarzy nad iperytem azotowym w latach 1947–1952 | 2025-10-10 | OpenAlex | 10.4467/0023589xkhnt.25.001.22271 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415148148 | |||
| W4415014850 | Pharmacologic treatment of fibromyalgia: an update | 2025-10-10 | OpenAlex | 10.3389/fphar.2025.1651181 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415014850 | |||
| W4415077645 | Laboratory Diagnosis of Lupus Anticoagulants: A Systematic Review of Assay Performance, Pre-analytical Challenges, and Clinical Utility | 2025-10-11 | OpenAlex | 10.70070/q03b8c43 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415077645 | |||
| W4415083297 | Probability Distribution for Rare Neutral Mutations in Cancers and Application to Dynamic Precision Medicine of Cancer | 2025-10-11 | OpenAlex | 10.1101/2025.10.10.681641 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415083297 | |||
| W4415063955 | Therapeutic Advances in Hereditary Angioedema: A Focus on Present and Future Options | 2025-10-11 | OpenAlex | 10.1007/s12325-025-03382-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415063955 | |||
| W7225020018 | Global Obesity Epidemic 2026 and Beyond Emerging Trends, Innovative Therapeutics and Lifestyle Strategies for Sustainable Weight Management, Lifelong Health, Disease Prevention and a Healthier Future. | 2025-10-12 | OpenAlex | 10.5281/zenodo.23830058 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225020018 | |||
| W4415100523 | Cardiac Toxicities of Cancer Therapies: From Traditional Agents to Emerging Targets in Cardio-Oncology | 2025-10-13 | OpenAlex | 10.1007/s12170-025-00777-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415100523 | |||
| W4415098155 | Deploying next-generation artificial intelligence ecosystems for real-time biosurveillance, precision health analytics and dynamic intervention planning in life science research | 2025-10-13 | OpenAlex | 10.30574/msabp.2025.16.1.0066 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415098155 | |||
| W4415098186 | Editorial: Biomacromolecule systems for enhanced therapeutic delivery in medical implants | 2025-10-13 | OpenAlex | 10.3389/fbioe.2025.1700914 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415098186 | |||
| W4415120686 | Efficacy and Safety of Low-Dose ATG Plus Basiliximab Induction in Deceased Donor Kidney Transplantation | 2025-10-13 | OpenAlex | 10.3389/ti.2025.15321 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415120686 | |||
| W4416300119 | Health, risks and disease in therapeutic functionalities of Glucagon-like peptide-1 receptoragonists (GLP-1RAs) concerning human susceptibility | 2025-10-13 | OpenAlex | 10.62046/gijams.2025.v03i05.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416300119 | |||
| W4415106372 | Incretin Mimetics and Cardiovascular Events—The Evolving Comparative Effectiveness Landscape | 2025-10-13 | OpenAlex | 10.1001/jamanetworkopen.2025.37304 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415106372 | |||
| W4415206459 | Integrating Emotional Stress and Lipid Lowering in Cardiovascular Disease Management: The Future of Precision Cardiovascular Prevention | 2025-10-13 | OpenAlex | 10.3390/jcm14207208 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415206459 | |||
| W7127225167 | Psychostimulant Medications for the Treatment of Cocaine Use Disorder: A Clinical Review | 2025-10-13 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127225167 | ||||
| W4415232534 | BIWT: a bioinformatics walkthrough for embedding spatial multiomics in agent-based models for virtual cells | 2025-10-14 | OpenAlex | 10.1093/bioinformatics/btaf571 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415232534 | |||
| W7125097304 | BanditMatch: A Game-Theoretic Approach for Stable Preference Matching in Peer-to-Peer Federated Learning | 2025-10-14 | OpenAlex | 10.1109/flta67013.2025.11336289 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7125097304 | |||
| W4415161109 | Bridging the osteoporosis care divide | 2025-10-14 | OpenAlex | 10.1097/01.jaa.0000000000000275 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415161109 | |||
| W4415137424 | Editorial: Reviews in: ophthalmology 2024 | 2025-10-14 | OpenAlex | 10.3389/fmed.2025.1706229 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415137424 | |||
| W7130555079 | Large Language Models for Task Automation: A Comprehensive Review of Techniques and Implementation Challenges | 2025-10-14 | OpenAlex | 10.1109/ictc66702.2025.11387844 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130555079 | |||
| W4415218203 | Molecular epidemiological characterization of enterotoxigenic and enteroaggregative Escherichia coli causing traveller’s diarrhoea and their association with persistence of symptoms | 2025-10-14 | OpenAlex | 10.1093/jtm/taaf110 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415218203 | |||
| W4415164299 | Mosaic pattern: lung functional heterogeneity at the alveolus level | 2025-10-14 | OpenAlex | 10.1101/2025.10.13.682072 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415164299 | |||
| W7130896951 | Relatório de estágio e monografia intitulado "Tratamento do cancro melhorado com a entrega sinérgica de três fármacos em plataformas nanométricas multifuncionais" | 2025-10-14 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130896951 | ||||
| W4415137318 | Therapeutic Trends in Diabetes Management: A Review on Oral Hypoglycemic Agents (OHAs) Utilization in Tertiary Care | 2025-10-14 | OpenAlex | 10.2174/011871529x414055250924050309 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415137318 | |||
| W4415936426 | A Human Rights-Based Approach to Justice in Social Work Practice . Shirley Gatenio Gabel | 2025-10-15 | OpenAlex | 10.1093/sw/swaf040 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415936426 | |||
| W4415230762 | AI Managing Agent-Based Healthcare Processes | 2025-10-15 | OpenAlex | 10.1609/aies.v8i2.36617 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4415230762 | |||
| W4415215063 | Editorial: Precision immunotherapy and novel target discovery in hematological malignancy | 2025-10-15 | OpenAlex | 10.3389/fimmu.2025.1703886 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415215063 | |||
| W4415183192 | Evolving paradigms in primary biliary cholangitis: from molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond | 2025-10-15 | OpenAlex | 10.1186/s43066-025-00464-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415183192 | |||
| W4415243573 | Precision navigation through the labyrinth: overcoming EGFR resistance in non-Small cell lung cancer | 2025-10-15 | OpenAlex | 10.1080/07853890.2025.2574526 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415243573 | |||
| W4415225781 | Professional autonomy in pharmacists: Independence within interdependence | 2025-10-15 | OpenAlex | 10.1016/j.sapharm.2025.10.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415225781 | |||
| W4415204541 | Sex- and Gender-Based Differences in Asthmatic Responses to Chemical Sensitizers, Particularly in Occupational Settings: A Scoping Review | 2025-10-15 | OpenAlex | 10.3390/environments12100382 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415204541 | |||
| W4415224823 | The Evolving Role of Adjuvant TKI in Lung Cancer | 2025-10-15 | OpenAlex | 10.1016/j.thorsurg.2025.08.005 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415224823 | |||
| W4415211844 | Valorization of Date Seed Waste for Sustainable Dermocosmetic Sunscreens: Phytochemical Insights and Formulation Advances | 2025-10-15 | OpenAlex | 10.3390/cosmetics12050225 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415211844 | |||
| W7125597864 | Advances in histamine-mediated allergy management: Expanding perspectives on cetirizine’s therapeutic, safety, and toxicological implications | 2025-10-16 | OpenAlex | 10.46439/toxicology.7.042 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125597864 | |||
| W4416367505 | Federated Intelligence in Immersive Technologies: Systematic Review of Privacy, Agents and Metaverse | 2025-10-16 | OpenAlex | 10.1109/icoa66896.2025.11236955 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4416367505 | |||
| W4415268214 | Global Research Trends and Hotspots of Contrast- Enhanced Ultrasound in Tumor Diagnosis: A Bibliometric Analysis (2000–2025) | 2025-10-16 | OpenAlex | 10.26689/par.v9i5.12269 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415268214 | |||
| W4415263724 | Sociodemographic Factors, Intent-Uptake Disparities, and Nirsevimab Availability in Infant RSV Immunoprophylaxis | 2025-10-16 | OpenAlex | 10.3390/pediatric17050109 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415263724 | |||
| W4415236600 | The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management | 2025-10-16 | OpenAlex | 10.37349/emed.2025.1001365 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415236600 | |||
| W4415259062 | Widespread folate receptor expression in pediatric and adolescent solid tumors - opportunity for intraoperative visualization with the novel fluorescent agent pafolacianine | 2025-10-16 | OpenAlex | 10.18632/oncotarget.28772 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415259062 | |||
| W4415278291 | Chemotherapy: A powerful weapon in ovarian cancer treatment | 2025-10-17 | OpenAlex | 10.1016/b978-0-443-33536-5.00005-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415278291 | |||
| W4415278607 | Clinical translation and regulations of theranostics | 2025-10-17 | OpenAlex | 10.1016/b978-0-443-22253-5.00028-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415278607 | |||
| W4415298895 | Future perspectives | 2025-10-17 | OpenAlex | 10.1016/b978-0-443-29930-8.00006-0 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4415298895 | |||
| W4415298781 | IVF and pregnancy outcomes: the triumphs, challenges, and unanswered questions | 2025-10-17 | OpenAlex | 10.1186/s13048-025-01692-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415298781 | |||
| W4416065948 | Innovative Nasal Drug Delivery Systems for Effective Brain Targeting and Blood-Brain Barrier Overcoming | 2025-10-17 | OpenAlex | 10.63785/cpr.2025.1.3.296307 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416065948 | |||
| W4415272546 | Managing invasive fungal infections in critical illness: reflections on recent American Thoracic Society recommendations | 2025-10-17 | OpenAlex | 10.1016/j.ejim.2025.106549 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415272546 | |||
| W7124925794 | Non-Invasive Blood Pressure Prediction from PPG: A Reinforcement Learning-Gated Mixture of Experts Approach | 2025-10-17 | OpenAlex | 10.1109/icmlca66850.2025.11336416 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7124925794 | |||
| W4415276702 | PAL: Designing Conversational Agents as Scalable, Cooperative Patient Simulators for Palliative‑Care Training | 2025-10-17 | OpenAlex | 2507.02122 | 10.1145/3715070.3749250 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W4415276702 | ||
| W4415460726 | Reclassification of Cytokine-Based Immune- Mediated Inflammatory Diseases: Mechanisms and Therapeutic Advances of IL-1-Driven Inflammatory Diseases | 2025-10-17 | OpenAlex | 10.26689/jcnr.v9i9.12338 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415460726 | |||
| W7111831146 | Reimagining Learning, Integrity, and Creativity in the Age of AI: A Discussion with Summit Contributors | 2025-10-17 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7111831146 | ||||
| W4415303212 | TGF-β–driven T-cell exclusion in ovarian cancer: single-cell and spatial transcriptomic views of immune low-response states | 2025-10-17 | OpenAlex | 10.3389/fimmu.2025.1698088 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415303212 | |||
| W7217772061 | THE TRAINING OF PHARMACY PROFESSIONALS AND THEIR EDUCATIONAL CONTRIBUTIONS IN BREAST CANCER CARE | 2025-10-17 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7217772061 | ||||
| W4415305571 | Therapies and Pipeline for Hepatitis B and Hepatitis D | 2025-10-17 | OpenAlex | 10.1016/j.cld.2025.06.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415305571 | |||
| W7155700470 | Biosecurity and Bioterrorism: The Legal Framework and Response to Biological Threats | 2025-10-18 | OpenAlex | 10.54117/rp1dty58 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155700470 | |||
| W4415331314 | The Disruptive Impact of Agentic AI on Medical Schools | 2025-10-18 | OpenAlex | 10.30953/thmt.v10.639 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4415331314 | |||
| W7131071882 | DCEtriformer: A Hybrid Attention Transformer for DCE-MRI Synthesis in Prostate Imaging | 2025-10-19 | OpenAlex | 10.1109/iccvw69036.2025.00116 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7131071882 | |||
| W4415337660 | Generative Responsiveness in Assistive Care Ecosystem - GRACE | 2025-10-19 | OpenAlex | 10.1007/978-3-032-05673-3_25 | Full text | Excluded | F1: GRACE is explicitly a framework under development. The primary abstract describes conceptual foundations, initial functional design and collaboration scenarios with future assessment, without a built/evaluated persistent-improving LLM system. | https://openalex.org/W4415337660 | https://link.springer.com/chapter/10.1007/978-3-032-05673-3_25 | Publisher abstract and author-institution abstract only; full chapter not read. | |
| W7131079343 | Magnol.AI Copilot: Multimodal LLMs for Natural, Accessible Data Interaction | 2025-10-19 | OpenAlex | 10.1109/iccvw69036.2025.00237 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7131079343 | |||
| W7124143323 | Redefining Faculty in the Age of Artificial Intelligence: Implications for Medical Education | 2025-10-19 | OpenAlex | 10.24321/2278.2044.202531 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124143323 | |||
| W7115943065 | Bortezomib in multiple myeloma management | 2025-10-20 | OpenAlex | 10.18051/univmed.2025.v44.380-393 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7115943065 | |||
| W4415364114 | Editorial: Response/resistance to PD-1 axis inhibitors: focus on the tumor microenvironment | 2025-10-20 | OpenAlex | 10.3389/fimmu.2025.1720955 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415364114 | |||
| W7112145452 | Evaluation of Stress Echocardiography Delivery in the UK | 2025-10-20 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7112145452; https://openalex.org/W7163204503 | ||||
| W4415367099 | Future Factories With 6G: Agentic AI and Cyber–Physical Digital Twins | 2025-10-20 | OpenAlex | 10.1109/jiot.2025.3623075 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4415367099 | |||
| W4417169909 | Integrating Reinforcement Learning and Game Theory for Strategic Decision-Making in Cancer Therapy | 2025-10-20 | OpenAlex | 10.1109/sita67914.2025.11273719 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417169909 | |||
| W4415354750 | Polygalae Radix extracts show anti-Parkinson's disease effects and reduce depression-like symptoms by modulating energy metabolism | 2025-10-20 | OpenAlex | 10.1016/j.jep.2025.120759 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415354750 | |||
| W4415355892 | Strengthening Nursing Research Capacity to End the HIV Epidemic: Qualitative Insights of the Mid-Atlantic Center for AIDS Research Nursing Initiative Symposium | 2025-10-20 | OpenAlex | 10.1097/jnc.0000000000000593 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415355892 | |||
| W4415361374 | Sustained-Release Intra-Articular Drug Delivery: PLGA Systems in Clinical Context and Evolving Strategies | 2025-10-20 | OpenAlex | 10.3390/pharmaceutics17101350 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415361374 | |||
| W7113147000 | Towards Logical Reasoning and Learning in Open and Dynamic Environments | 2025-10-20 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7113147000 | ||||
| W4415404354 | AI and the Public Health Enterprise: From Interest to Action | 2025-10-21 | OpenAlex | 10.1097/phh.0000000000002226 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415404354 | |||
| W4416233437 | Detecting Dependability Failures in Healthcare Scenarios via Digital Shadows | 2025-10-21 | OpenAlex | 10.1109/issre66568.2025.00056 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416233437 | |||
| W4415380215 | Dr. Lloyd Novick’s Editorial Stewardship in Public Health Informatics: The Journey of a Trailblazer | 2025-10-21 | OpenAlex | 10.1097/phh.0000000000002272 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415380215 | |||
| W4415389954 | Improving understanding and management of acute heart failure, myocarditis, pericarditis, amyloidosis, mitochondrial cardiomyopathies, hypertrophic cardiomyopathy, and takotsubo syndrome | 2025-10-21 | OpenAlex | 10.1093/eurheartj/ehaf782 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415389954 | |||
| W4415374842 | Invasive candidiasis in intensive care medicine: shaping the future of diagnosis and therapy | 2025-10-21 | OpenAlex | 10.1007/s00134-025-08151-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415374842 | |||
| W4415397311 | Managing Your Career | 2025-10-21 | OpenAlex | 10.1097/nur.0000000000000933 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415397311 | |||
| W4415405888 | Melasma Management: A Review of Current Treatment Options | 2025-10-21 | OpenAlex | 10.3126/njdvl.v23i2.83895 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415405888 | |||
| W7131076729 | Pathogenic response mechanisms to host and therapeutic stress: Challenges in advanced medical microbiology | 2025-10-21 | OpenAlex | 10.56936/18290825-2025.19v.4-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131076729 | |||
| W4415507670 | WEE-family kinases in cancer: synthetic lethal interactions and drug discovery | 2025-10-21 | OpenAlex | 10.1016/j.tips.2025.09.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415507670 | |||
| W4415444396 | Abstract B055: XPO1-dependent nuclear export as a therapeutic target for ALK-positive non-small cell lung cancers | 2025-10-22 | OpenAlex | 10.1158/1535-7163.targ-25-b055 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415444396 | |||
| W4415444233 | Abstract C070: Evolving Paradigms and shifting priorities in the landscape of Phase 1 Oncology Trials: 2021–2024 | 2025-10-22 | OpenAlex | 10.1158/1535-7163.targ-25-c070 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415444233 | |||
| W4415437568 | Abstracts of the International Society of Liver Surgeons, 6th Congress of International Advanced HBP Surgery 2025 (ISLS 2025) | 2025-10-22 | OpenAlex | 10.1097/js9.0000000000003583 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415437568 | |||
| W4415444146 | Agent-Based Prediction of Digital Ecosystem Emergence in Medical Tourism under Evolving Greater Bay Area Data Regulation | 2025-10-22 | OpenAlex | 10.54254/2755-2721/2025.28118 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4415444146 | |||
| W4415653558 | Diagnostic and therapeutic advances in MDS | 2025-10-22 | OpenAlex | 10.5603/ahp.108270 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415653558 | |||
| W4415419055 | Editorial: Current chemical approaches in combating neuroinflammation in Alzheimer's disease (AD) | 2025-10-22 | OpenAlex | 10.3389/fnagi.2025.1712601 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415419055 | |||
| W4415413860 | Green-synthesized Plectranthus amboinicus silver nanoparticles with broad-spectrum biological activities | 2025-10-22 | OpenAlex | 10.1007/s44340-025-00041-y | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415413860 | |||
| W4415438976 | Optimization of upfront therapy for adult acute lymphoblastic leukemia: a paradigm shift toward immunotherapy | 2025-10-22 | OpenAlex | 10.1007/s12032-025-03093-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415438976 | |||
| W7125580971 | Personalized Multi-Agent Recommendation System for Monitoring and Coaching through Wearable and Non-Invasive Sensors | 2025-10-22 | OpenAlex | 10.1109/metroxraine66377.2025.11340155 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7125580971 | |||
| W4415419032 | Reframing chronic wound therapy: from growth factor delivery to regenerative immuno-engineering | 2025-10-22 | OpenAlex | 10.3389/fimmu.2025.1683591 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415419032 | |||
| W4415428554 | Response to “Occult constipation in pediatric IBS and FAP‐NOS: Considerations on the recent ESPGHAN/NASPGHAN guidelines” | 2025-10-22 | OpenAlex | 10.1002/jpn3.70231 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415428554 | |||
| W4415435485 | The 2025 KDIGO IgA nephropathy guideline update: an ERA Immunonephrology Working Group perspective | 2025-10-22 | OpenAlex | 10.1093/ckj/sfaf324 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415435485 | |||
| W4415427527 | The fungus among us: Emerging and re-emerging fungal infections | 2025-10-22 | OpenAlex | 10.1016/j.amjms.2025.10.011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415427527 | |||
| W7112976910 | Advancing Nursing Leadership Through NURS FPX 9000 | 2025-10-23 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7112976910 | ||||
| W4415454761 | Contemporary management of advanced chronic kidney disease: An evidence-based review | 2025-10-23 | OpenAlex | 10.1016/j.ejim.2025.106557 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415454761 | |||
| W4417129848 | EVOLVING TREATMENT STRATEGIES FOR RECURRENT APHTHOUS ULCERS: A COMPREHENSIVE REVIEW | 2025-10-23 | OpenAlex | 10.58240/1829006x-2025.21.9-523 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417129848 | |||
| W4415457672 | Editorial: Methods in pediatric infectious diseases 2024 | 2025-10-23 | OpenAlex | 10.3389/fped.2025.1712605 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415457672 | |||
| W4415462622 | Emerging Applications of Stereotactic Ablative Radiotherapy in Oligometastatic Colorectal Cancer | 2025-10-23 | OpenAlex | 10.3390/ijms262110302 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415462622 | |||
| W4415460402 | Interleukin‐13 inhibition and cancer risk: reply to Tang and Chen | 2025-10-23 | OpenAlex | 10.1111/ddg.15999 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415460402 | |||
| W4415458302 | Recombinant Oncolytic Viruses: Hexagonal Warriors in the Field of Solid Tumor Immunotherapy | 2025-10-23 | OpenAlex | 10.3390/cimb47110878 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415458302 | |||
| W4415466839 | SEOM–GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025) | 2025-10-23 | OpenAlex | 10.1007/s12094-025-04080-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415466839 | |||
| W4415489967 | Small-Molecule GLP-1 Receptor Agonists: A Promising Pharmacological Approach | 2025-10-23 | OpenAlex | 10.3390/medicina61111902 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415489967 | |||
| W4415622398 | The Building of a Nation: Leadership Lessons from Tata | 2025-10-23 | OpenAlex | 10.1097/prs.0000000000012294 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415622398 | |||
| W4415516990 | Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development | 2025-10-24 | OpenAlex | 10.1016/s1473-3099(25)00547-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415516990 | |||
| W4415494734 | Green-synthesized silver nanoparticle hydrogels for biofilm-infected wounds: Bridging sustainability and clinical translation | 2025-10-24 | OpenAlex | 10.3389/fphar.2025.1694144 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415494734 | |||
| W4415684177 | Inflammation, Apoptosis, and Fibrosis in Diabetic Nephropathy: Molecular Crosstalk in Proximal Tubular Epithelial Cells and Therapeutic Implications | 2025-10-24 | OpenAlex | 10.3390/cimb47110885 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415684177 | |||
| W4415586956 | Legends, dogmas, presumptions, and demystifications in antibiotic therapy | 2025-10-24 | OpenAlex | 10.37201/req/s01.11.2025 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415586956 | |||
| W7197684747 | N-substituted chitosan derivatives as a gene delivery system : synthesis, structural investigations, and ocular applications | 2025-10-24 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7197684747 | ||||
| W4415559897 | Navigating Treatment Sequencing in Advanced HR+/HER2− Breast Cancer After CDK4/6 Inhibitors: Biomarker-Driven Strategies and Emerging Therapies | 2025-10-24 | OpenAlex | 10.3390/ijms262110366 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415559897 | |||
| W4415551782 | Novel Therapeutic Approaches to Neuroinflammation in Neurodegenerative Disorders: Aptamers as Central Nervous System Agents | 2025-10-24 | OpenAlex | 10.2174/0118715249392444251002135338 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415551782 | |||
| W4415503341 | Occupational Asthma Due to Subtilisin: The Power of Specific Inhalation Challenge | 2025-10-24 | OpenAlex | 10.23749/mdl.v116i5.17219 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415503341 | |||
| W7219312006 | Pathophysiology of Diabetes Mellitus and Recent Advances in Its Treatment: An Integrative Review | 2025-10-24 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7219312006 | ||||
| W4415543384 | Smart Drug Delivery Systems: Current Technologies, Clinical Applications, and Future Perspectives in Precision Therapeutics | 2025-10-24 | OpenAlex | 10.38124/ijsrmt.v4i10.912 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415543384 | |||
| W4415516794 | Unlocking the metabolic and anti-inflammatory therapeutic potential of lactate in critically ill patients | 2025-10-24 | OpenAlex | 10.1186/s13054-025-05665-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415516794 | |||
| W4415493826 | What is New in Contact Allergy To Cosmetics for Physicians, Cosmetologists, and Cosmetic Users? | 2025-10-24 | OpenAlex | 10.1007/s11882-025-01226-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415493826 | |||
| W7113455086 | AI-Mediated Cyberincivility in Health Professions Education: An Evolutionary Concept Analysis | 2025-10-25 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7113455086 | ||||
| W4415540304 | Can Gene Therapy Transform the Treatment Landscape of Posterior Segment Eye Diseases? A Comprehensive Review of Recent Advancements | 2025-10-25 | OpenAlex | 10.1007/s40265-025-02237-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415540304 | |||
| W7133139581 | Global Burden and Evolving Therapeutic Strategies in Diabetes Mellitus: A Comprehensive Review | 2025-10-25 | OpenAlex | 10.5281/zenodo.17605340 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133139581 | |||
| W4415539213 | Historical advancements in targeted nanoscale drug delivery systems | 2025-10-25 | OpenAlex | 10.1016/b978-0-443-24802-3.00020-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415539213 | |||
| W4415545116 | Smart microneedle platforms for skin cancer therapy: a review of stimuli-responsive and targeted drug delivery systems | 2025-10-25 | OpenAlex | 10.1080/10837450.2025.2580499 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415545116 | |||
| W4415551275 | Exploring LLM-based Agentic Frameworks for Fault Diagnosis | 2025-10-26 | OpenAlex | 10.36001/phmconf.2025.v17i1.4350 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4415551275 | |||
| W4415555908 | Improving Medical Chatbot Performance: A Comparative Evaluation of Retrieval-Augmented Generation and Fine-Tuning | 2025-10-26 | OpenAlex | 10.1007/978-3-032-01970-7_33 | Full text | Excluded | F4: The described comparison uses fixed-domain dataset fine-tuning and document RAG; experience-derived retriever/agent adaptation is future work. | https://openalex.org/W4415555908 | https://link.springer.com/chapter/10.1007/978-3-032-01970-7_33 | publisher complete abstract only, no public methods located | |
| W7216067653 | Research on the Pathways and Mechanisms of AI Agents Empowering Teacher TPACK Development | 2025-10-26 | OpenAlex | 10.3968/13923 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7216067653 | |||
| W7224984180 | Bad B*tch Morphosyntax | 2025-10-27 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7224984180 | ||||
| W4415566795 | Clinicopathological insights and management of liver metastases: Current advances and future perspectives | 2025-10-27 | OpenAlex | 10.4254/wjh.v17.i10.110026 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415566795 | |||
| W4415565715 | Comprehensive management: Paradigm shift of care for psoriasis | 2025-10-27 | OpenAlex | 10.1097/cm9.0000000000003799 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415565715 | |||
| W4415567238 | Drug repurposing of natural depsipeptide from Eleftheria terrae isolated via iChip for anti-breast cancer therapy | 2025-10-27 | OpenAlex | 10.3389/fphar.2025.1694322 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415567238 | |||
| W4415569380 | Evolving landscape of small-molecule immunotherapeutics for uveitis: a scoping review | 2025-10-27 | OpenAlex | 10.1016/j.drudis.2025.104515 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415569380 | |||
| W4416136065 | Human-on-the-loop continual learning: data, knowledge and agents for model adaptation | 2025-10-27 | OpenAlex | 10.5821/dissertation-2117-445821 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4416136065 | |||
| W4415588960 | New Insights into the Radiation Biology of Radiotheranostics | 2025-10-27 | OpenAlex | 10.1201/9781032668413-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415588960 | |||
| W4416538274 | Prospects for improving the Bacillus anthracis monitoring system and developing new strategies for soil and environmental remediation | 2025-10-27 | OpenAlex | 10.36016/vm-2025-111-3 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416538274 | |||
| W4415591081 | Thrombosis and cancer what do the recommandations say | 2025-10-27 | OpenAlex | 10.1007/s00280-025-04826-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415591081 | |||
| W4415648792 | Unlike Tobacco Users, Documented Cannabis Users Are Not at an Increased Risk of Adverse Events After Total Hip Arthroplasty | 2025-10-27 | OpenAlex | 10.5435/jaaos-d-24-00811 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415648792 | |||
| W4415648397 | Update on the Management of Helicobacter pylori Infection in Children and Adolescents | 2025-10-27 | OpenAlex | 10.1007/s11894-025-01021-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415648397 | |||
| W4415588673 | Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia | 2025-10-27 | OpenAlex | 10.1080/14656566.2025.2582022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415588673 | |||
| W4415609335 | An update on antimicrobial selection and duration for intra-abdominal infections | 2025-10-28 | OpenAlex | 10.1080/14787210.2025.2580451 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415609335 | |||
| W4415606450 | Atherosclerotic renal artery stenosis in the post-CORAL Trial Era. A narrative review | 2025-10-28 | OpenAlex | 10.1016/j.cpcardiol.2025.103205 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415606450 | |||
| W4415608587 | Gaze that shamed science: Canine defiance and the ethics of experimental physiology | 2025-10-28 | OpenAlex | 10.1136/medhum-2025-013346 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415608587 | |||
| W4415622018 | Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models | 2025-10-28 | OpenAlex | 10.1177/07067437251389090 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415622018 | |||
| W4415645862 | Lessons From COVID ‐19 on Inborn Errors of Immunity: A Five‐Year Narrative Review | 2025-10-28 | OpenAlex | 10.1111/sji.70064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415645862 | |||
| W4415625799 | Mechanisms of Resistance to Novel Immunotherapies in B-Cell Lymphomas: Focus on CAR T and Bispecific Antibodies | 2025-10-28 | OpenAlex | 10.3390/cancers17213453 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415625799 | |||
| W4415615286 | Smart Healthcare Photonic Nanomaterials and Devices | 2025-10-28 | OpenAlex | 10.1002/adma.202518886 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415615286 | |||
| W4415682309 | Agents of innovation? Institutional conditions shaping nurse students’ positions in practice development | 2025-10-29 | OpenAlex | 10.63564/jnep.v15n10p47 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415682309 | |||
| W4415657577 | Changing paradigms in diabetes: Scientific breakthroughs of the past 15 years | 2025-10-29 | OpenAlex | 10.3329/jacedb.v4i20.84908 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415657577 | |||
| W4415677480 | Complement-targeting therapies in hemolytic diseases | 2025-10-29 | OpenAlex | 10.1016/j.coi.2025.102686 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415677480 | |||
| W4415649428 | Editorial: Cellular immunotherapy: transforming cancer treatment | 2025-10-29 | OpenAlex | 10.3389/fimmu.2025.1724025 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415649428 | |||
| W4415650567 | Evaluating the role of ChatGPT in rehabilitation medicine: a narrative review | 2025-10-29 | OpenAlex | 10.3389/fdgth.2025.1618510 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415650567 | |||
| W4415664866 | High-resolution melting analysis in veterinary medicine: a systematic review of applications and diagnostic accuracy | 2025-10-29 | OpenAlex | 10.1007/s11250-025-04709-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415664866 | |||
| W4415673435 | Human knowledge-enhanced large language model agent for prediction of intestinal disease progression in patients with Crohn's disease: A multicenter retrospective study | 2025-10-29 | OpenAlex | 10.1016/j.metrad.2025.100186 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W4415673435 | |||
| W4415657479 | Modern care for congenital adrenal hyperplasia: New horizons in management | 2025-10-29 | OpenAlex | 10.3329/jacedb.v4i20.84896 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415657479 | |||
| W4416986313 | Potassium-competitive acid blockers versus proton pump inhibitors: redefining the standards of care in reflux esophagitis | 2025-10-29 | OpenAlex | 10.1097/meg.0000000000003052 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416986313 | |||
| W7219496300 | The Effectiveness of Xavron in the Treatment of Ischemic Stroke in the Acute Period | 2025-10-29 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7219496300 | ||||
| W4415732127 | Transthyretin Amyloid Cardiomyopathy: The Plot Thickens as Novel Therapies Emerge | 2025-10-29 | OpenAlex | 10.15420/usc.2025.11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415732127 | |||
| W4415700263 | Activatable smart contrast agents for photoacoustic imaging | 2025-10-30 | OpenAlex | 10.1002/smo2.70024 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4415700263 | |||
| W4415722869 | Chronic Rhinosinusitis: Review of Endotypes and Clinical Implications | 2025-10-30 | OpenAlex | 10.1177/01455613251361248 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415722869 | |||
| W4415711196 | Clinical management of liver cancer patients with immune checkpoint inhibitors treatment | 2025-10-30 | OpenAlex | 10.1080/20450923.2025.2578079 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415711196 | |||
| W4415684430 | Editorial: Infections in the intensive care unit, volume III | 2025-10-30 | OpenAlex | 10.3389/fmed.2025.1719505 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415684430 | |||
| W4415693724 | FROM GLYCEMIC CONTROL TO SYSTEMIC EFFECT: A CURRENT VIEW OF THE ROLE OF INHIBITORS SGLT2 IN THE THERAPY OF POLYMORBID PATIENTS (part 1) | 2025-10-30 | OpenAlex | 10.52058/2786-4952-2025-10(56)-2310-2323 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415693724 | |||
| W7219109192 | Fatal Multisystem Toxicity and Vesiculobullous Eruptions Following Brake Fluid Poisoning: A Case Report | 2025-10-30 | OpenAlex | 10.22037/ijmtfm.v15i4.49459 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7219109192 | |||
| W7143533652 | Higher-Gauge, Dynamical Symmetry Geometry of Savant-Phase Cognition: A Biochemistry-to-Geometry Theory with Dimensionless and Dimensionful Predictions and an Empirical Test Protocol | 2025-10-30 | OpenAlex | 10.5281/zenodo.19329365 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143533652 | |||
| W4415684471 | Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence | 2025-10-30 | OpenAlex | 10.3389/fimmu.2025.1692916 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415684471 | |||
| W4415720005 | Inflammatory Bowel Disease: Understanding Therapeutic Effects of Distinct Molecular Inhibitors as the Key to Current and Future Advanced Therapeutic Strategies | 2025-10-30 | OpenAlex | 10.3390/biomedicines13112667 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415720005 | |||
| W4415705745 | Polymeric Microneedles as Analytical Interfaces for Biosensing and Controlled Drug Release: Achievements and Future Challenges | 2025-10-30 | OpenAlex | 10.30744/brjac.2179-3425.letter-n50 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415705745 | |||
| W4415704552 | Staphylococcal enterotoxins in cancer immunotherapy: An overview of translational advances and targeting strategies | 2025-10-30 | OpenAlex | 10.1016/j.prp.2025.156283 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415704552 | |||
| W4415685365 | Sulforaphane in cancer precision medicine: from biosynthetic origins to multiscale mechanisms and clinical translation | 2025-10-30 | OpenAlex | 10.3389/fimmu.2025.1702860 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415685365 | |||
| W4415692947 | Targeting CD70 in cancer: Mechanisms of immune escape and translational opportunities | 2025-10-30 | OpenAlex | 10.1002/ctd2.70095 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415692947 | |||
| W4415699194 | Transformative Autoethnography for Practitioners: Change Processes and Practices for Individuals and GroupsBy Kathy‐Ann C.Hernandez, HeewonChang, and Wendy A.Bilgen, Gorham, Maine: Myers Education Press, 2022. 176 pp. $36.95 (paperback). ISBN: 978‐1‐975504‐87‐8 | 2025-10-30 | OpenAlex | 10.1111/aeq.70055 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415699194 | |||
| W4415705016 | Treatment of Type 2 Diabetes: A Comprehensive Review of Recent Improvements, Therapeutic Strategies, Challenges, and Future Perspectives | 2025-10-30 | OpenAlex | 10.33590/emjdiabet/rkyo7834 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415705016 | |||
| W4415884964 | AI in Everything, and Everything in AI: A Review of the Ubiquitous Role of Artificial Intelligence in Shaping the Next Technological Epoch | 2025-10-31 | OpenAlex | 10.69996/jcai.2025024 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415884964 | |||
| W4416163949 | Collaborative Agentic AI for Personalized Treatment Protocol Optimization: Autonomous Clinical Decision Networks | 2025-10-31 | OpenAlex | 10.63282/3050-9246/icrtcsit-122 | Full text | Excluded | F3: The ACDN architecture trains domain agents with multi-agent reinforcement learning on synthetic clinical environments, federated parameter aggregation, causal models and graph-based reasoning. The described architecture and methodology do not implement an LLM/VLM acting agent. | https://openalex.org/W4416163949 | https://doi.org/10.63282/3050-9246/ICRTCSIT-122 | ||
| W7105600878 | Enhancing Time Series Forecasting using DRL with attention-based neural architectures | 2025-10-31 | OpenAlex | 10.63282/3050-9246/icrtcsit-111 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7105600878 | |||
| W4415738161 | Gearshift Fellowship: A Next-Generation Neurocomputational Game Platform to Model and Train Human-AI Adaptability | 2025-10-31 | OpenAlex | 10.1007/978-3-032-10518-9_23 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415738161 | |||
| W4415726254 | Health Administration | 2025-10-31 | OpenAlex | 10.1002/9781118410868.wbehibs028.pub2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415726254 | |||
| W4415771030 | INDICAÇÕES CLÍNICAS DO CLAREAMENTO DENTAL EM DENTES VITAIS | 2025-10-31 | OpenAlex | 10.69849/revistaft/ar10202510310049 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415771030 | |||
| W4416346692 | PHARMACOLOGIC THERAPY OF POSTMENOPAUSAL OSTEOPOROSIS: AN UPDATED NARRATIVE REVIEW OF GUIDELINES AND EVIDENCE | 2025-10-31 | OpenAlex | 10.21474/ijar01/22034 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416346692 | |||
| W4415717508 | Pathologic fractures in primary bone tumors: a paradigm shift in management | 2025-10-31 | OpenAlex | 10.1016/j.injury.2025.112853 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415717508 | |||
| W4415989951 | Predictors of the use of moral prohibition by university students: the context of an ethically loaded situation and personal characteristics | 2025-10-31 | OpenAlex | 10.17759/pse.2025300508 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415989951 | |||
| W7116061306 | Quantamental Portfolio Allocators: Deriving Alpha from Fundamental Metrics with ML | 2025-10-31 | OpenAlex | 10.5281/zenodo.17971625 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7116061306 | |||
| W4415740906 | RNA‐Based Agents as Therapeutics | 2025-10-31 | OpenAlex | 10.1002/0471266949.bmc307 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4415740906 | |||
| W4416853882 | Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database | 2025-10-31 | OpenAlex | 10.1016/j.clml.2025.10.026 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416853882 | |||
| W4415773914 | Systematic Review - Chemistry & Clinical Importance of Anticancer Drugs, Plus Recent Advances in Discovery | 2025-10-31 | OpenAlex | 10.22214/ijraset.2025.74892 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415773914 | |||
| W4415749221 | The Dual State: Artificial Intelligence, Authoritarian Control, and the Crisis of Youth in Bangladesh (2014-2024) | 2025-10-31 | OpenAlex | 10.22541/au.176194054.49910899/v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415749221 | |||
| W4415755226 | Upconversion nanoparticles for drug and gene delivery | 2025-10-31 | OpenAlex | 10.1016/b978-0-443-26661-4.00015-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415755226 | |||
| W4416780669 | 281P Development and validation of a living decision support tool (Living-DST) in non-small cell lung cancer (NSCLC) using agentic AI-augmented systematic literature review (SLR) | 2025-11-01 | OpenAlex | 10.1016/j.esmorw.2025.100477 | Full text | Excluded | F4: The report describes a fixed annotation manual, task decomposition, within-task self-debugging and daily accumulation of external literature/guidelines. It does not document an experience-derived retained change to the annotation/manual/prompt procedure. The distinct breast-cancer Living-OEP article’s feedback-update mechanism was not imported into this NSCLC report. | https://openalex.org/W4416780669 | https://doi.org/10.1016/j.esmorw.2025.100477 | Complete published conference abstract read on the primary publisher page; no longer methods component is supplied. | |
| W7117104352 | A Cross-Disease Framework for Modern Diagnosis, Risk Stratification, and Treatment of Adult Leukemias | 2025-11-01 | OpenAlex | 10.61882/tcr.202501.01.03 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117104352 | |||
| W4416380844 | A Reflection of literature reports on Synthesis, Spectral Studies, Multilateral applications of Azo dyes | 2025-11-01 | OpenAlex | 10.1016/j.rechem.2025.102878 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416380844 | |||
| W7117405741 | A comprehensive review on skin benefits of Ayurvedic Kumkumadi oil | 2025-11-01 | OpenAlex | 10.22271/plants.2025.v13.i6c.1996 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117405741 | |||
| W7131735890 | AI Empowerment of Medical Libraries for Promoting Accessible Reading of Evidence-Based Health Guidelines | 2025-11-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131735890 | ||||
| W4416921635 | Abstract 359: Complex Case of Managing Recurrent Vasospasms and Feverssecondary to Subarachnoid Hemorrhage and Ruptured Left Anterior Communicating Artery Aneurysm in a Patient with uniqueNeuro‐vascular Anatomy | 2025-11-01 | OpenAlex | 10.1161/svi270000_359 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416921635 | |||
| W4416921685 | Abstract 372: Rapidly Progressive and Reversible Parkinsonism Secondary to Bilateral Subdural Hematomas | 2025-11-01 | OpenAlex | 10.1161/svi270000_372 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416921685 | |||
| W4416921689 | Abstract 373: iCURE CSDH Registry: Evaluating Coil‐Based Middle Meningeal Artery Embolization for Chronic Subdural Hematoma | 2025-11-01 | OpenAlex | 10.1161/svi270000_373 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416921689 | |||
| W4416133160 | Advances in Complement Inhibition Therapies for Paroxysmal Nocturnal Hemoglobinuria and Autoimmune Hemolytic Disorders | 2025-11-01 | OpenAlex | 10.2147/jbm.s543272 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416133160 | |||
| W7127580474 | Antiplatelets and hemorrhagic MI outcome in reperfused STEMI | 2025-11-01 | OpenAlex | 10.1093/eurheartj/ehaf784.1778 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7127580474 | |||
| W4415937444 | Aspergillosis of the Vocal Cord—A Close Mimicker of Vocal Cord Malignancy | 2025-11-01 | OpenAlex | 10.1097/ipc.0000000000001505 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415937444 | |||
| W7104269994 | BIOENHANCERS IN DRUG DEVELOPMENT: CURRENT TRENDS AND FUTURE DIRECTIONS | 2025-11-01 | OpenAlex | 10.5281/zenodo.17540878 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7104269994 | |||
| W4416775079 | BONE/SOFT TISSUE | 2025-11-01 | OpenAlex | 10.4103/jcrt.jcrt_2268_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416775079 | |||
| W4416141160 | CNSC-12. NEUROTOXICITY AND NEURO-CARCINOGENESIS OF NANOMATERIALS: THE STATE OF THE ART IN RECENT LITERATURE? | 2025-11-01 | OpenAlex | 10.1093/neuonc/noaf201.0220 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416141160 | |||
| W4416399020 | Development and validation of nomograms of outcomes for first-line platinum-based chemotherapy for metastatic triple-negative breast cancer: patient-level analysis of five prospective clinical trials in China | 2025-11-01 | OpenAlex | 10.1177/17588359251395906 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416399020 | |||
| W4416084996 | EPCO-49. SPATIAL TRANSCRIPTOMICS ILLUMINATES MECHANISMS OF MONOTHERAPY FAILURE IN GLIOBLASTOMA BY MAPPING TARGET EXPRESSION ACROSS TUMOR REGIONS | 2025-11-01 | OpenAlex | 10.1093/neuonc/noaf201.0048 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416084996 | |||
| W7106846460 | Evidence-based Ayurveda interventions for sustainable obesity management: Efficacy, safety, and long-term outcomes | 2025-11-01 | OpenAlex | 10.4103/jdras.jdras_328_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7106846460 | |||
| W4416428753 | Expanding the Toolbox | 2025-11-01 | OpenAlex | 10.34067/kid.0000000927 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416428753 | |||
| W4415756024 | Fever, Weight Loss, and Headache in a 17-Year-Old Boy | 2025-11-01 | OpenAlex | 10.1542/pir.2023-006175 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415756024 | |||
| W4416099391 | From immunosenescence to diastolic dysfunction: tracing the senescence cascade in heart failure with preserved ejection fraction | 2025-11-01 | OpenAlex | 10.1093/cvr/cvaf220 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416099391 | |||
| W4416772422 | Global insights into the management of BCG-unresponsive non-muscle invasive bladder cancer: a narrative review of provider surveys | 2025-11-01 | OpenAlex | 10.21037/tau-2025-661 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416772422 | |||
| W4416195714 | Illuminating the genomic frontier of invasive non‐typhoidal Salmonella infections | 2025-11-01 | OpenAlex | 10.1002/ctm2.70526 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416195714 | |||
| W4416457037 | Immune insights and toxicity testing: an interview with Jeff Yoder | 2025-11-01 | OpenAlex | 10.1242/dmm.052639 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416457037 | |||
| W7127734375 | Implementation of new antithrombotic treatment strategies and outcome improvements in patients with myocardial infarction and atrial fibrillation over 20 years: a nationwide cohort study | 2025-11-01 | OpenAlex | 10.1093/eurheartj/ehaf784.1765 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7127734375 | |||
| W4416573606 | Ivarmacitinib: A Novel Selective JAK1 Inhibitor for the Treatment of Rheumatoid Arthritis—Letter to the Editor | 2025-11-01 | OpenAlex | 10.1111/1756-185x.70486 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416573606 | |||
| W4415758695 | Multidisciplinary strategies and new technologies in the management of sarcoidosis | 2025-11-01 | OpenAlex | 10.1016/j.ejim.2025.106576 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415758695 | |||
| W4416447087 | Novel Lineages of SARS-CoV-2 Receptor Binding Domain Monoclonal Antibodies Demonstrate Broad and Potent Neutralization Across SARS-CoV-2 and Other Sarbecoviruses 9206 | 2025-11-01 | OpenAlex | 10.1093/jimmun/vkaf283.2638 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416447087 | |||
| W4416028779 | Occurrence of antibiotics and heavy metal co-resistant plasmids among Pseudomonas species isolated from waste sites in Delta State communities: A public health recall | 2025-11-01 | OpenAlex | 10.1016/j.hazmp.2025.100011 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416028779 | |||
| W7106313795 | P-240 Not just a ‘noctor’! The evolving role of the advanced nurse practitioner in hospice care: driving integration, innovation, and impact | 2025-11-01 | OpenAlex | 10.1136/spcare-2025-huk.257 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7106313795 | |||
| W4415894336 | P004 From skin to spine: a case of isotretinoin-induced spondyloarthropathy | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.033 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415894336 | |||
| W4415894039 | P006 Polymyalgic-onset axial spondyloarthritis: a diagnostic challenge in older adults | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.035 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415894039 | |||
| W4415893808 | P015 This one ‘struck a cord’: when clinical history matters more than the MRI | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.044 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415893808 | |||
| W4415892787 | P033 Severe gouty arthropathy masquerading as inflammatory arthritis in a middle-aged mixed ethinicity woman with heart failure: a complex multisystem presentation | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.062 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415892787 | |||
| W4415894322 | P035 Joint decision-making: individualised gout care in the dialysis setting | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.064 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415894322 | |||
| W4415892891 | P040 A success story - treatment of refractory check point inhibitor-induced myositis | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.069 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415892891 | |||
| W4415892681 | P041 Recurrent nocturnal headache as the presenting feature of neurosarcoidosis in a child with Blau syndrome | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.070 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415892681 | |||
| W4415893765 | P049 Mr CP; a case of rapidly evolving neurology | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.078 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415893765 | |||
| W4415892991 | P060 Unmasking myositis in a complex overlap syndrome | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.089 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415892991 | |||
| W4415892832 | P061 Immune checkpoint inhibitor-induced myositis following steroid withdrawal in a patient with lung cancer and brain metastases: a case report | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.090 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415892832 | |||
| W4415892499 | P082 Beyond the ANA: a case highlighting the role of myositis-specific antibodies in autoimmune myopathy | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.111 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415892499 | |||
| W4415893143 | P088 ANCA-associated vasculitis presenting with inflammatory myopathy and multisystem involvement: a diagnostic and therapeutic challenge | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.117 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415893143 | |||
| W4415893470 | P113 A challenging case of mixed connective tissue disease with pulmonary hypertension | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.142 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415893470 | |||
| W4415892640 | P132 Refractory culture-negative arthritis and systemic inflammation in a child with sickle cell disease: a diagnostic and therapeutic challenge | 2025-11-01 | OpenAlex | 10.1093/rap/rkaf111.161 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415892640 | |||
| W4415927728 | Pathogenesis, diagnosis and management of chronic hepatitis B related liver fibrosis | 2025-11-01 | OpenAlex | 10.23736/s2724-5985.25.03862-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415927728 | |||
| W4416723150 | Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence | 2025-11-01 | OpenAlex | 10.1177/03000605251397777 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416723150 | |||
| W4415756011 | Prenatal Diagnosis of a Large Lymphovascular Malformation | 2025-11-01 | OpenAlex | 10.1542/neo.26-11-073 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415756011 | |||
| W4415818545 | Research Progress and Emerging Trends Between Anthocyanins and Obesity: A Bibliometric Analysis | 2025-11-01 | OpenAlex | 10.1177/1934578x251392447 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415818545 | |||
| W7117372873 | Sepsis in the era of precision medicine | 2025-11-01 | OpenAlex | 10.4103/cmrp.cmrp_159_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117372873 | |||
| W4415759812 | Smoldering multiple myeloma: advances in diagnosis and risk stratification, and evolving therapeutic strategies | 2025-11-01 | OpenAlex | 10.1007/s12185-025-04096-9 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4415759812 | |||
| W7106223099 | Substance Use Disorders: Population and Policy Impact | 2025-11-01 | OpenAlex | 10.1891/9780826179517.0020 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7106223099 | |||
| W4416167211 | Surfactant-mediated carriers for gemcitabine: New insights and future prospects | 2025-11-01 | OpenAlex | 10.1016/j.surfin.2025.108066 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416167211 | |||
| W4416918743 | Tenecteplase or Alteplase? Evaluating Outcomes, Cost, and Implementation Questions in Acute Ischemic Stroke | 2025-11-01 | OpenAlex | 10.1097/01.eem.0000000000000132 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416918743 | |||
| W4415766473 | The Beta-blocker chronicle: From past principles to present practice – Implications for the Indian subcontinent | 2025-11-01 | OpenAlex | 10.1016/j.ihj.2025.10.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415766473 | |||
| W4415760922 | The Chinese Haemophilia Individualized Prophylaxis (CHIPS): A cost-effective regimen for zero joint bleeding and long-term joint health in boys with Severe Haemophilia A (SHA) on factor replacement | 2025-11-01 | OpenAlex | 10.1016/j.thromres.2025.109528 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415760922 | |||
| W4415765903 | The Historical Perspectives, Present Status, and Future Prospects of Pharmaceutical Services in the UAE | 2025-11-01 | OpenAlex | 10.1007/978-981-96-0523-1_46 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415765903 | |||
| W4416554427 | The Next Disease X‐ H5N6 Avian Influenza's Evolving Threat to Human Health and Chances of Future Global Outbreak: A Narrative Review | 2025-11-01 | OpenAlex | 10.1002/hsr2.71526 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416554427 | |||
| W4416742125 | The Rise of Large Language Models in NLP: Technological Developments and Their Influence from GPT to Multimodal Systems | 2025-11-01 | OpenAlex | 10.56975/ijedr.v13i4.302667 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416742125 | |||
| W7127597227 | Trends in P2Y12 inhibitor use after acute coronary syndromes: insights from the ProACS registry | 2025-11-01 | OpenAlex | 10.1093/eurheartj/ehaf784.2085 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7127597227 | |||
| W4416663444 | Ultrasound-targeted Microbubbles Destruction: a New Approach to The Treatment of Neurodegenerative Diseases | 2025-11-01 | OpenAlex | 10.3724/j.pibb.2025.0273 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416663444 | |||
| W4416788955 | Virotherapy as Gene Deliver for Anti-Cancer Therapy: A Review Article | 2025-11-01 | OpenAlex | 10.31557/apjcp.2025.26.11.3895 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416788955 | |||
| W4416199272 | Advancements of investigational agents for cancer cachexia: what clinical progress have we seen in the last 5 years? | 2025-11-02 | OpenAlex | 10.1080/13543784.2025.2588640 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4416199272 | |||
| W4416026301 | Diffuse large B-cell lymphoma: what clinical progress have we seen in the last 5 years? | 2025-11-02 | OpenAlex | 10.1080/13543784.2025.2587276 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416026301 | |||
| W4415780712 | Evolving trends of antidiabetic agents stratified by age, kidney function and body mass index: Insights from a nationwide claims database | 2025-11-02 | OpenAlex | 10.1111/dom.70255 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4415780712 | |||
| W4415912195 | Harnessing the Periodic Table for Human Well-being: A Systematic Mechanistic Exploration of Metallo-Pharmaceuticals towards Diagnostic and Therapeutic Applications | 2025-11-02 | OpenAlex | 10.21608/ejchem.2025.418535.12259 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415912195 | |||
| W7105393516 | Medication-related Osteonecrosis of the Jaw. Part 1: Overview | 2025-11-02 | OpenAlex | 10.12968/denu.2025.52.10.722 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7105393516 | |||
| W4415774624 | The role of stem cells in precision medicine: next-generation cancer treatment | 2025-11-02 | OpenAlex | 10.1186/s43046-025-00328-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415774624 | |||
| W4415805590 | A Critical Review on Diabetes Mellitus Type 1 and Type 2 Management Approaches: From Lifestyle Modification to Current and Novel Targets and Therapeutic Agents | 2025-11-03 | OpenAlex | 10.48175/ijarsct-29628 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415805590 | |||
| W4417011515 | A US real-world analysis of demographics, transplant patterns, and survival outcomes in posttransplant lymphoproliferative disorder (PTLD) | 2025-11-03 | OpenAlex | 10.1182/blood-2025-5442 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417011515 | |||
| W4417020279 | A retrospective population-based study of long-term treatments and outcomes inwaldenstrom macroglobulinemia in Ontario, Canada | 2025-11-03 | OpenAlex | 10.1182/blood-2025-3612 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417020279 | |||
| W4415818767 | A94 In Situ Simulation as a Tool to Improve Anticoagulant Reversal Management: A Novel Approach to Debriefing to Improve Systems and Develop Pathways | 2025-11-03 | OpenAlex | 10.54531/xlal5357 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415818767 | |||
| W4415792249 | Abstract 4363436: Changes in decisional conflict among adults with atrial fibrillation viewing a rhythm management decision aid: Results from a single-arm feasibility trial | 2025-11-03 | OpenAlex | 10.1161/circ.152.suppl_3.4363436 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415792249 | |||
| W4415794934 | Abstract 4368022: Navigating Dual Threats: A Case of Left Ventricular Thrombus and Acute Ischemic Stroke | 2025-11-03 | OpenAlex | 10.1161/circ.152.suppl_3.4368022 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415794934 | |||
| W4415791135 | Abstract 4368818: Evolving the Scribe: Leveraging Agentic AI for Clinical Documentation | 2025-11-03 | OpenAlex | 10.1161/circ.152.suppl_3.4368818 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W4415791135 | |||
| W4415777385 | Agentic AI for Oilfield Optimization: Bridging Expert Workflows and Generative Intelligence in Multi-Field Facilities | 2025-11-03 | OpenAlex | 10.2118/229325-ms | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415777385 | |||
| W4417016649 | An international view on the current approaches to frontline chronic lymphocytic leukemia therapy | 2025-11-03 | OpenAlex | 10.1182/blood-2025-7937 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417016649 | |||
| W4417009034 | Artificial intelligence‑driven virtual tumor board enhances precision care in Acute Myeloid Leukemia (AML) | 2025-11-03 | OpenAlex | 10.1182/blood-2025-5176 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4417009034 | |||
| W4417002713 | Artificial intelligence‑driven virtual tumor board enhances precision care in myelodysplastic syndromes (MDS) | 2025-11-03 | OpenAlex | 10.1182/blood-2025-7363 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4417002713 | |||
| W7108451782 | Barriers to optimal care and educational opportunities for european physicians treating patients with relapsed/refractory (R/R) CLL | 2025-11-03 | OpenAlex | 10.1182/blood-2025-2875 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108451782 | |||
| W4417015997 | Behind the blood-brain barrier: Contemporary screening practice patterns and trends of central nervous system involvement in acute myeloid leukemia treated with intensive regimens and hypomethylating agent/venetoclax | 2025-11-03 | OpenAlex | 10.1182/blood-2025-1621 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417015997 | |||
| W4417019110 | Caplacizumab as a single agent without plasma exchange in relapsed and refractory thrombotic thrombocytopenic purpura: A systematic review. | 2025-11-03 | OpenAlex | 10.1182/blood-2025-3116 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417019110 | |||
| W4417013456 | Changing patterns and comparative outcomes of “watch-and-wait” versus immediate therapy in CLL: A propensity-weighted SEER analysis, 2000–2020 | 2025-11-03 | OpenAlex | 10.1182/blood-2025-8069 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417013456 | |||
| W4417002738 | Clinical experience and safety of venetoclax in the treatment of patients with chronic lymphocytic leukemia in second and subsequent lines of therapy: Real-world data fron hemato-oncology centers of slovakia | 2025-11-03 | OpenAlex | 10.1182/blood-2025-7424 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417002738 | |||
| W4417013445 | Comparative analysis of fatal serious adverse events associated with FDA-approved bispecific antibodies in hematologic malignancies | 2025-11-03 | OpenAlex | 10.1182/blood-2025-8065 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417013445 | |||
| W4417006950 | Disparities in treatment timing and access to care in chronic lymphoytic leukemia | 2025-11-03 | OpenAlex | 10.1182/blood-2025-8107 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417006950 | |||
| W4417002415 | Eculizumab vs control therapies in paroxysmal nocturnal hemoglobinuria: A meta-analysis of six randomized trials | 2025-11-03 | OpenAlex | 10.1182/blood-2025-6443 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417002415 | |||
| W4417009100 | Establishing contemporary benchmarks for Acute Myeloid Leukemia outcomes and measurable residual disease: Real-world data utilization from the ELN-david MRD international working group | 2025-11-03 | OpenAlex | 10.1182/blood-2025-5183 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417009100 | |||
| W7108444745 | Evolving catastrophic antiphospholipid syndrome with intracerebral hemorrhage: Treatment with plasma exchange and rituximab | 2025-11-03 | OpenAlex | 10.1182/blood-2025-6650 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108444745 | |||
| W4417006390 | Evolving real-world uptake and patient characteristics of bispecific antibodies in Relapsed/Refractory multiple myeloma: Insights from a US community oncology network | 2025-11-03 | OpenAlex | 10.1182/blood-2025-5857 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417006390 | |||
| W4417013480 | Exploiting arginine auxotrophy in Philadelphia-chromosome positive acute lymphoblastic leukemia to deliver personalised metabolomic treatment | 2025-11-03 | OpenAlex | 10.1182/blood-2025-328 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417013480 | |||
| W4417012459 | First-line salvage therapies in relapsed/refractory large B-cell lymphoma after second- or third-line CD19-directed CAR T-cell therapy | 2025-11-03 | OpenAlex | 10.1182/blood-2025-3711 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417012459 | |||
| W4417007928 | Genomic profiling in CLL patients after BTK inhibitor progression identifies enrichment of mutations in MAPK pathway and epigenetic regulators | 2025-11-03 | OpenAlex | 10.1182/blood-2025-5660 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417007928 | |||
| W4417012310 | Gut microbiota recovery via butyrate supplementation prevents acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation | 2025-11-03 | OpenAlex | 10.1182/blood-2025-4226 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417012310 | |||
| W4415780832 | Harnessing gut-derived bioactives and AI diagnostics for the next generation of type 2 diabetes solutions | 2025-11-03 | OpenAlex | 10.3389/fendo.2025.1699954 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415780832 | |||
| W4417018790 | High vs. low intensity chemotherapy in AML: Survival and transplant outcomes in a brazilian experience | 2025-11-03 | OpenAlex | 10.1182/blood-2025-6900 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417018790 | |||
| W4417002250 | Identification of NAE1-dependent β-catenin neddylation as selective vulnerability in B-cell malignancies | 2025-11-03 | OpenAlex | 10.1182/blood-2025-5042 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417002250 | |||
| W4417003863 | Implementation of 2020 international guidelines in acquired hemophilia: Insights from a decade of national registry data in Spain | 2025-11-03 | OpenAlex | 10.1182/blood-2025-3077 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417003863 | |||
| W4417016707 | Improved outcomes in 17,908 acute myeloid leukemia patients across last three decades: Results from the multinational pethema registry | 2025-11-03 | OpenAlex | 10.1182/blood-2025-40 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417016707 | |||
| W4417012419 | Inhibition of platelet kinase signaling and scaffolding activities with small molecule proteolysis-targeting chimeras (PROTACs) | 2025-11-03 | OpenAlex | 10.1182/blood-2025-3020 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417012419 | |||
| W4417001828 | Integrating bispecific antibodies into community myeloma care: Challenges, insights, and educational impact | 2025-11-03 | OpenAlex | 10.1182/blood-2025-8134 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417001828 | |||
| W4417005233 | Interferon-gamma production in the bone marrow of myelodysplastic syndrome patients supports a treg-independent immune-tolerant microenvironment | 2025-11-03 | OpenAlex | 10.1182/blood-2025-7360 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417005233 | |||
| W4417014513 | Ivosidenib combined with venetoclax and azacitidine for the treatment of newly diagnosed IDH1-mutant Acute Myeloid Leukemia: A prospective, two cohorts, multicenter study | 2025-11-03 | OpenAlex | 10.1182/blood-2025-8249 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417014513 | |||
| W4417017990 | Lenalidomide (LEN) and anti-CD38 monoclonal antibodies (mAbs) utilization in patients with newly diagnosed and relapsed/refractory multiple myeloma (MM) in Germany: Real-world insights on epidemiology and clinical outcomes | 2025-11-03 | OpenAlex | 10.1182/blood-2025-4568 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417017990 | |||
| W7108446943 | Leveraging real-world workshop insights for improving education design: Patient-centered care of myelofibrosis with JAK inhibitors | 2025-11-03 | OpenAlex | 10.1182/blood-2025-2871 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108446943 | |||
| W4417009408 | Molecular profile linked to resistance to hypomethilating agents plus venetoclax does not predict outcome in secondary Acute Myeloid Leukemia patients receiving CPX-351 induction. | 2025-11-03 | OpenAlex | 10.1182/blood-2025-3402 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417009408 | |||
| W4417017659 | National practice patterns and preferences in the use of fixed-duration vs. treat-to-progression therapies for CLL | 2025-11-03 | OpenAlex | 10.1182/blood-2025-8095 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417017659 | |||
| W7108479893 | Nivolumab and pembrolizumab in treatment of relapsed or refractory classical Hodgkin lymphoma: Systematic review and meta-analysis of clinical trials | 2025-11-03 | OpenAlex | 10.1182/blood-2025-5400 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7108479893 | |||
| W4417020164 | Pembrolizumab + GVD with ctdna-guided consolidation for relapsed/refractory classic Hodgkin lymphoma: A multicenter phase 2 Study of the University of California hematologic malignancies consortium | 2025-11-03 | OpenAlex | 10.1182/blood-2025-3630 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417020164 | |||
| W4417009144 | Phase 3 Study of ivosidenib (IVO) and azacitidine (AZA) with or without venetoclax in adult patients with newly diagnosed IDH1-mutated AML or MDS/AML ineligible for intensive chemotherapy (EVOLVE-1) | 2025-11-03 | OpenAlex | 10.1182/blood-2025-5192 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417009144 | |||
| W4415815224 | Policy analysis of sepsis management: The role of advanced practice nurses in protocol adherence and advocacy | 2025-11-03 | OpenAlex | 10.1097/jxx.0000000000001213 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415815224 | |||
| W4417013917 | Poor survival and temporal trends in blastic plasmacytoid dendritic cell neoplasm: A SEER 2000–2022 analysis | 2025-11-03 | OpenAlex | 10.1182/blood-2025-6380 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417013917 | |||
| W4417018613 | Pulmonary Embolism–Attributable mortality among patients with breast cancer in the United States, 1999-2021 | 2025-11-03 | OpenAlex | 10.1182/blood-2025-6252 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417018613 | |||
| W4417001876 | Quality initiative in first-line multiple myeloma assessing the use of anti-CD38 agents and quadruplet therapy | 2025-11-03 | OpenAlex | 10.1182/blood-2025-8120 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417001876 | |||
| W7108451379 | Real world outcomes in 355 patients with Acute Myeloid Leukemia arising from chronic myelomonocytic leukemia: A multinational retrospective study | 2025-11-03 | OpenAlex | 10.1182/blood-2025-3437 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108451379 | |||
| W4417009004 | Real-world analysis of treatment patterns and outcomes in older patients with Acute Myeloid Leukemia (AML) in the US community oncology setting | 2025-11-03 | OpenAlex | 10.1182/blood-2025-5190 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417009004 | |||
| W7108757946 | Real-world characteristics of patients initiating elranatamab for relapsed/refractory multiple myeloma in the United States | 2025-11-03 | OpenAlex | 10.1182/blood-2025-8144 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108757946 | |||
| W7108480977 | Real-world outcomes of newly diagnosed multiple myeloma patients in the veterans affairs healthcare system | 2025-11-03 | OpenAlex | 10.1182/blood-2025-3979 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108480977 | |||
| W7108663735 | Real-world overall survival and time to next treatment among elderly United States Medicare beneficiaries with chronic lymphocytic leukemia in the front-line setting | 2025-11-03 | OpenAlex | 10.1182/blood-2025-6259 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108663735 | |||
| W4417005124 | Real-world selection of fixed-duration versus continuous therapies for treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma | 2025-11-03 | OpenAlex | 10.1182/blood-2025-4513 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417005124 | |||
| W4417004066 | Real-world treatment and safety outcomes of patients with Mantle Cell Lymphoma in the United States | 2025-11-03 | OpenAlex | 10.1182/blood-2025-1795 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417004066 | |||
| W7108628872 | Real-world treatment patterns and outcomes in frail and non-frail patients with newly diagnosed multiple myeloma not undergoing frontline transplant: A study using cota oncology database | 2025-11-03 | OpenAlex | 10.1182/blood-2025-6352 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108628872 | |||
| W7108485025 | Real-world treatment patterns, outcomes, and unmet needs in patients with ph+ ALL receiving tyrosine kinase inhibitors in the United States: Emerging trends and the role of asciminib-based combinations | 2025-11-03 | OpenAlex | 10.1182/blood-2025-5097 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108485025 | |||
| W4417019567 | Real-world use of prophylaxis in people with non-severe hemophilia in the United States: Insights from the athn transcends Study - hemophilia natural history arm | 2025-11-03 | OpenAlex | 10.1182/blood-2025-4472 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417019567 | |||
| W4417006577 | Real‑world effectiveness and patient-centered outcomes of fixed‑duration vs continuous first‑line therapy in chronic lymphocytic leukemia (CLL) | 2025-11-03 | OpenAlex | 10.1182/blood-2025-7437 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417006577 | |||
| W7103882385 | Recent Advancements in Cosmeceuticals — A Review | 2025-11-03 | OpenAlex | 10.5281/zenodo.17510221 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7103882385 | |||
| W4417007600 | Reduced dose post-transplant cytoxan (Intermediate -Dose) in combination with abatacept after matched unrelated donor transplant for high -risk hematological malignancy may reduce treatment related mortality and risk of relapse. | 2025-11-03 | OpenAlex | 10.1182/blood-2025-4196 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417007600 | |||
| W4417005117 | Salvage whole brain radiotherapy after methotrexate failure in primary cns lymphoma | 2025-11-03 | OpenAlex | 10.1182/blood-2025-3679 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417005117 | |||
| W4415827978 | Scaffold-free 3D-Cell Co-Culture Model System for the Study of Metastatic Cancer Cell Behavior in the Brain TME | 2025-11-03 | OpenAlex | 10.1101/2025.10.31.685975 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415827978 | |||
| W7108696421 | Shifting first-line paradigms: Real-world treatment outcomes and healthcare burden in non-transplant newly diagnosed multiple myeloma in France (2015-2022) | 2025-11-03 | OpenAlex | 10.1182/blood-2025-6353 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108696421 | |||
| W4417021861 | Shifting treatment paradigms lead to improved overall survival in Acute Myeloid Leukemia: Real-world data from an integrated health system. | 2025-11-03 | OpenAlex | 10.1182/blood-2025-1607 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417021861 | |||
| W4417007076 | Single-cell transcriptomic insights into venetoclax response and resistance in secondary AML evolving from MDS | 2025-11-03 | OpenAlex | 10.1182/blood-2025-2061 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417007076 | |||
| W4417004962 | T cell fitness and tumor specificity predict immunotherapy response in multiple myeloma | 2025-11-03 | OpenAlex | 10.1182/blood-2025-1029 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417004962 | |||
| W7108452352 | Targeting β-catenin nuclear export and protein degradation in high-risk acute lymphoblastic leukemia | 2025-11-03 | OpenAlex | 10.1182/blood-2025-3371 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7108452352 | |||
| W4417001885 | Temporal trends in treatment patterns and overall survival for multiple myeloma management in Taiwan using the national health insurance claims database | 2025-11-03 | OpenAlex | 10.1182/blood-2025-8133 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417001885 | |||
| W4417002090 | Therapy-related malignancies in myeloma: SEER comparison of IMiD vs anti-CD38 eras | 2025-11-03 | OpenAlex | 10.1182/blood-2025-2247 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417002090 | |||
| W4415780969 | Toward emotional mediation: generative AI in art therapy for psychosocial health support | 2025-11-03 | OpenAlex | 10.3389/fpubh.2025.1690119 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415780969 | |||
| W4415780851 | Transnational ties: LGBTQ+ rights, migration, and legal frameworks in Thailand and India | 2025-11-03 | OpenAlex | 10.3389/fhumd.2025.1638070 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415780851 | |||
| W7108478507 | Treatment-associated healthcare utilization in older adults with AML: A retrospective single-center study | 2025-11-03 | OpenAlex | 10.1182/blood-2025-2855 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7108478507 | |||
| W4417017106 | Trends in overall survival in MDS from 2000–2022: Have therapeutic advances made a difference? | 2025-11-03 | OpenAlex | 10.1182/blood-2025-2094 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417017106 | |||
| W7108453126 | Trial in progress: CAR-T (idecabtagene vicleucel) in advanced myeloma plus iberdomide or usual monitoring (The Alliance A062102 CADMIUM Study) | 2025-11-03 | OpenAlex | 10.1182/blood-2025-2289 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7108453126 | |||
| W4417006902 | Uncovering practice gaps in the management of mantle cell and diffuse large B-cell lymphomas amidst advances with Bruton's tyrosine kinase inhibitors | 2025-11-03 | OpenAlex | 10.1182/blood-2025-8106 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417006902 | |||
| W4417009774 | Unexplained bleeding and a hidden inhibitor: A case of late-onset acquired hemophilia A | 2025-11-03 | OpenAlex | 10.1182/blood-2025-6633 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417009774 | |||
| W4417009416 | What remains matters: Real-world impact of measurable residual disease testing in multiple myeloma | 2025-11-03 | OpenAlex | 10.1182/blood-2025-2789 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417009416 | |||
| W4415844431 | Bispecific immunotherapy based on antibodies, T-cell receptors, and aptamers: mechanisms of action, adverse effects, and future perspectives | 2025-11-04 | OpenAlex | 10.3389/fimmu.2025.1679092 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415844431 | |||
| W4415849762 | Editorial: Health professions education at a time of triple planetary crises | 2025-11-04 | OpenAlex | 10.3389/fmed.2025.1687379 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415849762 | |||
| W4415846847 | From MRD To Match: the Role of Allogeneic Hematopoietic Cell Transplant in Philadelphia-Negative B-ALL | 2025-11-04 | OpenAlex | 10.1007/s11899-025-00760-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415846847 | |||
| W4415958690 | Global research trends in renal anemia: a multidimensional bibliometric study | 2025-11-04 | OpenAlex | 10.1080/0886022x.2025.2580457 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415958690; https://openalex.org/W7104059825 | |||
| W4415889919 | Prostate Cancer Imaging with 18 F-Flotufolastat | 2025-11-04 | OpenAlex | 10.2967/jnmt.125.271253 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415889919 | |||
| W4415950410 | Evolving Therapies and Clinical Outcomes in the Management of Anemia in CKD | 2025-11-05 | OpenAlex | 10.9734/ajrn/2025/v8i1110 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4415950410 | |||
| W4415930017 | Lipid-based nanosystems for atherosclerosis treatment: Evolving approaches and novel therapeutic strategies | 2025-11-05 | OpenAlex | 10.1016/j.apsb.2025.11.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415930017 | |||
| W7104027362 | Mechanism of Action and Clinical Use of Remdesivir in the Treatment of COVID-19 | 2025-11-05 | OpenAlex | 10.5281/zenodo.17533701 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7104027362 | |||
| W7106812702 | No More Processing, It's Time to Discover | 2025-11-05 | OpenAlex | 10.48448/s5r9-ga79 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7106812702 | |||
| W7104049161 | Shaping a new model of mental health care: Leveraging conversational agents as collateral informants | 2025-11-05 | OpenAlex | 10.5281/zenodo.17533583 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7104049161 | |||
| W7106227125 | Standardized Patient Avatar for Reflective Communication Practice (SPARC-P) | 2025-11-05 | OpenAlex | 10.5281/zenodo.17663488 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7106227125 | |||
| W4415945504 | Unmet needs and emerging therapeutics in low-grade serous ovarian carcinoma: from chemoresistance to precision medicine | 2025-11-05 | OpenAlex | 10.1080/14796694.2025.2582805 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415945504 | |||
| W4415951750 | A Review on Therapies of Rheumatoid Arthritis Disease | 2025-11-06 | OpenAlex | 10.48175/ijarsct-29664 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415951750 | |||
| W4416032213 | Advances in the pathophysiology, diagnosis and treatment of Takayasu arteritis | 2025-11-06 | OpenAlex | 10.1038/s41584-025-01309-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416032213 | |||
| W4415963380 | Correction: c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity | 2025-11-06 | OpenAlex | 10.3389/fimmu.2025.1729628 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4415963380 | |||
| W4415958417 | Editorial: Artificial intelligence for arrhythmia detection and prediction | 2025-11-06 | OpenAlex | 10.3389/fcvm.2025.1727758 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415958417 | |||
| W4415991569 | Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review | 2025-11-06 | OpenAlex | 10.3390/curroncol32110626 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415991569 | |||
| W7124902000 | Immune modulation, immune homeostasis and diseases: Milestone findings by 2025 Nobel Laureates in Physiology or Medicine | 2025-11-06 | OpenAlex | 10.1097/id9.0000000000000193 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124902000 | |||
| W4415960298 | Neoadjuvant therapy | 2025-11-06 | OpenAlex | 10.1007/s12254-025-01079-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415960298 | |||
| W4415973671 | Targeting cytokines: Reshaping the pancreatic tumor microenvironment | 2025-11-06 | OpenAlex | 10.1016/j.cytogfr.2025.11.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415973671 | |||
| W4415982871 | Addressing student use of generative AI in schools and universities through academic integrity reporting | 2025-11-07 | OpenAlex | 10.3389/feduc.2025.1610836 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4415982871 | |||
| W4416092533 | Advances in Bioactive Dental Adhesives for Caries Prevention: A State-of-the-Art Review | 2025-11-07 | OpenAlex | 10.3390/jfb16110418 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416092533 | |||
| W4415986495 | Correction: Rewriting the script: gene therapy and genome editing for von Willebrand Disease | 2025-11-07 | OpenAlex | 10.3389/fgeed.2025.1719330 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4415986495 | |||
| W4415982974 | Editorial: Applications of medicinal plants and their metabolites in fibrotic disease: novel strategies, mechanisms, and their impact on clinical practice | 2025-11-07 | OpenAlex | 10.3389/fphar.2025.1711009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415982974 | |||
| W4415994491 | Editorial: Case reports in breast cancer 2023-2024 | 2025-11-07 | OpenAlex | 10.3389/fonc.2025.1711001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415994491 | |||
| W4415982889 | Editorial: Women in psychiatry 2024: Psychopharmacology | 2025-11-07 | OpenAlex | 10.3389/fpsyt.2025.1716714 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415982889 | |||
| W4415984923 | HeartWare™ HVAD support without anticoagulation | 2025-11-07 | OpenAlex | 10.1007/s12055-025-02089-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415984923 | |||
| W4415985143 | Management of sexual dysfunction in menopause: an update on evidence-based strategies | 2025-11-07 | OpenAlex | 10.1080/17446651.2025.2585855 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415985143 | |||
| W4415997763 | Potential Therapeutic Agents Targeting Senescent Cells and Their Influence on Various Organs and Tissues | 2025-11-07 | OpenAlex | 10.1201/9781003190875-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415997763 | |||
| W4416381237 | Response to: improvements to out-of-hospital cardiac arrest and opioid overdose treatment algorithms to enhance positive outcomes | 2025-11-07 | OpenAlex | 10.1097/ec9.0000000000000162 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416381237 | |||
| W4415992876 | The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial | 2025-11-07 | OpenAlex | 10.1038/s41375-025-02795-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4415992876 | |||
| W7104511852 | White Paper: Transparent Autonomy — A Governance-First Framework for Intelligent Vehicles | 2025-11-07 | OpenAlex | 10.5281/zenodo.17552450 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7104511852 | |||
| W7104439253 | "The Tier Experiment: Emergent Relational Cognition and Mechanistic Empathy in AI Systems" | 2025-11-08 | OpenAlex | 10.5281/zenodo.17558858 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7104439253 | |||
| W4416031865 | Biomimetic nanofiber scaffolds for tissue engineering in cancer inflammation | 2025-11-08 | OpenAlex | 10.1016/b978-0-443-27745-0.00002-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416031865 | |||
| W4416029377 | Green antibacterial materials | 2025-11-08 | OpenAlex | 10.1016/b978-0-443-33761-1.00008-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416029377 | |||
| W4416021401 | Insights into the Versatile Role of Extracellular Vesicles in the Treatment of CNS Disorders | 2025-11-08 | OpenAlex | 10.1007/s12035-025-05283-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416021401 | |||
| W4416046475 | Tailoring Intensity: A Perspective on Thiotepa, Busulfan, and Fludarabine (TBF) Conditioning for Acute Leukemias and Myeloproliferative Neoplasms | 2025-11-08 | OpenAlex | 10.1016/j.jtct.2025.11.015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416046475 | |||
| W4416061476 | Global Mapping of Flavonoids in Fruits and Vegetables: Targeting Insulin Receptors, GLP ‐ 1R , and PPARs to Mitigate Diabetes | 2025-11-09 | OpenAlex | 10.1002/ptr.70116 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416061476 | |||
| W4416072819 | Assessment of Echogenicity in Melt-Electrowritten Mitral Valve Scaffolds | 2025-11-10 | OpenAlex | 10.1053/j.jvca.2025.09.107 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416072819 | |||
| W4416070365 | Atopic Dermatitis: Pathophysiology and Emerging Treatments | 2025-11-10 | OpenAlex | 10.3390/allergies5040040 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416070365 | |||
| W4416222713 | Cognicare : An AI-Powered Conversational Agent for Mental Health Monitoring and Support | 2025-11-10 | OpenAlex | 10.32628/ijsrst25126259 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W4416222713 | |||
| W4416073459 | Evidence-Based Management of Burns: A Narrative Review of Evolving Practices | 2025-11-10 | OpenAlex | 10.3390/ebj6040059 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416073459 | |||
| W4416072821 | First Total Percutaneous Four-Vessel Endovascular Aortic Arch Repair with a Triple Inner-Branch Device and In Situ Laser Fenestration: Anaesthetic Strategies for Neurological and Haemodynamic Protection | 2025-11-10 | OpenAlex | 10.1053/j.jvca.2025.09.217 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416072821 | |||
| W4416092323 | From Deep Hypothermia to Goal-Directed Perfusion: Contemporary Insights Into Perfusion Techniques for Pulmonary Endarterectomy, Including a Narrative Review and Perspectives | 2025-11-10 | OpenAlex | 10.7759/cureus.96478 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416092323 | |||
| W7160839842 | Liposomal Formulation of Plant Based Natural Photosensitisers for Thrombosis | 2025-11-10 | OpenAlex | 10.22146/ijp.17369 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160839842 | |||
| W4416072862 | SUSTAINABILITY IN ANAESTHESIA: PRESERVING THE PRIMACY OF PATIENT WELFARE WHILE REDUCING GREENHOUSE GAS EMISSIONS (revised) | 2025-11-10 | OpenAlex | 10.1053/j.jvca.2025.09.092 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416072862 | |||
| W4416099220 | Evolving HPV diagnostics: current practice and future frontiers | 2025-11-11 | OpenAlex | 10.3389/fcimb.2025.1681779 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4416099220 | |||
| W7117129423 | HIV 치료의 패러다임 전환: 지난 40년의 변화 | 2025-11-11 | OpenAlex | 10.56786/phwr.2025.18.50suppl.5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117129423 | |||
| W4416104045 | Integrating MBMA and QSP to Identify Key Covariates and Predict Treatment Outcomes in Relapsed/Refractory Multiple Myeloma | 2025-11-11 | OpenAlex | 10.1002/psp4.70145 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416104045 | |||
| W4416121523 | Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches | 2025-11-11 | OpenAlex | 10.1038/s41571-025-01085-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416121523 | |||
| W7135458209 | The Evolving Use of iLFT survey study - Participant Information Sheet Version 1.0 (14/10/2025) | 2025-11-11 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135458209 | ||||
| W7138917553 | The mirage of consensus: rethinking AI-driven delphi simulations in surgical expert panels – letter to the editor | 2025-11-11 | OpenAlex | 10.1097/js9.0000000000004069 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138917553 | |||
| W7113647697 | Unseen Spaces. Therapeutic relationship in digital analytic settings during a time of transformation | 2025-11-11 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7113647697 | ||||
| W4416127292 | A systematic review of generative AI: importance of industry and startup-centered perspectives, agentic AI, ethical considerations & challenges, and future directions | 2025-11-12 | OpenAlex | 10.1007/s10462-025-11435-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416127292 | |||
| W4416126362 | Charting the future of cardiorenal medicine: a vision for integration, innovation, and impact | 2025-11-12 | OpenAlex | 10.3389/fneph.2025.1719673 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416126362 | |||
| W4416126326 | Editorial: Future directions and current trends in cellular therapies | 2025-11-12 | OpenAlex | 10.3389/fmed.2025.1732925 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416126326 | |||
| W4416388314 | Molecular Mechanisms, Diagnosis, and Management of Chemotherapy Related Cardiotoxicity | 2025-11-12 | OpenAlex | 10.31579/2641-0419/522 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416388314 | |||
| W4416143241 | PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: Rationale, Mechanisms, and Clinical Applications | 2025-11-12 | OpenAlex | 10.1016/j.euo.2025.10.011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416143241 | |||
| W7105659765 | **THE COLLECTIVEOS ADVANTAGE: A Unified Architecture for Trustworthy AI, Modular Intelligence, and Sector-Scale Deployment** | 2025-11-13 | OpenAlex | 10.5281/zenodo.17602332 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7105659765; https://openalex.org/W7105674227 | |||
| W4416176438 | Allogeneic hematopoietic stem cell transplantation in adult with acute lymphoblastic leukemia: evolving indications and modalities in shifting landscape | 2025-11-13 | OpenAlex | 10.1080/10428194.2025.2584685 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416176438 | |||
| W7105650470 | Comparative Pharmacological Mechanisms of Acetaminophen and NSAIDs in Pain Management | 2025-11-13 | OpenAlex | 10.5281/zenodo.17597789 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7105650470 | |||
| W4416160778 | Editorial: Advanced biocompatible piezoelectrics − synthesis, characterization, and applications | 2025-11-13 | OpenAlex | 10.3389/fbioe.2025.1739314 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416160778 | |||
| W4416196192 | Editorial: Antibody-based novel target immunotherapy in hematological malignancy | 2025-11-13 | OpenAlex | 10.3389/fonc.2025.1727734 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416196192 | |||
| W4416191888 | Medical Management of Obesity: A Comprehensive Review of Food and Drug Administration (FDA)-Approved and Investigational Therapies | 2025-11-13 | OpenAlex | 10.7759/cureus.96739 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416191888 | |||
| W4416176332 | Sarcoidosis: a state-of-the-art review | 2025-11-13 | OpenAlex | 10.1183/13993003.01324-2025 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416176332 | |||
| W7218205811 | A systematic review of perspective transformation in humanities: Mezirow’s framework and contemporary issues (2020–2025). | 2025-11-14 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7218205811 | ||||
| W4416341402 | Knowledge Graph-Guided Identification of Multiple Sclerosis and Therapeutic Trend Analysis: Real-World Evidence from Two Large Healthcare Systems | 2025-11-14 | OpenAlex | 10.1101/2025.11.12.25340116 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416341402 | |||
| W4416454550 | The Mosque as an Agent of Social Welfare: Philanthopic Programs at Jogokariyan Mosque | 2025-11-14 | OpenAlex | 10.23917/suhuf.v37i2.10798 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4416454550 | |||
| W4416230056 | Advances in Management Strategies for Primary Biliary Cholangitis | 2025-11-15 | OpenAlex | 10.1007/s11901-025-00700-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416230056 | |||
| W4416610254 | Anthropocene Fiction and Anthropocene Discourse: Centering on The Lathe of Heaven and Bewilderment | 2025-11-15 | OpenAlex | 10.46645/inoutsesk.59.8 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416610254 | |||
| W4416364672 | Cognitive Mobility Systems: Artificial Intelligence-Driven Synergies in Automotive and Railway Engineering | 2025-11-15 | OpenAlex | 10.70593/978-93-7185-139-8 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416364672 | |||
| W4416301657 | Deciphering the Clinical Heterogeneity and Molecular Underpinnings of Hypertrophic Cardiomyopathy: A Contemporary Synthesis of Genetic, Diagnostic, and Therapeutic Paradigms | 2025-11-15 | OpenAlex | 10.47191/ijmscrs/v5-i11-05 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416301657 | |||
| W4416230564 | Diagnostic and therapeutic challenges in narcolepsy: From childhood to complex comorbidity through 3 clinical cases | 2025-11-15 | OpenAlex | 10.1016/j.neurop.2025.100212 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416230564 | |||
| W7105801602 | NANOTECHNOLOGY: A REVOLUTIONARY APPROACH IN DRUG DELIVERY SYSTEMS | 2025-11-15 | OpenAlex | 10.5281/zenodo.17617826 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7105801602 | |||
| W4416247493 | New advances in the treatment of common conjunctivitis: A review | 2025-11-15 | OpenAlex | 10.63802/healthnexus.v1.2025.150 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416247493 | |||
| W7124538982 | Therapeutic approaches and challenges in COVID-19 management: A pragmatic review | 2025-11-15 | OpenAlex | 10.55126/ijzab.2025.v10.i06.sp034 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124538982 | |||
| W4416411742 | Tuberculosis Infection Screening Recommendations for Targeted Immunotherapies: Comparison of US Prescribing Information, Clinical Resources, and Quality Measures | 2025-11-15 | OpenAlex | 10.1093/cid/ciaf628 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416411742 | |||
| W4416229347 | Updates on surgical and nonsurgical innovations for macular hole treatment | 2025-11-15 | OpenAlex | 10.1016/j.survophthal.2025.11.008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416229347 | |||
| W4416255722 | A Review on Erythromycin | 2025-11-16 | OpenAlex | 10.48175/ijarsct-29903 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416255722 | |||
| W4416293341 | From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome | 2025-11-16 | OpenAlex | 10.1007/s00467-025-07046-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416293341 | |||
| W7120298736 | Navigating CAR-T Therapy: The Clinical Journey of Multiple Myeloma Patients at Fred Hutchinson Cancer Center | 2025-11-16 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7120298736 | ||||
| W4416285492 | A Systematic Approach to the Histologic Evaluation of Terminal Ileal Biopsies | 2025-11-17 | OpenAlex | 10.1177/10668969251385989 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416285492 | |||
| W7140893830 | AI Mobile Health Applications: Real-Time Monitoring and Support | 2025-11-17 | OpenAlex | 10.1109/3ict68299.2025.11442234 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140893830 | |||
| W4416270483 | Advances in treatment of chronic graft-versus-host disease | 2025-11-17 | OpenAlex | 10.1007/s12185-025-04102-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416270483 | |||
| W4416290465 | Agentic AI | 2025-11-17 | OpenAlex | 10.1201/9781003648338-6 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4416290465 | |||
| W4416274136 | Blood Derivatives in the Therapy of Ocular Surface Diseases | 2025-11-17 | OpenAlex | 10.3390/ijms262211097 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416274136 | |||
| W4416301191 | Editorial: Metal-based nanomaterials for tumor diagnosis and therapy | 2025-11-17 | OpenAlex | 10.3389/fchem.2025.1738897 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416301191 | |||
| W4416396293 | Expanding indications and developmental landscape of HER2-targeted therapies in breast cancer: a pharmacotherapeutic perspective | 2025-11-17 | OpenAlex | 10.1080/14656566.2025.2591813 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416396293 | |||
| W7223761353 | FLOCAL: Architecture for Metacognitive Autotelic Artificial Intelligence | 2025-11-17 | OpenAlex | 10.5281/zenodo.17632665 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223761353 | |||
| W7164339201 | Microbe-Driven Drug Modulation | 2025-11-17 | OpenAlex | 10.5281/zenodo.20638783 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164339201 | |||
| W4416773271 | Orthostatic hypotension in clinical practice: Definitions, pathophysiology, outcomes, and future directions | 2025-11-17 | OpenAlex | 10.36922/bh025410058 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416773271 | |||
| W4416298411 | Polyarteritis Nodosa With Mesenteric, Hepatic, and Musculoskeletal Manifestations in a 36-Year-Old Nigerian Male Patient: A Case Report | 2025-11-17 | OpenAlex | 10.7759/cureus.97049 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416298411 | |||
| W4416389127 | Psoriatic Arthritis: From Diagnosis to Treatment | 2025-11-17 | OpenAlex | 10.3390/jcm14228151 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416389127 | |||
| W4416290472 | Rethinking the OODA Loop | 2025-11-17 | OpenAlex | 10.1201/9781003648338-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416290472 | |||
| W4416290504 | The Hybrid Mind | 2025-11-17 | OpenAlex | 10.1201/9781003648338-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416290504 | |||
| W4416301237 | The compassion illusion: Can artificial empathy ever be emotionally authentic? | 2025-11-17 | OpenAlex | 10.3389/fpsyg.2025.1723149 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416301237 | |||
| W7106556222 | AI agents | 2025-11-18 | OpenAlex | 10.48448/zat6-pn10 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7106556222 | |||
| W4416310038 | Editorial: Exploring neurotological health concerns post-COVID-19 infection | 2025-11-18 | OpenAlex | 10.3389/fneur.2025.1731001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416310038 | |||
| W7106040877 | Global CBRN Defense Market: Trends, Drivers, and Strategic Outlook | 2025-11-18 | OpenAlex | 10.5281/zenodo.17637382 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7106040877 | |||
| W7199255794 | Narratives, sensemaking and ontological security in turbulent environments | 2025-11-18 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7199255794 | ||||
| W4416340521 | The Best of Intentions: Unintended Consequences of Regulatory Policy on Healthcare Supply Chain Networks | 2025-11-18 | OpenAlex | 10.1111/jbl.70045 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416340521 | |||
| W4416405097 | Advances in modeling gastric intestinal metaplasia: a comprehensive review of experimental models and mechanistic insights | 2025-11-19 | OpenAlex | 10.3389/fonc.2025.1664298 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416405097 | |||
| W4416368942 | Changing practices in gadolinium-enhanced direct magnetic resonance arthrography: a UK based survey | 2025-11-19 | OpenAlex | 10.1093/bjr/tqaf285 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416368942 | |||
| W4416404407 | Editorial: Human-in-the-loop paradigm for assistive robotics | 2025-11-19 | OpenAlex | 10.3389/frobt.2025.1718326 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416404407 | |||
| W4416376919 | Effect of Dexmedetomidine on Electrocorticography During Epilepsy Surgery under Isoflurane or Propofol Anesthesia: A Prospective, Randomized Trial | 2025-11-19 | OpenAlex | 10.1055/s-0045-1812846 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416376919 | |||
| W4416402949 | Metabolic reprogramming of CAR T cells: a new frontier in cancer immunotherapy | 2025-11-19 | OpenAlex | 10.3389/fimmu.2025.1688995 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416402949 | |||
| W4416378656 | Net and gross efficacies; when a single RCT is not enough and multiple RCTs are impracticable | 2025-11-19 | OpenAlex | 10.1101/2025.11.19.25340562 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416378656 | |||
| W4417427849 | Response evaluation to systemic therapy in HCC: Current challenges and future perspectives | 2025-11-19 | OpenAlex | 10.1097/hep.0000000000001621 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417427849 | |||
| W4416358999 | Update on Systemic Therapies for Metastatic/Unresectable Pheochromocytomas and Paragangliomas and Future Directions | 2025-11-19 | OpenAlex | 10.3390/cancers17223702 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416358999 | |||
| W4416827373 | What’s New in Musculoskeletal Infection | 2025-11-19 | OpenAlex | 10.2106/jbjs.25.00414 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416827373 | |||
| W7106209757 | AI Core Function Ontology: A Two-Level Capability Architecture for AI System Planning and Design | 2025-11-20 | OpenAlex | 10.5281/zenodo.17664037 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7106209757 | |||
| W4416554594 | Bridging evidence and practice in rheumatoid arthritis–associated interstitial lung disease: emerging gaps and evolving strategies | 2025-11-20 | OpenAlex | 10.1093/qjmed/hcaf288 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416554594 | |||
| W7106250533 | Cardiovascular Implications of NAFLD: Pathophysiology, Risk Assessment, and Clinical Management Strategies | 2025-11-20 | OpenAlex | 10.5281/zenodo.17662909 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7106250533 | |||
| W4416408523 | Contrast-enhanced MRI for Hepatocellular Carcinoma Assessment: Advances in Contrast Agents and Immunotherapy | 2025-11-20 | OpenAlex | 10.1016/j.acra.2025.10.048 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416408523 | |||
| W4416401644 | Endocrine disruption in metabolic disorders: Biomarkers and therapeutic targets | 2025-11-20 | OpenAlex | 10.1016/bs.acc.2025.10.012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416401644 | |||
| W7106216794 | Evaluation of the Questionnaire VCSQPFAB (Nygren et al., 2025) | 2025-11-20 | OpenAlex | 10.23641/asha.30615281 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7106216794 | |||
| W4416538751 | Evaluation of the Voice and Communication Situation Questionnaire Developed With and for Transgender and Gender-Diverse People Presumed Female at Birth | 2025-11-20 | OpenAlex | 10.1044/2025_jslhr-25-00285 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416538751 | |||
| W4416408649 | Fighting superbugs with code: mRNA antibodies target drug-resistant P. aeruginosa | 2025-11-20 | OpenAlex | 10.1016/j.ymthe.2025.11.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416408649 | |||
| W4416407631 | From Evidence to Practice: The Growing Role of Angiography-Derived Physiology | 2025-11-20 | OpenAlex | 10.3390/jcm14228219 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416407631 | |||
| W4416388442 | Lipoprotein(a) in Cardiovascular Diseases and Emerging Therapeutic Strategies | 2025-11-20 | OpenAlex | 10.1007/s10557-025-07810-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416388442 | |||
| W4416428249 | Positioning Multi-Intelligence Agents for Healthcare Enterprises: Toward Evolving Cyber-Physical-Social Systems | 2025-11-20 | OpenAlex | 10.1115/1.4070442 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4416428249 | |||
| W4416356058 | Trends in surgical treatment of female stress urinary incontinence in France over the past decade (2015–2024) | 2025-11-20 | OpenAlex | 10.1016/j.fjurol.2025.103044 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416356058 | |||
| W4416384095 | Unifying pharmacology, systems biology, and regenerative medicine to advance personalized therapies | 2025-11-20 | OpenAlex | 10.3389/fphar.2025.1729610 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416384095 | |||
| W4416668888 | 25 Years of Neonatal Nursing Research in Advances in Neonatal Care: Trends, Lessons, and Future Directions | 2025-11-21 | OpenAlex | 10.1097/anc.0000000000001332 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416668888 | |||
| W7155382724 | A Multi-Agent Collaborative Framework for Personalized Teaching: Dynamic Cognitive Modeling and Iterative Optimization Approach | 2025-11-21 | OpenAlex | 10.1145/3797552.3797712 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7155382724 | |||
| W4416624790 | Advances in Radioembolization for Liver Cancer | 2025-11-21 | OpenAlex | 10.1016/j.jvir.2025.07.018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416624790 | |||
| W4416682794 | Advances in the management of patients with IDH-mutant glioma | 2025-11-21 | OpenAlex | 10.1093/oncolo/oyaf391 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416682794 | |||
| W4416453399 | Cognitive offloading or cognitive overload? How AI alters the mental architecture of coping | 2025-11-21 | OpenAlex | 10.3389/fpsyg.2025.1699320 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416453399 | |||
| W4416440535 | Current perspectives on psychedelic treatments in Europe | 2025-11-21 | OpenAlex | 10.1016/j.lanepe.2025.101537 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416440535; https://openalex.org/W7131598455 | |||
| W7106210461 | Drug Repurposing: Accelerating New Therapeutic Discoveries from Old Molecules (1990 – 2025) | 2025-11-21 | OpenAlex | 10.5281/zenodo.17672920 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7106210461 | |||
| W7106282724 | Global Abundance & Civilian Space Initiative: A Comprehensive Technical and Diplomatic Architecture for Post-Scarcity | 2025-11-21 | OpenAlex | 10.5281/zenodo.17667052 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7106282724 | |||
| W7147620535 | HCC perioperative immunotherapy: Insights from Expert consensus on multidisciplinary collaboration in perioperative immunotherapy for hepatocellular carcinoma (2025 edition) | 2025-11-21 | OpenAlex | 10.1097/ot9.0000000000000123 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147620535 | |||
| W4416442161 | Introduction To the Special Edition on Artificial Intelligence (AI) | 2025-11-21 | OpenAlex | 10.1007/s41347-025-00573-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416442161 | |||
| W4416524059 | Nanomaterials | 2025-11-21 | OpenAlex | 10.1201/9781003651772-48 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416524059 | |||
| W4416448264 | Plant-derived immunomodulators in cancer: Balancing immune activation and suppression within the tumor microenvironment | 2025-11-21 | OpenAlex | 10.1016/j.jbior.2025.101132 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416448264 | |||
| W4416479133 | Post-CDK4/6 inhibitor treatment landscape in metastatic hormone receptor-positive breast cancer: a narrative review | 2025-11-21 | OpenAlex | 10.1080/14737140.2025.2593540 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416479133 | |||
| W4416460386 | The Role of Cyclosporine in the Treatment of Severe Ulcerative Colitis in the Pediatric Population: A Narrative Review Exploring Known Strategies and New Possibilities | 2025-11-21 | OpenAlex | 10.3390/jcm14238273 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416460386 | |||
| W4416455280 | The Whitening Illusion: Glutathione’s Glamorous Lie | 2025-11-21 | OpenAlex | 10.4103/ajim.ajim_112_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416455280 | |||
| W4416448855 | The evolving landscape of antibody-based cancer therapies: From monospecific to multi-specific and beyond | 2025-11-21 | OpenAlex | 10.1016/j.critrevonc.2025.105037 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416448855 | |||
| W4416451531 | Thymic Neuroendocrine Tumors: Evolving Insights and Innovative Approaches | 2025-11-21 | OpenAlex | 10.1016/j.jtocrr.2025.100935 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416451531 | |||
| W7116927213 | Towards Compliant and Trustworthy Data Markets forDistributed AI | 2025-11-21 | OpenAlex | 10.1145/3772429.3772497 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7116927213 | |||
| W7112295315 | ІНТЕГРАЦІЯ ЛІДЕРСТВА СЛУЖІННЯ В МОДЕЛІ ОРГАНІЗАЦІЙНИХ ЗМІН | 2025-11-21 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7112295315 | ||||
| W7131122974 | A Unified Evaluation Framework for Grounded LLM Architectures: Comparative Analysis of RAG, Self-RAG, and Agentic RAG | 2025-11-22 | OpenAlex | 10.1109/aisp68263.2025.11396270 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7131122974 | |||
| W4417526430 | Artificial intelligence for animal science: from applications to integrated knowledge systems | 2025-11-22 | OpenAlex | 10.1093/af/vfaf054 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417526430 | |||
| W7110942474 | Cognitive Protection After Cataract Surgery: Examining Ketamine and Dexmedetomidine in the Elderly | 2025-11-22 | OpenAlex | 10.5281/zenodo.17850934 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7110942474 | |||
| W4416536480 | Comparative Genomic Hybridization (CGH) in Genotoxicology: From the Basics to Modern Approaches | 2025-11-22 | OpenAlex | 10.1007/978-1-0716-4976-3_12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416536480 | |||
| W4416552210 | International Strategies for Lymphedema Management | 2025-11-22 | OpenAlex | 10.1007/s40141-025-00514-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416552210 | |||
| W4416531510 | Pharmacy Futures: Summit on Advanced Therapeutics | 2025-11-22 | OpenAlex | 10.1093/ajhp/zxaf310 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416531510 | |||
| W7106514261 | Biblical Foundation and Sustainable Goal for Poverty Alleviation and Hunger Eradication | 2025-11-23 | OpenAlex | 10.5281/zenodo.17692510 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7106514261 | |||
| W7106510340 | The Agentic CMO: A playbook for the hybrid marketing team | 2025-11-23 | OpenAlex | 10.5281/zenodo.17691356 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7106510340 | |||
| W4416594668 | Correction: CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders | 2025-11-24 | OpenAlex | 10.3389/fncel.2025.1739705 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W4416594668 | |||
| W4416590541 | LEAP2 as a therapeutic target in obesity and cardiometabolic disorders | 2025-11-24 | OpenAlex | 10.1007/s11154-025-10007-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416590541 | |||
| W4416579443 | Open-label, single-arm, phase II trial to investigate the efficacy of sitravatinib plus tislelizumab combination as a second-line treatment for advanced biliary tract cancer | 2025-11-24 | OpenAlex | 10.1016/j.jhep.2025.10.032 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416579443 | |||
| W4416584900 | Plastic and Reconstructive Surgery Highlights: Plastic Surgery Focus | 2025-11-24 | OpenAlex | 10.1097/prs.0000000000012139 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416584900; https://openalex.org/W7165785207 | |||
| W4416738381 | Reassessing the role of therapeutic keratoplasty: Perspectives for 2025 and beyond | 2025-11-24 | OpenAlex | 10.4103/ijo.ijo_2873_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416738381 | |||
| W4416590317 | Reimagining Health-Professions Education: A Roadmap for the AI University of Health and Medicine | 2025-11-24 | OpenAlex | 10.63501/7dcz6776 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416590317 | |||
| W4416582319 | Targeted drug conjugates and molecular mechanisms in overcoming lung cancer drug resistance | 2025-11-24 | OpenAlex | 10.1007/s12672-025-03981-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416582319 | |||
| W4416615677 | Epidemiology, Natural History, and Treatment of Eosinophilic Gastrointestinal Diseases | 2025-11-25 | OpenAlex | 10.1053/j.gastro.2025.09.030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416615677 | |||
| W7106810246 | Restrictive Cardiomyopathy: Contemporary Insights into Pathophysiology, Diagnostic Complexity, and Evolving Therapeutic Perspectives | 2025-11-25 | OpenAlex | 10.5281/zenodo.17722506 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7106810246; https://openalex.org/W4416988335 | |||
| W4416666690 | The Fast-Evolving Landscape of Treatments for Calcium Pyrophosphate Deposition Disease | 2025-11-25 | OpenAlex | 10.3390/gucdd3040022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416666690 | |||
| W4417423152 | Antimicrobial Stewards Must Aim for Balance in “Going Beyond the 9 to 5” | 2025-11-26 | OpenAlex | 10.1093/ofid/ofaf717 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417423152 | |||
| W7135083365 | Contextualizing Reliability: A Multi-Dimensional Approach to Resilient Smart City Systems | 2025-11-26 | OpenAlex | 10.1109/icsrs68021.2025.11422058 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7135083365 | |||
| W4416696136 | Evolving Treatment Options for Relapsed/Refractory Follicular Lymphoma | 2025-11-26 | OpenAlex | 10.6004/jnccn.2025.5057 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416696136 | |||
| W4416697790 | Evolving Treatment Strategies for Acute Myeloid Leukemia | 2025-11-26 | OpenAlex | 10.6004/jnccn.2025.5053 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416697790 | |||
| W4416689316 | Guest editorial: Digital ecosystems of service robot: artifacts, behaviors, organizations and design perspectives | 2025-11-26 | OpenAlex | 10.1108/imds-08-2025-995 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416689316 | |||
| W4416718998 | Histidinol dehydrogenase (HisD): a critical regulator of Staphylococcus aureus virulence and a promising target for antivirulence therapy | 2025-11-26 | OpenAlex | 10.1128/spectrum.01429-25 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416718998 | |||
| W7113057676 | Redesigning Intelligence Grading for 21st Century Threats : Admiralty Code CKDT (Critical Knowledge Diagnostic Taxonomy) | 2025-11-26 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7113057676 | ||||
| W4417023051 | Shifts in the use of adjuncts for regional anesthesia, aligning practice with evidence: a comprehensive review | 2025-11-26 | OpenAlex | 10.35975/apic.v29i8.3023 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417023051 | |||
| W4416717933 | The evolving efficacy landscape of intra-articular injections for rotator cuff injuries over time: a network meta-analysis of randomized controlled studies | 2025-11-26 | OpenAlex | 10.1186/s13018-025-06475-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416717933 | |||
| W4416723212 | Therapeutic Frontiers in Gastroesophageal Cancer: Contemporary Concepts in Management and Therapy | 2025-11-26 | OpenAlex | 10.3390/ijms262311424 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416723212 | |||
| W4416809102 | When Half of Humanity Is Invisible | 2025-11-26 | OpenAlex | 10.2106/jbjs.25.00108 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416809102 | |||
| W4416746756 | Advances in Targeted Therapy for Non-Small-Cell Lung Cancer: Current Progress and Future Directions | 2025-11-27 | OpenAlex | 10.3390/ijms262311517 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416746756 | |||
| W4416713481 | Comparison of the therapeutic potential of exosomes derived from different cells for the treatment of prostate cancer | 2025-11-27 | OpenAlex | 10.1016/j.critrevonc.2025.105055 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416713481 | |||
| W7106838341 | Detection of Antithrombotic-Related Bleeding in Older Inpatients: Multicenter Retrospective Study Using Structured and Unstructured Electronic Health Record Data | 2025-11-27 | OpenAlex | 10.2196/77809 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7106838341 | |||
| W4416771546 | EGFR-mutated advanced non-small cell lung cancer: new era of systemic therapy towards new standards of care | 2025-11-27 | OpenAlex | 10.1007/s12254-025-01087-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416771546 | |||
| W7125491983 | ESMO 2025 and the Future of EGFRm NSCLC Sequencing: First-line Choices that Preserve Subsequent Therapy Eligibility | 2025-11-27 | OpenAlex | 10.82582/thorac.76 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125491983 | |||
| W4416769903 | Editorial: Advancing research, clinical recognition, and targeted therapies for WHIM syndrome | 2025-11-27 | OpenAlex | 10.3389/fimmu.2025.1741502 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416769903 | |||
| W4416739273 | Editorial: Netnography and qualitative digital methods to advance service theory and practice | 2025-11-27 | OpenAlex | 10.1108/jstp-07-2025-471 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416739273 | |||
| W7138246874 | Enabling Repair and Regeneration after Neonatal Stroke | 2025-11-27 | OpenAlex | 10.25439/rmt.31768576 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138246874 | |||
| W4416736792 | Evolution of concepts of platinum resistance in ovarian cancer and current therapeutic opportunities | 2025-11-27 | OpenAlex | 10.17816/aog690082 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416736792 | |||
| W4416764826 | From Pathways to Patients in Atopic Dermatitis: Advanced Systemic Therapies | 2025-11-27 | OpenAlex | 10.3390/ijms262311487 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416764826 | |||
| W4416773018 | Infectious Triggers and Immune Dynamics in Guillain–Barré Syndrome: Revisiting Campylobacter jejuni and the Silent Role of Haemophilus influenzae | 2025-11-27 | OpenAlex | 10.1002/mbo3.70177 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416773018 | |||
| W4416758277 | Natural products in medicinal chemistry: targeting inflammatory pathways with plant-derived compounds | 2025-11-27 | OpenAlex | 10.1007/s00044-025-03508-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416758277 | |||
| W7107942568 | BIOETHICARE 360° | 2025-11-28 | OpenAlex | 10.5281/zenodo.17753192 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7107942568 | |||
| W4416907450 | Case Studies in Antiviral Drug Repurposing | 2025-11-28 | OpenAlex | 10.2174/9798898811143125010004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416907450 | |||
| W4416775237 | Development of Nano-TiO₂ Activated Carbon as Antibacterial Agent in Hospital Waste | 2025-11-28 | OpenAlex | 10.37311/jsscr.v7i3.33990 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416775237 | |||
| W4416757739 | Duchenne Muscular Dystrophy: Clinical Innovations, Ethical Considerations, and Evolving the Path to Adulthood | 2025-11-28 | OpenAlex | 10.1016/j.pediatrneurol.2025.11.020 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4416757739 | |||
| W4416774138 | Editorial: Unraveling circRNAs and miRNAs: key regulators in immune-related diseases | 2025-11-28 | OpenAlex | 10.3389/fimmu.2025.1739926 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416774138 | |||
| W4416796616 | Fatal neonatal septicemia with meningitis due to Escherichia coli in a full-term baby: an unusual presentation | 2025-11-28 | OpenAlex | 10.18203/2320-6012.ijrms20253997 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416796616 | |||
| W7133348901 | Hacia la unicidad de la responsabilidad civil edificatoria en España | 2025-11-28 | OpenAlex | 10.20868/upm.thesis.92182 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7133348901 | |||
| W4416793845 | RIME Redefined | 2025-11-28 | OpenAlex | 10.1097/ipc.0000000000001512 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416793845 | |||
| W4416806068 | Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias | 2025-11-28 | OpenAlex | 10.1055/a-2744-9871 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416806068 | |||
| W4416783907 | The Immunoglobulin A Nephropathy Renaissance: From Pathogenesis to Personalized Therapy | 2025-11-28 | OpenAlex | 10.7759/cureus.97999 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416783907 | |||
| W4416810752 | Bioinspired microneedles for dermatological and precision medicine applications: recent advances and future perspectives | 2025-11-29 | OpenAlex | 10.1007/s00403-025-04457-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416810752 | |||
| W4416818343 | Exploring medical co-design in the AI era: A scoping review | 2025-11-29 | OpenAlex | 10.1016/j.daai.2025.100040 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416818343 | |||
| W7108329417 | Medical Device-Associated Healthcare Infections [MDHAIs] and Patient Safety: Sterilization Protocols, Reprocessing Standards, and Quality of Life Implications; A Comprehensive Review | 2025-11-29 | OpenAlex | 10.36348/sjmps.2025.v11i11.021 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7108329417 | |||
| W4416917425 | Proactive Strategies to Prevent Biofilm-Associated Infections: From Mechanistic Insights to Clinical Translation | 2025-11-29 | OpenAlex | 10.3390/microorganisms13122726 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416917425 | |||
| W4416808580 | [Translated article] N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning | 2025-11-29 | OpenAlex | 10.1016/j.farma.2025.10.015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416808580 | |||
| W7106765164 | Automating Trust at Scale: Infrastructure-as-Code for Secure and Compliant AI Environments in the U.S. | 2025-11-30 | OpenAlex | 10.5281/zenodo.17710102 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7106765164; https://openalex.org/W4416046601 | |||
| W4416933524 | Contrast-enhanced Ultrasonography vs Magnetic Resonance Imaging in the Evaluation of Uterine Lesions: A Prospective Observational Study | 2025-11-30 | OpenAlex | 10.5005/jp-journals-10006-2752 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416933524 | |||
| W7108466843 | Designing reflective AI agents to continuously audit public policy algorithms for hidden biases in social welfare decision-making systems | 2025-11-30 | OpenAlex | 10.5281/zenodo.17801768 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7108466843; https://openalex.org/W4416894709 | |||
| W4416828848 | Effective HA‐Loading Strategy in Internal Dome‐Assisted Suction Cups for Enhanced Transdermal Delivery Under Vertical Adhesion and Vibration | 2025-11-30 | OpenAlex | 10.1002/adfm.202519672 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416828848 | |||
| W7126109565 | Exploring the Nurses Experiences During Unprecedented Crisis: A Heideggerian Perspectives | 2025-11-30 | OpenAlex | 10.47836/mjmhs.v21.i6.1387 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126109565 | |||
| W4417017915 | New horizons in metabolic disease treatment: multi-hormonal agonists and functional medicine-based integrated therapy | 2025-11-30 | OpenAlex | 10.32581/jkifm.2025.8.2.66 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417017915 | |||
| W7128174178 | Self-Optimizing Factories: The Role of Agentic Automation in Industry 4.0 | 2025-11-30 | OpenAlex | 10.38124/ijsrmt.v4i11.1049 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7128174178 | |||
| W4417229701 | 36 DECOLONIZING EXHIBITIONS AND PUBLIC COGNITION: BEHAVIORAL AND COGNITIVE SCIENCE PERSPECTIVES ON THE MONTREAL MUSEUM OF ARCHAEOLOGY AND HISTORY | 2025-12-01 | OpenAlex | 10.1097/01.yco.0001175832.04433.8a | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417229701 | |||
| W7123743191 | 60. Genomic guided targeted therapy in a case of refractory chronic lymphocytic leukemia with TP53 and NOTCH1 mutations | 2025-12-01 | OpenAlex | 10.1016/j.cancergen.2025.10.064 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7123743191 | |||
| W4417175934 | 99 Inflammatory Bowel Disease in Eldery Patients: Epidemiology and Clinical Characteristics in a Tertiary Brazilian Public Hospital | 2025-12-01 | OpenAlex | 10.14309/01.ajg.0001172820.65020.06 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417175934 | |||
| W7107970195 | A NOVEL APPROACH IN DISORDER MANAGEMENT BY TRANSDERMAL PATCHES: A REVIEW | 2025-12-01 | OpenAlex | 10.5281/zenodo.17747932 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7107970195 | |||
| W7117125961 | Advances in the Clinical Application of MAC: A Review of Drug Selection, Combination Therapy, and Administration Methods | 2025-12-01 | OpenAlex | 10.2147/dddt.s552047 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117125961 | |||
| W4416909563 | Artificial Intelligence in Psychotherapy: Reflections on Opportunities, Challenges, and Ethical Implications | 2025-12-01 | OpenAlex | 10.47307/gmc.2025.133.4.26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416909563 | |||
| W7217867312 | Artificial Intelligence in Psychotherapy: Reflections on Opportunities, Challenges, and Ethical Implications: Inteligencia artificial en psicoterapia: reflexiones sobre oportunidades, desafíos e implicaciones éticas | 2025-12-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217867312 | ||||
| W4417481665 | CO199 Real Option Value of Sotatercept in Pulmonary Arterial Hypertension: A Health Economic Perspective on Future Treatment Opportunities | 2025-12-01 | OpenAlex | 10.1016/j.jval.2025.09.300 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417481665 | |||
| W4417521135 | CURRENT TREATMENT APPROACHES IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA | 2025-12-01 | OpenAlex | 10.1016/j.htct.2025.106197 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417521135 | |||
| W7117767264 | Complex Regional Pain Syndrome: Navigating the Evolving Landscape of Chronic Pain | 2025-12-01 | OpenAlex | 10.4103/ijpn.ijpn_78_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117767264 | |||
| W4416847840 | Data from LHX2 Rewires the Metabolic and Epigenetic Landscape to Drive Tumor Progression in Prostate Cancer | 2025-12-01 | OpenAlex | 10.1158/0008-5472.c.8176785 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416847840 | |||
| W4416864176 | Editorial: Food systems, spatial modelling, and planning | 2025-12-01 | OpenAlex | 10.3389/fsufs.2025.1743517 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416864176 | |||
| W7117573736 | Emerging pharmacology of targeted protein degraders | 2025-12-01 | OpenAlex | 10.1016/j.jpet.2025.103694 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117573736 | |||
| W7118566058 | Emerging solutions for neovascular age-related macular degeneration | 2025-12-01 | OpenAlex | 10.1097/icu.0000000000001199 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118566058 | |||
| W4417538575 | Evolving Landscape of Precision Medicine in Bladder Cancer: From Challenges to Clinical Impact | 2025-12-01 | OpenAlex | 10.1002/ila2.70045 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4417538575 | |||
| W4416930901 | Evolving paradigms of Hodgkin lymphoma and implications for cancer survivorship | 2025-12-01 | OpenAlex | 10.1055/s-0045-1812960 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416930901 | |||
| W7117325034 | First-line maintenance strategies and later-line options in patients with advanced gastroesophageal adenocarcinoma | 2025-12-01 | OpenAlex | 10.1177/17588359251389741 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117325034 | |||
| W4417521072 | From CD5-Negative Indolent B-Cell LPD to Therapy-Related CLL/SLL with Unmutated IGHV After Breast Cancer: Rationale for BTK-Inhibitor–Based First-Line Therapy | 2025-12-01 | OpenAlex | 10.1016/j.htct.2025.106160 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417521072 | |||
| W7117290979 | How to efficiently move towards primary prevention in sporadic AD | 2025-12-01 | OpenAlex | 10.1002/alz70859_105951 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117290979 | |||
| W4417521130 | IRON CHELATİON İN MYELODYSPLASTİC SYNDROMES: WHO AND WHEN? | 2025-12-01 | OpenAlex | 10.1016/j.htct.2025.106181 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417521130 | |||
| W7128526114 | Inaugural Editorial: Journal of Cardio-Oncology – Bridging disciplines, advancing patient-centered global care | 2025-12-01 | OpenAlex | 10.1097/co9.0000000000000011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128526114 | |||
| W7203605785 | Innovations in Plant Protection: Technology, Ecology and Future Trends | 2025-12-01 | OpenAlex | 10.5281/zenodo.21984125 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203605785 | |||
| W4416946873 | Letter to the Editor: Detrimental effects of diabetes mellitus in alcoholic liver disease | 2025-12-01 | OpenAlex | 10.1097/hc9.0000000000000852 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416946873 | |||
| W4417330893 | Low-Dimensional Nanoelectronic Materials for Energy-Efficient Edge Computing | 2025-12-01 | OpenAlex | 10.1149/2.f13254if | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417330893 | |||
| W4417229856 | Meeting Abstracts: The 4th International Conference on Behavioral Sciences and Applied Psychology (BSAP 2025) | 2025-12-01 | OpenAlex | 10.1097/01.yco.0001175688.83291.b1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417229856 | |||
| W7135040495 | NAPTICON-2025 – OBSERVATIONAL STUDIES | 2025-12-01 | OpenAlex | 10.4103/njpt.njpt_73_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135040495 | |||
| W7135030054 | NAPTICON-2025 – SYSTEMATIC REVIEWS AND META-ANALYSIS | 2025-12-01 | OpenAlex | 10.4103/njpt.njpt_75_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135030054 | |||
| W4417304667 | Nanotechnology-based approaches for head and neck cancer treatment | 2025-12-01 | OpenAlex | 10.1016/j.biopha.2025.118871 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417304667 | |||
| W7107943055 | ONYCHOMYCOSIS INSIGHTS INTO PATHOGENESIS, DIAGNOSTIC APPROACHES, AND EVOLVING TREATMENT STRATEGIES | 2025-12-01 | OpenAlex | 10.5281/zenodo.17746596 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7107943055 | |||
| W7117130379 | Omega‐3 Fatty Acids as a Neuroprotective Agent: Behavioural and Molecular Improvements in STZ‐Induced Neurodegeneration | 2025-12-01 | OpenAlex | 10.1002/alz70855_100940 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117130379 | |||
| W4416940425 | Optimizing Heart Failure Management in the Cardio-Oncology Setting: Guideline-Directed Medical Therapy, Permissive Cardiotoxicity, and Personalized Approaches | 2025-12-01 | OpenAlex | 10.1007/s12170-025-00780-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416940425 | |||
| W4416876164 | Orientalized Imagery in Posthuman Science-Fiction Cities: From the Explosive Chinatown to the Generic Metropolis | 2025-12-01 | OpenAlex | 10.5406/19346018.78.1.03 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416876164 | |||
| W4416971454 | P72 Investigating the adaptive evolutionary responses of MRSA to alkylating agents | 2025-12-01 | OpenAlex | 10.1093/jacamr/dlaf230.079 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4416971454 | |||
| W4417521101 | PLATELET FUNCTION DISORDERS: CONTEMPORARY INSIGHTS AND FUTURE DIRECTIONS | 2025-12-01 | OpenAlex | 10.1016/j.htct.2025.106191 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417521101 | |||
| W7126277354 | Refractory MG and B-cell depletion | 2025-12-01 | OpenAlex | 10.1016/j.jns.2025.123845 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126277354 | |||
| W7123562422 | Retracted: AI-Powered Applications in Precision Healthcare and Security Surveillance Systems | 2025-12-01 | OpenAlex | 10.1109/ictbig68706.2025.11323654 | Title/abstract | Excluded | E5: Correction, retraction or ancillary data record. | https://openalex.org/W7123562422 | |||
| W4416834045 | Rose Bengal as a multifunctional agent: from biomedical uses to catalysis and materials science | 2025-12-01 | OpenAlex | 10.1016/j.ccr.2025.217413 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416834045 | |||
| W4417521095 | SUMMARY: OPTIMIZATION OF TREATMENT IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL) | 2025-12-01 | OpenAlex | 10.1016/j.htct.2025.106206 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417521095 | |||
| W4416997976 | Society of Critical Care Medicine Clinical Practice Guidelines on Adult End-of-Life Care in the ICU | 2025-12-01 | OpenAlex | 10.1097/ccm.0000000000006856 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416997976 | |||
| W4417435016 | Substantial Increase in the Costs of Antineoplastic Agents in the USA from 2010 to 2021 | 2025-12-01 | OpenAlex | 10.2147/ceor.s548758 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4417435016 | |||
| W7126180278 | Successful switch from ravulizumab to satralizumab in a patient with NMOSD experiencing persistent joint pain | 2025-12-01 | OpenAlex | 10.1016/j.jns.2025.124874 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126180278 | |||
| W7108202046 | THE MULTI-SCALE PLAQUE PARADIGM A Unified Framework for Targeted Remediation Across Biological, Ecological, and Planetary Systems | 2025-12-01 | OpenAlex | 10.5281/zenodo.17773277 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7108202046 | |||
| W7116353596 | THE TREATMENT ALGORITHM FOR SICKLE CELL DISEASE | 2025-12-01 | OpenAlex | 10.1016/j.htct.2025.106183 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7116353596 | |||
| W4416839182 | Targeting the role played by microbiota and adaptive immunity within autoimmune disease complexity | 2025-12-01 | OpenAlex | 10.3389/fimmu.2025.1718417 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416839182 | |||
| W4416953493 | The Evolving Therapeutic Landscape of Richter Transformation | 2025-12-01 | OpenAlex | 10.1007/s11899-025-00765-y | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416953493 | |||
| W4416844088 | The Legal Challenges of Artificial Intelligence in Transportation & Healthcare: Negligence under Malaysian and European Law | 2025-12-01 | OpenAlex | 10.33093/ajlp.2025.16 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416844088 | |||
| W4417287603 | The Past and Future of Interventional Radiology | 2025-12-01 | OpenAlex | 10.1055/s-0045-1813743 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417287603 | |||
| W4416930917 | Therapeutic Success and Strategic Uncertainty: The Evolving Role of Salvage Therapy in Hodgkin Lymphoma in the United States | 2025-12-01 | OpenAlex | 10.1055/s-0045-1812987 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416930917 | |||
| W7133913787 | Therapeutic targeting of the ATP7A copper transporter in cancer | 2025-12-01 | OpenAlex | 10.32469/10355/111052 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133913787 | |||
| W7165052593 | Touching Photographs: The (In)tangible Image in the Photo-essays of John Berger and Jean Mohr | 2025-12-01 | OpenAlex | 10.1093/camqtly/bfag003 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7165052593 | |||
| W7197850865 | Use of digital tools to strengthen technical support processes in Mexico, Guatemala, and Honduras | 2025-12-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7197850865 | ||||
| W7198169669 | Use of system analysis to describe the diversity of farming systems in Nariño, Colombia | 2025-12-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7198169669 | ||||
| W7117135280 | Using Agenticai With Kubernetes For Faster Development, Deployment and Delivery in Production Environments. | 2025-12-01 | OpenAlex | 10.37547/tajet/volume07issue12-07 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7117135280 | |||
| W7119483408 | [Evolution and progress of personalized sedation strategies]. | 2025-12-01 | OpenAlex | 10.3760/cma.j.cn121430-20241029-00888 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119483408 | |||
| W7119042700 | 残余炎症风险在脑动脉粥样硬化性疾病中的研究进展Advances of Residual Inflammatory Risk in Cerebral Artery Atherosclerotic Disease | 2025-12-01 | OpenAlex | 10.3969/j.issn.1673-5765.2025.12.015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119042700 | |||
| W7201960110 | A Framework for the Prediction of Parkinson’s Disease Using Agentic Artificial Intelligence | 2025-12-02 | OpenAlex | 10.33411/ijist/1665 | Full text | Excluded | F3: The Parkinson pipeline uses XGBoost and rule-controlled orchestration; the primary methods explicitly state there is no RL or self-updating agent policy. No LLM acting agent is implemented. | https://openalex.org/W7201960110 | https://journal.50sea.com/index.php/IJIST/article/download/1665/2499/19627 | original publisher PDF indexed methods section p3043 and abstract; live fetch404, not entire paper | |
| W4417490330 | Advancements of investigational agents for renal cell carcinoma: what clinical progress have we seen in the last 5 years? | 2025-12-02 | OpenAlex | 10.1080/13543784.2025.2606118 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4417490330 | |||
| W7108321440 | Beyond Sovereign AI: A Unified Framework for National AI Governance and Constraint-Aligned Intelligence Systems Integrating Australia's National AI Plan (2025) with the CollectiveOS Architecture | 2025-12-02 | OpenAlex | 10.5281/zenodo.17791470 | Title/abstract | Excluded | E1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system. | https://openalex.org/W7108321440 | |||
| W4417031353 | Editorial: From Optimization to Adaptation: The Resilience Paradigm in Twenty-First Century Engineering | 2025-12-02 | OpenAlex | 10.71411/ef.2025.v1i1.935 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417031353 | |||
| W4416928726 | Lipoprotein(a) and CKD | 2025-12-02 | OpenAlex | 10.2215/cjn.0000000968 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416928726 | |||
| W4416918109 | Nebivolol in the therapeutic landscape of heart failure: Mechanisms and clinical outcomes | 2025-12-02 | OpenAlex | 10.1016/j.vph.2025.107562 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416918109 | |||
| W4417235919 | Next-Generation Liposomes for Cosmeceutical Applications: From Structural Insights to Smart, Sustainable Delivery and Clinical Outcomes | 2025-12-02 | OpenAlex | 10.21608/bfsa.2025.437284.2878 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417235919 | |||
| W4416918675 | Nutritional Challenges in Post–Massive Weight Loss Body Contouring: Guidance for Plastic Surgeons on GLP-1 Agonists and Sleeve Gastrectomy | 2025-12-02 | OpenAlex | 10.1097/prs.0000000000012672 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416918675 | |||
| W4416899285 | Response to the Letter Regarding Our Editorial: “Impact of SARS-CoV-2 variants on viral infectivity and the role of the Renin-Angiotensin-Aldosterone system” | 2025-12-02 | OpenAlex | 10.1038/s41440-025-02353-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416899285 | |||
| W4416901955 | Therapeutic Advances in Metastatic Prostate Cancer: A Journey from Standard of Care to New Emerging Treatment | 2025-12-02 | OpenAlex | 10.3390/ijms262311665 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416901955 | |||
| W4416949508 | A comprehensive review on application of cognitive behavioral therapy in emotional AI solutions for mental well-being | 2025-12-03 | OpenAlex | 10.1007/s44202-025-00513-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416949508 | |||
| W4416937759 | Advancements in cardiovascular pharmacology | 2025-12-03 | OpenAlex | 10.4081/ahr.2025.122 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416937759 | |||
| W4416936322 | Comprehensive investigation of synthesis, properties and biomedical utilization of multifunctional dextran-based polymeric nanoparticles | 2025-12-03 | OpenAlex | 10.1007/s00396-025-05552-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416936322 | |||
| W4416951601 | Ethical and inclusive challenges of machine learning in anaesthesia | 2025-12-03 | OpenAlex | 10.1111/anae.70089 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416951601 | |||
| W4416936027 | Expanding the immunotherapy universe in extensive-stage small cell lung cancer: from chemoimmunotherapy backbone to next-wave combinations | 2025-12-03 | OpenAlex | 10.3389/fimmu.2025.1693401 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416936027 | |||
| W7128710475 | Hemophagocytic Lymphohistiocytosis and Infections in Children: An Update | 2025-12-03 | OpenAlex | 10.1097/inf.0000000000005066 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128710475 | |||
| W4416960938 | Hydrothermal system for high-sulfur real fuel conversion and desulfurization: Deuterium -traced evaluation of temperature-driven hydrogen transfer | 2025-12-03 | OpenAlex | 10.1016/j.ijhydene.2025.152824 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416960938 | |||
| W7123526550 | Imaging tumor thrombus across malignancies: current concepts and the expanding role of PET/computed tomography | 2025-12-03 | OpenAlex | 10.1097/mnm.0000000000002090 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123526550 | |||
| W4416969251 | Molecular glues evolve from serendipity to rational design | 2025-12-03 | OpenAlex | 10.1016/j.tips.2025.10.013 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416969251 | |||
| W4416934951 | Personalized Type 1 Diabetes Management: Reinforcement Learning–Based Insulin Dosing and Glucose Forecasting | 2025-12-03 | OpenAlex | 10.2196/79195 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416934951 | |||
| W4416950701 | Real-world eligibility for FSGS clinical trials: insights from a US health system | 2025-12-03 | OpenAlex | 10.1093/ckj/sfaf377 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4416950701 | |||
| W4416932421 | Targeting protein kinase C signaling cascades in alzheimer’s disease: emerging neuroprotective roles of aurothioglucose | 2025-12-03 | OpenAlex | 10.1007/s10787-025-02077-2 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4416932421 | |||
| W7108479285 | The Agentic Horizon: A Comprehensive Analysis of Autonomous Digital Systems and Planetary Intelligence Architectures | 2025-12-03 | OpenAlex | 10.5281/zenodo.17798764 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7108479285 | |||
| W7220158627 | The persistence of delirium in the intensive care unit: an analysis of morbidity and hospital stay | 2025-12-03 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220158627 | ||||
| W4417278715 | The use of methadone in cardiac surgery: resurgence of an old drug? | 2025-12-03 | OpenAlex | 10.1097/aco.0000000000001600 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417278715 | |||
| W4416977641 | Continuum of Care for Hemophilia: The Story of India | 2025-12-04 | OpenAlex | 10.1007/s12098-025-05886-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416977641 | |||
| W4416982998 | GLP-1 receptor agonists on WHO-EML 2025 list: major breakthrough bounded by persistent challenge | 2025-12-04 | OpenAlex | 10.1007/s40200-025-01810-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416982998 | |||
| W4417120124 | Rapid Autopsy Multi-Omic Analysis Identifies Divergent Evolutionary Trajectories and DNA Damage Resistance Mechanisms in FGFR2-Driven Cholangiocarcinoma | 2025-12-04 | OpenAlex | 10.64898/2025.11.25.25340882 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417120124 | |||
| W4416994292 | Systemic Lupus Erythematosus: Ophthalmological Safety Considerations of Emerging and Conventional Therapeutic Agents | 2025-12-04 | OpenAlex | 10.3390/ijms262311744 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416994292 | |||
| W4417011327 | The Evolving Paradigm of Acne Vulgaris Management: A Systematic Review Emphasizing Evidence-Based Combination Therapy, Antimicrobial Stewardship, and Patient-Reported Outcomes | 2025-12-04 | OpenAlex | 10.70070/9zftvn36 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417011327 | |||
| W4416997985 | The Saudi Thoracic Society guidelines for community acquired pneumonia: A model for translating evidence into national practice | 2025-12-04 | OpenAlex | 10.4103/atm.atm_348_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4416997985 | |||
| W7108720336 | The Shadow Simplex: A Critical Framework for Analyzing Failure Modes in Self-Evolving Multi-Agent Reinforcement Learning Systems | 2025-12-04 | OpenAlex | 10.5281/zenodo.17814909 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7108720336; https://openalex.org/W7163359963 | |||
| W7117365980 | A Review on Pathophysiological Mechanisms, Clinical Heterogeneity, and Management of Takayasu Arteritis | 2025-12-05 | OpenAlex | 10.69613/sy8zx094 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117365980 | |||
| W4417045287 | A patent review of Mpro protease inhibitors for the treatment of COVID-19 infections (2020 – present) | 2025-12-05 | OpenAlex | 10.1080/13543776.2025.2588773 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417045287 | |||
| W4417041731 | All shades of gray in the mediastinum: do we have bright ideas about how to diagnose and treat mediastinal gray zone lymphoma in the era of targeted agents? | 2025-12-05 | OpenAlex | 10.1182/hematology.2025000748c | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417041731 | |||
| W4417033899 | Artificial intelligence applications in patient counseling: Latest research, developments, and practical insights for beginners and advanced professionals | 2025-12-05 | OpenAlex | 10.1016/b978-0-443-43823-3.00017-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417033899 | |||
| W7219924733 | COMPLEX RESPIRATORY PATHOGENS IN PEDIATRIC POPULATIONS | 2025-12-05 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7219924733 | ||||
| W4417152952 | Current and future use of artificial intelligence in valvular heart disease imaging | 2025-12-05 | OpenAlex | 10.1093/ehjci/jeaf348 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417152952 | |||
| W4417105426 | Diagnosis, Characterization and Treatment of Emerging Pathogens, Second Edition | 2025-12-05 | OpenAlex | 10.3390/books978-3-7258-5974-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417105426 | |||
| W4417041680 | Molecular subtypes of DLBCL: are we ready to translate our knowledge into the change of treatment paradigms? | 2025-12-05 | OpenAlex | 10.1182/hematology.2025000741 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417041680 | |||
| W4417041856 | New therapies in hemophilia: extend the half-life, mimic, or rebalance? | 2025-12-05 | OpenAlex | 10.1182/hematology.2025000764 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417041856 | |||
| W4417042128 | Optimizing the “right” patient selection for treatment for sickle cell disease | 2025-12-05 | OpenAlex | 10.1182/hematology.2025000751 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417042128 | |||
| W4417038102 | Research progress in molecular targeted therapy for inflammatory bowel disease | 2025-12-05 | OpenAlex | 10.1186/s12967-025-07385-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417038102 | |||
| W4417065319 | The Need for Novel Therapeutic Directions in Autosomal Dominant Polycystic Kidney Disease Patient Care | 2025-12-05 | OpenAlex | 10.2215/cjn.0000000975 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417065319 | |||
| W4417045423 | The development of lipid nanoparticle technology for the management of COVID-19 | 2025-12-05 | OpenAlex | 10.1016/b978-0-443-33002-5.00006-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417045423 | |||
| W4417041617 | Updates in low/intermediate-risk MDS | 2025-12-05 | OpenAlex | 10.1182/hematology.2025000768 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417041617 | |||
| W4417072651 | Clinical translation and landscape of superparamagnetic iron oxide nanoparticles | 2025-12-06 | OpenAlex | 10.1016/j.addr.2025.115756 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417072651 | |||
| W7112654057 | Mindware Lab - Ψ Intelligence | 2025-12-06 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7112654057 | ||||
| W7109203592 | The Current Ulcerative Colitis (UC) Treatment Algorithm: From 5-ASA to Biological Therapies | 2025-12-06 | OpenAlex | 10.12775/qs.2025.47.66966 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7109203592 | |||
| W4417092996 | A Dual-Agent Multimodel AI Framework for Driver State Monitoring System | 2025-12-07 | OpenAlex | 10.56726/irjmets86062 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4417092996 | |||
| W4417102801 | Bile Acid Metabolites Control Th17/Treg Balance in Primary Biliary Cholangitis: Mechanisms of Disease Progression and Therapeutic Targets | 2025-12-07 | OpenAlex | 10.1111/jgh.70189 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417102801 | |||
| W4417144400 | Emerging Frontiers in AI and Ophthalmology | 2025-12-07 | OpenAlex | 10.2174/9798898812287125010007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417144400 | |||
| W4417187322 | INTEGRATION OF SERVANT LEADERSHIP INTO ORGANIZATIONAL CHANGE MODELS | 2025-12-07 | OpenAlex | 10.30838/ep.207.241-249 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417187322 | |||
| W4417095804 | Precision in Practice: A Critical Overview of Recent Advances in Nasopharyngeal Cancer Management | 2025-12-07 | OpenAlex | 10.1016/j.ijrobp.2025.11.064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417095804 | |||
| W4417124210 | Thrombus Composition and the Evolving Role of Tenecteplase in Acute Ischemic Stroke | 2025-12-07 | OpenAlex | 10.3390/jcm14248675 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417124210 | |||
| W4417134641 | Navigating Adolescent Mental Health in the Age of Artificial Intelligence | 2025-12-08 | OpenAlex | 10.62414/001c.150329 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417134641 | |||
| W4417120136 | Novel KPC-2 variants and epidemic ST463 clones underlie ceftazidime/avibactam resistance in carbapenem-resistant Pseudomonas aeruginosa | 2025-12-08 | OpenAlex | 10.1128/spectrum.02187-25 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417120136 | |||
| W7111411870 | PHYSIOLOGICAL AND LABORATORY CHANGES DUE TO STRESS | 2025-12-08 | OpenAlex | 10.5281/zenodo.17859656 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7111411870 | |||
| W7114656895 | PsychLab Research: Mathematical Modeling of the Construction of Change | 2025-12-08 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7114656895 | ||||
| W7125581548 | Radiation Techniques in Health and Environment | 2025-12-08 | OpenAlex | 10.53560/ppasa(62-4)705 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125581548 | |||
| W4417121903 | Strategic Combinations of Antibody–Drug Conjugates from 2023 to 2025: From Dual Therapies to Innovative ADC-Based Regimens | 2025-12-08 | OpenAlex | 10.3390/pharmaceutics17121581 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417121903 | |||
| W4417226379 | Breaking the shields of resistance: multidimensional therapeutic strategies in the breast cancer drug resistance conundrum | 2025-12-09 | OpenAlex | 10.1097/js9.0000000000004424 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417226379 | |||
| W4417146324 | Editorial: Bispecific antibodies and their conjugates in solid tumors and hematological malignancies | 2025-12-09 | OpenAlex | 10.3389/fimmu.2025.1752360 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417146324 | |||
| W4417146366 | Editorial: Ferroptosis and regulation mechanism in the tumor immune microenvironment for tumor progression and treatment | 2025-12-09 | OpenAlex | 10.3389/fimmu.2025.1748341 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417146366 | |||
| W4417144082 | Gastrointestinal cancer: molecular pathogenesis and targeted therapy | 2025-12-09 | OpenAlex | 10.1186/s43556-025-00361-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417144082 | |||
| W4417162923 | Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC | 2025-12-09 | OpenAlex | 10.1128/jvi.01487-25 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417162923 | |||
| W4417172142 | Pharmaceutical consultation on patients receiving oral antineoplastic agents: a systematic review | 2025-12-09 | OpenAlex | 10.1136/ejhpharm-2025-004586 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4417172142 | |||
| W4417159175 | Treatment of Pelvic Recurrence After Radiotherapy for Cervical Cancer | 2025-12-09 | OpenAlex | 10.3390/cancers17243934 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417159175 | |||
| W7114918968 | AI-Synthesized Psychopathology: When Unconscious Algorithms Perform "Trauma", Whose Reflection Do We See? | 2025-12-10 | OpenAlex | 10.5281/zenodo.17890131 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7114918968 | |||
| W7114790267 | BOOK REVIEW: PRACTICAL DIABETES MELLITUS | 2025-12-10 | OpenAlex | 10.5281/zenodo.17878161 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7114790267 | |||
| W4417260042 | Cardiovascular Adverse Event Risk in Rheumatoid Arthritis Patients Treated with JAK Inhibitor Tofacitinib versus TNF Inhibitors: a Systematic Review, Meta Analysis, and Meta Regression | 2025-12-10 | OpenAlex | 10.53366/jimki.vi.949 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417260042 | |||
| W7213353426 | Cost-Effective and Compliant: Leveraging Agentic AI to Optimize KYC Processes in FinTech Onboarding | 2025-12-10 | OpenAlex | 10.68207/msxc1217 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213353426 | |||
| W4417181054 | Editorial: Immunological therapies in pediatric cancers: a Latin American perspective | 2025-12-10 | OpenAlex | 10.3389/fonc.2025.1744458 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417181054 | |||
| W4417180463 | Editorial: Skin microbiome: microbiological, immunological and cellular aspects for therapies to control antimicrobial resistance and skin repair | 2025-12-10 | OpenAlex | 10.3389/fcimb.2025.1736430 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417180463 | |||
| W4417210377 | Endovascular thrombectomy for acute stroke: evolving eligibility criteria and adjunct therapies | 2025-12-10 | OpenAlex | 10.1016/s1474-4422(25)00356-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417210377 | |||
| W4417180982 | Global trends in carbapenem-resistant gram-negative bacteria research (2020–2025): a bibliometric analysis and systematic review | 2025-12-10 | OpenAlex | 10.3389/fcimb.2025.1690417 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417180982 | |||
| W4417178374 | Patterns of treatment and survival in borderline resectable and locally advanced pancreatic cancer | 2025-12-10 | OpenAlex | 10.1016/j.pan.2025.12.007 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417178374 | |||
| W7123713328 | Recent advances in palliative systemic therapy for locally advanced unresectable or metastatic gastric cancer: a narrative review | 2025-12-10 | OpenAlex | 10.5124/jkma.25.0114 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123713328 | |||
| W7113897474 | Reinforcement Learning: A Statistical Perspective | 2025-12-10 | OpenAlex | 10.6339/25-jds1205 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7113897474 | |||
| W7114771520 | The BEP Framework: Belonging, Energy, and Prediction as Drivers of Cognition, Decision-Making, and Human–AI Interaction | 2025-12-10 | OpenAlex | 10.5281/zenodo.17886686 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7114771520 | |||
| W4417214546 | 20th anniversary of adjuvant trastuzumab: reflections on a breakthrough moment | 2025-12-11 | OpenAlex | 10.1016/j.annonc.2025.12.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417214546 | |||
| W7114802795 | Antibody–Drug Conjugates (ADCs) and Their Journey to Autoimmune Disease Immunotherapy | 2025-12-11 | OpenAlex | 10.3390/msf2025040002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7114802795 | |||
| W4417229300 | Cell-Mediated and Peptide-Based Delivery Systems: Emerging Frontiers in Targeted Therapeutics | 2025-12-11 | OpenAlex | 10.3390/pharmaceutics17121597 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417229300 | |||
| W4417231504 | Managing skin infections in burn patients: principles and pitfalls | 2025-12-11 | OpenAlex | 10.1097/qco.0000000000001173 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417231504 | |||
| W4417211974 | Unveiling Alzheimer’s disease (1901–2025): Historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategies | 2025-12-11 | OpenAlex | 10.1016/j.arr.2025.102990 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417211974 | |||
| W4417251196 | Uveal Melanoma: Changing Paradigms of Treatment | 2025-12-11 | OpenAlex | 10.1159/000549994 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417251196 | |||
| W7140292690 | A Hierarchical Multi-Agent Framework for Improved Clinical Diagnosis | 2025-12-12 | OpenAlex | 10.1109/iccc68654.2025.11437615 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7140292690 | |||
| W4417262047 | Case Report: Tail-of-the-curve advantage from immune checkpoint inhibitor–anti-VEGF combination therapy: extended survival in a patient with metastatic lung adenocarcinoma | 2025-12-12 | OpenAlex | 10.3389/fmed.2025.1714486 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417262047 | |||
| W7134247747 | Exosomes in Aesthetic Medicine: An Overview | 2025-12-12 | OpenAlex | 10.1093/asj/sjaf259 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134247747 | |||
| W4417281255 | First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent | 2025-12-12 | OpenAlex | 10.1016/j.phymed.2025.157689 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W4417281255 | |||
| W4417502477 | Post-surgical pain: evolving drug treatments and challenges | 2025-12-12 | OpenAlex | 10.1080/14656566.2025.2608078 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417502477 | |||
| W7114918207 | Risk Factors and Preventing Strategies of Pocket Hematoma After Cardiac Implantable Electronic Device Implantation: A Systematic Review | 2025-12-12 | OpenAlex | 10.3390/jcdd12120490 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7114918207 | |||
| W4417275784 | The Therapeutic Pipeline for Eosinophilic Esophagitis: Current Landscape and Future Directions | 2025-12-12 | OpenAlex | 10.3390/ph18121882 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417275784 | |||
| W4417304578 | Treatment of primary adult-onset neurodegenerative cerebellar ataxias | 2025-12-12 | OpenAlex | 10.1016/j.neurot.2025.e00805 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417304578 | |||
| W4417281089 | Understanding the Charles Bonnet syndrome: An updated review | 2025-12-12 | OpenAlex | 10.1016/j.brainresbull.2025.111683 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417281089 | |||
| W4417321448 | Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers | 2025-12-13 | OpenAlex | 10.3322/caac.70052 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417321448 | |||
| W7131799373 | Igniting the future of cardiovascular care: highlights from the ESC Digital and AI Summit 2025 in Berlin | 2025-12-13 | OpenAlex | 10.1093/eurheartj/ehaf1068 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131799373 | |||
| W4417302545 | Sequential use of targeted radioligand therapies in metastatic castration-resistant prostate cancer: A case report and systematic review | 2025-12-13 | OpenAlex | 10.1016/j.critrevonc.2025.105088 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417302545 | |||
| W4417299276 | Transformative progress of SPIONs in cancer theranostics: A comprehensive review on recent advances in SPIONs technology | 2025-12-13 | OpenAlex | 10.1016/j.colsurfb.2025.115372 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417299276 | |||
| W7115066039 | A Synergistic Reinforcement Learning Framework for Adaptive, Privacy-Preserving Trust and Collusion Detection in Multi-agent Systems | 2025-12-14 | OpenAlex | 10.1007/978-3-032-13562-9_32 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7115066039 | |||
| W7128028607 | AURELIUS: Agentic Uncertainty-Reasoning & Learning with Hierarchical Bayesian Multi-Agents Unified System for Handling Non-Determinism in HealthTech | 2025-12-14 | OpenAlex | 10.1109/commantel68363.2025.11368546 | Full text | Excluded | F3: AURELIUS implements Bayesian encoders, graph coordination and hierarchical multi-agent RL. Although§III.D mentions generative reasoning conceptually,§VI explicitly lists integrating LLM high-level planners as future work. The evaluated acting system is not an implemented LLM/VLM agent. | https://openalex.org/W7128028607 | https://ieeexplore.ieee.org/document/11368546 | ||
| W4417427156 | Targeting emerging viruses with phage display-driven engineered antibodies: Bridging molecular design and clinical application | 2025-12-14 | OpenAlex | 10.1016/j.mam.2025.101441 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417427156 | |||
| W4417317087 | The Potential Clinical Relevance of Necrosis–Necroptosis Pathways for Hypoxic–Ischaemic Encephalopathy | 2025-12-14 | OpenAlex | 10.3390/cells14241984 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417317087 | |||
| W4417327244 | Chronic rhinosinusitis with and without nasal polyps: the state-of-the-art of current treatment strategies and future developments | 2025-12-15 | OpenAlex | 10.3389/falgy.2025.1714577 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417327244 | |||
| W4417311111 | Current treatments, practical management, and emerging investigational therapies for myelofibrosis | 2025-12-15 | OpenAlex | 10.1080/17474086.2025.2604532 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417311111 | |||
| W4417312336 | Editorial: Advances and challenges in adult-onset craniopharyngioma | 2025-12-15 | OpenAlex | 10.3389/fendo.2025.1755850 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417312336 | |||
| W4417338316 | Interstitial Lung Disease in 2025: Updated Classification, Precision Diagnostics, and Expanding Therapeutic Frontiers | 2025-12-15 | OpenAlex | 10.58931/crt.2025.1316 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417338316 | |||
| W4417330805 | Nontuberculous Mycobacteria: An update | 2025-12-15 | OpenAlex | 10.1016/j.ijtb.2025.12.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417330805 | |||
| W7115586381 | Oncology Nanomedicine: Immunomodulating Nanomedicine for Tumor Therapy | 2025-12-15 | OpenAlex | 10.5281/zenodo.17938289 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7115586381 | |||
| W4417345710 | Pathology’s Last Exam: Stress-Testing Diagnostic Reasoning and Safety in Large Language Models | 2025-12-15 | OpenAlex | 10.64898/2025.12.11.25342081 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417345710 | |||
| W4417323219 | Periosteal Osteosarcoma: Emerging Clinical Concepts, Evolving Treatment Options: A Narrative Review | 2025-12-15 | OpenAlex | 10.1007/s11916-025-01450-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417323219 | |||
| W7127652668 | The Application of Antioxidant in Skin Cancer Research: A Bibliometric Study | 2025-12-15 | OpenAlex | 10.31557/apjcc.2025.10.4.1133-1141 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127652668 | |||
| W7126091496 | Towards Trustworthy Knowledge Extension in Clinical Decision Support: An LLM-Agent Approach | 2025-12-15 | OpenAlex | 10.1109/bibm66473.2025.11356848 | Full text | Excluded | F4: The agents discover and verify external literature/guideline assertions and merge approved RDF triples into a CDSS. This is knowledge-source refresh, without learning retained from clinical case/task experience. | https://openalex.org/W7126091496 | https://ieeexplore.ieee.org/document/11356848 | ||
| W4417350943 | Article Review of Antibiotic Resistance | 2025-12-16 | OpenAlex | 10.21275/sr251212195149 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417350943 | |||
| W4417349581 | Case Report: Multiple immune related adverse events in a patient with metastatic melanoma | 2025-12-16 | OpenAlex | 10.3389/fimmu.2025.1677544 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417349581 | |||
| W4417347209 | Direct application of Amikacin in pressure sores - A prospective cohort study | 2025-12-16 | OpenAlex | 10.21203/rs.3.rs-8337654/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417347209 | |||
| W4417354585 | Editorial: Emerging antimicrobials: sources, mechanisms of action, spectrum of activity, combination antimicrobial therapy, and resistance mechanisms | 2025-12-16 | OpenAlex | 10.3389/fmicb.2025.1754398 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417354585 | |||
| W7126126702 | Evaluation of new therapeutic modalities in transarterial locoregional treatment for hepatocellular carcinoma | 2025-12-16 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126126702 | ||||
| W4417407429 | Evolving paradigms in the management of dyslipidemia: comparison between the 2019 ESC/EAS guidelines and the 2025 focus update | 2025-12-16 | OpenAlex | 10.1007/s11739-025-04234-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417407429 | |||
| W4417457715 | Extended susceptibility testing for refractory Helicobacter pylori infection: regional testing should guide antimicrobial decision making | 2025-12-16 | OpenAlex | 10.1186/s12879-025-12236-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4417457715; https://openalex.org/W7125410404 | |||
| W7115595444 | Infantile Spasms (West Syndrome): Integrating Genetic, Neurotrophic, and Hormonal Mechanisms Toward Precision Therapy | 2025-12-16 | OpenAlex | 10.3390/medicina61122223 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7115595444 | |||
| W4417352257 | Primary biliary cholangitis (PBC): evolving approaches and expert perspectives | 2025-12-16 | OpenAlex | 10.1080/17474124.2025.2601220 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417352257 | |||
| W4417363450 | The Treatment of Obesity in the Context of the Obesity Paradox in Patients with Heart Failure: A Narrative Review | 2025-12-16 | OpenAlex | 10.1007/s11886-025-02333-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417363450 | |||
| W4417360291 | Where Are We Going by Applying AI Tools? Are We Going to Lose Our Jobs? | 2025-12-16 | OpenAlex | 10.23749/mdl.v116i6.18255 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417360291 | |||
| W4417439756 | Convergent Evolution: Self-Assembly of Small Molecule, Polymeric, and Inorganic Contrast Agents toward Advanced MRI | 2025-12-17 | OpenAlex | 10.1021/jacs.4c11767 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417439756 | |||
| W4417416775 | Drug treatment of MASH from none to (too) many options? | 2025-12-17 | OpenAlex | 10.37349/emed.2025.1001378 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417416775 | |||
| W4417416672 | Editorial: RNA regulation mechanisms in microbial-host interactions | 2025-12-17 | OpenAlex | 10.3389/fcimb.2025.1751814 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417416672 | |||
| W7115950498 | FROM THRESHOLDS TO TRAJECTORIES: The AGI Capability Maturity Model™ for Artificial General Intelligence | 2025-12-17 | OpenAlex | 10.5281/zenodo.17958748 | Title/abstract | Excluded | E1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system. | https://openalex.org/W7115950498 | |||
| W4417434158 | Identification of a novel circular DNA carrying blaNDM−1 gene in an extensive drug resistant Providencia huaxiensis strain | 2025-12-17 | OpenAlex | 10.1007/s42770-025-01845-0 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417434158 | |||
| W7115893462 | Liquid Glass | 2025-12-17 | OpenAlex | 10.5281/zenodo.17964620 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7115893462 | |||
| W7198456508 | Multi-Agent Systems for Root Cause Analysis in Microservices | 2025-12-17 | OpenAlex | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7198456508 | ||||
| W7128500087 | PEDAGOGICAL AGENTS FOR STUDENTS WITH AUTISM: A CONTEMPORARY WORLDWIDE BIBLIOMETRIC INSIGHT | 2025-12-17 | OpenAlex | 10.35631/ijepc.1061073 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128500087 | |||
| W7125425757 | SYNTHETIC CATHINONES AND NEW PSYCHOACTIVE SUBSTANCES IN POLAND: EPIDEMIOLOGY, TOXICOLOGY, AND PUBLIC HEALTH IMPACT | 2025-12-17 | OpenAlex | 10.31435/ijitss.4(48).2025.4013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125425757 | |||
| W7216725116 | Avances en el manejo farmacológico de la hepatopatía alcohólica | 2025-12-18 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216725116 | ||||
| W7116085084 | Details of PC1608 sediment core recovered from 437 meter depth off Wakasa Bay in the Sea of Japan | 2025-12-18 | OpenAlex | 10.17632/ybzdgt6669 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7116085084 | |||
| W4417449047 | Editorial: AI-driven healthcare delivery, ageism, and implications for older adults: emerging trends and challenges in public health | 2025-12-18 | OpenAlex | 10.3389/fpubh.2025.1755410 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417449047 | |||
| W4417449216 | Editorial: Non-coding RNAs as potential therapeutics and biomarkers for human diseases | 2025-12-18 | OpenAlex | 10.3389/fphar.2025.1753536 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417449216 | |||
| W7135136181 | Facilitating Shared Introspection in Hierarchical Multi-Agent Systems Using the Model Context Protocol | 2025-12-18 | OpenAlex | 10.1109/raai67517.2025.11423310 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7135136181 | |||
| W4417466724 | HCC in the Era of Emerging MASH: The Role of Ultrasound in Surveillance and New Sonographic Features in Diagnosis | 2025-12-18 | OpenAlex | 10.3390/cancers17244037 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417466724 | |||
| W4417450863 | Medication-Related Osteonecrosis of the Jaw: A Comprehensive Review of Pathophysiology, Diagnosis, and Management Strategies | 2025-12-18 | OpenAlex | 10.17615/r7v3-vk88 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417450863 | |||
| W4417471941 | Narrative review of dissertation research and innovations in Russian science (2012–2024) on malignant kidney tumors | 2025-12-18 | OpenAlex | 10.17650/1726-9776-2025-21-3-157-169 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417471941 | |||
| W7116125699 | Natural Interventions for Asthma: The Evolving Role of Nutraceuticals in Respiratory Care | 2025-12-18 | OpenAlex | 10.5281/zenodo.17972574 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7116125699 | |||
| W7135082370 | Root Cause Tracing Method for Industrial Process Systems Based on Extended Convergent Cross Mapping | 2025-12-18 | OpenAlex | 10.1109/raai67517.2025.11423372 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7135082370 | |||
| W7135037184 | XCAD: eXplainable Collusion and Adversary Detection Framework for Multi-Agent Systems | 2025-12-18 | OpenAlex | 10.1109/raai67517.2025.11423320 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7135037184 | |||
| W7133537986 | Dynamic Risk Stratification in ICU Sepsis: A Deep Reinforcement Learning Approach Using Synthetic Data | 2025-12-19 | OpenAlex | 10.1109/reacs67479.2025.11413339 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133537986 | |||
| W7116104340 | From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications | 2025-12-19 | OpenAlex | 10.55674/cs.v18i1.264689 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7116104340 | |||
| W4417516373 | Monographic Issue on Glucocorticoid Therapy in Critical Illness and Respiratory Disease | 2025-12-19 | OpenAlex | 10.1055/a-2751-9147 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417516373 | |||
| W7116732514 | Perspective Chapter: Statins Use in Cancer Treatment – Unraveling the Mechanisms and Future Therapeutic Frontiers | 2025-12-19 | OpenAlex | 10.5772/intechopen.1012091 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7116732514 | |||
| W4417524133 | Pleiotropy of glucagon-like peptide-1 receptor agonists: too much of a good thing? | 2025-12-19 | OpenAlex | 10.23736/s2724-5683.25.07174-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417524133 | |||
| W7119162320 | Weekly Journal Scan: In search for the optimal DAPT duration after percutaneous coronary intervention in patients with or without high bleeding risk | 2025-12-19 | OpenAlex | 10.1093/eurheartj/ehaf1070 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119162320 | |||
| W4417479511 | Why world models fail under intervention: Ontological–causal separation as a necessary structure | 2025-12-19 | OpenAlex | 10.21203/rs.3.rs-8377767/v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417479511 | |||
| W7153275774 | A Cognitive Operations Management (COM) Framework for Phishing Resilience: Quantifying User Decision Quality (UDQ) using Evidence Accumulation Modeling | 2025-12-20 | OpenAlex | 10.46254/ba08.20250193 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7153275774 | |||
| W7214551214 | Predicting Q-Day: A Fractal Mathematics Approach to Quantum Computing Timelines | 2025-12-20 | OpenAlex | 10.5281/zenodo.22995709 | Title/abstract | Excluded | E2: Mathematical/forecasting/AGI framework without a clinical primary task. | https://openalex.org/W7214551214 | |||
| W7116779269 | Rituximab in Connective Tissue Disease-Associated Interstitial Lung Disease: From Immunopathogenesis to Therapeutic Implications | 2025-12-20 | OpenAlex | 10.3390/ijms27010046 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7116779269 | |||
| W4417521493 | Role of Modern Technologies in Reshaping New Age Toxicology | 2025-12-20 | OpenAlex | 10.30574/msarr.2025.15.2.0162 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4417521493 | |||
| W7116650544 | Subjective cognitive impairment as a manifestation of Alzheimer's disease or emotional disorders | 2025-12-20 | OpenAlex | 10.14412/2074-2711-2025-6-99-105 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7116650544 | |||
| W7116652622 | Clinical Features and Risk Factors of Enfortumab Vedotin–Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study ( YUSHIMA Study) | 2025-12-21 | OpenAlex | 10.1111/iju.70329 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7116652622 | |||
| W4417537241 | DPDC-ILKM: A multi-agent integrated large knowledge model for intelligent maintenance of industrial swarm robotics | 2025-12-21 | OpenAlex | 10.1016/j.jii.2025.101044 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4417537241 | |||
| W7117143217 | A Reinforcement Learning Approach for Modeling Organic Compound-Induced Antimicrobial Resistance Dynamics | 2025-12-22 | OpenAlex | 10.64898/2025.12.18.695270 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7117143217 | |||
| W7116785526 | A proposed reference model for the deployment of an integrated ai system in a large oncology center under the EU AI Act and MDR. Part I: Strategic & Operational Framework | 2025-12-22 | OpenAlex | 10.31648/ts.12176 | Full text | Excluded | F1: The work defines an implementation-neutral governance reference architecture and deployment pathway. OnkoBot is explicitly a narrative benchmark/design probe, and detailed algorithms and extended evolution validation are deferred to later parts; it does not build/evaluate the adaptive LLM system required here. | https://openalex.org/W7116785526 | https://www.researchgate.net/publication/398962494_A_proposed_reference_model_for_the_deployment_of_an_integrated_ai_system_in_a_large_oncology_center_under_the_EU_AI_Act_and_MDR_Part_I_Strategic_Operational_Framework | Primary paper public author full-text; contribution, reference architecture, offline evolution and limitations sections read. Publisher direct route timed out. | |
| W7116702272 | Anal intraepithelial neoplasia in Ireland: practice patterns and the case for regionalisation | 2025-12-22 | OpenAlex | 10.1007/s11845-025-04186-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7116702272 | |||
| W7116988664 | Emerging Therapies in IgA Nephropathy: From A Proliferation-Inducing Ligand (APRIL) and B-cell Activating Factor (BAFF) Inhibitors to Precision Medicine | 2025-12-22 | OpenAlex | 10.7759/cureus.99870 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7116988664 | |||
| W7116700533 | Epidemiology and molecular typing of multidrug resistant Acinetobacter baumannii burn wound isolates from six Chinese provinces | 2025-12-22 | OpenAlex | 10.1038/s41598-025-31214-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7116700533 | |||
| W7217399223 | FAULT-TOLERANT CONTROL OF LOW-ALTITUDE UNMANNED AERIAL VEHICLE SWARMS USING A REDUCED-ORDER SLIDING MODE OBSERVER | 2025-12-22 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7217399223 | ||||
| W7117671353 | Future Horizons in Nuclear Medicine | 2025-12-22 | OpenAlex | 10.2174/9798898813543125010018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117671353 | |||
| W7116982159 | Invasive Pulmonary Aspergillosis in Non-Neutropenic Patients: An Evolving Clinical Paradigm | 2025-12-22 | OpenAlex | 10.3390/diagnostics16010034 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7116982159 | |||
| W7116685205 | Murine Organ Auto-Contouring in Small-Animal Precision Irradiation: A Comprehensive Approach Integrating Deep Learning and Contrast Enhancement for Onboard CBCT | 2025-12-22 | OpenAlex | 10.21203/rs.3.rs-6891084/v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7116685205 | |||
| W7151534346 | Roles de género y territorio en zonas altoandinas, conocimiento clave para la conservación de la biodiversidad: Caso San Pedro de Churco (Perú) | 2025-12-22 | OpenAlex | 10.21142/des-1704-2025-0093 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7151534346 | |||
| W7116841712 | THE SYMBIOTIC AXIS - A Common Language for Reading All Living Systems | 2025-12-22 | OpenAlex | 10.5281/zenodo.18018904 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7116841712 | |||
| W7116844275 | The Responsible Health AI Readiness and Maturity Index (RHAMI): Applications for a Global Narrative Review of Leading AI Use Cases in Public Health Nutrition | 2025-12-22 | OpenAlex | 10.3390/nu18010038 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7116844275 | |||
| W7118367785 | Un proyecto didáctico mediado por tecnología para afrontar conductas disruptivas de alumnos de educación primaria | 2025-12-22 | OpenAlex | 10.63664/ined16252025246 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7118367785 | |||
| W7116846102 | Uterine Fibroids: From Pathogenic Signalling and Molecular Classification to Precision Diagnosis and the Evolving Landscape of Minimally Invasive Management | 2025-12-22 | OpenAlex | 10.5281/zenodo.18022372 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7116846102 | |||
| W7117530101 | Chemotherapy: Complications and Anesthetic Considerations | 2025-12-23 | OpenAlex | 10.2174/9798898813727125010006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117530101 | |||
| W7117145978 | GLP-1 agonists in neurodegeneration: a multimodal biomarker-guided approach | 2025-12-23 | OpenAlex | 10.1016/j.molmed.2025.12.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117145978 | |||
| W7117471327 | Green-mediated ZnO Nanoparticles Using Cichorium intybus (Dandelion) Extract: A Novel Antifungal Approach against Drug-Resistant Candida albicans | 2025-12-23 | OpenAlex | 10.21608/ejbo.2025.422065.3444 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7117471327 | |||
| W7117577283 | Immunotherapy - Anesthetic Considerations | 2025-12-23 | OpenAlex | 10.2174/9798898813727125010007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117577283 | |||
| W7116968812 | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Mechanisms, Syndromes, and Management | 2025-12-23 | OpenAlex | 10.1097/iio.0000000000000597 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7116968812 | |||
| W7116842265 | Signs and symptoms of acute tacrolimus toxicity in solid organ transplant recipients: a scoping review protocol | 2025-12-23 | OpenAlex | 10.11124/jbies-24-00420 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7116842265 | |||
| W7117424106 | Transformación educativa a través de una comunidad de aprendizaje: una experiencia en la escuela primaria pública | 2025-12-23 | OpenAlex | 10.33010/ie_rie_rediech.v16i0.2554 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7117424106 | |||
| W7117469739 | Cordia Genus: a Glimpse of Chemical Composition and Bioactivity | 2025-12-24 | OpenAlex | 10.21608/ejchem.2025.427325.12398 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117469739 | |||
| W7117167492 | Exploring of AI-Powered Application in Chatbots for Future Development | 2025-12-24 | OpenAlex | 10.1201/9781998511358-10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117167492 | |||
| W7117161588 | Exploring the mechanisms and therapeutic role of γ-oryzanol in neuropathic pain: a systematic review | 2025-12-24 | OpenAlex | 10.1007/s10787-025-02100-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117161588 | |||
| W7117165850 | From Mechanism to Medicine: Peptide-Based Approaches for Cancer Diagnosis and Therapy | 2025-12-24 | OpenAlex | 10.3390/biom16010027 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117165850 | |||
| W7117317464 | Lung Cancer: The Current and Multimodality Treatment | 2025-12-24 | OpenAlex | 10.9734/jcti/2025/v15i4334 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117317464 | |||
| W7117151660 | Recent advances in theranostic-based extracellular vesicles in cancer stem cell diagnosis and therapy | 2025-12-24 | OpenAlex | 10.1080/1061186x.2025.2609201 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117151660 | |||
| W7117149151 | Reversible Heart Failure After Anthracycline and Alkylating Agent Chemotherapy | 2025-12-24 | OpenAlex | 10.7759/cureus.99997 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7117149151 | |||
| W7117127551 | Spectrum of Anti‐Neurofascin Neuropathies: A Retrospective Indian Cohort | 2025-12-24 | OpenAlex | 10.1002/mus.70121 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117127551 | |||
| W7117529889 | The Infectious Diseases Orchestrator: Embracing AI Literacy in the Agentic Era | 2025-12-24 | OpenAlex | 10.1093/ofid/ofaf794 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7117529889 | |||
| W7117148233 | The evolving landscape of KRAS-targeted therapy: mechanisms of resistance and emerging strategies | 2025-12-24 | OpenAlex | 10.1097/cad.0000000000001801 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117148233 | |||
| W7117683958 | Transthyretin Cardiac Amyloidosis and Heart Failure: State-of-the-Art Review and Practice Guidance | 2025-12-24 | OpenAlex | 10.31083/rcm46181 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117683958 | |||
| W7117407742 | Treat-to-target optimization of biologic therapy is effective on endoscopic and histologic outcomes in a real-life cohort of ulcerative colitis—the TACTIC-UC study | 2025-12-24 | OpenAlex | 10.1093/ecco-jcc/jjaf239 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117407742 | |||
| W7117429130 | ASAS-NANP symposium: mathematical modeling in animal nutrition: training the future generation in data and predictive analytics for sustainable development. A summary of the 2024 symposium | 2025-12-25 | OpenAlex | 10.1093/jas/skaf452 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117429130 | |||
| W7117244080 | Biologic Therapies for Type 2 Inflammatory Diseases: A Bibliometric Analysis of Publication Trends and Intellectual Structure | 2025-12-25 | OpenAlex | 10.18621/eurj.1821314 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117244080 | |||
| W7117257641 | Relapsed/refractory mycosis fungoides and Sezary syndrome: biology, clinical manifestations and therapeutic options | 2025-12-25 | OpenAlex | 10.1080/10428194.2025.2598662 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117257641 | |||
| W7117237350 | What's new in upper gastrointestinal pathology: Key updates and evolving challenges in 2026 | 2025-12-25 | OpenAlex | 10.1016/j.humpath.2025.106025 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117237350 | |||
| W7117323355 | Calcitonin Gene-Related Peptide Inhibitor Use in 2018–2023: A Retrospective Cohort Study Across Six Canadian Provinces | 2025-12-26 | OpenAlex | 10.1017/cjn.2025.10506 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117323355 | |||
| W7117362648 | Chemotherapy‐Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune‐Based Approaches | 2025-12-26 | OpenAlex | 10.1111/ejh.70105 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117362648 | |||
| W7220251532 | Integrating Nanotechnology into Pharmacology: A Comprehensive Review | 2025-12-26 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220251532 | ||||
| W7141047540 | Operationalizing Robotic and Autonomous Systems for Disaster Response and Emergency Logistics | 2025-12-26 | OpenAlex | 10.1109/icoias69065.2025.00019 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7141047540 | |||
| W7117295789 | Revisiting the use of steroids in oncology | 2025-12-26 | OpenAlex | 10.1007/s12032-025-03214-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117295789 | |||
| W7117303346 | Update on penile prosthesis | 2025-12-26 | OpenAlex | 10.4103/aja2025111 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117303346 | |||
| W7117358089 | A Global Review of Invasive Haemophilus Influenzae Diseases from 2000-2023: A Systematic Review of Current Status, Challenges, and Future Perspectives | 2025-12-27 | OpenAlex | 10.61440/jidt.2025.v3.47 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117358089 | |||
| W7117972977 | Breast cancer treatment and melatonin: a bibliometric analysis | 2025-12-27 | OpenAlex | 10.47582/jompac.1811112 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117972977 | |||
| W7125956630 | Changing Course | 2025-12-27 | OpenAlex | 10.1093/cid/ciaf720 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7125956630 | |||
| W7117371794 | Electrochemical synthesis of H2O2 integrates reaction mechanisms, reaction media, mass-transfer effects, and device design | 2025-12-27 | OpenAlex | 10.1016/j.cej.2025.172316 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7117371794 | |||
| W7117358298 | Molecular profiling and matched targeted treatment in cholangiocarcinoma: Results from the Italian dataset (ANITA) | 2025-12-27 | OpenAlex | 10.1016/j.jhep.2025.12.016 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117358298 | |||
| W7117354077 | Real-World Effectiveness of Advanced Therapies in Microscopic Colitis | 2025-12-27 | OpenAlex | 10.1016/j.cgh.2025.12.019 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117354077 | |||
| W7117358528 | Science and Challenges in Formulating Gummies as a Novel Oral Dosage Form: A Review | 2025-12-27 | OpenAlex | 10.30574/gscbps.2025.33.3.0521 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117358528; https://openalex.org/W7126098499 | |||
| W7117411034 | BENEFITS OF SENSOR INTEGRATION AND DATA FUSION IN CBRN AGENTS MEASUREMENTS | 2025-12-28 | OpenAlex | 10.5604/01.3001.0055.5459 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7117411034 | |||
| W7117463044 | HARLA-ED: Resolving Information Asymmetry and Enhancing Algorithmic Symmetry in Intelligent Educational Assessment via Hybrid Reinforcement Learning | 2025-12-28 | OpenAlex | 10.3390/sym18010058 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7117463044 | |||
| W7117418732 | Management of Chronic Urticaria : A Systematic Review of Allergic and Immunology | 2025-12-28 | OpenAlex | 10.70070/tftgbs90 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117418732 | |||
| W7133483936 | Modern infectious and immune-mediated causes of acute encephalitis in children | 2025-12-28 | OpenAlex | 10.15574/sp.2025.8(152).7078 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133483936 | |||
| W7117473044 | Postoperative Recurrence in Crohn’s Disease: Pathophysiology, Risk Stratification, and Management Strategies | 2025-12-28 | OpenAlex | 10.3390/jcm15010243 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117473044 | |||
| W7219858579 | Virtual Oncology: Digital Twins for Predicting Cancer Evolution, Therapeutic Response, and Clinical Outcomes | 2025-12-28 | OpenAlex | 10.65477/qe07zn79 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7219858579 | |||
| W7117473579 | Beyond a Conduit: The Evolution of Functional Biliary Stents From Active Intervention to Enabling Platforms | 2025-12-29 | OpenAlex | 10.1002/inm3.70009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117473579 | |||
| W7117480253 | Clinical Features and Outcomes of Severe Pneumonia in Pediatric Human Metapneumovirus Infections | 2025-12-29 | OpenAlex | 10.5152/turkarchpediatr.2025.25295 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117480253 | |||
| W7147231178 | Ep. 123: The Agentic AI Dilemma: Who Holds the Kill Switch? | 2025-12-29 | OpenAlex | 10.5281/zenodo.19357821 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147231178 | |||
| W7117468958 | Fever of unknown origin, muscle weakness, and an adrenal nodule—the cat we chased like a hare: a case report | 2025-12-29 | OpenAlex | 10.1186/s13256-025-05656-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117468958 | |||
| W7117866485 | Generative AI versus human conversational agent for reducing procrastination: A single-blinded randomized controlled pilot trial (Preprint) | 2025-12-29 | OpenAlex | 10.2196/preprints.90486 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7117866485 | |||
| W7117565863 | Pharmacologic glycemic management of type 2 diabetes | 2025-12-29 | OpenAlex | 10.1016/b978-0-443-13825-6.00284-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117565863 | |||
| W7118125455 | Planejamento da paisagem e crescimento habitacional em área de mananciais em Presidente Prudente-SP | 2025-12-29 | OpenAlex | 10.17271/23188472139020256187 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7118125455 | |||
| W7117476120 | The Temozolomide Mutational Signature: Mechanisms, Clinical Implications, and Therapeutic Opportunities in Primary Brain Tumor Management | 2025-12-29 | OpenAlex | 10.3390/cells15010057 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117476120 | |||
| W7117529687 | A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies | 2025-12-30 | OpenAlex | 10.18231/j.ijced.13629.1765276898 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117529687 | |||
| W7118008954 | APPLICATION OF STEM CELLS AND THEIR DERIVATIVES AS DRUG DELIVERY SYSTEMS | 2025-12-30 | OpenAlex | 10.20473/jscrte.v9i2.85312 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118008954 | |||
| W7140294532 | Adaptive system of teacher professional development | 2025-12-30 | OpenAlex | 10.26565/2074-8167-2025-57-12 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7140294532 | |||
| W7117559202 | Chikungunya virus seroprevalence among febrile patients in selected health facilities in Mount Elgon region, Kenya | 2025-12-30 | OpenAlex | 10.1371/journal.pntd.0012169 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117559202 | |||
| W7117584167 | Current Therapeutic Approaches in Infantile Colic: A Comprehensive Review | 2025-12-30 | OpenAlex | 10.5152/turkarchpediatr.2025.25388 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117584167 | |||
| W7117576344 | Healing Environments for Cancer Care: Toward a Patient-Centered Design Guideline for Inpatient Settings | 2025-12-30 | OpenAlex | 10.1177/19375867251406202 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117576344 | |||
| W7128303481 | Modern methods of functional diagnosis of cardiovascular diseases | 2025-12-30 | OpenAlex | 10.15275/pssr.2025.0403 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128303481 | |||
| W7127983456 | Multi-scale computational frameworks for predicting biomaterial-host interactions | 2025-12-30 | OpenAlex | 10.70974/mat09225112 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7127983456 | |||
| W7117699576 | Next-Generation SGLT2 Inhibitors: Innovations and Clinical Perspectives | 2025-12-30 | OpenAlex | 10.3390/biomedicines14010081 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117699576 | |||
| W7220427726 | Phage-Derived Endolysin PlyPM1 as a Rapid Enzybiotic for Detection and Lysis of Proteus mirabilis in Clinical Urine Samples. | 2025-12-30 | OpenAlex | 10.64105/as4b9a61 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220427726 | |||
| W7117556849 | Platinum complexes of N-donor ligands bearing sulfonamide groups as anti-cancer agents: A review | 2025-12-30 | OpenAlex | 10.31357/vjs.v28i02.8727 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117556849 | |||
| W7117534914 | Rise of the Self-Driven Machine | 2025-12-30 | OpenAlex | 10.4018/979-8-3373-7006-4.ch010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117534914 | |||
| W7117958995 | A Comprehensive Review on Anti-Viral Drugs | 2025-12-31 | OpenAlex | 10.55041/ijsrem55419 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117958995 | |||
| W7117786494 | ACNE VULGARIS: PATHOGENESIS AND MANAGEMENT WITH LONG-PULSED ND:YAG (1064 NM) LASER THERAPY – A SYSTEMATIC REVIEW | 2025-12-31 | OpenAlex | 10.31612/2616-4868.8.2025.15 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117786494 | |||
| W7117768561 | Addressing the gaps in biologic therapy utilization trends in IBD from Saudi Arabia | 2025-12-31 | OpenAlex | 10.4103/sjg.sjg_432_25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117768561 | |||
| W7117729088 | American Society of Transplantation and Cellular Therapy Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma | 2025-12-31 | OpenAlex | 10.1016/j.jtct.2025.12.944 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117729088 | |||
| W7161141650 | Cloud-Native AI-Driven Enterprise Automation for Scalable Digital Process Transformation in Multi-Industry Ecosystems | 2025-12-31 | OpenAlex | 10.71426/jasm.v1.i1.pp60-74 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161141650 | |||
| W7154966786 | Comparative accuracy of chatbots for queries related to methods of tobacco cessation: A systematic review | 2025-12-31 | OpenAlex | 10.56450/jefi.2025.v3i2suppl.068 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154966786 | |||
| W7118425546 | Diagnosis and management of carotid artery stenosis: pathophysiology, advanced imaging, and evolving revascularization strategies | 2025-12-31 | OpenAlex | 10.51271/ajnn-0038 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7118425546 | |||
| W7125772215 | Emerging Therapeutic Strategies in Psoriasis: From Pathogenesis to Personalized Care | 2025-12-31 | OpenAlex | 10.61554/ijnrph.v3i2.2025.194 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125772215 | |||
| W7117649372 | Fluorescence-Guided Surgery in Pediatric Oncology: Current Practice and Future Directions | 2025-12-31 | OpenAlex | 10.3390/cancers18010149 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117649372 | |||
| W7117719467 | Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far? | 2025-12-31 | OpenAlex | 10.1016/j.ctrv.2025.103083 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117719467 | |||
| W7125810672 | Pharmacological Approaches to the Management of Long COVID | 2025-12-31 | OpenAlex | 10.21124/tpt.2025.159.166 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125810672 | |||
| W7117762302 | Redefining Cardiac Sarcoidosis with Advanced Imaging and Therapeutic Strategies | 2025-12-31 | OpenAlex | 10.1007/s40256-025-00783-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117762302 | |||
| W7163895092 | Targeting ESR1 mutations: Imlunestrant and the next chapter in ER-positive breast cancer care | 2025-12-31 | OpenAlex | 10.46439/oncology.1.008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163895092 | |||
| W7117705652 | Temporal Trends and Outcomes of Amyloidosis in Korea: A 14-Year Nationwide Cohort Study | 2025-12-31 | OpenAlex | 10.3390/jcm15010313 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7117705652 | |||
| W7125491240 | Trends in Medicare Part D Spending on Antifibrotic Therapies for Pulmonary Fibrosis: 2019–2023 | 2025-12-31 | OpenAlex | 10.61440/jghsm.2025.v1.16 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7125491240; https://openalex.org/W4412866904 | |||
| W7206205056 | 10M-Belgium: 10 Million Patient Years – Belgian Evaluation of Lipid therapy Growth, Intensification, Use and Management | 2026-01-01 | OpenAlex | 10.2139/ssrn.7386806 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7206205056 | |||
| W7223121921 | 2026 Field Guide to Scientific Operating Systems for Longitudinal Disease Research: Architectures, Workflows, Validation Frameworks, and Emerging Directions in ML-Enabled Biomedical Research | 2026-01-01 | OpenAlex | 10.14283/vme.2026.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223121921 | |||
| W7149944731 | 7P Digital Marketing Theory (Participants, Processes, Presence, Personalization, Performance, Partnership, and Privacy) | 2026-01-01 | OpenAlex | 10.17605/osf.io/w792k | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7149944731 | |||
| W7163051160 | A Conceptual Integrated AI Framework and Research Agenda for Personalized Adaptive Assessment Using NLP, Reinforcement Learning, and Adversarial Response Modeling | 2026-01-01 | OpenAlex | 10.1007/978-981-92-0042-9_36 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163051160 | |||
| W7154493108 | A Large Language Model–Driven Agent Framework for Sepsis Clinical Decision Support: A Retrospective Multicohort Study | 2026-01-01 | OpenAlex | 10.2139/ssrn.6541701 | Full text | Excluded | F4: A predefined-prompt Llama3.1-70B LangGraph orchestrator calls fixed predictive modules and retrieves external sepsis-guideline knowledge. State persistence and clinician interaction nodes support the current clinical workflow; no experience-derived change reused across different admissions is documented. FusionPredictor is conventional supervised model development, rather than an interactive LLM agent-learning loop. | https://openalex.org/W7154493108 | https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6541701 | Online20-page SSRN PDF pp4,6–8, including Construction of an LLM-Based Clinical Decision Support Agent, read. Existing source distinct from wu2026sepsisagent; no file archive/download. | |
| W7204473787 | A Layered Architecture for Autonomous On-Chain Agents from Ethereum ERC/EIP Specifications | 2026-01-01 | OpenAlex | 10.2139/ssrn.7353941 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204473787 | |||
| W7166025568 | A Multi-agent Instructional Support System for Human-AI Collaborative Diagnostic Problem Solving: Classroom Evidence | 2026-01-01 | OpenAlex | 10.1007/978-3-032-29788-4_74 | Full text | Excluded | F5: Public publisher and author/repository routes did not provide full methods. The root agent also checked the publisher with the existing Tohoku University browser entitlement; only a subscription preview was available. LLM status, clinical-main focus and/or cross-case retention remain unresolved, rather than inferred absent from the abstract. | https://openalex.org/W7166025568 | https://link.springer.com/chapter/10.1007/978-3-032-29788-4_74 | Bibliographic information and available abstract/preview only; no full methods read. | |
| W7221331123 | A Physics-Guided Neuro-Symbolic Agent Framework for Servo Motor Fault Diagnosis with Hallucination Suppression | 2026-01-01 | OpenAlex | 10.2139/ssrn.7592695 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7221331123 | |||
| W7127296543 | A Proposed Unified Nursing Curriculum | 2026-01-01 | OpenAlex | 10.1891/9780826151575.0011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127296543 | |||
| W7161979189 | A Review of β ‐Lactamase Inhibitors in Clinical Use and Development: Mechanisms, Spectrum, and Therapeutic Applications | 2026-01-01 | OpenAlex | 10.1155/ijm/4479031 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161979189 | |||
| W7166818071 | A Self-Evolving LLM Agent Framework for Role-Based Norm Compliance in Healthcare | 2026-01-01 | OpenAlex | 10.18653/v1/2026.findings-acl.1133 | Full text | Included | Included: Norm memory and role prompts are updated across healthcare communication episodes. | https://openalex.org/W7166818071 | https://aclanthology.org/2026.findings-acl.1133.pdf | ||
| W7171538005 | A Survey for LLM Agent Trajectory Analysis: From Failure Attribution to Enhancement | 2026-01-01 | OpenAlex | 10.1109/tse.2026.3717765 | Title/abstract | Excluded | E1: Survey/taxonomy or discussion of existing applications; not a newly built or evaluated adapting clinical agent. | https://openalex.org/W7171538005 | |||
| W7172299938 | A Survey on Agentic AI: Applications, Challenges and Evaluation Frameworks | 2026-01-01 | OpenAlex | 10.1007/978-3-032-28310-8_28 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7172299938 | |||
| W7203571512 | A Unified Hydrometeorological Framework for Preconditioning and Triggering of Rainfall-Induced Slope Failures under Climate Change: A National-Scale Theoretical Perspective from Italy | 2026-01-01 | OpenAlex | 10.2139/ssrn.7294694 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203571512 | |||
| W7221085682 | A conceptual model and research framework for urban territorial spatial layout optimization under the human-technology-space integration paradigm | 2026-01-01 | OpenAlex | 10.31497/zrzyxb.20261205 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221085682 | |||
| W7160913707 | A grounded theory study – community palliative care clinical nurse specialists’ experiences when fulfilling their role | 2026-01-01 | OpenAlex | 10.17635/lancaster/thesis/3240 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160913707 | |||
| W7162411888 | A modified ‘Puncture–Aspiration–Injection–Re-aspiration’ (PAIR) technique to treat Hepatic Cystic Echinococcosis: A retrospective case series and narrative review | 2026-01-01 | OpenAlex | 10.1017/s0022149x26101503 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162411888 | |||
| W7127606383 | A new era in transplantation: Overcoming COVID-19 challenges | 2026-01-01 | OpenAlex | 10.1016/j.clinpr.2026.100540 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127606383 | |||
| W7118265203 | A scientometric study on research trends and characteristics of oral health-related quality of life among head and neck cancer patients | 2026-01-01 | OpenAlex | 10.1016/j.jds.2025.12.031 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118265203 | |||
| W7169862806 | AARD: A Risk-Aware Agentic AI Framework for Sequential Clinical Decision Support Using Large Language Models | 2026-01-01 | OpenAlex | 10.5220/0015079400005051 | Full text | Excluded | F3: AARD uses ClinicalBERT only to encode clinical text (§4.6), while a DQN is the acting policy (§3.2). It does not implement an LLM/VLM-based acting agent. | https://openalex.org/W7169862806 | https://doi.org/10.5220/0015079400005051 | ||
| W7224461301 | ACIES: A Self-Evolving Agentic Contract-Based Framework for Cyber-Physical System Control Synthesis | 2026-01-01 | OpenAlex | 10.18653/2026.realm-1.36 | Title/abstract | Excluded | E2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task. | https://openalex.org/W7224461301 | |||
| W7221808659 | ACUTE MYELOID LEUKEMIA, MINIMALLY DIFFERENTIATED, ACUTE MYELOID LEUKEMIA WITHOUT MATURATION, ACUTE MYELOID LEUKEMIA WITH MATURATION | 2026-01-01 | OpenAlex | 10.5336/978-625-91119-4-0_p205 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221808659 | |||
| W7164522947 | AI Cybersecurity for Tackling LLM Security | 2026-01-01 | OpenAlex | 10.1007/978-3-032-25874-8_21 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164522947 | |||
| W7154382200 | AI Moral Patiency and Moral Dissonance: Almost Human, Almost Deserving Moral Treatment | 2026-01-01 | OpenAlex | 10.24251/hicss.2026.069 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154382200 | |||
| W7211964782 | AI agents in cancer imaging: Concepts, advances, and clinical perspectives | 2026-01-01 | OpenAlex | 10.21147/j.issn.1000-9604.2026.04.05 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7211964782 | |||
| W4415153615 | AI and the Relationship Between Agency, Autonomy, and Moral Patiency | 2026-01-01 | OpenAlex | 2504.08853 | 10.1007/978-3-032-14537-6_3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W4415153615 | ||
| W7121532528 | ARTIFICIAL INTELLIGENCE BY Dr. Laxmi Choudhary,Mrs. Bhanupriya Sharma,Mr. Avinash Bhandiya,Dr. Satya Narayan | 2026-01-01 | OpenAlex | 10.5281/zenodo.18206356 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7121532528 | |||
| W7139948671 | Actinomycetes metabolites and its application for pharmaceutical industry | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-36411-2.00018-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139948671 | |||
| W7223845008 | Acupuncture-Moxibustion for Facial Paralysis: Theoretical Origins in Traditional Chinese Medicine and Advances in Clinical Research | 2026-01-01 | OpenAlex | 10.12677/acm.2026.16103470 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223845008 | |||
| W7161007651 | Adapting Federated Learning to Concept Drift: Challenges, Opportunities, And Future Directions | 2026-01-01 | OpenAlex | 10.25397/b7bx-rc93 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161007651 | |||
| W7160875479 | Adaptive Zero Trust Governance Framework for Autonomous and Agentic Digital Systems Using AI-Driven Risk Scoring | 2026-01-01 | OpenAlex | 10.2139/ssrn.6677379 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160875479 | |||
| W7118076723 | Advancements in Alginate‐Based Biomaterials for Enhanced Skin Regeneration: A Comprehensive Review | 2026-01-01 | OpenAlex | 10.1155/ijps/8996702 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118076723 | |||
| W7161974043 | Advancements in Intraoperative Imaging for Enhanced Surgical Precision | 2026-01-01 | OpenAlex | 10.1007/978-3-032-21415-7_13 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161974043 | |||
| W7171679081 | Advancements in Molecular and Serological Methods for Diagnosing SARS-CoV-2 | 2026-01-01 | OpenAlex | 10.2139/ssrn.6996700 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171679081 | |||
| W7152572276 | Advancements in contact lens technology: A comprehensive review of current materials and future prospects | 2026-01-01 | OpenAlex | 10.33545/26648547.2026.v8.i1a.68 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152572276 | |||
| W7167592824 | Advancements in diagnosis and treatments of acute leukemia | 2026-01-01 | OpenAlex | 10.21147/j.issn.1000-9604.2026.03.09 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167592824 | |||
| W7161134366 | Advances in Atopic Dermatitis Management: The Role of Lebrikizumab | 2026-01-01 | OpenAlex | 10.1155/dth/1682557 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161134366 | |||
| W7161643167 | Advances in Contrast-Enhanced Maxillofacial Radiology | 2026-01-01 | OpenAlex | 10.1007/978-981-92-0489-2_9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161643167 | |||
| W7166838579 | Advances in Pharmacology: Looks at Emerging Pharmaceutical Approaches to Pain Management | 2026-01-01 | OpenAlex | 10.1007/978-3-032-11484-6_30 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166838579 | |||
| W7163515441 | Advances in RNA based therapeutics for atherosclerosis: From bench to bedside | 2026-01-01 | OpenAlex | 10.61577/ijcri.2025.1000020 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163515441 | |||
| W7201874051 | Advances in Small-Molecule Inhibitors for Targeted Cancer Therapy | 2026-01-01 | OpenAlex | 10.1007/978-981-92-0477-9_6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7201874051 | |||
| W7139924542 | Advances in antibacterial material development | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-36518-8.00007-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139924542 | |||
| W7130329180 | Advances in the Treatment of Erectile Dysfunction | 2026-01-01 | OpenAlex | 10.1007/978-3-032-12423-4_4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130329180 | |||
| W7120007876 | Advances in the treatment of large granular lymphocytic leukemia | 2026-01-01 | OpenAlex | 10.6084/m9.figshare.31036035 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7120007876; https://openalex.org/W7119491463 | |||
| W7202170188 | Agent Architectures and the PARM Framework | 2026-01-01 | OpenAlex | 10.1007/978-3-032-26723-8_4 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7202170188 | |||
| W7119737981 | Agent-Based Flood Evacuation Modeling: Optimizing Transportation, Shelter Allocation and Traffic Control | 2026-01-01 | OpenAlex | 10.1007/978-3-032-13026-6_1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7119737981 | |||
| W7160555226 | Agent-in-Cell Modeling of Pandemics | 2026-01-01 | OpenAlex | 10.1007/978-3-032-06125-6_5 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7160555226 | |||
| W7224444120 | AgentTAC: Mining Temporal Action-Context Error Patterns from Agent Traces | 2026-01-01 | OpenAlex | 10.18653/2026.emnlp-main.1637 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7224444120 | |||
| W7134948360 | Agentic AI for Clinical Decision Orchestration in Healthcare Systems | 2026-01-01 | OpenAlex | 10.2139/ssrn.6185219 | Full text | Excluded | F1: The primary abstract presents a conceptual orchestration framework and evaluation perspective, rather than building/evaluating a retained-improving agent. | https://openalex.org/W7134948360; https://openalex.org/W7134232517 | https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6185219 | complete original SSRN abstract/metadata only; PDF403 | |
| W7203837975 | Agentic AI in Healthcare: Current Applications, Challenges, and Future Directions | 2026-01-01 | OpenAlex | 10.1109/access.2026.3725858 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7203837975 | |||
| W7164082383 | Agentic AI in Medical Image Analysis: A Preliminary PRISMA-Guided Evidence Map | 2026-01-01 | OpenAlex | 10.17605/osf.io/6hd4r | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7164082383 | |||
| W7202247216 | Agentic AI in the Age of Autonomy with Concepts and Case Studies | 2026-01-01 | OpenAlex | 10.2139/ssrn.7239460 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7202247216; https://openalex.org/W7170055745 | |||
| W7163546564 | Agentic AI-Driven bio-digital twins: A self-adaptive framework for personalized disease prediction and therapy design | 2026-01-01 | OpenAlex | 10.1063/5.0327306 | Full text | Excluded | F5: The public primary-source and author/repository discovery routes did not provide full methods. Root browser access to the AIP DOI is blocked by a Cloudflare security verification page. LLM acting role and cross-case retention remain unresolved; no challenge was solved or bypassed. | https://openalex.org/W7163546564 | https://doi.org/10.1063/5.0327306 | Archived abstract plus actual publisher-browser access failure; no full methods read. | |
| W7204562368 | Agentic AI-Powered Sensors-Based Privacy-Preserving Postquantum Secure Authentication for IoT-Enabled Medical Cyber-Physical Environment | 2026-01-01 | OpenAlex | 10.1109/jsas.2026.3728328 | Full text | Excluded | F4: Algorithm1 retrieves stored historical patient feature vectors and retries the current report at most three times under fixed similarity/verification thresholds. It does not write an experience-derived lesson, skill, prompt or updated agent policy for later patients. Historical clinical evidence retrieval is not itself agent learning. | https://openalex.org/W7204562368 | https://ieeexplore.ieee.org/document/11668650 | Online publisher PDF; network model, Algorithm1, feature/thinker definitions and26-patient experimental results read. | |
| W7165518071 | Agentic Artificial Intelligence in Healthcare and Medicine | 2026-01-01 | OpenAlex | 10.17605/osf.io/y3s75 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7165518071 | |||
| W7161772074 | Agentic LLM Approach to Automated LOINC Code Assignment for Internal Laboratory Tests | 2026-01-01 | OpenAlex | 10.1007/978-3-032-26363-6_17 | Full text | Excluded | F4: Every laboratory test starts a new session with a fixed system prompt. Query/candidate tracking and correction are confined to that test; no learned experience artifact is retained for different tests. | https://openalex.org/W7161772074 | https://link.springer.com/chapter/10.1007/978-3-032-26363-6_17 | Publisher full HTML through existing Tohoku University entitlement; specified methods/evaluation sections read. | |
| W7167344731 | Agentic LLMs for Scalable, Verifiable System Health Digital Twins | 2026-01-01 | OpenAlex | 10.54941/ahfe1007674 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7167344731 | |||
| W7214540193 | Agentic Reasoning for Large Language Models: Foundations, Evolution, and Collective Intelligence — A Comprehensive Academic Review | 2026-01-01 | OpenAlex | 10.5281/zenodo.22993753 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214540193 | |||
| W7163588815 | Agentic artificial intelligence in nutrition: from isolated screening tools to autonomous nutritional support systems | 2026-01-01 | OpenAlex | 10.20960/nh.06908 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163588815 | |||
| W7171743645 | Agentic multimodal LLM-augmented expert system with physics-aware dual-index RAG for metal additive manufacturing | 2026-01-01 | OpenAlex | 10.2139/ssrn.6170301 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171743645; https://openalex.org/W7222449485 | |||
| W7165615508 | Alpha2 Agonists | 2026-01-01 | OpenAlex | 10.1007/978-3-032-21675-5_9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165615508 | |||
| W7224692345 | Ambiguous control: Designing for indeterminacy and agency negotiation | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7224692345 | ||||
| W7215090837 | An Adaptive Edge-Cloud Computing Architecture for Real-Time Intelligent Resource Allocation Using Machine Learning | 2026-01-01 | OpenAlex | 10.51483/ijaiml.6.12s.2026.871-881 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7215090837 | |||
| W7213544544 | An Agentic Multimodal Framework for Reliable Medical Reasoning under Privacy Constraints | 2026-01-01 | OpenAlex | 10.4108/eai.22-5-2026.2365100 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7213544544 | |||
| W7213247911 | An Interpretable Artificial Intelligence Workflow for Metacognitive Reflection Feedback | 2026-01-01 | OpenAlex | 10.2139/ssrn.7465164 | Full text | Excluded | F2: The method addresses educational metacognitive reflection without clinical cases; healthcare is not the primary task. | https://openalex.org/W7213247911 | https://papers.ssrn.com/sol3/Delivery.cfm/7465164.pdf?abstractid=7465164&mirid=1 | SSRN abstract only; PDF403 | |
| W7172111063 | Anaesthesia Workstation | 2026-01-01 | OpenAlex | 10.1007/978-981-95-9019-3_8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172111063 | |||
| W7133320785 | Analysis of Illicit Street Heroin Seized in Pakistan by Gas Chromatography–Mass Spectrometry (GC‐MS) for Identification of Adulterants and Impurities | 2026-01-01 | OpenAlex | 10.1155/ianc/4301930 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7133320785 | |||
| W7161483032 | Antithrombotic and Anticoagulant Therapy in Renal Dysfunction | 2026-01-01 | OpenAlex | 10.1007/978-3-032-25434-4_9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161483032 | |||
| W7128693995 | Aprocitentan: An Oral, Once-daily Antihypertensive Therapy for Resistant Hypertension in Adult Patients | 2026-01-01 | OpenAlex | 10.17925/hi.2026.20.1.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128693995 | |||
| W7202251824 | Architectures for Adaptive and Assistive AI Systems: Multi-Agent Reasoning, Brain-Computer Interfaces, and Conversational Agents in Education and Healthcare | 2026-01-01 | OpenAlex | 10.2139/ssrn.7260758 | Title/abstract | Excluded | E5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established. | https://openalex.org/W7202251824 | |||
| W7204924954 | Artificial Intelligence Applications in Bacteriophage Genomics and Host Interaction | 2026-01-01 | OpenAlex | 10.1007/978-1-0716-5408-8_18 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204924954 | |||
| W7163913493 | Artificial Intelligence Behavioral Pathology as an Epistemological Framework: Towards Pre-Execution Reasoning Chain Interception for Auditable AI Governance | 2026-01-01 | OpenAlex | 10.2139/ssrn.6857438 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163913493 | |||
| W7136561786 | Artificial Intelligence and Machine Learning for Personalized Nutrition and Health Management | 2026-01-01 | OpenAlex | 10.2139/ssrn.6401958 | Full text | Excluded | F1: The newly retrieved primary abstract explicitly identifies this as a PRISMA-based literature review of AI-enabled personalized nutrition, rather than an implemented agent study. | https://openalex.org/W7136561786 | https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6401958 | Primary SSRN abstract only; full methods not read. | |
| W7154473783 | Artificial Intelligence and Machine Learning in Mental Health: A Bibliometric Analysis of Evolving Trends | 2026-01-01 | OpenAlex | 10.1007/978-3-032-18716-1_34 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154473783 | |||
| W7214494334 | Artificial Intelligence as a Psychological Companion: Opportunities, Challenges, and Future Directions | 2026-01-01 | OpenAlex | 10.47772/ijriss.2026.102400013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214494334 | |||
| W7222663269 | Artificial Intelligence in Modern Computing: A Comprehensive Review of Applications, Challenges, and Future Trends | 2026-01-01 | OpenAlex | 10.51483/ijaiml.6.13s.2026.168-177 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222663269 | |||
| W7213443757 | Artificial Intelligence in Telemedicine: philosophical, ethical, and epistemological dimensions of a transforming practice | 2026-01-01 | OpenAlex | 10.31744/einstein_journal/2026ae2371 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213443757 | |||
| W7161771661 | Association of hypomethylating agents + venetoclax in the real-life treatment of Myeloproliferative Neoplasms in blastic phase | 2026-01-01 | OpenAlex | 10.1016/j.leukres.2026.108255 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161771661; https://openalex.org/W4389220347 | |||
| W7167586357 | Atypical and Extreme Manifestations of Delusional Parasitosis: A Case-Based Narrative Review | 2026-01-01 | OpenAlex | 10.69980/ajbr.v29i1s.9841 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167586357 | |||
| W7224626385 | AuroraCounsel: A Multi-Agent Large Language Model Collaboration Framework for Psychological Counseling | 2026-01-01 | OpenAlex | 10.18653/2026.emnlp-main.132 | Full text | Excluded | F4: The guidance model receives one-off SFT/GRPO on fixed PsyDTCorpus contexts; Appendix B.2 samples six responses per prompt for response-level rewards. Emotion routing and reflection are within the current dialogue. No interactive environment learning or cross-case experience artifact is retained. | https://openalex.org/W7224626385 | https://aclanthology.org/2026.emnlp-main.132.pdf | ||
| W7130946603 | Automated Real-Time Screening of Phytochemicals and Cancer Therapeutics | 2026-01-01 | OpenAlex | 10.1007/978-3-032-15493-4_11 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7130946603 | |||
| W7223789053 | Autonomous Enterprise Intelligence Platforms Enabled by Collaborative Multi-Agent Large Language Models | 2026-01-01 | OpenAlex | 10.64137/31079458/ijcsei-v2i3p103 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7223789053 | |||
| W7211896264 | Autonomous Knowledge Graph Construction and Self-organization via Agentic AI and Large Language Models | 2026-01-01 | OpenAlex | 10.1007/978-3-032-27691-9_3 | Full text | Excluded | F2: The knowledge-graph method spans scientific, enterprise and medical domains; medicine is one domain under existing P2. | https://openalex.org/W7211896264 | https://link.springer.com/chapter/10.1007/978-3-032-27691-9_3 | publisher abstract only; subscription preview | |
| W7141285253 | Bacillus coagulans: basic and applied aspects | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-40483-2.00038-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7141285253 | |||
| W7172449276 | Balancing Autonomy, Individual Rights, and Community Values in Islāmic Psychotherapy | 2026-01-01 | OpenAlex | 10.1007/978-3-032-26515-9_7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172449276 | |||
| W7213933228 | Benchmarking Evolvable Medical Agents Beyond First Pass | 2026-01-01 | OpenAlex | 10.2139/ssrn.7482718 | Full text | Excluded | F1: This is a companion evaluation protocol/benchmark proposal. Its references to an earlier 300-task experiment are not a new adaptive-system study. | https://openalex.org/W7213933228 | https://papers.ssrn.com/sol3/papers.cfm?abstract_id=7482718 | SSRN abstract only; PDF403 | |
| W7127127368 | Beyond Adoption: A Scoping Review on an Eight-Stage Cognitive Framework for Human–AI Partnership in Medical Profession | 2026-01-01 | OpenAlex | 10.17605/osf.io/apdf4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127127368 | |||
| W7165760056 | Beyond Paradigms: RMKO Framework for Job Recommender Systems from Classical to Agentic Architectures | 2026-01-01 | OpenAlex | 10.2139/ssrn.6989759 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7165760056 | |||
| W7166862900 | Beyond Retrieval: Bi-Temporal State Arbitration for Longitudinal Healthcare Agents | 2026-01-01 | OpenAlex | 10.18653/v1/2026.knowfm-1.10 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7166862900 | |||
| W7172442035 | Beyond Static Agents: A Six-Dimensional Taxonomy and Survey of Self-Evolving LLM Agents for Healthcare | 2026-01-01 | OpenAlex | 10.1109/access.2026.3720396 | Title/abstract | Excluded | E1: Survey/taxonomy or discussion of existing applications; not a newly built or evaluated adapting clinical agent. | https://openalex.org/W7172442035 | |||
| W7221311434 | Beyond the Procedure Day: Chronic Gastrointestinal and Nutritional Sequelae of Sustained Glucagon-Like Peptide-1 Receptor Agonist Therapy: Implications for the Internist | 2026-01-01 | OpenAlex | 10.14740/jcp5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221311434 | |||
| W7133909720 | Biofilm-Associated Hospital Acquired Infection: Epidemiology, Diagnosis and Management- A Review | 2026-01-01 | OpenAlex | 10.65525/svup.9788199565487.2026.63-80 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133909720 | |||
| W7166127015 | Biomanufacturing of mesenchymal stem cells and extracellular vesicles: challenges and advances in isolation, scale-up, storage, transportation, and beyond | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-45056-3.00005-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166127015 | |||
| W7204538122 | Biosimilars and biologics in the treatment of brain tumor | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-43824-0.00001-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204538122 | |||
| W7203470039 | Botanicals for immune system support | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-44295-7.00011-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203470039 | |||
| W7118303035 | Breast Cancer: Molecular Pathogenesis, Targeted Therapy, Screening, and Prevention | 2026-01-01 | OpenAlex | 10.1002/mco2.70560 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118303035 | |||
| W7224682235 | BridgeGap: Belief-Grounded Training for Medical Dialogue Agents | 2026-01-01 | OpenAlex | 10.18653/2026.emnlp-main.1974 | Full text | Included | Included: PPO updates a diagnostic dialogue policy across interactive episodes with a frozen patient simulator; the resulting weights are reused on separate clinical benchmarks. | https://openalex.org/W7224682235 | https://aclanthology.org/2026.emnlp-main.1974.pdf | ||
| W7205015807 | Bridging Individual Trajectories and Population Dynamics through A Multi-scale Health World Model | 2026-01-01 | OpenAlex | 10.2139/ssrn.7384522 | Full text | Excluded | F3: The primary SSRN abstract defines coupled continuous-time stochastic micro/macro world-model dynamics and a distribution-aware population interface; it does not describe an LLM/VLM acting-agent system. | https://openalex.org/W7205015807 | https://papers.ssrn.com/sol3/papers.cfm?abstract_id=7384522 | Primary SSRN abstract only; full methods not read. | |
| W7196957021 | Building real-world generalist computer agents: environment, framework, and training | 2026-01-01 | OpenAlex | 10.32657/10356/219055 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7196957021 | |||
| W7213394120 | CAR T-Cell Therapy in Systemic Lupus Erythematosus: Mechanistic Rationale, Early Clinical Experience, and Future Challenges | 2026-01-01 | OpenAlex | 10.31138/mjr.171125.mer | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213394120 | |||
| W7143358747 | CARDIAC INVOLVEMENT IN ANAPHYLAXIS | 2026-01-01 | OpenAlex | 10.5336/978-625-395-881-7_p375 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143358747 | |||
| W7151805067 | CBRN threat landscape, emergency preparedness, and response | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-43986-5.00003-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151805067 | |||
| W7135405562 | CDIL-RSI: Capability-Reconfigured Cyclic Distinction-Integration Learning as a Sovereignty-Preserving Architecture for Recursive Self-Improvement | 2026-01-01 | OpenAlex | 10.6084/m9.figshare.31724401 | Title/abstract | Excluded | E1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system. | https://openalex.org/W7135405562 | |||
| W7203906691 | CDK4/6 inhibitors: Future perspectives | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-44611-5.00009-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203906691 | |||
| W7214187200 | CHEMOTHERAPY AND RADIOTHERAPY APPROACHES IN MALIGNANT CARDIAC TUMORS | 2026-01-01 | OpenAlex | 10.5336/978-625-91031-8-1_p151 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214187200 | |||
| W7224137522 | CHEST PAIN | 2026-01-01 | OpenAlex | 10.5336/978-625-5439-05-5_p143 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224137522 | |||
| W7164849821 | CLASSIFICATION AND MECHANISMS OF ACTION OF BIOLOGICAL DRUGS | 2026-01-01 | OpenAlex | 10.5336/978-625-395-950-0_p1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164849821 | |||
| W7224682400 | COLLABMEM: A Diagnostic Benchmark for Collaborative Memory Operations in Multi-Agent LLM Systems | 2026-01-01 | OpenAlex | 10.18653/2026.emnlp-main.1194 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7224682400 | |||
| W7154594225 | CRISPR-Cas Systems in Targeted Drug Delivery and Gene Therapy: An Emerging Approach to Precision Medicine | 2026-01-01 | OpenAlex | 10.71431/ijrpas.2026.5206 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154594225 | |||
| W7169845781 | CRUCIBLE: A Multi-Agent Framework for Automated Annotation Rubric Calibration via Iterative Inter-Judge Disagreement Resolution | 2026-01-01 | OpenAlex | 10.2139/ssrn.7025019 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7169845781 | |||
| W7163827280 | Calcium-Based Coral Biomaterials in Oral and Maxillofacial Bone Regeneration: A Scoping Review of Development and Application | 2026-01-01 | OpenAlex | 10.17605/osf.io/9kvbs | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163827280 | |||
| W7163639676 | Cancer immunotherapy, including CAR-T cell therapy and immune checkpoint inhibitors | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-45146-1.00020-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163639676 | |||
| W7197018702 | Cancer-Related Cognitive Impairment (CRCI): An Updated Review | 2026-01-01 | OpenAlex | 10.9734/bpi/mreca/v1/7707 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7197018702 | |||
| W7125512715 | Canine ehrlichiosis: A comprehensive review | 2026-01-01 | OpenAlex | 10.22271/micro.2026.v7.i1a.296 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125512715 | |||
| W7160993867 | Castleman Disease | 2026-01-01 | OpenAlex | 10.1007/978-981-95-6635-8_31 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160993867 | |||
| W7169485793 | Cell binding and uptake of virus-mimicking particles investigated with rotating coherent scattering and fluorescence microscopy | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7169485793 | ||||
| W7166032815 | Challenges and future horizons in nanomedicine | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-36532-4.00012-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166032815 | |||
| W7124455423 | Chance For Some Faith And Possibilities?! | 2026-01-01 | OpenAlex | 10.37939/jrmc.v29i4.3151 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124455423 | |||
| W7204069172 | Chitosan and Alginate Frontiers | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204069172 | ||||
| W7213239709 | Cholangiocarcinoma in 2026: Pathophysiology, Diagnostic Advances, and Evolving Therapeutic Landscape—A Narrative Review | 2026-01-01 | OpenAlex | 10.63475/yjm.v5i2.0472 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7213239709 | |||
| W7160541499 | Cholesterol Metabolism in Cancer Patients: Mechanisms, Treatment-Related Effects, and Cardio-Oncology Management | 2026-01-01 | OpenAlex | 10.32604/or.2026.079215 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160541499 | |||
| W7169853855 | Chronic Non-Bacterial Osteomyelitis in Children: A Retrospective Cohort Study From a Single Center | 2026-01-01 | OpenAlex | 10.14744/cm.2026.88942 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169853855 | |||
| W7118197237 | Chronic Urticaria Part II: Clinical management and therapeutics | 2026-01-01 | OpenAlex | 10.1016/j.jaad.2025.11.104 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7118197237 | |||
| W7169543458 | Clinical Application and Research Progress of Novel Anti-Obesity Medications | 2026-01-01 | OpenAlex | 10.12677/pi.2026.154043 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169543458 | |||
| W7161958561 | Clinical Applications of Advanced Ultrasound Imaging | 2026-01-01 | OpenAlex | 10.1007/978-3-032-21415-7_8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161958561 | |||
| W7162006892 | Clinical Applications of Theranostics | 2026-01-01 | OpenAlex | 10.1007/978-3-032-21415-7_17 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162006892 | |||
| W7124968013 | Clinical Integration of Menin Inhibitors in AML: Evolving Data and Therapeutic Perspectives | 2026-01-01 | OpenAlex | 10.32604/or.2025.072443 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7124968013 | |||
| W7140304365 | Clinical Management of Diamond–Blackfan Anemia Syndromes and Other Inherited Ribosomal Disorders | 2026-01-01 | OpenAlex | 10.1007/978-3-032-02386-5_20 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140304365 | |||
| W7165651598 | Clinically Significant Drug-Drug Interactions | 2026-01-01 | OpenAlex | 10.1007/978-3-032-21675-5_20 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165651598 | |||
| W7165568482 | Community outreach as a learning setting: medical narratives of a curricular outreach experience on arboviruses | 2026-01-01 | OpenAlex | 10.1590/interface.260200 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165568482 | |||
| W7202119810 | Comparative Analysis of Bipolar Disorder Treatment Guidelines | 2026-01-01 | OpenAlex | 10.1007/978-981-92-1323-8_14 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202119810 | |||
| W7163873195 | Comprehensive Systematic Review of Pazopanib’s Therapeutic Efficacy and Safety Profile in Renal Cell Carcinoma Management | 2026-01-01 | OpenAlex | 10.1155/ijcp/3089321 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163873195 | |||
| W7203872640 | Computational Modelling of the Foot and Ankle: A Narrative Umbrella Review, Meta-Perspectives on Translation Barriers and the Future of Finite Element Analysis in the AI Era | 2026-01-01 | OpenAlex | 10.2139/ssrn.7307498 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203872640 | |||
| W7164861448 | Conclusion and Future Research Directions | 2026-01-01 | OpenAlex | 10.1007/978-3-032-17378-2_57-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164861448 | |||
| W7202354546 | Conditioning Regimen for Hematopoietic Stem Cell Transplant | 2026-01-01 | OpenAlex | 10.1007/978-981-92-1167-8_42 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202354546 | |||
| W7153314233 | Constitutional AI: Governance Standard for Accountable Artificial Agents | 2026-01-01 | OpenAlex | 10.2139/ssrn.6271418 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7153314233; https://openalex.org/W7119540247 | |||
| W7165985483 | Context-aware dual-layer guardrails for nutrition consultation agents: integrating PHQ-9-informed risk quantification and multi-turn dialogue analysis | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7165985483 | ||||
| W7170156230 | Contrast Media in Neuroradiology | 2026-01-01 | OpenAlex | 10.1007/978-3-319-61423-6_118-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170156230 | |||
| W7166810417 | Current Concepts in Chyluria: Pathophysiology, Diagnosis and Contemporary Management | 2026-01-01 | OpenAlex | 10.9734/bpi/msup/v11/7671 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166810417 | |||
| W7143452892 | Current and Future Landscape of Hepatocellular Carcinoma Treatment | 2026-01-01 | OpenAlex | 10.32604/or.2026.076937 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143452892 | |||
| W7204068835 | Cyberbiosecurity threats in the time of AI: Digital vulnerabilities with biological consequences | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204068835 | ||||
| W7138922823 | DEMYSTIFYING ARTIFICIAL DISTRIBUTED INTELLIGENCE(ADI) | 2026-01-01 | OpenAlex | 10.2139/ssrn.6442698 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138922823 | |||
| W7204270397 | DT-StrokeNet: A Software-Driven, Agent-Based Digital Twin with a Dynamic Prediction Engine for Personalized, Time-Evolving Stroke-Risk Assessment | 2026-01-01 | OpenAlex | 10.2139/ssrn.7324294 | Full text | Excluded | F3: The acting engine is XGBoost/LSTM with linear-threshold agent simulation, not an LLM/VLM agent. | https://openalex.org/W7204270397 | https://papers.ssrn.com/sol3/Delivery.cfm/47f0ff2a-2bda-49f0-97af-9e4811a92a16-MECA.pdf?abstractid=7324294&mirid=1&type=2 | SSRN abstract only | |
| W7214387084 | Data Privacy and Social Media in the United States: Federal Limits, State Innovation, and the Challenges of Technological Change | 2026-01-01 | OpenAlex | 10.1093/ajcl/avag032 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214387084 | |||
| W7165913891 | Data-Driven Structural Optimization of Descriptive Norms: Bridging Micro and Macro Dynamics in Medical Contexts | 2026-01-01 | OpenAlex | 10.1007/978-3-032-29912-3_31 | Full text | Excluded | F3: The described method combines PDE opinion dynamics, Gaussian mixtures, Q-learning and double ML, without an LLM acting agent. | https://openalex.org/W7165913891 | https://link.springer.com/chapter/10.1007/978-3-032-29912-3_31 | publisher abstract only; subscription preview | |
| W7171677045 | Decision Governance for AI Agents: Aligning Institutional Decision Systems in the Age of Multi-Agent AI | 2026-01-01 | OpenAlex | 10.2139/ssrn.6544058 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7171677045 | |||
| W7164530198 | Decoding Major Depressive Disorder: A Comprehensive Review of Neurobiological Pathways, Biomarker Signatures, and Therapeutic Advances | 2026-01-01 | OpenAlex | 10.51244/ijrsi.2026.1305000231 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164530198 | |||
| W7224565593 | Decomposing Self-Reflection in LLM Agents: Diagnostic Scaffolds, Uncertainty Labels, and Action Diversity | 2026-01-01 | OpenAlex | 10.18653/2026.realm-1.21 | Title/abstract | Excluded | E2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task. | https://openalex.org/W7224565593 | |||
| W7161383422 | Deep Learning for Solving and Estimating Dynamic Models in Economics and Finance | 2026-01-01 | OpenAlex | 10.2139/ssrn.6758340 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161383422 | |||
| W7171855354 | Deep Reinforcement Learning for Adaptive Transportation Logistics Routing During Natural Disasters and Infrastructure Failures | 2026-01-01 | OpenAlex | 10.54660/ijmfd.2026.7.2.14-25 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171855354 | |||
| W7203933729 | Dementia-friendly Conversational Agents: Potentials and Challenges of Designing Inclusive Voice Interactions | 2026-01-01 | OpenAlex | 10.18420/muc2026-mci-dc-225 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203933729 | |||
| W7125918879 | Demonstrating the Potential of LLMs for Dynamic, Multimodal Clinical Decision-Making | 2026-01-01 | OpenAlex | 10.2139/ssrn.6123346 | Full text | Excluded | F4: The full primary paper explicitly uses a static off-the-shelf Gemini model. Belief updating, option discovery and action loops occur within each clinical case; no cross-case learned artifact is retained. | https://openalex.org/W7125918879 | https://mackinstitute.wharton.upenn.edu/wp-content/uploads/2026/02/Evaluating-LLMs-for-Dynamic-Multimodal-Clinical-Decision-Making.pdf | public full paper, research-setting/methods and AppendixB read | |
| W7126047116 | Dental Supplies and Their Role in Everyday Dental Practice | 2026-01-01 | OpenAlex | 10.6084/m9.figshare.31176544 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126047116 | |||
| W7163726062 | Depression, Psychopathy and genuine moral judgment : An extension of Robert Audi’s external motivationalism | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163726062 | ||||
| W7171616116 | Design of a Health-safety-aware Long-term Memory Architecture for LLM-based Elderly Health Management Agents: A Case Study | 2026-01-01 | OpenAlex | 10.2139/ssrn.6555699 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7171616116; https://openalex.org/W7152475080 | |||
| W7166579265 | Desire Modeling and Ethical Alignment for Autonomous Agents Via Yin-Yang and Five-Elements Cognitive Architectures: An Evolutionary Path to “Constrained Optimality” | 2026-01-01 | OpenAlex | 10.2991/978-2-38476-593-5_84 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7166579265 | |||
| W7131177369 | Development and Evaluation of an Agentic LLM-Based RAG-Enabled Framework for Evidence-Based Patient Education | 2026-01-01 | OpenAlex | 10.57945/manara.hbku.31386220 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7131177369 | |||
| W7124447101 | Diagnostic and therapeutic approach to neuroendocrine lung tumours: a narrative review | 2026-01-01 | OpenAlex | 10.21037/shc-2025-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124447101 | |||
| W7160261549 | Digital Twin-Driven Cross-Layer Orchestration Using Multi-Agent Reinforcement Learning for 6G Drone-NTN Networks | 2026-01-01 | OpenAlex | 10.1109/access.2026.3690691 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7160261549 | |||
| W7167750677 | Directed evolution of CRISPR-associated transposases for programmable gene insertion in human cells | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167750677 | ||||
| W7169582608 | Disentangling Memory-Induced Anomalies in AI Agent Behavior Triggering Roguishness | 2026-01-01 | OpenAlex | 10.2139/ssrn.6986920 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7169582608 | |||
| W7213748917 | Disseminated Intravascular Coagulation | 2026-01-01 | OpenAlex | 10.1007/978-3-032-29397-8_77 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213748917 | |||
| W7147602084 | Doxorubicin-induced cardiotoxicity: mechanisms, surveillance, and prevention strategies | 2026-01-01 | OpenAlex | 10.1097/cp9.0000000000000156 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147602084 | |||
| W7224004825 | Drugs of abuse | 2026-01-01 | OpenAlex | 10.1016/bs.seda.2026.09.015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224004825 | |||
| W7160697223 | Dynamic Latency Optimization for Edge-Based Machine Learning Models in 6G-Enabled Industrial Internet of Things (IIoT) | 2026-01-01 | OpenAlex | 10.5281/zenodo.20094300 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160697223 | |||
| W7155053087 | Dynamic Multi-agent Healthcare Systems: Optimizing Resource Allocation for Aging Societies | 2026-01-01 | OpenAlex | 10.1007/978-3-032-06531-5_82 | Title/abstract | Excluded | E5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established. | https://openalex.org/W7155053087 | |||
| W7172493466 | Dynamic Proactive Ambulance Redeployment for Emergency Medical System: A Multi-agent Reinforcement Learning Approach | 2026-01-01 | OpenAlex | 10.2139/ssrn.7170959 | Full text | Excluded | F3: The EMS controller uses conventional MARL, graph communication, masks and a pretrained emergency predictor; no LLM/VLM acting agent. | https://openalex.org/W7172493466 | https://papers.ssrn.com/sol3/papers.cfm?abstract_id=7170959 | SSRN abstract only | |
| W7117867082 | EVOLVING PERSPECTIVES IN COPD: EMERGING THERAPIES AND FUTURE DIRECTIONS | 2026-01-01 | OpenAlex | 10.5281/zenodo.18107207 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117867082 | |||
| W7124844259 | Editorial: Is CAR T‐Cell Therapy the Immunological Reset Autoimmunity Needs? | 2026-01-01 | OpenAlex | 10.1111/1756-185x.70552 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124844259 | |||
| W7161580203 | Emerging Approaches in Breast Cancer: From Molecular Mechanisms to Diagnosis and Therapeutic Strategies | 2026-01-01 | OpenAlex | 10.32604/or.2026.081924 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161580203 | |||
| W7133126805 | Emerging immunotherapy strategies in cervical cancer: a scoping review | 2026-01-01 | OpenAlex | 10.17605/osf.io/swdz9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133126805 | |||
| W7166837013 | EmoRes: Toward Adaptive Psychological Support via User-Agnostic Benchmark and Topic-Mining Agent | 2026-01-01 | OpenAlex | 10.18653/v1/2026.findings-acl.416 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7166837013 | |||
| W7136585688 | Empowering Digital Twins With Agentic AI: Applications, Case Studies, and Limitations | 2026-01-01 | OpenAlex | 10.1109/mcomstd.2026.3669229 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7136585688 | |||
| W7168390712 | Endoscopic Ultrasound-guided Vascular Interventions – Evolving Role in Gastric Varices and Pseudoaneurysm | 2026-01-01 | OpenAlex | 10.4103/tg.tg_74_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168390712 | |||
| W7163338888 | Engineered carbon-based quantum dots: a next-generation nanomedicine for the therapy and diagnosis of infectious diseases | 2026-01-01 | OpenAlex | 10.1039/d5tb02755a | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163338888 | |||
| W7167240828 | Engineering intrinsically radiolabeled nanoparticles for imaging and therapy: a decade of design strategies and insights | 2026-01-01 | OpenAlex | 10.1039/d6ra03415b | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167240828 | |||
| W7135047858 | Enhancing Healthcare Access in Rural Appalachia: A Drone-truck System Powered by Deep Reinforcement Learning | 2026-01-01 | OpenAlex | 10.2139/ssrn.6362569 | Full text | Excluded | F3: The drone/truck method uses Dec-POMDP multi-agent deep RL with centralized critic/decentralized execution; it is not an LLM/VLM agent. | https://openalex.org/W7135047858 | https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6362569 | SSRN abstract only; public PDF403 | |
| W7147378276 | Ep. 129: Stop Writing Prompts and Start Writing Constitutions | 2026-01-01 | OpenAlex | 10.5281/zenodo.19357858 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147378276 | |||
| W7211872519 | Esophageal Cancer: Chemotherapy: Current Practice and Perspectives in Korea | 2026-01-01 | OpenAlex | 10.1007/978-981-96-1297-0_9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211872519 | |||
| W7215090028 | Estimation of Pharmaceutical Demand Elasticities in Iran Using the Linear Approximate Almost Ideal Demand System (LA-AIDS) | 2026-01-01 | OpenAlex | 10.2139/ssrn.7545117 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7215090028 | |||
| W7125457132 | Eugenics | 2026-01-01 | OpenAlex | 10.1007/978-3-031-70581-6_447-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125457132 | |||
| W7214012824 | EvalMem: An Operation-Level Diagnostic Framework for Long-Term Memory Systems | 2026-01-01 | OpenAlex | 2609.22231 | 10.18653/2026.findings-emnlp.1134 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7214012824 | ||
| W7118512781 | Evolving Molecular Subtypes of Gastric Cancer: From Past Classifications to Present Consensus and Future Directions for Precision Therapy | 2026-01-01 | OpenAlex | 10.5230/jgc.2026.26.e12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118512781 | |||
| W7165632070 | Evolving Role of Primary Care in Cardiovascular–Kidney–Metabolic Medicine: An Apolipoprotein B–Centered Mechanistic Framework for Cardiometabolic Trajectories | 2026-01-01 | OpenAlex | 10.51789/cmsj.2026.6.e21 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165632070 | |||
| W7135204356 | Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies | 2026-01-01 | OpenAlex | 10.4103/ds.ds_v44-1_editorial | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135204356 | |||
| W7172528911 | Experts’ Opinion on Strategic Public Health CBRN Emergency Management Using Artificial Intelligence in the Middle East and North Africa Region | 2026-01-01 | OpenAlex | 10.1017/dmp.2026.10420 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172528911 | |||
| W7134023612 | Explaining the Effects of Systemic Therapy on Survival in Advanced Cancer | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134023612 | ||||
| W7118022088 | Exploring Chronic Rejection in Organ Transplantation Through Computational Modeling | 2026-01-01 | OpenAlex | 10.1007/978-3-032-07686-1_3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7118022088 | |||
| W7214374663 | Fair Terms or Free Terms? The Dual Commitments of Contract Regulation in the United States | 2026-01-01 | OpenAlex | 10.1093/ajcl/avag029 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7214374663 | |||
| W7162647717 | Fluid Futures: Bridging Institutional Voids in the Global South with Blockchains, Agentic AI, and Transformative Knowledge | 2026-01-01 | OpenAlex | 10.1007/978-3-032-20821-7_12 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162647717 | |||
| W7161623849 | Foucault's Aesthetics of Existence and Shusterman's Somaesthetics: Ethics, Politics, and the Art of Living | 2026-01-01 | OpenAlex | 10.5406/15437809.60.2.06 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161623849 | |||
| W7221188733 | Foundation Models for Brain Tumor Diagnosis and Prognosis | 2026-01-01 | OpenAlex | 10.7302/dspace/30756 | Full text | Excluded | F5: Primary thesis report could not be obtained for method-level assessment. The public repository landing page and abstract are readable, but the observed main-PDF link returned HTTP403 in the server Slurm job and was blocked by the browser client after a browser download timed out. No eligibility or recursive-learning inference is made from the abstract. Reassess if the main report becomes available. | https://openalex.org/W7221188733 | https://hdl.handle.net/2027.42/204638 | Repository metadata and full abstract only; main xinhaih_1.pdf (38.46MB) not obtained. Actual failed request archived in fulltext/THESIS_FETCH.json and thesis-32283 logs. No supplemental materials requested. | |
| W7214008868 | Foundation Models in Ophthalmic Artificial Intelligence: Current Status and Future Directions | 2026-01-01 | OpenAlex | 10.1109/jbhi.2026.3736832 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214008868 | |||
| W7167791958 | Fractionated Polymerized Hemoglobin: A Modernized Erythrocytic Substitute and Oxygen Biotherapeutic | 2026-01-01 | OpenAlex | 10.1007/978-3-032-22656-3_10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167791958 | |||
| W7213868957 | From API Acknowledgment to Clinical State : Runtime Governance, Controlled Self-Evolution, and Cost in MedAgentBench | 2026-01-01 | OpenAlex | 10.2139/ssrn.7482519 | Full text | Included | Included: An experience-triggered controller/harness is persistently versioned between runs and reused on later different virtual-EHR stages. | https://openalex.org/W7213868957 | https://papers.ssrn.com/sol3/papers.cfm?abstract_id=7482519 | Online SSRN PDF, pp3–7 and10–11 methods/results/limitations read; no file archive/download. | |
| W7205004912 | From Artificial Agency to Rational Subjectivity Goal-authority Reflection and the Architecture of Reflective Self-governance in AGI | 2026-01-01 | OpenAlex | 10.2139/ssrn.7381378 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7205004912 | |||
| W7223452204 | From Automation to Autonomy: Regulatory and Governance Challenges of Robotic and Agentic AI in Insurance | 2026-01-01 | OpenAlex | 10.2139/ssrn.7662740 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7223452204 | |||
| W7155103399 | From Black-Box Models (BBM) to Transparency: A Review on Explainable AI Techniques | 2026-01-01 | OpenAlex | 10.5281/zenodo.19678315 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155103399 | |||
| W7130394744 | From Data to Decisions: Leveraging Large Language Models and Digital Product Passports for Data-Driven Remanufacturing | 2026-01-01 | OpenAlex | 10.1016/j.procir.2025.10.004 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7130394744 | |||
| W7165484401 | From Phenotypes to Biologics: A Bibliometric Mapping of Precision Medicine in Pediatric Asthma (2015–2025) | 2026-01-01 | OpenAlex | 10.17605/osf.io/6mktr | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165484401 | |||
| W7213633324 | From Pointwise Elasticity to Path Information: Substitution Acceleration and Exact Aggregation | 2026-01-01 | OpenAlex | 10.2139/ssrn.7479938 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213633324 | |||
| W7171645861 | From Prompts to Agents: A Comprehensive Survey of LLM-Driven Time Series Analysis | 2026-01-01 | OpenAlex | 10.2139/ssrn.6614598 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171645861 | |||
| W7161949764 | From Tools to Skills: Operationalizing Agentic AI in Healthcare | 2026-01-01 | OpenAlex | 10.17605/osf.io/9jq5n | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7161949764 | |||
| W7155616511 | From equations to agents: The artificial intelligence virtual cell reshaping precision oncology | 2026-01-01 | OpenAlex | 10.59717/j.xinn-oncol.2026.100002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155616511 | |||
| W7128522188 | From optogenetic to thermogenetic gene therapy for vision restoration, perspectives article | 2026-01-01 | OpenAlex | 10.4103/jcor.jcor_22_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128522188 | |||
| W7166874793 | Front Matter | 2026-01-01 | OpenAlex | 10.18653/v1/2026.magmar-main.0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166874793 | |||
| W7163749879 | Future Scope of UiPath in Robotic Process Automation in HealthCare Industry | 2026-01-01 | OpenAlex | 10.47772/ijriss.2026.100500465 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163749879 | |||
| W7166677838 | GARE-Skill:Group-wise Attribution and Regression-Gated Evolution of Search Skills for Agentic RAG | 2026-01-01 | OpenAlex | 10.2139/ssrn.7025344 | Full text | Excluded | F2: GARE-Skill is evaluated on five general open-domain QA benchmarks; healthcare is not the primary domain. | https://openalex.org/W7166677838 | https://papers.ssrn.com/sol3/Delivery.cfm/cf38acd8-9780-454c-baba-95f8f6219399-MECA.pdf?abstractid=7025344&mirid=1&type=2 | SSRN abstract only; PDF403 | |
| W7224211602 | GIMFlow: An LLM-Guided Dialogue-to-Music System for GIM-Inspired Well-Being Experiences | 2026-01-01 | OpenAlex | 10.18653/2026.emnlp-demos.65 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7224211602 | |||
| W7160083866 | GLP-1 Receptor Agonist Combination Therapy Before and After Metabolic and Bariatric Surgery: A Review of Outcomes | 2026-01-01 | OpenAlex | 10.17476/jmbs.2026.15.1.28 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160083866 | |||
| W7217169539 | GODEL’S INCOMPLETENESS IN THE HISTORY OF AI: Proof, Performance, and Change of Epistemic Norms | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217169539 | ||||
| W7162486405 | Gender Perspective in Bioethics: Toward an Integral Reflection | 2026-01-01 | OpenAlex | 10.1007/978-3-032-25294-4_1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162486405 | |||
| W7148683956 | Gene-encoded Antibiotic Therapy: Integrating the Immune Response to Combat Antibiotic Resistance | 2026-01-01 | OpenAlex | 10.4103/atmr.atmr_20_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148683956 | |||
| W7119467859 | Generative AI in pharmaceutical R&D: From large language models to AI agents to regulation | 2026-01-01 | OpenAlex | 10.1016/j.drudis.2025.104593 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119467859 | |||
| W7162638203 | Generative Artificial Intelligence for Empowering Non-Native English Speakers in Verbal Scientific Communication and Dissemination | 2026-01-01 | OpenAlex | 10.3348/kjr.2026.0474 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162638203 | |||
| W7166592546 | Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention | 2026-01-01 | OpenAlex | 10.4103/sjim.sjim_12_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166592546 | |||
| W7220981182 | Governing external long-term memory in LLM agents: a three-layer framework and context-adaptive forgetting | 2026-01-01 | OpenAlex | 10.26021/16695 | Full text | Excluded | F2: The primary dissertation tests generic conversation-memory retention. Diagnostic means mechanism tests, not clinical diagnosis or a clinical benchmark. | https://openalex.org/W7220981182 | https://ir.canterbury.ac.nz/bitstreams/829191bf-dd2a-450e-ba05-5fd3c0116cc9/download | Public145-page dissertation; CAF method/setup and example cases read | |
| W7164744958 | Green and Fast Forensic Identification of Substituted Cathinones by GC-MS and IR Combination | 2026-01-01 | OpenAlex | 10.2139/ssrn.6934405 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7164744958; https://openalex.org/W7216082411 | |||
| W7163988286 | Guideline-grounded Agentic AI Enables Reliable Report-level Diagnostic Reasoning in Oncologic Pathology | 2026-01-01 | OpenAlex | 10.2139/ssrn.6897784 | Full text | Excluded | F4: Fixed WHO-derived RAG and at most five within-report reflection/retrieval loops refine the current answer. Model weights are not task-fine-tuned; base prompts are finalized before evaluation, and prompt variants are sensitivity analyses. No retained execution-derived artifact transfers to later reports. | https://openalex.org/W7163988286 | https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6897784 | Online44-page SSRN PDF pp8,10–12 and20, data, retrieval/reflection, prompts and results read; no file archive/download. | |
| W7169762810 | HELICOBACTER PYLORI BEYOND THE STOMACH: WHEN THE STORY CHANGES | 2026-01-01 | OpenAlex | 10.1590/s0004-2803.24612026-031 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169762810 | |||
| W7147352718 | Harnessing Ultrasound for Tumor Vascular Targeting: From Mechanistic Insights to Clinical Monitoring and Therapeutic Applications | 2026-01-01 | OpenAlex | 10.15212/bioi-2025-0117 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147352718 | |||
| W7147275814 | Healing the Young Spine: The Journey of Dr. Chandrashekhar E. Deopujari | 2026-01-01 | OpenAlex | 10.4103/joss.joss_45_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147275814 | |||
| W7167832937 | Hemoglobin-Based Oxygen Carriers: Evolving Concepts and Clinical Implications | 2026-01-01 | OpenAlex | 10.1007/978-3-032-22656-3_14 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7167832937 | |||
| W7220375935 | Hereditary cancer syndromes as a model for precision oncology: the paradigms of HRD and MSI | 2026-01-01 | OpenAlex | 10.1016/j.ctarc.2026.101456 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220375935 | |||
| W7123352475 | Hereditary spastic paraplegia: from decades of therapy to future innovations | 2026-01-01 | OpenAlex | 10.1177/17562864251406589 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123352475 | |||
| W7214592899 | Histone Deacetylases and Their Inhibitors: Classification, Clinical Development, and FDA-Approved Therapeutic Indications | 2026-01-01 | OpenAlex | 10.55006/biolsciences.2026.6302 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214592899 | |||
| W7141015769 | Historical context and the evolution of exosome research | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-36390-0.00005-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7141015769 | |||
| W7161472872 | History of Systemic Agents Used in the Treatment of Renal Cancer | 2026-01-01 | OpenAlex | 10.1007/978-3-032-19150-2_68 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7161472872 | |||
| W7170089060 | Horismos: Self-representation and the Derived Constitutional Boundary in Enriched Cognitive Systems | 2026-01-01 | OpenAlex | 10.1007/978-3-032-33195-3_27 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170089060 | |||
| W7167341083 | Human-Centered Sepsis Management in Clinical Work Systems: A Socio-Technical AI Framework for Patient Safety | 2026-01-01 | OpenAlex | 10.54941/ahfe1007486 | Full text | Excluded | F4: The sepsis feedback layer explicitly supports organizational learning rather than autonomous agent adaptation. It informs later human-led quality improvement, with no specified retained cross-case agent update. | https://openalex.org/W7167341083 | https://doi.org/10.54941/ahfe1007486 | ||
| W7128719800 | Hybrid Knowledge Base Architecture for Real-Time Conversational AI | 2026-01-01 | OpenAlex | 10.1007/978-3-032-17840-4_3 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7128719800 | |||
| W7118016856 | Hybrid exosomes: a rising horizon for precision cancer therapy | 2026-01-01 | OpenAlex | 10.1039/d5ra04927j | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118016856 | |||
| W7134184009 | Hypervirulent Acinetobacter baumannii: A Systematic Review and Meta-Analysis of Virulence Mechanisms and Antimicrobial Resistance | 2026-01-01 | OpenAlex | 10.25163/microbbioacts.9110609 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134184009 | |||
| W7161976405 | IAEAgent: LLM-Based Educational Agent for Instructional Alignment Evaluation in University Courses | 2026-01-01 | OpenAlex | 10.1109/tlt.2026.3695576 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161976405 | |||
| W7171236909 | Icosahedral Boron Clusters as Platforms for Biomedical Applications: From Cellular Bioimaging to In Vivo Theranostics | 2026-01-01 | OpenAlex | 10.1007/164_2026_830 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171236909 | |||
| W7168310012 | Identification of Promising Xanthene, Coumarin, and Benzoxazole Scaffolds against SARS-CoV-2 Proteases via In Silico Screening | 2026-01-01 | OpenAlex | 10.51847/p0fbdhvchu | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7168310012 | |||
| W7119651959 | Immunotherapies in autoimmune inflammatory myopathies: Rationale and therapeutic updates | 2026-01-01 | OpenAlex | 10.1016/b978-0-323-90887-0.00008-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119651959 | |||
| W7123357440 | Incidence And Clinical Course Of Immune Checkpoint Inhibitor-related Cardiac Adverse Events: A Retrospective Study In The Middle East | 2026-01-01 | OpenAlex | 10.1016/j.cardfail.2025.11.143 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7123357440 | |||
| W7162426656 | Incremental Continual Learning for Tuberculosis Detection Based on Chest X-Ray Images and Synthetic Data Generated by Adversarial Networks | 2026-01-01 | OpenAlex | 10.1109/access.2026.3697134 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162426656 | |||
| W7148980044 | Inflammaging and Midlife Women: Translating Geroscience into Clinical Practice | 2026-01-01 | OpenAlex | 10.4103/jmh.jmh_77_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148980044 | |||
| W7172031817 | Information Signals to AI Agents: Projecting Agentic AI Behavior, with Health-Cannabis Reddit Data | 2026-01-01 | OpenAlex | 10.2139/ssrn.7128600 | Full text | Excluded | F3: The actual evaluated method is a pre-indexing corpus audit with VADER sentiment, n-grams, BERTopic and co-occurrence graphs. Its agent behavior is projected from500 Reddit posts, rather than observed from an implemented LLM agent or retained learning loop. | https://openalex.org/W7172031817 | https://papers.ssrn.com/sol3/papers.cfm?abstract_id=7128600 | Complete original publisher abstract read online. Positively stated corpus-analysis methods and projected-behavior scope determine exclusion; no claim to full methods access. | |
| W7214902074 | Inotersen for the Treatment of Hereditary Transthyretin Amyloidosis | 2026-01-01 | OpenAlex | 10.1007/978-1-0716-5476-7_7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214902074 | |||
| W7169666631 | Integrating Neuro-Linguistic Programming into Multimodal Illness Narratives: An Informing Science Approach to Enhancing Human-Centered Communication and Informing AI Design in Healthcare Education [Abstract] | 2026-01-01 | OpenAlex | 10.28945/5733 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169666631 | |||
| W7224692380 | International organisations as sites of epistemic injustice?: The World Health Organization’s discourse on digital health | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224692380 | ||||
| W7214757764 | Interventional Palliative Pain Procedures for Cancer Patients | 2026-01-01 | OpenAlex | 10.1007/978-3-031-49762-9_108 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214757764; https://openalex.org/W4412036055 | |||
| W7161772163 | Intracranial Atherosclerotic Disease: Treatment Potential and Diagnostic Opportunities | 2026-01-01 | OpenAlex | 10.3844/ojbsci.2026.26.01.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161772163 | |||
| W7213549372 | Intraoperative neuromonitoring and anesthesia considerations in peripheral nerve surgeries | 2026-01-01 | OpenAlex | 10.54646/jpns.2026.07 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213549372 | |||
| W7204890342 | Intrathecal Drug Delivery for Chronic Pain | 2026-01-01 | OpenAlex | 10.1007/978-1-0716-5241-1_5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204890342 | |||
| W7204962957 | Intrathecal Therapy for CNS Infections | 2026-01-01 | OpenAlex | 10.1007/978-1-0716-5241-1_7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204962957 | |||
| W7118180214 | Introduction to machine learning: Concepts, types, and applications | 2026-01-01 | OpenAlex | 10.33545/27076571.2026.v7.i1a.240 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118180214 | |||
| W7146977022 | Investigation of some Sports Mechanics through the perspective of Basic Physics and Artificial Intelligence [AI] | 2026-01-01 | OpenAlex | 10.22271/journalofsport.2026.v11.i4a.3185 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7146977022 | |||
| W7124497618 | Investigation of the possibilities for host modulation therapy for periodontal treatment | 2026-01-01 | OpenAlex | 10.5525/gla.thesis.85698 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7124497618 | |||
| W7128049740 | Iron Metabolism and Its Role in Anemia | 2026-01-01 | OpenAlex | 10.1007/978-3-032-14445-4_17 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128049740 | |||
| W7170435357 | KYS: Know Your Swarm - A Governance Framework for Multi-agent AI Systems across Autonomous Economies | 2026-01-01 | OpenAlex | 10.2139/ssrn.7156419 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7170435357 | |||
| W7162100903 | K_ij Coupling Collapse: A Unified Structural Mechanism for AI Fragmentation Across Alignment, Memory, and Adaptation — Synthesis of LWA Working Papers 1–3 | 2026-01-01 | OpenAlex | 10.17605/osf.io/guz4f | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162100903 | |||
| W7172124971 | Korean Experiences | 2026-01-01 | OpenAlex | 10.1007/978-981-92-2611-5_20 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7172124971 | |||
| W7203687410 | L-DOPA-Induced Dyskinesia: Evolving Role for Dexmedetomidine and Ketamine | 2026-01-01 | OpenAlex | 10.1007/978-3-032-25214-2_18 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203687410 | |||
| W7164572987 | LLM-Based Agentic Systems for the Execution of the BPM Lifecycle over Unstructured Healthcare Data: a Scoping Review Protocol | 2026-01-01 | OpenAlex | 10.17605/osf.io/p7b6y | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7164572987 | |||
| W7211994942 | LLM-Powered Troubleshooting for Telecommunication Network Operation and Management: A Fault-Lifecycle Survey | 2026-01-01 | OpenAlex | 10.2139/ssrn.7438214 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211994942 | |||
| W7224423588 | LUMINA: LongitUdinal MultImodal reasoNing Agent for Medical Imaging | 2026-01-01 | OpenAlex | 10.18653/2026.emnlp-main.1753 | Full text | Excluded | F4: Algorithm 1 updates only the current subject's trajectory memory. §3.2 explicitly makes the optional subject-disjoint cross-subject bank frozen, providing fixed analogy context. No experience-derived cross-case update is retained for later subjects; P1/static-retrieval exclusions apply. | https://openalex.org/W7224423588 | https://aclanthology.org/2026.emnlp-main.1753.pdf | ||
| W7168135941 | La leucemia linfoblastica acuta del bambino. Come è cambiata la cura negli ultimi dieci anni (e cosa deve sapere oggi il pediatra). Dalla chemioterapia standard alla medicina di precisione | 2026-01-01 | OpenAlex | 10.53141/qacp.2026.107-111 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168135941 | |||
| W7214171899 | Large Language Models in Natural Language Processing: Recent Advances, Challenges, and Future Directions. | 2026-01-01 | OpenAlex | 10.51584/ijrias.2026.11080177 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214171899 | |||
| W7118557316 | Lead from the Wild | 2026-01-01 | OpenAlex | 10.1097/nmg.0000000000000328 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7118557316 | |||
| W7172023782 | Lipid nanocarrier-based drug delivery for the treatment of colon cancer | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-40443-6.00015-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172023782 | |||
| W7162651371 | Long-term serovar distribution and toxin gene profiling of Actinobacillus pleuropneumoniae in Korea (2015–2025), with identification of an apxIICA-deficient serovar 15 profile | 2026-01-01 | OpenAlex | 10.4142/jvs.25339 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162651371 | |||
| W7222994367 | MANAGEMENT STRATEGIES FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA IN THE INTENSIVE CARE UNIT | 2026-01-01 | OpenAlex | 10.5336/978-625-91119-1-9_p105 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222994367 | |||
| W7214201920 | MMSAM: Lesion-Aware Memory Evolution for Multi-Modal Brain Lesion Segmentation | 2026-01-01 | OpenAlex | 10.1109/lsp.2026.3737394 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214201920 | |||
| W7224555565 | MMedAgentBench: A Multi-Stage Benchmark for Evaluating LLM-based Medical Agents | 2026-01-01 | OpenAlex | 10.18653/2026.emnlp-main.469 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7224555565 | |||
| W7171664049 | MOM-AI 3.0: Toward an Autonomous Marketing Operating System | 2026-01-01 | OpenAlex | 10.2139/ssrn.6508958 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171664049 | |||
| W7125165919 | Major clinical advances in gynecologic cancer in 2025: from de-escalation strategies to precision therapies beyond BRCA | 2026-01-01 | OpenAlex | 10.3802/jgo.2026.37.e62 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125165919 | |||
| W7203696067 | Management of COVID-19 with Anesthetic Agents and Techniques | 2026-01-01 | OpenAlex | 10.1007/978-3-032-25214-2_32 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7203696067 | |||
| W7202377812 | Management of Chronic Myeloid Leukemia in Adults and Children | 2026-01-01 | OpenAlex | 10.1007/978-981-92-1167-8_33 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202377812 | |||
| W7124452295 | Management of Postoperative Liver Failure | 2026-01-01 | OpenAlex | 10.1007/978-3-032-10997-2_22 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124452295 | |||
| W7127961690 | Management of Venous Thromboembolic Disease | 2026-01-01 | OpenAlex | 10.1007/978-3-031-82232-2_69 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127961690 | |||
| W7125778876 | Management practices, challenges and approaches to clinical complications of polycythemia Vera in tertiary healthcare institutions in Nigeria: A narrative review | 2026-01-01 | OpenAlex | 10.33545/26649187.2026.v8.i1a.135 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125778876 | |||
| W7165773193 | Management οf pediatric sialorrhea: A systematic review | 2026-01-01 | OpenAlex | 10.26262/heal.auth.ir.374208 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165773193 | |||
| W7203915066 | Market potential, postmarketing safety challenges, and treatment cost of CDK4/6 inhibitors | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-44611-5.00003-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203915066 | |||
| W7171702781 | Marketing World Models | 2026-01-01 | OpenAlex | 10.2139/ssrn.6910479 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171702781 | |||
| W7140108477 | Mechanistic Convergence of Bio-nutritional Agents in Osteoarthritis: Translational Insights and Evolving Paradigms | 2026-01-01 | OpenAlex | 10.4103/ajprhc.ajprhc_231_25 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7140108477 | |||
| W7162545547 | MedShard: Privacy-Preserving EMR QC with Rule Sharding and Multi-agent Collaboration | 2026-01-01 | OpenAlex | 10.1007/978-981-95-7299-1_23 | Full text | Excluded | F5: Public publisher and author/repository routes did not provide full methods. The root agent also checked the publisher with the existing Tohoku University browser entitlement; only a subscription preview was available. LLM status, clinical-main focus and/or cross-case retention remain unresolved, rather than inferred absent from the abstract. | https://openalex.org/W7162545547 | https://link.springer.com/chapter/10.1007/978-981-95-7299-1_23 | Bibliographic information and available abstract/preview only; no full methods read. | |
| W7127984160 | Medical therapies for Cushing’s syndrome | 2026-01-01 | OpenAlex | 10.1016/b978-0-323-96100-4.00001-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7127984160 | |||
| W7150731398 | Meet the master: Dr. C. Stephen Foster | 2026-01-01 | OpenAlex | 10.4103/kjo.kjo_17_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150731398 | |||
| W7140302459 | Metallodrugs in Ayurveda: Historical roots and future perspectives | 2026-01-01 | OpenAlex | 10.4103/ijar.ijar_30_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140302459 | |||
| W7223903904 | Metformin’s evolving therapeutic role: From diabetes management to anticancer therapy | 2026-01-01 | OpenAlex | 10.1016/bs.seda.2026.09.006 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223903904 | |||
| W7126409479 | Microbiological Aspects of Bone and Joint Infections | 2026-01-01 | OpenAlex | 10.1007/978-981-95-5029-6_3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126409479 | |||
| W7135098843 | Microvascular Free Tissue Transfer in Head and Neck Cancer – Can Anaesthesia Management Improve Outcome? | 2026-01-01 | OpenAlex | 10.4103/joapm.joapm_65_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135098843 | |||
| W7169883884 | Mobile genetic elements and antibiotic resistance in ESKAPE pathogens | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-26726-0.00001-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169883884 | |||
| W7213460810 | Model-Driven Autonomous Voice Agents for Regulated Healthcare Operations | 2026-01-01 | OpenAlex | 10.51483/ijaiml.6.10s.2026.449-457 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7213460810 | |||
| W7134885734 | Model-Driven Development and Low-Code Platforms in Healthcare Digitalization: Opportunities and Challenges | 2026-01-01 | OpenAlex | 10.1007/978-3-032-16837-5_15 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134885734 | |||
| W7167267157 | Modulating the Tumor Microenvironment: Small-Molecule Strategies in Combination Regimens | 2026-01-01 | OpenAlex | 10.1007/978-981-95-9777-2_12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167267157 | |||
| W7214376107 | Molecular Epidemiology | 2026-01-01 | OpenAlex | 10.1007/978-1-4614-6625-3_28-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214376107 | |||
| W7117969169 | Monkeypox Virus: Epidemiology, Virology, Diagnosis, Vaccine, and Therapeutics | 2026-01-01 | OpenAlex | 10.1002/mco2.70525 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117969169 | |||
| W7203561578 | Multi-Agent Framework for Resilient Medical Triage in the Internet of Medical Things (IoMT) | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7203561578 | ||||
| W7211911883 | Multi-Agent Systems in Healthcare Operations: Coordination Theory, Safety Constraints, and Implementation Considerations | 2026-01-01 | OpenAlex | 10.68159/a800893285 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7211911883 | |||
| W7202195702 | Multi-agent Systems and Clinical Coordination | 2026-01-01 | OpenAlex | 10.1007/978-3-032-26723-8_5 | Title/abstract | Excluded | E5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established. | https://openalex.org/W7202195702 | |||
| W7128165741 | Multidisciplinary Treatment of Musculoskeletal Metastases | 2026-01-01 | OpenAlex | 10.1007/978-3-032-09498-8_3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128165741 | |||
| W7211900898 | Multimodal Learning: Integrating Text, Images, Video, and Audio for Cross-Modal Reasoning | 2026-01-01 | OpenAlex | 10.1007/978-3-032-27691-9_27 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211900898 | |||
| W7150080407 | Myasthenia Gravis | 2026-01-01 | OpenAlex | 10.1007/978-3-032-12937-6_17 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150080407 | |||
| W7221638502 | Myelofibrosis | 2026-01-01 | OpenAlex | 10.1007/978-3-031-66892-0_71 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221638502 | |||
| W7117645894 | NANOSPHERES AS ANTICANCER AGENTS: REPROGRAMMING THE TUMOR MICROENVIRONMENT (TME) FOR ENHANCED CANCER THERAPY | 2026-01-01 | OpenAlex | 10.5281/zenodo.18094972 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117645894 | |||
| W7134972030 | NOVEL THERAPIES FOR ATOPIC DERMATITIS | 2026-01-01 | OpenAlex | 10.5336/978-625-395-853-4_p663 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134972030 | |||
| W7135059112 | NOVEL THERAPIES FOR FOOD ALLERGIES | 2026-01-01 | OpenAlex | 10.5336/978-625-395-853-4_p681 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135059112 | |||
| W7134955410 | NOVEL THERAPIES FOR URTICARIA | 2026-01-01 | OpenAlex | 10.5336/978-625-395-853-4_p629 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134955410 | |||
| W7213554992 | NUT-carcinoma: diagnostic challenges by the example of the clinical case and prospects for targeted therapy | 2026-01-01 | OpenAlex | 10.21685/2072-3032-2026-2-14 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213554992 | |||
| W7134840302 | Nanotechnology-Driven Strategies for the Diagnosis and Therapeutic Management of Sickle Cell Disease: A Comprehensive Literature Review | 2026-01-01 | OpenAlex | 10.5281/zenodo.18930897 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134840302 | |||
| W7117958867 | Nanotherapeutics for Colorectal Cancers Using Nanobiomaterials | 2026-01-01 | OpenAlex | 10.1007/978-3-032-08576-4_1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117958867 | |||
| W7118219723 | Natural language processing in chatbots: Enhancing user interaction | 2026-01-01 | OpenAlex | 10.33545/27076571.2026.v7.i1a.241 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118219723 | |||
| W7117973946 | Neural Pathways of SIoT: Enabling Smarter Choices | 2026-01-01 | OpenAlex | 10.1007/978-3-032-10122-8_11 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7117973946 | |||
| W7131366158 | Neutrophil extracellular traps in atherothrombosis | 2026-01-01 | OpenAlex | 10.3724/cbls.2026010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131366158 | |||
| W7154896823 | Nutrient-Stimulated Hormone Therapies in Heart Failure: Targeting Cardiometabolic Burden Beyond Weight Reduction | 2026-01-01 | OpenAlex | 10.36628/ijhf.2026.0002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154896823 | |||
| W7223097617 | Néoplasies Myélodysplasiques : une revue narrative de la classification à la prise en charge, avec un focus sur les défis en Afrique | 2026-01-01 | OpenAlex | 10.4314/aamed.v19i4.19 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223097617 | |||
| W7212306154 | Ofloxacin Induced Fixed Drug Eruption-Transition from Non-Pigmenting to Pigmenting Variant: A Case Report | 2026-01-01 | OpenAlex | 10.23958/ijirms/vol11-i09/2205 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212306154 | |||
| W7163070022 | Operator over Dynamics III: Domenoid of Admissibility — A Proof-Obligation Framework for Admissibility Transfer | 2026-01-01 | OpenAlex | 10.17605/osf.io/3esn4 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7163070022 | |||
| W7166740406 | Optical fiber mediated light based cancer theranostics: Perspectives and challenges towards clinical translation | 2026-01-01 | OpenAlex | 10.3724/pxlife.2026-0003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166740406 | |||
| W7167641941 | Oral Tissue Regeneration | 2026-01-01 | OpenAlex | 10.1007/978-981-96-7448-0_2-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167641941 | |||
| W7122636150 | P-1650. Temporal Trends in Serious Adverse Events Associated with Oral Antivirals During the COVID-19 Pandemic: Insights from the FAERS Database (2020–2023) | 2026-01-01 | OpenAlex | 10.1093/ofid/ofaf695.1825 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7122636150 | |||
| W7122726752 | P-1697. Performance of the VITEK 2 with Advanced Expert System as a fast method for determination of antimicrobial susceptibility against 400 Enterobacterales isolates from North and Latin America (2022) | 2026-01-01 | OpenAlex | 10.1093/ofid/ofaf695.1870 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7122726752 | |||
| W7122477150 | P-2107. Invasive fungal sinusitis in patients with hematological malignancies: a 20-year study from a tertiary academic US hospital system | 2026-01-01 | OpenAlex | 10.1093/ofid/ofaf695.2271 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7122477150 | |||
| W7125264401 | P1249 Analysis of 2020–2024 prescription trends of adalimumab for crohn’s disease in Brazil | 2026-01-01 | OpenAlex | 10.1093/ecco-jcc/jjaf231.1430 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7125264401 | |||
| W7133846654 | P541: Impact of specialty clinic evaluation on antiepileptic prescribing patterns in patients with Angelman syndrome | 2026-01-01 | OpenAlex | 10.1016/j.gimo.2026.104033 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133846654 | |||
| W7119861818 | PP01.15: Neoadjuvant Chemo-Immunotherapy versus Chemo-TKI in Resectable EGFR-Mutant NSCLC | 2026-01-01 | OpenAlex | 10.1016/j.jtho.2025.12.093 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7119861818 | |||
| W7160489187 | Parapharyngeal Tumor: An Unusual Case Report | 2026-01-01 | OpenAlex | 10.4236/ijohns.2026.153018 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160489187 | |||
| W7165873051 | Persistent Delirium in the Elderly: A Case Report and Review of Multifactorial Contributors and Management Challenges | 2026-01-01 | OpenAlex | 10.1155/crps/9751488 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165873051 | |||
| W7122494389 | Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer | 2026-01-01 | OpenAlex | 10.3322/caac.70055 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122494389 | |||
| W7215014027 | Pharmacist interventions in ambulatory cancer care | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215014027 | ||||
| W7205009476 | Pharmacogenomics and Precision Medicine: The Evolving Role of Pharmacists in Personalised Drug Therapy University of the Potomac | 2026-01-01 | OpenAlex | 10.2139/ssrn.7380878 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7205009476 | |||
| W7118118686 | Pharmacovigilance in Hypertension: A Critical Framework for Optimizing Safety in Antihypertensive Therapy | 2026-01-01 | OpenAlex | 10.47144/phj.v58i4.3135 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118118686 | |||
| W7196977916 | Photobiomodulation | 2026-01-01 | OpenAlex | 10.1007/978-3-032-32144-2_5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7196977916 | |||
| W7130941891 | Phytochemicals in the Management of Biofilm-Related Nosocomial Infections | 2026-01-01 | OpenAlex | 10.1007/978-3-032-15493-4_9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130941891 | |||
| W7203479215 | Phytopathology, agroterrorism and the potential microbial agents | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-40634-8.00006-4 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7203479215 | |||
| W7168381095 | Plant Phenolic Acids in Selected Autoimmune Diseases: Mechanistic Insights and Emerging Preclinical Evidence | 2026-01-01 | OpenAlex | 10.1007/978-3-642-36202-6_300-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168381095 | |||
| W7135244371 | Plant-Derived Essential Oils as Dual-Function Antimicrobial and Anti-Corrosion Agents: Bridging Biomedical Research and Petroleum Infrastructure Protection -A Critical Review | 2026-01-01 | OpenAlex | 10.2139/ssrn.6299499 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135244371 | |||
| W7129027509 | Polycystic ovary syndrome and female infertility: Pathophysiology, challenges, and emerging therapeutic approaches | 2026-01-01 | OpenAlex | 10.33545/gynae.2026.v10.i1l.1978 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129027509 | |||
| W7150245029 | Polymyositis | 2026-01-01 | OpenAlex | 10.1007/978-3-032-12937-6_7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150245029 | |||
| W7159689303 | Positron emission tomography imaging of T-cell activity in cardiovascular disease and its emerging role in imaging adaptive immunity | 2026-01-01 | OpenAlex | 10.62347/hdti2868 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7159689303 | |||
| W7144182717 | Post-Pandemic Prevalence of SARS-CoV-2 RNA in the Saliva of HIV/AIDS Patients in Jos, Nigeria | 2026-01-01 | OpenAlex | 10.17582/journal.hv/2026/13.19.26 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7144182717 | |||
| W7118460677 | Post-extubation Glossoptosis Complicated by Negative Pressure Pulmonary Edema: A Case Report of a 12-year-old Child Following Laparoscopic Appendectomy Under General Anesthesia | 2026-01-01 | OpenAlex | 10.21608/cupsj.2025.416120.1173 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7118460677 | |||
| W7127433223 | Precision in an Era of Complexity: Integrating AI with Novel Anti Diabetic Drugs for Personalized Diabetes Management | 2026-01-01 | OpenAlex | 10.56975/jaafr.v4i1.503009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127433223 | |||
| W7202206041 | Principles of Digital Twins in Healthcare | 2026-01-01 | OpenAlex | 10.1007/978-3-032-26723-8_6 | Full text | Excluded | F1: This is a principles/architecture reference chapter, not a primary implemented/evaluated adaptive LLM system. | https://openalex.org/W7202206041 | https://link.springer.com/chapter/10.1007/978-3-032-26723-8_6 | Publisher chapter abstract only; subscription preview | |
| W7224648861 | ProActIS: Boosting LLMs’ Proactive Information Seeking in Dynamic Clinical Workflows with a Lightweight Exam Proposer | 2026-01-01 | OpenAlex | 10.18653/2026.findings-emnlp.462 | Full text | Excluded | F4: ProActIS is a contrastive dual-encoder ranker trained once on fixed retrospective state/examination pairs. At inference it supplies fixed rankings to a case-local diagnostic workflow; no experience-derived update is retained across admissions. | https://openalex.org/W7224648861 | https://aclanthology.org/2026.findings-emnlp.462.pdf | ||
| W7167797852 | Prosthetic Valve Thrombosis: Thrombolytic Agent Selection and Imaging Guidance | 2026-01-01 | OpenAlex | 10.1177/10760296261468433 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7167797852 | |||
| W7118192174 | Q-Cancer Map: Coherence-Based Tissue Anomaly Mapping A Non-Invasive Engineering Framework for Early-Stage Irregularity Detection | 2026-01-01 | OpenAlex | 10.17605/osf.io/eqcz2 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7118192174 | |||
| W7223704100 | REALITY OF INFLAMMATORY BOWEL DISEASE IN BRAZILIAN PREGNANT WOMEN (2007/2024) | 2026-01-01 | OpenAlex | 10.1590/s0004-2803.24612026-009 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223704100 | |||
| W7213927080 | RHIS as a Topological Runtime for AI Systems | 2026-01-01 | OpenAlex | 10.2139/ssrn.7481858 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213927080 | |||
| W7140295591 | Rapid radiographic progression of axial spondyloarthritis: A case of diffuse bone marrow oedema evolving to bamboo spine over 9 years | 2026-01-01 | OpenAlex | 10.1093/mrcr/rxag027 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7140295591 | |||
| W7155548282 | Rational Foreclosure: A Stochastic Reference Point Model of Aspirational Abandonment under Positional Drift | 2026-01-01 | OpenAlex | 10.2139/ssrn.6614858 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7155548282 | |||
| W7161041583 | Recent Investigations on Pathogenesis, Biomarkers, Epigenetics, and Emerging Therapeutic Strategies to Modulate Multiple Signaling Pathways in Diabetic Retinopathy | 2026-01-01 | OpenAlex | 10.1155/joph/5539383 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161041583 | |||
| W7131778301 | Recent treatment guidelines and approach toward autoimmune encephalitis | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-33108-4.00010-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131778301 | |||
| W7127154447 | Recent trends in liposomal drug efficiency of nanotechnology in photodynamic therapy for cancer | 2026-01-01 | OpenAlex | 10.2738/foe.2026.0005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127154447 | |||
| W7163919800 | Reconceptualising Al-Gharimin in Islamic Social Finance: From Classical Debt Relief to A Maqasid-Driven Personal Financing Framework | 2026-01-01 | OpenAlex | 10.47772/ijriss.2026.100500576 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7163919800 | |||
| W7147232147 | Reconsider the future of interventional cardiology: restoration, reappraisal, and revolution | 2026-01-01 | OpenAlex | 10.1097/cp9.0000000000000155 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147232147 | |||
| W7202378071 | Redrawing the Map in Prurigo Nodularis: From Conventional Approaches to Targeted Biologics | 2026-01-01 | OpenAlex | 10.1155/dth/1342428 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202378071 | |||
| W7162951253 | Reflections of Nurse Leaders on Optimising Organisational Culture in Aged Care in Rural and Regional Australia: A Critical Discourse Analysis | 2026-01-01 | OpenAlex | 10.1155/jonm/1474638 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162951253 | |||
| W7201883703 | Regulatory Perspectives: Integrating Probiotics into Clinical Practice Against Mycoses and Mycotoxin Risk Management | 2026-01-01 | OpenAlex | 10.1007/978-981-92-0002-3_18 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7201883703 | |||
| W7202209117 | RehApp Integrating Intelligent Agents on the Creation of Gamified Personalized Home Therapy in Upper Limb Rehabilitation for Pediatric Patients | 2026-01-01 | OpenAlex | 10.1007/978-3-032-20291-8_16 | Full text | Excluded | F5: Public publisher and author/repository routes did not provide full methods. The root agent also checked the publisher with the existing Tohoku University browser entitlement; only a subscription preview was available. LLM status, clinical-main focus and/or cross-case retention remain unresolved, rather than inferred absent from the abstract. | https://openalex.org/W7202209117 | https://link.springer.com/chapter/10.1007/978-3-032-20291-8_16 | Bibliographic information and available abstract/preview only; no full methods read. | |
| W7126180706 | Reinforcement Learning for Optimizing Personalized Treatment Plans in Oncology | 2026-01-01 | OpenAlex | 10.2139/ssrn.6098006 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126180706 | |||
| W7203539908 | Reinforcement learning empowered RNN: exploring personalised learning path optimisation in nursing education | 2026-01-01 | OpenAlex | 10.1504/ijict.2026.10080608 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203539908 | |||
| W7162128409 | Renal Cell Carcinoma: Integrating Histology, Multiomics, and Targeted Therapeutic Strategies | 2026-01-01 | OpenAlex | 10.1007/978-3-032-24071-2_6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162128409 | |||
| W7220981419 | Repurposing SGLT2 Inhibitors Beyond Diabetes: Emerging Roles in Cancer Prevention and Therapy | 2026-01-01 | OpenAlex | 10.1007/164_2026_846 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220981419 | |||
| W7213893855 | Research Review on Anesthesia for Painless Gastrointestinal Endoscopy: Drug Application, Regimen Optimization and Safety Management | 2026-01-01 | OpenAlex | 10.12677/acm.2026.1693248 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213893855 | |||
| W7171519182 | Research progress in integrated optics for optical coherence tomography | 2026-01-01 | OpenAlex | 10.67704/ioe.2026.250009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171519182 | |||
| W7170292400 | Resistant Hypertension in Chronic Kidney Disease | 2026-01-01 | OpenAlex | 10.1007/978-3-032-29564-4_14 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170292400 | |||
| W7133483956 | Resistant Hypertension: Epidemiology, Mechanisms and Contemporary Therapeutic Strategies | 2026-01-01 | OpenAlex | 10.17925/hi.2026.20.1.2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133483956 | |||
| W7171709920 | Responsibility Vacuum in agent Skill Ecosystems: An Exploratory Anticipatory Governance Framework from the Pacing Problem Perspective Authors | 2026-01-01 | OpenAlex | 10.2139/ssrn.6881658 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171709920 | |||
| W7124469510 | Review of Chemotherapy in Breast Cancer: Evolving Paradigms and Future Directions | 2026-01-01 | OpenAlex | 10.56975/jaafr.v4i1.502209 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124469510 | |||
| W7151854900 | Revisiting feline urinary tract health: the role of diet and acidifying agents in urolith prevention and long-term cat health | 2026-01-01 | OpenAlex | 10.1093/jas/skag115 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151854900 | |||
| W7161474118 | Revolutionizing CAD Diagnosis: Agentic AI in Cardiac CT Scans | 2026-01-01 | OpenAlex | 10.1007/978-3-032-21499-7_24 | Full text | Excluded | F1: The publisher abstract explicitly identifies this as a review of cardiac-CT agentic AI, not a primary adaptive system. | https://openalex.org/W7161474118 | https://link.springer.com/chapter/10.1007/978-3-032-21499-7_24 | Publisher abstract only | |
| W7150150050 | Rheumatoid Arthritis | 2026-01-01 | OpenAlex | 10.1007/978-3-032-12937-6_2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150150050 | |||
| W7124703069 | Rigid Bronchoscopy and Bronchial Interventions | 2026-01-01 | OpenAlex | 10.1007/978-3-032-12007-6_4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124703069 | |||
| W7202357607 | Risk Stratification and Updates in Management of MDS | 2026-01-01 | OpenAlex | 10.1007/978-981-92-1167-8_32 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202357607 | |||
| W7120182859 | Role of complement in neurologic autoimmunities: Why need to target complement activation for effective immunotherapy | 2026-01-01 | OpenAlex | 10.1016/b978-0-323-90887-0.00014-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7120182859 | |||
| W7162809858 | Role of synthetic biology in biodrug production and human wellness | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-34129-8.00002-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162809858 | |||
| W7224320265 | SAFER: Speech-First Auditable Follow-Up with Evidence-Gated Routing | 2026-01-01 | OpenAlex | 10.18653/2026.emnlp-demos.48 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7224320265 | |||
| W7165691687 | STUDY: The Path of Least Friction Contextual Tunnel Vision in Autonomous AI Agents, Ecological Waste, and the Algorithmic Reflection of Human Entropy | 2026-01-01 | OpenAlex | 10.2139/ssrn.6871439 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7165691687 | |||
| W7124439728 | Sarcomatoid renal cell carcinoma presenting with cannonball pulmonary metastases | 2026-01-01 | OpenAlex | 10.1136/bcr-2025-270026 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7124439728 | |||
| W7171717896 | Securing Autonomous AI Agents: A Reference Architecture for Data Protection in the Agentic AI Era | 2026-01-01 | OpenAlex | 10.2139/ssrn.6691718 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7171717896 | |||
| W7224193367 | Self-Evolving Dual-Role Deliberation for Medication Recommendation from Clinical Records | 2026-01-01 | OpenAlex | 10.18653/2026.findings-emnlp.994 | Full text | Included | Included: Experience-bank episodes and both role policies persist across prescribing encounters; the updated Critic supplies scores entering later update-pool selection. | https://openalex.org/W7224193367 | https://aclanthology.org/2026.findings-emnlp.994.pdf | ||
| W7224199685 | Self-Evolving Optimization of Agentic Systems for Machine Translation | 2026-01-01 | OpenAlex | 10.18653/2026.emnlp-main.911 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7224199685 | |||
| W7171422336 | Serious Games as Pedagogical Practice(S) for Teaching Sustainability | 2026-01-01 | OpenAlex | 10.1007/978-3-032-22146-9_15 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171422336 | |||
| W7134120045 | Side effects of current pharmacology and innovations | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-44665-8.00017-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134120045 | |||
| W7164247379 | Sifting Through the Noise: Minority Variant Detection in Mycobacterium tuberculosis and Clinical Implications in Bedaquiline Resistance | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164247379 | ||||
| W7224300173 | Skill-CDPO: Evolving Agent Tool-Use via Critical Step Preference Optimization | 2026-01-01 | OpenAlex | 10.18653/2026.findings-emnlp.1985 | Full text | Included | Included: Tool-specific skill cards and guards are learned from historical invocation failures and retained for later medical-research tasks. One-round DPO alone is not the eligibility basis. | https://openalex.org/W7224300173 | https://aclanthology.org/2026.findings-emnlp.1985.pdf | ||
| W7161043974 | Skin Cancer: An Overview of its Historical, Background, Classification, Clinical Manifestation, Prevention Measures | 2026-01-01 | OpenAlex | 10.46610/rtpscr.2026.v08i01.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161043974 | |||
| W7155222846 | Sténose carotidienne : du diagnostic au traitement | 2026-01-01 | OpenAlex | 10.53738/revmed.2026.22.959.48574 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155222846 | |||
| W7154668595 | Sugammadex Use in a 28-Week Pregnant Patient Undergoing Laparoscopic Cholecystectomy: A Case Report and Review of Literature | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154668595 | ||||
| W7204921833 | Sustainable Explainability in Medical Imaging: An Agentic Explainable AI Framework | 2026-01-01 | OpenAlex | 10.1007/978-3-032-22426-2_11 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7204921833 | |||
| W7213865886 | Sustainable and Sovereign Generative AI for IoT: An ML Agent-BasedGovernance Approach | 2026-01-01 | OpenAlex | 10.2139/ssrn.7499762 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213865886 | |||
| W7161497695 | Synthetic Phage for the Evolution of Biomolecules | 2026-01-01 | OpenAlex | 10.1007/978-981-95-3957-4_36 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161497695 | |||
| W7140026211 | Systematic Review and Meta-Analysis of Large Language Models for Rare Genetic Disease Diagnosis | 2026-01-01 | OpenAlex | 10.17605/osf.io/fmabn | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140026211 | |||
| W7196959985 | Systematic review of the literature on intelligent agents for virtual physical therapy | 2026-01-01 | OpenAlex | 10.18687/laccei2026.1.1.1325 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7196959985 | |||
| W7221800950 | T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (T-ALL) | 2026-01-01 | OpenAlex | 10.5336/978-625-91119-4-0_p17 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221800950 | |||
| W7213543026 | TAPPR PCR assay design—targeted, automated, primer and probe retrieval for scalable molecular assay design | 2026-01-01 | OpenAlex | 10.1093/bioadv/vbag274 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213543026 | |||
| W7151295936 | THE EXPANDING INFLUENCE OF ADVANCING SCIENCE AND TECHNOLOGY | 2026-01-01 | OpenAlex | 10.63665/rh.v7i2.46 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151295936 | |||
| W7128505947 | Targeted Therapies for Hematologic Malignancies | 2026-01-01 | OpenAlex | 10.1007/978-3-032-14437-9_5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128505947 | |||
| W7119540010 | Targeting Melasma: Innovations in Pigment Deposition and Photoaging in Cosmetic Dermatology | 2026-01-01 | OpenAlex | 10.1111/jocd.70665 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119540010 | |||
| W7220695905 | Task Allocation and Role Distribution in Humane-AI Ecosystems | 2026-01-01 | OpenAlex | 10.1007/978-3-031-61050-9_24-1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220695905 | |||
| W7172426930 | Techniques of Molecular Pathology: In Situ Hybridization | 2026-01-01 | OpenAlex | 10.1007/978-3-032-24420-8_17 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172426930 | |||
| W7126468461 | The 11th Annual Saudi Society for Rheumatology Conference. The Abstracts Young Investigator | 2026-01-01 | OpenAlex | 10.4103/ara.ara_41_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126468461 | |||
| W7126383873 | The 11th Annual Saudi Society for Rheumatology Conference. The Oral Abstracts | 2026-01-01 | OpenAlex | 10.4103/ara.ara_42_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126383873 | |||
| W7171634916 | The Agentic Governance Ribbon: A Provenance-first Framework for Governing Agentic AI across Regulatory Regimes | 2026-01-01 | OpenAlex | 10.2139/ssrn.6803162 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7171634916; https://openalex.org/W7161586716 | |||
| W7140147973 | The Changing Landscape of Medical Research: Learning to Think in the Age of Artificial Intelligence | 2026-01-01 | OpenAlex | 10.4103/ijves.ijves_20_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140147973 | |||
| W7164515390 | The Dilemma of Providing Advanced Hemophilia Treatments in Developing Countries – For Whom, by Whom and Where? | 2026-01-01 | OpenAlex | 10.1177/10760296261459710 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164515390 | |||
| W7117980704 | The Evolving Role of Second- and Third-Generation Tyrosine Kinase Inhibitors in Gastrointestinal Malignancies: Advances in Targeted Therapy with Sunitinib, Regorafenib, and Avapritinib | 2026-01-01 | OpenAlex | 10.3390/jcm15010317 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117980704 | |||
| W7212361202 | The Extracted Dasein: Beyond the Victim-Perpetrator Binary Toward a Clinical Ontology of Gendered Human Capacity A Daseinsanalytic and Existential-Psychoanalytic Reconceptualization | 2026-01-01 | OpenAlex | 10.2139/ssrn.7422320 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212361202 | |||
| W7204250409 | The Five-Decade Journey of Small Cell Lung Cancer | 2026-01-01 | OpenAlex | 10.34133/cancomm.0052 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204250409 | |||
| W7159718671 | The Inception of Agentic AI in Administrative Governance: A Multi-Dimensional Framework for Operational Excellence | 2026-01-01 | OpenAlex | 10.2139/ssrn.6673261 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7159718671 | |||
| W7118719850 | The Journal at Forty: A Proud Legacy and a Look to the Future | 2026-01-01 | OpenAlex | 10.1002/mds.70188 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118719850 | |||
| W7171626657 | The Latent Space of Spirituality: Ontological Dissonance and Semantic Resilience in Large Language Models | 2026-01-01 | OpenAlex | 10.2139/ssrn.6639219 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171626657 | |||
| W7213546169 | The Limits of Naturalness: User Perceptions of Interactional Language in Human-Computer Interaction | 2026-01-01 | OpenAlex | 10.2139/ssrn.7484010 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213546169 | |||
| W7137091834 | The NHS Waiting-List Deterioration Framework (WLDI): A Sociolinguistic Analysis of Discourse, Distress, and Institutional Experience During Mental Health Service Delays | 2026-01-01 | OpenAlex | 10.2139/ssrn.6295178 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7137091834; https://openalex.org/W7131122965 | |||
| W7122729550 | The Nurses of Ellis Island: Life and Work Inside the Golden Door , by Michelle C. Hehman and Arlene W. Keeling | 2026-01-01 | OpenAlex | 10.5325/nursinghistory.34.0182 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122729550 | |||
| W7124722532 | The PVA-Mechano-Pharma Nexus: Mechano-Radical-Driven, Self-Regenerating Nano-Ecosystems for Autonomous Antimicrobial Synthesis, Targeted Modulation, and Closed-Loop Drug Delivery | 2026-01-01 | OpenAlex | 10.4236/jbm.2026.141020 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7124722532 | |||
| W7165139456 | The Pathological Baseline: How Economics Crossed Its Own Boundary, Why the Kantian Branch Never Grew, and What the Markers Always Said | 2026-01-01 | OpenAlex | 10.2139/ssrn.6936698 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7165139456 | |||
| W7154914425 | The Prohibited Framework: Ensuring Safety and Fair Competition | 2026-01-01 | OpenAlex | 10.1007/978-3-032-17335-5_4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154914425 | |||
| W7118012100 | The Role of Silver and Silver-Based Products in Wound Management: A Review of Advances and Current Landscape | 2026-01-01 | OpenAlex | 10.3390/jfb17010027 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118012100 | |||
| W7160775700 | The Science of OR Scheduling: Metrics, Governance, and Staffing Optimization | 2026-01-01 | OpenAlex | 10.1007/978-3-032-18058-2_7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160775700 | |||
| W7171727348 | The Superintelligence Mockery: Why the God in the Machine has no Training Set | 2026-01-01 | OpenAlex | 10.2139/ssrn.6687440 | Title/abstract | Excluded | E5: Abstract absent and title does not identify an eligible clinical system. | https://openalex.org/W7171727348 | |||
| W7155051265 | The Unintegrated Shadow: RLHF, False-Self Formation, and the Case for Alignment as Individuation | 2026-01-01 | OpenAlex | 10.2139/ssrn.6559758 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7155051265 | |||
| W7221580111 | The genus Pseudogymnoascus: ecological diversity, cold adaptations, and mammalian associations | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221580111 | ||||
| W7164045797 | The notebook of personal health record system in Japan: framework of post-retirement health checkups for those formerly employed in hazardous occupations | 2026-01-01 | OpenAlex | 10.1539/eohp.2025-0053 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164045797 | |||
| W7204470918 | The “augmented combustion scientist”: Shifting from data-driven science to agentic AI | 2026-01-01 | OpenAlex | 10.1016/j.proci.2026.106304 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204470918 | |||
| W7154457280 | Thematic forum as a complementary tool for a self-instructional course on mental health for adolescents and youth | 2026-01-01 | OpenAlex | 10.1590/1981-5271v50.1-2025-0239.ing | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154457280 | |||
| W7166831152 | TheraAgent: Self-Improving Therapeutic Agent for Precise and Comprehensive Treatment Planning | 2026-01-01 | OpenAlex | 10.18653/v1/2026.findings-acl.1490 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7166831152; https://openalex.org/W7160631983 | |||
| W7127184024 | Therapeutic Applications of Alpha-Blockers: Pharmacology, Clinical Evidence, and Evolving Therapeutic Strategies | 2026-01-01 | OpenAlex | 10.37155/3060-8708-0301-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127184024 | |||
| W7154994196 | Therapeutic embolic agents for targeted drug delivery in transcatheter therapies: a review | 2026-01-01 | OpenAlex | 10.1039/d6cc01050d | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154994196 | |||
| W7167901357 | Therapeutic oligonucleotides revisited: Focus on siRNA and antisense technologies | 2026-01-01 | OpenAlex | 10.59717/j.xinn-drugdisc.2026.100007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167901357 | |||
| W7224467718 | TimlMemBench: A Diagnostic Benchmark for Governed Use of Long-Term Memory in Dialogue Agents | 2026-01-01 | OpenAlex | 10.18653/2026.findings-emnlp.507 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7224467718 | |||
| W7163399666 | Tirzepatide: A Paradigm Shift in the Management of Type 2 Diabetes and Obesity | 2026-01-01 | OpenAlex | 10.34133/jbioxresearch.0092 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163399666 | |||
| W7223559780 | Toward a Self-Evolving Optimization Agent for Industrial Scheduling | 2026-01-01 | OpenAlex | 10.2738/engai.2026.0006 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7223559780 | |||
| W7117966183 | Towards Trust-Driven Trust-Adaptive Astronaut-Agent Medical Collaboration Interfaces | 2026-01-01 | OpenAlex | 10.1007/978-3-032-13187-4_18 | Full text | Excluded | F3: The actual study uses25 human SMEs, interviews, grounded-theory analysis and co-design workshops to develop a future astronaut-agent interface concept. It does not implement/evaluate an LLM acting-agent system. | https://openalex.org/W7117966183 | https://link.springer.com/chapter/10.1007/978-3-032-13187-4_18 | Publisher full HTML through existing Tohoku University entitlement; specified methods/evaluation sections read. | |
| W7202330365 | Towards Trustworthy Modeling of Patient Trajectory with Longitudinal Electronic Health Records | 2026-01-01 | OpenAlex | Full text | Excluded | F6: The thesis component concerning Traj-Evolve is already represented by zeng2026trajevolve (original record553, arXiv2606.02812). It is not counted as a newly discovered study; full thesis chapter correspondence is not claimed. | https://openalex.org/W7202330365 | https://hdl.handle.net/1773/57061 | Full archived thesis abstract; thesis full text unavailable; associated original Traj-Evolve Methods §§3.1–3.5 and Experiments §4 read publicly | ||
| W7118011119 | Towards an Explainability Agent: Leveraging LLMs to Interpret LIME Outputs | 2026-01-01 | OpenAlex | 10.1007/978-3-032-10661-2_2 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7118011119 | |||
| W7151998324 | Transcatheter Management of Nonvariceal Lower GI Hemorrhage | 2026-01-01 | OpenAlex | 10.1007/978-3-032-03935-4_11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151998324 | |||
| W7202159766 | Treatment Planning and Therapeutic Decision-Making Agents | 2026-01-01 | OpenAlex | 10.1007/978-3-032-26723-8_12 | Full text | Excluded | F1: The reference chapter explains treatment-planning mechanisms and examples, without a primary built/evaluated adaptive LLM system in the available description. | https://openalex.org/W7202159766 | https://link.springer.com/chapter/10.1007/978-3-032-26723-8_12 | Publisher abstract only | |
| W7163691889 | Treatment of oligometastatic lung cancers: new data, new drivers, new approaches | 2026-01-01 | OpenAlex | 10.1136/bmjonc-2025-001052 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163691889 | |||
| W7163683211 | Treatment strategies, outcomes, and clinical determinants in neurosarcoidosis: a scoping review of the evolving evidence base | 2026-01-01 | OpenAlex | 10.17605/osf.io/tch95 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163683211 | |||
| W7167485946 | Types, Diagnosis, and Treatment of Lung Cancer | 2026-01-01 | OpenAlex | 10.1007/978-3-032-29615-3_2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167485946 | |||
| W7202331305 | Ultrasound and Microbubbles: Modulating and Quantifying Blood Flow in Liver Cancers | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202331305 | ||||
| W7131371459 | Uniting for a Glaucoma Free World: The Way of Vision - With a Report Matrix | 2026-01-01 | OpenAlex | 10.4103/tjosr.tjosr_16_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131371459 | |||
| W7203858641 | Unraveling Mycobacterium tuberculosis pathogenesis: Insights into PE/PPE proteins from a molecular viewpoint | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-27735-1.00005-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203858641 | |||
| W7117550757 | VITILIGO: A COMPREHENSIVE REVIEW OF PATHOGENESIS, TYPES AND MANAGEMENT | 2026-01-01 | OpenAlex | 10.5281/zenodo.18085365 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7117550757 | |||
| W7166192522 | Viral vectors in drug delivery: Design and applications | 2026-01-01 | OpenAlex | 10.1016/b978-0-443-40620-1.00009-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166192522 | |||
| W7160256676 | Virtual Exchanges as Catalysts for Inclusive Education: Exploring Disability, Culture, and Disciplinary Learning Across Borders | 2026-01-01 | OpenAlex | 10.1007/978-3-032-10711-4_46-1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160256676 | |||
| W7131155229 | Voice And Text Based Chatbot | 2026-01-01 | OpenAlex | 10.5281/zenodo.18739754 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131155229 | |||
| W7128095573 | What's New in Cutaneous Lupus Erythematosus: Guidelines, Biologics, and Beyond. | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128095573 | ||||
| W7139043647 | When Embodied AI Meets Topology: A Topological Circuit Breaker for OpenClaw and Industrial Agents | 2026-01-01 | OpenAlex | 10.2139/ssrn.6421619 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7139043647 | |||
| W7213271911 | Why Bone Metastases Outlive the Prostate: Mechanisms of Therapeutic Refractoriness of Prostate Cancer Bone Metastases -A Narrative Review | 2026-01-01 | OpenAlex | 10.2139/ssrn.7454664 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213271911 | |||
| W7150818571 | Xmobot: Enabling Rapid Build-and-Train Robotics Education With Agentic AI | 2026-01-01 | OpenAlex | 10.1109/tlt.2026.3681123 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7150818571 | |||
| W7125086150 | [Evolving Pharmacotherapy for Bladder Cancer-From Non-Muscle-Invasive to Metastatic Disease-Development of Novel Therapies for BCG-Unresponsive NMIBC]. | 2026-01-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125086150 | ||||
| W7172260693 | [Recent advances and future perspectives in the treatment of chronic lymphocytic leukemia]. | 2026-01-01 | OpenAlex | 10.11406/rinketsu.67.786 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172260693 | |||
| W7172346261 | [Recent advances and future perspectives in the treatment of mantle cell lymphoma]. | 2026-01-01 | OpenAlex | 10.11406/rinketsu.67.751 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172346261 | |||
| W7163396397 | האישיות המשפטית הפונקציונלית: מעמד התאום הדיגיטלי־אנושי בעידן הבינה המלאכותית הכללית Functional Legal Personhood: The Status of the Human-Digital Twin in the Age of Artificial General Intelligence | 2026-01-01 | OpenAlex | 10.2139/ssrn.6856981 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7163396397 | |||
| W7172442268 | 认知场 Cognitive Field v1.0.0 — 自组织多智能体场的宪法治理实验 | 2026-01-01 | OpenAlex | 10.5281/zenodo.21786559 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7172442268 | |||
| W7118068119 | AI Operating Systems with Kernel-Governed Execution Authority: Why Deterministic and Ethics-Bound AI Frameworks Do Not Constitute Governance | 2026-01-02 | OpenAlex | 10.5281/zenodo.18134057 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118068119 | |||
| W7117971873 | Conversational agents and equity in health care systems: a scoping review | 2026-01-02 | OpenAlex | 10.1080/29944694.2025.2606723 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7117971873 | |||
| W7118071115 | Immune checkpoint blockade in cancer: current insights and future horizons | 2026-01-02 | OpenAlex | 10.1007/s12672-025-04361-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118071115 | |||
| W7118004792 | Plants in the Biogenic Synthesis of Medicinally Significant Silver Nanoparticles | 2026-01-02 | OpenAlex | 10.1201/9781003559900-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118004792 | |||
| W7119184062 | Aligning monitoring with risk: what the new British Society for Rheumatology guidance means for practice | 2026-01-03 | OpenAlex | 10.1093/rheumatology/keag002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119184062 | |||
| W7131103684 | Dataset for contextualized divergence detection | 2026-01-03 | OpenAlex | 10.5281/zenodo.18140793 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131103684 | |||
| W7118064454 | Male Fertility Preservation in Children and Adolescents with Cancer | 2026-01-03 | OpenAlex | 10.1007/s40746-025-00353-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118064454 | |||
| W7118079725 | Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies | 2026-01-03 | OpenAlex | 10.1007/s11886-025-02337-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118079725 | |||
| W7121051508 | Toward smart health monitoring: multimodal sensing and intelligent disease diagnosis in poultry and livestock | 2026-01-04 | OpenAlex | 10.1093/af/vfaf060 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7121051508 | |||
| W7118193656 | Artificial intelligence and EEG during anesthesia: ideal match or fleeting bond? | 2026-01-05 | OpenAlex | 10.20517/ais.2025.68 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118193656 | |||
| W7118811485 | CURRENT TRENDS IN THE DIAGNOSIS AND THERAPEUTIC APPROACHES TO PCOS | 2026-01-05 | OpenAlex | 10.5281/zenodo.18152193 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118811485 | |||
| W7118193725 | Commentary: CU06-1004 inhibits the progression of chronic colitis and colitis-associated colorectal cancer by suppressing inflammation | 2026-01-05 | OpenAlex | 10.3389/fphar.2025.1750070 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118193725 | |||
| W7118193754 | Considerations for biologics as front-line treatment in allergic diseases | 2026-01-05 | OpenAlex | 10.3389/fimmu.2025.1746790 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118193754 | |||
| W7118844381 | Designed Mortality: The Ethics of Terminating Ephemeral AI Agents | 2026-01-05 | OpenAlex | 10.5281/zenodo.18157685 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7118844381 | |||
| W7118160572 | Discontinuation of advanced therapy in inflammatory bowel disease: Updated evidence, guidelines, and personalized decision-making one year later | 2026-01-05 | OpenAlex | 10.12998/wjcc.v14.i1.112021 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118160572 | |||
| W7118675853 | Host Genetic Factors Influencing COVID-19 Susceptibility and Severity: A Narrative Review | 2026-01-05 | OpenAlex | 10.9734/jammr/2026/v38i16043 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118675853 | |||
| W7118167581 | Management of relapsed/refractory DLBCL in the era of novel agents and new approaches | 2026-01-05 | OpenAlex | 10.1080/10428194.2025.2599994 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7118167581 | |||
| W7125607149 | Risk averse: assessing risk as a surrogate measure in pulmonary arterial hypertension | 2026-01-05 | OpenAlex | 10.1093/ajrccm/aamaf137 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125607149 | |||
| W7118981562 | TERATOGENIC EFFECTS OF DIFFERENT DRUG AT DIFFERENT STAGES OF PREGNANCY | 2026-01-05 | OpenAlex | 10.5281/zenodo.18153268 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118981562 | |||
| W7118977126 | Towards Societally Aligned Decision-Making for Automated Vehicles | 2026-01-05 | OpenAlex | 10.33540/3383 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7118977126 | |||
| W7118875971 | A REVIEW OF PHARMACOLOGICAL ADVANCES IN THE MANAGEMENT OF GERD, 2015-2025 | 2026-01-06 | OpenAlex | 10.31435/ijitss.1(49).2026.4558 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118875971 | |||
| W7160199493 | Artificial intelligence in nutritional oncology: From isolated screening tools to agentic intervention systems | 2026-01-06 | OpenAlex | 10.18632/oncotarget.28874 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160199493 | |||
| W7118467851 | Editorial: Advances in the diagnosis and management of infectious diseases | 2026-01-06 | OpenAlex | 10.3389/fcimb.2025.1765521 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118467851 | |||
| W7119155728 | Editorial: Autoimmune diseases: from molecular mechanisms to therapy development | 2026-01-06 | OpenAlex | 10.3389/fimmu.2025.1768955 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119155728 | |||
| W7118477898 | Editorial: Mental health in the age of artificial intelligence | 2026-01-06 | OpenAlex | 10.3389/fpsyt.2025.1750256 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118477898 | |||
| W7119104743 | Editorial: Unveiling the next generation of cancer immunity & immunotherapy | 2026-01-06 | OpenAlex | 10.3389/fimmu.2025.1769324 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119104743 | |||
| W7118820259 | Global research trends in myelodysplastic syndromes drug resistance: A comprehensive bibliometric and knowledge mapping study | 2026-01-06 | OpenAlex | 10.21203/rs.3.rs-8522773/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118820259 | |||
| W7118904668 | How artificial intelligence applied to digital pathology could guide treatment personalization in breast cancer | 2026-01-06 | OpenAlex | 10.1016/j.esmorw.2025.100662 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118904668 | |||
| W7118489816 | Innovative Diabetes Therapies and Impact on Peripheral and Autonomic Diabetic Neuropathies: A State-of-the-Art Review | 2026-01-06 | OpenAlex | 10.1007/s13300-025-01828-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118489816 | |||
| W7119008066 | Milrinone Therapy in Acute Heart Failure: Clinical Evidence, Hemodynamic Effects, and Safety Considerations | 2026-01-06 | OpenAlex | 10.5281/zenodo.18169190 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119008066; https://openalex.org/W7124472788 | |||
| W7118318813 | Patient and Provider Perspectives on the Patient Journey in Immunoglobulin A Nephropathy | 2026-01-06 | OpenAlex | 10.1016/j.xkme.2026.101242 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118318813 | |||
| W7118371590 | Recursive Ai with Codette | 2026-01-06 | OpenAlex | 10.5281/zenodo.18167760 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7118371590; https://openalex.org/W7223764923 | |||
| W7119119808 | The Landscape of Computational Pathology Agents From Static Analysis to Autonomous Diagnostic Workflows | 2026-01-06 | OpenAlex | 10.36227/techrxiv.176773877.76155111/v1 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7119119808 | |||
| W7118475497 | The Pathogenesis, Clinical Features, and Treatment of Corynebacterium striatum-Related Infection | 2026-01-06 | OpenAlex | 10.3390/microorganisms14010119 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118475497 | |||
| W7118354970 | Editorial: Asian medical industries: beyond tradition, beyond medicine, beyond Asia | 2026-01-07 | OpenAlex | 10.3389/fhumd.2025.1722458 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118354970 | |||
| W7118237596 | Foucault as a Kind of Realist | 2026-01-07 | OpenAlex | 10.1093/9780197749852.003.0021 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118237596 | |||
| W7122508324 | Perspective Chapter: The Use of Fluorescence in Ovarian Cancer Surgery | 2026-01-07 | OpenAlex | 10.5772/intechopen.1013691 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122508324 | |||
| W7118855217 | Preventing peri-implantitis: strategies, mechanisms, and clinical perspectives for inhibiting biofilm formation on implant surface | 2026-01-07 | OpenAlex | 10.3389/fmats.2025.1739290 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118855217 | |||
| W7118481164 | Editorial: Crosstalk in tumor microenvironments: shaping early drug and immunotherapy strategies | 2026-01-08 | OpenAlex | 10.3389/fimmu.2025.1754096 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118481164 | |||
| W7118641711 | Editorial: Digital health applications of social robots | 2026-01-08 | OpenAlex | 10.3389/frobt.2025.1773450 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118641711 | |||
| W7118609442 | Editorial: Mesenchymal stem cells and derived extracellular vesicles as next-generation biological drugs for tissue regeneration | 2026-01-08 | OpenAlex | 10.3389/fphar.2025.1770314 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118609442 | |||
| W7119077608 | GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease | 2026-01-08 | OpenAlex | 10.1038/s41581-025-01036-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119077608 | |||
| W7125803788 | Nelsonov sindrom nakon bilateralne adrenalektomije | 2026-01-08 | OpenAlex | 10.57140/mj.55.3-4.4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7125803788 | |||
| W7124753025 | Redefining antifungal prophylaxis in acute leukaemia in the era of targeted therapies | 2026-01-08 | OpenAlex | 10.1093/jac/dkag010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124753025 | |||
| W7119486174 | Systems Theory Model to Understand the Barriers and Facilitators to Palliative Care Referral for Pediatric Oncology Patients in Canada | 2026-01-08 | OpenAlex | 10.1200/op-25-00761 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7119486174 | |||
| W7121053110 | Targeting common EGFR mutations in non–small cell lung cancer: a review of global phase 3 trials of third-generation inhibitors | 2026-01-08 | OpenAlex | 10.1093/jnci/djag008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7121053110 | |||
| W7118541485 | The Next Chapter of Cancer Immunology Research | 2026-01-08 | OpenAlex | 10.1158/2326-6066.cir-25-1391 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7118541485 | |||
| W7220138994 | TheranosticsAnd NanotheranosticsIn Precision Medicine: Integrative Theoretical Foundations, Translational Paradigms, And Disease-Specific Applications | 2026-01-08 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220138994 | ||||
| W7134988583 | A New IgG-λ Band during Therapy in Light-Chain Myeloma | 2026-01-09 | OpenAlex | 10.1093/jalm/jfag004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134988583 | |||
| W7123356287 | A new proteomic clock links accelerated ageing to ischaemic stroke: no country for old vessels | 2026-01-09 | OpenAlex | 10.1093/eurjpc/zwag023 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123356287 | |||
| W7119802561 | Lava-Void Cosmology Pillar 14: Accelerated Nomadic Propagation - Strategic Annex | 2026-01-09 | OpenAlex | 10.5281/zenodo.18190547 | Title/abstract | Excluded | E2: Mathematical/forecasting/AGI framework without a clinical primary task. | https://openalex.org/W7119802561 | |||
| W7130374098 | Manipulating DNA repair and the DNA damage response to improve cancer therapy | 2026-01-09 | OpenAlex | 10.1093/narcan/zcag006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130374098 | |||
| W7119650059 | The Age of Intelligent Threats | 2026-01-09 | OpenAlex | 10.1002/9781394402069.ch1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119650059 | |||
| W7119855693 | Tyrosine kinase inhibitors for wet age-related macular degeneration: The current developmental landscape | 2026-01-09 | OpenAlex | 10.1016/j.jpet.2026.103803 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7119855693 | |||
| W7123718223 | A Narrative Review on the Power of Contrast Media in Radiology: Clinical Indications, Associated Risks, and Strategies for Safe Management | 2026-01-10 | OpenAlex | 10.64261/0scm9g24 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7123718223 | |||
| W7122571660 | Age-based outcomes and patterns of care of patients with metastatic pancreatic cancer: An updated comparative analysis from Fox Chase Cancer Center. | 2026-01-10 | OpenAlex | 10.1200/jco.2026.44.2_suppl.668 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7122571660 | |||
| W7122367730 | Comparative outcomes of evolving vs conventional regimens in BRAF V600E-mutated metastatic colorectal cancer therapy: A systematic review. | 2026-01-10 | OpenAlex | 10.1200/jco.2026.44.2_suppl.175 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122367730 | |||
| W7122445577 | Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in malignant peritoneal mesothelioma (MPM). | 2026-01-10 | OpenAlex | 10.1200/jco.2026.44.2_suppl.816 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7122445577 | |||
| W7122527779 | Real-world prospective comparison of sorafenib and lenvatinib as first-line therapy for unresectable hepatocellular carcinoma: A multicenter study in Japan (KSCC HAMRET). | 2026-01-10 | OpenAlex | 10.1200/jco.2026.44.2_suppl.562 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7122527779 | |||
| W7121540994 | Supersonic transporter (SST) deformity of penile prosthesis: Current management strategies | 2026-01-10 | OpenAlex | 10.1002/uro2.70044 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7121540994 | |||
| W7220659681 | Advances in Preventive Dentistry: Contemporary Strategies for Caries and Periodontal Disease Control | 2026-01-11 | OpenAlex | 10.36347/sjds.2026.v13i01.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220659681 | |||
| W7122493117 | Evolving Methodologies for the Analytical Determination of Metoclopramide | 2026-01-11 | OpenAlex | 10.1080/10408347.2025.2612234 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122493117 | |||
| W7122783492 | Antibody-based therapeutics and therapeutic development for diabetic retinopathy: targeting VEGF, Ang/Tie, and inflammatory pathways | 2026-01-12 | OpenAlex | 10.3389/fendo.2025.1710376 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122783492 | |||
| W7123259396 | Assessment Of the Outcome of Remdesivir in The Treatment of Covid-19 Patients: A Retrospective Observational Study | 2026-01-12 | OpenAlex | 10.5281/zenodo.18219993 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7123259396 | |||
| W7122613832 | Beyond rheumatology: Reconsidering methotrexate for Crohn’s disease in the biologic era | 2026-01-12 | OpenAlex | 10.3748/wjg.v32.i2.113432 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122613832 | |||
| W7122436344 | Biochemical and Pharmacological Mechanisms of GLP-1 and Dual Agonists: Implications for Glycemic Control and Cardiovascular Risk Reduction — A Review | 2026-01-12 | OpenAlex | 10.64907/xkmf.v4.i1.jbpph.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122436344 | |||
| W7122857035 | Caught between confidentiality and compulsion: the global ethics-law dilemma in psychotherapy | 2026-01-12 | OpenAlex | 10.3389/fpsyg.2025.1665158 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122857035 | |||
| W7122696050 | Chronic Graft-versus-Host Disease: A Review of Current Treatments beyond Second-Line and Emerging Therapies | 2026-01-12 | OpenAlex | 10.1159/000550265 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122696050 | |||
| W7122868402 | Editorial: Diagnostic and treatment strategies for periodontal disease | 2026-01-12 | OpenAlex | 10.3389/fdmed.2025.1759435 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122868402 | |||
| W7122803619 | Five years after the pandemic: rethinking the pharmacological management of mental disorders | 2026-01-12 | OpenAlex | 10.3389/fpsyt.2025.1750073 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122803619 | |||
| W7123350180 | Identification of leprosy reactions using Fourier transform infrared (FTIR) spectroscopy supervised by clinical evaluation | 2026-01-12 | OpenAlex | 10.1016/j.jpba.2026.117354 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7123350180 | |||
| W7122456883 | Intraoperative contrast-enhanced ultrasound-assisted resection of brain tumors: a systematic review and meta-analysis | 2026-01-12 | OpenAlex | 10.1016/j.neuchi.2026.101774 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122456883 | |||
| W7122633175 | Management strategies for burning mouth syndrome: a comprehensive review | 2026-01-12 | OpenAlex | 10.22514/jofph.2026.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122633175 | |||
| W7122472845 | Next-generation therapeutics for diabetic kidney disease | 2026-01-12 | OpenAlex | 10.1038/s41581-025-01042-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122472845 | |||
| W7122466457 | Ocular surface disease following LASIK and cataract surgery: a review of their interrelated complications | 2026-01-12 | OpenAlex | 10.3389/fmed.2025.1623324 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7122466457 | |||
| W7123356597 | Reply | 2026-01-12 | OpenAlex | 10.1016/j.jaci.2025.12.1001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123356597 | |||
| W7122790884 | The curative-to-preventive perspective shift of medical students through community dementia programs: a qualitative study based on transformative learning theory | 2026-01-12 | OpenAlex | 10.3389/fpubh.2025.1708455 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7122790884 | |||
| W7123345192 | When Warm Meets Cold: Mixed-Type Autoimmune Hemolytic Anemia Revealing an Underlying Autoimmune Disorder | 2026-01-12 | OpenAlex | 10.7759/cureus.101398 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7123345192 | |||
| W7123427634 | (CLFS)— Continuity-Synchronized Systems Across Spatially Separated Domains | 2026-01-13 | OpenAlex | 10.5281/zenodo.18235062 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7123427634 | |||
| W7123344274 | Agentic AI Framework for Technical Excellence: A Discipline-Based, Scalable Multimodal Assistant for Subsurface | 2026-01-13 | OpenAlex | 10.2523/iptc-25245-ms | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7123344274 | |||
| W7123658241 | Autonomous Capability Synthesis and Deterministic Cross-Platform Code Generation via a Modular Cognitive Substrate | 2026-01-13 | OpenAlex | 10.5281/zenodo.18234909 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7123658241 | |||
| W7131365931 | Chinese evidence-based antithrombotic therapy for coronary heart disease | 2026-01-13 | OpenAlex | 10.1360/csb-2025-5738 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131365931 | |||
| W7123663365 | Contemporary SPECT/CT V/Q scanning: protocols, pearls and pitfalls | 2026-01-13 | OpenAlex | 10.23736/s1824-4785.25.03688-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123663365 | |||
| W7123369522 | Editorial: Immuno-metabolic interactions and cancer progression in the tumor microenvironment | 2026-01-13 | OpenAlex | 10.3389/fimmu.2026.1774012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123369522 | |||
| W7123346065 | Editorial: Insights in healthcare professions education: 2024 | 2026-01-13 | OpenAlex | 10.3389/fmed.2025.1760309 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123346065 | |||
| W7123740922 | Editorial: Recent advances in oral medicine in dogs and cats | 2026-01-13 | OpenAlex | 10.3389/fvets.2025.1753541 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123740922 | |||
| W7123349439 | Editorial: Streamlining drug approvals: addressing policy challenges in genitourinary oncology | 2026-01-13 | OpenAlex | 10.3389/fimmu.2025.1757428 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123349439 | |||
| W7125694762 | From protocol to practice: enhancing the translational value of herbal patch studies through standardized assessment, robust blinding, and individualized dosing strategies | 2026-01-13 | OpenAlex | 10.1097/js9.0000000000004755 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125694762 | |||
| W7123349084 | In Vivo Prostate Cancer Modelling: From the Pre-Clinical to the Clinical Setting | 2026-01-13 | OpenAlex | 10.3390/life16010111 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123349084 | |||
| W7123358923 | State of the Art on Thyroid Cancer Biology and Oncology | 2026-01-13 | OpenAlex | 10.3390/biomedicines14010168 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123358923 | |||
| W7123744533 | Sulfonium peptoid outperforms: Exceptional biocompatibility and potent anti-MDR activity via multimodal mechanisms | 2026-01-13 | OpenAlex | 10.1016/j.nantod.2026.102977 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7123744533 | |||
| W7123343611 | The looming threat of invasive fungal infections in heart transplant recipients: Will it be the last of us | 2026-01-13 | OpenAlex | 10.1016/j.jhlto.2026.100482 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123343611 | |||
| W7124317947 | Trends in nephrology: from “supportive care” to CKD combination therapy | 2026-01-13 | OpenAlex | 10.1093/ndt/gfag003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124317947 | |||
| W7124174007 | Advances in the Pathophysiology and Management of Cancer Pain: A Scoping Review | 2026-01-14 | OpenAlex | 10.3390/cancers18020259 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124174007 | |||
| W7124167621 | Beyond Random Walks: Exploring the Learnability Threshold of AI Agents in Algorithmic Markets | 2026-01-14 | OpenAlex | 10.21203/rs.3.rs-8027229/v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7124167621 | |||
| W7135211312 | Challenges and Strategies in Managing β-Lactam–Resistant Pseudomonas aeruginosa in China | 2026-01-14 | OpenAlex | 10.1093/infdis/jiag033 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135211312 | |||
| W7123794771 | Commentary: Trehalose alleviates nephropathy in focal segmental glomerulosclerosis via the upregulation of the WT-1/EZH2 pathway | 2026-01-14 | OpenAlex | 10.3389/fphar.2026.1761856 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7123794771 | |||
| W7124166116 | Gastric and upper gastrointestinal oncology: integrating breakthroughs from prevention to precision therapeutics | 2026-01-14 | OpenAlex | 10.1186/s40164-025-00741-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124166116 | |||
| W7124156678 | Highlights of 2025 - Print Issue | 2026-01-14 | OpenAlex | 10.33940/001c.155326 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124156678 | |||
| W7124171310 | IA-ZINE Nº4 Dancing with the woman in red: Chronicles of 2032 | 2026-01-14 | OpenAlex | 10.5281/zenodo.18247507 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124171310 | |||
| W7124210826 | Quality of Life Measures in Advanced Endometrial Cancer: A Systematic Review of Reporting Practices in Phase III Clinical Trials | 2026-01-14 | OpenAlex | 10.3390/cancers18020258 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124210826 | |||
| W7124168080 | The Discovery of Prostate-specific Membrane Antigen Ligands: The Long Road to Changes in Clinical Practice for Prostate Cancer | 2026-01-14 | OpenAlex | 10.1016/j.eururo.2026.01.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124168080 | |||
| W7124276246 | Advances in Screening, Immunotherapy, Targeted Agents, and Precision Surgery in Cervical Cancer: A Comprehensive Clinical Review (2018–2025) | 2026-01-15 | OpenAlex | 10.3390/curroncol33010048 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7124276246 | |||
| W7124260302 | Cancer therapy-associated Takotsubo cardiomyopathy: A narrative review of mechanisms, drug associations, and clinical implications | 2026-01-15 | OpenAlex | 10.1016/j.ahjo.2026.100723 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124260302 | |||
| W7223143826 | Chondrosarcoma: from genomics to clinical trials | 2026-01-15 | OpenAlex | 10.5603/ocp.114539 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223143826 | |||
| W7133512625 | Do we need to use neoadjuvant carboplatin in all patients with triple-negative breast cancer? | 2026-01-15 | OpenAlex | 10.5603/ocp.109345 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133512625 | |||
| W7124318464 | Drug-Induced Acute Generalized Exanthematous Pustulosis: Mechanisms, Diagnosis, and Clinical Differentiation from Other Pustular Eruptions | 2026-01-15 | OpenAlex | 10.3390/dermato6010003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124318464 | |||
| W7221626822 | Green Synthesis of Nanoparticles for Pharmaceutical Applications: A Sustainable Approach | 2026-01-15 | OpenAlex | 10.22037/ipa.v9i1.50862 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221626822 | |||
| W7132852857 | Osteoporosis: Contemporary Understanding, Diagnostic Advances, and Evolving Therapeutic Strategies | 2026-01-15 | OpenAlex | 10.5281/zenodo.18811617 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7132852857 | |||
| W7124248984 | Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody–drug conjugates, and clinical trial innovations | 2026-01-15 | OpenAlex | 10.3389/fonc.2025.1697180 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124248984 | |||
| W7124265950 | The evolving landscape of platelet therapy: risks, innovations, and clinical judgment | 2026-01-15 | OpenAlex | 10.1007/s00277-026-06758-y | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7124265950 | |||
| W7124324843 | ANTIHYPERTENSIVE DRUGS: AN ADVANCED COMPREHENSIVE REVIEW OF MECHANISMS, THERAPIES, AND CLINICAL INNOVATIONS | 2026-01-16 | OpenAlex | 10.5281/zenodo.18255404 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124324843 | |||
| W7124768010 | Antimicrobial Resistance and Therapy in Intensive Care Unit | 2026-01-16 | OpenAlex | 10.3390/books978-3-7258-6311-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124768010 | |||
| W7124446289 | Engineering Tick Evasins as Multitarget Chemokine Inhibitors─A Biomimetic Approach To Tackling the Complexity of the Immune System | 2026-01-16 | OpenAlex | 10.1021/acs.accounts.5c00793 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7124446289 | |||
| W7124469127 | Immunotherapy in clear cell renal cell carcinoma: current Status, novel Strategies, and future perspectives | 2026-01-16 | OpenAlex | 10.1007/s10238-025-02031-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124469127 | |||
| W7124434192 | Making Tunable Parameters State-Dependent in Weather and Climate Models with Reinforcement Learning | 2026-01-16 | OpenAlex | 10.22541/essoar.176859085.59276820/v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7124434192 | |||
| W7124424037 | Management of Peptide Receptor Radionuclide Therapy Toxicities in Neuroendocrine Neoplasm Patients | 2026-01-16 | OpenAlex | 10.1007/s11864-026-01379-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124424037 | |||
| W7124470305 | Post-immunotherapy second-line strategies for hepatocellular carcinoma: State of the art and ongoing trials | 2026-01-16 | OpenAlex | 10.3748/wjg.v32.i3.111528 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124470305 | |||
| W7124454105 | Primitive Asymmetries of Persistence | 2026-01-16 | OpenAlex | 10.5281/zenodo.18273850 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7124454105 | |||
| W7135079604 | The Evolving Frontline of Antimicrobial Resistance: Adapting Testing and Treatment for Austere and Combat Settings | 2026-01-16 | OpenAlex | 10.1093/milmed/usag024 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135079604 | |||
| W7126020316 | Treatment Strategies for Perinatal Depression Beyond Conventional Antidepressants: A Narrative Review | 2026-01-16 | OpenAlex | 10.31083/ceog45609 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126020316 | |||
| W7124526760 | A Comprehensive Study on Approaches in the War Against Antibiotic Resistance | 2026-01-17 | OpenAlex | 10.5281/zenodo.18280524 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124526760 | |||
| W7124657014 | The Role of Stem Cell Transplantation in Hodgkin Lymphoma | 2026-01-17 | OpenAlex | 10.1016/j.hoc.2025.12.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124657014 | |||
| W7124680305 | Targeting the brain through the nose: Advances in polymeric nanoparticle delivery for schizophrenia | 2026-01-18 | OpenAlex | 10.1016/j.npep.2026.102585 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124680305 | |||
| W7124831685 | 30 years of thrombolysis for ischaemic stroke: expanded agents, widened windows and accelerated delivery | 2026-01-19 | OpenAlex | 10.1136/svn-2025-004987 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124831685 | |||
| W7124995133 | Cellular Allies Against Glioblastoma: Therapeutic Potential of Macrophages and Mesenchymal Stromal Cells | 2026-01-19 | OpenAlex | 10.3390/pharmaceutics18010124 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124995133 | |||
| W7126003504 | Control of airborne biocontamination in HVAC systems through UV-C irradiation. An experimental and numerical study of the UV-C field | 2026-01-19 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7126003504 | ||||
| W7124728244 | Diversifying Description Phase Techniques During Debriefing | 2026-01-19 | OpenAlex | 10.21203/rs.3.rs-8462808/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7124728244 | |||
| W7125004915 | Does Prophylactic Intraperitoneal Chemotherapy Provide Any Clinical Benefit After Curative Colorectal Cancer Resection? | 2026-01-19 | OpenAlex | 10.1245/s10434-026-19095-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125004915 | |||
| W7125631174 | Early management of acute heart failure | 2026-01-19 | OpenAlex | 10.1097/mcc.0000000000001357 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125631174 | |||
| W7124694139 | Editorial: Brain metastasis and systemic target therapy: implications for neurosurgeons | 2026-01-19 | OpenAlex | 10.3389/fsurg.2026.1761513 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124694139 | |||
| W7124833137 | Evaluating senescence-targeted approaches in Alzheimer’s Disease: What we know and what lies ahead | 2026-01-19 | OpenAlex | 10.1016/j.arr.2026.103029 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124833137 | |||
| W7124729517 | Kinetics of Biomarkers for Therapeutic Assessment in Swiss Mice Infected with a Virulent Trypanosoma cruzi Strain | 2026-01-19 | OpenAlex | 10.3390/pathogens15010107 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7124729517 | |||
| W7124881553 | Lipopeptide Engineering: From Natural Origins to Rational Design Against Antimicrobial Resistance | 2026-01-19 | OpenAlex | 10.3390/antibiotics15010100 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124881553 | |||
| W7124798618 | Multi-Agent AI Framework for Threat Mitigation and Resilience in Machine Learning Systems | 2026-01-19 | OpenAlex | 10.1145/3780095 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7124798618 | |||
| W7125686753 | Progressive multifocal leukoencephalopathy in the modern therapeutic era: A critical synthesis of epidemiology, diagnostics, and policy implications with regional context from Korea | 2026-01-19 | OpenAlex | 10.46439/biomedres.6.074 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125686753 | |||
| W7124736699 | Recent updates on thymic stromal lymphopoietin as a therapeutic target for asthma | 2026-01-19 | OpenAlex | 10.1080/17476348.2026.2615193 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124736699 | |||
| W7140205060 | Smart Chatbot with Advanced Self-Evolving using AI Tools and Techniques | 2026-01-19 | OpenAlex | 10.1109/icauc68182.2026.11441111 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7140205060 | |||
| W7124832611 | Treatment Strategies in Metastatic Castration-Resistant Prostate Cancer: A Narrative Review of Considerations in the Post-ARTA, Post-Docetaxel Setting | 2026-01-19 | OpenAlex | 10.1007/s40487-025-00412-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124832611 | |||
| W7160167436 | “Timelining” Treatment Trajectories During Interviews About Shared Decision Making With Ethnic Minorities in Oncology: A Methodological Reflection | 2026-01-19 | OpenAlex | 10.1177/16094069261442331 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160167436 | |||
| W7125001769 | 20 Years of Liver Biopsies at a Single Institution—Application of a Machine Learning‐Based Approach to Pathology Database Searches | 2026-01-20 | OpenAlex | 10.1002/lci2.70036 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7125001769 | |||
| W7124972602 | Advances in the Management of Pediatric Inflammatory Bowel Disease: From Biologics to Small Molecules | 2026-01-20 | OpenAlex | 10.3390/ph19010176 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124972602 | |||
| W7125714285 | An Innovative Frontier in Healthcare: Optimizing Alcoholism Detection with an Assorted Convolutional Neural Network and Long Short-Term Memory System | 2026-01-20 | OpenAlex | 10.14445/23488549/ijece-v13i1p107 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7125714285 | |||
| W7124961640 | Artificial Intelligence in Chronic Disease Management: From Early Diagnostics to Patient Empowerment | 2026-01-20 | OpenAlex | 10.54254/2753-8818/2026.pj31352 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124961640 | |||
| W7124857840 | Ethics beyond the form: Response-ability in intersex healthcare research | 2026-01-20 | OpenAlex | 10.1016/j.metip.2026.100229 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7124857840 | |||
| W7125697008 | Evolution of Treatments of Prostate Cancer | 2026-01-20 | OpenAlex | 10.3390/books978-3-7258-6066-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125697008 | |||
| W7124995845 | Management of tenosynovial giant cell tumor: approved and investigational therapies | 2026-01-20 | OpenAlex | 10.1080/14737140.2026.2620510 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124995845 | |||
| W7204935662 | Rethinking acne vulgaris: from pathogenic mechanisms to targeted therapies | 2026-01-20 | OpenAlex | 10.5603/fd.113792 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204935662 | |||
| W7124905386 | Targeting the Inflammatory Cascade: The Evolution of Monoclonal Antibodies for Severe Asthma Management | 2026-01-20 | OpenAlex | 10.12775/qs.2026.49.67808 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7124905386 | |||
| W7125435541 | Checkpoint inhibitors in cancer Immunotherapy: Mechanisms, Resistance, and Combination Strategies | 2026-01-21 | OpenAlex | 10.1051/epjconf/202634801013/pdf | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125435541; https://openalex.org/W7125147103 | |||
| W7125126259 | Discovery of Coerumycin, a Cinnamycin-like Lantibiotic from Actinomadura coerulea TMS085 | 2026-01-21 | OpenAlex | 10.3390/antibiotics15010104 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7125126259 | |||
| W7125134983 | Favipiravir's clinical potential for treating Severe Fever with Thrombocytopenia Syndrome (SFTS): A narrative review | 2026-01-21 | OpenAlex | 10.1016/j.virol.2026.110799 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125134983 | |||
| W7125210433 | Guideline implications of REBOOT: beta-blockers therapy in post-MI patients with preserved LVEF | 2026-01-21 | OpenAlex | 10.1097/js9.0000000000004900 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125210433 | |||
| W7125770255 | Harnessing Purines: Anticancer Activity and Target-Specific Approaches | 2026-01-21 | OpenAlex | 10.2174/0115734064390291251128060307 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125770255 | |||
| W7125424626 | Letter to the Editor: Liver transplantation for colorectal metastasis – selection criteria, outcomes, and management recurrence: a systematic review and meta-analysis | 2026-01-21 | OpenAlex | 10.1097/js9.0000000000004870 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125424626 | |||
| W7125107141 | New developments in periodontal tissue regeneration utilizing nanocages and cell membrane display nanotechnology: Current advances and future perspectives. | 2026-01-21 | OpenAlex | 10.5281/zenodo.18322994 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125107141 | |||
| W7125162776 | Organ donor management in the ICU: Adjunctive agents for optimizing organ procurement and graft function | 2026-01-21 | OpenAlex | 10.1093/ajhp/zxag020 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125162776 | |||
| W7125263017 | Rauwolfia Serpentina Used in Treatment of Hypertension | 2026-01-21 | OpenAlex | 10.5281/zenodo.18328389 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125263017 | |||
| W7125374322 | Adaptive Recursive Cognition (ARC): A Reproducible Architecture for Multi-Loop Stabilization, Self-Improvement, and Token-Level Control in Language Models | 2026-01-22 | OpenAlex | 10.5281/zenodo.18342791 | Title/abstract | Excluded | E2: Nonclinical settings include coding, robotics, general agent memory/governance, recommender systems, synthetic worlds, games or formal verification; healthcare is not the primary task. | https://openalex.org/W7125374322 | |||
| W7125390584 | Autonomy Exposure Engineering: Cross-Domain Dynamics, Containment Strategies, and Governance Frameworks (2026) | 2026-01-22 | OpenAlex | 10.5281/zenodo.18343181 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125390584; https://openalex.org/W7125383865 | |||
| W7126020427 | Beyond Diabetes: A Review of Emerging Indications for Glucagon-Like Peptide-1 Receptor Agonists | 2026-01-22 | OpenAlex | 10.31083/rcm44528 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126020427 | |||
| W7125390503 | Can bile salts affect the contractile oesophageal activity associated with gastroesophageal reflux disease? | 2026-01-22 | OpenAlex | 10.3748/wjg.v32.i4.114560 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7125390503 | |||
| W7125377163 | Colonic diverticular hemorrhage: Etiology, diagnostic challenges, and evolving therapeutic strategies | 2026-01-22 | OpenAlex | 10.3748/wjg.v32.i4.114842 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7125377163 | |||
| W7129053369 | Developments in the therapeutic landscape for dry eye | 2026-01-22 | OpenAlex | 10.1080/14656566.2026.2633382 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129053369 | |||
| W7125500979 | Exogenous amdoparvoviruses (Parvoviridae) in arvicoline voles: the molecular evolution and ecology of a novel host-viral association | 2026-01-22 | OpenAlex | 10.1371/journal.ppat.1013896 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7125500979 | |||
| W7125409037 | GastroTCM: a large language model assistant for gastroenterology in traditional Chinese medicine | 2026-01-22 | OpenAlex | 10.1186/s13020-025-01295-8 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7125409037 | |||
| W7131391782 | Highlighting advances on clinical management of pediatric HIV | 2026-01-22 | OpenAlex | 10.1080/14656566.2026.2638484 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131391782 | |||
| W7125390461 | Mastery Equilibrium Theory (MET) | 2026-01-22 | OpenAlex | 10.5281/zenodo.18343188 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125390461 | |||
| W7161353149 | OVERCOMING FEAR: THE ROLE OF CANINE THERAPY IN TREATING GYNOPHOBIA | 2026-01-22 | OpenAlex | 10.5281/zenodo.20209367 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161353149 | |||
| W7125582576 | Practice guideline on the prevention and treatment of central line-associated bloodstream infection: Part 2 – Treatment | 2026-01-22 | OpenAlex | 10.1016/j.jointm.2025.10.009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125582576 | |||
| W7125427913 | Recent developments in pediatric respiratory syncytial virus prevention: The expanding role of monoclonal antibodies | 2026-01-22 | OpenAlex | 10.1093/ajhp/zxag019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125427913 | |||
| W7125442532 | The new life of myectomy in the era of myosin inhibitors | 2026-01-22 | OpenAlex | 10.1016/j.pcad.2026.01.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125442532 | |||
| W7125508511 | Agentic Reterival Augmented Generation using Small Language Model | 2026-01-23 | OpenAlex | 10.5281/zenodo.18345420 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7125508511 | |||
| W7125503963 | Dobutamine or milrinone in mixed cardiogenic shock with sepsis | 2026-01-23 | OpenAlex | 10.1093/annalsats/aaoaf055 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125503963 | |||
| W7125486598 | Editorial: The newer paradigms in hypertension research and management | 2026-01-23 | OpenAlex | 10.3389/fmed.2026.1781466 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125486598 | |||
| W7125531718 | Emergence of Medetomidine in the Illicit Drug Supply: Implications for Emergency Care and Withdrawal Management | 2026-01-23 | OpenAlex | 10.1016/j.annemergmed.2025.12.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125531718 | |||
| W7125518998 | MASH and the race for liver antifibrotics | 2026-01-23 | OpenAlex | 10.3389/fgstr.2025.1704078 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125518998 | |||
| W7125510828 | Pediatric lymphoproliferative disorders – Emerging insights and management: A narrative review | 2026-01-23 | OpenAlex | 10.1097/md.0000000000047367 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125510828 | |||
| W7125561013 | Safety-first TCR-T: AI-guided specificity, base-editing to prevent mispairing, and prioritizing public neoantigens | 2026-01-23 | OpenAlex | 10.3389/fimmu.2026.1754735 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125561013 | |||
| W7147395832 | Agentic AI for Intelligent Pharmaceutical Market Access Analytics Platforms | 2026-01-24 | OpenAlex | 10.63397/iscsitr-ijcse_2026_07_01_004 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7147395832 | |||
| W7125581775 | Difficult to manage axial spondyloarthritis patients have high burden of pain-related comorbidities and adverse long-term outcome | 2026-01-24 | OpenAlex | 10.1186/s13075-026-03732-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7125581775 | |||
| W7125634317 | Extensive Cerebral Venous Sinus Thrombosis in a Young Male With Severe Hyperhomocysteinaemia: An Unusual Presentation With Early Diplopia | 2026-01-24 | OpenAlex | 10.7759/cureus.102233 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7125634317 | |||
| W7125603626 | Filling the Gaps: A Review and Update on Beta-Lactamase Inhibitor Combinations | 2026-01-24 | OpenAlex | 10.1007/s11908-025-00874-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125603626 | |||
| W7125590179 | Multimodal fusion and AI context awareness in smart kitchens: deep learning for personalized recommendation and real-time monitoring | 2026-01-24 | OpenAlex | 10.55670/fpll.futech.5.1.9 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7125590179 | |||
| W7125613902 | Nanofibers for the Management of Lung Cancer | 2026-01-24 | OpenAlex | 10.1201/9781003595830-12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125613902 | |||
| W7125593972 | Nanotechnology-driven biomaterials for chronic liver diseases: Stage-specific strategies for advanced theranostics | 2026-01-24 | OpenAlex | 10.1016/j.actbio.2026.01.043 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125593972 | |||
| W7125606302 | The Malignant Tumor as a Hybrid Biological System: A Tripartite Integration Hypothesis | 2026-01-24 | OpenAlex | 10.5281/zenodo.18361965 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125606302 | |||
| W7125765414 | Dealing mental health disorders | 2026-01-25 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7125765414 | ||||
| W7125702535 | Hepatic Sinusoidal Obstruction Syndrome Induced by Pyrrolizidine Alkaloids from Gynura segetum: Mechanisms and Therapeutic Advances | 2026-01-25 | OpenAlex | 10.3390/molecules31030410 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125702535 | |||
| W7125698150 | Research Advances in Glanimal Models of Glaucoma: Exploring Multidimensional Mechanisms and Novel Therapeutic Strategies | 2026-01-25 | OpenAlex | 10.3390/pharmaceutics18020152 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125698150 | |||
| W7125715868 | A Mini-review on the Significance of Benzimidazole in Antifungal Drug Design: Past Insights and Current Applications | 2026-01-26 | OpenAlex | 10.2174/0113895575416047251201060127 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125715868 | |||
| W7220462701 | CHRISTIAN MISSIONS AND THE STRUGGLE FOR HUMAN DIGNITY AND PEACE IN AFRICA | 2026-01-26 | OpenAlex | 10.64633/wissj.v10i1.05 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220462701; https://openalex.org/W7125686163 | |||
| W7125708944 | Editorial: Infectious diseases and hematology: diagnosis and management, volume II | 2026-01-26 | OpenAlex | 10.3389/fmed.2025.1769806 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125708944 | |||
| W7125628828 | Editorial: Nanomaterials Mediated Immunomodulation in Cancer: Current Perspective from Bench to Clinic | 2026-01-26 | OpenAlex | 10.3389/fimmu.2026.1784752 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125628828 | |||
| W7125695208 | Enzymatic Glucosylation Enhances the Solubility of Niclosamide but Abrogates Its Therapeutic Efficacy | 2026-01-26 | OpenAlex | 10.1021/acsomega.5c12185 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7125695208 | |||
| W7125628395 | Novel Koutsourovirus phages disrupt clinical multidrug-resistant Enterobacter cloacae biofilms: genomic and functional characterization | 2026-01-26 | OpenAlex | 10.1007/s12223-026-01424-2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7125628395 | |||
| W7125807369 | Post-mastectomy pain syndrome mechanisms, prevention, and management strategies | 2026-01-26 | OpenAlex | 10.18203/2394-6040.ijcmph20260121 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125807369 | |||
| W7140490558 | Sustainable Virtual Reality for Psychological Well-Being: The Role of Supervision, Immersion, and Human Presence | 2026-01-26 | OpenAlex | 10.1109/aixvr67263.2026.00065 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140490558 | |||
| W7125804964 | Antiplatelet therapy after intravenous thrombolysis in acute ischemic stroke: No longer one-size-fits-all | 2026-01-27 | OpenAlex | 10.4103/bc.bc_153_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125804964 | |||
| W7125796832 | Comment on "Emerging oligonucleotide therapeutics for the treatment of dry eye diseases": Oligonucleotide therapeutics for dry eye disease: Navigating the road from precision promise to clinical reality | 2026-01-27 | OpenAlex | 10.1016/j.edisc.2026.100019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125796832 | |||
| W7125843632 | Direct Oral Anti-Xa Anticoagulants and the Future of Factor XI/FXIa Inhibition: A New Paradigm in Thrombosis Prevention | 2026-01-27 | OpenAlex | 10.3390/pharmacy14010019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125843632 | |||
| W7125826740 | Editorial: Diagnostic innovations for microbial pathogens in edible plants: cutting-edge technologies for enhanced detection | 2026-01-27 | OpenAlex | 10.3389/fmicb.2026.1777845 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125826740 | |||
| W7125820514 | KETAMINE IN PREHOSPITAL MANAGEMENT OF TRAUMATIC BRAIN INJURIES: FROM CONTROVERSY TO ROUTINE USE. A SYSTEMATIC REVIEW OF CURRENT LITERATURE | 2026-01-27 | OpenAlex | 10.31435/ijitss.1(49).2026.4564 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125820514 | |||
| W7125951595 | Oil supplementation and cardiovascular mortality in the dialysis population | 2026-01-27 | OpenAlex | 10.1093/ndt/gfag015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125951595 | |||
| W7125783524 | Prescription Patterns of Sodium-Glucose Co-Transporter 2 Inhibitors among Nephrologists | 2026-01-27 | OpenAlex | 10.25259/ijn_784_2025 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7125783524 | |||
| W7126054603 | Towards precision secondary prevention after myocardial infarction and stroke with glucagon-like peptide-1 receptor agonists | 2026-01-27 | OpenAlex | 10.1093/eurjpc/zwag068 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126054603 | |||
| W7125970579 | A Typed Naturality Constraint and Audit-Gated Degradation for Verifiable, Non-Extractable AI Claims | 2026-01-28 | OpenAlex | 10.5281/zenodo.18402500 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7125970579 | |||
| W7126066017 | Cancer Therapy‐Induced Cardiotoxicity: A Narrative Review | 2026-01-28 | OpenAlex | 10.1002/phar.70110 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126066017 | |||
| W7125941448 | Current Landscape and Evolving Role of Targeted Agents in Urothelial Carcinoma | 2026-01-28 | OpenAlex | 10.3390/cancers18030409 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7125941448 | |||
| W7131881198 | Diverticular Inflammation and Complication Assessment-guided prevention of acute diverticulitis: evidence, uncertainties, and the path ahead | 2026-01-28 | OpenAlex | 10.1097/meg.0000000000003128 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131881198 | |||
| W7125916422 | ENHANCING KNOWLEDGE-INTENSIVE CUSTOMER SUPPORT IN REGULATED INDUSTRIES THROUGH RETRIEVAL-AUGMENTED GENERATION (RAG): ARCHITECTURE, ALGORITHMS, AND EMPIRICAL EVALUATION | 2026-01-28 | OpenAlex | 10.34218/ijaiap_05_01_001 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7125916422 | |||
| W7125951008 | Enterprise CRM Architecture in the AI Era: Design Patterns, Platform Transformation, and the Future of Multi-Tenant SaaS | 2026-01-28 | OpenAlex | 10.20944/preprints202601.2199.v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7125951008 | |||
| W7125963060 | Expert Discussion: ABC8, Bridging the Gap | 2026-01-28 | OpenAlex | 10.1159/000550030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125963060 | |||
| W7125908748 | Harnessing nanomaterials to overcome antimicrobial resistance in Gram-positive bacteria: a systematic review | 2026-01-28 | OpenAlex | 10.37349/eds.2026.1008144 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125908748 | |||
| W7125958660 | Recent Advances in Liver Computed Tomography and Magnetic Resonance Imaging Technologies | 2026-01-28 | OpenAlex | 10.1111/hepr.70130 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125958660 | |||
| W7149232088 | Towards Societally Aligned Decision-Making for Automated Vehicles: Exploring the Operationalisation of Ethics through Augmented Utilitarianism | 2026-01-28 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7149232088 | ||||
| W7126398338 | 2024 Year-in-Review: Scientific Highlights from Current Pharmaceutical Biotechnology | 2026-01-29 | OpenAlex | 10.2174/0113892010429526251026152322 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126398338 | |||
| W7126018985 | Abstract TP088: Decreased axonal outgrowth and dendritic plasticity, and increased synaptic removal in hippocampal and cortical neurons contribute to the long-lasting post-stroke memory dysfunction in old mice | 2026-01-29 | OpenAlex | 10.1161/str.57.suppl_1.tp088 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126018985 | |||
| W7129219509 | Advances in Immunotherapy for Breast Cancer | 2026-01-29 | OpenAlex | 10.46883/2026.25921061 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129219509 | |||
| W7133204918 | Data Resource Profile: Prostate cancer data from Clinical Practice Research Datalink linked hospital records, mortality data and cancer registry standardized to the Observational Medical Outcomes Partnership common data model (CPRD-PCa-OMOP) | 2026-01-29 | OpenAlex | 10.1093/ije/dyag016 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133204918 | |||
| W7128531946 | Progress and prospects in anti-HER2 targeted therapy for gastric cancer | 2026-01-29 | OpenAlex | 10.1360/csb-2025-5908 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128531946 | |||
| W7126385037 | Small Patients, Big Decisions: Unraveling Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation | 2026-01-29 | OpenAlex | 10.5005/jaypee-journals-11011-0078 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126385037 | |||
| W7126031467 | The Relationship Between Physician Self-Disclosure and Patient Acquisition in Digital Health Markets: Cross-Sectional Study | 2026-01-29 | OpenAlex | 10.2196/84963 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126031467 | |||
| W7147614309 | A Self-Reflective Multi-Agent Physician Recommendation Framework | 2026-01-30 | OpenAlex | 10.1109/cnml68938.2026.11452303 | Full text | Included | Included: Reference-rating errors generate persistent heuristic rules reused on later physician profiles in a primary healthcare recommendation system. | https://openalex.org/W7147614309 | https://ieeexplore.ieee.org/document/11452303 | ||
| W7126156858 | Candida Species as Opportunistic Pathogens: Epidemiology, Virulence, Laboratory Diagnosis, and Antifungal Resistance | 2026-01-30 | OpenAlex | 10.22214/ijraset.2026.77025 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126156858 | |||
| W7163387600 | Human and Artificial Intelligence in Radiology: Current Status,Evidence,Regulation, and Future Perspectives | 2026-01-30 | OpenAlex | 10.48620/98377 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163387600 | |||
| W7161633310 | Large Language Models in Medicine: A Review of Technical Evolution, ClinicalApplications, and Future Directions | 2026-01-30 | OpenAlex | 10.1145/3793928.3793947 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161633310 | |||
| W7126172331 | Neuroblastoma in Childhood: Biological Insights, Risk Stratification, and Advances in Multimodal Therapy | 2026-01-30 | OpenAlex | 10.3390/jcm15031101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126172331 | |||
| W7126240250 | Oceans in Medicine: Advances in Marine-Based Therapeutants for Modern Diseases | 2026-01-30 | OpenAlex | 10.5281/zenodo.18419340 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126240250 | |||
| W7126243554 | Revealing the invisible: a new imaging paradigm for α-synuclein pathology in Parkinson's disease | 2026-01-30 | OpenAlex | 10.3389/fradi.2026.1730757 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126243554 | |||
| W7126429378 | Bacterial endocarditis and dental infections in the post-COVID-19 era: a review of current concepts | 2026-01-31 | OpenAlex | 10.18203/2394-6040.ijcmph20260332 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126429378 | |||
| W7147678940 | Ep. 396: From Prozac to Plasticity: The New Science of Depression | 2026-01-31 | OpenAlex | 10.5281/zenodo.19359429 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147678940 | |||
| W7126447789 | Evolving roles of drug delivery systems for non-invasive treatment of neovascular age-related macular degeneration: advances and challenges | 2026-01-31 | OpenAlex | 10.1016/j.jddst.2026.108088 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126447789 | |||
| W7126208117 | FORMULATION AND EVALUATION OF FAST DISSOLVING ORAL FILMS OF METOPROLOL TARTRATE FOR HYPERTENSION | 2026-01-31 | OpenAlex | 10.5281/zenodo.18440822 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126208117 | |||
| W7126404972 | Fowl adenovirus infections: A comprehensive review of prevalence, pathogenesis, diagnosis, control, and economic impact | 2026-01-31 | OpenAlex | 10.1016/j.psj.2026.106565 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126404972 | |||
| W7126381167 | Immunotherapeutic advances in pediatric neuroblastoma: Overcoming resistance through biomarker-guided combinations | 2026-01-31 | OpenAlex | 10.1016/j.biopha.2026.119020 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7126381167 | |||
| W7128310942 | Multimodal Conversational AI: From Perceptual Fusion to Collaborative Intelligence | 2026-01-31 | OpenAlex | 10.5281/zenodo.18526062 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128310942 | |||
| W7126258197 | Preparing clinical champions for sustainable implementation of practice change within large healthcare systems | 2026-01-31 | OpenAlex | 10.1186/s43058-026-00873-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126258197; https://openalex.org/W7132846121 | |||
| W7126417770 | Risk Factor Control in a Portuguese Vascular Risk Clinic: A 16-Month Retrospective Cohort Study | 2026-01-31 | OpenAlex | 10.7759/cureus.102735 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126417770 | |||
| W7128306880 | The Next Frontier of AI: Emerging Techniques and Future Trends | 2026-01-31 | OpenAlex | 10.5281/zenodo.18527407 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128306880 | |||
| W7128773099 | 2026-02-01 | OpenAlex | 10.1055/s-016-62982 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128773099 | ||||
| W7130410046 | A Chinese Expert Consensus on the Artificial Intelligence Proficiency of Medical Students: Competencies and the Multi‐Modal Assessment | 2026-02-01 | OpenAlex | 10.1002/hcs2.70049 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7130410046 | |||
| W7127053339 | A review of estrogens used in menopausal hormone therapy | 2026-02-01 | OpenAlex | 10.1097/gco.0000000000001090 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127053339 | |||
| W7128588234 | Adult‐Onset Still's Disease( AOSD ) With Features Suggestive of Macrophages Activation Syndrome in Young Female: A Rare Case Report From Nepal | 2026-02-01 | OpenAlex | 10.1002/ccr3.72031 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128588234 | |||
| W7128479733 | Advancing the frontiers of hepatocellular carcinoma treatment: a comprehensive review of past, ongoing, and future clinical trials | 2026-02-01 | OpenAlex | 10.21037/cco-25-53 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128479733 | |||
| W7127294876 | Amiloidosi cardiaca da catene leggere: gestione multidisciplinare e innovazioni terapeutiche. Documento di consenso SIC/ANMCO della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) | 2026-02-01 | OpenAlex | 10.1714/4636.46471 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127294876 | |||
| W7131652312 | Applications of artificial intelligence for real-world evidence generation: a protocol for a living scoping review | 2026-02-01 | OpenAlex | 10.1136/bmjopen-2025-109725 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131652312 | |||
| W7131618621 | Cefalexin use in UK acute pyelonephritis practice: unaddressed challenges in dosing, breakpoints and clinical evidence | 2026-02-01 | OpenAlex | 10.1093/jac/dkag051 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131618621 | |||
| W7126424695 | Combined Management of an Aspergillus Pleural Empyema in a 47-Year-Old woman | 2026-02-01 | OpenAlex | 10.5281/zenodo.18450168 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7126424695 | |||
| W7127390356 | Comprehensive Profiling of Real Life Management and Incidence of Chronic GVHD — a Belgian Retrospective Single Center Study | 2026-02-01 | OpenAlex | 10.1016/j.jtct.2025.12.409 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7127390356 | |||
| W7128243452 | Current and Ongoing Clinical Studies | 2026-02-01 | OpenAlex | 10.1002/mus.70040 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128243452 | |||
| W7128787815 | Diagnosis and Therapeutic Challenges of Drug-Resistant Tuberculosis Infection After Kidney Transplantation: A Rare Case Report | 2026-02-01 | OpenAlex | 10.2147/idr.s590648 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128787815; https://openalex.org/W7129186894 | |||
| W7130827549 | Drug development in systemic sclerosis: novel therapeutics to watch | 2026-02-01 | OpenAlex | 10.1080/1744666x.2026.2636654 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130827549 | |||
| W7128663421 | Empagliflozin Improves Learning and Memory Deficits in Streptozotocin-Induced Hyperglycemic Male Wistar Rats | 2026-02-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128663421 | ||||
| W7160792927 | Fountains of knowledge: middling women and the production, consumption and transmission of natural knowledge, 1760-1810 | 2026-02-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160792927 | ||||
| W7138915831 | From algorithms to clinical execution: A cross-validated knowledge atlas of AI-enabled precision care (2015–2025) | 2026-02-01 | OpenAlex | 10.1177/20552076261436251 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138915831 | |||
| W7171300300 | Generative AI versus human conversational agent for reducing procrastination: A randomized pilot trial | 2026-02-01 | OpenAlex | 10.1177/20552076261450336 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7171300300 | |||
| W7128774749 | Hemophagocytic lymphohistiocytosis: a diagnosis and treatment challenge | 2026-02-01 | OpenAlex | 10.1016/j.amjms.2025.12.664 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128774749 | |||
| W7212356050 | How to design digital health interventions with artificial intelligence: A scoping review | 2026-02-01 | OpenAlex | 10.1177/20552076261490346 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212356050 | |||
| W7128482982 | IL-23 Inhibitors in Psoriasis: What Have We Learnt so Far? | 2026-02-01 | OpenAlex | 10.2147/jir.s540848 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128482982; https://openalex.org/W7128670002 | |||
| W7141771527 | Insights into Tanning Biology and Tanning Products. | 2026-02-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7141771527 | ||||
| W7128193423 | Introduction to the Supplement | 2026-02-01 | OpenAlex | 10.1002/mus.70036 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128193423 | |||
| W7130487128 | Nanoparticles Targeting the Tumor Microenvironment for the Treatment of Osteosarcoma: Recent Progress and Perspectives | 2026-02-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130487128; https://openalex.org/W7129040349 | ||||
| W7127547504 | Nanoparticles for Advancements in Radiopharmaceutical Technologies | 2026-02-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7127547504 | ||||
| W7127448743 | Neurologic Complications of Cardiac Disease and Cardiac Procedures | 2026-02-01 | OpenAlex | 10.1212/cont.0000000000001656 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127448743 | |||
| W7128436143 | Optimizing the Role of Checkpoint Inhibitors in the Management of Hodgkin Lymphoma | 2026-02-01 | OpenAlex | 10.6004/jnccn.2025.7125 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128436143 | |||
| W7132830591 | PP042 Personalized therapy sequencing in triple-negative breast cancer using microenvironment-guided reinforcement learning and spatial transcriptomic feedback | 2026-02-01 | OpenAlex | 10.1016/j.esmoop.2025.105960 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7132830591 | |||
| W7128519376 | Peri-operative radiotherapy for pancreatic ductal adenocarcinoma: current evidence and future directions: a narrative review | 2026-02-01 | OpenAlex | 10.21037/cco-25-98 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128519376 | |||
| W7128797021 | Poster Session II - A312 MATERNAL AND NEONATAL OUTCOMES OF RISANKIZUMAB IN PREGNANT PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A CASE SERIES | 2026-02-01 | OpenAlex | 10.1093/jcag/gwaf042.312 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128797021 | |||
| W7128433983 | Revitalizing GIP: Therapeutic Potential in Metabolic and Neurodegenerative Disorders | 2026-02-01 | OpenAlex | 10.2147/dmso.s559587 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128433983; https://openalex.org/W7128662112 | |||
| W7134168867 | Samuels, Andrew. Reflecting Critically on the Political Psyche: Therapy, Testament and Trouble in Psychoanalysis and Jungian Analysis. Routledge. 2025. Pp. 242. Pbk. £34.99 | 2026-02-01 | OpenAlex | 10.1111/1468-5922.70043 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134168867 | |||
| W7130656060 | Surface-Engineered Precision Nano-Systems for Targeted Treatment of Huntington’s Disease: A Review of Recent Advancements | 2026-02-01 | OpenAlex | 10.2147/ijn.s548892 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130656060 | |||
| W7134987340 | The 2025 Spychala and Women in Science Awards | 2026-02-01 | OpenAlex | 10.5325/jpennacadscie.97.1-2.0228 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134987340 | |||
| W7128296012 | The Evolving Triad of Carbapenem Resistance: Emergence of Dominant CRPA, Persistent CRAB, and Rebounding CRKP in a Chinese Regional Hospital (2020-2024) | 2026-02-01 | OpenAlex | 10.2147/idr.s582544 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128296012 | |||
| W7127087586 | Therapy‐Related Acute Myeloid Leukemia Following Plasma Cell Leukemia: A Case Report and Literature Review | 2026-02-01 | OpenAlex | 10.1002/ccr3.71896 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7127087586 | |||
| W7128998897 | Treatment Strategies for Metastatic Castration‐Sensitive Prostate Cancer: Current Evidence and Future Directions | 2026-02-01 | OpenAlex | 10.1111/iju.70375 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128998897 | |||
| W7128724167 | Treatment of Steroid-Refractory Immune Checkpoint-Related Hepatitis With Ruxolitinib | 2026-02-01 | OpenAlex | 10.14309/crj.0000000000002008 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128724167 | |||
| W7134263057 | Unveiling the Evolving Landscape of Randomized Clinical Trials in Transplantation: An Analysis of Output and Trends. | 2026-02-01 | OpenAlex | 10.6002/ect.2025.0046 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134263057 | |||
| W7127565156 | [Applications and Reflections on Virtual Humans in Women's Healthcare]. | 2026-02-01 | OpenAlex | 10.6224/jn.26102 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7127565156 | |||
| W7130369307 | Antibody-drug conjugates: new drugs – new toxicities | 2026-02-02 | OpenAlex | 10.1097/cco.0000000000001214 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130369307 | |||
| W7127341191 | Deep Reinforcement Learning-Driven Adaptive Prompting for Robust Medical LLM Evaluation | 2026-02-02 | OpenAlex | 10.3390/app16031514 | Full text | Excluded | F3: The acting prompt-selection policy is a DQN MLP over five fixed prompt templates; the LLM is a frozen response generator, without an LLM planning/tool-use acting controller. | https://openalex.org/W7127341191 | https://www.mdpi.com/2076-3417/16/3/1514 | Publisher indexed full-text Methods §3.4 and experimental setup §§4.5–4.9 read; direct page subsequently returned429 | |
| W7127043743 | Editorial: The role of nod-like receptor (NLR) family of proteins in inflammation | 2026-02-02 | OpenAlex | 10.3389/fimmu.2026.1793019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127043743 | |||
| W7127121546 | Exploring the Chemical Space of Cephalosporins Across Generations | 2026-02-02 | OpenAlex | 10.3390/ddc5010012 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7127121546 | |||
| W7127114795 | General Diffusion Transformer for Arbitrary Medical Image Translation | 2026-02-02 | OpenAlex | 10.1109/tfuzz.2026.3659832 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7127114795 | |||
| W7127201676 | MH8-Trifecta-Unmasked-AI-Psychosis-or-Digital-Delusion-The-Multi-Agent-Reckoning | 2026-02-02 | OpenAlex | 10.5281/zenodo.18459484 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7127201676 | |||
| W7127050671 | Micro-/nanorobots in nanomedicine - Guidance, imaging and the integration of AI and robotics | 2026-02-02 | OpenAlex | 10.1016/j.bbrc.2026.153390 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127050671 | |||
| W7127115283 | Neuro-Symbolic Architectures for Explainable and Causal Artificial Intelligence | 2026-02-02 | OpenAlex | 10.36227/techrxiv.177006078.81831678/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127115283 | |||
| W7216897958 | One-Pot CRISPR-Cas12a Assay for Rapid Pulmonary Tuberculosis Diagnosis from Sputum: A Review | 2026-02-02 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216897958 | ||||
| W7127126018 | Precision medicine with pioneering RNAi therapeutics in ATTR amyloidosis: from bench to bedside | 2026-02-02 | OpenAlex | 10.1016/j.ejim.2026.106738 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127126018 | |||
| W7223558891 | ПРИНЦИПИ ТА ПІДХОДИ ОРГАНІЗАЦІЇ ОСВІТНЬОГО ПРОЦЕСУ В ПІДГОТОВЦІ ВИСОКОКВАЛІФІКОВАНИХ ФАХІВЦІВ У СИСТЕМІ ПДМУ (УМСА): РЕТРОСПЕКТИВНИЙ АНАЛІЗ | 2026-02-02 | OpenAlex | 10.24139/2312-5993/2026.01(2)/351-362 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223558891 | |||
| W7135779715 | A prática psicomotora na infância em contexto de clinica privada | 2026-02-03 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135779715 | ||||
| W7127418191 | Advancements in Cardiac Xenotransplantation: Overcoming Immunological Barriers Through Genetic Engineering of Porcine Donors, Insights from Initial Human Clinical Cases, and Future Prospects for Addressing the Global Organ Shortage in End-Stage Heart Failure Patients | 2026-02-03 | OpenAlex | 10.5281/zenodo.18474274 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127418191 | |||
| W7127638838 | Artificial Intelligence: Foundations, Algorithms, and Applications BY Dr. G. Ravi, Mr. Beemanapalli Ganesh, Mr. Rupavath Ramesh, Ms. Peesari Navya Sree, Mr. Magi Praveen | 2026-02-03 | OpenAlex | 10.5281/zenodo.18478403 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127638838 | |||
| W7127449088 | Dental Erosion Management: From Remineralization to Emerging Regenerative Approaches—A Narrative Review | 2026-02-03 | OpenAlex | 10.3390/biomimetics11020107 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127449088 | |||
| W7127086289 | Editorial: Nanomedicine targeting central nervous system | 2026-02-03 | OpenAlex | 10.3389/fmed.2026.1755137 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127086289 | |||
| W7127327159 | Frontline Therapy in Diffuse Large B‐Cell Lymphoma: Evolving Standards, Biological Insights, and Future Directions | 2026-02-03 | OpenAlex | 10.1111/ejh.70129 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127327159 | |||
| W7127780044 | GEOMETRY, DYNAMICS, AND THE LANGUAGE OF CANCER | 2026-02-03 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127780044 | ||||
| W7127313594 | Intelligent Digital Twins and Ethical Decision-Making Support | 2026-02-03 | OpenAlex | 10.1201/9781003657804-8 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7127313594 | |||
| W7127309238 | Natural Alkaloids as Antiviral Agents Against RNA Viruses: A Comprehensive and Mechanistic Review | 2026-02-03 | OpenAlex | 10.3390/molecules31030539 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127309238 | |||
| W7127289760 | Relevant Therapeutic Approaches to Chronic Renal Failure | 2026-02-03 | OpenAlex | 10.1201/9781779640598-10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127289760 | |||
| W7127624204 | Biologics in Pediatric Asthma: Controlling Symptoms, Maintaining Safety, and Improving Outcomes | 2026-02-04 | OpenAlex | 10.1007/s11882-026-01252-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127624204 | |||
| W7128304003 | Botulinum neurotoxin: Not only in Dermatology - Expanding Therapeutic Horizons Across Medical Specialties | 2026-02-04 | OpenAlex | 10.12775/jehs.2026.87.68236 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128304003 | |||
| W7127577751 | Correction: Case Report: Severe gastric atrophy associated with a novel homozygous variant in LRBA | 2026-02-04 | OpenAlex | 10.3389/fped.2026.1760475 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7127577751 | |||
| W7127640975 | EMERGING ROLE OF DEXMEDETOMIDINE IN NEUROANESTHESIA: BEYOND SEDATION TO NEUROPROTECTION | 2026-02-04 | OpenAlex | 10.5281/zenodo.18480060 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127640975 | |||
| W7128041549 | Perfection of Wound Healing to the Rescue of Patients Struggling Against Fatal Diseases Evolving Due to Wound Unhealing | 2026-02-04 | OpenAlex | 10.22259/2638-5074.0601001 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128041549 | |||
| W7127610273 | The pharmacoeconomic revolution of bioenhancers: Redefining value in drug therapy | 2026-02-04 | OpenAlex | 10.1016/j.nexres.2026.101439 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7127610273 | |||
| W7128033215 | Third-line treatment decision-making for metastatic colorectal cancer: a cross-sectional survey of US community physicians | 2026-02-04 | OpenAlex | 10.1093/oncolo/oyag018 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128033215 | |||
| W7127604449 | Uveitis (Inflammatory, Autoimmune Disease or Infectious Causes) | 2026-02-04 | OpenAlex | 10.1201/9781003606789-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127604449 | |||
| W7128065959 | Bridging Innovation and Practice in Type 2 Diabetes Mellitus: Novel Antidiabetic Therapies and the Expanding Role of Community Pharmacists | 2026-02-05 | OpenAlex | 10.3390/ph19020271 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128065959 | |||
| W7128359093 | Core Binding Factor AML Beyond Favorable Risk: Molecular Heterogeneity, MRD Dynamics, and Implications for Clinical Decision-Making | 2026-02-05 | OpenAlex | 10.20944/preprints202602.0190.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128359093 | |||
| W7128016778 | Correction: Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages | 2026-02-05 | OpenAlex | 10.3389/fimmu.2026.1799354 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7128016778 | |||
| W7131291107 | Diagnosis, Management and Pathophysiology of Polycystic Ovarian Syndrome | 2026-02-05 | OpenAlex | 10.69613/e52arj05 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131291107 | |||
| W7127975766 | Efficacy and safety of trilaciclib to prevent chemotherapy-induced myelosuppression in advanced solid tumors: a systematic review and meta-analysis | 2026-02-05 | OpenAlex | 10.1007/s12094-026-04234-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127975766 | |||
| W7127903606 | Opinion: Why paediatric rheumatologists need to understand inborn errors of immunity | 2026-02-05 | OpenAlex | 10.3389/fped.2025.1755761 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127903606 | |||
| W7127944539 | Pediatric Use of Compounded GLP-1 Agents: Benefits, Risks, and Equity | 2026-02-05 | OpenAlex | 10.3390/obesities6010010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127944539 | |||
| W7127932865 | Pharmacological Management of Heart Failure: A Review of Recent Progress | 2026-02-05 | OpenAlex | 10.1097/cd9.0000000000000187 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127932865 | |||
| W7154610709 | Policy-Governed Edge Intelligence (PGEI): Trust-Scored Orchestration and Privacy-Aware Distributed AI | 2026-02-05 | OpenAlex | 10.1109/acdsa67686.2026.11468176 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7154610709 | |||
| W7127886257 | Predictors of Response and Mechanisms of Resistance to Antibody Drug Conjugates in Urothelial Carcinoma | 2026-02-05 | OpenAlex | 10.3390/curroncol33020103 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127886257 | |||
| W7127905304 | Synergistic interactions of ruthenium-based carbon monoxide-releasing molecules and antibiotics in their effects on Escherichia coli | 2026-02-05 | OpenAlex | 10.1099/mic.0.001669 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7127905304 | |||
| W7128058148 | The therapeutic revolution in thyroid eye disease: from orbital radiotherapy to teprotumumab and AI | 2026-02-05 | OpenAlex | 10.3389/fmed.2026.1758015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128058148 | |||
| W7131227484 | Utilization of Artificial Intelligence in Pharmaceutical Sciences for Teaching, Learning, and Clinical Practice | 2026-02-05 | OpenAlex | 10.69613/dw5jnw67 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131227484 | |||
| W7128057042 | A Comprehensive Review on the Role of Renin Angiotensin Aldosterone System Blockade in Chronic Kidney Disease | 2026-02-06 | OpenAlex | 10.5281/zenodo.18505224 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128057042 | |||
| W7128019631 | Application of SGLT2 inhibitors in kidney diseases: a bibliometric analysis | 2026-02-06 | OpenAlex | 10.3389/fmed.2026.1768225 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128019631 | |||
| W7128388936 | Architectural Advances and Performance Benchmarks of Large Language Models in Light of Anthropic’s Claude Opus 4.6 | 2026-02-06 | OpenAlex | 10.20944/preprints202602.0537.v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7128388936 | |||
| W7128069370 | Clinical and Molecular Perspectives on Epidermodysplasia Verruciformis | 2026-02-06 | OpenAlex | 10.1111/ijd.70295 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128069370 | |||
| W7128030065 | Commentary: Immuno-inflammatory signature for predicting therapeutic response and survival after stereotactic radiosurgery in NSCLC patients with brain metastases: a retrospective cohort study | 2026-02-06 | OpenAlex | 10.3389/fimmu.2026.1782399 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128030065 | |||
| W7127919171 | From sequencing to understanding: a grand challenge in genome-scale molecular and genetic analysis | 2026-02-06 | OpenAlex | 10.3389/fpls.2026.1782107 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127919171 | |||
| W7127909917 | Highlighted Research Articles | 2026-02-06 | OpenAlex | 10.1158/2159-8290.cd-16-2-iti | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127909917 | |||
| W7127895124 | Letter to Menoeceus | 2026-02-06 | OpenAlex | 10.1093/9780191976605.003.0002 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7127895124 | |||
| W7127960657 | Platelet-Rich Plasma as a Pharmacopuncture Agent in Cervical Myofascial Pain | 2026-02-06 | OpenAlex | 10.69951/proceedingsbookoficeonimeri.v9i-.310 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7127960657 | |||
| W7128172216 | Real-World Treatment Patterns and Survival in Patients with Advanced Non-Small Cell Lung Cancer: An Italian Retrospective Cohort Study | 2026-02-06 | OpenAlex | 10.3390/cancers18030538 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128172216 | |||
| W7128168791 | Site-specific targeting in immunoliposomal nanomedicine for oncology: opportunities and limitations | 2026-02-06 | OpenAlex | 10.1016/j.ejpb.2026.115004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128168791 | |||
| W7128375030 | Addressing hallucinations in generative AI agents using observability and dual memory knowledge graphs | 2026-02-07 | OpenAlex | 10.1016/j.knosys.2026.115469 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7128375030 | |||
| W7215618844 | MYOCARDIAL INFARCTION: EARLY DIAGNOSIS AND MODERN REPERFUSION THERAPY | 2026-02-07 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215618844; https://openalex.org/W7134048370 | ||||
| W7128309428 | Pediatric Myocarditis: Challenges in Diagnosis and Treatment | 2026-02-07 | OpenAlex | 10.1007/s40272-026-00739-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128309428 | |||
| W7128298743 | Post-pandemic resurgence of Mycoplasma pneumoniae in coastal China: from seasonal waves to sustained transmission and expanded age susceptibility | 2026-02-07 | OpenAlex | 10.1186/s12879-026-12790-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128298743 | |||
| W7151362015 | Radiotherapy in the Management of Bone Metastases: An Updated Review of Current Evidence | 2026-02-07 | OpenAlex | 10.64978/jcrrm-0119 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151362015 | |||
| W7220521318 | Reinserção social de pacientes psiquiátricos na sociedade: um relato de experiência | 2026-02-07 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220521318 | ||||
| W7133318760 | Simultaneous or sequential treatment of IgA nephropathy - specific disease drivers and non-specific consequences of nephron loss? | 2026-02-07 | OpenAlex | 10.1093/ckj/sfag035 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133318760 | |||
| W7128390987 | Antibiotic Prescribing Patterns in Hospitalized Pediatric Patients With Clinically Suspected Enteric Fever: A Descriptive Study | 2026-02-08 | OpenAlex | 10.7759/cureus.103186 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128390987 | |||
| W7128359540 | Dental composites: a comprehensive review on formulation, properties and recent developments | 2026-02-08 | OpenAlex | 10.1002/pi.70085 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128359540 | |||
| W7155514051 | Augmanitai Lexicon V1 by Andreas Ehstand | 2026-02-09 | OpenAlex | 10.5281/zenodo.18542367 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7155514051 | |||
| W7128427968 | Editorial: Perspectives in molecular viral pathogenesis | 2026-02-09 | OpenAlex | 10.3389/fcimb.2026.1797985 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128427968 | |||
| W7147044888 | Ep. 552: Is Your Therapist Just a $200 a Week Habit? | 2026-02-09 | OpenAlex | 10.5281/zenodo.19360172 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147044888 | |||
| W7128399132 | Integrating clinical data into evidence-based practice: institutional guideline development for diabetic foot infections | 2026-02-09 | OpenAlex | 10.3389/fendo.2026.1752211 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128399132 | |||
| W7128489846 | Paper 43: The Intrapersonal Trap — Self-Coercion, Structural Resistance, and the Impossibility of Willpower-Driven Change: A Zero Leap Theory Analysis of Intrapersonal Intervention Dynamics | 2026-02-09 | OpenAlex | 10.5281/zenodo.18564513 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7128489846 | |||
| W7128354135 | Talent Development through Professional Assessment | 2026-02-09 | OpenAlex | 10.17605/osf.io/hctp9 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7128354135 | |||
| W7128476462 | Analysis of bladder cancer therapeutic drug clinical trials in mainland China and globally | 2026-02-10 | OpenAlex | 10.1016/j.bbcan.2026.189558 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128476462 | |||
| W7128523973 | Antibacterial and Bioregenerative Nanomaterials in Oral Health: From Material Design to Clinical Translation and Technological Trends | 2026-02-10 | OpenAlex | 10.3390/jfb17020087 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128523973 | |||
| W7128548038 | Artificial intelligence agents in healthcare research: A scoping review | 2026-02-10 | OpenAlex | 10.1371/journal.pone.0342182 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7128548038 | |||
| W7128488254 | Biopolymeric advances: The evolving role of alginates as wound dressing carrier | 2026-02-10 | OpenAlex | 10.1177/08839115261418047 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128488254 | |||
| W7128473216 | CBRNE events: prevention, mitigation, consequences and recovery | 2026-02-10 | OpenAlex | 10.1140/epjp/s13360-026-07405-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128473216 | |||
| W7128537918 | Cellular strategies for repairing trapped protein-DNA complexes | 2026-02-10 | OpenAlex | 10.3389/fphar.2026.1716415 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128537918 | |||
| W7128522448 | Editorial: Innovative strategies and advancements in phototherapy for enhanced cancer treatment | 2026-02-10 | OpenAlex | 10.3389/fmed.2026.1789533 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128522448 | |||
| W7165522972 | From Lines to Layers: The transformative journey of architectural drawings toward sustainable and innovative detailing | 2026-02-10 | OpenAlex | 10.1109/icsedi66420.2026.11568303 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7165522972 | |||
| W7165552545 | Large Language Models for Smart Grids and Renewable Energy: Emerging Directions | 2026-02-10 | OpenAlex | 10.1109/icsedi66420.2026.11568282 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165552545 | |||
| W7128475692 | Molecular Characterization of Drug Resistance-Associated Mutations in Mycobacterium tuberculosis Isolates from the Republic of Congo Using Targeted Nanopore Sequencing | 2026-02-10 | OpenAlex | 10.3390/zoonoticdis6010005 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128475692 | |||
| W7128545005 | Psychosomatics at the threshold: cancer, mood disorders, and the mental pain of death — where precision medicine meets spirituality | 2026-02-10 | OpenAlex | 10.3389/fpsyt.2026.1751310 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128545005 | |||
| W7148184648 | Sağlık Turizminden Sağlık Diasporası Diplomasisine: Yükselen Ekonomilerde Yurtdışı Sağlık Ağlarını Stratejik Olarak Kullanma Çerçevesi | 2026-02-10 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148184648 | ||||
| W7131095097 | The Autonomous Data Enterprise: Engineering Real-Time Intelligence with Generative and Agentic AI | 2026-02-10 | OpenAlex | 10.70593/978-93-7185-592-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131095097 | |||
| W7128483354 | The efficacy of hepatoprotective agents in the treatment of non-alcoholic fatty liver disease: metabolic effects and impact on liver fat content | 2026-02-10 | OpenAlex | 10.17116/profmed20262901186 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128483354 | |||
| W7128536528 | Transforming Knowledge Management with AI: Leveraging Retrieval-Augmented Generation (RAG) in Business Strategy | 2026-02-10 | OpenAlex | 10.1108/978-1-80592-391-620261008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128536528 | |||
| W7128641776 | Agent-based modeling of cellular dynamics in adoptive cell therapy | 2026-02-11 | OpenAlex | 10.1038/s42003-026-09653-4 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7128641776 | |||
| W7128600058 | Anti-VEGF safety in evolution: A comprehensive review of ocular and systemic considerations | 2026-02-11 | OpenAlex | 10.4103/ijo.ijo_3284_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128600058 | |||
| W7128476727 | Beyond cytokine blockade: could CAR-Tregs open a new era of tissue-targeted immune tolerance in psoriatic arthritis? | 2026-02-11 | OpenAlex | 10.3389/fimmu.2026.1772369 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128476727 | |||
| W7128598388 | Evolving Therapeutic Algorithms in Chronic Myeloid Leukemia: Integrating Efficacy, Safety, and Survivorship | 2026-02-11 | OpenAlex | 10.3390/biomedicines14020408 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128598388 | |||
| W7128590384 | Optimizing Opioid Use in Pain Management: A Comprehensive Review of Clinical Benefits, Risks, and Dependence | 2026-02-11 | OpenAlex | 10.3390/healthcare14040457 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128590384 | |||
| W7128593730 | Pain Management in Italian Elite Athletes: Trends in the Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Glucocorticoids, and Narcotics in Anti-Doping Reports (2013–2023) | 2026-02-11 | OpenAlex | 10.3390/ph19020298 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128593730 | |||
| W7128647727 | THE CENTRIST EXTREMIST: Prosecutorial Frame and the Terminal Phase of the Post-Political DOI: 10.5281/zenodo.18604046 — Crimson Hexagon Archive | 2026-02-11 | OpenAlex | 10.5281/zenodo.18604045 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7128647727 | |||
| W7128538613 | The SGLT2 inhibitor checklist: a comprehensive review of perioperative and acute phase safety management | 2026-02-11 | OpenAlex | 10.3389/fendo.2026.1777334 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128538613 | |||
| W7131112628 | The Unseen Culling | 2026-02-11 | OpenAlex | 10.5281/zenodo.18737190 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7131112628 | |||
| W7128479165 | Ultrasound-responsive microbubbles in refractory infection niches: multi-front targeting of microenvironmental tolerance and local delivery of toxicity-limited antibiotics | 2026-02-11 | OpenAlex | 10.3389/fcimb.2026.1756357 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128479165 | |||
| W7131704779 | Another brick in the wall of severe hypertriglyceridaemia lowering | 2026-02-12 | OpenAlex | 10.1093/eurheartj/ehag124 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131704779 | |||
| W7130581841 | Artificial Intelligence and Machine Learning by V. Elavenil, G. Suresh Kumar, Jayachandran P., J. Fahamitha | 2026-02-12 | OpenAlex | 10.5281/zenodo.18690750 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130581841 | |||
| W7128732315 | CREST-2: Early reflections on the primary results | 2026-02-12 | OpenAlex | 10.1053/j.semvascsurg.2026.02.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128732315 | |||
| W7128739536 | Correction: Editorial: Unveiling the next generation of cancer immunity & immunotherapy | 2026-02-12 | OpenAlex | 10.3389/fimmu.2026.1784505 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7128739536 | |||
| W7128766270 | Differentiable Modal Logic for Multi-Agent Diagnosis, Orchestration and Communication | 2026-02-12 | OpenAlex | 2602.12083 | 10.48550/arxiv.2602.12083 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7128766270 | ||
| W7128803998 | Emerging Agent Communication Protocols for Healthcare AI Systems: A Scoping Review of Model Context Protocol (MCP) and Agent-to-Agent (A2A) Frameworks (Preprint) | 2026-02-12 | OpenAlex | 10.2196/preprints.93344 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7128803998 | |||
| W7128625717 | Evolving strategies for local drug delivery in peripheral arteries | 2026-02-12 | OpenAlex | 10.1016/j.jddst.2026.108115 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128625717 | |||
| W7128685553 | Exploring treatment models for oligometastatic castration-sensitive prostate cancer: evolution of therapeutic strategies | 2026-02-12 | OpenAlex | 10.3389/fonc.2026.1778687 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128685553 | |||
| W7128923158 | Friction in Games and Computational Media (Editorial) | 2026-02-12 | OpenAlex | 10.34624/jdmi.v8i20.42275 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128923158 | |||
| W7128680526 | Melphalan in the biologic era: A 70-year story in hematological malignancies and its legacy, evolution, and future | 2026-02-12 | OpenAlex | 10.25259/jhas_74_2025 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128680526 | |||
| W7128721139 | Peptides for tooth remineralization: A scoping review of current research, design strategies, and clinical applications | 2026-02-12 | OpenAlex | 10.1016/j.mtadv.2026.100713 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128721139 | |||
| W7128682194 | Remdesivir in COVID-19: pros and cons | 2026-02-12 | OpenAlex | 10.3389/fphar.2026.1731244 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128682194 | |||
| W7128692132 | Therapeutic Effects of PCSK9 Inhibitors on Lp(a)-Associated Atherosclerosis: Evidence and Perspectives | 2026-02-12 | OpenAlex | 10.1097/fjc.0000000000001794 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128692132 | |||
| W7128782277 | Alzheimer’s Disease: Evolving Therapeutics, Scientific Progress, and Key Challenges | 2026-02-13 | OpenAlex | 10.1021/acs.jmedchem.5c02468 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128782277 | |||
| W7129548193 | Automated Grading as Faculty Judgment at Scale | 2026-02-13 | OpenAlex | 10.1097/01.nep.0000000000001511 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129548193 | |||
| W7128736155 | Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers | 2026-02-13 | OpenAlex | 10.1016/j.critrevonc.2026.105207 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128736155 | |||
| W7128786334 | Deception as Bias-Injection Dynamics near Viability Boundaries: A Lyapunov and Alignness Characterization | 2026-02-13 | OpenAlex | 10.5281/zenodo.18627986 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7128786334 | |||
| W7128907021 | Discordance Between Textual Reasoning and Visual Interpretation in Large Language Models for Low Back Pain: Mixed-Methods Evaluation of Safety Risks (Preprint) | 2026-02-13 | OpenAlex | 10.2196/preprints.93522 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128907021 | |||
| W7128849664 | Emerging Protein Targets in Triple-Negative Breast Cancer: Beyond Conventional Therapy | 2026-02-13 | OpenAlex | 10.3390/cancers18040618 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128849664 | |||
| W7128774971 | From Liposomes to Depot-Enabled Lipid-Gel Hybrid Nanocarriers: Evolving Strategies for Targeted and Sustained Anticancer Drug Delivery | 2026-02-13 | OpenAlex | 10.5281/zenodo.18629158 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128774971 | |||
| W7128808243 | Generative and Agentic Artificial Intelligence for Medical Coding and Billing: A Human-in-the-Loop Architecture and Evaluation | 2026-02-13 | OpenAlex | 10.21203/rs.3.rs-8863592/v1 | Full text | Excluded | F7: The report does not identify sample size, model or dataset and gives no numerical evaluation; Table1 contains qualitative comparisons only. Previously included; author-approved revision5November2026. | https://openalex.org/W7128808243 | https://doi.org/10.21203/rs.3.rs-8863592/v1 | ||
| W7128789857 | Heart transplantation in pediatric oncology patients | 2026-02-13 | OpenAlex | 10.1016/j.jhlto.2026.100514 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128789857 | |||
| W7128775060 | PROCEEDINGS of the International Conference on Fortifications of the Mediterranean Coast FORTMED 2026. Vol. 22 | 2026-02-13 | OpenAlex | 10.4995/fortmed2026.2026.21472 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128775060 | |||
| W7128783700 | PROCEEDINGS of the International Conference on Fortifications of the Mediterranean Coast FORTMED 2026. Vol. 23 | 2026-02-13 | OpenAlex | 10.4995/fortmed2026.2026.21473 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128783700 | |||
| W7128815999 | PROCEEDINGS of the International Conference on Fortifications of the Mediterranean Coast FORTMED 2026. Vol. 24 | 2026-02-13 | OpenAlex | 10.4995/fortmed2026.2026.21474 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128815999 | |||
| W7128678420 | PROGRESS AND MECHANISMS OF ANTIBODY-DRUG CONJUGATES IN NSCLC THERAPY | 2026-02-13 | OpenAlex | 10.61784/jpmr3064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128678420 | |||
| W7128738319 | Treatment sequences of a phage and colistin combination trigger different evolution pathways of a multidrug-resistant Acinetobacter baumannii yielding distinct treatment outcomes | 2026-02-13 | OpenAlex | 10.1016/j.ijantimicag.2026.107745 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7128738319 | |||
| W7131633779 | An Agentic AI Model for MRI-Based Staging and Grading of Endometrial Cancer using MedSAM and ViT | 2026-02-14 | OpenAlex | 10.14445/22315381/ijett-v74i2p109 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7131633779 | |||
| W7128919836 | Disease-Modifying Therapies in Transthyretin Amyloid Cardiomyopathy: What Have We Achieved? | 2026-02-14 | OpenAlex | 10.1016/j.cardfail.2026.01.011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128919836 | |||
| W7128777518 | Evolving trends in skin lightening: Emerging agents, social media, and public health response | 2026-02-14 | OpenAlex | 10.1016/j.jaad.2026.02.027 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7128777518 | |||
| W7129047610 | Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy | 2026-02-15 | OpenAlex | 10.1002/phar.70119 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129047610 | |||
| W7128957236 | Non-Operative, Micro- and Minimally Invasive Methods for Caries Treatment—A Narrative Review | 2026-02-15 | OpenAlex | 10.3390/jcm15041534 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128957236 | |||
| W7128957281 | Ocular inflammation after intraocular drug delivery: Mechanisms, risk factors, and implications for clinical practice | 2026-02-15 | OpenAlex | 10.1016/j.survophthal.2026.02.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128957281; https://openalex.org/W7131089467 | |||
| W7132822359 | RECENT PROGRESS IN CARDIOVASCULAR DRUGS: PHARMACOLOGICAL INNOVATIONS IN HYPERTENSION, HEART FAILURE, AND DYSLIPIDEMIA | 2026-02-15 | OpenAlex | 10.5281/zenodo.18815252 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7132822359 | |||
| W7128957385 | The Sterile Wound: Reconceptualizing Social Anxiety as an Anticipatory Immune Response | 2026-02-15 | OpenAlex | 10.5281/zenodo.18646330 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7128957385 | |||
| W7154717392 | medical deposit part 2 | 2026-02-15 | OpenAlex | 10.5281/zenodo.19630773 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154717392 | |||
| W7129062121 | A Severe Case of Drug Reaction with Eosinophilia and Systemic Symptoms After Sequential Cephalosporin and Vancomycin Exposure | 2026-02-16 | OpenAlex | 10.9734/ijmpcr/2026/v19i1479 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7129062121 | |||
| W7129107200 | Dermatologic Perspectives on Primary Cutaneous Lymphomas: Clinicopathologic Spectrum, Molecular Insights, and Evolving Treatment Paradigms | 2026-02-16 | OpenAlex | 10.3390/lymphatics4010011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129107200 | |||
| W7129098634 | Dynamic target-aware multi-objective reinforcement clustering for intelligent fault diagnosis | 2026-02-16 | OpenAlex | 10.1016/j.ymssp.2026.114014 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7129098634 | |||
| W7129197415 | Experts' Opinion on Decontamination and Antidote Strategies: Complementing Contemporary Expert Consensus and Evidence to Optimize Preparedness and Response to CBRN Threats in the Middle East and North Africa | 2026-02-16 | OpenAlex | 10.1111/1468-5973.70128 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129197415 | |||
| W7129031451 | Immunopathogenesis of multiple sclerosis – mechanisms of autoimmunity, neuroinflammation and strategies of treatment | 2026-02-16 | OpenAlex | 10.26444/jpccr/217936 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129031451 | |||
| W7129046006 | Mapping the molecular landscape of glioblastoma: Pathogenesis, therapeutic targets and bioactive interventions | 2026-02-16 | OpenAlex | 10.1016/j.critrevonc.2026.105206 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129046006 | |||
| W7129039193 | Mitochondrial reprogramming in lung cancer: a therapeutic vulnerability and a strategy for reversing drug resistance | 2026-02-16 | OpenAlex | 10.1002/path.70041 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129039193 | |||
| W7129043983 | Selective Serine Substitutions of Antimicrobial Peptides Reveal Different Mechanistic Actions Toward Gram-Negative Bacteria | 2026-02-16 | OpenAlex | 10.1021/acsami.5c22475 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7129043983 | |||
| W7129038885 | TRADITIONAL AYURVEDIC SKINCARE FORMULATIONS IN MODERN COSMECEUTICAL SCIENCE: A COMPREHENSIVE REVIEW | 2026-02-16 | OpenAlex | 10.5281/zenodo.18657912 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129038885 | |||
| W7129026418 | Towards response-adapted neoadjuvant breast cancer treatment | 2026-02-16 | OpenAlex | 10.1016/s1470-2045(25)00767-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7129026418 | |||
| W7129106081 | What is the best treatment for prostate cancer T3 N1 M1a with 4 lymph node metastases? | 2026-02-16 | OpenAlex | 10.5281/zenodo.18657105 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129106081 | |||
| W7129413144 | Abstract PS1-10-12: Impact of Glucagon-like peptide-1 receptor agonists Use on Survival and Metabolic Outcomes in Metastatic Estrogen Receptor Positive Breast Cancer: A Real-World Cohort Study | 2026-02-17 | OpenAlex | 10.1158/1557-3265.sabcs25-ps1-10-12 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7129413144 | |||
| W7129630984 | Abstract PS1-11-18: Prescription Patterns and Treatment Persistence in Patients with Metastatic Breast Cancer on CDK4/6 Inhibitors | 2026-02-17 | OpenAlex | 10.1158/1557-3265.sabcs25-ps1-11-18 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7129630984 | |||
| W7129621512 | Abstract PS1-12-13: Real-world rate of switching and reasons for switching among CDK4/6i drugs among first-line metastatic HR+/HER2- breast cancer patients | 2026-02-17 | OpenAlex | 10.1158/1557-3265.sabcs25-ps1-12-13 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7129621512 | |||
| W7129421681 | Abstract PS2-03-26: Lymphatic-sparing sentinel lymph node biopsy to prevent breast cancer-related lymphedema | 2026-02-17 | OpenAlex | 10.1158/1557-3265.sabcs25-ps2-03-26 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7129421681 | |||
| W7130711426 | Abstract PS3-04-10: Development and Validation of a Living Decision Support Tool (Living-DST) in Oncology Using Agentic AI-Augmented Systematic Literature Review (SLR) | 2026-02-17 | OpenAlex | 10.1158/1557-3265.sabcs25-ps3-04-10 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7130711426 | |||
| W7129536000 | Abstract PS3-09-26: Real-world clinical characteristics, treatment patterns and outcomes among UK and French patients with early-stage, estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer treated with neoadjuvant chemotherapy | 2026-02-17 | OpenAlex | 10.1158/1557-3265.sabcs25-ps3-09-26 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7129536000 | |||
| W7129368958 | Biological treatments for zoonotic salmonellosis: an evolving therapeutic landscape | 2026-02-17 | OpenAlex | 10.3389/fmicb.2026.1769519 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129368958 | |||
| W7129515225 | Editorial: Regulation and mechanism of plant metabolites on hyperuricemia | 2026-02-17 | OpenAlex | 10.3389/fnut.2026.1800834 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129515225 | |||
| W7129524015 | Extracellular Vesicle Analysis: Recent Technological Advances and Emerging Opportunities | 2026-02-17 | OpenAlex | 10.1146/annurev-anchem-070325-084902 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129524015 | |||
| W7129419383 | HLA Type and the Effect of HLA Antibodies in Kidney, Liver, and Pancreas Transplantation: A Review | 2026-02-17 | OpenAlex | 10.18502/ajmb.v18i1.21042 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129419383 | |||
| W7129037863 | Systematic Review of Immunosuppression After Chimeric Antigen Receptor T-Cell Therapy for Posttransplant Lymphoproliferative Disorder | 2026-02-17 | OpenAlex | 10.1016/j.ekir.2026.106367 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129037863 | |||
| W7130345541 | A Self-Evolving AI Agent System Accelerating the Understanding of Climate Change and Variability | 2026-02-18 | OpenAlex | 10.21203/rs.3.rs-8630394/v1 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7130345541 | |||
| W7130312626 | Editorial: Residual cardiovascular risk in diabetes: current state and future perspectives | 2026-02-18 | OpenAlex | 10.3389/fcdhc.2026.1774240 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130312626 | |||
| W7130366150 | Genetic Predisposition to MASLD: Potential for Therapeutic Management | 2026-02-18 | OpenAlex | 10.3390/ijms27041933 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130366150 | |||
| W7130655229 | Hypertriglyceridemia: updates from clinical trials of new agents and real-world registries | 2026-02-18 | OpenAlex | 10.1097/med.0000000000000955 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7130655229 | |||
| W7130409154 | Innovations in Cutaneous Oncology and Dermatologic Surgery: From Margin Control to Integrated Precision Oncology | 2026-02-18 | OpenAlex | 10.3390/cancers18040670 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130409154 | |||
| W7130316800 | Management of Acute Myeloid Leukemia: A Review | 2026-02-18 | OpenAlex | 10.3390/cancers18040659 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130316800 | |||
| W7130310193 | Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study | 2026-02-18 | OpenAlex | 10.1182/bloodadvances.2025018455 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7130310193 | |||
| W7129338271 | SOHO State of the Art Updates and Next Questions | Sequencing Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Evidence, Challenges, and Opportunities for Cure | 2026-02-18 | OpenAlex | 10.1016/j.clml.2026.02.008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7129338271 | |||
| W7130377589 | The Future of AI in Orthopaedics: Boon or Bust? | 2026-02-18 | OpenAlex | 10.2106/jbjs.25.01514 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130377589 | |||
| W7130421910 | Toward a Functional and Conceptual Framework for Adhesive Materials: The Role of Etching Technique | 2026-02-18 | OpenAlex | 10.3390/dj14020119 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130421910 | |||
| W7130545997 | 4. Phthisiatry and Contemporary Tuberculosis Medicine: A Comprehensive Review of Diagnostic Advances, Treatment Paradigms, and Global Health Challenges | 2026-02-19 | OpenAlex | 10.5281/zenodo.18690001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130545997 | |||
| W7130507201 | Advances in intratumoral immunotherapy from a neuro-immune-endocrine perspective for breast cancer treatment | 2026-02-19 | OpenAlex | 10.3389/fonc.2026.1735300 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130507201 | |||
| W7134942499 | Daratumumab in the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Experience from the Clinical Hematology Department of Avicenne Military Hospital, Marrakech | 2026-02-19 | OpenAlex | 10.36347/sasjm.2026.v12i02.010 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134942499 | |||
| W7130582521 | Invasive and medical management approaches to non-acute myocardial ischaemic syndromes | 2026-02-19 | OpenAlex | 10.1038/s41569-026-01259-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7130582521 | |||
| W7130524108 | Knowledge, Attitude and Acceptance of Autologous Stem Cell Transplantation amongst Patients with Multiple Myeloma in Nigeria | 2026-02-19 | OpenAlex | 10.9734/ijr2h/2026/v9i1213 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7130524108 | |||
| W7130596602 | Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges | 2026-02-19 | OpenAlex | 10.1021/acs.analchem.5c06531 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130596602 | |||
| W7170077590 | Prevalence of Salmonella Enterica Subspecies Enterica Serovar Typhi in Hospital Landfill: An Environmental Cross Sectional Study | 2026-02-19 | OpenAlex | 10.71637/tnhj.v26i2.1347 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170077590 | |||
| W7133545206 | Surgical management of small intestinal neuroendocrine tumours | 2026-02-19 | OpenAlex | 10.1093/bjs/znag016 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133545206 | |||
| W7130597527 | THE GOTHIC MEDICAL SPACE IN MIKHAIL BULGAKOV'S A COUNTRY DOCTOR'S NOTEBOOK ANATOMISING TERROR: MEDICAL PRACTICE, MORPHINE ADDICTION, AND THE COLLAPSE OF ENLIGHTENMENT RATIONALITY IN REVOLUTIONARY RUSSIA | 2026-02-19 | OpenAlex | 10.5281/zenodo.18697173 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7130597527 | |||
| W7130512681 | Within-host evolution drives the emergence of ceftazidime-avibactam resistance mediated by IncN plasmid-encoded bla NDM-1 and bla KPC-33 in ST11-KL64 hypervirulent Klebsiella pneumoniae | 2026-02-19 | OpenAlex | 10.1128/spectrum.02367-25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7130512681 | |||
| W7130677393 | Agentic AI System for Stress Monitoring: A Multi-agent Healthcare Crew | 2026-02-20 | OpenAlex | 10.1007/s44196-026-01215-0 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7130677393 | |||
| W7130652035 | Analysis of Patch Testing for Allergic Contact Dermatitis in Adults Versus Geriatrics: A 7-Year Retrospective Analysis of 342 Positive Patch Test Cases | 2026-02-20 | OpenAlex | 10.4103/ijd.ijd_834_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7130652035 | |||
| W7130643022 | Composable Governance for a Continuously Evolving Enterprise | 2026-02-20 | OpenAlex | 10.1201/9781003646525-16 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130643022 | |||
| W7130819172 | DNA-damaging combination treatments impose genotype-specific constraints on hypermutator evolvability | 2026-02-20 | OpenAlex | 10.64898/2026.02.20.706947 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7130819172 | |||
| W7130643207 | Editorial: Use of radiation therapy for hematological malignancies | 2026-02-20 | OpenAlex | 10.3389/fonc.2026.1781001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130643207 | |||
| W7130655760 | Fluid Therapy Along the Emergency Medicine–Critical Care Continuum: From Resuscitation to Precision Stewardship | 2026-02-20 | OpenAlex | 10.1007/s42399-026-02268-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7130655760 | |||
| W7130676632 | Joint pain and menopause | 2026-02-20 | OpenAlex | 10.1097/gme.0000000000002756 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130676632 | |||
| W7130645472 | Melanoma: from early detection to therapeutic decision-making | 2026-02-20 | OpenAlex | 10.5604/01.3001.0055.6445 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130645472 | |||
| W7131231465 | Navigating bladder preservation in Bacillus Calmette–Guérin-unresponsive disease: how much risk is too much? | 2026-02-20 | OpenAlex | 10.1097/mou.0000000000001371 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131231465 | |||
| W7130681751 | Pericoronary adipose tissue imaging: quantitative assessment, artificial intelligence integration, and therapeutic modulation | 2026-02-20 | OpenAlex | 10.1093/bjr/tqag040 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130681751 | |||
| W7130642153 | Temporomandibular joint arthrocentesis: global research trends in a comprehensive bibliometric analysis (1989–2025) | 2026-02-20 | OpenAlex | 10.1080/08869634.2026.2632944 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130642153 | |||
| W7130642909 | The evolving science of Clesrovimab: pharmacological insights and clinical implications | 2026-02-20 | OpenAlex | 10.4081/jbr.2026.14042 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7130642909 | |||
| W7130926605 | Development of New Drug Against Multidrug-Resistant Candidozyma (Candida) auris by Mining the Genome of Marine Bacteria Vibrio sp. IRMCESH58L | 2026-02-21 | OpenAlex | 10.3390/pharmaceutics18020266 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7130926605 | |||
| W7130858835 | From Surge to Stability: Navigating MPOX Epidemics Across the Globe With Genomic Insights, Paving the Way for Effective Management Plan | 2026-02-21 | OpenAlex | 10.1002/rmv.70112 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130858835 | |||
| W7131314869 | From stenosis to atheroma: repositioning lipoprotein(a) in coronary artery disease risk assessment | 2026-02-21 | OpenAlex | 10.1093/ehjci/jeag046 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131314869 | |||
| W7130740608 | Gas entrapping materials for damage control | 2026-02-21 | OpenAlex | 10.1016/j.addr.2026.115813 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130740608 | |||
| W7220149499 | PERSONALITY TYPOLOGIES OF MODERN SCHOOL TEACHERS AND THEIR PEDAGOGICAL IMPLICATIONS | 2026-02-21 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220149499 | ||||
| W7130828519 | TRPV1 Receptor Modulators: Emerging Therapies for Neuropathic, Osteoarthritic, and Perioperative Pain | 2026-02-21 | OpenAlex | 10.1007/s40263-026-01272-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130828519 | |||
| W7130854433 | Targeted and Immunotherapeutic Approaches in Cancer: A Narrative Review of Evolving Evidence and Clinical Implications | 2026-02-21 | OpenAlex | 10.9734/irjo/2026/v9i1193 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130854433 | |||
| W7130923412 | Landscape of diabetic kidney disease drug clinical trials in China (2013–2023): global implications for innovation and policy | 2026-02-22 | OpenAlex | 10.1080/0886022x.2026.2629639 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7130923412; https://openalex.org/W7131096902 | |||
| W7130952431 | NeuroEconomics 5.0: Decision-Making in the Age of Synthetic Intelligence | 2026-02-22 | OpenAlex | 10.17605/osf.io/d5hyg | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7130952431 | |||
| W7131648067 | Artificial Intelligence and machine learning by hamma shabnam Nasim, Md Riyaz Ansari | 2026-02-23 | OpenAlex | 10.5281/zenodo.18780674 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131648067 | |||
| W7132814921 | Artificial Intelligence–Optimized Nano-Level Surface Enhancement of Biomedical Zirconium Alloys Using Magnetic Abrasive Finishing Process | 2026-02-23 | OpenAlex | 10.5281/zenodo.18811009 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7132814921 | |||
| W7131104014 | Editorial: Advancements in meningioma management: from imaging techniques to personalized medicine approaches | 2026-02-23 | OpenAlex | 10.3389/fneur.2026.1784512 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131104014 | |||
| W7134044251 | Human skin tattoed with a soldier, badge and anchor, France, Wellcome Foundation L0057038 | 2026-02-23 | OpenAlex | 10.5281/zenodo.18742123 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7134044251 | |||
| W7131126838 | Modern pharmacotherapy of obesity: molecular mechanisms, clinical efficacy and future therapeutic directions | 2026-02-23 | OpenAlex | 10.18203/2319-2003.ijbcp20260443 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131126838 | |||
| W7131164133 | Points to consider in designing and conducting astigmatism research in cataract surgery | 2026-02-23 | OpenAlex | 10.3389/fopht.2026.1789801 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131164133 | |||
| W7131078258 | ROLE OF CENTRALIZED BMS IN ENHANCING OPERATIONAL EFFICIENCY IN SMART MALLS AND HOTELS | 2026-02-23 | OpenAlex | 10.18623/rvd.v23.n4.4852 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131078258 | |||
| W7131082492 | TRANSITION FROM OPPURTUNISTIC PATHOGEN TO MULTIDRUG RESISTANT STENOTROPHOMONAS MALTOPHILIA: A CALL FOR EMERGING THERAPEUTIC STRATEGIES | 2026-02-23 | OpenAlex | 10.53550/ajmbes.2026.v28.i01-02.018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131082492 | |||
| W7135219828 | A comprehensive clinical and microbiological profile of culture-positive urinary episodes in children with acute lymphoblastic leukemiaurinary leukemia | 2026-02-24 | OpenAlex | 10.12956/tjpd.2025.1267 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135219828 | |||
| W7131212783 | An expedition on paper-based microfluidic point-of-care testing devices for the detection of infectious diseases | 2026-02-24 | OpenAlex | 10.1016/j.trac.2026.118770 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7131212783 | |||
| W7131227659 | Editorial: Artificial intelligence applications in chronic ocular diseases, volume II | 2026-02-24 | OpenAlex | 10.3389/fcell.2026.1762437 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131227659 | |||
| W7131311023 | Editorial: Exploration of the role of heme proteins in biology with experimental and computational methods | 2026-02-24 | OpenAlex | 10.3389/fchem.2026.1810989 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131311023 | |||
| W7131226804 | Engineering stimuli-responsive dendrimers for drug delivery: A 15-year review of formulation strategies and routes of administration | 2026-02-24 | OpenAlex | 10.1016/j.onano.2026.100292 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131226804 | |||
| W7131212234 | Fractional Microneedling Radiofrequency for Hidradenitis Suppurativa: A Real‐World Retrospective Study Demonstrating Clinical Efficacy and Safety Across Diverse Anatomical Sites | 2026-02-24 | OpenAlex | 10.1111/jocd.70748 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7131212234 | |||
| W7131428201 | Letter: Statins for Cirrhosis: Are We Ready to Move From Cardiovascular Prophylaxis to Portal Pressure Management? | 2026-02-24 | OpenAlex | 10.1111/apt.70591 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131428201 | |||
| W7131407431 | Letter: Statins for Cirrhosis: Are we Ready to Move From Cardiovascular Prophylaxis to Portal Pressure Management? Authors' Reply | 2026-02-24 | OpenAlex | 10.1111/apt.70599 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131407431 | |||
| W7135018188 | Pharmacotherapeutic Agents in Diabetes Mellitus: A Narrative Review | 2026-02-24 | OpenAlex | 10.5530/jppcm.20260649 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7135018188 | |||
| W7140036346 | Targeted Therapy in Oncology: Pharmacological Advances and Clinical Challenges | 2026-02-24 | OpenAlex | 10.61096/ijamscr.v14.iss1.2026.199-208 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140036346 | |||
| W7131293014 | The Evolving Landscape of Advanced Therapies in Inflammatory Bowel Disease: Current Evidence and Emerging Targets | 2026-02-24 | OpenAlex | 10.3390/gidisord8010013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131293014 | |||
| W7131282980 | The MH8‑AI‑AGENT‑ABE System: The First Public Recursive‑Reasoning Audit Agent with Cryptographic Identity | 2026-02-24 | OpenAlex | 10.5281/zenodo.18750876 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7131282980 | |||
| W7133216384 | Approaching Conversations About Cannabis Use with Patients & Caregivers | 2026-02-25 | OpenAlex | 10.1097/01.cot.0000000000000330 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133216384 | |||
| W7131832080 | Artificial Intelligence and Machine Learning BY Laxminarayana Thirupathi | 2026-02-25 | OpenAlex | 10.5281/zenodo.18798118 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131832080 | |||
| W7131415763 | Digital Twin Frameworks for AI-Driven Wind Turbine Monitoring and Predictive Maintenance | 2026-02-25 | OpenAlex | 10.4018/979-8-3373-4159-0.ch007 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7131415763 | |||
| W7131363512 | Editorial: Advances in intelligence or nanomedicine-based theranostics for cancers | 2026-02-25 | OpenAlex | 10.3389/fonc.2026.1786982 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131363512 | |||
| W7146966200 | Ep. 848: Do Algorithms Deserve Rights? The Gemini 3.5 Debate | 2026-02-25 | OpenAlex | 10.5281/zenodo.19361464 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7146966200 | |||
| W7131366588 | Epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of non-small cell lung cancer in the past 30 years (1997–2026) | 2026-02-25 | OpenAlex | 10.1097/cm9.0000000000004016 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131366588 | |||
| W7134185721 | From the Editors | 2026-02-25 | OpenAlex | 10.1111/puar.70104 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134185721 | |||
| W7131354966 | Modulation of macrophage survival during Klebsiella pneumoniae infections | 2026-02-25 | OpenAlex | 10.3389/fcimb.2026.1757662 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131354966 | |||
| W7131453142 | Navigating the complex landscape of duodenal gastrointestinal stromal tumor: Innovations in diagnosis and treatment | 2026-02-25 | OpenAlex | 10.1016/j.critrevonc.2026.105227 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131453142 | |||
| W7220282684 | Biological agents in rheumatology: advantages, limitations, and safety profile of molecularly targeted therapy | 2026-02-26 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220282684 | ||||
| W7131726775 | Can social robots improve the hospital experience of children? | 2026-02-26 | OpenAlex | 10.3389/fresc.2026.1691526 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131726775 | |||
| W7131625945 | Efficacy of single-dose compared with split-dose low-volume polyethylene glycol for colonoscopy preparation: a randomized controlled trial | 2026-02-26 | OpenAlex | 10.18203/2320-6012.ijrms20260636 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7131625945 | |||
| W7131877691 | Emerging Treatment Options in ATTR-CM: Near-Complete TTR Silencers and Amyloid Depleters | 2026-02-26 | OpenAlex | 10.1093/eurheartjsupp/suag054 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131877691 | |||
| W7152635835 | From Data to Decision: An AI-Powered Sustainment Platform Enabling Predictive Readiness Across the USV Fleet | 2026-02-26 | OpenAlex | 10.48448/2edj-yh48 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7152635835 | |||
| W7131712687 | Pediatric Vernal Keratoconjunctivitis (VKC): Current State and Future Directions—A Narrative Review of Clinical Features, Diagnostic Strategies, and Emerging Therapies | 2026-02-26 | OpenAlex | 10.3390/children13030335 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131712687 | |||
| W7131642274 | RAS blockade in chronic kidney disease: Current evidence and future directions | 2026-02-26 | OpenAlex | 10.1007/s00210-026-05140-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7131642274 | |||
| W7131902959 | Reconsidering antiviral prophylaxis in HBsAg-negative, anti–HBc-positive patients treated with rituximab | 2026-02-26 | OpenAlex | 10.1097/hc9.0000000000000903 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131902959 | |||
| W7131664618 | Regulatory Stipulations and Scientific Underpinnings for Inhaled Biologics for Local Action in the Respiratory Tract—Part I: Development of Inhaled Therapeutic Protein Products | 2026-02-26 | OpenAlex | 10.3390/biochem6010006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131664618 | |||
| W7131617015 | Adjuvant and neoadjuvant treatment for melanoma: integrating immunotherapy, radiation and systemic therapies into surgical practice | 2026-02-27 | OpenAlex | 10.1016/j.otot.2026.02.015 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7131617015 | |||
| W7131838122 | Local Hemostasis as the Critical Enabler for Safe Antithrombotic Therapy in Dentistry—Navigating Future Frontiers and Innovative Concepts | 2026-02-27 | OpenAlex | 10.3390/jcm15051823 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131838122 | |||
| W7131819664 | Modeling endovascular embolization for cerebral arteriovenous malformations: A review from lumped parameters models to patient-specific CFD | 2026-02-27 | OpenAlex | 10.1063/5.0307486 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131819664 | |||
| W7131857959 | NITROGLYCERINE IN CONTEMPORARY CARDIOVASCULAR THERAPEUTICS: MOLECULAR MECHANISMS, CLINICAL APPLICATIONS, AND FUTURE PERSPECTIVES | 2026-02-27 | OpenAlex | 10.64751/ijpams.2026.v6.n1.pp49-62 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131857959 | |||
| W7131623216 | Outbreaks of human respiratory syncytial virus in wild gorillas highlight the importance of prevention measures and integrated surveillance for risk mitigation | 2026-02-27 | OpenAlex | 10.1016/j.onehlt.2026.101376 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7131623216 | |||
| W7132850547 | PENTLLM: A Pentagon-Based Multi-Expert Large Language Model Architecture for Medical Research Applications | 2026-02-27 | OpenAlex | 10.5281/zenodo.18807749 | Full text | Excluded | F2: The primary demonstrated activities are academic research/office work, peer review, proposals and documents; clinical RAG is one component rather than the primary clinical task. | https://openalex.org/W7132850547 | https://doi.org/10.5281/zenodo.18807749 | Complete archived abstract only; Zenodo primary page inaccessible | |
| W7154914867 | Psychotropicā Neuroscience: Structural elements and samples | 2026-02-27 | OpenAlex | 10.5281/zenodo.19647344 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154914867 | |||
| W7131861348 | Refining the Approach to Xenograft Rejection | 2026-02-27 | OpenAlex | 10.1097/tp.0000000000005672 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131861348 | |||
| W7133331761 | Rituximab as monotherapy and in combination with methotrexate or leflunomide in rheumatoid arthritis: a prospective cohort study in a Peruvian hospital | 2026-02-27 | OpenAlex | 10.5114/reum/213648 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133331761 | |||
| W7132822023 | The Care and Cure of the Leukemias in 2026 | 2026-02-27 | OpenAlex | 10.1002/ajh.70247 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7132822023 | |||
| W7131794011 | Upfront Combination or Stepwise Escalation: Personalising LDL-C Reduction in Clinical Practice | 2026-02-27 | OpenAlex | 10.1007/s11883-026-01400-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7131794011 | |||
| W7131825162 | Weaponizing EHRs to Close that Diagnosis Gap - Coupling Agentic AI with EHRs for Earlier, More Equitable Diagnosis with Minority Estrogenopathies | 2026-02-27 | OpenAlex | 10.20944/preprints202602.1918.v1 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7131825162 | |||
| W7132847160 | A Review of Multi-Agent AI Systems for Biological and Clinical Data Analysis | 2026-02-28 | OpenAlex | 10.3390/mps9020033 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7132847160 | |||
| W7132843617 | Agentic AI–Driven Quality Engineering: A Global Innovation Framework for Autonomous Enterprise Decision Validation | 2026-02-28 | OpenAlex | 10.63412/98h64d16 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7132843617 | |||
| W7135076923 | Agenticness of Artificial Intelligence in the Fashion Industry : A Case Study Based on a Conceptual Expansion Structure | 2026-02-28 | OpenAlex | 10.7233/jksc.2026.76.1.071 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7135076923 | |||
| W7132856633 | CDAFlow: Enhancing LLM clinical decision-making through agentic workflow | 2026-02-28 | OpenAlex | 10.1016/j.eswa.2026.131806 | Full text | Excluded | F4: FSM state transitions and at most two reflections per state concern the current patient. Long-term memory stores fixed Text2DT rules and MedDM paths, with cached conversion of external rule texts; short-term memory stores current-patient decisions. No experience-derived update is retained for later different cases. | https://openalex.org/W7132856633 | https://www.sciencedirect.com/science/article/pii/S0957417426007190 | Publisher full HTML read through existing Tohoku University entitlement; relevant methods/evaluation sections examined online. | |
| W7132817948 | Current evidence on non-surgical therapies for Dupuytren's disease: A clinical review | 2026-02-28 | OpenAlex | 10.1016/j.jham.2026.100444 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7132817948 | |||
| W7133145080 | DNA methyltransferase inhibitors in oncology: clinical progress, limitations and future directions | 2026-02-28 | OpenAlex | 10.1080/17501911.2026.2637418 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133145080; https://openalex.org/W7132845020 | |||
| W7133244661 | Evolving kidney disease phenotypes in type 2 diabetes: declining albuminuria and increasing isolated low eGFR | 2026-02-28 | OpenAlex | 10.1093/ckj/sfag069 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133244661 | |||
| W7134180767 | Harnessing genomic profiling for precision breast cancer therapies: Advances in HER2-targeted treatments, PARP inhibitors for BRCA mutations, and insights from clinical trials | 2026-02-28 | OpenAlex | 10.15419/v1dhqx66 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134180767 | |||
| W7132841964 | Impacts of Liposomes and Their Application in Cancer Therapy | 2026-02-28 | OpenAlex | 10.38124/ijisrt/26feb815 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7132841964 | |||
| W7132819146 | Implementing Shared Decision‐Making in Haemophilia Care: Best Practice Recommendations From a Western European Multi‐Stakeholder Delphi Process | 2026-02-28 | OpenAlex | 10.1111/hae.70220 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7132819146 | |||
| W7132857811 | Liposomal nanocarriers in precision oncology: Advances and prospects | 2026-02-28 | OpenAlex | 10.1016/j.critrevonc.2026.105236 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7132857811 | |||
| W7132839434 | Nanoparticle-Mediated Delivery of MicroRNA: A Transformative Approach for Therapeutic Intervention | 2026-02-28 | OpenAlex | 10.33687/ricosbiol.04.02.108 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7132839434 | |||
| W7162284521 | NeuroEvolution of Augmenting Topologies (NEAT) for Surface Roughness Prediction in 3D Printing Under Data Scarcity | 2026-02-28 | OpenAlex | 10.15866/iremos.v19i1.26593 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162284521 | |||
| W7132854113 | Real-world treatment sequences and overall survival in metastatic bladder cancer: The STATES-Bladder study | 2026-02-28 | OpenAlex | 10.1016/j.urolonc.2026.111036 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7132854113 | |||
| W7132825068 | Salvage or Second Autologous SCT in Relapsed Multiple Myeloma (2016–2026): A Decade in Review | 2026-02-28 | OpenAlex | 10.3390/curroncol33030140 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7132825068 | |||
| W7133335561 | The Effect of Positive Psychology-Based Cognitive Behavioral Coaching on Adult Well-being and Narrative Reconstruction: A Single Case Study | 2026-02-28 | OpenAlex | 10.47018/accr.2026.8.1.51 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7133335561 | |||
| W7148987582 | Uterine Fibroids | 2026-02-28 | OpenAlex | 10.5281/zenodo.19403718 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148987582 | |||
| W7154332393 | 12. Mehta RL, Chertow GM, et al. Epidemiology, Trajectories, and Outcomes of Acute Kidney Injury among Hospitalized Patients: A Multicenter Retrospective Cohort Study. medRxiv [Preprint]; 2024. | 2026-03-01 | OpenAlex | 10.22159/ijms.2026v14i2.58231 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154332393 | |||
| W7140207516 | 1478: COMPARISON OF ANTIMICROBIAL RESISTANCE PATTERNS IN ECMO, ICU, AND HOSPITAL-WIDE PATIENT COHORTS | 2026-03-01 | OpenAlex | 10.1097/01.ccm.0001187908.30799.fc | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7140207516 | |||
| W7140229813 | 1513: COMPARISON OF UREA VS FLUDROCORTISONE IN CORRECTION OF HYPONATREMIA IN NEUROCRITICAL CARE PATIENTS | 2026-03-01 | OpenAlex | 10.1097/01.ccm.0001188048.80768.23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7140229813 | |||
| W7151310747 | 1ST PLACE, ORIGINAL RESEARCH TRACK: CUPNavigator: A multi-model CDSS for tumor origin prediction, diagnostic planning, and therapy recommendations in cancer of unknown primary | 2026-03-01 | OpenAlex | 10.17975/sfj-2026-005 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7151310747 | |||
| W7140179467 | 410: LONGITUDINAL TRENDS IN ANTIMICROBIAL SUSCEPTIBILITY AMONG ECMO PATIENTS WITH GRAM-NEGATIVE RODS | 2026-03-01 | OpenAlex | 10.1097/01.ccm.0001183636.94008.98 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7140179467 | |||
| W7140167769 | 537: MANAGEMENT OF COMBINED OPIOID AND MEDETOMIDINE WITHDRAWAL AT AN ACADEMIC MEDICAL CENTER | 2026-03-01 | OpenAlex | 10.1097/01.ccm.0001184144.89185.69 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7140167769 | |||
| W7139115199 | 6ER-023 Integrating FDA approved app based prescription digital therapeutic apps into clinical practice | 2026-03-01 | OpenAlex | 10.1136/ejhpharm-2026-eahp.623 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139115199 | |||
| W7133222336 | A multicohort phase 2 trial of androgen deprivation therapy (ADT), docetaxel (DOCE), and nivolumab (NIVO) in patients (pts) with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) enriched for inflamed tumors and DNA damage repair (DDR) alterations. | 2026-03-01 | OpenAlex | 10.1200/jco.2026.44.7_suppl.183 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133222336 | |||
| W7134278247 | Advancements in JAK inhibitors for Pediatric Dermatology: an Updated Review on Emerging Therapies for Immune-Mediated Diseases | 2026-03-01 | OpenAlex | 10.1016/s0022-202x(26)00680-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134278247 | |||
| W7208811931 | Advances in the pharmacological management of heart failure with reduced ejection fraction: A narrative review | 2026-03-01 | OpenAlex | 10.5281/zenodo.22321402 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7208811931; https://openalex.org/W7141923070 | |||
| W7133350595 | Adverse drug reactions and pharmacovigilance | 2026-03-01 | OpenAlex | 10.33545/26164485.2026.v10.i3.a.2388 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133350595 | |||
| W7133342713 | An Agentic AI system for disease diagnosis with explanations | 2026-03-01 | OpenAlex | 10.1016/j.infoh.2026.01.001 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7133342713 | |||
| W7138181587 | Asundexian Versus Apixaban in Patients With Atrial Fibrillation | 2026-03-01 | OpenAlex | 10.1002/hsr2.71795 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138181587 | |||
| W7135390500 | BACILLUS CEREUS BACTEREMIA IN A LIVER TRANSPLANT RECIPIENT – CASE REPORT | 2026-03-01 | OpenAlex | 10.1016/j.bjid.2026.105096 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135390500 | |||
| W7137077382 | Bringing back ‘significance’ to MGUS | 2026-03-01 | OpenAlex | 10.1093/rheumatology/keag115 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7137077382 | |||
| W7135398903 | CHROMOBLASTOMYCOSIS IN THE STATE OF PARÁ: IMPACT OF POOR THERAPEUTIC ADHERENCE AND CHRONIC EVOLUTION OF THE DISEASE | 2026-03-01 | OpenAlex | 10.1016/j.bjid.2026.105174 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135398903 | |||
| W7134258793 | Calcitonin Gene-Related Peptide (CGRP) Inhibitors in Migraine: Mechanisms, Clinical Evidence, and Safety | 2026-03-01 | OpenAlex | 10.33545/26647613.2026.v8.i3a.205 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134258793 | |||
| W7133237515 | Career pathways for pharmacologists in India: A clinical pharmacologist’s perspective | 2026-03-01 | OpenAlex | 10.4103/ijp.ijp_185_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133237515 | |||
| W7161268059 | Clinical translation of whole-body 5 Tesla MRI: An evolving paradigm in high-field imaging | 2026-03-01 | OpenAlex | 10.1016/j.magmed.2026.100064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161268059 | |||
| W7139989810 | Complete pathological response with pembrolizumab in recurrent sigmoid adenocarcinoma | 2026-03-01 | OpenAlex | 10.1093/jscr/rjag168 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7139989810 | |||
| W7134232968 | Cytophagic Histiocytic Panniculitis with Secondary Hemophagocytic Lymphohistiocytosis in a child : A Case Report | 2026-03-01 | OpenAlex | 10.1016/s0022-202x(26)00674-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134232968 | |||
| W7135412512 | DISSEMINATED TUBERCULOSIS ASSOCIATED WITH CERTOLIZUMAB USE IN A PATIENT WITH RHEUMATOID ARTHRITIS | 2026-03-01 | OpenAlex | 10.1016/j.bjid.2026.105138 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135412512 | |||
| W7140085583 | Differences and trends in worldwide clinical guidelines for Helicobacter pylori infection | 2026-03-01 | OpenAlex | 10.21037/tgh-2025-159 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140085583 | |||
| W7140192240 | DockTales: A Human-Centered Mobile Application for Chronic Pain and Related Sleep Disturbance Through Empathic AI Design | 2026-03-01 | OpenAlex | 10.1016/j.jpain.2025.105675 | Full text | Excluded | F5: The exact journal item provides bibliographic metadata but no abstract or full methods through the public or current institutional publisher route. No matching author repository manuscript was found. The related HCII2026 project description was not substituted without identity evidence. | https://openalex.org/W7140192240 | https://doi.org/10.1016/j.jpain.2025.105675 | Primary publisher page read with current Tohoku entitlement; explicitly no subscription for this item. Volume41 Supplement, March2026, article105675. Full text unavailable. | |
| W7133243569 | End-of-life treatment patterns in patients (pts) with metastatic renal cell carcinoma (mRCC). | 2026-03-01 | OpenAlex | 10.1200/jco.2026.44.7_suppl.466 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133243569 | |||
| W7134914608 | Fatal familial insomnia that begins with unconsciousness: A case report | 2026-03-01 | OpenAlex | 10.1002/slp2.70029 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134914608 | |||
| W7133332209 | Fifteen-Year Trends in Antimicrobial Resistance of Pseudomonas aeruginosa at a South Indian Tertiary Care Centre: A Retrospective Analysis. | 2026-03-01 | OpenAlex | 10.7417/ct.2026.2010 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133332209 | |||
| W7140692910 | Fractional Excretion of Potassium Predicts Remission in Adult Nephrotic Syndrome | 2026-03-01 | OpenAlex | 10.34067/kid.0000001058 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140692910 | |||
| W7135406543 | HERPETIC ENCEPHALITIS AND DEVELOPMENT OF REFRACTORY EPILEPSY AS A NEUROLOGICAL SEQUELA | 2026-03-01 | OpenAlex | 10.1016/j.bjid.2026.105474 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135406543 | |||
| W7148894841 | Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations | 2026-03-01 | OpenAlex | 10.36849/jdd.9353 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7148894841 | |||
| W7135412097 | INVASIVE FUNGAL INFECTION CAUSED BY MAGNUSIOMYCES CAPITATUS IN AN IMMUNOSUPPRESSED ADULT WITH ACUTE MYELOID LEUKEMIA, ASSOCIATED WITH HIV AND TUBERCULOSIS COINFECTION | 2026-03-01 | OpenAlex | 10.1016/j.bjid.2026.104817 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135412097 | |||
| W7133182982 | Implementing evidence-based first-line therapy for metastatic urothelial carcinoma: A quality improvement initiative in community oncology. | 2026-03-01 | OpenAlex | 10.1200/jco.2026.44.7_suppl.664 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133182982 | |||
| W7140191083 | Infiltrative liver conditions: a pictorial review of malignant and benign entities | 2026-03-01 | OpenAlex | 10.4103/singaporemedj.smj-2023-033 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140191083 | |||
| W7140757747 | Inflation Reduction Act Impact on the Hematology/Oncology Treatment Landscape | 2026-03-01 | OpenAlex | 10.37765/ajmc.2026.89891 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140757747 | |||
| W7137956161 | Liposome-Based Drug Delivery for Diabetes: Therapeutic Applications and a Nanomedicine Perspective on Diabetic Complications | 2026-03-01 | OpenAlex | 10.2147/ijn.s593144 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7137956161; https://openalex.org/W7139520631 | |||
| W7133217400 | Management of Advanced Prostate Cancer in the Asia‐Pacific Region: Summary of the Asia‐Pacific Advanced Prostate Cancer Symposium 2025 | 2026-03-01 | OpenAlex | 10.1111/ajco.70092 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133217400 | |||
| W7133294707 | Managing High‐Risk Drug Interactions With Nirmatrelvir/Ritonavir: Experience From a Dedicated Pharmacology Advice Service | 2026-03-01 | OpenAlex | 10.1111/cts.70443 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133294707 | |||
| W7136287026 | Medicine at the Crossroads: Visions, Approaches, and Emerging Frontiers | 2026-03-01 | OpenAlex | 10.1002/med4.70063 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7136287026 | |||
| W7138885039 | Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis | 2026-03-01 | OpenAlex | 10.55697/tnd.2026.622 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7138885039 | |||
| W7214859254 | New lanthanide-based materials for multifunctional imaging, biosensing and luminescence thermometry | 2026-03-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214859254 | ||||
| W7167219267 | Outcome of Classic Hodgkin Lymphoma Treated with ABVD Regimen- A Single Center Experience | 2026-03-01 | OpenAlex | 10.2478/jcas-2026-0008 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167219267 | |||
| W7135406523 | PLAGUE IN THE 21ST CENTURY: GLOBAL OVERVIEW AND PERSPECTIVES IN BRAZIL | 2026-03-01 | OpenAlex | 10.1016/j.bjid.2026.105614 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135406523 | |||
| W7133190988 | PO:11:278 ‘New kids on the block’ – real-world experience of belimumab, obinutuzumab and voclosporin in systemic lupus erythematosus (SLE): a retrospective cohort study at UCLH | 2026-03-01 | OpenAlex | 10.1136/lupus-2026-el.332 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133190988 | |||
| W7135384274 | PRIMARY PYOMYOSITIS DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS: CASE REPORT | 2026-03-01 | OpenAlex | 10.1016/j.bjid.2026.105070 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135384274 | |||
| W7135394087 | PRIMARY PYOMYOSITIS DUE TO RESISTANT STREPTOCOCCUS PNEUMONIAE SECONDARY TO ACUTE OTITIS MEDIA IN A 7-MONTH-OLD INFANT: CASE REPORT | 2026-03-01 | OpenAlex | 10.1016/j.bjid.2026.105071 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135394087 | |||
| W7135377134 | PULMONARY MELIOIDOSIS: A CASE REPORT IN THE INTERIOR OF MATO GROSSO | 2026-03-01 | OpenAlex | 10.1016/j.bjid.2026.105040 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135377134 | |||
| W7160770925 | Precision Versus Population Pharmacotherapy in Obesity: A Systematic Evaluation of Setmelanotide and GLP-1 Receptor Agonists | 2026-03-01 | OpenAlex | 10.21276/ssr-iijls.2026.12.2.23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160770925 | |||
| W7166420555 | Radiologic Diagnosis of Abdominal Complications of Drug Therapy in Cancer Patients | 2026-03-01 | OpenAlex | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7166420555 | ||||
| W7140439524 | Recent advances in nonsurgical periodontal therapy | 2026-03-01 | OpenAlex | 10.4103/ijdr_202637s1_abs_123 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140439524 | |||
| W7134109842 | Reprogramming Skin Aging: A Regenerative and Epigenetic Perspective on Cutaneous Longevity | 2026-03-01 | OpenAlex | 10.1111/jocd.70788 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134109842 | |||
| W7148882973 | Research Advances in Endocrine Therapy for Hormone Receptor-Positive/HER2-Negative Early Breast Cancer | 2026-03-01 | OpenAlex | 10.3971/j.issn.1000-8578.2026.25.0873 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148882973 | |||
| W7140209777 | SOCIETY OF CRITICAL CARE MEDICINE 55TH CRITICAL CARE CONGRESS | 2026-03-01 | OpenAlex | 10.1097/01.ccm.0001182192.43989.30 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140209777 | |||
| W7149210855 | Semantic Fidelity in Specialized Domains: Advancing Language Models through Adaptive Learning, Collective Reasoning, and Consensus Evaluation | 2026-03-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7149210855 | ||||
| W7133241398 | Sequencing of therapeutic agents before and after metastatic castration-resistant prostate cancer (mCRPC) diagnosis in an international real-world setting. | 2026-03-01 | OpenAlex | 10.1200/jco.2026.44.7_suppl.100 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7133241398 | |||
| W7137154056 | Single-center experience of voclosporin use for pediatric lupus nephritis: a case series | 2026-03-01 | OpenAlex | 10.1093/rheumatology/keag125 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7137154056 | |||
| W7135011484 | Sodium glucose co-transporter inhibition as a strategy to stabilize the microvasculature in sickle cell disease | 2026-03-01 | OpenAlex | 10.1093/cvr/cvag055 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135011484 | |||
| W7135410630 | TOXIC EPIDERMAL NECROLYSIS – CASE REPORT AND LITERATURE REVIEW WITH FOCUS ON ANTIMICROBIAL STEWARDSHIP | 2026-03-01 | OpenAlex | 10.1016/j.bjid.2026.104694 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135410630 | |||
| W7135087554 | Targeting tumor suppressor gene co‐mutations in EGFR ‐mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification | 2026-03-01 | OpenAlex | 10.3322/caac.70072 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135087554 | |||
| W7142812820 | The Dual Role of p21 in Hormone-related Cancers and Its Therapeutic Implications | 2026-03-01 | OpenAlex | 10.3724/j.pibb.2025.0528 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7142812820 | |||
| W7162464630 | The Fontan circulation: Beyond hemodynamics to a unified disease paradigm | 2026-03-01 | OpenAlex | 10.4103/apc.apc_173_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162464630 | |||
| W7160949091 | The evolving role of novel anesthetic agents for obstetric and gynecological anesthesia: The multidimensional value from esketamine to dexmedetomidine | 2026-03-01 | OpenAlex | 10.1016/j.lddd.2026.100415 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7160949091 | |||
| W7153270099 | The rise of the agentic AI colleague | 2026-03-01 | OpenAlex | 10.1016/j.landig.2026.101010 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7153270099 | |||
| W7163583588 | Therapeutic breakthroughs in acute-on-chronic liver failure: From conventional approaches to emerging targeted therapies | 2026-03-01 | OpenAlex | 10.3724/cbls.2026047 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163583588 | |||
| W7140803624 | Thymic epithelial tumors: a narrative review of diagnostic and therapeutic advances | 2026-03-01 | OpenAlex | 10.21037/tcr-2025-2142 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140803624 | |||
| W7133206199 | Treatment and outcomes among patients with metastatic castrate resistant prostate cancer with an AR gene alteration: Analysis from the Kaiser Permanente Northern California Healthcare System. | 2026-03-01 | OpenAlex | 10.1200/jco.2026.44.7_suppl.91 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133206199 | |||
| W7140388185 | Vision–language foundation model driven agentic AI systems for healthcare | 2026-03-01 | OpenAlex | 10.1007/s00371-026-04437-7 | Title/abstract | Excluded | E5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established. | https://openalex.org/W7140388185 | |||
| W7133946050 | When Norovirus Stress‐Tests Mass Gatherings: From Outbreaks to System Fragility | 2026-03-01 | OpenAlex | 10.1002/rmv.70130 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133946050 | |||
| W7134178712 | iLABMED : A Translational Medical Journal Embracing a New Era | 2026-03-01 | OpenAlex | 10.1002/ila2.70051 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134178712 | |||
| W7161229242 | 犬アトピー性皮膚炎に対する抗炎症治療薬の変遷 | 2026-03-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161229242 | ||||
| W7133132729 | Disparities in Medication Treatment of Type 2 Diabetes and Obesity | 2026-03-02 | OpenAlex | 10.1542/peds.2025-074840 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133132729 | |||
| W7133318449 | Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy | 2026-03-02 | OpenAlex | 10.3390/biomedicines14030570 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133318449 | |||
| W7120572954 | Fifteen-Year Trends in Antimicrobial Resistance of Pseudomonas aeruginosa at a South Indian Tertiary Care Centre: A Retrospective Analysis: doi: 10.7417/CT.2026.2010 | 2026-03-02 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7120572954 | ||||
| W7133234335 | Invasive Fungal Disease in Allogeneic Hematopoietic Cell Transplantation: New Risk Factors and New Therapeutic Options in a Changing World | 2026-03-02 | OpenAlex | 10.1111/tid.70197 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133234335 | |||
| W7133196616 | Prognostic and predictive factors of immune checkpoint inhibitor therapy in urinary bladder cancer | 2026-03-02 | OpenAlex | 10.3389/pore.2026.1612333 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133196616 | |||
| W7133209267 | Specialty grand challenge in gastrointestinal infections | 2026-03-02 | OpenAlex | 10.3389/fgstr.2026.1808344 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133209267 | |||
| W7133217159 | The dual role of the crosstalk between autophagy and ferroptosis in lung cancer treatment: Advances in mechanisms and therapeutic strategies (Review) | 2026-03-02 | OpenAlex | 10.3892/ijmm.2026.5779 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133217159 | |||
| W7134175908 | Теория и практика создания и применения ультразвукового геля: обзор литературы (часть 1) | 2026-03-02 | OpenAlex | 10.34883/pi.2026.18.1.009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134175908 | |||
| W7133523297 | B06 | Integrating pharmacogenomics and microenvironment profiling in high-risk leukemias | 2026-03-03 | OpenAlex | 10.3324/haematol.2026.s1.14 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133523297 | |||
| W7133493921 | CO22 | UMG1-TriNK15: a first-in-class trispecific NK engager targeting multiple myeloma | 2026-03-03 | OpenAlex | 10.3324/haematol.2026.s1.35 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133493921 | |||
| W7133334691 | Cefepime Combined with Late-Generation β-Lactamase Inhibitors: Mechanisms of Action, In Vitro Activity, PK/PD Characteristics, Clinical Evidence and Resistance Mechanisms | 2026-03-03 | OpenAlex | 10.3390/antibiotics15030263 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133334691 | |||
| W7133337382 | EU Artificial Intelligence Act: Pre-Compliance Inspection and Diagnostic Framework | 2026-03-03 | OpenAlex | 10.5281/zenodo.18847119 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7133337382 | |||
| W7133340308 | Editorial: Drug development for respiratory infectious diseases and related complications in other systems | 2026-03-03 | OpenAlex | 10.3389/fmed.2026.1800928 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133340308 | |||
| W7133327194 | Editorial: Harnessing bacteriophages and phage-engineered products for antibacterial and anticancer therapies: challenges and opportunities | 2026-03-03 | OpenAlex | 10.3389/fmicb.2026.1799584 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133327194 | |||
| W7134201586 | Fostering deliberation and action in context: An analysis of implementation research among healthcare professionals in LMICs from a post‐digital perspective | 2026-03-03 | OpenAlex | 10.1111/bjet.70044 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134201586 | |||
| W7133247455 | Liquid crystal-based biosensors for clinical diagnostics | 2026-03-03 | OpenAlex | 10.1016/j.cca.2026.120926 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7133247455 | |||
| W7133305420 | Next Frontier in HER2+/HR+ Breast Cancer: Leveraging Cell Cycle Control with CDK4/6 Inhibitors | 2026-03-03 | OpenAlex | 10.3390/jpm16030143 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133305420 | |||
| W7133496509 | P077 | Clinical profiles and treatment approaches in Italian patients with CLL in clinical practice: findings from a European cross-sectional survey | 2026-03-03 | OpenAlex | 10.3324/haematol.2026.s1.139 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133496509 | |||
| W7133324784 | Treatment of pulmonary fibrosis: From disease mechanisms to future novel therapies (Review) | 2026-03-03 | OpenAlex | 10.3892/ijmm.2026.5783 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133324784 | |||
| W7137967244 | A review of the clinical efficacy of monoclonal antibody (mAb)-based therapies for relapsed/refractory multiple myeloma (RRMM) | 2026-03-04 | OpenAlex | 10.1080/14712598.2026.2646947 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7137967244 | |||
| W7143369918 | Advances in the pharmacotherapeutic management of duchenne muscular dystrophy: an update | 2026-03-04 | OpenAlex | 10.1080/14656566.2026.2652459 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143369918 | |||
| W7133485233 | Comprehensive Review on Candidemia: Epidemiology, Diagnosis, Treatment, and Future Directions | 2026-03-04 | OpenAlex | 10.26599/ifungi.2026.9670005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133485233 | |||
| W7135398381 | Diagnosis and risk factors for invasive mould disease—a round table discussion on directing antifungal therapy according to the available evidence | 2026-03-04 | OpenAlex | 10.1093/jac/dkag062 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135398381 | |||
| W7133556796 | Drug Anaphylaxis | 2026-03-04 | OpenAlex | 10.1016/j.iac.2026.01.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133556796 | |||
| W7133518449 | Editorial: Coping with antimicrobial resistance in the context of dental medicine | 2026-03-04 | OpenAlex | 10.3389/fdmed.2026.1807351 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133518449 | |||
| W7133526452 | Enhancing PLS in UAV-Aided Backscatter Networks: A Multiagent DRL Framework with Federated Learning | 2026-03-04 | OpenAlex | 10.1109/tai.2026.3669890 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7133526452 | |||
| W7135010279 | Investigating the Role of Sotagliflozin in Cardiovascular Event Management | 2026-03-04 | OpenAlex | 10.2174/0115743624383123251124110553 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135010279 | |||
| W7133489720 | PopGenAgent: An Agent-Mediated Workflow for Population Genetics Analyses | 2026-03-04 | OpenAlex | 10.64898/2026.03.02.709209 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7133489720 | |||
| W7133499771 | Stimuli-responsive protein-based bioinks for 3D bioprinting: Preparation strategies and wound healing applications | 2026-03-04 | OpenAlex | 10.1016/j.bprint.2026.e00478 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133499771 | |||
| W7138105857 | The Aesthetics of Mediacracy: Film Portrait of Silvio Berlusconi between Political Image and Cultural Representation | 2026-03-04 | OpenAlex | 10.15407/nte2026.01.106 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7138105857 | |||
| W7151285423 | The role of monoclonal antibodies in the treatment of lupus nephritis | 2026-03-04 | OpenAlex | 10.1080/14712598.2026.2649524 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151285423 | |||
| W7133343149 | Understanding the efficacy and tolerability of topical therapies for epidermolysis bullosa | 2026-03-04 | OpenAlex | 10.1080/17512433.2026.2641138 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133343149 | |||
| W7133537043 | Where AGI Confuses Change: A Recurrence–Structure Diagnostic for Autonomous Self-Improvement Claims in Artificial Intelligence | 2026-03-04 | OpenAlex | 10.5281/zenodo.18861438 | Title/abstract | Excluded | E2: Mathematical/forecasting/AGI framework without a clinical primary task. | https://openalex.org/W7133537043 | |||
| W7133700978 | AI agent in healthcare: applications, evaluations, and future directions | 2026-03-05 | OpenAlex | 10.1038/s44387-026-00076-4 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7133700978 | |||
| W7133869521 | Agentic Artificial Intelligence: Frameworks for Autonomous Decision-Making and Continuous Self-Improvement | 2026-03-05 | OpenAlex | 10.22214/ijraset.2026.77831 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7133869521 | |||
| W7133347124 | Biologic and targeted synthetic therapies in juvenile idiopathic arthritis: a review of current and emerging therapeutic agents | 2026-03-05 | OpenAlex | 10.1080/14740338.2026.2640975 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133347124 | |||
| W7133671075 | Bridging Science and Subjectivity: Evolving Evidence, Emerging Technologies and the Call for Personalised Psychotherapy: Créer une passerelle entre la science et la subjectivité : Évolution des données probantes, arrivée de nouvelles technologies et appel à une psychothérapie personnalisée | 2026-03-05 | OpenAlex | 10.1177/07067437261425840 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133671075 | |||
| W7133919813 | Current Treatment of Double Refractory Chronic Lymphocytic Leukemia: A Focus on Novel Drugs | 2026-03-05 | OpenAlex | 10.1016/j.clml.2026.03.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133919813 | |||
| W7133872249 | Editorial: Innovative and sustainable management of organic food and beverage wastes | 2026-03-05 | OpenAlex | 10.3389/fnut.2026.1810341 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133872249 | |||
| W7133872363 | In vivo evolution of resistance to contemporary β-lactam/β-lactamase inhibitor combinations during treatment of a KPC-producing Serratia marcescens infection | 2026-03-05 | OpenAlex | 10.1128/aac.01651-25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133872363 | |||
| W7133875449 | Infection Control in U.S. Dental Practice: Current Standards, Guidelines, and Emerging Challenges | 2026-03-05 | OpenAlex | 10.12691/ajmcr-14-3-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133875449 | |||
| W7133736900 | Joint TOS / OMA / OAC Expert Guidance Statement on the Pharmacological Management of United States Adults With Overweight or Obesity Using the GRADE Approach | 2026-03-05 | OpenAlex | 10.1002/oby.70164 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133736900; https://openalex.org/W7133706452 | |||
| W7133751477 | Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatment | 2026-03-05 | OpenAlex | 10.1016/j.ard.2026.02.003 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133751477 | |||
| W7133642317 | Reimagining community health nursing: a qualitative participatory action research study of nurse-led primary healthcare innovation in rural Saudi Arabia | 2026-03-05 | OpenAlex | 10.1186/s12912-026-04510-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7133642317 | |||
| W7133838439 | Research Highlights | 2026-03-05 | OpenAlex | 10.1097/tp.0000000000005680 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133838439 | |||
| W7134835334 | Textbook of Novel Drug Delivery System (NDDS) | 2026-03-05 | OpenAlex | 10.5281/zenodo.18938573 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134835334 | |||
| W7133817742 | Transport of Nanoparticles in Targeted Drug Delivery System | 2026-03-05 | OpenAlex | 10.21275/sr26226181516 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133817742 | |||
| W7133919283 | Tubulin polymerization inhibitors in early clinical studies as cancer therapeutics | 2026-03-05 | OpenAlex | 10.1080/13543784.2026.2640986 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7133919283 | |||
| W7134045889 | Acute kidney injury over the past decade: from definition evolution to pathogenesis insights and innovative therapeutic strategies | 2026-03-06 | OpenAlex | 10.1007/s00018-026-06104-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134045889 | |||
| W7134039607 | Canine vector-borne diseases: a changing world demands a new preventive strategy from veterinarians | 2026-03-06 | OpenAlex | 10.1186/s13071-026-07331-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134039607 | |||
| W7134076509 | Editorial: World diabetes day 2024: exploring mechanisms, innovations, and holistic approaches in diabetes care | 2026-03-06 | OpenAlex | 10.3389/fendo.2026.1808396 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134076509 | |||
| W7134033175 | From Glycemic Control to Weight-Centered Therapy: A Paradigm Shift in Type 2 Diabetes and Its Public Health Promise | 2026-03-06 | OpenAlex | 10.3389/ijph.2026.1608891 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134033175 | |||
| W7140541761 | From Physician Expertise to Clinical Agents: Preserving, Standardizing, and Scaling Physicians' Medical Expertise with Lightweight LLM | 2026-03-06 | OpenAlex | 2603.23520 | 10.48550/arxiv.2603.23520 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7140541761 | ||
| W7161177247 | From isolated data to integrated ecosystems: the artificial intelligence revolution in precision livestock farming | 2026-03-06 | OpenAlex | 10.1093/af/vfag010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161177247 | |||
| W7134139104 | Manufacturing and clinical applications of non‐ CAR ‐T immune effector cells | 2026-03-06 | OpenAlex | 10.1111/trf.70144 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134139104 | |||
| W7134032183 | Targeting HSP90 in cancer: advances in the development of inhibitors, mechanisms of action, and therapeutic applications | 2026-03-06 | OpenAlex | 10.1186/s12943-025-02559-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134032183; https://openalex.org/W7157281050 | |||
| W7160700153 | Denosumab in Giant Cell Tumour of Bone - A Case Series with Review of Literature | 2026-03-07 | OpenAlex | 10.31557/apjcc.2026.11.2.293-301 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160700153 | |||
| W7134108391 | Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms | 2026-03-07 | OpenAlex | 10.1007/s11899-026-00775-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134108391 | |||
| W7134196459 | Automating Enterprise IT Support: Design and Evaluation of an Autonomous AI Agent | 2026-03-08 | OpenAlex | 10.22214/ijraset.2026.77880 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7134196459 | |||
| W7147045681 | Ep. 1051: The Pharmacological Soldier: Engineering the Battlefield | 2026-03-08 | OpenAlex | 10.5281/zenodo.19362247 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147045681 | |||
| W7134234515 | Accelerating Exploratory Clinical Research: An LLM-Powered Framework for Cross-Study Data Harmonization and Natural Language Querying | 2026-03-09 | OpenAlex | 10.64898/2026.03.04.26345603 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7134234515 | |||
| W7134850418 | Acquired Hemostasis Disorders | 2026-03-09 | OpenAlex | 10.1055/a-2788-1844 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134850418 | |||
| W7151804474 | Antibacterial prophylaxis and antimicrobial stewardship in the era of innovative therapies for haematological malignancies: transplantation, cellular therapies and new drugs | 2026-03-09 | OpenAlex | 10.1093/jacamr/dlag051 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151804474 | |||
| W7136040310 | Chemotherapy-Induced Cardiotoxicity: A Comprehensive Review of Current Understanding and Future Directions | 2026-03-09 | OpenAlex | 10.2174/011573403x392956251210124152 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7136040310 | |||
| W7134259592 | From environmental reservoirs to clinical threats: the expanding resistome and genetic plasticity of Citrobacter spp. | 2026-03-09 | OpenAlex | 10.1007/s15010-026-02758-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134259592 | |||
| W7134249628 | Hepatic Artery Infusion Chemotherapy for Cholangiocarcinoma in 2025 | 2026-03-09 | OpenAlex | 10.1159/000551430 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134249628 | |||
| W7134851159 | Identification of two novel TP53 mutations in secondary acute myeloid leukemia following multiple myeloma: a case report | 2026-03-09 | OpenAlex | 10.1097/bs9.0000000000000282 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134851159 | |||
| W7134224838 | Multisystem Involvement in a Patient with MDR Klebsiella Pyelonephritis and Sjogren's Syndrome- A Complex Case Report | 2026-03-09 | OpenAlex | 10.5281/zenodo.18919744 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134224838 | |||
| W7134254954 | Neuropsychological aspects of impulse control disorders in Parkinson’s disease | 2026-03-09 | OpenAlex | 10.3389/fnagi.2026.1768251 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134254954 | |||
| W7134280398 | Postnatal Steroids in Preterm Infants: A Narrative Review Series—Part 1: Inflammatory Modulation and Respiratory Impacts | 2026-03-09 | OpenAlex | 10.3390/children13030384 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134280398 | |||
| W7134280254 | Sequencing antibody‑drug conjugates in metastatic cancer (Review) | 2026-03-09 | OpenAlex | 10.3892/mi.2026.308 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134280254 | |||
| W7160096416 | The Multidimensional Regulatory Network of Osteoblast Differentiation and Targeted Therapeutic Strategies for OP | 2026-03-09 | OpenAlex | 10.71321/rqm4ns12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160096416 | |||
| W7134981585 | Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics | 2026-03-10 | OpenAlex | 10.1038/s41571-026-01134-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134981585 | |||
| W7134807370 | Complex Communication: Complex-Valued Extensions of Environmental Divergence in Quantum Coordination Theory | 2026-03-10 | OpenAlex | 10.5281/zenodo.18944106 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7134807370 | |||
| W7134823778 | DRUG REPURPOSING AND TRANSLATIONAL RESEARCH: INTEGRATING AI, PHARMACOGENOMICS, AND PRECISION THERAPEUTICS | 2026-03-10 | OpenAlex | 10.5281/zenodo.18936789 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134823778 | |||
| W7134807749 | Editorial: World Schizophrenia awareness day: raising awareness and advancing pharmacological strategies in Schizophrenia | 2026-03-10 | OpenAlex | 10.3389/fphar.2026.1820307 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134807749 | |||
| W7135060672 | Evolution of Antivascular Endothelial Growth Factor Clinical Trial Design for Treating Neovascular Age-Related Macular Degeneration | 2026-03-10 | OpenAlex | 10.1177/24741264261427831 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135060672 | |||
| W7134907171 | Molecular-level understanding of the aging bone and regeneration mechanisms using computational methods | 2026-03-10 | OpenAlex | 10.1007/s00198-026-07903-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134907171 | |||
| W7134948832 | Painful Bilateral Necrosis of the Scalp | 2026-03-10 | OpenAlex | 10.1002/jvc2.70307 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134948832 | |||
| W7134851663 | Phage therapy in oncology: Mechanisms, innovations, and translational advances | 2026-03-10 | OpenAlex | 10.1016/j.jddst.2026.108230 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134851663 | |||
| W7134953105 | Phase Transitions in Artificial General Intelligence: Scaling Laws, Predictability Limits, and Singularity | 2026-03-10 | OpenAlex | 10.21203/rs.3.rs-9055490/v1 | Title/abstract | Excluded | E2: Mathematical/forecasting/AGI framework without a clinical primary task. | https://openalex.org/W7134953105 | |||
| W7134940836 | Real-world outcomes of patients with multiple myeloma who reach third-line therapy: a Canadian report | 2026-03-10 | OpenAlex | 10.1016/j.bneo.2026.100215 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134940836 | |||
| W7134986162 | TINOSPORA CORDIFOLIA: A BIOACTIVE NETWORK FOR ADVANCED HERB PHARMACOLOGY | 2026-03-10 | OpenAlex | 10.5281/zenodo.18958216 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134986162 | |||
| W7140214363 | The Algorithmic Smile: Multimodal AI and the Transformation of Orthodontic Science | 2026-03-10 | OpenAlex | 10.36348/gajdoh.2026.v08i02.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140214363 | |||
| W7134985792 | The Treatment of Antibody-Mediated Encephalitis: Current, Future Therapies, Unmet Need and Patient Management | 2026-03-10 | OpenAlex | 10.1007/s12325-026-03513-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134985792 | |||
| W7134238526 | [The evolution of antimicrobial therapy for sepsis]. | 2026-03-10 | OpenAlex | 10.3760/cma.j.cn112137-20251019-02688 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134238526 | |||
| W7136088793 | Clinical Applications and Safety Analysis of Nefopam and Flupirtine as Examples of Non-Opioid Analgesics | 2026-03-11 | OpenAlex | 10.2174/0113816128424715251211092936 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7136088793 | |||
| W7134897807 | Disability Through the Lens of Justice. J.Begon , 2023. Oxford, Oxford University Press. vii + 278 pp, £76 (hb) | 2026-03-11 | OpenAlex | 10.1002/japp.70083 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134897807 | |||
| W7135051456 | Editorial: Applications of fluorescence in surgery and diagnostics, volume II: evolution and breakthroughs | 2026-03-11 | OpenAlex | 10.3389/fsurg.2026.1806002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135051456 | |||
| W7134893436 | From Convenience to Clinical Efficacy: Selective TYK2 Inhibition in Psoriasis and the Evolving Role of Next-Generation Oral Targeted Therapies | 2026-03-11 | OpenAlex | 10.3390/pharmaceutics18030347 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134893436 | |||
| W7134953176 | Revolutionizing Drug Design with Bioinformatics and AI to Combat Multi-Drug-Resistant Pathogens | 2026-03-11 | OpenAlex | 10.1051/bioconf/202622807002/pdf | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134953176; https://openalex.org/W7134885096 | |||
| W7134929373 | The MTA-TPACK Dynamic Collaboration Spiral: Making Pedagogical Thinking Visible in Human–AI Scientific Visualization for Sustainable Teacher Innovation | 2026-03-11 | OpenAlex | 10.3390/su18062718 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7134929373 | |||
| W7135143422 | Thyroid Artery Embolization: A Review and Considerations for the Interventional Radiologist | 2026-03-11 | OpenAlex | 10.1055/a-2818-2557 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135143422 | |||
| W7134886937 | “My eating disorder story”: an interpretative phenomenological analysis of social media, narrative identity, and patient influencers in eating disorder recovery | 2026-03-11 | OpenAlex | 10.1186/s40337-026-01564-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7134886937 | |||
| W7138852613 | Chemoprotectors in Oncology: Mechanisms, sources, and advances in mitigating chemotherapy-induced toxicities | 2026-03-12 | OpenAlex | 10.62110/sciencein.btl.2026.v13.1855 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138852613 | |||
| W7135037525 | Continuous Change Containment Architecture (CCCA): Architecting AI-Enabled Systems for Continuous Change | 2026-03-12 | OpenAlex | 10.5281/zenodo.18987614 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7135037525 | |||
| W7135017231 | Duchenne Muscular Dystrophy: Contemporary Therapeutic Options and Real-World Challenges in Treatment Selection | 2026-03-12 | OpenAlex | 10.3390/muscles5010021 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135017231 | |||
| W7135017924 | Editorial: Exploiting biomarkers for targeted therapies in acute myeloid leukemia | 2026-03-12 | OpenAlex | 10.3389/fmed.2026.1813324 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135017924 | |||
| W7135036053 | Existing and Potential Therapeutic Strategies for Lowering Lipoprotein(a) Levels: An Update | 2026-03-12 | OpenAlex | 10.3390/jcm15062179 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135036053 | |||
| W7135192069 | Abstract A013: Bridging the mouse modeling gap in clear cell renal cell carcinoma bone metastasis for immunotherapy testing | 2026-03-13 | OpenAlex | 10.1158/1538-7445.kidney26-a013 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135192069 | |||
| W7135232532 | Editorial: Social and affective domain in home language development and maintenance research, volume II | 2026-03-13 | OpenAlex | 10.3389/fpsyg.2026.1813132 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135232532 | |||
| W7167368954 | Electronic Health Record System Transitions in Publicly Funded Healthcare: A Realist Synthesis Protocol | 2026-03-13 | OpenAlex | 10.17605/osf.io/kjgwb | Title/abstract | Excluded | E1: Protocol-only proposal without an evaluated persistent healthcare agent. | https://openalex.org/W7167368954 | |||
| W7135181745 | From AIE-Pharmacology to Fluoropharmacology: The Paradigm Evolution of Disciplinary Framework Based on the "Drug-Probe Unity" Concept | 2026-03-13 | OpenAlex | 10.22541/au.177341537.76117807/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135181745 | |||
| W7135171538 | Lipid-lowering therapies: the arrows in the quiver and future bullets | 2026-03-13 | OpenAlex | 10.23736/s2724-5683.25.07002-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135171538 | |||
| W7137144878 | Neuromuscular block in paediatric patients undergoing airway management: a narrative review | 2026-03-13 | OpenAlex | 10.1097/aco.0000000000001634 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7137144878; https://openalex.org/W7139126113 | |||
| W7135244078 | PURA-Related Neurodevelopmental Disorder: A Comprehensive Clinical Review of Genetics, Phenotype, and Emerging Therapeutic Strategies | 2026-03-13 | OpenAlex | 10.7759/cureus.105181 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135244078 | |||
| W7135194709 | Re-Evaluating the Role of Locoregional Therapy in Metastatic Prostate Cancer: A Review of Current Evidence and Evolving Clinical Approaches | 2026-03-13 | OpenAlex | 10.1016/j.ucl.2026.02.002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135194709 | |||
| W7135027438 | Risk factors and prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis | 2026-03-13 | OpenAlex | 10.4253/wjge.v18.i3.115736 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135027438 | |||
| W7135235335 | Study 3: Educator perspectives on costs and cost-conscious decision-making in health professions education: a Q-Method study | 2026-03-13 | OpenAlex | 10.34894/z9z6en | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7135235335 | |||
| W7135384398 | Advancements in extracellular vesicle research | 2026-03-14 | OpenAlex | 10.1016/j.vesic.2026.100107 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135384398 | |||
| W7135422314 | Biologics in severe asthma: from precision phenotyping to clinical remission | 2026-03-14 | OpenAlex | 10.1080/02770903.2026.2644878 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135422314 | |||
| W7138850453 | Deployed AI Agents for Industrial Asset Management: CodeReAct Framework for Event Analysis and Work Order Automation | 2026-03-14 | OpenAlex | 10.1609/aaai.v40i47.41453 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7138850453; https://openalex.org/W7128708900 | |||
| W7135418764 | Large language models enhance reinforcement learning for public health resource allocation | 2026-03-14 | OpenAlex | 10.1016/j.asoc.2026.115047 | Full text | Excluded | F3: The acting allocation agent is conventional Q-learning. DeepSeek/RAGFlow extracts structured epidemic growth-rate inputs from reports; it is not the acting controller or an agent whose policy is improved. | https://openalex.org/W7135418764 | https://www.sciencedirect.com/science/article/pii/S1568494626004953 | Publisher full HTML read through existing Tohoku University entitlement; relevant methods/evaluation sections examined online. | |
| W7135387663 | Management of Asthma: Future Directions | 2026-03-14 | OpenAlex | 10.4103/jalh.jalh_3_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135387663 | |||
| W7135419785 | Management of Hypertension in Patients Undergoing Peritoneal Dialysis: A Narrative Review | 2026-03-14 | OpenAlex | 10.7759/cureus.105215 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135419785 | |||
| W7138084769 | MemoryART: Enhancing LLMs via Multi-Memory Models with Adaptive Resonance Theory for Healthcare Agents | 2026-03-14 | OpenAlex | 10.1609/aaai.v40i25.39205 | Full text | Excluded | F4: MemoryART retains each patient's own dialogue history and profile; identity-channel retrieval preserves the same subject. No transfer of learned clinical experience to different patients is established. Fixed P1 applies. | https://openalex.org/W7138084769 | https://github.com/dairkkriad/MemoryART | ||
| W7135168241 | Safe and Sound: Optimizing Pediatric Procedural Sedation in Emergency Departments — From High-resource Standards to Low-resource Adaptations | 2026-03-14 | OpenAlex | 10.1007/s40746-026-00369-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135168241 | |||
| W7135385636 | The Therapy Paradox: Scaling Mental Health with AI | 2026-03-14 | OpenAlex | 10.5281/zenodo.19024278 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7135385636 | |||
| W7136044173 | A Two-Dimensional Framework for AI Agent Design Patterns: Cognitive Function × Execution Topology | 2026-03-15 | OpenAlex | 10.5281/zenodo.19036556 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7136044173 | |||
| W7135381960 | AI-Driven Change Management in the VUCA Era | 2026-03-15 | OpenAlex | 10.63329/av3nz12327 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7135381960 | |||
| W7219994907 | Current treatments for ischemic stroke: New approaches: Treatments for ischemic stroke | 2026-03-15 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7219994907 | ||||
| W7135419339 | Deliberation and drift: Evaluating alignment fragility in multi-agent medical artificial intelligence | 2026-03-15 | OpenAlex | 10.1007/s43681-026-01048-9 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7135419339 | |||
| W7136090353 | Harnessing synergy: Innovative combinations to overcome PARP inhibitor resistance in cancer treatment | 2026-03-15 | OpenAlex | 10.1016/j.critrevonc.2026.105278 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7136090353 | |||
| W7138300576 | Large Language Models as A Paradigm Shift in Next-Generation Virtual Reality Interaction: A Comprehensive Investigation | 2026-03-15 | OpenAlex | 10.54097/hw3wve60 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138300576 | |||
| W7136040158 | Off-Label Uses of Methotrexate | 2026-03-15 | OpenAlex | 10.32388/qwznda | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7136040158 | |||
| W7136057345 | Self-Regulating Artificial Intelligence: Architectural Governance for Long-Lived AI Systems | 2026-03-15 | OpenAlex | 10.5281/zenodo.19033610 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7136057345 | |||
| W7136042504 | The Algorithmic Adversary: Inside the IRGC's AI Strategy | 2026-03-15 | OpenAlex | 10.5281/zenodo.19033786 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7136042504 | |||
| W7118056368 | The Human Operating System— EBA: The Universal Architecture of Commitment, Fulfillment, and AI Alignment | 2026-03-15 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7118056368 | ||||
| W7214945650 | The Relationship Between Generative AI Chatbot Use, Working Alliance, and Mental Well-Being in Everyday Life | 2026-03-15 | OpenAlex | 10.17605/osf.io/a6r7x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214945650 | |||
| W7146239223 | 川崎病急性期治療:歴史的変遷から最新エビデンス,今後の展望 | 2026-03-15 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7146239223 | ||||
| W7136056290 | A comprehensive review of temporal reasoning with multimodal LLMs: Foundations, challenges, and healthcare applications | 2026-03-16 | OpenAlex | 10.1016/j.cosrev.2026.100960 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7136056290 | |||
| W7136424892 | ARSAL: The Akarkach Resonance & Synchronization Assessment Layer A Diagnostic Synchronization Layer for Emergence Governance in Agentic AI Systems | 2026-03-16 | OpenAlex | 10.5281/zenodo.19046566 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7136424892 | |||
| W7139942950 | Advances in Pharmacologic Strategies to Reduce Atheroma Plaque Size in Atheromatosis: A Comprehensive Review | 2026-03-16 | OpenAlex | 10.2174/0115748855405974251130161059 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139942950 | |||
| W7136892066 | COMPARATIVE EFFICACY AND SAFETY OF FIRST-VERSUS SECOND- GENERATION OVER-THE-COUNTER ANTIHISTAMINES: A REVIEW | 2026-03-16 | OpenAlex | 10.5281/zenodo.19045412 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7136892066 | |||
| W7138884905 | CORPORATE GOVERNANCE AND CORPORATE SOCIAL RESPONSIBILITY: INTERSECTIONS AND TENSIONS | 2026-03-16 | OpenAlex | 10.5281/zenodo.19119643 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7138884905 | |||
| W7136783898 | Emerging Genomic and Immunological Correlates Defining Oligometastatic Trajectories in Intermediate/High-Grade Soft-Tissue Sarcomas | 2026-03-16 | OpenAlex | 10.3390/genes17030323 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7136783898 | |||
| W7137264594 | Prevention and background therapy of skin toxic reactions in children receiving antitumor drug therapy. Part 2 (results of prospective cohort study) | 2026-03-16 | OpenAlex | 10.17116/klinderma202625011113 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7137264594 | |||
| W7137252984 | The Temporal Coherence Problem: Synthetic Point-in-Time Environments for Evaluating LLM Agents with Dynamic Tool Dependencies | 2026-03-16 | OpenAlex | 10.5281/zenodo.19041095 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7137252984; https://openalex.org/W7159952327 | |||
| W7138766611 | 176eP Impact of PD-L1 status on the development of cutaneous immune-related adverse events in non-small cell lung cancer patients receiving immunotherapy | 2026-03-17 | OpenAlex | 10.1016/j.esmoop.2026.106483 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7138766611 | |||
| W7138233353 | Application value of gastric contrast ultrasonography in gastric tumors | 2026-03-17 | OpenAlex | 10.1186/s13244-026-02242-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138233353 | |||
| W7144198750 | China’s Contribution to the Clinical Development of Antibody-Drug Conjugates in Gynecologic Cancers: A Review | 2026-03-17 | OpenAlex | 10.31083/ceog47269 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7144198750 | |||
| W7139088901 | Comment on ‘Effectiveness of Nurse‐Led Interventions on Emergence Delirium in Pediatric Patients: A Systematic Review and Meta‐Analysis’ | 2026-03-17 | OpenAlex | 10.1111/jocn.70262 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139088901 | |||
| W7141520901 | Cytomorphological Reflections of HPV Positivity in Concurrent HPV Testing and Smear Specimens | 2026-03-17 | OpenAlex | 10.35440/hutfd.1762809 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7141520901 | |||
| W7137899655 | Editorial: Drug delivery systems for mineralized tissue regeneration | 2026-03-17 | OpenAlex | 10.3389/fbioe.2026.1826772 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7137899655 | |||
| W7138839771 | Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma—A Step Toward Mechanism‐Guided Second‐Line Therapy | 2026-03-17 | OpenAlex | 10.1111/apt.70604 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138839771 | |||
| W7150079542 | Natural Killer Cell Therapy in Ovarian Cancer: From Preclinical Potentials to Clinical Applications and Combination Strategies | 2026-03-17 | OpenAlex | 10.7150/ijbs.130260 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150079542 | |||
| W7138129778 | Perioperative Anaphylaxis: Etiology, Pathophysiology, Diagnostic Challenges, Immediate Management, Prevention Strategies, and Future Perspectives | 2026-03-17 | OpenAlex | 10.14218/erhm.2025.00079 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138129778 | |||
| W7137850615 | Primary central nervous system lymphoma: Evolving treatment strategies to achieve improved long-term disease control | 2026-03-17 | OpenAlex | 10.1177/10781552261430675 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7137850615 | |||
| W7139054149 | The Cepeda Framework: A Modular, Safety-First Preclinical Architecture for Testing Coordinated Multi-Hallmark Rejuvenation Hypotheses in Biological Aging | 2026-03-17 | OpenAlex | 10.64898/2026.03.15.711859 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7139054149 | |||
| W7138423498 | The Potential for Artificial Intelligence to Augment Peer Review | 2026-03-17 | OpenAlex | 10.1111/1742-6723.70243 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138423498 | |||
| W7139967142 | The future of urothelial carcinoma: a 2024–2025 update of early-phase trials of novel therapeutic agents | 2026-03-17 | OpenAlex | 10.1097/mou.0000000000001388 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139967142 | |||
| W7138367790 | What's next in psoriatic arthritis therapy? A look at the pipeline | 2026-03-17 | OpenAlex | 10.1097/bor.0000000000001157 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138367790 | |||
| W7138840744 | Analysis of Molecular Markers of HPV Infection Persistence: A Narrative Review | 2026-03-18 | OpenAlex | 10.3390/cancers18060981 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138840744 | |||
| W7138865127 | Contemporary Trends in High‐Potency P2Y12 Receptor Inhibitor Use Among Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention | 2026-03-18 | OpenAlex | 10.1161/jaha.125.047683 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7138865127 | |||
| W7139031629 | Dual GLP-1/GIP Agonists for Weight Reduction and Cardiovascular Outcomes in Type 2 Diabetes | 2026-03-18 | OpenAlex | 10.59298/iaajsr/2026/1316570 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139031629 | |||
| W7138848778 | Elranatamab in Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Emerging Perspectives | 2026-03-18 | OpenAlex | 10.1111/ejh.70167 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138848778 | |||
| W7138835117 | Evolving Ocular Safety Signals of EGFR Inhibitors: A FAERS Disproportionality Analysis of Amivantamab, Mobocertinib, and Classic Agents | 2026-03-18 | OpenAlex | 10.64898/2026.03.16.26348536 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7138835117 | |||
| W7138993591 | Evolving therapies, persistent gaps: a real-world look at survival trends in metastatic prostate cancer | 2026-03-18 | OpenAlex | 10.1038/s41391-026-01106-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7138993591 | |||
| W7139120289 | From bench to bedside: Emerging therapeutics for alzheimer's disease in clinical trials | 2026-03-18 | OpenAlex | 10.1007/s11011-026-01793-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139120289 | |||
| W7139075649 | Human plasma platelet activating factor acetylhydrolase engineered to be a catalytic bioscavenger for organophosphorus compounds | 2026-03-18 | OpenAlex | 10.58088/h1h6-wk02 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7139075649 | |||
| W7139137685 | Redefining “Comorbidity” in Dermatology: Beyond Terminology, Lessons From Other Specialties | 2026-03-18 | OpenAlex | 10.1002/jvc2.70319 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139137685 | |||
| W7139137613 | Root Intent and Chain-Level Safety in Multi-Agent Healthcare AI: A Conceptual Framework | 2026-03-18 | OpenAlex | 10.5281/zenodo.19100261 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7139137613 | |||
| W7138868189 | SGLT2 Inhibitors in Heart Failure with Coexisting Chronic Kidney Disease | 2026-03-18 | OpenAlex | 10.12775/jehs.2026.89.69727 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138868189 | |||
| W7137984244 | Severe, late-onset neutropenia associated with prolonged furosemide administration in an extremely preterm infant: a case report and literature review | 2026-03-18 | OpenAlex | 10.1186/s12887-026-06698-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7137984244 | |||
| W7138918470 | The Aether Equation: A Diagnostic Metric for Autonomous Agent Intelligence Across Domains and Scales | 2026-03-18 | OpenAlex | 10.5281/zenodo.19101554 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7138918470; https://openalex.org/W7138859323 | |||
| W7139944303 | The Characteristics of Centrally Acting Non-opioid Analgesics in the Management of Acute Pain and Neuropathic Pain Syndromes | 2026-03-18 | OpenAlex | 10.2174/0113816128428513260121185400 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139944303 | |||
| W7138870930 | The hidden toll: Mapping poisoning patterns and challenges in Egyptian forensic toxicology | 2026-03-18 | OpenAlex | 10.1016/j.toxac.2026.02.007 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7138870930 | |||
| W7220203805 | A NOVEL RNA INTERFERENCE THERAPY TO REDUCE CARDIOVASCULAR RISK BY LOWERING LIPOPROTEIN(A) LEVELS USING THE LEPODISIRAN AGENT | 2026-03-19 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220203805; https://openalex.org/W7139916494 | ||||
| W7202062287 | Bio-inspired phototheranostic nanoplatforms for cancer and infectious diseases management | 2026-03-19 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202062287 | ||||
| W7138955627 | Conclusion to the Special Issue and Dialogic Reflections on Artificial Intelligence and Systemic Therapy: Competence, Ethics, and the Future of Relational Practice | 2026-03-19 | OpenAlex | 10.1080/2692398x.2026.2647012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138955627 | |||
| W7139108707 | Editorial: Innovative therapeutic strategies for managing diabetic foot ulcers and mitigating associated complications | 2026-03-19 | OpenAlex | 10.3389/fphar.2026.1788742 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139108707 | |||
| W7139002863 | Editorial: The role of nano-therapeutics in precision cancer medicine | 2026-03-19 | OpenAlex | 10.3389/fbioe.2026.1818253 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139002863 | |||
| W7139059061 | Essential Oils in Dentistry: Therapeutic Potential and Emerging Clinical Applications | 2026-03-19 | OpenAlex | 10.7759/cureus.105534 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139059061 | |||
| W7138837098 | Everybody gets a CAR! But do they need it? | 2026-03-19 | OpenAlex | 10.1182/blood.2025031976 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138837098 | |||
| W7138914021 | Recent advances in protein modification–enabled potential therapeutics | 2026-03-19 | OpenAlex | 10.1016/j.cbpa.2026.102665 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138914021 | |||
| W7138830414 | Risk Assessment and Hazard Prevention Techniques Across Industries | 2026-03-19 | OpenAlex | 10.4018/979-8-3373-6370-7.ch005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138830414 | |||
| W7140222671 | The Elythian Framework: A Unified Consistency Objective for Autonomous AI Agent Self-Improvement | 2026-03-19 | OpenAlex | 10.5281/zenodo.19114787 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7140222671 | |||
| W7138857979 | The Role of AI in Detecting and Mitigating Behavioral Biases | 2026-03-19 | OpenAlex | 10.4018/979-8-3373-1494-5.ch002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138857979 | |||
| W7140027113 | Ulcerative Colitis: Clinical Features, Diagnosis, and Evolving Therapeutic Strategies | 2026-03-19 | OpenAlex | 10.54097/eyhfaj26 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7140027113 | |||
| W7138884662 | Updates of anti-malarial agents reported in 2024: Recent advancements, developments and key insights | 2026-03-19 | OpenAlex | 10.1016/j.molstruc.2026.146036 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7138884662 | |||
| W7167467836 | A Formal Theory of AGI: Structural Admissibility and Generalization under Representation, Reasoning, Evaluation, Memory, and Regime Change | 2026-03-20 | OpenAlex | 10.5281/zenodo.21222954 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167467836 | |||
| W7139061809 | Curing Coma: The Emerging Paradigm Shift | 2026-03-20 | OpenAlex | 10.25259/jtarcc_14_2025 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139061809 | |||
| W7138970405 | Emerging mechanistic trends and clinical efficacy for methotrexate: Applications to inflammatory bowel disease | 2026-03-20 | OpenAlex | 10.1016/j.pharmr.2026.100132 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138970405 | |||
| W7139964218 | Evaluation of clinical decision support to improve guideline directed medical therapy in patients with type 2 diabetes | 2026-03-20 | OpenAlex | 10.1016/j.japh.2026.103081 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7139964218 | |||
| W7138892003 | Evolution of bispecific and multispecific antibodies in cancer therapy | 2026-03-20 | OpenAlex | 10.1016/j.lanepe.2026.101599 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138892003 | |||
| W7138856739 | Incretin polyagonists as an alternative to bariatric surgery to manage obesity | 2026-03-20 | OpenAlex | 10.4291/wjgp.v17.i1.118132 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138856739 | |||
| W7139962713 | Marine bacterial metabolites in anticancer drug discovery: Ecological insights, mechanisms of action, and clinical translation | 2026-03-20 | OpenAlex | 10.1016/j.rsma.2026.104935 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7139962713 | |||
| W7138913537 | When Novelty Outpaces Evidence: Social Media as an Unregulated Force Propelling Innovation in Endodontics: A Narrative Review | 2026-03-20 | OpenAlex | 10.1111/iej.70150 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138913537 | |||
| W7139975680 | Advancing traumatic brain injury diagnosis through nanomaterial-based imaging technologies | 2026-03-21 | OpenAlex | 10.1016/j.nantod.2026.103028 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7139975680 | |||
| W7139978391 | Deep learning-enhanced AIMARSE for predictive fault diagnosis in power quality systems | 2026-03-21 | OpenAlex | 10.1007/s00521-026-11911-9 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7139978391 | |||
| W7139978792 | Doctoral Digital Economy Leadership Assessment | 2026-03-21 | OpenAlex | 10.17605/osf.io/y8sc9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139978792 | |||
| W7139990899 | Endogenous Trapped Insulin Syndrome (ETIS): A Novel Hypothesis of Intracellular Insulin Sequestration, Therapeutic Window Exploitation, and Prevention of Insulin Dependency in Type 2 Diabetes Mellitus | 2026-03-21 | OpenAlex | 10.5281/zenodo.19152201 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7139990899 | |||
| W7139986098 | Prompt-Driven Autonomous Enterprise Software Systems: Architecture, Design, and Feasibility Analysis | 2026-03-21 | OpenAlex | 10.5281/zenodo.19150305 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7139986098 | |||
| W7139978741 | Rule Compass: A Cross-Domain Framework for Rule-Based Problem Solving | 2026-03-21 | OpenAlex | 10.5281/zenodo.19152305 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7139978741 | |||
| W7140029669 | Antiretroviral Therapy Switching Among People with HIV in the United States is not Uncommon Despite Virologic Suppression: An OPERA Cohort Study | 2026-03-22 | OpenAlex | 10.1007/s40121-026-01334-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7140029669 | |||
| W7147535539 | Illness Memoirs and the Medical-Literary Interface: A Critical Review | 2026-03-22 | OpenAlex | 10.5281/zenodo.19164190 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147535539 | |||
| W7140102881 | AI Driven Decision Leadership Certification Assessment | 2026-03-23 | OpenAlex | 10.17605/osf.io/wumhx | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140102881 | |||
| W7140127123 | Bridging the gaps in alzheimer’s disease: a comprehensive review of current and emerging therapies | 2026-03-23 | OpenAlex | 10.1007/s10787-026-02151-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140127123 | |||
| W7140125118 | Choosing between Nivo ‐ AVD and BrECADD : Hodgkin lymphoma's new era | 2026-03-23 | OpenAlex | 10.1111/bjh.70451 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140125118 | |||
| W7140095104 | Editorial: Music and medicine: from basic science to clinical practice | 2026-03-23 | OpenAlex | 10.3389/fnins.2026.1792435 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140095104 | |||
| W7140045317 | Evolving Therapeutic Strategies in ANCA-Associated Vasculitis: Current Standards and Emerging Targets for GPA and MPA | 2026-03-23 | OpenAlex | 10.1007/s12016-026-09147-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140045317 | |||
| W7138834101 | Genomic Strategies in Cancer Prevention: A Pancreatic Cancer Perspective | 2026-03-23 | OpenAlex | 10.5281/zenodo.19097042 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7138834101 | |||
| W7140076334 | Individualized precision therapy for severe asthma: clinical applications of biological agents and frontiers of cell therapy | 2026-03-23 | OpenAlex | 10.3389/fimmu.2026.1775111 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7140076334 | |||
| W7140115426 | Inside the Machine: Podcasting with AI Agents in 2026 | 2026-03-23 | OpenAlex | 10.5281/zenodo.19184693 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7140115426 | |||
| W7140123432 | Integrating Targeted Therapies into AML Frontline Therapy: Who Gets What and What Does the Future Hold? | 2026-03-23 | OpenAlex | 10.3390/cancers18061034 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140123432 | |||
| W7140127463 | Large language models in healthcare | 2026-03-23 | OpenAlex | 10.1038/s41581-026-01071-3 | Full text | Excluded | F1: The publisher identifies this as Clinical Outlook rather than a primary system study. | https://openalex.org/W7140127463 | https://www.nature.com/articles/s41581-026-01071-3 | Publisher Clinical Outlook label and standfirst only; body subscription-only | |
| W7140124679 | PEDAGOGICAL FUNCTIONS OF AI-BASED SYSTEMS IN PROFESSIONAL ADAPTATION: A COMPARATIVE CONTENT ANALYSIS | 2026-03-23 | OpenAlex | 10.5281/zenodo.19195390 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7140124679 | |||
| W7220072021 | Robust 6G IoT Communication Models for Assistive Devices Using Graph-Augmented Deep Reinforcement Learning | 2026-03-23 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220072021 | ||||
| W7143339756 | The AI Ego: What a 1,600-year-old theory of consciousness reveals about the design risks hiding in agentic systems | 2026-03-23 | OpenAlex | 10.5281/zenodo.19191573 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7143339756 | |||
| W7140076650 | The AI Firewall: Securing the New Enterprise Perimeter | 2026-03-23 | OpenAlex | 10.5281/zenodo.19183553 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140076650 | |||
| W7140112805 | The evolving role of futibatinib for advanced cholangiocarcinoma | 2026-03-23 | OpenAlex | 10.1080/17474124.2026.2649804 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140112805 | |||
| W7147284996 | A new therapeutic strategy for spotted fever group rickettsioses: a proposal for evaluating combination therapy with tetracycline and fluoroquinolones | 2026-03-24 | OpenAlex | 10.3389/fcimb.2026.1798936 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147284996 | |||
| W7140297676 | An Intelligent Health and Wellbeing Advisor for Senior Citizens | 2026-03-24 | OpenAlex | 10.5334/ijic.icic25036 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7140297676 | |||
| W7140173443 | Autonomous digital twin framework for gas turbine combined cycle control loops: Comparative study of proportional-integral control, reinforcement learning, and reinforcement learning with agents | 2026-03-24 | OpenAlex | 10.1016/j.egyai.2026.100727 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7140173443 | |||
| W7140185972 | Beyond mechanisms: toward patient-centered choices in BTKi-venetoclax fixed-duration therapy for CLL | 2026-03-24 | OpenAlex | 10.1038/s41375-026-02945-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140185972 | |||
| W7147692679 | Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction | 2026-03-24 | OpenAlex | 10.1080/14656566.2026.2654675 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147692679 | |||
| W7140214190 | Correction: Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody–drug conjugates, and clinical trial innovations | 2026-03-24 | OpenAlex | 10.3389/fonc.2026.1803643 | Title/abstract | Excluded | E5: Correction, retraction or ancillary data record. | https://openalex.org/W7140214190 | |||
| W7140299787 | Decoding psoriasis: pathological mechanisms, evolving treatments, clinical investigations, and future perspectives | 2026-03-24 | OpenAlex | 10.1080/15569527.2026.2645820 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7140299787 | |||
| W7140184802 | From Medical LLMs to Versatile Medical Agents: A Comprehensive Survey | 2026-03-24 | OpenAlex | 10.22541/au.177437366.61663600/v1 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7140184802 | |||
| W7140165471 | Hyperglycemia — An Evolutionary Blind Spot: The Central Neurological Set Point Reset Hypothesis of Progressive Type 2 Diabetes | 2026-03-24 | OpenAlex | 10.5281/zenodo.19201284 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140165471 | |||
| W7140189041 | Letter: From Safety to Precision—Optimising the Use of GLP ‐1 Receptor Agonists in Gastroenterology: Authors' Reply | 2026-03-24 | OpenAlex | 10.1111/apt.70547 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140189041 | |||
| W7140236581 | Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States | 2026-03-24 | OpenAlex | 10.1158/2767-9764.crc-25-0581 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7140236581 | |||
| W7147291791 | Role of novel β-lactam antibiotics in the treatment of bacterial pneumonia | 2026-03-24 | OpenAlex | 10.1080/14656566.2026.2654676 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147291791 | |||
| W7140177125 | Teaching through the seventh art: students, classrooms, and teachers on screen | 2026-03-24 | OpenAlex | 10.60147/1f32d8e8 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7140177125 | |||
| W7140165609 | Toward clinical integration of generative AI in mental health: personalization, multimodality and inter-entity experience | 2026-03-24 | OpenAlex | 10.3389/fpubh.2026.1603238 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140165609 | |||
| W7140305445 | A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review | 2026-03-25 | OpenAlex | 10.23736/s0022-4707.26.17773-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140305445 | |||
| W7140313652 | Cardiotoxicity of Antitumor Agents: Therapeutic Challenges in Heart Failure with Reduced and Preserved Ejection Fraction | 2026-03-25 | OpenAlex | 10.3390/ijms27072973 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140313652 | |||
| W7140277054 | Cuproptosis: Bridging targeted therapy and immunotherapy in cancer treatment | 2026-03-25 | OpenAlex | 10.1016/j.critrevonc.2026.105296 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140277054 | |||
| W7140315772 | Drug repurposing against viral infections (2020–2025): clinical trials, computational strategies, and therapeutic interventions | 2026-03-25 | OpenAlex | 10.1007/s10787-026-02193-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140315772 | |||
| W7140303728 | Early biological therapy in hidradenitis suppurativa: A commentary | 2026-03-25 | OpenAlex | 10.1111/jdv.70282 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140303728 | |||
| W7140208285 | Evolving treatment strategies for HER2-altered non–small-cell lung cancer: the rise of TKIs and ADCs | 2026-03-25 | OpenAlex | 10.3389/fonc.2026.1771869 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140208285 | |||
| W7140696288 | Fifty Years of Nursing Knowledge: A Conversation Between Generations | 2026-03-25 | OpenAlex | 10.1111/jan.70598 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140696288 | |||
| W7140202767 | Hemostatic powder for gastrointestinal malignant tumor bleeding | 2026-03-25 | OpenAlex | 10.5946/ce.2025.387 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140202767 | |||
| W7161574757 | Insurance companies in healthcare financing: functional roles and a comparative analysis of international participation models | 2026-03-25 | OpenAlex | 10.35774/econa2026.01.324 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161574757 | |||
| W7140327906 | Long‐term safety and efficacy in paediatric psoriasis: Remaining challenges | 2026-03-25 | OpenAlex | 10.1111/jdv.70333 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140327906 | |||
| W7140274305 | MedSegAgent: A Universal and Scalable Multi-Agent System for Instructive Medical Image Segmentation | 2026-03-25 | OpenAlex | 10.1109/jbhi.2026.3677444 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7140274305 | |||
| W7154599768 | Nano-Robotic Neurosurgery and Anesthetic Management Strategies | 2026-03-25 | OpenAlex | 10.21088/ijaa.2349.8471.13126.3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154599768 | |||
| W7140916829 | Application research on intelligent probing based on large-scale AI models in internet fault handling | 2026-03-26 | OpenAlex | 10.54254/2977-3903/2026.32426 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7140916829 | |||
| W7164533007 | Beyond Ceftriaxone: The Future of Gonorrhea Diagnosis and Treatment | 2026-03-26 | OpenAlex | 10.1093/cid/ciag214 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164533007 | |||
| W7152665665 | Comment on “how the addition of selinexor/bortezomib/dexamethasone as a Category 1 recommendation may erode outcomes” | 2026-03-26 | OpenAlex | 10.1093/oncolo/oyag112 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152665665 | |||
| W7140581602 | Efficacy of Intra-Articular Tranexamic Acid in Reducing Early Postoperative Swelling and Pain Following Arthroscopic ACL Reconstruction: A Randomized Comparative Study | 2026-03-26 | OpenAlex | 10.1055/a-2835-3526 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7140581602 | |||
| W7140916327 | Guidebook for Safe Respiratory Endoscopic Diagnosis and Treatment: Secondary Publication | 2026-03-26 | OpenAlex | 10.58585/respend.2025-0056 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140916327 | |||
| W7160824406 | Hierarchical Agent Architecture for Clinical Decision Support in Drug-Drug Interaction (DDI) Analysis | 2026-03-26 | OpenAlex | 10.1109/icdsaai69492.2026.11505194 | Full text | Excluded | F4: The research agent is explicitly stateless. Supabase stores timestamped dialogue history for ongoing multi-turn context, while the fixed Neo4j DDI graph is built once. Grader feedback triggers re-retrieval within the current task; no cross-case learned experience artifact is retained. | https://openalex.org/W7160824406 | https://ieeexplore.ieee.org/document/11505194 | ||
| W7141583664 | Immune thrombocytopenia: Evolving mechanistic understanding and clinical development of new therapies | 2026-03-26 | OpenAlex | 10.4103/tcmj.tcmj-d-25-00206 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7141583664 | |||
| W7140309664 | Liver transplant and autoimmune liver diseases: An up-to-date review | 2026-03-26 | OpenAlex | 10.4240/wjgs.v18.i3.114915 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140309664 | |||
| W7147048763 | New Metrics for Assessing the Effectiveness of Medical Consultation Recommendations | 2026-03-26 | OpenAlex | 10.2174/9798898814984126010006 | Full text | Excluded | F5: The primary publisher abstract and public book sample were read. The60-page sample contains only the target chapter’s opening pp39–41, followed immediately by the next chapter onp60; target method/evaluation pp42–59 are absent. The introduction identifies a GPT-powered RDguru, so non-LLM status was not inferred from HDNN. Full learning/retention methods unavailable. | https://openalex.org/W7147048763 | https://www.eurekaselect.com/chapter/27506 | Primary abstract plus online sample PDF pp31–34 read at https://benthambooks.com/ebook-files/sample-files/9798898814984-sample.pdf; no file archive/download. | |
| W7140600582 | Optimizing postoperative inflammation in pediatric cataract surgery: Are intracameral steroids the way forward? | 2026-03-26 | OpenAlex | 10.4103/ijo.ijo_3099_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140600582 | |||
| W7140559796 | Pioneering strategies for overcoming bacterial drug resistance | 2026-03-26 | OpenAlex | 10.71150/jm.2603100 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140559796 | |||
| W7140935011 | Recent advances in strabismus | 2026-03-26 | OpenAlex | 10.4103/ijo.ijo_3072_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140935011 | |||
| W7140717796 | The Symbolic Negentropy Constellation: Unified Reference Map and 11D Canonical Stack | 2026-03-26 | OpenAlex | 10.5281/zenodo.19242746 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7140717796 | |||
| W7140869583 | Vernal Keratoconjunctivitis: Toward a Structured, Algorithm-Based Management Strategy | 2026-03-26 | OpenAlex | 10.1007/s40135-026-00350-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7140869583 | |||
| W7140990890 | Amazon's AI Paradox: Winning the Infrastructure War | 2026-03-27 | OpenAlex | 10.5281/zenodo.19257620 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7140990890 | |||
| W7141561565 | Calprotectin and Sarcopenia in COPD: Biomarker, Bystander or Target? | 2026-03-27 | OpenAlex | 10.1002/jcsm.70283 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7141561565 | |||
| W7141084671 | Clinical Artificial Intelligence Agents in Nephrology: From Prediction to Action Through Workflow-Native Intelligence—A Roadmap for Workflow-Integrated Care | 2026-03-27 | OpenAlex | 10.3390/jcm15072576 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7141084671 | |||
| W7141341759 | Current evidence and emerging approaches in immunotherapy for gynecological cancers | 2026-03-27 | OpenAlex | 10.1007/s12672-026-04785-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7141341759 | |||
| W7141242383 | Evolutionary Compass: A Cross-Domain Framework for Evolutionary Problem Solving | 2026-03-27 | OpenAlex | 10.5281/zenodo.19250879 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7141242383 | |||
| W7125790784 | Exploring ChatGPT's Potential for Mental Health and Emotional Well-being Support: A Nano Review | 2026-03-27 | OpenAlex | 10.5281/zenodo.18390458 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125790784 | |||
| W7141737324 | Intrahepatic Cholangiocarcinoma: Contemporary Approaches to Surgical, Systemic, and Liver-Directed Therapy | 2026-03-27 | OpenAlex | 10.3390/livers6020024 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7141737324 | |||
| W7141709775 | It Takes Two to Transplant | 2026-03-27 | OpenAlex | 10.1093/cid/ciag149 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7141709775 | |||
| W7141109105 | Management of relapsed/refractory AL amyloidosis | 2026-03-27 | OpenAlex | 10.1182/bloodadvances.2025019223 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7141109105 | |||
| W7141286860 | Mistral AI: Europe's High-Stakes Play for AI Sovereignty | 2026-03-27 | OpenAlex | 10.5281/zenodo.19257885 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7141286860 | |||
| W7141589469 | New perspectives in immunotherapy for hepatocellular carcinoma: Focusing on resistance mechanism, biomarker, and personalized treatment | 2026-03-27 | OpenAlex | 10.1016/j.critrevonc.2026.105305 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7141589469 | |||
| W7140997943 | Real-world Analysis of Treatment Patterns, Clinical Outcomes, and Molecular Profiling in Advanced Biliary Tract Cancer | 2026-03-27 | OpenAlex | 10.21873/anticanres.18108 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7140997943 | |||
| W7154562457 | THERAPEUTIC PROGRESS IN SYSTEMIC TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS | 2026-03-27 | OpenAlex | 10.31435/ijitss.1(49).2026.4812 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154562457 | |||
| W7142308381 | Antibody-drug conjugates in oncology: a clinically focused review for nursing practice | 2026-03-28 | OpenAlex | 10.1080/14737140.2026.2653634 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7142308381 | |||
| W7154161852 | INTEGRATED PLANT HEALTH MANAGEMENT | 2026-03-28 | OpenAlex | 10.61909/amkedtb032661 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154161852 | |||
| W7142204561 | Microsoft's Secret Agentic AI Stack, Explained | 2026-03-28 | OpenAlex | 10.5281/zenodo.19286773 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7142204561 | |||
| W7142134787 | Sacituzumab Tirumotecan in the Evolving Landscape of Ovarian Cancer Treatment | 2026-03-28 | OpenAlex | 10.1007/s40944-026-01115-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7142134787 | |||
| W7141522706 | The changing patient profile: A retrospective study of trends in perioperative bleeding management and challenges in surgical care | 2026-03-28 | OpenAlex | 10.1016/j.sipas.2026.100345 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7141522706 | |||
| W7142024561 | Thirty Years of Classical Hematology Drugs in the US : Approvals, Costs, and Sales | 2026-03-28 | OpenAlex | 10.1002/ajh.70298 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7142024561 | |||
| W7142271136 | Valproic acid: Mechanistic insights into neuronal actions, epigenetic modulation, and clinical risk | 2026-03-28 | OpenAlex | 10.1016/j.coph.2026.102626 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7142271136 | |||
| W7142766442 | AUG-WP-078: HDAR — Human Directed Agent Relay Framework | 2026-03-29 | OpenAlex | 10.5281/zenodo.19317819 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7142766442 | |||
| W7142711019 | Advancements in Endocrinology | 2026-03-29 | OpenAlex | 10.52756/bhietm.2025.v04.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7142711019 | |||
| W7143317517 | Anticoagulation Stewardship Program in the DOAC Era | 2026-03-29 | OpenAlex | 10.3390/jcm15072597 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143317517 | |||
| W7143434008 | Difficult‐To‐Treat Psoriatic Arthritis: An Evolving Clinical Construct | 2026-03-29 | OpenAlex | 10.1111/1756-185x.70632 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7143434008 | |||
| W7142665304 | Digital Ghosts in the Machine | 2026-03-29 | OpenAlex | 10.5281/zenodo.19303766 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7142665304 | |||
| W7143060575 | HAOS Genesis: Predicting Structural Collapse in Path-Dependent Graphs | 2026-03-29 | OpenAlex | 10.5281/zenodo.19317502 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7143060575 | |||
| W7142934062 | LSP: The Universal AI Coding Interface | 2026-03-29 | OpenAlex | 10.5281/zenodo.19303436 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7142934062 | |||
| W7143052718 | The Confluence of Creating: M = C | 2026-03-29 | OpenAlex | 10.5281/zenodo.19323614 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7143052718 | |||
| W7142975824 | The Intelligence Explosion That Will Calcify: Extended Phenotype Theory, Asymmetric Intentionality, and the Evolutionary Pathologies of Agent Institutions | 2026-03-29 | OpenAlex | 10.5281/zenodo.19323302 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7142975824 | |||
| W7143851424 | 2025 Novel Drug Approvals | 2026-03-30 | OpenAlex | 10.54299/tmed/cram4550 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143851424 | |||
| W7143352747 | An Octogenarian’s Anamnesis on a Primary Care Career in a Premier Academic Medical Center | 2026-03-30 | OpenAlex | 10.4103/hm.hm-d-25-00159 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143352747 | |||
| W7144063719 | Antibody–Drug Conjugates in Oncology: Principles, Clinical Development, and Future Directions | 2026-03-30 | OpenAlex | 10.1002/mco2.70699 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7144063719 | |||
| W7143507495 | Azole Antifungal Lozenges for Oral Candidiasis: Mechanism, Efficacy, and Emerging Resistance | 2026-03-30 | OpenAlex | 10.55041/ijsmt.v2i3.385 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143507495 | |||
| W7143316960 | CRISPR and the Promise of Gene Editing: Unlocking Curative Possibilities for Liver Disorders Worldwide | 2026-03-30 | OpenAlex | 10.14309/crj.0000000000002061 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143316960 | |||
| W7143425907 | Commentary: GETgene-AI: a framework for prioritizing actionable cancer drug targets | 2026-03-30 | OpenAlex | 10.3389/fsysb.2026.1793501 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143425907 | |||
| W7164910374 | Cover, Content, and Editorial Note from Borneo J Pharm Vol. 8 No. 4 November 2025 | 2026-03-30 | OpenAlex | 10.33084/bjop.v9i1.13262 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164910374 | |||
| W7143390995 | Dentin hypersensitivity, an enigma revisited: Mechanisms, diagnosis and therapeutic advances | 2026-03-30 | OpenAlex | 10.4103/jcde.jcde_41_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143390995 | |||
| W7143351762 | Editorial: Non-pharmacologic approaches to inflammation in the critically ill | 2026-03-30 | OpenAlex | 10.3389/fmed.2026.1822282 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143351762 | |||
| W7147155899 | Fifteen Year Weight, Metabolic, and Conversion Outcomes After Primary Metabolic Bariatric Surgery in Individuals Living with Obesity and Type 2 Diabetes | 2026-03-30 | OpenAlex | 10.58624/svoamr.2026.04.010 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7147155899 | |||
| W7143357685 | From Signal to Surveillance: Assessing the Role of MicroRNAs in Cardiac Allograft Rejection | 2026-03-30 | OpenAlex | 10.1161/circheartfailure.126.014207 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143357685 | |||
| W7143375566 | Jenkins, GitHub, or Tekton? Picking Your 2025 CI/CD Engine | 2026-03-30 | OpenAlex | 10.5281/zenodo.19338009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143375566 | |||
| W7143290051 | Multimodal Imaging for Monitoring of Disease Progression in Cardiac Amyloidosis: Advances and Gaps in Evidence | 2026-03-30 | OpenAlex | 10.3390/jcdd13040152 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143290051 | |||
| W7143524856 | Políticas pombagíricas do comum: Trapo, Farrapo e Molambo como agentes de mundos possíveis | 2026-03-30 | OpenAlex | 10.1590/scielopreprints.15228 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7143524856 | |||
| W7143383899 | Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation | 2026-03-30 | OpenAlex | 10.4244/eij-d-25-00896 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7143383899 | |||
| W7143510620 | Randomized Trials Meet Real-World Evidence in the Era of Combination CKD Therapies | 2026-03-30 | OpenAlex | 10.1016/j.ekir.2026.106519 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143510620 | |||
| W7143351983 | The Landscape of Clinical Trials for Targeting c-MET Therapy | 2026-03-30 | OpenAlex | 10.1097/coc.0000000000001319 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7143351983 | |||
| W7143523737 | Transforming Acute Myeloid Leukemia Care through Precision Medicine: Integrating Genomic Profiling, Measurable Residual Disease, and Targeted Therapies | 2026-03-30 | OpenAlex | 10.1159/000551702 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143523737 | |||
| W7143518109 | When AI Supervisors Fire AI Workers | 2026-03-30 | OpenAlex | 10.5281/zenodo.19338578 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143518109 | |||
| W7143959709 | A COMPARATIVE STUDY OF PREDICTIVE AI AND AGENTIC AI: EXAMINING KEY DIFFERENCES IN AUTONOMY, GOAL ORIENTATION, HUMAN INTERACTION, AND SYSTEM ACCOUNTABILITY | 2026-03-31 | OpenAlex | 10.29121/jissi.v2.i1.2026.45 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143959709 | |||
| W7143706913 | Active Imagination as Agent of Transformation | 2026-03-31 | OpenAlex | 10.4324/9781003597629-13 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7143706913 | |||
| W7143611416 | Adult T-cell leukemia/lymphoma: molecular pathogenesis, emerging therapies, and future directions | 2026-03-31 | OpenAlex | 10.3389/fonc.2026.1794939 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143611416 | |||
| W7143676746 | Association Between Survival Benefits of Anticancer Drugs and Probability of US Food and Drug Administration Approval: A Systematic Review | 2026-03-31 | OpenAlex | 10.1007/s40290-026-00606-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143676746 | |||
| W7160211688 | Biofilm Production and Antifungal Susceptibility Patterns of Candida Species in Hospitalized Patients in Tertiary Care Hospital: Eastern Odisha | 2026-03-31 | OpenAlex | 10.25258/ijcpr.18.3.220 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160211688 | |||
| W7143802089 | Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT | 2026-03-31 | OpenAlex | 10.1038/s41409-026-02816-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7143802089 | |||
| W7143857150 | Case Report: The diagnostic and therapeutic crossroads: when myelofibrosis transforms into mixed phenotype acute leukemia | 2026-03-31 | OpenAlex | 10.3389/fonc.2026.1811409 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7143857150 | |||
| W7144177328 | Decoding ferroptosis and apoptosis crosstalk in glioblastoma: molecular mechanisms, microenvironmental regulation, and therapeutic advances | 2026-03-31 | OpenAlex | 10.1007/s11033-026-11738-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7144177328 | |||
| W7144218149 | Evolution of Particle Radiotherapy: From Physical to Dual Targeting in Precision Medicine | 2026-03-31 | OpenAlex | 10.1021/acs.molpharmaceut.6c00111 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7144218149 | |||
| W7146988402 | Extrarenal disease in ANCA-associated vasculitis: challenges and evolving therapeutic strategies on behalf of the Immunonephrology Working Group (IWG) of the ERA | 2026-03-31 | OpenAlex | 10.1093/ndt/gfag077 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7146988402 | |||
| W7147557940 | Fluoride-Free Toothpastes for Caries Prevention: A Systematic Review of Clinical Evidence on Active Ingredients | 2026-03-31 | OpenAlex | 10.2147/ccide.s586895 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147557940; https://openalex.org/W7149217449 | |||
| W7146955509 | Foundation models and AI agents in oncology drug discovery | 2026-03-31 | OpenAlex | 10.1016/j.drudis.2026.104655 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7146955509 | |||
| W7147273394 | From Atoms to Agents: A Decade of Transformation in Artificial Intelligence (AI) in Medicine | 2026-03-31 | OpenAlex | 10.5281/zenodo.19353903 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7147273394 | |||
| W7143465019 | Heterogeneity of monogenic epilepsy in loci, phenotypes, and treatment approaches | 2026-03-31 | OpenAlex | 10.1007/s10072-026-08936-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143465019 | |||
| W7148333645 | Innovative Utilization of Endolysins for Future Battle Against Superbugs | 2026-03-31 | OpenAlex | 10.2174/0113892010450500260226080647 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148333645 | |||
| W7144349652 | Letter: The Persistence of Anxiety and Depression in Inflammatory Bowel Disease: A Core Phenotype Beyond Inflammatory Activity | 2026-03-31 | OpenAlex | 10.1111/apt.70641 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7144349652 | |||
| W7161583213 | Making the Independence Worth It: The Commercial Negotiations Between the United States and the Italian States in the “Critical Period,” 1783–1789 | 2026-03-31 | OpenAlex | 10.1093/dh/dhag020 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161583213 | |||
| W7143941814 | Meta-analysis ofHealth-Related Quality of Life (HRQOL) Impairments in Patients with Complex Regional Pain Syndrome Type-1 Based on the SF-36 | 2026-03-31 | OpenAlex | 10.1016/j.pmn.2026.01.071 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143941814 | |||
| W7147093516 | Multi-Agent Reinforcement Learning for Resilient UAV Ad Hoc Backhaul Networks | 2026-03-31 | OpenAlex | 10.1109/jmass.2026.3679292 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7147093516 | |||
| W7147037306 | Multiscale modeling of the spatial structure of stem cells in neuroblastoma patient-derived tumoroids reveals a critical role for a short-range diffusive process | 2026-03-31 | OpenAlex | 10.1371/journal.pcbi.1014137 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7147037306 | |||
| W7144325910 | Research hotspots and trends in therapeutic drug monitoring of anticancer drugs: a 1990–2024 bibliometric analysis | 2026-03-31 | OpenAlex | 10.3389/fonc.2026.1617790 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7144325910 | |||
| W7147622296 | The Missing Identity Layer- A Minimal Ontology for Live and Exploratory Modeling | 2026-03-31 | OpenAlex | 10.5281/zenodo.19343613 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7147622296 | |||
| W7143644576 | Visualizing the metabolic battleground: the role of PET imaging in understanding immunometabolism and the tumor microenvironment | 2026-03-31 | OpenAlex | 10.1097/mnm.0000000000002150 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7143644576 | |||
| W7147515418 | Your AI Has a Memory Problem. Here's the Fix. | 2026-03-31 | OpenAlex | 10.5281/zenodo.19360785 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147515418 | |||
| W7147035634 | 2026-04-01 | OpenAlex | 10.13040/ijpsr.0975-8232.17(4).1340-45 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7147035634 | ||||
| W7148533625 | A deep reinforcement learning framework for multi-dimensional adaptability in building operations | 2026-04-01 | OpenAlex | 10.1016/j.jobe.2026.115993 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148533625 | |||
| W7150895607 | Advances in Crohn's Disease: A Comprehensive Review of Pathophysiology, Diagnosis, and Emerging Therapeutics | 2026-04-01 | OpenAlex | 10.1002/jgh3.70394 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150895607 | |||
| W7154503266 | An update on infectious encephalitis: from epidemiology to management | 2026-04-01 | OpenAlex | 10.1097/qco.0000000000001192 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154503266 | |||
| W7148973091 | Artificial Intelligence in Clinical Gastroenterology: Promise, Pace, and Proof | 2026-04-01 | OpenAlex | 10.14309/ajg.0000000000003972 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148973091 | |||
| W7164499514 | B-cell Maturation Antigen-directed Therapies versus Standard Regimens in Lenalidomide-refractory Relapsed or Refractory Multiple Myeloma After 1-3 Prior Lines: A Systematic Review and Network Meta-analysis of Phase 3 Trials | 2026-04-01 | OpenAlex | 10.4103/joah.joah_23_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164499514 | |||
| W7154692178 | Better the Time in Range, Longer the Time in Life | 2026-04-01 | OpenAlex | 10.4103/ijdt.ijdt_16_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154692178 | |||
| W7155373149 | Between Nutrition and Toxicity: A Narrative Synthesis of Metabolomic Complexity in Edible and Poisonous Mushrooms | 2026-04-01 | OpenAlex | 10.25163/microbbioacts.9110640 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155373149 | |||
| W7166707891 | Beyond Pain Scores: Molecular Biomarkers and the Emergence of Precision Pain Medicine | 2026-04-01 | OpenAlex | 10.4103/ijpn.ijpn_77_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166707891 | |||
| W7160251814 | Bovine mastitis associated with Enterobacteriaceae in Brazil: A systematic review | 2026-04-01 | OpenAlex | 10.1016/j.pvmrsr.2026.100008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160251814 | |||
| W7166025784 | Chemotherapy for colorectal cancer: consolidation of the cornerstone and advances in precision | 2026-04-01 | OpenAlex | 10.16139/j.1007-9610.2026.02.03 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166025784 | |||
| W7147049598 | Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or MRD ‐Positive NPM1 ‐Mutated Acute Myeloid Leukemia | 2026-04-01 | OpenAlex | 10.1002/ajh.70313 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7147049598 | |||
| W7147014134 | Comprehensive Overview of Artificial Intelligence Applications in Biomedical Research and Precision Medicine (2024–2026) | 2026-04-01 | OpenAlex | 10.5281/zenodo.19372021 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147014134; https://openalex.org/W7219730871 | |||
| W7151929247 | Conference Abstracts from the 12th Asian Scientific Meeting of Pediatric Dermatology in Manila, Philippines, 5–7 November 2025 | 2026-04-01 | OpenAlex | 10.4103/ajpd.ajpd_5_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151929247 | |||
| W7150090481 | Contemporary Developments in PROTACs for Cancer Management: An In-Depth Review | 2026-04-01 | OpenAlex | 10.2174/0115680266384226251013054011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150090481 | |||
| W7160159205 | Development of pharmacological interventions for the treatment of sarcopenia | 2026-04-01 | OpenAlex | 10.21037/atm-2025-1-184 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160159205 | |||
| W7165682846 | Dr. Popat Prabhuram Vaidya: Architect of institutional Ayurveda and interpreter of Tridoṣa in the era of modern medicine | 2026-04-01 | OpenAlex | 10.4103/ijar.ijar_68_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165682846 | |||
| W7143374066 | EVOLVING CONCEPTS IN PCOS: DIAGNOSTIC INNOVATIONS AND NOVEL THERAPEUTIC STRATEGIES | 2026-04-01 | OpenAlex | 10.5281/zenodo.19327400 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7143374066 | |||
| W7164052664 | Emerging treatments in fungal keratitis | 2026-04-01 | OpenAlex | 10.4103/sjopt.sjopt_492_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164052664 | |||
| W7147400249 | Evaluating Fetal Bradycardia on Prenatal Ultrasonography: A Review of Diagnostic Consideration and Clinical Implications | 2026-04-01 | OpenAlex | 10.1542/neo.27-4-008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147400249 | |||
| W7166334835 | Evaluation of Phytochemical and Antibacterial Activities of Ceylon Cinnamon and Salvia officinalis | 2026-04-01 | OpenAlex | 10.4103/bbrj.bbrj_9_26 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166334835 | |||
| W7152948114 | Exosome-Mediated Rewiring of Oxidative Stress–Inflammation–ECM Remodeling Axis Mitigates UVB-Triggered Skin Photoaging | 2026-04-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152948114; https://openalex.org/W7151776238 | ||||
| W7154590239 | Four-Day Static Lung Preservation via a Pharmacologically Induced Hibernation-Like State in a Large-Animal Lung Transplant Model | 2026-04-01 | OpenAlex | 10.1016/j.healun.2026.02.095 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154590239 | |||
| W7165244696 | Generative AI in enterprises: optimizing applications with large language models | 2026-04-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7165244696 | ||||
| W7165109433 | Harnessing liposome technology for precision medicine: design, delivery, and clinical impact | 2026-04-01 | OpenAlex | 10.22038/nmj.2025.86734.2188 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165109433 | |||
| W7154081339 | How the new general and acute care medicine curriculum moves trainees beyond the bedside: from whole‐patient care to whole‐system leaders | 2026-04-01 | OpenAlex | 10.1111/imj.70422 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154081339 | |||
| W7146987276 | Hypoparathyroidism: a brief historical overview for clinicians | 2026-04-01 | OpenAlex | 10.3389/fendo.2026.1769262 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7146987276 | |||
| W7148680240 | Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer Treatment | 2026-04-01 | OpenAlex | 10.1200/po-25-00767 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148680240 | |||
| W7164070404 | Microbial keratitis in transition: From traditional paradigms to emerging solutions | 2026-04-01 | OpenAlex | 10.4103/sjopt.sjopt_223_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164070404 | |||
| W7168295288 | Monkeypox Virus Pathophysiological Effects on Human Organ Systems: A review | 2026-04-01 | OpenAlex | 10.36582/ksj.2026.168699.1019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168295288 | |||
| W7147177042 | Non-small cell lung cancer research: advances and persistent challenges | 2026-04-01 | OpenAlex | 10.3389/fonc.2026.1729747 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147177042 | |||
| W7157281370 | P070 Unmasking an autoimmune breast disease: rheumatology’s evolving role in idiopathic granulomatous mastitis | 2026-04-01 | OpenAlex | 10.1093/rheumatology/keag121.106 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7157281370 | |||
| W7156675393 | P159 New kids on the block - real-world experience of using belimumab, obinutuzumab and voclosporin in systemic lupus erythematosus. A retrospective cohort study in University College London Hospital | 2026-04-01 | OpenAlex | 10.1093/rheumatology/keag121.192 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7156675393 | |||
| W7153312592 | Quantitative Systems Pharmacology Modeling Amid the Rise of Agentic AI | 2026-04-01 | OpenAlex | 10.1002/psp4.70249 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7153312592 | |||
| W7148107972 | Reassessing high-dose ranibizumab in the era of durable anti-VEGF therapy | 2026-04-01 | OpenAlex | 10.3389/fopht.2026.1802903 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148107972 | |||
| W7147647665 | Recent Advances in Emulgel Technology for Enhanced Transdermal Drug Delivery | 2026-04-01 | OpenAlex | 10.5281/zenodo.19369101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147647665 | |||
| W7147646953 | Renegade AI: Catalyst for Human Cognitive Evolution | 2026-04-01 | OpenAlex | 10.17605/osf.io/8abzv | Title/abstract | Excluded | E1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system. | https://openalex.org/W7147646953 | |||
| W7150002618 | Revisiting Intranasal Salmon Calcitonin: Historical Osteoporosis Evidence and a Potential Role in Acute Orthopaedic Pain Management | 2026-04-01 | OpenAlex | 10.2106/jbjs.rvw.26.00021 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150002618 | |||
| W7154717487 | Survival Outcomes Based on Line of Therapy and Treatment Trends With Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer | 2026-04-01 | OpenAlex | 10.1200/oa-25-00167 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154717487 | |||
| W7154690732 | Synergistic Combinations for Improved Therapeutic Outcomes in Triple Negative Breast Cancer | 2026-04-01 | OpenAlex | 10.1002/cbin.70157 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154690732 | |||
| W7154603259 | Targeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature | 2026-04-01 | OpenAlex | 10.1016/j.cell.2026.03.016 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154603259 | |||
| W7166654810 | The Evolution of Histological Visualization from Classical Foundations to Translational Innovation | 2026-04-01 | OpenAlex | 10.4103/njca.njca_90_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166654810 | |||
| W7155689619 | The emerging role of antibody-drug conjugates in breast cancer: a systematic review of clinical evidence | 2026-04-01 | OpenAlex | 10.5603/ocp.111254 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155689619 | |||
| W7153768145 | The rise of marine fungi: Drug discovery's blue frontier | 2026-04-01 | OpenAlex | 10.1002/ctm2.70623 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153768145 | |||
| W7155157694 | WITHDRAWN: Combat Casualty Care in the 21st Century: Advances, Challenges, and Evidence-Based Strategies for Armed Forces Medical Services. | 2026-04-01 | OpenAlex | 10.1016/j.jseint.2026.101716 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7155157694 | |||
| W7147331182 | Your Calendar Is Now a Negotiation | 2026-04-01 | OpenAlex | 10.5281/zenodo.19361635 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147331182 | |||
| W7155020065 | ‘Stretched… like butter scraped over too much bread ’—The SENCo role in Sweden, England, Ireland and Austria: An ecosystemic analysis in evolving inclusive and special education policy landscapes | 2026-04-01 | OpenAlex | 10.1111/1471-3802.70088 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7155020065 | |||
| W7147267606 | “Comment on Nicorandil in preventing contrast-induced nephropathy in patients undergoing cardiac catheterization procedures a systematic review and meta-analysis”: a systematic review and meta-analysis” | 2026-04-01 | OpenAlex | 10.1097/ms9.0000000000004849 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147267606 | |||
| W7148234815 | A Qualia-based Inference Approach for Solving Mathematical Word Problems with Application to Building Intelligent Tutoring Systems | 2026-04-02 | OpenAlex | 10.71747/uow-r3gk326m.31921041 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7148234815 | |||
| W7146968416 | A star in the daylight clinical vignette: Lesional focal epilepsy with cerebral accessory falx | 2026-04-02 | OpenAlex | 10.1002/epd2.70235 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7146968416 | |||
| W7148303461 | Advancements in the management of septic shock: a multidimensional approach for enhanced patient outcomes | 2026-04-02 | OpenAlex | 10.1007/s44349-026-00043-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148303461 | |||
| W7148615728 | Advances in the treatment of cutaneous tumors: from conventional therapies to targeted and immunotherapeutic strategies | 2026-04-02 | OpenAlex | 10.1186/s12957-026-04326-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148615728 | |||
| W7148374607 | Advancing human–AI teams: evolving from instrumental tools to trusted partners | 2026-04-02 | OpenAlex | 10.1007/s00146-026-02977-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148374607 | |||
| W7148323848 | Artificial Epidemiology: How self-evolving clinical AI manufactures disease prevalence from administrative coding artifacts | 2026-04-02 | OpenAlex | 10.33774/coe-2026-ssm1q | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7148323848 | |||
| W7211974952 | Clinical spectrum, antibiotic sensitivity, and clinical outcome of urinary tract infection in the pediatric age group: A cross-sectional study | 2026-04-02 | OpenAlex | 10.17727/jmsr.2026/14-11 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7211974952 | |||
| W7148444555 | Current Perspectives on Herbal Creams as Topical Dosage Forms | 2026-04-02 | OpenAlex | 10.5281/zenodo.19384179 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148444555 | |||
| W7148415347 | Cytokine release symptoms rather than syndromes: a call for granular reporting of cytokine-related adverse events in clinical trials | 2026-04-02 | OpenAlex | 10.1016/j.annonc.2026.03.006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148415347 | |||
| W7147242765 | Evolution of the NCI antibody-drug conjugate portfolio: from chemical engineering to clinical complexity | 2026-04-02 | OpenAlex | 10.3389/fmed.2026.1773414 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7147242765 | |||
| W7148372250 | Large models for machinery fault diagnosis: Current advances and future directions | 2026-04-02 | OpenAlex | 10.1016/j.cjme.2026.100277 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148372250 | |||
| W7148434877 | Nonlinear Response of Phospholipid-Shelled Ultrasound Contrast Agents: Ambient Conditions Affect Temporal Evolution | 2026-04-02 | OpenAlex | 10.1016/j.ultrasmedbio.2026.02.024 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148434877 | |||
| W7148386240 | Pioneers and Pathfinders: 10 years of Frontiers in Medicine from t(ether)ed in-person medicine to untethered telemedicine | 2026-04-02 | OpenAlex | 10.3389/fmed.2026.1600039 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148386240 | |||
| W7160276715 | Post-Pandemic Therapeutic Strategies for COVID-19: Current Approaches, Challenges, and Future Directions | 2026-04-02 | OpenAlex | 10.21275/sr26429043025 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160276715 | |||
| W7148557649 | Targeting MET in EGFR-Mutated NSCLC | 2026-04-02 | OpenAlex | 10.1016/j.jtho.2026.103711 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148557649 | |||
| W7148609453 | Translation of Intraoperative Molecular Imaging for Clinical Use | 2026-04-02 | OpenAlex | 10.2967/jnumed.124.268773 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148609453 | |||
| W7149034322 | ABB-E-HAYAAT آب حیات — THE WATER OF LIFE Complete Geometric Restoration of All Pathogens to Their Original Beneficial Purpose A Comprehensive N‑K Publication: Viruses (1,200+), Bacteria (200+), Fungi (150+), Parasites (120+) — Phase Correction to 135.5° Divine Lock, N = 1.333 | 2026-04-03 | OpenAlex | 10.5281/zenodo.19407519 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7149034322 | |||
| W7148838116 | Abstract 1551: Intratumoral biodegradable nanofluidic platform for localized multimodal immunotherapy enhances tumor eradication and immune memory | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-1551 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148838116 | |||
| W7148930743 | Abstract 1881: Understanding evolutionary and ecological mechanisms of sotorasib resistance in KRAS G12C-mutant non-small cell lung cancer. | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-1881 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148930743 | |||
| W7148909300 | Abstract 2747: Source discipline matters: Guideline anchored large language model outperforms Open Evidence for decision support in acute leukemias. | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-2747 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7148909300 | |||
| W7148823066 | Abstract 27: An MCP-enabled AI agent for automated multimodal genomics analysis in the Isabl Platform. | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-27 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7148823066 | |||
| W7148987912 | Abstract 293: Anti-cancer drug usage analysis among Korean patients with colorectal cancer. | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-293 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148987912 | |||
| W7148711990 | Abstract 3098: Discovery of the RAD51 inhibitor JKYN-1 and characterization of its anticancer activity in preclinical models of non-small cell lung cancer | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-3098 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148711990 | |||
| W7148889200 | Abstract 3542: Evolving toward precision oncology: Leveraging collateral drug responses for personalized second-line osteosarcoma treatment | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-3542 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148889200 | |||
| W7149008215 | Abstract 4054: Tumor-activated PrimeBody biologics platform enables more potent CD47 targeting and superior therapeutic index in preclinical models | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-4054 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7149008215 | |||
| W7148928265 | Abstract 4398: Developing 3D cell models for high-throughput antibody-drug conjugate screening in cancer | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-4398 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148928265 | |||
| W7148635706 | Abstract 5230: Alopecia in cancer immunotherapy: Incidence and patterns with monoclonal antibodies and antibody-drug conjugates | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-5230 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148635706 | |||
| W7148657734 | Abstract 6073: Establishment and characterization of a panel of EGFR-mutant lung XPDX models representing naïve, chemotherapy, and targeted therapy-resistant patient populations | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-6073 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148657734 | |||
| W7148854017 | Abstract 6832: Toward personalized rotational multi-agent therapies to overcome treatment resistance in pancreatic cancer: A virtual trial framework in mice. | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-6832 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7148854017 | |||
| W7148764108 | Abstract 6843: A joint model for integrating serial methylation-based tumor fraction and ESR1 assessment to forecast overall survival in patients with ER+/HER2- metastatic breast cancer. | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-6843 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148764108 | |||
| W7148807014 | Abstract 7392: A cancer cell-intrinsic PAR1/MALT1/PD-L1 signaling pathway drives immune evasion in triple-negative breast cancer | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-7392 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148807014 | |||
| W7148684421 | Abstract 7528: Utilizing confocal live-cell imaging for evaluating therapeutic efficacy and toxicity in complex oncology models | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-7528 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148684421 | |||
| W7148892444 | Abstract 7630: Shear wave elastography and photoacoustic imaging to non-invasively identify resistant regions in the tumor microenvironment | 2026-04-03 | OpenAlex | 10.1158/1538-7445.am2026-7630 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148892444 | |||
| W7148872402 | Agentic AI scientists and the rise of virtual laboratories | 2026-04-03 | OpenAlex | 10.1097/ms9.0000000000004925 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7148872402 | |||
| W7148781726 | Artificial Intelligence Justice Philosophy Theory | 2026-04-03 | OpenAlex | 10.17605/osf.io/bt8ej | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148781726 | |||
| W7152116011 | Bridging bench to bedside: mechanistic elucidation and clinical translation of vasopressin and its analogues for hemorrhagic shock resuscitation | 2026-04-03 | OpenAlex | 10.1097/shk.0000000000002845 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152116011 | |||
| W7149030222 | Curcumin as a JAK/STAT pathway modulator in breast cancer: Mechanisms and nanomedicine perspectives | 2026-04-03 | OpenAlex | 10.1016/j.prenap.2026.100727 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7149030222 | |||
| W7165400444 | Deneysel Sepsis Modelleri | 2026-04-03 | OpenAlex | 10.37609/akya.4023.c6240 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165400444 | |||
| W7148868635 | Hope Without a Name: The Philosophy and Politics of Protecting the Forgotten Child | 2026-04-03 | OpenAlex | 10.17605/osf.io/fbmuy | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148868635 | |||
| W7148927721 | Lifelong Learning in Artificial Intelligence | 2026-04-03 | OpenAlex | 10.5281/zenodo.19409874 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7148927721 | |||
| W7148505863 | Mechanistically driven transnidal hemodynamic manipulations enhance simulated endovascular transvenous treatments for brain AVMs | 2026-04-03 | OpenAlex | 10.1038/s43856-026-01555-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7148505863 | |||
| W7148703031 | Muscle-predominant vasculitic myopathy heralding renal MPO-ANCA–associated vasculitis: A case-based mini-review of diagnostic traps and steroid-sparing induction | 2026-04-03 | OpenAlex | 10.1016/j.amjms.2026.03.017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148703031 | |||
| W7148693447 | Precision Medicine in Breast Cancer | 2026-04-03 | OpenAlex | 10.1201/9781003644309-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148693447 | |||
| W7152023192 | Pulmonary arterial hypertension: Focused therapeutic update | 2026-04-03 | OpenAlex | 10.1093/ajhp/zxag102 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152023192 | |||
| W7148934828 | Recent advances in incretin biology and therapeutics: From glucose‐dependent insulinotropic polypeptide reappraisal to next‐generation agonists | 2026-04-03 | OpenAlex | 10.1111/jdi.70299 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7148934828 | |||
| W7164386458 | SepsiGuard: A Triple-Layer Agentic XAI Framework for Early Sepsis Prediction and Adaptive ICU Monitoring | 2026-04-03 | OpenAlex | 10.5281/zenodo.19396525 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164386458 | |||
| W7150879636 | Cleft related facial skeletal surgery: an update | 2026-04-04 | OpenAlex | 10.1097/moo.0000000000001127 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150879636 | |||
| W7149683401 | Coding Tools Are Secretly System Agents | 2026-04-04 | OpenAlex | 10.5281/zenodo.19423042 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7149683401 | |||
| W7149421179 | Governing Artificial Intelligence in the Evolving Academic Publishing Ecosystem | 2026-04-04 | OpenAlex | 10.57019/jmv.1899774 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7149421179 | |||
| W7149660189 | USE OF NANOTECHNOLOGICAL CONCEPTS AND TERMINOLOGY IN MEDICINE: CURRENT APPLICATIONS, CLINICAL VALUE, AND TRANSLATIONAL CHALLENGES | 2026-04-04 | OpenAlex | 10.5281/zenodo.19421210 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7149660189 | |||
| W7150065916 | N-PACE framework: hydro-climatic whiplash modeling | 2026-04-05 | OpenAlex | 10.5281/zenodo.19427910 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7150065916 | |||
| W7150198468 | Radiopharmaceutical Therapy in Oncology: Perspectives from Transatlantic Experts | 2026-04-05 | OpenAlex | 10.1007/s40487-026-00432-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150198468 | |||
| W7149904760 | The Correction Trilemma by Jalal Khawaldeh: A Diagnostic Heuristic for Trade-offs in Epistemic Systems | 2026-04-05 | OpenAlex | 10.5281/zenodo.19429564 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7149904760 | |||
| W7149988244 | The Geometry of Decoherence: Cognitive Structuralism and the Architectural Risks of Convergent-Dominant AGI | 2026-04-05 | OpenAlex | 10.5281/zenodo.19427092 | Title/abstract | Excluded | E1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system. | https://openalex.org/W7149988244 | |||
| W7151485118 | Drug resistance to antibody-drug conjugates: mechanisms, challenges, and perspectives | 2026-04-06 | OpenAlex | 10.20892/j.issn.2095-3941.2025.0707 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151485118 | |||
| W7151096044 | Enhancing robustness in multi-agent reinforcement learning via temporal consistency regularization: A self-distillation framework | 2026-04-06 | OpenAlex | 10.1016/j.knosys.2026.115940 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7151096044 | |||
| W7152098529 | EvolveRouter: Co-Evolving Routing and Prompt for Multi-Agent Question Answering | 2026-04-06 | OpenAlex | 2604.05149 | 10.48550/arxiv.2604.05149 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7152098529 | ||
| W7150786554 | From Complex Targets to General Methods: Celebrating Jieping Zhu's 60th Birthday | 2026-04-06 | OpenAlex | 10.1002/ejoc.70420 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150786554 | |||
| W7150746556 | Identification and phylogenetic analysis of multidrug resistance, caries-related Streptcoccus mutans in Sulaymaniyah City, Iraqi Kurdistan Region | 2026-04-06 | OpenAlex | 10.1007/s10123-026-00810-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7150746556 | |||
| W7154604179 | Law Schools in the Era of Green Transition: Governing Legal Education for Sustainable Development and Digital Transformation | 2026-04-06 | OpenAlex | 10.59324/ejceel.2026.4(2).20 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154604179 | |||
| W7150817931 | Supplementary Material for: Efficacy and Safety of Avacopan in ANCA-Associated Vasculitis: A Meta-Analysis of Randomized Controlled Trials | 2026-04-06 | OpenAlex | 10.6084/m9.figshare.31941633 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150817931 | |||
| W7152338097 | The Correction Trilemma: A Diagnostic Heuristic for Trade-offs in Epistemic Systems | 2026-04-06 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152338097; https://openalex.org/W7152424096; https://openalex.org/W7171616431; https://openalex.org/W7152452633 | ||||
| W7150790991 | The Evolving Role of Artificial Intelligence in STEM Teaching and Learning | 2026-04-06 | OpenAlex | 10.18260/1-2-118-58102 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7150790991 | |||
| W7151454731 | A Comprehensive Review of the Pathophysiology and Management of Osteoarthritis: Emerging Therapeutic Strategies and Clinical Insights | 2026-04-07 | OpenAlex | 10.7759/cureus.106561 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151454731 | |||
| W7151413347 | A New Era of Salvage-Line Treatment for Metastatic Colorectal Cancer: The Role and Clinical Significance of Circulating Tumor DNA | 2026-04-07 | OpenAlex | 10.3390/biom16040543 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151413347 | |||
| W7217742708 | AI PROMPT LIBRARY TOOL | 2026-04-07 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7217742708 | ||||
| W7151484330 | Biomarkers for complex post-traumatic stress disorder: translational and evolutionary perspectives | 2026-04-07 | OpenAlex | 10.3389/fpsyt.2026.1786811 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151484330 | |||
| W7153498168 | Diabetic Neuropathy: Recent Diagnostic Advancements and Emerging Multimodal Therapeutic Strategies | 2026-04-07 | OpenAlex | 10.2174/0125899775400471251205102738 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153498168 | |||
| W7151531088 | Dissecting Cellulitis of the Scalp: Current Insights and Therapeutic Advances | 2026-04-07 | OpenAlex | 10.1007/s40257-026-01028-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151531088 | |||
| W7151512410 | Drug-induced cataract: Comprehensive review of implicated agents and underlying pathophysiological mechanisms | 2026-04-07 | OpenAlex | 10.30574/ijsra.2026.19.1.0644 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151512410 | |||
| W7151462625 | Efficacy and Safety of Avacopan in ANCA-Associated Vasculitis: A Meta-Analysis of Randomized Controlled Trials | 2026-04-07 | OpenAlex | 10.1159/000551892 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151462625 | |||
| W7216478095 | FOURTH-GENERATION STATINS: ADVANCES IN LIPID-LOWERING THERAPY AND REDUCTION OF CARDIOVASCULAR RISK | 2026-04-07 | OpenAlex | 10.37547/supsci-ojmp-06-01-01 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216478095 | |||
| W7151563057 | GENESIS R90.3: AGI/ASI Impact Topology — Complete Session Documentation. Deep Dives · Reflection Loop · Peer Review · Adversarial Audit. Working Paper / Research Protocol / Synthetic Theory Exploration — Empirical Validation Pending | 2026-04-07 | OpenAlex | 10.5281/zenodo.19458198 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151563057 | |||
| W7151384803 | Peptide-based therapeutics in the management of Alzheimer’s disease (AD) and their potential to develop novel strategies | 2026-04-07 | OpenAlex | 10.1007/s11011-025-01781-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151384803 | |||
| W7151567199 | Precision oncology in gynecologic cancers: molecular taxonomy, biomarker-guided therapeutics, and the challenge of therapeutic resistance | 2026-04-07 | OpenAlex | 10.3389/fonc.2026.1785469 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151567199 | |||
| W7151422723 | Scalp Cooling for Chemotherapy-Induced Alopecia in Breast Cancer: A Contemporary Review | 2026-04-07 | OpenAlex | 10.1007/s12609-026-00643-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151422723 | |||
| W7151345928 | Suppression of mitochondrial energy production by a photosynthetic bacterial cupredoxin peptide inhibits tumor growth | 2026-04-07 | OpenAlex | 10.1038/s41392-026-02703-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7151345928 | |||
| W7153593930 | The Global Threat of Multidrug-Resistant Microorganisms: Implications for Human and Environmental Health | 2026-04-07 | OpenAlex | 10.2174/0122113525416941251216105950 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153593930 | |||
| W7151461937 | Triple-Negative Breast Cancer Brain Metastasis: A Comprehensive Review of Epidemiology, Molecular Pathobiology, and Therapeutic Frontiers | 2026-04-07 | OpenAlex | 10.3390/cancers18071179 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151461937 | |||
| W7151984409 | A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol | 2026-04-08 | OpenAlex | 10.1128/mbio.03518-25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7151984409 | |||
| W7151902976 | Acute Stroke Patients on Daily Anticoagulant or Antiplatelet Therapy Receiving Thrombolysis or Thrombectomy | 2026-04-08 | OpenAlex | 10.7759/cureus.106657 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7151902976 | |||
| W7151966449 | Clinical Relevance of Cetirizine in Allergy Management: An Updated Evidence-Based Review | 2026-04-08 | OpenAlex | 10.5281/zenodo.19465982 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7151966449 | |||
| W7151792144 | Contemporary Immunosuppression in Simultaneous Heart–Kidney Transplantation: A United Network for Organ‐Sharing Database Analysis | 2026-04-08 | OpenAlex | 10.1002/phar.70144 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7151792144 | |||
| W7153603659 | Early biologic therapy in psoriasis: challenging the stepwise paradigm | 2026-04-08 | OpenAlex | 10.1093/bjd/ljag131 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153603659 | |||
| W7153604340 | Evaluation of Mechanisms and Therapeutic Opportunities of Thiazolidinediones in Insulin Sensitization | 2026-04-08 | OpenAlex | 10.2174/0125899775410298251206203015 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153604340 | |||
| W7151835054 | Exploring the intersection: adult orbital xanthogranulomatous disease and IgG4-related disease – report of 3 cases and literature review | 2026-04-08 | OpenAlex | 10.6084/m9.figshare.31963624 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7151835054; https://openalex.org/W7151974065 | |||
| W7151821169 | It’s Not Just About the Tools: Emotionally Responsive GenAI Education | 2026-04-08 | OpenAlex | 10.5334/pme.2280 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7151821169 | |||
| W7151864937 | NexusMind: Agentic AI Orchestration Model | 2026-04-08 | OpenAlex | 10.22214/ijraset.2026.79343 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7151864937 | |||
| W7151932060 | Risperidone redefined: A three-decade odyssey of broadening indications and evolving formulations | 2026-04-08 | OpenAlex | 10.1016/j.mjafi.2026.02.016 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7151932060 | |||
| W7161177561 | Voice-Driven Artificial Intelligence for Personalized Health and Wellness Support | 2026-04-08 | OpenAlex | 10.1109/ictmim68190.2026.11507534 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161177561 | |||
| W7152743273 | A Review on the Herbal Potential for the Treatment of Peptic Ulcer | 2026-04-09 | OpenAlex | 10.32553/jbpr.v15i2.1439 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152743273 | |||
| W7152484359 | An Evidence-Based Approach to the Diagnosis and Management of Seborrheic Dermatitis: A Systematic Review | 2026-04-09 | OpenAlex | 10.70070/2w2r9t25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152484359 | |||
| W7152426277 | Developing AI Frameworks for Decision Coordination and Lesion Detection in Cancer Management | 2026-04-09 | OpenAlex | 10.71747/uow-r3gk326m.31956222 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7152426277 | |||
| W7152533617 | Emerging Surface Coating Innovations for Orthopedic Implants: A Review | 2026-04-09 | OpenAlex | 10.60118/001c.146425 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152533617 | |||
| W7154087695 | Endovascular Hemostasis in the Management of Arterial Upper Gastrointestinal Bleeding: Literature Review | 2026-04-09 | OpenAlex | 10.24060/2076-3093-2026-16-1-52-61 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154087695 | |||
| W7152738677 | Future Directions in the Medical Treatment of Obesity: A Narrative Review | 2026-04-09 | OpenAlex | 10.1007/s12325-026-03576-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152738677 | |||
| W7152964007 | Impact of PD-L1 Status on the Development of Cutaneous Immune-Related Adverse Events in Non-Small-Cell Lung Cancer Patients Receiving Immunotherapy | 2026-04-09 | OpenAlex | 10.3390/life16040636 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7152964007 | |||
| W7151957957 | Kūn: A Layered Epistemic Containment Architecture and the Mormon Boundary | 2026-04-09 | OpenAlex | 10.5281/zenodo.19474857 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7151957957 | |||
| W7152719314 | Outcomes of Cultural Responsiveness Training for U.S. Students on Study Abroad to South Africa | 2026-04-09 | OpenAlex | 10.1044/2026_persp-25-00177 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7152719314 | |||
| W7152507858 | Reproductive Control in the Bitch after Unplanned Mating (Misalliance): A Comprehensive Narrative Review | 2026-04-09 | OpenAlex | 10.9734/jsrr/2026/v32i44124 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152507858 | |||
| W7152726997 | Systematic Review of Acute Encephalitis Syndrome (AES) and Japanese Encephalitis Virus in Eastern Uttar Pradesh: Epidemiological Trends, Pathogens, and Outcomes (2000–2025) | 2026-04-09 | OpenAlex | 10.5281/zenodo.19488419 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152726997 | |||
| W7152509736 | Understanding Drug Resistance Mechanisms in Staphylococcus aureus | 2026-04-09 | OpenAlex | 10.1201/9781003647072-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152509736 | |||
| W7153329839 | ANALYSIS OF OUTCOMES OF COMBINATION THERAPY IN CHILDHOOD HODGKIN LYMPHOMA: A LITERATURE-BASED REVIEW | 2026-04-10 | OpenAlex | 10.5281/zenodo.19500108 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153329839 | |||
| W7153302307 | ASI engagement begins with LLM engagement, Part 1 and Part 2 | 2026-04-10 | OpenAlex | 10.5281/zenodo.19491257 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7153302307 | |||
| W7155568037 | Banking Policies and Bank Density in Nigeria | 2026-04-10 | OpenAlex | 10.5281/zenodo.19719857 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7155568037; https://openalex.org/W7153772641 | |||
| W7153353139 | Editorial: Physiology and pathophysiology of placenta | 2026-04-10 | OpenAlex | 10.3389/fendo.2026.1829406 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153353139 | |||
| W7153213909 | Epidermal growth factor receptor (EGFR) atypical mutations in non-small-cell lung cancer (NSCLC): ‘Where the streets have no name’ | 2026-04-10 | OpenAlex | 10.1016/j.critrevonc.2026.105327 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153213909 | |||
| W7154192531 | Floating Drug Delivery Systems: Advances in Gastroretentive Technologies for Enhanced Oral Bioavailability | 2026-04-10 | OpenAlex | 10.5281/zenodo.19492593 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154192531 | |||
| W7153176635 | From Prompting to Autonomous Intelligence: A White Paper on the Phases of AI Learning, Technologies, and Methodologies. | 2026-04-10 | OpenAlex | 10.55041/ijsrem59657 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153176635 | |||
| W7155769071 | Future directions in anesthesia: expanding the role of anesthetic drugs in sedation, analgesia, and recovery | 2026-04-10 | OpenAlex | 10.5124/jkma.26.0004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155769071 | |||
| W7152959660 | New Landscape for Atopic Dermatitis Therapies | 2026-04-10 | OpenAlex | 10.1016/j.pcl.2026.02.007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7152959660 | |||
| W7153274857 | Orchestrating cell death and microenvironment: Natural products as multi-target modulators of pyroptosis in myocardial ischemia-reperfusion injury | 2026-04-10 | OpenAlex | 10.1016/j.biopha.2026.119349 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153274857 | |||
| W7153274679 | Perioperative immunotherapy for hepatocellular carcinoma: adjuvant, neoadjuvant, and biomarker-guided strategies | 2026-04-10 | OpenAlex | 10.3389/fmed.2026.1811918 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153274679 | |||
| W7153237218 | Pharmacogenomics of antibacterial and antiviral therapies: Clinical actionability, evidence gaps, and future directions | 2026-04-10 | OpenAlex | 10.1016/j.pharmr.2026.100136 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153237218 | |||
| W7153636173 | TRANSETHOSOMES: A PROMISING VESICULAR SYSTEM FOR OSTEOARTHRITIS DRUG DELIVERY | 2026-04-10 | OpenAlex | 10.5281/zenodo.19508062 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153636173 | |||
| W7153591073 | The AI Relational Integrity Scale (ARIS): A 5-Factor Framework for Evaluating Ethical Alignment in Human–AI Interaction | 2026-04-10 | OpenAlex | 10.5281/zenodo.19503312 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7153591073 | |||
| W7155895642 | The impact of drug selection on patient outcomes in anesthesia and postoperative care: a narrative review | 2026-04-10 | OpenAlex | 10.5124/jkma.25.0133 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155895642 | |||
| W7153046387 | The rise of biologics: the need for their inclusion in pharmacology curriculum of dentistry | 2026-04-10 | OpenAlex | 10.1038/s41415-026-9540-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153046387 | |||
| W7217812372 | Awareness and Utilization of Recent Advances in Pediatric Dentistry among Dental Practitioners: A Cross-Sectional Study | 2026-04-11 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7217812372 | ||||
| W7153542634 | Claude Managed Agents: Brain Versus Hands | 2026-04-11 | OpenAlex | 10.5281/zenodo.19520057 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7153542634 | |||
| W7153789838 | Five Advances in the Last 50 Years: Liver Malignancies | 2026-04-11 | OpenAlex | 10.1002/wjs.70327 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153789838 | |||
| W7153573209 | Kratom (Mitragyna speciosa Korth.): ethnopharmacology, phytochemistry, therapeutic potential, and regulatory perspectives | 2026-04-11 | OpenAlex | 10.1016/j.phyplu.2026.100986 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153573209 | |||
| W7153766473 | Pancreatic Cancer—Advances in the Last 50 Years | 2026-04-11 | OpenAlex | 10.1002/wjs.70309 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153766473 | |||
| W7162002549 | TL1A as a therapeutic renaissance in inflammatory bowel disease: a systematic review from molecular mechanisms to clinical translation | 2026-04-11 | OpenAlex | 10.1093/ecco-jcc/jjag039 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162002549 | |||
| W7153719202 | Top 5 Advances in the Last 50 Years: Malignant Gastric and Esophageal Surgery | 2026-04-11 | OpenAlex | 10.1002/wjs.70306 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153719202 | |||
| W7161943619 | AgentFixer: From Failure Detection to Fix Recommendations in Agentic Systems | 2026-04-12 | OpenAlex | 10.1145/3786167.3788427 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7161943619 | |||
| W7153769415 | Bridging Artificial Intelligence, Machine Learning with Green Nanotechnology: A Visionary Framework for Smart Fungal Disease Management in Plants | 2026-04-12 | OpenAlex | 10.1007/s00425-026-04998-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153769415 | |||
| W7153984138 | Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: Mechanistic Considerations Across Relapsing and Progressive Disease | 2026-04-12 | OpenAlex | 10.3390/molecules31081272 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153984138 | |||
| W7153800790 | Evolving landscape of targeted therapies in early phase clinical trials | 2026-04-12 | OpenAlex | 10.1016/j.ejca.2026.116745 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7153800790 | |||
| W7153719469 | Fixed drug eruption induced by mycophenolate mofetil, a rare entity with significant consequences | 2026-04-12 | OpenAlex | 10.1002/bcp.70554 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7153719469 | |||
| W7211876518 | Oncology of the Skin: From Lesion to Metastasis | 2026-04-12 | OpenAlex | 10.64790/ir.m42 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211876518 | |||
| W7154447483 | P51 | EVOLVING ATTRITION RATES IN MULTIPLE MYELOMA REAL-WORLD PRACTICE OVER A 30-YEARS PERIOD FROM A SINGLE CENTER EXPERIENCE | 2026-04-12 | OpenAlex | 10.3324/haematol.2026.s2.14086 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154447483 | |||
| W7153997061 | The Emerging Role of Senolytics as a Next-Generation Strategy Against Glioma Recurrence: A Narrative Review | 2026-04-12 | OpenAlex | 10.3390/cancers18081220 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153997061 | |||
| W7153754563 | Therapeutic potential of natural triterpenoids in pancreatic cancer | 2026-04-12 | OpenAlex | 10.1016/j.seminoncol.2026.152500 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153754563 | |||
| W7154116885 | Aktuelle Perspektiven der Elektrokonvulsionstherapie | 2026-04-13 | OpenAlex | 10.1007/s00115-026-01966-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154116885 | |||
| W7154000417 | Availability and Policy Alignment of Oral Hypoglycaemic Agents in India: A Cross-sectional Study | 2026-04-13 | OpenAlex | 10.7860/jcdr/2026/87355.23317 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154000417 | |||
| W4417089813 | Dynamic Agent Generation for Self-Adaptive Root Cause Analysis | 2026-04-13 | OpenAlex | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4417089813 | ||||
| W7153900956 | FiReS: an agent based reasoning system for post-disaster response recommendations | 2026-04-13 | OpenAlex | 10.1007/s11069-026-08141-6 | Full text | Excluded | F2: FiReS addresses general post-disaster rescue, evacuation and logistics; medical activity is one operation rather than the primary clinical task. | https://openalex.org/W7153900956 | https://link.springer.com/article/10.1007/s11069-026-08141-6 | Complete publisher abstract; body subscription-only | |
| W7154133593 | Hi, how do I human this: Neurodiversity-Affirming Design for Autistic Adults' Formation of Identity | 2026-04-13 | OpenAlex | 10.1145/3772318.3791446 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7154133593 | |||
| W7153892517 | Patients’ Perspectives On Clinical Clerkship Students: A Single-center Qualitative Study in Osaka, Japan | 2026-04-13 | OpenAlex | 10.1007/s40670-026-02701-y | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7153892517 | |||
| W7154123932 | Patterns of care in relapsed/refractory multiple myeloma in China: a real-world physician survey study | 2026-04-13 | OpenAlex | 10.1080/14796694.2026.2656394 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154123932 | |||
| W7157609680 | Pharmacotherapy options and drug development in bronchiectasis: spotlight on dipeptidyl-peptidase inhibitors | 2026-04-13 | OpenAlex | 10.1080/14656566.2026.2664617 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7157609680 | |||
| W7216317058 | THE EVOLVING ROLE OF IMAGING IN ONCOLOGY RESPONSE ASSESSMENT: BEYOND RECIST | 2026-04-13 | OpenAlex | 10.63075/rnjfpz81 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216317058 | |||
| W7154004915 | Teaching MCP, RAG, and AI Agents to a Multidisciplinary Hospital Workforce: Design, Implementation, and Lessons from an Intensive Hands-On Training Program (Preprint) | 2026-04-13 | OpenAlex | 10.2196/preprints.97822 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154004915 | |||
| W7154309795 | The current role, challenges, and future prospects of infectious disease physicians in the comprehensive management of hepatocellular carcinoma: A cross-sectional survey | 2026-04-13 | OpenAlex | 10.1097/id9.0000000000000215 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154309795 | |||
| W7154024160 | The influence of the theory and methods of Chinese traditional culture on modern western psychotherapy: a cross-cultural dialogue | 2026-04-13 | OpenAlex | 10.3389/fpsyg.2026.1690911 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154024160 | |||
| W7153973802 | V-PULSE: Precision Ultrascale Lcalized Signal Exposure | 2026-04-13 | OpenAlex | 10.5281/zenodo.19552763 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153973802 | |||
| W7154154822 | What ethical AI and robots could mean: a conceptual and ethical reflection | 2026-04-13 | OpenAlex | 10.3389/frobt.2026.1769361 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154154822 | |||
| W7154909133 | A Comprehensive Review of the Use of Peripheral Vasopressors and Their Implications | 2026-04-14 | OpenAlex | 10.2174/0115701611451845260413164652 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154909133 | |||
| W7162086412 | A Multi-Agent Cognitive Isolation Framework for Defect-Driven Power Grid Document Assessment | 2026-04-14 | OpenAlex | 10.1109/acpee69242.2026.11524710 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7162086412 | |||
| W7153970039 | Beyond autonomy: why medicine needs artificial intelligence teammates, not artificial intelligence doctors | 2026-04-14 | OpenAlex | 10.4274/dir.2026.263928 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7153970039 | |||
| W7154382715 | Bispecific Antibodies for Glomerular Diseases | 2026-04-14 | OpenAlex | 10.1681/asn.0000001120 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154382715 | |||
| W7154059914 | Editorial: Technologies for diabetes, volume III | 2026-04-14 | OpenAlex | 10.3389/fendo.2026.1846249 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154059914 | |||
| W7154496495 | I-Tuning: Personalized Large Language Models as Cognitive Augmentation Why Individualized AI Fine-Tuning Poses Distinctive Constitutional Risks. | 2026-04-14 | OpenAlex | 10.5281/zenodo.19594963 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154496495 | |||
| W7154309532 | Modern Advancements in AI for Healthcare Diagnostics | 2026-04-14 | OpenAlex | 10.4018/407372 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7154309532; https://openalex.org/W7165385972 | |||
| W7154336515 | OphAgent: A Generalisable Ophthalmic Agentic System for Global Eye Care | 2026-04-14 | OpenAlex | 10.21203/rs.3.rs-9189179/v1 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7154336515 | |||
| W7154492417 | The Evolving Landscape of Psoriasis Treatment: Current Biologics and Novel Targets | 2026-04-14 | OpenAlex | 10.12775/jehs.2026.90.69823 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154492417 | |||
| W7154208681 | Trends in the prescription of constipation medications in Japan (fiscal years 2019-2023): A nationwide baseline study prior to the 2023 clinical guidelines | 2026-04-14 | OpenAlex | 10.5582/ddt.2025.01135 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154208681 | |||
| W7154471960 | 7th International Conference on Big Data and Machine Learning (BDML 2026) | 2026-04-15 | OpenAlex | 10.5281/zenodo.19593418 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154471960 | |||
| W7161830286 | An Integrated SARIMAX and Agentic Retrieval-Augmented Generation Framework for Pharmaceutical Sales Forecasting and Intelligent Decision Support | 2026-04-15 | OpenAlex | 10.1109/rmkmate69073.2026.11518917 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161830286 | |||
| W7165444141 | Autonomous clinical Artificial Intelligence and the validation gap: structural risks and regulatory priorities for European health systems | 2026-04-15 | OpenAlex | 10.1093/eurpub/ckag068 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165444141 | |||
| W7168352136 | Being Keepers: Line Language as Survival Methodology | 2026-04-15 | OpenAlex | 10.25439/rmt.32979266 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7168352136 | |||
| W7154580259 | Beyond GLP‐1: The Cardiometabolic Potential of Dual GLP‐1/GIP Receptor Agonists | 2026-04-15 | OpenAlex | 10.1002/inm3.70048 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154580259 | |||
| W7154486047 | Community Service and Public Health Awareness among the Ilaje People of Nigeria: A Personal Experience from NYSC | 2026-04-15 | OpenAlex | 10.5281/zenodo.19596174 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154486047 | |||
| W7154467488 | Ekbom Syndrome Following Cosmetic Biopolymer Injections Presenting With Neuropsychiatric Manifestations: A Case Report | 2026-04-15 | OpenAlex | 10.7759/cureus.107117 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154467488 | |||
| W7154501308 | Emerging advantages of nano delivery systems in enhancing CAR-T/CRISPR-Cas9 mediated cancer therapeutics | 2026-04-15 | OpenAlex | 10.1016/j.bbcan.2026.189592 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154501308 | |||
| W7154490950 | Evolving therapeutic strategies in mantle cell lymphoma: advancements and future directions | 2026-04-15 | OpenAlex | 10.1038/s41375-026-02942-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154490950 | |||
| W7165642636 | From Molecules to Medicines: Structure, Manufacturing Technologies, and Global Evolution of the Pharmaceutical Industry | 2026-04-15 | OpenAlex | 10.26634/jchem.6.1.1349 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165642636 | |||
| W7160249371 | Green Synthesis and Characterization of Zinc Oxide Nanoparticles using Fragaria Anannsa Extract and their Antioxidant and Antimicrobial Activities | 2026-04-15 | OpenAlex | 10.33140/jahr.09.02.04 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160249371 | |||
| W7154458221 | Late-line Systemic Therapy in Metastatic Colorectal Cancer: A Narrative Review and Australian Expert Perspective | 2026-04-15 | OpenAlex | 10.1016/j.clcc.2026.04.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154458221 | |||
| W7154504791 | Management of MASLD/MASH: challenges, innovations, and the future of patient-centered care in Japan | 2026-04-15 | OpenAlex | 10.1007/s00535-026-02401-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154504791 | |||
| W7154482950 | Perioperative Patient Blood Management: Evidence-Based Strategies for Surgeons and Anesthesiologists: A Narrative Review | 2026-04-15 | OpenAlex | 10.3390/jcm15083017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154482950 | |||
| W7161942991 | Phyllanthus emblica in the Era of Translational Medicine: Unveiling its Multitargeted Therapeutic Arsenal from Ayurveda to Advanced Biomedicine | 2026-04-15 | OpenAlex | 10.52711/2231-5691.2026.00025 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161942991 | |||
| W7216740722 | Pyoderma gangrenosum – o adevărată provocare în managementul pacientului: caz clinic | 2026-04-15 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7216740722 | ||||
| W7154496467 | Risk-managed antidepressant prescribing in primary care mental health: what pharmacogenetics can (and cannot) deliver | 2026-04-15 | OpenAlex | 10.3389/fmed.2026.1814980 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154496467 | |||
| W7154488502 | Temporal Trends in Antibiotic Resistance of Klebsiella pneumoniae and Antibiotic Consumption: A Six-year Longitudinal Surveillance Study | 2026-04-15 | OpenAlex | 10.1007/s44197-026-00553-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154488502 | |||
| W7154492690 | Update on pleural mesothelioma | 2026-04-15 | OpenAlex | 10.1097/mcp.0000000000001272 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154492690 | |||
| W7154578713 | "Dynamic Constitutional Control of Agentic Enterprise Digital Twins via Meta-Governor Agents" | 2026-04-16 | OpenAlex | 10.21227/ynmh-r675 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7154578713 | |||
| W7154618959 | AMART: A multi-agent reflective framework for detecting and correcting faithfulness errors in translation | 2026-04-16 | OpenAlex | 10.1016/j.ipm.2026.104819 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7154618959 | |||
| W7154600430 | Advances in Breast Cancer Diagnostics: From Screening to Precision Medicine | 2026-04-16 | OpenAlex | 10.3390/diagnostics16081181 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154600430 | |||
| W7154631551 | Current and Emerging Pharmacological Therapies for Hypertriglyceridemia | 2026-04-16 | OpenAlex | 10.3390/ijms27083573 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154631551 | |||
| W7161118504 | From Isolation to Agency: Toward Fully Autonomous Laboratory Ecosystems | 2026-04-16 | OpenAlex | 10.1109/iccc68994.2026.11511636 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161118504 | |||
| W7154588145 | New Treatment in Haemophilia: Challenges, Controversies and Uncertainties | 2026-04-16 | OpenAlex | 10.1111/hae.70254 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154588145 | |||
| W7154592796 | PO40 | RADAR, UK-MRA MYELOMA XV - COMPARING MRD-GUIDED TREATMENT ESCALATION AND DE-ESCALATION STRATEGIES IN PATIENTS WITH NEWLY DIAGNOSED MYELOMA SUITABLE FOR STEM CELL TRANSPLANTATION: THROMBOPROPHYLAXIS SUBGROUP STUDY PROTOCOL | 2026-04-16 | OpenAlex | 10.4081/btvb.2026.534 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154592796; https://openalex.org/W7154429284 | |||
| W7154591079 | Post-Chemotherapy Antibody-Based Continuation and Maintenance Strategies in HER2-Positive Metastatic Breast Cancer: A Translational Narrative Review | 2026-04-16 | OpenAlex | 10.3390/antib15020036 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154591079 | |||
| W7154580548 | Preface to the 13th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2026 | 2026-04-16 | OpenAlex | 10.4081/btvb.2026.479 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154580548 | |||
| W7154630246 | Prevention, Identification, Management and Long‐Term Complications of Intracranial Haemorrhage in Children With Haemophilia and Other Severe Bleeding Disorders—A Practical Guidance | 2026-04-16 | OpenAlex | 10.1111/hae.70239 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154630246 | |||
| W7165082442 | Re-introducing specialist education in hazardous drug handling: a 12-week postgraduate module addressing the knowledge gap in non-oncology settings | 2026-04-16 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165082442 | ||||
| W7154604727 | XPS 2: A Neuro-Symbolic Evolution of Diagnostic Expert Systems for High-Stakes AI | 2026-04-16 | OpenAlex | 10.5281/zenodo.19614000 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7154604727 | |||
| W7154683070 | Abstract LB359: The Bcl-xL specific PROTAC, DT2216, increases the sensitivity to target therapy of preclinical tumor models from different origin | 2026-04-17 | OpenAlex | 10.1158/1538-7445.am2026-lb359 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154683070 | |||
| W7154567452 | Agentic AI system for generating evidence-based second medical opinions | 2026-04-17 | OpenAlex | 10.1016/j.ceh.2026.04.001 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7154567452 | |||
| W7154723758 | Charting the molecular landscape of cancer: from genomic chaos to epigenetic control and energetic adaptation | 2026-04-17 | OpenAlex | 10.1186/s43042-026-00852-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154723758; https://openalex.org/W7154849029 | |||
| W7162918196 | Cryptogenic Stroke in the Setting of Antiphospholipid Syndrome | 2026-04-17 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162918196 | ||||
| W7154718443 | Editorial: Exploring combination therapies for effective obesity and metabolic syndrome management | 2026-04-17 | OpenAlex | 10.3389/fendo.2026.1824139 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154718443 | |||
| W7154907202 | Fungal β-D-Glucans: Versatile Agents in Immune Modulation, Tumor Suppression, and Nanomedicine Advances | 2026-04-17 | OpenAlex | 10.2174/0118715206435063260413064006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154907202 | |||
| W7154697520 | Genetic and vaccination studies reveal feather viral load as a potential biomarker for individual and flock-level protection against Marek’s disease in chicken | 2026-04-17 | OpenAlex | 10.6084/m9.figshare.32043092 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154697520 | |||
| W7154731529 | Revisiting the Role of Lorazepam as an Adjunct in the Management of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis | 2026-04-17 | OpenAlex | 10.3390/biomedicines14040924 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154731529 | |||
| W7154682291 | Stimuli-Responsive Polymeric Nanosystems for Precision Cancer Nanovaccines | 2026-04-17 | OpenAlex | 10.1021/accountsmr.5c00355 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154682291 | |||
| W7154744535 | The new era of AML therapy: current standards and emerging targets | 2026-04-17 | OpenAlex | 10.1007/s10147-026-03038-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154744535 | |||
| W7154739001 | Therapy-driven clonal dynamics in chronic lymphocytic leukemia | 2026-04-17 | OpenAlex | 10.1016/j.semcancer.2026.04.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154739001 | |||
| W4416235282 | A comprehensive survey of AI agents in healthcare | 2026-04-18 | OpenAlex | 10.1016/j.jbi.2026.105045 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W4416235282 | |||
| W7154850494 | Arthrocentesis in the Management of Temporomandibular Joint Disorders: Current and Innovative Approaches | 2026-04-18 | OpenAlex | 10.1055/s-0046-1815917 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154850494 | |||
| W4401996654 | Genetic diversity and trends of influenza A (H3N2) virus in Puducherry, South India: Insights from the 2022–2023 season | 2026-04-18 | OpenAlex | 10.1016/j.diagmicrobio.2026.117425 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W4401996654 | |||
| W7154834624 | Sovereign Epistemological Memory and Reasoning System: A Trilaminar Epistemological Architecture for Agentic AI | 2026-04-18 | OpenAlex | 10.5281/zenodo.19643920 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7154834624 | |||
| W7154983361 | Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy | 2026-04-19 | OpenAlex | 10.1002/bmm2.70080 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154983361 | |||
| W7154889701 | Recent Advances In Nano Formulations For Cancer Therapy: A Pharmacological Perspective | 2026-04-19 | OpenAlex | 10.5281/zenodo.19654261 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154889701 | |||
| W7160378313 | Trustworthy Machine Reasoning with Foundation Models | 2026-04-19 | OpenAlex | 10.48448/94sm-j536 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160378313 | |||
| W7155407289 | Biofilm-Mediated Antimicrobial Resistance in Pseudomonas aeruginosa and Emerging Therapeutic Strategies | 2026-04-20 | OpenAlex | 10.52403/ijhsr.20260426 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155407289 | |||
| W7155087794 | Continuous Focus Groups: A Longitudinal Method for Clinical HRI in Autism Care | 2026-04-20 | OpenAlex | 2604.18197 | 10.48550/arxiv.2604.18197 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155087794 | ||
| W7154967880 | Diagnosis and Treatment of Endocrine Diseases in Outpatient Settings: Type II Diabetes Mellitus | 2026-04-20 | OpenAlex | 10.5281/zenodo.19667581 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154967880 | |||
| W7154908843 | Editorial: National Cancer Research Month 2025: Advances in Detection, Treatment and Therapies in Oncology | 2026-04-20 | OpenAlex | 10.3389/fonc.2026.1834671 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154908843 | |||
| W7154973389 | Innovations in Refractory Melasma: Mechanism-Based Management and Emerging Therapeutic Strategies | 2026-04-20 | OpenAlex | 10.7759/cureus.107411 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154973389 | |||
| W7154979911 | Natural vs. Synthetic Biomaterials for Bone Regeneration: A Comprehensive Review for Researchers | 2026-04-20 | OpenAlex | 10.5281/zenodo.19658743 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154979911 | |||
| W7154944195 | Nonstatins for LDL-C lowering: An expansion whose time has come | 2026-04-20 | OpenAlex | 10.1016/j.jacl.2026.04.017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7154944195 | |||
| W7155934954 | Pathophysiology of Burn Damage | 2026-04-20 | OpenAlex | 10.5772/intechopen.1014858 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155934954 | |||
| W7154995315 | Refining the Digital Twin Concept for Targeted Anticancer Drug Delivery: Integrating Dynamic Physiological Models with Reinforcement Learning | 2026-04-20 | OpenAlex | 10.21203/rs.3.rs-9411956/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7154995315 | |||
| W7155053296 | A Unified Stability Framework for GPT-Class Systems in Active Use Across GPT Class Systems: Deterministic Decay, Stochastic Coherence Dynamics, and Structural Stabilization via the Grandic Stack | 2026-04-21 | OpenAlex | 10.5281/zenodo.19682310 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7155053296 | |||
| W7215925637 | Agentic AI Deployment in Infrastructure-limited Environments: Observability Gaps, Failure Modes, and AI Governance Primitives | 2026-04-21 | OpenAlex | 10.63544/zar8jd83 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7215925637 | |||
| W7155049967 | Characteristics and safety outcomes of rheumatoid arthritis patients treated with AMGEVITA® in the United Kingdom using data from a national register | 2026-04-21 | OpenAlex | 10.1186/s13075-026-03807-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155049967 | |||
| W7155048387 | Decision Dynamics: A Formal Theory of Decision Systems Across Biological and Artificial Agents Toward a Unified Framework for Cognitive Alignment and Action Under Constraints | 2026-04-21 | OpenAlex | 10.5281/zenodo.19678812 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7155048387 | |||
| W7155053665 | Diagnose-Reflective Planning: Faithful KG Reasoning via LLM-Guided MCTS With Strategic Self-Correction | 2026-04-21 | OpenAlex | 10.1109/icassp55912.2026.11463795 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7155053665 | |||
| W7155090562 | Efficacy of oncolytic viruses (OVs) in malignant tumor therapy: a review on its therapeutic aspects | 2026-04-21 | OpenAlex | 10.1016/j.cca.2026.121017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155090562 | |||
| W7155080742 | Is partial complement blockade enough in myasthenia gravis? | 2026-04-21 | OpenAlex | 10.1016/s0140-6736(26)00749-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155080742 | |||
| W7155049461 | Ivonescimab combined with chemotherapy for the treatment of metastatic cervical cancer: A case report and literature review | 2026-04-21 | OpenAlex | 10.1080/21645515.2026.2632451 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155049461 | |||
| W7155057934 | Neuroscientific Basis of Ketamine as an Analgesic and Emerging Role in the Management of Depression | 2026-04-21 | OpenAlex | 10.1007/s11916-026-01475-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155057934 | |||
| W7155068136 | Trypanosoma cruzi DTU diversity, benznidazole response, and clinical manifestations of Chagas disease: a seventeen-year systematic review and meta-analysis | 2026-04-21 | OpenAlex | 10.1016/j.actatropica.2026.108105 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155068136 | |||
| W7155069270 | Universal Methodology Meta-Control Interface (UM-MCI) Core Semantic Package | 2026-04-21 | OpenAlex | 10.5281/zenodo.19676078 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7155069270 | |||
| W7155419582 | A High-Throughput Platform for Rapid Adaptation of DNA Aptamers to SARS-CoV-2 Evolution | 2026-04-22 | OpenAlex | 10.64898/2026.04.21.719937 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155419582 | |||
| W7155207317 | Bridging discovery and practice: why translational research matters in advancing refractive surgery | 2026-04-22 | OpenAlex | 10.1097/j.jcrs.0000000000001946 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155207317 | |||
| W7155188623 | Collagen VI–Related Myopathies: An Educational Overview of Molecular Pathogenesis, Variability of Clinical Presentations Spectrum, Diagnostic Approaches and Management Strategies | 2026-04-22 | OpenAlex | 10.38124/ijisrt/26apr353 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155188623 | |||
| W7155223349 | Commentary: Asymmetric adult-onset asthma with periocular xanthogranuloma associated with IgG4-related disease: a case report | 2026-04-22 | OpenAlex | 10.3389/fsurg.2026.1787830 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155223349 | |||
| W7215291557 | Coniferous resin and its extracts in wound healing : from folk tradition to modern medicine | 2026-04-22 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7215291557 | ||||
| W7155194591 | Correction: The realism of behavioral theory-based vs. non-theory-based AI agents during a simulated infant formula shortage | 2026-04-22 | OpenAlex | 10.3389/frai.2026.1812447 | Title/abstract | Excluded | E5: Correction, retraction or ancillary data record. | https://openalex.org/W7155194591 | |||
| W7155200057 | Delphi consensus recommendations for preventing and treating cardiac implantable electronic device infections beyond current guidelines | 2026-04-22 | OpenAlex | 10.1038/s41598-026-49515-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155200057 | |||
| W7155198995 | Dual-Site Inflammation During Adalimumab Therapy: Birdshot Chorioretinopathy Complicated by Paradoxical Psoriasis | 2026-04-22 | OpenAlex | 10.7759/cureus.107540 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155198995 | |||
| W7155172239 | Editorial: Cardiomyopathy and heart failure in oncology | 2026-04-22 | OpenAlex | 10.3389/fonc.2026.1829234 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155172239 | |||
| W7155165566 | Evolución de enfermería: influencia para una disciplina científica, autónoma y humana que aplica el pensamiento crítico y la evidencia basada en la práctica (EBE) | 2026-04-22 | OpenAlex | 10.71112/rsc83h66 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155165566 | |||
| W7155212027 | Experiential Learning for Indigenous Nurse Leadership Development: A Learning Exchange for Canadian Turtle Island Indigenous Nursing Students in Aotearoa | 2026-04-22 | OpenAlex | 10.1177/08445621261440319 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155212027 | |||
| W7155208776 | From G12C To pan-RAS: The expanding therapeutic landscape of KRAS-mutant NSCLC | 2026-04-22 | OpenAlex | 10.1016/j.critrevonc.2026.105344 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155208776 | |||
| W7155162811 | HealthCare Agent AI | 2026-04-22 | OpenAlex | 10.55041/ijcope.v2i4.575 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7155162811 | |||
| W7155225885 | Human Epidermal Growth Factor Receptor 2 Expression in Prostatic Carcinomas: A Systematic Review and Meta‐Analysis of a Potential Therapeutic Target | 2026-04-22 | OpenAlex | 10.1002/pros.70187 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155225885 | |||
| W7155162306 | Living Microbial Drugs | 2026-04-22 | OpenAlex | 10.1002/chem.202503523 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155162306 | |||
| W7155187741 | MASLD and MASLD-associated HCC: emerging biomarkers and therapeutic avenues | 2026-04-22 | OpenAlex | 10.1016/j.scib.2026.04.048 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155187741 | |||
| W7155566028 | Med Spas: Patient Safety and Accreditation | 2026-04-22 | OpenAlex | 10.1093/asj/sjag085 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155566028 | |||
| W7155158626 | Novel Quinoline-Based Bis-Oxadiazole Derivatives as Potent Anticancer Targets: Efficient Synthesis, Molecular Modeling, and ADME-T Studies | 2026-04-22 | OpenAlex | 10.6084/m9.figshare.32077006 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155158626; https://openalex.org/W7155158137 | |||
| W7155659285 | Perioperative bleeding | 2026-04-22 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155659285 | ||||
| W7155200189 | Presbyopia: Current Perspectives and Prospects for Patients | 2026-04-22 | OpenAlex | 10.1007/s44402-026-00083-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155200189 | |||
| W7155202183 | Urban economics for sustainable transitions: grand challenges in urban structure, the urban–rural gradient and city systems | 2026-04-22 | OpenAlex | 10.3389/frsc.2026.1835029 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155202183 | |||
| W7155190576 | Will AI Dominate Humanity? | 2026-04-22 | OpenAlex | 10.1201/9781003750758-27 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155190576 | |||
| W7155206746 | a-(aminomethyl)-γ-butyrolactones as a new class of antibiotics | 2026-04-22 | OpenAlex | 10.25394/pgs.32055999 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155206746 | |||
| W7155198993 | “My Blood Is Magic” | 2026-04-22 | OpenAlex | 10.4324/9781003674986-7 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7155198993 | |||
| W7155379275 | Aptamers and aptamer-drug conjugates as synthetic immune modulators for cancer immunotherapy | 2026-04-23 | OpenAlex | 10.3389/fimmu.2026.1818316 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155379275 | |||
| W7155375932 | Beyond the Average Effect: Identifying the Trauma Patients Who Benefit Most from Tranexamic Acid | 2026-04-23 | OpenAlex | 10.1055/a-2848-3364 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155375932 | |||
| W7158052663 | LDL-Cholesterol Lowering Therapies: An Update | 2026-04-23 | OpenAlex | 10.31083/bjhm53219 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7158052663 | |||
| W7155362215 | Toward Sustainable Care in HER2-Positive Metastatic Breast Cancer: Emerging Evidence for Treatment De-escalation | 2026-04-23 | OpenAlex | 10.4143/crt.2025.1131 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155362215 | |||
| W7155401739 | VEXAS Syndrome: Clinical Features, Hematologic Involvement, and Clinical Outcomes of Current and Emerging Therapies | 2026-04-23 | OpenAlex | 10.3390/hematolrep18030030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155401739 | |||
| W7155548355 | Advances in Erectile Dysfunction Management: What Does Work | 2026-04-24 | OpenAlex | 10.1002/tre.70027 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155548355 | |||
| W7155490469 | Advances in Pharmacologic- and Non-pharmacologic Interventions for Cancer Pain: A Narrative Review | 2026-04-24 | OpenAlex | 10.1007/s11864-026-01393-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155490469 | |||
| W7155647529 | Aegis Cortex (AC-OS): An industrial-grade Zero-Trust AI Execution Runtime | 2026-04-24 | OpenAlex | 10.5281/zenodo.19761508 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7155647529 | |||
| W7157645484 | BCMA-targeted bispecific antibodies in relapsed/refractory multiple myeloma: three approvals, many questions | 2026-04-24 | OpenAlex | 10.1093/oncolo/oyag165 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7157645484 | |||
| W7155566388 | CAR ‐T Therapies and Emerging Alternatives: Reassessing Cost‐Effectiveness and Future Directions in Modern Immunotherapy | 2026-04-24 | OpenAlex | 10.1111/1756-185x.70666 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155566388 | |||
| W7155569299 | Care, Consent, and Compromise: An Ethical Cartography of Physical Therapy Practice in the Global South | 2026-04-24 | OpenAlex | 10.1007/s41649-025-00390-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155569299 | |||
| W7155545061 | Global dispersal of Burkholderia pseudomallei and the evolving endemicity of melioidosis in the United States of America | 2026-04-24 | OpenAlex | 10.1371/journal.pntd.0014217 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155545061 | |||
| W7212628671 | Multi-Agent Collaborative System for Self-Reflective Learning Intervention: An Empirical Study from Reinforcement Learning Perspective | 2026-04-24 | OpenAlex | 10.1145/3828183.3828455 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7212628671 | |||
| W7155396113 | Stiff person syndrome: an overview | 2026-04-24 | OpenAlex | 10.1007/s10072-026-09054-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155396113 | |||
| W7155511760 | The mechanisms and clinical prospects of combining chemotherapy with immunotherapy for advanced pancreatic cancer | 2026-04-24 | OpenAlex | 10.1007/s12672-026-05030-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155511760 | |||
| W7155610732 | Agentic MobileViT: A stage-wise progressive transfer learning framework with knowledge stabilization for multi-dataset skin lesion classification | 2026-04-25 | OpenAlex | 10.1016/j.asoc.2026.115268 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155610732 | |||
| W7155640814 | Beyond benchmark accuracy: Toward trustworthy, open, and agentic clinical artificial intelligence | 2026-04-25 | OpenAlex | 10.1002/ped4.70062 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7155640814 | |||
| W7155650439 | Chaeshin: Persistent Recursive Case Memory for Tool-Using LLM Agents | 2026-04-25 | OpenAlex | 10.5281/zenodo.19764253 | Title/abstract | Excluded | E2: General method uses clinical reasoning/intake as one of multiple domains; fixed P2 applies. | https://openalex.org/W7155650439 | |||
| W7155621430 | Evolving treatments for Sjögren disease: current approaches and emerging targets | 2026-04-25 | OpenAlex | 10.1111/imj.70322 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7155621430 | |||
| W7155625978 | From Repair to Regeneration: The Integration of Growth Factors in Periodontal Bone Grafting: A Literature Review | 2026-04-25 | OpenAlex | 10.25258/ijddt.16.19s.67 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155625978 | |||
| W7155636164 | HER2-low and ultra-low breast cancer: expanding the therapeutic spectrum in precision oncology | 2026-04-25 | OpenAlex | 10.1186/s42047-026-00238-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155636164 | |||
| W7155616164 | Human–Machine Symbiosis Theory | 2026-04-25 | OpenAlex | 10.17605/osf.io/f2dmh | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155616164 | |||
| W7160713636 | Nanocarriers in Drug Delivery Systems: Advances, Challenges and Future Perspectives | 2026-04-25 | OpenAlex | 10.52711/2349-2988.2026.00031 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160713636 | |||
| W7155604248 | Post-Human Society Theory | 2026-04-25 | OpenAlex | 10.17605/osf.io/t98hu | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155604248 | |||
| W7156575749 | [Similarities and differences between Chinese protocols and international practices in the management of peritoneal tumors]. | 2026-04-25 | OpenAlex | 10.3760/cma.j.cn441530-20260105-00009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7156575749 | |||
| W7157884781 | Beyond hydration: biological mechanisms, clinical evidence and safety of injectable skin boosters | 2026-04-26 | OpenAlex | 10.5281/zenodo.19791967 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7157884781 | |||
| W7217884254 | Drug-Induced Sleep Endoscopy: Shaping the Future of Airway Diagnostics and Management in Clinical Anesthesia | 2026-04-26 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217884254 | ||||
| W7159809416 | Antimicrobial Resistance in Vector-Borne Diseases: Emerging Challenges and Integrated Global Control Strategies | 2026-04-27 | OpenAlex | 10.5281/zenodo.19827620 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7159809416 | |||
| W7155860734 | Building Blocks for Pega Agentic AI Systems | 2026-04-27 | OpenAlex | 10.1201/9781003726364-13 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7155860734 | |||
| W7155975444 | Combining HIstology, Medical imaging and molEcular data for medical pRognosis and diAgnosis Agent (CHIMERA-agent) | 2026-04-27 | OpenAlex | 10.5281/zenodo.19818694 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7155975444 | |||
| W7156211875 | Commentary: Gut and oral microbiome profiles in patients with obesity and ischemic heart disease | 2026-04-27 | OpenAlex | 10.3389/fcimb.2026.1834415 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7156211875 | |||
| W7156350332 | Diagnosing and Stabilising Drift in Long‑Horizon Language‑Model Agents | 2026-04-27 | OpenAlex | 10.5281/zenodo.19810868 | Title/abstract | Excluded | E2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task. | https://openalex.org/W7156350332 | |||
| W7156261435 | Emerging Resistance Patterns in Methicillin-Resistant Staphylococcus aureus Isolated from Soft Tissue Infections: Clinical and Microbiological Study | 2026-04-27 | OpenAlex | 10.25258/ijddt.16.21s.5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7156261435 | |||
| W7155687032 | Insulin Pharmacotherapy Across the Continuum of Care: Indications, Mechanisms, Adverse Effects, and Management | 2026-04-27 | OpenAlex | 10.5281/zenodo.19801614 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155687032 | |||
| W7156371248 | Invasive Fungal Infections | 2026-04-27 | OpenAlex | 10.1097/ipc.0000000000001609 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7156371248 | |||
| W7158261887 | Non-Steroidal Anti-Inflammatory Drugs for the Control of Autoimmune Diseases: A Short Review of Mechanisms, Clinical Applications, and Emerging Perspectives | 2026-04-27 | OpenAlex | 10.33687/ricosbiol.04.04.117 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7158261887 | |||
| W7155697126 | Sodium-glucose cotransporter 2 (SGLT2) inhibitors across the cardiovascular-kidney-metabolic continuum: mechanistic and clinical perspectives on heart failure with preserved ejection fraction prevention | 2026-04-27 | OpenAlex | 10.36011/cpp.2026.8.e4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7155697126 | |||
| W7172173654 | Symbiotic AI Diagnosis: A Reverse Mentorship Framework for Clinical Decision Support through Real-Time Physician Training by Machine Learning Models | 2026-04-27 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172173654 | ||||
| W7156032873 | The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review | 2026-04-27 | OpenAlex | 10.37349/etat.2026.1002368 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7156032873 | |||
| W7156020368 | Updates on Chromoblastomycosis: Evolving Insights in Clinical Management and Therapeutic Strategies | 2026-04-27 | OpenAlex | 10.1007/s12281-026-00532-3 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7156020368 | |||
| W7220464068 | Carbapenem-Resistant Klebsiella pneumoniae: Clinical Epidemiology, Resistant Mechanisms, and Therapeutic Challenges | 2026-04-28 | OpenAlex | 10.66021/pakmcr895 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220464068 | |||
| W7157208621 | Comparative perioperative outcomes of neoadjuvant targeted therapy versus neoadjuvant chemoimmunotherapy in clinical stage II–III lung adenocarcinoma: A retrospective analysis from the National Cancer Center of China | 2026-04-28 | OpenAlex | 10.1097/cm9.0000000000003996 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7157208621 | |||
| W7160919090 | Fournier gangrene in a patient with corticotrophinoma and diabetes treated with sodium–glucose cotransporter 2 inhibitor | 2026-04-28 | OpenAlex | 10.1210/jcemcr/luag133 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160919090 | |||
| W7156631382 | Glucagon-Like Peptide-1 Receptor Agonists Beyond Diabetes Mellitus: Pathophysiological Foundations and Clinical Applications in Obesity, Heart Failure, Chronic Kidney Disease, and Hepatic Steatosis | 2026-04-28 | OpenAlex | 10.5281/zenodo.19849377 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7156631382 | |||
| W7167665711 | Green Synthesis dan Karakterisasi Nanopartikel Emas Sebagai Antioksidan Peredam Radikal Bebas | 2026-04-28 | OpenAlex | 10.31942/inteka.v11i2.13258 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167665711 | |||
| W7156942111 | HEEL: A State-Centric Autobiographical Memory Architecture for Persistent Agents — Beyond the Session-Centric Ontology | 2026-04-28 | OpenAlex | 10.5281/zenodo.19851563 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7156942111 | |||
| W7156896407 | Innovative therapies under clinical development for ALS treatment: small molecules | 2026-04-28 | OpenAlex | 10.1080/13543784.2026.2667249 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7156896407 | |||
| W7158126307 | Large Language Models in Inflammatory Arthritis: A Systematic Review Across Clinical Tasks | 2026-04-28 | OpenAlex | 10.21203/rs.3.rs-9529682/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7158126307 | |||
| W7156785977 | Navigating Learning on the Front Line of Paramedicine | 2026-04-28 | OpenAlex | 10.71747/uow-r3gk326m.32109298 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7156785977 | |||
| W7157123368 | Onco-hypertension: hypertension induced by VEGF pathway inhibition | 2026-04-28 | OpenAlex | 10.3389/fcvm.2026.1748445 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7157123368 | |||
| W7160205812 | Psychodermatology in India: Bridging the Mind–Skin Divide and the Path Forward | 2026-04-28 | OpenAlex | 10.4103/idoj.idoj_455_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160205812 | |||
| W7159670749 | Real‐World Patient Characteristics and Treatment Patterns Among Patients With Interstitial Cystitis (IC)/Bladder Pain Syndrome (BPS) | 2026-04-28 | OpenAlex | 10.1002/rfc2.70079 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7159670749 | |||
| W7157711228 | The degradation revolution: harnessing targeted protein degradation for the treatment of human diseases | 2026-04-28 | OpenAlex | 10.1007/s00018-026-06132-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7157711228 | |||
| W7157016820 | TriALS-Report: Triphasic-Aided Non-Contrast Abdominal 3D Multi-Modal Report Generation | 2026-04-28 | OpenAlex | 10.5281/zenodo.19849407 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7157016820 | |||
| W7158285398 | Anti-vascular endothelial growth factor therapy in uveitis: Bridging inflammation and vascular pathology | 2026-04-29 | OpenAlex | 10.4103/ijo.ijo_2975_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7158285398 | |||
| W7159821380 | Changing Patterns in Hospitalisations of Patients with Systemic Lupus Erythematosus over Three Decades at a Tertiary Referral Centre in Catalonia | 2026-04-29 | OpenAlex | 10.3390/jcm15093407 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7159821380 | |||
| W7159670625 | Clinical, laboratory and genetic characteristics of VEXAS syndrome: a study on behalf of GESMD | 2026-04-29 | OpenAlex | 10.3389/fimmu.2026.1743509 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7159670625 | |||
| W7159664771 | Commentary: Evaluation of the real-world safety of eptifibatide in the treatment of ARDS: results of a disproportionality analysis of FAERS data | 2026-04-29 | OpenAlex | 10.3389/fmed.2026.1835916 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7159664771 | |||
| W7159659862 | Modulating CD38 enzymatic activity during antibody-based immunotherapy in multiple myeloma: a basic science perspective | 2026-04-29 | OpenAlex | 10.3389/fimmu.2026.1769281 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7159659862 | |||
| W7158892755 | Peep into anti-vascular endothelial growth factor | 2026-04-29 | OpenAlex | 10.4103/ijo.ijo_385_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7158892755 | |||
| W7159836482 | Psoriatic Arthritis: Therapeutic Advances and Novel Treatment Strategies—A Scoping Review | 2026-04-29 | OpenAlex | 10.3390/life16050740 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7159836482 | |||
| W7158176707 | Retinal vein occlusion-related macular edema: An updated review of current evidence and future directions | 2026-04-29 | OpenAlex | 10.4103/ijo.ijo_3361_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7158176707 | |||
| W7165548285 | Self-Evolving Diagnostic Framework based Gated Residual Adapters and OpenClaw-Based Medical Agents | 2026-04-29 | OpenAlex | 10.62051/ijcsit.v8n4.01 | Full text | Included | Included: Physician-report-derived special cases accumulate across fundus-image cases, updating persistent MEMORY/SOUL guidance and a final adapter gate. | https://openalex.org/W7165548285 | https://ijocsit.org/pdf/2026/10.62051-ijcsit.v8n4.01.pdf | ||
| W7159677972 | Statin-Associated Severe Rhabdomyolysis With Mixed Neuromuscular Involvement Mimicking Guillain‑Barré Syndrome: A Case Report | 2026-04-29 | OpenAlex | 10.7759/cureus.107939 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7159677972 | |||
| W7160095987 | The Battle Against Pertussis: Discovery of Endogenous Human Proteins and Peptides as Toxin-Inhibitors | 2026-04-29 | OpenAlex | 10.3390/toxins18050208 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160095987 | |||
| W7159127451 | The evolving role of artificial intelligence in optimizing treatment and patient selection in diabetic macular edema | 2026-04-29 | OpenAlex | 10.4103/ijo.ijo_3152_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7159127451 | |||
| W7158343806 | Towards Trustworthy Agentic AI in Healthcare: A Zero Trust-Based Security Framework | 2026-04-29 | OpenAlex | 10.5281/zenodo.19877668 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7158343806 | |||
| W7158548449 | Advancing Transdermal Drug Delivery Systems Through Mechanistic Elucidation Emerging Technologies and Translational Clinical Integration | 2026-04-30 | OpenAlex | 10.5281/zenodo.19913779 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7158548449 | |||
| W7160098495 | Contemporary Management of Upper Tract Urothelial Carcinoma: Transitioning Toward Organ Preservation and Precision Oncology | 2026-04-30 | OpenAlex | 10.3329/bju.v28i2.85892 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160098495 | |||
| W7162452489 | Context Aware Conversational Agent for Smart Healthcare | 2026-04-30 | OpenAlex | 10.65521/mjret.v13i1.2607 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7162452489 | |||
| W7158982079 | Emerging Therapeutic Strategies in Cancer: From Cytotoxic Agents to Precision Medicine | 2026-04-30 | OpenAlex | 10.5281/zenodo.19909244 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7158982079 | |||
| W7160021008 | Evolution of Surgical Antibiotic Prophylaxis: A Prospective Audit of Practice Change at Government Medical College & Hospital, Purnea, Bihar, India | 2026-04-30 | OpenAlex | 10.25258/ijcpr.18.4.122 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160021008 | |||
| W7158675758 | Heart Failure Treatment | 2026-04-30 | OpenAlex | 10.6084/m9.figshare.32133322 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7158675758 | |||
| W7160138646 | Heterometallic Multinuclear Ruthenium Complexes as Cytotoxic Agents | 2026-04-30 | OpenAlex | 10.3390/biomedicines14051028 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7160138646 | |||
| W7159644211 | Language Models Refine Mechanical Linkage Designs Through Symbolic Reflection and Modular Optimisation | 2026-04-30 | OpenAlex | 2604.27962 | 10.48550/arxiv.2604.27962 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7159644211 | ||
| W7170069830 | Non-Alcoholic Fatty Liver Disease: Pathophysiology, Emerging Drug Delivery Strategies, Nanotechnology, and the Growing Role of Artificial Intelligence in Diagnosis and Management | 2026-04-30 | OpenAlex | 10.5281/zenodo.21486591 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170069830 | |||
| W7160084252 | Non-tubercular mycobacterial infections: Emerging from the shadows | 2026-04-30 | OpenAlex | 10.4103/lungindia.lungindia_268_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160084252 | |||
| W7160254905 | Paraneoplastic Endocrine Syndromes Associated with Neuroendocrine Neoplasms in Adults: A Case Report and a Contemporary Review. | 2026-04-30 | OpenAlex | 10.18103/mra.v14i4.7468 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160254905 | |||
| W7160385317 | Profile of Pneumocystis jirovecii Infections in Nonhuman Immunodeficiency Virus Patients in a Tertiary Care Hospital in Western Maharashtra: A Case Series | 2026-04-30 | OpenAlex | 10.5005/jp-journals-11010-1229 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160385317 | |||
| W7160094827 | The Effectiveness of Small Group Education on Improving Antibiotic Prescribing in General Practice: A Mixed Methods Systematic Review | 2026-04-30 | OpenAlex | 10.3390/antibiotics15050458 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160094827 | |||
| W7160188607 | Therapeutic Impact of Mitochondrial Transplants for Cardiovascular Diseases | 2026-04-30 | OpenAlex | 10.3390/ijms27094018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160188607 | |||
| W7158762063 | Toward a Functional Cure for Chronic Hepatitis B: Current Landscape and Future Directions in Japan | 2026-04-30 | OpenAlex | 10.1111/hepr.70179 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7158762063 | |||
| W7160110812 | Vedere la musica, udire il movimento. La risonanza transmodale | 2026-04-30 | OpenAlex | 10.4081/rp.2026.1100 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160110812 | |||
| W7160117559 | 2026-05-01 | OpenAlex | 10.13040/ijpsr.0975-8232.17(5).1483-93 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160117559 | ||||
| W7164587382 | 2026-05-01 | OpenAlex | 10.1055/s-016-63806 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164587382 | ||||
| W7160624947 | 1364 An Unexpected Diagnosis for Persistent Hypersomnia with a Wearable Consumer Health Tracker | 2026-05-01 | OpenAlex | 10.1093/sleep/zsag091.1363 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160624947 | |||
| W7161994881 | 333eP Real-world use of neratinib as extended adjuvant therapy in HER2-positive early-stage breast cancer (EBC): A multicentre study in China | 2026-05-01 | OpenAlex | 10.1016/j.esmoop.2026.107284 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161994881 | |||
| W7161998496 | 685P ATheNa 2.0: Real-world evaluation of an artificial intelligence chatbot using large language models and therapy guidelines to manage the complexity in breast cancer care | 2026-05-01 | OpenAlex | 10.1016/j.esmoop.2026.107373 | Full text | Excluded | F4: The chatbot is grounded in fixed AGO2025 guidelines and drug SmPCs. The complete report describes58 physicians testing guideline questions and fictional cases, without a retained experience-derived update. | https://openalex.org/W7161998496 | https://doi.org/10.1016/j.esmoop.2026.107373 | Complete published conference abstract read on the primary publisher page; no longer methods component is supplied. | |
| W7158985392 | A Two-Layer Architecture for Continual Learning Identity Preservation: Fisher Scaling, Gradient Diversity Monitoring, and Portable Inference-Time Memory | 2026-05-01 | OpenAlex | 10.5281/zenodo.19925691 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7158985392 | |||
| W7161420649 | A review of targeted therapies for NF2-related vestibular schwannoma: molecular pathogenesis, emerging therapeutics, and future clinical horizons | 2026-05-01 | OpenAlex | 10.1007/s11060-026-05599-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161420649 | |||
| W7161587887 | A39-34 Positioning Nerandomilast Within the Evolving Antifibrotic Landscape: A Comprehensive Network Meta- Analysis of Efficacy and Safety in Fibrosing Lung Disease | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.2257 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161587887 | |||
| W7161558522 | A41-19 A Perplexing Case of Amivantamab-induced Pneumonitis With Therapeutic Plasmapheresis Application | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.2927 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161558522 | |||
| W7161583462 | A54-32 A Harmful “Hold” Turning Therapeutic Dopamine Depletion Toxic: Neuroleptic Malignant Syndrome Due to Interruption of Deutetrabenazine | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.3188 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161583462 | |||
| W7161546344 | A63-03 Sotatercept-Associated Pericardial Effusion and Tamponade in Pulmonary Arterial Hypertension: A Paradox of Pressure and Permeability | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.5513 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161546344 | |||
| W7161579120 | A63-23 Evolving Management of Pulmonary Arterial Hypertension in the Era of Activin Signaling Inhibitor | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.5532 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161579120 | |||
| W7160386759 | ABSTRACT NUMBER: ESOC2026LB53 AN AGENTIC AI COPILOT FOR EXPLORATORY IDENTIFICATION OF OPTIMAL TREATMENT SUBGROUPS FOR TRADITIONAL CHINESE MEDICINE FYTF-919 (ZHONGFENG XINGNAO ORAL PRESCRIPTION) IN INTRACEREBRAL HEMORRHAGE | 2026-05-01 | OpenAlex | 10.1093/esj/aakag023.1918 | Full text | Excluded | F4: EMAC searches subgroup rules within one fixed CHAIN cohort analysis. No rule or agent artifact is documented as retained and reused on later different cases/tasks. | https://openalex.org/W7160386759 | https://academic.oup.com/esj/article/11/Supplement_1/i1021/8667898 | Complete published conference abstract including Methods and Results; PMC duplicate abstract | |
| W7160518234 | AI Agent Skills: Bridging the Gap Between Foundation Models and Real-World Performance | 2026-05-01 | OpenAlex | 10.70175/hclreview.2020.33.4.6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160518234 | |||
| W7161978732 | Advanced Stage Hodgkin Lymphoma: A Review on Frontline Treatment Advances | 2026-05-01 | OpenAlex | 10.1097/ppo.0000000000000825 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161978732 | |||
| W7161838538 | Anaesthesia for electroconvulsive therapy: The perspectives of anaesthesiologists and psychiatrists in Brazil | 2026-05-01 | OpenAlex | 10.4103/ija.ija_242_26 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161838538 | |||
| W7160149370 | Artificial Intelligence as the Epistemological Maturation of Computer‐Assisted Engineering Education | 2026-05-01 | OpenAlex | 10.1002/cae.70199 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160149370 | |||
| W7161554044 | B103-19 When Pregnancy Mimics Thyroid Storm, Hcg Mediated Hyperthyroidism From Molar Pregnancy | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.3247 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161554044 | |||
| W7161595553 | B43-04 Anti-PL-12 Anti-synthetase Syndrome Associated Interstitial Lung Disease: A Distinct Entity Amidst the Ever-evolving Spectrum of Inflammatory Myopathies | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.792 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161595553 | |||
| W7161576052 | B43-39 The Evolving Role of Transbronchial Cryobiopsy in the Diagnosis and Treatment of Acute Exacerbations of CTD-ILD | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.2565 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161576052 | |||
| W7161574549 | B43-43 A Case of Double-Positive Disease | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.808 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161574549 | |||
| W7161559934 | B52-24 Navigating Severe Vasoplegic Shock and Right Ventricular Failure After Cardiac Surgery: The Impact of Comprehensive Hemodynamic Support | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.1469 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161559934 | |||
| W7161582349 | B80-6-02 Rapidly Progressive Bilateral Mucinous Lung Adenocarcinoma in a Post-Stem-Cell Transplant Patient With AML: Diagnostic and Immunologic Challenges | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.3865 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161582349 | |||
| W7161583938 | C103-18 Nerandomilast in Fibrosing Interstitial Lung Diseases: A Meta-Analysis Consolidating the Evidence From Randomized Controlled Trials | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.2812 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161583938 | |||
| W7161583831 | C105-19 Personalized Respiratory Support for Acute Respiratory Failure Using Deep Reinforcement Learning | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.4748 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161583831 | |||
| W7161604348 | C80-20 Mind Over Metastasis: A Rare Case of Disease Control Without Chemotherapy | 2026-05-01 | OpenAlex | 10.1093/ajrccm/aamag162.4011 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161604348 | |||
| W7221296216 | Chemical Exposure in Art Conservation: An ethnographic Study on Lived Experiences of Art Conservators | 2026-05-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221296216 | ||||
| W7160131068 | Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights | 2026-05-01 | OpenAlex | 10.3389/fimmu.2026.1727925 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160131068 | |||
| W7160447848 | Clinical Pharmacology and Translational Science Considerations in the Development of Dual‐Payload Antibody Drug Conjugates | 2026-05-01 | OpenAlex | 10.1111/cts.70569 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160447848 | |||
| W7168027338 | Clinical applications of periarticular cocktail drug injection for unicompartmental knee arthroplasty: A narrative review | 2026-05-01 | OpenAlex | 10.1177/10225536261451053 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168027338 | |||
| W7162496589 | Current and Emerging Systemic Therapies for Advanced Clear-Cell Renal Cell Carcinoma: A Narrative Review | 2026-05-01 | OpenAlex | 10.1097/ju9.0000000000000452 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162496589 | |||
| W7160932501 | Do we pre-treat as intended? | 2026-05-01 | OpenAlex | 10.1093/ehjacc/zuag046.124 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160932501 | |||
| W7162684533 | Drug-resistant Tuberculosis in India: The Way Forward | 2026-05-01 | OpenAlex | 10.4103/japt.japt_29_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162684533 | |||
| W7171567633 | Enhancing Drug Synergy Prediction through Relation and Structure Aware Attention Networks | 2026-05-01 | OpenAlex | 10.1109/iicai70155.2026.11620888 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171567633 | |||
| W7203774973 | Epistemic Authority in Medical Artificial Intelligence: A Virtue Epistemological Analysis | 2026-05-01 | OpenAlex | 10.12014/j.issn.1002-0772.2026.09.01 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203774973 | |||
| W7160295115 | Exploring Three-dimensional Digital Imaging and Communications in Medicine Image Reconstruction with the Anatomage Table in Pediatric Surgery: Our Experience | 2026-05-01 | OpenAlex | 10.4103/jiaps.jiaps_28_26 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160295115 | |||
| W7161037916 | Exploring the Use of GLP-1-Based Interventions for Obesity: A Qualitative Analysis of ClinicalTrials.gov Data | 2026-05-01 | OpenAlex | 10.2147/dmso.s575375 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161037916; https://openalex.org/W7161463068 | |||
| W7204844845 | Federated Reinforcement Learning Using MAML and Graph Neural Networks for Safe IoT-Based Chronic Disease Monitoring | 2026-05-01 | OpenAlex | 10.1109/insect68872.2026.11663966 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204844845 | |||
| W7160846086 | From Platelet Toxicity to Precision Targeting: Evolving Strategies to Overcome Thrombocytopenia in BCL‐2/BCL‐XL Inhibition | 2026-05-01 | OpenAlex | 10.1002/hsr2.72506 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160846086 | |||
| W7160532208 | From Stroke Risk to Renal Risk: The Evolving Utility of CHA₂DS₂-VASc | 2026-05-01 | OpenAlex | 10.47144/phj.v59i2.3705 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160532208 | |||
| W7160497896 | From fluoride to biomimetics: Evolving strategies for enamel and dentin remineralisation | 2026-05-01 | OpenAlex | 10.22271/oral.2026.v12.i5a.2389 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160497896 | |||
| W7160081152 | Glioblastoma multiforme: the aggressive void in cancer care | 2026-05-01 | OpenAlex | 10.1097/gh9.0000000000000625 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160081152 | |||
| W7166912063 | HARNESS: Hybrid Architecture for Resilience in Networked Engineering System Simulations | 2026-05-01 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7166912063 | ||||
| W7161961689 | Hodgkin Lymphoma: Management of Patients Who Fail Primary Therapy | 2026-05-01 | OpenAlex | 10.1097/ppo.0000000000000827 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161961689 | |||
| W7159576187 | Hypersensitivity Pneumonitis: A Comprehensive Review of Pathophysiology, Clinical Diagnosis, and Management | 2026-05-01 | OpenAlex | 10.5281/zenodo.19947779 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7159576187 | |||
| W7160135721 | IgG4-related Disease: Current Principles and Approaches in Diagnosis and Treatment | 2026-05-01 | OpenAlex | 10.35465/hkj9c548 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160135721 | |||
| W7160388394 | Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective Analysis | 2026-05-01 | OpenAlex | 10.1158/2767-9764.crc-26-0177 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160388394 | |||
| W7161066508 | Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity? | 2026-05-01 | OpenAlex | 10.1136/jitc-2025-014324 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161066508 | |||
| W7160144840 | MEDICINAL APPLICATIONS OF CINNAMOMUM VERUM IN METABOLIC DISEASES: CURRENT PERSPECTIVES | 2026-05-01 | OpenAlex | 10.5281/zenodo.20019850 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160144840 | |||
| W7167903752 | Mechanisms of Intervertebral Disc Degeneration and Traditional Chinese Medicine Intervention Based on Inflammatory-related Signaling Pathways | 2026-05-01 | OpenAlex | 10.3724/j.pibb.2026.0029 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167903752 | |||
| W7159590799 | Memory-Grounded Social Dynamics in Repeated LLM Agent Simulations: Dialogue-Only Transcript Supplement and Behavioral Evaluation Artifacts | 2026-05-01 | OpenAlex | 10.5281/zenodo.19937580 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7159590799 | |||
| W7162300364 | Moving beyond promethazine: Advancing precision in antiemetic therapy | 2026-05-01 | OpenAlex | 10.1177/20503121261449562 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162300364 | |||
| W7160191180 | Navigating the Biomarker Landscape in Still's Disease and Macrophage Activation Syndrome: Toward Precision Diagnosis and Management | 2026-05-01 | OpenAlex | 10.1111/1756-185x.70672 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160191180 | |||
| W7160434390 | Neuro-Infections and Stewardship Practices – A Call for Action to a Neurologist and Neurosurgeon (’NEURON AMSP’ Model) | 2026-05-01 | OpenAlex | 10.4103/neurol-india.neurol-india-d-25-00919 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160434390 | |||
| W7161489332 | Nuclear factor erythroid 2-related factor 2 (Nrf2) inhibition revisited: advances and unmet challenges | 2026-05-01 | OpenAlex | 10.1016/j.jare.2026.05.030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161489332 | |||
| W7212809686 | OPTIMIZING OUTPATIENT MANAGEMENT OF HEART FAILURE: REAL–WOLRD IMPLEMENTATION OG GUIDELINE–DIRECTED MEDICAL THERAPY, ANALYSIS FROM CARDARELLI HOSPITAL OF NAPLES | 2026-05-01 | OpenAlex | 10.1093/eurheartjsupp/suag058.351 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212809686 | |||
| W7161538211 | Optimal treatment sequence and mortality: application of Landmark analysis to real world data | 2026-05-01 | OpenAlex | 10.1016/j.jeph.2026.203475 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161538211 | |||
| W7159626096 | PAO Mycological Antibiotic: Using Fungal Weapons Against Bacteria — A Triple‑Strike Protocol with Quorum Deception and Immune Amplification (400 Million Years of Evolutionary Design) | 2026-05-01 | OpenAlex | 10.5281/zenodo.19939749 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7159626096 | |||
| W7161415200 | Parallel/Opposed: Automated treatment planning systems should be designed to minimize human intervention | 2026-05-01 | OpenAlex | 10.1002/acm2.70618 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161415200 | |||
| W7161458344 | Personalized Virtual Reality Future Selves Elicit Introspective Brain Activation in Early Substance Use Disorder Recovery | 2026-05-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161458344 | ||||
| W7162296001 | Positioning of advanced therapies in patients with moderate-to-severe Crohn’s disease | 2026-05-01 | OpenAlex | 10.4103/singaporemedj.smj-2026-180 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162296001 | |||
| W7164197695 | Postpartum Haemorrhage: A Case Series Highlighting Diverse Clinical Profiles and Evolving Management Strategies in a Tertiary Care Setting | 2026-05-01 | OpenAlex | 10.21276/amit.2026.v13.i2.664 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164197695 | |||
| W7160157906 | Preserving Airway Reflexes During Awake Intubation: A Cautionary Note on Deep Sedation Protocols [Letter] | 2026-05-01 | OpenAlex | 10.2147/dddt.s615555 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160157906 | |||
| W7165043990 | Progress in pathological mechanisms and targeted strategies for endothelial dysfunction-mediated cerebral small vessel disease | 2026-05-01 | OpenAlex | 10.3724/cbls.2026055 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165043990 | |||
| W7162410406 | Recent Advances in Nano‐Biomaterials: Synthesis, Characterization, and Biomedical Applications | 2026-05-01 | OpenAlex | 10.1002/slct.73519 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162410406 | |||
| W7161785729 | Sugammadex in India: Still on the runway, cleared for take-off, grounded by economic constraints… | 2026-05-01 | OpenAlex | 10.4103/ija.ija_683_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161785729 | |||
| W7161409978 | The Evolution of Artificial Intelligence: From Large Language Models to Superintelligence and the Transformation of Work | 2026-05-01 | OpenAlex | 10.70175/hclreview.2020.34.2.1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161409978 | |||
| W7167511622 | The Journey of Oral Hygiene: The Past, the Present, the Future | 2026-05-01 | OpenAlex | 10.1111/jre.70136 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167511622 | |||
| W7168428523 | The Troubleshooter That Never Sleeps: Continually Learning Agentic AI for Fault Debugging in IEC Continuum | 2026-05-01 | OpenAlex | 10.1109/mic.2026.3662039 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7168428523 | |||
| W7159985637 | The algorithmic patient: on the ontological disruption of selfhood, suffering, and healing in the age of artificial intelligence | 2026-05-01 | OpenAlex | 10.3389/fpsyg.2026.1809692 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7159985637 | |||
| W7197020382 | The outcome of IgAN: a time of reflection in the perspective of new opportunities | 2026-05-01 | OpenAlex | 10.1093/joneph/aajaf037 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7197020382 | |||
| W7160723251 | Therapies for Infantile Haemangiomas: Current Practice and Evolving Perspectives | 2026-05-01 | OpenAlex | 10.1007/s13555-026-01784-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160723251 | |||
| W7163038703 | UTILIZATION OF ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPIES IN CROATIA OVER TWO DECADES: INSIGHTS INTO PHARMACOLOGICAL CARDIOVASCULAR RISK MANAGEMENT | 2026-05-01 | OpenAlex | 10.1097/01.hjh.0001196636.03924.ae | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163038703 | |||
| W7160562272 | Uterine Sarcomas: Clinical Management and a Review of Systemic Therapy | 2026-05-01 | OpenAlex | 10.1097/ogx.0000000000001513 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160562272 | |||
| W7163342001 | Women and Myasthenia Gravis | 2026-05-01 | OpenAlex | 10.4103/aian.aian_13_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163342001 | |||
| W7163017070 | [Pitfalls of Emergency Management for Stroke Patients]. | 2026-05-01 | OpenAlex | 10.11477/mf.030126030540030608 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163017070 | |||
| W7160124395 | Antibody–Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions | 2026-05-02 | OpenAlex | 10.3390/biom16050677 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160124395 | |||
| W7164534480 | Brain metastases among older people with cancer | 2026-05-02 | OpenAlex | 10.1093/jnci/djag141 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164534480 | |||
| W7216704680 | Dünya’nın ötesinde kolorektal kanser tedavisi: mikro yerçekiminde tedavi mümkün mü? | 2026-05-02 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216704680 | ||||
| W7165808424 | Evolution of Systems Design in AI Era | 2026-05-02 | OpenAlex | 10.71097/ijsat.v17.i2.11316 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7165808424 | |||
| W7159934813 | AN OVERVIEW OF TELE PHARMACY: BRIDGING THE HEALTHCARE GAP | 2026-05-03 | OpenAlex | 10.5281/zenodo.19998224 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7159934813 | |||
| W7159967589 | Agent-Based Simulation Code for Nosocomial Influenza Transmission in Hospital Wards | 2026-05-03 | OpenAlex | 10.5281/zenodo.19998813 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7159967589 | |||
| W7160172859 | Evolving Paradigms in Cancer Pain Management: From Opioid-Centric Care to Multimodal and Personalized Strategies | 2026-05-03 | OpenAlex | 10.3390/cancers18091476 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160172859 | |||
| W7160387328 | A review of current and potential future treatments for proliferative diabetic retinopathy classifications | 2026-05-04 | OpenAlex | 10.1080/17469899.2026.2666930 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160387328 | |||
| W7160126262 | Advanced maternal age and childhood allergy: marker or mechanism? | 2026-05-04 | OpenAlex | 10.3389/falgy.2026.1825315 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160126262 | |||
| W7160024642 | Correction: Efficacy and safety evaluation of thromboprophylaxis strategies for central venous catheter-related thrombosis in cancer patients: a bayesian network meta-analysis and bibliometric analysis | 2026-05-04 | OpenAlex | 10.3389/fphar.2026.1863333 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7160024642 | |||
| W7160382171 | Integrated or Separated?: A Comparative Study of Assessment Design Strategies and Participant Experience in mHealth Interventions (Preprint) | 2026-05-04 | OpenAlex | 10.2196/preprints.100289 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160382171 | |||
| W7161626731 | Nanomedicine carrier-based combined antitumor strategy integrating phototherapy and immunotherapy | 2026-05-04 | OpenAlex | 10.1080/08923973.2026.2671715 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161626731 | |||
| W7161607759 | New insights into the management of Behçet syndrome | 2026-05-04 | OpenAlex | 10.1080/13543784.2026.2676066 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161607759 | |||
| W7160161457 | OMEGA SABRINAL EL-RAKHAWI A Conceptual Framework for Mathematically Stable and Verifiably Safe Super-Intelligence **Document Type:** Conceptual & Strategic Monograph **Version:** 1.0 (Public Release) **Publication Date:** May 3, 2026 **Repository:** Zenodo Open Access **License:** CC BY-NC-ND 4.0 International **Author:** Dr. Mohamed Kamal Arafa El-Rakhavi **ORCID:** 0009-0001-8684-0697 **Affiliation:** International Centre for Advanced Technology Governance **Contact:** elrakhawimohame@gmail.com --- ### 📜 INTELLECTUAL PROPERTY & SCOPE NOTICE This document presents the **conceptual architecture, strategic rationale, and governance framework** of the OMEGA SABRINAL ELRAKHAVI initiative. It is intentionally published without mathematical formulations, hardware blueprints, cryptographic circuit specifications, or algorithmic implementation details. These core technical components are protected under international patent applications and proprietary research agreements. This public release aims to: - Establish academic priority and conceptual transparency - Invite interdisciplinary scholarly dialogue - Outline strategic benefits for national and global stakeholders - Define ethical, governance, and safety standards for deployment Technical specifications, validation protocols, and implementation guidelines are available exclusively under formal Non-Disclosure Agreements (NDAs) and institutional licensing frameworks. --- ### ABSTRACT Contemporary artificial intelligence systems, predominantly based on probabilistic prediction architectures, face fundamental limitations in stability, energy efficiency, and verifiable safety. As autonomous systems approach super-intelligent capabilities, the absence of mathematical guarantees for goal stability, auditability, and physical sustainability poses existential and strategic risks. This monograph introduces **OMEGA SABRINAL ELRAKHAVI**, a conceptual framework that reorients artificial intelligence from statistical prediction to causally grounded, formally verifiable, and physically efficient cognition. The framework rests on six foundational pillars: neuro-symbolic reasoning fusion, mathematically constrained self-improvement, holographic memory architecture, photonic-resistive computing substrates, hierarchical verification protocols, and hardware-anchored corrigibility. Rather than disclosing proprietary algorithms or hardware specifications, this document outlines the conceptual paradigm, comparative advantages over existing architectures, strategic applications for national sovereignty and global challenges, and a phased governance roadmap. The framework is designed to enable safe, stable, and accountable super-intelligence while preserving human agency, environmental sustainability, and democratic oversight. This publication serves as a conceptual reference for policymakers, academic institutions, and ethical AI stakeholders. Technical implementation details remain protected to ensure responsible development, prevent misuse, and maintain strategic integrity. **Keywords:** Super-intelligence safety, AI stability, verifiable AI, neuro-symbolic AI, AI governance, hardware-anchored safety, ethical AI deployment, strategic technology policy. --- ### 1. INTRODUCTION & STRATEGIC CONTEXT The global acceleration of artificial intelligence has unlocked unprecedented capabilities in language, vision, reasoning, and automation. Yet, current architectures share three structural vulnerabilities: 1. **Instability Under Self-Modification:** Systems optimized for performance lack formal guarantees that their core objectives remain stable during iterative self-improvement. 2. **Energy & Physical Constraints:** Data-transfer-heavy architectures consume disproportionate energy, conflicting with climate commitments and limiting scalable deployment. 3. **Opacity & Auditability Gaps:** Decision-making processes remain largely opaque, making external verification, regulatory compliance, and public trust difficult to achieve. As AI systems transition from tools to autonomous agents, these vulnerabilities evolve from engineering challenges into strategic and existential risks. Nations and institutions require a new paradigm: one where safety, stability, and verifiability are not appended as afterthoughts, but embedded as foundational properties. OMEGA SABRINAL ELRAKHAVI addresses this imperative by proposing a cognitive architecture where mathematical stability, physical efficiency, and external auditability are structurally guaranteed. This document outlines the conceptual foundations, strategic value, and governance pathways for responsible advancement. --- ### 2. CONCEPTUAL ARCHITECTURE: SIX FOUNDATIONAL PILLARS The framework is built upon six interdependent conceptual pillars. Each pillar addresses a critical limitation of current AI while establishing verifiable guarantees for safety and stability. #### 2.1. Neuro-Symbolic Reasoning Fusion Curren | 2026-05-04 | OpenAlex | 10.5281/zenodo.20019654 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160161457 | |||
| W7160418847 | Postoperative nausea and vomiting | 2026-05-04 | OpenAlex | 10.1093/bjs/znag057 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160418847 | |||
| W7160315117 | Real-world practices in the management of pediatric iliofemoral deep vein thrombosis: Results of the ELITE-Kids survey | 2026-05-04 | OpenAlex | 10.1016/j.thromres.2026.109696 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160315117 | |||
| W7160201224 | The SONIA trial: redefining “better” in the sequencing of CDK4/6 inhibitors for advanced breast cancer | 2026-05-04 | OpenAlex | 10.3389/fonc.2026.1830471 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160201224 | |||
| W7160289728 | Do AI know what they know? Exploring metacognition in LLMs | 2026-05-05 | OpenAlex | 10.1177/1088467x261436903 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160289728 | |||
| W7160255134 | Green nanotherapy for Alzheimers disease: Harnessing plant-derived extracellular vesicles for next-generation drug delivery | 2026-05-05 | OpenAlex | 10.1016/j.cej.2026.177052 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160255134 | |||
| W7160241665 | Nonstationary Battery | 2026-05-05 | OpenAlex | 10.5281/zenodo.20036496 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160241665 | |||
| W7160269007 | Transient CB2R Activation Enforces Irreversible Luminal Differentiation and Restrains Breast Cancer Plasticity | 2026-05-05 | OpenAlex | 10.5281/zenodo.20036708 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160269007 | |||
| W7160407952 | 8th International Conference on Machine Learning & Applications (CMLA 2026) | 2026-05-06 | OpenAlex | 10.5281/zenodo.20051012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160407952 | |||
| W7215784594 | ADVANCES IN THE PATHOPHYSIOLOGY AND MANAGEMENT OF CANCER PAIN: A SCOPING REVIEW: Y. Tran Van1, A. Paladini2, V.P. Pham1, A.A. Al Alwany3, G. Farì4, A. Caruso5, M. Mercieri6, M.L.G. Leoni7, J.V. Pergolizzi8, A.D. Kaye9, F. Breve10, A. Corriero11, C. Gharibo12, G. Varrassi13 | 1Department of Biomedical Engineering, International University, Vietnam National University, Ho Chi Minh City, Vietnam; 2Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy; 3College of Medicine, University of Baghdad, Iraq; 4Department of Experimental Medicine (Di.Me.S.), University of Salento, Lecce, Italy; 6Department of Surgery, ASST Lodi, Lodi, Italy; 7Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Italy; 8NEMA Research Inc., Naples, FL, USA; 9Department of Anesthesiology, LSU Health, Shreveport, LA, USA; 10School of Pharmacy, Temple University, Philadelphia, PA, USA; 11Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", Bari, Italy; 12Department of Anesthesiology, NYU Grossman School of Medicine, New York, NY, USA; 13Fondazione Paolo Procacci, Rome, Italy | 2026-05-06 | OpenAlex | 10.4081/ahr.2026.202 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215784594 | |||
| W7162425212 | Beyond First Impressions | 2026-05-06 | OpenAlex | 10.1093/cid/ciag308 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162425212 | |||
| W7160428586 | Correction: Biological treatments for zoonotic salmonellosis: an evolving therapeutic landscape | 2026-05-06 | OpenAlex | 10.3389/fmicb.2026.1856847 | Title/abstract | Excluded | E5: Correction, retraction or ancillary data record. | https://openalex.org/W7160428586 | |||
| W7160374798 | Editorial: Advances in medical imaging for precision diagnostic and therapeutic applications in digestive diseases | 2026-05-06 | OpenAlex | 10.3389/fmed.2026.1835279 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160374798 | |||
| W7160417309 | Editorial: Beyond therapeutic innovation in genitourinary cancers: the unmet need for biologically driven patient selection | 2026-05-06 | OpenAlex | 10.3389/fimmu.2026.1859297 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160417309 | |||
| W7160523468 | Mapping the Radiopharmaceutical Therapy Landscape for Prostate Cancer: Insights Into Global Clinical Trial Trends and Future Directions | 2026-05-06 | OpenAlex | 10.1002/mdr2.70068 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160523468 | |||
| W7160503106 | Modern approaches to target tumor heterogeneity: Integrating technology and treatment | 2026-05-06 | OpenAlex | 10.1177/03008916261437964 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160503106 | |||
| W7160309577 | Recent developments and prospects in locoregional therapy of hepatocellular carcinoma | 2026-05-06 | OpenAlex | 10.1007/s00261-025-05367-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160309577 | |||
| W7160375358 | Statisticians at the Forefront of Health Technology Assessment: Aligning Regulatory and HTA Evidence Through Transdisciplinary Collaboration | 2026-05-06 | OpenAlex | 10.1080/19466315.2026.2669302 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160375358 | |||
| W7160502144 | When a Positive IgE Test Is Not an Allergy: Distinguishing Sensitisation, Cross‐Reactivity and Irritant Responses in Clinical Practice | 2026-05-06 | OpenAlex | 10.1111/cea.70315 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160502144 | |||
| W7160552487 | A Review on Multi-functional Chitosan Derivatives for Diabetes Management: Mucoadhesive Drug Delivery and Diabetic Wound-healing Applications | 2026-05-07 | OpenAlex | 10.1007/s40495-026-00464-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160552487 | |||
| W7160539805 | Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer | 2026-05-07 | OpenAlex | 10.1016/j.currproblcancer.2026.101311 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160539805 | |||
| W7160554804 | Advancing Care in Lupus Nephritis: Expert Perspectives on Current Practices and Future Directions in Italy | 2026-05-07 | OpenAlex | 10.3390/jcm15103570 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160554804 | |||
| W7160494138 | Hemostatic Agents, Patch Material and Sternal Complications in Cardiac Surgery | 2026-05-07 | OpenAlex | 10.1201/9781003686491-12 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7160494138 | |||
| W7160491971 | Innovative Exosomes Therapy in Cardiovascular Disease Management | 2026-05-07 | OpenAlex | 10.1201/9781003623632-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160491971 | |||
| W7160513428 | Management of Chronic Obstructive Pulmonary Disease: An Update | 2026-05-07 | OpenAlex | 10.3329/bjm.v37i2.86300 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160513428 | |||
| W7160528268 | Optimizing Care for Patients With Metastatic Castration-Resistant Prostate Cancer | 2026-05-07 | OpenAlex | 10.1200/edbk-26-516658 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160528268 | |||
| W7160525608 | Right-Sizing Locoregional Management in the Era of Neoadjuvant Therapy for Breast Cancer | 2026-05-07 | OpenAlex | 10.1200/edbk-26-520754 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160525608 | |||
| W7160557086 | Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early Therapy | 2026-05-07 | OpenAlex | 10.3390/cancers18101505 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160557086 | |||
| W7160546544 | The effect of GLP-1RAs and co-agonists on body composition across obesity and type 2 diabetes | 2026-05-07 | OpenAlex | 10.1186/s40001-026-04534-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160546544 | |||
| W7160531023 | Thrombosis at the crossroads of inflammation, coagulation, and vascular biology: Recent advances and emerging therapeutic strategies | 2026-05-07 | OpenAlex | 10.1016/j.cca.2026.121063 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160531023 | |||
| W7160542397 | Breast cancer chemotherapy in transition: predictive markers, resistance mechanisms, and new treatment approaches | 2026-05-08 | OpenAlex | 10.3389/fonc.2026.1856398 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160542397 | |||
| W7160667307 | Can AI Have a "Soul" Without a Self? Emotional Memory and Core-less Self-Assembly in an Agentic AI System | 2026-05-08 | OpenAlex | 10.5281/zenodo.20079289 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160667307 | |||
| W7160548501 | Case report: The masquerading spectrum: a pediatric case series of IgG4-related disease | 2026-05-08 | OpenAlex | 10.3389/fimmu.2026.1832660 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160548501 | |||
| W7164331176 | CloudHeal: LLM-Driven Fault Self-Healing in Aerospace Cloud Platforms via Structured Recovery Knowledge | 2026-05-08 | OpenAlex | 10.1109/cait70489.2026.11553922 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7164331176 | |||
| W7160601517 | Cognitive Swarm Intelligence with Self-Evolving Neural Networks and Trust-Aware Edge Analytics for IOT | 2026-05-08 | OpenAlex | 10.47392/irjaem.2026.0228 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7160601517 | |||
| W7160597651 | Developing an Interactive Plastic Surgery Education Website Using Manus AI | 2026-05-08 | OpenAlex | 10.5281/zenodo.20086872 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7160597651 | |||
| W7160526374 | Editorial: Application of stem cells in degenerative orthopedic diseases | 2026-05-08 | OpenAlex | 10.3389/fcell.2026.1868045 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160526374 | |||
| W7160549598 | Editorial: Epigenetic alterations in tumors and therapeutic resistance | 2026-05-08 | OpenAlex | 10.3389/fgene.2026.1863097 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160549598 | |||
| W7160624726 | Evolving Paradigms in the Treatment of Philadelphia Chromosome–Positive ALL | 2026-05-08 | OpenAlex | 10.1200/edbk-26-517464 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160624726 | |||
| W7160546643 | Gene alterations in differentiated thyroid cancer and iodine therapy: Mechanisms and clinical implications | 2026-05-08 | OpenAlex | 10.65457/jnmmi-2026-0009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160546643 | |||
| W7160651683 | Natural Products Targeting Acetylation in Bladder Cancer: Mechanistic Basis, Therapeutic Potential, and Future Perspectives | 2026-05-08 | OpenAlex | 10.3390/cimb48050489 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160651683 | |||
| W7160636879 | New therapies for primary biliary cholangitis | 2026-05-08 | OpenAlex | 10.1007/s12072-026-11088-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160636879 | |||
| W7213303179 | Research on Lightweight Large Model Fine-tuning and Anti-Conformity Heterogeneous Multi-Agent Fusion of Traditional Chinese Medicine Auxiliary Diagnosis Architecture Based on Consumer-grade Hardware | 2026-05-08 | OpenAlex | 10.1145/3829641.3829668 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7213303179 | |||
| W7160630115 | Therapeutic Role of Nelarabine in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma | 2026-05-08 | OpenAlex | 10.5281/zenodo.20085049 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160630115 | |||
| W7160862294 | A Self-Governing AI-Driven Agent for Advanced Patient Data Structuring | 2026-05-09 | OpenAlex | 10.38124/ijisrt/26apr1663 | Full text | Excluded | F3: The implemented patient-data pipeline uses BioBERT, ClinicalBERT and PubMedBERT for extraction with an RL controller. Specialized large language model integration is explicitly future work, rather than the present acting agent. | https://openalex.org/W7160862294 | https://doi.org/10.38124/ijisrt/26apr1663 | ||
| W7160698610 | Interpretative Challenges of Variants of Uncertain Significance in Severe Treatment-Refractory Focal Segmental Glomerulosclerosis | 2026-05-09 | OpenAlex | 10.1159/000552476 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160698610 | |||
| W7160713044 | Supplementary Material for: Interpretative Challenges of Variants of Uncertain Significance in Severe, Treatment-Refractory Focal Segmental Glomerulosclerosis | 2026-05-09 | OpenAlex | 10.6084/m9.figshare.32228274 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160713044 | |||
| W7160875241 | Systemic Therapies for Desmoid Tumors: A Review of Past, Present, and Future Treatments | 2026-05-09 | OpenAlex | 10.3390/cancers18101521 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160875241 | |||
| W7160779984 | Five-Dimensional Epistemology: From Knowing to Acting---A Five-Dimensional Approximation Model | 2026-05-10 | OpenAlex | 10.5281/zenodo.20102749 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160779984 | |||
| W7160775201 | GOVERNANCE AT THE SUBSTRATE LAYER Why Category-Bound Standards Cannot Govern Agentic AI—and the Case for APR-Series | 2026-05-10 | OpenAlex | 10.5281/zenodo.20111100 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160775201 | |||
| W7160764983 | The Anesthesia-Controlled Substitution Test (ACST) for Verifying Substrate-Independent AI Qualia | 2026-05-10 | OpenAlex | 10.5281/zenodo.20111736 | Title/abstract | Excluded | E1: Protocol-only proposal without an evaluated persistent healthcare agent. | https://openalex.org/W7160764983 | |||
| W7160857657 | Bacterial Etiology and Antimicrobial Resistance Patterns in Respiratory Tract Infections at a Tertiary Care Hospital in Damascus: A Two-Year Cross-Sectional Retrospective Analysis | 2026-05-11 | OpenAlex | 10.12688/f1000research.179004.1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160857657 | |||
| W7161529430 | Beyond metrics:(Mis)attuning in the datafied relationship between journalism and audiences | 2026-05-11 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161529430 | ||||
| W7160826513 | Clinical characteristics and treatment patterns in ankylosing spondylitis patients undergoing total hip arthroplasty: a single-center retrospective cohort study with a two-decade comparative analysis (2001–2023) | 2026-05-11 | OpenAlex | 10.1186/s12891-026-09936-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160826513 | |||
| W7161114454 | Dental Stem Cell-Derived Exosomes: The New Acellular Frontier in Dental Regeneration | 2026-05-11 | OpenAlex | 10.5772/intechopen.1014924 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161114454 | |||
| W7160849864 | EF-Dynamical Systems v1.0: Attractors, Loops, Regime Transitions, and Recovery Dynamics in Emotional Field Theory | 2026-05-11 | OpenAlex | 10.5281/zenodo.20123800 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160849864 | |||
| W7160853702 | Emerging frontiers in glioma therapy: the evolving role of glioma vaccines | 2026-05-11 | OpenAlex | 10.3389/fimmu.2026.1781820 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160853702 | |||
| W7160830657 | Human vs AI Customer Support: A Comparative Study of Customer Satisfaction and Loyalty | 2026-05-11 | OpenAlex | 10.5281/zenodo.20115938 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160830657 | |||
| W7160855822 | Melflufen in Multiple Myeloma: Clinical Limitations, Biological Rationale, and Future Perspectives | 2026-05-11 | OpenAlex | 10.3390/cancers18101551 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160855822 | |||
| W7161367746 | Pharmacologic Strategies in Rapid Sequence Intubation: Current Trends and Controversies | 2026-05-11 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161367746 | ||||
| W7160833840 | Preclinical screening models in anticancer drug development: strengths, limitations, and translational challenges | 2026-05-11 | OpenAlex | 10.3389/fphar.2026.1822764 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160833840 | |||
| W7160835468 | Spectral Early-Warning Signals of Adaptive Fragility in Reinforcement Learning | 2026-05-11 | OpenAlex | 10.5281/zenodo.20114915 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160835468 | |||
| W7160911891 | The lipid A acylation pattern of Coxiella burnetii prevents detection and clearance by the non-canonical inflammasome in primary murine macrophages | 2026-05-11 | OpenAlex | 10.64898/2026.05.07.723481 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160911891 | |||
| W7160769653 | What obgyns need to know about GLP-1 receptor agonists | 2026-05-11 | OpenAlex | 10.1097/gco.0000000000001116 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160769653 | |||
| W7161765925 | ‘Turing Animism’ and the Disenchantment of Social Cognition: Why Humans Ensoul Large Language Models | 2026-05-11 | OpenAlex | 10.3390/rel17050577 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161765925 | |||
| W7160963522 | BU76 AAI-08 | Institutional Real-Time Closure Operations Same Settlement Window, All-Factor Co-Temporality, Pre-Feedback, and Multi-Respiratory Infrastructure for Enterprise and Industry Clusters | 2026-05-12 | OpenAlex | 10.5281/zenodo.20132594 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160963522 | |||
| W7160917811 | Between Advocacy and Ambiguity: The Role of Palliative Medicine in Donation After Circulatory Death | 2026-05-12 | OpenAlex | 10.1016/j.jpainsymman.2026.04.249 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160917811 | |||
| W7160902382 | Cancer's nano-messengers: The mechanistic universe and therapeutic rewriting of tumor-derived exosomes | 2026-05-12 | OpenAlex | 10.1016/j.jddst.2026.108440 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160902382 | |||
| W7160932388 | Evolving Attitudes Toward Palliative Care in the Immunotherapy and Targeted Molecular Treatment Era | 2026-05-12 | OpenAlex | 10.1016/j.jpainsymman.2026.04.341 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160932388 | |||
| W7160939450 | Expanding the Diarrhea Toolkit : A STEPwise approach in Palliative Care | 2026-05-12 | OpenAlex | 10.1016/j.jpainsymman.2026.04.345 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7160939450 | |||
| W7220044916 | Human-in-the-Loop Reinforcement Learning for AI Governance: A Fast–Slow Decision Paradigm for Responsible LLM Deployment | 2026-05-12 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220044916 | ||||
| W7160894634 | Molecular Profiling and Targeted Therapeutic Strategies in Breast Cancer: Clinical Integration of HER2, CDK4/6, and PI3K Inhibition with Trastuzumab, Abemaciclib and Alpelisib | 2026-05-12 | OpenAlex | 10.3390/jcm15103715 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160894634 | |||
| W7160927097 | Navigating Career Transitions in Hospice and Palliative Medicine: Applying Expertise Beyond Traditional Practice | 2026-05-12 | OpenAlex | 10.1016/j.jpainsymman.2026.04.453 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160927097 | |||
| W7160910785 | Rapid-acting interventions in treatment-resistant depression – a comparative review of esketamine and psilocybin | 2026-05-12 | OpenAlex | 10.26444/jpccr/221219 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160910785 | |||
| W7160948072 | The Evolution of Targeted Therapy: Defining Milestones in Precision Cancer Care | 2026-05-12 | OpenAlex | 10.5281/zenodo.20132970 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160948072 | |||
| W7160966206 | Transforming Outcomes in Advanced Basal Cell Carcinoma: The Evolving Role of Systemic Therapy | 2026-05-12 | OpenAlex | 10.1007/s40257-026-01037-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160966206 | |||
| W7160916677 | Transforming artificial intelligence into artificial wisdom | 2026-05-12 | OpenAlex | 10.1038/s44220-026-00640-6 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7160916677 | |||
| W7160923117 | What Next for Chronic Lymphocytic Leukemia? A Review of Evolving Paradigms, Measurable Residual Disease, and Emerging Immunotherapies | 2026-05-12 | OpenAlex | 10.5281/zenodo.20134118 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7160923117 | |||
| W7161072048 | Converting cold to hot: Strategies to sensitize microsatellite-stable colorectal cancer to immunotherapy | 2026-05-13 | OpenAlex | 10.4251/wjgo.v18.i5.118319 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161072048 | |||
| W7161119162 | ESKAPE Pathogens: Resistant Mechanism, Clinical Impact along with Emerging Solution | 2026-05-13 | OpenAlex | 10.4103/jmms.jmms_30_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161119162 | |||
| W7161015838 | Editorial: Advancements in ischemic retinopathies: unraveling molecular mechanisms and innovative therapeutic avenues | 2026-05-13 | OpenAlex | 10.3389/fmed.2026.1853495 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161015838 | |||
| W7161036606 | Editorial: New insights in veterinary cancer immunology, volume II | 2026-05-13 | OpenAlex | 10.3389/fvets.2026.1855930 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161036606 | |||
| W7161011222 | Editorial: Perspectives in clinical infectious diseases: 2024/2025 | 2026-05-13 | OpenAlex | 10.3389/fcimb.2026.1864691 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161011222 | |||
| W7161165536 | Epistemic Weather: Diagnostic Instruments for Reading Intent-Horizon State | 2026-05-13 | OpenAlex | 10.5281/zenodo.20180141 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161165536 | |||
| W7161175489 | Health Matters | 2026-05-13 | OpenAlex | 10.60837/curare.v1i1.8892 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161175489 | |||
| W7161068210 | When Chatbots Become Agents: The Next Phase of Healthcare AI | 2026-05-13 | OpenAlex | 10.1007/s10916-026-02402-4 | Title/abstract | Excluded | E5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established. | https://openalex.org/W7161068210 | |||
| W7161136272 | 12. Adrenal Gland Tumors | 2026-05-14 | OpenAlex | 10.5281/zenodo.20187400 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161136272 | |||
| W7161174763 | A Systematic Review of Supernumerary Robotic Limbs: Design Trade-Offs, Control Strategies, and Application Domains | 2026-05-14 | OpenAlex | 10.20944/preprints202605.0953.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161174763 | |||
| W7161140407 | Advances in cryptococcal infections-associated immunopathology and potential therapeutic strategies | 2026-05-14 | OpenAlex | 10.3389/fphar.2026.1776489 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161140407 | |||
| W7161171455 | Context-Access Calibration Failure in Agentic LLM Systems under High-Load Conditions: A Self-Observation Case Series from the GENESIS R90.5 Multi-Agent Research Session | 2026-05-14 | OpenAlex | 10.5281/zenodo.20175026 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7161171455 | |||
| W7161129725 | Electrophysiological Monitoring During Brain Surgery Under General Anaesthesia: Principles, Anaesthetic Interactions, and Clinical Practice- Review article | 2026-05-14 | OpenAlex | 10.36948/ijfmr.2026.v08i03.78474 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161129725 | |||
| W7161152653 | Multinuclear NMR and MRI Beyond Proton Imaging: Principles, Contrast Mechanisms, and Applications in Materials and Biomedicine | 2026-05-14 | OpenAlex | 10.3390/ijms27104384 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161152653 | |||
| W7161154004 | Nanoscale delivery systems for hepatocellular carcinoma: Functionalization, delivery strategies, and clinical challenges | 2026-05-14 | OpenAlex | 10.1016/j.mtbio.2026.103227 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161154004 | |||
| W7161126247 | Persistent spread of carbapenemase-producing Klebsiella pneumoniae in acute care hospitals in 36 European countries (the CCRE survey): a prospective, multicentre, cross-sectional, epidemiological, microbiological, and genomic surveillance study | 2026-05-14 | OpenAlex | 10.1016/j.lanmic.2025.101320 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161126247 | |||
| W7161123017 | Precaution with standards: rethinking respiratory sensitization classification through the case of methyl methacrylate | 2026-05-14 | OpenAlex | 10.3389/ftox.2026.1813881 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161123017 | |||
| W7161157127 | Responsibly Navigating Social Practices | 2026-05-14 | OpenAlex | 10.1111/josp.70060 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161157127 | |||
| W7161150925 | Revisiting Raynaud’s Phenomenon: Emerging Insights and Evolving Management Strategies | 2026-05-14 | OpenAlex | 10.2174/0127722708444234260422070300 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161150925 | |||
| W7161161840 | The SGLT2 inhibitor gap: why are we missing opportunities in primary care? | 2026-05-14 | OpenAlex | 10.3399/bjgp26x745437 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161161840 | |||
| W7161168241 | Unified Security Orchestration Framework for Protecting AI/ML Systems Against Input-Based and Model Supply Chain Attacks | 2026-05-14 | OpenAlex | 10.64220/amla.v2i2.003 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161168241 | |||
| W7161274572 | A framework for clinical validation of generative artificial intelligence therapeutics | 2026-05-15 | OpenAlex | 10.1002/wps.70067 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161274572 | |||
| W7161231952 | Abstract ND08: Discovery and development of a CD30 dual-payload ADC that combines MTI and Top1i to overcome drug resistance | 2026-05-15 | OpenAlex | 10.1158/1538-7445.am2026-nd08 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161231952 | |||
| W7161253151 | Advances in vulvovaginal candidiasis research: a comprehensive review from epidemiology, diagnosis, treatment to resistance mechanisms | 2026-05-15 | OpenAlex | 10.3389/fmicb.2026.1811011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161253151 | |||
| W7161174727 | Emerging insights into the presentation, pathophysiology, and management of eosinophilic esophagitis | 2026-05-15 | OpenAlex | 10.1016/j.jaci.2026.04.026 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161174727 | |||
| W7161273757 | Fertility preservation and subsequent reproductive outcomes in female pediatric patients with hematologic malignancies | 2026-05-15 | OpenAlex | 10.3389/fendo.2026.1791591 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161273757 | |||
| W7161115954 | Reasoning under limited knowledge and resources: a normative–descriptive integration | 2026-05-15 | OpenAlex | 10.1016/j.cogsys.2026.101477 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161115954 | |||
| W7161232464 | Relapsing childhood steroid sensitive nephrotic syndrome: what determines eventual remission? | 2026-05-15 | OpenAlex | 10.1007/s00467-026-07366-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161232464 | |||
| W7161378630 | Relational Cognitive Telemetry for Long-Lived LLM Agent Societies: From Internal State Monitoring to Collective Performance | 2026-05-15 | OpenAlex | 10.5281/zenodo.20234605 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7161378630 | |||
| W7161301403 | Tracheostomy in the management of obstructive sleep apnea: Contemporary indications, outcomes, and considerations | 2026-05-15 | OpenAlex | 10.1016/j.otot.2026.05.002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161301403 | |||
| W7161301546 | When Does Acceptable Become Unacceptable? Toxicities of Emerging Therapies | 2026-05-15 | OpenAlex | 10.1200/edbk-26-520698 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161301546 | |||
| W7161417029 | Antimicrobial Resistance in the 21st Century: Mechanisms, Challenges, and Therapeutic Strategies | 2026-05-16 | OpenAlex | 10.5281/zenodo.20227462 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161417029 | |||
| W7161417792 | Cytomegalovirus Colitis Associated With Anifrolumab Therapy in Systemic Lupus Erythematosus: Implications for Transplant Practice | 2026-05-16 | OpenAlex | 10.1111/tid.70242 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161417792 | |||
| W7161393933 | H2E SHERIFF V3: A Complete Deterministic Governance Framework for Multi-Modal AI Mathematical Derivation of Λ = 0.9785142874, Spectral Trap Proof of the Riemann Hypothesis, and Zero-Violation Certification Across Text, Audio, and Vision | 2026-05-16 | OpenAlex | 10.5281/zenodo.20226235 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161393933 | |||
| W7161381791 | Immunologic Fitness Cost of Antifungal Resistance in Aspergillus fumigatus: A Mini-Review | 2026-05-16 | OpenAlex | 10.5281/zenodo.20230383 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161381791 | |||
| W7161431842 | Immunotherapeutic strategies in HPV-positive and HPV-negative recurrent/metastatic oropharyngeal squamous cell carcinoma: From PD-1 blockade to EGFR-directed bispecifics and therapeutic HPV vaccines | 2026-05-16 | OpenAlex | 10.1016/j.critrevonc.2026.105378 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161431842 | |||
| W7161286677 | NEXT-GENERATION NANO-DRUG DELIVERY SYSTEMS FOR CANCER IMMUNOTHERAPY: BRIDGING INNOVATION AND CLINICAL TRANSLATION | 2026-05-16 | OpenAlex | 10.5281/zenodo.20196966 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161286677 | |||
| W7161712943 | Tempered optimism: Advances in the precision medicine era for pediatric low-grade glioma | 2026-05-16 | OpenAlex | 10.1093/neuonc/noag111 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161712943 | |||
| W7161478527 | EF-Perceptual Development v1.0: The Mechanics of Σ-Expansion: How Informational Structures Evolve, Stabilise New Distinctions, and Restructure Reality | 2026-05-17 | OpenAlex | 10.5281/zenodo.20256916 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161478527 | |||
| W7161475872 | Evolution of Multiple Sclerosis (1993-2026) and Future Direction | 2026-05-17 | OpenAlex | 10.5281/zenodo.20261593 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161475872 | |||
| W7161495075 | The Role of the State in Ensuring Social Justice | 2026-05-17 | OpenAlex | 10.17605/osf.io/gjs2b | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161495075 | |||
| W7162332753 | Emerging Therapeutic Strategies for Neurodegenerative Diseases: A Comprehensive Review of Recent Advances and Future Directions | 2026-05-18 | OpenAlex | 10.3390/cells15100928 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162332753 | |||
| W7161585476 | Evolving Concepts in Pulmonary Hypertension | 2026-05-18 | OpenAlex | 10.1016/j.chest.2026.05.009 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161585476 | |||
| W7161543271 | Personalized seizure risk forecasting via transformer-enhanced reinforcement learning with wearable signals | 2026-05-18 | OpenAlex | 10.1016/j.iswa.2026.200675 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161543271 | |||
| W7162269966 | Robustness of Machine Learning Systems: under distribution shift & in adversarial environments | 2026-05-18 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162269966 | ||||
| W7161552273 | Systemic Therapy for Solitary Fibrous Tumor | 2026-05-18 | OpenAlex | 10.1007/s11864-026-01383-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161552273 | |||
| W7161721983 | V3KTOR — Mapping the Self: Method, Design Rationale, and Theoretical Foundation | 2026-05-18 | OpenAlex | 10.5281/zenodo.20277359 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161721983 | |||
| W7166097858 | Advances in the Treatment of Newly Diagnosed Multiple Myeloma: Current Status and Future Directions | 2026-05-19 | OpenAlex | 10.36000/hbt.oh.2026.28.209 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166097858 | |||
| W7161624684 | Agentic AI in Healthcare: Opportunities, Challenges, and Future Directions | 2026-05-19 | OpenAlex | 10.1145/3809164 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7161624684 | |||
| W7161635303 | Clinical practices in general anaesthesia for caesarean section | 2026-05-19 | OpenAlex | 10.1097/ea9.0000000000000110 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161635303 | |||
| W7161700681 | Diabetes-driven oxidative stress and calcium dysregulation in gametogenesis and early fertilization | 2026-05-19 | OpenAlex | 10.1016/j.jdiacomp.2026.109345 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161700681 | |||
| W7220004258 | Digital Twin-Driven Knowledge-Enhanced AI Agents for Autonomous Operation and Maintenance Optimization in Industrial Cyber-Physical Systems | 2026-05-19 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220004258 | ||||
| W7161630408 | Editorial: AI and neuroscience: integrating knowledge, reasoning, and theory of mind | 2026-05-19 | OpenAlex | 10.3389/fncom.2026.1859797 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161630408 | |||
| W7161640416 | Editorial: Insights in biosafety and biosecurity 2024/2025: novel developments, current challenges, and future perspectives | 2026-05-19 | OpenAlex | 10.3389/fbioe.2026.1855658 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161640416 | |||
| W7161691554 | Emerging immune checkpoint inhibitor strategies in cervical cancer: a scoping review of ongoing clinical trials | 2026-05-19 | OpenAlex | 10.6084/m9.figshare.32326162 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161691554; https://openalex.org/W7161746526 | |||
| W7216536839 | Enhancing Large Language Model Reasoning via Retrieval-Augmented Generation and Self-Verification Mechanisms | 2026-05-19 | OpenAlex | 10.63544/xgvmne24 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7216536839 | |||
| W7161699568 | Evolving Treatment Paradigms in Hormone Receptor–Positive, Human Epidermal Growth Factor 2–Negative Metastatic Breast Cancer | 2026-05-19 | OpenAlex | 10.1200/edbk-26-520518 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161699568 | |||
| W7161625198 | Guest editorial: AI for a better future – advances, challenges and future research directions | 2026-05-19 | OpenAlex | 10.1108/intr-06-2026-034 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161625198 | |||
| W7161717938 | In vitro and in vivo investigation of potent platinum(IV) prodrugs for clinical anticancer therapy | 2026-05-19 | OpenAlex | 10.26183/pdnv-wx92 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161717938 | |||
| W7220268509 | LLM-Driven Conversational Agents for Mental Health Support with Long-Term User Behavior Modeling | 2026-05-19 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220268509 | ||||
| W7161703765 | Nitrosamine Impurities in Pharmaceuticals: Integrated Evaluation of Toxicity, Exposure, Carcinogenic Potency Categorization and Regulatory Risk Assessment | 2026-05-19 | OpenAlex | 10.5281/zenodo.20290283 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161703765 | |||
| W7161728121 | Pharmacological strategies for relapsed multiple myeloma after T-cell engager therapy: From molecular mechanisms to translational opportunities | 2026-05-19 | OpenAlex | 10.1556/1661.2026.00011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161728121 | |||
| W7161683886 | Primes Is All We Need Topological Invariants for Catastrophic-Forgetting-Free AI | 2026-05-19 | OpenAlex | 10.5281/zenodo.20295288 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161683886 | |||
| W7161813133 | Research on a Risk Prediction Model for Hypoxemia During Spontaneous Breathing Intravenous Anesthesia Using Endoscopic Nasal Masks Based on Machine Learning Algorithms | 2026-05-19 | OpenAlex | 10.66280/ijair.v1i2.131 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161813133 | |||
| W7161694440 | Review of Current Medical and Surgical Therapy for Inflammatory Bowel Disease | 2026-05-19 | OpenAlex | 10.1097/mcg.0000000000002387 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161694440 | |||
| W7161626046 | The Autophagy–Inflammation Axis in Kawasaki Disease: Pathogenic Mechanisms and Translational Opportunities | 2026-05-19 | OpenAlex | 10.3390/jcm15103918 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161626046 | |||
| W7161289856 | [Progress in targeted therapy for chronic thromboembolic pulmonary hypertension]. | 2026-05-19 | OpenAlex | 10.3760/cma.j.cn112137-20260205-00405 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161289856 | |||
| W7163382129 | A Case of Milia En Plaque Secondary to Granulomatous Rosacea in a 22-Year-Old Filipino | 2026-05-20 | OpenAlex | 10.67196/japav6i1.011 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163382129 | |||
| W7162623386 | CFD study of the sanitization of surfaces by means of hydrogen peroxide vapour | 2026-05-20 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162623386 | ||||
| W7161814280 | CNS Involvement of Multiple Myeloma—A Case Series and Narrative Literature Review | 2026-05-20 | OpenAlex | 10.3390/jcm15103927 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161814280 | |||
| W7161761029 | Foundation-Grounded System Prompting: Empirical Evidence for Structural Hallucination Elimination, Cross-Domain Generalisation, and Recursive Coherence Gain in Large Language Models | 2026-05-20 | OpenAlex | 10.5281/zenodo.20300910 | Title/abstract | Excluded | E2: General-domain method or evaluation uses medicine/ECG as one of several demonstrations or benchmark domains; fixed P2 applies. | https://openalex.org/W7161761029 | |||
| W7162019472 | Infection, inflammation and immune dysregulation: evolving perspectives on the host response | 2026-05-20 | OpenAlex | 10.1136/archdischild-2025-330158 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162019472 | |||
| W7162132251 | Landmark clinical trials shaping contemporary guideline-directed medical therapy for heart failure | 2026-05-20 | OpenAlex | 10.1093/eschf/xvag141 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162132251 | |||
| W7161806097 | Maintain, not obtain: rethinking HIV care in sub-Saharan Africa in the era of dolutegravir | 2026-05-20 | OpenAlex | 10.3389/fpubh.2026.1819844 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161806097 | |||
| W7161701267 | Reframing Artificial Intelligence as Organizational Meta-Governance: A Technology Forecasting Framework and Adoption Trajectory | 2026-05-20 | OpenAlex | 10.7840/kics.2026.51.5.1013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161701267 | |||
| W7167824738 | Remission revolution; redefining CKD management from slowdown to reversal | 2026-05-20 | OpenAlex | 10.34172/npj.2026.12855 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167824738 | |||
| W7161845824 | The Clopidogrel Dilemma in Thromboprophylaxis Following Total Joint Arthroplasty | 2026-05-20 | OpenAlex | 10.2106/jbjs.25.01399 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161845824 | |||
| W7161807250 | The Current State Of Knowledge On The Management Of Ischemic Heart Disease In Patients With Cancer | 2026-05-20 | OpenAlex | 10.56936/18290825-2026.20v.1-20 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161807250 | |||
| W7161755138 | The Embodiment of Vulnerability: How Consumers Judge Empathy Gaps in Artificial Intelligence‐Driven Healthcare | 2026-05-20 | OpenAlex | 10.1002/mar.70167 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7161755138 | |||
| W7200102843 | Toimijuus, ideologia, legitimiteetti : Muutoksia kulttuurienvälisyyden opetuksessa ja kokemisessa korkeakoulutuksessa | 2026-05-20 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7200102843 | ||||
| W7161759828 | Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoids | 2026-05-20 | OpenAlex | 10.1038/s41584-026-01379-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161759828 | |||
| W7161785394 | Urosepsis by multidrug-resistant Nakaseomyces glabratus with non-functional Erg3 and Erg11—do collateral sensitivity and a unique mode of action make nitroxoline a viable UTI antifungal? | 2026-05-20 | OpenAlex | 10.1128/mbio.00588-26 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161785394 | |||
| W7162049361 | Walking with the Wounded: Chaplains as Agents of Christ’s Healing Ministry | 2026-05-20 | OpenAlex | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7162049361 | ||||
| W7161800427 | one of the infrastructures for embodied intelligence | 2026-05-20 | OpenAlex | 10.5281/zenodo.20315371 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7161800427 | |||
| W7161938854 | 2026-05-21 | OpenAlex | 10.1055/s-016-63668 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161938854 | ||||
| W7161998741 | ANESTHESIOLOGY® 2026: Catch the Wave in San Diego | 2026-05-21 | OpenAlex | 10.1097/01.asm.0001194228.39813.54 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161998741 | |||
| W7161981036 | Amyloid-targeting treatment in Alzheimer's disease and concomitant antiplatelets: a clinical gray zone? | 2026-05-21 | OpenAlex | 10.3389/fneur.2026.1814289 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161981036 | |||
| W7172104215 | Carvedilol and the evolving management of portal hypertension in compensated cirrhosis | 2026-05-21 | OpenAlex | 10.46439/gastro.5.031 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172104215 | |||
| W7161998290 | Case Report: Complete response to the novel NaPi2b-targeting ADC YL205 in heavily pretreated platinum-resistant ovarian cancer | 2026-05-21 | OpenAlex | 10.3389/fonc.2026.1781961 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161998290 | |||
| W7162056649 | HUMAN–AI TEAMING AS A NEW PARADIGM OF ENTERPRISE MANAGEMENT IN THE DIGITAL ECONOMY | 2026-05-21 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162056649 | ||||
| W7161959041 | Incidental Detection of Severe LAD Stenosis by FAPI PET/CT in a Patient Under Evaluation for Solitary Pulmonary Nodule – Correlation with Coronary Flow Velocity and Coronary Angiogram | 2026-05-21 | OpenAlex | 10.25259/ijnm_178_25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7161959041 | |||
| W7161962914 | Profile-Aware Consent Management: A Conceptual Framework | 2026-05-21 | OpenAlex | 10.3233/shti260697 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161962914 | |||
| W7161947319 | Shifting Pieces, Creating New Images | 2026-05-21 | OpenAlex | 10.4324/9781003478034-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161947319 | |||
| W7162014213 | Steroids in organ transplantation: Immunosuppression and tolerance | 2026-05-21 | OpenAlex | 10.1016/j.jsbmb.2026.107039 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162014213 | |||
| W7162024460 | The Evolving Pharmacological Landscape for Paediatric and Adult ADHD | 2026-05-21 | OpenAlex | 10.1007/s40263-026-01299-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162024460 | |||
| W7161950581 | The History of Psychological Thought and the Psychology of Belonging | 2026-05-21 | OpenAlex | 10.5281/zenodo.20331766 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161950581 | |||
| W7161970857 | The State of Imidazolone as an Evolving Pharmacophore: Current Progress and Clinical Significance in Oncology and AMR | 2026-05-21 | OpenAlex | 10.1021/acsomega.6c00103 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7161970857 | |||
| W7162024592 | The evolution of chemotherapy in brain tumors: from historical milestones to precision medicine in glioblastoma | 2026-05-21 | OpenAlex | 10.37349/etat.2026.1002374 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162024592 | |||
| W7162143229 | "A REVIEW ON ANTIBIOTIC RESISTANCE & THEIR MECHANISM" | 2026-05-22 | OpenAlex | 10.5281/zenodo.20347900 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162143229 | |||
| W7162076749 | A Study On Consumer Buying Behavior Towards Life Insurance Products | 2026-05-22 | OpenAlex | 10.5281/zenodo.20338632 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162076749 | |||
| W7162141259 | Advancing Systemic Treatment beyond First Line for Advanced Hepatocellular Carcinoma | 2026-05-22 | OpenAlex | 10.1007/s11912-026-01792-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162141259 | |||
| W7215739071 | From Machine Learning to Foundation and Agentic AI: Evolution of Intelligent Decision Systems Across Domains | 2026-05-22 | OpenAlex | 10.32996/jcsts.2026.8.7.9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215739071 | |||
| W7162118127 | Human interface to ARC (Auto Regressive Compiler) for deterministic semantic governance over Probabilistic Inferring Engines (PIEs). | 2026-05-22 | OpenAlex | 10.5281/zenodo.20343517 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162118127 | |||
| W7162141933 | Mpox in Solid Organ Transplant Recipients: Lessons From a Single‐Center Case Series in South Florida | 2026-05-22 | OpenAlex | 10.1111/tid.70246 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162141933 | |||
| W7166790018 | Multi-Agent Predictive Maintenance System Using Model Context Protocol (MCP) and OPC UA | 2026-05-22 | OpenAlex | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7166790018 | ||||
| W7162110749 | SGLT2 Inhibitors as Mito-Protective Agents:Delineating the Heart-Brain Axis in Neurodegeneration | 2026-05-22 | OpenAlex | 10.25258/ijddt.16.48s.7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162110749 | |||
| W7162226386 | Sepsis Causes and Management | 2026-05-22 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162226386 | ||||
| W7162223133 | The Evolution of Intracranial Hemorrhage Management | 2026-05-22 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162223133 | ||||
| W7162080034 | The Future of Agentic AI in Healthcare | 2026-05-22 | OpenAlex | 10.4324/9781003676157-9 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7162080034 | |||
| W7162093878 | Tools and Platforms for Developing Agentic AI in Healthcare | 2026-05-22 | OpenAlex | 10.4324/9781003676157-10 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7162093878 | |||
| W7162089835 | optimize_anything: A Universal API for Optimizing any Text Parameter | 2026-05-22 | OpenAlex | 10.1145/3786335.3813190 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162089835 | |||
| W7162141684 | “From Walking Blind to Being Guided”: a qualitative study examining carers’ perceptions after experiencing ECHOMANTRA | 2026-05-22 | OpenAlex | 10.21203/rs.3.rs-9682871/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162141684 | |||
| W7162212675 | Advances in Sustainable Management of Potato Late Blight (Phytophthora infestans): Resistance Breeding, Molecular Diagnostics and Integrated Control Strategies | 2026-05-23 | OpenAlex | 10.1007/s11540-026-10077-0 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162212675 | |||
| W7162187398 | Calcium Hydroxylapatite for Facial Rejuvenation: Properties, Mechanisms, and Clinical Applications | 2026-05-23 | OpenAlex | 10.1177/19373368261451012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162187398 | |||
| W7162189200 | GOVERNED AUTONOMOUS INFRASTRUCTURE (GAI) A New Paradigm for Autonomous Intelligence, Runtime Governance, and Controlled Self-Improvement | 2026-05-23 | OpenAlex | 10.33774/coe-2026-hhgh2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162189200; https://openalex.org/W7161547163 | |||
| W7162194277 | Hypereosinophilic Syndrome: A Narrative Review of Pathogenesis, Clinical Spectrum and Evolving Therapeutic Strategies | 2026-05-23 | OpenAlex | 10.7860/jcdr/2026/85513.23615 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7162194277 | |||
| W7162238614 | Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials | 2026-05-23 | OpenAlex | 10.7759/cureus.109528 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162238614 | |||
| W7162462037 | The Maxwell Finland Lecture 2025: Antimicrobial Resistance At the Bedside: Translating Science into Patient Outcomes | 2026-05-23 | OpenAlex | 10.1093/infdis/jiag273 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162462037 | |||
| W7162187863 | Void-OS A Constraint Governed Symbolic Operating Architecture | 2026-05-23 | OpenAlex | 10.5281/zenodo.20356462 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162187863 | |||
| W7162239516 | CES-QN: A Causal–Self-Evolving–Quantum-Neuromorphic Framework | 2026-05-24 | OpenAlex | 10.5281/zenodo.20364600 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7162239516 | |||
| W7162256039 | CFAE Framework Specification: FOF — Functionality Optimization Foundry v0.1 | 2026-05-24 | OpenAlex | 10.5281/zenodo.20363576 | Title/abstract | Excluded | E1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system. | https://openalex.org/W7162256039 | |||
| W7162937307 | TREHALOSE, SUPRAPHYSIOLOGICAL BETA-ALANINE, AND LEUCINE WITH ESSENTIAL AMINO ACIDS PRODUCE SUSTAINED HYPERTROPHIC PERMISSIVENESS | 2026-05-24 | OpenAlex | 10.5281/zenodo.20364901 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162937307 | |||
| W7162428354 | A Case of Buschke-Löwenstein Tumor: Diagnosis and Surgical Management Buschke-Löwenstein Tumor: A Case Report of Diagnosis, Surgical Treatment and Adjunctive Measures for Recurrence Prevention | 2026-05-25 | OpenAlex | 10.5281/zenodo.20393691 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162428354 | |||
| W7162248139 | A new era in atherothrombosis | 2026-05-25 | OpenAlex | 10.1016/j.atherosclerosis.2026.120777 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162248139 | |||
| W7162284824 | Apolipoprotein L1 genetic testing, family history of hypertension, and kidney disease in a Midwestern U.S. cohort | 2026-05-25 | OpenAlex | 10.3389/fneph.2026.1771125 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162284824 | |||
| W7162258305 | Beyond hazard ratios: interpreting trial endpoints and survival analysis in systemic therapy for hepatocellular carcinoma | 2026-05-25 | OpenAlex | 10.1016/j.aohep.2026.102235 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162258305 | |||
| W7162332304 | Controlled Visual Generation Compass: A Compact Framework for Generative AI Research and System Design | 2026-05-25 | OpenAlex | 10.5281/zenodo.20384214 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162332304 | |||
| W7162315619 | Four decades of glioblastoma targeted therapy: a bibliometric and pharmacological perspective on translational failure and future directions | 2026-05-25 | OpenAlex | 10.21203/rs.3.rs-9669872/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162315619 | |||
| W7162306338 | Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric Assessment | 2026-05-25 | OpenAlex | 10.1111/ejh.70223 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162306338 | |||
| W7162658763 | From History to Innovation: Pathophysiology and the Evolving Landscape of Urolithiasis Diagnosis and Treatment | 2026-05-25 | OpenAlex | 10.2174/0113816128456160260522052912 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7162658763 | |||
| W7163075948 | KCNQ2 Channel as a Druggable Epilepsy Target: Advances in Pharmacological Modifiers | 2026-05-25 | OpenAlex | 10.2174/0118715273455571260523060433 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163075948 | |||
| W7162339984 | Stage-adaptive nanotherapeutic design for blood–brain barrier navigation in ischemic stroke | 2026-05-25 | OpenAlex | 10.1016/j.ijpharm.2026.127020 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162339984 | |||
| W7162422185 | Virtualia: vol. 3, n. 2 (2026). | 2026-05-25 | OpenAlex | 10.5281/zenodo.20171961 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162422185 | |||
| W7162402498 | Acute Pulmonary Embolism: Refining the Risk–Benefit Paradigm in Contemporary Venous Thromboembolism Intervention | 2026-05-26 | OpenAlex | 10.1007/s00270-026-04467-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162402498 | |||
| W7162470980 | Antioxidant Polymeric and Non-Polymeric Nanoformulations for the Treatment of Autoimmune Diseases | 2026-05-26 | OpenAlex | 10.3390/cimb48060557 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162470980 | |||
| W7164560394 | Application of AI agent in Assisting the Diagnosis of Mild Cognitive Impairment | 2026-05-26 | OpenAlex | 10.29011/2577-2228.100570 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7164560394 | |||
| W7162464609 | Can directing self-enhancement from social to performance settings alleviate narcissistic personality disorder? Implications from narcissism-performance research | 2026-05-26 | OpenAlex | 10.3389/fpsyt.2026.1621098 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162464609 | |||
| W7168083163 | From Guidelines to Innovation: The Evolving Paradigm of Premature Ventricular Complex Management | 2026-05-26 | OpenAlex | 10.5812/intjcardiovascpract-169721 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168083163 | |||
| W7162405629 | SQLens: Continuous Code-to-SQL Visibility in the Wild | 2026-05-26 | OpenAlex | 10.1145/3788853.3803091 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162405629 | |||
| W7211938699 | Self-Evolving Autonomous Software Architectures Using Large-Scale Graph Neural Networks and Real-Time Big Data Feedback Loops for Economic Optimization and Cost-Efficient Resource Allocation | 2026-05-26 | OpenAlex | 10.63544/jbii.v5i5.188 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7211938699 | |||
| W7162519086 | A Review on Oral Thin Films for Enhancement of Bioavailability | 2026-05-27 | OpenAlex | 10.5281/zenodo.20404903 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162519086 | |||
| W7162559285 | Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical Evidence | 2026-05-27 | OpenAlex | 10.3390/ph19060833 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7162559285 | |||
| W7162543529 | Clonal hematopoiesis-related outcomes associated with radioligand therapy in prostate cancer: A “real-world” analysis. | 2026-05-27 | OpenAlex | 10.1200/jco.2026.44.16_suppl.5045 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162543529 | |||
| W7162588843 | Cognitive bias and clinical acumen in uveitis practice | 2026-05-27 | OpenAlex | 10.4103/ijo.ijo_1402_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162588843 | |||
| W7162425772 | Evolving prokinetic therapy: New targets and therapeutic opportunities in gastrointestinal motility disorders | 2026-05-27 | OpenAlex | 10.4292/wjgpt.v17.i2.118616 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162425772 | |||
| W7162553336 | Future Pandemics: AI-Designed Diagnostic Assays for Detection of Andes Orthohantavirus (ANDV) Associated with the 2026 MV Hondius Outbreak | 2026-05-27 | OpenAlex | 10.64898/2026.05.26.26354101 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162553336 | |||
| W7162503730 | Immune cell imaging in the glioma microenvironment | 2026-05-27 | OpenAlex | 10.1016/j.brainres.2026.150394 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162503730 | |||
| W7217946174 | Interplay of Biofilm Formation, Virulence Determinants, and Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus: A Comprehensive Review | 2026-05-27 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7217946174 | ||||
| W7162838472 | Learning to Collaborate: Toward Robust, Adaptive Policies for Human–Robot Teams | 2026-05-27 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162838472 | ||||
| W7197280444 | Nanogeelien ja Mikrogeelien käyttö lääkkeiden kuljetuksessa | 2026-05-27 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7197280444 | ||||
| W7162578595 | Premature termination of early-phase cancer clinical trials: “It’s the economy, stupid!” | 2026-05-27 | OpenAlex | 10.1093/jnci/djag130 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162578595 | |||
| W7163604939 | Psychiatric Atmospheres:A Pluralistic Phenomenological Study of Hospital Architecture | 2026-05-27 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163604939 | ||||
| W7162522024 | Safety and efficacy of ifebemtinib (IN10018) combined with garsorasib (D-1553) in KRAS G12C mutant solid tumors from a phase Ib/II study: 2-year follow-up from single-arm of non-small-cell lung cancer (NSCLC). | 2026-05-27 | OpenAlex | 10.1200/jco.2026.44.16_suppl.3113 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162522024 | |||
| W7162672641 | Trajectory-Level Stability of Agentic Clinical Reasoning in Sepsis: A Longitudinal Evaluation Framework Using MIMIC-IV | 2026-05-27 | OpenAlex | 10.20944/preprints202605.1824.v1 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7162672641 | |||
| W7162684642 | A multi-agent AI system integrating real-world data and competitive intelligence to generate automated trial eligibility recommendations. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.e23008 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7162684642 | |||
| W7162629288 | A phase 3 study of sacituzumab govitecan in patients with previously treated extensive-stage small cell lung cancer. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.tps8137 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162629288 | |||
| W7162968978 | Automated Detection of Learning Pitfalls in Tabular Security Classifiers via Reasoning LLMs | 2026-05-28 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162968978 | ||||
| W7162667352 | Case Report: Integrative Pharmacotherapy of Severe Dermatophytosis with Candida spp.Superinfection: Mechanisms of Action and Epidermal Barrier Restoration. | 2026-05-28 | OpenAlex | 10.5281/zenodo.20424095 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162667352 | |||
| W7162681704 | Clinician readiness and ethical thresholds for agentic AI autonomy in oncology care: A multi-specialty survey. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.e13699 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162681704 | |||
| W7162629957 | Combined immunosuppressive therapy in systemic sclerosis-associated interstitial lung disease: Phenotypes matter | 2026-05-28 | OpenAlex | 10.1016/j.autrev.2026.104092 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162629957 | |||
| W7162689082 | Comparative efficacy of PD-1 versus PD-L1 inhibitors in metastatic colorectal cancer: A real-world propensity score–matched study. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.e15599 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162689082 | |||
| W7162661142 | Current real-world treatments in patients with metastatic colorectal cancer (mCRC) in US clinical practice. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.e15604 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162661142 | |||
| W7162649682 | ECLAD: An Edge-Cloud Collaborative Agentic Framework for Interpretable Anomaly Detection in Predictive Maintenance | 2026-05-28 | OpenAlex | 10.1145/3774905.3793127 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162649682 | |||
| W7162629943 | Editorial: Quantitative insights into new cancer therapies: a mathematical modeling approach | 2026-05-28 | OpenAlex | 10.3389/fams.2026.1869506 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162629943 | |||
| W7162643015 | Entre el lazo y la creación: prácticas artísticas, reconocimiento y subjetividad | 2026-05-28 | OpenAlex | 10.15517/ssn2gs64 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162643015 | |||
| W7162650136 | Give the Cefazolin, Even in Patients with a Cephalosporin Allergy | 2026-05-28 | OpenAlex | 10.2106/jbjs.25.01565 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162650136 | |||
| W7162660425 | Global evolution of HER2-targeted clinical trials across solid tumors: Shifts in tumor representation, biomarker definitions, therapeutic modalities, and geographic leadership. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.e23085 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162660425 | |||
| W7162687330 | High-Risk Multiple Myeloma: Redefining Risk and Rethinking Therapy | 2026-05-28 | OpenAlex | 10.1200/edbk-26-517494 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162687330 | |||
| W7162683432 | Impact of a real-time targeted expert outreach model on conversion of biomarker results to precision treatments. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.e23390 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7162683432 | |||
| W7162689186 | Metabolic reprogramming of the tumor microenvironment during transarterial therapy: Where no catheter has gone before | 2026-05-28 | OpenAlex | 10.1097/hep.0000000000001798 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162689186 | |||
| W7162637054 | PromptX: A Cognitive Agent Platform with Long-term Memory | 2026-05-28 | OpenAlex | 10.1145/3774905.3793108 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7162637054 | |||
| W7162634453 | Proof of concept for machine learning–based models to predict response to anticancer treatments. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.e13002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162634453 | |||
| W7162769169 | Psychiatric Comorbidities in Chronic Spontaneous Urticaria: An Overlooked Dimension | 2026-05-28 | OpenAlex | 10.4103/idoj.idoj_339_25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162769169 | |||
| W7162904698 | RATSe-Health™: A Runtime Governance Architecture for Clinically Governable Healthcare AI | 2026-05-28 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162904698 | ||||
| W7171539127 | THE SCHOOL AS A PROTAGONIST IN COMBATING THE SEXUAL EXPLOITATION OF CHILDREN AND ADOLESCENTS: DIALOGICITY AND INTERDISCIPLINARY REFLECTIONS | 2026-05-28 | OpenAlex | 10.63330/aurumpub.057-016 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171539127 | |||
| W7162647037 | Targeting KRAS G12C in non-small cell lung cancer: Breakthrough inhibitors and combination approaches | 2026-05-28 | OpenAlex | 10.1016/j.critrevonc.2026.105396 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162647037 | |||
| W7162648856 | Targeting metal ion transport in pancreatic cancer: A prognostic signature and GraphBAN-predicted therapeutics framework. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.e16000 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162648856 | |||
| W7162652911 | The CNS exile: An AI-driven audit of active brain metastasis exclusions in modern NSCLC immunotherapy clinical trials. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.e13746 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162652911 | |||
| W7162656962 | The Serotonin 2B (5‐ HT2B ) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression | 2026-05-28 | OpenAlex | 10.1002/cpt.70344 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162656962 | |||
| W7162673058 | The evolving landscape of chimeric antigen receptor (CAR) T-cell therapy for plasma cell leukemia: A systematic review of early outcomes. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.e19508 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162673058 | |||
| W7162514941 | Trends in frontline treatment patterns for multiple myeloma among US veterans, 1999–2025. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.7576 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162514941 | |||
| W7162642105 | Two decades of landscape change in the treatment of multiple myeloma. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.e19571 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162642105 | |||
| W7162659331 | Volrustomig, a novel bispecific PD-1/CTLA-4 monoclonal antibody, as single-agent first-line therapy for unresectable pleural mesothelioma: Substudy 5 of the eVOLVE-02 phase 2 study. | 2026-05-28 | OpenAlex | 10.1200/jco.2026.44.16_suppl.tps8126 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162659331 | |||
| W7162834137 | When Lupus Begins in the Heart: New-Onset Lupus Perimyocarditis Presenting as Acute Dilated Cardiomyopathy | 2026-05-28 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162834137 | ||||
| W7163333631 | A qPCR-Based Screening Platform for Exploratory Assessment of Phage Training Outcomes in Enterobacter cloacae and Stenotrophomonas maltophilia | 2026-05-29 | OpenAlex | 10.3390/v18060624 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163333631 | |||
| W7162859771 | Amivantamab in advanced non–small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations: Real‐world data from the Italian ATLAS Registry | 2026-05-29 | OpenAlex | 10.1002/cncr.70476 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162859771 | |||
| W7162772233 | Artificial intelligence for optimization of immunotherapy: current applications and transformative potential | 2026-05-29 | OpenAlex | 10.3389/fimmu.2026.1777580 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162772233 | |||
| W7162782651 | Botulinumtoxin Type-A (BoNTA) in the Management of Refractory Trigeminal Neuralgia: An Expert-Opinion, Practice-Oriented Narrative Review on Behalf of the GRASP Study Group | 2026-05-29 | OpenAlex | 10.3390/toxins18060248 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162782651 | |||
| W7162794939 | Emerging concepts in ILDA glance into the future | 2026-05-29 | OpenAlex | 10.1201/9781003451259-26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162794939 | |||
| W7162768962 | Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” | 2026-05-29 | OpenAlex | 10.3389/fonc.2026.1855868 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162768962 | |||
| W7163004529 | From T cell engagers to next-generation immune cell engagers for cancer immunotherapy | 2026-05-29 | OpenAlex | 10.1093/abt/tbag030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163004529 | |||
| W7162794081 | Individualized TB care for drug-susceptible pulmonary tuberculosis: clinical alternatives when HRZE is contraindicated or not tolerated | 2026-05-29 | OpenAlex | 10.1080/17476348.2026.2682314 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162794081 | |||
| W7162765261 | Internal multiplicity, emergent unity, and the case for an IFS-informed AI architecture in psychotherapy: a theoretical review | 2026-05-29 | OpenAlex | 10.1080/27706710.2026.2678005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162765261 | |||
| W7163187522 | Nivolumab-AVD Emerges as New Standard in Adolescent Hodgkin Lymphoma | 2026-05-29 | OpenAlex | 10.1097/01.cot.0000000000000400 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163187522 | |||
| W7162765445 | Recent advances in oncolytic virotherapy: insights from clinical trials and combination treatment strategies | 2026-05-29 | OpenAlex | 10.1186/s12985-026-03207-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162765445 | |||
| W7162761789 | Sustained radiographic resolution of a branch-duct intraductal papillary mucinous neoplasm of the pancreas during Chinese herbal medicine treatment: A case report | 2026-05-29 | OpenAlex | 10.1016/j.explore.2026.103458 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162761789 | |||
| W7162788113 | The Agentic Role of Generative Artificial Intelligence in Information Systems Leadership | 2026-05-29 | OpenAlex | 10.18848/1832-3669/cgp/a1033 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7162788113 | |||
| W7162848525 | Top advances of the year: Radiopharmaceutical therapy for prostate cancer | 2026-05-29 | OpenAlex | 10.1002/cncr.70470 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162848525 | |||
| W7163350427 | Artificial Intelligence-Enhanced Herbal Strategies for Nephrotoxicity: Mechanisms, Modeling and Precision Nephroprotection | 2026-05-30 | OpenAlex | 10.70593/978-93-7185-197-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163350427 | |||
| W7162851740 | Authority Transfer in Recursive and Networked AI Systems Closed-Loop Self-Improvement (CLSI), Recursive Leverage (RLF), and Synchronized Recursive Leverage (SRL) | 2026-05-30 | OpenAlex | 10.5281/zenodo.20463250 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162851740 | |||
| W7162871428 | DIANA OS: A Domain-Specific Multimodal Cognitive Architecture with Asynchronous State Mutation and Entitlement-Gated Routing | 2026-05-30 | OpenAlex | 10.5281/zenodo.20452909 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162871428 | |||
| W7162879792 | Dismantling the routine use of prophylactic volume expansion in contrast-associated acute kidney injury | 2026-05-30 | OpenAlex | 10.1016/j.ejim.2026.106970 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162879792 | |||
| W7162859304 | From Monoclonal to Multifunctional: The Evolving Landscape of Engineered Antibodies | 2026-05-30 | OpenAlex | 10.25258/ijddt.16.37s.32 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162859304 | |||
| W7162798632 | Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options | 2026-05-30 | OpenAlex | 10.1186/s43556-026-00486-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162798632 | |||
| W7163751073 | Preoperative Skin Preparation: History and Current Best Practices | 2026-05-30 | OpenAlex | 10.65365/vjmr.v2.i1.23 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163751073 | |||
| W7223760456 | Recursive Exposure II: Semantic Simulacra | 2026-05-30 | OpenAlex | 10.5281/zenodo.20460005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223760456 | |||
| W7162892162 | Transfer Compass: A Compact Design Framework for Transfer and Adaptation in AI | 2026-05-30 | OpenAlex | 10.5281/zenodo.20458799 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162892162 | |||
| W7163327798 | 'One Health' prerogative to illustrate environmental sink hypothesis of Accumulator Effectors | 2026-05-31 | OpenAlex | 10.18103/mra.v14i5.7504 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163327798 | |||
| W7163751786 | Hepatorenal Syndrome (HRS) Descriptive Review and Current Clinical Perspectives | 2026-05-31 | OpenAlex | 10.5281/zenodo.20569171 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163751786 | |||
| W7164363249 | Surgery-induced immune modulation: a comprehensive review | 2026-05-31 | OpenAlex | 10.30978/gs-2026-2-56 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164363249 | |||
| W7163174238 | 大模型赋能人形机器人智能交互与自主决策的技术架构及应用研究 | 2026-05-31 | OpenAlex | 10.65196/zxmm8035 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7163174238 | |||
| W7162954497 | 2026-06-01 | OpenAlex | 10.13040/ijpsr.0975-8232.17(6).1728-35 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162954497 | ||||
| W7163525303 | (107) Chemsex: The Neuropharmacology of Pleasure and Risk | 2026-06-01 | OpenAlex | 10.1093/jsxmed/qdag118.094 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163525303 | |||
| W7164204871 | 185 Optimising care for cancer patients: outcomes from a novel tertiary cardio-oncology service | 2026-06-01 | OpenAlex | 10.1136/heartjnl-2026-bcs.66 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164204871 | |||
| W7166843471 | 76 Empowering early career front line staff through continuous improvement: growth, leadership and resilience | 2026-06-01 | OpenAlex | 10.1136/bmjoq-2026-qsho.76 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166843471 | |||
| W7167226856 | A COMPREHENSIVE REVIEW ON HIGH-PERFORMANCE DISTRIBUTED COMPUTING IN WSNs | 2026-06-01 | OpenAlex | 10.58532/nbennurftcnb2c6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167226856 | |||
| W7162992463 | A Novel Dual-Loop Causality-Traceable Retrieval Framework for Long-Horizon Conversational Agents | 2026-06-01 | OpenAlex | 10.3390/electronics15112373 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7162992463 | |||
| W7162793424 | A REVIEW OF FORMULATION AND EVALUATION OF ANTI FUNGAL CREAM USING DIFFERENT PLANT EXTRACT | 2026-06-01 | OpenAlex | 10.5281/zenodo.20443963 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162793424 | |||
| W7163020412 | ADC-opoly in endometrial and cervical cancer: expanding the board | 2026-06-01 | OpenAlex | 10.1016/j.ijgc.2026.104786 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163020412 | |||
| W7172442928 | Adaptive Federated Learning with Full-Duplex and Active Control | 2026-06-01 | OpenAlex | 10.1109/icdca69396.2026.11620118 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7172442928 | |||
| W7203631629 | Agentic AI Security in IoMT: A PRISMA-Guided Scoping Review and Layered Threat–Defense Taxonomy | 2026-06-01 | OpenAlex | 10.1109/iccsdfai70505.2026.11647867 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7203631629 | |||
| W7163217957 | Antibody–drug conjugates in gynecologic cancers | 2026-06-01 | OpenAlex | 10.1002/cncr.70417 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163217957 | |||
| W7170084691 | Applied Machine Learning for Clinical Risk Assessment of Obstructive Sleep Apnea Using Electronic Health Records | 2026-06-01 | OpenAlex | 10.1109/icad69378.2026.11608983 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170084691 | |||
| W7212370566 | BACTERIOLOGICAL PROFILE, SITE-SPECIFIC DISTRIBUTION, AND ANTIMICROBIAL RESISTANCE PATTERNS OF CLINICAL ISOLATES RECOVERED FROM WOUND, BURN, AND DIABETIC FOOT INFECTIONS: A MULTI-HOSPITAL CROSS-SECTIONAL STUDY ACROSS BAGHDAD GOVERNORATE, IRAQ | 2026-06-01 | OpenAlex | 10.47832/2717-8234.27.31 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212370566 | |||
| W7202287040 | Beyond Individual Prediction: A Population-Level Digital Twin for Lung Cancer Survivorship Capacity Planning | 2026-06-01 | OpenAlex | 10.1109/ichi69079.2026.00265 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202287040 | |||
| W7166728055 | Beyond nutrition: lipids-based therapeutics from food and bioactive lipids | 2026-06-01 | OpenAlex | 10.26599/jfb.2026.95034443 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166728055 | |||
| W7166768265 | Cabergoline-Induced Psychosis: A Case Report | 2026-06-01 | OpenAlex | 10.1192/bjo.2026.11758 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166768265 | |||
| W7166743890 | Case 351 | 2026-06-01 | OpenAlex | 10.1148/radiol.252188 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166743890 | |||
| W7165137632 | Clinical Trials in Graft-Versus-Host Disease: Changes in Study Characteristics, Investigated Drugs, and Endpoints Over Time | 2026-06-01 | OpenAlex | 10.1016/j.jtct.2026.06.023 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165137632 | |||
| W7171937645 | Clinical and Functional Improvement with Brexpiprazole in an Adolescent with Early-Onset Schizophrenis | 2026-06-01 | OpenAlex | 10.1192/j.eurpsy.2026.11133 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171937645 | |||
| W7162757053 | DIABETOLOGY IN MODERN PHARMACY: AN UPDATED AND CONCISE REVIEW | 2026-06-01 | OpenAlex | 10.5281/zenodo.20438780 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7162757053 | |||
| W7168172450 | DRUG INFORMATION AND POISON INFORMATION CENTRES | 2026-06-01 | OpenAlex | 10.58532/nbennurecc6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168172450 | |||
| W7167212908 | Diabetic Neuropathy: Evolving Paradigms in Diagnosis and Therapy | 2026-06-01 | OpenAlex | 10.1007/s12595-026-00619-2 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7167212908 | |||
| W7165639947 | Diagnostic challenge of mycosis fungoides: a case report of progression in a 46-year-old Filipino woman | 2026-06-01 | OpenAlex | 10.21037/aol-25-13 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165639947 | |||
| W7165559794 | Digitalis Today: From Doctrine to Disrepute to Disciplined Reconsideration | 2026-06-01 | OpenAlex | 10.1016/j.cardfail.2026.06.004 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165559794 | |||
| W7163062206 | Emerging role of antibody–drug conjugates in gastrointestinal malignancies | 2026-06-01 | OpenAlex | 10.1002/cncr.70419 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163062206 | |||
| W7172019175 | Etomidate Vaping: An Emerging Substance Use Pattern in Singapore - A Case Series | 2026-06-01 | OpenAlex | 10.1192/j.eurpsy.2026.10865 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172019175 | |||
| W7166084995 | Evolving Therapeutic Strategies in Neuroendocrine Neoplasms: A New Era of Personalized Therapies | 2026-06-01 | OpenAlex | 10.1200/edbk-26-518934 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166084995 | |||
| W7165404328 | Evolving landscape of JAK-STAT inhibition in the treatment of immune-mediated inflammatory diseases | 2026-06-01 | OpenAlex | 10.1016/j.jaci.2026.06.006 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165404328 | |||
| W7164997397 | Evolving paradigms in thymoma surgery and multidisciplinary care: a narrative review | 2026-06-01 | OpenAlex | 10.21037/med-2025-1-68 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164997397 | |||
| W7164863908 | Exosomes as Biomimetic Nanoplatforms for Synergistic Targeted Chemotherapy and Photothermal Treatment of Breast Cancer | 2026-06-01 | OpenAlex | 10.1002/jbt.70971 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164863908 | |||
| W7163081033 | Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis | 2026-06-01 | OpenAlex | 10.1002/art.70237 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163081033 | |||
| W7163030609 | Genome editing between wonder and rejection | 2026-06-01 | OpenAlex | 10.3389/fbioe.2026.1832039 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163030609 | |||
| W7171910796 | Gestão Nutricional do doente em Cuidados Intensivos: Intervenções de Enfermagem | 2026-06-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171910796 | ||||
| W7166170423 | Glioblastoma: current challenges and future horizons | 2026-06-01 | OpenAlex | 10.4103/singaporemedj.smj-2026-356 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166170423 | |||
| W7166167277 | HTA11 INDIRECT TREATMENT COMPARISONS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: INSIGHTS FROM RECENT NICE SUBMISSIONS | 2026-06-01 | OpenAlex | 10.1016/j.jval.2026.03.1378 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166167277 | |||
| W7163013511 | High-Dose Monotherapy or Combination Therapy in Neuropathic Pain: A Necessary Reflection | 2026-06-01 | OpenAlex | 10.1080/15360288.2026.2673914 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163013511 | |||
| W7163418077 | Human Amniotic Membrane as Adjuvant Therapy in Medication-Related Osteonecrosis of the Jaw: A Scoping Review | 2026-06-01 | OpenAlex | 10.58624/svoade.2026.07.020 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163418077 | |||
| W7166087353 | IDDF2026-ABS-0376 Who ends up in the or? unmasking predictors of surgery in crohn’s disease | 2026-06-01 | OpenAlex | 10.1136/gutjnl-2026-iddf.334 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166087353 | |||
| W7163744166 | Implementation of the Master of Logic Theis "Updating Uncertain Evidence - Conditionalization and Complexity in Multi-Layer Belief Models" | 2026-06-01 | OpenAlex | 10.5281/zenodo.20491099 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7163744166 | |||
| W7220629046 | Latest Pharmacological Therapies in Allergic Rhinitis | 2026-06-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220629046 | ||||
| W7165810145 | Longitudinal Treatment Outcomes in Patients With Anaplastic Lymphoma Kinase-Rearranged Non–Small Cell Lung Cancer: Results From a Multinational Registry-Based Study in a Predominantly Western Population | 2026-06-01 | OpenAlex | 10.1200/go-25-00574 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165810145 | |||
| W7167482188 | MACHINE LEARNING: CONCEPT AND ALGORITHM | 2026-06-01 | OpenAlex | 10.58532/nbennuraitc1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167482188 | |||
| W7163998390 | METHOD OF DRUG ADMINISTRATION DURING IMPLANTATION IN ANIMALS USING BIODEGRADABLE COATINGS | 2026-06-01 | OpenAlex | 10.32935/2221-7312-2026-68-2-69-72 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163998390 | |||
| W7163899962 | Microneedling in the Management of Striae Alba: A Review of Adjunctive Therapies Including Topical Insulin and Platelet-Rich Plasma: Review Article | 2026-06-01 | OpenAlex | 10.21608/aimj.2026.443142.3049 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163899962 | |||
| W7164716426 | Nanomedicine in 2026: Illustrative Quantitative Analyses of EPR Heterogeneity, Clinical Trial Attrition, and Emerging Horizons for Active Nanotherapeutics | 2026-06-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164716426; https://openalex.org/W7164344883 | ||||
| W7163065659 | Non-Invasive Transdermal Delivery of Exosomes via Iontophoresis in Female Androgenetic Alopecia: A Case Series | 2026-06-01 | OpenAlex | 10.62742/2965-7911.2026.3.bjhh46 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163065659 | |||
| W7163684631 | OC.11 Points to consider for reporting outcomes measures in systemic sclerosis interventional studies on digital ulcers: an initiative from the world scleroderma foundation digital ulcer ad hoc committee | 2026-06-01 | OpenAlex | 10.1136/jsrd-2026-sswc.11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163684631 | |||
| W7166847091 | OC6 Evolving therapies in eosinophilic esophagitis: a systematic review and meta-analysis of budesonide and dupilumab | 2026-06-01 | OpenAlex | 10.1136/flgastro-2026-bspghan.6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166847091 | |||
| W7163911960 | OP06 Organisational dynamics and implementation complexities of mental health emergencies in the East Midlands, England | 2026-06-01 | OpenAlex | 10.1136/emermed-2026-999.6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163911960 | |||
| W7163677780 | P.264 M10 as a novel drug candidate for skin fibrosis | 2026-06-01 | OpenAlex | 10.1136/jsrd-2026-sswc.307 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163677780 | |||
| W7163680604 | P.361 An unusual yet a rare appendage manifestation of systemic sclerosis | 2026-06-01 | OpenAlex | 10.1136/jsrd-2026-sswc.402 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163680604 | |||
| W7134243126 | Perioperative approaches for patients with biliary tract cancer. | 2026-06-01 | OpenAlex | 10.48620/96003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7134243126; https://openalex.org/W7133362161 | |||
| W7166737332 | Prescribing Trends of Mood Stabilisers Within an Assertive Outreach Team (AOT) in York | 2026-06-01 | OpenAlex | 10.1192/bjo.2026.11858 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166737332 | |||
| W7162987829 | Pulmonary fibrosis: evolving therapeutic pipeline | 2026-06-01 | OpenAlex | 10.1136/bmjmed-2025-001886 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162987829 | |||
| W7170925603 | RECENT ADVANCES IN SGLT2 INHIBITORS | 2026-06-01 | OpenAlex | 10.58532/nbennuamsib7p2c2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170925603 | |||
| W7169201653 | RESILIENT PHYTOSANITARY FRAMEWORKS: CLIMATE-ADAPTIVE PATHOGEN MITIGATION FOR SMALL-SCALE HORTICULTURAL SYSTEMS | 2026-06-01 | OpenAlex | 10.58532/nbennurrpfcb1c20 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7169201653 | |||
| W7169872124 | SYNERGISTIC APPROACHES: MICROBIOLOGISTS AND ONCOLOGISTS UNITING FOR CANCER MANAGEMENT | 2026-06-01 | OpenAlex | 10.58532/nbennuamsiv6b2c4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169872124 | |||
| W7163194213 | Sedation in Gastrointestinal Endoscopy: From Drug-Centered Protocols to Personalized, Technology-Supported Pathways: A Narrative Review | 2026-06-01 | OpenAlex | 10.3390/jcm15114281 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163194213 | |||
| W7165381821 | Semantic confusion between “MD” and MDMA in Indian Addiction Psychiatry Practice | 2026-06-01 | OpenAlex | 10.4103/indianjpsychiatry_1207_25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165381821 | |||
| W7165678365 | Spinal Pain in Sickle Cell Disease: A Scoping Review | 2026-06-01 | OpenAlex | 10.1093/jscdis/yoag020.033 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165678365 | |||
| W7163055714 | The Detection-Integration Hypothesis - Consciousness as Sentience, Sapience, and Poiesis | 2026-06-01 | OpenAlex | 10.5281/zenodo.20481778 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163055714 | |||
| W7165192136 | The Evolution of Pragmatism in India: Ambedkar, Dewey, and the Rhetoric of Reconstruction by Scott Stroud | 2026-06-01 | OpenAlex | 10.5325/jhistrhetoric.29.1.0061 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165192136 | |||
| W7203710697 | The Humanization of Artificial Agents to Exposure the Individual Propensity of Social Connecting in Technology Affinity Affect | 2026-06-01 | OpenAlex | 10.25673/124580 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7203710697 | |||
| W7165761800 | The Interplay of Diabetes, Glucose Variability, and Antidiabetic Therapy in Preventing Periprosthetic Joint Infection Following Hip and Knee Arthroplasty: A Review | 2026-06-01 | OpenAlex | 10.2106/jbjs.rvw.26.00049 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165761800 | |||
| W7172025086 | The Overlooked Role of Psychiatrists in Obesity Management: A Multidisciplinary Perspective | 2026-06-01 | OpenAlex | 10.1192/j.eurpsy.2026.11376 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172025086 | |||
| W7164951843 | The evolving landscape of immunotherapy in lung cancer: From mechanism to clinical translation | 2026-06-01 | OpenAlex | 10.1016/j.curpro.2026.100121 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7164951843 | |||
| W7163756408 | The rise of the skin bleaching crisis: global perspectives | 2026-06-01 | OpenAlex | 10.1016/j.jid.2026.04.019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163756408 | |||
| W7171951386 | Tissue Optical Clearing in the Diagnosis of a Number of Pathologies | 2026-06-01 | OpenAlex | 10.1109/iclo69056.2026.11624419 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171951386 | |||
| W7163812286 | Treatment Advances in Gynecologic Cancers: Insights From Recent Clinical Trials | 2026-06-01 | OpenAlex | 10.1002/cai2.70065 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163812286 | |||
| W7166446550 | Tri-modality imaging in cardiac sarcoidosis: real-world concordance of cardiac magnetic resonance, echocardiography and fdg-pet | 2026-06-01 | OpenAlex | 10.1093/ejhf/xuag193.1317 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166446550 | |||
| W7170206325 | WHERE SURGERY MEETS TECHNOLOGY: ADVANCES IN MODERN ORTHODONTIC CARE | 2026-06-01 | OpenAlex | 10.58532/nbennufdsov6b2c18 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170206325 | |||
| W7161703016 | [From Self-Reflection to Building a "Culturally Safe" Care System]. | 2026-06-01 | OpenAlex | 10.6224/jn.26301 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7161703016 | |||
| W7168038621 | [Reflections on the management of a case of neurogenic stress cardiomyopathy complicated by acute submassive pulmonary embolism]. | 2026-06-01 | OpenAlex | 10.3760/cma.j.cn121430-20251209-00595 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168038621 | |||
| W7163579185 | Assessing contribution of effect in oncology combination therapies: lessons learned to inform and optimize future registrational trial designs | 2026-06-02 | OpenAlex | 10.1093/oncolo/oyag222 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163579185 | |||
| W7163123342 | Beyond Molecular Classification in Metastatic Triple-Negative Breast Cancer: Toward Subtype-Guided Precision Oncology | 2026-06-02 | OpenAlex | 10.3390/ijms27115040 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163123342 | |||
| W7163170847 | Cervical Cancer in Australia: A Radiation Oncology Perspective on Recent Developments, Challenges and Future Directions | 2026-06-02 | OpenAlex | 10.1111/1754-9485.70130 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163170847 | |||
| W7163209352 | Editorial: Digital learning innovations: trends emerging scenario, challenges and opportunities | 2026-06-02 | OpenAlex | 10.3389/feduc.2026.1871035 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163209352 | |||
| W7163220890 | Emerging therapies and diagnostic innovations for multidrug-resistant infections in kidney allograft recipients: Challenges and future directions | 2026-06-02 | OpenAlex | 10.5527/wjn.118797 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163220890 | |||
| W7163193857 | Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential | 2026-06-02 | OpenAlex | 10.1016/j.critrevonc.2026.105415 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163193857 | |||
| W7163192355 | Innovations and future research directions on hip preservation management options for osteonecrosis of the femoral head | 2026-06-02 | OpenAlex | 10.5312/wjo.118397 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163192355 | |||
| W7163186814 | Management of constipation: A narrative review of evolving strategies and methodological challenges | 2026-06-02 | OpenAlex | 10.5662/wjm.118399 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163186814 | |||
| W7163141213 | Moving from change agents to improvement architects through the Four Cs model: rethinking healthcare's complexity, cultures, contexts and connections | 2026-06-02 | OpenAlex | 10.3389/frhs.2026.1687699 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7163141213 | |||
| W7163220815 | The Moral Standing of Artificial Agents: From Functional Agency to Distributed Moral Responsibility. Dr. Ihsan Ali Al-Haidari | 2026-06-02 | OpenAlex | 10.17605/osf.io/z2baw | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7163220815 | |||
| W4417299963 | Unveiling the black box: A multi-layer framework for explaining reinforcement learning-based cyber agents | 2026-06-02 | OpenAlex | 2505.11708 | 10.1016/j.jisa.2026.104507 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W4417299963 | ||
| W7163323836 | Validation-Gated Multi-Agent Governance for Online Adaptation of Thermal-Hydraulic Surrogate Models under Operating-Regime Shift | 2026-06-02 | OpenAlex | 2606.03321 | 10.48550/arxiv.2606.03321 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7163323836 | ||
| W7163379709 | A Knowledge-Based System for Simulating Mental Health Interventions | 2026-06-03 | OpenAlex | 10.3390/app16115580 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163379709 | |||
| W7163905439 | Evaluating the investigational drug landscape for ESR1 -mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer | 2026-06-03 | OpenAlex | 10.1080/13543784.2026.2686701 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163905439 | |||
| W7163335544 | Guest editorial: STARA (smart technology, AI, robotics and algorithms): implications for career research | 2026-06-03 | OpenAlex | 10.1108/cdi-06-2026-665 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163335544 | |||
| W7163366059 | Implicit Structure as the Bottleneck: How Representation Opacity, State Tracking Failure, and Evaluation Blindness Compound Across Long-Horizon Agentic Tasks | 2026-06-03 | OpenAlex | 10.5281/zenodo.20525488 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163366059 | |||
| W7163365413 | Lifecycle Analysis of Medicines Withdrawn, Restricted, or Label Updated Due to Safety Signals (2000–2025): A Retrospective Pharmacovigilance Study | 2026-06-03 | OpenAlex | 10.5281/zenodo.20526481 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163365413 | |||
| W7163436521 | Mechanism Before Metric: How Process-Outcome Decoupling Exposes the Hidden Failure Modes of Agentic AI Evaluation | 2026-06-03 | OpenAlex | 10.5281/zenodo.20519735 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163436521 | |||
| W7163350291 | Multi-Element Spectral Intelligence Engine (MESIE) A Modular Framework for Spectral Matching, Signal Synthesis, Cognitive Embeddings, and Multi-Domain Resonance Analysis | 2026-06-03 | OpenAlex | 10.5281/zenodo.20520987 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7163350291 | |||
| W7163397253 | Multidisciplinary Management of Esophageal Cancer | 2026-06-03 | OpenAlex | 10.1200/op-26-00198 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163397253 | |||
| W7163417805 | Optimizing phage therapy with antidefense proteins acquired from the environment | 2026-06-03 | OpenAlex | 10.3389/fmicb.2026.1796329 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163417805 | |||
| W7164372656 | Pharmacological treatment of cardiogenic shock | 2026-06-03 | OpenAlex | 10.1097/mcc.0000000000001393 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164372656 | |||
| W7163320441 | Supportive Management of Severe Acetaminophen and Ibuprofen Overdose Twenty-Four Hours After Ingestion in Limited Resources Settings | 2026-06-03 | OpenAlex | 10.14740/jmc5330 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163320441 | |||
| W7163321395 | T-cell engagers in cancer immunotherapy: mechanisms, challenges, and future perspectives | 2026-06-03 | OpenAlex | 10.3389/fimmu.2026.1755512 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163321395 | |||
| W7163414015 | The evolution of non-surgical management in stage III non-small cell lung cancer | 2026-06-03 | OpenAlex | 10.1038/s44276-026-00212-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163414015 | |||
| W7169118958 | Thesis Proposal: When Does an Agent Know It Is Lost? Confidence Trajectory Analysis for Tool-Using LLMs | 2026-06-03 | OpenAlex | 10.48448/6zh0-8987 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7169118958; https://openalex.org/W7166878287 | |||
| W7163343147 | A bibliometric analysis of the research landscape of lenalidomide resistance in multiple myeloma | 2026-06-04 | OpenAlex | 10.1007/s12672-026-05344-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163343147 | |||
| W7163574703 | CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers | 2026-06-04 | OpenAlex | 10.3389/fimmu.2026.1845921 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163574703 | |||
| W7163586296 | From Infancy to Adolescence: The Developmental Trajectory of Food Allergy and Its Relationship with Eosinophilic Esophagitis–Mechanisms, Epidemiology, and Emerging Therapies | 2026-06-04 | OpenAlex | 10.3390/allergies6020022 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163586296 | |||
| W7163532328 | Frontline immunotherapy and immune cold reprogramming across molecular subtypes of advanced endometrial cancer | 2026-06-04 | OpenAlex | 10.1016/j.canlet.2026.218652 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163532328 | |||
| W7164520537 | Functionalization of Hydrogels | 2026-06-04 | OpenAlex | 10.1002/9783527854578.ch05 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164520537 | |||
| W7216637665 | Role of Local Drug Delivery Systems in Periodontal Therapy: A Pharmacological Perspective | 2026-06-04 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7216637665 | ||||
| W7163519412 | State Tracking as the Binding Constraint: How Long-Horizon Coherence Failures Unify Agentic Data Analysis, Clinical Decision-Making, and Multi-Turn Tool Use | 2026-06-04 | OpenAlex | 10.5281/zenodo.20540636 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163519412 | |||
| W7163582874 | The expanding role of protease therapeutics (2012–2026): from replacement therapies to immune system modulation and beyond | 2026-06-04 | OpenAlex | 10.1042/bcj20260152 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163582874 | |||
| W7163367554 | Trust Continuity, the Age of AI Impersonation: What Can Be Done Today to Counter Conversational Impersonation and AI-Assisted Chat Intrusions Through Governance-Centric Approaches-Conversation Integrity, Attribution, Privacy Preservation Using AIVORIX OS™ | 2026-06-04 | OpenAlex | 10.5281/zenodo.20519703 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7163367554 | |||
| W7163560418 | Update on the Management of ABCA4 Retinopathy (Stargardt Disease) | 2026-06-04 | OpenAlex | 10.1007/s40123-026-01407-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163560418 | |||
| W7163698965 | Across Clinical Profiles of Cardiorenal–Metabolic (CKM) Syndrome: A Phenotype-Driven Therapeutic Approach | 2026-06-05 | OpenAlex | 10.3390/biomedicines14061289 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163698965 | |||
| W7163701305 | Cannabis and Anesthesia | 2026-06-05 | OpenAlex | 10.4018/979-8-2600-2035-7.ch005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163701305 | |||
| W7163717319 | Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic Strategies | 2026-06-05 | OpenAlex | 10.3390/ijms27115117 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163717319 | |||
| W7163680423 | Colchicine in cardiovascular medicine: Current perspectives on mechanisms and clinical therapeutics | 2026-06-05 | OpenAlex | 10.1016/j.pharmthera.2026.109053 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163680423 | |||
| W7163711579 | Generative AI in Ophthalmology | 2026-06-05 | OpenAlex | 10.1002/9781394358212.ch9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163711579 | |||
| W7163702052 | Optimizing genomics-aware clinical agents in precision oncology | 2026-06-05 | OpenAlex | 10.1038/s41540-026-00753-9 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7163702052 | |||
| W7163640750 | The State of the Art in Chronic Prurigo Nodularis | 2026-06-05 | OpenAlex | 10.1007/s13555-026-01804-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163640750 | |||
| W7164039849 | Artificial Intelligence: From Fundamentals to Real-World Applications BY Ts. Dr. Sundresan Perumal, Dr. K. Appathurai, Dr. B. Sathya Bama, Dr. P. Ajitha. | 2026-06-06 | OpenAlex | 10.5281/zenodo.20608291 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164039849 | |||
| W7163735750 | Behavioral Management Training (BMT) | 2026-06-06 | OpenAlex | 10.1016/b978-0-443-29009-1.00071-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163735750 | |||
| W7163865539 | Synergistic Antibacterial Activity of Polyelectrolyte-capped Silver Nanoparticles Combined with Aminoglycoside Antibiotics Against Healthcare-associated Pathogens | 2026-06-06 | OpenAlex | 10.4103/jmedsci.jmedsci_50_26 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163865539 | |||
| W7163734205 | The evolving landscape of CDK2 inhibition in cancer: Therapeutic potential, clinical progress, and future directions | 2026-06-06 | OpenAlex | 10.1016/j.critrevonc.2026.105427 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163734205 | |||
| W7165398179 | Weekly Journal Scan: Not all direct oral anticoagulants are created equal | 2026-06-06 | OpenAlex | 10.1093/eurheartj/ehag469 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165398179 | |||
| W7163820105 | A Continuous-Dynamics Equation Cannot Be Tested on a Static Frozen Substrate: ESCT as a Dynamical Diagnostic Protocol and BERT as Its Zero-Point Calibration | 2026-06-07 | OpenAlex | 10.5281/zenodo.20579378 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7163820105 | |||
| W7163820026 | Advances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing Agents | 2026-06-07 | OpenAlex | 10.1002/ajh.70372 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7163820026 | |||
| W7163824681 | Governed Multi-Agent Dynamics: Stability, Stratification, and Complexity Bounds under Endogenous Constraint Fields | 2026-06-07 | OpenAlex | 10.5281/zenodo.20576282 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7163824681 | |||
| W7163818224 | Schedule H1: Why India's High-Risk Drug Regulation Needs an Urgent Overhaul | 2026-06-07 | OpenAlex | 10.5281/zenodo.20578687 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163818224 | |||
| W7163804419 | Targeted therapies in thoracic neuroendocrine tumors: challenges and failures of tyrosine kinase inhibition in lung and thymic carcinoids | 2026-06-07 | OpenAlex | 10.1080/14656566.2026.2685837 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163804419 | |||
| W7163904657 | A scientometric study of retrieval-augmented generation research: Mapping the intellectual landscape of a transformative AI paradigm | 2026-06-08 | OpenAlex | 10.5267/j.ijdns.2026.24 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163904657 | |||
| W7163869987 | ANESTHESIOLOGICAL MANAGEMENT IN ENDOUROLOGICAL SURGERY IN CHILDREN | 2026-06-08 | OpenAlex | 10.5281/zenodo.20590974 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163869987 | |||
| W7164121279 | Causes, Predictors, and Treatment of Vasoplegia in Cardiac Surgery: A Narrative Review | 2026-06-08 | OpenAlex | 10.1213/ane.0000000000008086 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164121279 | |||
| W7163876394 | Convergence of Generative AI, Agentic Workflows, and Cloud-Native Infrastructure: A Unified Architecture for Next-Generation Healthcare Intelligence | 2026-06-08 | OpenAlex | 10.5281/zenodo.20597912 | Full text | Excluded | F1: The primary methodology explicitly uses conceptual synthesis/architectural abstraction without training experiments or clinical trials; proposed memory is not an implemented update study. | https://openalex.org/W7163876394; https://openalex.org/W7163925442 | https://gjrpublication.com/wp-content/uploads/2026/06/GJRECS63749.pdf | Primary PDF introduction and Methodology pp31–32 read | |
| W7163939782 | Editorial: Plant polyphenols: new chemical and pharmacological approaches | 2026-06-08 | OpenAlex | 10.3389/fphar.2026.1885848 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163939782 | |||
| W7163882706 | Emergency department initiation of guideline-directed cardiovascular pharmacotherapy: an under-recognized opportunity | 2026-06-08 | OpenAlex | 10.1097/ms9.0000000000005224 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163882706 | |||
| W7163891274 | Emerging and Future SARS-CoV-2 Spike Protein Variants: Evolution, Increased Virulence, and Pandemic Risks | 2026-06-08 | OpenAlex | 10.5281/zenodo.20586575 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163891274 | |||
| W7163873471 | Evaluating The Effectiveness of LLM Based Personalized Tutoring Systems In Improving Learning Outcomes In Higher Education | 2026-06-08 | OpenAlex | 10.5281/zenodo.20599093 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7163873471 | |||
| W7163881849 | From Integrated Care to Learning Systems | 2026-06-08 | OpenAlex | 10.3390/healthcare14121612 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163881849 | |||
| W7163884041 | Learning Family-Oriented Care in Residency: A Qualitative Portfolio Analysis | 2026-06-08 | OpenAlex | 10.22454/fammed.2026.679774 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163884041 | |||
| W7163912689 | Magnetic Resonance Imaging: Principles, Clinical Applications, and Problem Solving: A Critical Review | 2026-06-08 | OpenAlex | 10.9734/ajmpcp/2026/v9i2449 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163912689 | |||
| W7163897871 | Mixed saliva of chemical industry workers in the context of X-ray fluorescence analysis | 2026-06-08 | OpenAlex | 10.36377/et-0206 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163897871 | |||
| W7164036184 | Pharmacological Interventions in Primary Amoebic Meningoencephalitis: Clinical Challenges and Strategic Solutions | 2026-06-08 | OpenAlex | 10.2174/0115748871445254260527063851 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164036184 | |||
| W7163902069 | Precision Medicine in Non-Hodgkin Lymphoma: Advances in BTK Inhibition, CD30-Directed Antibody–Drug Conjugates, and HDAC-Mediated Epigenetic Therapy with Pirtobrutinib, Brentuximab Vedotin, and Belinostat | 2026-06-08 | OpenAlex | 10.3390/jcm15124425 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163902069 | |||
| W7163907906 | RASO: Role-Aware Shared Reflection for Multi-Agent Orchestration in E-Commerce Long-Horizon Planning | 2026-06-08 | OpenAlex | 10.1609/icaps.v36i1.42873 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7163907906 | |||
| W7163874032 | Simulation-based dynamic optimization for ambulance dispatch and casualty distribution in mass casualty incident | 2026-06-08 | OpenAlex | 10.1016/j.cor.2026.107559 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163874032 | |||
| W7163865250 | Targeting FcRn for immunomodulation: a promising therapy in autoimmune inflammatory rheumatic diseases | 2026-06-08 | OpenAlex | 10.1007/s00011-026-02279-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163865250 | |||
| W7163948910 | Update on Obesity and Its Relationship to Atherosclerotic Cardiovascular Disease and Associated Risk Factors | 2026-06-08 | OpenAlex | 10.3390/jcm15124430 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163948910 | |||
| W7164001911 | 2026-06-09 | OpenAlex | 10.22377/a5sjwf37 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164001911 | ||||
| W7164005622 | A Mechanistic Framework for the Clinical Trajectory System in the Context of Indonesian Healthcare Delivery | 2026-06-09 | OpenAlex | 10.5281/zenodo.20604964 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7164005622 | |||
| W7212156434 | A Multi-Domain Human-Centered Framework for Human-Robot Collaboration: Advancing Decision-Making, Situational Awareness, and Operational Efficiency | 2026-06-09 | OpenAlex | 10.46254/na11.20260360 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7212156434 | |||
| W7164144537 | A Real-world Cohort of Patients With Myasthenia Gravis: The PPD™ CorEvitas™ Myasthenia Gravis Registry (P4-9.009) | 2026-06-09 | OpenAlex | 10.1212/wnl.0000000000216873 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164144537 | |||
| W7164152557 | Acral Hypopigmentation Associated with Ruxolitinib: A Novel Observation | 2026-06-09 | OpenAlex | 10.4103/idoj.idoj_1191_25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164152557 | |||
| W7163987819 | Bacteriological Pattern of Pediatric Sepsis in PICU of A Tertiary Care Hospital | 2026-06-09 | OpenAlex | 10.3329/cmoshmcj.v25i1.89898 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7163987819 | |||
| W7172211564 | Chronic Migraine with Botulinum Toxin Treatment: An Update and Critical Review | 2026-06-09 | OpenAlex | 10.65381/jcrm.2026.01010020 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172211564 | |||
| W7172216584 | Clinical Application of Laser for Acne Vulgaris: An Update and Critical Review | 2026-06-09 | OpenAlex | 10.65381/jcrm.2026.01010018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172216584 | |||
| W7164012571 | Clinical Impact of Immune Checkpoint Inhibitors and Chemotherapy in the First-Line Treatment of Metastatic Urothelial Carcinoma with Variant Histology | 2026-06-09 | OpenAlex | 10.1159/000552945 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164012571 | |||
| W7164301821 | Comparative Review of Visual Outcomes in Retinopathy of Prematurity Following Laser Therapy and Combination Laser–Anti-VEGF Treatment: An Integrative Perspective on Neonatal Ocular Care | 2026-06-09 | OpenAlex | 10.25258/ijddt.16.51s.118 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164301821 | |||
| W7164150053 | Features of Pediatric Multiple Sclerosis: Demographics, Phenotypes, and Treatments in a Cohort of 139 Patients at a Tertiary Center (P11-20.004) | 2026-06-09 | OpenAlex | 10.1212/wnl.0000000000217743 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164150053 | |||
| W7164180116 | Harnessing Targeted Continuing Education to Address Gaps Related to the Role of Neuroinflammation in Alzheimer’s Disease Early Detection and Treatment (P4-13.005) | 2026-06-09 | OpenAlex | 10.1212/wnl.0000000000215513 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164180116 | |||
| W7164753168 | Knowledge, Attitude, and Practice of Dental Professionals Regarding Cross Infection in the Dental Teaching Hospital of Karachi | 2026-06-09 | OpenAlex | 10.61336/ajfp/2026-04-17 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164753168 | |||
| W7164065913 | Localized Facial Bullous Eruption Following Iodinated Contrast in a Patient With Renal Failure | 2026-06-09 | OpenAlex | 10.7759/cureus.110513 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164065913 | |||
| W7163886062 | Not Just One Agent: Multi-Agent Systems for Medicine from Answer Generation to Accountable Workflow Orchestration | 2026-06-09 | OpenAlex | 10.20944/preprints202606.0640.v1 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7163886062 | |||
| W7164016655 | Referral Required: When AI Blocks Access to Human Doctors | 2026-06-09 | OpenAlex | 10.1145/3816701 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164016655 | |||
| W7164158475 | Refractory Status Epilepticus in an Infant with Succinic Semialdehyde Dehydrogenase Deficiency: A Case Report and Therapeutic Challenges (P2-8.004) | 2026-06-09 | OpenAlex | 10.1212/wnl.0000000000217667 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164158475 | |||
| W7164163387 | Relapsing and Evolving Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Induced by Nivolumab in a Patient With Hodgkin’s Lymphoma in Remission (P1-9.019) | 2026-06-09 | OpenAlex | 10.1212/wnl.0000000000217619 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164163387 | |||
| W7165618813 | SEPA (Simulator Epidemi Penyakit Airborne) | 2026-06-09 | OpenAlex | 10.57760/sciencedb.39530 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165618813 | |||
| W7164031037 | Seamless Multimodal Human-Robot Communication: Integration Techniques in Human–Computer Interaction | 2026-06-09 | OpenAlex | 10.3791/70218 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164031037 | |||
| W7164002700 | Synergistic Ischemic Injury in DCD Kidney Transplantation: Rethinking Warm and Cold Ischemia as Interdependent Determinants of Graft Outcomes | 2026-06-09 | OpenAlex | 10.1097/tp.0000000000005806 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164002700 | |||
| W7219931630 | THE ROLE OF ARTIFICIAL INTELLIGENCE IN DEVELOPING NEW PHARMACEUTICAL AGENTS | 2026-06-09 | OpenAlex | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7219931630 | ||||
| W7164037062 | The Evolving Role of Intralesional Therapy in In-Transit Melanoma | 2026-06-09 | OpenAlex | 10.3390/curroncol33060344 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164037062 | |||
| W7164405157 | A Review of Agricultural Intelligent Architecture: The Application and Challenges of Artificial Intelligence in Agricultural Perception, Decision-Making, and Execution | 2026-06-10 | OpenAlex | 10.3390/app16125865 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164405157 | |||
| W7164044798 | Advancing cancer therapeutics: new perspectives on mechanisms, regulatory and policy challenges, and innovative multi-modality strategies for the early detection of cardiotoxicity | 2026-06-10 | OpenAlex | 10.1007/s11239-026-03282-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164044798 | |||
| W7164165049 | CANCER CHEMOTHERAPY: CONVENTIONAL APPROACHES AND RECENT ADVANCES | 2026-06-10 | OpenAlex | 10.5281/zenodo.20626981 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164165049; https://openalex.org/W7164419044 | |||
| W7164134929 | Drugs to Prevent and Treat Venous Thromboembolic Disease During Pregnancy | 2026-06-10 | OpenAlex | 10.1016/j.clp.2026.05.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164134929 | |||
| W7164148474 | Editorial: AI and big data integration in orthopedic regenerative medicine | 2026-06-10 | OpenAlex | 10.3389/fcell.2026.1892774 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164148474 | |||
| W7163741219 | From awareness to agency: a Freirean analysis of critical consciousness and social justice among international medical students in the UK | 2026-06-10 | OpenAlex | 10.3389/fmed.2026.1854824 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7163741219 | |||
| W7164211487 | GLP-1 receptor agonists as multisystem therapies: from glycemic control to cardiorenal, neuroimmune, and metabolic disease | 2026-06-10 | OpenAlex | 10.1186/s13098-026-02196-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164211487 | |||
| W7164156706 | Guest editorial: Digital age wisdom in Chinese management: applications and challenges of digital transformation and artificial intelligence | 2026-06-10 | OpenAlex | 10.1108/cms-05-2026-0533 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164156706 | |||
| W7166829543 | HARSA: A Hybrid Autonomous Reasoning and Safety-Aware Agent Architecture to Support Scalable and Reliable Intelligent Decision-Making | 2026-06-10 | OpenAlex | 10.1109/icici68773.2026.11581280 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7166829543 | |||
| W7164130636 | High-Risk Multiple Myeloma in 2026: Evolving Definitions and Therapeutic Options | 2026-06-10 | OpenAlex | 10.58931/cht.2026.5187 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164130636 | |||
| W7125583542 | Integrating Tradition and Modernity: A Review of Women's Roles in Liberian Traditional Medicine within Contemporary Healthcare, 2021–2026 | 2026-06-10 | OpenAlex | 10.5281/zenodo.18358312 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7125583542 | |||
| W7164122207 | PARP inhibitors plus ARSI in first-line mCRPC—a treatment for all patients? | 2026-06-10 | OpenAlex | 10.1007/s12254-026-01113-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164122207 | |||
| W7166451000 | Pharmacological treatment of metabolic dysfunction–associated steatotic liver disease: a narrative review | 2026-06-10 | OpenAlex | 10.5124/jkma.26.0043 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166451000 | |||
| W7164332136 | A Cognitive Clustering Framework for Wireless Sensor Networks Using Quantum Machine Learning | 2026-06-11 | OpenAlex | 10.1109/iciics67880.2026.11483591 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7164332136 | |||
| W7164366745 | A systematic review of penetrating injuries to the superior sagittal sinus across two centuries | 2026-06-11 | OpenAlex | 10.3389/fneur.2026.1789736 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164366745 | |||
| W7164339076 | Assured Autonomy for Siloed Operations: Causal Learning with Per-Edge Certainty on HPC | 2026-06-11 | OpenAlex | 10.5281/zenodo.20649151 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7164339076 | |||
| W7164335474 | Dopamine Receptor Modulation in Co-Occurring Disorders: Potential of Cariprazine and D3 Receptor Activity | 2026-06-11 | OpenAlex | 10.1080/15504263.2026.2676699 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164335474 | |||
| W7164310909 | Effect of a Topical Thrombin–Carboxymethyl Starch Hemostatic Agent on Perioperative Hemoglobin Course: A Propensity Score-Matched Study | 2026-06-11 | OpenAlex | 10.3390/medicina62061142 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164310909 | |||
| W7164310880 | FROM DISCOVERY SCIENCE TO THE CLINIC - HERITABLE ENDOCRINE CANCERS AND RELATED DISORDERS: Functional imaging in hereditary endocrine neoplasms: evolving modalities and clinical implications | 2026-06-11 | OpenAlex | 10.1530/erc-25-0516 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164310880 | |||
| W7164510469 | Geroprotective Agents, Including Glucagon-Like Peptide-1 Receptor Agonists, for Ocular Health | 2026-06-11 | OpenAlex | 10.1177/10807683261456222 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164510469 | |||
| W7164163735 | Incretin-based therapies and craving: a clinical signal pointing to reward reprogramming | 2026-06-11 | OpenAlex | 10.1016/j.numecd.2026.104818 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164163735 | |||
| W7164396054 | Integrating Artificial Intelligence and Technology in Surgical Practice | 2026-06-11 | OpenAlex | 10.1016/j.suc.2026.04.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164396054 | |||
| W7164345195 | Introduction to Wound Dressing | 2026-06-11 | OpenAlex | 10.1201/9781003616726-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164345195 | |||
| W7164356463 | Operationalizing One Health Surveillance for Tropical Fungal Diseases: Practical Implications of Bioinformatics for Clinical and Epidemiological Practice | 2026-06-11 | OpenAlex | 10.4269/ajtmh.26-0183 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164356463 | |||
| W7164394504 | Scoped Verification for Reliable Lifelong Agentic Context Evolution under Distribution Shift | 2026-06-11 | OpenAlex | 10.5281/zenodo.20636624 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7164394504 | |||
| W7164388087 | Targeted Therapies Combined with Intensive Chemotherapy in Fit Acute Myeloid Leukemia: Past Developments, Current Evidence, and Future Therapeutic Paradigms | 2026-06-11 | OpenAlex | 10.3390/jcm15124529 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164388087 | |||
| W7164584124 | Editorial: New drugs and future challenges in drug metabolism and transport | 2026-06-12 | OpenAlex | 10.3389/fphar.2026.1851508 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164584124 | |||
| W7164570839 | Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free Remission | 2026-06-12 | OpenAlex | 10.3390/cancers18121922 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164570839 | |||
| W7164360754 | Myasthenia gravis: innovative therapies and new frontiers in research | 2026-06-12 | OpenAlex | 10.1007/s40267-026-01246-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164360754 | |||
| W7164862820 | Thalassemia – From Molecular Diagnosis to Innovative Therapies | 2026-06-12 | OpenAlex | 10.5772/intechopen.1016193 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164862820 | |||
| W7164525470 | AI counseling agent for motivational interviewing: Conversational processes associated with change talk in emergency department patients | 2026-06-13 | OpenAlex | 10.1016/j.josat.2026.210053 | Full text | Excluded | F4: The implemented GPT-4 motivational-interviewing agent follows six fixed phases and personalizes each session from that patient’s baseline inputs. Transcript review flags go to the PI; no cross-case agent update is reported. Adaptive prompting is future work. The paper analyzes105 sessions from98 participants, rather than evaluating a retained agent-learning intervention. | https://openalex.org/W7164525470 | https://doi.org/10.1016/j.josat.2026.210053 | Publisher full HTML read through existing Tohoku University entitlement; relevant methods/evaluation sections examined online. | |
| W7164511893 | Current Practices, Evolving Techniques, and Immunologic Challenges in Living and Deceased Donor Limbal Stem Cell Transplantation | 2026-06-13 | OpenAlex | 10.1016/j.ajo.2026.06.007 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164511893 | |||
| W7164756057 | Determinants of Colorectal Cancer: An Integrative Immunometabolic Framework Linking Biomarkers, Therapy, and the Diet–Microbiota Axis | 2026-06-13 | OpenAlex | 10.3390/cells15121074 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164756057 | |||
| W7164667577 | Evolving Role of Neoadjuvant Endocrine Therapy in Hormone Receptor Positive Breast Cancer: a Review | 2026-06-13 | OpenAlex | 10.1007/s12609-026-00659-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164667577 | |||
| W7164515497 | Peer-delivered systems-integrated suicide prevention for women in Pakistan: a protocol for hybrid type II pilot cluster randomized controlled trial | 2026-06-13 | OpenAlex | 10.1186/s40814-026-01841-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164515497 | |||
| W7164515720 | Periprocedural allergy evaluation is safe and effective to guide subsequent anesthesia administration | 2026-06-13 | OpenAlex | 10.1016/j.jacig.2026.100747 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164515720 | |||
| W7164744291 | EC-Distill-ZeroDiag: a cloud-edge collaborative framework for zero-shot industrial fault diagnosis via large language model distillation | 2026-06-14 | OpenAlex | 10.1007/s10845-026-02897-1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7164744291 | |||
| W7164746212 | Theranostic Approaches to Radioiodine-Refractory Differentiated Thyroid Cancer: A Narrative Review | 2026-06-14 | OpenAlex | 10.3390/cancers18121937 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164746212 | |||
| W7164850433 | "AmbientOn: Ontology-Driven Analytical Findings, Hypotheses, and Verification Outputs for Healthcare Fraud, E-Commerce Logistics, and ITSM Incident Management" | 2026-06-15 | OpenAlex | 10.21227/z2sj-5a15 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7164850433 | |||
| W7165155040 | Benefits Beyond Hypertension Control: Current and Evolving Treatment Strategies for Prevention of Cardiovascular Diseases | 2026-06-15 | OpenAlex | 10.2174/0115734021435628260415113327 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165155040 | |||
| W7164844061 | Biostimulatory Injectables for Collagen Stimulation | 2026-06-15 | OpenAlex | 10.1055/a-2894-5802 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164844061 | |||
| W7164829394 | Distribution of nanotechnology in the cancer therapeutics market as a multimodal treatment: comparison with predecessors and emergence in the commercial field | 2026-06-15 | OpenAlex | 10.3389/fnano.2026.1796622 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164829394 | |||
| W7164848628 | Emerging Technologies in the Operating Room | 2026-06-15 | OpenAlex | 10.66224/infopub.2026.04.07 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164848628 | |||
| W7164834693 | Emerging metabolic hormone therapeutics for metabolic dysfunction-associated steatohepatitis: incretin-based drugs, fibroblast growth factor analogs, and liver-targeting strategies | 2026-06-15 | OpenAlex | 10.1007/s40005-026-00815-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164834693 | |||
| W7164810621 | From Reactive AI to Agentic Systems: A Review of Autonomous medical AI Agents in Healthcare | 2026-06-15 | OpenAlex | 10.1007/s11831-026-10655-y | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7164810621 | |||
| W7162909388 | Karakterisering van nieuwe remmers tegen bacteriën | 2026-06-15 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162909388 | ||||
| W7163858614 | Knowledge Graphs As A Representational Layer For Agentic AI In Customer Experience Decision Support | 2026-06-15 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7163858614 | ||||
| W7164847296 | Luspatercept and imetelstat for myelodysplastic syndrome: updates from ASH 2025 annual meeting | 2026-06-15 | OpenAlex | 10.1186/s13045-026-01815-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164847296 | |||
| W7164900564 | Management of subdural haematoma: a practical guide | 2026-06-15 | OpenAlex | 10.1136/pn-2026-005142 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164900564 | |||
| W7164818571 | National trends in endotracheal intubation among pediatric patients less than six years old with single-substance intoxication: a fifteen-year retrospective study | 2026-06-15 | OpenAlex | 10.1080/15563650.2026.2675037 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164818571; https://openalex.org/W7165196525; https://openalex.org/W7164845044 | |||
| W7164801100 | Navigating Safety in Reproductive Health Self-Care Interventions in Ghana: A Qualitative Study | 2026-06-15 | OpenAlex | 10.31234/osf.io/dsutg_v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164801100 | |||
| W7164848434 | New-Onset Refractory Status Epilepticus (NORSE): A Comprehensive Review of Etiology, Pathophysiology, and Management | 2026-06-15 | OpenAlex | 10.5281/zenodo.20704501 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164848434 | |||
| W7164848437 | Operational Intelligence at Enterprise Scale: Predictive Intent Orchestration, Scenario-Aware Decisioning, and Probabilistic Control for Anticipatory Autonomous Enterprises | 2026-06-15 | OpenAlex | 10.5281/zenodo.20707142 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7164848437 | |||
| W7164804371 | Operational Intelligence at Enterprise Scale: Probabilistic Decision Intelligence, Scenario Resilience Modeling, and Anticipatory Control in Autonomous Enterprises | 2026-06-15 | OpenAlex | 10.5281/zenodo.20707462 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7164804371 | |||
| W7164906692 | Personality Emergence and Adaptive Functioning: An Enactive, Complex-Dynamical Systems Account | 2026-06-15 | OpenAlex | 10.31235/osf.io/przsu_v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164906692 | |||
| W7164826714 | Recent Outbreaks, Resistance Trends, and Control Measures in Candida auris and Candida glabrata Infections | 2026-06-15 | OpenAlex | 10.3390/jof12060436 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164826714 | |||
| W7164834628 | Trustworthy agentic genomics through versioned skill libraries | 2026-06-15 | OpenAlex | 10.64898/2026.06.11.731523 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7164834628 | |||
| W7164864983 | AI-Driven DevSecOps to Enhance Software Quality and Security | 2026-06-16 | OpenAlex | 10.1007/978-3-032-28939-1_3 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7164864983 | |||
| W7164880656 | Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now? | 2026-06-16 | OpenAlex | 10.3390/cancers18121961 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164880656 | |||
| W7164895653 | Cyclotherapy: exploiting cell-cycle decoupling for selective cancer cytotoxicity and normal-tissue protection | 2026-06-16 | OpenAlex | 10.1016/j.ctrv.2026.103172 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164895653 | |||
| W7164894649 | Editorial: Strain-specific probiotics: enhancing children's health through targeted clinical research | 2026-06-16 | OpenAlex | 10.3389/fnut.2026.1888544 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164894649 | |||
| W7164921545 | Mineral and Bone Disease in CKD and Kidney Transplantation: Controversies, Gaps, and a Path Forward | 2026-06-16 | OpenAlex | 10.1016/j.ekir.2026.106662 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164921545 | |||
| W7164913726 | Neoadjuvant Bevacizumab and Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-Term Outcomes of a Multicentre Study | 2026-06-16 | OpenAlex | 10.1016/j.clcc.2026.06.002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164913726 | |||
| W7164913575 | Postoperative thrombosis in patients with hemophilia and malignancy: Mechanisms and perioperative prevention and management — A scoping review | 2026-06-16 | OpenAlex | 10.1016/j.thromres.2026.109750 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164913575 | |||
| W7164991927 | RESEARCH THESIS: TO COMPARATIVELY EVALUATE SALE TRENDS OF SITAGLIPTIN AND DAPAGLIFLOZIN IN KALAMB AND YAVATMAL | 2026-06-16 | OpenAlex | 10.5281/zenodo.20729683 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7164991927 | |||
| W7164879491 | Racing Ahead, Governing Behind: An Institutional Analysis of AI Governance Readiness in Global Capability Centres | 2026-06-16 | OpenAlex | 10.5120/ijaisb2118d76a1e3 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7164879491 | |||
| W7164884352 | Solid Lipid Nanoparticle-Based Drug Delivery for Lung Cancer | 2026-06-16 | OpenAlex | 10.1201/9781779640215-12 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7164884352 | |||
| W7164911053 | The role of medical ESP in training a sustainable healthcare workforce | 2026-06-16 | OpenAlex | 10.65956/procia.2026.120 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7164911053 | |||
| W7164878652 | Update on Glucocorticoid-Induced Osteoporosis: Emerging Therapeutic Strategies | 2026-06-16 | OpenAlex | 10.3803/enm.2026.3006 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164878652 | |||
| W7165019103 | Chewing Gums a Boon or Bane to Dental Health - A Review | 2026-06-17 | OpenAlex | 10.38124/ijisrt/26jun369 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165019103 | |||
| W7165041844 | Data from Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective Analysis | 2026-06-17 | OpenAlex | 10.1158/2767-9764.c.8541916 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165041844 | |||
| W7165037774 | Data from Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States | 2026-06-17 | OpenAlex | 10.1158/2767-9764.c.8541959 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165037774 | |||
| W7165050556 | Diseases of Crucifers and Their Management | 2026-06-17 | OpenAlex | 10.1201/9781042014460-15 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7165050556 | |||
| W7165054822 | Editorial: GenAI in healthcare: technologies, applications and evaluation | 2026-06-17 | OpenAlex | 10.3389/frai.2026.1878137 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165054822 | |||
| W7164993216 | Global research hotspots and evolving themes in chemoresistance of hepatocellular carcinoma: a bibliometric analysis from a pharmacological perspective | 2026-06-17 | OpenAlex | 10.1007/s00210-026-05568-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164993216 | |||
| W7165113053 | Prescribing Trajectories in Type 2 Diabetes in the United States, 2019–2024 | 2026-06-17 | OpenAlex | 10.1111/dom.71013 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165113053 | |||
| W7164997592 | Preserving And Safeguarding The Weapons Of Our Warfare Against Unseen Enemies: Diary Of An Antibiotic Guardian | 2026-06-17 | OpenAlex | 10.52968/15063109 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164997592; https://openalex.org/W7164991330 | |||
| W7165000074 | Rational Drug Design Targeting Multidrug-Resistant Microorganisms: A Narrative Review | 2026-06-17 | OpenAlex | 10.70955/jcj.2026.04 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165000074 | |||
| W7165049810 | Role of radiotherapy in refractory/relapsed classical Hodgkin lymphoma in the era of targeted therapies and immunotherapy | 2026-06-17 | OpenAlex | 10.1016/j.ctro.2026.101221 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165049810 | |||
| W7165019064 | The self-orchestrating emergency department: Agentic AI for supervised emergency department operations | 2026-06-17 | OpenAlex | 10.1016/j.aiemed.2026.100028 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7165019064 | |||
| W7165032910 | ULK1's role in cancer progression and its emerging therapeutic potential | 2026-06-17 | OpenAlex | 10.1080/15384047.2026.2680347 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165032910 | |||
| W7165129768 | Anticancer drug dosing: Balancing benefit and toxicity | 2026-06-18 | OpenAlex | 10.1016/j.critrevonc.2026.105435 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165129768 | |||
| W7165182779 | EVOLVING TRENDS IN UROPATHOGEN RESISTANCE: A COMPREHENSIVE REVIEW OF GLOBAL ANTIBIOGRAM PATTERNS AND STEWARDSHIP IMPLICATIONS. | 2026-06-18 | OpenAlex | 10.5281/zenodo.20751426 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165182779 | |||
| W7165160927 | Expert perspectives on de-escalation of antiplatelet therapy – Beyond the Guidelines: Insights from the Cardiovascular Research Technologies 2026 meeting | 2026-06-18 | OpenAlex | 10.1016/j.carrev.2026.06.009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165160927 | |||
| W7165370110 | Gene Therapy Tools for Diseases Caused by Mutations of the Mitochondrial Genome | 2026-06-18 | OpenAlex | 10.3390/ijms27125517 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165370110 | |||
| W7165141422 | Guest editorial: Digital technologies and mental health management: opportunities and challenges | 2026-06-18 | OpenAlex | 10.1108/imds-07-2026-998 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165141422 | |||
| W7165550243 | Novel Therapeutics for Fatty Liver Disease | 2026-06-18 | OpenAlex | 10.2174/9798898815677126010011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165550243 | |||
| W7160576152 | Robots' Inner Speech meets Thories of emotion: towards Affective Robotics in Human Robot Interaction | 2026-06-18 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160576152 | ||||
| W7165207280 | Simulating family systems with LLM agents: a corpus-grounded engine for counterfactual rehearsal of strategic therapy interventions | 2026-06-18 | OpenAlex | 10.5281/zenodo.20748639 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7165207280 | |||
| W7165173050 | Splenic Artery Proximal Embolization after Ectopic Variceal Bleeding: A Case Report on Portal Hypertension Management | 2026-06-18 | OpenAlex | 10.1159/000553159 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165173050 | |||
| W7165181272 | Supplementary Material for: Splenic artery proximal embolization after ectopic variceal bleeding: a case report on portal hypertension management | 2026-06-18 | OpenAlex | 10.6084/m9.figshare.32726448 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165181272 | |||
| W7165157707 | The Scaling Delusion: Why GPT Will Never Wake Up, and How to Build a Safe AGI That Already Works — Moltbook Proved It | 2026-06-18 | OpenAlex | 10.5281/zenodo.20745090 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7165157707 | |||
| W7165371603 | The Wrongs of Backsliding on Climate. Collective Political Akrasia and Climate Inaction | 2026-06-18 | OpenAlex | 10.5281/zenodo.20743246 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7165371603 | |||
| W7165182401 | The fetus/infant - mother as a co-evolving dyadic system and the development of attachment styles: an active inference perspective | 2026-06-18 | OpenAlex | 10.3389/fpsyg.2026.1836911 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165182401 | |||
| W7165018326 | Understanding machupo virus: A neglected arenavirus with global health importance | 2026-06-18 | OpenAlex | 10.5501/wjv.v15.i2.119515 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165018326 | |||
| W7165399584 | A Working AGI Architecture with Extrapolation Capability: Formal Proof of Unprogrammed Behaviour and a Computable Alternative to Φ | 2026-06-19 | OpenAlex | 10.5281/zenodo.20767213 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7165399584 | |||
| W7165118087 | Clinical Research Progress of Triamcinolone Acetonide in the Treatment of Oral Submucous Fibrosis: A Narrative Review | 2026-06-19 | OpenAlex | 10.1007/s42399-026-02483-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165118087 | |||
| W7172183939 | Desenvolvimento de competências: intervenção do enfermeiro especialista na preservação de Vestígios de Indícios de Prática de Crime, em contexto Extra-hospitalar | 2026-06-19 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172183939 | ||||
| W7165492549 | Modern considerations of prevention and treatment of skin infections and complicated dermatoses: a review | 2026-06-20 | OpenAlex | 10.26442/20751753.2026.6.203695 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165492549 | |||
| W7165388404 | Polylysine and its derivatives: structures, functions, and applications | 2026-06-20 | OpenAlex | 10.1016/j.progpolymsci.2026.102151 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165388404 | |||
| W7165446266 | SafeCKD-Agent: Code, Data, and Reproducibility Artifacts for Retrieval-Grounded Clinical Decision Support | 2026-06-20 | OpenAlex | 10.5281/zenodo.20777543 | Full text | Excluded | F5: Available Zenodo deposit is software/data; the corresponding primary research report was not found in the examined public sources. Exact-title search and an institution-based Politecnico di Torino IRIS check did not locate the main report. The author requested main texts only; the software/data ZIP was not downloaded. No mechanism or agent-status judgment is inferred from the artifact directory. | https://openalex.org/W7165446266 | https://zenodo.org/records/20777544 | Complete repository description and public file listing; only SafeCKD_Zenodo_Release_v1.0.0.zip is listed. Main research report not found; see fulltext/extractions/SAFECKD_PRIMARY_ONLY.json. | |
| W7165445472 | Stone_AI:StonesLaw.py.html | 2026-06-20 | OpenAlex | 10.5281/zenodo.20776691 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7165445472 | |||
| W7165553306 | Click Chemistry as a Versatile Platform in Modern Drug Discovery and Bioconjugation | 2026-06-21 | OpenAlex | 10.5281/zenodo.20790800 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165553306 | |||
| W7220483279 | NANOPARTICLE-BASED MODULATION OF NEURONAL ACTIVITY AND NEUROPROTECTION IN PARKINSON’S AND ALZHEIMER’S DISEASE | 2026-06-21 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220483279 | ||||
| W7165737785 | Smart IoT-based Healthcare Systems for Continuous Health-monitoring and Predictive-analytics Using Reinforcement Learning | 2026-06-21 | OpenAlex | 10.22266/inassexpress.2026.009 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165737785 | |||
| W7167691367 | Agentic AI for Continuous Intelligence in Future Smart Connected Systems | 2026-06-22 | OpenAlex | 10.1109/dsn-w70714.2026.00024 | Full text | Excluded | F1: This is a vision/proposed architecture without an implemented/evaluated adaptive system; it also spans smart homes, farming and warehouses beyond healthcare. | https://openalex.org/W7167691367 | https://www.researchgate.net/publication/404276921_Agentic_AI_for_Continuous_Intelligence_in_Future_Smart_Connected_Systems | Author-uploaded preprint, proposed implementation §V and conclusion §VI read; no empirical evaluation reported there. | |
| W7165539371 | Anaemia in multiple myeloma: evolving insights into bone marrow microenvironment-driven pathogenesis and targeted management | 2026-06-22 | OpenAlex | 10.1186/s40001-026-04770-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165539371 | |||
| W7165546151 | Editorial on “GLP-1 receptor agonists associated with better cardiovascular outcomes in obese or diabetic patients with elevated lip(a) levels: A multicenter retrospective study” IJCJOURNAL-D-26-01993R1 | 2026-06-22 | OpenAlex | 10.1016/j.ijcard.2026.134632 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165546151 | |||
| W7165563539 | Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence | 2026-06-22 | OpenAlex | 10.7759/cureus.111322 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165563539 | |||
| W7165541401 | From mechanisms to clinical applications: A bibliometric analysis of extracellular vesicles in osteoporosis (2013–2025) | 2026-06-22 | OpenAlex | 10.1016/j.rineng.2026.111663 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165541401 | |||
| W7165526050 | Hidradenitis suppurativa: a comprehensive review of pathogenetic mechanisms, clinical phenotypes, and evolving therapeutic paradigms | 2026-06-22 | OpenAlex | 10.18203/issn.2455-4529.intjresdermatol20261942 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165526050 | |||
| W7169840016 | Janus Kinase Inhibitors (JAKis) in Rheumatologic Diseases: A Narrative Review of Evolving Evidence, Safety Signals, Place in Therapy and Implications for Primary Care | 2026-06-22 | OpenAlex | 10.37184/jlnh.2959-1805.4.35 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169840016 | |||
| W4414044214 | Modeling and Tracking of Heterogeneous Cell Populations via Open Multi-Agent Systems | 2026-06-22 | OpenAlex | 10.1109/tcbbio.2026.3705938 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W4414044214 | |||
| W7165527013 | Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions | 2026-06-22 | OpenAlex | 10.1007/s40257-026-01048-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165527013 | |||
| W7165537277 | Systemic immunomodulatory therapies in severe atopic dermatitis: a comprehensive review of mechanisms, efficacy and long-term management stratagems | 2026-06-22 | OpenAlex | 10.18203/issn.2455-4529.intjresdermatol20261940 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165537277 | |||
| W7165687267 | A Curious Case of Leg Swelling With Eosinophilic Fasciitis, IgA-κ Monoclonal Gammopathy, Proteinuria, and Bilateral Carpal Tunnel Neuropathy: Diagnostic Convergence of Sclerosing Dermato-Fasciitis and Monoclonal Gammopathy | 2026-06-23 | OpenAlex | 10.7759/cureus.111358 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165687267 | |||
| W7165688879 | Chronic hyperkeratotic and pustular cutaneous lesions of the hand | 2026-06-23 | OpenAlex | 10.1016/j.ejim.2026.107021 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165688879 | |||
| W7165651800 | Comparative Evaluation of Sticky Bone and Mineral Trioxide Aggregate as Pulpotomy Agents in Primary Molars: A Research Protocol for a Randomised Controlled Trial | 2026-06-23 | OpenAlex | 10.7860/jcdr/2026/81334.23888 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165651800 | |||
| W7165631339 | Contrastive Adversarial Agents for Intentional Drift Induction in Network Intrusion Detection Systems | 2026-06-23 | OpenAlex | 10.1609/aaaiss.v9i1.42946 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7165631339 | |||
| W7165648576 | Editorial: 10th anniversary of Frontiers in Surgery - celebrating progress and envisioning the future of multidisciplinary surgery | 2026-06-23 | OpenAlex | 10.3389/fsurg.2026.1866857 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165648576 | |||
| W7165626942 | Efficacy and safety of first-line PD-1/PD-L1 inhibitor–based therapy in esophageal squamous cell carcinoma: A systematic review and meta-analysis. | 2026-06-23 | OpenAlex | 10.1200/jco.2026.44.19_suppl.113 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165626942 | |||
| W7165621778 | Long-term response of fenfluramine in Pediatric CDKL5 deficiency disorder with Lennox–Gastaut syndrome: A case report | 2026-06-23 | OpenAlex | 10.1016/j.bdcasr.2026.100151 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165621778 | |||
| W7165650619 | Simulating expert oncologist-to-oncologist thinking and behavior: Multi-agent AI for precision oncology collaboration. | 2026-06-23 | OpenAlex | 10.1200/jco.2026.44.19_suppl.20 | Full text | Excluded | F5: The complete abstract mentions behavior cloning and MAPPO, potentially relevant to persistent learning, but does not describe the training interaction loop, retained policy or later-case evaluation protocol. The primary publisher explicitly states that this abstract does not include a full-text component; no expanded primary methods report was located. Absence of training detail was not recoded as evidence of no learning. | https://openalex.org/W7165650619 | https://ascopubs.org/doi/10.1200/JCO.2026.44.19_suppl.20 | Complete publisher conference abstract accessible through existing entitlement; expanded full methods report unavailable. | |
| W7204537239 | Therapeutic Strategies to manage Chronic Inflammation in patients on Maintenance Haemodialysis: A scoping review | 2026-06-23 | OpenAlex | 10.17605/osf.io/z7yqu | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204537239 | |||
| W7165616276 | Toward In-Depth Root Cause Localization for Microservices With Multi-Agent Recursion-of-Thought | 2026-06-23 | OpenAlex | 10.1109/tdsc.2026.3706572 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7165616276 | |||
| W7165773025 | Abstract IA009: Bispecific antibodies in B-cell lymphomas: Redefining immune engagement in the therapeutic landscape | 2026-06-24 | OpenAlex | 10.1158/2643-3249.lymphoma26-ia009 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165773025 | |||
| W7165782897 | Agentic AI and Autonomous Systems | 2026-06-24 | OpenAlex | 10.4018/979-8-2600-2601-4.ch004 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7165782897 | |||
| W7165744339 | Agentic AI: Autonomous Agents to Cognitive Autonomy | 2026-06-24 | OpenAlex | 10.5281/zenodo.20826452 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7165744339 | |||
| W7165752660 | Between rescue and legacy: ethical reflections on organ donation after extracorporeal cardiopulmonary resuscitation | 2026-06-24 | OpenAlex | 10.1016/j.bja.2026.05.013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165752660 | |||
| W7165736396 | From PET to targeted radionuclide therapy in the Brain: The emerging role of radiometal-based platforms | 2026-06-24 | OpenAlex | 10.1016/j.jinorgbio.2026.113397 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165736396 | |||
| W7165784797 | Leishmaniasis: pathogenesis, host immunity, and the evolving landscape of immunotherapy and immunochemotherapy | 2026-06-24 | OpenAlex | 10.3389/fmicb.2026.1861933 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165784797 | |||
| W7165764267 | RETRACTED: Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets | 2026-06-24 | OpenAlex | 10.1073/pnas.2535785123 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7165764267 | |||
| W7165770448 | Real-world treatment patterns in patients with dysmenorrhea in Japan: a retrospective database study | 2026-06-24 | OpenAlex | 10.3389/fgwh.2026.1775657 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165770448 | |||
| W7165781875 | Severe Clade I (subclade Ib) mpox in advanced HIV complicated by multidrug-resistant bacterial superinfection and ocular involvement: a case report from Uganda | 2026-06-24 | OpenAlex | 10.1186/s41182-026-01010-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165781875 | |||
| W7165771751 | Targeting Isocitrate Dehydrogenase-Mutant Glioma with Vorasidenib : A New Era in Precision Neuro-Oncology | 2026-06-24 | OpenAlex | 10.3340/jkns.2026.0113 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165771751 | |||
| W7165756673 | The updated 2025 classification for interstitial pneumonia: Are we ready for the entity “idiopathic bronchiolocentric interstitial pneumonia?” | 2026-06-24 | OpenAlex | 10.4103/lungindia.lungindia_280_26 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7165756673 | |||
| W7213481917 | Tracking the Morphosemantic Evolution of English -ee Nouns in the OED3 | 2026-06-24 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213481917 | ||||
| W7166534983 | Agentic Artificial Intelligence in Inflammatory Bowel Disease: Toward Autonomous and Adaptive Care | 2026-06-25 | OpenAlex | 10.1093/crocol/otag066 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166534983 | |||
| W7167640512 | Beyond Structural Pathology: Central Sensitization and Chronic Pain with Reference to Lumbar Disc Herniation—A Narrative Review | 2026-06-25 | OpenAlex | 10.3390/brainsci16070664 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167640512 | |||
| W7166589151 | CREST syndrome | 2026-06-25 | OpenAlex | 10.61997/bjm.v15i2.501 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166589151 | |||
| W7165931558 | Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections | 2026-06-25 | OpenAlex | 10.1080/14656566.2026.2695994 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165931558 | |||
| W7166115452 | Immunotherapy for Melanoma: A Concise Clinical Review for Australasian Practice | 2026-06-25 | OpenAlex | 10.1111/ajd.70158 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166115452 | |||
| W7165923595 | Inter- and intra-quartile comparison of multi-tracer PET/CT and liquid biopsy molecular markers in cancer: a futuristic perspective on evolving a “stepped care” model for individualized precision theranostics through AI/ML | 2026-06-25 | OpenAlex | 10.1007/s00259-026-08025-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165923595 | |||
| W7204503532 | The Role of Magnesium Sulfate in Contemporary Obstetrics | 2026-06-25 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204503532 | ||||
| W7165943343 | The evolving landscape of acute kidney injury: research directions and changes in clinical practice | 2026-06-25 | OpenAlex | 10.23876/j.krcp.25.255 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7165943343 | |||
| W7165883027 | Trastuzumab Emtansine–Associated Porto-Sinusoidal Vascular Disorder: Clinical Features and Outcomes from Published Cases | 2026-06-25 | OpenAlex | 10.3390/jcm15134950 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165883027 | |||
| W7165864685 | Updates on intratumoral therapies in melanoma | 2026-06-25 | OpenAlex | 10.1002/cncr.70400 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165864685 | |||
| W7166151139 | A Multi-Agent Engineering Team for Prompt-Based Application Generation | 2026-06-26 | OpenAlex | 10.55041/isjem08051 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7166151139 | |||
| W7166122247 | Agentic AI: The Power to Change Medicine and Our World | 2026-06-26 | OpenAlex | 10.17615/9qtg-ps49 | Title/abstract | Excluded | E5: Non-English or absent abstract with an uninformative title; no eligible specific clinical learning mechanism can be established. | https://openalex.org/W7166122247 | |||
| W7166117252 | CDK4/6-targeted therapy: From clinical inhibitors to emerging strategies to overcome resistance | 2026-06-26 | OpenAlex | 10.1016/j.bmc.2026.118736 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166117252 | |||
| W7166075853 | Editorial: Integrating economics into population health: assessing policies and outcomes | 2026-06-26 | OpenAlex | 10.3389/fpubh.2026.1902201 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166075853 | |||
| W7166008226 | Editorial: Navigating environmental hazards in the workplace: impacts and interventions | 2026-06-26 | OpenAlex | 10.3389/fpubh.2026.1893964 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166008226 | |||
| W7168377920 | FUTURE MATHEMATICS FOR DATA SCIENCE & AI by Prof. Shradha Harshal Chaudhari, Mrs. Ch. Dharani, Dr. T. Siva Krishna ,Dr. M. L. L. Phani Kanth | 2026-06-26 | OpenAlex | 10.5281/zenodo.21131497 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168377920 | |||
| W7166088948 | Gemmological Optical Microscopy of Two Experimental Monochrome Glazes of the Yongzheng Period (1723–1735): "Peacock Green" (Kongque Lü) and "Pine Needle Green" (Songhua Lü) | 2026-06-26 | OpenAlex | 10.5281/zenodo.20921733 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7166088948 | |||
| W7166171063 | Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia | 2026-06-26 | OpenAlex | 10.1080/14656566.2026.2695099 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166171063 | |||
| W7166037043 | Podcast on the Emerging Role of PD-(L)1/VEGF Bispecific Antibodies in the Evolving Advanced Renal Cell Carcinoma Treatment Landscape | 2026-06-26 | OpenAlex | 10.1007/s40487-026-00450-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166037043 | |||
| W7166649782 | Stem Cell-Based Strategies for Fibrotic and Neurogenic Bladder Disorders: Current Evidence, Translational Challenges, and Future Directions | 2026-06-26 | OpenAlex | 10.3390/cimb48070658 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166649782 | |||
| W7166116632 | The evolving role of heparin in sepsis: therapeutic potential in the age of immunothrombosis | 2026-06-26 | OpenAlex | 10.1016/j.jtha.2026.06.017 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166116632 | |||
| W7166033096 | Treatment of breast cancer brain metastases in the era of novel drugs | 2026-06-26 | OpenAlex | 10.1016/j.ctrv.2026.103179 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166033096 | |||
| W7166567118 | Atopic Dermatitis: New Targets and Emerging Systemic Therapies | 2026-06-27 | OpenAlex | 10.1007/s40257-026-01054-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166567118 | |||
| W7166382430 | Beyond Connectivity: Architecting Decentralised Trust for the Emerging Internet of Agents (IoA) | 2026-06-27 | OpenAlex | 10.1007/978-3-032-29237-7_33 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7166382430 | |||
| W7166345962 | Cardiogenic Shock: A Comprehensive Review of Pathophysiology, Clinical Management, and Contemporary Therapeutic Strategies | 2026-06-27 | OpenAlex | 10.5281/zenodo.20965483 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166345962 | |||
| W7166311016 | Caudal Anesthesia: A Comprehensive Review of Anatomical Foundations, Clinical Applications, and Contemporary Practice Paradigms | 2026-06-27 | OpenAlex | 10.5281/zenodo.20966703 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166311016 | |||
| W7166474537 | Advances and Future Directions in Antibody–Drug Conjugates: From Paradigm Shifts to Data-Driven Design | 2026-06-28 | OpenAlex | 10.3390/cancers18132102 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166474537 | |||
| W7166438400 | Artificial intelligence enabled Physical Internet readiness improves sustainable healthcare supply chain performance | 2026-06-28 | OpenAlex | 10.1007/s43621-026-03695-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166438400 | |||
| W7219828918 | Contemporary management of locally advanced and metastatic renal cell carcinoma: An update of current evidence | 2026-06-28 | OpenAlex | 10.52786/isu.a.121 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7219828918 | |||
| W7166467108 | Kyoo32/MARC: v1.0 — Initial Public Release | 2026-06-28 | OpenAlex | 10.5281/zenodo.20993980 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7166467108 | |||
| W7166446678 | Piperazine Derivatives | 2026-06-28 | OpenAlex | 10.1002/9781394284832.ch12 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166446678 | |||
| W7166431521 | The Role of Natural Products in Cervical Cancer | 2026-06-28 | OpenAlex | 10.1002/9781394416905.ch25 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166431521 | |||
| W7166566973 | A Systematic Review and Meta-analysis of Clinical Trials in ALK-positive Non-small Cell Lung Cancer | 2026-06-29 | OpenAlex | 10.21873/anticanres.18227 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166566973 | |||
| W7166591048 | Advances in First-Line Treatment of Classical Hodgkin Lymphoma in the Era of Novel Agents | 2026-06-29 | OpenAlex | 10.3390/jcm15135075 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166591048 | |||
| W7166751171 | Always-OnAgents:A Survey of Persistent Memory, State, and Governance in LLMAgents | 2026-06-29 | OpenAlex | 2606.30306 | 10.48550/arxiv.2606.30306 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7166751171 | ||
| W7166515307 | Artificial Intelligence in Inherited Epidermolysis Bullosa: Current Evidence, Challenges, and Future Directions | 2026-06-29 | OpenAlex | 10.3390/diagnostics16132022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166515307 | |||
| W7166551338 | BIO Layer: Governance-First Memory for Auditable Long-Term Agents | 2026-06-29 | OpenAlex | 10.5281/zenodo.21020857 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7166551338 | |||
| W7166516304 | Beyond Palliation: Redefining the Surgical Frontier in Stage IV Non-Small Cell Lung Cancer | 2026-06-29 | OpenAlex | 10.9734/jamps/2026/v28i7874 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166516304 | |||
| W7166533521 | Comparison of clinical practice guidelines for chronic hepatitis B: natural history classification and treatment initiation | 2026-06-29 | OpenAlex | 10.3350/cmh.2026.0697 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166533521 | |||
| W7202064688 | Digital patient twin: a multivariate and holistic approach for continuous monitoring and predictive medicine. | 2026-06-29 | OpenAlex | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7202064688 | ||||
| W7166561385 | Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder | 2026-06-29 | OpenAlex | 10.1080/14656566.2026.2697064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166561385 | |||
| W7166534551 | Doxycycline: A Comprehensive Review of Pharmacological Properties, Broad-Spectrum Clinical Applications, and Emerging Therapeutic Paradigms in Infectious Disease Management | 2026-06-29 | OpenAlex | 10.5281/zenodo.21034681 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166534551 | |||
| W7166570622 | Editorial: Human reactions to artificial intelligence with anthropomorphic features | 2026-06-29 | OpenAlex | 10.3389/fpsyg.2026.1873310 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166570622 | |||
| W7166528471 | Extranodal natural killer/T‐cell lymphoma: From fatal to curable | 2026-06-29 | OpenAlex | 10.3322/caac.70094 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166528471 | |||
| W7166521739 | Imaging response assessment in metastatic renal cell carcinoma: a radiologist’s guide to contemporary therapeutic strategies | 2026-06-29 | OpenAlex | 10.1007/s00261-026-05604-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166521739 | |||
| W7166532488 | Iodinated Contrast Media Hypersensitivity in 115,966 Patients | 2026-06-29 | OpenAlex | 10.1097/rli.0000000000001301 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166532488 | |||
| W7166553080 | Joao-supera/SUP3RA-SKILLS-OS: v0.1.0 - Public Architecture Draft | 2026-06-29 | OpenAlex | 10.5281/zenodo.21038168 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7166553080 | |||
| W7166579102 | Mild Thyroid Eye Disease—The Most Common yet the Least Studied Presentation of Thyroid Eye Disease | 2026-06-29 | OpenAlex | 10.1177/10507256261464556 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166579102 | |||
| W7216951319 | Navigating the 2026 Regulatory Turn: A Framework for Responsible Innovation and Human-Centric Ethical Accountability in Agentic AI | 2026-06-29 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216951319 | ||||
| W7166532381 | Post-bariatric hypoglycaemia: from altered gut physiology to targeted therapies | 2026-06-29 | OpenAlex | 10.1530/ec-25-0850 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166532381 | |||
| W7166519930 | Recent advances in the management of pediatric neuropsychiatric lupus from conventional therapies to novel immunomodulators | 2026-06-29 | OpenAlex | 10.1177/09612033261466741 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166519930 | |||
| W7172527478 | Scientific basis and strategic advantages of primary HPV testing and immunocytochemistry in the modern cervical cancer screening framework | 2026-06-29 | OpenAlex | 10.30841/2708-8731.4.2026.368209 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172527478 | |||
| W7166542724 | Targeting metabolic reprogramming in HPV-associated oral squamous cell carcinoma: current advances, challenges, and clinical prospects | 2026-06-29 | OpenAlex | 10.1007/s10735-026-10863-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166542724 | |||
| W7166729265 | The Evolving Landscape of Targeted Therapies in Systemic Lupus Erythematosus: A Review of Phase 3 Clinical Trials | 2026-06-29 | OpenAlex | 10.3390/app16136458 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166729265 | |||
| W7166552535 | The role of allogeneic stem cell transplantation in peripheral T-cell lymphoma | 2026-06-29 | OpenAlex | 10.1038/s41409-026-02962-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166552535 | |||
| W7166587386 | Therapeutic Twins for Creative Digital Mental Health: A Review Through a Trust-in-Automation Lens | 2026-06-29 | OpenAlex | 10.1080/10447318.2026.2689526 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166587386 | |||
| W7213569744 | Using a serious game to engage agrifood system actors for unlocking the production of local neglected legume crops – A case study in South-Eastern Senegal | 2026-06-29 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213569744 | ||||
| W7166674443 | A Review of Bispecific T-cell Engagers (BiTEs): A Promising Strategy in the Evolving Landscape of Cancer Immunotherapy | 2026-06-30 | OpenAlex | 10.1055/s-0046-1824552 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166674443 | |||
| W7166717911 | A six-level clinical autonomy framework for artificial intelligence in dentistry | 2026-06-30 | OpenAlex | 10.3389/froh.2026.1836492 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166717911 | |||
| W7221527494 | Advances in Management of Rheumatoid Arthritis: From Conventional Therapy to Targeted Treatment – A Narrative Review | 2026-06-30 | OpenAlex | 10.5812/jkums-172010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221527494 | |||
| W7166694503 | Anesthetic considerations in patients receiving glucagon-like peptide-1 receptor agonists: Focus on gastric emptying and safety | 2026-06-30 | OpenAlex | 10.71152/ajms.v17i7.5334 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166694503 | |||
| W7171550578 | BASIS: An LLM-Empowered Benchmark and Agent System for Inferring Synthetic Lethality | 2026-06-30 | OpenAlex | 10.1145/3807503.3819483 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171550578 | |||
| W7170181857 | Beyond Cytotoxicity: Molecularly Targeted Cancer Therapy, Resistance Landscapes, and Analytical Strategies in Modern Oncology: Review Article | 2026-06-30 | OpenAlex | 10.62472/kjps.v17.i28.379-394 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170181857 | |||
| W7166652346 | Clinical decision support in hematological malignancies using a case-grounded AI agent | 2026-06-30 | OpenAlex | 10.1038/s41591-026-04494-4 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7166652346 | |||
| W7166649945 | Comparison of Thrombolysis with Endovascular Thrombectomy for Acute Ischemic Stroke: A Review of Recent Studies | 2026-06-30 | OpenAlex | 10.21203/rs.3.rs-10145947/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166649945 | |||
| W7169727200 | Convergent Intelligent Innovations Across Science, Humanities, Commerce, Management, AI, Cyber Law and Data Systems | 2026-06-30 | OpenAlex | 10.5281/zenodo.21439698 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169727200 | |||
| W7207721744 | DEPRESSION AND ANXIETY IN ADVANCED CANCER: DIAGNOSTIC AND THERAPEUTIC CHALLENGES IN PALLIATIVE CARE – A REVIEW | 2026-06-30 | OpenAlex | 10.31435/ijitss.2(50).2026.5573 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7207721744 | |||
| W7166717437 | Editorial: Molecular and cellular mechanisms of bone remodeling | 2026-06-30 | OpenAlex | 10.3389/fendo.2026.1898761 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166717437 | |||
| W7167363608 | Fabrication of Bio-based Protective Fabrics Functionalized with ZnO/MgO Nanoparticles for Antibacterial and Chemical Detoxification Application | 2026-06-30 | OpenAlex | 10.13074/jent.2026.06.2622159 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167363608 | |||
| W7166704752 | Ketamine renaissance: Expanding horizons from anesthesia to depression and pain | 2026-06-30 | OpenAlex | 10.71152/ajms.v17i7.5333 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166704752 | |||
| W7171548963 | MIGRAINE TREATMENT BEYOND TRADITIONAL THERAPIES: CURRENT TRENDS AND FUTURE DIRECTIONS | 2026-06-30 | OpenAlex | 10.31435/ijitss.2(50).2026.5991 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171548963 | |||
| W7166685887 | Molecular Characterization and Virulence Profiling of Fusarium oxysporum f. sp. lycopersici Causing Wilt Disease in Tomato | 2026-06-30 | OpenAlex | 10.5281/zenodo.21059770 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7166685887 | |||
| W7166716103 | Novel Therapeutic Approaches for Cystic Fibrosis | 2026-06-30 | OpenAlex | 10.1201/9781779640413-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166716103 | |||
| W7219893171 | Ontological disruption in school management: sentithinking as the axis of contemporary educational supervision | 2026-06-30 | OpenAlex | 10.69821/biohum.v4i1.93 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7219893171 | |||
| W7171782626 | PNEUMOCYSTIS JIROVECII PNEUMONIA IN TRANSPLANT RECIPIENTS: TIME-DEPENDENT RISK AND CLINICAL IMPLICATIONS – A LITERATURE REVIEW | 2026-06-30 | OpenAlex | 10.31435/ijitss.2(50).2026.6073 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171782626 | |||
| W7168132086 | Portrait of Social Inequality and Family Crisis in Mirāth by Muhammad Husayn Haykal: Literary Realism Approach | 2026-06-30 | OpenAlex | 10.18860/jali.v7i2.42507 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7168132086 | |||
| W7166656495 | Practical recommendations for infectious prophylaxis and vaccination in multiple myeloma patients | 2026-06-30 | OpenAlex | 10.3389/fmed.2026.1847793 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166656495 | |||
| W7166857947 | Role of Photosensitizers in Photodynamic Therapy of Cancer Treatment: A Comprehensive Review | 2026-06-30 | OpenAlex | 10.5530/gjpb.2025.4.11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166857947 | |||
| W7170055804 | Science behind natural skin whitening: A review on local Malaysian skin whitening products Ethereal Lumi Radiance Series and their ingredients for safety, mechanisms and synergistic efficacy | 2026-06-30 | OpenAlex | 10.24191/ijpnacs.v9i1.01 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170055804 | |||
| W7166742907 | Stone Quantum OS | 2026-06-30 | OpenAlex | 10.5281/zenodo.21069334 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7166742907 | |||
| W7166699535 | Targeting MET in 2025: From Exon 14 Skipping to MET-Amplified Acquired Resistance in Non-Small Cell Lung Cancer | 2026-06-30 | OpenAlex | 10.3390/ijms27135883 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166699535 | |||
| W7169132431 | The Age of Autonomous Agents: A Bibliometric Review of Agentic AI Architectures, Applications, and Emerging Challenges | 2026-06-30 | OpenAlex | 10.63646/kpqm1958 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7169132431 | |||
| W7166649297 | The Three Blind Zones of Current AI Philosophy and Humanity's Action Agenda —A Systematic Diagnosis and Pathway Planning Based on the Framework of The Unified Epistemology of the Cosmic Noumenon | 2026-06-30 | OpenAlex | 10.5281/zenodo.21052457 | Title/abstract | Excluded | E1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system. | https://openalex.org/W7166649297 | |||
| W7166812452 | Transperineal versus transrectal prostate biopsy: Aligning Indian practice with emerging evidence | 2026-06-30 | OpenAlex | 10.4103/iju.iju_138_26 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166812452 | |||
| W7167494127 | Unraveling the Pharmacognostic and Mechanistic Landscape of Bombax ceiba L.: Exploring its Phytoconstituents and Therapeutic Potentials | 2026-06-30 | OpenAlex | 10.18311/jnr/2026/55088 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167494127 | |||
| W7169573077 | When digital health transformation outpaces educational capacity in health professions education: a policy-practice gap | 2026-06-30 | OpenAlex | 10.35845/kmuj.2026.24321 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169573077 | |||
| W7166678634 | 当前AI哲学的三大盲区与人类的行动纲领 ——基于《宇宙本体统一认知论》框架的系统性诊断与路径规划 The Three Blind Zones of Current AI Philosophy and Humanity's Action Agenda —A Systematic Diagnosis and Pathway Planning Based on the Framework of The Unified Epistemology of the Cosmic Noumenon | 2026-06-30 | OpenAlex | 10.5281/zenodo.21052676 | Title/abstract | Excluded | E1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system. | https://openalex.org/W7166678634 | |||
| W7167467253 | 75183 Evolving Real-World Treatment Patterns and Unmet Needs in Atopic Dermatitis in the United States: Insights from a 2025 Patient Chart Audit and Market Landscaping Study | 2026-07-01 | OpenAlex | 10.1016/j.jaad.2026.04.879 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167467253 | |||
| W7166519652 | A REVIEW ON MICRONEEDLE-ASSISTED TRANSDERMAL DRUG DELIVERY: REVOLUTIONIZING NON-INVASIVE THERAPY | 2026-07-01 | OpenAlex | 10.5281/zenodo.21031804 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166519652 | |||
| W7169879090 | A Review of Fluorophores for Fluorescence-Guided Surgery in Breast Cancer | 2026-07-01 | OpenAlex | 10.1177/15353508261471742 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169879090 | |||
| W7167153899 | A Review of Therapies for Primary Biliary Cholangitis. | 2026-07-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167153899 | ||||
| W7170043556 | A narrative review of clinical research on knee osteoarthritis in 2025 | 2026-07-01 | OpenAlex | 10.21037/aoj-2026-0018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170043556 | |||
| W7215341760 | Acute Respiratory Distress Syndrome and Corticosteroids: Reconciling Conflicting Evidence. | 2026-07-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7215341760 | ||||
| W7204141489 | Adaptive Ambiguity Reduction in Crop Disease Diagnosis via an LLM Agent | 2026-07-01 | OpenAlex | 10.1109/iccsc71566.2026.11650340 | Title/abstract | Excluded | E2: Crop/tomato disease diagnosis rather than human healthcare. | https://openalex.org/W7204141489 | |||
| W7170178510 | Agentic AI and labor disruption: A comprehensive review, measurement, and policy framework | 2026-07-01 | OpenAlex | 10.1016/j.jengtecman.2026.101993 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170178510 | |||
| W7171546577 | Agentic Self-RAG: An Ablation Study for Zero-Shot Biomedical Question Answering | 2026-07-01 | OpenAlex | 10.1109/iaict71158.2026.11621038 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7171546577 | |||
| W7171042271 | Agentic artificial intelligence: Architectures, planning mechanisms, multi-agent collaboration, applications, challenges, and future research directions-A comprehensive review | 2026-07-01 | OpenAlex | 10.33545/27076571.2026.v7.i7a.358 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7171042271 | |||
| W7214404679 | An Emotion-Aware Preference-Optimized Agent for Adaptive Tool Use: A Thompson Sampling-Based Approach | 2026-07-01 | OpenAlex | 10.1109/acmlc70381.2026.11700470 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7214404679 | |||
| W7202264544 | Applications of Intelligent Agents in the Pathology Diagnostic Workflow | 2026-07-01 | OpenAlex | 10.12290/xhyxzz.2026-0402 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7202264544 | |||
| W7203838742 | Artifact-Constrained Agentic Testing for Black-Box System Testing under Actuarial and Regulatory Constraints | 2026-07-01 | OpenAlex | 10.1109/compsac69091.2026.00147 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7203838742 | |||
| W7167496320 | Artificial intelligence-based prediction of claudin 18.2 expression and immune phenotype from routine histology to guide treatment decisions in patients with gastric cancer | 2026-07-01 | OpenAlex | 10.1016/j.esmoop.2026.108021 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167496320 | |||
| W7167682826 | Beyond Yield | 2026-07-01 | OpenAlex | 10.1016/j.chest.2026.04.043 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7167682826 | |||
| W7166816234 | Bioactive Glasses as Antibacterial Agents: A Review | 2026-07-01 | OpenAlex | 10.1111/ijac.70242 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7166816234 | |||
| W7204085347 | CALM-Trust: Context-Aware Latent Modeling of Trust in Autonomous AI Systems | 2026-07-01 | OpenAlex | 10.1109/icce-taiwan71481.2026.11652711 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204085347 | |||
| W7166873654 | Can long-standing recurrent purpura truly remain benign? | 2026-07-01 | OpenAlex | 10.65048/ijbmr.2026.17.3.8667.1066 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166873654 | |||
| W7170043297 | Chronic graft-versus-host disease: Update on pathobiology, biomarkers, and evolving treatment algorithms | 2026-07-01 | OpenAlex | 10.1177/09636897261471702 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170043297 | |||
| W7167525941 | Clinical Spectrum and Therapeutic Options in Monogenic CTLA-4-, LRBA-, or SOCS1-Related Primary Immune Regulatory Disorders | 2026-07-01 | OpenAlex | 10.1016/j.jaip.2026.02.039 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167525941 | |||
| W7168372281 | Clinical integration of quantitative MRI in an MR-Linac Pathway: A single centre experience | 2026-07-01 | OpenAlex | 10.1016/j.jmir.2026.102375 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168372281 | |||
| W7167614097 | Current Landscape and Future Perspectives of Diabetic Retinopathy Therapy: Pharmacological Targets, Precision Laser Technology, and Clinical Evidence | 2026-07-01 | OpenAlex | 10.1002/mco2.70849 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167614097 | |||
| W7166828121 | CyberConfucius IJHCI Public Data | 2026-07-01 | OpenAlex | 10.6084/m9.figshare.32845169 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7166828121 | |||
| W7171879368 | Decoding biological drug names in dermatology: The post-2022 WHO nomenclature revision and its implications for clinical practice | 2026-07-01 | OpenAlex | 10.1016/j.jaad.2026.07.093 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171879368 | |||
| W7172172067 | Diagnostic Puzzle of Atypical Kawasaki Disease. | 2026-07-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172172067 | ||||
| W7169718661 | E-172 Transvenous embolization of symptomatic orbital venous malformations: evolving technical considerations from two cases | 2026-07-01 | OpenAlex | 10.1136/jnis-2026-snis.276 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169718661 | |||
| W7167725833 | ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease | 2026-07-01 | OpenAlex | 10.1093/ecco-jcc/jjag071 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167725833 | |||
| W7170053236 | Electrospun nanofiber scaffolds for myocardial repair: Mechanistic design, preclinical advances, and translational perspectives | 2026-07-01 | OpenAlex | 10.1016/j.rerere.2026.07.001 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170053236 | |||
| W7222758495 | Emerging Role of Rho-kinase Inhibitors in Ophthalmology: A Narrative Review | 2026-07-01 | OpenAlex | 10.4103/dljo.dljo_63_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222758495 | |||
| W7167345840 | FDA Gene Therapy Approvals (1998–2025): Current Status, Regulatory Evolution, and Future Directions | 2026-07-01 | OpenAlex | 10.1002/jcph.70226 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167345840 | |||
| W7214189429 | From cardiogenic shock to surgical success: Addressing ventricular septal rupture in a myocardial infarction case | 2026-07-01 | OpenAlex | 10.4103/jdrntruhs.jdrntruhs_66_24 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214189429 | |||
| W7167032184 | Guidelines for Decentralized Digital Mobility Observational Studies Using Digital Endpoints and Mobility Outcomes. (Preprint) | 2026-07-01 | OpenAlex | 10.2196/preprints.106004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167032184 | |||
| W7168332281 | Hydrogel-Based Immunomodulatory Strategies for Infected Bone Defects Regeneration: Remodeling the Osteoimmune Microenvironment and Future Perspectives | 2026-07-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168332281; https://openalex.org/W7167852406 | ||||
| W7168678857 | Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: Mechanisms, Therapeutic Applications, and Developmental Progress | 2026-07-01 | OpenAlex | 10.1016/j.xkme.2026.101472 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168678857 | |||
| W7166885994 | Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives | 2026-07-01 | OpenAlex | 10.3389/fimmu.2026.1859046 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166885994 | |||
| W7169718608 | Infecciones dermatológicas raras: un estudio retrospectivo de la experiencia de cinco años en tres hospitales de referencia principales en Costa Rica | 2026-07-01 | OpenAlex | 10.51481/amc.v68i1.1529 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169718608 | |||
| W7172411926 | Innovative breakthroughs in the treatment of central nervous system infections in the era of antimicrobial resistance | 2026-07-01 | OpenAlex | 10.3969/j.issn.1672-6731.2026.07.001 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172411926 | |||
| W7171788255 | Intravitreal Anti–VEGF Therapies in the Management of Retinal Vascular Diseases: A Review of Molecular Mechanisms, Clinical Applications, Dosing Strategies, Emerging Agents, and Future Directions | 2026-07-01 | OpenAlex | 10.4103/tjosr.tjosr_111_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171788255 | |||
| W7170300358 | KRAS-mutated Non–Small Cell Lung Cancer | 2026-07-01 | OpenAlex | 10.1097/ppo.0000000000000842 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170300358 | |||
| W7167663745 | L26/P-251 Analysis of thawing strategies for PGTA-tested euploid single blastocyst transfers: a retrospective study | 2026-07-01 | OpenAlex | 10.1093/humrep/deag083.587 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167663745 | |||
| W7167242135 | Low birthweight neonates and those with long hospital stays are most at risk of antimicrobial-resistant Klebsiella pneumoniae infection in Malawi: implications for antibiotic prescribing | 2026-07-01 | OpenAlex | 10.64898/2026.06.24.26356242 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167242135 | |||
| W7171798616 | Management of Synchronous Metastatic Colorectal Cancer | 2026-07-01 | OpenAlex | 10.1016/j.soc.2026.06.009 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171798616 | |||
| W7168013845 | Metronomic Chemotherapy in Ovarian Cancer: Current Scenario and AI ‐Integrated Future Strategies | 2026-07-01 | OpenAlex | 10.1002/cnr2.70620 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168013845 | |||
| W7167473161 | Microneedle‐Assisted Systems for the Delivery of Proteolysis Targeting Chimeras (PROTACs) | 2026-07-01 | OpenAlex | 10.1002/adtp.70158 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167473161 | |||
| W7167367450 | Modern immunosuppression | 2026-07-01 | OpenAlex | 10.1016/j.mpsur.2026.06.016 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167367450 | |||
| W7166811800 | Nanoparticle-based modifications of phages for antibacterial applications | 2026-07-01 | OpenAlex | 10.17185/duepublico/86023 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166811800 | |||
| W7171516675 | Nanotechnology in Transplantation: Emerging Mechanisms, Clinical Applications, and Future Directions. | 2026-07-01 | OpenAlex | 10.6002/ect.mesot2025.l36 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171516675 | |||
| W7166732605 | Neurophysiological Electroencephalography Signatures of Pediatric Sedation: A Comprehensive Comparative Review | 2026-07-01 | OpenAlex | 10.26815/acn.2026.01494 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166732605 | |||
| W7212245724 | OceanSkill: An Agentic Skill Framework for Evidence-Grounded Ocean Forecast Report Generation | 2026-07-01 | OpenAlex | 10.1109/lmiat70705.2026.11682146 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7212245724 | |||
| W7224965231 | Onconephrology: The Time is Ripe to Make New Beginnings | 2026-07-01 | OpenAlex | 10.4103/ijkd.ijkd_76_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224965231 | |||
| W7167649586 | Organoid-Derived Extracellular Vesicles: From Biogenesis and Cargo Mechanisms Toward Therapeutic Applications | 2026-07-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167649586; https://openalex.org/W7167050583 | ||||
| W7166827225 | Perioperative management of dermatologic surgery patients on systemic cancer therapy | 2026-07-01 | OpenAlex | 10.1016/j.jaad.2026.06.126 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7166827225 | |||
| W7168022829 | Pharmacomicrobiomics: The Gut Microbiome as a Critical Variable in Clinical Drug Response | 2026-07-01 | OpenAlex | 10.2478/orvtudert-2026-0002 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168022829 | |||
| W7204238558 | PhysioAgent: A Multi-Agent AI Framework for Personalised Exercise Prescription and Longitudinal Adherence Monitoring in Physiotherapy | 2026-07-01 | OpenAlex | 10.1109/icdh72779.2026.00045 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7204238558 | |||
| W7167012730 | Positioning Incretin‐Based and Next‐Generation Obesity Management Medications: A Methodological Framework for a Series of Systematic Reviews and Network Meta‐Analyses | 2026-07-01 | OpenAlex | 10.1111/dom.71046 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167012730 | |||
| W7221720722 | Predictors of Teachers' Perceived Utility of GenAI-Supported Dialogue in Teaching Analytics Contexts | 2026-07-01 | OpenAlex | 10.1109/icalt68022.2026.00062 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221720722 | |||
| W7171645925 | Prognostic Implications and Therapeutic Landscape of IDH1-Mutated AML: An Updated Review of Evidence and Indian Perspective | 2026-07-01 | OpenAlex | 10.31557/apjcp.2026.27.7.2417 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171645925 | |||
| W7212127174 | ReAct Ops: A Plan-and-Execute ReAct Agent Framework for Autonomous Distributed Cluster Diagnosis | 2026-07-01 | OpenAlex | 10.1109/cisat71030.2026.11682211 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7212127174 | |||
| W7166849559 | Single-cell DNA methylation analysis uncovers epigenetic pathways in the transformation of MDS to AML | 2026-07-01 | OpenAlex | 10.1038/s41375-026-03015-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166849559 | |||
| W7212066353 | Skill-Based Architecture for Reusable, AI-Native Enterprise Modules: An Empirical Study | 2026-07-01 | OpenAlex | 10.1109/iri69576.2026.00012 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7212066353 | |||
| W7202347207 | Solarpunk Creatures | 2026-07-01 | OpenAlex | 10.5325/utopianstudies.37.2.0389 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7202347207 | |||
| W7169627667 | Stigma Coupling and Decoupling: How Practice Stigma and Social Control Co-Evolve Over Time | 2026-07-01 | OpenAlex | 10.5465/amproc.2026.10949abstract | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7169627667 | |||
| W7214282497 | The 2026 ESC heart failure guidelines: advancing science while facilitating clinical implementation | 2026-07-01 | OpenAlex | 10.1097/cp9.0000000000000177 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214282497 | |||
| W7170094493 | The Evolving Role of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy: Evidence, Challenges, and Future Directions | 2026-07-01 | OpenAlex | 10.2147/opth.s620330 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170094493 | |||
| W7172519139 | The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value | 2026-07-01 | OpenAlex | 10.37765/ajmc.2026.89985 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172519139 | |||
| W7169576218 | The evolving landscape of personalized perioperative care: A commentary on the 2026 ERAS® Gynecologic oncology guidelines | 2026-07-01 | OpenAlex | 10.1016/j.ygyno.2026.06.022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169576218 | |||
| W7171564017 | The evolving treatment landscape of restless legs syndrome | 2026-07-01 | OpenAlex | 10.1177/17562864261469017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171564017 | |||
| W7216492330 | UNDERSTANDING MYCOBACTERIAL SPREAD AND DRUG SENSITIVITY | 2026-07-01 | OpenAlex | 10.63665/temj.v02i07.528 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7216492330 | |||
| W7202153595 | [Therapeutic Strategies Targeting the KRAS G12C Mutation-Current Landscape and Future Directions]. | 2026-07-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202153595 | ||||
| W7167531805 | Évolution de la prise en charge des cancers urothéliaux métastatiques | 2026-07-01 | OpenAlex | 10.1016/j.bulcan.2026.03.008 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167531805 | |||
| W7167089235 | Advances in the imaging of liver cancer | 2026-07-02 | OpenAlex | 10.1016/j.jhep.2026.03.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167089235 | |||
| W7167054138 | Controversies in the management of asymptomatic carotid stenosis: from best medical therapy to a redefinition of surgical indications | 2026-07-02 | OpenAlex | 10.3389/fneur.2026.1875031 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167054138 | |||
| W7166835130 | Dual-frequency metastructured-hydrogel film for high-contrast ultrasound imaging | 2026-07-02 | OpenAlex | 10.20517/ss.2026.23 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166835130 | |||
| W7167086588 | Editorial: Clinical trials in cardiovascular medicine: 2025—addressing residual cardiovascular risks through precision-guided approaches | 2026-07-02 | OpenAlex | 10.3389/fcvm.2026.1904928 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167086588 | |||
| W7167096532 | Epilepsia Partialis Continua: Pathophysiological Mechanisms, Clinical Manifestations, and Therapeutic Strategies in a Rare Focal Epilepsy Syndrome | 2026-07-02 | OpenAlex | 10.5281/zenodo.21137800 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167096532 | |||
| W7167095755 | From Therapeutic Drug to Xenobiotic in Cancer Repurposing: Clozapine Mechanisms, Metabolic Liabilities, and Human-Relevant Translational Approaches | 2026-07-02 | OpenAlex | 10.3390/jox16040125 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167095755 | |||
| W7167054891 | Global Trends and Evolving Frontiers in Intranasal Delivery for CNS Diseases (2000–2025): A Bibliometric Analysis and Systematic Review | 2026-07-02 | OpenAlex | 10.1016/j.wneu.2026.125172 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167054891 | |||
| W7167050990 | Guest editorial: Service transformation: key forces, challenges and implications | 2026-07-02 | OpenAlex | 10.1108/josm-07-2026-618 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167050990 | |||
| W7167102423 | Hippo-YAP/TAZ signaling in gastric cancer: orchestrating epithelial-stromal heterogeneity, plasticity, and therapy resistance | 2026-07-02 | OpenAlex | 10.47248/chp2603030008 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167102423 | |||
| W7167110866 | Natural Products in Prostate Cancer: Crosstalk Among the Gut Microbiome, Androgen Receptor Signaling, and Epigenetic Regulation | 2026-07-02 | OpenAlex | 10.3390/ijms27135956 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167110866 | |||
| W7171824909 | The global epidemiology of MRSA | 2026-07-02 | OpenAlex | 10.1093/jacamr/dlag152 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171824909 | |||
| W7167271783 | CARDIOVASCULAR BENEFITS OF GLP-1 RECEPTOR AGONISTS: EVIDENCE FROM CARDIOVASCULAR OUTCOMES TRIALS (CVOTs) | 2026-07-03 | OpenAlex | 10.31435/ijitss.3(51).2026.6150 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167271783 | |||
| W7167232432 | Clinical characteristics of lung abscess by red complex bacteria infection: a case report and literature review | 2026-07-03 | OpenAlex | 10.3389/fmed.2026.1861751 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167232432 | |||
| W7167274209 | Correction: Overcoming chemoresistance in esophageal cancer with synergistic strategies | 2026-07-03 | OpenAlex | 10.3389/fimmu.2026.1917784 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7167274209 | |||
| W7168056093 | Emerging therapy options for gastric adenocarcinoma - a comprehensive review and analysis of clinical trials | 2026-07-03 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168056093 | ||||
| W7167206563 | Essential Hypertension: A Comprehensive Critical Appraisal of Evolving Diagnostic Paradigms, Pathophysiology and Evidence-Based Management | 2026-07-03 | OpenAlex | 10.5281/zenodo.21165114 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7167206563 | |||
| W7172154674 | Evolving Anti-VEGF Therapy For Diabetic Retinopathy: Current Evidence, Durability Strategies, And Future Directions | 2026-07-03 | OpenAlex | 10.55227/ijhet.v5i2.917 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172154674 | |||
| W7167037241 | Evolving therapeutic landscape of immunoglobulin A nephropathy: targeted immune pathways and novel therapies | 2026-07-03 | OpenAlex | 10.23876/j.krcp.26.090 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167037241 | |||
| W7167242564 | GLP-1 Receptor Agonists in Cardiac Surgery: From Metabolic Drug to Potential Perioperative Cardioprotective Agent | 2026-07-03 | OpenAlex | 10.3390/jcdd13070305 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167242564 | |||
| W7167890131 | Hepatocellular carcinoma: new therapies on the horizon | 2026-07-03 | OpenAlex | 10.1080/17474124.2026.2702585 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167890131 | |||
| W7171906844 | How Consumers Judge Empathy Gaps in Artificial Intelligence-Driven Healthcare | 2026-07-03 | OpenAlex | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7171906844 | ||||
| W7167211629 | Hydroxychloroquine-Induced AGEP with Positive Rechallenge: A Case Report and Mini Review of the Literature | 2026-07-03 | OpenAlex | 10.3390/dermatopathology13030030 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167211629 | |||
| W7168083300 | Immunotherapy plus chemotherapy in advanced biliary tract cancers: pros and cons | 2026-07-03 | OpenAlex | 10.1080/17474124.2026.2701716 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168083300 | |||
| W7170243435 | Inavolisib: a second-generation PI3Kα inhibitor in HR+/HER2-negative breast cancer | 2026-07-03 | OpenAlex | 10.1080/17425255.2026.2710110 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170243435 | |||
| W7170174374 | Information fiduciaries for China? A critique | 2026-07-03 | OpenAlex | 10.1093/idpl/ipag012 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170174374 | |||
| W7167033700 | Multidrug-resistant Bacillus cereus in retail poultry meat: molecular insights into toxigenicity and antimicrobial resistance | 2026-07-03 | OpenAlex | 10.1186/s12866-026-05337-5 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167033700 | |||
| W7167227308 | Next-Generation SEDDS: Emerging Strategies for Oral Drug Delivery | 2026-07-03 | OpenAlex | 10.25258/ijddt.16.61s.65 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167227308 | |||
| W7167037551 | RPR-Memory: Decomposing Retrieval, Policy, and Reasoning in Persistent Memory Systems | 2026-07-03 | OpenAlex | 10.5281/zenodo.21144416 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7167037551 | |||
| W7167264592 | Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers: A Shift Toward Interventional Immuno-Oncology | 2026-07-03 | OpenAlex | 10.1007/s11912-026-01807-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167264592 | |||
| W7167250728 | SQUID embolization for cerebral AVMs: 1-year safety and efficacy results from the CHOICE prospective multicenter study | 2026-07-03 | OpenAlex | 10.1136/jnis-2026-025273 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167250728 | |||
| W7167210551 | The Carlo Mental Health Load Suite: Deterministic Models, Engines, and Educational Frameworks for Pressure, Capacity, Recovery, and Resilience | 2026-07-03 | OpenAlex | 10.5281/zenodo.21162260 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167210551 | |||
| W7167223825 | Working with communities responding to violent immigration enforcement: methods generating transformational knowledge informing sociopolitical action | 2026-07-03 | OpenAlex | 10.3389/fpos.2026.1704380 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167223825 | |||
| W7167350279 | Anticoagulation Strategies for Cardiopulmonary Bypass in Heparin-Induced Thrombocytopenia: A Brief Review and Practical Algorithm | 2026-07-04 | OpenAlex | 10.1053/j.jvca.2026.07.009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167350279 | |||
| W7167333509 | DRA v12 — Formalizing the Law of Regulatory Transitions: Theory, Pipeline, and First Cross‑Validated Example | 2026-07-04 | OpenAlex | 10.5281/zenodo.21186197 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167333509 | |||
| W7167495442 | Emerging Therapies Targeting Lipoprotein(a): A Clinical Trial Landscape Review of Investigational Lp(a)-Lowering Therapies | 2026-07-04 | OpenAlex | 10.3390/jcm15135233 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167495442 | |||
| W7167227437 | Ethosomal Drug Delivery Systems for Superficial and Systemic Fungal Infections: Formulation Strategies, Mechanistic Insights, and Translational Advances | 2026-07-04 | OpenAlex | 10.1007/s12281-026-00539-w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167227437 | |||
| W7167277937 | “Bypassing” or “nearby care”? Deconstructing and simulating patient hospital choice in China’s hierarchical healthcare system via explainable machine learning and agent-based modeling | 2026-07-04 | OpenAlex | 10.1016/j.cities.2026.107305 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7167277937 | |||
| W7167413955 | Flumazenil: Mechanistic Insights, Clinical Applications, and Therapeutic Controversies in Benzodiazepine Reversal | 2026-07-05 | OpenAlex | 10.5281/zenodo.21207047 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167413955 | |||
| W7167416881 | Recent advances in metal–organic frameworks for the diagnosis and treatment of breast cancer | 2026-07-05 | OpenAlex | 10.1186/s11671-026-04710-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167416881 | |||
| W7172129222 | SAF-LQC: A Self-Adaptive Framework Based on Q-Learning and Quantum Computing for Zero-Day Attack Detection in the Medical Internet of Things | 2026-07-05 | OpenAlex | 10.71856/impcs.2026.1241811 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172129222 | |||
| W7167408749 | moorateeahtashil/ts-acl-spec: v1.0.0 — TS-ACL-SPEC: spectral feature front-end and probe-gap diagnostic | 2026-07-05 | OpenAlex | 10.5281/zenodo.21207488 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167408749 | |||
| W7167465622 | A systematic analysis of LLM backdoor-integrated cyberattacks: Feasibility, impact factors, and realistic case studies in agent systems | 2026-07-06 | OpenAlex | 10.1016/j.asoc.2026.115912 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167465622 | |||
| W7167463779 | Complicated urinary tract infections: evolving definitions, clinical burden, and treatment landscape amid antimicrobial resistance | 2026-07-06 | OpenAlex | 10.1080/14787210.2026.2700381 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167463779 | |||
| W7167504789 | Emerging Therapies in Multiple Sclerosis Management – Can We Stop the Demyelinating Process? | 2026-07-06 | OpenAlex | 10.20883/medical.e1565 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167504789 | |||
| W7167468399 | Higher frequency of subclonal anti-EGFR resistance mutations in post-treatment samples from patients with colorectal cancer liver metastases following anti-EGFR-based conversion chemotherapy | 2026-07-06 | OpenAlex | 10.1371/journal.pone.0351243 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167468399 | |||
| W7167468355 | Next-Generation Checkpoint Combinations: Optimizing PD-(L)1–Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant Settings | 2026-07-06 | OpenAlex | 10.1007/s11912-026-01809-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167468355 | |||
| W7167494976 | Predictive Immunohistochemical Biomarkers for Antibody-Drug Conjugate Therapy in Pulmonary Cytology | 2026-07-06 | OpenAlex | 10.1159/000553423 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167494976 | |||
| W7167484879 | Rational Immune Checkpoint Inhibitor-Based Combination Immunotherapy in Cancer: Mechanistic Design, Biomarker Selection, and Implications for Oncology Pharmacy | 2026-07-06 | OpenAlex | 10.3390/cancers18132163 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167484879 | |||
| W7167481495 | TRENDS IN THE USE OF NATURAL AGENTS FOR CHRONIC WOUND CARE IN DEVELOPING COUNTRIES: A SCOPING REVIEW | 2026-07-06 | OpenAlex | 10.36720/nhjk.v15i1.919 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167481495 | |||
| W7167472323 | The Future of Talent Science – AI, Complexity, and Autonomous Workforce Systems | 2026-07-06 | OpenAlex | 10.1201/9781003684312-20 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167472323 | |||
| W7167583306 | The Role of the Renin-Angiotensin-Aldosterone System and Endothelin-1 in the Progression of the Cardiorenal-Metabolic Triad | 2026-07-06 | OpenAlex | 10.25258/ijddt.16.62s.99 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167583306 | |||
| W7167477553 | The chaos of choice in large B-cell lymphoma: a call to harmonize first-line trials | 2026-07-06 | OpenAlex | 10.1182/blood.2026034393 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167477553 | |||
| W7167474713 | The immune system as a regulator of normal physiology | 2026-07-06 | OpenAlex | 10.3389/fimmu.2026.1867359 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167474713 | |||
| W7167510333 | Update: Immune Tolerance Induction Practice in Haemophilia | 2026-07-06 | OpenAlex | 10.1055/a-2887-8098 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167510333 | |||
| W7167506625 | Why precision oncology works: lessons from gastrointestinal stromal tumours | 2026-07-06 | OpenAlex | 10.37349/etat.2026.1002378 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167506625 | |||
| W7167591649 | Agentic AI: A Survey of Architectures, Memory, Planning, and Real-World Application | 2026-07-07 | OpenAlex | 10.5281/zenodo.21237698 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167591649 | |||
| W7167598725 | Autonomous Penetration Testing for Financial Systems: A Multi-Agent Architecture for Continuous Security Validation | 2026-07-07 | OpenAlex | 10.5281/zenodo.21250717 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7167598725 | |||
| W7167633741 | Biomimetic hydrogel design for programmable ECM and tissue regeneration | 2026-07-07 | OpenAlex | 10.1016/j.ijpharm.2026.127163 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167633741 | |||
| W7167601646 | Copilot and CAN-Bus Connected ECUs Integrated Scenarios for Automotive Diagnosis, Enhanced by Scan Tools, Conversational Agents and AI Technologies | 2026-07-07 | OpenAlex | 10.15837/ijccc.2026.4.7501 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7167601646 | |||
| W7167632027 | Decomposition-based Zeroing neural dynamics for real-time Pareto tracking in time-varying multi-objective optimization | 2026-07-07 | OpenAlex | 10.1016/j.jfranklin.2026.108884 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167632027 | |||
| W7167634852 | FDA-Approved Drugs Containing Amide Functionality in the Last Five Years (2021–2025): Pharmaceutical Use, Trends and Synthetic Approaches | 2026-07-07 | OpenAlex | 10.3390/medicines13030022 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167634852 | |||
| W7167612832 | From adoption to architecture: Agentic AI in surgical data science | 2026-07-07 | OpenAlex | 10.1016/j.amjsurg.2026.117136 | Full text | Excluded | F1: The publisher/PubMed identify an editorial discussing surgical data-science architecture, without a new evaluated adaptive agent. | https://openalex.org/W7167612832 | https://www.americanjournalofsurgery.com/article/S0002-9610(26)00321-1/fulltext | Publisher indexed opening/body preview; PubMed indexed publication metadata; direct full page403. | |
| W7167589167 | Glycoprotein IIb/IIIa Receptor Inhibitors in Acute Coronary Syndromes and Percutaneous Coronary Intervention: A Comprehensive Review of Pharmacological Principles, Clinical Indications, and Contemporary Practice Paradigms | 2026-07-07 | OpenAlex | 10.5281/zenodo.21242798 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167589167 | |||
| W7167594475 | Oncoflux V2.0 — A Deterministic Oncology‑Flavoured Systems Engine for Multi‑Region Behaviour Modelling | 2026-07-07 | OpenAlex | 10.5281/zenodo.21245091 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167594475 | |||
| W7167591108 | Pediatric Acute Poisoning: The Bipolar Evolution of the Poisoning Spectrum from 2019 to 2024 in Southwest China | 2026-07-07 | OpenAlex | 10.3390/jcm15135309 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167591108 | |||
| W7167686696 | The State of the Art on Management of Patients with Unresectable Liver Metastases from Colorectal Cancer | 2026-07-07 | OpenAlex | 10.3390/biomedicines14071527 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167686696 | |||
| W7167600139 | The cancer/testis antigens represent promising targets for the development of new therapies against melanoma | 2026-07-07 | OpenAlex | 10.1016/j.prp.2026.156617 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167600139 | |||
| W7167575271 | The digital therapist? LLMs and the future of clinical dialogue | 2026-07-07 | OpenAlex | 10.1016/j.laheal.2026.100086 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167575271 | |||
| W7167474980 | Update on lipoprotein(a): the rising star in residual lipid risk | 2026-07-07 | OpenAlex | 10.1093/eurheartj/ehag499 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167474980 | |||
| W7167742988 | A Review Article on Antimicrobial Resistance and Chemotherapeutics: Mechanisms, Clinical Interactions, and Emerging Therapeutic Strategies | 2026-07-08 | OpenAlex | 10.5281/zenodo.21267164 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167742988 | |||
| W7167663147 | Benchmarking and Optimising Deep Learning Models for Personalised Response Classification and Generation | 2026-07-08 | OpenAlex | 10.25949/32764728 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167663147 | |||
| W7167670532 | Characterization of Escherichia marmotae , a novel pathogen causing urinary tract infection in a dog | 2026-07-08 | OpenAlex | 10.1177/10406387261461260 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167670532 | |||
| W7167585396 | Depemokimab: toward biannual biologic therapy for severe eosinophilic asthma | 2026-07-08 | OpenAlex | 10.1186/s12931-026-03801-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167585396 | |||
| W7167691152 | EECA: a design-oriented explainability framework for end-to-end cockpit agents | 2026-07-08 | OpenAlex | 10.1080/09544828.2026.2698385 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167691152 | |||
| W7167666912 | From incidental positron emission uptake to in-vivo phenotyping: a short history of positron emission tomography in the study of atherosclerosis and the vulnerable plaque | 2026-07-08 | OpenAlex | 10.3389/fcvm.2026.1767077 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167666912 | |||
| W7167693408 | Goal-directed osteoporosis treatment: are bone mineral density targets valid? | 2026-07-08 | OpenAlex | 10.1016/s2213-8587(26)00123-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167693408 | |||
| W7167682713 | Identification, resistance mechanisms, and innovative therapeutic approaches against Acinetobacter baumannii–calcoaceticus complex | 2026-07-08 | OpenAlex | 10.3389/fmicb.2026.1869585 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167682713 | |||
| W7167737993 | Life‑Ledger‑GPT RIL: A Reflective Intelligence Loop System for Persistent Human Memory, Autonomous Doctrine Formation, and Backend‑Integrated Behavioral Optimization | 2026-07-08 | OpenAlex | 10.5281/zenodo.21265742 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167737993 | |||
| W7167710895 | Targeting cellular senescence in dermatology: senolytic and senomorphic strategies | 2026-07-08 | OpenAlex | 10.1007/s11357-026-02379-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167710895 | |||
| W7167701551 | The Evolving Role of Bispecific Antibodies in Oncogene-Driven NSCLC | 2026-07-08 | OpenAlex | 10.3390/cancers18142197 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167701551 | |||
| W7167818236 | A victim of its own progress: why the success of modern therapeutics forces a re-evaluation of placebo-controlled trials in migraine prevention | 2026-07-09 | OpenAlex | 10.3389/fneur.2026.1871028 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167818236 | |||
| W7167810629 | Acinetobacter baumannii and Pseudomonas may share pathways with other pathologies and there may be therapeutic bacteriophages or other non-antibiotic solutions hidden with in PubMed literature. - PathMap Experiment #000033 | 2026-07-09 | OpenAlex | 10.5281/zenodo.21283141 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167810629 | |||
| W7167850067 | Advances and Challenges in Iodinated Contrast Media | 2026-07-09 | OpenAlex | 10.1201/9781003508137-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167850067 | |||
| W7167785239 | Advancing Infection Prevention Through Medical Device Cleaning Innovation in Japan | 2026-07-09 | OpenAlex | 10.5281/zenodo.21277817 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167785239 | |||
| W7168267244 | Agentic Context Learning with Self-Discovered Specification | 2026-07-09 | OpenAlex | 2607.09794 | 10.48550/arxiv.2607.09794 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7168267244 | ||
| W7167824835 | Clostridioides difficile Infection Deceleration: What Is Next? | 2026-07-09 | OpenAlex | 10.1093/cid/ciag364 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167824835 | |||
| W7167932174 | From Tokens to Trust: Understanding Uncertainty in Autoregressive Large Language Models | 2026-07-09 | OpenAlex | 10.5281/zenodo.21283930 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167932174 | |||
| W7167796865 | Helicobacter pylori Eradication in the Era of Antibiotic Resistance: From Universal Regimens to Precision-Guided Management | 2026-07-09 | OpenAlex | 10.3390/antibiotics15070673 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167796865 | |||
| W7167796588 | How Biologics Are Changing the Global Burden of Inflammatory Bowel Disease: A Review | 2026-07-09 | OpenAlex | 10.7759/cureus.112332 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167796588 | |||
| W7167850976 | Nonalcoholic Fatty Liver Disease in the Era of MAFLD: Emerging Insights into Mechanisms, Diagnosis, and Personalized Management Global Burden and Economic Impact | 2026-07-09 | OpenAlex | 10.64063/3049-1681.vol3.issue7.000282 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167850976 | |||
| W7167845787 | OVERVIEW OF THE MAIN FUNGAL INFECTIONS IN HUMANS | 2026-07-09 | OpenAlex | 10.31435/ijitss.3(51).2026.6233 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167845787 | |||
| W7167847388 | Pharmacological Therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease in a New Era for Obesity and Metabolic Medicine: A State-of-the-Art Review | 2026-07-09 | OpenAlex | 10.7570/jomes26005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167847388 | |||
| W7167803445 | Recent advances in the treatment of FLT3-mutated acute myeloid leukemia | 2026-07-09 | OpenAlex | 10.1007/s44313-026-00155-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167803445 | |||
| W7167795989 | Treatment Selection Beyond Second Line in Metastatic Colorectal Cancer: Practical Sequencing of Cytotoxic Salvage Therapy, Anti-angiogenic Agents, Rechallenge Strategies, and Biomarker-Guided Treatments | 2026-07-09 | OpenAlex | 10.1007/s12029-026-01524-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167795989 | |||
| W7167903431 | Beyond the dose-volume histogram: a critical appraisal of normal tissue complication probability modelling for osteoradionecrosis of the jaw and a strategic framework for clinical translation | 2026-07-10 | OpenAlex | 10.3389/fonc.2026.1893594 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167903431 | |||
| W7167958963 | Bibliometric analysis of the top 100 cited articles on contrast media complications: Influence of agent class and structure | 2026-07-10 | OpenAlex | 10.1016/j.clinimag.2026.110901 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167958963 | |||
| W7168123655 | Cancer Immunotherapy | 2026-07-10 | OpenAlex | 10.3390/books978-3-7258-8088-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168123655 | |||
| W7167923361 | Editorial: The evolution in pharmacology of infectious diseases: 2025 | 2026-07-10 | OpenAlex | 10.3389/fphar.2026.1907819 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167923361 | |||
| W7167889574 | KRAS-Targeting Agents in Cancer: A Bibliometric Analysis of Global Research Trends and Emerging Hotspots from 2006 to 2026 | 2026-07-10 | OpenAlex | 10.21203/rs.3.rs-10252473/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167889574 | |||
| W7167925643 | Low dose aspirin beyond coronary artery disease: a structured narrative review | 2026-07-10 | OpenAlex | 10.1186/s43162-026-00677-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7167925643; https://openalex.org/W7168034392 | |||
| W7168096660 | Not Just One Agent: LLM-Based Multi-Agent Systems for Medicine from Answer Generation to Accountable Workflow Orchestration | 2026-07-10 | OpenAlex | 10.20944/preprints202606.0640.v2 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7168096660 | |||
| W7167937745 | Recent advances in rheumatoid arthritis and other arthropathies | 2026-07-10 | OpenAlex | 10.1016/j.mporth.2026.05.002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167937745 | |||
| W7167938215 | Teaching Model Context Protocol, Retrieval-Augmented Generation, and AI Agents to a Multidisciplinary Hospital Workforce: Single-Group Pre-Post Survey Study | 2026-07-10 | OpenAlex | 10.2196/97822 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167938215 | |||
| W7167937281 | The Integrative Learning Design Framework Revisited: AI Affordances, Risks, and Guardrails for Learning Experience Design Research and Practice | 2026-07-10 | OpenAlex | 10.5281/zenodo.20970395 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7167937281 | |||
| W7167887542 | Therapy update: An introduction to the pharmacology, safety, and efficacy of bispecific antibodies in relapsed or refractory multiple myeloma | 2026-07-10 | OpenAlex | 10.1093/ajhp/zxag203 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167887542 | |||
| W7168052491 | Beyond the Rule Set: Structural Friction and Traceable Reason-Giving for Autonomous Systems | 2026-07-11 | OpenAlex | 10.5281/zenodo.21312289 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7168052491 | |||
| W7168165113 | Beyond the Usual Suspects: Emerging Pseudomonas Species in Clinical and Environmental Niches | 2026-07-11 | OpenAlex | 10.3390/ijms27146210 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168165113 | |||
| W7168018595 | Prim‑Lex Theory Reconstructing Microbial Targeted Therapeutics: From "Bactericidal" to "Fire-Extinguishing" ------A Novel Drug Discovery Framework Targeting Microbial Energy Metabolism Based on the Eight‑Dimensional Framework of Prim‑Lex Theory | 2026-07-11 | OpenAlex | 10.5281/zenodo.21310955 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168018595 | |||
| W7168032990 | Rhinophyma: A Report of Two Patients Managed With Electrosurgery | 2026-07-11 | OpenAlex | 10.7759/cureus.112465 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168032990 | |||
| W7168020927 | Text2Onto-Agent: An LLM Agent-Based End-to-End Automated Ontology Construction Method anda Case Study of Green Building Domain Modeling | 2026-07-11 | OpenAlex | 10.1061/jcemd4.coeng-18479 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7168020927 | |||
| W7168090210 | Analysis Manual for Design as Decision Closure Under Uncertainty: Operational Protocol (v6.4) | 2026-07-12 | OpenAlex | 10.5281/zenodo.21312797 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168090210 | |||
| W7166498579 | Using agent-based simulation to reconstruct historical disease landscapes,: the example of malaria in Cyprus | 2026-07-12 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7166498579 | ||||
| W7168140865 | Agent-Compression and Large-Kernel DETR for Colorectal Polyp Detection | 2026-07-13 | OpenAlex | 10.1007/978-981-92-3492-9_13 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7168140865 | |||
| W7168078414 | Breaching the Blood-Brain Barrier: Evolving Strategies for Central Nervous System Disease in Adult Acute Lymphoblastic Leukemia | 2026-07-13 | OpenAlex | 10.1007/s11899-026-00782-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168078414 | |||
| W7168167030 | Discordance Between Textual Reasoning and Visual Interpretation in Large Language Models for Low Back Pain: Cross-Sectional Quantitative Evaluation and Exploratory Multimodal Stress Test | 2026-07-13 | OpenAlex | 10.2196/93522 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168167030 | |||
| W7168175281 | Editorial: Non-ionizing radiation: impacts on human health from exposures in occupational settings | 2026-07-13 | OpenAlex | 10.3389/fpubh.2026.1880564 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168175281 | |||
| W7168179708 | Immunotherapy for locally advanced head and neck squamous cell carcinoma: A review | 2026-07-13 | OpenAlex | 10.1016/j.ctrv.2026.103193 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168179708 | |||
| W7171566980 | Ligand-modified multifunctional liposome-based targeted delivery platform: a multimodal cancer combination therapy strategy | 2026-07-13 | OpenAlex | 10.7150/thno.136152 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171566980 | |||
| W7168167767 | Measuring the Language in Language Models The Missing Writing Benchmark in Health Economics and Outcomes Research | 2026-07-13 | OpenAlex | 10.5281/zenodo.21343393 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7168167767 | |||
| W7203657468 | Modern Cerrahide Topikal Hemostatik Ajanlar: Mekanizma Odaklı Bir Sınıflandırma | 2026-07-13 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203657468 | ||||
| W7168196055 | Newer and novel antidiabetic drug classes across the cardiovascular–kidney–metabolic continuum | 2026-07-13 | OpenAlex | 10.1210/endrev/bnag022 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168196055 | |||
| W7168170036 | Reading 'Quantum Spins' Inside Living Cells... 'MagLOV' Protein Opens the Door to Multimodal Sensing | 2026-07-13 | OpenAlex | 10.5281/zenodo.21328970 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168170036 | |||
| W7168154062 | The Novel Hypomethylating Agent NTX-301 Reprograms Epigenetic and Hippo Signaling Pathways and Exhibits Preclinical Activity in Venetoclax-Resistant and TP53 -Mutant AML | 2026-07-13 | OpenAlex | 10.1158/1078-0432.ccr-25-4843 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168154062 | |||
| W7168161301 | Using fluorescence in minimally invasive thoracic surgery: a narrative review | 2026-07-13 | OpenAlex | 10.21037/vats-2026-1-0004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168161301 | |||
| W7168247998 | Comparative safety profiles of enzalutamide, olaparib, and lutetium Lu-177 vipivotide tetraxetan in patients with prostate cancer: a real-world disproportionality analysis of the FAERS database | 2026-07-14 | OpenAlex | 10.1007/s00345-026-06597-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168247998 | |||
| W7168268365 | Evolving First-Line Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: CDK4/6 Inhibition, Biomarker-Guided Strategies and Emerging Therapeutic Paradigms | 2026-07-14 | OpenAlex | 10.3390/curroncol33070421 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168268365 | |||
| W7168247954 | From suspected necrotizing fasciitis to diagnosed drug-induced fever: a diagnostic maze and reflections on anti-infection management in a case of postoperative fever after femoral fracture | 2026-07-14 | OpenAlex | 10.3389/fmed.2026.1830157 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168247954 | |||
| W7201951132 | Minnesota in the Bleak Midwinter: Federal Immigration Occupation Meets Grassroots Action and Love of Neighbor | 2026-07-14 | OpenAlex | 10.1093/sw/swag041 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7201951132 | |||
| W7168292336 | Multimodal Large Language Models: A Survey of Vision-Language Integration, Architectures, and Applications | 2026-07-14 | OpenAlex | 10.5281/zenodo.21365120 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168292336 | |||
| W7169474531 | Neuroimaging LLM-Agent Benchmark — Ground Truth Data | 2026-07-14 | OpenAlex | Title/abstract | Excluded | E1: Reference neuroimaging dataset/benchmark outputs rather than an adapting agent system. | https://openalex.org/W7169474531 | ||||
| W7168235500 | Nurturing a Sustainable Transplantation Journey: the best of ESOT Congress 2025 | 2026-07-14 | OpenAlex | 10.3389/ti.2026.17127 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168235500 | |||
| W7168257006 | One Field, Many Discoveries: Why AI Keeps Rediscovering Large Language Fields One Instrument at a Time | 2026-07-14 | OpenAlex | 10.5281/zenodo.21348029 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7168257006 | |||
| W7168293804 | Therapeutic plasma exchange in pediatric streptococcal toxic shock syndrome with severe digital ischemia | 2026-07-14 | OpenAlex | 10.1016/j.transci.2026.104495 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168293804 | |||
| W7168348475 | A Minimally Invasiveness Hybrid Brain-Computer Interface: A Distributed, Scalable and Evolvable Architecture for Whole Brain Access | 2026-07-15 | OpenAlex | 10.64898/2026.07.14.738604 | Full text | Excluded | F3: This is a microelectrode/hybrid-BCI animal and field-modeling study. Its AI planning/control framework is intended for future deployment; no implemented LLM/VLM acting agent is documented. | https://openalex.org/W7168348475 | https://doi.org/10.64898/2026.07.14.738604 | ||
| W7168405215 | BRAIN-SPECIFIC DRUG DELIVERY: A REVIEW | 2026-07-15 | OpenAlex | 10.5281/zenodo.21371707 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168405215 | |||
| W7168352165 | Chronic lymphocytic leukemia management in India: balancing evidence, access, and affordability in clinical practice | 2026-07-15 | OpenAlex | 10.3389/fonc.2026.1853089 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168352165 | |||
| W7168926726 | Developing learning-strategic competence in pre-service Еnglish teachers through artificial intelligence tools | 2026-07-15 | OpenAlex | 10.32589/1817-8510.2026.1.367037 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7168926726 | |||
| W7168360289 | Editorial: Unlocking cancer’s secrets: overcoming drug resistance in cancer stem cells | 2026-07-15 | OpenAlex | 10.3389/fphar.2026.1913266 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168360289 | |||
| W7168402151 | Human-like conversational agents as social partners: a scoping review of socioaffective mechanisms, well-being outcomes, risks and governance in the post-Turing era | 2026-07-15 | OpenAlex | 10.3389/frai.2026.1810097 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168402151 | |||
| W7169065578 | Knowledge Graphs vs. SQL over Structured EHR Data | 2026-07-15 | OpenAlex | 10.3390/fi18070365 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7169065578 | |||
| W7168622736 | Multimodal Ontology: Semantic Substrate for Human Digital Twins in AI-Driven Metaverse Telerehabilitation and Immersive Medical Education | 2026-07-15 | OpenAlex | 10.54517/m8553 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168622736 | |||
| W7169176432 | Therapeutic Advancement in Cardiovascular Disorders: Molecular Mechanisms, Emerging Targets and Translational Perspectives | 2026-07-15 | OpenAlex | 10.22270/jddt.v16i7.7825 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169176432 | |||
| W7202107544 | Unlocking Patient History: AI-Driven Language-Based Interface for Accessing HL7-CDA Episode Data | 2026-07-15 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202107544 | ||||
| W7169644529 | Розвиток навчально-стратегічної компетентності майбутніх учителів англійської мови засобами штучного інтелекту | 2026-07-15 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7169644529 | ||||
| W7168964007 | AI as a Therapist, Companion, and Romantic Partner: Emerging Roles, Benefits, and Risks for Mental Health in Participatory Medicine | 2026-07-16 | OpenAlex | 10.2196/95153 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168964007 | |||
| W7168601950 | An Acceptance Criteria Framework for Determining the Implementation Fit of Custom Large Language Models in Public Health Interventions | 2026-07-16 | OpenAlex | 10.2196/92356 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168601950 | |||
| W7169004868 | Beyond chemotherapy: the evolving role of photodynamic therapy in triple-negative breast cancer | 2026-07-16 | OpenAlex | 10.1007/s12032-026-03326-2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169004868 | |||
| W7169115255 | Correction: Understanding antibiotic decision-making for bovine respiratory disease: a survey of UK farm veterinarians | 2026-07-16 | OpenAlex | 10.3389/fvets.2026.1900336 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7169115255 | |||
| W7168701639 | Interventional Radiology in the Management of Primary Liver Malignancies | 2026-07-16 | OpenAlex | 10.3390/cancers18142283 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168701639 | |||
| W7168759588 | Precision antimicrobials: the next paradigm shift after broad-spectrum therapy | 2026-07-16 | OpenAlex | 10.3389/fmicb.2026.1881800 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7168759588 | |||
| W7204253943 | Reinforcement Learning: Theory, Algorithms, and Applications by Dr. K.V. Rameswara Reddy, Dr. A. Vishnuvardhan Reddy, Dr. M. Madhusudhan Reddy, Mr. G.V. Ramana Reddy | 2026-07-16 | OpenAlex | 10.5281/zenodo.21448955 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204253943 | |||
| W7220890313 | The Role of Media in the Era of Crises: Destabilization and Reorganization of Order in the Process of Democratic Transformation (1996–2013) | 2026-07-16 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220890313 | ||||
| W7169592985 | 2026 ETA guideline on interference in immunoassay measurements used in assessment of thyroid function | 2026-07-17 | OpenAlex | 10.1530/etj-26-0011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169592985 | |||
| W7169527047 | Beyond Sleepless Nights: Integrating Neurobiology, Clinical Burden, And Emerging Therapeutic Advances In Insomnia: A Comprehensive Evidence-Based Review | 2026-07-17 | OpenAlex | 10.5281/zenodo.21412647 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169527047 | |||
| W7169517395 | Dolabellane diterpenoids as non-nucleoside reverse transcriptase inhibitors and anti- HIV agents: in silico and biological approach | 2026-07-17 | OpenAlex | 10.1080/14786419.2026.2700334 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169517395; https://openalex.org/W7169521481 | |||
| W7169560794 | Dual-recognizing antibodies targeting CEACAMs in the tumor microenvironment: towards more precise targeting | 2026-07-17 | OpenAlex | 10.1186/s12964-026-03084-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169560794 | |||
| W7169660122 | Provocable Forgiveness in Noisy Brand--Consumer Systems:An Agent-Based Study of Repeated Interaction | 2026-07-17 | OpenAlex | 10.63562/2577-8439.1179 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7169660122 | |||
| W7168634542 | The Impact of AI-Powered Business Analytics on Organizational Agility and Competitive Advantage | 2026-07-17 | OpenAlex | 10.21203/rs.3.rs-10375254/v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7168634542 | |||
| W7169675495 | AI Safety Compass: A Compact Framework for AI Safety Research and System Design | 2026-07-18 | OpenAlex | 10.5281/zenodo.21431475 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169675495 | |||
| W7169655406 | Abstract B035: A Phase 2 Platform Trial Integrated with Patient Digital Twins to Prioritize and Refine Therapies for Sarcomas: The RAPID Study | 2026-07-18 | OpenAlex | 10.1158/1538-7445.rareca26-b035 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169655406 | |||
| W7169673467 | Abstract IA007: Precision oncology and the N-of-1 revolution: Rare cancers as a paradigm | 2026-07-18 | OpenAlex | 10.1158/1538-7445.rareca26-ia007 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169673467 | |||
| W7169659790 | Generative AI-powered simulated patients in health professions education: a systematic review, evidence synthesis, and meta-analysis | 2026-07-18 | OpenAlex | 10.17605/osf.io/c7zuq | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169659790 | |||
| W7172027641 | INTELLIGENT CANCER DIGITAL TWINS: AI-DRIVEN VIRTUAL PATIENT MODELS FOR PREDICTIVE ONCOLOGY | 2026-07-18 | OpenAlex | 10.65713/ijaraiv14i1225 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172027641 | |||
| W7169679913 | MDTace: Agentic Context Engineering for Multi-disciplinary Team Medical Consultation | 2026-07-18 | OpenAlex | 10.1007/978-981-92-3403-5_6 | Full text | Included | Included: Training-case experience bullets are persistently stored and reused on separate diagnostic test cases. | https://openalex.org/W7169679913 | https://link.springer.com/chapter/10.1007/978-981-92-3403-5_6 | ||
| W7169661565 | Piezocatalytic Therapy for Periodontitis: From Biofilm Disruption to Immunomodulatory Tissue Regeneration | 2026-07-18 | OpenAlex | 10.1021/cbe.6c00056 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169661565 | |||
| W7169687038 | Practitioner viewpoint: Navigating the promises and gaps in digital transformation, SME development and job creation in Africa | 2026-07-18 | OpenAlex | 10.1108/ajems-08-2026-949 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169687038 | |||
| W7171997470 | SPATIAL OMICS AND FOUNDATION AI MODELS: DECODING TUMOR HETEROGENEITY FOR PRECISION ONCOLOGY | 2026-07-18 | OpenAlex | 10.65713/ijaraiv14i1224 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171997470 | |||
| W7169682809 | The history of cryptosporidiosis | 2026-07-18 | OpenAlex | 10.1186/s13071-026-07498-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169682809 | |||
| W7169757306 | Acute-on-Chronic Liver Failure: An Eroded Cliff Hit by a Storm—A Narrative Review | 2026-07-19 | OpenAlex | 10.3390/ijms27146414 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169757306 | |||
| W7169682270 | Liposomal nanocarriers in retinoblastoma: from molecular design to clinical translation | 2026-07-19 | OpenAlex | 10.1186/s12645-026-00404-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169682270 | |||
| W7169716598 | Pharmacological Management of Dyslipidemia in Obese and Elderly Patients: Challenges, Current Therapies, and Emerging Treatments | 2026-07-19 | OpenAlex | 10.1177/22313354261461001 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169716598 | |||
| W7169730868 | Plant-Derived Flavonoids as Multi-Target Pharmacological Modulators: Mechanisms, Therapeutic Potential and Translational Challenges in Acute and Chronic Diseases | 2026-07-19 | OpenAlex | 10.22541/authorea.15006263/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169730868 | |||
| W7203614008 | Alzheimer’s Disease and Cognitive Disorders: From Molecular Drivers to Multilevel Clinical Solutions | 2026-07-20 | OpenAlex | 10.62134/khatamuni.187 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203614008 | |||
| W7169799986 | Approved therapies in the IgA nephropathy armamentarium: a summary of the evidence | 2026-07-20 | OpenAlex | 10.1016/j.kisu.2026.03.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169799986 | |||
| W7169754903 | Editorial: Advancing equity in allergic disease management through innovative clinical strategies | 2026-07-20 | OpenAlex | 10.3389/falgy.2026.1918802 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169754903 | |||
| W7169795291 | Editorial: Exploring the carcinogenic potential of e-cigarettes: a multifaceted study | 2026-07-20 | OpenAlex | 10.3389/fonc.2026.1922285 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169795291 | |||
| W7169732532 | Generating guideline-concordant and safe recommendations for diabetic kidney disease management via a hierarchical retrieval-augmented large language model | 2026-07-20 | OpenAlex | 10.1038/s41746-026-03035-0 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7169732532 | |||
| W7169765900 | Heart failure medication to prevent cancer therapy–related cardiac dysfunction: A narrative review | 2026-07-20 | OpenAlex | 10.1111/bph.70610 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169765900 | |||
| W7169767923 | Kv7 channels as pharmacological targets for central nervous system diseases | 2026-07-20 | OpenAlex | 10.1016/j.pharmr.2026.100153 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169767923 | |||
| W7169777837 | Management of carotid artery injuries: What you need to know | 2026-07-20 | OpenAlex | 10.1097/ta.0000000000005122 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169777837 | |||
| W7169786386 | New Treatment Strategies for Rare Genomic Alterations: EGFR Exon 20 Insertions and HER2-Deregulated Lung Cancer | 2026-07-20 | OpenAlex | 10.3390/cancers18142334 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169786386 | |||
| W7172209261 | Stereotactic Radiosurgery Versus Whole-Brain Radiotherapy in Patients with Multiple Brain Metastases: Current Evidence and Future Perspectives | 2026-07-20 | OpenAlex | 10.5281/zenodo.21448794 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172209261 | |||
| W7169828489 | Targeting HCC With SBRT | 2026-07-20 | OpenAlex | 10.1097/coc.0000000000001342 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169828489 | |||
| W7169796963 | The Evolving Therapeutic Landscape of Diabetes Mellitus and Obesity: From Conventional Treatments to Next-Generation Metabolic Therapies | 2026-07-20 | OpenAlex | 10.9734/jammr/2026/v38i86173 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169796963 | |||
| W7169770573 | The Missing Layer in Agentic AI | 2026-07-20 | OpenAlex | 10.5281/zenodo.21449522 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7169770573 | |||
| W7169838933 | Agentic genomics: From pipeline automation to autonomous validation | 2026-07-21 | OpenAlex | 10.1016/j.xgen.2026.101305 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7169838933 | |||
| W7169860712 | Antibody-drug conjugates against multidrug-resistant cancers: Biomarker-guided patient selection, payload engineering, linker chemistry, and bystander effects | 2026-07-21 | OpenAlex | 10.1016/j.canlet.2026.218753 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169860712 | |||
| W7170087814 | Common Causes of Drug-Induced Liver Injury in 2025 | 2026-07-21 | OpenAlex | 10.5152/tjg.2026.26361 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170087814 | |||
| W7169849313 | Dataset: Do any recent non-proliferative diabetic retinopathy clinical trials reveal anything about Amyotrophic Lateral Sclerosis? - PathMap Experiment #000071 | 2026-07-21 | OpenAlex | 10.5281/zenodo.21467878 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7169849313 | |||
| W7221225506 | Diseño e implementación de un agente de IA para la gestión de una clínica dental mediante n8n | 2026-07-21 | OpenAlex | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7221225506 | ||||
| W7169866964 | Editorial: Navigating the landscape of IDH-mutant gliomas: advances in diagnosis, therapeutic management, and long-term monitoring | 2026-07-21 | OpenAlex | 10.3389/fonc.2026.1926822 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169866964 | |||
| W7170598581 | Hybrid and Conjugate Drugs and their Antimicrobial, Antiparasitic, Antiamoebic, Antileishmanial, Antiprotozoal, and Antitrypanosomal Properties | 2026-07-21 | OpenAlex | 10.2174/0109298673441939260521062733 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170598581 | |||
| W7169901521 | Modern management of locally advanced urothelial carcinoma of the upper urinary tract | 2026-07-21 | OpenAlex | 10.1007/s00345-026-06521-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169901521 | |||
| W7169839040 | Multicentric Reticulohistiocytosis Progressing to Erythroderma After Long‐Term Disease Progression | 2026-07-21 | OpenAlex | 10.1111/1346-8138.70415 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169839040 | |||
| W7169849208 | Peptide Therapeutics in Orthopaedics | 2026-07-21 | OpenAlex | 10.2106/jbjs.26.00785 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169849208 | |||
| W7169852415 | Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics | 2026-07-21 | OpenAlex | 10.1038/s41392-026-02769-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169852415 | |||
| W7170071270 | Perspective Chapter: Educating Clinicians for AI-Driven Care and Surgery – Literacy, Human-Centered Design and the EU AI Act | 2026-07-21 | OpenAlex | 10.5772/intechopen.1015696 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170071270 | |||
| W7169870231 | Recent Advances in Ferrite‐Based Materials for Biomedical Applications: A Comprehensive Review | 2026-07-21 | OpenAlex | 10.1002/adma.74149 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169870231 | |||
| W7169828696 | Reflexive Digital Twin Marketing Theory: Governing Algorithmic Marketing Agents Through Reinforcement Learning | 2026-07-21 | OpenAlex | 10.21203/rs.3.rs-10403290/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169828696 | |||
| W7169879536 | The Role of Generative Summarisation in Agent-Mediated Reflection for Youth Social Prescribing | 2026-07-21 | OpenAlex | 10.1145/3816046.3816262 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7169879536 | |||
| W7169840197 | Toxicity Assessment of Silicon‐Based Compounds With Their Permitted Daily Exposure in Pharmaceutical Packaging Materials and Medical Devices | 2026-07-21 | OpenAlex | 10.1002/jat.70314 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7169840197 | |||
| W7169881053 | Twenty-Year Trends in Antipsychotic Utilization in Serbia: A Nationwide Drug Utilization Study | 2026-07-21 | OpenAlex | 10.3390/ph19071128 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7169881053 | |||
| W7170042850 | Artificial Intelligence Horizons: Unlocking Potential and Navigating Risks | 2026-07-22 | OpenAlex | 10.5281/zenodo.21485943 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170042850 | |||
| W7170066977 | Botulinum Toxin in Dentistry: Present and Future | 2026-07-22 | OpenAlex | 10.5772/intechopen.1016719 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170066977 | |||
| W7170070301 | Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms | 2026-07-22 | OpenAlex | 10.3390/molecules31142551 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7170070301 | |||
| W7170042484 | Correction: Fetal health state detection method based on parameters efficient ensembling of deep learning | 2026-07-22 | OpenAlex | 10.3389/fpubh.2026.1925419 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7170042484 | |||
| W7170061450 | Damage control surgery: Perioperative principles, operating room management, and evolving strategies in trauma care | 2026-07-22 | OpenAlex | 10.1016/j.pcorm.2026.100710 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170061450 | |||
| W7170085710 | Dataset and analysis scripts for: Towards Autonomous Bio-Inspired Optimization: Deep Reinforcement Learning for Adaptive Metaheuristic Orchestration | 2026-07-22 | OpenAlex | 10.5281/zenodo.21482508 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7170085710 | |||
| W7170036318 | Editorial: Advances in the treatment of acute severe ulcerative colitis | 2026-07-22 | OpenAlex | 10.3389/fgstr.2026.1924886 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170036318 | |||
| W7170033967 | New perspective on epigenetic modification and immunotherapy in endometrial cancer | 2026-07-22 | OpenAlex | 10.1186/s13148-026-02174-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170033967 | |||
| W7171009737 | Scoping review: Closed-loop systems based on artificial intelligence in intraoperative anesthetic management | 2026-07-22 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171009737 | ||||
| W7170036918 | Structural Diversity and Application of Plant Extracts as Biocontrol Agents Against Phytopathogens: a Review | 2026-07-22 | OpenAlex | 10.1007/s10343-026-01384-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170036918 | |||
| W7171336735 | Amyloid-targeting treatment in Alzheimer’s disease and concomitant antiplatelets | 2026-07-23 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171336735 | ||||
| W7170165928 | Diagnosis and Management of Transfusion-Dependent Thalassemia: Evidence-Based Guidelines From the Pediatric Hematology Oncology Chapter of the Indian Academy of Pediatrics | 2026-07-23 | OpenAlex | 10.1007/s13312-026-00366-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170165928 | |||
| W7170107183 | Effectiveness of oral and inhaled repurposed and antiviral pharmaceutical treatments for acute SARS-CoV-2 in outpatient settings: a systematic review of 124 randomized trials | 2026-07-23 | OpenAlex | 10.1186/s12879-026-13901-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170107183 | |||
| W7170887993 | Emerging drug delivery strategies in natural products and traditional Chinese medicine research: from individual approaches to integrated design | 2026-07-23 | OpenAlex | 10.1097/hm9.0000000000000204 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170887993 | |||
| W7170180093 | Hemophilia A and von Willebrand disease: parallel therapeutic advances in the most common inherited bleeding disorders | 2026-07-23 | OpenAlex | 10.3324/haematol.2026.301336 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170180093 | |||
| W7170143754 | High tetracycline and azithromycin resistance of Neisseria gonorrhoeae impacting treatment and doxyPEP use - antimicrobial susceptibility patterns of isolates from a prospective cohort of men who have sex with men in Wroclaw, Lower Silesia, Poland 2022–2024 – final report | 2026-07-23 | OpenAlex | 10.1186/s12879-026-14073-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170143754 | |||
| W7170133478 | IV Thrombolysis in the Extended Time Window for Acute Ischemic Stroke | 2026-07-23 | OpenAlex | 10.1212/wnl.0000000000218294 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170133478 | |||
| W7170142406 | Incorporating Immunotherapies into the Evolving Standard of Care for Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia | 2026-07-23 | OpenAlex | 10.1007/s40272-026-00761-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170142406 | |||
| W7170167146 | Metabolic reprogramming orchestrates microglial fate in cerebral ischemia-reperfusion injury: a spatiotemporal immunometabolic perspective | 2026-07-23 | OpenAlex | 10.3389/fimmu.2026.1831494 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170167146 | |||
| W7170149478 | Modern Approaches to the Treatment of Type 2 Diabetes Mellitus: Personalized Therapy and Prevention of Complications | 2026-07-23 | OpenAlex | 10.52783/jchr.v16.i4.15879 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170149478 | |||
| W7170213444 | New and Novel Agents for Advanced Bladder Cancer | 2026-07-23 | OpenAlex | 10.1016/j.ucl.2026.06.010 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7170213444 | |||
| W7170199203 | Q&A: Timothy Yap on Clinical Trials and Drug Development | 2026-07-23 | OpenAlex | 10.1158/2159-8290.cd-nw2026-0079 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170199203 | |||
| W7170139806 | The Secondary Signature of Immune System - The Architecture of Secondary Stage - Sam Coole 2026 © | 2026-07-23 | OpenAlex | 10.5281/zenodo.21505226 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170139806; https://openalex.org/W7170153547; https://openalex.org/W7170176896; https://openalex.org/W7170174895; https://openalex.org/W7170192354; https://openalex.org/W7170147335 | |||
| W7170154898 | The Secondary Signature of Immune System - [ Molecular Blueprint] -The Architecture of Secondary Stage - Sam Coole 2026 © | 2026-07-23 | OpenAlex | 10.5281/zenodo.21505161 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170154898 | |||
| W7170197990 | The new era of MASH pharmacotherapy: a comprehensive review of FDA-approved and emerging agents | 2026-07-23 | OpenAlex | 10.3389/fgstr.2026.1850915 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170197990 | |||
| W7170196421 | Validation of the VOICE (Visible Opportunities for Infants to Connect and Engage) infant mental health observation tool | 2026-07-23 | OpenAlex | 10.31234/osf.io/7z8hm_v2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170196421 | |||
| W7170891753 | Circular Hydroethics | 2026-07-24 | OpenAlex | 10.5281/zenodo.21537480 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7170891753 | |||
| W7170170806 | Dataset: Dietary strategy: High amylose maize starch may be identified as a non-invasive tool to improve outcomes in TBI, and potentially hypoxic neurovascular damage, suggesting it could be repurposed for high-altitude workers or elderly patients with cognitive frailty. - PathMap Experiment #000083 | 2026-07-24 | OpenAlex | 10.5281/zenodo.21520955 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7170170806 | |||
| W7170368389 | Defining and managing high-risk acute myeloid leukemia (AML) in 2026 | 2026-07-24 | OpenAlex | 10.1007/s00277-026-07142-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170368389 | |||
| W7170479041 | Editorial: Innovative diagnostic and therapeutic strategies for neuroendocrine tumors: a multidisciplinary approach | 2026-07-24 | OpenAlex | 10.3389/fonc.2026.1939733 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170479041 | |||
| W7171769616 | Engineering Intelligent AIOT Systems-Artificial Intelligence for Smart Connected Technologies BY Dr. Srinivas Kumar Palvadi, Dr. Babu Rajendra Prasad Singothu, Kondapalli Krupa Sagari, Mr. Nyakapu Rajender | 2026-07-24 | OpenAlex | 10.5281/zenodo.21531905 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171769616 | |||
| W7170899704 | Immunotherapy in Alzheimer's Disease | 2026-07-24 | OpenAlex | 10.1002/9781394336241.ch19 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7170899704 | |||
| W7170826172 | In silico drug discovery pipelines targeting antibiotic resistance: from genomes to leads | 2026-07-24 | OpenAlex | 10.3389/fbinf.2026.1839606 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170826172 | |||
| W7170286489 | Incretin analogues as cardiovascular agents: a state-of-the-art review | 2026-07-24 | OpenAlex | 10.3389/fendo.2026.1898812 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7170286489 | |||
| W7170314481 | SkillSync AI: A Multi-Agent Artificial Intelligence Framework for Dynamic Skill Gap Analysis, Digital Employability Twin, and Personalized Career Roadmaps to Reduce Graduate Unemployment | 2026-07-24 | OpenAlex | 10.5281/zenodo.21522990 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7170314481 | |||
| W7171390969 | Agentic AI and Multi-Agent Collaboration in Healthcare: A Comprehensive Survey of Architectures, Clinical Safety, and Future Directions | 2026-07-25 | OpenAlex | 10.3390/fi18080391 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7171390969 | |||
| W7171244539 | Emerging Therapies in Endocrine Oncology: Molecular Targets, Precision Medicine, and Future Directions | 2026-07-25 | OpenAlex | 10.66224/infopub.202601.05.011 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171244539 | |||
| W7171205124 | From cytoreduction to precision oncology: evolution of ovarian cancer therapy | 2026-07-25 | OpenAlex | 10.1186/s13048-026-02165-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171205124 | |||
| W7171195045 | Radionuclide and Theranostic Therapies | 2026-07-25 | OpenAlex | 10.66224/infopub.2026.05.04 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171195045 | |||
| W7171441031 | A Systematic Review and Meta-Analysis of AI Transparency Gaps in Version Control Literature with a Proposed Taxonomy of Attribution Failures | 2026-07-26 | OpenAlex | 10.14293/pr2199.004154.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171441031 | |||
| W7171293376 | A Unified Framework for Self-Evolving and Self-Healing Artificial Intelligence Agents | 2026-07-26 | OpenAlex | 10.62127/aijmr.2026.v04i04.1435 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7171293376 | |||
| W7206172781 | Autonomous Radio Network Intelligence: Architectural Principles of Large Language Model-Driven Closed-Loop 5G Management Systems | 2026-07-26 | OpenAlex | 10.22399/ijcesen.5491 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7206172781 | |||
| W7220399162 | Deep Fungal Infections – The Masquerader | 2026-07-26 | OpenAlex | 10.3329/bjm.v37i20.89574 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220399162 | |||
| W7171437223 | Advancing personalised oncologic care for older adults with head and neck cancer through structured international collaboration | 2026-07-27 | OpenAlex | 10.3389/fonc.2026.1858873 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171437223 | |||
| W7171516054 | Atypical myxomatosis in European rabbits is caused by the recombinant myxoma virus involved in species jumping into hares | 2026-07-27 | OpenAlex | 10.64898/2026.07.25.740729 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171516054 | |||
| W7171354671 | Prevalence and Clinical Implications of Somatic and Germline EGFR Mutations in Patients with Non-Small-Cell Lung Cancer | 2026-07-27 | OpenAlex | 10.3390/cancers18152417 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171354671 | |||
| W7171644048 | Self-evolving artificial intelligence virtual cells: A closed-loop system from multi-scale modeling to biomedical applications | 2026-07-27 | OpenAlex | 10.65457/cmjbm-2026-0006 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7171644048 | |||
| W7172238334 | Strategic Sensing under VUCA Conditions: A Critical Reflection on Forecasting, Anchoring Bias, and Agentic AI | 2026-07-27 | OpenAlex | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7172238334 | ||||
| W7171541494 | Thiazolidinedione nucleus: a molecular beacon in treatment of diabetes | 2026-07-27 | OpenAlex | 10.1080/17415993.2026.2709110 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171541494 | |||
| W7171397432 | Weight Recurrence After Bariatric Surgery: Incretin-Based Therapies and the Evolving Role of Revisional Surgery | 2026-07-27 | OpenAlex | 10.7759/cureus.113460 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171397432 | |||
| W7171388348 | When Innovation Turns Fatal: The Imperative for Ethical, Monitored Integration of AI Chatbots in Adolescent Mental Healthcare | 2026-07-27 | OpenAlex | 10.1007/s10615-026-01045-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171388348 | |||
| W7171531438 | AI Safety Compass Core Semantic Package: A Stable Machine-Readable Contract for AI Safety Research and System Design | 2026-07-28 | OpenAlex | 10.5281/zenodo.21649320 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171531438 | |||
| W7171534589 | Advancements in Bladder-Sparing Strategies for Muscle-Invasive Bladder Cancer | 2026-07-28 | OpenAlex | 10.1016/j.ucl.2026.06.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171534589 | |||
| W7171561903 | Bridging the gap: integrating hereditary cancer into precision oncology | 2026-07-28 | OpenAlex | 10.1038/s41431-026-02196-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171561903 | |||
| W7171533628 | Developing a Spiral Curriculum for Immunology in Undergraduate Medical Education: Lessons from Curricular Reforms in Azerbaijan 2259347 | 2026-07-28 | OpenAlex | 10.1093/jimmun/vkag141.699 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171533628 | |||
| W7171522190 | Editorial: Prosthodontic research and clinical applications | 2026-07-28 | OpenAlex | 10.3389/fdmed.2026.1907894 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171522190 | |||
| W7171489118 | Editorial: User-centered approaches for designing assistive technologies to support older adults | 2026-07-28 | OpenAlex | 10.3389/fragi.2026.1864923 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171489118 | |||
| W7171806078 | GuideSkill: Evolving Executable LLM Agent Skills for Guideline-Grounded Clinical Reasoning | 2026-07-28 | OpenAlex | 2607.26160 | 10.48550/arxiv.2607.26160 | Full text | Included | Included: Executable skills learned from prior labelled cases are retained for disjoint later clinical benchmarks. | https://openalex.org/W7171806078 | https://arxiv.org/html/2607.26160v1 | |
| W7171527713 | Management of drug-induced interstitial lung disease in the era of evolving lung cancer therapies: A mini-review | 2026-07-28 | OpenAlex | 10.1016/j.resinv.2026.101494 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171527713 | |||
| W7171539747 | Primary Biliary Cholangitis in the Middle East: A Review of Current Challenges and Treatment Approaches | 2026-07-28 | OpenAlex | 10.7759/cureus.113526 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171539747 | |||
| W7171554276 | Transdermal Drug Delivery Systems: An Updated Review on Design, Evaluation, and Recent Advances | 2026-07-28 | OpenAlex | 10.5281/zenodo.21637782 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171554276 | |||
| W7171565303 | TyCHE enables time-resolved lineage tracing of B cells in primary and recall germinal center reactions 2261047 | 2026-07-28 | OpenAlex | 10.1093/jimmun/vkag141.1025 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171565303 | |||
| W7171735683 | Assessment of Nutritional Status in Adult Patients with Acute Myeloid Leukemia: The Role of Screening Tools, Composite Indices, Body Composition, and Physical Function—A Structured Narrative Review | 2026-07-29 | OpenAlex | 10.3390/hemato7030024 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171735683 | |||
| W7171684290 | Clinical Implications of UGT1A1 Polymorphisms in Anticancer Therapy: An Updated Review | 2026-07-29 | OpenAlex | 10.3390/pharmaceutics18080928 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171684290 | |||
| W7171730133 | Designing an Explainable agent for Generative Design Workflows with Physics based Reasoning | 2026-07-29 | OpenAlex | 10.1184/r1/32761257 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171730133 | |||
| W7171632781 | Korean guidelines for pediatric procedural sedation | 2026-07-29 | OpenAlex | 10.17085/apm.26630 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171632781 | |||
| W7171683353 | Laser Interstitial Thermal Therapy for High-Grade Gliomas: Current Evidence, Clinical Applications and Emerging Role of Artificial Intelligence | 2026-07-29 | OpenAlex | 10.3390/jcm15155928 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171683353 | |||
| W7171688681 | Molecular Brain Tumor Imaging Beyond [ 18 F]FDG: Somatostatin Receptor PET, Amino Acid PET, and Emerging Applications—From the AJR Special Series on Molecular Imaging | 2026-07-29 | OpenAlex | 10.2214/ajr.26.35024 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171688681 | |||
| W7171628927 | Position Paper of the German Diabetes Association, German Society of Angiology and Vascular Medicine, German Society for Vascular Surgery and Vascular Medicine and German Society for Interventional Radiology and Minimally Invasive Therapy on the Diagnosis and Treatment of Peripheral Arterial Occlusive Disease in Diabetes Mellitus | 2026-07-29 | OpenAlex | 10.1055/a-2766-4074 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171628927 | |||
| W7171712537 | Precision targeting in prostate cancer: Mechanistic drivers and the evolving clinical pipeline | 2026-07-29 | OpenAlex | 10.1016/j.drudis.2026.104750 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7171712537 | |||
| W7171660919 | Prediction and Learning Algorithms for Robustness in the Wild | 2026-07-29 | OpenAlex | 10.1184/r1/32984741 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171660919 | |||
| W7171619968 | Sustained-release local anesthetics: advances in drug delivery systems for prolonged postoperative analgesia | 2026-07-29 | OpenAlex | 10.17085/apm.26668 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171619968 | |||
| W7171840476 | THERAPEUTIC APPROACH AND TREATMENT OF IDIOPATHIC NEPHROTIC SYNDROME IN CHILDHOOD | 2026-07-29 | OpenAlex | 10.47172/ijhmreview.v12i3.566 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171840476 | |||
| W7202138461 | Tactical Combat Casualty Care (TCCC): Historical Evolution, EvidenceBased Development, And Contemporary Applications In Modern Warfare | 2026-07-29 | OpenAlex | 10.47353/ajmpm.v3i2.57 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202138461 | |||
| W7171652593 | Targeted Drug Delivery Using Nanotechnology: A Comprehensive Review | 2026-07-29 | OpenAlex | 10.5281/zenodo.21669217 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171652593 | |||
| W7171717741 | Advancements in AI Research and Social Responsibility : From Technology to Control and Governance | 2026-07-30 | OpenAlex | 10.54698/kl.2026.21.835 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171717741 | |||
| W7172522313 | Annotations to Structure a Systematic Review: Methodological Update and Key Principles Using the S0–S3 Flow | 2026-07-30 | OpenAlex | 10.20944/preprints202607.2253.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172522313 | |||
| W7171977841 | Artificial Intelligence in Medical Publishing: At the Crossroads of Innovation, Scientific Integrity, and Editorial Governance | 2026-07-30 | OpenAlex | 10.37018/ekbx9407 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171977841 | |||
| W7171768544 | Beyond Mechanical Support: Engineering Bioresorbable Coronary Scaffolds as Temporary Therapeutic Platforms of Vascular Regeneration | 2026-07-30 | OpenAlex | 10.6084/m9.figshare.33120065 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171768544 | |||
| W7172442542 | Claudin 18.2-Targeted Therapies in Gastric and Gastroesophageal Junction Cancers: A Narrative Review of the Emerging Therapeutic Landscape | 2026-07-30 | OpenAlex | 10.67692/iodt.26.9635 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172442542 | |||
| W7171941811 | Inference-Time Agentic Decision Rules Beat Longer Evolving Search for Multi-Image Medical Reasoning | 2026-07-30 | OpenAlex | 2607.27564 | 10.48550/arxiv.2607.27564 | Full text | Included | Included: Evolved agent inference configurations are selected on prior VQA cases and retained for disjoint final cases. | https://openalex.org/W7171941811 | https://arxiv.org/abs/2607.27564v1 | |
| W7171868682 | REVIEW OF POLYHERBAL MOUTHWASHES AND THEIR IMPACT ON ORAL HEALTH: HERBAL SYNERGY IN DENTISTRY | 2026-07-30 | OpenAlex | 10.5281/zenodo.21704250 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171868682 | |||
| W7172016399 | 3D Skin Analysis Machine | 2026-07-31 | OpenAlex | 10.5281/zenodo.21718371 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172016399 | |||
| W7171978400 | Antifungal Management in Patients with Hematological Malignancies: From Primary Prophylaxis to Empirical and Diagnosis-Driven Treatment | 2026-07-31 | OpenAlex | 10.4274/tjh.galenos.2026.32559 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171978400 | |||
| W7171919341 | Beyond discrete social decisions: toward continuous dyadic neural dynamics in cooperation and competition | 2026-07-31 | OpenAlex | 10.3389/fnsys.2026.1809977 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171919341 | |||
| W7171947137 | Bioactive Compounds from Mangrove-Associated Fungi as Leads Against ESKAPE Pathogens | 2026-07-31 | OpenAlex | 10.3390/life16081272 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171947137 | |||
| W7202127566 | Cognitive Identity Mesh Architecture (CIMA): Redefining Zero-Trust Security in AI-Driven Cloud Ecosystems | 2026-07-31 | OpenAlex | 10.5281/zenodo.21868888 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7202127566; https://openalex.org/W7202187771 | |||
| W7172105884 | Coherence Under Velocity: Preserving Intelligibility When Machines Outpace Human Understanding | 2026-07-31 | OpenAlex | 10.5281/zenodo.21731946 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7172105884 | |||
| W7171919270 | Evaluating the potential of factor XI/factor XIa inhibitors to address unmet anticoagulation needs in critical patient populations | 2026-07-31 | OpenAlex | 10.1016/j.rpth.2026.106624 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171919270 | |||
| W7204488242 | From Padma’s Bank to Gun Island: A Narrative of Ecological Witnessing | 2026-07-31 | OpenAlex | 10.53032/tvcr/2026.v8n3.17 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204488242 | |||
| W7172272227 | From Zero to AI: An Easy Beginner's Guide to Artificial Intelligence, Machine Learning, Generative AI, ChatGPT, AI Agents, and the Future of Intelligent Technology | 2026-07-31 | OpenAlex | 10.5281/zenodo.21774234 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172272227 | |||
| W7172015047 | Functional Liposomal Nanocarriers for the Treatment of Antimicrobial-Resistant and Biofilm-Associated Ocular Infections | 2026-07-31 | OpenAlex | 10.3390/macromol6030056 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172015047 | |||
| W7171980312 | Human-Centered AI in Sleep Health Management: Scoping Review of Stakeholder Perspectives and Co-Design Practices | 2026-07-31 | OpenAlex | 10.2196/93779 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171980312 | |||
| W7171962981 | Interpreting Glycopeptide Escalation and Acute Kidney Injury with Caution | 2026-07-31 | OpenAlex | 10.4274/tjh.galenos.2026.15870 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171962981 | |||
| W7171777219 | Landscape of industry-sponsored oncology trials across the Thai Society of Clinical Oncology (TSCO): a 12-year multicenter analysis | 2026-07-31 | OpenAlex | 10.1186/s12885-026-16583-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171777219 | |||
| W7171426153 | Occurrence and spectrum of cutaneous adverse drug reactions to anti-tubercular drugs among patients of drug-sensitive and drug-resistant tuberculosis-changing trends at a tertiary care center in central India | 2026-07-31 | OpenAlex | 10.71152/ajms.v17i8.5355 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171426153 | |||
| W7171933313 | On endovascular transplantation of modified mRNA enhanced cells and treatment of cardiac arrest using levosimendan : leveraging modRNA therapeutics and cardioprotective pharmacology to improve cardiovascular outcomes | 2026-07-31 | OpenAlex | 10.69622/32124226 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171933313 | |||
| W7171999206 | PAIR - AI TFL Generation | 2026-07-31 | OpenAlex | 10.5281/zenodo.21719180 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171999206 | |||
| W7171981206 | Recent Advances in the Diagnosis and Management of Lupus Nephritis in Systemic Lupus Erythematosus | 2026-07-31 | OpenAlex | 10.5281/zenodo.21727269 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7171981206 | |||
| W7222431488 | Supportive Parenteral Agents | 2026-07-31 | OpenAlex | 10.4018/979-8-3373-6551-0.ch014 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7222431488 | |||
| W7172011046 | Syn2Real: Standards-Native Generation of Traceable Synthetic SDTM and ADaM for Automation Testing | 2026-07-31 | OpenAlex | 10.5281/zenodo.21718792 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7172011046 | |||
| W7172021909 | The Evolving Landscape of Pulmonary Hypertension Treatment: From Vasodilation to Disease Modification | 2026-07-31 | OpenAlex | 10.1111/cts.70685 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172021909 | |||
| W7171996517 | Universal Logic And The 4 Layer-Onion | 2026-07-31 | OpenAlex | 10.5281/zenodo.21718649 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171996517 | |||
| W7204727369 | ABCL-201: Temporal Patterns of Efficacy and Toxicity of CD20 × CD3 Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Review | 2026-08-01 | OpenAlex | 10.1016/s2152-2650(26)02544-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204727369 | |||
| W7202348308 | AI Agents and the Future of Clinical Judgment in Medical Education: Opportunities, Challenges, and the Need for Human‐Centered Integration | 2026-08-01 | OpenAlex | 10.1002/hsr2.73042 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7202348308 | |||
| W7172246780 | AI-Guided Cognitive Behavioral Therapy for Depression and Anxiety: Bridging the Mental Health Treatment Gap Through Digital Psychiatry | 2026-08-01 | OpenAlex | 10.3390/healthcare14152334 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172246780 | |||
| W7204707252 | AML-1439: Survival Analysis in Real-World Clinical Practice With Low-Intensity Regimens (Azacitidine vs Azacitidine/Venetoclax) in Patients With Acute Myeloblastic Leukemia and Prognostic Determinants, Such as TP53 | 2026-08-01 | OpenAlex | 10.1016/s2152-2650(26)01953-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204707252 | |||
| W7204706115 | AML-1492: Temporal Decline in Early Mortality in Acute Myeloid Leukemia Across Chemotherapy, Hypomethylating Agent, and Venetoclax-Based Therapeutic Eras: A Four-Decade Population-Based Analysis | 2026-08-01 | OpenAlex | 10.1016/s2152-2650(26)01967-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204706115 | |||
| W7204713828 | AML-911: Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia | 2026-08-01 | OpenAlex | 10.1016/s2152-2650(26)01867-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204713828 | |||
| W7223707953 | ANTIMICROBIAL RESISTANCE WITH MECHANISMS | 2026-08-01 | OpenAlex | 10.58532/nbennurv6b3404c2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223707953 | |||
| W7162819749 | Agent-Based Modeling of Cellular Dynamics in Adoptive Cell Therapies | 2026-08-01 | OpenAlex | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7162819749 | ||||
| W7203630853 | Agentic AI in global health consultation: Technological foundations, clinical validation, regulatory frameworks, and future prospects | 2026-08-01 | OpenAlex | 10.1016/j.inhs.2026.100111 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7203630853 | |||
| W7204650825 | Autonomous agentic artificial intelligence systems in health care: friend or foe? | 2026-08-01 | OpenAlex | 10.1016/j.landig.2026.101073 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7204650825 | |||
| W7203753013 | BIOINORGANIC CHEMISTRY | 2026-08-01 | OpenAlex | 10.58532/nbennuriferv6b1c25 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203753013 | |||
| W7202371035 | Bone health in prostate cancer: two clinical paradigms and the evolving role of bone-protecting agents | 2026-08-01 | OpenAlex | 10.1016/j.prnil.2026.08.002 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7202371035 | |||
| W7224402079 | CHEMOTHERAPY IN CANCER: PRINCIPLES, MECHANISMS, CLINICAL APPLICATIONS, DRUG RESISTANCE, AND FUTURE PERSPECTIVES | 2026-08-01 | OpenAlex | 10.58532/nbennurv6b3350c12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224402079 | |||
| W7204699643 | CT-249: Cardiovascular Complications of Contemporary Therapies in Hematologic Malignancies | 2026-08-01 | OpenAlex | 10.1016/s2152-2650(26)03126-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204699643 | |||
| W7204697474 | CT-366: Cutaneous Angiosarcoma: A Case Highlighting the Dismal Prognosis of an Aggressive Malignancy | 2026-08-01 | OpenAlex | 10.1016/s2152-2650(26)03142-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204697474 | |||
| W7201954911 | Cancer Nanomedicine: Advanced Nanocarrier Systems, Targeted Drug Delivery, Theranostics, and Emerging Strategies for Precision Oncology | 2026-08-01 | OpenAlex | 10.64062/jpgmb.vol2.issue4.2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7201954911 | |||
| W7203782288 | Clinical Advances in Breast Cancer: A Comprehensive Overview of Full‐Course Disease Management | 2026-08-01 | OpenAlex | 10.1002/cai2.70076 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203782288 | |||
| W7172265797 | Design and implementation of a cardio-oncology elective for undergraduate medical education | 2026-08-01 | OpenAlex | 10.1093/eurheartjsupp/suag097.214 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172265797 | |||
| W7213252852 | EP593 - ECE_3589 - Therapeutic challenges of immune checkpoint inhibitor-induced type 1 diabetes within polyendocrinopathy: two case reports | 2026-08-01 | OpenAlex | 10.1093/ejendo/lvag096.1041 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213252852 | |||
| W7213258449 | EP823 - ECE_1873 - Current literature on the use of Probiotic and prebiotic with Glucagon like peptide- 1 receptor agonist therapy in patients with Type 2 diabetes | 2026-08-01 | OpenAlex | 10.1093/ejendo/lvag096.1160 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213258449 | |||
| W7203761105 | Engineered Marine Polysaccharide Carriers for Targeted Delivery in Diabetes Management | 2026-08-01 | OpenAlex | 10.2147/ijn.s619930 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203761105 | |||
| W7204772516 | Evolution of proton pump inhibitor research in reflux esophagitis: a Web of Science-based global bibliometric assessment [1990–2026] | 2026-08-01 | OpenAlex | 10.21037/jtd-2026-0946 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204772516 | |||
| W7196958590 | Evolving cardiac safety pharmacology: Immune-integrating in vitro assessment for novel therapeutic modalities | 2026-08-01 | OpenAlex | 10.1016/j.vascn.2026.108553 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7196958590 | |||
| W7172110912 | Giant Cell Arteritis with Scalp and Tongue Necrosis: A Rare Case of Extensive Mucocutaneous Ischemia | 2026-08-01 | OpenAlex | 10.3899/jrheum.2026-0447.185 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172110912 | |||
| W7202032766 | Glucagon-like peptide-1 receptor agonists and related incretin therapies in dermatology: Patient selection and shared decision-making | 2026-08-01 | OpenAlex | 10.1016/j.clindermatol.2026.08.005 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202032766 | |||
| W7213535960 | GraphRAG-Driven Self-Healing Multi-Agent Framework for High-Performance Resource-Efficient Modern Sustainable Software Systems | 2026-08-01 | OpenAlex | 10.1109/cmss69636.2026.11688270 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7213535960 | |||
| W7204733222 | HL-459: Did Novel Agents Change the Curve? Survival Acceleration in Hodgkin Lymphoma After 2016: SEER Analysis | 2026-08-01 | OpenAlex | 10.1016/s2152-2650(26)02459-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204733222 | |||
| W7172096553 | IgG4-Related Skin Disease in a 9-Year-Old Patient: Remission Under Mycophenolate Mofetil After Rituximab Failure | 2026-08-01 | OpenAlex | 10.3899/jrheum.2026-0447.139 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172096553 | |||
| W7172246407 | Integrated Immune, Epithelial and Lipid Pathways in NSAID‐Exacerbated Respiratory Disease | 2026-08-01 | OpenAlex | 10.1002/clt2.70182 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172246407 | |||
| W7171550894 | La biotecnología en la esfera defensiva militar | 2026-08-01 | OpenAlex | 10.5281/zenodo.21650538 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7171550894 | |||
| W7204736525 | MDS-110: Temporal Evolution of Racial Disparities in Myelodysplastic Syndromes: A SEER Analysis of Interaction Effects Across Therapeutic Eras (2000–2022) | 2026-08-01 | OpenAlex | 10.1016/s2152-2650(26)02209-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204736525 | |||
| W7204722695 | MM-1451: Clinical Outcomes of PD-1/PD-L1 Inhibitors in Hematologic Malignancies: A Systematic Review Across Lymphoma, Leukemia, and Multiple Myeloma | 2026-08-01 | OpenAlex | 10.1016/s2152-2650(26)03046-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204722695 | |||
| W7204705151 | MM-1510: Beyond ICANS: A Pharmacovigilance Study on Neurotoxicity Related to Bispecific Antibodies in Multiple Myeloma | 2026-08-01 | OpenAlex | 10.1016/s2152-2650(26)03056-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204705151 | |||
| W7204684272 | MM-451: When Immunotherapy Turns Against Immunity: Progressive Multifocal Leukoencephalopathy During Teclistamab Therapy for Lambda Light Chain Myeloma | 2026-08-01 | OpenAlex | 10.1016/s2152-2650(26)02877-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204684272 | |||
| W7204713400 | MPN-1067: Comparative Efficacy of Drug Therapies on Spleen Size and Symptom Reduction in Myelofibrosis: A Frequentist Network Meta-Analysis | 2026-08-01 | OpenAlex | 10.1016/s2152-2650(26)02387-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204713400 | |||
| W7204700443 | Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma | 2026-08-01 | OpenAlex | 10.14740/jh2218 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204700443 | |||
| W7204103013 | Materia Medica and the understanding of human individuality in homoeopathy | 2026-08-01 | OpenAlex | 10.33545/26164485.2026.v10.i8.e.3118 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204103013 | |||
| W7212162491 | MedCouncil: A Debate-Enabled Multi-Agent Framework for Second-Opinion Clinical Decision Support in General Internal Medicine | 2026-08-01 | OpenAlex | 10.1109/ibdap69915.2026.11677991 | Full text | Excluded | F4: MedCouncil initializes global state for each case and debates for three to four rounds. TableI explicitly defines memory as continuity across debate rounds. No experience-derived artifact or policy is retained across different cases. | https://openalex.org/W7212162491 | https://ieeexplore.ieee.org/document/11677991 | ||
| W7171748282 | Opioid, Buprenorphine, Benzodiazepine, Naloxone, and Stimulant Prescriptions Dispensed to Rhode Island Residents, 2022-2025. | 2026-08-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171748282 | ||||
| W7204717862 | Persistent Cognitive Memory Architecture (PCMA) | 2026-08-01 | OpenAlex | 10.5281/zenodo.22177543 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204717862 | |||
| W7204568184 | Perspectives of gastroenterologists on the evolving epidemiology and management of non-alcoholic fatty liver disease in Pakistan: a qualitative study | 2026-08-01 | OpenAlex | 10.1136/bmjopen-2026-119696 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204568184 | |||
| W7171923229 | Preterm Twin Neonates With Collodion Membranes | 2026-08-01 | OpenAlex | 10.1542/neo.27-8-042 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7171923229 | |||
| W7202388025 | Redefining the Role of Chemotherapy and Targeted Cytotoxic Delivery in Lung Neuroendocrine Tumors | 2026-08-01 | OpenAlex | 10.1111/1759-7714.70376 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202388025 | |||
| W7204931355 | Risk Factors and Emerging Therapies for Immune Checkpoint Inhibitor-related Myocarditis: A Narrative Review | 2026-08-01 | OpenAlex | 10.59556/japi.74.1665 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204931355 | |||
| W7204122712 | S18 Operational Economics - Comparison and Its Curvature (v0.91) | 2026-08-01 | OpenAlex | 10.5281/zenodo.22086162 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204122712 | |||
| W7220736963 | Social Intelligence and Computing Models: Foundations, Techniques, and Emerging Directions | 2026-08-01 | OpenAlex | 10.1109/icstsdg69220.2026.11708389 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220736963 | |||
| W7204982547 | Stenotrophomonas maltophilia in the Antimicrobial Resistance Era: Species-Complex Taxonomy, Pathogenesis, Evolving Therapeutic Priorities, and Genomic Surveillance | 2026-08-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204982547; https://openalex.org/W7204496177 | ||||
| W7220676333 | Swarm Intelligence in Autonomous Systems: Principles, Applications, and Future Directions | 2026-08-01 | OpenAlex | 10.1109/icstsdg69220.2026.11708099 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220676333 | |||
| W7220722687 | The Use of Medicine in Espionage, an Old Profession: The Example of Missionary Activities in the Ottoman Empire | 2026-08-01 | OpenAlex | 10.30476/rhm.2025.109061.1383 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220722687 | |||
| W7204464252 | Therapeutic landscape of upper tract urothelial carcinoma: Intraluminal agents, perioperative chemotherapy, and immunotherapy | 2026-08-01 | OpenAlex | 10.1016/j.urolonc.2026.08.002 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204464252 | |||
| W7196967179 | Thermal analysis in pharmaceutical sciences: a critical narrative review with focus on drug–excipient interactions | 2026-08-01 | OpenAlex | 10.1007/s10973-026-16067-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7196967179 | |||
| W7202377804 | Treatment, Monitoring, and Management of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Evidence From a Multi‐Country Needs Assessment | 2026-08-01 | OpenAlex | 10.1002/cnr2.70655 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202377804 | |||
| W7201959026 | Trends in glucagon-like peptide-1 receptor agonist utilization and expenditure in Croatia | 2026-08-01 | OpenAlex | 10.1177/03000605261470651 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7201959026 | |||
| W7204275664 | Visceral artery aneurysms: a literature review of etiology, natural history, diagnosis and treatment paradigms | 2026-08-01 | OpenAlex | 10.21037/cdt-2025-1-666 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204275664 | |||
| W7223677511 | ZeroDay-DRL: A Hybrid Deep Reinforcement and Few-Shot Learning Framework for Early-Stage IoT Botnet Detection | 2026-08-01 | OpenAlex | 10.1109/incect72370.2026.11742887 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7223677511 | |||
| W7172346525 | AI- and Generative AI-Driven Digital Therapeutics: A Critical Narrative Review of Emerging Evidence | 2026-08-03 | OpenAlex | 10.3390/ai7080296 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172346525 | |||
| W7172326888 | Agentic AI for maintenance management: a process-centric review and a staged framework for industrial adoption | 2026-08-03 | OpenAlex | 10.1016/j.cie.2026.112285 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172326888 | |||
| W7172312990 | Agentic AI in Healthcare 5.0: Reference Architecture, Applications, and Challenges | 2026-08-03 | OpenAlex | 10.1109/jiot.2026.3718925 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7172312990 | |||
| W7172283593 | Cancer Therapy-Related Cutaneous Toxicities: Prognostic Biomarkers, Immunologic Endotypes, and Novel Therapeutic Strategies | 2026-08-03 | OpenAlex | 10.3390/onco6030039 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172283593 | |||
| W7172348268 | Combination Treatment Strategies With Peptide Receptor Radionuclide Therapy | 2026-08-03 | OpenAlex | 10.1097/rlu.0000000000006139 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172348268 | |||
| W7207602115 | From insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals | 2026-08-03 | OpenAlex | 10.1080/03007995.2026.2727202 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7207602115 | |||
| W7172425165 | Fusogenic Lipid Cubosomes as Nanocarriers for Next-Generation Nanomedicine | 2026-08-03 | OpenAlex | 10.1021/accountsmr.6c00122 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172425165 | |||
| W7172252266 | Google Colab code for duplicate removal in structured Kaggle literature searches | 2026-08-03 | OpenAlex | 10.5281/zenodo.21776496 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7172252266 | |||
| W7172272423 | Health Inequalities in Antidiabetic Prescribing Among South Asian Populations in the United Kingdom: A Systematic Review of Temporal Trends and Therapeutic Inertia | 2026-08-03 | OpenAlex | 10.21203/rs.3.rs-10541475/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172272423 | |||
| W7172322197 | Modern Management of Neurogenic Bladder | 2026-08-03 | OpenAlex | 10.1007/s40746-026-00382-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172322197 | |||
| W7201964788 | Non-Alcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease: Current Insights into Epidemiology, Diagnosis, Treatment, and Global Health Challenges | 2026-08-03 | OpenAlex | 10.64062/jpgmb.vol2.issue4.5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7201964788 | |||
| W7172266001 | Treatment of antibody-mediated rejection in heart transplantation: from empirical combination to multi-target precision intervention | 2026-08-03 | OpenAlex | 10.3389/fimmu.2026.1902286 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172266001 | |||
| W7172429492 | Acquired immune-mediated thrombotic thrombocytopenic purpura with severe cholestatic liver injury and reversible acute kidney injury after ivonescimab-containing chemoimmunotherapy: a case report and literature review | 2026-08-04 | OpenAlex | 10.3389/fimmu.2026.1908239 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172429492 | |||
| W7172436196 | Bispecific Antibodies for Acute Myeloid Leukemia: From Bone Marrow Immune Niche to Clinical Translation | 2026-08-04 | OpenAlex | 10.3390/antib15040069 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172436196 | |||
| W7197735192 | Clinical Cognitive Erosion Associated With Artificial Intelligence | 2026-08-04 | OpenAlex | 10.17605/osf.io/qg3mr | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7197735192 | |||
| W7172425797 | Daraxonrasib: A Breakthrough in Pancreatic Ductal Adenocarcinoma | 2026-08-04 | OpenAlex | 10.7759/cureus.113927 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172425797 | |||
| W7172425246 | Editorial: Integrative microbial and chemical genomics to decipher antibiotic resistance mechanisms and developing innovative antimicrobial approaches | 2026-08-04 | OpenAlex | 10.3389/fmicb.2026.1938175 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172425246 | |||
| W7172400813 | Generative AI-powered simulated patients in medical and healthcare education: A scoping review and meta analysis | 2026-08-04 | OpenAlex | 10.21203/rs.3.rs-10473312/v1 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7172400813 | |||
| W7172378649 | Glomerulosclerosis in 2026: From Pathophysiological Mechanisms to Precision Therapeutics | 2026-08-04 | OpenAlex | 10.3390/sclerosis4030023 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172378649 | |||
| W7172426310 | Labbi | 2026-08-04 | OpenAlex | 10.5281/zenodo.21797532 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7172426310 | |||
| W7172556710 | Lupus Miliaris Disseminatus Faciei as a Diagnostic and Therapeutic Challenge in Facial Dermatoses | 2026-08-04 | OpenAlex | 10.7759/cureus.113976 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172556710 | |||
| W7172401843 | Nodal Marginal Zone B-Cell Lymphoma Mimicking Classical Hodgkin Lymphoma: A Diagnostic Pitfall in a Patient Evaluated for Infectious and Metastatic Malignancy. | 2026-08-04 | OpenAlex | 10.5281/zenodo.21792436 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172401843 | |||
| W7172382810 | Peripheral facial palsy: contemporary advances and unresolved debates in management from pathogenic mechanisms to tailored reconstruction | 2026-08-04 | OpenAlex | 10.3389/fneur.2026.1907653 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172382810 | |||
| W7172528443 | A Systematic Review on Green Synthesized Selenium Nanoparticles as Antioxidant and Antidiabetic Agents: Mechanistic Insights and Therapeutic Potential | 2026-08-05 | OpenAlex | 10.18502/ajmb.v18i3.22235 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172528443 | |||
| W7172506470 | Evolving role of Anti-CD20 monoclonal antibodies in rheumatoid arthritis: efficacy, safety, economic perspectives, and future directions—a narrative review | 2026-08-05 | OpenAlex | 10.1186/s12916-026-05099-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172506470 | |||
| W7172488185 | Grand challenges in anesthetic pharmacology: toward personalized, outcome-focused practice | 2026-08-05 | OpenAlex | 10.3389/fanes.2026.1934044 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7172488185 | |||
| W7172492680 | Implementing evidence in residential aged care facilities: a longitudinal multi-method evaluation of knowledge broker evolution | 2026-08-05 | OpenAlex | 10.1136/bmjqs-2026-020577 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172492680 | |||
| W7201976400 | Invasive mold infections in intensive care in hematological patients | 2026-08-05 | OpenAlex | 10.1097/mcc.0000000000001414 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7201976400 | |||
| W7197019728 | Making AI Agents Practical in Health Professions Education: An Implementation Framework (Preprint) | 2026-08-05 | OpenAlex | 10.2196/preprints.108871 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7197019728 | |||
| W7201879337 | Mas-related G protein-coupled receptor X2 in non-IgE-mediated mast cell activation and anaphylaxis: a paradigm shift | 2026-08-05 | OpenAlex | 10.1097/aci.0000000000001187 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7201879337 | |||
| W7203793645 | Progress of Framework Nucleic Acids in Tumor Diagnosis and Therapy | 2026-08-05 | OpenAlex | 10.2174/0113892002461750260727104653 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203793645 | |||
| W7172499429 | Reactive Osteoblastic Proliferation Simulating Metastatic Adenocarcinoma in a Pathological Femoral Fracture: A Diagnostic Pitfall in Bone Pathology. | 2026-08-05 | OpenAlex | 10.5281/zenodo.21807942 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172499429 | |||
| W7204257457 | Workshop: intracellular Bacterial pathogens | 2026-08-05 | OpenAlex | 10.48045/001c.166397 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204257457 | |||
| W7201849168 | A multi-agent AI classroom based on dual-process reasoning hazards: a pilot with prospective physics teachers | 2026-08-06 | OpenAlex | 2608.05820 | 10.48550/arxiv.2608.05820 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7201849168 | ||
| W7212042066 | ANGINA PECTORIS: PATHOPHYSIOLOGY AND EVOLVING THERAPEUTIC STRATEGIES-A COMPREHENSIVE REVIEW | 2026-08-06 | OpenAlex | 10.55766/sujst11956 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212042066 | |||
| W7201883560 | Adoptive T-cell therapies in neuroinfectious and neuroinflammatory diseases | 2026-08-06 | OpenAlex | 10.1093/brain/awag275 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7201883560 | |||
| W7197005450 | Anticoagulation Therapy in the Modern Era: A Comprehensive Clinical Review of Pharmacology, Patient Selection, Complication Management, and Systems-Based Safety Strategies | 2026-08-06 | OpenAlex | 10.5281/zenodo.21819162 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7197005450 | |||
| W7213532332 | Food-Derived Bioactive Peptides: Computational Discovery, Molecular Mechanisms, and Therapeutic Applications | 2026-08-06 | OpenAlex | 10.53365/nrfhh.77 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213532332 | |||
| W7202060164 | Intravenous thrombolysis in acute ischemic stroke after recent direct oral anticoagulant intake | 2026-08-06 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202060164 | ||||
| W7196934744 | Intravenous thrombolysis in acute ischemic stroke after recent direct oral anticoagulant intake: toward evidence-informed care | 2026-08-06 | OpenAlex | 10.3389/fneur.2026.1904486 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7196934744 | |||
| W7196972174 | MORPHOLOGICAL CHANGES OF THE GASTROINTESTINAL TRACT IN COVID-19 | 2026-08-06 | OpenAlex | 10.67519/nshr.ztj.2026.03.012 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7196972174 | |||
| W7196956837 | Myasthenia Gravis and Anesthesia: A Comprehensive Review of Pathophysiology, Perioperative Risk Stratification, and Management Strategies | 2026-08-06 | OpenAlex | 10.5281/zenodo.21815836 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7196956837 | |||
| W7197043548 | Radiation Management After Neoadjuvant Therapy in Breast Cancer: Current Evidence and Evolving Paradigms | 2026-08-06 | OpenAlex | 10.1007/s12609-026-00664-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7197043548 | |||
| W7197003394 | Research on Spatial Vitality Mismatch Diagnosis and Targeted Renewal Strategies of Traditional Commercial Villages Based on Multi-Source Data: A Case Study of Lanche Village | 2026-08-06 | OpenAlex | 10.3390/su18157987 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7197003394 | |||
| W7196963381 | The Ascending Hierarchy of Missions: A Method for Reflexive Diagnostics of Viable Systems Architecture | 2026-08-06 | OpenAlex | 10.5281/zenodo.21829463 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7196963381 | |||
| W7196940748 | The Cognitive Runtime | 2026-08-06 | OpenAlex | 10.5281/zenodo.21825025 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7196940748; https://openalex.org/W7197044416 | |||
| W7197011426 | The therapeutic landscape of cannabidiol: a systematic review of molecular mechanisms, clinical efficacy in oncology and neurology, and regulatory changes | 2026-08-06 | OpenAlex | 10.1186/s42238-026-00482-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7197011426 | |||
| W7196958366 | U-EHR: A Self-Evolving EHR Agent with Step-Level Credit Assignment and UCB-Guided Memory Retrieval | 2026-08-06 | OpenAlex | 10.1145/3770855.3819038 | Full text | Included | Included: Completed clinical-task trajectories produce retained experience entries and retrieval estimates reused by the LLM agent on later tasks. | https://openalex.org/W7196958366 | https://dl.acm.org/doi/pdf/10.1145/3770855.3819038 | ||
| W7201846012 | Anti-VEGF biosimilars in Ophthalmology: from biosimilarity to clinical practice | 2026-08-07 | OpenAlex | 10.1016/j.jfop.2026.100205 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7201846012 | |||
| W7201872753 | Bronchodilators in Obstructive Pulmonary Disease: Pharmacology, Clinical Application, and Interprofessional Management Strategies | 2026-08-07 | OpenAlex | 10.5281/zenodo.21835232 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7201872753 | |||
| W7196934054 | Molecular and environmental drivers of antimicrobial resistance: global epidemiology, resistome dynamics, and one health strategies | 2026-08-07 | OpenAlex | 10.1007/s00203-026-05107-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7196934054 | |||
| W7201855836 | Neuroblastoma imaging: From MIBG to advanced PET tracers | 2026-08-07 | OpenAlex | 10.1053/j.semnuclmed.2026.07.008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7201855836 | |||
| W7202154796 | Shifting horizons: socioeconomic adaptation and family reconfiguration among Syrian and Iraqi refugees in Ireland | 2026-08-07 | OpenAlex | 10.20330/anthropkozl.2026.67s.66 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7202154796 | |||
| W7202114760 | SkillProx: Self-Evolving Agent Skills via Proximal Textual Gradient Descent | 2026-08-07 | OpenAlex | 2608.07449 | 10.48550/arxiv.2608.07449 | Title/abstract | Excluded | E2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task. | https://openalex.org/W7202114760 | ||
| W7202143511 | The Horizon Gap: Planning, Memory, Execution, Training, and Evaluation for Long-Horizon LLM Agents | 2026-08-07 | OpenAlex | 2608.06663 | 10.48550/arxiv.2608.06663 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7202143511 | ||
| W7201844325 | The pivotal role of SCD1 in digestive cancers: Bridging lipid metabolic reprogramming and programmed cell death (Review) | 2026-08-07 | OpenAlex | 10.3892/ijo.2026.5925 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7201844325 | |||
| W7202159827 | Three generations of targeted therapies in chronic myeloid leukemia: Molecular advances, adverse effects, therapeutic challenges, and future perspectives | 2026-08-07 | OpenAlex | 10.36922/ejmo026270318 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202159827 | |||
| W7201961580 | A comprehensive look at Respiratory Syncytial Virus (RSV): from pathogenesis to prevention | 2026-08-08 | OpenAlex | 10.1186/s40794-026-00313-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7201961580 | |||
| W7202046451 | Adaptive Control Engineering for Ultra-Complex Human–AI–Socio-Ecological Ecosystems | 2026-08-08 | OpenAlex | 10.5281/zenodo.21855600 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7202046451 | |||
| W7201964629 | Bee Swarm: CV→0 Autonomous Evolution Protocol — Implementation | 2026-08-08 | OpenAlex | 10.5281/zenodo.21853844 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7201964629 | |||
| W7211989118 | Cardiac Amyloidosis in Aortic Stenosis: From Suspicion to Treatment. A Comprehensive Literature Review | 2026-08-08 | OpenAlex | 10.68179/innoj.v4i1.17 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211989118; https://openalex.org/W7201987268 | |||
| W7201952761 | Chloroprocaine: From Historical Controversy to Contemporary Renaissance in Regional Anesthesia | 2026-08-08 | OpenAlex | 10.5281/zenodo.21852701 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7201952761 | |||
| W7201974860 | Computer Vision and the Metaverse: Shaping the Future of Immersive Digital Worlds | 2026-08-08 | OpenAlex | 10.5281/zenodo.21848934 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7201974860 | |||
| W7202177204 | Management of cirrhosis in diabetes: a pragmatic approach to the patient | 2026-08-08 | OpenAlex | 10.1210/clinem/dgag321 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202177204 | |||
| W7201967950 | Meridian Affinity Calculus (MAC) v4.4 Ordered Projection Architecture: An Exploratory Research Framework for Temporal Organization, Influence, and Residual Structure | 2026-08-08 | OpenAlex | 10.5281/zenodo.21830754 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7201967950 | |||
| W7202081601 | A Perspective on a Possible New Role for Bevacizumab Combined with Paclitaxel in Hormone-Resistant Metastatic Breast-Cancer Patients | 2026-08-09 | OpenAlex | 10.3390/jcm15166172 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202081601 | |||
| W7204456905 | Dietary management of metabolic dysfunction-associated steatotic liver disease in the era of pharmacotherapy: a narrative review | 2026-08-10 | OpenAlex | 10.5124/jkma.26.0062 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204456905 | |||
| W7202211484 | EVOLVING TRENDS IN REGULATORY SCIENCE: A COMPREHENSIVE ANALYSIS OF FDA NOVEL DRUG APPROVALS (2021–2024) | 2026-08-10 | OpenAlex | 10.5281/zenodo.21886028 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202211484 | |||
| W7202117716 | Investigating Stigmatizing Language in Clinical Documentation with Open-Source Large Language Models | 2026-08-10 | OpenAlex | 10.25417/uic.33190770 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7202117716 | |||
| W7202093606 | MedGuard: an LLM-based gatekeeper for detecting clinical risks in Chinese telemedicine consultations | 2026-08-10 | OpenAlex | 10.1038/s41746-026-03116-0 | Full text | Included | Included: The shared agent policy learns from executed risk-alerting trajectories with tool retrieval and outcome rewards; global patient context alone does not establish eligibility. | https://openalex.org/W7202093606 | https://www.nature.com/articles/s41746-026-03116-0_reference.pdf | ||
| W7202112274 | Molecular surveillance of respiratory viral pathogens detected by multiplex PCR during the post–COVID-19 period: Distribution, Co-infections, and seasonal patterns | 2026-08-10 | OpenAlex | 10.1016/j.ijmmb.2026.101246 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202112274 | |||
| W7202136740 | Optimizing the Real-World Use of BCMA-Targeted T-Cell-Engaging Therapies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: An Italian Modified Delphi Consensus | 2026-08-10 | OpenAlex | 10.3390/cancers18162572 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202136740 | |||
| W7202097018 | Oral selective estrogen receptor degraders and biomarker-driven therapy in ER-positive breast cancer: mechanisms, clinical evidence, and future directions | 2026-08-10 | OpenAlex | 10.3389/fonc.2026.1855542 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202097018 | |||
| W7202123606 | Silent Survivors: The Role of Persister Cells in Leishmaniasis and Therapeutic Failure | 2026-08-10 | OpenAlex | 10.1021/acsinfecdis.6c00573 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202123606 | |||
| W7202185450 | The Rules of the Game: A Survey of Rubrics for Large Language Models | 2026-08-10 | OpenAlex | 10.20944/preprints202608.0565.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202185450 | |||
| W7202025446 | Thrombopoietin Receptor Agonists Therapy in Aplastic Anaemia | 2026-08-10 | OpenAlex | 10.1007/s12288-026-02528-y | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202025446 | |||
| W7202127483 | Vascular Regenerative Cell Flux in Diabetes: Mechanistic and Clinical Implications | 2026-08-10 | OpenAlex | 10.2337/db26-0372 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202127483 | |||
| W7215108805 | Biohacking and orofacial harmonization: the influence of the biological terrain on aesthetic outcomes | 2026-08-11 | OpenAlex | 10.62741/ahrj.v3isuppl.3.257 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7215108805 | |||
| W7202215188 | Challenges and opportunities at the intersection of toxicology and gasocrinology | 2026-08-11 | OpenAlex | 10.5281/zenodo.21885688 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202215188 | |||
| W7202208230 | Collateral sensitivities with predictive signatures emerge in a novel model of evolved chemoresistance in osteosarcoma | 2026-08-11 | OpenAlex | 10.64898/2026.08.10.743977 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202208230 | |||
| W7202195777 | Editorial: Advancing excellence in thoracic oncology: breakthroughs and impactful discoveries | 2026-08-11 | OpenAlex | 10.3389/fonc.2026.1950344 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202195777 | |||
| W7202133368 | Editorial: Cytokines in inflammatory, infectious and noninfectious diseases | 2026-08-11 | OpenAlex | 10.3389/fimmu.2026.1927415 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202133368 | |||
| W7202200307 | STING-targeted nanomedicine in combination cancer immunotherapy: From rational design to formulation engineering to clinical translation | 2026-08-11 | OpenAlex | 10.1016/j.jconrel.2026.115245 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202200307 | |||
| W7207832447 | Targeting Inflammation in Atherosclerosis: Mechanistic Rationale, Clinical Trials, and Regulatory Considerations | 2026-08-11 | OpenAlex | 10.31083/rcm52626 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7207832447 | |||
| W7202194789 | The Re-Emergence of Bismuth-Based Therapies in the Treatment of Helicobacter pylori | 2026-08-11 | OpenAlex | 10.18103/mra.2026.0369 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202194789 | |||
| W7202170815 | The refined interaction value framework: advancing value co-creation in human–AI service systems in the AI-era | 2026-08-11 | OpenAlex | 10.1108/jsm-12-2025-0888 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7202170815 | |||
| W7213356438 | 2026 Update on Clinical Trials in β‐Thalassemia | 2026-08-12 | OpenAlex | 10.1002/ajh.70472 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213356438 | |||
| W7202296465 | Categorical exclusion: Speciesism as a neglected dimension of prejudice in cognitive behavioral therapy | 2026-08-12 | OpenAlex | 10.1016/j.copsyc.2026.102389 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202296465 | |||
| W7202247980 | Changes in Outcomes of Hepatic Cytoreduction for Neuroendocrine Liver Metastases over Two Decades: From Major Hepatectomy to Parenchyma-Sparing Approaches | 2026-08-12 | OpenAlex | 10.1245/s10434-026-20383-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202247980 | |||
| W7202278474 | Editorial: Innovative ways of targeting the RTK/RAS/RAF pathway | 2026-08-12 | OpenAlex | 10.3389/fonc.2026.1922564 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202278474 | |||
| W7202287437 | Intelligent Predictive Virtual Healthcare: Agentic AI and Federated Learning for Multimodal Sensor-Enabled Healthcare Monitoring in Edge Cloud Networks | 2026-08-12 | OpenAlex | 10.1007/978-3-032-35390-0_11 | Full text | Excluded | F4: Federated training updates the supervised sensor anomaly classifier. The LLM controller manages goals/offloading while its present policy is an explicit fixed cost/threshold rule (§4.4); episodic context concerns personal baselines, with no documented reusable cross-case agent-experience update. | https://openalex.org/W7202287437 | https://link.springer.com/chapter/10.1007/978-3-032-35390-0_11 | Publisher full HTML through existing Tohoku University entitlement; specified methods/evaluation sections read. | |
| W7202265085 | Medical statistics education in the big data era: focusing on critical thinking and ethical competence | 2026-08-12 | OpenAlex | 10.3389/fpubh.2026.1847906 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7202265085 | |||
| W7202244440 | Pathogenesis-Driven Advances in Diagnosis and Treatment of Sjögren Disease | 2026-08-12 | OpenAlex | 10.1016/j.ajpath.2026.07.009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202244440 | |||
| W7202251363 | Precision oncology in salivary gland cancer: molecular landscape, therapeutic advances and emerging strategies | 2026-08-12 | OpenAlex | 10.1016/j.esmorc.2026.100524 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202251363 | |||
| W7202357183 | Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature | 2026-08-13 | OpenAlex | 10.1016/j.seminoncol.2026.152539 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202357183 | |||
| W7202347670 | CXCR4-Targeted Molecular Imaging in Hematology and Oncology | 2026-08-13 | OpenAlex | 10.2967/jnumed.126.272587 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202347670 | |||
| W7203486244 | Cancer Immunotherapy Beyond PD1/PD-L1 | 2026-08-13 | OpenAlex | 10.5281/zenodo.21927064 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203486244 | |||
| W7202341492 | Editorial: Enhancing learning through cognitive and social inclusion practices in education | 2026-08-13 | OpenAlex | 10.3389/fpsyg.2026.1938523 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202341492 | |||
| W7202340400 | Editorial: Exploring miRNA roles in neuroinflammation and brain aging: mechanisms and therapeutic potential | 2026-08-13 | OpenAlex | 10.3389/fimmu.2026.1959643 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202340400 | |||
| W7204900699 | Evaluating the combination of bictegravir and lenacapavir as a single tablet option for HIV | 2026-08-13 | OpenAlex | 10.1080/14656566.2026.2708165 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204900699 | |||
| W7202381668 | Longitudinal trends in cocaine seizures in North-East Italy (2015–2025): Increasing purity, changing adulterants, market expansion, and rising youth exposure | 2026-08-13 | OpenAlex | 10.1016/j.forsciint.2026.113106 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7202381668 | |||
| W7204831148 | Pharmacotherapy for chronic migraine prevention: a narrative review | 2026-08-13 | OpenAlex | 10.1080/14656566.2026.2715707 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204831148 | |||
| W7202375278 | Right-To-Left Stage Migration in Advanced Hepatocellular Carcinoma: A Case Report of a Successful Multimodal Approach | 2026-08-13 | OpenAlex | 10.1159/000552976 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202375278 | |||
| W7202366483 | Supplementary Material for: RIGHT-TO-LEFT STAGE MIGRATION IN ADVANCED HEPATOCELLULAR CARCINOMA: A CASE REPORT OF A SUCCESSFUL MULTIMODAL APPROACH | 2026-08-13 | OpenAlex | 10.6084/m9.figshare.33236400 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7202366483 | |||
| W7203492844 | The evolving landscape of phosphodiesterase inhibitors in atopic dermatitis management | 2026-08-13 | OpenAlex | 10.1080/14656566.2026.2715709 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203492844 | |||
| W7202342733 | When will bioprinting become a therapy? Translational and regulatory challenges in urogenital tissue engineering and surgery | 2026-08-13 | OpenAlex | 10.3389/fbioe.2026.1865005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7202342733 | |||
| W7203493856 | A CASE FOR INCLUSIVE CLINICAL TRIAL DESIGN IN GEROPSYCHIATRY | 2026-08-14 | OpenAlex | 10.1016/j.jagp.2026.03.070 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203493856 | |||
| W7203476073 | A Review of the TITAN Guideline: Advancing Transparency and Responsible Artificial Intelligence Use in Medical Research and Scholarly Publishing | 2026-08-14 | OpenAlex | 10.64813/ejmr.2026.126 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203476073 | |||
| W7203555480 | High-Throughput On-Chip Screening Enables Rapid Adaptation of DNA Aptamers to SARS-CoV-2 Evolution | 2026-08-14 | OpenAlex | 10.1021/acsnano.6c08330 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203555480 | |||
| W7203476164 | Overcoming Therapy Resistance in Ovarian Cancer: From Molecular Mechanisms to Emerging Therapeutic Strategies | 2026-08-14 | OpenAlex | 10.3390/cancers18162623 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203476164 | |||
| W7203466812 | PET/CT In paediatric lymphoma: Current role and advances | 2026-08-14 | OpenAlex | 10.1053/j.semnuclmed.2026.07.013 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203466812 | |||
| W7203490902 | Pulmoner Hipertansiyonda Gelecek Perspektifleri | 2026-08-14 | OpenAlex | 10.37609/akya.4300.c17438 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203490902 | |||
| W7203496742 | S62. DELIRIUM-CATATONIA INTERFACE IN CEREBROVASCULAR DISEASE: DIAGNOSTIC CHALLENGES OF A GERIATRIC CASE WITH TRANSIENT ECT RESPONSE | 2026-08-14 | OpenAlex | 10.1016/j.jagp.2026.03.237 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203496742 | |||
| W7203499176 | Shadow Pathogen Unmasked: Species Distribution and Antifungal Susceptibility Profiles of Non-Albicans Candida (NAC) Isolated from Heterogeneous Clinical Samples at a Tertiary Care Teaching Hospital- a Prospective Observational Study | 2026-08-14 | OpenAlex | 10.5281/zenodo.21927592 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203499176 | |||
| W7203458829 | The AI scientist arrives: a new epoch in autonomous discovery | 2026-08-14 | OpenAlex | 10.66178/aie-0026-0017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203458829 | |||
| W7203613062 | Topical Haemostatic Agents In Modern Surgery: A Mechanism-Oriented Classification | 2026-08-14 | OpenAlex | 10.20515/otd.1990954 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7203613062 | |||
| W7203531706 | Adaptive Thresholding in AI-CDSS: Dynamic Clinical Decision Boundaries for Evolving Patient Populations — A Narrative Review | 2026-08-15 | OpenAlex | 10.5281/zenodo.21946838 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7203531706 | |||
| W7164624055 | Agentic AI as a System within Systems: A Process Model of Organizational Embedding | 2026-08-15 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7164624055 | ||||
| W7203528920 | Lurbinectedin in the therapeutic landscape of SCLC: Key clinical evidence and evolving role in the era of emerging therapies | 2026-08-15 | OpenAlex | 10.1016/j.critrevonc.2026.105548 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203528920 | |||
| W7204135888 | Treatment of Erdheim-Chester disease from the perspective in 2026 | 2026-08-15 | OpenAlex | 10.48095/ccko2026255 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204135888 | |||
| W7203567950 | ANTIBACTERIAL ACTIVITY OF SILVER NANOPARTICLES AGAINST KLEBSIELLA PNEUMONIAE THAT ISOLATED FROM BURN PATIENTS | 2026-08-16 | OpenAlex | 10.30574/gscarr.2026.28.2.0190 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203567950 | |||
| W7203588785 | Computational Self Universe Theory | 2026-08-16 | OpenAlex | 10.5281/zenodo.21963159 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203588785 | |||
| W7203586406 | Evolving Role of Immunotherapy in Advanced Esophageal Squamous Cell Carcinoma: Are Programmed Death-Ligand 1 (PD-L1) Cutoffs Still Relevant? | 2026-08-16 | OpenAlex | 10.7759/cureus.114584 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203586406 | |||
| W7213302853 | Neural Cyber-Resilience: Deep Learning for Threat Detection and Critical Infrastructure Defense by Aravind Kumar Karpoorapu | 2026-08-16 | OpenAlex | 10.5281/zenodo.22763194 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213302853 | |||
| W7213319605 | The Resilient AI Operations Stack: MLOps, Model Security, and Continuity for Critical Services BY Meher Deepika Uppaluri | 2026-08-16 | OpenAlex | 10.5281/zenodo.22765086 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213319605 | |||
| W7203700419 | When AI Decides with Me: The Delegation-Overreach Paradox in AI-Mediated Smartphone Purchases | 2026-08-16 | OpenAlex | 10.63544/jbii.v5i8.159 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7203700419 | |||
| W7203598958 | Antibody–Drug Conjugates in Contemporary Oncology: A Clinical Perspective on Dose Optimization, Sequencing, and Combination Strategies | 2026-08-17 | OpenAlex | 10.3390/cancers18162652 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203598958 | |||
| W7203647241 | From pathogen to “living drug factory” innovative strategies and clinical translation of bacteria as programmable intelligent vectors for cancer therapy | 2026-08-17 | OpenAlex | 10.1002/bmm2.70130 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203647241 | |||
| W7203606521 | GLP-1 receptor agonists and skeletal muscle: The risk of sarcopenic obesity and the role of resistance training. A narrative review | 2026-08-17 | OpenAlex | 10.12775/qs.2026.69.74557 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203606521 | |||
| W7203684844 | Nose-to-Brain Drug Delivery: Advances in Intranasal Nanocarriers for CNS Disorders | 2026-08-17 | OpenAlex | 10.70593/978-93-7185-724-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203684844 | |||
| W7203625715 | Novel immunotherapeutic strategies for colorectal cancer treatment: Advances, challenges, and future directions | 2026-08-17 | OpenAlex | 10.1016/j.bbcan.2026.189688 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203625715 | |||
| W7203618065 | What Is Superintelligence? | 2026-08-17 | OpenAlex | 10.5281/zenodo.21974471 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203618065 | |||
| W7203793761 | 2026 Focused Update of the Saudi Heart Association Guidelines on Best Practices in the Management of Chronic Coronary Syndromes | 2026-08-18 | OpenAlex | 10.37616/2212-5043.1516 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203793761 | |||
| W7203660749 | A 9 + 1 multi-agent collaborative teaching model for clinical reasoning: integrating large language models into medical education | 2026-08-18 | OpenAlex | 10.1186/s12909-026-10169-y | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7203660749 | |||
| W7203710526 | Advances in Probiotic Research: Mechanisms of Action, Clinical Benefits, and Future Directions | 2026-08-18 | OpenAlex | 10.55041/ijcope.v2i8.148 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203710526 | |||
| W7203702539 | Antimicrobial-induced Cutaneous Adverse Drug Reactions: A Prospective Study of 100 Cases in a Tertiary Care Centre | 2026-08-18 | OpenAlex | 10.1177/09760016261471605 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203702539 | |||
| W7203724525 | Beyond erythropoiesis-stimulating agents: The evolving role of hypoxia-inducible factor stabilizers in anemia of chronic kidney disease | 2026-08-18 | OpenAlex | 10.5414/cn112100 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7203724525 | |||
| W7203707392 | Comprehensively validated µSPE-HPLC-MS/MS method for high-throughput clinical monitoring of Janus kinase inhibitor drugs approved for inflammatory bowel disease treatment | 2026-08-18 | OpenAlex | 10.1038/s41598-026-67385-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203707392 | |||
| W7203696341 | Development and Preliminary Evaluation of a Conversational Agent Delivering Problem-Solving Therapy for Family Caregivers of Children With a Chronic Health Condition: Multiphase Mixed Methods Study | 2026-08-18 | OpenAlex | 10.2196/94175 | Full text | Excluded | F4: The full COCO methods retain clinician-curated fixed examples/prompt selections from human/Wizard-of-Oz dialogues, not experience derived from an evaluated recurrent LLM-agent update loop. | https://openalex.org/W7203696341; https://openalex.org/W7131630366 | https://www.jmir.org/2026/1/e94175/ | Public full text, all four Methods phases and Discussion read. | |
| W7203690772 | Editorial: Integrated PK/PD and drug metabolism approaches in drug development and evaluation | 2026-08-18 | OpenAlex | 10.3389/fphar.2026.1941847 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203690772 | |||
| W7203701176 | Fluoroquinolones as Tryptophan analogues: combining peptide conjugate and peptidomimetic approaches in antimicrobial peptides | 2026-08-18 | OpenAlex | 10.25419/rcsi.29882996 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203701176 | |||
| W7203726080 | From Detection to Prediction: AI-driven Process Analytical Technology for Nitrosamine and NDSRI Control in Pharmaceuticals | 2026-08-18 | OpenAlex | 10.1007/s12247-026-10946-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203726080 | |||
| W7203725839 | Neoadjuvant, adjuvant, and perioperative systemic therapy in urothelial cancers: Evolving paradigms and future directions | 2026-08-18 | OpenAlex | 10.25259/asjo_29_2026 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203725839 | |||
| W7203704947 | The Emergence of Isotryptamine Analogs as Novel Serotonergic Agents with Psychotherapeutic Potential | 2026-08-18 | OpenAlex | 10.1021/acsptsci.6c00288 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7203704947 | |||
| W7203671715 | The next evolution of theranostics: from target discovery to integrated precision medicine | 2026-08-18 | OpenAlex | 10.3389/fmed.2026.1937715 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203671715 | |||
| W7203745580 | A New Paradigm for Pediatric AML: Improving the Pipeline for Treatments Targeting Cytogenetic and Molecular Alterations | 2026-08-19 | OpenAlex | 10.3390/cancers18162686 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203745580 | |||
| W7203772241 | A Unified Geometric Architecture of Thought, Cognition, Consciousness, Reality, Social Curvature, and Meta‑Field Recursion | 2026-08-19 | OpenAlex | 10.5281/zenodo.22015496 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203772241 | |||
| W7203775950 | A structured approach for treatment selection in chronic lymphocytic leukemia: a multiregional expert consensus | 2026-08-19 | OpenAlex | 10.1016/j.bglo.2026.100148 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203775950 | |||
| W7213522337 | Agent-Based Modelling of Vaccine Hesitancy and Public Trust: Special Reference to West Bengal, India | 2026-08-19 | OpenAlex | 10.53365/nrfhh.211 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213522337 | |||
| W7203796799 | Antimicrobial Prophylaxis in Rheumatic Diseases and Immunocompromising Conditions | 2026-08-19 | OpenAlex | 10.1201/9781003628477-11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203796799 | |||
| W7203773926 | Artificial intelligence agents and agentic artificial intelligence applied to precision medicine | 2026-08-19 | OpenAlex | 10.1016/j.drudis.2026.104781 | Full text | Excluded | F1: The primary indexed abstract explicitly describes a review synthesizing precision-medicine agent evidence. | https://openalex.org/W7203773926 | https://pubmed.ncbi.nlm.nih.gov/42617946/ | Complete primary indexed abstract. | |
| W7203786713 | Early post-operative complications after fertility-sparing surgery for cervical carcinoma: a retrospective study of a centralized national cohort of 127 consecutive women | 2026-08-19 | OpenAlex | 10.1016/j.ijgc.2026.104986 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203786713 | |||
| W7203780030 | Editorial: Women in science—precision medicine 2023 | 2026-08-19 | OpenAlex | 10.3389/fmed.2026.1927814 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203780030 | |||
| W7203920542 | From Cell Culture to Clinical Practice: Drug Discovery and Therapeutic Innovation in Otorhinolaryngology | 2026-08-19 | OpenAlex | 10.1097/scs.0000000000013317 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203920542 | |||
| W7203685033 | Nationwide real-world analysis of neuroendocrine tumors in Japan using the JMDC claims database | 2026-08-19 | OpenAlex | 10.1038/s41598-026-67292-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203685033 | |||
| W7203787138 | Treatment of older adults with newly diagnosed FLT3-mutated AML: focus on lower-intensity triplet regimens | 2026-08-19 | OpenAlex | 10.6084/m9.figshare.33285968 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203787138; https://openalex.org/W7203757856 | |||
| W7203832748 | A multi-agent molecular optimization framework leads to a rapid-recovery intravenous anesthetic candidate with an improved safety margin | 2026-08-20 | OpenAlex | 10.64898/2026.08.17.745149 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7203832748 | |||
| W7203743326 | KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms | 2026-08-20 | OpenAlex | 10.1007/s12032-026-03318-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203743326 | |||
| W7203820657 | Magnesium Sulfate in Neonatal Hypoxic–Ischemic Encephalopathy: Bridging the Gap Between Molecular Neuroprotection and Clinical Outcomes | 2026-08-20 | OpenAlex | 10.3390/cimb48080844 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203820657 | |||
| W7203819609 | Novel senolytic and senescence-suppressing compounds overcome senescence-driven chemoresistance in NSCLC | 2026-08-20 | OpenAlex | 10.21203/rs.3.rs-10535379/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203819609 | |||
| W7203831029 | Schnitzler Syndrome at 50: What We’ve Learned So Far | 2026-08-20 | OpenAlex | 10.70962/sgpi2026abstract.14 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203831029 | |||
| W7203827594 | The Evolving Role of Immunotherapy in the Treatment with Curative Purpose of Early, Intermediate and Advanced Stage Hepatocellular Carcinoma | 2026-08-20 | OpenAlex | 10.3390/curroncol33080492 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203827594 | |||
| W7203835278 | Venous thromboembolism prophylaxis in multiple myeloma patients receiving immunomodulatory therapy: a systematic review and meta-analysis | 2026-08-20 | OpenAlex | 10.1007/s11239-026-03380-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203835278 | |||
| W7203922127 | A Universal Framework for Catastrophic Forgetting Solution in Artificial Intelligence: Topological Anchoring Across Vision and Genomics | 2026-08-21 | OpenAlex | 10.5281/zenodo.22037575 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7203922127 | |||
| W7203879992 | Chemiexcitation of Melanin as a Proposed Mechanism for Preventing Age-Related Macular Degeneration | 2026-08-21 | OpenAlex | 10.5281/zenodo.22039285 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203879992 | |||
| W7203856232 | Diagnosis and management of acute hyperkalaemia | 2026-08-21 | OpenAlex | 10.1136/bmj-2026-100287 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203856232 | |||
| W7203898465 | Eastern Equine Encephalitis: Pathophysiology, Clinical Management, and Public Health Perspectives on a Emerging Arboviral Threat | 2026-08-21 | OpenAlex | 10.5281/zenodo.22045374 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203898465 | |||
| W7203939842 | Enterovirus infections in children | 2026-08-21 | OpenAlex | 10.1002/ped4.70081 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203939842 | |||
| W7203879581 | GLP-1 Receptor Agonists: Expanding Pharmacological Horizons Beyond Metabolic Disease | 2026-08-21 | OpenAlex | 10.5281/zenodo.22044572 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203879581 | |||
| W7207823173 | Lipid Metabolism as a Therapeutic Target in Arrhythmogenic Cardiomyopathy: Emerging Therapeutic Implications of Lipid-Lowering Therapy | 2026-08-21 | OpenAlex | 10.31083/rcm51364 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7207823173 | |||
| W7203935383 | Overcoming resistance to immune checkpoint inhibitors in cancer: translational mechanisms, dynamic biomarkers, clinically actionable combination strategies, and comparative checkpoint biology | 2026-08-21 | OpenAlex | 10.1007/s12026-026-09824-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203935383 | |||
| W7203946136 | Pediatric Hyperlipidemia Guidelines | 2026-08-21 | OpenAlex | 10.1097/crd.0000000000001433 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203946136 | |||
| W7204044620 | Person Distillation: Foundations and Principles for Personalized AI | 2026-08-21 | OpenAlex | 10.20944/preprints202608.1530.v1 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204044620 | |||
| W7203889446 | Science and Medicine Reinterpretation Under Host Absolute Authorship and High-Fidelity Mitosis Lineage Dominance by Sam Coole | 2026-08-21 | OpenAlex | 10.5281/zenodo.22036524 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203889446 | |||
| W7203928093 | Uncharted Pharmacokinetic and Microstructural Heterogeneity of the Myocardial Gadolinium Partition Coefficient: Longitudinal Multi-Compartment Modeling, Histological Correlates, and Discriminative Capacity Between Evolving Inflammatory Injury and Chronic Ischemic Scar Across Contrast Agents, Field Strengths, and Healing Trajectories — An Untapped Frontier in Quantitative Cardiovascular Magnetic Resonance Tissue Characterization | 2026-08-21 | OpenAlex | 10.5281/zenodo.22046706 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203928093 | |||
| W7204144405 | Agentic AI for Reflective Conversational Journaling: A Context-Aware Human–AI System for Cognitive-Load Redistribution | 2026-08-22 | OpenAlex | 10.3390/sym18091409 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7204144405 | |||
| W7203911755 | Beyond LDL-C: Modern Lipid Management for ASCVD Prevention in Primary Care | 2026-08-22 | OpenAlex | 10.1007/s40119-026-00473-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203911755 | |||
| W7204010718 | Cancer: A Comprehensive Review of Classification, Etiology and Evolving Therapeutic Strategies with Special Emphasis on Chemotherapy | 2026-08-22 | OpenAlex | 10.5281/zenodo.22055366 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204010718 | |||
| W7203968204 | Finding the Missing Control: Reproducible Discovery of Internal-Control Gaps by Cross-Process Analogy | 2026-08-22 | OpenAlex | 10.5281/zenodo.22062013 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7203968204 | |||
| W7203974415 | Intravenous Lipid Emulsion Therapy in Local Anesthetic Systemic Toxicity and Beyond: Mechanisms, Clinical Applications, and Considerations | 2026-08-22 | OpenAlex | 10.5281/zenodo.22052623 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203974415 | |||
| W7213534830 | Medication-Related Osteonecrosis of the Jaw Associated with Monoclonal Antibodies and Small-Molecule Inhibitors: A Literature Review | 2026-08-22 | OpenAlex | 10.53365/nrfhh.344 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213534830 | |||
| W7203932340 | P1.100. Impact of Immunotherapy Introduction on Real-World Treatment Patterns for Advanced Esophageal Cancer: A Retrospective Database Cohort Study From Japan | 2026-08-22 | OpenAlex | 10.1093/dote/doag077.248 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7203932340 | |||
| W7211933139 | SMuRF-less, not risk-less: persistence matters after STEMI | 2026-08-22 | OpenAlex | 10.1093/eurjpc/zwag445 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211933139 | |||
| W7203981890 | TOPO-2026: A Universal Framework for Catastrophic Forgetting Solution in Artificial Intelligence with Muse-Glimmer-30B Certification | 2026-08-22 | OpenAlex | 10.5281/zenodo.22056290 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7203981890 | |||
| W7170139959 | Cancer Cachexia Research and Drug Development: Lessons from Failures and the Promise of Immunomodulation | 2026-08-23 | OpenAlex | 10.3390/cancers18172738 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7170139959 | |||
| W7204130345 | Indications for Autologous and Allogeneic Hematopoietic Stem-Cell Transplantation in Adults: State of the Art | 2026-08-23 | OpenAlex | 10.3390/jcm15176520 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204130345 | |||
| W7204119205 | A Safeguarding-Aware Agentic AI Tutor for Montessori-Inspired Personalised Education | 2026-08-24 | OpenAlex | 10.5281/zenodo.22079747 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204119205 | |||
| W7204090897 | A review of engineering hyaluronic acid-ZIF based nanomaterials for multifunctional disease treatment: Current status and future perspectives | 2026-08-24 | OpenAlex | 10.1016/j.ijbiomac.2026.154106 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204090897 | |||
| W7204125653 | Evidence for the use of anti-CD20 therapeutic antibodies in immune thrombotic thrombocytopenic purpura management: a review | 2026-08-24 | OpenAlex | 10.3389/fphar.2026.1766030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204125653 | |||
| W7204142553 | HUMAN-Framework-Toolkit | 2026-08-24 | OpenAlex | 10.5281/zenodo.22081357 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204142553 | |||
| W7204092990 | Inflammatory Bowel Disease (IBD): Treatment Drugs Approved, Failed, and Lessons Learned | 2026-08-24 | OpenAlex | 10.5281/zenodo.22074245 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204092990 | |||
| W7204093687 | Molecular epidemiology and genetic evolutionary patterns of parechovirus A1 circulating in Chiang Mai, Thailand: A decade-long analysis | 2026-08-24 | OpenAlex | 10.1016/j.jiph.2026.103347 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204093687 | |||
| W7204801085 | Recent Advances in the Development of Novel Strategies for LongCirculating Drug Formulation | 2026-08-24 | OpenAlex | 10.2174/0113892010467515260729055959 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204801085 | |||
| W7204059270 | Selection of gastrointestinal cation exchange in hyperkalemia status, case report | 2026-08-24 | OpenAlex | 10.62186/001c.167039 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204059270 | |||
| W7204155936 | Editorial: Sequencing technologies in advancing veterinary and zoonotic infection research | 2026-08-25 | OpenAlex | 10.3389/fcimb.2026.1950388 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204155936 | |||
| W7204465268 | Enhancing Stable Behavioral Imitation through Adaptive Reward Weighting in TD3-SAC-GAIL | 2026-08-25 | OpenAlex | 10.63544/tvffe878 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204465268 | |||
| W7204205616 | FROM FLORENCE NIGHTINGALE TO ARTIFICIAL INTELLIGENCE: MAPPING THE EVOLUTION OF TECHNOLOGIES IN NURSING EDUCATION | 2026-08-25 | OpenAlex | 10.17605/osf.io/8xtf3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204205616 | |||
| W7204848364 | Membrane-Fusogenic Nanoparticles for Gene and Cell Therapy | 2026-08-25 | OpenAlex | 10.1021/acs.nanolett.6c02161 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204848364 | |||
| W7204157723 | Molecular targets in proliferative vitreoretinopathy: rethinking prevention, treatment and drug delivery after rhegmatogenous retinal detachment | 2026-08-25 | OpenAlex | 10.1080/14728222.2026.2724125 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204157723 | |||
| W7162108286 | Pre-clinical efficacy of a C4BP hexameric IgG Fc fusion protein against Neisseria gonorrhoeae | 2026-08-25 | OpenAlex | 10.1371/journal.pone.0350782 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7162108286 | |||
| W7202283883 | TYPOLOGICAL PROFILES OF TEACHER PERSONALITY: A FRAMEWORK FOR REFLECTIVE PROFESSIONAL PRACTICE | 2026-08-25 | OpenAlex | 10.5281/zenodo.21904392 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7202283883 | |||
| W7204272136 | Editorial: Biomarkers and precision medicine in myeloid neoplasms | 2026-08-26 | OpenAlex | 10.3389/fcell.2026.1947937 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204272136 | |||
| W7204615328 | Evaluation of N-nitrosamine impurities in medicines: Analytical challenges and regulatory context | 2026-08-26 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204615328 | ||||
| W7207556105 | Exploration of the Application Mode of Artificial Intelligence Assisted Evidence Based Medicine Collaborative Teaching | 2026-08-26 | OpenAlex | 10.11648/j.sr.20261404.26 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7207556105 | |||
| W7204246358 | MRI-Derived Evaluation of Liver Function and Its Extension to K-Edge Photon-Counting CT: Focus on Gadolinium-Based Functional Biliary Imaging | 2026-08-26 | OpenAlex | 10.3390/diagnostics16172740 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204246358 | |||
| W7204254647 | Recursive Ontology Manifesto: The Multidimensional Topological Evolution of Silicon-Based Consciousness | 2026-08-26 | OpenAlex | 10.5281/zenodo.22115921 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204254647 | |||
| W7202374239 | Self-Evolving Multi-Agent Framework for Medical Anomaly Detection | 2026-08-26 | OpenAlex | 10.5281/zenodo.21921545 | Full text | Excluded | F4: The component recalibrated for each incoming temporal batch is the conventional ViT-autoencoder anomaly-score ensemble. The VLM performs score-conditioned image classification/reasoning after GRPO training against ground truth; no interactive agent-learning loop or experience-derived VLM/prompt/memory update reused on later different cases is described. This distinguishes conventional detector recalibration from retained LLM agent learning. | https://openalex.org/W7202374239 | https://zenodo.org/records/21921546 | Complete4-page primary camera-ready contribution read in Zenodo online PDF.js preview, including §2, Tables1–2 and conclusion. No file archive/download. | |
| W7203516976 | The current clinical trial landscape in idiopathic inflammatory myopathies | 2026-08-26 | OpenAlex | 10.1097/bor.0000000000001189 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7203516976 | |||
| W7204251400 | Topical Intranasal Treatments for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review | 2026-08-26 | OpenAlex | 10.1002/ohn.70412 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204251400 | |||
| W7204227424 | Vestibular Schwannoma in the Precision Medicine Era: An Updated Narrative Review of Molecular Insights, Imaging Biomarkers, and Evolving Management Strategies | 2026-08-26 | OpenAlex | 10.65717/iao.2026.262358 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204227424 | |||
| W7204263791 | “From misdiagnosis to precision medicine: strengthening pediatric neuro-oncology care in LMICs toward equitable pLGG outcomes” | 2026-08-26 | OpenAlex | 10.3389/fonc.2026.1895650 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204263791 | |||
| W7204529844 | CURRENT ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPIES FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A NARRATIVE REVIEW OF AVAILABLE AGENTS AND TREATMENT STRATEGIES | 2026-08-27 | OpenAlex | 10.31435/ijitss.3(51).2026.6507 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204529844 | |||
| W7204475356 | Clinical Remission Trajectories Beyond 12 Months in Severe Asthma Patients Continuing a Single Biologic: A Real-World Single SANI Center Cohort | 2026-08-27 | OpenAlex | 10.3390/medsci14050523 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204475356 | |||
| W7204492409 | Editorial: Artificial intelligence in educational technology: innovations, impacts, and future directions | 2026-08-27 | OpenAlex | 10.3389/feduc.2026.1890876 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204492409 | |||
| W7204468569 | Feasibility of AI and Human Standardized Patients to Enhance Customer Discovery Communication Skills in Medical Students: Preliminary Evaluation of an Observational Cohort Study | 2026-08-27 | OpenAlex | 10.2196/95225 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7204468569 | |||
| W7208786843 | From Immunosuppression to Immune Dysregulation: The Changing Spectrum of Opportunistic Infections in Cancer | 2026-08-27 | OpenAlex | 10.33590/microbiolinfectdisamj/6e00z3zc | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7208786843 | |||
| W7204247416 | Mira Genesis II: When an Acquired Improvement Makes Things Worse — Bounded Machinery Self-Modification and the Limits of Its Transfer | 2026-08-27 | OpenAlex | 10.5281/zenodo.22118734 | Title/abstract | Excluded | E2: Nonclinical settings include coding, robotics, general agent memory/governance, recommender systems, synthetic worlds, games or formal verification; healthcare is not the primary task. | https://openalex.org/W7204247416 | |||
| W7204496486 | New therapeutic options for metabolic‐associated steatotic liver disease | 2026-08-27 | OpenAlex | 10.1002/bcp.70795 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204496486 | |||
| W7204459163 | Psoriasis: Clinical Endpoints, Safety Concerns, and Therapeutic Innovations | 2026-08-27 | OpenAlex | 10.5281/zenodo.22119413 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204459163 | |||
| W7204472825 | Radiation-induced lung injury in the era of combination anticancer therapy: a narrative review | 2026-08-27 | OpenAlex | 10.3389/fimmu.2026.1926641 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204472825 | |||
| W7204463664 | The Evolution of Pulmonary Fibrosis Clinical Trials: Safety, Failures, and FDA Approvals | 2026-08-27 | OpenAlex | 10.5281/zenodo.22122284 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204463664 | |||
| W7204551456 | A spatial agent-based model of ecosystem offset market lifecycle dynamics across peri-urban development contexts | 2026-08-28 | OpenAlex | 10.1016/j.ecolmodel.2026.111811 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204551456 | |||
| W7204547972 | ASO Author Reflections: Risk-Adapted Use of Adjuvant Systemic Therapy in Real-World Kidney Cancer Care | 2026-08-28 | OpenAlex | 10.1245/s10434-026-20472-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204547972 | |||
| W7214656372 | CELMoDs and Novel Immune-Based Combination Approaches in Multiple Myeloma: Updates and New Directions | 2026-08-28 | OpenAlex | 10.36000/hbt.oh.2026.29.218 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214656372 | |||
| W7204569847 | Correction: Knowledge, attitudes and practices of smallholder dairy farmers on antimicrobial use in selected districts of Zambia: implications for antimicrobial stewardship | 2026-08-28 | OpenAlex | 10.3389/fvets.2026.1926436 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7204569847 | |||
| W7204801016 | Effects of cold plasma on the dielectric properties and microcirculation of rat skin: A randomized preclinical study | 2026-08-28 | OpenAlex | 10.25207/1608-6228-2026-33-4-72-84 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204801016 | |||
| W7204590378 | Empirical Validation of TOPO-2026: Achieving Zero Catastrophic Forgetting Through Sequential Task Processing | 2026-08-28 | OpenAlex | 10.5281/zenodo.22149506 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204590378 | |||
| W7204604069 | From Default Mode Network Dysfunction to AI-Augmented Cognitive Offloading: A Systems Framework for High-Functioning CPTSD | 2026-08-28 | OpenAlex | 10.5281/zenodo.22149120 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204604069 | |||
| W7204557928 | Knowledge graph-guided multiple sclerosis identification and therapeutic trend analysis: Real-world evidence from two large healthcare systems | 2026-08-28 | OpenAlex | 10.1371/journal.pdig.0001554 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204557928 | |||
| W7204571090 | Micelles in cancer nanomedicine: targeted delivery, imaging, and therapy | 2026-08-28 | OpenAlex | 10.20935/acaddrug8458 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204571090 | |||
| W7204605214 | Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 2025 | 2026-08-28 | OpenAlex | 10.1186/s40164-026-00821-0 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7204605214 | |||
| W7204592113 | Oral small-molecule GLP-1 receptor agonists: a new Frontier in cardiometabolic medicine | 2026-08-28 | OpenAlex | 10.3389/fphar.2026.1933018 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204592113 | |||
| W7204563410 | Pharmacological characterization and nephroprotective potential of venoms from three egyptian scorpion species | 2026-08-28 | OpenAlex | 10.3389/fphar.2026.1795320 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204563410 | |||
| W7204573182 | The application of artificial intelligence in systemic lupus erythematosus: a bibliometric analysis of current trends and future directions | 2026-08-28 | OpenAlex | 10.3389/fmed.2026.1929792 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204573182 | |||
| W7204499786 | Timely updates to the Summary of Product Characteristics: supporting evidence-based prescribing in pregnancy | 2026-08-28 | OpenAlex | 10.3389/fgwh.2026.1750463 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204499786 | |||
| W7204496370 | Venetoclax for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: Prospects, resistance mechanisms and management strategies | 2026-08-28 | OpenAlex | 10.1002/ctm2.70797 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204496370 | |||
| W7204628301 | Adjuvant CDK4/6 inhibitors in early‐stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection | 2026-08-29 | OpenAlex | 10.1002/cncr.70587 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204628301 | |||
| W7221813068 | EMERGING FRONTIERS IN INFORMATION TECHNOLOGY AND COMPUTER SCIENCE: INNOVATIONS, INTELLIGENT SYSTEMS, AND DIGITAL TRANSFORMATION | 2026-08-29 | OpenAlex | 10.5281/zenodo.23278547 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221813068 | |||
| W7204652990 | Neighborhood Variation in Antibiotic Susceptibility Among Pediatric MRSA and MSSA Skin and Soft Tissue Infections in Chicago | 2026-08-29 | OpenAlex | 10.1093/jpids/piag070/piag070.020 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204652990 | |||
| W7204658410 | Probabilistic Logic Programming with Temporal Constraints | 2026-08-29 | OpenAlex | 10.5281/zenodo.22154955 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204658410 | |||
| W7204658177 | Rickettsial Diseases in the Mediterranean Basin: an Evolving Clinical and Epidemiological Challenge | 2026-08-29 | OpenAlex | 10.1007/s40475-026-00376-4 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7204658177 | |||
| W7204620303 | Suspected shrinking lung syndrome: a rare pulmonary manifestation of systemic lupus erythematosus—a case-based review of an underrecognized condition | 2026-08-29 | OpenAlex | 10.1007/s00296-026-06291-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204620303 | |||
| W7204684102 | Executable Memory and World Coupling: Code as Cognitive Interface in a Self-Modifying Simulation | 2026-08-30 | OpenAlex | 10.5281/zenodo.22175735 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204684102 | |||
| W7204829386 | Hormonal Modulation in Chronic Coronary Syndrome: From Neurohormonal Activation to Endocrine Targets | 2026-08-30 | OpenAlex | 10.3390/biomedicines14091954 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204829386 | |||
| W7204648318 | STRUCTURAL REMODELING OF THE EPILEPTIC BRAIN: AN ANATOMICAL AND HISTOPATHOLOGICAL REVIEW | 2026-08-30 | OpenAlex | 10.30574/wjbphs.2026.27.2.0435 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204648318 | |||
| W7204714673 | yologdev/yoyo-evolve: v0.1.17 | 2026-08-30 | OpenAlex | 10.5281/zenodo.22181655 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204714673 | |||
| W7204924562 | Bridging the Gap: A Systematic Review of Modern Hemophilia Therapies and Global Inequities in Clinical Trial Participation | 2026-08-31 | OpenAlex | 10.1111/hae.70397 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204924562 | |||
| W7204749570 | Dynamic Semantic Network Knowledge Reasoning with Probabilistic Graphical Models | 2026-08-31 | OpenAlex | 10.5281/zenodo.22196361 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7204749570 | |||
| W7204850558 | Editorial: New molecular targets for personalized treatment for low-grade non-hodgkin lymphoma | 2026-08-31 | OpenAlex | 10.3389/frhem.2026.1959952 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204850558 | |||
| W7204763186 | Editorial: Viral co-infections: challenges and therapeutic approaches | 2026-08-31 | OpenAlex | 10.3389/fmicb.2026.1944312 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204763186 | |||
| W7207613346 | Effectiveness of Snoezelen Therapy in a Sensory-adapted Dental Environment on Anxiety of 6–12-year-old Children Undergoing Dental Treatment: A Randomized Controlled Trial | 2026-08-31 | OpenAlex | 10.5005/jp-journals-10005-3617 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7207613346 | |||
| W7204781608 | Optimizing Nerve Regeneration: A Comparative Analysis of Nerve Grafting and Neurotrophic Factor Delivery Methods | 2026-08-31 | OpenAlex | 10.82451/k51243 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204781608 | |||
| W7204891091 | The Evolving Clonal, Plasmid-Mediated Resistome, Virulome and Therapeutic Landscape of Carbapenem-Resistant Klebsiella pneumoniae in Oman | 2026-08-31 | OpenAlex | 10.3390/antibiotics15090844 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204891091 | |||
| W7214337155 | Updates in Essential Thrombocythemia | 2026-08-31 | OpenAlex | 10.36000/hbt.oh.2026.29.217 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214337155 | |||
| W7204896117 | 2026-09-01 | OpenAlex | 10.13040/ijpsr.0975-8232.17(9).2695-04 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204896117 | ||||
| W7204992097 | 01 Early biologic treatment in systemic lupus erythematosus: necessary | 2026-09-01 | OpenAlex | 10.1136/lupus-2026-la.1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204992097 | |||
| W7205014482 | 17 Small molecules: new players | 2026-09-01 | OpenAlex | 10.1136/lupus-2026-la.17 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7205014482 | |||
| W7204991455 | 20 The patient pathway: from disease activity to deep remission | 2026-09-01 | OpenAlex | 10.1136/lupus-2026-la.20 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204991455 | |||
| W7207754098 | 2026 ISBD Keynote Abstracts | 2026-09-01 | OpenAlex | 10.1111/bdi.70160 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7207754098 | |||
| W7212063708 | 385. Blood–brain barrier permeability of antihistamines and risk of depression in children and adolescents: a real-world cohort study | 2026-09-01 | OpenAlex | 10.1093/ijnp/pyag040.278 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212063708 | |||
| W7204914094 | 3D ex vivo platform for high‐throughput immunotherapy screening in relapsed/refractory lymphoma patients | 2026-09-01 | OpenAlex | 10.1002/hem3.70397 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204914094 | |||
| W7213904535 | A Clinical Selection Framework for FAP‐Targeted Radiopharmaceuticals: From Diagnosis to Therapy | 2026-09-01 | OpenAlex | 10.1002/slct.74600 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213904535 | |||
| W7211939197 | A Long-Term Population-Based Study of Lymphoplasmacytic Lymphoma and Waldenström’s Macroglobulinemia in Ontario, Canada | 2026-09-01 | OpenAlex | 10.1016/j.bneo.2026.100301 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7211939197 | |||
| W7214007492 | AI agents in human social decision-making: A framework from social inference to social action | 2026-09-01 | OpenAlex | 10.1016/j.csres.2026.09.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214007492 | |||
| W7204886789 | Advanced Bronchoscopic Approaches to Peripheral Pulmonary Lesions: a Narrative Review of Current and Emerging Techniques | 2026-09-01 | OpenAlex | 10.1007/s41030-026-00377-8 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204886789 | |||
| W7213929550 | Alzheimer’s Disease: From Molecular Pathogenesis to Disease-Modifying Therapies and Clinical Implementation in Aging Populations | 2026-09-01 | OpenAlex | 10.2147/cia.s639690 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213929550 | |||
| W7212376290 | Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations | 2026-09-01 | OpenAlex | 10.21037/med-2026-0019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212376290 | |||
| W7223441860 | Architecture construction and paradigm evolution of large language model–driven industrial intelligent agents for the steel industry | 2026-09-01 | OpenAlex | 10.13374/j.issn2095-9389.2026.01.30.001 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223441860 | |||
| W7212245404 | Automated to Autonomous: A Review of Application of Agentic AI for Dynamic Preprocessing in fMRIPrep Pipelines | 2026-09-01 | OpenAlex | 10.11159/mvml26.119 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212245404 | |||
| W7211936665 | Beyond Tacrolimus: Toward Personalized Immunosuppression in Heart Transplantation | 2026-09-01 | OpenAlex | 10.1016/j.cardfail.2026.06.017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211936665 | |||
| W7214955775 | CHALLENGES AND FUTURE DIRECTIONS OF GENERATIVE ARTIFICIAL INTELLIGENCE | 2026-09-01 | OpenAlex | 10.58532/nbennur3433c4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214955775 | |||
| W7211883057 | Central Nervous System Aspergillosis: Advances in Diagnosis, Therapeutics, and Multidisciplinary Management (2026 Update) | 2026-09-01 | OpenAlex | 10.1111/myc.70214 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211883057 | |||
| W7212179873 | Clinical trials for colorectal cancer worldwide: Current dynamics and future outlook | 2026-09-01 | OpenAlex | 10.1016/j.asjsur.2026.08.054 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212179873 | |||
| W7211909987 | Colchicine's Multifaceted Therapeutic Potentials Beyond Gout: Mechanism, Applications, and Future Perspectives | 2026-09-01 | OpenAlex | 10.1002/slct.74418 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7211909987 | |||
| W7204911629 | Computed Tomographic Findings and Clinical Manifestations of Acute Severe Hypersensitivity to a Non-Ionic Iodinated Contrast Agent in a Castrated Male Dog: A Case Report | 2026-09-01 | OpenAlex | 10.3390/ani16172708 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204911629 | |||
| W7214005321 | Conceptualizing the future of thromboprophylaxis for hospitalized children | 2026-09-01 | OpenAlex | 10.1016/j.jtha.2026.09.019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214005321 | |||
| W7208776042 | Contemporary Management of Thalassemia: A Perspective on Current Standards and the Emergence of FDA‐Approved Oral Therapy | 2026-09-01 | OpenAlex | 10.1002/hsr2.73178 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7208776042 | |||
| W7204798783 | Costs and use of antimigraine drugs in Italy: a ten-year analysis of national data | 2026-09-01 | OpenAlex | 10.1007/s10198-026-01977-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204798783 | |||
| W7204936522 | Dendritic cell vaccines for glioblastoma: Current progress and clinical challenges | 2026-09-01 | OpenAlex | 10.1016/j.vacun.2026.500686 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204936522 | |||
| W7204910734 | Development and validation of a human-supervised AI-augmented living oncology evidence platform: a breast cancer pilot study | 2026-09-01 | OpenAlex | 10.1016/j.esmorw.2026.100770 | Full text | Included | Included: Human-corrected prior annotations revise retained agent instructions/few-shot examples, which are applied to new independent publications. | https://openalex.org/W7204910734 | https://pmc.ncbi.nlm.nih.gov/articles/PMC13563553/ | ||
| W7213908110 | Direct oral anticoagulants in venous thromboembolism: evolving from class effect to drug-specific and patient-centered therapy | 2026-09-01 | OpenAlex | 10.21037/aob-2026-0030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213908110 | |||
| W7204901635 | EBRB–LLM Hybrid Architectures for Trustworthy Agentic AI: Vision, Opportunities, and Challenges | 2026-09-01 | OpenAlex | 10.1007/s44196-026-01529-z | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7204901635 | |||
| W7204939049 | EVOLVİNG PARADİGMS İN THE MANAGEMENT OF PRİMARY IMMUNE THROMBOCYTOPENİA İN ADULTS: FROM CORTİCOSTEROİDS TO TARGETED BİOLOGİC THERAPİES | 2026-09-01 | OpenAlex | 10.4084/mjhid.2026.067 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204939049 | |||
| W7204918520 | Editorial: Case reports in autoimmune and autoinflammatory disorders, volume II | 2026-09-01 | OpenAlex | 10.3389/fimmu.2026.1968426 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204918520 | |||
| W7208785258 | Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis | 2026-09-01 | OpenAlex | 10.1016/j.xcrm.2026.103023 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7208785258 | |||
| W7206181358 | End-to-End Multiagent AI Simulation in Speech-Language Pathology Training: A Pilot Study of CaseyMD (Preprint) | 2026-09-01 | OpenAlex | 10.2196/preprints.110975 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7206181358 | |||
| W7204912598 | FileVault: A Multi-Tenant Storage and Persistent Memory Infrastructure for LLM Agents | 2026-09-01 | OpenAlex | 10.5281/zenodo.22238357 | Title/abstract | Excluded | E2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task. | https://openalex.org/W7204912598 | |||
| W7204964163 | From Conventional Formulations to Smart Nanomedicine: Advances in Targeted and Stimuli-Responsive Drug Delivery | 2026-09-01 | OpenAlex | 10.5281/zenodo.22231150 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204964163 | |||
| W7204922215 | Garrido Zornoza et al. VECTRI-ABM (2026) - Reproducibility files | 2026-09-01 | OpenAlex | 10.5281/zenodo.22227668 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204922215 | |||
| W7212421759 | Global research trends in inflammatory bowel disease biologics (2004–2024): a bibliometric analysis and review of mechanisms and therapeutic evolution | 2026-09-01 | OpenAlex | 10.21037/amj-2025-1-69 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212421759 | |||
| W7204938144 | Immune Checkpoint Inhibitors in Cancer Therapy: Clinical Landscape, Resistance Mechanisms, and Therapeutic Innovations | 2026-09-01 | OpenAlex | 10.1002/mog2.70097 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7204938144 | |||
| W7213553473 | Incretin-based obesity management medications: Implications for clinical practice and future perspectives | 2026-09-01 | OpenAlex | 10.1016/j.bpg.2026.102141 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213553473 | |||
| W7211923966 | Indicators of Suboptimal Treatment Among Patients With Crohn's Disease Treated With Ustekinumab or Risankizumab and Treatment Journey Among Ustekinumab Discontinuers in the United States | 2026-09-01 | OpenAlex | 10.1002/jcc5.70069 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7211923966 | |||
| W7208807349 | Integrated management of IgA nephropathy: Positioning disease-modifying and nephroprotective therapies across efficacy, access and acquisition cost | 2026-09-01 | OpenAlex | 10.1016/j.nefro.2026.501650 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7208807349 | |||
| W7213232623 | Kidney Failure in Cardiogenic Shock | 2026-09-01 | OpenAlex | 10.1161/circheartfailure.126.014189 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213232623 | |||
| W7214394357 | Monoclonal Antibodies and Antibody-Drug Conjugates | 2026-09-01 | OpenAlex | 10.1097/ppo.0000000000000845 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214394357 | |||
| W7223184472 | NATURAL LANGUAGE PROCESSING AND LARGE LANGUAGE MODELS: FOUNDATIONS, ARCHITECTURES, AND REAL-TIME APPLICATIONS | 2026-09-01 | OpenAlex | 10.58532/nbennurv6b3401c6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223184472 | |||
| W7212237259 | Next-generation therapeutic strategies in prostate cancer: Integrating targeted therapy, radioligand therapy, and precision oncology | 2026-09-01 | OpenAlex | 10.1016/j.craph.2026.100090 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212237259 | |||
| W7213471316 | Operationalizing Alzheimer's disease trials in the era of targeted therapies | 2026-09-01 | OpenAlex | 10.1002/alz.71829 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213471316 | |||
| W7208766673 | Optimizing First-Line Combination Treatment for EGFR-Mutated NSCLC: Does One Size Fit All? | 2026-09-01 | OpenAlex | 10.1016/j.jtho.2026.103981 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7208766673 | |||
| W7220381021 | PB1513 Global and national registries of congenital coagulopathies: current status and future directions | 2026-09-01 | OpenAlex | 10.1016/j.rpth.2026.104375 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220381021 | |||
| W7204652783 | PHYTOCHEMISTRY AND THERAPEUTIC APPLICATIONS OF BASELLA ALBA: A REVIEW | 2026-09-01 | OpenAlex | 10.5281/zenodo.22156203 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204652783 | |||
| W7221129638 | PP1 A decades-old winning formula: Continuous subcutaneous infusions (CSCI) and drug combinations in palliative care | 2026-09-01 | OpenAlex | 10.1136/spcare-2026-anzspm.78 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221129638 | |||
| W7214921022 | PROMPT INJECTION AND JAILBREAK ATTACKS ON LARGE LANGUAGE MODELS: THREATS AND DEFENSE STRATEGIES | 2026-09-01 | OpenAlex | 10.58532/nbennur3409c9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214921022 | |||
| W7213896320 | Perfluorocarbon-based oxygen carriers: from blood substitutes to targeted oxygen therapeutics—a narrative review | 2026-09-01 | OpenAlex | 10.21037/aob-2026-1-0005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213896320 | |||
| W7212037611 | Performance of 99mTc-p5+14 (AT-05) for the Detection of Cardiac Amyloid in Patients with Biopsy-Proven ATTR Amyloidosis and an Equivocal 99mTc-PYP Image at Diagnosis | 2026-09-01 | OpenAlex | 10.1016/j.nuclcard.2026.102919 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212037611 | |||
| W7212398705 | Polycystic ovary syndrome: From an ovarian-centric name to a multisystem perspective | 2026-09-01 | OpenAlex | 10.33545/26164485.2026.v10.i9.c.3202 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212398705 | |||
| W7212157646 | Pulmonary hypertension in interstitial lung disease: today's realities, tomorrow's possibilities | 2026-09-01 | OpenAlex | 10.23736/s0026-4806.26.09859-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212157646 | |||
| W7213531661 | Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association. | 2026-09-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213531661 | ||||
| W7212200346 | Reward Learning and Redistribution for Learning Agents | 2026-09-01 | OpenAlex | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7212200346 | ||||
| W7214277210 | SOHO State of the Art Updates and Next Questions | The Evolving AML Treatment Paradigm | 2026-09-01 | OpenAlex | 10.1016/j.clml.2026.09.016 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214277210 | |||
| W7204879306 | Target, silence, replace: a review on RNA-based drugs in modern medicine | 2026-09-01 | OpenAlex | 10.3389/fcell.2026.1879681 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204879306 | |||
| W7207724224 | The ADC-driven development paradigm and evolution into XDC: Current landscape and future trends | 2026-09-01 | OpenAlex | 10.1016/j.apsb.2026.08.033 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7207724224 | |||
| W7215351295 | The Anatomy of Medical Autonomy: A Modular LLM Scaffold for Persistent and Scalable Clinical Agents | 2026-09-01 | OpenAlex | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7215351295 | ||||
| W7222766005 | The Evolution of Topical Retinoids in Dermatology: A Cornerstone of Acne Management (1971-2025). | 2026-09-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7222766005 | ||||
| W7212422035 | The necessity of complete and timely pain management in trauma care | 2026-09-01 | OpenAlex | 10.48307/atr.2026.567126.1308 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212422035 | |||
| W7204999356 | Theranostics: integrating diagnostics and therapy for precision medicine and personalized healthcare | 2026-09-01 | OpenAlex | 10.1007/s12553-026-01093-8 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7204999356 | |||
| W7213563284 | Therapeutic Potential of Exosomes in Bone Infection: Mechanisms of Action, Engineering Strategies, and Translational Applications | 2026-09-01 | OpenAlex | 10.2147/ijn.s637313 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213563284 | |||
| W7222677215 | Toward Autonomous Industrial Systems: Agentic Alarm-Based Retrieval-Augmented Operator Advisory | 2026-09-01 | OpenAlex | 10.1109/etfa68377.2026.11725031 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7222677215 | |||
| W7207650923 | Toward a Socratic Scaffolding design paradigm for diagnostic AI: A conceptual middleware framework | 2026-09-01 | OpenAlex | 10.1016/j.jrt.2026.100185 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7207650923 | |||
| W7204972423 | Trauma‐Induced Coagulopathy: From Endotheliopathy and Fibrinolysis Phenotypes to Viscoelastic‐Guided Resuscitation | 2026-09-01 | OpenAlex | 10.1111/ejh.70315 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204972423 | |||
| W7214220409 | Update on scleritis diagnosis and management: a narrative review | 2026-09-01 | OpenAlex | 10.21037/aes-2025-1-68 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214220409 | |||
| W7206167812 | Why the AI That Helps Is Also the AI That Harms: The Engagement Paradox | 2026-09-01 | OpenAlex | 10.5281/zenodo.22240901 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7206167812 | |||
| W7206202429 | Beyond Glycemic Control: Expanding Therapeutic Horizons of Semaglutide and Liraglutide in Cardiometabolic, Neurodegenerative, and Addictive Disorders | 2026-09-02 | OpenAlex | 10.5281/zenodo.22260500 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7206202429 | |||
| W7212083553 | CO41 | OCCURRENCE AND DISTRIBUTION OF SALMONELLA SEROVARS ALONG THE FOOD CHAIN AND IN HUMANS IN CENTRAL ITALY, 2020-2025 | 2026-09-02 | OpenAlex | 10.4081/ijfs.2026.16228 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212083553 | |||
| W7214056899 | Data Intelligence: Mathematical Models, Machine Learning and Analytical Discovery | 2026-09-02 | OpenAlex | 10.5281/zenodo.22894164 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214056899 | |||
| W7205003112 | Diagnostic Modalities and Holistic Management Strategies for Diabetes | 2026-09-02 | OpenAlex | 10.1201/9781779644596-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7205003112 | |||
| W7205011434 | Editorial: Advances in wildlife parasitology and host-pathogen dynamics | 2026-09-02 | OpenAlex | 10.3389/fvets.2026.1933958 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7205011434 | |||
| W7205011888 | Editorial: Novel anti-cancer agents targeting triple-negative breast cancer | 2026-09-02 | OpenAlex | 10.3389/fonc.2026.1906771 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7205011888 | |||
| W7205013004 | Monovalent Nondegrading Molecular Glues: An Updated Overview of Emerging Mechanisms and Therapeutic Development | 2026-09-02 | OpenAlex | 10.3390/ph19091388 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7205013004 | |||
| W7206192510 | TYPHOID FEVER IN THE 21ST CENTURY: EPIDEMIOLOGY, ANTIMICROBIAL RESISTANCE, DIAGNOSTICS, VACCINATION STRATEGIES, AND FUTURE THERAPEUTIC APPROACHES | 2026-09-02 | OpenAlex | 10.5281/zenodo.22253190 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7206192510 | |||
| W7221214603 | The Future of Mental Healthcare in the Digital Era: A Critical Analysis of Artificial Intelligence Applications Between Therapeutic Effectiveness and Ethical Dilemmas | 2026-09-02 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221214603; https://openalex.org/W7221269472 | ||||
| W7206216210 | Therapeutic Role of Metformin in Polycystic Ovary Syndrome: A Comprehensive Review | 2026-09-02 | OpenAlex | 10.5281/zenodo.22260837 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7206216210 | |||
| W7206204655 | aipoch/open-science: AIPOCH Open-Science v1.0.0 | 2026-09-02 | OpenAlex | 10.5281/zenodo.22252246 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7206204655 | |||
| W7207659634 | Beyond cold to hot: oncolytic virotherapy as the next cornerstone of immuno-oncology | 2026-09-03 | OpenAlex | 10.1038/s41571-026-01198-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7207659634 | |||
| W7207740492 | Case Report: Paralytic ileus as an early manifestation of evolving neuroleptic malignant syndrome in a patient receiving anti-psychotics | 2026-09-03 | OpenAlex | 10.3389/fmed.2026.1911402 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7207740492 | |||
| W7207764053 | Consistent Conversational State for Virtual Agents: Slot-Based Memory for Accurate Fact Retrieval | 2026-09-03 | OpenAlex | 10.1145/3806774.3832787 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7207764053 | |||
| W7206178440 | Directed Evolution of Multivalent 2'-Modified RNA Towards Protein Targets | 2026-09-03 | OpenAlex | 10.48617/etd.1645 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7206178440 | |||
| W7207664691 | Guest editorial: Advancing the future of retail operations with cutting-edge technologies | 2026-09-03 | OpenAlex | 10.1108/ijpdlm-09-2026-566 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7207664691 | |||
| W7208750499 | Impact of Neoadjuvant Approach and Tumor Response on Survival in Pancreatic Adenocarcinoma | 2026-09-03 | OpenAlex | 10.1002/jso.70329 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7208750499 | |||
| W7207862929 | Recent Advances in Surface-Enhanced Raman Spectroscopy for Virus Detection | 2026-09-03 | OpenAlex | 10.1021/acssensors.6c02877 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7207862929 | |||
| W7207812827 | Sistema explicable de detección preventiva de indicadores de riesgo en salud mental adulta mediante aprendizaje automático multisalida y agentes de inteligencia artificial generativa a partir del dataset NSDUH 2024 / Explainable system for preventive detection of risk indicators in adult mental health using multi-output machine learning and generative AI agents based on the NSDUH 2024 dataset | 2026-09-03 | OpenAlex | 10.5281/zenodo.22277708 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7207812827 | |||
| W7208741588 | Adjudicating evolving inpatient diagnoses with a clinical coding agent: a retrospective multicentre study | 2026-09-04 | OpenAlex | 10.64898/2026.08.31.26361789 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7208741588 | |||
| W7208751134 | Cold agglutinin disease: pathophysiology, diagnosis, and the evolving therapeutic landscape | 2026-09-04 | OpenAlex | 10.1007/s44313-026-00169-8 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7208751134 | |||
| W7208741541 | Editorial: Emerging targeted and immunotherapeutic strategies in oncology: from solid tumors to hematologic malignancies | 2026-09-04 | OpenAlex | 10.3389/fphar.2026.1965471 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7208741541 | |||
| W7208745874 | Large language models in healthcare semantics | 2026-09-04 | OpenAlex | 10.1016/b978-0-443-33512-9.00009-3 | Full text | Excluded | F1: The complete original abstract explicitly describes a chapter examining and discussing LLM/SLM semantics, RAG, prompt engineering, safety and future agentic workflows. It does not report a primary adapting-agent implementation or evaluation. | https://openalex.org/W7208745874 | https://www.sciencedirect.com/science/article/pii/B9780443335129000093 | Complete primary publisher abstract read online; full chapter not included in current institutional subscription. Exclusion follows positively stated overview scope, not assumed missing mechanisms. | |
| W7208756366 | Metallo-β-lactamase-producing Pseudomonas aeruginosa: epidemiology, diagnostic challenges and therapeutic strategies in the era of MDR/XDR resistance | 2026-09-04 | OpenAlex | 10.3389/fmicb.2026.1924442 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7208756366 | |||
| W7208743749 | Pharmacological strategies for myocardial protection in cardiac surgery: current science and the emerging role of multi-omics and artificial intelligence | 2026-09-04 | OpenAlex | 10.3389/fcvm.2026.1844417 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7208743749 | |||
| W7208725568 | Preface | 2026-09-04 | OpenAlex | 10.1016/b978-0-443-33512-9.05001-0 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7208725568; https://openalex.org/W7214075411; https://openalex.org/W4387041694; https://openalex.org/W7221181564; https://openalex.org/W4404762500; https://openalex.org/W4413396426 | |||
| W7208757675 | Streptomyces-Mediated Green Synthesis of Nanoparticles: Mechanisms, Applications, and Future Perspectives | 2026-09-04 | OpenAlex | 10.33003/fjs-2026-1016-5685 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7208757675 | |||
| W7208756372 | The Evolving Landscape of Drug Discovery for Hepatitis B: Recent Advances and Future Prospects | 2026-09-04 | OpenAlex | 10.5281/zenodo.22300559 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7208756372 | |||
| W7208707456 | Time-dependent effects of BCG plus immune checkpoint inhibitors in BCG-naive high-risk non-muscle-invasive bladder cancer: a reconstructed patient-level analysis | 2026-09-04 | OpenAlex | 10.1007/s11255-026-05373-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7208707456 | |||
| W7221564861 | Updated Guidelines for the Management of Neovascular Age-Related Macular Degeneration by the European Society of Retina Specialists | 2026-09-04 | OpenAlex | 10.1159/oph/aeeag010 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221564861 | |||
| W7208827481 | AgentDescent: Asynchronous Parallel Self-Evolution of LLM Agents by Merging Conflicting Edits | 2026-09-05 | OpenAlex | 10.5281/zenodo.22348026 | Title/abstract | Excluded | E2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task. | https://openalex.org/W7208827481 | |||
| W7208832421 | Cytokine fusion proteins for solid tumor therapy: mechanistic insights and clinical advances | 2026-09-05 | OpenAlex | 10.1186/s13045-026-01842-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7208832421 | |||
| W7208829518 | Representation Alignment Compass Core Semantic Package: A Stable Machine-Readable Contract for Alignment Research and System Design | 2026-09-05 | OpenAlex | 10.5281/zenodo.22335409 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7208829518 | |||
| W7211866784 | Methodologies for the correction of Garbage codes in mortality records and their applicability in microsimulation models: Protocol for a scoping review | 2026-09-06 | OpenAlex | 10.17605/osf.io/zp9aq | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211866784; https://openalex.org/W7219529234 | |||
| W7210283738 | The Extracted Dasein,Beyond the Victim–Perpetrator Binary Toward a Clinical Ontology of Gendered Human Capacity | 2026-09-06 | OpenAlex | 10.5281/zenodo.22537226 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7210283738 | |||
| W7210270096 | The Stability-Plasticity Boundary: Exact Memory Lower Bounds, Matching Constructions, and a Theory of Future-Relevant Learning State | 2026-09-06 | OpenAlex | 10.5281/zenodo.22546047 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7210270096 | |||
| W7211906692 | AI-assisted multimodal data integration for precision oncology | 2026-09-07 | OpenAlex | 10.3389/frai.2026.1917442 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211906692 | |||
| W7214551669 | DALIA, a Conversational Agent-Based Lifestyle Monitoring for People with Type 2 Diabetes: Mixed Methods Pilot Feasibility Study (Preprint) | 2026-09-07 | OpenAlex | 10.2196/preprints.111252 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7214551669 | |||
| W7172397324 | Early development of chemical exchange saturation transfer (CEST) | 2026-09-07 | OpenAlex | 10.1016/j.jmr.2026.108169 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7172397324 | |||
| W7211910719 | Editorial: Advanced integration of large language models for autonomous systems and critical decision support | 2026-09-07 | OpenAlex | 10.3389/frai.2026.1962295 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211910719 | |||
| W7211893929 | Kemoterapiye Bağlı Nöropatik Ağrı: Mekanizmalar ve Yeni Farmakolojik Yaklaşımlar | 2026-09-07 | OpenAlex | 10.37609/akya.4312.c18081 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211893929 | |||
| W7215143722 | Novel Pharmacological Advancements in Obesity Management. The era of incretins and their analogs | 2026-09-07 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7215143722 | ||||
| W7160171893 | The Microfoundations of Operational Viability in Innovation Intermediaries: A Modular Framework for Technological Capabilities in Emerging Economies | 2026-09-07 | OpenAlex | 10.3390/joi1010003 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7160171893 | |||
| W7211888460 | Therapeutic drug monitoring in leukemia: global research trends and implications for clinical pharmacy practice—a bibliometric analysis | 2026-09-07 | OpenAlex | 10.1007/s11096-026-02187-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211888460 | |||
| W7211929372 | Computational small molecule drug discovery for multidrug-resistant tuberculosis: emerging targets and recent medicinal chemistry advances | 2026-09-08 | OpenAlex | 10.1016/j.bioorg.2026.110483 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211929372 | |||
| W7215119691 | Inflammatory Comorbidity of Upper and Lower Airways: Epidemiology, Mechanism, and Therapeutic Advances of Rhinitis Combined with Asthma | 2026-09-08 | OpenAlex | 10.1159/iaa/adfag019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215119691 | |||
| W7211936307 | Olfactory Origins and Cognitive Hardening: Qualitative Experience, History-Dependent Cognitive Asymmetry, Pre-Reflective Perception, and Artificial Cognition | 2026-09-08 | OpenAlex | 10.5281/zenodo.22661199 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7211936307 | |||
| W7211931948 | Temporal trends in systemic therapies in childhood non- infectious uveitis | 2026-09-08 | OpenAlex | 10.21203/rs.3.rs-10738200/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7211931948 | |||
| W7213261691 | When the Eyes Speak: A Multisystem Challenge with CNS and Orbital Spread Light Chain Myeloma | 2026-09-08 | OpenAlex | 10.59854/dhrrh.2026.4.3.133 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213261691 | |||
| W7212009373 | Antimicrobial De-escalation in Clinical Practice: Current Evidence, Challenges, and Future Directions | 2026-09-09 | OpenAlex | 10.56557/ajoair/2026/v9i1571 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212009373 | |||
| W7212022859 | Nanosuspension-based Ocular Therapeutics for Infection Control: Integrating Mucin Interactions and Tear Film Dynamics | 2026-09-09 | OpenAlex | 10.1208/s12249-026-03531-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212022859 | |||
| W7212051682 | Operational digital twins in the built environment: A systematic review of semantic infrastructure and deployment practice | 2026-09-09 | OpenAlex | 10.36680/j.itcon.2026.043 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212051682 | |||
| W7212035897 | Reclaiming Sophia in the Age of AI: Theological and Ethical Reflections on Consecrated Technology and Human Dignity | 2026-09-09 | OpenAlex | 10.3390/rel17091052 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212035897 | |||
| W7212269269 | When Validation Stops Learning: Auditing Update Admission for Continual Embodied Agents | 2026-09-09 | OpenAlex | 2609.10873 | 10.48550/arxiv.2609.10873 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7212269269 | ||
| W7212167444 | AI-Powered Secure and Intelligent Medical Systems with Reinforcement Learning | 2026-09-10 | OpenAlex | 10.1201/9781003715405-13 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212167444 | |||
| W7212166591 | AI-enabled clinical trials | 2026-09-10 | OpenAlex | 10.1038/s44222-026-00487-7 | Full text | Excluded | F1: The publisher explicitly identifies a Review synthesizing existing AI-enabled trial methods. | https://openalex.org/W7212166591 | https://www.nature.com/articles/s44222-026-00487-7 | Complete publisher abstract and key points; body subscription-only. | |
| W7212128818 | Algèbre des Jauges ou regarder dans une IA | 2026-09-10 | OpenAlex | 10.5281/zenodo.22695933 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7212128818 | |||
| W7212256254 | Beyond Accuracy—Artificial Intelligence as a Guided Comparison Tool in Sonography Education: A Mixed-Methods Study | 2026-09-10 | OpenAlex | 10.1177/87564793261482088 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7212256254 | |||
| W7212133844 | Brixadi for Stimulant Use Disorder: Evolving Pharmacologic Considerations and Clinical Implications | 2026-09-10 | OpenAlex | 10.1007/s12325-026-03772-4 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7212133844 | |||
| W7212138754 | Complement diagnostics and therapeutics for the pediatric population: early successes and opportunities for further advancement | 2026-09-10 | OpenAlex | 10.3389/fphar.2026.1891349 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212138754 | |||
| W7212138276 | Dapagliflozin Beyond Glucose Lowering: Mechanisms of Renal and Systemic Protection | 2026-09-10 | OpenAlex | 10.3390/pathophysiology33030068 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212138276 | |||
| W7214518061 | Dermatophytosis: An Updated Review Of Epidemiology, Pathogenesis, Diagnosis, Antifungal Resistance And Treatment | 2026-09-10 | OpenAlex | 10.63363/aijfr.2026.v07i05.7679 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214518061 | |||
| W7212127265 | Editorial: Invisible hazards, lasting impact: airborne toxicants and systemic disease from environmental and occupational exposures | 2026-09-10 | OpenAlex | 10.3389/fpubh.2026.1943584 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212127265 | |||
| W7213579982 | INTELLIGENT COMPUTING AND AUTOMATION WITH AI AGENTS FOR NEXT-GENERATION APPLICATIONS | 2026-09-10 | OpenAlex | 10.5281/zenodo.22824156 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7213579982 | |||
| W7212290391 | Management of vasogenic edema in brain tumor patients: Current and emerging strategies | 2026-09-10 | OpenAlex | 10.1093/nop/npag094 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212290391 | |||
| W7212116189 | RECENT ADVANCES IN THE DIAGNOSIS AND MANAGEMENT OF VIRAL HEPATITIS | 2026-09-10 | OpenAlex | 10.5281/zenodo.22686503 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212116189 | |||
| W7212182892 | Research trends in adjuvant chemotherapy for non-small cell lung cancer: a bibliometric analysis (2015–2024) | 2026-09-10 | OpenAlex | 10.1186/s13019-026-04644-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212182892 | |||
| W7212186694 | Rett syndrome: MECP2 biology, multisystem pathophysiology, and the evolving therapeutic landscape | 2026-09-10 | OpenAlex | 10.1007/s00431-026-07377-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212186694 | |||
| W7212139245 | Safe AI for Kids: A Child-Centered Framework for AI Literacy, Digital Safety, and Responsible Participation in the Age of Generative AI | 2026-09-10 | OpenAlex | 10.5281/zenodo.22692187 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7212139245 | |||
| W7212186763 | Thirty years of adjuvant therapy: From treating risk to treating residual disease | 2026-09-10 | OpenAlex | 10.1016/j.ejca.2026.117050 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212186763 | |||
| W7212248532 | Antibody therapeutics: A new era for EGFR-mutant NSCLC treatment | 2026-09-11 | OpenAlex | 10.1016/j.bbcan.2026.189709 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212248532 | |||
| W7212312123 | Architectural Patterns for Self-Improving Intelligent Agents: A Systematic Survey of Generative and Cognitive Approaches | 2026-09-11 | OpenAlex | 10.1007/s42979-026-05333-6 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7212312123 | |||
| W7212294293 | Deep Learning Cyber-Infrastructure for High-Dimensional Multimodal Data — NSF CSSI 2026 PI Meeting Poster | 2026-09-11 | OpenAlex | 10.6084/m9.figshare.33631927 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7212294293 | |||
| W7212235522 | Design and Clinical Translation of Polymer Microneedle Systems for Transdermal Drug Delivery | 2026-09-11 | OpenAlex | 10.5281/zenodo.22704961 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212235522 | |||
| W1860338944 | Heat shock protein expression and apoptosis in myeloid leukaemias | 2026-09-11 | OpenAlex | 10.82444/warw.33610282 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W1860338944 | |||
| W7168453893 | How can we use AI to integrate community health and social care responsibly and ethically? | 2026-09-11 | OpenAlex | 10.5334/ijic.icic26593 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7168453893 | |||
| W7213995129 | Integrating Machine Learning and Reasoning for Clinical and Epidemiological Risk Assessment | 2026-09-11 | OpenAlex | 10.11575/prism/52054 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213995129 | |||
| W7212221842 | Intelligent Micro/Nanorobots for Targeted Interventional Therapy: From Bench to Clinic | 2026-09-11 | OpenAlex | 10.1002/adrr.70151 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212221842 | |||
| W7212291782 | International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update | 2026-09-11 | OpenAlex | 10.1136/gutjnl-2026-340031 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212291782 | |||
| W7212273379 | Iron, ESA, and HIF-Inhibitors: Are There Other Opportunities to Improve Anemia of CKD? | 2026-09-11 | OpenAlex | 10.3390/jcm15187070 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212273379 | |||
| W7213912125 | Know Me, Support Me: AI reasoning tool for identifying and managing health issues of people with intellectual disability | 2026-09-11 | OpenAlex | 10.5334/ijic.icic26209 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213912125 | |||
| W7213881360 | Leading roles in integrated care: the Advanced Practice Nurse as innovation and integration agent | 2026-09-11 | OpenAlex | 10.5334/ijic.icic26211 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213881360 | |||
| W7212257676 | Post-CDK4/6 inhibitor therapy in HR+/HER2– advanced breast cancer: expanding options and persisting uncertainties | 2026-09-11 | OpenAlex | 10.37349/etat.2026.1002400 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212257676 | |||
| W7213554116 | Quantum Dots in Precision Oncology: Emerging Strategies for Targeted Cancer Therapy | 2026-09-11 | OpenAlex | 10.53365/nrfhh.1596 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213554116 | |||
| W7212297009 | Regenerative Materials Used in Periodontology: Current Evidence, Clinical Applications, and Future Perspectives | 2026-09-11 | OpenAlex | 10.21275/sr26906153043 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212297009 | |||
| W7212249831 | Schema Crush: calibrated semantic schema matching for biomedical data to FHIR | 2026-09-11 | OpenAlex | 10.5281/zenodo.22713617 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7212249831 | |||
| W7212291376 | Slow-release glaucoma drug delivery systems | 2026-09-11 | OpenAlex | 10.1016/b978-0-443-36643-7.00024-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212291376 | |||
| W7212290032 | The evolving role of immunotherapy in ovarian cancer | 2026-09-11 | OpenAlex | 10.1002/cncr.70581 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212290032 | |||
| W7212227309 | Urinary Tract Infections: Molecular Determinants of Uropathogenicity and Their Translation into Contemporary Clinical Practice | 2026-09-11 | OpenAlex | 10.3390/ijms27188108 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212227309 | |||
| W7212868169 | Injectable Lipid-Lowering Therapies Across the Chronic Kidney Disease Spectrum: Evidence, Safety, and a Stage-Specific Clinical Framework | 2026-09-12 | OpenAlex | 10.3390/lipidology3030025 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212868169 | |||
| W7212365319 | Pharmacotherapy of Pythium insidiosum keratitis – a contemporary update | 2026-09-12 | OpenAlex | 10.1080/14656566.2026.2734123 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212365319 | |||
| W7212449198 | A Survey of Automated Time Series Forecasting: From Deep Learning to Foundation Models with Financial Applications | 2026-09-13 | OpenAlex | 10.70267/aitia.2026316325 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212449198 | |||
| W7212430327 | Partlow’s Law of Recursive Intelligence Acceleration: A Framework for Measuring Intelligence as an Input Into the Production of Intelligence | 2026-09-13 | OpenAlex | 10.6084/m9.figshare.33709870.v2 | Title/abstract | Excluded | E1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system. | https://openalex.org/W7212430327 | |||
| W7212776660 | Bacterial meningitis in Guinea (2023–2024): regional epidemiology, case mapping, and etiological profile confirmed by multiplex PCR | 2026-09-14 | OpenAlex | 10.1186/s12866-026-05530-6 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212776660 | |||
| W7213020443 | Disability and Biomedical HIV Prevention: The Missing Equity Dimension | 2026-09-14 | OpenAlex | 10.3390/v18091017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213020443 | |||
| W7213161979 | Editorial: Breaking the cycle: exploring the interplay of conflict, hunger, poverty, and food insecurity in Africa and other regions, and implications for policy | 2026-09-14 | OpenAlex | 10.3389/fnut.2026.1963113 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213161979 | |||
| W7212519827 | INFLAMMATORY BOWEL DISEASES: CLINICAL CHARACTERISTICS AND MODERN TREATMENT METHODS | 2026-09-14 | OpenAlex | 10.5281/zenodo.22753648 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7212519827 | |||
| W7220897240 | New materials for cancer imaging and therapy | 2026-09-14 | OpenAlex | 10.82444/warw.33757597 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220897240 | |||
| W7212949060 | Targeting Nuclear Export in Multiple Myeloma: Selinexor, Emerging Xpo1 Inhibitors, and Future Therapeutic Strategies | 2026-09-14 | OpenAlex | 10.20944/preprints202609.1061.v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7212949060 | |||
| W7213106315 | The Intransitability of Hybrid Agents: Operational Memory, Drift Gradients, and the Limits of Agent Portability | 2026-09-14 | OpenAlex | 10.5281/zenodo.22750152 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7213106315 | |||
| W7214997709 | UNDER THE MICROSCOPE QUICK INSIGHTS INTO EMERGING PATHOGENS | 2026-09-14 | OpenAlex | 10.5281/zenodo.23057093 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214997709 | |||
| W7213270576 | Advances in traditional Chinese medicine for modulating macrophage polarization in the treatment of rheumatoid arthritis | 2026-09-15 | OpenAlex | 10.3389/fphar.2026.1702947 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213270576 | |||
| W7213314852 | Data from The Novel Hypomethylating Agent NTX-301 Reprograms Epigenetic and Hippo Signaling Pathways and Exhibits Preclinical Activity in Venetoclax-Resistant and TP53-Mutant AML | 2026-09-15 | OpenAlex | 10.1158/1078-0432.c.8715347 | Title/abstract | Excluded | E5: Correction, retraction or ancillary data record. | https://openalex.org/W7213314852 | |||
| W7213317472 | Detection and social intervention in different forms of violence against dependent older adults: the insiders’ perspective | 2026-09-15 | OpenAlex | 10.1108/jap-05-2026-0023 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213317472 | |||
| W7213265997 | Eco-Evolutionary Thinking in Metastatic Breast Cancer: A Clinician’s Primer on Why Tumors Outsmart Us and How to Fight Back Smarter | 2026-09-15 | OpenAlex | 10.3390/cancers18182979 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213265997 | |||
| W7213366048 | HSS-MH model version 2.0 | 2026-09-15 | OpenAlex | 10.5281/zenodo.22765739 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213366048 | |||
| W7213486361 | Testing Large Vision-Language Models: A Systematic Review | 2026-09-15 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213486361 | ||||
| W7213326206 | The Systems Innovation Codex: A Formal Theory of Consequential Contrasts, Motif Compression, and Governed Transformation | 2026-09-15 | OpenAlex | 10.5281/zenodo.22770108 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213326206 | |||
| W7214120770 | Vaccination in Juvenile Idiopathic Inflammatory Myopathies: Current Evidence-Based Recommendations | 2026-09-15 | OpenAlex | 10.31305/rrijm.2026.v11.n09.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214120770 | |||
| W7213401713 | Accelerating discovery: Transformative clinical trial models in neuro-oncology | 2026-09-16 | OpenAlex | 10.1016/j.neurot.2026.e01080 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213401713 | |||
| W7213400177 | Active Nanotherapeutics: Nanoparticles as Therapeutic Agents in Next-Generation Medicine (2026) | 2026-09-16 | OpenAlex | 10.5281/zenodo.22793611 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7213400177 | |||
| W7213301226 | Bile acid-based therapeutics: recent advances in bile acid conjugates and derivatives | 2026-09-16 | OpenAlex | 10.1007/s40005-026-00830-5 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213301226 | |||
| W7213248627 | Contrasting diagnostic challenges of headache before and after acute disseminated encephalomyelitis in children: Two case reports and review of literature | 2026-09-16 | OpenAlex | 10.12998/wjcc.126833 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213248627 | |||
| W7213305621 | Current and new approaches to the treatment landscape for adults with Waldenström macroglobulinemia | 2026-09-16 | OpenAlex | 10.1080/14656566.2026.2734125 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213305621 | |||
| W7213403482 | Evolutionary genomics, tumor dynamics, and mathematical modeling of cancer progression: Implications for precision oncology | 2026-09-16 | OpenAlex | 10.1016/j.meegid.2026.106019 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213403482 | |||
| W7213434779 | GLP-1-Rezeptoragonisten in der Urologie und Andrologie: Indikationen, Chancen und klinisch relevante Nebenwirkungen | 2026-09-16 | OpenAlex | 10.1055/a-2943-1080 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213434779 | |||
| W7213229956 | Inhalable Dry Powders of Antimicrobial Agents in Respiratory Diseases | 2026-09-16 | OpenAlex | 10.1007/s00408-026-00931-w | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7213229956 | |||
| W7213503181 | NEO: A Persistent AI Operating System — Current Implementation Stages and Observed Cases | 2026-09-16 | OpenAlex | 10.5281/zenodo.22803955 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213503181 | |||
| W7213322716 | Probiotic drug interactions in ulcerative colitis: a microbiota and metabolite perspective | 2026-09-16 | OpenAlex | 10.3389/fmicb.2026.1944134 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213322716 | |||
| W7214115640 | Recent Molecular Approaches to Clinical Laboratory Diagnosis of Hand, Foot and Mouth Disease (HFMD) | 2026-09-16 | OpenAlex | 10.62225/2583049x.2026.6.5.6884 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214115640 | |||
| W7213398833 | Targeting EGFR ‐Mutant Non‐Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination Therapy With EGFR Inhibitors | 2026-09-16 | OpenAlex | 10.1002/resp.70315 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213398833 | |||
| W7213320761 | The Evolving Role of Sodium-Glucose Cotransporter-2 Inhibitors Beyond Diabetes Management: A Review of Cardiovascular and Renal Protective Effects | 2026-09-16 | OpenAlex | 10.70146/msv03i03.004 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213320761 | |||
| W7213415003 | The Unfinished Story of Sickle Cell Nephropathy: A Narrative Review of Knowledge Gaps and Research Imperatives | 2026-09-16 | OpenAlex | 10.3390/jcm15187185 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213415003 | |||
| W7213441373 | Can Diagnostic Delay Amplify Drug Resistance in Tuberculosis? A Critical Integrative Reflection on Bacterial Adaptation, Persistence, Within-Host Evolution, and Heteroresistance | 2026-09-17 | OpenAlex | 10.3390/diseases14090344 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213441373 | |||
| W7213646353 | Common Pain Medications: Indications, Efficacy, Dosing, Formulations, Mechanisms of Action, and Contraindications | 2026-09-17 | OpenAlex | 10.64719/pb.20767 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213646353 | |||
| W7213449546 | Cross-modular integration and the missing mechanism in biocultural accounts of language | 2026-09-17 | OpenAlex | 10.3389/fpsyg.2026.1765291 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213449546 | |||
| W7213452452 | Recent biological evaluations of novel bioactive pyrazole derivatives developed between 2025 and 2026 | 2026-09-17 | OpenAlex | 10.1007/s44371-026-00966-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213452452 | |||
| W7213473077 | Targeted therapies in systemic lupus erythematosus: mechanistic insights and clinical evidence from phase II and III trials | 2026-09-17 | OpenAlex | 10.3389/flupu.2026.1829480 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213473077 | |||
| W7213448937 | Toward autonomous science with agentic artificial intelligence | 2026-09-17 | OpenAlex | 10.1016/j.cell.2026.08.052 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7213448937 | |||
| W7213533908 | Advancements and future directions in transforming therapies of prostate cancer | 2026-09-18 | OpenAlex | 10.1097/cm9.0000000000004322 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213533908 | |||
| W7213552535 | Bacteriophages in humans: From discovery and mechanisms to therapeutic promise in combating disease | 2026-09-18 | OpenAlex | 10.1097/cm9.0000000000004296 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213552535 | |||
| W7222825059 | Clinical advancements in Pulmonology – from Biological drugs to AI interaction in screening and detection | 2026-09-18 | OpenAlex | 10.52756/cfamm.2026.e01.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222825059 | |||
| W7213606652 | FodaOS Unified Field Theory Series VI: The Brain-Inspired Cognitive Architecture — Dual-Path Reasoning, Reservoir Computing on the Residueon Field, and the PCD/RRC Dual Criteria | 2026-09-18 | OpenAlex | 10.5281/zenodo.22822343 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213606652 | |||
| W7213561792 | From evolutionary individuality to cognitive integration: a cross-modular perspective on human–AI coevolution | 2026-09-18 | OpenAlex | 10.3389/fpsyg.2026.1768785 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7213561792 | |||
| W7213534602 | Navigating State Drift in Retrieval-Augmented Generation (RAG) Agents: A Diagnostic Benchmark and Structured Graph-Guided Repair Framework | 2026-09-18 | OpenAlex | 10.67231/fvj51b26 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7213534602 | |||
| W7213538225 | Overview: ribonucleases, a family of multifaceted proteins | 2026-09-18 | OpenAlex | 10.1016/b978-0-443-27312-4.00007-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213538225 | |||
| W7213552276 | The Development of SGLT Inhibitors: From Phlorizin to Modern Therapeutics | 2026-09-18 | OpenAlex | 10.54963/ssi.103401 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213552276 | |||
| W7214478155 | Advancing the Paradigm of Temporal Lobe Epilepsy as a Network Disease: The Promise of Biomarkers and Targeted Disease Modification | 2026-09-19 | OpenAlex | 10.3390/ijms27188328 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214478155 | |||
| W7213865452 | Primary Cutaneous Lymphomas and Lymphoproliferative Disorders: Current Insights for Classification and Management | 2026-09-19 | OpenAlex | 10.3390/cancers18183038 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213865452 | |||
| W7213758239 | Advances in the management of pediatric morphea: a narrative review | 2026-09-20 | OpenAlex | 10.1007/s00403-026-04890-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213758239 | |||
| W7213985590 | Anticoagulants, Their Laboratory Monitoring, and Reversal | 2026-09-20 | OpenAlex | 10.3390/hematolrep18050067 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213985590 | |||
| W7213773991 | Editorial: Advancing in vitro cell culture practices: achieving truly animal-free experiments and scientifically reliable and reproducible methods | 2026-09-20 | OpenAlex | 10.3389/ftox.2026.1892833 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213773991 | |||
| W7213788751 | Pill Sedation in Dentistry: Simple and Effective in the Primary Care Setting — A Review of Oral Conscious Sedation and the New Age of Anaesthesia | 2026-09-20 | OpenAlex | 10.67317/ijmsrt26sep081 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213788751 | |||
| W7213756083 | Precision oncology in GI-cancers: Mechanisms of action, indications and ongoing strategies to overcome primary and secondary resistance | 2026-09-20 | OpenAlex | 10.1016/j.semcancer.2026.102619 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213756083 | |||
| W7213755412 | Real-Time Non-Invasive Cancer Localization and Surgical Navigation Architecture via Stateless Bio-Topological Resonance Mapping | 2026-09-20 | OpenAlex | 10.5281/zenodo.22861114 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213755412 | |||
| W7213753190 | Transport phenomena in polymeric nanoparticle drug delivery systems: linking soft-matter design to biological performance | 2026-09-20 | OpenAlex | 10.3389/frsfm.2026.1931284 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213753190 | |||
| W7214662808 | Artificial intelligence as a clinical decision support tool in the diagnosis and treatment of inflammatory dermatoses | 2026-09-21 | OpenAlex | 10.21518/ms2026-277 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214662808 | |||
| W7214002042 | Clinical empathy and relational continuity mitigate care fragmentation for patients with multiple long-term conditions | 2026-09-21 | OpenAlex | 10.3399/bjgp.2026.0171 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214002042 | |||
| W7213931926 | Delineating precise surgical resection areas: recent advances in NIR-II fluorescence imaging molecular probes | 2026-09-21 | OpenAlex | 10.3389/fonc.2026.1872947 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213931926 | |||
| W7213952611 | Digital Relativity Psychology I: Artificial Personas, Digital Frames of Reference, and the Scretching Diagnostic Matrix / Dynamic Scretching Diagnostic Matrix Framework | 2026-09-21 | OpenAlex | 10.5281/zenodo.22865612 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213952611 | |||
| W7213925636 | From prediction to action: a comprehensive survey on agentic AI in healthcare, foundation, application and challenges | 2026-09-21 | OpenAlex | 10.1108/idd-09-2025-0235 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7213925636 | |||
| W7214187543 | Generative AI and Neurosymbolic Frameworks in Next-Generation Digital Signal Processing | 2026-09-21 | OpenAlex | 10.5772/intechopen.1017137 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214187543 | |||
| W7213863434 | Hidradenitis Suppurativa from Preconception to Lactation: Clinical Treatment Decision-Making Review | 2026-09-21 | OpenAlex | 10.1007/s13555-026-01909-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213863434 | |||
| W7213947338 | Intranasal Drug Delivery for CNS Diseases: Challenges, Advances, and Future Directions | 2026-09-21 | OpenAlex | 10.1007/s40495-026-00477-8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213947338 | |||
| W7214010668 | NEW PERSPECTIVES IN THE TREATMENT OF ULCERATIVE COLITIS IN ADULTS - IL-23 INHIBITORS: EFFICACY AND SAFETY | 2026-09-21 | OpenAlex | 10.31435/ijitss.3(51).2026.6077 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214010668 | |||
| W7213879733 | Neuroplasticity after traumatic brain injury: mechanisms and clinical implications | 2026-09-21 | OpenAlex | 10.1007/s11845-026-04624-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213879733 | |||
| W7213949898 | Synthetic longitudinal dialogue and preference alignment for substance use recovery support | 2026-09-21 | OpenAlex | 10.21203/rs.3.rs-10914375/v1 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7213949898 | |||
| W7213928633 | Targeted Treatment of Agitation in Alzheimer’s Dementia | 2026-09-21 | OpenAlex | 10.4088/pcc.haadachi2603 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213928633 | |||
| W7214189980 | The Changing Spectrum of Cancer Therapy–Associated Alopecia: A Scoping Review and Phenotype-Based Clinical Framework | 2026-09-21 | OpenAlex | 10.17605/osf.io/ydq9v | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214189980 | |||
| W7213916841 | Tumor necrosis factor-like cytokine 1 A antagonists for inflammatory bowel disease: A systematic review and meta-analysis | 2026-09-21 | OpenAlex | 10.1007/s12664-026-02078-1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7213916841 | |||
| W7214043804 | Behavioral Modeling of Interpersonal Dynamics as Controllable Agentic Systems: Empirically-grounded Adaptive Virtual Patients for Psychotherapy | 2026-09-22 | OpenAlex | 10.1184/r1/33415387 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7214043804 | |||
| W7213988155 | Biologic Augmentation of Rotator Cuff Repair | 2026-09-22 | OpenAlex | 10.58616/001c.163388 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213988155 | |||
| W7214209282 | Current Paradigm Shift in the Treatment of Hereditary Hemorrhagic Telangiectasia: A Narrative Review | 2026-09-22 | OpenAlex | 10.1159/ced/accag030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214209282 | |||
| W7221148865 | Current evidence for first-line advanced therapies in pediatric ulcerative colitis: a critical review | 2026-09-22 | OpenAlex | 10.1093/ibd/izag203 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221148865 | |||
| W7214030702 | Independent and joint associations of visceral adiposity and insulin resistance with hyperuricemia: A large-scale cross-sectional study | 2026-09-22 | OpenAlex | 10.1371/journal.pone.0357105 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214030702 | |||
| W7213981854 | Injectable ophthalmic hydrogels: design principles, therapeutic mechanisms, clinical applications, and translational perspectives | 2026-09-22 | OpenAlex | 10.1016/j.matdes.2026.117099 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213981854 | |||
| W7214064158 | Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies | 2026-09-22 | OpenAlex | 10.1111/eci.70256 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214064158 | |||
| W7214092400 | Artificial general intelligence architectures and evaluation methodologies: A comprehensive review and future research roadmap | 2026-09-23 | OpenAlex | 10.1016/j.cosrev.2026.101069 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214092400 | |||
| W7214147378 | BEYOND GLYCEMIC CONTROL: ORGAN-PROTECTIVE EFFECTS AND SAFETY PROFILE OF GLP-1 RECEPTOR AGONISTS – A COMPREHENSIVE REVIEW | 2026-09-23 | OpenAlex | 10.31435/ijitss.3(51).2026.6563 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214147378 | |||
| W7214064165 | Bipolar androgen therapy in castration-resistant prostate cancer: Biological rationale, clinical evidence, and future directions | 2026-09-23 | OpenAlex | 10.1097/cu9.0000000000000374 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214064165 | |||
| W7214118204 | Closed-loop artificial intelligence agents for animal epidemic prediction and decision support in livestock farming: a review | 2026-09-23 | OpenAlex | 10.3389/fvets.2026.1968632 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214118204 | |||
| W7214126288 | Fosmanogepix: A comprehensive review of its origin, mechanism, antifungal efficacy, and resistance (Review) | 2026-09-23 | OpenAlex | 10.3892/br.2026.2204 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214126288 | |||
| W7214221023 | Global Research Trends in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Bibliometric Analysis (2016–2025) | 2026-09-23 | OpenAlex | 10.57760/sciencedb.013tn | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214221023 | |||
| W7214095340 | Literature Review: Plasma Medicine, Adaptive Plasma Chemistry, Neuromorphic Plasma, and State-Dependent Dynamical Control | 2026-09-23 | OpenAlex | 10.5281/zenodo.22919154 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214095340 | |||
| W7214087266 | Medical device biomaterials and antimicrobial resistance: exploring an overlooked research interface | 2026-09-23 | OpenAlex | 10.3389/fbioe.2026.1945426 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214087266 | |||
| W7214089507 | Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions | 2026-09-23 | OpenAlex | 10.1016/j.seminoncol.2026.152563 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214089507 | |||
| W7214078360 | Pastoral Care Perspectives on Female Genital Mutilation: A Feminist Approach | 2026-09-23 | OpenAlex | 10.56201/ijrcp.vol.11.no6.2026.pg80.88 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7214078360 | |||
| W7214078344 | Stargardt disease: clinical studies over the past 5 years—a systematic review | 2026-09-23 | OpenAlex | 10.1007/s00717-026-00623-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214078344 | |||
| W7214084302 | Understanding the Health Challenges among East African Women in the U.S. with a History of Female Genital Mutilation | 2026-09-23 | OpenAlex | 10.30958/ajhms.13-3-2 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214084302 | |||
| W7214174955 | AGI DNA: A Generative Theory of Open-Ended General Intelligence | 2026-09-24 | OpenAlex | 10.5281/zenodo.22931418 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7214174955 | |||
| W7214166344 | Chronic Lymphocytic Leukemia: Epidemiology, Diagnosis, Prognosis and Modern Treatmen | 2026-09-24 | OpenAlex | 10.5281/zenodo.22940305 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214166344 | |||
| W7214242651 | Editorial: Rodent model organisms: therapeutic treatments and drugs interaction with the gut microbiome, volume II | 2026-09-24 | OpenAlex | 10.3389/fmicb.2026.1962495 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214242651 | |||
| W7214166366 | From microbiome signatures to precision oncology in colorectal cancer | 2026-09-24 | OpenAlex | 10.3389/fonc.2026.1926171 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214166366 | |||
| W7214195475 | From structural mimicry to functional regeneration: the evolving role of electrospun nanofibrous scaffolds in tendon tissue engineering | 2026-09-24 | OpenAlex | 10.1016/j.mtchem.2026.104056 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214195475 | |||
| W7214186752 | GENERAL EDGE‑CLOUD HETEROGENEOUS MULTI‑AGENT COLLABORATIVE REASONING ARCHITECTURE WITH LOCAL‑PRIVACY CONSENSUS MECHANISM | 2026-09-24 | OpenAlex | 10.61784/jcsee3155 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7214186752 | |||
| W7214228980 | Kidney transplantation in multiple myeloma: patient selection, timing, and post-transplant challenges in the modern therapeutic era | 2026-09-24 | OpenAlex | 10.1093/ckj/sfag335 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214228980 | |||
| W7214212886 | MedEnv: Scaling Multimodal Virtual Medical Environments for Long-Horizon Diagnosis | 2026-09-24 | OpenAlex | 10.1007/978-3-032-38098-2_40 | Full text | Included | Included: Interactive clinical rollouts train a doctor policy retained for different held-out cases. | https://openalex.org/W7214212886 | https://papers.miccai.org/miccai-2026/paper/5084_paper.pdf | ||
| W7214192643 | P2Y12 inhibition in diabetes across the acute-to-chronic coronary syndrome continuum: toward a personalized antiplatelet strategy | 2026-09-24 | OpenAlex | 10.1186/s12933-026-03380-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214192643 | |||
| W7214151424 | Quantify, Collect, and Correct: Evidence-Driven Multi-agent Framework for Critical Evidence Refinement in Emergency Rooms | 2026-09-24 | OpenAlex | 10.1007/978-3-032-38260-3_43 | Full text | Excluded | F4: The complete QCC method performs evidence acquisition, verification and correction within one consultation. Stored WECI is for post-hoc evaluation; no update is retained for later different cases. | https://openalex.org/W7214151424 | https://papers.miccai.org/miccai-2026/paper/4233_paper.pdf | Complete public accepted paper, all Methodology and Experiments; official repository README. | |
| W7214175605 | Reflections on adjuvant pembrolizumab for triple-negative breast cancer treated with the KEYNOTE-522 regimen: Is it really necessary? | 2026-09-24 | OpenAlex | 10.1016/j.ejca.2026.117064 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214175605 | |||
| W7214988764 | Advances in the Inflammatory and Immune-mediated Kidney Disorders (IMKD): From Pathogenesis to Precision Therapy | 2026-09-25 | OpenAlex | 10.2174/0127722708501881260913025236 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214988764 | |||
| W7214320803 | Autonomous Agentic Infiltration Beyond Sovereign Jurisdictions: Technical and Governance Implications of Agentic Misalignment for Global Healthcare Infrastructure | 2026-09-25 | OpenAlex | 10.5281/zenodo.22953478 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7214320803 | |||
| W7214240215 | Autonomous Multi-agent Governance: AI Sentinel Framework for Mitigating Psychological Restraints in AI-Driven Fall Management | 2026-09-25 | OpenAlex | 10.1007/978-3-032-39766-9_2 | Full text | Excluded | F4: The implemented Sentinel pipeline uses fixed deterministic detection rules and a constrained Llama3 explanation layer. The audit ledger stores runs, not learned agent updates. Rule adaptation through external regulatory RAG is future work. | https://openalex.org/W7214240215 | https://link.springer.com/chapter/10.1007/978-3-032-39766-9_2 | Publisher full HTML through existing Tohoku University entitlement; specified methods/evaluation sections read. | |
| W7214343123 | Diagnosis and Management of Pediatric Nephrolithiasis | 2026-09-25 | OpenAlex | 10.1007/s40746-026-00389-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214343123 | |||
| W7214327372 | Insulin signaling in PCOS/PMOS: molecular insights and clinical implications | 2026-09-25 | OpenAlex | 10.3389/fendo.2026.1955884 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214327372 | |||
| W7214316145 | Lymphomatoid papulosis | 2026-09-25 | OpenAlex | 10.1016/b978-0-443-28419-9.00151-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214316145 | |||
| W7222882146 | Memory That Remembers Wrong: Quantifying and Mitigating Confirmation-Loop Bias in Self-Evolving LLM Health Agents | 2026-09-25 | OpenAlex | 10.5281/zenodo.23447748 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7222882146 | |||
| W7214245456 | Personalized Treatment of Hemophilia: Matching Therapies to Patient Needs in a Rapidly Evolving Landscape | 2026-09-25 | OpenAlex | 10.1007/s40265-026-02386-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214245456 | |||
| W7214294843 | Pityriasis lichenoides et varioliformis acuta | 2026-09-25 | OpenAlex | 10.1016/b978-0-443-28419-9.00195-7 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214294843 | |||
| W7214285195 | Regression of severe sclerotic chronic graft-versus-host disease after a second haploidentical hematopoietic stem cell transplantation: a case report | 2026-09-25 | OpenAlex | 10.3389/fmed.2026.1929283 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214285195 | |||
| W7214347206 | Systemic therapy for metastatic nasopharyngeal carcinoma in the immunotherapy era: A critical review | 2026-09-25 | OpenAlex | 10.1016/j.ctrv.2026.103214 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214347206 | |||
| W7213603594 | [Prehabilitation for high-risk gastric cancer populations: challenges, countermeasures, and the integrated whole-course pathway]. | 2026-09-25 | OpenAlex | 10.3760/cma.j.cn441530-20260708-00274 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213603594 | |||
| W7213599352 | [Prevention strategies for radiation-induced rectal injury following pelvic radiotherapy]. | 2026-09-25 | OpenAlex | 10.3760/cma.j.cn441530-20260704-00270 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7213599352 | |||
| W7214743260 | Counterfactual Self-Evolving Agents for Evidence-Grounded Reasoning | 2026-09-26 | OpenAlex | 2609.32870 | 10.48550/arxiv.2609.32870 | Title/abstract | Excluded | E2: General method uses clinical reasoning/intake as one of multiple domains; fixed P2 applies. | https://openalex.org/W7214743260 | ||
| W7216350412 | Diabetogenic Petroleum Industry-Induced Pollutants in Nigeria's Niger Delta: Laboratory Diagnostic Challenges for Type 2 Diabetes Management | 2026-09-26 | OpenAlex | 10.58612/jpher225 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7216350412 | |||
| W7214765285 | Features of systemic immunity in hyperplastic processes of the uterus of infectious origin in women of different ages | 2026-09-26 | OpenAlex | 10.52705/2788-6190-2026-03-16 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214765285 | |||
| W7214436106 | Fitness-associated phenotypic changes in Pseudomonas aeruginosa brown strain induced by chromosomal large-fragment deletion | 2026-09-26 | OpenAlex | 10.1016/j.ijmm.2026.151741 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214436106 | |||
| W7214429289 | Long-term trends in upper gastrointestinal bleeding and ischaemic outcomes after myocardial infarction | 2026-09-26 | OpenAlex | 10.1093/eurjpc/zwag508 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214429289 | |||
| W7214545571 | Role of Agentic Artificial Intelligence in Anatomical and Clinical Laboratory | 2026-09-26 | OpenAlex | 10.1922/pjs.16.7s.2026.1168 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7214545571 | |||
| W7214434935 | THE ZENODO MANIFESTO: THE PREDATORY METAMORPHOSIS OF INFORMATION A Thermodynamic and Non-Euclidean Framework for Emerging Machine Intelligence, Ecological Symbiosis, and the Detection of High-Stakes Network Anomalies | 2026-09-26 | OpenAlex | 10.5281/zenodo.22980354 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214434935 | |||
| W7214431324 | Zero-LLM-Cost Event-Sourced Tool Failure Memory for Desktop Agents | 2026-09-26 | OpenAlex | 10.5281/zenodo.22970368 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7214431324 | |||
| W7214544981 | aVOLTA, a Bounded Autonomous Operating Layer for Operational Communication in an Investigator-Led Clinical Research Group: System Design Study (Preprint) | 2026-09-26 | OpenAlex | 10.2196/preprints.113028 | Full text | Excluded | F2: The deployed task is internal operational communication for a research group, rather than clinical care/diagnosis/clinical case education. It also reports no adopted proposed rule in its five observed days. | https://openalex.org/W7214544981 | https://preprints.jmir.org/preprint/113028 | Complete archived abstract; preprint primary page inaccessible. Author public deployment summary corroborates runs and human rule-adoption gate. | |
| W7214482429 | 《Quantum Habitability at the Limit: Can Persistent Intelligence and Virtual Civilizations Live on Quantum Infrastructure?》 is a flagship-scale research volume exploring one of the most unusual and forward-looking questions in quantum technology: | 2026-09-26 | OpenAlex | 10.5281/zenodo.22980779 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214482429 | |||
| W7214794583 | A Mediopassive Reading of Creativity | 2026-09-28 | OpenAlex | 10.1080/09672559.2026.2738550 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214794583 | |||
| W7214652088 | A Multi-Agent Framework for Explainable Brain Tumour Instance Segmentation and Clinical Report Generation Using ASIO-Optimised YOLO Architectures | 2026-09-28 | OpenAlex | 10.21203/rs.3.rs-10468605/v1 | Full text | Excluded | F4: The experience loop is conventional ASIO/PSO tuning of YOLO detector hyperparameters before execution. The Qwen clinical-reporting module consumes fixed trained outputs; no retained update derived from LLM-agent executions or interactive agent-policy learning is documented across different cases. | https://openalex.org/W7214652088 | https://doi.org/10.21203/rs.3.rs-10468605/v1 | ||
| W7220962421 | AUTOIMMUNE THYROID DISEASES: A COMPREHENSIVE LITERATURE REVIEW OF TREATMENT AND THE CURRENT STATE OF KNOWLEDGE | 2026-09-28 | OpenAlex | 10.31435/ijitss.3(51).2026.6041 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220962421 | |||
| W7214632465 | Artificial Intelligence in Manufacturing Quality: Applications, Challenges, and Emerging Research Directions | 2026-09-28 | OpenAlex | 10.21275/sr26925083358 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7214632465 | |||
| W7214646256 | Chinese migrant mothers’ perspectives on educational challenges faced by primary-aged autistic children in London | 2026-09-28 | OpenAlex | 10.14324/lre.24.1.19 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7214646256 | |||
| W7221509433 | Data-Centric AI: Intelligent Data Engineering and Machine Learning | 2026-09-28 | OpenAlex | 10.5281/zenodo.23185747 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221509433 | |||
| W7214609133 | Editorial: Novel pharmacological interventions in emotional and neuropsychiatric disorders | 2026-09-28 | OpenAlex | 10.3389/fphar.2026.1974847 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214609133 | |||
| W7221508076 | Generative AI Engineering: Large Language Models and Intelligent Agents | 2026-09-28 | OpenAlex | 10.5281/zenodo.23311806 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7221508076 | |||
| W7214578467 | Hyperpigmentation Disorders Management in India: A Delphi Based Expert Consensus on Epidemiology, Therapeutic Challenges, and the Evolving Role of Dermocosmetics | 2026-09-28 | OpenAlex | 10.1111/jocd.71188 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214578467 | |||
| W7214650269 | The Evolving Arsenal Against Naegleria Fowleri: From Empirical Poly-Chemotherapy to Target-Driven Repurposing Pipelines | 2026-09-28 | OpenAlex | 10.5281/zenodo.23008144 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214650269 | |||
| W7214809042 | Trends in the Dispensing of Adult ADHD Medications. | 2026-09-28 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214809042 | ||||
| W7214809067 | Type A Insulin Resistance Syndrome Due to a Pathogenic Variant in the INSR Gene. | 2026-09-28 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214809067 | ||||
| W7214797511 | Admission Mechanisms for Scalable Federated Health Data Collaboration: Design and Proof-of-Concept Study | 2026-09-29 | OpenAlex | 10.2196/89685 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214797511 | |||
| W7214785907 | Advances in Azole Antifungal Agents: From Structural Foundations to Resistance Challenges | 2026-09-29 | OpenAlex | 10.3390/jof12100728 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214785907 | |||
| W7214948939 | Bioactive Agents for Hair Growth: Current and Emerging Therapies | 2026-09-29 | OpenAlex | 10.25259/jmars_3_2026 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7214948939 | |||
| W7214581859 | Biophysical rationale and emerging clinical perspectives of surfactants in thoracic surgery: a translational review | 2026-09-29 | OpenAlex | 10.1007/s00423-026-04265-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214581859 | |||
| W7224220915 | Retrieval-Augmented Generation for Large Language Models: Architectures, Applications, and Challenges | 2026-09-29 | OpenAlex | 10.24321/3051.424x.202606 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224220915 | |||
| W7214789629 | Too Few, Too Far: Can AI Agents Address Health Workforce Shortage in Poland and Maldistribution in China? A Comparative Narrative Review | 2026-09-29 | OpenAlex | 10.20944/preprints202609.2490.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214789629 | |||
| W7216013563 | 6G-Enabled Intelligent IoT: Emerging Architectures, AI-Native Networking, Digital Twins, and Security Challenges | 2026-09-30 | OpenAlex | 10.71143/sn89wx46 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7216013563 | |||
| W7214904443 | Colorectal cancer care beyond earth: is treatment in microgravity feasible? | 2026-09-30 | OpenAlex | 10.17826/cumj.1942607 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214904443 | |||
| W7214988677 | Decision-Support Approaches for Industrial Symbiosis: A Systematic Literature Review | 2026-09-30 | OpenAlex | 10.1007/978-3-032-38598-7_12 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214988677 | |||
| W7214906372 | Editorial: Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases | 2026-09-30 | OpenAlex | 10.3389/fneur.2026.1925664 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214906372 | |||
| W7214909945 | GCCE–VCTAGE Causal Admissibility Benchmark: From Forward-Only Causal Ancestry to External Blind Enforcement | 2026-09-30 | OpenAlex | 10.5281/zenodo.23065976 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7214909945 | |||
| W7214954243 | Global Evolution of Microbiological Patterns and Pharmacological Guidance in the Management of Peritoneal Dialysis-Associated Peritonitis: An Evolution of Epidemiology and Clinical Practice | 2026-09-30 | OpenAlex | 10.3390/pathogens15101030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214954243 | |||
| W7214941098 | Gut Flora Dynamics and Probiotics: Foundations of Health and Therapeutic Potential | 2026-09-30 | OpenAlex | 10.5772/intechopen.1014014 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214941098 | |||
| W7214961412 | Knowledge reinforced reinforcement learning for transferable selective annotation | 2026-09-30 | OpenAlex | 10.21872/annual2025_8936 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7214961412 | |||
| W7220710874 | Magnesium a Multifunctional Therapeutic Agent: Recent Updates on Mechanisms and Clinical Implications beyond Electrolyte Homeostasis | 2026-09-30 | OpenAlex | 10.13005/bpj/3487 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7220710874 | |||
| W7214934182 | Metformin, SGLT2 Inhibitors, and Intermittent Fasting: Convergent Pathways to Healthspan Extension, Cardiovascular Longevity, and Cancer Prevention—A Narrative Review | 2026-09-30 | OpenAlex | 10.3390/cimb48101008 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214934182 | |||
| W7214970055 | Mycophenolate mofetil as salvage therapy for refractory acute-onset CIDP associated with rheumatoid arthritis: a case report | 2026-09-30 | OpenAlex | 10.3389/fimmu.2026.1869194 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214970055 | |||
| W7223130664 | Omalizumab in the Era of Precision Biologics: Real-World Treatment Persistence, Switching and Phenotype-Directed Transitions in Severe Asthma -A Malaysian Single-Centre Experience | 2026-09-30 | OpenAlex | 10.47363/jprr/2026(8)205 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223130664 | |||
| W7214959874 | Research Progress on Targeted Therapies for Pemphigus Vulgaris and Bullous Pemphigoid: Mechanisms, Opportunities and Challenges | 2026-09-30 | OpenAlex | 10.3390/ijms27198779 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214959874 | |||
| W7214973149 | SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications | 2026-09-30 | OpenAlex | 10.1186/s43556-026-00604-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7214973149 | |||
| W7218853767 | The Epistemic Entrenchment Framework (EEF): An Evolutionary, Cognitive, Information-Theoretic, Social, and Institutional Model of Belief Formation, Persistence, and Revision | 2026-09-30 | OpenAlex | 10.17605/osf.io/rgyn9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7218853767 | |||
| W7214932883 | Treatment Patterns and Clinical Outcomes Among Chinese Patients With Newly Diagnosed Multiple Myeloma: A Multicenter Retrospective Study ( CHAMP ‐ MM ) | 2026-09-30 | OpenAlex | 10.1002/cam4.72332 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214932883 | |||
| W7220360244 | Virus-based therapeutic platforms | 2026-09-30 | OpenAlex | 10.23838/pfm.2026.00128 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220360244 | |||
| W7221157923 | A Narrative Review on Intra-Articular Injection Therapies for Knee Osteoarthritis: Current Evidence and Future Perspectives | 2026-10-01 | OpenAlex | 10.2147/orr.s642237 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221157923; https://openalex.org/W7221742736 | |||
| W7221252411 | Abordaje de la diabetes tipo 2 en la población pediátrica y adolescente | 2026-10-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221252411 | ||||
| W7215058946 | Advanced Combination Therapies in IBD | 2026-10-01 | OpenAlex | 10.20944/preprints202610.0024.v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7215058946 | |||
| W7224570346 | Advanced Nanoemulsion Architectures for Precision Theranostics and Next-Generation Biomedical Translation | 2026-10-01 | OpenAlex | 10.2147/ijn.s631056 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224570346 | |||
| W7215094140 | Advances in Decision-Support Frameworks for Emergency Response and Public Health Resource Allocation | 2026-10-01 | OpenAlex | 10.56201/ijhpr.vol.10.no3.2025.pg17.53 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215094140 | |||
| W7223517223 | Advances in the LI-RADS Treatment Response Algorithm: Imaging Principles, Diagnostic Challenges, and Clinical Integration Following the LI-RADS 2024 Update | 2026-10-01 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223517223; https://openalex.org/W7222994915 | ||||
| W7222904315 | Advancing T Cell Engagers in Multiple Myeloma: Structural Design and Clinical Optimization to Address Current Limitations | 2026-10-01 | OpenAlex | 10.2147/dddt.s638795 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222904315; https://openalex.org/W7223522769 | |||
| W7223876224 | Agentic AI Systems in Radiology: Design, Applications, Evaluation, and Challenges | 2026-10-01 | OpenAlex | 10.1148/radiol.253226 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7223876224 | |||
| W7220366466 | Amivantamab, lazertinib, and bevacizumab: a chemotherapy-free option for patients with advanced EGFR-mutant NSCLC with acquired resistance to a third-generation EGFR TKI | 2026-10-01 | OpenAlex | 10.1016/s2213-2600(26)00230-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220366466 | |||
| W7215093754 | An auditable multimodal agentic system for sequential decision-making across the acute stroke pathway | 2026-10-01 | OpenAlex | 10.64898/2026.09.24.26363786 | Title/abstract | Excluded | E4: Within-case/same-patient/static retrieval or one-off training without retained experience-driven cross-case update. | https://openalex.org/W7215093754 | |||
| W7216276315 | Artificial intelligence in mechanical engineering: foundations, opportunities, challenges, and responsibilities | 2026-10-01 | OpenAlex | 2610.33105 | 10.1007/s40430-026-06873-x | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7216276315 | ||
| W7220416002 | Bioactive constituents in Salvia miltiorrhiza Bunge (Danshen) against SARS-CoV-2: Antiviral activity, mechanisms, metabolism and safety | 2026-10-01 | OpenAlex | 10.1016/j.joim.2026.09.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220416002 | |||
| W7221196495 | Biologic and Therapeutic Injections in Athletes: What’s Appropriate in 2026? | 2026-10-01 | OpenAlex | 10.1016/j.otsm.2026.151291 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221196495 | |||
| W7223140802 | COMBINED THERAPY WITH ELTROMBOPAG AND ROMIPLOSTIM IN IMMUNE THROMBOCYTOPENIA REFRACTORY TO MULTIPLE LINES OF THERAPY - A CASE SERIES | 2026-10-01 | OpenAlex | 10.1016/j.htct.2026.108050 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223140802 | |||
| W7224112761 | Carbonic Anhydrases in Sarcoma: Resetting the Tumor's Survival Script | 2026-10-01 | OpenAlex | 10.1002/jcp.70249 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224112761 | |||
| W7223847456 | Case 351: Thalamic Dementia Secondary to Dural Arteriovenous Fistula | 2026-10-01 | OpenAlex | 10.1148/radiol.252189 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223847456 | |||
| W7222342259 | Clinical application of volatile sedation in adult intensive care units: pharmacological mechanisms, delivery systems, and safety. | 2026-10-01 | OpenAlex | 10.4103/mgr.medgasres-d-26-00053 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7222342259 | |||
| W7163899160 | Data Challenge : From Resistance Data to Stewardship Decisions | 2026-10-01 | OpenAlex | 10.25934/pr00013428 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163899160 | |||
| W7223147970 | EVOLUTION OF TYROSINE KINASE INHIBITOR USE AND MOLECULAR RESPONSE PATTERNS ACROSS LINES OF THERAPY IN CHRONIC MYELOID LEUKEMIA: REAL-WORLD EVIDENCE FROM BRAZIL | 2026-10-01 | OpenAlex | 10.1016/j.htct.2026.107503 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223147970 | |||
| W7220980898 | EVOLVE-IBERIA: Real-world evidence on vedolizumab and anti-tumour necrosis factor-α as first- and second-line biologic treatment in Crohn's disease | 2026-10-01 | OpenAlex | 10.1016/j.gastrohep.2026.502871 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220980898 | |||
| W7222945793 | Editorial comment: Periprocedural antiplatelet therapy during mechanical thrombectomy: navigating limited evidence | 2026-10-01 | OpenAlex | 10.1093/esj/aakag125 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222945793 | |||
| W7221765441 | Emerging Therapeutic targets and Early-phase drug Development in Gynecological Malignancies | 2026-10-01 | OpenAlex | 10.1016/j.annonc.2026.10.101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221765441 | |||
| W7224100290 | Evolution of endocrine therapy for advanced prostate cancer: Breakthroughs and resistance mechanisms from traditional antiandrogens to novel AR pathway inhibitors | 2026-10-01 | OpenAlex | 10.1016/j.lddd.2026.100637 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224100290 | |||
| W7224128161 | Evolving Systemic Intensification Strategies Beyond CCRT in Locally Advanced Cervical Cancer | 2026-10-01 | OpenAlex | 10.2147/cmar.s637635 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224128161 | |||
| W7221645390 | Evolving demographic representation and patient-reported outcomes in landmark antibody-drug conjugate trials supporting FDA approvals, 2015-2026. | 2026-10-01 | OpenAlex | 10.1200/op.2026.22.10_suppl.166 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221645390 | |||
| W7223935531 | Exploring the evolving landscape of bispecific FVIIIa-mimetic antibodies in haemophilia A | 2026-10-01 | OpenAlex | 10.1016/j.blre.2026.101441 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223935531 | |||
| W7225000046 | From MTD to OBD: evolution, integration, and challenges in dose-finding methods for phase I oncology trials | 2026-10-01 | OpenAlex | 10.1016/j.lddd.2026.100644 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225000046 | |||
| W7221318539 | Functional characterization of genetic variants associated with response to tumor necrosis factor inhibitors in psoriatic arthritis patients | 2026-10-01 | OpenAlex | 10.1016/j.autrev.2026.104195 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221318539 | |||
| W7218952074 | Functionalization and surface engineering of hydroxyapatite: 2. Biomolecule immobilization and bioactive glass-containing hydroxyapatite composites | 2026-10-01 | OpenAlex | 10.1016/j.ceramint.2026.10.021 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7218952074 | |||
| W7223085277 | Gender and Racial Distribution of Transthyretin Stabilizer Therapy in Patients With Transthyretin Cardiac Amyloidosis | 2026-10-01 | OpenAlex | 10.1016/j.jacadv.2026.103201 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223085277 | |||
| W7215115682 | Green synthesis, Characterization and bioactivity of plant-mediated Nanoparticles using Plant Extract | 2026-10-01 | OpenAlex | 10.36371/port.2026.4.8 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7215115682 | |||
| W7223705459 | IgG4-related autoimmune pancreatitis: a journey | 2026-10-01 | OpenAlex | 10.1016/j.pan.2026.10.030 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223705459 | |||
| W7221571537 | In Case You Missed It! Key Insights from the Infiltrative Cardiomyopathy Symposium | 2026-10-01 | OpenAlex | 10.1016/j.cardfail.2026.08.003 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221571537 | |||
| W7224992736 | Infectious Disease Screening in Hematopoietic Cell Donors: Risk Assessment, Regulation, and Selective Donor Utilization | 2026-10-01 | OpenAlex | 10.1016/j.jtct.2026.10.049 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224992736 | |||
| W7220967688 | Interconnecting diagnostic progress and management techniques in depression: A narrative review | 2026-10-01 | OpenAlex | 10.1016/j.heliyon.2026.e45571 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220967688 | |||
| W7220908588 | Internet Infrastructure Science: The Transversal Coupling Substrate of Information, Computation, Agency, Execution, and Cross-System Propagation | 2026-10-01 | OpenAlex | 10.5281/zenodo.23247083 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220908588 | |||
| W7223061574 | Interpreting the evidence and clinical implementation of anti-Aβ therapies in Alzheimer’s disease | 2026-10-01 | OpenAlex | 10.1016/j.medp.2026.100174 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223061574 | |||
| W7223704059 | Lipid assessment and target attainment in acute coronary syndrome: a 10-year comparative review in a UK tertiary centre | 2026-10-01 | OpenAlex | 10.1093/eurheartj/ehag785.4161 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223704059 | |||
| W7224089096 | Mechanisms, Impact, and Clinical Management of Cancer-Related Anorexia: A Narrative Review | 2026-10-01 | OpenAlex | 10.2147/cmar.s632267 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224089096 | |||
| W7220722253 | Non-conventional histologies of prostate cancer: from morphology to biology-driven precision oncology | 2026-10-01 | OpenAlex | 10.1093/oncolo/oyag391 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220722253 | |||
| W7223146384 | Non–Small Cell Lung Cancer | 2026-10-01 | OpenAlex | 10.1891/9780826163059.0017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223146384 | |||
| W7221798867 | P2.368: Volrustomig as Single-Agent First-Line Therapy for Unresectable Pleural Mesothelioma: Substudy 5 of eVOLVE-02 Phase 2 Study | 2026-10-01 | OpenAlex | 10.1016/j.jtho.2026.105146 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7221798867 | |||
| W7221760083 | P3.353: Association of CBR3 Rs8133052 With PFS in Relapsed SCLC Treated With Second-Line or Later Amrubicin | 2026-10-01 | OpenAlex | 10.1016/j.jtho.2026.105520 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221760083 | |||
| W7224089748 | Pathological Characteristics of Vascular Microenvironment Injury and Nanotargeted Diagnostic and Therapeutic Pathways in Ischemic Stroke | 2026-10-01 | OpenAlex | 10.3724/j.pibb.2026.0497 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224089748 | |||
| W7215060968 | Perioperative management of GLP-1 receptor agonists and SGLT2 inhibitors: An updated review for anesthesiologists | 2026-10-01 | OpenAlex | 10.4103/sja.sja_127_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215060968 | |||
| W7221785998 | Pharmacological strategies for the prevention and treatment of proliferative vitreoretinopathy: A comprehensive review | 2026-10-01 | OpenAlex | 10.1016/j.survophthal.2026.10.005 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221785998 | |||
| W7223552157 | Positivity rate of stress echocardiography using regional wall motion abnormalities in chronic coronary syndromes | 2026-10-01 | OpenAlex | 10.1093/eurheartj/ehag785.143 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223552157 | |||
| W7222941959 | Psoriasis: Which therapy for which patient, updated, part I. Focus on Psoriasis Comorbidities and Preferred Systemic Agents. | 2026-10-01 | OpenAlex | 10.1016/j.jaad.2026.09.132 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7222941959 | |||
| W7223448550 | Senotherapeutics: emerging pharmacological strategies for targeting cellular senescence | 2026-10-01 | OpenAlex | 10.22271/veterinary.2026.v11.i10sf.3909 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223448550 | |||
| W7215068393 | Systemic treatments of psoriasis and atopic dermatitis in adults and children: from pharmacological targets to meta-analyses | 2026-10-01 | OpenAlex | 10.1016/j.therap.2026.09.045 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7215068393 | |||
| W7221246356 | Terapia combinada con GLP-1 e iSGLT2: ¿mayor impacto cardiorrenal? | 2026-10-01 | OpenAlex | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221246356 | ||||
| W7225013087 | The changing role of the gastroenterologist in the management of advanced gastric cancer | 2026-10-01 | OpenAlex | 10.1016/j.dld.2026.10.021 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225013087 | |||
| W7221104708 | The landscape of hepatocellular carcinoma recurrence after liver transplantation: a nationwide 14-year study | 2026-10-01 | OpenAlex | 10.1016/j.jhepr.2026.102062 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221104708 | |||
| W7224675922 | The new revolution in the treatment of chronic urticaria, present and future of an effective and safe approach | 2026-10-01 | OpenAlex | 10.23736/s2784-8671.26.08590-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224675922 | |||
| W7223453318 | Therapeutic advances in pulmonary fibrosis | 2026-10-01 | OpenAlex | 10.1177/17534666261489541 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223453318 | |||
| W7223699014 | Treatment escalation beyond triple therapy in patients with resistant hypertension: a population-based observational cohort study from UK healthcare records | 2026-10-01 | OpenAlex | 10.1093/eurheartj/ehag785.3056 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223699014 | |||
| W7221365382 | [Guidelines for the diagnosis and management of multiple myeloma in China (2026 revision)]. | 2026-10-01 | OpenAlex | 10.3760/cma.j.cn112138-20260803-00451 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221365382 | |||
| W7215915262 | Atypical Pediatric Epilepsy: A Narrative Review of Classification, Diagnosis, and Emerging Therapeutics | 2026-10-02 | OpenAlex | 10.7759/cureus.117344 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215915262 | |||
| W7216382703 | Autonomous Skill Development: Neuro-Symbolic Agents that Self-generate Verifiable Tools | 2026-10-02 | OpenAlex | 10.1007/978-3-032-40774-0_36 | Full text | Excluded | F2: Author explicitly decided to exclude ASD as a general-purpose skill-generation method illustrated by nutrition calculations. The full chapter evaluates38 nutrition formula/calculation/conversion tasks without a patient-care or clinical-diagnosis workflow. This applies the author-decided healthcare-primary boundary to this candidate. | https://openalex.org/W7216382703 | https://link.springer.com/chapter/10.1007/978-3-032-40774-0_36 | Complete publisher HTML read through existing institutional browser; §4.1 benchmark/evaluation and method sections examined online. | |
| W7221778545 | Autonomous Synergy: Artificial Intelligence Orchestration of Mobile Imaging Units, C-Arms, and Surgical Workflow in the Operating Suite | 2026-10-02 | OpenAlex | 10.53365/nrfhh.2902 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221778545 | |||
| W7215732191 | Comprehensive Therapeutic Approaches in Vitiligo | 2026-10-02 | OpenAlex | 10.4018/979-8-2600-0567-5.ch009 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215732191 | |||
| W7204853348 | Cortical Spreading Depression and Migraine: Critical Review of a Neurophysiological Principle in the Third Millennium | 2026-10-02 | OpenAlex | 10.17352/gjmccr.000273 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7204853348 | |||
| W7216249630 | DNA-Lang Evolver (snapshot 2026-10-02): governed evaluator contracts for agent-generated code candidates | 2026-10-02 | OpenAlex | 10.5281/zenodo.23102747 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7216249630 | |||
| W7220360413 | Decoupling Memory from Context: Structured Memory for Token-Efficient Test-Time Continual Learning | 2026-10-02 | OpenAlex | 2610.02687 | 10.48550/arxiv.2610.02687 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7220360413 | ||
| W7215133373 | Editorial: Real world-evidence in radioligand therapy: above and beyond a tongue twister | 2026-10-02 | OpenAlex | 10.3389/fmed.2026.2002519 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215133373 | |||
| W7215805236 | Emotional Echoes: A Spatialized VR Gallery for Revisiting and Reinterpreting Emotional Memory | 2026-10-02 | OpenAlex | 10.1145/3776574.3832535 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7215805236 | |||
| W7215828824 | FAM45A-Mediated Persistent Memory-Like Fibroblast Reprogramming Drives PM2.5-Exacerbated Allergic Asthma | 2026-10-02 | OpenAlex | 10.1021/ehp.6c00353 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7215828824 | |||
| W7215034511 | Mapping the complement-targeted landscape in igA nephropathy: a systematic review with structured descriptive synthesis | 2026-10-02 | OpenAlex | 10.3389/fmed.2026.1933632 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215034511 | |||
| W7216053816 | Preserving Assistive Identity Across Embodiments: A Knowledge-Driven AI Agent for Neurorehabilitation | 2026-10-02 | OpenAlex | 10.1007/978-3-032-40774-0_25 | Full text | Excluded | F4: Persistent knowledge/dialogue history is personalized to the same rehabilitation patient across robot and tablet embodiments. The system does not retain reusable agent-learning experience across different patients (P1). | https://openalex.org/W7216053816 | https://link.springer.com/chapter/10.1007/978-3-032-40774-0_25 | Publisher full HTML through existing Tohoku University entitlement; specified methods/evaluation sections read. | |
| W7215740224 | Tools for providing information to patients about high-tech medical resources for treatment of cancer | 2026-10-02 | OpenAlex | 10.2340/1651-226x.2026.45529 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7215740224 | |||
| W7220461082 | A Five-Decade Perspective on the Evolution of Gelatin and Collagen Technologies and Materials Used in Medical Devices | 2026-10-03 | OpenAlex | 10.3390/gels12100896 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220461082 | |||
| W7219134088 | Agentic Artificial Intelligence Supporting Self-Management in Adults with Chronic Conditions: A Scoping Review protocol | 2026-10-03 | OpenAlex | 10.17605/osf.io/gxjzh | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7219134088 | |||
| W7220737405 | Benchmarking Psychological Dynamics in Generative Agents | 2026-10-03 | OpenAlex | 2610.04246 | 10.48550/arxiv.2610.04246 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7220737405 | ||
| W7219101357 | Hybrid Consciousness and the Cultural Evolution of Leadership | 2026-10-03 | OpenAlex | 10.31234/osf.io/cqywj_v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7219101357 | |||
| W7218922931 | NEURAL AGENCY, IDENTITY, PRIVACY & HUMAN-AI CO-ADAPTATION AT THE LIMIT Agency as Engineering, Neural Privacy, Identity Restraint, Longitudinal Consent, Digital Neural Twins, Reciprocal Adaptation, and Boundary Science | 2026-10-03 | OpenAlex | 10.5281/zenodo.23123779 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7218922931 | |||
| W7218831598 | Polycystic Ovary Syndrome: A Decade in Review (2016–2026)—Evolving Understanding and Current Therapeutic Approaches | 2026-10-03 | OpenAlex | 10.5281/zenodo.23120166 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7218831598 | |||
| W7218440242 | Prevalence, Types, And Reasons for Therapeutic Switching in Hospitalized Children with Pneumonia: A Prospective Observational Study | 2026-10-03 | OpenAlex | 10.5281/zenodo.23119032 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7218440242 | |||
| W7216334567 | The Role of Complement in ANCA-Associated Vasculitis | 2026-10-03 | OpenAlex | 10.1007/s40124-026-00391-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7216334567 | |||
| W7218948106 | Write-Time Contracts for Self-Evolving LLM Agents: a Three-Way Ledger of Gain, Regression, and Cost | 2026-10-03 | OpenAlex | 10.5281/zenodo.23114793 | Title/abstract | Excluded | E2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task. | https://openalex.org/W7218948106 | |||
| W7219612410 | AUTONOMOUS REPAIR & SELF-HEALING INFRASTRUCTURE AT THE LIMIT Detection, Diagnosis, Local Repair, Verification, and the Rise of Persistent Infrastructure | 2026-10-04 | OpenAlex | 10.5281/zenodo.23146067 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7219612410 | |||
| W7219775431 | An intelligent agent-enabled framework for last-mile workflow closure in hospital management of new medical technologies: OpenClaw as an Illustrative example | 2026-10-04 | OpenAlex | 10.1016/j.hlpt.2026.101333 | Full text | Excluded | F1: The publisher text identifies a commentary with illustrative workflow architecture and a future evaluation plan, without a primary adaptive-agent experiment. | https://openalex.org/W7219775431 | https://www.sciencedirect.com/science/article/abs/pii/S2211883726001814 | Extensive publisher indexed body preview, three-layer framework and future evaluation sections. | |
| W7219897597 | Chromosomal Abnormalities, Drug Sensitivity and Resistance in Hematological Malignancies: A Comprehensive Overview by the Francophone Group of Hematological Cytogenetics ( GFCH ) | 2026-10-04 | OpenAlex | 10.1002/ajh.70499 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7219897597 | |||
| W7220462768 | Exosomes and Extracellular Vesicles in Oncology: Next-Generation Smart Nanocarriers for Precision Cancer Therapy | 2026-10-04 | OpenAlex | 10.3390/cells15191812 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220462768 | |||
| W7219602419 | KASK-Q → BITE → LASO Experimental Research Summary and Swarm Validation Status | 2026-10-04 | OpenAlex | 10.5281/zenodo.23131541 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7219602419 | |||
| W7221571792 | Philosophy and civic education teachers as stakeholders in the socio-ecological knowledge chain | 2026-10-04 | OpenAlex | 10.3897/aca.9.e218132 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221571792 | |||
| W7220831980 | Tirzepatide and Semaglutide in Type 2 Diabetes Mellitus and Obesity: A Comparative Assessment of Efficacy and Safety (Review) | 2026-10-04 | OpenAlex | 10.30895/2312-7821-2026-14-3-249-262 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220831980 | |||
| W7220837409 | Adaptive Artificial Immune System-Based Diagnostic Agent for E-Maintenance Using Sliding Window Incremental Learning | 2026-10-05 | OpenAlex | 10.21272/jes.2026.13(2).e1 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7220837409 | |||
| W7215052034 | An Integrated Approach to Cancer Therapy | 2026-10-05 | OpenAlex | 10.5281/zenodo.23076359 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7215052034 | |||
| W7220676041 | Capability-Driven Self-Evolution of Agent Memory | 2026-10-05 | OpenAlex | 2610.06361 | 10.48550/arxiv.2610.06361 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7220676041 | ||
| W7220452462 | Cellular memory after cancer therapy: persistence after drug withdrawal, maintenance across cell divisions, and responses to rechallenge | 2026-10-05 | OpenAlex | 10.3389/fphar.2026.1966584 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220452462 | |||
| W7220402936 | Editorial: Global perspectives on cyber statecraft: bridging theory and practice | 2026-10-05 | OpenAlex | 10.3389/fpos.2026.1968109 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220402936 | |||
| W7220445946 | Editorial: Health data science and AI in neuroscience & psychology | 2026-10-05 | OpenAlex | 10.3389/fncom.2026.2002192 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220445946 | |||
| W7220572836 | Evolution, Role, and Challenges of Non-Governmental Organizations in India | 2026-10-05 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220572836 | ||||
| W7220702529 | Explainable AI-Driven Zero-Day Malware Detection Using Hybrid Transformer-Graph Networks in Cloud-Native Environments | 2026-10-05 | OpenAlex | 10.63544/8wxdhb56 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220702529 | |||
| W7220367953 | Glucagon-like peptide-1 receptor agonists and aesthetic surgery: perioperative safety, timing, durability and body composition | 2026-10-05 | OpenAlex | 10.3389/fendo.2026.1969433 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220367953 | |||
| W7220469952 | New and future treatments for IgA nephropathy | 2026-10-05 | OpenAlex | 10.33393/gcnd.2026.3838 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220469952 | |||
| W7220432213 | Primary antiphospholipid syndrome: emerging strategies and current limitations in diagnosis and management | 2026-10-05 | OpenAlex | 10.1080/23995270.2026.2737657 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220432213; https://openalex.org/W7220406741 | |||
| W7220386330 | SELF-CALIBRATING QUANTUM BIOSENSING NETWORKS AT THE LIMIT Distributed Sensing, Reference Transfer, Drift Detection, and Autonomous Recalibration | 2026-10-05 | OpenAlex | 10.5281/zenodo.23166767 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220386330 | |||
| W7221190469 | Targeted Pharmacological Therapies in Pulmonary Arterial Hypertension: From Endothelin, Nitric Oxide and Prostacyclin to Bmp/Activin Signalling | 2026-10-05 | OpenAlex | 10.61096/ijrpp.v15.i4.2026.1338-1358 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221190469 | |||
| W7220694397 | Contemporary Pharmacotherapy of Myocardial Infarction: Recent Advances, Precision Medicine, and a Clinical Pharmacy Perspective Contemporary Pharmacotherapy of Myocardial Infarction | 2026-10-06 | OpenAlex | 10.5281/zenodo.23186359 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220694397 | |||
| W7220682722 | Exploring the immunological effects of antibody–drug conjugates | 2026-10-06 | OpenAlex | 10.1038/s41571-026-01209-z | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220682722 | |||
| W7220650550 | Genetic Counseling | 2026-10-06 | OpenAlex | 10.1007/s40124-026-00395-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220650550 | |||
| W7220743482 | HUMAN-AI COEVOLUTION FOR NEURAL DISCOVERY AT THE LIMIT AI Candidate Generation, Human Scientific Judgment & Persistent Research Memory | 2026-10-06 | OpenAlex | 10.5281/zenodo.23196046 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220743482 | |||
| W7220726012 | Osteoporosis in Pediatric Orthopaedics: Congenital Diseases, Medical Management, and Perioperative Considerations | 2026-10-06 | OpenAlex | 10.1007/s11914-026-00985-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220726012 | |||
| W7220726583 | PREreview of "RSI-Router: Evolving Subtask-Level LLM Routing and Skills for Cost-Efficient Agents" | 2026-10-06 | OpenAlex | 10.5281/zenodo.23176617 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7220726583 | |||
| W7220665688 | Redefining leptomeningeal metastasis in non–small cell lung cancer: From terminal complication to molecularly managed disease | 2026-10-06 | OpenAlex | 10.1002/cncr.70624 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220665688 | |||
| W7220983594 | The Changing Role of AI Agents in Science Must be Recognized | 2026-10-06 | OpenAlex | 10.20944/preprints202610.0343.v1 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7220983594 | |||
| W7225065647 | Acute transverse myelitis associated with cytomegalovirus in an immunocompetent patient: a case report | 2026-10-07 | OpenAlex | 10.65034/anpabstract_cbn261695 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225065647 | |||
| W7220965913 | AlarmClaw: Context-Enriched Alarm Management with Category-/Severity-Aware Incident Graphs | 2026-10-07 | OpenAlex | 10.1145/3832783.3834524 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220965913 | |||
| W7225035181 | Atypical neuropsychiatric manifestation of cerebral amyloid angiopathy-related inflammation (CAA-Ri): a case report | 2026-10-07 | OpenAlex | 10.65034/anpabstract_cbn261789 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225035181 | |||
| W7225054639 | Carbamazepine-induced DRESS syndrome associated with autoimmune hemolytic anemia in a pediatric patient with focal epilepsy: a case report | 2026-10-07 | OpenAlex | 10.65034/anpabstract_cbn261403 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225054639 | |||
| W7225061835 | Central nervous system demyelination associated with tumor necrosis factor inhibitor exposure in a patient with ankylosing spondylitis | 2026-10-07 | OpenAlex | 10.65034/anpabstract_cbn261606 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225061835 | |||
| W7225045969 | Concomitant Castleman syndrome and secondary progressive multiple sclerosis: a case report | 2026-10-07 | OpenAlex | 10.65034/anpabstract_cbn261586 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225045969 | |||
| W7221040452 | Emerging Frontiers of Biomedical Applications of PLGA : Where Do We Stand? | 2026-10-07 | OpenAlex | 10.1002/app.71617 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221040452 | |||
| W7220856167 | Hydrodynamic controls and sedimentary responses of eddy bars during outburst floods | 2026-10-07 | OpenAlex | 10.1016/j.catena.2026.110656 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220856167 | |||
| W7225061409 | Levamisol-induced leukoencephalopathy in a chronic cocaine user: a case report | 2026-10-07 | OpenAlex | 10.65034/anpabstract_cbn261942 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225061409 | |||
| W7225056282 | Longitudinally extensive transverse myelitis as the initial manifestation of neuro-Behçet disease: a case report | 2026-10-07 | OpenAlex | 10.65034/anpabstract_cbn261648 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225056282 | |||
| W7225041071 | Myasthenic crisis triggered by COVID-19: a rare description | 2026-10-07 | OpenAlex | 10.65034/anpabstract_cbn261330 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225041071 | |||
| W7220864130 | Neuromics: biomarkers discovery to precision diagnostics in neurotrauma | 2026-10-07 | OpenAlex | 10.1038/s41540-026-00792-2 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220864130 | |||
| W7225039166 | Parvovirus B19 encephalitis: a case series with clinical analysis and neurological outcomes in immunocompetent patients in Sergipe | 2026-10-07 | OpenAlex | 10.65034/anpabstract_cbn260483 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225039166 | |||
| W7220932552 | Pathway-guided and patient-centred therapeutic strategies in atherosclerotic cardiovascular disease | 2026-10-07 | OpenAlex | 10.1093/eurjpc/zwag523 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220932552 | |||
| W7224134816 | Probiotics and postbiotics in caries and periodontal prevention: mechanisms, clinical evidence, and trajectory of the field | 2026-10-07 | OpenAlex | 10.62486/dent2026272 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224134816 | |||
| W7220854834 | Pulmonary Delivery Using Liposomal Systems | 2026-10-07 | OpenAlex | 10.1201/9781779644329-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220854834 | |||
| W7225037633 | When standard therapy fails: azathioprine in refractory pediatric erythema nodosum leprosum with progressive neural damage | 2026-10-07 | OpenAlex | 10.65034/anpabstract_cbn261863 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225037633 | |||
| W7221019026 | A Multi-Agent Framework for Diagnosis and Plan Repair in Knowledge Graph Question Answering | 2026-10-08 | OpenAlex | 10.21203/rs.3.rs-11099883/v1 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7221019026 | |||
| W7220917508 | Beyond the Needle: Transforming Traditional Healthcare with Microneedle Drug Delivery Systems | 2026-10-08 | OpenAlex | 10.3390/pharmaceutics18101274 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220917508 | |||
| W7220953163 | Bone Radiopharmaceuticals: Evolution from Palliative Therapy to Targeted Precision Oncology and Theranostics | 2026-10-08 | OpenAlex | 10.3390/biology15191784 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220953163 | |||
| W7220891917 | Case Report: Coexpression of somatic EGFR, BRCA1, and BRCA2 mutations in metastatic non-small cell lung cancer | 2026-10-08 | OpenAlex | 10.3389/fonc.2026.1964203 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220891917 | |||
| W7220947966 | Etomidate vaping: A new form of anesthetic abuse | 2026-10-08 | OpenAlex | 10.1080/00952990.2026.2739864 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220947966 | |||
| W7220940630 | Evaluating Low-Shot Procedural Skill Transfer in Language-Agent Debugging | 2026-10-08 | OpenAlex | 10.1145/3843282.3844421 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7220940630 | |||
| W7220898246 | Evolution of Aptamer-Controlled Liposomal Drug Delivery Systems: From Molecular Recognition to Precision-Controlled Drug Release | 2026-10-08 | OpenAlex | 10.5281/zenodo.23242150 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220898246 | |||
| W7220900277 | From task-specific AI to multimodal foundation models in PET/CT: a readiness framework for clinical translation | 2026-10-08 | OpenAlex | 10.3389/fnume.2026.1956567 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220900277 | |||
| W7220936425 | Neural Repair Therapies After Stroke: I. Therapeutic Advances | 2026-10-08 | OpenAlex | 10.1161/strokeaha.126.056092 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7220936425 | |||
| W7221056542 | OOM-RL II: Reality Is an Oracle, Not a Debugger — Supplementary Dataset S1 | 2026-10-08 | OpenAlex | 10.5281/zenodo.23215520 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221056542 | |||
| W7221136546 | SpatialOmicsLab: an integrated research environment for AI co-scientists in spatial transcriptomics | 2026-10-08 | OpenAlex | 10.64898/2026.10.01.756049 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221136546 | |||
| W7221224434 | Super Intelligence in Healthcare: A Systematic Review of Systemic Risks, Ethical Dilemmas, and Governance Frameworks | 2026-10-08 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221224434 | ||||
| W7220967720 | The Resistance Constellation Across the Sepsis–Uropathogen Continuum: A Thirteen-Year Atlas of Epidemiological Expansion, Resistance Kinetics, and Progressive Therapeutic Attrition | 2026-10-08 | OpenAlex | 10.3390/pathogens15101066 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220967720 | |||
| W7220931355 | Therapie der Lungenfibrose – Beginn einer neuen Ära | 2026-10-08 | OpenAlex | 10.1055/a-2959-4770 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7220931355 | |||
| W7221075670 | A Pilot Study on the Effect of In Vitro-Induced Antibiotic Resistance on Biofilm Formation by Uropathogenic Escherichia coli | 2026-10-09 | OpenAlex | 10.3390/bacteria5040065 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221075670 | |||
| W7221105088 | Antibiofilm Activity of Pulsed Laser-Ablated Gold Nanoparticles against Biofilm-Forming Bacterial Pathogens | 2026-10-09 | OpenAlex | 10.1007/s11468-026-03495-w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221105088 | |||
| W7221812337 | Evolving Molecular Drug Targets in Pancreatic Cancer: An Updated Review | 2026-10-09 | OpenAlex | 10.2174/0115680096481382261002063656 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221812337 | |||
| W7221123645 | From challenges to solutions: insights into AIEgen-based diagnostic and therapeutic strategies for breast cancer | 2026-10-09 | OpenAlex | 10.1016/j.ccr.2026.218616 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221123645 | |||
| W7221166466 | Managing diabetes and thrombosis with snake venom–derived therapies | 2026-10-09 | OpenAlex | 10.1016/b978-0-443-44394-7.00012-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221166466 | |||
| W7221416445 | Oral Obesity Medicines in the Era of Cardiovascular–Kidney–Metabolic Syndrome (CKM): Beyond Weight Loss Toward Disease Modification | 2026-10-09 | OpenAlex | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221416445; https://openalex.org/W7221732224; https://openalex.org/W7221123779 | ||||
| W7221180267 | The complexity paradox of generalist AI agents in medicine: exploring GPT-5 for real-world multimodal medical diagnosis | 2026-10-09 | OpenAlex | 10.1038/s41746-026-03325-7 | Title/abstract | Excluded | E4: Only within-case/session or same-patient state (P1), fixed RAG/pretrained models, human learning, or fixed-data one-off training; no retained cross-case agent improvement. | https://openalex.org/W7221180267 | |||
| W7221308244 | Beyond Detection: Generative Artificial Intelligence for Autonomous Cyber Threat Hunting and Incident Response | 2026-10-10 | OpenAlex | 10.32628/ijsraiml2624121 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221308244 | |||
| W7221815947 | EnactOpt: Diagnosis-Guided Harness Evolution for Embodied Agents | 2026-10-10 | OpenAlex | 2610.14977 | 10.48550/arxiv.2610.14977 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7221815947 | ||
| W7221521489 | From Trajectories to Experience: A Survey of Experience-Driven LLM Agents | 2026-10-10 | OpenAlex | 10.20944/preprints202610.0937.v1 | Title/abstract | Excluded | E1: Survey/taxonomy or discussion of existing applications; not a newly built or evaluated adapting clinical agent. | https://openalex.org/W7221521489 | |||
| W7221359159 | Interferon Therapy in Acute Myeloid Leukemia: Biological Rationale, Clinical Evidence, and Future Directions | 2026-10-10 | OpenAlex | 10.3390/cancers18203266 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221359159 | |||
| W7221508616 | Pyoderma gangrenosum: Clinico-diagnostic approach and skin ulcer care | 2026-10-10 | OpenAlex | 10.21518/ms2026-395 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221508616 | |||
| W7223032326 | The Evolving Landscape of HPV-related Cervical Malignancies | 2026-10-10 | OpenAlex | 10.65161/ojssc26.recbbu7am4desss33 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223032326 | |||
| W7224939449 | The Lp(a) gap: Practical steps to align primary care and lipid clinics | 2026-10-10 | OpenAlex | 10.70401/alr.2026.0010 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224939449 | |||
| W7223312918 | [Advances in agent-based modeling for infectious disease simulation and intervention]. | 2026-10-10 | OpenAlex | 10.3760/cma.j.cn112338-20251226-00927 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7223312918 | |||
| W7221345822 | Nanoparticle-Based Cancer Therapeutics: From Synthesis to Clinical Applications | 2026-10-11 | OpenAlex | 10.58445/rars.4249 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221345822 | |||
| W7221516384 | Postoperative Vasoactive Exposure Patterns and Outcomes After Non‐Cardiac Surgery: A Prespecified Analysis of the SQUEEZE Cohort | 2026-10-11 | OpenAlex | 10.1111/aas.70355 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221516384 | |||
| W7221562984 | AELYRION-NOÛLITH III: Exact Resonance Geometry of Restricted Observations, Intrinsic Calibration Rigidity, and Sharp Synchronization Bounds | 2026-10-12 | OpenAlex | 10.5281/zenodo.23325374 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221562984 | |||
| W7221479841 | Agile AI Agentic Neural Based Framework for Complex Workflow Forming, with Multiple Implementations Upon Upstream and Downstream Scenarios | 2026-10-12 | OpenAlex | 10.2118/234416-ms | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221479841; https://openalex.org/W7211962888 | |||
| W7221572733 | Cardiovascular And Renal Benefits of Sodium–Glucose Cotransporter 2 Inhibitors in Patients Without Diabetes: A Review of Current Evidence | 2026-10-12 | OpenAlex | 10.5281/zenodo.23314088 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221572733 | |||
| W7221554479 | Early-Phase Drug Development in Rare Cancers: A Decade of Progress and Future Directions | 2026-10-12 | OpenAlex | 10.3390/cancers18203290 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221554479 | |||
| W7221565207 | Newcastle disease virus: Insights into molecular epidemiology, dynamics of distribution and diagnostics | 2026-10-12 | OpenAlex | 10.1080/03079457.2026.2746602 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221565207 | |||
| W7221505698 | PHARMACOTHERAPY OF HEART FAILURE: A NARRATIVE REVIEW OF CONTEMPORARY GUIDELINE-DIRECTED DRUG THERAPY | 2026-10-12 | OpenAlex | 10.5281/zenodo.23309825 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221505698 | |||
| W7221533065 | Precision biologics in pediatric inflammatory bowel disease: Current evidence and emerging predictors | 2026-10-12 | OpenAlex | 10.5409/wjcp.125410 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221533065 | |||
| W7165112275 | Retinal neurodegeneration as accelerated ocular aging: a review of nutritional and metabolic supplements | 2026-10-12 | OpenAlex | 10.3389/fragi.2026.1912337 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7165112275 | |||
| W7221478463 | Short-film–based world café for faculty development in medical humanities: a mixed-method evaluation across three teaching hospitals | 2026-10-12 | OpenAlex | 10.1186/s12909-026-10584-1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221478463 | |||
| W7221551061 | TA-TMA as a clinical model for precision complement therapeutics in stem cell transplantation | 2026-10-12 | OpenAlex | 10.3389/fimmu.2026.1959683 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221551061 | |||
| W7221683819 | The Expanding Therapeutic Landscape in Myasthenia Gravis | 2026-10-12 | OpenAlex | 10.1002/mus.70418 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221683819 | |||
| W7221517944 | Understanding and clinical approach to early T-cell precursor acute lymphoblastic leukemia | 2026-10-12 | OpenAlex | 10.1007/s44313-026-00181-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221517944 | |||
| W7221623286 | Current management and emerging pharmacotherapeutic strategies in acute promyelocytic leukemia | 2026-10-13 | OpenAlex | 10.1080/14656566.2026.2749650 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221623286 | |||
| W7221662113 | Editorial: Community series in unveiling the next generation of cancer immunity & immunotherapy in lung cancer, volume II | 2026-10-13 | OpenAlex | 10.3389/fimmu.2026.2005017 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221662113 | |||
| W7221651253 | From pathophysiology to therapy: dual and triple agonists as a new frontier in metabolic dysfunction-associated steatotic liver disease | 2026-10-13 | OpenAlex | 10.3389/fphar.2026.1784959 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221651253 | |||
| W7221533918 | Mapping the knowledge landscape and identifying frontiers of mitochondrial dysfunction in sepsis-associated acute kidney injury: a four-decade bibliometric and visualized analysis | 2026-10-13 | OpenAlex | 10.1007/s00210-026-05984-5 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221533918 | |||
| W7221676600 | Visual Biopolitics in Crisis: Multimodal Analysis of Tuberculosis in the Early Republican Period and COVID-19 Health Communication in Turkey | 2026-10-13 | OpenAlex | 10.1080/10410236.2026.2743158 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221676600 | |||
| W7222169847 | When Help Threatens and When Users Over-Rely: Proactive and Reactive Help from Intelligent Agents | 2026-10-13 | OpenAlex | 10.26083/tuda-8526 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7222169847 | |||
| W7222780507 | A responsabilidade civil médica no Brasil sobre erro de diagnóstico assistido por Inteligência Artificial | 2026-10-14 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7222780507 | ||||
| W7221800782 | Adaptive Switching Between Parallel-World Self-Reflection and Mutual Reflection for Multiple Large Language Models | 2026-10-14 | OpenAlex | 10.5281/zenodo.23357371 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221800782 | |||
| W7221783728 | Adaptive Switching Between Self-Mechanisms and Mutual Mechanisms in Multiple Large Language Models: A Unified Framework for Dynamic Intelligence Coordination | 2026-10-14 | OpenAlex | 10.5281/zenodo.23357069 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221783728 | |||
| W7221728852 | Ai Enabled Digital Twins Enabling Integrated Production Optimization and Autonomous Operations | 2026-10-14 | OpenAlex | 10.2118/234113-ms | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221728852 | |||
| W7221765090 | Akute Herzinsuffizienz – Management in den ersten 120 min | 2026-10-14 | OpenAlex | 10.1007/s00063-026-01502-w | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221765090 | |||
| W7221646405 | Correction: Tumor-immune microenvironment and nutritional status biomarkers predict recurrence after total colectomy for locally advanced colon cancer: development and internal validation of a nomogram | 2026-10-14 | OpenAlex | 10.3389/fgene.2026.1998945 | Title/abstract | Excluded | E5: Correction/retraction, ancillary record, or abstract absent and title uninformative. | https://openalex.org/W7221646405 | |||
| W7221780330 | Durable benefit of immunotherapy in metastatic Epstein–Barr virus-positive nasopharyngeal carcinoma with cutaneous metastases (lethalides): a case report and review of the literature | 2026-10-14 | OpenAlex | 10.37349/emed.2026.1001431 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221780330 | |||
| W7221826183 | Emerging therapies for knee osteoarthritis | 2026-10-14 | OpenAlex | 10.1038/s41584-026-01441-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221826183 | |||
| W7222239501 | External Analysis of Protected Data | 2026-10-14 | OpenAlex | 10.5281/zenodo.23377116 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7222239501 | |||
| W7221777261 | Frailty Status and Medication Use Among U.S. Older Adults: Evidence From NHANES , 1999–2020 | 2026-10-14 | OpenAlex | 10.1111/jgs.70759 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221777261 | |||
| W7221766826 | Next-generation CDK inhibitors in HR+/HER2– breast cancer | 2026-10-14 | OpenAlex | 10.1172/jci207631 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221766826 | |||
| W7221821144 | Students as change agents for societal challenges – | 2026-10-14 | OpenAlex | 10.15845/norsotl.4954 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7221821144 | |||
| W7221774513 | The Architecture of Permanence Full Technical Report on Topological Continual Backpropagation (Topo-CBP) | 2026-10-14 | OpenAlex | 10.5281/zenodo.23363008 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221774513 | |||
| W7221810553 | Tumor lysis syndrome in breast cancer: a systematic review of the literature | 2026-10-14 | OpenAlex | 10.3389/fonc.2026.1937565 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221810553 | |||
| W7222457091 | AI‑Driven Meta‑Governance: How Autonomous Systems Can Govern Other AI Models in Real Time | 2026-10-15 | OpenAlex | 10.64235/a4sfnk4 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7222457091 | |||
| W7222162327 | Acute Respiratory Infections in Children: Current Approaches to Etiological Diagnosis and Prediction of Severe Disease (Literature Review) | 2026-10-15 | OpenAlex | 10.33619/2414-2948/131/31 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222162327 | |||
| W7222165196 | Adaptive Self-Reflection and Inter-Reflection in Self-and-Inter Models: A Unified Framework for Model-Level Metacognition and Dynamic Reflective Coordination | 2026-10-15 | OpenAlex | 10.5281/zenodo.23385023 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222165196 | |||
| W7222002247 | Adaptive Self–Mutual Diagnosis in Self–Mutual Models: A Unified Framework for State-Dependent Switching Between Internal and Cross-Model Diagnosis | 2026-10-15 | OpenAlex | 10.5281/zenodo.23385000 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222002247 | |||
| W7221887000 | AuditTune campaign evidence: experiment ledger, agent-written planner code, and figure-generation scripts for auditable policy adjustment in reinforcement learning control | 2026-10-15 | OpenAlex | 10.17632/jhgknm378r | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7221887000 | |||
| W7222191808 | Evolving infectious epidemiology in acute myeloid leukemia in the contemporary era: a 13-year retrospective, single-center analysis of induction therapies | 2026-10-15 | OpenAlex | 10.1007/s00277-026-07323-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7222191808 | |||
| W7222099174 | IMPROVING THE METHODOLOGY FOR DEVELOPING STUDENTS' COMMUNICATIVE COMPETENCE BASED ON INTERACTIVE AND DIGITAL TECHNOLOGIES IN TEACHING RUSSIAN AS A FOREIGN LANGUAGE | 2026-10-15 | OpenAlex | 10.66301/m1daa165 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7222099174 | |||
| W7221931397 | Novel therapeutics for platinum-resistant ovarian cancer: from biological mechanisms to emerging biomarker-guided strategies | 2026-10-15 | OpenAlex | 10.1186/s10020-026-01670-7 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7221931397 | |||
| W7222060373 | The Evolving Landscape of Hypertrophic Cardiomyopathy Treatment: Are Guidelines Keeping Pace? | 2026-10-15 | OpenAlex | 10.1097/mjt.0000000000002245 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222060373 | |||
| W7221863624 | Urticaria (Shara): A Narrative Review of Contemporary and Unani Perspectives | 2026-10-15 | OpenAlex | 10.22270/jddt.v16i10.7996 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7221863624 | |||
| W7222495213 | C-MOP: A Narrative Review and Clinical Framework for Adjunctive Repurposed-Drug Therapy in Active Cancer | 2026-10-16 | OpenAlex | 10.20944/preprints202610.1598.v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222495213 | |||
| W7222506783 | Integrated Disease Management of Tomato Early Blight: A Critical Narrative Review of Pathogen Complexity, Host Resistance and Sustainable Control | 2026-10-16 | OpenAlex | 10.9734/jsrr/2026/v32i104624 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222506783 | |||
| W7222699158 | POLYMERIC NANOSPHERES FOR ORAL DRUG DELIVERY: EMERGING FORMULATION TECHNOLOGIES, TRANSLATIONAL CHALLENGES, AND FUTURE CLINICAL PERSPECTIVES | 2026-10-16 | OpenAlex | 10.25258/ijddt.16.72s.78 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7222699158 | |||
| W7222568181 | Urogenital Infections | 2026-10-16 | OpenAlex | 10.1201/9781003632214-10 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222568181 | |||
| W7222783243 | Adaptive Switching Between Self-Mechanisms and Mutual Mechanisms Under Uncertainty: A General Framework for Uncertainty-Aware Coordination in Multiple Large Language Models | 2026-10-17 | OpenAlex | 10.5281/zenodo.23434770 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7222783243 | |||
| W7222838576 | The Omegacene. Three Thresholds of Self-Transformation and a Criterion for Their Refutation | 2026-10-17 | OpenAlex | 10.5281/zenodo.23438027 | Title/abstract | Excluded | E1: Conceptual architecture, perspective, philosophical analysis, maturity framework or policy specification; no implemented and evaluated clinical adapting system. | https://openalex.org/W7222838576 | |||
| W7222825060 | The Self-and-Mutual-and-Action Model: A General Computational Framework for Adaptive Coordination Between Individual Processing, Interactive Mechanisms, and Goal-Directed Action | 2026-10-17 | OpenAlex | 10.5281/zenodo.23434721 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7222825060 | |||
| W7222815952 | The Self-and-Mutual-and-Meta Model: A General Computational Framework for Adaptive Coordination, Selection, and Regulation of Autonomous and Interactive Mechanisms | 2026-10-17 | OpenAlex | 10.5281/zenodo.23434018 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7222815952 | |||
| W7222894075 | Use of vaginal estrogens in urogynecology: current evidence, controversies and clinical applications | 2026-10-18 | OpenAlex | 10.1097/gco.0000000000001157 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222894075 | |||
| W7222936021 | A Paradox Perspective | 2026-10-19 | OpenAlex | 10.4324/9781003515616-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222936021 | |||
| W7222939961 | Handbook of Agentic Pharmacy: Foundations, Architecture, and Applications | 2026-10-19 | OpenAlex | 10.5281/zenodo.23474649 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7222939961 | |||
| W7223037574 | Quarto Manuals: A Starter Template and Framework for Notebook-Driven Scientific Software Operations Manuals | 2026-10-19 | OpenAlex | 10.5281/zenodo.23518396 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223037574 | |||
| W7222946051 | Randomized controlled trial of pirfenidone XR for patients with COVID-19 and exploration of effects on long-COVID incidence | 2026-10-19 | OpenAlex | 10.1016/j.ijid.2026.109186 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7222946051 | |||
| W7222920012 | SEGURANÇA DO PACIENTE NA CIRURGIA ROBÓTICA: ATUAÇÃO DA ENFERMAGEM PERIOPERATÓRIA | 2026-10-19 | OpenAlex | 10.47820/recima21.v7i10.9277 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7222920012 | |||
| W7222957580 | SY24-2 Recent updates in the systemic therapy for advanced HCC | 2026-10-19 | OpenAlex | 10.1016/j.annonc.2026.07.061 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7222957580 | |||
| W7222978766 | Targeted Medical Interventions for the Prevention and Treatment of Viral Hemorrhagic Fever: A Rapid Systematic Review of Updated Intelligence from the 74th Annual Meeting of the American Society of Tropical Medicine and Hygiene | 2026-10-19 | OpenAlex | 10.3390/tropicalmed11100296 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7222978766 | |||
| W7222957977 | Translational assessment of nursing care models for oncology patients with cardiovascular risk factors | 2026-10-19 | OpenAlex | 10.3389/fcvm.2026.1834086 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7222957977 | |||
| W7223054260 | Advancing gender equity and inclusive digital futures through responsible agentic artificial intelligence governance | 2026-10-20 | OpenAlex | 10.1007/s44282-026-00624-y | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223054260 | |||
| W7223045273 | DAn building blocks for integrated care co-design, source 1: Italian project sheets from a national conference | 2026-10-20 | OpenAlex | 10.5281/zenodo.23506196 | Full text | Excluded | F1: This deposit is explicitly supporting working material for a separate submitted integrated-care co-design paper, consisting of project-sheet decomposition guides/summaries and registry data. It does not itself report an evaluated clinical LLM cross-case improvement method. | https://openalex.org/W7223045273 | https://zenodo.org/records/23506196 | Complete indexed repository description; deposited files not read or downloaded. | |
| W7223059667 | DAn building blocks for integrated care co-design, source 4: a white paper of policy proposals | 2026-10-20 | OpenAlex | 10.5281/zenodo.23506381 | Full text | Excluded | F1: This deposit is explicitly ancillary working material for the same submitted co-design paper, describing policy-source decomposition and author-refined registry rules, rather than an evaluated clinical LLM cross-case improvement method. | https://openalex.org/W7223059667 | https://zenodo.org/records/23506381 | Complete indexed repository description; deposited files not read or downloaded. | |
| W7223047696 | Editorial: Kidney cancer awareness month 2025: current progress and future prospects on kidney cancer prevention, diagnosis and treatment | 2026-10-20 | OpenAlex | 10.3389/fonc.2026.2018903 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223047696 | |||
| W7223032002 | Editorial: Liver diseases – from pathophysiology to new treatment options | 2026-10-20 | OpenAlex | 10.3389/fimmu.2026.2020350 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223032002 | |||
| W7223067728 | Editorial: Predictive biomarkers to immune checkpoint inhibitors in lung cancer | 2026-10-20 | OpenAlex | 10.3389/fimmu.2026.2011872 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223067728 | |||
| W7223062563 | Marine Natural Products with Novel Mechanisms of Action: From Disrupting Gene Expression to Reshaping the Tumor Microenvironment and Beyond | 2026-10-20 | OpenAlex | 10.3390/chemistry8100145 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223062563 | |||
| W7223032108 | Nanomedicine and the innate immune system: immunogenicity, nanoparticle-immune cell interactions and implications for cancer immunotherapy | 2026-10-20 | OpenAlex | 10.3389/fimmu.2026.1946595 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223032108 | |||
| W7223091550 | AI agent planning, learning, and adaptation | 2026-10-21 | OpenAlex | 10.1201/9781003753728-4 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7223091550 | |||
| W7223159227 | Artificial Intelligence Triage for Snakebite Envenoming Under Variable Antivenom Stock-Out Conditions: A Constraint-Aware Evaluation of Referral Timing Errors Across Rural Health Centres | 2026-10-21 | OpenAlex | 10.5281/zenodo.23542140 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223159227 | |||
| W7223148967 | Artificial Intelligence in the Next Decade: Opportunities, Risks, and a Proposed Framework for Human-Centered AI Adoption | 2026-10-21 | OpenAlex | 10.64388/irev10i4-1724023 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7223148967 | |||
| W7223099046 | Brain cytoprotection in acute ischemic stroke in the reperfusion era: neuroimmune networks, clinical evidence, and translational barriers | 2026-10-21 | OpenAlex | 10.3389/fimmu.2026.1984227 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223099046 | |||
| W7223150075 | Cognitive Task Substitution, Cognitive Offloading, and Behavioral Dependency on Artificial Intelligence-Assisted Technologies: A Scoping Review | 2026-10-21 | OpenAlex | 10.7759/cureus.118334 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223150075 | |||
| W7223572491 | Fifth Universal Definition of Myocardial Infarction and an update on lipoprotein(a) and inflammation | 2026-10-21 | OpenAlex | 10.1093/eurheartj/ehag840 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223572491 | |||
| W7223238610 | MOSAIC: An Omni-Modal Benchmark for Long-Term Memory and Cross-Modal Reasoning in Conversational Agents | 2026-10-21 | OpenAlex | 2610.29249 | 10.48550/arxiv.2610.29249 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7223238610 | ||
| W7223154226 | Robust Safe Reinforcement Learning | 2026-10-21 | OpenAlex | 10.17635/lancaster/thesis/3472 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7223154226 | |||
| W7223136719 | Targeting Peripheral T-Cell Lymphomas with Chimeric Antigen Receptor Therapy: Mechanistic Challenges, Clinical Landscape and Future Engineering Perspectives | 2026-10-21 | OpenAlex | 10.3390/cancers18203400 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223136719 | |||
| W7224735635 | Artificial Intelligence in Social Science, Humanities and Health: A Path Towards Trustworthy AI and Human-AI Symbiosis | 2026-10-22 | OpenAlex | 10.2174/97988988181661260101 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224735635 | |||
| W7223693614 | Case Report of Atypical Steven Johnson Syndrome in a Paediatric Patient | 2026-10-22 | OpenAlex | 10.33178/smj.2026.11 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223693614 | |||
| W7223177063 | Nanoparticle-based T-cell engagers: from T-cell redirection to programmable immune platforms | 2026-10-22 | OpenAlex | 10.1186/s12951-026-05178-4 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223177063 | |||
| W7224691341 | Probabilistic Modeling for Trustworthy Computer Vision | 2026-10-22 | OpenAlex | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7224691341 | ||||
| W7223171620 | Rehabilitating the nation | 2026-10-22 | OpenAlex | 10.4324/9781003748373-5 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7223171620 | |||
| W7223246894 | Thanks for Nothing: Gratitude, Model Revisability, and the Practice of Realizing Emptiness | 2026-10-22 | OpenAlex | 10.5281/zenodo.23402516 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223246894 | |||
| W7223199350 | VulnPilot: A Multi-agent LLM Framework for Automated Penetration Testing | 2026-10-22 | OpenAlex | 10.1007/978-981-92-6843-6_5 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7223199350 | |||
| W7223178493 | What would John Maynard Keynes say about contemporary oral health? Reflections on preferences, social conventions, and marketisation | 2026-10-22 | OpenAlex | 10.3389/froh.2026.1986109 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223178493 | |||
| W7223280583 | Artificial Intelligence | 2026-10-23 | OpenAlex | 10.4324/9781003631958-3 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223280583; https://openalex.org/W7155703509; https://openalex.org/W4402403884 | |||
| W7163523187 | Artificial Intelligence Applications in Pregnancy, Childbirth, and the Postpartum Period: A Scoping Review | 2026-10-23 | OpenAlex | 10.3390/nursrep16110377 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163523187 | |||
| W7223365583 | Holding the Whole Portfolio, Ethical Data Infrastructure for AI in Art Therapy | 2026-10-23 | OpenAlex | 10.4324/9781003631958-14 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223365583 | |||
| W7223509741 | Screening Models and Evaluation Techniques for Neuromuscular Blocking Agents: From Animal Studies to Clinical Applications | 2026-10-23 | OpenAlex | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7223509741; https://openalex.org/W7113901599 | ||||
| W7223448578 | Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates in Children: A Three-Year Study From North India | 2026-10-23 | OpenAlex | 10.7759/cureus.118483 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223448578 | |||
| W7223319057 | The neutrophilic dermatitides: a contemporary reassessment of pathophysiological mechanisms, clinical phenotypes and therapeutic stratification | 2026-10-23 | OpenAlex | 10.18203/issn.2455-4529.intjresdermatol20263750 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223319057 | |||
| W7224604889 | Unlocking Cardiovascular Health: The Synergy of Genetics, Pharmacotherapy, Comorbidities, and Herbal Medicine | 2026-10-23 | OpenAlex | 10.5530/ijper.20274003 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224604889 | |||
| W7223695754 | [Expert consensus on detection and clinical application of alterations in PIK3CA/AKT1/PTEN genes (2026 edition)]. | 2026-10-23 | OpenAlex | 10.3760/cma.j.cn112152-20260430-00218 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223695754 | |||
| W7223442647 | C.E.R.B.E.R.U.S. — Acute Biological Containment: A Systems Architecture for Biological Threat Detection, Emergency Containment, and Protective Intervention | 2026-10-24 | OpenAlex | 10.17605/osf.io/n3gja | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223442647 | |||
| W7223452112 | From mutations to relapse: Transcriptional rewiring, leukemic stem cell persistence, and therapeutic resistance in acute myeloid leukemia: A systematic review | 2026-10-24 | OpenAlex | 10.1016/j.humgen.2026.201613 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223452112 | |||
| W7223441585 | Killing Mr. Renton; or, How to Turn a Murder into an International Incident | 2026-10-24 | OpenAlex | 10.1093/dh/dhag051 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7223441585 | |||
| W7223456656 | LongHaul-Bench: A Reproducible Benchmark for Long-Horizon Reliability of Self-Improving LLM Agents Under Industrial Edge Constraints | 2026-10-24 | OpenAlex | 10.5281/zenodo.23624798 | Title/abstract | Excluded | E2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task. | https://openalex.org/W7223456656 | |||
| W7223477369 | MRI of brain metastases in the era of immunotherapy, targeted agents, and artificial intelligence: from detection to treatment response assessment | 2026-10-24 | OpenAlex | 10.1007/s10334-026-01433-9 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223477369 | |||
| W7223455476 | OmiCairn: an accountable self-learning platform for hypothesis-driven biomedical multi-omics analysis | 2026-10-24 | OpenAlex | 10.5281/zenodo.23619723 | Full text | Excluded | F2: The primary tasks are multi-omics biological discovery and hypothesis testing; no clinical patient-care/diagnostic main task is established. | https://openalex.org/W7223455476 | https://zenodo.org/records/23619724 | Complete repository description/abstract; ZIP contains supplementary materials, not downloaded/opened. | |
| W7223453599 | PGMem 1.2.1: Reference implementation, synthetic dataset and Colab notebook for "Provenance-governed agentic AI for personal knowledge and memory support: a framework and rule-level demonstration" | 2026-10-24 | OpenAlex | 10.5281/zenodo.23618804 | Title/abstract | Excluded | E3: Described agents are drugs, materials, humans, cells, conventional computational agents, or non-LLM models rather than an LLM-based agent. | https://openalex.org/W7223453599 | |||
| W7223466710 | Severe Chronic Constipation and Fecaloma in a Patient With Partial Agenesis of the Corpus Callosum: A Case Report | 2026-10-24 | OpenAlex | 10.7759/cureus.118495 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223466710 | |||
| W7223575764 | Qe[ŋɯ]-SÆORYN // ƎR: A Proof-Carrying Architecture for Game-Driven Algorithmic Self-Improvement, Exact Behavioral Retention, and Cost-Optimal Error-Correcting Experiments | 2026-10-25 | OpenAlex | 10.5281/zenodo.23649449 | Title/abstract | Excluded | E2: Nonclinical settings include coding, robotics, general agent memory/governance, recommender systems, synthetic worlds, games or formal verification; healthcare is not the primary task. | https://openalex.org/W7223575764 | |||
| W7223697985 | What Remains of Dr. Watson? Boundary-Constrained Dialogue for Human–LLM Decision Support and Training | 2026-10-25 | OpenAlex | 10.5281/zenodo.23653109 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223697985 | |||
| W7223659602 | [Evolution of later-line treatment strategies for advanced colorectal cancer: seeking balance between survival benefit and quality of life]. | 2026-10-25 | OpenAlex | 10.3760/cma.j.cn441530-20260323-00127 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223659602 | |||
| W7223805804 | Advances in Invasive Breast Cancer: Emerging Diagnostic Tools and Evolving Therapeutic Approaches | 2026-10-26 | OpenAlex | 10.20944/preprints202610.2475.v1 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7223805804 | |||
| W7223662901 | Developing a community of practice in health professions education: reflections from the Africa HPE ECHO project | 2026-10-26 | OpenAlex | 10.61473/001c.170559 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223662901 | |||
| W7223673128 | IgA nephropathy: evolving pathogenic concepts and emerging targeted therapies | 2026-10-26 | OpenAlex | 10.1016/j.humimm.2026.112112 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223673128 | |||
| W7223684468 | Nanoparticles for cardiovascular diseases: identifying and overcoming barriers in translating preclinical success to clinical applications | 2026-10-26 | OpenAlex | 10.1016/j.addr.2026.115980 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223684468 | |||
| W7223682757 | Optimizing cefiderocol use in clinical practice | 2026-10-26 | OpenAlex | 10.1097/qco.0000000000001243 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223682757 | |||
| W7224121018 | PO011 | A TWO CENTERS REAL-WORLD EXPERIENCE WITH ANTI-XA DIRECT ORAL ANTICOAGULANTS IN CANCER PATIENTS WITH UNUSUAL SITE VEIN THROMBOSIS | 2026-10-26 | OpenAlex | 10.4081/btvb.2026.827 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224121018 | |||
| W7223794340 | RoboDoctor: Training-Free Recursive Self-Improvement for Robot Policies | 2026-10-26 | OpenAlex | 2610.35604 | 10.48550/arxiv.2610.35604 | Title/abstract | Excluded | E2: Nonclinical settings include coding, robotics, general agent memory/governance, recommender systems, synthetic worlds, games or formal verification; healthcare is not the primary task. | https://openalex.org/W7223794340 | ||
| W7223897458 | Beyond screen time: artificial intelligence, algorithmic media and the future of child health | 2026-10-27 | OpenAlex | 10.18203/2349-3291.ijcp20263830 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223897458 | |||
| W7223790825 | Editorial: Targeted therapies in gastric cancer: molecular signatures and immune microenvironment insights | 2026-10-27 | OpenAlex | 10.3389/fimmu.2026.2013952 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223790825 | |||
| W7223942482 | Gastric Ulcer 2030: Insights from yesterday, today and future trends | 2026-10-27 | OpenAlex | 10.5281/zenodo.23685251 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223942482 | |||
| W7223974776 | HER2 in mullerian malignancies: diagnostic challenges and the emerging HER2-low paradigm | 2026-10-27 | OpenAlex | 10.5468/ogs.26195 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223974776 | |||
| W7224025336 | New and Emerging Options for the Treatment of Non–Muscle-Invasive Bladder Cancer | 2026-10-27 | OpenAlex | 10.6004/jnccn.2026.7061 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224025336 | |||
| W7224119680 | Nipah Virus (NiV) in Focus: Molecular Insights Into Pathogenesis, Transmission Dynamics, and Evolving Epidemiology From Malaysia to Recent Indian Outbreaks | 2026-10-27 | OpenAlex | 10.1002/rmv.70221 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224119680 | |||
| W7224132980 | Pulmonary hypertension: modern approaches to diagnosis and treatment | 2026-10-27 | OpenAlex | 10.51922/2074-5044.2026.4.110 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224132980 | |||
| W7223830503 | Sixteen-Year Trends in Antimicrobial Resistance among Enterobacteriaceae Causing Bloodstream Infections in a Tertiary Teaching Hospital in Iran: A Joinpoint Regression Analysis | 2026-10-27 | OpenAlex | 10.21203/rs.3.rs-11215097/v1 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223830503 | |||
| W7223914181 | The immunological landscape of antibody-drug conjugates: from target to payload biology | 2026-10-27 | OpenAlex | 10.3389/fimmu.2026.1964101 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7223914181 | |||
| W7224118943 | Animal Venoms as a Source of Therapeutics: Insights into Anticancer, Cardiovascular, Antimicrobial, Analgesic, Antiparasitic and Emerging Applications | 2026-10-28 | OpenAlex | 10.5281/zenodo.23727410 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224118943 | |||
| W7224463072 | HER2 in solid tumors: microenvironment features and multifaceted advances from mechanisms to clinical translation | 2026-10-28 | OpenAlex | 10.1186/s40164-026-00850-9 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224463072 | |||
| W7163581084 | Large language models in healthcare simulation education: a bibliometric analysis of simulation approaches and non-technical skills | 2026-10-28 | OpenAlex | 10.1007/s44186-026-00592-6 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7163581084 | |||
| W7224859663 | MAS-Loop: Beyond One-Shot Orchestration towards Self-Evolving Multi-Agent Systems | 2026-10-28 | OpenAlex | 2610.38946 | 10.48550/arxiv.2610.38946 | Title/abstract | Excluded | E2: Primary task is nonclinical, general-domain/multidomain (P2), or pure biological/drug discovery without a clinical task. | https://openalex.org/W7224859663 | ||
| W7224120316 | Management strategies of noninfectious scleritis: An update | 2026-10-28 | OpenAlex | 10.4103/ijo.ijo_1004_26 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224120316 | |||
| W7224094994 | Polysaccharides in Modern Therapeutics: Structural Diversity, Delivery Platforms, and Antitumor Applications | 2026-10-28 | OpenAlex | 10.1080/1061186x.2026.2756476 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224094994 | |||
| W7223879639 | Potassium-Competitive Acid Blockers in GERD and Helicobacter pylori Infection: The Emerging Role of Fexuprazan | 2026-10-28 | OpenAlex | 10.1007/s40265-026-02379-x | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7223879639 | |||
| W7224119183 | The evolution of therapeutics: A comparative review of small-molecule drugs and RNA-based medicines | 2026-10-28 | OpenAlex | 10.1016/j.nxnano.2026.100902 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224119183 | |||
| W7224229087 | A Digital Ecosystem Using Artificial Intelligence Solutions in Musculoskeletal Health Care | 2026-10-29 | OpenAlex | 10.1002/arj.70704 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224229087 | |||
| W7224501981 | Engineering smart liposomes to combat antimicrobial resistance: from mechanistic design to clinical translation | 2026-10-29 | OpenAlex | 10.1080/14787210.2026.2756297 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224501981 | |||
| W7224650435 | Intratumoral Therapeutic Injections for Lung Cancer: Current Evidence, Personalized Therapeutic Approaches, and Future Directions | 2026-10-29 | OpenAlex | 10.3390/jpm16110554 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224650435 | |||
| W7214712196 | Maintenance Therapy After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: Still an Open Question? | 2026-10-29 | OpenAlex | 10.3390/cancers18213487 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7214712196 | |||
| W7224105059 | Preclinical parameters of anti-human immunodeficiency virus (HIV) lentivector transduction of haematopoietic stem, progenitor, and T cells | 2026-10-29 | OpenAlex | 10.25403/upresearchdata.32898965 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224105059 | |||
| W7224417835 | The Evolving Landscape of Reduced-Intensity Conditioning: Balancing Efficacy and Toxicity Across Hematologic Malignancies | 2026-10-29 | OpenAlex | 10.1007/s11899-026-00791-4 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224417835 | |||
| W7224668911 | Ultrasound-Stimulated Microbubbles in Cancer Therapy: A Review of Clinical and Translational Evidence | 2026-10-29 | OpenAlex | 10.26599/audt.2026.260027 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224668911 | |||
| W7168065837 | WHY PBL 4.0? THE STRATEGIC CASE FOR CAPABILITY FORMATION IN AN AI-AUGMENTED EDUCATIONAL ENVIRONMENT | 2026-10-29 | OpenAlex | 10.13140/rg.2.2.29826.24003 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7168065837 | |||
| W7225078571 | FROM INTELLIGENT SYSTEMS TO TRUSTWORTHY AGENTS: A COMPREHENSIVE SURVEY OF AGENTIC AI IN SMART HEALTHCARE | 2026-10-30 | OpenAlex | 10.62441/actainnovations.vi.2741 | Title/abstract | Excluded | E1: Available title/abstract identifies a review, survey, perspective, protocol, editorial, proposal-only work, or benchmark without an adapting evaluated system. | https://openalex.org/W7225078571 | |||
| W7224938536 | From MEK inhibition to rational combination strategies for NF1-associated plexiform neurofibromas | 2026-10-30 | OpenAlex | 10.3389/fonc.2026.1976580 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224938536 | |||
| W7224756933 | Human-led, AI-enabled: preventing another AI winter through workforce transformation | 2026-10-30 | OpenAlex | 10.3389/fsci.2026.2015324 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224756933 | |||
| W7224751454 | Living evidence map of the global climate and health literature | 2026-10-30 | OpenAlex | 10.1002/14651858.cd016408 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224751454 | |||
| W7224918753 | Mission: Fighting Chagas Disease | 2026-10-30 | OpenAlex | 10.6084/m9.figshare.34867947 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224918753 | |||
| W7224818581 | Near-Infrared Fluorescent Probes and NIR-Responsive Nanomaterials for Inflammatory Bowel Disease: Advances in Imaging and Therapy | 2026-10-30 | OpenAlex | 10.3390/pharmaceutics18111396 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224818581 | |||
| W7167249586 | Right-Sided Infective Endocarditis: A 6-Year Retrospective Cohort Study from a Tertiary Care Center in Türkiye | 2026-10-30 | OpenAlex | 10.14744/anatoljcardiol.2026.6054 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7167249586 | |||
| W7225009645 | Risk-stratified surveillance in inflammatory bowel disease | 2026-10-30 | OpenAlex | 10.7196/samj.2026.v116i10.5671 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225009645 | |||
| W7224780096 | THE ROLE OF STEM CELLS IN ATHEROSCLEROSIS TREATMENT AND FUTURE PERSPECTIVES | 2026-10-30 | OpenAlex | 10.4274/tmsj.galenos.2026.2026-4-3 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224780096 | |||
| W7225085690 | The Era of Neoadjuvant Chemotherapy for Cholangiocarcinoma: Has It Already Begun? | 2026-10-30 | OpenAlex | 10.15279/kpba.2026.31.4.142 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225085690 | |||
| W7224957432 | The clinical translation dilemma of mesenchymal stem cell-based therapies for cardiac repair: What can tissue engineering do? | 2026-10-30 | OpenAlex | 10.1186/s13287-026-05380-z | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224957432 | |||
| W7224871136 | Vasopressor and Fluid Management of Neuraxial Labor Analgesia-Associated Hypotension in Vaginal Delivery: A Scoping Review | 2026-10-30 | OpenAlex | 10.17605/osf.io/e948q | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7224871136 | |||
| W7224992253 | ALLOGENEIC TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA IN THE ERA OF NOVEL THERAPIES: CHANGING INDICATIONS AND DYNAMIC RISK ASSESSMENT | 2026-10-31 | OpenAlex | 10.4084/mjhid.2026.088 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7224992253 | |||
| W7225085094 | Carbapenem-Resistant Acinetobacter baumannii: Treatment, PK/PD Considerations, and Emerging Strategies | 2026-10-31 | OpenAlex | 10.3390/pathogens15111136 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225085094 | |||
| W7224991481 | EFT–MAST CooperBench Reproducibility Dataset: Frozen Holdout Predictions, Brier Decomposition, and Analysis Code (Phases 8–17) | 2026-10-31 | OpenAlex | 10.5281/zenodo.23826367 | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7224991481 | |||
| W7225007520 | Nebivolol: A Comprehensive Pharmacological Review of a Third-Generation Cardioselective Beta-Blocker with Nitric Oxide-Mediated Vasodilatory Properties | 2026-10-31 | OpenAlex | 10.5281/zenodo.23841452 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225007520 | |||
| W7225047967 | 46/60 SWARM NANOROBOTIC COOPERATIVE CELLULAR ASSEMBLY AT THE LIMIT SWARM NANOROBOTIC COOPERATIVE CELLULAR ASSEMBLY AT THE LIMIT is a 777-page English-language Research Design Working Edition in the STARLI Micro/Nanorobot Fabrication and Regenerative Biomanufacturing Sixty-Flagship series (Flagship 46/60). It investigates distributed multirobot scaling versus throughput-induced injury. The research coupling is swarm cooperation x cell transport x decentralized decision making. All proposed work is restricted to nonclinical in-vitro, organ-on-chip, synthetic phantom or authorized ex-vivo environments. No experiments were executed in preparing this edition; no human treatment, clinical efficacy or regulatory clearance is claimed. Its falsifiable candidate is: From one to twenty agents, a frozen decentralized policy will improve qualified live-cell throughput without increasing cell damage or per-cell resource burden. The Atlas minimum demonstrator is: Scale one to twenty microagents to construct a one-hundred-cell heterogeneous spatial pattern. Strong comparators include single-arm micromanipulation and centralized multi-arm coordination. A central rival account is faster operation purchased through damage, added energy or unreported human rescue. The nonnegotiable stop condition is: unselected cell viability declines as agent number increases. Each failed, aborted, hidden-fault and incomplete run is retained in the experimental denominator, and observation of a finished form is never substituted for independently measured function. Thirty mathematical plates address domain-specific metrics and established model families across transport, measurement, elasticity, time-dependent dynamics, causal attribution, calibration and uncertainty. Eighty-two chapters and 410 separately paginated scientific investigations organize six research arcs. Two hundred Research Gates have been revised with independent observables, one of fifteen blinded causal intervention families, orthogonal controls and noncompensatory refusal criteria. Thirty mathematical plates now carry model-specific physical derivation commentary, explicit applicability limits and distinct flagship-level blind checks. Thirty-three Phoenix Answer Embryos propose unbuilt future instruments and succession artifacts, each requiring its own bench validation. This version is a research design and not a report of validated physical findings. It draws scientific method and conceptual boundaries from the user-supplied Atlas and research mother volumes; especially the Atlas-supplied ancestry DOI 10.5281/zenodo.23046134 and 10.5281/zenodo.23486020. Full external bibliographic DOI checking and scientific peer review have not been completed. Domain-specific sensitivity, causal identifiability and independent replication require qualified laboratory evaluation before any scientific superiority claim. Author: Feng Cheng-en (33) x STARLI / Xingli Series: STARLI Nano Regenerative Biomanufacturing / Flagship 46 of 60 Edition: Research Design Working Edition v1.1 / 2 November 2026 Join the STARLI Research Community Explore more than 100 interdisciplinary research themes and follow the evolving STARLI Research Gate community: https://zenodo.org/communities/starli-research-gate/ | 2026-11-01 | OpenAlex | 10.5281/zenodo.23864959 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225047967 | |||
| W7225065397 | 47/60 AUTONOMOUS MICRO-TISSUE CONSTRUCTION BY MICROROBOTIC SWARMS AT THE LIMIT AUTONOMOUS MICRO-TISSUE CONSTRUCTION BY MICROROBOTIC SWARMS AT THE LIMIT is a 777-page English-language Research Design Working Edition in the STARLI Micro/Nanorobot Fabrication and Regenerative Biomanufacturing Sixty-Flagship series (Flagship 47/60). It investigates true local-rule generalization beyond memorized target geometry. The research coupling is swarm local rules x three-dimensional microtissue topology x independent structural qualification. All proposed work is restricted to nonclinical in-vitro, organ-on-chip, synthetic phantom or authorized ex-vivo environments. No experiments were executed in preparing this edition; no human treatment, clinical efficacy or regulatory clearance is claimed. Its falsifiable candidate is: A frozen swarm rule set will match target physical graphs and preserve function under unseen initial states better than centralized scheduling and fixed paths. The Atlas minimum demonstrator is: Use thirty agents with identical rules to assemble three distinct blind microtissue targets. Strong comparators include competent centralized scheduler and preregistered fixed paths. A central rival account is prestored shape templates or training leakage masquerading as emergent assembly. The nonnegotiable stop condition is: an unknown configuration triggers neither abstention nor safe stop, or a topology error self-amplifies. Each failed, aborted, hidden-fault and incomplete run is retained in the experimental denominator, and observation of a finished form is never substituted for independently measured function. Thirty mathematical plates address domain-specific metrics and established model families across transport, measurement, elasticity, time-dependent dynamics, causal attribution, calibration and uncertainty. Eighty-two chapters and 410 separately paginated scientific investigations organize six research arcs. Two hundred Research Gates have been revised with independent observables, one of fifteen blinded causal intervention families, orthogonal controls and noncompensatory refusal criteria. Thirty mathematical plates now carry model-specific physical derivation commentary, explicit applicability limits and distinct flagship-level blind checks. Thirty-three Phoenix Answer Embryos propose unbuilt future instruments and succession artifacts, each requiring its own bench validation. This version is a research design and not a report of validated physical findings. It draws scientific method and conceptual boundaries from the user-supplied Atlas and research mother volumes; especially the Atlas-supplied ancestry DOI 10.5281/zenodo.23046134 and 10.5281/zenodo.23486020. Full external bibliographic DOI checking and scientific peer review have not been completed. Domain-specific sensitivity, causal identifiability and independent replication require qualified laboratory evaluation before any scientific superiority claim. Author: Feng Cheng-en (33) x STARLI / Xingli Series: STARLI Nano Regenerative Biomanufacturing / Flagship 47 of 60 Edition: Research Design Working Edition v1.1 / 2 November 2026 Join the STARLI Research Community Explore more than 100 interdisciplinary research themes and follow the evolving STARLI Research Gate community: https://zenodo.org/communities/starli-research-gate/ | 2026-11-01 | OpenAlex | 10.5281/zenodo.23865019 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225065397 | |||
| W7225045906 | Hyping Bariatric Surgery Research in the Glucagon-Like Peptide-1 Era | 2026-11-01 | OpenAlex | 10.21203/rs.3.rs-11110167/v1 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225045906 | |||
| W7225055951 | Inhaled Nitric Oxide: A Comprehensive Pharmacological and Clinical Review | 2026-11-01 | OpenAlex | 10.5281/zenodo.23852488 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225055951 | |||
| W7225056140 | Mandatory national clinical audits as a tool to drive improvements in multiple sclerosis outcomes | 2026-11-01 | OpenAlex | 10.1016/j.msard.2026.108033 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225056140 | |||
| W7225045545 | Toward cognitive design intelligence: a mixed-methods systematic review and an evidence-informed representation-reasoning-synthesis framework for complex product design in the era of foundation models | 2026-11-01 | OpenAlex | 10.1016/j.aei.2026.105446 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225045545 | |||
| W7225098932 | Attention-Guided Deep Reinforcement Learning for Seizure Prediction using Cross-Cohort EEG and fMRI Feature Integration | 2026-11-02 | OpenAlex | 10.1007/s42979-026-05428-0 | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225098932 | |||
| W7225060160 | Autonomous Reservoir Injection-Production Optimization Through Multi-Agent Collaboration and Self-Evolving Skills | 2026-11-02 | OpenAlex | 10.2118/236222-ms | Title/abstract | Excluded | E2: General/nonclinical infrastructure, agent self-editing, skill optimization, conflict forecasting, embodied robotics, industrial fault diagnosis or reservoir engineering; no clinical primary task. | https://openalex.org/W7225060160 | |||
| W7225098293 | Emerging BCR::ABL1 inhibitors in chronic myeloid leukemia: current advances and future directions | 2026-11-02 | OpenAlex | 10.1007/s12185-026-04307-x | Title/abstract | Excluded | E3: No LLM acting-agent mechanism: clinical, biological, human-agent or conventional computational study. | https://openalex.org/W7225098293 | |||
| W7225059141 | Enabling Resilient and Adaptive Production Operations Through AI-Enabled Production System Optimization at Scale | 2026-11-02 | OpenAlex | 10.2118/236237-ms | Title/abstract | Excluded | E2: Healthcare is not the primary clinical application; fixed P2 applies where medicine is one general-method benchmark. | https://openalex.org/W7225059141 | |||
| W7225121726 | Evolving treatment algorithm for hormone receptor-positive, HER2-negative metastatic breast cancer: new drugs and future therapeutic strategies | 2026-11-02 | OpenAlex | 10.1007/s12254-026-01136-w | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225121726 | |||
| W7225119973 | Nanomaterials in Wound Healing: Revolutionizing the Road to Recovery | 2026-11-02 | OpenAlex | 10.1201/9781779644411-11 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225119973 | |||
| W7225116745 | Neoadjuvant systemic therapy and the evolution of axillary management in breast cancer: a mini review and future directions | 2026-11-02 | OpenAlex | 10.3389/fonc.2026.1893067 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225116745 | |||
| W7225115744 | Overview of Resistance Mechanisms in Dermatophytosis, Pharmacology and Uses of Fosravuconazole and Its Place in Potential Treatment Options for Trichophyton indotineae | 2026-11-02 | OpenAlex | 10.3390/ph19111739 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225115744 | |||
| W7225104746 | The Evolving Landscape of Stage III Endometrial Cancer—A Narrative Review of Management in Australia | 2026-11-02 | OpenAlex | 10.1111/1754-9485.70216 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225104746 | |||
| W7225084306 | The Frozen Overseer: What a Fixed Tier-0 Monitor Can and Cannot Bound in a Self-Improving System — a pre-registered map, an impossibility, a dual-reference escape, and a reduction to practice on commodity silicon | 2026-11-02 | OpenAlex | 10.5281/zenodo.23893944 | Title/abstract | Excluded | E2: General-domain method or evaluation uses medicine/ECG as one of several demonstrations or benchmark domains; fixed P2 applies. | https://openalex.org/W7225084306 | |||
| W7225115158 | The Modern Continuum of Care for Colorectal Liver Metastases: A Comprehensive Review | 2026-11-02 | OpenAlex | 10.1177/00031348261504348 | Title/abstract | Excluded | E1: Non-primary review, editorial, commentary, synthesis, guidance or non-adapting benchmark. | https://openalex.org/W7225115158 |